Citrus Sinensis ID: 002358
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 931 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGI2 | 929 | Probable LRR receptor-lik | yes | no | 0.989 | 0.991 | 0.723 | 0.0 | |
| Q8LKZ1 | 924 | Nodulation receptor kinas | N/A | no | 0.917 | 0.924 | 0.361 | 1e-132 | |
| Q9ZQQ7 | 886 | Putative leucine-rich rep | no | no | 0.883 | 0.928 | 0.349 | 1e-128 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.900 | 0.941 | 0.331 | 1e-128 | |
| Q9ZQR3 | 868 | Leucine-rich repeat recep | no | no | 0.871 | 0.934 | 0.346 | 1e-128 | |
| Q8L4H4 | 925 | Nodulation receptor kinas | N/A | no | 0.928 | 0.934 | 0.347 | 1e-127 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.878 | 0.928 | 0.328 | 1e-123 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.862 | 0.921 | 0.333 | 1e-123 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.873 | 0.932 | 0.332 | 1e-122 | |
| C0LGD6 | 852 | Probable LRR receptor-lik | no | no | 0.873 | 0.954 | 0.345 | 1e-122 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1365 bits (3532), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 673/930 (72%), Positives = 779/930 (83%), Gaps = 9/930 (0%)
Query: 5 SHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPS 64
+ V L + V+SQVTEF+SIDCG +SNYTDP TGL W+SD I+ GK V + N +
Sbjct: 6 AQLAVTCLFLVPFVLSQVTEFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTN 65
Query: 65 GNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLW 124
N MQYR RRD P DNKKYCY L TKERRRY+VR TF YG LGSE +YPKFQLYLDAT W
Sbjct: 66 WNSMQYRRRRDFPTDNKKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKW 125
Query: 125 STVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNF 184
+TVT+ + SRVY +E+I+RA S +DVC+CCA+TGSPF+STLELRPLNLSMYATD+EDNF
Sbjct: 126 ATVTIQEVSRVYVEELIVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNF 185
Query: 185 FLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRT 244
FLKVAARVNFGA DALRYPDDPYDRIW+SD+++RPN++VG A GT RINT+K I T T
Sbjct: 186 FLKVAARVNFGAPNMDALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLT 245
Query: 245 REYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYF 304
REYPP+KVMQTAVVGT+G++SYRLNLEDFPANARA+AYFAEI++LG +ETRKFKL QPYF
Sbjct: 246 REYPPMKVMQTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYF 305
Query: 305 ADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQK 364
DYSNAVVNIAENANGSYTLYEPSYMNVTL+FVL+FSF KT+DST GPLLNAIEISKY
Sbjct: 306 PDYSNAVVNIAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLP 365
Query: 365 IAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKN 424
I+ KT+ DV VL+A+RS+S +S+ ++ GDPC+PV W WV CS+T+PPR+TKIALS KN
Sbjct: 366 ISVKTDRSDVSVLDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKN 425
Query: 425 LKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLP 484
L+GEIPP + MEALTELWLD N LTG LPDMS+L++L+I+HLENN+L+GSLP Y+ LP
Sbjct: 426 LRGEIPPGINYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLP 485
Query: 485 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILL 544
NLQEL IENNSF G+IP ALL GKV+FKY+NNP+L E++R+ F ILG SI +AILL
Sbjct: 486 NLQELSIENNSFKGKIPSALLKGKVLFKYNNNPELQNEAQRK-HFWQILGISIAAVAILL 544
Query: 545 VLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLP 604
+L SL++L LR+ K +K DS T K AYS RGGH +DEGVAYFI LP
Sbjct: 545 LLVGGSLVLLCALRK----TKRADKGDSTETKKK-GLVAYSAVRGGHLLDEGVAYFISLP 599
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 664
LEEAT+NF KK+G+GSFGSVYYG+MKDGKEVAVKI AD SH +QFVTEVALLSRIHH
Sbjct: 600 VLEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHH 659
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
RNLVPLIGYCEE +RILVYEYMHNG+L D LHGS + KPLDWLTRLQIA DAAKGLEYL
Sbjct: 660 RNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYL 719
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
HTGCNP IIHRDVKSSNILLDINMRAKVSDFGLSRQ EEDLTH+SSVA+GTVGYLDPEYY
Sbjct: 720 HTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYY 779
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844
+QQLTEKSDVYSFGVVL EL+SGKKPVS EDFG ELNIVHWARS+I+KGDV I+DP +
Sbjct: 780 ASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCI 839
Query: 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---SSSSSK 901
NVKIES+WR+AEVA QCVEQRG +RP+MQE+++AIQD+I+IE+G + SSSSSK
Sbjct: 840 ASNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSK 899
Query: 902 GQSSRKTLLTSFLEIESPDLSNECLAPAAR 931
QSSRKTLLTSFLE+ESPD+S LAPAAR
Sbjct: 900 AQSSRKTLLTSFLELESPDISRNSLAPAAR 929
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 472 bits (1215), Expect = e-132, Method: Compositional matrix adjust.
Identities = 332/919 (36%), Positives = 492/919 (53%), Gaps = 65/919 (7%)
Query: 13 LFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRT 72
+F+ S S F SI C + SNYTDP T L + +D ++ + + + P + +R+
Sbjct: 22 IFIRSASSATEGFESIACCADSNYTDPKTNLNYTTDYRWYSDKSNCR-QIPE-ILLSHRS 79
Query: 73 R---RDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTV 129
R ID K CYNL T + + YL+R TF + S+ + F + + AT VT
Sbjct: 80 NINFRLFDIDEGKRCYNLPTIKDQVYLIRGTFPFDSVNT-----SFYVSIGATELGEVT- 133
Query: 130 LDASRVYAKEM--IIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLK 187
+SR+ E+ + RAP D+ID C+ +PFIS LELRPL Y DF N LK
Sbjct: 134 --SSRLEDLEIEGVFRAPKDNIDFCLLKEDV-NPFISQLELRPLP-EEYLHDFSTNV-LK 188
Query: 188 VAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREY 247
+ +R N + +D +R+P D DRIW + P++ + + N + N+E +
Sbjct: 189 LISRNNLCGI-EDDIRFPVDQNDRIWKAT--STPSYAL-----PLSFNVS-NVELNGKVT 239
Query: 248 PPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADY 307
PP++V+QTA+ E + + LE YF E+ D K Q F Y
Sbjct: 240 PPLQVLQTALTHPERLEFVHVGLETDDYEYSVLLYFLELND-------TLKAGQRVFDIY 292
Query: 308 SNAVV-----NIAENANG-SYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISK 361
N+ + ++ E + SYT+ +N++ N L+ + VK S GPLLNA EI +
Sbjct: 293 LNSEIKKEGFDVLEGGSKYSYTV-----LNISANGSLNITLVKASGSKFGPLLNAYEILQ 347
Query: 362 YQKIAAKTEWQDVMVLEALRSISDESERTND-----RGDPCVPVPWEWVTCSTTTPPR-I 415
+ +T+ D+ V++ +R + N+ GDPC+ PW+ V C + I
Sbjct: 348 ARPWIDETDQTDLEVIQKMRKELLLQNQDNEALESWSGDPCMLFPWKGVACDGSNGSSVI 407
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 475
TK+ LS NLKG IP + M L L L N G +P L V L N+LTG
Sbjct: 408 TKLDLSSSNLKGTIPSSVTEMTKLQILNLSHNHFDGYIPSFPPSSLLISVDLSYNDLTGQ 467
Query: 476 LPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRF-KLILG 534
LP + SLP+L L+ N + + A L +I N + + ++ +F ++ +
Sbjct: 468 LPESIISLPHLNSLYFGCNQHMRDDDEAKLNSSLI-----NTDYGRCNAKKPKFGQVFMI 522
Query: 535 TSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMD 594
+I +IL+ L + L R + I+ + K + T N +S+ F
Sbjct: 523 GAITSGSILITLAVVILFFCRYRHKSITLEGFGGKTYPMAT-----NIIFSLPSKDDFFI 577
Query: 595 EGVAYF-IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFV 653
+ V+ L +E AT + IG+G FGSVY G + DG+EVAVK+ + + + T++F
Sbjct: 578 KSVSVKPFTLEYIELATEKYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSATSTQGTREFD 637
Query: 654 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQ 712
E+ LLS I H NLVPL+GYC E Q+ILVY +M NG+L DRL+G +K LDW TRL
Sbjct: 638 NELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEPAKRKILDWPTRLS 697
Query: 713 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSV 771
IA AA+GL YLHT +IHRDVKSSNILLD +M AKV+DFG S+ A +E +++S
Sbjct: 698 IALGAARGLAYLHTFPGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSYVSLE 757
Query: 772 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 831
RGT GYLDPEYY QQL+EKSDV+SFGVVLLE++SG++P++++ E ++V WA+ I
Sbjct: 758 VRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRVEWSLVEWAKPYI 817
Query: 832 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 891
+ V IVDP + G E++WR+ EVA+QC+E RP M +IV ++D++ IE
Sbjct: 818 RASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENNA 877
Query: 892 DQKFSSSSSKGQSSRKTLL 910
+ S S G S+R +++
Sbjct: 878 SEYMKSIDSLGGSNRYSIV 896
|
Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Pisum sativum (taxid: 3888) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQQ7|Y2144_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14440 OS=Arabidopsis thaliana GN=At2g14440 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 461 bits (1185), Expect = e-128, Method: Compositional matrix adjust.
Identities = 316/904 (34%), Positives = 480/904 (53%), Gaps = 81/904 (8%)
Query: 25 FISIDCGSTSN---YTDPSTGLAWISDIGIMNNGKSVKVENPSG---NWMQYRTRRDLPI 78
FIS+ CG SN Y +P T L +ISD+ + GK+ ++N S Y+ R P
Sbjct: 29 FISLYCGLPSNESPYIEPLTNLTYISDVNFVRGGKTGNIKNNSDIDFTSRPYKVLRYFP- 87
Query: 79 DNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTV--LDASRVY 136
+ + CY+L K+ +YL+R F YG+ + P+F L+L +W++V V +D
Sbjct: 88 EGIRNCYSLSVKQGTKYLIRTLFFYGNYDGLNTSPRFDLFLGPNIWTSVDVQKVDGGDGV 147
Query: 137 AKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGA 196
+E+I + +D+C+ T +P IS +ELRPL Y LK F
Sbjct: 148 IEEIIHVTRCNILDICLVKTGTTTPMISAIELRPLRYDTYTARTGS---LKKILHFYFTN 204
Query: 197 LTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREY-PPVKVMQT 255
K+ +RYP+D YDR+W + + +INTT+N+ + Y PP V++T
Sbjct: 205 SGKE-VRYPEDVYDRVW----------IPHSQPEWTQINTTRNVSGFSDGYNPPQDVIKT 253
Query: 256 AVVGTE--GVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKL--EQPYFADYSNAV 311
A + T L++ E A+ YFAEIQ L +ETR+FK+ Y+ DY
Sbjct: 254 ASIPTNVSEPLTFTWMSESSDDETYAYLYFAEIQQLKANETRQFKILVNGVYYIDY---- 309
Query: 312 VNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI-SKYQKIAAKTE 370
+ TL P+ + V KT STL P +NAIEI S Q + T
Sbjct: 310 ---IPRKFEAETLITPAALKCG-GGVCRVQLSKTPKSTLPPQMNAIEIFSVIQFPQSDTN 365
Query: 371 WQDVMVLEALRSISDESERTNDRGDPCVPVPWEW--VTCST---TTPPRITKIALSGKNL 425
+V+ ++ ++S S R + +GDPCVP+ + W V+C+ +TPPRI + LS L
Sbjct: 366 TDEVIAIKNIQSTYKVS-RISWQGDPCVPIQFSWMGVSCNVIDISTPPRIISLDLSSSGL 424
Query: 426 KGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLP 484
G I P ++N+ L EL L N LTG +P + L LR + L NN LTG +P ++ ++
Sbjct: 425 TGVITPSIQNLTMLRELDLSNNNLTGVIPPSLQNLTMLRELDLSNNNLTGEVPEFLATIK 484
Query: 485 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILL 544
L +H+ N+ G +P AL + ++ KL + + + + + SI +A+ +
Sbjct: 485 PLLVIHLRGNNLRGSVPQALQDRE----NNDGLKLLRGKHQPKSWLVAIVASISCVAVTI 540
Query: 545 VLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLP 604
++ L + + R RRK S +K +R S + N + +
Sbjct: 541 IV-LVLIFIFR--RRKSSTRKV------IRPSLEMKNRRFKYS----------------- 574
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 664
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV LL R+HH
Sbjct: 575 EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHH 633
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
NLV L+GYC++ + L+YE+M NG L++ L G L+W RL+IA ++A G+EYL
Sbjct: 634 VNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGKRGGPVLNWPGRLKIAIESALGIEYL 693
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 783
H GC P ++HRDVKS+NILL + AK++DFGLSR TH+S+ GT+GYLDPEY
Sbjct: 694 HIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYLDPEY 753
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843
Y LTEKSDVYSFG+VLLE+I+G +PV +E + IV WA+SM+ GD+ SI+D
Sbjct: 754 YQKNWLTEKSDVYSFGIVLLEIITG-QPV-IEQSRDKSYIVEWAKSMLANGDIESIMDRN 811
Query: 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI---EKGGDQKFSSSSS 900
L + S W+ E+A+ C+ RP M + + + ++I K Q +SS S
Sbjct: 812 LHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHELNECLEIYNLTKRRSQDQNSSKS 871
Query: 901 KGQS 904
G +
Sbjct: 872 SGHT 875
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 459 bits (1181), Expect = e-128, Method: Compositional matrix adjust.
Identities = 307/926 (33%), Positives = 489/926 (52%), Gaps = 88/926 (9%)
Query: 4 YSHFLVIYLLFLSSVVSQ-VTEFISIDCG---STSNYTDPSTGLAWISDIGIMNNGKSVK 59
+ H L+I L SV +Q FIS+DCG + YT+ ST + + SD+ +++G K
Sbjct: 7 FLHLLIIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGLVGK 66
Query: 60 VENPSGNWMQYRTR--RDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQL 117
+ + Q + R P+ ++ CYN+ +YL+R TF YG+ +P F L
Sbjct: 67 INDAYKTQFQQQVWAVRSFPV-GQRNCYNVNLTANNKYLIRGTFVYGNYDGLNQFPSFDL 125
Query: 118 YLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYA 177
++ WS+V +L + E+I P DS++VC+ +PFIS+LE+RPLN Y
Sbjct: 126 HIGPNKWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESYL 185
Query: 178 TDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTT 237
T L + ARV F + + +RY +D +DR+W+S D TV I+T
Sbjct: 186 TQSGS---LMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDE----------TVWISTD 232
Query: 238 KNIETRTREYPPVKVMQTAVVGTEGVLSYRL--NLEDFPANARAFAYFAEIQDLGPSETR 295
I+T P VM+TA V + L L++ A + + +FAE+Q+L +ETR
Sbjct: 233 LPIDTSNSYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETR 292
Query: 296 KFKLEQP----YFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLG 351
+F + +F+ ++I+ T++ P ++ + N + +F+F T +STL
Sbjct: 293 EFNITYNGGLRWFSYLRPPNLSIS-------TIFNPRAVSSS-NGIFNFTFAMTGNSTLP 344
Query: 352 PLLNAIEISKYQKIAA-KTEWQDVMVLEALRSISDESERTNDRGDPCVP--VPWEWVTCS 408
PLLNA+EI I +T +V + ++ S++ + +GDPC P WE + CS
Sbjct: 345 PLLNALEIYTVVDILQLETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCS 404
Query: 409 --TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 466
+ RI + L+G L G I D+S+L L ++
Sbjct: 405 YPDSEGSRIISLNLNGSELTGSI-----------------------TSDISKLTLLTVLD 441
Query: 467 LENNELTGSLPSYMGSLPNLQELHIENNSFVG--EIPPAL---LTGK--VIFKYDNNPKL 519
L NN+L+G +P++ + +L+ +++ N + IP +L + K + +N
Sbjct: 442 LSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNLTAIPDSLQQRVNSKSLTLILGENLTLT 501
Query: 520 HKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLR-RKISNQKSYEKADSLRTSTK 578
K+ +++ I + GV A+L++L + +I + ++ K +++ T+
Sbjct: 502 PKKESKKVPMVAIAASVAGVFALLVILAIFFVIKRKNVKAHKSPGPPPLVTPGIVKSETR 561
Query: 579 PSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAV 638
SN + I R + + Y PE+ + TNNF + +GKG FG+VY+G + DG EVAV
Sbjct: 562 SSNPSI-ITR-----ERKITY----PEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAV 610
Query: 639 KIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 698
K+++ S + ++F EV LL R+HHR+LV L+GYC++ L+YEYM NG LR+ + G
Sbjct: 611 KMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSG 670
Query: 699 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758
L W R+QIA +AA+GLEYLH GC P ++HRDVK++NILL+ AK++DFGLS
Sbjct: 671 KRGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLS 730
Query: 759 RQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 817
R D H+S+V GT GYLDPEYY L+EKSDVYSFGVVLLE+++ +PV ++
Sbjct: 731 RSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVT-NQPV-IDKT 788
Query: 818 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 877
+I W M+ KGD+ SIVDP L+G+ W+I E+A+ CV RP M +
Sbjct: 789 RERPHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHV 848
Query: 878 VLAIQDSIKIE----KGGDQKFSSSS 899
V+ + D + +E +G ++ +S S
Sbjct: 849 VMELNDCVALENARRQGSEEMYSMGS 874
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQR3|Y2451_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14510 OS=Arabidopsis thaliana GN=At2g14510 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 458 bits (1178), Expect = e-128, Method: Compositional matrix adjust.
Identities = 319/921 (34%), Positives = 488/921 (52%), Gaps = 110/921 (11%)
Query: 15 LSSVVSQVTE-FISIDCG--STSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGN---WM 68
+S V SQ + FIS+DCG S +Y +PS+ L +ISD+ + GK+ ++N S +
Sbjct: 18 MSLVKSQNQQGFISLDCGLPSKESYIEPSSNLTFISDVNFIRGGKTGNIQNNSRTNFIFK 77
Query: 69 QYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVT 128
++ R P D + CY+L K+ +YL+R F YG+ + P+F L+L +W++V
Sbjct: 78 PFKVLRYFP-DGIRNCYSLSVKQGTKYLIRTLFYYGNYDGLNTSPRFDLFLGPNIWTSVD 136
Query: 129 VL--DASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFL 186
VL D +E++ S+ +D+C+ T +P IS +ELRPL Y L
Sbjct: 137 VLIADVGDGVVEEIVHVTRSNILDICLVKTGTSTPMISAIELRPLRYDTYTARTGS---L 193
Query: 187 KVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTRE 246
K A F + +A+RYP+D YDR+W +P + +INTT+N+ +
Sbjct: 194 KSMAHFYFTN-SDEAIRYPEDVYDRVWMPY--SQPEWT--------QINTTRNVSGFSDG 242
Query: 247 Y-PPVKVMQTAVVGTEGV--LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPY 303
Y PP V+QTA + T G L++ NLE A+ +FAEIQ L +ETR+FK+
Sbjct: 243 YNPPQGVIQTASIPTNGSEPLTFTWNLESSDDETYAYLFFAEIQQLKVNETREFKI---- 298
Query: 304 FADYSNAV--VNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI-S 360
+N V ++ + TL P+ + V KT STL PL+NAIEI S
Sbjct: 299 ---LANGVDYIDYTPWKFEARTLSNPAPLKCE-GGVCRVQLSKTPKSTLPPLMNAIEIFS 354
Query: 361 KYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEW--VTCST---TTPPRI 415
Q + T +V+ ++ ++S S R + +GDPCVP + W V+C+ +TPPRI
Sbjct: 355 VIQFPQSDTNTDEVIAIKKIQSTYQLS-RISWQGDPCVPKQFSWMGVSCNVIDISTPPRI 413
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 475
+ LS L G I P ++N+ L EL L NN LTG
Sbjct: 414 ISLDLSLSGLTGVISPSIQNLTMLREL-----------------------DLSNNNLTGE 450
Query: 476 LPSYMGSLPNLQELHIENNSFVGEIPPALLT-----GKVIFKYDNNPKLHKESRRRMRFK 530
+P ++ ++ L +H+ N+ G +P AL G +F +P + + + + +
Sbjct: 451 VPEFLATIKPLLVIHLRGNNLRGSVPQALQDREKNDGLKLFV---DPNITRRGKHQPKSW 507
Query: 531 LI-LGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARG 589
L+ + SI +A+ +++ L + + R RRK S +K +R S + N + +
Sbjct: 508 LVAIVASISCVAVTIIV-LVLIFIFR--RRKSSTRKV------IRPSLEMKNRRFKYS-- 556
Query: 590 GHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT 649
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S +
Sbjct: 557 ---------------EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGY 600
Query: 650 QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 709
++F TEV LL R+HH NLV L+GYC+E L+YE+M NG L++ L G L+W +
Sbjct: 601 KEFKTEVELLLRVHHVNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSGKRGGSVLNWSS 660
Query: 710 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHI 768
RL+IA ++A G+EYLH GC P ++HRDVKS+NILL + AK++DFGLSR H+
Sbjct: 661 RLKIAIESALGIEYLHIGCQPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQAHV 720
Query: 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 828
S+ GT+GYLDPEYY LTEKSDVYSFG+VLLE I+G +PV +E + IV WA+
Sbjct: 721 STNVAGTLGYLDPEYYLKNWLTEKSDVYSFGIVLLESITG-QPV-IEQSRDKSYIVEWAK 778
Query: 829 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888
SM+ GD+ SI+DP L + S W+ E+A+ C+ RP M + + + ++I
Sbjct: 779 SMLANGDIESIMDPNLHQDYDSSSSWKALELAMLCINPSSTQRPNMTRVAHELNECLEI- 837
Query: 889 KGGDQKFSSSSSKGQSSRKTL 909
+ S+ Q+S K+L
Sbjct: 838 ----YNLTKIRSQDQNSSKSL 854
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 457 bits (1177), Expect = e-127, Method: Compositional matrix adjust.
Identities = 320/922 (34%), Positives = 479/922 (51%), Gaps = 58/922 (6%)
Query: 7 FLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVK-VENPSG 65
F++ +F+ S S F SI C + SNYTDP T L + +D ++ +S + +
Sbjct: 16 FVLCLCIFIRSASSATKGFESIACCADSNYTDPKTTLTYTTDHIWFSDKRSCRQIPEILF 75
Query: 66 NWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWS 125
+ + R I K CYNL T + + YL+R F + SL S F + + T
Sbjct: 76 SHRSNKNVRKFEIYEGKRCYNLPTVKDQVYLIRGIFPFDSLNS-----SFYVSIGVT--- 127
Query: 126 TVTVLDASRVYAKEM--IIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDN 183
+ L +SR+ E+ + RA D ID C+ +PFIS +ELRPL Y F +
Sbjct: 128 ELGELRSSRLEDLEIEGVFRATKDYIDFCLLKEDV-NPFISQIELRPLP-EEYLHGFGTS 185
Query: 184 FFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETR 243
LK+ +R N G T D +R+PDD DRIW +R ++ + N + N++ +
Sbjct: 186 V-LKLISRNNLGD-TNDDIRFPDDQNDRIW-----KRKETSTPTSALPLSFNVS-NVDLK 237
Query: 244 TREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPY 303
PP++V+QTA+ E + LE F +F E+ + R F +
Sbjct: 238 DSVTPPLQVLQTALTHPERLEFVHDGLETDDYEYSVFLHFLELNGTVRAGQRVFDI---- 293
Query: 304 FADYSNAVVN------IAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAI 357
Y N + +A + SYT +N++ N L+ + VK S GPLLNA
Sbjct: 294 ---YLNNEIKKEKFDVLAGGSKNSYTA-----LNISANGSLNITLVKASGSEFGPLLNAY 345
Query: 358 EISKYQKIAAKTEWQDVMVLEALRSISDESERTND-----RGDPCVPVPWEWVTCSTTTP 412
EI + + +T +D+ V++ +R + N+ GDPC+ PW+ +TC +T
Sbjct: 346 EILQARSWIEETNQKDLEVIQKMREELLLHNQENEALESWSGDPCMIFPWKGITCDDSTG 405
Query: 413 PRI-TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
I TK+ LS NLKG IP + M L L L N P L + L N+
Sbjct: 406 SSIITKLDLSSNNLKGAIPSIVTKMTNLQILNLSHNQFDMLFPSFPPSSLLISLDLSYND 465
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKL 531
L+G LP + SLP+L+ L+ N + + L +I N + ++ +F
Sbjct: 466 LSGWLPESIISLPHLKSLYFGCNPSMSDEDTTKLNSSLI-----NTDYGRCKAKKPKFGQ 520
Query: 532 ILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGH 591
+ LL+ ++ + R K + + K + T N +S+
Sbjct: 521 VFVIGAITSGSLLITLAVGILFFCRYRHKSITLEGFGKTYPMAT-----NIIFSLPSKDD 575
Query: 592 FMDEGVAYF-IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ 650
F + V+ L +E+AT + IG+G FGSVY G + DG+EVAVK+ + + + T+
Sbjct: 576 FFIKSVSVKPFTLEYIEQATEQYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSSTSTQGTR 635
Query: 651 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLT 709
+F E+ LLS I H NLVPL+GYC E Q+ILVY +M NG+L DRL+G ++ K LDW T
Sbjct: 636 EFDNELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEASKRKILDWPT 695
Query: 710 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHI 768
RL IA AA+GL YLHT +IHRDVKSSNILLD +M AKV+DFG S+ A +E +++
Sbjct: 696 RLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDQSMCAKVADFGFSKYAPQEGDSYV 755
Query: 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 828
S RGT GYLDPEYY QQL+EKSDV+SFGVVLLE++SG++P++++ E ++V WA+
Sbjct: 756 SLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRIEWSLVEWAK 815
Query: 829 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888
I+ V IVDP + G E++WR+ EVA+QC+E RP M +IV ++D++ IE
Sbjct: 816 PYIRASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIE 875
Query: 889 KGGDQKFSSSSSKGQSSRKTLL 910
+ S S G S+R +++
Sbjct: 876 NNASEYMKSIDSLGGSNRYSIV 897
|
Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Medicago truncatula (taxid: 3880) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1143), Expect = e-123, Method: Compositional matrix adjust.
Identities = 307/935 (32%), Positives = 475/935 (50%), Gaps = 117/935 (12%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCG--STSNYTDPSTGLAWISDIGIMNNGKSV 58
+++++ F +++L + + + F+SIDCG S+Y D +T + ++SD + +G
Sbjct: 9 LIIFACFFAVFVLLVRA--QDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIH 66
Query: 59 KVE---NPSGNWMQYRTRRDLPIDNKKYCYNLITKERR--RYLVRATFQYGSLGSEASYP 113
++ S Q++ R P N+ CY++ + + +YL+R F YG+ + P
Sbjct: 67 SIDPEFQTSSLEKQFQNVRSFPEGNRN-CYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAP 125
Query: 114 KFQLYLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNL 173
F LYL +W +VT+ +A+ + KE+I SD + VC+ G+PF+S LE+R L
Sbjct: 126 DFDLYLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKS 185
Query: 174 SMYATDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVR 233
+ Y T ++ K R + G L +RY DD +DRIW R P + + AS T+
Sbjct: 186 NTYETPYDSLILFK---RWDLGGLGALPVRYKDDVFDRIWIPL--RFPKYTIFNASLTID 240
Query: 234 INTTKNIETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAY--FAEIQDLGP 291
N + + P VM TA + + E + F Y FAE+ +L
Sbjct: 241 SNNNEGFQ------PARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVELPS 294
Query: 292 SETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFV--------LSFSFV 343
+ETR+FK+ ++N E S++ P Y+ FV L F
Sbjct: 295 NETREFKV-----------LLNEKEINMSSFS---PRYLYTDTLFVQNPVSGPKLEFRLQ 340
Query: 344 KTRDSTLGPLLNAIEISKYQK-IAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPV-- 400
+T STL P++NAIE + + + + T+ QDV + +R S + + GDPC PV
Sbjct: 341 QTPRSTLPPIINAIETYRVNEFLQSPTDQQDVDAI--MRIKSKYGVKKSWLGDPCAPVKY 398
Query: 401 PWEWVTCS--TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSR 458
PW+ + CS PRI + LS L GEI D F S
Sbjct: 399 PWKDINCSYVDNESPRIISVNLSSSGLTGEI---------------DAAF--------SN 435
Query: 459 LIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK----VIFKYD 514
L L I+ L NN LTG +P ++G+L NL EL++E N G IP LL ++ + D
Sbjct: 436 LTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKLILLRID 495
Query: 515 NNPKL---------HKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQK 565
NP L +++++ + ++ + +GVL ++L + +L +L K R +
Sbjct: 496 GNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAI---ALFLLYKKRHRRGGSG 552
Query: 566 SYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSV 625
+A L T+ + + E+ + TNNF + +G+G FG V
Sbjct: 553 GV-RAGPLDTTKR---------------------YYKYSEVVKVTNNFERVLGQGGFGKV 590
Query: 626 YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685
Y+G + D +VAVKI+++S + ++F EV LL R+HH+NL LIGYC E + L+YE
Sbjct: 591 YHGVLND-DQVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYE 649
Query: 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 745
+M NGTL D L G L W RLQI+ DAA+GLEYLH GC P I+ RDVK +NIL++
Sbjct: 650 FMANGTLGDYLSGE-KSYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILIN 708
Query: 746 INMRAKVSDFGLSRQAEEDLTHISSVA-RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLE 804
++AK++DFGLSR D + + A GT+GYLDPEY+ Q+L+EKSD+YSFGVVLLE
Sbjct: 709 EKLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLE 768
Query: 805 LISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQC 863
++SG+ ++ AE ++I M+ GD+ IVDP L S W+I EVA+ C
Sbjct: 769 VVSGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMAC 828
Query: 864 VEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSS 898
+RP M +V +++S+ + G +SS
Sbjct: 829 ASSSSKNRPTMSHVVAELKESVSRARAGGGSGASS 863
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1138), Expect = e-123, Method: Compositional matrix adjust.
Identities = 309/926 (33%), Positives = 483/926 (52%), Gaps = 123/926 (13%)
Query: 7 FLVIYLLFLSSVVSQ-VTEFISIDCGST---SNYTDPSTGLAWISDIGIMNNGKSVKV-- 60
F VI+ L L V +Q FI++DCG + S Y + STGL + SD G + +GK K+
Sbjct: 7 FFVIFSLILHLVQAQDPIGFINLDCGLSIQGSPYKESSTGLTYTSDDGFVQSGKIGKITK 66
Query: 61 ENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLD 120
E S RT R P D + C++L +YL++ TF YG+ P F LY+
Sbjct: 67 ELESLYKKPERTLRYFP-DGVRNCFSLNVTRGTKYLIKPTFLYGNYDGRNVIPDFDLYIG 125
Query: 121 ATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF 180
+W TV + KE++ + S+++ VC+ T P+I+TLELRPL +Y +
Sbjct: 126 PNMWITVNTDNT----IKEILHVSKSNTLQVCLVKTGTSIPYINTLELRPLADDIYTNES 181
Query: 181 EDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
L RV + L K + YPDD +DRIW L + ++ + ++IN + +
Sbjct: 182 GS---LNYLFRVYYSNL-KGYIEYPDDVHDRIWKQILPYQDWQIL---TTNLQINVSNDY 234
Query: 241 ETRTREYPPVKVMQTAVV---GTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKF 297
+ P +VM+TAV + + + NLE + F +FAE+Q L +ETR+F
Sbjct: 235 DL------PQRVMKTAVTPIKASTTTMEFPWNLEPPTSQFYLFLHFAELQSLQANETREF 288
Query: 298 KLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLS----------FSFVKTRD 347
N+ N N ++ Y P ++ + + + VKT
Sbjct: 289 ---------------NVVLNGNVTFKSYSPKFLEMQTVYSTAPKQCDGGKCLLQLVKTSR 333
Query: 348 STLGPLLNAIE---ISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVP--W 402
STL PL+NA+E + + +I +T +V+ ++ ++S S +T +GDPCVP W
Sbjct: 334 STLPPLINAMEAYTVLDFPQI--ETNVDEVIAIKNIQSTYGLS-KTTWQGDPCVPKKFLW 390
Query: 403 EWVTCSTT---TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRL 459
+ + C+ + TPP IT + LS L G I ++N+ L EL
Sbjct: 391 DGLNCNNSDDSTPPIITSLNLSSSGLTGIIVLTIQNLANLQEL----------------- 433
Query: 460 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVI-FKYDNNPK 518
L NN L+G +P ++ + +L +++ N+ G +P L+ K++ + NPK
Sbjct: 434 ------DLSNNNLSGGVPEFLADMKSLLVINLSGNNLSGVVPQKLIEKKMLKLNIEGNPK 487
Query: 519 LH----------KESRRRMRFKLI-LGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSY 567
L+ +E R+++ I + SIG + V F +L++ +R+ N S
Sbjct: 488 LNCTVESCVNKDEEGGRQIKSMTIPIVASIGSV----VAFTVALMIFCVVRK---NNPSN 540
Query: 568 EKADSLRTSTKPSNTAYS----IARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFG 623
++A + + P+++ S + + F E+ TNNF K +GKG FG
Sbjct: 541 DEAPT--SCMLPADSRSSEPTIVTKNKKFT---------YAEVLTMTNNFQKILGKGGFG 589
Query: 624 SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683
VYYG + ++VAVK+++ S + +QF EV LL R+HH+NLV L+GYCEE + L+
Sbjct: 590 IVYYGSVNGTEQVAVKMLSHSSAQGYKQFKAEVELLLRVHHKNLVGLVGYCEEGDKLALI 649
Query: 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 743
YEYM NG L + + G L+W TRL+IA +AA+GLEYLH GC P ++HRDVK++NIL
Sbjct: 650 YEYMANGDLDEHMSGKRGGSILNWGTRLKIALEAAQGLEYLHNGCKPLMVHRDVKTTNIL 709
Query: 744 LDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 802
L+ + K++DFGLSR E TH+S+V GT+GYLDPEYY LTEKSDVYSFGVVL
Sbjct: 710 LNEHFDTKLADFGLSRSFPIEGETHVSTVVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVL 769
Query: 803 LELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ 862
L +I+ +PV ++ + +I W M+ KGD+ SI DP L+G+ S+W+ E+A+
Sbjct: 770 LVMIT-NQPV-IDQNREKRHIAEWVGGMLTKGDIKSITDPNLLGDYNSGSVWKAVELAMS 827
Query: 863 CVEQRGFSRPKMQEIVLAIQDSIKIE 888
C+ +RP M ++V +++ + E
Sbjct: 828 CMNPSSMTRPTMSQVVFELKECLASE 853
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 440 bits (1131), Expect = e-122, Method: Compositional matrix adjust.
Identities = 303/911 (33%), Positives = 471/911 (51%), Gaps = 98/911 (10%)
Query: 7 FLVIYLLFLSSVVSQ-VTEFISIDCG---STSNYTDPSTGLAWISDIGIMNNG--KSVKV 60
FL+ + L SV +Q FIS+DCG + YT+ +T + + SD +++G +
Sbjct: 10 FLITAYVILESVQAQDQLGFISLDCGLVPKNATYTEKTTNITYKSDANYIDSGLVGRISA 69
Query: 61 ENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLD 120
E + Q T R P + ++ CYN + RYL+RATF YG+ PKF +++
Sbjct: 70 EYKAQLQQQTWTVRSFP-EGERNCYNFNLTAKSRYLIRATFTYGNYDGLRQVPKFDIHIG 128
Query: 121 ATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF 180
+ W++V + EMI D + +C+ G PFIS+LELRPLN + Y T
Sbjct: 129 PSKWTSVKLDGVGNGAVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPLNNNTYLTQS 188
Query: 181 EDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
L ARV F A T +RY +D +DR+W V +G I+T +
Sbjct: 189 GS---LIGFARVFFSA-TPTFIRYDEDIHDRVW----------VRQFGNGLKSISTDLLV 234
Query: 241 ETRTREYPPVKVMQTAVVGTEGV--LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFK 298
+T P V +TA V + L + L++ + + + +FAEIQ L ++ R+F
Sbjct: 235 DTSNPYDVPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREF- 293
Query: 299 LEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNF----------VLSFSFVKTRDS 348
N N +N Y+ P ++ F S SF KT +S
Sbjct: 294 ----------NITYNGGQNV---YSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNS 340
Query: 349 TLGPLLNAIEISK-YQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEW--V 405
TL PL+N +EI K + +T+ +V + +++ D S++ + +GDPC P ++W +
Sbjct: 341 TLPPLINGLEIYKVLDLLELETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGL 400
Query: 406 TCS--TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 463
CS + PRI + L+ L G I PE+ + L EL L N L+G +P+ D++
Sbjct: 401 NCSYPNSDQPRIISLNLAENKLTGTITPEISKLTQLIELDLSKNDLSGEIPEF--FADMK 458
Query: 464 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKES 523
++ L N L+G+L ++P+ + +++ S + L+ K + K K
Sbjct: 459 LLKLIN--LSGNL-GLNSTIPDSIQQRLDSKSLI------LILSKTVTK----TVTLKGK 505
Query: 524 RRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTA 583
+++ I+ + GV A+L++L + ++ RRK N +S K + TK
Sbjct: 506 SKKVPMIPIVASVAGVFALLVILAIFFVV-----RRK--NGES-NKGTNPSIITKERRIT 557
Query: 584 YSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMAD 643
Y PE+ + TNNF + +GKG FG+VY+G ++D +VAVK+++
Sbjct: 558 Y-------------------PEVLKMTNNFERVLGKGGFGTVYHGNLED-TQVAVKMLSH 597
Query: 644 SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK 703
S + ++F EV LL R+HHRNLV L+GYC++ L+YEYM NG L++ + G
Sbjct: 598 SSAQGYKEFKAEVELLLRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSGKRGGN 657
Query: 704 PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763
L W R+QIA +AA+GLEYLH GC P ++HRDVK++NILL+ AK++DFGLSR
Sbjct: 658 VLTWENRMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSRSFPV 717
Query: 764 D-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 822
D +H+S+V GT GYLDPEYY L+EKSDVYSFGVVLLE+++ +PV+ + +
Sbjct: 718 DGESHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVT-NQPVT-DKTRERTH 775
Query: 823 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882
I W SM+ KGD+ SI+DP L+G+ W+I E+A+ CV RP M +V +
Sbjct: 776 INEWVGSMLTKGDIKSILDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVTELN 835
Query: 883 DSIKIEKGGDQ 893
+ + +E Q
Sbjct: 836 ECVALENARRQ 846
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD6|Y1570_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g05700 OS=Arabidopsis thaliana GN=At1g05700 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 439 bits (1128), Expect = e-122, Method: Compositional matrix adjust.
Identities = 316/914 (34%), Positives = 465/914 (50%), Gaps = 101/914 (11%)
Query: 7 FLVIYLLF-----LSSVVSQVTE----FISIDCG--STSNYTDPSTGLAWISDIGIMNNG 55
F +YL++ L VVS + + FISIDCG S S+Y D +TG+ ++SD + G
Sbjct: 4 FRFLYLIYSAAFALCLVVSVLAQDQSGFISIDCGIPSGSSYKDDTTGINYVSDSSFVETG 63
Query: 56 KSVKVENPSGNWMQYRTRRDLPIDNKKYCYNLI--TKERRRYLVRATFQYGSLGSEASYP 113
S + P Q + R P + + CY LI + ++YL+RA+F YG+ E P
Sbjct: 64 VSKSI--PFTAQRQLQNLRSFP-EGSRNCYTLIPIQGKGKKYLIRASFMYGNYDGENGSP 120
Query: 114 KFQLYLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNL 173
+F L+L +W TV + + S + +KE++ + S++I VC+ G+PFISTLELR L
Sbjct: 121 EFDLFLGGNIWDTVLLSNGSSIVSKEVVYLSQSENIFVCLGNKGKGTPFISTLELRFLGN 180
Query: 174 SMYATDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVR 233
D N L + R + +L +RY DD YDRIW + R NF G R
Sbjct: 181 DNTTYD-SPNGALFFSRRWDLRSLMGSPVRYDDDVYDRIW---IPR--NF------GYCR 228
Query: 234 -INTTKNIETRTREYPPVK-VMQTAVVGTEGVLSYRLNLEDFPANARAFAY--FAEIQDL 289
INT+ + + Y VM TA+ + LE+ N R F Y FAE++DL
Sbjct: 229 EINTSLPVTSDNNSYSLSSLVMSTAMTPINTTRPITMTLENSDPNVRYFVYMHFAEVEDL 288
Query: 290 G--PSETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRD 347
P++TR+F D S V +A + Y ++N ++FS V+T
Sbjct: 289 SLKPNQTREF--------DISINGVTVAAGFSPKYLQTNTFFLNPESQSKIAFSLVRTPK 340
Query: 348 STLGPLLNAIEISKYQKIAAK-TEWQDVMVLEALRSISDESERTNDRGDPCVP--VPWEW 404
STL P++NA+EI + T +D + +L++ + N GDPC+P WE
Sbjct: 341 STLPPIVNALEIYVANSFSQSLTNQEDGDAVTSLKT--SYKVKKNWHGDPCLPNDYIWEG 398
Query: 405 VTCS--TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL 462
+ CS + TPPRIT + LS L G I N+ + EL
Sbjct: 399 LNCSYDSLTPPRITSLNLSSSGLTGHISSSFSNLTMIQEL-------------------- 438
Query: 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL----TGKVIFKYDNNPK 518
L NN LTG +P ++ L L+ L++ENN+ G +P LL TG + NP
Sbjct: 439 ---DLSNNGLTGDIPEFLSKLKFLRVLNLENNTLTGSVPSELLERSNTGSFSLRLGENPG 495
Query: 519 LHKE-SRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTST 577
L E S R+ K ++ + A L +L L S + R R+ KS A
Sbjct: 496 LCTEISCRKSNSKKLVIPLVASFAALFILLLLSGVFWRIRNRR---NKSVNSAPQTSPMA 552
Query: 578 KPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVA 637
K N ++ + TNNF + +GKG FG+VY+G D +VA
Sbjct: 553 KSEN----------------KLLFTFADVIKMTNNFGQVLGKGGFGTVYHG-FYDNLQVA 595
Query: 638 VKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH 697
VK+++++ + ++F +EV +L R+HH NL LIGY E Q L+YE+M NG + D L
Sbjct: 596 VKLLSETSAQGFKEFRSEVEVLVRVHHVNLTALIGYFHEGDQMGLIYEFMANGNMADHLA 655
Query: 698 GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 757
G Q L W RLQIA DAA+GLEYLH GC P I+HRDVK+SNILL+ RAK++DFGL
Sbjct: 656 GKY-QHTLSWRQRLQIALDAAQGLEYLHCGCKPPIVHRDVKTSNILLNEKNRAKLADFGL 714
Query: 758 SRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
SR E +H+S++ GT GYLDP + L EKSD+YSFGVVLLE+I+GK + E
Sbjct: 715 SRSFHTESRSHVSTLVAGTPGYLDPLCFETNGLNEKSDIYSFGVVLLEMITGKTVIK-ES 773
Query: 817 FGAELNIVHWARSMIKK-GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ 875
+++ W S+++ DV +++D + + + S+W++ E+A+ V Q RP M
Sbjct: 774 QTKRVHVSDWVISILRSTNDVNNVIDSKMAKDFDVNSVWKVVELALSSVSQNVSDRPNMP 833
Query: 876 EIVLAIQDSIKIEK 889
IV + + ++ E+
Sbjct: 834 HIVRGLNECLQREE 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 931 | ||||||
| 224107699 | 934 | predicted protein [Populus trichocarpa] | 0.997 | 0.994 | 0.793 | 0.0 | |
| 224100089 | 932 | predicted protein [Populus trichocarpa] | 0.997 | 0.996 | 0.795 | 0.0 | |
| 255547926 | 911 | protein with unknown function [Ricinus c | 0.974 | 0.995 | 0.778 | 0.0 | |
| 225425928 | 930 | PREDICTED: probable LRR receptor-like se | 0.996 | 0.997 | 0.762 | 0.0 | |
| 297738322 | 926 | unnamed protein product [Vitis vinifera] | 0.992 | 0.997 | 0.759 | 0.0 | |
| 356567402 | 929 | PREDICTED: probable LRR receptor-like se | 0.978 | 0.980 | 0.750 | 0.0 | |
| 449512995 | 956 | PREDICTED: probable LRR receptor-like se | 0.983 | 0.958 | 0.756 | 0.0 | |
| 449435025 | 923 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.979 | 0.988 | 0.759 | 0.0 | |
| 356538111 | 930 | PREDICTED: probable LRR receptor-like se | 0.976 | 0.977 | 0.746 | 0.0 | |
| 357463139 | 930 | Leucine-rich repeat family protein / pro | 0.979 | 0.980 | 0.733 | 0.0 |
| >gi|224107699|ref|XP_002314568.1| predicted protein [Populus trichocarpa] gi|222863608|gb|EEF00739.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1548 bits (4009), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 743/936 (79%), Positives = 829/936 (88%), Gaps = 7/936 (0%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIG-IMNNGKSVK 59
M YSHFL++YL +SSV+ QVTEFISIDCG TSNYTDP TGLAW+SD G IMN GKS +
Sbjct: 1 MASYSHFLLLYLFLMSSVICQVTEFISIDCGGTSNYTDPITGLAWVSDNGAIMNYGKSAE 60
Query: 60 VENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYL 119
VE P+GN MQYR RRD PID+KKYCY L TKERRRYLVRATFQYG LG+ +YPKF LYL
Sbjct: 61 VEIPNGN-MQYRRRRDFPIDSKKYCYTLGTKERRRYLVRATFQYGILGNGDAYPKFDLYL 119
Query: 120 DATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATD 179
DAT WSTV VLDASRVY KEMIIRAPS SIDVCICCA TGSPFISTLELRPLNLSMYATD
Sbjct: 120 DATKWSTVVVLDASRVYVKEMIIRAPSSSIDVCICCASTGSPFISTLELRPLNLSMYATD 179
Query: 180 FEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKN 239
FEDNFFL+VAARVNFGAL+KD +RYPDDPYDRIWDSDL++R N++VG A GTVRINT+K
Sbjct: 180 FEDNFFLEVAARVNFGALSKDVIRYPDDPYDRIWDSDLEKRQNYLVGVAPGTVRINTSKY 239
Query: 240 IETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKL 299
I+TRTREYPPVKVMQTAVVGT+G+LSYRLNL+DFPANARA+AYFAEI+DLG +ETRKFKL
Sbjct: 240 IDTRTREYPPVKVMQTAVVGTQGILSYRLNLDDFPANARAYAYFAEIEDLGANETRKFKL 299
Query: 300 EQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI 359
+QPYF DYSNAVVNIAENANGS+TLYEPSYMNVTL+FVLSFSFVKTRDST GPLLNAIEI
Sbjct: 300 QQPYFPDYSNAVVNIAENANGSHTLYEPSYMNVTLDFVLSFSFVKTRDSTQGPLLNAIEI 359
Query: 360 SKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIA 419
SKY KI +T+ QDV VL ALRS+S ES TN++GDPCVP W+WV C++TTPPRITKIA
Sbjct: 360 SKYLKIEPRTDSQDVTVLNALRSLSAESAWTNEQGDPCVPAHWDWVNCTSTTPPRITKIA 419
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 479
LSGKNLKGEIPPE+ NME LTELWLDGNFLTGP+P +S L++L+IVHLENN+L+G LP Y
Sbjct: 420 LSGKNLKGEIPPEINNMETLTELWLDGNFLTGPIPSISNLVNLKIVHLENNKLSGQLPKY 479
Query: 480 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGV 539
+GSLP+LQEL+I+NN F GEIP LLTGKVI Y++NP LHKE+ ++ KLILG SIG+
Sbjct: 480 LGSLPDLQELYIQNNYFSGEIPSGLLTGKVIINYEHNPGLHKEAGKKKHSKLILGVSIGI 539
Query: 540 LAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAY 599
LA LLV+ + SL+ LR L+RK S+QK+ + SLR S KPS TAYS++RG H MDEGV+Y
Sbjct: 540 LAALLVVLIGSLLFLRNLQRKTSHQKTAVQGSSLRVSAKPS-TAYSVSRGWHMMDEGVSY 598
Query: 600 FIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALL 659
+IPL E+EEAT NF KKIG+GSFG+VYYG+MK+GKEVAVKIM DS +H TQQFVTEVALL
Sbjct: 599 YIPLSEIEEATKNFSKKIGRGSFGTVYYGQMKEGKEVAVKIMGDSTTHMTQQFVTEVALL 658
Query: 660 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 719
SRIHHRNLVPLIGYCEEE+QRILVYEYMHNGTLRD +HGSVNQK LDWL RLQIA D+AK
Sbjct: 659 SRIHHRNLVPLIGYCEEENQRILVYEYMHNGTLRDHIHGSVNQKRLDWLARLQIAEDSAK 718
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 779
GLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYL
Sbjct: 719 GLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYL 778
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839
DPEYY NQQLTEKSDVYSFGVVLLEL+SGKKPVS EDFGAE+NIVHWAR++I+KGD +SI
Sbjct: 779 DPEYYANQQLTEKSDVYSFGVVLLELLSGKKPVSTEDFGAEMNIVHWARALIRKGDAMSI 838
Query: 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSS 897
VDPVLIGNVKIESIWRIAEVAIQCVEQR SRP+MQEI+LAIQ++ KIEKG G QK S
Sbjct: 839 VDPVLIGNVKIESIWRIAEVAIQCVEQRAVSRPRMQEIILAIQEANKIEKGTYGSQKLPS 898
Query: 898 SSSKGQSSRKTLLTSFLEIE--SPDLSNECLAPAAR 931
SSK QSSRKTLLTSFLEIE SPDLSN CL PAAR
Sbjct: 899 GSSKAQSSRKTLLTSFLEIESQSPDLSNGCLVPAAR 934
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100089|ref|XP_002311739.1| predicted protein [Populus trichocarpa] gi|222851559|gb|EEE89106.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1529 bits (3959), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 743/934 (79%), Positives = 826/934 (88%), Gaps = 5/934 (0%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIG-IMNNGKSVK 59
M LYSHFLV+YL F+SSV+ QVTEFISIDCG TSNYTDP TGLAW+SD G IM GKS +
Sbjct: 1 MALYSHFLVLYLFFVSSVICQVTEFISIDCGGTSNYTDPRTGLAWVSDNGTIMKYGKSSE 60
Query: 60 VENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYL 119
+ +GN QY+ RRD PID+ KYCY L TKERRRYLVRATFQYGS +E +YPKF LYL
Sbjct: 61 AQVSNGN-TQYQRRRDFPIDSNKYCYTLGTKERRRYLVRATFQYGSSENEDAYPKFDLYL 119
Query: 120 DATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATD 179
D T WST+ VLDASRVY KEMIIRAPS SIDVCICCA TGSPFISTLELRPLNLSMYATD
Sbjct: 120 DTTKWSTMVVLDASRVYVKEMIIRAPSSSIDVCICCATTGSPFISTLELRPLNLSMYATD 179
Query: 180 FEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKN 239
FEDNFFL+VAARVNFGAL+KDA+RYPDDPYDRIW SDL++R N++VG A GTVRINT+K
Sbjct: 180 FEDNFFLEVAARVNFGALSKDAIRYPDDPYDRIWGSDLEKRQNYLVGVAPGTVRINTSKY 239
Query: 240 IETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKL 299
++TRTREYPPVKVMQTAVVGTEG+LSYRLNLEDFPANARA+AYFAEI+DLG +ETRKFKL
Sbjct: 240 VDTRTREYPPVKVMQTAVVGTEGILSYRLNLEDFPANARAYAYFAEIEDLGANETRKFKL 299
Query: 300 EQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI 359
+QP+ +DYSNAVVNIAENANGSYTLYEPSYMNV+L+FVLSFSF KTRDSTLGPLLNAIEI
Sbjct: 300 QQPFLSDYSNAVVNIAENANGSYTLYEPSYMNVSLDFVLSFSFAKTRDSTLGPLLNAIEI 359
Query: 360 SKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIA 419
SKY KI KT+ +DV VL ALR +S ES N++GDPCVP WEWV CS+TTPPRITKIA
Sbjct: 360 SKYLKIEPKTDSKDVTVLNALRFLSAESAWANEQGDPCVPAHWEWVNCSSTTPPRITKIA 419
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 479
LSGKNLKGEIPPE+ NME LTELWLDGNFLTGP+P +S L++L+IVHLENN+L G LP Y
Sbjct: 420 LSGKNLKGEIPPEINNMEQLTELWLDGNFLTGPIPGISNLVNLKIVHLENNKLNGPLPKY 479
Query: 480 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGV 539
+GSLP LQ L+I+NNSF GEIP LTGKVIF Y++NP LHKE+R++M KLI+G SIG+
Sbjct: 480 LGSLPKLQALYIQNNSFSGEIPSEFLTGKVIFNYEHNPGLHKEARKKMHLKLIVGISIGI 539
Query: 540 LAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAY 599
LA LLV+ + SL+ LR L+RK S++KS + +SLR STKPS TAYS+ARG H MDEGV+Y
Sbjct: 540 LAGLLVVVIGSLLFLRNLQRKTSHKKSEVQGNSLRASTKPS-TAYSVARGWHMMDEGVSY 598
Query: 600 FIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALL 659
+IPLPELEEAT NF KKIG+GSFG+VYYG+MKDGKEVAVKIMADS +H T QFVTEVALL
Sbjct: 599 YIPLPELEEATKNFSKKIGRGSFGTVYYGQMKDGKEVAVKIMADSSTHLTLQFVTEVALL 658
Query: 660 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 719
SRIHHRNLVPL+GYCEEEHQRILVYEYMHNGTLRD +HG VNQK LDWL RLQIA DAAK
Sbjct: 659 SRIHHRNLVPLLGYCEEEHQRILVYEYMHNGTLRDHIHGPVNQKRLDWLARLQIAEDAAK 718
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 779
GLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYL
Sbjct: 719 GLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYL 778
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839
DPEYY NQQLTEKSDVYSFGVVLLEL+SGKKPVS EDFG+ELNIVHWARS+I+KGDV+SI
Sbjct: 779 DPEYYANQQLTEKSDVYSFGVVLLELVSGKKPVSTEDFGSELNIVHWARSLIRKGDVMSI 838
Query: 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSS 897
VDPVLIGN KIESIWRIAEVAIQCVEQR FSRP+M EI+LAIQ++ KIEKG G QK S
Sbjct: 839 VDPVLIGNAKIESIWRIAEVAIQCVEQRAFSRPRMHEIILAIQEANKIEKGTDGSQKQQS 898
Query: 898 SSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 931
+SSK QSSRKTLLTSFLEIESPDLSN CL PAAR
Sbjct: 899 ASSKAQSSRKTLLTSFLEIESPDLSNGCLVPAAR 932
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255547926|ref|XP_002515020.1| protein with unknown function [Ricinus communis] gi|223546071|gb|EEF47574.1| protein with unknown function [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1469 bits (3802), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 728/935 (77%), Positives = 807/935 (86%), Gaps = 28/935 (2%)
Query: 1 MVLYSH-FLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVK 59
M LYSH +LV+Y+ +SS+V QVTEFISIDCGSTSNYTD TGL WISD GIMN+GKSV+
Sbjct: 1 MALYSHIYLVLYISLVSSIVCQVTEFISIDCGSTSNYTDKRTGLEWISDNGIMNHGKSVE 60
Query: 60 VENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYL 119
V+NP G W QY RRD PID+KKYCYNL TKERRRYLVRATFQYGSL +E SYPKF LYL
Sbjct: 61 VKNPDGYWAQYGKRRDFPIDSKKYCYNLGTKERRRYLVRATFQYGSLENEDSYPKFDLYL 120
Query: 120 DATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATD 179
DAT WSTVTVL+ASR+Y KEMIIRAPS SIDVCICCA TGSPFISTLELRPLNLSMYATD
Sbjct: 121 DATKWSTVTVLEASRIYVKEMIIRAPSSSIDVCICCATTGSPFISTLELRPLNLSMYATD 180
Query: 180 FEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKN 239
+ED FFLK+AARVNFGA + ALRYPDDPYDRIWDSDL +R NF+VG A GTVRINT+KN
Sbjct: 181 YEDRFFLKLAARVNFGAPDEFALRYPDDPYDRIWDSDLAKRQNFLVGVAPGTVRINTSKN 240
Query: 240 IETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKL 299
I+ +TREYPPVKVMQTAVVGTEG+LSYRLNLEDFPANARA+AYF+EI+DLG +ETRKFKL
Sbjct: 241 IDIQTREYPPVKVMQTAVVGTEGLLSYRLNLEDFPANARAYAYFSEIEDLGSNETRKFKL 300
Query: 300 EQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI 359
+PY +DYSNAVVNIAENANGSY LYEPSYMNVTL+FVLSFSFVKTRDST GPL+NAIEI
Sbjct: 301 MKPYISDYSNAVVNIAENANGSYRLYEPSYMNVTLDFVLSFSFVKTRDSTQGPLINAIEI 360
Query: 360 SKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIA 419
SKY KI +KT+ QD VL A RSIS S T + GDPCVP WEWV CS+T+PPRITKIA
Sbjct: 361 SKYLKIESKTDIQDANVLNAFRSISAGSYWTTEGGDPCVPAQWEWVNCSSTSPPRITKIA 420
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 479
LSGKNLKGE+PPE+ NM L+EL HLENN+L+GSLP Y
Sbjct: 421 LSGKNLKGEVPPEINNMVELSEL-----------------------HLENNKLSGSLPKY 457
Query: 480 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGV 539
+GSLPNL+EL+I+NNSFVG++P ALLTGKV Y++NP LHKE ++M FKL LG SIGV
Sbjct: 458 LGSLPNLRELYIQNNSFVGKVPAALLTGKVNLNYEDNPGLHKEVAKKMHFKLTLGISIGV 517
Query: 540 LAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAY 599
LAILLVL L +LI LR+L+RK S+QK+ +S+R STKPS TAYSI RG H MDEG +Y
Sbjct: 518 LAILLVLLLGTLIYLRRLQRKTSHQKTDNPGNSMRASTKPS-TAYSITRGWHLMDEGGSY 576
Query: 600 FIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALL 659
+I ELEEAT NF KKIGKGSFGSVYYG+MKDGKEVAVKIMADSCSH TQQFVTEVALL
Sbjct: 577 YISFAELEEATKNFFKKIGKGSFGSVYYGQMKDGKEVAVKIMADSCSHLTQQFVTEVALL 636
Query: 660 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 719
SRIHHRNLVPLIG+CEEEHQRILVYEYMHNGTLRD +HG N+K LDWLTRLQIA DAAK
Sbjct: 637 SRIHHRNLVPLIGFCEEEHQRILVYEYMHNGTLRDHIHGIDNRKSLDWLTRLQIAEDAAK 696
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 779
GLEYLHTGC+P IIHRDVK+SNILLDINMRAKVSDFGLSRQAE+DLTHISSVARGTVGYL
Sbjct: 697 GLEYLHTGCSPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEDDLTHISSVARGTVGYL 756
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839
DPEYY NQQLTEKSDVYSFGVVLLELISGKKPVS EDFGAE+NIVHWAR++I+KGDV+SI
Sbjct: 757 DPEYYANQQLTEKSDVYSFGVVLLELISGKKPVSTEDFGAEMNIVHWARALIRKGDVVSI 816
Query: 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSS 897
VDPVLIGNVKIESIWR+AEVAIQCV+QR SRP+MQE++L+IQ++IKIEKG G QK S+
Sbjct: 817 VDPVLIGNVKIESIWRVAEVAIQCVQQRAVSRPRMQEVILSIQEAIKIEKGTDGSQKLSN 876
Query: 898 S-SSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 931
S SSK QSSRKTLLTSFLEIESPDLSN CL PAAR
Sbjct: 877 SGSSKAQSSRKTLLTSFLEIESPDLSNGCLVPAAR 911
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425928|ref|XP_002267668.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1456 bits (3769), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 711/933 (76%), Positives = 803/933 (86%), Gaps = 5/933 (0%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKV 60
M L+SHFLV +L +++ + QVTEFISIDCG TSNYTD TGL WISD G ++ GKSV+V
Sbjct: 1 MGLFSHFLVSFLCLITTTLCQVTEFISIDCGGTSNYTDSRTGLQWISDTGAISYGKSVQV 60
Query: 61 ENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLD 120
ENP G W+QY+ RRD P ++K YCY L T+ERRRYLVRATFQYGSL SE +YPKFQLYLD
Sbjct: 61 ENPYGGWLQYQQRRDFPTESK-YCYTLKTEERRRYLVRATFQYGSLESEGTYPKFQLYLD 119
Query: 121 ATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF 180
AT W+TVTVL+++RVY KEMIIRAPS SIDVC+CCA TGSPFISTLELRPLNLSMYATDF
Sbjct: 120 ATKWATVTVLESARVYVKEMIIRAPSSSIDVCLCCATTGSPFISTLELRPLNLSMYATDF 179
Query: 181 EDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
ED FFLKV+ARVNFGA ++D +RYPDDPYDRIW+SDL +R N++VG A GT R+NT+K I
Sbjct: 180 EDGFFLKVSARVNFGAPSEDPIRYPDDPYDRIWESDLVKRQNYLVGVAPGTERVNTSKQI 239
Query: 241 ETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLE 300
+ RTREYPPVKVMQTAVVGT G LSYRLNLEDFPANARA+A+FAEI++LG +ETRKF++E
Sbjct: 240 DVRTREYPPVKVMQTAVVGTRGRLSYRLNLEDFPANARAYAFFAEIEELGVNETRKFRME 299
Query: 301 QPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEIS 360
+PY DYSNAVVNIAENANGSY+LYEPSYMNVT++FVLSFSFVKTRDST GPLL+AIEIS
Sbjct: 300 RPYLPDYSNAVVNIAENANGSYSLYEPSYMNVTMDFVLSFSFVKTRDSTRGPLLSAIEIS 359
Query: 361 KYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIAL 420
KY +IA KT+ DV VL AL ++S ES +N+ DPCVP W WV CS TT PRITKI L
Sbjct: 360 KYVQIAPKTDKGDVTVLNALCAMSTESAWSNEGRDPCVPAHWSWVACSPTTTPRITKITL 419
Query: 421 SGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM 480
SGKNL G IP ELKNME LTELWLDGN+LTGP+PDMS LI L+IVHLENN LTG LPSY+
Sbjct: 420 SGKNLNGVIPSELKNMEGLTELWLDGNYLTGPIPDMSNLISLKIVHLENNRLTGPLPSYL 479
Query: 481 GSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVL 540
GSLP+LQELH++NN GEIPPALLTGKVIF Y+ N KLHKE+ + FKLILG S+G+L
Sbjct: 480 GSLPSLQELHVQNNLLSGEIPPALLTGKVIFNYEGNSKLHKEA-HKTHFKLILGASVGLL 538
Query: 541 AILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYF 600
A+LLVL + SL +L RRK S KS +K SLRTSTK S T+YSIARGG+ MDEGVA +
Sbjct: 539 ALLLVLCIGSLFLLCNTRRKESQSKSNDKGSSLRTSTKAS-TSYSIARGGNLMDEGVACY 597
Query: 601 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 660
I L +LEEAT NF K+IG+GSFG VYYGKM DGKE+AVKIMADS SH TQQFVTEVALLS
Sbjct: 598 ISLSDLEEATKNFAKQIGRGSFGPVYYGKMPDGKEIAVKIMADSSSHGTQQFVTEVALLS 657
Query: 661 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 720
RIHHRNLVPLIGYCE+EHQ +LVYEYMHNGTLR+ +H S NQK LDWL RL +A DAAKG
Sbjct: 658 RIHHRNLVPLIGYCEDEHQHLLVYEYMHNGTLRNHIHDSTNQKCLDWLGRLYVAEDAAKG 717
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 780
LEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLD
Sbjct: 718 LEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLD 777
Query: 781 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840
PEYY NQQLTEKSDVYSFG+VLLELISG+KPVS ED+GAE NIVHWARS+I GDVISIV
Sbjct: 778 PEYYANQQLTEKSDVYSFGIVLLELISGRKPVSPEDYGAEWNIVHWARSLICNGDVISIV 837
Query: 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSS 898
DP L+GNVKIESIWRIAE+AI CVEQ G SRPKMQEI+LAIQD+IKIE+G GD K S
Sbjct: 838 DPFLLGNVKIESIWRIAEIAILCVEQHGTSRPKMQEIILAIQDAIKIERGNEGDHKACSG 897
Query: 899 SSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 931
SSKGQSSRKTLLT+FL+IESPDLSN+CL P+AR
Sbjct: 898 SSKGQSSRKTLLTNFLDIESPDLSNDCLVPSAR 930
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297738322|emb|CBI27523.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1448 bits (3749), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 709/933 (75%), Positives = 801/933 (85%), Gaps = 9/933 (0%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKV 60
M L+SHFLV +L +++ + QVTEFISIDCG TSNYTD TGL WISD G ++ GKSV+V
Sbjct: 1 MGLFSHFLVSFLCLITTTLCQVTEFISIDCGGTSNYTDSRTGLQWISDTGAISYGKSVQV 60
Query: 61 ENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLD 120
ENP G W+QY+ RRD P ++K YCY L T+ERRRYLVRATFQYGSL SE +YPKFQLYLD
Sbjct: 61 ENPYGGWLQYQQRRDFPTESK-YCYTLKTEERRRYLVRATFQYGSLESEGTYPKFQLYLD 119
Query: 121 ATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF 180
AT W+TVTVL+++RVY KEMIIRAPS SIDVC+CCA TGSPFISTLELRPLNLSMYATDF
Sbjct: 120 ATKWATVTVLESARVYVKEMIIRAPSSSIDVCLCCATTGSPFISTLELRPLNLSMYATDF 179
Query: 181 EDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
ED FFLKV+ARVNFGA ++D +RYPDDPYDRIW+SDL +R N++VG A GT R+NT+K I
Sbjct: 180 EDGFFLKVSARVNFGAPSEDPIRYPDDPYDRIWESDLVKRQNYLVGVAPGTERVNTSKQI 239
Query: 241 ETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLE 300
+ RTREYPPVKVMQTAVVGT G LSYRLNLEDFPANARA+A+FAEI++LG +ETRKF++E
Sbjct: 240 DVRTREYPPVKVMQTAVVGTRGRLSYRLNLEDFPANARAYAFFAEIEELGVNETRKFRME 299
Query: 301 QPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEIS 360
+PY DYSNAVVNIAENANGSY+LYEPSYMNVT++FVLSFSFVKTRDST GPLL+AIEIS
Sbjct: 300 RPYLPDYSNAVVNIAENANGSYSLYEPSYMNVTMDFVLSFSFVKTRDSTRGPLLSAIEIS 359
Query: 361 KYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIAL 420
KY +IA KT+ DV VL AL ++S ES +N+ DPCVP W WV CS TT PRITKI L
Sbjct: 360 KYVQIAPKTDKGDVTVLNALCAMSTESAWSNEGRDPCVPAHWSWVACSPTTTPRITKITL 419
Query: 421 SGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM 480
SGKNL G IP ELKNME LTELWLDGN+LTGP+PDMS LI L+IVHLENN LTG LPSY+
Sbjct: 420 SGKNLNGVIPSELKNMEGLTELWLDGNYLTGPIPDMSNLISLKIVHLENNRLTGPLPSYL 479
Query: 481 GSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVL 540
GSLP+LQELH++NN GEIPPALLTGKVIF Y+ N KLHKE+ + FKLILG S+G+L
Sbjct: 480 GSLPSLQELHVQNNLLSGEIPPALLTGKVIFNYEGNSKLHKEA-HKTHFKLILGASVGLL 538
Query: 541 AILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYF 600
A+LLVL + SL +L RRK +S K SLRTSTK S T+YSIARGG+ MDEGVA +
Sbjct: 539 ALLLVLCIGSLFLLCNTRRK----ESQSKRSSLRTSTKAS-TSYSIARGGNLMDEGVACY 593
Query: 601 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 660
I L +LEEAT NF K+IG+GSFG VYYGKM DGKE+AVKIMADS SH TQQFVTEVALLS
Sbjct: 594 ISLSDLEEATKNFAKQIGRGSFGPVYYGKMPDGKEIAVKIMADSSSHGTQQFVTEVALLS 653
Query: 661 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 720
RIHHRNLVPLIGYCE+EHQ +LVYEYMHNGTLR+ +H S NQK LDWL RL +A DAAKG
Sbjct: 654 RIHHRNLVPLIGYCEDEHQHLLVYEYMHNGTLRNHIHDSTNQKCLDWLGRLYVAEDAAKG 713
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 780
LEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLD
Sbjct: 714 LEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLD 773
Query: 781 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840
PEYY NQQLTEKSDVYSFG+VLLELISG+KPVS ED+GAE NIVHWARS+I GDVISIV
Sbjct: 774 PEYYANQQLTEKSDVYSFGIVLLELISGRKPVSPEDYGAEWNIVHWARSLICNGDVISIV 833
Query: 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSS 898
DP L+GNVKIESIWRIAE+AI CVEQ G SRPKMQEI+LAIQD+IKIE+G GD K S
Sbjct: 834 DPFLLGNVKIESIWRIAEIAILCVEQHGTSRPKMQEIILAIQDAIKIERGNEGDHKACSG 893
Query: 899 SSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 931
SSKGQSSRKTLLT+FL+IESPDLSN+CL P+AR
Sbjct: 894 SSKGQSSRKTLLTNFLDIESPDLSNDCLVPSAR 926
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567402|ref|XP_003551909.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1404 bits (3633), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 690/919 (75%), Positives = 781/919 (84%), Gaps = 8/919 (0%)
Query: 16 SSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRD 75
S V Q+ EFISIDCG T+NYTD STGLAWISD GIM +GK V+V+NPSGN +QY+ RR+
Sbjct: 16 SYAVCQLEEFISIDCGGTNNYTDKSTGLAWISDYGIMKHGKPVEVQNPSGNKVQYQRRRE 75
Query: 76 LPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRV 135
PID++KYCY L T+ERRR+LVRATFQYGSL +YP+FQLYLDAT W+TV++ DASR+
Sbjct: 76 FPIDSRKYCYTLGTEERRRHLVRATFQYGSLDDGDTYPQFQLYLDATKWATVSIYDASRI 135
Query: 136 YAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFG 195
Y KEMI RAPS+SIDVC+CCA TGSPFISTLELRPLNLSMYATDFE +FFLKVAAR+NFG
Sbjct: 136 YVKEMIFRAPSNSIDVCMCCATTGSPFISTLELRPLNLSMYATDFEGSFFLKVAARINFG 195
Query: 196 ALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQT 255
A ++D +RYPDDPYDRIW+SDL +R N++VG A GT RINTTK IE TREYPPVKVMQT
Sbjct: 196 APSEDVVRYPDDPYDRIWESDLIKRQNYLVGVAPGTERINTTKKIEIETREYPPVKVMQT 255
Query: 256 AVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIA 315
AVVGT+G+LSYRLNLEDFP NARA+AYFAEI+DL +ETRKFKLEQPY ADYSNAVVNIA
Sbjct: 256 AVVGTKGILSYRLNLEDFPGNARAYAYFAEIEDLPKNETRKFKLEQPYIADYSNAVVNIA 315
Query: 316 ENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVM 375
ENANGSYTLYEPSYMNV+L FVLSFSFVKTRDST GPLLNA+EISKY IA+KT+ QD
Sbjct: 316 ENANGSYTLYEPSYMNVSLEFVLSFSFVKTRDSTQGPLLNAMEISKYVSIASKTDRQDSN 375
Query: 376 VLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKN 435
+ A R +S ES N+ GDPCVP PWEWV CSTTTPPRITKI LS +N+KGEIP EL N
Sbjct: 376 FVNAFRFLSAESVLKNE-GDPCVPTPWEWVNCSTTTPPRITKINLSRRNMKGEIPRELNN 434
Query: 436 MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 495
MEALTELWLDGN LTG LPDM LI+L+IVHLENN+L+G LPSY+GSLP+LQ L I+NNS
Sbjct: 435 MEALTELWLDGNMLTGQLPDMRNLINLKIVHLENNKLSGPLPSYLGSLPSLQALFIQNNS 494
Query: 496 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 555
F G IP LL+GK+IF +D+NP+LHK +++ F+L+LG SIGVLAILL+LFL SL++L
Sbjct: 495 FSGVIPSGLLSGKIIFNFDDNPELHKGNKK--HFQLMLGISIGVLAILLILFLTSLVLLL 552
Query: 556 KLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCK 615
LRRK S QK EK S R+STKP T YS R G+ MDEG AY+I L EL+EATNNF K
Sbjct: 553 NLRRKTSRQKCDEKGISGRSSTKPL-TGYSFGRNGNIMDEGTAYYITLSELKEATNNFSK 611
Query: 616 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 675
IGKGSFGSVYYGKMKDGKEVAVK M D S+ QQFV EVALLSRIHHRNLVPLIGYCE
Sbjct: 612 NIGKGSFGSVYYGKMKDGKEVAVKTMTDPSSYGNQQFVNEVALLSRIHHRNLVPLIGYCE 671
Query: 676 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 735
EE+Q ILVYEYMHNGTLR+ +H +QK LDWL RL+IA DA+KGLEYLHTGCNP IIHR
Sbjct: 672 EEYQHILVYEYMHNGTLREYIHECSSQKQLDWLARLRIAEDASKGLEYLHTGCNPSIIHR 731
Query: 736 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 795
DVK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVARGTVGYLDPEYY NQQLTEKSDV
Sbjct: 732 DVKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVARGTVGYLDPEYYANQQLTEKSDV 791
Query: 796 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 855
YSFGVVLLELISGKKPVS ED+G E+NIVHWARS+I+KGDVISI+DP L+GNVK ES+WR
Sbjct: 792 YSFGVVLLELISGKKPVSSEDYGPEMNIVHWARSLIRKGDVISIMDPSLVGNVKTESVWR 851
Query: 856 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---SSSSSKGQSSRKTLLTS 912
+AE+AIQCVEQ G RP+MQE++LAIQD+ IEKG + + SS SK QSSRKTLL S
Sbjct: 852 VAEIAIQCVEQHGACRPRMQEVILAIQDASNIEKGSEIQLKLSSSGGSKPQSSRKTLLAS 911
Query: 913 FLEIESPDLSNECLAPAAR 931
FLEIESPDLSN CL P+AR
Sbjct: 912 FLEIESPDLSNSCL-PSAR 929
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449512995|ref|XP_004164199.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1396 bits (3614), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 703/929 (75%), Positives = 787/929 (84%), Gaps = 13/929 (1%)
Query: 5 SHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPS 64
S + +I LL +SSV QV EFISIDCG T NYTDP TGLAWISD GIMN G S VENP+
Sbjct: 39 SFWGLILLLVVSSVHCQVKEFISIDCGGTKNYTDPVTGLAWISDAGIMNAGGSSPVENPN 98
Query: 65 GNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLW 124
GN MQY+TRRD PID+KKYCY L T+ERRRYLVRATFQYGSL E +YPKFQLYLDAT W
Sbjct: 99 GNLMQYQTRRDFPIDDKKYCYTLKTEERRRYLVRATFQYGSLKDEETYPKFQLYLDATKW 158
Query: 125 STVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNF 184
STVT+ DASRVY KEMIIRAPS+S DVCICCA TGSPFISTLELRP NLSMYATDFEDNF
Sbjct: 159 STVTIFDASRVYVKEMIIRAPSNSFDVCICCATTGSPFISTLELRPFNLSMYATDFEDNF 218
Query: 185 FLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRT 244
FL+VAARVNFGALTKDA+RYPDDPYDRIWDSDL++R N++VG A GT RI+T NI T
Sbjct: 219 FLEVAARVNFGALTKDAIRYPDDPYDRIWDSDLEKRQNYLVGVAPGTERISTLNNINVMT 278
Query: 245 REYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYF 304
REYPPVKVMQTAV+GT+GVLSYRLNL+DFPANARA+AYFAEI+DLG +ETRKFKLE+P
Sbjct: 279 REYPPVKVMQTAVLGTKGVLSYRLNLDDFPANARAYAYFAEIEDLGWNETRKFKLEEPNI 338
Query: 305 ADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQK 364
D SNAVVNIAENANG+YTLYEPSYMNVTL+FVLSFSFVKTRDST GPLLNA+EIS+Y +
Sbjct: 339 PDSSNAVVNIAENANGTYTLYEPSYMNVTLSFVLSFSFVKTRDSTRGPLLNALEISRYVE 398
Query: 365 IAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKN 424
IA KT+ +D V R++S E+ +N GDPCVP WEWVTCS T PPRITKI LS KN
Sbjct: 399 IAPKTDGRDEAVANIFRNVSAENVWSN-IGDPCVPTSWEWVTCSATQPPRITKIELSRKN 457
Query: 425 LKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLP 484
LKGEIPPE+ M+ L ELWLDGN L GPLPDMS LI+L+I+HLENN+LTG+LPSY+ SLP
Sbjct: 458 LKGEIPPEINTMDGLVELWLDGNSLAGPLPDMSNLINLKILHLENNKLTGTLPSYLCSLP 517
Query: 485 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILL 544
NLQEL+I+NN+F GEIP LL K+IFKYD N LHK R ++ KLILG S+GVL +L+
Sbjct: 518 NLQELYIQNNTFSGEIPSELLAKKLIFKYDGNVGLHKTERYKVHSKLILGVSLGVLVLLV 577
Query: 545 VLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLP 604
+L L SL++LRKLRRK + + +K SL STK S +AYSI +G DEG+AY++ L
Sbjct: 578 ILLLGSLLLLRKLRRKTAPYQ--KKGGSLNISTKRS-SAYSIGKG----DEGMAYYLSLS 630
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 664
ELEEATNNF KKIGKGSFGSV+YGKM DGKEVAVKIMA+S +H QQF+TEVALLSRIHH
Sbjct: 631 ELEEATNNFSKKIGKGSFGSVFYGKMIDGKEVAVKIMAESSTHGNQQFMTEVALLSRIHH 690
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
RNLVPLIGYCEEEHQRILVYEYMHNGTLRD L+GS QK LDWL RL IA DAAKGLEYL
Sbjct: 691 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDHLYGSTTQKHLDWLARLHIAEDAAKGLEYL 750
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
HTGC+P IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY
Sbjct: 751 HTGCSPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYY 810
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844
QQLTEKSDVYSFGVVLLELISGKKPVS ED+G ELNIVHWARS++ KGDV SIVDP L
Sbjct: 811 ACQQLTEKSDVYSFGVVLLELISGKKPVSPEDYGNELNIVHWARSLVHKGDVTSIVDPFL 870
Query: 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKG 902
G VKIES+WRIAEVAIQCV+Q G SRP+MQE++LAIQD+IKIE G G+QK SS + K
Sbjct: 871 EGKVKIESVWRIAEVAIQCVQQHGVSRPRMQEVILAIQDAIKIEHGTEGNQKLSSENLKA 930
Query: 903 QSSRKTLLTSFLEIESPDLSNECLAPAAR 931
QSSRKTLLT+FLEIESPD S L P+AR
Sbjct: 931 QSSRKTLLTTFLEIESPDGS---LLPSAR 956
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435025|ref|XP_004135296.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1391 bits (3600), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 703/926 (75%), Positives = 785/926 (84%), Gaps = 14/926 (1%)
Query: 9 VIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWM 68
+I LL +SSV QV EFISIDCG T NYTDP TGLAWISD GIMN G S VENP+GN M
Sbjct: 9 LILLLVVSSVHCQVKEFISIDCGGTKNYTDPVTGLAWISDAGIMNAGGSSPVENPNGNLM 68
Query: 69 QYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVT 128
QY+TRRD PID+KKYCY L T+ERRRYLVRATFQYGSL E +YPKFQLYLDAT WSTVT
Sbjct: 69 QYQTRRDFPIDDKKYCYTLKTEERRRYLVRATFQYGSLKDEETYPKFQLYLDATKWSTVT 128
Query: 129 VLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKV 188
+ DASRVY KEMIIRAPS+S DVCICCA TGSPFISTLELRP NLSMYATDFEDNFFL+V
Sbjct: 129 IFDASRVYVKEMIIRAPSNSFDVCICCATTGSPFISTLELRPFNLSMYATDFEDNFFLEV 188
Query: 189 AARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYP 248
AARVNFGALTKDA+RYPDDPYDRIWDSDL++R N++VG A GT RI+T NI TREYP
Sbjct: 189 AARVNFGALTKDAIRYPDDPYDRIWDSDLEKRQNYLVGVAPGTERISTLNNINVMTREYP 248
Query: 249 PVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYS 308
PVKVMQTAV+GT+GVLSYRLNL+DFPANARA+AYFAEI+DLG +ETRKFKLE+P D S
Sbjct: 249 PVKVMQTAVLGTKGVLSYRLNLDDFPANARAYAYFAEIEDLGWNETRKFKLEEPNIPDSS 308
Query: 309 NAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAK 368
NAVVNIAENANG+YTLYEPSYMNVTL+FVLSFSFVKTRDST GPLLNA+EIS+Y +IA K
Sbjct: 309 NAVVNIAENANGTYTLYEPSYMNVTLSFVLSFSFVKTRDSTRGPLLNALEISRYVEIAPK 368
Query: 369 TEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGE 428
T+ +D V R++S E+ TN GDPCVP WEWVTCS T PPRITKI LS KNLKGE
Sbjct: 369 TDGRDEAVANIFRNVSAENVWTN-IGDPCVPTSWEWVTCSATQPPRITKIELSRKNLKGE 427
Query: 429 IPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 488
IPPE+ M+ L ELWLDGN L GPLPDMS LI+L+I+HLENN+LTG+LPSY+ SLPNLQE
Sbjct: 428 IPPEINTMDGLVELWLDGNSLAGPLPDMSNLINLKILHLENNKLTGTLPSYLCSLPNLQE 487
Query: 489 LHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFL 548
L+I+NN+F GEIP LL K+IFKYD N LHK R ++ KLILG S+GVL +L++L L
Sbjct: 488 LYIQNNTFSGEIPSELLAKKLIFKYDGNVGLHKTERYKVHSKLILGVSLGVLVLLVILLL 547
Query: 549 CSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEE 608
SL++LRKLRRK + + +K SL STK S +AYSI +G DEG+AY++ L ELEE
Sbjct: 548 GSLLLLRKLRRKTAPYQ--KKGGSLNISTKRS-SAYSIGKG----DEGMAYYLSLSELEE 600
Query: 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 668
ATNNF KKIGKGSFGSV+YGKM DGKEVAVKIMA+S +H QQF+TEVALLSRIHHRNLV
Sbjct: 601 ATNNFSKKIGKGSFGSVFYGKMIDGKEVAVKIMAESSTHGNQQFMTEVALLSRIHHRNLV 660
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
PLIGYCEEEHQRILVYEYMHNGTLRD L+GS QK LDWL RL IA DAAKGLEYLHTGC
Sbjct: 661 PLIGYCEEEHQRILVYEYMHNGTLRDHLYGSTTQKHLDWLARLHIAEDAAKGLEYLHTGC 720
Query: 729 NPG-IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 787
+P IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY Q
Sbjct: 721 SPSIIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYACQ 780
Query: 788 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847
QLTEKSDVYSFGVVLLELISGKKPVS ED+G ELNIVHWARS++ KGDV SIVDP L G
Sbjct: 781 QLTEKSDVYSFGVVLLELISGKKPVSPEDYGNELNIVHWARSLVHKGDVTSIVDPFLEGK 840
Query: 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSS 905
VKIES+WRIAEVAIQCV+Q G SRP+MQE++LAIQD+IKIE G G+QK SS + K QSS
Sbjct: 841 VKIESVWRIAEVAIQCVQQHGVSRPRMQEVILAIQDAIKIEHGTEGNQKLSSENLKAQSS 900
Query: 906 RKTLLTSFLEIESPDLSNECLAPAAR 931
RKTLLT+FLEIESPD S L P+AR
Sbjct: 901 RKTLLTTFLEIESPDGS---LLPSAR 923
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356538111|ref|XP_003537548.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1385 bits (3584), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 685/918 (74%), Positives = 779/918 (84%), Gaps = 9/918 (0%)
Query: 18 VVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLP 77
V Q+ EFISIDCG TSNYTD STGLAWISD GIM +GK V+V+NPSGN QY+ RR+ P
Sbjct: 18 AVCQLEEFISIDCGGTSNYTDKSTGLAWISDSGIMKHGKPVEVQNPSGNKFQYQRRREFP 77
Query: 78 IDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYA 137
ID++KYCY L+T+ERRRYLVRATF+YG+L +YP+FQLYLDAT W+TV++ DASR+YA
Sbjct: 78 IDSRKYCYTLVTEERRRYLVRATFKYGNLDDGDTYPQFQLYLDATKWATVSIYDASRIYA 137
Query: 138 KEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGAL 197
KEMI RAPS+SIDVC+CCA TGSPFISTLELRPLNLSMYATDFE +FFLKVAAR+NFGA
Sbjct: 138 KEMIFRAPSNSIDVCMCCATTGSPFISTLELRPLNLSMYATDFEGSFFLKVAARINFGAP 197
Query: 198 TKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAV 257
++D +RYPDDPYDRIW+SDL +R N++VG A GT RINTTK IE TRE PPVKVMQTAV
Sbjct: 198 SEDVVRYPDDPYDRIWESDLIKRQNYLVGVAPGTERINTTKKIEIETRENPPVKVMQTAV 257
Query: 258 VGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAEN 317
VGT+G+LSYRLNLEDFP NARA+AYFAEI+DL +ETRKFKLEQPY ADYSNAVVNIAEN
Sbjct: 258 VGTKGILSYRLNLEDFPGNARAYAYFAEIEDLPKNETRKFKLEQPYIADYSNAVVNIAEN 317
Query: 318 ANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVL 377
ANGSYTLYEPSYMNV+L FVLSFSFVKTRDST GPLLNA+EISKY IA+KT+ QD +
Sbjct: 318 ANGSYTLYEPSYMNVSLEFVLSFSFVKTRDSTQGPLLNAMEISKYMPIASKTDRQDSNFV 377
Query: 378 EALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNME 437
A R +S ES N+ GDPCVP PWEWV CSTTTPPRITKI LS +NLKGEIP +L NME
Sbjct: 378 NAFRFLSAESVLKNE-GDPCVPTPWEWVNCSTTTPPRITKINLSRRNLKGEIPGKLNNME 436
Query: 438 ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 497
ALTELWLDGN LTG LPDMS LI+++I+HLENN+LTG LPSY+GSLP+LQ L I+NNSF
Sbjct: 437 ALTELWLDGNMLTGQLPDMSNLINVKIMHLENNKLTGPLPSYLGSLPSLQALFIQNNSFS 496
Query: 498 GEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKL 557
G IP LL+GK+IF +D+NP+LHK +++ F+L+LG SIGVL ILL+LFL SL++L L
Sbjct: 497 GVIPSGLLSGKIIFNFDDNPELHKGNKK--HFQLMLGISIGVLVILLILFLTSLVLLLIL 554
Query: 558 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKI 617
RRK S QK EK S R+STKP T YS R G+ MDEG AY+I L EL+EATNNF K I
Sbjct: 555 RRKTSQQKRDEKGVSGRSSTKPL-TGYSFGRDGNIMDEGTAYYITLSELKEATNNFSKNI 613
Query: 618 GKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 677
GKGSFGSVYYGKMKDGKEVAVK M D S+ QQFV EVALLSRIHHRNLVPLIGYCEEE
Sbjct: 614 GKGSFGSVYYGKMKDGKEVAVKTMTDPSSYGNQQFVNEVALLSRIHHRNLVPLIGYCEEE 673
Query: 678 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV 737
+Q ILVYEYMHNGTLR+ +H +QK LDWL RL+IA DAAKGLEYLHTGCNP IIHRDV
Sbjct: 674 YQHILVYEYMHNGTLREYIHECSSQKQLDWLARLRIAEDAAKGLEYLHTGCNPSIIHRDV 733
Query: 738 KSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYS 797
K+SNILLDINMRAKVSDFGLSR AEEDLTHISSVARGTVGYLDPEYY NQQLTEKSDVYS
Sbjct: 734 KTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVARGTVGYLDPEYYANQQLTEKSDVYS 793
Query: 798 FGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIA 857
FGVVLLEL+SGKK VS ED+G E+NIVHWARS+I+KGDVISI+DP L+GN+K ES+WR+A
Sbjct: 794 FGVVLLELLSGKKAVSSEDYGPEMNIVHWARSLIRKGDVISIMDPSLVGNLKTESVWRVA 853
Query: 858 EVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSSKG----QSSRKTLLTSF 913
E+A+QCVEQ G RP+MQE++LAIQD+ IEKG + + SSS G QSSRKTLL SF
Sbjct: 854 EIAMQCVEQHGACRPRMQEVILAIQDASNIEKGTESQLKLSSSGGNSKPQSSRKTLLASF 913
Query: 914 LEIESPDLSNECLAPAAR 931
LEIESPDLSN CL P+AR
Sbjct: 914 LEIESPDLSNSCL-PSAR 930
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357463139|ref|XP_003601851.1| Leucine-rich repeat family protein / protein kinase family protein [Medicago truncatula] gi|355490899|gb|AES72102.1| Leucine-rich repeat family protein / protein kinase family protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1380 bits (3572), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 676/921 (73%), Positives = 775/921 (84%), Gaps = 9/921 (0%)
Query: 15 LSSVVSQVTEFISIDCGST-SNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTR 73
+S Q+ EFISIDCG T SNYTD +TGL WISD IM +G++V+V+NP+GN +QY+ R
Sbjct: 15 ISCASCQLQEFISIDCGGTRSNYTDTTTGLTWISDSEIMKHGETVEVKNPNGNKVQYQKR 74
Query: 74 RDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDAS 133
RD P D++KYCY L +ERRRYLVRATFQYGSL + +YP+FQLYLDAT W+TV++ D S
Sbjct: 75 RDFPTDSRKYCYTLEAEERRRYLVRATFQYGSLQNGDTYPQFQLYLDATKWATVSIYDES 134
Query: 134 RVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVN 193
R+Y KEMI RAPS+S+DVCICCA TGSPFIST+ELRPLNLSMYATDFED+FFLKVAAR+N
Sbjct: 135 RIYVKEMIFRAPSNSVDVCICCATTGSPFISTIELRPLNLSMYATDFEDDFFLKVAARIN 194
Query: 194 FGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVM 253
FGA T DA+RYP+DPYDRIW+SDL +R NF+VG A+GT RINTT+NI TREYPPVKVM
Sbjct: 195 FGAPTGDAVRYPEDPYDRIWESDLGKRQNFLVGVAAGTERINTTRNIAIETREYPPVKVM 254
Query: 254 QTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVN 313
Q+AVVGT+G+LSYRLNLEDFP NARA+AY AEI+DL +ETRKFKLEQP+ ADYSNAVVN
Sbjct: 255 QSAVVGTKGLLSYRLNLEDFPGNARAYAYLAEIEDLSQNETRKFKLEQPFIADYSNAVVN 314
Query: 314 IAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQD 373
IAENANGSYTLYEPSYMNV+L FVLSFSF +T DST GPLLNA+EISKYQ+IA+KT QD
Sbjct: 315 IAENANGSYTLYEPSYMNVSLEFVLSFSFKRTPDSTRGPLLNAMEISKYQEIASKTFKQD 374
Query: 374 VMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPEL 433
+ A S+SDE N+ GDPCVP PWEWV CST TP RIT I LSG+NL GEIP EL
Sbjct: 375 SNFVNAFSSLSDEIIPKNE-GDPCVPTPWEWVNCSTATPARITNINLSGRNLTGEIPREL 433
Query: 434 KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493
NMEALTELWLD N LTG LPDMS LI+L+I+HLENN+LTG LP+Y+GSLP LQ L+I+N
Sbjct: 434 NNMEALTELWLDRNLLTGQLPDMSNLINLKIMHLENNKLTGPLPTYLGSLPGLQALYIQN 493
Query: 494 NSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIV 553
NSF G+IP LL+ K+ F YD+NP LHK S++ F L++G SIGVL IL+V+FL SL++
Sbjct: 494 NSFTGDIPAGLLSTKITFIYDDNPGLHKRSKK--HFPLMIGISIGVLVILMVMFLASLVL 551
Query: 554 LRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNF 613
LR LRRK S QKS E+A S RT TK T YS R G+ MDEG AY+I L +L+ ATNNF
Sbjct: 552 LRYLRRKASQQKSDERAISGRTGTK-HLTGYSFGRDGNLMDEGTAYYITLSDLKVATNNF 610
Query: 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
KKIGKGSFGSVYYGKMKDGKE+AVK M D SH QFVTEVALLSRIHHRNLVPLIGY
Sbjct: 611 SKKIGKGSFGSVYYGKMKDGKEIAVKTMTDPSSHGNHQFVTEVALLSRIHHRNLVPLIGY 670
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
CEEE+Q ILVYEYMHNGTLRD +H ++K LDWLTRL+IA DAAKGLEYLHTGCNP II
Sbjct: 671 CEEEYQHILVYEYMHNGTLRDHIHECSSEKRLDWLTRLRIAEDAAKGLEYLHTGCNPSII 730
Query: 734 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 793
HRDVK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVA+GTVGYLDPEYY NQQLTEKS
Sbjct: 731 HRDVKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVAKGTVGYLDPEYYANQQLTEKS 790
Query: 794 DVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESI 853
DVYSFGVVLLELI GKKPVS ED+G E+NIVHWARS+I+KGD+ISI+DP+LIGNVK ESI
Sbjct: 791 DVYSFGVVLLELICGKKPVSPEDYGPEMNIVHWARSLIRKGDIISIMDPLLIGNVKTESI 850
Query: 854 WRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS---SSSSKGQSSRKTLL 910
WR+AE+A+QCVE G SRP+MQE++LAIQD+ KIEKG + + SSSS QSSRKTLL
Sbjct: 851 WRVAEIAMQCVEPHGASRPRMQEVILAIQDASKIEKGTESQLKVSSSSSSIPQSSRKTLL 910
Query: 911 TSFLEIESPDLSNECLAPAAR 931
TSFLEIESPDLSN CL P+AR
Sbjct: 911 TSFLEIESPDLSNGCL-PSAR 930
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 931 | ||||||
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.986 | 0.988 | 0.706 | 0.0 | |
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.931 | 0.928 | 0.482 | 2.4e-218 | |
| TAIR|locus:2824870 | 884 | AT1G51805 [Arabidopsis thalian | 0.464 | 0.488 | 0.380 | 4.8e-129 | |
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.456 | 0.485 | 0.397 | 2.7e-126 | |
| TAIR|locus:2055165 | 868 | AT2G14510 [Arabidopsis thalian | 0.300 | 0.322 | 0.464 | 3.1e-125 | |
| TAIR|locus:2055160 | 886 | AT2G14440 [Arabidopsis thalian | 0.300 | 0.316 | 0.461 | 1.3e-124 | |
| TAIR|locus:2028446 | 888 | AT1G49100 [Arabidopsis thalian | 0.302 | 0.317 | 0.491 | 6.5e-123 | |
| TAIR|locus:2195850 | 890 | AT1G51860 [Arabidopsis thalian | 0.306 | 0.320 | 0.477 | 1.2e-121 | |
| TAIR|locus:2078191 | 838 | AT3G46420 [Arabidopsis thalian | 0.299 | 0.332 | 0.471 | 1.1e-120 | |
| TAIR|locus:2017557 | 894 | IOS1 "IMPAIRED OOMYCETE SUSCEP | 0.470 | 0.489 | 0.357 | 1.1e-118 |
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3424 (1210.4 bits), Expect = 0., P = 0.
Identities = 656/928 (70%), Positives = 755/928 (81%)
Query: 8 LVIYLLFLSS-VVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGN 66
L + LFL V+SQVTEF+SIDCG +SNYTDP TGL W+SD I+ GK V + N + N
Sbjct: 8 LAVTCLFLVPFVLSQVTEFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTNWN 67
Query: 67 WMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWST 126
MQYR RRD P DNKKYCY L TKERRRY+VR TF YG LGSE +YPKFQLYLDAT W+T
Sbjct: 68 SMQYRRRRDFPTDNKKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWAT 127
Query: 127 VTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFL 186
VT+ + SRVY +E+I+RA S +DVC+CCA+TGSPF+STLELRPLNLSMYATD+EDNFFL
Sbjct: 128 VTIQEVSRVYVEELIVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFL 187
Query: 187 KVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTRE 246
KVAARVNFGA DALRYPDDPYDRIW+SD+++RPN++VG A GT RINT+K I T TRE
Sbjct: 188 KVAARVNFGAPNMDALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTRE 247
Query: 247 YPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFAD 306
YPP+KVMQTAVVGT+G++SYRLNLEDFPANARA+AYFAEI++LG +ETRKFKL QPYF D
Sbjct: 248 YPPMKVMQTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPD 307
Query: 307 YSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIA 366
YSNAVVNIAENANGSYTLYEPSYMNVTL+FVL+FSF KT+DST GPLLNAIEISKY I+
Sbjct: 308 YSNAVVNIAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPIS 367
Query: 367 AKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLK 426
KT+ DV VL+A+RS+S +S+ ++ GDPC+PV W WV CS+T+PPR+TKIALS KNL+
Sbjct: 368 VKTDRSDVSVLDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLR 427
Query: 427 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 486
GEIPP + MEALTELWLD N LTG LPDMS+L++L+I+HLENN+L+GSLP Y+ LPNL
Sbjct: 428 GEIPPGINYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNL 487
Query: 487 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXXXX 546
QEL IENNSF G+IP ALL GKV+FKY+NNP+L E++R+ F ILG S
Sbjct: 488 QELSIENNSFKGKIPSALLKGKVLFKYNNNPELQNEAQRK-HFWQILGISIAAVAILLLL 546
Query: 547 XXXXXXXXRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPEL 606
LR+ K +K DS T K AYS RGGH +DEGVAYFI LP L
Sbjct: 547 VGGSLVLLCALRKT----KRADKGDSTETKKK-GLVAYSAVRGGHLLDEGVAYFISLPVL 601
Query: 607 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN 666
EEAT+NF KK+G+GSFGSVYYG+MKDGKEVAVKI AD SH +QFVTEVALLSRIHHRN
Sbjct: 602 EEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRN 661
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
LVPLIGYCEE +RILVYEYMHNG+L D LHGS + KPLDWLTRLQIA DAAKGLEYLHT
Sbjct: 662 LVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLHT 721
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
GCNP IIHRDVKSSNILLDINMRAKVSDFGLSRQ EEDLTH+SSVA+GTVGYLDPEYY +
Sbjct: 722 GCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYAS 781
Query: 787 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846
QQLTEKSDVYSFGVVL EL+SGKKPVS EDFG ELNIVHWARS+I+KGDV I+DP +
Sbjct: 782 QQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCIAS 841
Query: 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEXXXXX---XXXXXXXXXX 903
NVKIES+WR+AEVA QCVEQRG +RP+MQE+++AIQD+I+IE
Sbjct: 842 NVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKAQ 901
Query: 904 XXRKTLLTSFLEIESPDLSNECLAPAAR 931
RKTLLTSFLE+ESPD+S LAPAAR
Sbjct: 902 SSRKTLLTSFLELESPDISRNSLAPAAR 929
|
|
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2109 (747.5 bits), Expect = 2.4e-218, P = 2.4e-218
Identities = 428/887 (48%), Positives = 572/887 (64%)
Query: 8 LVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNW 67
LV LF SS +Q F+S+DCG +TD GL W D ++ G++ + + +
Sbjct: 12 LVSTCLFTSSS-AQAPGFVSLDCGGAEPFTD-ELGLKWSPDNHLIY-GETANISSVNETR 68
Query: 68 MQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSL-GSEASYPKFQLYLDATLWST 126
QY T R P D++KYCY L R RYL+RATF YG+ S YPKF + L AT W+T
Sbjct: 69 TQYTTLRHFPADSRKYCYTLNVTSRNRYLIRATFLYGNFDNSNNVYPKFDISLGATHWAT 128
Query: 127 VTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF-EDNFF 185
+ + + + E++ A S ++ VC+ A TG PFISTLELR L+ SMY + ED F+
Sbjct: 129 IVISETYIIETAELVFLASSPTVSVCLSNATTGQPFISTLELRQLSGSMYGSMLSEDRFY 188
Query: 186 LKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTR 245
L VAAR+NFGA ++ ++RYPDDPYDRIW+SDL ++PN++V A+GTVR++TT IE+R
Sbjct: 189 LSVAARINFGAESEASVRYPDDPYDRIWESDLQKKPNYLVDVAAGTVRVSTTLPIESRVD 248
Query: 246 EYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFA 305
+ PP KVMQTAVVGT G L+YR+NL+ FP AF YFAEI+DL E+RKF+L P
Sbjct: 249 DRPPQKVMQTAVVGTNGSLTYRMNLDGFPGFGWAFTYFAEIEDLAEDESRKFRLVLPEQP 308
Query: 306 DYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKI 365
+YS +VVNI EN Y +Y P Y N+TL FVL+F F KT DS+ GP+LNA+EISKY +
Sbjct: 309 EYSKSVVNIKENTQRPYRVYAPGYPNITLPFVLNFRFAKTADSSRGPILNAMEISKYLR- 367
Query: 366 AAKTEWQ-DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKN 424
K++ D V+ + S+ +E + GDPC P PW WV C++ PR+ I LS N
Sbjct: 368 --KSDGSVDATVMANVASLYSSTEWAQEGGDPCSPSPWSWVQCNSDPQPRVVAIKLSSMN 425
Query: 425 LKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLP 484
L G IP +L + L ELWLDGN TGP+PD SR +L I+HLENN LTG +PS + LP
Sbjct: 426 LTGNIPSDLVKLTGLVELWLDGNSFTGPIPDFSRCPNLEIIHLENNRLTGKIPSSLTKLP 485
Query: 485 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXX 544
NL+EL+++NN G IP L VI + N L K + + +I+G S
Sbjct: 486 NLKELYLQNNVLTGTIPSDLAKD-VISNFSGNLNLEKSGDKGKKLGVIIGASVGAFVLLI 544
Query: 545 XXXXXXXXXXRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLP 604
+ + + S E + + S+T S A G A+ L
Sbjct: 545 ATIISCIVMCKSKKNNKLGKTSAELTNRPLPIQRVSSTL-SEAHGD------AAHCFTLY 597
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 664
E+EEAT F K+IG G FG VYYGK ++GKE+AVK++A++ ++F EV LLSRIHH
Sbjct: 598 EIEEATKKFEKRIGSGGFGIVYYGKTREGKEIAVKVLANNSYQGKREFANEVTLLSRIHH 657
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEY 723
RNLV +GYC+EE + +LVYE+MHNGTL++ L+G V + + W+ RL+IA DAA+G+EY
Sbjct: 658 RNLVQFLGYCQEEGKNMLVYEFMHNGTLKEHLYGVVPRDRRISWIKRLEIAEDAARGIEY 717
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
LHTGC P IIHRD+K+SNILLD +MRAKVSDFGLS+ A + +H+SS+ RGTVGYLDPEY
Sbjct: 718 LHTGCVPAIIHRDLKTSNILLDKHMRAKVSDFGLSKFAVDGTSHVSSIVRGTVGYLDPEY 777
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKGDVISIVDP 842
Y +QQLTEKSDVYSFGV+LLEL+SG++ +S E FG NIV WA+ I GD+ I+DP
Sbjct: 778 YISQQLTEKSDVYSFGVILLELMSGQEAISNESFGVNCRNIVQWAKMHIDNGDIRGIIDP 837
Query: 843 VLI-GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888
L + ++S+W+IAE A+ CV+ G RP M E+ IQD+I+IE
Sbjct: 838 ALAEDDYSLQSMWKIAEKALLCVKPHGNMRPSMSEVQKDIQDAIRIE 884
|
|
| TAIR|locus:2824870 AT1G51805 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 762 (273.3 bits), Expect = 4.8e-129, Sum P(2) = 4.8e-129
Identities = 174/457 (38%), Positives = 258/457 (56%)
Query: 444 LDGNFLTGPL-PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
L + LTG + P + L L I+ L NN LTG +P ++ L ++ + + N+ G +P
Sbjct: 410 LSASGLTGIIAPAIQNLTHLEILALSNNNLTGEVPEFLADLKSIMVIDLRGNNLSGPVPA 469
Query: 503 ALLTGK-VIFKYDNNPKL--------HKESRRRMRFKLILGTSXXXXXXXXXXXXXXXXX 553
+LL K ++ D+NP + HK + + + S
Sbjct: 470 SLLQKKGLMLHLDDNPHILCTTGSCMHKGEGEKKSIIVPVVASIVSLAVIIGALILFLVF 529
Query: 554 XRKLRRKISNQ-KSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 612
+K K+ SY +A R S + S A + + F V TNN
Sbjct: 530 RKKKASKVEGTLPSYMQASDGR-SPRSSEPAI-VTKNKRFTYSQVVIM---------TNN 578
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
F + +GKG FG VY+G + ++VAVKI++ S S +QF EV LL R+HH+NLV L+G
Sbjct: 579 FQRILGKGGFGIVYHGFVNGVEQVAVKILSHSSSQGYKQFKAEVELLLRVHHKNLVGLVG 638
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
YC+E L+YEYM NG L++ + G+ N+ L+W TRL+I D+A+GLEYLH GC P +
Sbjct: 639 YCDEGENMALIYEYMANGDLKEHMSGTRNRFILNWETRLKIVIDSAQGLEYLHNGCKPLM 698
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTE 791
+HRDVK++NILL+ + AK++DFGLSR TH+S+V GT GYLDPEYY +LTE
Sbjct: 699 VHRDVKTTNILLNEHFEAKLADFGLSRSFPIGGETHVSTVVAGTPGYLDPEYYKTNRLTE 758
Query: 792 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 851
KSDVYSFG+VLLE+I+ + PV ++ + I W M+ KGD+ISI+DP L G+
Sbjct: 759 KSDVYSFGIVLLEMITNR-PV-IDQSREKPYISEWVGIMLTKGDIISIMDPSLNGDYDSG 816
Query: 852 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888
S+W+ E+A+ C+ RP M ++++A+ + + E
Sbjct: 817 SVWKAVELAMSCLNPSSTRRPTMSQVLIALNECLVSE 853
|
|
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 770 (276.1 bits), Expect = 2.7e-126, Sum P(2) = 2.7e-126
Identities = 178/448 (39%), Positives = 251/448 (56%)
Query: 444 LDGNFLTGPL-PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
L + LTG + P + L + + L NN LTG +P ++ SLPNL EL++E N G IP
Sbjct: 416 LSSSGLTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTELNLEGNKLTGSIPA 475
Query: 503 ALLT----GKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXXXXXXXXXXXXRKLR 558
LL G + ++ NP L + + K +G
Sbjct: 476 KLLEKSKDGSLSLRFGGNPDLCQSPSCQTTTKKKIGYIVPVVASLAGLLIVLTALAL--- 532
Query: 559 RKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIG 618
I + K + ++ S KP + G +D YFI E+ TNNF + +G
Sbjct: 533 --IWHFKKRSRRGTI--SNKP----LGVNTGP--LDTAKRYFI-YSEVVNITNNFERVLG 581
Query: 619 KGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 678
KG FG VY+G + +G +VAVKI+++ + ++F EV LL R+HH NL LIGYC E++
Sbjct: 582 KGGFGKVYHGFL-NGDQVAVKILSEESTQGYKEFRAEVELLMRVHHTNLTSLIGYCNEDN 640
Query: 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 738
L+YEYM NG L D L G + L W RLQI+ DAA+GLEYLH GC P I+HRDVK
Sbjct: 641 HMALIYEYMANGNLGDYLSGK-SSLILSWEERLQISLDAAQGLEYLHYGCKPPIVHRDVK 699
Query: 739 SSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYS 797
+NILL+ N++AK++DFGLSR E + +S+V GT+GYLDPEYY +Q+ EKSDVYS
Sbjct: 700 PANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATRQMNEKSDVYS 759
Query: 798 FGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIA 857
FGVVLLE+I+GK P +++ SM+ GD+ IVD L ++ S W+I
Sbjct: 760 FGVVLLEVITGK-PAIWHSRTESVHLSDQVGSMLANGDIKGIVDQRLGDRFEVGSAWKIT 818
Query: 858 EVAIQCVEQRGFSRPKMQEIVLAIQDSI 885
E+A+ C + RP M ++V+ ++ SI
Sbjct: 819 ELALACASESSEQRPTMSQVVMELKQSI 846
|
|
| TAIR|locus:2055165 AT2G14510 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 658 (236.7 bits), Expect = 3.1e-125, Sum P(2) = 3.1e-125
Identities = 132/284 (46%), Positives = 187/284 (65%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 664
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV LL R+HH
Sbjct: 557 EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHH 615
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
NLV L+GYC+E L+YE+M NG L++ L G L+W +RL+IA ++A G+EYL
Sbjct: 616 VNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSGKRGGSVLNWSSRLKIAIESALGIEYL 675
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 783
H GC P ++HRDVKS+NILL + AK++DFGLSR H+S+ GT+GYLDPEY
Sbjct: 676 HIGCQPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQAHVSTNVAGTLGYLDPEY 735
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843
Y LTEKSDVYSFG+VLLE I+G+ PV +E + IV WA+SM+ GD+ SI+DP
Sbjct: 736 YLKNWLTEKSDVYSFGIVLLESITGQ-PV-IEQSRDKSYIVEWAKSMLANGDIESIMDPN 793
Query: 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887
L + S W+ E+A+ C+ RP M + + + ++I
Sbjct: 794 LHQDYDSSSSWKALELAMLCINPSSTQRPNMTRVAHELNECLEI 837
|
|
| TAIR|locus:2055160 AT2G14440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 654 (235.3 bits), Expect = 1.3e-124, Sum P(2) = 1.3e-124
Identities = 131/284 (46%), Positives = 188/284 (66%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 664
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV LL R+HH
Sbjct: 575 EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHH 633
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
NLV L+GYC++ + L+YE+M NG L++ L G L+W RL+IA ++A G+EYL
Sbjct: 634 VNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGKRGGPVLNWPGRLKIAIESALGIEYL 693
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 783
H GC P ++HRDVKS+NILL + AK++DFGLSR TH+S+ GT+GYLDPEY
Sbjct: 694 HIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYLDPEY 753
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843
Y LTEKSDVYSFG+VLLE+I+G+ PV +E + IV WA+SM+ GD+ SI+D
Sbjct: 754 YQKNWLTEKSDVYSFGIVLLEIITGQ-PV-IEQSRDKSYIVEWAKSMLANGDIESIMDRN 811
Query: 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887
L + S W+ E+A+ C+ RP M + + + ++I
Sbjct: 812 LHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHELNECLEI 855
|
|
| TAIR|locus:2028446 AT1G49100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 720 (258.5 bits), Expect = 6.5e-123, Sum P(2) = 6.5e-123
Identities = 140/285 (49%), Positives = 192/285 (67%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 664
E+ E TNNF +GKG FG VY+G + ++VAVK+++ + H +QF EV LL R+HH
Sbjct: 575 EVTEMTNNFRSVLGKGGFGMVYHGYVNGREQVAVKVLSHASKHGHKQFKAEVELLLRVHH 634
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
+NLV L+GYCE+ + LVYEYM NG L++ G L W TRLQIA +AA+GLEYL
Sbjct: 635 KNLVSLVGYCEKGKELALVYEYMANGDLKEFFSGKRGDDVLRWETRLQIAVEAAQGLEYL 694
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 783
H GC P I+HRDVK++NILLD + +AK++DFGLSR E +H+S+V GT+GYLDPEY
Sbjct: 695 HKGCRPPIVHRDVKTANILLDEHFQAKLADFGLSRSFLNEGESHVSTVVAGTIGYLDPEY 754
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843
Y LTEKSDVYSFGVVLLE+I+ ++ + E + +I W MI KGD+ IVDP
Sbjct: 755 YRTNWLTEKSDVYSFGVVLLEIITNQRVI--ERTREKPHIAEWVNLMITKGDIRKIVDPN 812
Query: 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888
L G+ +S+W+ E+A+ CV +RP M ++V + + + +E
Sbjct: 813 LKGDYHSDSVWKFVELAMTCVNDSSATRPTMTQVVTELTECVTLE 857
|
|
| TAIR|locus:2195850 AT1G51860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 693 (249.0 bits), Expect = 1.2e-121, Sum P(2) = 1.2e-121
Identities = 138/289 (47%), Positives = 191/289 (66%)
Query: 601 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 660
I PE+ + TNNF + +GKG FG+VY+G + DG EVAVK+++ S + ++F EV LL
Sbjct: 574 ITYPEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKMLSHSSAQGYKEFKAEVELLL 632
Query: 661 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 720
R+HHR+LV L+GYC++ L+YEYM NG LR+ + G L W R+QIA +AA+G
Sbjct: 633 RVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQG 692
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYL 779
LEYLH GC P ++HRDVK++NILL+ AK++DFGLSR D H+S+V GT GYL
Sbjct: 693 LEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYL 752
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839
DPEYY L+EKSDVYSFGVVLLE+++ + PV ++ +I W M+ KGD+ SI
Sbjct: 753 DPEYYRTNWLSEKSDVYSFGVVLLEIVTNQ-PV-IDKTRERPHINDWVGFMLTKGDIKSI 810
Query: 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888
VDP L+G+ W+I E+A+ CV RP M +V+ + D + +E
Sbjct: 811 VDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALE 859
|
|
| TAIR|locus:2078191 AT3G46420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 1.1e-120, Sum P(2) = 1.1e-120
Identities = 133/282 (47%), Positives = 184/282 (65%)
Query: 608 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL 667
+ TNNF + +G+G FG VY+G + ++VAVK+++ S ++F EV LL R+HH NL
Sbjct: 528 DMTNNFQRALGEGGFGVVYHGYLNGSEQVAVKLLSQSSVQGYKEFKAEVELLLRVHHINL 587
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
V L+GYC++ + LVYEYM NG L+ L G N L W TRLQIA DAA GLEYLH G
Sbjct: 588 VSLVGYCDDRNHLALVYEYMSNGDLKHHLSGRNNGFVLSWSTRLQIAVDAALGLEYLHIG 647
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGN 786
C P ++HRDVKS+NILL AK++DFGLSR + D HIS+V GT GYLDPEYY
Sbjct: 648 CRPSMVHRDVKSTNILLGEQFTAKMADFGLSRSFQIGDENHISTVVAGTPGYLDPEYYRT 707
Query: 787 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846
+L EKSD+YSFG+VLLE+I+ + +++ + +I W S+I +GD+ I+DP L G
Sbjct: 708 SRLAEKSDIYSFGIVLLEMITSQH--AIDRTRVKHHITDWVVSLISRGDITRIIDPNLQG 765
Query: 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888
N S+WR E+A+ C RP M ++V+ +++ + E
Sbjct: 766 NYNSRSVWRALELAMSCANPTSEKRPNMSQVVIDLKECLATE 807
|
|
| TAIR|locus:2017557 IOS1 "IMPAIRED OOMYCETE SUSCEPTIBILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 715 (256.8 bits), Expect = 1.1e-118, Sum P(2) = 1.1e-118
Identities = 166/464 (35%), Positives = 260/464 (56%)
Query: 439 LTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 497
+ L L + LTG + + +S L L ++ L NN LTGS+P ++ ++ L+ +++ N
Sbjct: 410 IISLDLSTSGLTGEILEFISDLTSLEVLDLSNNSLTGSVPEFLANMETLKLINLSGNELN 469
Query: 498 GEIPPALLT----GKVIFKYDNNPKLHKES-----RRRMRFKLI--LGTSXXXXXXXXXX 546
G IP LL G + + N L + +++ + +I + S
Sbjct: 470 GSIPATLLDKERRGSITLSIEGNTGLCSSTSCATTKKKKKNTVIAPVAASLVSVFLIGAG 529
Query: 547 XXXXXXXXRKLRRKIS-NQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPE 605
RK R K+ N S L + + IA+ + + Y +
Sbjct: 530 IVTFLILKRKKRTKLGLNPNSGTGTTPLHSRSHHGFEPPVIAK-----NRKLTYI----D 580
Query: 606 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 665
+ + TNNF + +G+G FG VYYG + + + VAVK++ +S + +QF EV LL R+HH+
Sbjct: 581 VVKITNNFERVLGRGGFGVVYYGVLNN-EPVAVKMLTESTALGYKQFKAEVELLLRVHHK 639
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
+L L+GYCEE + L+YE+M NG L++ L G L W RL+IA ++A+GLEYLH
Sbjct: 640 DLTCLVGYCEEGDKMSLIYEFMANGDLKEHLSGKRGPSILTWEGRLRIAAESAQGLEYLH 699
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYY 784
GC P I+HRD+K++NILL+ +AK++DFGLSR TH+S++ GT GYLDPEYY
Sbjct: 700 NGCKPQIVHRDIKTTNILLNEKFQAKLADFGLSRSFPLGTETHVSTIVAGTPGYLDPEYY 759
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844
LTEKSDV+SFGVVLLEL++ + PV ++ + +I W M+ +GD+ SIVDP L
Sbjct: 760 RTNWLTEKSDVFSFGVVLLELVTNQ-PV-IDMKREKSHIAEWVGLMLSRGDINSIVDPKL 817
Query: 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888
G+ +IW++ E A+ C+ RP M ++V+ +++ + +E
Sbjct: 818 QGDFDPNTIWKVVETAMTCLNPSSSRRPTMTQVVMDLKECLNME 861
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGI2 | Y1677_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7236 | 0.9892 | 0.9913 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00100504 | hypothetical protein (934 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 931 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 3e-90 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-39 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-34 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-32 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-29 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-29 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-28 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-27 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-27 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-24 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-23 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.003 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 290 bits (743), Expect = 3e-90
Identities = 134/355 (37%), Positives = 185/355 (52%), Gaps = 40/355 (11%)
Query: 28 IDCGSTSN--YTDPSTGLAWISDIGIMNNGKSVKV-ENPSGNWM--QYRTRRDLPIDNKK 82
IDCG SN YTDPSTG+ W+SD G ++ GKS + + S +++ Y+T R P D K+
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFP-DGKR 59
Query: 83 YCYNL--ITKERRRYLVRATFQYGS---LGSEASYPKFQLYLDATLWSTV-TVLDASRVY 136
CY L + +YL+RATF YG+ L S +S P F LYL LW+TV D+
Sbjct: 60 NCYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSV 119
Query: 137 AKEMIIRAP-SDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFG 195
KE II SD++ VC+ TG+PFIS LELRPL S+Y + + LK+ AR+NFG
Sbjct: 120 VKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSG-GSQALKLVARLNFG 178
Query: 196 ALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI---ETRTREYPPVKV 252
++ +RYPDD YDRIW+ + G +I+T+ ++ PP V
Sbjct: 179 G-SEGTIRYPDDVYDRIWEPFFS---------SPGWSQISTSLSVDISSNNAPYIPPSAV 228
Query: 253 MQTAVVGTEGVLSYRL--NLEDFPANARAFAYFAEIQDLGPSETRKFKL---EQPYFADY 307
+QTAV T +L D + +FAEIQ L ETR+F + + + D
Sbjct: 229 LQTAVTPTNASAPLNFTWDLVDPNFEYYVYLHFAEIQSL---ETREFDIYINGKTVYGDV 285
Query: 308 SNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKY 362
S + LY +NV+ +L+ S V T STL PLLNA+EI K
Sbjct: 286 S-----PKYLGTDTGALYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 4e-53
Identities = 73/207 (35%), Positives = 115/207 (55%), Gaps = 13/207 (6%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 666
KK+G+G+FG VY G +K E VAVK + + S ++ F+ E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
+V L+G C + +V EYM G L D L + + L LQ+A AKG+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKLTLKDLLQMALQIAKGMEYLE- 119
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV-ARGTVGYLDPEYYG 785
+ +HRD+ + N L+ N+ K+SDFGLSR ED + + + ++ PE
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 786 NQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ + T KSDV+SFGV+L E+ + G++P
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 2e-52
Identities = 77/193 (39%), Positives = 113/193 (58%), Gaps = 10/193 (5%)
Query: 617 IGKGSFGSVYYGK-MKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 674
+G+G FG+VY + K GK+VA+KI+ + S ++ + E+ +L +++H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 675 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 734
E+E+ LV EY G+L+D L N+ L L+I +GLEYLH + GIIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 735 RDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLTEK 792
RD+K NILLD N + K++DFGLS+ D + GT Y+ PE G +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 793 SDVYSFGVVLLEL 805
SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 3e-52
Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGK-----EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 666
KK+G+G+FG VY G +K EVAVK + + S + + F+ E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
+V L+G C EE ++V EYM G L D L + K L L A A+G+EYL +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES 121
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
IHRD+ + N L+ N+ K+SDFGLSR +D + + + ++ PE
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 787 QQLTEKSDVYSFGVVLLELIS-GKKP 811
+ T KSDV+SFGV+L E+ + G++P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 7e-52
Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 12/206 (5%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGK-----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRN 666
KK+G+G+FG VY GK+K EVAVK + + S + ++F+ E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
+V L+G C EE +V EYM G L L N+ L L A A+G+EYL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLES 120
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
IHRD+ + N L+ N+ K+SDFGLSR +D + + + ++ PE
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 787 QQLTEKSDVYSFGVVLLELIS-GKKP 811
+ T KSDV+SFGV+L E+ + G++P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 5e-48
Identities = 70/199 (35%), Positives = 105/199 (52%), Gaps = 10/199 (5%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+K+G+GSFG VY + K GK VA+K++ ++ + E+ +L ++ H N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
E+E + LV EY G L D L + L LEYLH + GI
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLH---SKGI 118
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
+HRD+K NILLD + K++DFGL+RQ + + V GT Y+ PE + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYGKA 176
Query: 793 SDVYSFGVVLLELISGKKP 811
D++S GV+L EL++GK P
Sbjct: 177 VDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 8e-48
Identities = 75/210 (35%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 615 KKIGKGSFGSVYYGKMKDGK----EVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVP 669
KK+G+G+FG VY GK+K EVAVK + + S + F+ E ++ ++ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRL------HGSVNQKPLDWLTRLQIAHDAAKGLEY 723
L+G C EE LV EYM G L D L S + L L A AKG+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VGYLDPE 782
L + +HRD+ + N L+ ++ K+SDFGLSR +D + + ++ PE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 783 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ T KSDV+SFGV+L E+ + G P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 82/203 (40%), Positives = 112/203 (55%), Gaps = 15/203 (7%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVP 669
+K+G GSFG+VY K K GK VAVKI+ S + Q E+ +L R+ H N+V
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK--KDQTARREIRILRRLSHPNIVR 62
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
LI E++ LV EY G L D L PL +IA +GLEYLH +
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---S 116
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQ 788
GIIHRD+K NILLD N K++DFGL+++ + + +++ GT Y+ PE G
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175
Query: 789 LTEKSDVYSFGVVLLELISGKKP 811
K DV+S GV+L EL++GK P
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 671
+ +G+GSFGSVY KD G+ +AVK + S + E+ +LS + H N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 672 G-YCEEEHQRILVY-EYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
G +EE + ++ EY+ G+L L G + + + TR QI GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR-QILE----GLAYLH-- 118
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGN 786
+ GI+HRD+K +NIL+D + K++DFG +++ + + + RGT ++ PE
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 787 QQLTEKSDVYSFGVVLLELISGKKP 811
++ +D++S G ++E+ +GK P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 74/201 (36%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+KIGKG FG VY + K GKEVA+K++ + ++ + E+ +L + H N+V G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 730
++ + +V E+ G+L+D L + NQ LT QIA + KGLEYLH +
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKST-NQT----LTESQIAYVCKELLKGLEYLH---SN 117
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
GIIHRD+K++NILL + K+ DFGLS Q + + V GT ++ PE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYD 175
Query: 791 EKSDVYSFGVVLLELISGKKP 811
K+D++S G+ +EL GK P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-35
Identities = 125/487 (25%), Positives = 210/487 (43%), Gaps = 45/487 (9%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 471
+ ++ LS L GEIP EL + + L L L N L+G +P S + L + L N+
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP--ALL-------TGKVIFKYDNNPKLHKE 522
L+G +P +G++ +L +++I +N G +P A L G + +
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618
Query: 523 SRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNT 582
+R + L LVL L + + R K E D
Sbjct: 619 CKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWEL------ 672
Query: 583 AYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIM 641
F D V+ I + ++ + I +G G+ Y GK +K+G + VK +
Sbjct: 673 --------QFFDSKVSKSITINDILSSLKEE-NVISRGKKGASYKGKSIKNGMQFVVKEI 723
Query: 642 ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN 701
D S + +E+A + ++ H N+V LIG C E L++EY+ L + L
Sbjct: 724 NDVNSIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--- 776
Query: 702 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761
L W R +IA AK L +LH C+P ++ ++ I++D + L
Sbjct: 777 ---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832
Query: 762 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 821
D S A Y+ PE + +TEKSD+Y FG++L+EL++GK P E FG
Sbjct: 833 CTDTKCFISSA-----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE-FGVHG 886
Query: 822 NIVHWARSMIKKGDVISIVDPVLIGNVKIES--IWRIAEVAIQCVEQRGFSRPKMQEIVL 879
+IV WAR + +DP + G+V + I + +A+ C +RP +++
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
Query: 880 AIQDSIK 886
++ + +
Sbjct: 947 TLESASR 953
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 75/216 (34%), Positives = 105/216 (48%), Gaps = 38/216 (17%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLI 671
K+IGKGSFG VY + K DGK +K + S + + EV +L +++H N+ I
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI---I 62
Query: 672 GYCE--EEHQRIL-VYEYMHNGTLRDRLHGSVNQKP----------LDWLTRLQIAHDAA 718
Y E EE ++ V EY G L ++ QK LDW Q+
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIK---KQKKEGKPFPEEQILDWFV--QLC---- 113
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 777
L+YLH+ I+HRD+K NI L N K+ DFG+S+ L+ +A+ VG
Sbjct: 114 LALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV----LSSTVDLAKTVVGT 166
Query: 778 --YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
YL PE N+ KSD++S G VL EL + K P
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 69/196 (35%), Positives = 110/196 (56%), Gaps = 11/196 (5%)
Query: 617 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 676
IGKG FG V G + G++VAVK + D S Q F+ E ++++ + H NLV L+G +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 677 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 736
+ +V EYM G+L D L S + + +L A D +G+EYL +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLR-SRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRD 127
Query: 737 VKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVY 796
+ + N+L+ ++ AKVSDFGL+++A + + V + PE ++ + KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 797 SFGVVLLELIS-GKKP 811
SFG++L E+ S G+ P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 4e-33
Identities = 143/578 (24%), Positives = 235/578 (40%), Gaps = 64/578 (11%)
Query: 14 FLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTR 73
L+S+ S + I CG+ N T W D G PS +T
Sbjct: 14 VLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFA-YTGGIPANATRPSFIAPPLKTL 72
Query: 74 RDLPI-DNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATL-------WS 125
R P+ D + CYN+ + Y VR F + + S P F + ++ T WS
Sbjct: 73 RYFPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWS 132
Query: 126 TVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMY--ATDFEDN 183
+ +V+A E ++ S +C G P I ++E+ ++ Y +
Sbjct: 133 S----HDEQVFA-EALVFLTDGSASICFHSTGHGDPAILSIEILQVDDKAYNFGPSWGQG 187
Query: 184 FFLKVAARVNFGA-LTKDALRYPDDPY--DRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
L+ A R++ GA +K Y D + DR W+ F G+ N K
Sbjct: 188 VILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRM----QTFGSGSDQAISTENVIKKA 243
Query: 241 ETRTREYPPVKVMQTAVVGTEGV--LSYRLNLEDFP-ANARAFAYFAEI-QDLGPSETRK 296
YP + Q+A+V T+ LSY ++++ P N + +FAEI + R
Sbjct: 244 SNAPNFYPE-SLYQSALVSTDTQPDLSYTMDVD--PNRNYSVWLHFAEIDNSITAEGKRV 300
Query: 297 FKL---EQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNF---VLSFSFVKTRDSTL 350
F + F D V+I + + YT +N T+ L+ + +
Sbjct: 301 FDVLINGDTAFKD-----VDIVKMSGERYTAL---VLNKTVAVSGRTLTIVLQPKKGTH- 351
Query: 351 GPLLNAIEISKYQKIAA--KTEWQDVMVLEALRSISDESERTNDRGDPCVPV--PWEWVT 406
++NAIE+ ++ I A KT ++V L+ L+S R GDPCVP PW
Sbjct: 352 -AIINAIEV--FEIITAESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGAD 408
Query: 407 C---STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDL 462
C ST I + L + L+G IP ++ + L + L GN + G +P + + L
Sbjct: 409 CQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL 468
Query: 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL---LTGKVIFKYDNNPKL 519
++ L N GS+P +G L +L+ L++ NS G +P AL L + F + +N L
Sbjct: 469 EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL 528
Query: 520 -----HKESRRRMRFKLILGTSIGVLAILLVLFLCSLI 552
+ + +G + GV L L +C++
Sbjct: 529 CGIPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAMC 566
|
Length = 623 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 72/208 (34%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
K +G+GS G VY + K GK A+K I D +Q + E+ L +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 673 -YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
+ +E I V EYM G+L D L G + + L ++ R QI GL+YLHT +
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIAR-QILK----GLDYLHTKRH 120
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGY-----LDPEY 783
IIHRD+K SN+L++ K++DFG+S+ E L + V GTV Y + E
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQGES 176
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKP 811
Y +D++S G+ LLE GK P
Sbjct: 177 YSY-----AADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 71/201 (35%), Positives = 107/201 (53%), Gaps = 17/201 (8%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVP 669
+KIGKG+FG VY G +K EVAVK +C ++F+ E +L + H N+V
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
LIG C ++ +V E + G+L L N+ + L LQ++ DAA G+EYL +
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL--LQMSLDAAAGMEYLESKN- 113
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYGNQ 787
IHRD+ + N L+ N K+SDFG+SR+ EE + S + + PE
Sbjct: 114 --CIHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 788 QLTEKSDVYSFGVVLLELISG 808
+ T +SDV+S+G++L E S
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 6e-32
Identities = 75/218 (34%), Positives = 114/218 (52%), Gaps = 18/218 (8%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRI-HHRNL 667
+K+G+GSFG VY + D K VA+K++A +S S ++F+ E+ +L+ + H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
V L + ++E LV EY+ G+L D L + PL L I LEYLH+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 728 CNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTH-----ISSVARGTVGYLDP 781
GIIHRD+K NILLD + K+ DFGL++ + + + S + GT GY+ P
Sbjct: 121 ---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 782 EYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
E + SD++S G+ L EL++G P E
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 613 FCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHR 665
F K++G+G FG V + G++VAVK + S HR+ F E+ +L + H
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHE 66
Query: 666 NLVPLIGYCEEEHQRI--LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 723
N+V G CE+ R L+ EY+ +G+LRD L +Q ++ L + KG++Y
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDY 124
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDP 781
L + IHRD+ + NIL++ K+SDFGL++ ED + G + + P
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 782 EYYGNQQLTEKSDVYSFGVVLLELIS 807
E + + SDV+SFGV L EL +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 616 KIGKGSFGSVYYG-KMKDGKEVAVK--IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
IG+G+FG VY G ++ G VA+K + + + E+ LL + H N+V IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCN 729
E ++ EY NG+LR + K +A + +GL YLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQII------KKFGPFPESLVAVYVYQVLQGLAYLH---E 117
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 789
G+IHRD+K++NIL + K++DFG++ + + +SV GT ++ PE
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEVIEMSGA 176
Query: 790 TEKSDVYSFGVVLLELISGKKP 811
+ SD++S G ++EL++G P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 670
+KIG+G+ G VY + GKEVA+K M + + E+ ++ H N+V
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 671 IG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 726
Y + +V EYM G+L D + Q + + QIA + +GLEYLH+
Sbjct: 81 YDSYLVGDEL-WVVMEYMDGGSLTD----IITQNFVR-MNEPQIAYVCREVLQGLEYLHS 134
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
+IHRD+KS NILL + K++DFG + Q ++ + +SV GT ++ PE
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 787 QQLTEKSDVYSFGVVLLELISGKKP 811
+ K D++S G++ +E+ G+ P
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 68/200 (34%), Positives = 108/200 (54%), Gaps = 7/200 (3%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
F K++G G FG V+ GK + +VA+K++ + + F+ E ++ ++ H NLV L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
C ++ +V EYM NG L + L + +WL L + D + +EYL +
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---F 121
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
IHRD+ + N L+ + KVSDFGL+R +D S + V + PE + + + K
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 793 SDVYSFGVVLLELIS-GKKP 811
SDV+SFGV++ E+ S GK P
Sbjct: 182 SDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 72/225 (32%), Positives = 110/225 (48%), Gaps = 34/225 (15%)
Query: 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVT-EVALLSRI-HHRNL 667
F K IG+GSF +V K K KE A+KI+ + ++V E +L+R+ H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
+ L ++E V EY NG L R +GS+++K TR A + LEYLH
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK----CTRF-YAAEILLALEYLH 119
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFG---------LSRQAEEDLTHISSVAR--- 773
+ GIIHRD+K NILLD +M K++DFG + D T+I S
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 774 -------GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
GT Y+ PE + + SD+++ G ++ ++++GK P
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 65/199 (32%), Positives = 106/199 (53%), Gaps = 6/199 (3%)
Query: 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+K+G G FG V+ G K+ VA+KI+ + Q F EV L R+ H++L+ L
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
C ++ E M G+L L S + L + + +A A+G+ YL I
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSI 126
Query: 734 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 793
HRD+ + NIL+ ++ KV+DFGL+R +ED+ ++SS + + PE + + KS
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFSTKS 185
Query: 794 DVYSFGVVLLELIS-GKKP 811
DV+SFG++L E+ + G+ P
Sbjct: 186 DVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 6/202 (2%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 663
E+E K+G G +G VY G K VAVK + + + ++F+ E A++ I
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 60
Query: 664 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 723
H NLV L+G C E ++ E+M G L D L N++ ++ + L +A + +EY
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 119
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
L IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE
Sbjct: 120 LEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 784 YGNQQLTEKSDVYSFGVVLLEL 805
+ + KSDV++FGV+L E+
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 71/201 (35%), Positives = 109/201 (54%), Gaps = 9/201 (4%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
F K++G G FG V YGK + +VA+K++ + S +F+ E ++ ++ H LV L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
C ++ +V EYM NG L + L K L++ D +G+ YL +
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQF 121
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV-ARGTVGYLDPEYYGNQQLTE 791
IHRD+ + N L+D KVSDFGLSR +D + SSV ++ V + PE + +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 792 KSDVYSFGVVLLELIS-GKKP 811
KSDV++FGV++ E+ S GK P
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 617 IGKGSFGSVYYGKMKD-GKEVAVKIM--ADSCSHRTQQFV-TEVALLSRIHHRNLVPLIG 672
+GKGSFG V + KD GK A+K++ + + TE +LSRI+H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 673 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+ E + LV EY G L L G +++ R A + LEYLH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE----RARFYAA-EIVLALEYLH---SL 112
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
GII+RD+K NILLD + K++DFGL+++ + + ++ GT YL PE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYG 171
Query: 791 EKSDVYSFGVVLLELISGKKPVSVED 816
+ D +S GV+L E+++GK P ED
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAED 197
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVK-----IMADSCSHRTQQFVTEVALLSRIHHRNLV 668
+ IGKGSFG+V + K DGK + K M QQ V+EV +L + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT---EKEKQQLVSEVNILRELKHPNIV 62
Query: 669 PLIGYCEEEH----QRI-LVYEYMHNGTLRDRL-HGSVNQKPLD----WLTRLQIAHDAA 718
Y + Q + +V EY G L + +K ++ W Q+
Sbjct: 63 ---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL--- 116
Query: 719 KGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 776
L H +PG ++HRD+K +NI LD N K+ DFGL++ L H SS A+ V
Sbjct: 117 -ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK----ILGHDSSFAKTYV 171
Query: 777 G---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
G Y+ PE + EKSD++S G ++ EL + P
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 69/201 (34%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 674
+K+G G FG V+ G +VAVK + + + F+ E ++ ++ H LV L C
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 675 EEEHQRILVYEYMHNGTLRDRLH-GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
EE +V EYM G+L D L G + L L + +A A+G+ YL + I
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL--VDMAAQIAEGMAYLES---RNYI 125
Query: 734 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--YYGNQQLTE 791
HRD+ + NIL+ N+ K++DFGL+R E+D A+ + + PE YG T
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR--FTI 183
Query: 792 KSDVYSFGVVLLELIS-GKKP 811
KSDV+SFG++L E+++ G+ P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 12/204 (5%)
Query: 615 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVP 669
K IG G FG V G++ K +VA+K + S + + F+TE +++ + H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
L G + +++ EYM NG+L L N + + A G++YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYL---SE 124
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQ 788
+HRD+ + NIL++ N+ KVSDFGLSR+ E+ + T+ + + + + PE ++
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 789 LTEKSDVYSFGVVLLELIS-GKKP 811
T SDV+SFG+V+ E++S G++P
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 70/219 (31%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 665
+++G+G+FG V+ G+ + VAVK + ++ S+ ++ F E LL+ H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG------SVNQKPLDWLTR---LQIA 714
N+V G C E I+V+EYM +G L R HG P+ LT LQIA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 715 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVAR 773
A G+ YL + +HRD+ + N L+ ++ K+ DFG+SR D +
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 774 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ ++ PE ++ T +SDV+SFGVVL E+ + GK+P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 72/203 (35%), Positives = 115/203 (56%), Gaps = 23/203 (11%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 674
+ IG+G FG+V G+ G++VAVK + C Q F+ E A+++++HH+NLV L+G
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 675 EEEHQRI-LVYEYMHNGTL----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
H + +V E M G L R R V+ L LQ + D A+G+EYL +
Sbjct: 69 L--HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLES--- 118
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 789
++HRD+ + NIL+ + AKVSDFGL+R + + ++ V + PE +++
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN----SKLPVKWTAPEALKHKKF 174
Query: 790 TEKSDVYSFGVVLLELIS-GKKP 811
+ KSDV+S+GV+L E+ S G+ P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 67/203 (33%), Positives = 109/203 (53%), Gaps = 13/203 (6%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
++IG G FG V+ G + ++VA+K + + + + F+ E ++ ++ H LV L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLH---GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
C E LV+E+M +G L D L G +Q+ L L + D +G+ YL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN- 120
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 789
+IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + +
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 790 TEKSDVYSFGVVLLELIS-GKKP 811
+ KSDV+SFGV++ E+ S GK P
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 23/270 (8%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
F K++G G FG V+ GK + +VA+K + + + + F+ E ++ ++ H LV L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
C ++ +V E+M NG L + L + D L L + D +G+EYL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SF 121
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
IHRD+ + N L+ KVSDFG++R +D SS A+ V + PE + + + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 793 SDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 851
SDV+SFGV++ E+ + GK P + + +V MI +G + P L
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKK---SNYEVV----EMISRGF--RLYRPKLASMT--- 229
Query: 852 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 881
+ EV C ++ RP E++ AI
Sbjct: 230 ----VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-27
Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 30/233 (12%)
Query: 601 IPLPELEEATNNFCKKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQ-FV 653
IPL + F +++G+G+FG VY G+ VA+K + ++ + QQ F
Sbjct: 2 IPLSAVR-----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR 56
Query: 654 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVN------- 701
E L+S + H N+V L+G C +E +++EY+ +G L + L H V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 702 -QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760
+ LD L IA A G+EYL + +HRD+ + N L+ + K+SDFGLSR
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
Query: 761 A-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
D + S + V ++ PE + T +SD++SFGVVL E+ S G +P
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 68/197 (34%), Positives = 109/197 (55%), Gaps = 13/197 (6%)
Query: 617 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 676
IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G E
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 677 EHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 735
E + +V EYM G+L D L S + L L+ + D + +EYL +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR 126
Query: 736 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 795
D+ + N+L+ + AKVSDFGL+++A + + V + PE ++ + KSDV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 796 YSFGVVLLELIS-GKKP 811
+SFG++L E+ S G+ P
Sbjct: 183 WSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 615 KKIGKGSFGSVYYG-KMKDGKEVAVKIMA--DSCSHRTQQFVTEVALLSRIHHRNLVPLI 671
KIG G+FG VY + G+ +AVK + D+ ++ E+ +L + H NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 672 GYCEEEHQRILVY-EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
G E +++ ++ EY GTL + L + LD +GL YLH+
Sbjct: 66 G-VEVHREKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGNQ 787
GI+HRD+K +NI LD N K+ DFG + + + + T + + G Y+ PE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 788 QLTEK---SDVYSFGVVLLELISGKKP 811
+ +D++S G V+LE+ +GK+P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 64/220 (29%), Positives = 119/220 (54%), Gaps = 25/220 (11%)
Query: 617 IGKGSFGSVYY------GKMKDGKEVAV-KIMADSCSHRTQQFV----TEVALLSRIHHR 665
IGKG++G VY G+M K+V + +A R + V +E+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEY 723
N+V +G+ E + EY+ G++ R +G ++ + + T Q+ +GL Y
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-QVL----EGLAY 123
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-RGTVGYLDPE 782
LH + GI+HRD+K+ N+L+D + K+SDFG+S+++++ + +++ +G+V ++ PE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 783 YYGNQQ--LTEKSDVYSFGVVLLELISGKKPVS-VEDFGA 819
+ + K D++S G V+LE+ +G++P S E A
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 75/218 (34%), Positives = 112/218 (51%), Gaps = 20/218 (9%)
Query: 617 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLVPL 670
+G GSFGSVY G + DG AVK + Q+ V E+ALLS++ H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
+G EE + E + G+L L +GS + + TR QI GLEYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QIL----LGLEYLH--- 119
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 788
+ +HRD+K +NIL+D N K++DFG+++Q E + S +G+ ++ PE Q
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKSF-KGSPYWMAPEVIAQQG 177
Query: 789 L-TEKSDVYSFGVVLLELISGKKPVS-VEDFGAELNIV 824
+D++S G +LE+ +GK P S +E A I
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 73/209 (34%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 615 KKIGKGSFGSVYYG--KMKDGKE--VAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 669
K++G G+FGSV G MK GKE VAVK + ++F+ E ++++++ H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
LIG C+ E +LV E G L L + L ++AH A G+ YL
Sbjct: 61 LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLE-S 113
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE--Y 783
+ +HRD+ + N+LL +AK+SDFG+SR A D ++ R + + PE
Sbjct: 114 KH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 784 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
YG + + KSDV+S+GV L E S G KP
Sbjct: 172 YG--KFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 71/216 (32%), Positives = 113/216 (52%), Gaps = 24/216 (11%)
Query: 615 KKIGKGSFGSVYYGKMK--DGK--EVAVKIM-ADSCSHR-TQQFVTEVALLSRIHHRNLV 668
K +G+G FGSV G++ DG +VAVK M D ++ ++F++E A + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 669 PLIGYC--EEEHQRI----LVYEYMHNGTLRD-----RLHGSVNQKPLDWLTRLQIAHDA 717
LIG C Q+I ++ +M +G L RL G + PL L + + D
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV--DI 122
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 776
A G+EYL N IHRD+ + N +L +M V+DFGLS++ D +A+ V
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 777 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
++ E ++ T KSDV++FGV + E+ + G+ P
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 615 KKIGKGSFGSVYYGKMK---DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPL 670
++G G+ G V K+ GK +AVK + + +Q + E+ +L + + +V
Sbjct: 7 GELGAGNSGVVS--KVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
G + EYM G+L L + P L ++ +A KGL YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA--VLKGLTYLHE--KH 120
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQ 787
IIHRDVK SNIL++ + K+ DFG+S Q ++S+A+ GT Y+ PE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVGTSSYMAPERIQGN 174
Query: 788 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 820
+ KSD++S G+ L+EL +G+ P E+ +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 70/219 (31%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 604 PELEEATNNFCKKIGKGSFGSVYYGKM--KDGK----EVAVKIMADSCSHRTQQ-FVTEV 656
PE+ + + +G G+FG VY G +DG +VAVK + +SCS + + F+ E
Sbjct: 1 PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60
Query: 657 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----VNQKPLDWLTRLQ 712
++S+ +H+N+V LIG E R ++ E M G L+ L + L L
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 713 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA-EEDLTHI 768
A D AKG +YL IHRD+ + N LL AK++DFG++R
Sbjct: 121 CARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 807
A + ++ PE + + T K+DV+SFGV+L E+ S
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 14/210 (6%)
Query: 607 EEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALLSR 661
EE F +++GKG+FGSV Y ++D G+ VAVK + S + + F E+ +L
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61
Query: 662 IHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 719
+ H N+V G C +R LV EY+ G+LRD L +++ LD L A K
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICK 119
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVG 777
G+EYL + +HRD+ + NIL++ R K+ DFGL++ +D + + +
Sbjct: 120 GMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 778 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS 807
+ PE + + SDV+SFGVVL EL +
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 6/208 (2%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 664
E++ + +K+G G FG V+ G + VAVK + + + F+ E ++ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRH 60
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
L+ L C E +V E M G+L + L G + L + +A A G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYL 119
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
IHRD+ + N+L+ N KV+DFGL+R +ED+ A+ + + PE
Sbjct: 120 EA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA 176
Query: 785 GNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ + KSDV+SFG++L E+++ G+ P
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 72/213 (33%), Positives = 112/213 (52%), Gaps = 27/213 (12%)
Query: 617 IGKGSFGSVYYG-KMKDGKEVAVK------IMADSCSHRT---QQFVTEVALLSRIHHRN 666
IG GSFGSVY G G+ +AVK + A S + E+ALL + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 667 LVPLIG-YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 723
+V +G + +H I + EY+ G++ L +G+ + + R QI KGL Y
Sbjct: 68 IVQYLGSSLDADHLNIFL-EYVPGGSVAALLNNYGAFEETLVRNFVR-QIL----KGLNY 121
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-----RGTVGY 778
LH N GIIHRD+K +NIL+D K+SDFG+S++ E + + +G+V +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ PE T K+D++S G +++E+++GK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 615 KKIGKGSFGSVYYGKMKDG------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 668
KKIG+GSFG +Y K K KE+ + M +++ EV LL+++ H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIV 62
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRL---HGSV--NQKPLDWLTRLQIAHDAAKGLEY 723
+E + +V EY G L R+ G + + L W ++ + GL++
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKH 116
Query: 724 LHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 782
+H + I+HRD+KS NI L N M AK+ DFG++RQ D ++ GT YL PE
Sbjct: 117 IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPE 172
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
N+ K+D++S G VL EL + K P
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 78/272 (28%), Positives = 133/272 (48%), Gaps = 29/272 (10%)
Query: 615 KKIGKGSFGSVYYG--KMKDGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVP 669
K IG G FG V+ G KM KEVAV I + Q F++E +++ + H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
L G + +++ EYM NG L L + + + A G++YL +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGNQ 787
+HRD+ + NIL++ N+ KVSDFGLSR E+D T+ +S + + + PE +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 788 QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846
+ T SDV+SFG+V+ E++S G++P +W S +V+ ++
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERP-------------YWDMS---NHEVMKAINDGFRL 229
Query: 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878
++ + ++ +QC +Q RP+ +IV
Sbjct: 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 11/209 (5%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVP 669
+ IG G+ VY E VA+K + + C + EV +S+ +H N+V
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
+ LV Y+ G+L D + S + LD + + KGLEYLH+
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYG 785
G IHRD+K+ NILL + K++DFG+S + + R GT ++ PE
Sbjct: 122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG-GDRTRKVRKTFVGTPCWMAPEVME 179
Query: 786 NQQ-LTEKSDVYSFGVVLLELISGKKPVS 813
K+D++SFG+ +EL +G P S
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 616 KIGKGSFGSVYYGKMKDGKEV-AVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
++G+G+ GSV ++K+ + A+K I D +Q + E+ + +V G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 674 CEEEHQRIL--VYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYL 724
+E + EY G+L D ++ V +K L +IA KGL YL
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL-----GKIAESVLKGLSYL 121
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDP 781
H+ IIHRD+K SNILL + K+ DFG+S + ++S+A GT Y+ P
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL------VNSLAGTFTGTSFYMAP 172
Query: 782 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
E + + SDV+S G+ LLE+ + P
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 615 KKIGKGSFGSVYYGKMKD--GK--EVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVP 669
KK+G GSFG V G+ GK VAVK + +D S F+ E A++ + H NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEYLHTGC 728
L G H ++V E G+L DRL + ++ L A A G+ YL +
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRK--DALGHFLISTLCDYAVQIANGMRYLES-- 115
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV--GYLDPEYYGN 786
IHRD+ + NILL + + K+ DFGL R ++ H V + PE
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 787 QQLTEKSDVYSFGVVLLELIS-GKKP 811
+ + SDV+ FGV L E+ + G++P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 672
++IG+G+FG V+ G+++ D VAVK ++ + +F+ E +L + H N+V LIG
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPG 731
C ++ +V E + G L + P L +Q+ +AA G+EYL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKH--- 114
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVGYLDPEYYGNQQL 789
IHRD+ + N L+ K+SDFG+SR+ EED + S+ + + V + PE +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 790 TEKSDVYSFGVVLLELIS 807
+ +SDV+SFG++L E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 615 KKIGKGSFGSVYYGKMKDGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 669
+ IG+G FG VY G + VAVK + S ++F+ E ++ + H ++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
LIG E I V E G LR L VN+ LD + + ++ + L YL +
Sbjct: 72 LIGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES--- 125
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 789
+HRD+ + N+L+ K+ DFGLSR E++ + +S + + ++ PE ++
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 790 TEKSDVYSFGVVLLELIS-GKKP 811
T SDV+ FGV + E++ G KP
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 72/262 (27%), Positives = 128/262 (48%), Gaps = 21/262 (8%)
Query: 617 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIGYCE 675
+GKG+FG V+ G +KD VAVK + + +F++E +L + H N+V LIG C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 676 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 735
+ +V E + G L ++ L + + DAA G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLES---KNCIHR 117
Query: 736 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 795
D+ + N L+ N K+SDFG+SRQ ++ + S + + + + PE + + +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 796 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 855
+S+G++L E S + V + N AR ++KG +S + +++
Sbjct: 178 WSYGILLWETFS----LGVCPYPGMTN--QQAREQVEKGYRMSCPQKC------PDDVYK 225
Query: 856 IAEVAIQCVEQRGFSRPKMQEI 877
+ + +C + + +RPK E+
Sbjct: 226 VMQ---RCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 15/202 (7%)
Query: 616 KIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 674
K+G+GS+GSVY + G+ VA+K++ Q+ + E+++L + +V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 675 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPG 731
+ +V EY G++ D + + K L T +IA + KGLEYLH +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIM--KITNKTL---TEEEIAAILYQTLKGLEYLH---SNK 119
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
IHRD+K+ NILL+ +AK++DFG+S Q + + ++V GT ++ PE
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNN 178
Query: 792 KSDVYSFGVVLLELISGKKPVS 813
K+D++S G+ +E+ GK P S
Sbjct: 179 KADIWSLGITAIEMAEGKPPYS 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 77/275 (28%), Positives = 135/275 (49%), Gaps = 35/275 (12%)
Query: 615 KKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVP 669
K IG G FG V G++K +E+ V I + +Q F++E +++ + H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 726
L G + ++V EYM NG+L L Q T +Q+ A G++YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRGIASGMKYL-- 122
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYY 784
+ G +HRD+ + NIL++ N+ KVSDFGLSR E+D + + + + + PE
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 785 GNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843
++ T SDV+S+G+V+ E++S G++P +W S DVI ++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWEMS---NQDVIKAIEEG 225
Query: 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878
++ + ++ + C ++ RPK ++IV
Sbjct: 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 38/214 (17%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF-VT---EVALLSRIHHRNLVP 669
+IG+G++G VY + K G+ VA+K + + + F +T E+ LL ++ H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 670 LIGYCEEEHQR--ILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEY 723
L + + +V+EYM H+ T L S K T QI +GL+Y
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLT---GLLDSPEVK----FTESQIKCYMKQLLEGLQY 115
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG-------TV 776
LH + GI+HRD+K SNIL++ + K++DFGL+R + T+
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLAR-------PYTKRNSADYTNRVITL 165
Query: 777 GYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 809
Y PE G + + D++S G +L EL GK
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 14/217 (6%)
Query: 603 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEV 656
L L+E K +G G+FG+VY G E VA+K++ + S + + + E
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60
Query: 657 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 716
+++ + H ++V L+G C Q L+ + M G L D + ++ + L
Sbjct: 61 YVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQ 117
Query: 717 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGT 775
AKG+ YL ++HRD+ + N+L+ K++DFGL++ + D + +
Sbjct: 118 IAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 776 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ ++ E ++ T KSDV+S+GV + EL++ G KP
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNLV 668
K +G+G+FG VY D G+E+AVK + + E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 669 PLIGYCEEEHQRILVY-EYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
G C + + + ++ EYM G+++D + +G++ + TR QI G+EYLH
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QILE----GVEYLH 121
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDPE 782
+ I+HRD+K +NIL D K+ DFG S++ + T + SV GT ++ PE
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPE 177
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ K+DV+S G ++E+++ K P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 66/199 (33%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 617 IGKGSFGSVYYGKMKDGKEV-AVKIMADS-C--SHRTQQFVTEVALLSRIHHRNLVPLIG 672
IGKG+FG V + +D K++ A+K M C + + E +L ++H LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
++E LV + + G LR H S K + + I + LEYLH + GI
Sbjct: 68 SFQDEENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKFWIC-EIVLALEYLH---SKGI 121
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
IHRD+K NILLD ++DF ++ + D T +S + GT GY+ PE Q +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTS-GTPGYMAPEVLCRQGYSVA 179
Query: 793 SDVYSFGVVLLELISGKKP 811
D +S GV E + GK+P
Sbjct: 180 VDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 10/208 (4%)
Query: 616 KIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ--FVTEVALLSRIHHRNLVPLIG 672
KIGKGSFG V+ K K V A+K + S +R ++ + E +L+++ ++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
++ + +V EY NG L L + P D + R I GL +LH+
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLHSK---K 121
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
I+HRD+KS N+ LD K+ D G+++ D T+ ++ GT YL PE ++ E
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 792 KSDVYSFGVVLLELISGKKPVSVEDFGA 819
KSDV++ GVVL E +GK P + GA
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGA 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 615 KKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
++IG G++G VY + G+ VA+K++ + E+++L H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 730
+ +V EY G+L+D V + PL + LQIA+ + KGL YLH
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQ--VTRGPL---SELQIAYVCRETLKGLAYLH---ET 120
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLDPEYYG 785
G IHRD+K +NILL + K++DFG+S Q LT ++A+ GT ++ PE
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQ----LTA--TIAKRKSFIGTPYWMAPEVAA 174
Query: 786 NQQL---TEKSDVYSFGVVLLELISGKKPVS 813
++ K D+++ G+ +EL + P+
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 7e-23
Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 615 KKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 668
+++G+G+FG V+ + +D VAVK + D+ + + F E LL+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKPLDWLTR---LQIAHDAA 718
G C E I+V+EYM +G L R HG LT+ L IA A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 777
G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D + +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 778 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
++ PE ++ T +SDV+S GVVL E+ + GK+P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 617 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRNLVPLI 671
IGKG FG VY+G + D + S + T +QF+ E ++ H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 672 GYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR--LQIAHDAAKGLEYLHTGC 728
G C E ++V YM +G LR+ + + + L LQ+A KG+EYL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA----KGMEYL---A 115
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPEYYG 785
+ +HRD+ + N +LD + KV+DFGL+R E H + A+ V ++ E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKP 811
Q+ T KSDV+SFGV+L EL++ P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 70/216 (32%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 617 IGKGSFGSVYYGKMK-DGKEVAVKIM--AD-SCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
I KG++G V+ K K G A+K++ AD ++ Q +TE +LS+ +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
+ + LV EY+ G L L +V D R+ IA + LEYLH + GI
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDV-ARIYIA-EIVLALEYLH---SNGI 114
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQ--------AEEDLTHISSVARGTVGYLDPEYY 784
IHRD+K NIL+D N K++DFGLS+ +D + GT Y+ PE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEVI 173
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 820
Q ++ D +S G +L E + G P F E
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP-----FHGE 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 2e-22
Identities = 71/235 (30%), Positives = 107/235 (45%), Gaps = 47/235 (20%)
Query: 613 FCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHR 665
+ + IG+G+FG V+ + + VAVK++ + S Q F E AL++ H
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------------HGSV-------NQKPLD 706
N+V L+G C L++EYM G L + L H + N PL
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 707 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ------ 760
+L IA A G+ YL +HRD+ + N L+ NM K++DFGLSR
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 761 ---AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+E D I ++ PE + T +SDV+++GVVL E+ S G +P
Sbjct: 186 YKASENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 8/209 (3%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 664
E+ + KK+G G FG V+ G + +VAVK + + Q F+ E L+ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQH 60
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEY 723
LV L +E ++ EYM G+L D L K L L +L + A+G+ Y
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL--LPKLIDFSAQIAEGMAY 118
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
+ IHRD++++N+L+ ++ K++DFGL+R E++ A+ + + PE
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 784 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
T KSDV+SFG++L E+++ GK P
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 664
E+ T KK+G G FG V+ G +VA+K + S + F+ E L+ ++ H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQH 60
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
LV L +E I + EYM NG+L D L K L + +A A+G+ ++
Sbjct: 61 PRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFI 118
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE
Sbjct: 119 ER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 785 GNQQLTEKSDVYSFGVVLLELIS-GKKP 811
T KSDV+SFG++L E+++ G+ P
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 617 IGKGSFGSVYYGKMK----DGKE--VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVP 669
+G+G FG V+ K K +G E V VK + + Q F E+ + ++ H+N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGS------VNQKPLDWLTRLQIAHDAAKGLEY 723
L+G C E ++ EY G L+ L + + PL ++ + A G+++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
L +HRD+ + N L+ KVS LS+ + A + +L PE
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 784 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ KSDV+SFGV++ E+ + G+ P
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 617 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG-- 672
IG+G++G VY + K G+ VA+KIM D ++ E +L + +H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 673 ----YCEEEHQRILVYEYMHNGTLRD---RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
+ Q LV E G++ D L + +W+ I + +GL YLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--YILRETLRGLAYLH 130
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 780
+IHRD+K NILL N K+ DFG+S Q + S++ R GT ++
Sbjct: 131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD------STLGRRNTFIGTPYWMA 181
Query: 781 PE-----YYGNQQLTEKSDVYSFGVVLLELISGKKPVS 813
PE + +SDV+S G+ +EL GK P+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 4e-22
Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 670
++IG GSFG+VY+ + ++ + VA+K M+ S Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
G EH LV EY G+ D L V++KPL + I H A +GL YLH+
Sbjct: 81 KGCYLREHTAWLVMEYCL-GSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQ 787
IHRD+K+ NILL K++DFG + + + GT ++ PE
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 788 QLTEKSDVYSFGVVLLELISGKKP 811
Q K DV+S G+ +EL K P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-22
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 615 KKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 668
+++G+G+FG V+ + KD VAVK + D + F E LL+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKP------LDWLTRLQIAH 715
G C + I+V+EYM +G L R HG V+ +P L L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 716 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARG 774
A G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 775 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ ++ PE ++ T +SDV+SFGV+L E+ + GK+P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 9e-22
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 616 KIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 669
++G+G+FG V+ + +D VAVK + ++ Q F E LL+ + H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKPLDWLTRLQIAHDA 717
G C E ++V+EYM +G L R HG V L L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 776
A G+ YL + +HRD+ + N L+ + K+ DFG+SR D + +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 777 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
++ PE ++ T +SD++SFGVVL E+ + GK+P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 9e-22
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 612 NFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 670
NF KIG+GS G V G++VAVK M R + EV ++ H N+V +
Sbjct: 23 NF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 726
+ +V E++ G L D + H +N++ QIA K L +LH
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIATVCLAVLKALSFLHA 133
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
G+IHRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE
Sbjct: 134 ---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISR 189
Query: 787 QQLTEKSDVYSFGVVLLELISGKKP 811
+ D++S G++++E++ G+ P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 614 CKKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 671
+ IGKGSFG VY K + VA+K++ + + E+ LS+ +
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
G + + ++ EY G+ D L LD I + GLEYLH G
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEG 118
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGNQQ 788
IHRD+K++NILL K++DFG+S Q LT S VG ++ PE
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQ----LTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 789 LTEKSDVYSFGVVLLELISGKKPVS 813
EK+D++S G+ +EL G+ P+S
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLS 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 67/229 (29%), Positives = 115/229 (50%), Gaps = 25/229 (10%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGK-----MKDGKEVAVKIMAD-SCSHRTQQFVTEVAL 658
EL + F +++G+ +FG +Y G M + VA+K + D + + +F E +L
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 659 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVN---------QKP 704
++ +HH N+V L+G +E +++EY++ G L + L H V +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 705 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 763
LD L IA A G+EYL + +H+D+ + NIL+ + K+SD GLSR+
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
D + + + ++ PE + + SD++SFGVVL E+ S G +P
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 77/235 (32%), Positives = 115/235 (48%), Gaps = 19/235 (8%)
Query: 585 SIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMAD 643
S +R G D +A + E+ + ++IG GSFG+VY+ + ++ + VA+K M+
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPEKLFTDL-REIGHGSFGAVYFARDVRTNEVVAIKKMSY 60
Query: 644 SCSHRT---QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV 700
S Q + EV L RI H N + G EH LV EY G+ D L V
Sbjct: 61 SGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE--V 117
Query: 701 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760
++KPL + I H A +GL YLH+ +IHRD+K+ NILL + K++DFG +
Sbjct: 118 HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI 174
Query: 761 AEEDLTHISSVARGTVGYLDPEY---YGNQQLTEKSDVYSFGVVLLELISGKKPV 812
A + + GT ++ PE Q K DV+S G+ +EL K P+
Sbjct: 175 ASPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 65/205 (31%), Positives = 114/205 (55%), Gaps = 15/205 (7%)
Query: 617 IGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 671
IG G FG V G++K GK VA+K + + + ++ F++E +++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
G + +++ E+M NG L L + Q + L + + A G++YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL--VGMLRGIAAGMKYL---SEMN 126
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVA-RGTVGYLDPEYYGNQ 787
+HRD+ + NIL++ N+ KVSDFGLSR E+ D T+ SS+ + + + PE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 788 QLTEKSDVYSFGVVLLELIS-GKKP 811
+ T SDV+S+G+V+ E++S G++P
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 66/223 (29%), Positives = 111/223 (49%), Gaps = 33/223 (14%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ----FVTEVALLSRIHHRNLVP 669
KK+GKGS+GSVY K + D + A+K + +Q+ V E+ +L+ ++H N+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEV--DLGSMSQKEREDAVNEIRILASVNHPNI-- 61
Query: 670 LIGYCE---EEHQRILVYEYMHNGTLRDRLHGSVNQKPL-----DWLTRLQIAHDAAKGL 721
I Y E + ++ +V EY G L + ++ L W +Q+ +GL
Sbjct: 62 -ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGL 116
Query: 722 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--THISSVARGTVGYL 779
+ LH I+HRD+KS+NILL N K+ D G+S+ ++++ T I GT Y+
Sbjct: 117 QALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYM 168
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 822
PE + + + KSD++S G +L E+ + P +L
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLR 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 616 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ-----QFVTEVALLSRIHHRNLVP 669
+IG+G+ G V+ K + G+ VA+K + R + Q + E+ L H +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEYLHT 726
L+ +LV EYM L + L ++PL Q+ KG+ Y+H
Sbjct: 64 LLDVFPHGSGFVLVMEYM-PSDLSEVLRDE--ERPL---PEAQVKSYMRMLLKGVAYMH- 116
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 785
GI+HRD+K +N+L+ + K++DFGL+R E+ + S T Y PE YG
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 824
++ D+++ G + EL++G E+ +L IV
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 674
KK+G G FG V+ G +VAVK + + + F+ E ++ ++ H LV L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 675 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 734
EE I V EYM G+L D L + L + +A A G+ Y+ IH
Sbjct: 71 SEEPIYI-VTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 735 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 794
RD++S+NIL+ + K++DFGL+R E++ A+ + + PE + T KSD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 795 VYSFGVVLLELIS-GKKP 811
V+SFG++L EL++ G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 617 IGKGSFGS-VYYGKMKDGKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLIGY 673
+GKG+FG Y + +D V K + S + ++ E+ +LS + H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH--DAAKGLEYLHTGCNPG 731
+++ ++ EY + GTL D++ V QK + + + + + Y+H G
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
I+HRD+K+ NI L K+ DFG+S+ + + +V GT Y+ PE +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNF 180
Query: 792 KSDVYSFGVVLLELISGKK 810
KSD+++ G VL EL++ K+
Sbjct: 181 KSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 616 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 675
K+G+G FG V+ G +VA+K + + + F+ E ++ ++ H LVPL
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 676 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 735
EE I V E+M G+L D L + K L + +A A G+ Y+ IHR
Sbjct: 72 EEPIYI-VTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 736 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 795
D++++NIL+ N+ K++DFGL+R E++ A+ + + PE + T KSDV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 796 YSFGVVLLELIS-GKKP 811
+SFG++L EL++ G+ P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 5e-21
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 616 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 675
K+G+G FG V+ G VA+K + + + F+ E ++ ++ H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 676 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 735
EE I V EYM G+L D L G + K L + +A A G+ Y+ +HR
Sbjct: 72 EEPIYI-VTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 736 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 795
D++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T KSDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 796 YSFGVVLLELIS-GKKP 811
+SFG++L EL + G+ P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 8e-21
Identities = 69/232 (29%), Positives = 113/232 (48%), Gaps = 33/232 (14%)
Query: 602 PLPELEEATNNFCKKIGKGSFGSVYYG------KMKDGKEVAVKIM-ADSCSHRTQQFVT 654
P EL K +G+G+FG V + VAVK++ D+ V+
Sbjct: 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS 64
Query: 655 EVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQK-------- 703
E+ ++ I H+N++ L+G C +E +V EY +G LRD R +
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 704 PLDWLTR---LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760
P + LT+ + A+ A+G+E+L + IHRD+ + N+L+ + K++DFGL+R
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR- 180
Query: 761 AEEDLTHISSVARGTVGYLD-----PEYYGNQQLTEKSDVYSFGVVLLELIS 807
D+ HI + T G L PE ++ T +SDV+SFGV+L E+ +
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 9e-21
Identities = 75/224 (33%), Positives = 111/224 (49%), Gaps = 27/224 (12%)
Query: 604 PELEEATNNFCKKIGKGSFGSVYYGKM-KDG--KEVAVKIMADSCS---HRTQQFVTEVA 657
P LE F IG+G+FG V ++ KDG + A+K M + S HR F E+
Sbjct: 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELE 59
Query: 658 LLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----------VNQKPLD 706
+L ++ HH N++ L+G CE L EY +G L D L S +
Sbjct: 60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119
Query: 707 WLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763
L+ Q+ H D A+G++YL IHRD+ + NIL+ N AK++DFGLSR E
Sbjct: 120 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176
Query: 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 807
+ ++ R V ++ E T SDV+S+GV+L E++S
Sbjct: 177 YVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 27/211 (12%)
Query: 617 IGKGSFGSVYYGKMK-DGKEV--AVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLI 671
IG+G+FG V +K DG ++ A+K++ + S + F E+ +L ++ HH N++ L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 672 GYCEEEHQRILVYEYMHNGTLRD---------------RLHGSVNQKPLDWLTRLQIAHD 716
G CE + EY G L D + HG+ + L LQ A D
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST--LTSQQLLQFASD 127
Query: 717 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 776
A G++YL IHRD+ + N+L+ N+ +K++DFGLSR E++ ++ R V
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG--EEVYVKKTMGRLPV 182
Query: 777 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 807
++ E T KSDV+SFGV+L E++S
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 617 IGKGSFGSVYYGKMKDGKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHHRNLVPL 670
+GKG++G+VY G G+ +AVK + + ++ EV LL + H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
+G C +++ + E++ G++ L+ G + + T+ QI G+ YLH C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QIL----DGVAYLHNNC 122
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTH--ISSVARGTVGYLDPEY 783
++HRD+K +N++L N K+ DFG +R+ TH + GT ++ PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
KSD++S G + E+ +GK P++ D
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 68/276 (24%), Positives = 126/276 (45%), Gaps = 31/276 (11%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ------FVTEVALLSRIHHRNL 667
+++G G+F S Y + +K G +AVK + + ++Q E+ L++R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 668 VPLIG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
+ ++G CE+ H + V E+M G++ L + +GL YLH
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLH- 120
Query: 727 GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLT---HISSVARGTVGYLDPE 782
IIHRDVK +N+L+D R +++DFG + + T GT+ ++ PE
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842
+Q DV+S G V++E+ + K P + E L ++ S + + P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878
L +V ++C+E + RP +E++
Sbjct: 239 GL------------RDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 617 IGKGSFGSVYYGKMK-DGKEV--AVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLI 671
IG+G+FG V ++K DG + A+K M + S + F E+ +L ++ HH N++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 672 GYCEEEHQRILVYEYMHNGTLRD---------------RLHGSVNQKPLDWLTRLQIAHD 716
G CE L EY +G L D + + + L L A D
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST--LSSQQLLHFAAD 120
Query: 717 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 776
A+G++YL IHRD+ + NIL+ N AK++DFGLSR +++ ++ R V
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPV 175
Query: 777 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 807
++ E T SDV+S+GV+L E++S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 616 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 674
KIG+GS G V + K G++VAVK+M R + EV ++ H+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 675 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 734
+ ++ E++ G L D V+Q L+ + + L YLH+ G+IH
Sbjct: 88 LVGEELWVLMEFLQGGALTD----IVSQTRLNEEQIATVCESVLQALCYLHS---QGVIH 140
Query: 735 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 794
RD+KS +ILL ++ R K+SDFG Q +D+ S+ GT ++ PE + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVD 199
Query: 795 VYSFGVVLLELISGKKP 811
++S G++++E++ G+ P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 70/208 (33%), Positives = 105/208 (50%), Gaps = 24/208 (11%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 670
++IG GSFG+VY+ + +++ + VA+K M+ S + + Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
G EH LV EY G+ D L V++KPL + + H A +GL YLH +
Sbjct: 81 RGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY---Y 784
+IHRDVK+ NILL K+ DFG + I + A VG ++ PE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSAS--------IMAPANXFVGTPYWMAPEVILAM 186
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKPV 812
Q K DV+S G+ +EL K P+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 19/213 (8%)
Query: 615 KKIGKGSFGSVYYGKMKDGK---EVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVP 669
K +G+G FGSV G++ +VAVK M + R++ F++E + H N++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 670 LIGYCEEEHQR------ILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRL--QIAHDAAKG 720
LIG C + + +++ +M +G L L+ + P T++ + D A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYL 779
+EYL + IHRD+ + N +L+ NM V+DFGLS++ D +A+ V ++
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
E ++ T KSDV+SFGV + E+ + G+ P
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 70/204 (34%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 616 KIGKGSFGSVYYGKMKDGKE-VAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLI 671
+IG GSFG+VY+ E VAVK M+ S + + Q + EV L ++ H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
G +EH LV EY G+ D L V++KPL + I H A +GL YLH+
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQQ 788
+IHRD+K+ NILL + K++DFG + ++ + + GT ++ PE Q
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196
Query: 789 LTEKSDVYSFGVVLLELISGKKPV 812
K DV+S G+ +EL K P+
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 20/214 (9%)
Query: 615 KKIGKGSFGSVYYGKMK----DGKEVAVKIM-AD-SCSHRTQQFVTEVALLSRIHHRNLV 668
+ +GKG FGSV ++K ++VAVK++ AD S ++F+ E A + H N++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 669 PLIGYC--EEEHQRI----LVYEYMHNGTLRDRLHGS-VNQKP--LDWLTRLQIAHDAAK 719
LIG R+ ++ +M +G L L S + ++P L T ++ D A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGY 778
G+EYL + IHRD+ + N +L+ NM V+DFGLS++ D ++ V +
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
L E + T SDV++FGV + E+++ G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 4e-20
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 616 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 674
KIG+GS G V K GK+VAVK M R + EV ++ HH N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 675 EEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
+ +V E++ G L D + H +N++ + + + L YLH N G+I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLH---NQGVI 140
Query: 734 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 793
HRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 794 DVYSFGVVLLELISGKKP 811
D++S G++++E+I G+ P
Sbjct: 200 DIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 6e-20
Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 613 FCKKIGKGSFGSVY----YGKMKDGK--EVAVKIMADSCSHRT--QQFVTEVALLSRI-H 663
F K +G G+FG V YG K +VAVK M +H + + ++E+ ++S + +
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK-MLKPTAHSSEREALMSELKIMSHLGN 97
Query: 664 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 723
H N+V L+G C +++ EY G L + L + L L ++ AKG+ +
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 724 LHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDP 781
L + C IHRD+ + N+LL K+ DFGL+R D ++ AR V ++ P
Sbjct: 157 LASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 782 EYYGNQQLTEKSDVYSFGVVLLELIS 807
E N T +SDV+S+G++L E+ S
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 9/209 (4%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 664
E+ + KK+G G FG V+ +VAVK M S + F+ E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQH 60
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEY 723
LV L +E I+ E+M G+L D L +++PL L + + A+G+ +
Sbjct: 61 DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAF 117
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
+ IHRD++++NIL+ ++ K++DFGL+R E++ A+ + + PE
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 784 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
T KSDV+SFG++L+E+++ G+ P
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 615 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 667
+++G+GSFG VY G K VA+K + ++ S R + +F+ E +++ + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----SVNQKPLDWLTR---LQIAHDAAKG 720
V L+G ++V E M G L+ L + N L T +Q+A + A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 779
+ YL +HRD+ + N ++ ++ K+ DFG++R E D V ++
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELIS 807
PE + T KSDV+SFGVVL E+ +
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 1e-19
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 614 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMA---------DSCSHRTQQFVTEVALLSRIH 663
+K+G+G++G VY + K G+ VA+K + + + E++LL +
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA-------LREISLLKELK 56
Query: 664 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 723
H N+V L+ E + LV+EY L+ L PL I + +GL Y
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 782
H+ I+HRD+K NIL++ + K++DFGL+R L T+ V T+ Y PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPE 168
Query: 783 -YYGNQQLTEKSDVYSFGVVLLELISGK 809
G++ + D++S G + E+I+GK
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 613 FCKKI---GKGSFGSVY---YGKMKD--GKEVAVKIMADSCSHR-TQQFVTEVALLSRIH 663
+ KKI G+G FG V Y D G+ VAVK + C + T + E+ +L ++
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64
Query: 664 HRNLVPLIGYCEEEHQRI--LVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKG 720
H N+V G C E+ + L+ EY+ G+LRD L +N L L A +G
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEG 119
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGY 778
+ YLH+ IHRD+ + N+LLD + K+ DFGL++ E + + V +
Sbjct: 120 MAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELIS 807
E + + SDV+SFGV L EL++
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVP 669
KIG+G++G VY + K E VA+K + ++ + E+ LL ++H N++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKI--KLRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
L+ + LV+E+M L + Q+ L + +GL + H+
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHISSVARGTVGYLDPE-YYG 785
GI+HRD+K N+L++ K++DFGL+R TH T Y PE G
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV----TRWYRAPELLLG 172
Query: 786 NQQLTEKSDVYSFGVVLLELISGK 809
++ + D++S G + EL+S +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 614 CKKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRN 666
+++G+GSFG VY G +KD E VA+K + ++ S R + +F+ E +++ + +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 667 LVPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAK 719
+V L+G + +++ E M G +LR + + Q P +Q+A + A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGY 778
G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLEL 805
+ PE + T SDV+SFGVVL E+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 67/211 (31%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR-----NLV 668
K I KG+FGSVY K + G A+K++ S Q VT V I +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVA 60
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYL 724
L + + LV EY++ G S+ + P DW Q + G+E L
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDC-----ASLIKTLGGLPEDWAK--QYIAEVVLGVEDL 113
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
H GIIHRD+K N+L+D K++DFGLSR E+ + GT YL PE
Sbjct: 114 H---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETI 165
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKPVSVE 815
+ SD +S G V+ E + G P E
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 63/227 (27%), Positives = 112/227 (49%), Gaps = 33/227 (14%)
Query: 615 KKIGKGSFGSVYYGKMKDGK------EVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNL 667
K +G+G FG V K VAVK++ + + S + ++E LL +++H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------------GSVN--------QKPLD 706
+ L G C ++ +L+ EY G+LR L G+ N ++ L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 707 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766
+ A ++G++YL ++HRD+ + N+L+ + K+SDFGLSR E+ +
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 767 HIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
++ S R V ++ E + T +SDV+SFGV+L E+++ G P
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 28/222 (12%)
Query: 615 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 664
K +G+G FG V K K+ VAVK++ D + + V+E+ ++ I H
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRL 711
+N++ L+G C ++ ++ EY G LR+ L V + + + +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 712 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 770
+ A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D ++
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 771 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
R V ++ PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 64/218 (29%), Positives = 113/218 (51%), Gaps = 29/218 (13%)
Query: 615 KKIGKGSFGSVY----YGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRI-HH 664
K +G+G FG V YG K + VAVK++ D+ + + ++E+ L+ I H
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTRL 711
+N++ L+G C +E ++ EY G LR+ L V ++ L + +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 712 QIAHDAAKGLEYLHTG-CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHIS 769
A+ A+G+EYL + C IHRD+ + N+L+ + K++DFGL+R + D +
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 807
S R V ++ PE ++ T +SDV+SFG+++ E+ +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 5e-19
Identities = 66/254 (25%), Positives = 105/254 (41%), Gaps = 41/254 (16%)
Query: 611 NNFC--KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHH 664
++F K IG+G+FG V+ + KD +V A+K++ S + Q E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
+V L ++E LV EYM G L L + P + R IA + L+ +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEET-ARFYIA-ELVLALDSV 117
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS-------------------------- 758
H G IHRD+K NIL+D + K++DFGL
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 759 --RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
R+ + ++ GT Y+ PE + D +S GV+L E++ G P +
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 817 -FGAELNIVHWARS 829
I++W S
Sbjct: 235 LQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 668
K +G+G+FG VY D G+E+AVK + D S T + V E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 669 PLIGYCEEEHQRIL--VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
G + +R L E+M G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-QIL----EGVSYL 122
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 781
H+ I+HRD+K +NIL D K+ DFG S++ + T + SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSP 178
Query: 782 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
E + K+D++S G ++E+++ K P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 620 GSFGSVYYGKMKDGK-----EVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGY 673
G+FG ++YG + D K EV VK + D S + + E LL + H+N++P++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 674 CEEEHQRILV-YEYMHNGTLRDRL----HGSVNQKPLDWLTRLQIAHDA---AKGLEYLH 725
C E+ + V Y YM+ G L+ L G N L+ Q+ H A A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA--LSTQQLVHMAIQIACGMSYLH 134
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYY 784
G+IH+D+ + N ++D ++ K++D LSR H + V ++ E
Sbjct: 135 ---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191
Query: 785 GNQQLTEKSDVYSFGVVLLELIS-GKKP 811
N++ + SDV+SFGV+L EL++ G+ P
Sbjct: 192 VNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 615 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+KIG+G+ G+VY + G+EVA+K M + + + E+ ++ H N+V +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
+ +V EY+ G+L D V + +D + + + LE+LH+ +I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 734 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 793
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 794 DVYSFGVVLLELISGKKP 811
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 615 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 669
++G G+FG+V Y K K VAVKI+ + + + + E ++ ++ + +V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
+IG CE E +LV E G L L + V +K + ++ H + G++YL
Sbjct: 61 MIGICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLE-- 112
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYG 785
+HRD+ + N+LL AK+SDFGLS+ D + + G V + PE
Sbjct: 113 -ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 786 NQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ + KSDV+SFGV++ E S G+KP
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 668
K +G+G+FG VY D G+E+AVK + D S T + V E+ LL + H +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 669 PLIGYCEEEHQRIL--VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
G + ++ L EYM G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-QIL----QGVSYL 122
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 781
H+ I+HRD+K +NIL D K+ DFG S++ + T I SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-GTPYWMSP 178
Query: 782 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
E + K+DV+S ++E+++ K P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 612 NFCKKIGKGSFGSVYYGKM--------KDGKE---------VAVKIM-ADSCSHRTQQFV 653
NF +K+G+G FG V+ + K E VAVK++ D+ + + F+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 654 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPL 705
EV +LSR+ N+ L+G C + ++ EYM NG L L V N K L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 706 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EED 764
+ T L +A A G+ YL + +HRD+ + N L+ N K++DFG+SR D
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 807
+ A + ++ E + T KSDV++FGV L E+++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 616 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 674
KIG+GS G V +K GK VAVK M R + EV ++ H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 675 EEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
+ +V E++ G L D + H +N++ + + K L LH G+I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVI 138
Query: 734 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 793
HRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197
Query: 794 DVYSFGVVLLELISGKKP 811
D++S G++++E++ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 617 IGKGSFGSVYYGKMKD----GKE---VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLV 668
+G G+FG VY G D G VAVK + + + + +F+ E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK---PLDWLTRL-QIAHDAAKGLEYL 724
L+G C + ++ E M G L L + ++ PL L L I D AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 725 HTGCNPGIIHRDVKSSNILL-----DINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGY 778
IHRD+ + N L+ D + K+ DFGL+R + D V +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ PE + + T +SDV+SFGV++ E+++ G++P
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 68/210 (32%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 668
K +G+G+FG VY D G+E+A K + D S T + V+ E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 669 PLIGYCEEEHQRILV--YEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
G + ++ L EYM G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-QIL----EGMSYL 122
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 781
H+ I+HRD+K +NIL D K+ DFG S++ + T I SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPYWMSP 178
Query: 782 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
E + K+DV+S G ++E+++ K P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLI 671
KKIG+GSFG K K DGK+ +K + S ++ EVA+LS + H N+V
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGS-----VNQKPLDWLTRLQIAHDAAKGLEYLHT 726
EE +V +Y G L +++ + LDW ++ +A L+++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH- 118
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEY 783
+ I+HRD+KS NI L + K+ DFG++R L +AR GT YL PE
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV----LNSTVELARTCIGTPYYLSPEI 172
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGK 809
N+ KSD+++ G VL E+ + K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 617 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 675
+GKG++G VY + + +A+K + + S Q E+AL S + HRN+V +G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 676 EEHQRILVYEYMHNGTLRDRLHG-----SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
E + E + G+L L N++ + + T+ QI +GL+YLH +
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QI----LEGLKYLH---DN 127
Query: 731 GIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY--YGNQ 787
I+HRD+K N+L++ + K+SDFG S++ + + GT+ Y+ PE G +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 788 QLTEKSDVYSFGVVLLELISGKKP 811
+D++S G ++E+ +GK P
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLI 671
+ +G+G+FG V+ + K D K V +K I + + + E +L + H N+ I
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI---I 62
Query: 672 GYCE---EEHQRILVYEYMHNGTLRDRLHGSVN-----QKPLDWLTRLQIAHDAAKGLEY 723
Y E E+ ++V EY GTL + + N L + ++ +A L +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHH 116
Query: 724 LHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 782
+HT I+HRD+K+ NILLD + M K+ DFG+S+ + V GT Y+ PE
Sbjct: 117 VHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPE 171
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 819
+ +KSD+++ G VL EL S K+ + A
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 617 IGKGSFGSVYYGK-MKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY- 673
IG+G++G+VY GK + G+ VA+KI+ D+ EVALLS++ + Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 674 -CEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
+ R+ ++ EY G++R + P+ I + L+Y+H G
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---G 121
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLT 790
+IHRD+K++NIL+ K+ DFG++ ++ + S+ GT ++ PE +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180
Query: 791 EKSDVYSFGVVLLELISGKKPVSVED 816
K+D++S G+ + E+ +G P S D
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-17
Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 21/194 (10%)
Query: 633 GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL-VYEYMH 688
G EVA+K++ H+ +F E AL +R++H N+V L+ E + V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---D 745
TLR+ L L ++ L H N GI+HRD+K NI++
Sbjct: 63 GRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116
Query: 746 INMRAKVSDFGLS-------RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 798
+ AKV DFG+ LT + V GT Y PE + +T SD+Y++
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL-GTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 799 GVVLLELISGKKPV 812
G++ LE ++G++ V
Sbjct: 176 GLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 612 NFCKKIGKGSFGS--VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 669
N + +G+GSFG + D K +I S + E LL+++ H N+V
Sbjct: 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRL---HGSV--NQKPLDWLTRLQIAHDAAKGLEYL 724
E + +V EY G L ++ G + L W ++ + G++++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDP 781
H ++HRD+KS NI L N + K+ DFG +R LT + A VG Y+ P
Sbjct: 117 H---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL----LTSPGAYACTYVGTPYYVPP 169
Query: 782 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
E + N KSD++S G +L EL + K P
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 69/235 (29%), Positives = 119/235 (50%), Gaps = 39/235 (16%)
Query: 615 KKIGKGSFGSVYYG------KMKDGK--EVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 664
K +G+G FG V K K + +VAVK++ +D+ ++E+ ++ I H
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 711
+N++ L+G C ++ ++ EY G LR+ L + Q P + L+ +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 712 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 771
A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R D+ HI
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 196
Query: 772 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 817
+ T G ++ PE ++ T +SDV+SFGV+L E+ + G P V VE+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 13/220 (5%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEV----AVKIMADSCSHRTQQFVT--EVALLSRIHHRNLV 668
K +G+GSFG V+ + G + A+K++ + + T E +L+ ++H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
L + E + L+ +++ G L RL V D + +A + A L++LH+
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYLA-ELALALDHLHS-- 116
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 788
GII+RD+K NILLD K++DFGLS+++ + S GTV Y+ PE +
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRG 174
Query: 789 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 828
T+ +D +SFGV++ E+++G P +D + ++ A+
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 3e-17
Identities = 70/210 (33%), Positives = 112/210 (53%), Gaps = 27/210 (12%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRT--QQFVTEVALLSRI-HHRNLVPL 670
+K+GKG++G V+ + KE VA+K + D+ + T Q+ E+ L + H N+V L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 671 IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
+ + E+ + LV+EYM D LH + L+ + + I + K L+Y+H+G
Sbjct: 73 LNVIKAENDKDIYLVFEYMET----D-LHAVIRANILEDVHKRYIMYQLLKALKYIHSG- 126
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR--------QAEEDLTHISSVARGTVGYLD 780
+IHRD+K SNILL+ + R K++DFGL+R LT VA T Y
Sbjct: 127 --NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY--VA--TRWYRA 180
Query: 781 PE-YYGNQQLTEKSDVYSFGVVLLELISGK 809
PE G+ + T+ D++S G +L E++ GK
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 67/235 (28%), Positives = 114/235 (48%), Gaps = 28/235 (11%)
Query: 602 PLPELEEATNNFCKKIGKGSFGSVYYG------KMKDGK--EVAVKIMADSCSHRT-QQF 652
P EL K +G+G FG V K K K VAVK++ D + +
Sbjct: 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64
Query: 653 VTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG------------- 698
V+E+ ++ I H+N++ L+G C ++ ++ EY G LR+ L
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 699 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758
+ ++ L + + A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 759 RQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
R D ++ R V ++ PE ++ T +SDV+SFGV+L E+ + G P
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+G G+ GSV K + G +A K + + S +Q + E+ ++ +V G
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
E+ + E+M G+L DR++ P++ L + IA +GL YL+ I
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--I 125
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQL 789
+HRD+K SNIL++ + K+ DFG+S + I+S+A GT Y+ PE +
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGEL------INSIADTFVGTSTYMSPERIQGGKY 179
Query: 790 TEKSDVYSFGVVLLELISGKKPVS 813
T KSDV+S G+ ++EL GK P +
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 46/218 (21%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVK-I------MADSCSHRTQQFVTEVALLSRIHHRN 666
KK+G+G++ VY + K G+ VA+K I A + T + E+ LL + H N
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA--LREIKLLQELKHPN 63
Query: 667 LVPLIG-YCEEEHQRI-LVYEYMHN---GTLRDRLHGSVNQKPLDWLTRLQIAHDAA--- 718
++ L+ + + I LV+E+M ++D+ L A +
Sbjct: 64 IIGLLDVFGHK--SNINLVFEFMETDLEKVIKDKS------------IVLTPADIKSYML 109
Query: 719 ---KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVA 772
+GLEYLH + I+HRD+K +N+L+ + K++DFGL+R +TH V
Sbjct: 110 MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH--QVV 164
Query: 773 RGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 809
T Y PE +G + D++S G + EL+
Sbjct: 165 --TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 616 KIGKGSFGSVYYG--KMKDGK-EVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLI 671
++G G+FG V G KM+ + +VA+K++ + + + E ++ ++ + +V +I
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
G CE E +LV E G L L G ++ + + L H + G++YL
Sbjct: 62 GVCEAE-ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELM--HQVSMGMKYLE---GKN 115
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQQL 789
+HRD+ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 790 TEKSDVYSFGVVLLELIS-GKKP 811
+ +SDV+S+G+ + E S G+KP
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 31/230 (13%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE---------------VAVKIM-ADSCSHRTQQFVTEV 656
+K+G+G FG V+ + + E VAVK++ AD F+ E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 657 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL---------RDRLHGSVNQKPLDW 707
++SR+ + N++ L+G C + ++ EYM NG L + N +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 708 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLT 766
L +A A G++YL + +HRD+ + N L+ + K++DFG+SR D
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSV 814
I A + ++ E + T SDV++FGV L E+ + ++P S+
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 615 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+KIGKGSFG V+ G + K VA+KI+ + + E+ +LS+ + G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
++ + ++ EY+ G+ D L PLD I + KGL+YLH+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHS---EKK 122
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTE 791
IHRD+K++N+LL + K++DFG++ Q + T I + GT ++ PE
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 792 KSDVYSFGVVLLELISGKKPVS 813
K+D++S G+ +EL G+ P S
Sbjct: 181 KADIWSLGITAIELAKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 616 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS----HRTQQFVTEVALLSRIHHRNLVPL 670
+G+G++G V + K G+ VA+K +S +T + EV +L ++ H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLRHENIVNL 65
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+ + LV+EY+ TL + L S P D R I + + Y H+
Sbjct: 66 KEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD-AVRSYI-WQLLQAIAYCHSH--- 119
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ----AEEDLTHISSVARGTVGYLDPEYY-G 785
IIHRD+K NIL+ + K+ DFG +R LT VA T Y PE G
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT--DYVA--TRWYRAPELLVG 175
Query: 786 NQQLTEKSDVYSFGVVLLELISG 808
+ + DV++ G ++ EL+ G
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 610 TNNFC--KKIGKGSFGSVYYGKMK-DGKEVA---VKIMADSCSHRTQQFVTEVALLSRIH 663
NF KKIGKG F VY DG+ VA V+I + Q + E+ LL ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 664 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL-----DWLTRLQIAHDAA 718
H N++ + E ++ +V E G L + QK L W +Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 778
LE++H+ I+HRD+K +N+ + K+ D GL R T S+ GT Y
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ PE KSD++S G +L E+ + + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 5e-17
Identities = 55/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 615 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+KIG+G+ G+VY + G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
+ +V EY+ G+L D V + +D + + + LE+LH+ +I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 734 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 793
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 794 DVYSFGVVLLELISGKKP 811
D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 617 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPLIG 672
+GKG FG V ++K GK A K + + + + E +L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
E + LV M+ G L+ ++ +V + + A GLE+LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
++RD+K N+LLD + ++SD GL+ + + GT GY+ PE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVYDFS 174
Query: 793 SDVYSFGVVLLELISGKKP 811
D ++ G L E+I+G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 6e-17
Identities = 54/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 615 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+KIG+G+ G+VY + G+EVA+K M + + + E+ ++ + N+V +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
+ +V EY+ G+L D V + +D + + + L++LH+ +I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 734 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 793
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 794 DVYSFGVVLLELISGKKP 811
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 7e-17
Identities = 52/198 (26%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+KIG+G+ G+V+ + G+EVA+K + + + + E+ ++ + + N+V +
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
+ +V EY+ G+L D V + +D + + + LE+LH +I
Sbjct: 85 FLVGDELFVVMEYLAGGSLTD----VVTETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 734 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 793
HRD+KS N+LL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 794 DVYSFGVVLLELISGKKP 811
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALL 659
EL+ + + +G G FG + G +K K VA+ + CS + ++ F+ E L
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 660 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 719
+ H N+V L G + ++V EYM NG L L Q L + + A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLAS 118
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG--TVG 777
G++YL G +H+ + + +L++ ++ K+S F R E+ I + G V
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVL 173
Query: 778 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ PE + SDV+SFG+V+ E++S G++P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 9e-17
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 32/213 (15%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 671
K IG G++G V K G++VA+K +++ ++ + E+ LL + H N++ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 672 -----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEY 723
E+ + +V E M D LH V + P LT I + +GL+Y
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET----D-LH-KVIKSPQP-LTDDHIQYFLYQILRGLKY 118
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
LH+ +IHRD+K SNIL++ N K+ DFGL+R + D Y+ +
Sbjct: 119 LHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE----KGFLTEYVVTRW 171
Query: 784 Y-------GNQQLTEKSDVYSFGVVLLELISGK 809
Y + + T+ D++S G + EL++ K
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 38/230 (16%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE-----------------VAVKIM-ADSCSHRTQQFVT 654
F +K+G+G FG V+ ++ + ++ VAVKI+ D+ + F+
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 655 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL------RDRLHGSVNQKPLD-- 706
EV +LSR+ N++ L+G C +E ++ EYM NG L N
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 707 --------WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758
+ + L +A A G++YL + +HRD+ + N L+ N+ K++DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 759 RQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 807
R D I A + ++ E + T SDV++FGV L E++
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHH 664
+++G+GSFG VY G +D VAVK + +S S R + +F+ E +++
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----SVNQ--KPLDWLTRL-QIAHDA 717
++V L+G + ++V E M +G L+ L + N +P L + Q+A +
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 776
A G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 777 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 807
++ PE + T SD++SFGVVL E+ S
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVA---VKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 670
+IG G FG V G+ G A VK + S + Q F+ EV ++H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
+G C E +LV E+ G L++ L G V Q ++A + A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA-QKDVLQRMACEVASGLLWLHQA 119
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEYYGN 786
IH D+ N L ++ K+ D+GL+ Q ED + +L PE
Sbjct: 120 ---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 787 QQ-------LTEKSDVYSFGVVLLEL 805
+ T+KS+++S GV + EL
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 613 FCKKI---GKGSFGSV---YYGKMKD--GKEVAVK-IMADSCSHRTQQFVTEVALLSRIH 663
F K+I G+G FG V Y D G++VAVK + +S + E+ +L ++
Sbjct: 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64
Query: 664 HRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 721
H N+V G C E+ L+ E++ +G+L++ L + N+ L +L+ A KG+
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGM 122
Query: 722 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYL 779
+YL + +HRD+ + N+L++ + K+ DFGL++ E D + + V +
Sbjct: 123 DYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELIS 807
PE + SDV+SFGV L EL++
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 4e-16
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 617 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYC 674
+G G++G VY G+ +K G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 675 EEEH------QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 727
+++ Q LV E+ G++ D + + N +W+ I + +GL +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH-- 128
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 787
+IHRD+K N+LL N K+ DFG+S Q + + ++ GT ++ PE
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 186
Query: 788 QLTE-----KSDVYSFGVVLLELISGKKPV 812
+ + KSD++S G+ +E+ G P+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEV-AVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
++IGKGSFG VY G KEV A+KI+ + + E+ +LS+ + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
+ + ++ EY+ G+ D L PL+ I + KGL+YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK--- 122
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
IHRD+K++N+LL K++DFG++ Q + ++ GT ++ PE K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181
Query: 793 SDVYSFGVVLLELISGKKPVS 813
+D++S G+ +EL G+ P S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 617 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY- 673
+G G++G VY G+ +K G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 674 -----CEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 727
+ Q LV E+ G++ D + + N DW+ I + +GL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLHAH 140
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 787
+IHRD+K N+LL N K+ DFG+S Q + + ++ GT ++ PE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 196
Query: 788 QLTE-----KSDVYSFGVVLLELISGKKPV 812
+ + +SD++S G+ +E+ G P+
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 5e-16
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 602 PLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM----ADSCSHRTQQFVTEV 656
L ELE +IG G+ G+VY + G+ A+K++ D+ +Q E+
Sbjct: 72 SLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR---RQICREI 123
Query: 657 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 716
+L ++H N+V + + ++ E+M G+L + + +A
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT---HIADEQ-------FLADV 173
Query: 717 AAK---GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVA 772
A + G+ YLH I+HRD+K SN+L++ K++DFG+SR + + SSV
Sbjct: 174 ARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV- 229
Query: 773 RGTVGYLDPEYYGNQQLTE------KSDVYSFGVVLLELISGKKPVSV 814
GT+ Y+ PE N L D++S GV +LE G+ P V
Sbjct: 230 -GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 617 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-GYC 674
+G G+FG VY + K+ G A KI+ + F+ E+ +LS H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 675 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPG 731
E IL+ E+ G L S+ + LT QI + L +LH +
Sbjct: 73 YENKLWILI-EFCDGGAL-----DSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHK 123
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEY-----YG 785
+IHRD+K+ NILL ++ K++DFG+S + + + GT ++ PE +
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFK 181
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKP 811
+ K+D++S G+ L+EL + P
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 21/200 (10%)
Query: 617 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 674
+G G+ G+VY + + +AVK I D +Q ++E+ +L + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 675 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 734
E++ + E+M G+L ++ + P L R+ +A KGL YL + I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKI---PEHVLGRIAVA--VVKGLTYLWS---LKILH 118
Query: 735 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQLTE 791
RDVK SN+L++ + K+ DFG+S Q ++S+A+ GT Y+ PE +Q
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL------VNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 792 KSDVYSFGVVLLELISGKKP 811
SDV+S G+ +EL G+ P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 9e-16
Identities = 64/218 (29%), Positives = 116/218 (53%), Gaps = 22/218 (10%)
Query: 606 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRTQ-QFVTEVALL 659
L+E K +G G+FG+VY G + +G+ V A+KI+ ++ + +F+ E ++
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 660 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAH 715
+ + H +LV L+G C + LV + M +G L D +H + Q L+W ++
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI---- 118
Query: 716 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-VARG 774
AKG+ YL ++HRD+ + N+L+ K++DFGL+R E D ++ +
Sbjct: 119 --AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173
Query: 775 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 74/228 (32%), Positives = 113/228 (49%), Gaps = 22/228 (9%)
Query: 601 IPLPELEEATNNF--CKKIGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVA 657
+ L L + T+ + + IGKG++G VY KDG AVKI+ D S ++ E
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEYN 70
Query: 658 LLSRI-HHRNLVPLIG-YCEEEH----QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTR 710
+L + +H N+V G + + + Q LV E + G++ + + G + + LD
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 711 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHIS 769
I + A GL++LH N IIHRDVK +NILL K+ DFG+S Q L +
Sbjct: 131 SYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 770 SVARGTVGYLDPEYYGNQQLTEKS-----DVYSFGVVLLELISGKKPV 812
SV GT ++ PE +Q + S DV+S G+ +EL G P+
Sbjct: 188 SV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 54/198 (27%), Positives = 104/198 (52%), Gaps = 8/198 (4%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+K+G+G++ +VY G+ + E VA+K I D+ + E++L+ + H N+V L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
E++ +LV+EYM + L+ + + LD T + KG+ + H +
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTE 791
+HRD+K N+L++ K++DFGL+R + S+ T+ Y P+ G++ +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYST 180
Query: 792 KSDVYSFGVVLLELISGK 809
D++S G ++ E+I+G+
Sbjct: 181 SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 616 KIGKGSFGSVYYGKMKD-GKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+G+GS+G V K K+ G+ VA+K +S + + E+ +L ++ H NLV LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
+ + LV+E++ + T+ D L N LD + +G+E+ H + I
Sbjct: 68 VFRRKKRLYLVFEFVDH-TVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH---SHNI 121
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYY-GNQQLT 790
IHRD+K NIL+ + K+ DFG +R A + VA T Y PE G+ +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA--TRWYRAPELLVGDTKYG 179
Query: 791 EKSDVYSFGVVLLELISG 808
D+++ G ++ E+++G
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVP 669
F + +GKGS+G V + + DGK+ +K + ++ + E LLS++ H N+V
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 670 LIGYCE-EEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEY 723
E E+ +V + G L +L + + ++W ++ +A L+Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQY 117
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
LH I+HRD+K+ N+ L KV D G++R E+ ++S GT Y+ PE
Sbjct: 118 LH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPEL 173
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 819
+ N+ KSDV++ G + E+ + K + +D +
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 617 IGKGSFGSVYYGKMKDGKE-VAVKIMA---DSCSH--RTQQFVTEVALLSRIHHRNLVPL 670
+G G++G V VA+K ++ S H RT + E+ LL + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR---ELRLLKHMDHENVIGL 79
Query: 671 IG-YCEEEHQRIL--VYEYMHNGTLRDR-LHGSVNQKPL--DWLTRL--QIAHDAAKGLE 722
+ + VY H L L+ V + L D + L QI +GL+
Sbjct: 80 LDVFTPASSLEDFQDVYLVTH---LMGADLNNIVKCQKLSDDHIQFLVYQIL----RGLK 132
Query: 723 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 782
Y+H+ GIIHRD+K SNI ++ + K+ DFGL+R ++++T VA T Y PE
Sbjct: 133 YIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPE 185
Query: 783 YYGN-QQLTEKSDVYSFGVVLLELISGK 809
N + D++S G ++ EL++GK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 15/144 (10%)
Query: 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 744
E+M G+L D++ + P + L ++ IA +GL YL I+HRDVK SNIL+
Sbjct: 79 EHMDGGSL-DQVLKKAGRIPENILGKISIA--VLRGLTYLRE--KHKIMHRDVKPSNILV 133
Query: 745 DINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVV 801
+ K+ DFG+S Q I S+A GT Y+ PE T +SD++S G+
Sbjct: 134 NSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 802 LLELISGKKPVSVEDFGAELNIVH 825
L+E+ G+ P+ D EL +
Sbjct: 188 LVEMAIGRYPIPPPD-AKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 615 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
++IGKGSFG V+ G + + VA+KI+ + + E+ +LS+ + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
+ + ++ EY+ G+ D L P D + + KGL+YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHS---EKK 122
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
IHRD+K++N+LL K++DFG++ Q + ++ GT ++ PE K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSK 181
Query: 793 SDVYSFGVVLLELISGKKPVS 813
+D++S G+ +EL G+ P S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 617 IGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 668
+G+G+F ++ G ++ EV +K++ S + ++ F +++S++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
G C + I+V EY+ G+L L + N + W +L++A A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE--- 117
Query: 729 NPGIIHRDVKSSNILLDINMRA--------KVSDFGLS--RQAEEDLTHISSVARGTVGY 778
+ G+ H +V + N+LL K+SD G+S +E L + +
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-------RIPW 170
Query: 779 LDPEYYGN-QQLTEKSDVYSFGVVLLELISG-KKPVSVED 816
+ PE N Q L+ +D +SFG L E+ SG KP+S D
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 53/220 (24%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQF--------VTEVALLSRI-HH 664
K++G G+FGSVY + K+ E VA+K M ++F + EV L ++ H
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEH 57
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPL------DWLTRLQIAH 715
N+V L E + V+EYM ++DR KP + QI
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDR-----KGKPFSESVIRSII--YQIL- 109
Query: 716 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 775
+GL ++H G HRD+K N+L+ K++DFGL+R+ + V T
Sbjct: 110 ---QGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV--ST 161
Query: 776 VGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGK 809
Y PE Y + + D+++ G ++ EL + +
Sbjct: 162 RWYRAPEILLRSTSY-SSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-15
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 40/216 (18%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMAD------SCSHRTQQFVTEVALLSRIHHRNL 667
+ IG G+FG V+ +DGK VA+K M + SC ++ E+ +L H N+
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSC----KRVFRELKMLCFFKHDNV 61
Query: 668 V--------PLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLD----WLTRLQIA 714
+ P I EE + +V E M + LH V+ +PL + QI
Sbjct: 62 LSALDILQPPHIDPFEEIY---VVTELMQSD-----LHKIIVSPQPLSSDHVKVFLYQIL 113
Query: 715 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 774
+GL+YLH+ GI+HRD+K N+L++ N K+ DFGL+R E D + +
Sbjct: 114 ----RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 775 TVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 809
T Y PE G++ T D++S G + EL+ +
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 617 IGKGSFGSVYYGKMKDG-------KEVAVKIMADSCSHRTQ-----QFVTEVALL-SRIH 663
+G G+FG VY + K+ KE+ V A R + V+EV ++ ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 664 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------HGSVNQKPLDWLTRLQIAHDA 717
H N+V E + +V + + L + ++ + W +Q+
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WNIFVQMV--- 123
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 777
L YLH I+HRD+ +NI+L + + ++DFGL++Q + + + ++SV GT+
Sbjct: 124 -LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSVV-GTIL 178
Query: 778 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
Y PE N+ EK+DV++FG +L ++ + + P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
++IG G++G VY + + G+ A+K++ E+ ++ H N+V G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
+ + E+ G+L+D H + PL ++ + +GL YLH + G +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLH---SKGKM 128
Query: 734 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ---LT 790
HRD+K +NILL N K++DFG+S Q + S GT ++ PE ++
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYN 187
Query: 791 EKSDVYSFGVVLLELISGKKPV 812
+ D+++ G+ +EL + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 617 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 672
+GKG FG V +++ GK A K + + + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
E + LV M+ G L+ ++ + + + + A + GLE LH I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLH---QERI 123
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
++RD+K NILLD + ++SD GL+ E T V GTVGY+ PE N++ T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTFS 181
Query: 793 SDVYSFGVVLLELISGKKP 811
D ++ G +L E+I+G+ P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 624 SVYYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIGY----CEE 676
S+Y G + KEV ++ E+ L RI N++ + G+ ++
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 677 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN-PGIIHR 735
+ L+ EY G LR+ L +K L + T+L +A D KGL L+ N P ++
Sbjct: 94 LPRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147
Query: 736 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKS 793
++ S + L+ N + K+ GL E+ L+ + Y + + + T K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGL----EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKD 203
Query: 794 DVYSFGVVLLELISGKKP 811
D+YS GVVL E+ +GK P
Sbjct: 204 DIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 9e-15
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 617 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPLIG 672
+GKG FG V +M+ GK A K + + + + + E +L+++H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPG 731
+ + LV M+ G LR ++ + P GLE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
II+RD+K N+LLD + ++SD GL+ + ++ + A GT G++ PE ++
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDF 176
Query: 792 KSDVYSFGVVLLELISGKKP 811
D ++ GV L E+I+ + P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 616 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVP 669
IG+G++G VY K K DGKE A+K T Q E+ALL + H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 670 LIGYCEEEHQRI--LVYEY----------MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 717
L+ E + L+++Y H R + S+ K L W QI +
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM-VKSLLW----QILN-- 119
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILL--DINMRA--KVSDFGLSRQAEEDLTHISSVAR 773
G+ YLH+ ++HRD+K +NIL+ + R K+ D GL+R L ++ +
Sbjct: 120 --GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 774 G--TVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELIS 807
T+ Y PE G + T+ D+++ G + EL++
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD---SCSHRTQQFVTEVALLSRIHHRNLVPL 670
K IG+G+FG V K+K+ +V A+KI+ T F E +L ++ + L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKGLEYLHT 726
++E+ LV +Y G L L ++ P D +L + IA D+ L Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-- 784
+HRD+K NIL+D+N +++DFG + ED T SSVA GT Y+ PE
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 785 ---GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 822
G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 617 IGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQ--FVTEVALLSRIHHRNLVPLIG 672
+G G FG V K+K + A+K + QQ +E +L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+++ ++ EY G L L G + ++ R IA EYLH N
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFD----EYTARFYIAC-VVLAFEYLH---NR 112
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLDPEYYG 785
GII+RD+K N+LLD N K+ DFG +++ + S + GT Y+ PE
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKK-------LKSGQKTWTFCGTPEYVAPEIIL 165
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
N+ D +S G++L EL++G+ P +D
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 616 KIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLI 671
++G+G +G V+ K KD E VA+K M S + + +TE +L+ LV L+
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 672 GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD------WLTRLQIAHDAAKGLEYL 724
Y ++ + + L EY+ G R L N L ++ + A DA L
Sbjct: 68 -YAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDA------L 117
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
H G IHRD+K N L+D + K++DFGLS+ +T+ +SV G+ Y+ PE
Sbjct: 118 H---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVV-GSPDYMAPEVL 170
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKPVS 813
+ D +S G +L E + G P S
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 58/229 (25%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVA 657
E+ +T F +++G+ FG VY G + + + VA+K + D ++F E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 658 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVNQKPLDWLTR-- 710
+ SR+ H N+V L+G +E +++ Y + L + L H V D +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 711 ------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 763
+ I A G+E+L + ++H+D+ + N+L+ + K+SD GL R+
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
D + + + ++ PE + + SD++S+GVVL E+ S G +P
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRIHHRNL 667
K +GKGSFG V ++K E A+K ++ D T V L H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECT--MVERRVLALAWEHPFL 58
Query: 668 VPLIGYC--EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
L +C + + V EY++ G D + + D A + GL++LH
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 785
GII+RD+K N+LLD + K++DFG+ ++ + +S GT Y+ PE
Sbjct: 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILK 169
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
Q+ E D +SFGV+L E++ G+ P ED
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 617 IGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIG-Y 673
IGKG++G V+ K+G + AVKI+ D ++ E +L + H N+V G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 674 CEEE----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 726
+++ Q LV E + G++ D + G + + + + IA H+A GL++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG--ERMEEPIIAYILHEALMGLQHLH- 141
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG- 785
IHRDVK +NILL K+ DFG+S Q + + GT ++ PE
Sbjct: 142 --VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 786 NQQL----TEKSDVYSFGVVLLELISGKKPVS 813
QQL + DV+S G+ +EL G P++
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 74/261 (28%), Positives = 114/261 (43%), Gaps = 65/261 (24%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVA---VKIM-----ADSCSHRTQQFVTEVALLSRIHHRN 666
+++GKGSFG+VY +KD K VA +K++ + + T Q E LLS++ H
Sbjct: 6 QRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 667 LVP-------------LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI 713
+V + YCE + E H G S NQ +W +L +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL-----SENQV-CEWFIQLLL 117
Query: 714 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSV 771
G+ Y+H I+HRD+K+ NI L N+ K+ DFG+SR DL ++
Sbjct: 118 ------GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL---ATT 164
Query: 772 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLEL-------------------ISGKKPV 812
GT Y+ PE +Q KSD++S G +L E+ + G P
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS 224
Query: 813 SVEDFGAELNIVHWARSMIKK 833
E + +LN + +SM+ K
Sbjct: 225 LPETYSRQLNSI--MQSMLNK 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 48/228 (21%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA--------DSCSHRTQQFVTEVALLSRI 662
NF +GKGSFG V + K E+ A+KI+ D ++ V +AL +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV--LALPGKP 60
Query: 663 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI--------- 713
L L + + V EY++ G D + +Q
Sbjct: 61 PF--LTQLHSCFQTMDRLYFVMEYVNGG---------------DLMYHIQQVGKFKEPHA 103
Query: 714 ---AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHI 768
A + A GL +LH+ GII+RD+K N++LD K++DFG+ ++ T
Sbjct: 104 VFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160
Query: 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
GT Y+ PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 161 FC---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE-VAVKIMA--DSCSHRTQQFV-TEVALLSRIHHRNLVPL 670
K +G G+FG V+ + + + A+K+MA + + +Q V E +L + H ++ L
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 671 IGYCEEEHQRIL--VYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
+ E QR L + EY+ G L R G + T L A + LEYLH+
Sbjct: 67 --FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS-----TGLFYASEIVCALEYLHS 119
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
I++RD+K NILLD K++DFG +++ + + GT YL PE +
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQS 172
Query: 787 QQLTEKSDVYSFGVVLLELISGKKP 811
+ + D ++ G+++ E++ G P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 35/217 (16%)
Query: 617 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVPL- 670
IG+G++G VY + KD G+ VA+K + + + F + E+ +L +++HRN+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKV--RLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 671 ---------IGYCEEEHQRILVYEYM-HN--GTLRDRLHGSVNQKPLDWLTRLQIAHDAA 718
+ + +++ LV+EYM H+ G L L ++ +L
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL------L 126
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTV 776
+GL Y H +HRD+K SNILL+ + K++DFGL+R +EE + + V T+
Sbjct: 127 EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--TL 181
Query: 777 GYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPV 812
Y PE G ++ DV+S G +L EL + KKP+
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 22/211 (10%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRTQQFVTEVAL-LSRIHHRNLV 668
K +G G FG+V+ G + +G VA+K + D +T Q +T+ L + + H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLH---GSVN-QKPLDWLTRLQIAHDAAKGLEYL 724
L+G C + LV + G+L D + S++ Q+ L+W ++ AKG+ YL
Sbjct: 73 RLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYLDPEY 783
++HR++ + NILL + +++DFG++ +D + S + + ++ E
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 784 YGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 813
+ T +SDV+S+GV + E++S G +P +
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 608 EATNNFC--KKIGKGSFGSVYYGK-MKDGKEVAVK-IMAD-SCSHRTQQFVTEVALLSRI 662
E TN + + +G G+FG V + G+ VA+K IM S ++ E+ LL +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 663 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 721
H N++ L + I V E + GT LH + +PL+ + +GL
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELL--GT---DLHRLLTSRPLEKQFIQYFLYQILRGL 121
Query: 722 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 781
+Y+H+ G++HRD+K SNIL++ N K+ DFGL+R + +T GY+
Sbjct: 122 KYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT----------GYVST 168
Query: 782 EYYGN-------QQLTEKSDVYSFGVVLLELISGK 809
YY Q+ + D++S G + E++ GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 670
++GKG++GSVY + G +A+K I + + Q + E+ +L + +V
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
G E + EYM G+L D+L+ + P D L R I + KGL++L
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEE 121
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY- 783
N IIHRDVK +N+L++ N + K+ DFG+S +S+A+ +G Y+ PE
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV------ASLAKTNIGCQSYMAPERI 173
Query: 784 -----YGNQQLTEKSDVYSFGVVLLELISGKKP 811
N T +SDV+S G+ +LE+ G+ P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 6e-14
Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 613 FCKKIGKGSFGSVYYGK---MKDGKE--------------VAVKIM-ADSCSHRTQQFVT 654
F +K+G+G FG V+ + M+ + VAVK++ D+ + F+
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 655 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL-----RDRLHGSV---NQKPLD 706
E+ ++SR+ N++ L+ C ++ EYM NG L R + + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 707 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DL 765
+ T + +A A G++YL + +HRD+ + N L+ N K++DFG+SR D
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 807
I A + ++ E + T SDV++FGV L E+++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 617 IGKGSFGSVYYGKM---KDGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHR--NLV 668
IG G+ G VY KM K G +AVK M + + + + +V L S H +V
Sbjct: 23 IGSGTCGQVY--KMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIV 77
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTG 727
GY + + E M T D+L + P D L ++ +A K L YL
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA--IVKALHYLKE- 132
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 787
G+IHRDVK SNILLD + K+ DFG+S + + S G Y+ PE
Sbjct: 133 -KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPERIDPP 189
Query: 788 QLTEK----SDVYSFGVVLLELISGKKP 811
K +DV+S G+ L+EL +G+ P
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 612 NFCKKIGKGSFGSVYYG-KMKDGKEVAVK--IMADSCSHRTQQF-VT---EVALLSRIHH 664
K+G+G+FG VY ++K G+ VA+K +M + F +T E+ +L ++ H
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKH 66
Query: 665 RNLVPLIGYCEEEHQRI--------LVYEYM-H--NGTLRD-RLHGSVNQ-KPLDWLTRL 711
N+VPLI E + +V YM H +G L + + + +Q K L
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK----CYML 122
Query: 712 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHI 768
Q+ G+ YLH N I+HRD+K++NIL+D K++DFGL+R +
Sbjct: 123 QLLE----GINYLH--EN-HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 769 SSVARG-------TVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 809
T Y PE G ++ T D++ G V E+ + +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 616 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIG 672
KIG+GS+G V+ + ++ G+ VA+K +S + + E+ +L ++ H NLV LI
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-GCNPG 731
+ + LV+EY + T+ + L N + + +I + + + H C
Sbjct: 68 VFRRKRKLHLVFEYCDH-TVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHNC--- 121
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPEYY-GNQ 787
IHRDVK NIL+ + K+ DFG +R +D T VA T Y PE G+
Sbjct: 122 -IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT--DYVA--TRWYRAPELLVGDT 176
Query: 788 QLTEKSDVYSFGVVLLELISG 808
Q DV++ G V EL++G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHHRNL 667
F K +G GSFG V + K + A+KI++ + + +Q + E +L I H L
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
V L G +++ LV EY+ G L L + P R A LEYLH
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPV-ARFYAA-QVVLALEYLH-- 118
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 787
+ I++RD+K N+LLD + K++DFG +++ + + GT YL PE ++
Sbjct: 119 -SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPEIILSK 173
Query: 788 QLTEKSDVYSFGVVLLELISGKKP 811
+ D ++ G+++ E+++G P
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 8e-14
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 670
K +GKG+FG V + K GK A+KI+ +TE +L H L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+ + + V EY++ G L H S + + TR A + L+YLH+G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRFYGA-EIVSALDYLHSG--- 114
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
I++RD+K N++LD + K++DFGL ++ D + + GT YL PE +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 791 EKSDVYSFGVVLLELISGKKPVSVED 816
D + GVV+ E++ G+ P +D
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-13
Identities = 40/102 (39%), Positives = 61/102 (59%), Gaps = 6/102 (5%)
Query: 402 WEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRL 459
W+ +TC+ ++ R+ I LSGKN+ G+I + + + + L N L+GP+PD +
Sbjct: 60 WQGITCNNSS--RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 460 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 501
LR ++L NN TGS+P GS+PNL+ L + NN GEIP
Sbjct: 118 SSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIP 157
|
Length = 968 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 617 IGKGSFGSV------YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 670
+GKG FG V GKM K++ K + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKQILEKVNSRFVVSL 65
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
E + LV M+ G L+ ++ ++ D + A + GLE LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFDEERAVFYAAEITCGLEDLHR---E 121
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
I++RD+K NILLD ++SD GL+ + E T V GTVGY+ PE N++ T
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNERYT 179
Query: 791 EKSDVYSFGVVLLELISGKKP 811
D + G ++ E+I GK P
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 617 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 672
+GKGSFG V ++K G+ AVK++ + +TE +LS + + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 673 YCEEEHQRIL-VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
C + R+ V E+++ G L + S + D A + L +LH + G
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLH---DKG 116
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
II+RD+K N+LLD K++DFG+ ++ + S+ GT Y+ PE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYGP 175
Query: 792 KSDVYSFGVVLLELISGKKPVSVED----FGAELN 822
D ++ GV+L E++ G P E+ F A LN
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHHRN 666
K +GKG+FG V + K GK A+KI+ D +H +TE +L H
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT----LTESRVLQNTRHPF 56
Query: 667 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
L L Y + H R+ V EY + G L H S + + R A + L YLH
Sbjct: 57 LTAL-KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALGYLH 112
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEY 783
+ +++RD+K N++LD + K++DFGL + E ++ +++ GT YL PE
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEV 166
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
+ D + GVV+ E++ G+ P +D
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 615 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+++G G++G VY + G+ AVKI+ E+ ++ H N+V G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 730
+ + EY G+L+D H + PL + LQIA+ + +GL YLH+
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVT---GPL---SELQIAYVCRETLQGLAYLHS---K 125
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG---NQ 787
G +HRD+K +NILL N K++DFG++ + + S GT ++ PE N
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNG 184
Query: 788 QLTEKSDVYSFGVVLLELISGKKPV 812
+ D+++ G+ +EL + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 64/220 (29%), Positives = 92/220 (41%), Gaps = 29/220 (13%)
Query: 613 FCKKIGKGSFG--SVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNL 667
IGK V+ K K VAVK + DSCS + + E+ ++ H N+
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYL 724
+P + + + +V M G+ D L + L L IA D L+Y+
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP----EGLPELAIAFILKDVLNALDYI 117
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS--------RQAEEDLTHISSVARGTV 776
H + G IHR VK+S+ILL + + +S S RQ SSV +
Sbjct: 118 H---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK--NL 172
Query: 777 GYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVS 813
+L PE Q L EKSD+YS G+ EL +G P
Sbjct: 173 PWLSPEVL-QQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 614 CKKIGKGSFGSVYYGKM---KDGKEVAVK-IMADSCSHRTQQFVTEV-ALLSRIHHRNLV 668
+IG+G+FG+V KM G +AVK I + ++ + ++ ++ +V
Sbjct: 9 LGEIGRGAFGTVN--KMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIV 66
Query: 669 PLIGYCEEEHQRILVYEYMHNG--TLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLH 725
G E + E M ++ + P + L + IA K L YL
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK--IAVATVKALNYLK 124
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 781
IIHRDVK SNILLD N K+ DFG+S Q + S+A+ G Y+ P
Sbjct: 125 EELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SIAKTRDAGCRPYMAP 176
Query: 782 EY---YGNQQLTEKSDVYSFGVVLLELISGKKP 811
E +SDV+S G+ L E+ +GK P
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 51/219 (23%)
Query: 616 KIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQ--------FVTEVALLSRIHHRN 666
+IG+G++G VY + E VA+K + R + E+ LL + H N
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREITLLLNLRHPN 67
Query: 667 LVPL---------------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL 711
+V L + YCE++ +L D + ++ + L L
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLL-----------DNMPTPFSESQVKCLM-L 115
Query: 712 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 771
Q+ +GL+YLH IIHRD+K SN+LL K++DFGL+R ++
Sbjct: 116 QLL----RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168
Query: 772 ARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 809
T+ Y PE G T D+++ G +L EL++ K
Sbjct: 169 VV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 67/217 (30%), Positives = 95/217 (43%), Gaps = 13/217 (5%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ----FVTEVALLSRIHHRNLVP 669
K IGKGSFG V K K DG AVK++ + ++ LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
L + + V +Y++ G L H + L+ R A + A + YLH+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARFYAA-EVASAIGYLHS--- 114
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 789
II+RD+K NILLD ++DFGL ++ E S+ GT YL PE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPY 173
Query: 790 TEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVH 825
D + G VL E++ G P D NI+H
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 617 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRI---HHRNLVPL 670
IG+G++G+VY + + G+ VA+K + S + E+ALL ++ H N+V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 671 IGYC-----EEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLE 722
+ C + E + LV+E++ +D L + L T + +G++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVD----QD-LATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 723 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 782
+LH+ I+HRD+K NIL+ + + K++DFGL+R ++ S V T+ Y PE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176
Query: 783 YYGNQQLTEKSDVYSFGVVLLEL 805
D++S G + EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 672
+K+G+GS+ +VY GK K +GK VA+K++ T + E +LL + H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 673 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+ LV+EY+H + D+ G ++ + + L Q+ +GL Y+H
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVK-LFLFQLL----RGLSYIH---QR 122
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 789
I+HRD+K N+L+ K++DFGL+R A+ +H S T+ Y P+ G+ +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 790 TEKSDVYSFGVVLLELISG 808
+ D++ G + +E+I G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 61/257 (23%), Positives = 98/257 (38%), Gaps = 68/257 (26%)
Query: 593 MDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVY-YGKMKDGKEVAVKIM------ADSC 645
+I +G+G++G V GK VA+K + D
Sbjct: 3 SFSISERYIQKG----------AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVT 52
Query: 646 SHRTQ------QFVT--EVALLSRIHHRNLVPLIG-YCEEEHQRILVYEYMHNGTLRDRL 696
R F T E+ +++ I H N++ L+ Y E + LV + M L+
Sbjct: 53 KDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFIN-LVMDIMA-SDLK--- 107
Query: 697 HGSVNQKPLDWLTRLQIAH------DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 750
K +D RL + GL LH +HRD+ +NI ++
Sbjct: 108 ------KVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158
Query: 751 KVSDFGLSR-----------------QAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEK 792
K++DFGL+R Q E++T S V T+ Y PE G ++
Sbjct: 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMT--SKVV--TLWYRAPELLMGAEKYHFA 214
Query: 793 SDVYSFGVVLLELISGK 809
D++S G + EL++GK
Sbjct: 215 VDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 615 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 670
K+IG G FG V G++ G +V VK + S S + Q +F+ E + H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRLQIAHDAAKGLEYLHTGC 728
+G C E +LV E+ G L+ L + + D T ++A + A GL +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-----VARGTVGYLDPEY 783
IH D+ N LL ++ K+ D+GLS ++ +++ R L E
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 784 YGNQQL---TEKSDVYSFGVVLLELIS-GKKP 811
+GN + T++S+V+S GV + EL G +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-13
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 42/233 (18%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEV-AVKIM--------ADSCSHRTQQFVT---EVALLSRI 662
K IG+G+FG V KMK + + A+KI+ A++ R ++ V + ++ +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 663 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAA 718
H+ ++E+ LV +Y G L L ++ P D ++ + +A +
Sbjct: 67 HYA--------FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 778
L Y +HRD+K N+LLD+N +++DFG + +D T SSVA GT Y
Sbjct: 119 HQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 779 LDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 822
+ PE G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 38/231 (16%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEV-AVKIM---------ADSCSHRTQQFVTEVALLSRIHH 664
K IG+G+FG V KMK+ +V A+KI+ +C F E +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC------FREERDVLVNGDR 60
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKG 720
R + L ++E+ LV +Y G L L ++ P D +L + +A D+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 780
L Y +HRD+K N+LLD N +++DFG + D T S+VA GT Y+
Sbjct: 121 LGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 781 PEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPV----SVEDFGAELN 822
PE G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 31/212 (14%)
Query: 617 IGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQ-QFVTEVALLSR-IHHRNLVPLI 671
+G+G++G V KM+ G +AVK + + + + Q + + ++ + R + V
Sbjct: 9 LGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL----DWLTRLQIAHDAAKGLEYLHTG 727
G E + E M T D+ + V K L D L + IA K LEYLH+
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHSK 122
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 783
+ +IHRDVK SN+L++ N + K+ DFG+S + SVA+ G Y+ PE
Sbjct: 123 LS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL------VDSVAKTIDAGCKPYMAPER 174
Query: 784 Y---GNQQLTE-KSDVYSFGVVLLELISGKKP 811
NQ+ + KSDV+S G+ ++EL +G+ P
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 617 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 672
+GKG FG V +++ GK A K + + + + E +L +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
E + LV M+ G L+ ++ N + L A + GLE LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLH---RENT 123
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
++RD+K NILLD ++SD GL+ + E + V GTVGY+ PE NQ+ T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQRYTLS 181
Query: 793 SDVYSFGVVLLELISGKKP 811
D + G ++ E+I G+ P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 27/218 (12%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA--------DSCSHRTQQFVTEVALLSRI 662
+G+G FG V + K E+ A+K + + S ++ + E A +
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETA--NSE 59
Query: 663 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKG 720
H LV L C + + V EY G L +H V +P R A G
Sbjct: 60 RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVLG 113
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGY 778
L+YLH I++RD+K N+LLD K++DFGL + E + + GT +
Sbjct: 114 LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEF 167
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
L PE T D + GV++ E++ G+ P +D
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVP 669
K +GKGSFG V+ ++K + A+K + + + E +LS H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
L + + V EY++ G L H K D A + GL++LH+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLM--FHIQSCHK-FDLPRATFYAAEIICGLQFLHS--- 114
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 789
GI++RD+K NILLD + K++DFG+ ++ + GT Y+ PE Q+
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKY 173
Query: 790 TEKSDVYSFGVVLLELISGKKPVSVED 816
D +SFGV+L E++ G+ P D
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-13
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQ--FVTEVALLSRIHHRNL 667
+ K IG+G+FG V + K K+V A+K+++ R+ F E +++ + +
Sbjct: 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWI 105
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
V L +++ +V EYM G L + + S P W R A + L+ +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKW-ARFYTA-EVVLALDAIH-- 159
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 787
+ G IHRDVK N+LLD + K++DFG + + + A GT Y+ PE +Q
Sbjct: 160 -SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 788 ----QLTEKSDVYSFGVVLLELISGKKP 811
+ D +S GV L E++ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-13
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 42/225 (18%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMAD---------SCS---HRTQQFVTEVAL 658
NF +GKGSFG V + K E+ A+KI+ C+ R +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 659 LSRIHHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH-- 715
L+++H C + R+ V EY++ G L ++ + R + H
Sbjct: 63 LTQLHS---------CFQTMDRLYFVMEYVNGGDLMYQIQQ---------VGRFKEPHAV 104
Query: 716 ----DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 771
+ A GL +LH+ GII+RD+K N++LD K++DFG+ ++ D +
Sbjct: 105 FYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF 161
Query: 772 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
GT Y+ PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 162 C-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 21/231 (9%)
Query: 615 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRN 666
K +G G++G V+ + GK A+K++ + + T+ TE +L I
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 667 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKGLEYL 724
+ + Y + ++ L+ +Y++ G L L K +QI + + LE+L
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEHL 121
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
H GII+RD+K NILLD N ++DFGLS++ ED + GT+ Y+ P+
Sbjct: 122 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 785 --GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 833
G+ + D +S GV++ EL++G P +V+ G + + +R ++K
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD--GEKNSQAEISRRILKS 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 58/210 (27%), Positives = 112/210 (53%), Gaps = 24/210 (11%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLV 668
K +G G+FG+VY G + +G++ VA+K + ++ S + ++ + E +++ + + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAHDAAKGLEYL 724
L+G C + L+ + M G L D R H +Q L+W ++ AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 125
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE 782
++HRD+ + N+L+ K++DFGL++ A+E H + + ++ E
Sbjct: 126 E---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG-GKVPIKWMALE 181
Query: 783 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
++ T +SDV+S+GV + EL++ G KP
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 612 NFCK--KIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRN 666
NF K KIG+G++G VY + K G+ VA+K I D+ + + E++LL ++H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 723
+V L+ E++ LV+E++H L ++ PL + I +GL +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 782
H+ ++HRD+K N+L++ K++DFGL+R + T+ V T+ Y PE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 170
Query: 783 -YYGNQQLTEKSDVYSFGVVLLELISGK 809
G + + D++S G + E+++ +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 71/225 (31%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVA----LLSRIHHRNLVP 669
K IGKGSFG V K K DGK AVK++ + ++ +A LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 670 LIGYCEEEHQRILVYEYMHNGTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
L + + V +Y++ G L R+R + A + A L YL
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR--------FYAAEIASALGYL 112
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPE 782
H+ II+RD+K NILLD ++DFGL ++ T S GT YL PE
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT---STFCGTPEYLAPE 166
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVH 825
Q D + G VL E++ G P D AE+ NI++
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-AEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 71/220 (32%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVT--EVALLSRIHHRNLVP 669
K IGKGSFG V K K DGK AVK++ + + Q+ + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
L + + V ++++ G L H + + R A + A L YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGYLHS--- 114
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQ 787
I++RD+K NILLD ++DFGL ++ A+ D T + GT YL PE Q
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRKQ 171
Query: 788 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVH 825
D + G VL E++ G P D AE+ NI+H
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-AEMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRNLV 668
KKIG+G F VY + D K VA+K M D+ + Q V E+ LL +++H N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR--QDCVKEIDLLKQLNHPNVI 65
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEY 723
+ E+++ +V E G L + QK L W +Q+ +E+
Sbjct: 66 KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEH 121
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
+H+ ++HRD+K +N+ + K+ D GL R T S+ GT Y+ PE
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 823
KSD++S G +L E+ + + P +G ++N+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 616 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQF-VTEVALLSRIHHRNLVPLIG 672
KIG+G++G+V+ K ++ E VA+K + D + E+ LL + H+N+V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 673 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+ + LV+EY + D +G ++ + + Q+ KGL + H+
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-FQLL----KGLAFCHS---H 118
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 789
++HRD+K N+L++ N K++DFGL+R + S+ T+ Y P+ +G +
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLY 177
Query: 790 TEKSDVYSFGVVLLELISGKKPV----SVED 816
+ D++S G + EL + +P+ V+D
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 616 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 674
++G G+FG VY K K+ G A K++ + ++ E+ +L+ +H +V L+G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 675 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 734
+ + ++ E+ G + D + +++ LT QI + LE L + IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAV-DAIMLELDRG----LTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 735 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE--- 791
RD+K+ N+LL ++ K++DFG+S + + L S GT ++ PE + + +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPY 192
Query: 792 --KSDVYSFGVVLLELISGKKP 811
K+D++S G+ L+E+ + P
Sbjct: 193 DYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVK---IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 670
KKIG+G F VY + DG VA+K I + + E+ LL +++H N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLH 725
E+++ +V E G L + QK L W +Q+ LE++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMH 123
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 785
+ ++HRD+K +N+ + K+ D GL R T S+ GT Y+ PE
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 823
KSD++S G +L E+ + + P +G ++N+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHHRN 666
K +GKG+FG V K K G+ A+KI+ D +H +TE +L H
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT----LTENRVLQNSRHPF 56
Query: 667 LVPLIGYCEEEHQRI-LVYEYMHNGTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKG 720
L L Y + H R+ V EY + G L R+R+ + +
Sbjct: 57 LTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--------FYGAEIVSA 107
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 780
L+YLH+ N +++RD+K N++LD + K++DFGL ++ +D + + GT YL
Sbjct: 108 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLA 164
Query: 781 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
PE + D + GVV+ E++ G+ P +D
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 617 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 672
+GKG FG V +++ GK A K + + + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
E + LV M+ G L+ ++ N D + A + GLE L I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQ---RERI 123
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
++RD+K NILLD ++SD GL+ Q E T V GTVGY+ PE N++ T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNEKYTFS 181
Query: 793 SDVYSFGVVLLELISGKKP 811
D + G ++ E+I G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIHHRN 666
K +GKG+FG V + K G+ A+KI+ D +H VTE +L H
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTRHPF 56
Query: 667 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
L L Y + H R+ V EY + G L H S + + R A + LEYLH
Sbjct: 57 LTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLH 112
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 785
+ +++RD+K N++LD + K++DFGL ++ D + + GT YL PE
Sbjct: 113 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLE 168
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
+ D + GVV+ E++ G+ P +D
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 45/213 (21%)
Query: 616 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT---EVALLSRI-HHRNLVPL 670
KIG+G+F V + K GK A+K M Q V E+ L R+ H N++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRL 63
Query: 671 IGYC-EEEHQRI-LV--------YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 720
I + + R+ LV YE + + R ++ ++ +L K
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELI-----KGRKRPLPEKRVKSYMYQL------LKS 112
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 780
L+++H GI HRD+K NIL+ + K++DFG R + ++ T Y
Sbjct: 113 LDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS--TRWYRA 166
Query: 781 PE------YYGNQQLTEKSDVYSFGVVLLELIS 807
PE YYG K D+++ G V E++S
Sbjct: 167 PECLLTDGYYG-----PKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 63/221 (28%), Positives = 116/221 (52%), Gaps = 28/221 (12%)
Query: 606 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRT-QQFVTEVALL 659
L+E K +G G+FG+VY G + DG+ VA+K++ ++ S + ++ + E ++
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63
Query: 660 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL-------RDRLHGSVNQKPLDWLTRLQ 712
+ + + L+G C + LV + M G L +DR+ GS Q L+W ++
Sbjct: 64 AGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRI-GS--QDLLNWCVQI- 118
Query: 713 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 771
AKG+ YL ++HRD+ + N+L+ K++DFGL+R + D T +
Sbjct: 119 -----AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170
Query: 772 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ + ++ E +++ T +SDV+S+GV + EL++ G KP
Sbjct: 171 GKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 81/324 (25%), Positives = 145/324 (44%), Gaps = 48/324 (14%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVK-------IMAD--SCS---HRTQQFVTEVALLSR 661
K +GKGSFG V ++K G+ AVK ++ D C+ R E L+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 662 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 721
++ + +EH V E+++ G L + ++ D A + GL
Sbjct: 61 LY-------CTFQTKEHL-FFVMEFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGL 109
Query: 722 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 781
++LH+ GII+RD+K N++LD + K++DFG+ ++ S+ GT Y+ P
Sbjct: 110 QFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAP 165
Query: 782 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED----FGA-ELNIVHWARSMIKKG-D 835
E + T D +SFGV+L E++ G+ P +D F + ++ H+ R + K+ D
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKD 225
Query: 836 VISIV---DPV----LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888
++ + DP ++GN++ ++ +E+R P + V + D
Sbjct: 226 ILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA--LEKRELD-PPFKPKVKSPSDYSNF- 281
Query: 889 KGGDQKFSSSSSKGQSSRKTLLTS 912
D++F S + S K L+ S
Sbjct: 282 ---DREFLSEKPRLSYSDKNLIDS 302
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE--VAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVPL 670
K I G++G+VY + K+ ++ KI + R Q Q E +L+ + +V +
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 671 IGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
+C E +R L V EY+ G L ++ P+D + R+ A + LEYLH
Sbjct: 67 --FCSFETKRHLCMVMEYVEGGDCATLLK-NIGALPVD-MARMYFA-ETVLALEYLH--- 118
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------HISSVAR--------G 774
N GI+HRD+K N+L+ K++DFGLS+ LT HI R G
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 775 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
T Y+ PE Q + D ++ G++L E + G P
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 35/212 (16%)
Query: 616 KIGKGSFGSVYYGKMK-DGKEVAVK-IMAD-------SCSHRTQQFVTEVALLSRIHHRN 666
KIG+G++G VY + K G+ VA+K I + S + R E++LL ++H N
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR------EISLLKELNHPN 59
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 723
+V L+ E++ LV+E++ L ++ PL L I + +G+ Y
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLD-----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL---THISSVARGTVGYLD 780
H+ ++HRD+K N+L+D K++DFGL+R + TH V T+ Y
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH--EVV--TLWYRA 167
Query: 781 PE-YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
PE G++Q + D++S G + E+++ ++P
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-12
Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 14/169 (8%)
Query: 651 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 710
Q + E+ +L + +V G + + + E+M G+L D++ + P + L +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGK 107
Query: 711 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 770
+ IA +GL YL I+HRDVK SNIL++ K+ DFG+S Q I S
Sbjct: 108 VSIA--VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDS 157
Query: 771 VAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
+A GT Y+ PE + +SD++S G+ L+EL G+ P+ D
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-12
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 617 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPLIG 672
+G GSFG V K K G+ A+K + + +Q E ++L + H +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK--------GLEYL 724
++E++ + E++ G L L + P +D AK EYL
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLR-KAGRFP----------NDVAKFYHAELVLAFEYL 134
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
H + II+RD+K N+LLD KV+DFG +++ + + GT YL PE
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC----GTPEYLAPEVI 187
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKP 811
++ + D ++ GV+L E I+G P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 610 TNNFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHR 665
NF +GKGSFG V + K E+ A+KI+ + + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 666 NLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLE 722
+ + C + R+ V EY++ G L + G + + A + + GL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----QAVFYAAEISVGLF 115
Query: 723 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 782
+LH GII+RD+K N++LD K++DFG+ ++ D + GT Y+ PE
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPE 171
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
Q + D +++GV+L E+++G+ P ED
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 616 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ--------QFVTEVALLSRIH--- 663
+IG G++G+VY + G VA+K S R Q V EVALL R+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALK------SVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 664 HRNLVPLIGYC-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 718
H N+V L+ C + E + LV+E++ + LR L V L T +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLD-KVPPPGLPAETIKDLMRQFL 118
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 778
+GL++LH C I+HRD+K NIL+ + K++DFGL+R + V T+ Y
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWY 173
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 812
PE D++S G + E+ +KP+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 616 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYC 674
++G G+FG VY + K+ +A + D+ S + ++ E+ +L+ H N+V L+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 675 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 734
E+ ++ E+ G + D + + ++PL + + L YLH IIH
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH---ENKIIH 126
Query: 735 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-----GNQQL 789
RD+K+ NIL ++ K++DFG+S + + S GT ++ PE ++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 185
Query: 790 TEKSDVYSFGVVLLELISGKKP 811
K+DV+S G+ L+E+ + P
Sbjct: 186 DYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 25/233 (10%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRIHHRNL 667
K +GKGSFG V ++K E+ AVK I+ D T +AL + H L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFL 58
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
L + + + V EY++ G L + D A + GL++LH
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLH-- 113
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYG 785
GII+RD+K N+LLD K++DFG+ ++ T S GT Y+ PE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS 169
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKPVSVED----FGAELNI-VHWARSMIKK 833
Q D ++ GV+L E+++G+ P +D F + L V + R + K+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKE 222
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 671
+KIG+G++G VY G+ K G+ VA+K I +S + E++LL + H N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
+E + L++E++ + L+ L + +D + +G+ + H+
Sbjct: 66 DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RR 121
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE-YYGNQ 787
++HRD+K N+L+D K++DFGL+R TH V T+ Y PE G+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH--EVV--TLWYRAPEVLLGSP 177
Query: 788 QLTEKSDVYSFGVVLLELISGKKPV 812
+ + D++S G + E+ + KKP+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 33/218 (15%)
Query: 617 IGKGSFGSVYYGKMKD---------GKEVAVKI-MADSCSHRTQQFVTEVALLSRIHHRN 666
+G+G+F ++Y G ++ G+EV+V + + S + F +L+S++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 667 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
LV L G C +E+ I+V EY+ G L LH N L W L +A A L YL
Sbjct: 63 LVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLE 118
Query: 726 TGCNPGIIHRDVKSSNILL---DINMR----AKVSDFGLSRQAEEDLTHISSVARGTVGY 778
+ ++H +V NIL+ +N K+SD G+ L+ V R + +
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV---LSREERVER--IPW 170
Query: 779 LDPEYYGNQQ--LTEKSDVYSFGVVLLELIS-GKKPVS 813
+ PE N Q LT +D +SFG LLE+ S G++P+S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 617 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-----PL 670
IG+G FG VY + D GK A+K + D + +Q T +AL RI +LV P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGET-LALNERIM-LSLVSTGDCPF 58
Query: 671 I---GYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
I Y ++ + + M+ G L L HG ++ + + A + GLE++
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY-----AAEIILGLEHM 113
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ PE
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 785 GNQQLTEKS-DVYSFGVVLLELISGKKP 811
+ S D +S G +L +L+ G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-11
Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 53/237 (22%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR------TQQFVTEVALLSRIHHRNLV 668
KKIG G FG V+ K K +E + S+R Q V EV ++ + H+N+V
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEF---FCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIV 75
Query: 669 PLIG-YCEEEHQRI-LVYEYMHNGTLRD------RLHGSVNQKPLDWLTRLQIAHDAAKG 720
I + + +Q++ ++ E+ G L ++ G + + + +TR Q+ H
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR-QLLH----A 130
Query: 721 LEYLHT---GCN-PGIIHRDVKSSNILLDINMR-----------------AKVSDFGLSR 759
L Y H G N ++HRD+K NI L +R AK+ DFGLS+
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 760 QAEEDLTHISSVARGTVG---YLDPEY--YGNQQLTEKSDVYSFGVVLLELISGKKP 811
I S+A VG Y PE + + +KSD+++ G ++ EL SGK P
Sbjct: 191 N-----IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLI 671
K IG+G++G V K + ++VA+K +A++ +R T E+ LL + H N++ +
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 672 GYCEEEHQRI-----LVYEYMHNGTLRDRLHGSV--NQKPLD-----WLTRLQIAHDAAK 719
H+ +VYE M LH + +Q D +L +L +
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQL------LR 119
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVG 777
GL+Y+H+ ++HRD+K SN+LL+ N K+ DFGL+R E ++ V R
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---W 173
Query: 778 YLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPV 812
Y PE N + T DV+S G + EL+ G+KP+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 617 IGKGSFGSV------YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 670
+GKG FG V GKM K++ K + + + E +L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA--LLEKEILEKVNSPFIVNL 58
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
E + LV M+ G L+ ++ +V ++ L+ + + G+ +LH+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIY-NVGERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
I++RD+K N+LLD ++SD GL+ + ++ T I+ A GT GY+ PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRA-GTNGYMAPEILKEEPYS 172
Query: 791 EKSDVYSFGVVLLELISGKKP 811
D ++ G + E+++G+ P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 14/169 (8%)
Query: 651 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 710
Q + E+ +L + +V G + + + E+M G+L D++ + P L +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 107
Query: 711 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 770
+ IA KGL YL I+HRDVK SNIL++ K+ DFG+S Q I S
Sbjct: 108 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDS 157
Query: 771 VAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
+A GT Y+ PE + +SD++S G+ L+E+ G+ P+ D
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 36/213 (16%)
Query: 616 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI- 671
IG+G++G V K G +VA+K ++ H+T Q+ + E+ +L R H N++ ++
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 672 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRL--QIAHDAAKGLEY 723
E + +V E M L+ + + L D + QI +GL+Y
Sbjct: 71 IIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQIL----RGLKY 121
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS------VARGTVG 777
+H N ++HRD+K SN+LL+ N K+ DFGL+R A D H + VA T
Sbjct: 122 IH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIA--DPEHDHTGFLTEYVA--TRW 174
Query: 778 YLDPEYYGNQQLTEKS-DVYSFGVVLLELISGK 809
Y PE N + K+ D++S G +L E++S +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 65/244 (26%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQFVT----EVALLSRIHHRN 666
K +GKG +G V+ + G + A+K++ + R Q+ E +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAKGLEY 723
+V LI + + L+ EY+ G L L + +L+ + +A LE+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA------LEH 115
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDP 781
LH GII+RD+K NILLD K++DFGL +++ E +TH GT+ Y+ P
Sbjct: 116 LHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAP 169
Query: 782 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--------FGAELNI----VHWARS 829
E + D +S G ++ ++++G P + E+ +LN+ AR
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARD 229
Query: 830 MIKK 833
++KK
Sbjct: 230 LLKK 233
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 41/111 (36%), Positives = 63/111 (56%), Gaps = 7/111 (6%)
Query: 704 PLDWLTRLQIAHDAAKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762
PLD L+ + A+G+++L + C IHRDV + N+LL AK+ DFGL+R
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIM 263
Query: 763 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
D + + AR V ++ PE + T +SDV+S+G++L E+ S GK P
Sbjct: 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 615 KKIGKGSFGSVYY----GKMKDGKEVAVKIMADSC---SHRTQQFV-TEVALLSRIHHRN 666
+ +G G++G V+ G GK A+K++ + +T + TE +L +
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 667 -LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
LV L + + + L+ +Y++ G L L+ + + R+ IA + L++LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE--VRVYIA-EIVLALDHLH 122
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 782
GII+RD+K NILLD ++DFGLS++ EE+ + GT+ Y+ PE
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GTIEYMAPE 176
Query: 783 YY--GNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
G+ + D +S GV+ EL++G P +V+
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 32/210 (15%)
Query: 615 KKIGKGSFGSVYYG-KMKDGKEVAVK-----IMADSCSHRTQQFVTEVALLSRIHHRNLV 668
K++G G++G+V + G +VA+K ++ + R + E+ LL + H N++
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR---ELRLLKHMKHENVI 77
Query: 669 PLIGY------CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKG 720
L+ + H LV +M GT +L H +++ + +L + KG
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLV-----YQMLKG 130
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 780
L+Y+H GIIHRD+K N+ ++ + K+ DFGL+RQ + ++T T Y
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----TRWYRA 183
Query: 781 PEYYGN-QQLTEKSDVYSFGVVLLELISGK 809
PE N T+ D++S G ++ E+++GK
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-11
Identities = 34/81 (41%), Positives = 50/81 (61%), Gaps = 1/81 (1%)
Query: 425 LKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSL 483
L G IPP + +++ L L L N L+G +P++ +L +L I+HL +N TG +P + SL
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 484 PNLQELHIENNSFVGEIPPAL 504
P LQ L + +N F GEIP L
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-11
Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 615 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 670
+ IGKG G VY + VA+K + + S ++F+ E + + + H +VP+
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTR----LQIAHDAAKGL 721
C + Y+ TL+ L SV Q K L T L I H +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLK-SVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 722 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG--LSRQAEEDLTHISSVAR------ 773
EY+H+ G++HRD+K NILL + + D+G + ++ EE+ V
Sbjct: 127 EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 774 ---------GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 817
GT Y+ PE +E +D+Y+ GV+L ++++ P +
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
|
Length = 932 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 42/232 (18%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 670
K +GKG G V+ ++K ++ A+K++ ++ ++ +TE +L+ + H L L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK---GLEYLHTG 727
+ E LV +Y G L + ++P L+ AA+ LEYLH
Sbjct: 67 YASFQTETYLCLVMDYCPGG----ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH-- 120
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----------------------EEDL 765
GI++RD+K NILL + +SDF LS+Q+
Sbjct: 121 -LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 766 THI-SSVAR-----GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
T R GT Y+ PE D ++ G++L E++ G P
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLS-RIHHRNLVP 669
K +GKGSFG V ++K EV A+K++ + +TE +L+ H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
L + + + V EY++ G L ++ S + D A + L +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH-- 115
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQ 787
G+I+RD+K NILLD K++DFG+ ++ T + GT Y+ PE
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQEL 171
Query: 788 QLTEKSDVYSFGVVLLELISGKKPVSVED 816
+ D ++ GV++ E+++G+ P ++
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 616 KIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVT---EVALLSRIHHRNLVPL 670
+I +G++G VY + K G+ VA+K + + + +T E+ +L ++ H N+V +
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEK--EKEGFPITSLREINILLKLQHPNIVTV 69
Query: 671 --IGYCEEEHQRILVYEYMHNG--TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
+ + +V EY+ + +L + + Q + L LQ+ G+ +LH
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM-LQLL----SGVAHLHD 124
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 785
I+HRD+K+SN+LL+ K+ DFGL+R+ L + + T+ Y PE G
Sbjct: 125 NW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLG 180
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKPV 812
++ + D++S G + EL++ KKP+
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-11
Identities = 69/268 (25%), Positives = 112/268 (41%), Gaps = 75/268 (27%)
Query: 615 KKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 666
K +G G+FG V K VAVK++ + + + ++E+ +L I +H N
Sbjct: 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72
Query: 667 LVPLIGYCEEEHQRILV-YEYMHNGTL---------------------RDRLHGSVNQKP 704
+V L+G C + + ++V E+ G L R R V Q
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 705 LD--------------------------------WLTRLQI------AHDAAKGLEYLHT 726
+D W + L + + A+G+E+L +
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 727 -GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYY 784
C IHRD+ + NILL N K+ DFGL+R +D ++ AR + ++ PE
Sbjct: 193 RKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248
Query: 785 GNQQLTEKSDVYSFGVVLLELIS-GKKP 811
++ T +SDV+SFGV+L E+ S G P
Sbjct: 249 FDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 617 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI--GY 673
IG+G FG VY + D GK A+K + D + +Q T +AL RI ++ L+ G
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGET-LALNERI----MLSLVSTGD 55
Query: 674 C----------EEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 721
C + + + M+ G L L HG ++K + + A + GL
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY-----ATEIILGL 110
Query: 722 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 781
E++H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ P
Sbjct: 111 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
Query: 782 EYYGNQQLTEKS-DVYSFGVVLLELISGKKP 811
E + S D +S G +L +L+ G P
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-11
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 615 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 671
K IG G+ G V G VAVK ++ ++T ++ E+ LL ++H+N++ L+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 672 GY------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
EE LV E M + L +H ++ + + +L + G+++LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLC-----GIKHLH 140
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 785
+ GIIHRD+K SNI++ + K+ DFGL+R A + V T Y PE
Sbjct: 141 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVIL 195
Query: 786 NQQLTEKSDVYSFGVVLLELISG 808
E D++S G ++ EL+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 30/207 (14%)
Query: 617 IGKGSFGSV---YYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPL 670
+G G++GSV Y +++ ++VAVK ++ S H + + E+ LL + H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGL 79
Query: 671 IGY------CEEEHQRILVYEYMHNGTLRDRLHGSVN-QKPLDWLTRLQIAHDAAKGLEY 723
+ E ++ LV M L+ V QK D + I + +GL+Y
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGAD-----LNNIVKCQKLSDEHVQFLI-YQLLRGLKY 133
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
+H+ GIIHRD+K SN+ ++ + ++ DFGL+RQA++++T VA T Y PE
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT--GYVA--TRWYRAPEI 186
Query: 784 YGN-QQLTEKSDVYSFGVVLLELISGK 809
N + D++S G ++ EL+ GK
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 617 IGKGSFGSVYYGK-MKDGKEVAVKI-----MADSCSHRTQQFVTEVALLSRIH------- 663
+G G+ G+V K + DG+ AVK+ M+++ +R Q EV L
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ---AEVCCLLNCDFFSIVKC 96
Query: 664 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 722
H + E I LV +Y + G LR + R H+A GL
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT------NRTFREHEA--GLL 148
Query: 723 YL------HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--- 773
++ H + +IHRD+KS+NILL N K+ DFG S+ ++ V R
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS--DDVGRTFC 206
Query: 774 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
GT Y+ PE + + ++K+D++S GV+L EL++ K+P E+
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEV-ALLSRIHHRNLVP 669
K IGKGSFG V + K + K AVK++ + ++E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
L + + V +Y++ G L H + L+ R A + A L YLH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARFYAA-EIASALGYLHS--- 114
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 789
I++RD+K NILLD ++DFGL ++ E S+ GT YL PE Q
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPY 173
Query: 790 TEKSDVYSFGVVLLELISGKKP 811
D + G VL E++ G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 27/207 (13%)
Query: 615 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 669
K++G G++GSV + G++VA+K + S +++ F E+ LL + H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQHENVIG 78
Query: 670 LIGY------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 723
L+ +E LV YM + H +++ + +L + GL+Y
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH-PLSEDKVQYLV-----YQMLCGLKY 132
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
+H+ GIIHRD+K N+ ++ + K+ DFGL+R A+ ++T T Y PE
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEV 185
Query: 784 YGN-QQLTEKSDVYSFGVVLLELISGK 809
N + D++S G ++ E+++GK
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 617 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 671
+G G++GSV K G VAVK ++ S H + + E+ LL + H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 672 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
EE + + ++ L + + QK D + I + +GL+Y+H+
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 139
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 786
IIHRD+K SN+ ++ + K+ DFGL+R ++++T VA T Y PE N
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPEIMLNW 192
Query: 787 QQLTEKSDVYSFGVVLLELISGK 809
+ D++S G ++ EL++G+
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVT-----EVALLSRIHHRNLV 668
+K+G+GS+ +VY G + +G+ VA+K++ S +T++ V E +LL + H N+V
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP--LDWLTRLQIAHDAAKGLEYLHT 726
L + V+EYMH L + Q P L +GL Y+H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTD-----LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH- 120
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPE-YY 784
I+HRD+K N+L+ K++DFGL+R ++ T+ S V T+ Y P+
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176
Query: 785 GNQQLTEKSDVYSFGVVLLELISGK 809
G + D++ G + +E++ G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 617 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 667
IG+GS+ V ++K ++ A+K++ H +T++ V E A + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF----L 58
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
V L + + LV EY++ G L H +K + R A + L +LH
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDLM--FHMQRQRKLPEEHARFYAA-EICIALNFLH-- 113
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 787
GII+RD+K N+LLD + K++D+G+ ++ S+ GT Y+ PE +
Sbjct: 114 -ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGE 171
Query: 788 QLTEKSDVYSFGVVLLELISGKKPVSV 814
+ D ++ GV++ E+++G+ P +
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 670
K IG+G+FG V + K ++V A+K+++ R+ F E +++ + +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+++ +V EYM G L + + S P W + A + L+ +H+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKW-AKFYTA-EVVLALDAIHS---M 161
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 782
G+IHRDVK N+LLD + K++DFG + +E A GT Y+ PE
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 783 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
YYG + D +S GV L E++ G P
Sbjct: 222 GYYGRE-----CDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 617 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRN---LVP 669
IGKG+FG VY + KD + + A+K+++ ++ + E +L R +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
L + + LV +YM G L L G ++ + IA + LE+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR----AKFYIA-ELVLALEHLHKY 115
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYG 785
I++RD+K NILLD + DFGLS+ + T+ GT YL PE
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLL 169
Query: 786 NQQ-LTEKSDVYSFGVVLLELISGKKPVSVED 816
+++ T+ D +S GV++ E+ G P ED
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 412 PPRITKIA------LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 464
P +T + L+ L G+IP EL M++L ++L N L+G +P ++ L L
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 465 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ L N LTG +PS +G+L NLQ L + N G IPP++
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280
|
Length = 968 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 68/272 (25%), Positives = 108/272 (39%), Gaps = 64/272 (23%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 670
K IG+G+FG V + KD G A+K + S +Q E +L+ + +V L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 671 IGYC--EEEHQRILVYEYMHNG---TL---RDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 722
Y ++E+ L+ EY+ G TL +D TR IA + ++
Sbjct: 67 --YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE--------TRFYIA-ETILAID 115
Query: 723 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL--------SRQAEEDLTHISS---- 770
+H G IHRD+K N+LLD K+SDFGL + L+H
Sbjct: 116 SIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 771 ----------------------VARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLEL 805
+A TVG Y+ PE + ++ D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 806 ISGKKP-VSVEDFGAELNIVHWARSMIKKGDV 836
+ G P S I++W ++ +V
Sbjct: 233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEV 264
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 617 IGKGSFGSVYYGKMKDGKEV-AVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIG 672
IGKGSFG V + +D + + A+K + + + E +L++++ +VPL
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+ + LV +++ G L L G + R A + LE LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL----SRARFYTA-ELLCALENLHKF--- 112
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQ 788
+I+RD+K NILLD + DFGL + ++D T+ GT YL PE
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAPELLLGHG 169
Query: 789 LTEKSDVYSFGVVLLELISGKKPVSVED 816
T+ D ++ GV+L E+++G P E+
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN 197
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 30/232 (12%)
Query: 617 IGKGSFGSVYYGKMKDGKEV-AVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+G+G FG V + K ++ A+K+M S F E +LS + + L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD------WLTRLQIAHDAAKGLEYLHT 726
+++ LV EY G L L + + D +L L +A +H+
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLA---------IHS 117
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY--- 783
G +HRD+K N+L+D K++DFG + + + S + GT Y+ PE
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 784 ---YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVHWARSM 830
G + D +S GV+ E+I G+ P E A+ NI+++ R +
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH-EGTSAKTYNNIMNFQRFL 228
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 7/97 (7%)
Query: 718 AKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGT 775
A+G+E+L + C IHRD+ + NILL N K+ DFGL+R +D ++ AR
Sbjct: 183 ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 776 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ ++ PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 616 KIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
K+G+G++ +V+ G+ K VA+K I + + EV+LL + H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA-------KGLEYLHT 726
E LV+EY+ + ++ LD L H+ +GL Y H
Sbjct: 72 IHTERCLTLVFEYLDSDL----------KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH- 120
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 785
I+HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G
Sbjct: 121 --KRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 786 NQQLTEKSDVYSFGVVLLELISGK 809
+ + + D++ G +L E+ +G+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-10
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 604 PELEEATNNFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADS---CSHRTQQFVTEVALL 659
P +EE K I +G+FG VY G K + K AVK++ + + Q E L
Sbjct: 1 PSIEEFV--IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL 58
Query: 660 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDA 717
+ +V L + + LV EY+ G ++ LH G +++ ++ +
Sbjct: 59 ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEV 113
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759
A L+YLH GIIHRD+K N+L+ K++DFGLS+
Sbjct: 114 ALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-10
Identities = 42/160 (26%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 654 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQ 712
+E+ L+ H +V + + + +L+ EY G L ++ + + P
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 713 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSV 771
+ + L+ +H+ ++HRD+KS+NI L K+ DFG S+Q + ++ ++S
Sbjct: 174 LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 772 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
GT YL PE + ++ ++K+D++S GV+L EL++ +P
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 36/212 (16%)
Query: 615 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRTQQFVT-------EVALLSRIHH 664
K IG G+ G V Y G+ VA+K ++ R Q VT E+ L+ ++H
Sbjct: 22 KPIGSGAQGIVCAAYD--TVTGQNVAIKKLS-----RPFQNVTHAKRAYRELVLMKLVNH 74
Query: 665 RNLVPLIGYCE-----EEHQRI-LVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 717
+N++ L+ EE Q + LV E M N L V Q LD + +
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN------LC-QVIQMDLDHERMSYLLYQM 127
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 777
G+++LH + GIIHRD+K SNI++ + K+ DFGL+R A V T
Sbjct: 128 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 182
Query: 778 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 809
Y PE E D++S G ++ E+I G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 8e-10
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 45/236 (19%)
Query: 613 FCKKIGKGSFG---SVYYGKMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIH-HRN 666
K++G+G++G S + + + VA+K + + S + ++ + E+ LL H+N
Sbjct: 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKN 63
Query: 667 LVPLI--------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH--- 715
+ L + E + +YE + L + L AH
Sbjct: 64 ITCLYDMDIVFPGNFNE-----LYLYEELMEADLHQIIRSGQ---------PLTDAHFQS 109
Query: 716 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR----QAEEDLTHI 768
GL+Y+H+ ++HRD+K N+L++ + K+ DFGL+R E+ +
Sbjct: 110 FIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166
Query: 769 SS-VARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 822
+ VA T Y PE Q T+ DV+S G +L EL+ K +D+ +LN
Sbjct: 167 TEYVA--TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 39/109 (35%), Positives = 58/109 (53%), Gaps = 5/109 (4%)
Query: 705 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764
LD L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 765 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ + AR V ++ PE N T +SDV+S+G++L E+ S G P
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 617 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 667
IG+GS+ V ++K + + A+K++ + +T++ V E A +H L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFL 58
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
V L + E + V EY++ G L H +K + R A + + L YLH
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEEHARFYSA-EISLALNYLH-- 113
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 787
GII+RD+K N+LLD K++D+G+ ++ +S GT Y+ PE +
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGE 171
Query: 788 QLTEKSDVYSFGVVLLELISGKKPVSV 814
D ++ GV++ E+++G+ P +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 670
K IG+G+FG V + K ++V A+K+++ R+ F E +++ + +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+++ +V EYM G L + + S P W R A + L+ +H+
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHS---M 161
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 782
G IHRDVK N+LLD + K++DFG + ++ A GT Y+ PE
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 783 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
YYG + D +S GV L E++ G P
Sbjct: 222 GYYGRE-----CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 617 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVP---- 669
IGKGS+G V G++VA+K + D H + + + E+ LL + H ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 670 LIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 725
++ E + I +V+E M + LH + K D LT + + L+Y+H
Sbjct: 68 MLPPSRREFKDIYVVFELMESD-----LHQVI--KANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THI---SSVARGTVGYLDP 781
T + HRD+K NIL + + + K+ DFGL+R A D T I VA T Y P
Sbjct: 121 TA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA--TRWYRAP 175
Query: 782 EYYGN--QQLTEKSDVYSFGVVLLELISGK 809
E G+ + T D++S G + E+++GK
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 39/97 (40%), Positives = 58/97 (59%), Gaps = 7/97 (7%)
Query: 718 AKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGT 775
AKG+E+L + C IHRD+ + NILL N K+ DFGL+R +D ++ AR
Sbjct: 189 AKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 776 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ ++ PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 616 KIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 670
K+G+G++G VY K KDG KE A+K + + + E+ALL + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQK 65
Query: 671 IGYCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRL--QIAHDAAKGLEYLH 725
+ + + L+++Y + ++ N+KP+ + + + G+ YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 726 TGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSV--ARGTVGYL 779
++HRD+K +NIL+ R K++D G +R L ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 780 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 809
PE G + T+ D+++ G + EL++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 60/241 (24%), Positives = 111/241 (46%), Gaps = 53/241 (21%)
Query: 616 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQF----VTEVALLSRIHHRNLVP 669
KIG+G+FG V+ + K K+ VA+K ++ + + + F + E+ +L + H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITALREIKILQLLKHENVVN 75
Query: 670 LIGYCEEEHQR--------ILVYEYM-HNGTLRDRLHGSVNQKPLDW-LTRLQ-IAHDAA 718
LI C + LV+E+ H+ L G ++ K + + L+ ++ +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHD------LAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGT 775
GL Y+H I+HRD+K++NIL+ + K++DFGL+R ++ + + T
Sbjct: 130 NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 776 VGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 834
+ Y PE G + D++ G ++ E+ W RS I +G
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEM--------------------WTRSPIMQG 226
Query: 835 D 835
+
Sbjct: 227 N 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 615 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 670
K IG G+ G V Y + D + VA+K ++ ++T ++ E+ L+ ++H+N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 671 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
+ EE Q + + + + L + ++ + + +L + G+++LH
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 136
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 785
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 191
Query: 786 NQQLTEKSDVYSFGVVLLELISGK 809
E D++S G ++ E++ K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 615 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 670
K IG G+ G V Y + + + VA+K ++ ++T ++ E+ L+ ++H+N++ L
Sbjct: 30 KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 671 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
+ EE Q + + + + L + ++ + + +L + G+++LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 785
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 786 NQQLTEKSDVYSFGVVLLELISGK 809
E D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 615 KKIGKGSFGSVYY----GKMKDGKEVAVKIMADSC---SHRTQQFV-TEVALLSRIHHRN 666
K +G G++G V+ GK A+K++ + +T + TE +L +
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 667 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK------ 719
+ + Y + ++ L+ +Y+ G + L+ R + D +
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-----------QRDNFSEDEVRFYSGEI 114
Query: 720 --GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 777
LE+LH GI++RD+K NILLD ++DFGLS++ + + GT+
Sbjct: 115 ILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 778 YLDPEYYGNQQLTEKS-DVYSFGVVLLELISGKKPVSVE 815
Y+ PE + K+ D +S G+++ EL++G P ++E
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 37/219 (16%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-- 671
+ +G GS G V+ D K VAVK + + + + E+ ++ R+ H N+V +
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 672 ----GYCEEEHQRIL--------VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 719
G E L V EYM L + Q PL + +
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSEEHARLFMYQLLR 125
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 777
GL+Y+H+ ++HRD+K +N+ ++ ++ K+ DFGL+R + +H ++ G V
Sbjct: 126 GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 778 -------YLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 809
L P Y T+ D+++ G + E+++GK
Sbjct: 183 WYRSPRLLLSPNNY-----TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQ--------FVTEVALLSRIHHR 665
+KIG+G++G VY + + E +A+K + R +Q + E++LL + H
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKI------RLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA----HDAAKGL 721
N+V L E + LV+EY L L ++ P D+ ++ + +G+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSP-DFAKNPRLIKTYLYQILRGI 115
Query: 722 EYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGTVG 777
Y H+ ++HRD+K N+L+D A K++DFGL+R TH V T+
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH--EVV--TLW 168
Query: 778 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 809
Y PE G++ + D++S G + E+++ K
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 53/212 (25%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 616 KIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 670
K+G+G++G VY K KDG ++ A+K + + + E+ALL + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65
Query: 671 IGYCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYL 724
+ + + L+++Y + ++ N+KP+ L R + + G+ YL
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ-LPRGMVKSLLYQILDGIHYL 124
Query: 725 HTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSV--ARGTVGY 778
H ++HRD+K +NIL+ R K++D G +R L ++ + T Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 779 LDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 809
PE G + T+ D+++ G + EL++ +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-09
Identities = 35/85 (41%), Positives = 49/85 (57%), Gaps = 1/85 (1%)
Query: 418 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSL 476
I L NL GEIP E+ + +L L L N LTGP+P + L +L+ + L N+L+G +
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 477 PSYMGSLPNLQELHIENNSFVGEIP 501
P + SL L L + +NS GEIP
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 616 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
K+G+G++ +VY G+ K VA+K I + + EV+LL + H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 674 CEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
E LV+EY+ + D S+N + L Q+ +GL Y H
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVK-LFLFQLL----RGLNYCH---RRK 124
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLT 790
++HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 791 EKSDVYSFGVVLLELISGK 809
+ D++ G + E+ +G+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 616 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ-------FVTEVALLSRIHHRNL 667
K+G+GS+ +VY G+ K G+ VA+K + R + + E +LL + H N+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI------RLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA-------KG 720
V L + LV+EY+ D ++ +D H+ +G
Sbjct: 66 VTLHDIIHTKKTLTLVFEYLD----TDL------KQYMDDCGGGLSMHNVRLFLFQLLRG 115
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 780
L Y H ++HRD+K N+L+ K++DFGL+R A+ + S T+ Y
Sbjct: 116 LAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRP 171
Query: 781 PE-YYGNQQLTEKSDVYSFGVVLLELISG 808
P+ G+ + + D++ G + E+ +G
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 617 IGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLIGY 673
+G+G++G V + K+ KE VA+K DS + + T E+ +L + N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 674 CEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+ LV+EY+ L + +G +K ++ +L K + + H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------IKAIHWCHKN--- 119
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEYYGNQQ 788
I+HRD+K N+L+ N K+ DFG +R E + + VA T Y PE
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA--TRWYRSPELLLGAP 177
Query: 789 LTEKSDVYSFGVVLLELISGK 809
+ D++S G +L EL G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 617 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 667
IG+GS+ V ++K + + A+K++ + +T++ V E A +H L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA----SNHPFL 58
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
V L + E + V E++ G L H +K + R A + + L +LH
Sbjct: 59 VGLHSCFQTESRLFFVIEFVSGGDLM--FHMQRQRKLPEEHARFYSA-EISLALNFLHER 115
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYG 785
GII+RD+K N+LLD K++D+G+ ++ D T S GT Y+ PE
Sbjct: 116 ---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILR 169
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKP 811
+ D ++ GV++ E+++G+ P
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+K+G+G++ +V+ G+ K + VA+K I + + EV+LL + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+ LV+EY+ + L+ + G++ + QI +GL Y H
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL----RGLAYCH---RR 123
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 789
++HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 790 TEKSDVYSFGVVLLELISGK 809
+ + D++ G + E+ SG+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGK--EVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRN 666
NF + +G GSFG V K+ VA+K S + +Q +E +L+ I+H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
V L G ++E LV E++ G L + + P D A EYL +
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPND--VGCFYAAQIVLIFEYLQS 149
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
I++RD+K N+LLD + K++DFG ++ + + GT Y+ PE N
Sbjct: 150 ---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC----GTPEYIAPEILLN 202
Query: 787 QQLTEKSDVYSFGVVLLELISGKKP 811
+ +D ++ G+ + E++ G P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 616 KIGKGSFGSVYYG-KMKDGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVP 669
IG G++G V + GK+VA+K + + + RT + E+ +L H N++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT---LRELKILRHFKHDNIIA 68
Query: 670 L--IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL---QIAHDAAKGLE 722
+ I + +V + M + L +H +Q + R Q+ +GL+
Sbjct: 69 IRDILRPPGADFKDVYVVMDLMES-DLHHIIHS--DQPLTEEHIRYFLYQLL----RGLK 121
Query: 723 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----EEDLTHISS-VARGTVG 777
Y+H+ +IHRD+K SN+L++ + ++ DFG++R E ++ VA T
Sbjct: 122 YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA--TRW 176
Query: 778 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPV 812
Y PE + T D++S G + E++ G++ +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVA---VKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 670
++IG G FG V ++ VA VK + + S + Q +F+ + + H N++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKGLEYLHTGCN 729
+G C E +LV+EY G L+ L + L LQ +A + A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEYYGNQQ 788
+H D+ N L ++ KV D+G+ + +ED + +L PE G
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 789 -------LTEKSDVYSFGVVLLELI-SGKKPVS 813
T+ S+V++ GV L EL + +P S
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-08
Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 24/194 (12%)
Query: 624 SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV--------PLIGYCE 675
S GK K + +A ++ A S Q E+ L R++H N++ Y
Sbjct: 184 STNQGKPKCERLIAKRVKAGS--RAAIQLENEILALGRLNHENILKIEEILRSEANTYMI 241
Query: 676 EEHQRILVYEYMHNGTL--RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
+ +Y +M++ +DR PL TR I +EY+H + +I
Sbjct: 242 TQKYDFDLYSFMYDEAFDWKDR--------PLLKQTR-AIMKQLLCAVEYIH---DKKLI 289
Query: 734 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 793
HRD+K NI L+ + + + DFG + E++ GTV PE E +
Sbjct: 290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEIT 349
Query: 794 DVYSFGVVLLELIS 807
D++S G++LL+++S
Sbjct: 350 DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 5e-08
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 15/145 (10%)
Query: 681 ILVYEYMHNGTLRDRLHGSVNQKPLDW-LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 739
+L+ +Y+ +G L D L + L + I + L LH IIH D+K
Sbjct: 85 VLIMDYIKDGDLFDLLK---KEGKLSEAEVKK-IIRQLVEALNDLH---KHNIIHNDIKL 137
Query: 740 SNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 798
N+L D R + D+GL + + S GT+ Y PE D ++
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAV 192
Query: 799 GVVLLELISGKKPVSVEDFGAELNI 823
GV+ EL++GK P ED EL++
Sbjct: 193 GVLTYELLTGKHPF-KEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-08
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 1/94 (1%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 478
LS +L GEIP + ++ L L L N TG +P ++ L L+++ L +N+ +G +P
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
Query: 479 YMGSLPNLQELHIENNSFVGEIPPALLTGKVIFK 512
+G NL L + N+ GEIP L + +FK
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-08
Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 1/90 (1%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 471
P + + LS L GEIP ++ + +L L L GN L G +P ++ L L + L +N+
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIP 501
L G +P +G + +L+ +++ N+ GEIP
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIP 229
|
Length = 968 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 690 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 748
T RD L +N+ P L ++ + ++ A G+E+L + +HRD+ + N+L+
Sbjct: 223 RTRRDTL---INESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGK 276
Query: 749 RAKVSDFGLSRQAEEDLTHISSVARGT----VGYLDPEYYGNQQLTEKSDVYSFGVVLLE 804
K+ DFGL+R D +IS +G+ + ++ PE N T SDV+SFG++L E
Sbjct: 277 LVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 805 LIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQC 863
+ + G P EL + + IK+G + P + I E+ +C
Sbjct: 334 IFTLGGTPYP------ELPMNEQFYNAIKRG--YRMAKPAHASD-------EIYEIMQKC 378
Query: 864 VEQRGFSRPKMQEIVLAIQD 883
E++ RP ++V + D
Sbjct: 379 WEEKFEIRPDFSQLVHLVGD 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKI----MADSCSHRTQQFVTEVALLSRIHHRN-LV 668
+KIG+G++G VY + K+ GK VA+K M + T + E++LL + +V
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIV 64
Query: 669 PLIG--YCEEEHQRI---LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 721
L+ + EE++ + LV+EY+ + L+ + +G +PL T + KG+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 722 EYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDL---THISSVARGTVG 777
+ H G++HRD+K N+L+D K++D GL R + TH V T+
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH-EIV---TLW 176
Query: 778 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISG 808
Y PE G+ + D++S G + E+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 36/108 (33%), Positives = 60/108 (55%), Gaps = 12/108 (11%)
Query: 705 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764
L L L + A+G+E+L + +HRD+ + N+LL K+ DFGL+R D
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----D 286
Query: 765 LTHISS-VARGT----VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 807
+ H S+ V++G+ V ++ PE + T SDV+S+G++L E+ S
Sbjct: 287 IMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 632 DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689
+G+E+ V + SHR F +L+S++ H +L + G C + I+V E++ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 690 GTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 744
G L +++ P+ W ++ +A A L YL + ++H +V + NILL
Sbjct: 101 GPLDVCLRKEKGR-----VPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILL 150
Query: 745 DINMRA-------KVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEKSDVY 796
A K+SD G+S A L+ V R + ++ PE G L+ +D +
Sbjct: 151 ARLGLAEGTSPFIKLSDPGVSFTA---LSREERVER--IPWIAPECVPGGNSLSTAADKW 205
Query: 797 SFGVVLLEL-------ISGKKPVSVEDF 817
SFG LLE+ + + P E F
Sbjct: 206 SFGTTLLEICFDGEVPLKERTPSEKERF 233
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 39/206 (18%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE--VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 670
K + GS G V+ K G+ V +KI + + E LL ++H +++ +
Sbjct: 72 KTLTPGSEGRVFVAT-KPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVIRMKD 124
Query: 671 ------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
I H +Y Y+ T R R PL L I +GL YL
Sbjct: 125 TLVSGAITCMVLPHYSSDLYTYL---TKRSR--------PLPIDQALIIEKQILEGLRYL 173
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDP 781
H IIHRDVK+ NI ++ + + D G ++ A L +A GTV P
Sbjct: 174 HA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----GLA-GTVETNAP 225
Query: 782 EYYGNQQLTEKSDVYSFGVVLLELIS 807
E + K+D++S G+VL E+++
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 1/92 (1%)
Query: 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNEL 472
R+ + LS G +P +L ++ L +L L N L+G +PD +S L + L +N+L
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+G +P+ +P L +L + N GEIP L
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567
|
Length = 968 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 42/275 (15%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-IGY 673
K IG G FG VY + + + +A + + V E + + I+ + + L
Sbjct: 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77
Query: 674 CEEEHQRILVY---------EYMHNGTLRDRLHGSVNQ---------KPLDWLTRLQIAH 715
+H I Y + L ++L + + K L I
Sbjct: 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKL----IKNIMK 133
Query: 716 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS------ 769
D LEY+H GI H D+K NI++D N R + D+G++ HI
Sbjct: 134 DMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190
Query: 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 829
+ RGT+ Y + + +T + D+ S G +L+ + + FG N++H A
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW--AGIKLPWKGFGHNGNLIHAA-- 246
Query: 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 864
K D I + G +KI++ + I+CV
Sbjct: 247 ---KCDFIKRLHE---GKIKIKNANKFIYDFIECV 275
|
Length = 294 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 420 LSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 477
LS N G IP + N+E L L N L+G +P D+ L+++ L N L G +P
Sbjct: 125 LSNNNFTGSIPRGSIPNLETLD---LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
Query: 478 SYMGSLPNLQELHIENNSFVGEIPPAL 504
+ + +L +L+ L + +N VG+IP L
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 616 KIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHRTQQFVT--EVALLSRIH---HRN 666
+IG+G++G V+ K +D G+ VA+K + T EVA+L + H N
Sbjct: 8 EIGEGAYGKVF--KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 667 LVPLIGYC-----EEEHQRILVYEYMHNG--TLRDRLH--GSVNQKPLDWLTRLQIAHDA 717
+V L C + E + LV+E++ T D++ G + D + +L
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL------ 119
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 777
+GL++LH+ ++HRD+K NIL+ + + K++DFGL+R + T+
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLW 174
Query: 778 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 812
Y PE D++S G + E+ +KP+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 50/178 (28%), Positives = 78/178 (43%), Gaps = 22/178 (12%)
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
N+V L Y E LV ++ G L + P + + R A + L+ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRW--AAEMVVALDALH 102
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEY 783
GI+ RD+ +NILLD +++ F + E+ D + ++ Y PE
Sbjct: 103 ---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEV 153
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIVHW----ARSMIKK 833
G + TE D +S G +L EL++GK V G LNI W ARS++++
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQ 211
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 34/105 (32%), Positives = 50/105 (47%)
Query: 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 469
T P + + +S NL+G I +M +L L L N G LPD L + L
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSR 484
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYD 514
N+ +G++P +GSL L +L + N GEIP L + K + D
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLD 529
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 34/87 (39%), Positives = 45/87 (51%), Gaps = 1/87 (1%)
Query: 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELT 473
+T + LS NL GEIP L + L +L L N L G +P + LR V L++N +
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417
Query: 474 GSLPSYMGSLPNLQELHIENNSFVGEI 500
G LPS LP + L I NN+ G I
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-06
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 617 IGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 675
IG GSFG VY D E VA+K + ++ + E+ ++ ++H N++ L Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDYYY 129
Query: 676 EEHQRI--------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
E + +V E++ + H + N L ++ + L Y+H+
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189
Query: 728 CNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE- 782
I HRD+K N+L+D N K+ DFG ++ + +++I S Y PE
Sbjct: 190 F---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPEL 241
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISG 808
G T D++S G ++ E+I G
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 42/223 (18%)
Query: 617 IGKGSFGSVYYGKMKD-----------GKEVAVKIMADSCSHR--TQQFVTEVALLSRIH 663
+G+G+ +Y G + KE+ V + SHR + F +++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 664 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 723
H+++V L G C + + I+V E++ G L +H + W + ++A A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 724 LHTGCNPGIIHRDVKSSNILL-------DINMRAKVSDFG-----LSRQAEEDLTHISSV 771
L + ++H +V + NILL + K+SD G LSRQ E + I +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ--ECVERIPWI 175
Query: 772 ARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLEL-ISGKKPV 812
A PE ++ L+ +D +SFG L E+ +G+ P+
Sbjct: 176 A--------PECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 23/186 (12%)
Query: 654 TEVALLSRIHHRNLVPLI-GYCEEEHQRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRL 711
E+ +L I HR ++ LI Y + +++ +Y + T DR PL +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS------GPLPLEQAI 188
Query: 712 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 771
I + L YLH GIIHRDVK+ NI LD A + DFG + + + H +
Sbjct: 189 TIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTP 242
Query: 772 A----RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HW 826
GT+ PE K+D++S G+VL E+ + FG ++
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL----FGKQVKSSSSQ 298
Query: 827 ARSMIK 832
RS+I+
Sbjct: 299 LRSIIR 304
|
Length = 392 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 47/166 (28%)
Query: 708 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL---------- 757
L R IA + +E +H G IHRD+K NIL+D + K++DFGL
Sbjct: 102 LARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 758 --------SRQ---------AEEDLTHISSVAR---------------GTVGYLDPEYYG 785
RQ +E D + + R GT Y+ PE
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKPVSVED-FGAELNIVHWARSM 830
T+ D +S GV+L E++ G+ P + +L +++W ++
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 61/245 (24%), Positives = 96/245 (39%), Gaps = 56/245 (22%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 670
K IG+G+FG V + KD G A+KI+ + +Q E +L +V +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 671 IGYCEEEHQRILVYEYMHNGTL------RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
+++ L+ E++ G + +D L Q ++ +A DA L
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF---YIAETVLAIDAIHQL--- 120
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL--------------------------- 757
G IHRD+K N+LLD K+SDFGL
Sbjct: 121 ------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 758 ----SRQAEEDLTHISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 810
R+AE + +A TVG Y+ PE + + D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 811 PVSVE 815
P E
Sbjct: 235 PFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-------MSRLIDL 462
T+ PR+ + L GEIP L LT L L N LTG +P+ + +LI
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI-- 386
Query: 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 501
L +N L G +P +G+ +L+ + +++NSF GE+P
Sbjct: 387 ----LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421
|
Length = 968 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 48/193 (24%), Positives = 91/193 (47%), Gaps = 22/193 (11%)
Query: 633 GKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690
G+ V V+ I ++C++ F+ E+ + +H N+VP +++ +V +M G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 691 TLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 747
+ +D + +D ++ L IA+ K L+Y+H + G +HR VK+S+IL+ ++
Sbjct: 85 SAKDLICTHF----MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVD 137
Query: 748 ----MRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGN--QQLTEKSDVYSF 798
+ S+ + + L + + +V +L PE Q KSD+YS
Sbjct: 138 GKVYLSGLRSNLSMINHGQR-LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 799 GVVLLELISGKKP 811
G+ EL +G P
Sbjct: 197 GITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 44/239 (18%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 670
K IG+G+FG V + KD G A+KI+ + +Q E +L +V +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+++ L+ E++ G + L D LT + A+ + + +
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQL 120
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGL-------------------------------SR 759
G IHRD+K N+LLD K+SDFGL R
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 760 QAEEDLTHISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 815
+AE + +A TVG Y+ PE + + D +S GV++ E++ G P E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 63/258 (24%), Positives = 98/258 (37%), Gaps = 68/258 (26%)
Query: 615 KKIGKGSFGSV-YYGKMKDGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 670
K IGKG+FG V K GK A+K + S + Q E +L+ +V L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW------LTRLQIAHDAAKGLEYL 724
++ L+ E++ G L L + + +TR +A + +E +
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMA-ECVLAIEAV 117
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS---------------RQAEEDLTHIS 769
H G IHRD+K NIL+D K+SDFGLS Q + + I
Sbjct: 118 H---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 770 S----------------------------VARGTVG---YLDPEYYGNQQLTEKSDVYSF 798
+ +A TVG Y+ PE + Q ++ D +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 799 GVVLLELISGKKPVSVED 816
G ++ E + G P E+
Sbjct: 235 GAIMFECLIGWPPFCSEN 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-05
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 1/86 (1%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 478
L N G+IP L ++ L L L N +G +P ++ + +L ++ L N LTG +P
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
Query: 479 YMGSLPNLQELHIENNSFVGEIPPAL 504
+ S NL +L + +NS GEIP +L
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 36/150 (24%), Positives = 61/150 (40%), Gaps = 53/150 (35%)
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGL--------------------------------- 757
G IHRD+K NIL+D++ K++DFGL
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 758 ----------------SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVV 801
++Q + L H S V GT Y+ PE + T+ D +S GV+
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAH-SLV--GTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 802 LLELISGKKP-VSVEDFGAELNIVHWARSM 830
L E++ G+ P ++ +L +++W ++
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 616 KIGKG--SFGSVYYGK-MKDGKEVAVKIM-ADSCS-HRTQQFVTEVALLSRIHHRNLVPL 670
+IG+G + SVY + G V V+I ++C+ + EV L H N++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
++ +M G+ L + + L I A +GL YLH
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-NILFGALRGLNYLHQN--- 120
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSR--------QAEEDLTHISSVARGTVGYLDPE 782
G IHR++K+S+IL I+ VS GLS Q + + + + +L PE
Sbjct: 121 GYIHRNIKASHIL--ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 783 YYGNQQL---TEKSDVYSFGVVLLELISGKKP 811
Q L KSD+YS G+ EL +G+ P
Sbjct: 179 LL-RQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 36/147 (24%), Positives = 58/147 (39%), Gaps = 47/147 (31%)
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLS------------------RQAEEDLT------ 766
G IHRD+K NIL+D + K++DFGL RQ D +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 767 -------------------HISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLE 804
H +A VG Y+ PE T+ D +S GV+L E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 805 LISGKKP-VSVEDFGAELNIVHWARSM 830
++ G+ P ++ ++ +++W S+
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 26/99 (26%), Positives = 43/99 (43%), Gaps = 3/99 (3%)
Query: 711 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 770
L I + ++YLH IIHRD+K+ NI ++ + DFG + + +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 771 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 809
GT+ PE D++S G+VL E+ +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 32/149 (21%), Positives = 54/149 (36%), Gaps = 17/149 (11%)
Query: 614 CKKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VP-L 670
K + G VY + E +KI + EVA+L + + L VP +
Sbjct: 3 IKLLKGGLTNRVY--LLGTKDEDYVLKINPSR--EKGADREREVAILQLLARKGLPVPKV 58
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+ E + L+ E++ TL + + IA A+ L LH
Sbjct: 59 LASGESDGWSYLLMEWIEGETL----------DEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSR 759
+ H D+ NIL+D + D+ +
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 7e-04
Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 8/105 (7%)
Query: 703 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762
+PL +A ++Y+H GIIHRD+K+ N+L++ + DFG + A
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311
Query: 763 EDLTHISSVARGTVGYLD---PEYYGNQQLTEKSDVYSFGVVLLE 804
+ + G G +D PE T D++S G+V+ E
Sbjct: 312 GSWS--TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 10/89 (11%)
Query: 613 FCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI-H 663
F K +G G+FG V GK + VAVK M + +H ++ ++E+ +LS +
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVK-MLKASAHTDEREALMSELKILSHLGQ 100
Query: 664 HRNLVPLIGYCEEEHQRILVYEYMHNGTL 692
H+N+V L+G C +++ EY G L
Sbjct: 101 HKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 20/60 (33%), Positives = 30/60 (50%), Gaps = 3/60 (5%)
Query: 439 LTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 496
L L L N LT +PD + L +L+++ L N LT P LP+L+ L + N+
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 30/83 (36%), Positives = 46/83 (55%), Gaps = 2/83 (2%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
+ + LSG N ++PPE++ + AL EL L N + L +S L +L + L NN+
Sbjct: 185 LSNLNNLDLSG-NKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNK 243
Query: 472 LTGSLPSYMGSLPNLQELHIENN 494
L LP +G+L NL+ L + NN
Sbjct: 244 LE-DLPESIGNLSNLETLDLSNN 265
|
Length = 394 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 931 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.59 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.51 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.49 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.39 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.35 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.11 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.03 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.01 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.99 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.99 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.97 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.88 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.86 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.83 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.66 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.6 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.59 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.59 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.56 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.55 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.55 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.54 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.5 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.45 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.42 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.39 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.39 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.36 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.36 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.32 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.31 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.3 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.25 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.21 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.2 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.18 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.15 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.12 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.12 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.11 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.08 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.03 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.01 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.01 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.99 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.98 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 97.96 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 97.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.91 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.87 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.84 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.84 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.83 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 97.82 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.79 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.77 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 97.75 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.72 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.68 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-83 Score=770.44 Aligned_cols=535 Identities=24% Similarity=0.392 Sum_probs=416.6
Q ss_pred HHHHHHHHHHHHhhhcccCceEEEecCCCCCccCCCCCeEEecCCccccCCceeeecCCCCCcccccccccccC-CCccc
Q 002358 5 SHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPI-DNKKY 83 (931)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~idcg~~~~~~~~~~~~~~~~d~~~~~~g~~~~~~~~~~~~~~~~tlr~fp~-~~~~~ 83 (931)
+..+..+++++.+.+.++.++++||||++++++.+.+|++|++|.+|+. |....++.+....++|.|+|+||. .|++|
T Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~~-~~~~~~~~~~~~~~~~~t~R~F~~~~g~~~ 83 (623)
T PLN03150 5 LLAASALLAVLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTG-GIPANATRPSFIAPPLKTLRYFPLSDGPEN 83 (623)
T ss_pred HHHHHHHHHhhcccccCCCccEEEeCCCCCCcccCCCCCEEcCCccccc-CccccccCcccccchhhccccCCccccccc
Confidence 3334444566667777788999999999988843368999999999854 444444444556788999999996 58999
Q ss_pred eEEeeecCCceeEEEEEEeecCCCCCCCCCcEEEEEcCceeEEEEec--CCccceEEEEEEecCCCCcccceeecCCCCc
Q 002358 84 CYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVL--DASRVYAKEMIIRAPSDSIDVCICCAVTGSP 161 (931)
Q Consensus 84 cy~l~~~~~~~ylvr~~f~yg~yd~~~~~~~fd~~~~~~~w~~v~~~--~~~~~~~~e~~~~~~~~~~~vcl~~~~~~~p 161 (931)
||+||+++++|||||++|+|||||+.+++|.|||++|||+|.+|... +.+...++|+|+.+++++++|||+++++|+|
T Consensus 84 cY~~~~~~~g~ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~p 163 (623)
T PLN03150 84 CYNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDP 163 (623)
T ss_pred ceEeeecCCCcEEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCC
Confidence 99999999999999999999999999999999999999999999752 2344566899999999999999999999999
Q ss_pred eeeeeeeeecCCCCCcccc--cccceeEEEEeeccCCCC-CCcccCCCCCC--CCccccCCCCCCCceeccCCceeeecc
Q 002358 162 FISTLELRPLNLSMYATDF--EDNFFLKVAARVNFGALT-KDALRYPDDPY--DRIWDSDLDRRPNFVVGAASGTVRINT 236 (931)
Q Consensus 162 fis~le~~~l~~~~y~~~~--~~~~~l~l~~R~~~g~~~-~~~~~y~~d~~--dR~W~~~~~~~~~~~~~~~~~~~~i~~ 236 (931)
|||+||||+|++++|.... +.+.+|.++.|.|+|+.+ ...+|||+|+| ||+|+|+.+... ..+..+++
T Consensus 164 FIs~iEv~~l~~~~y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~-------~~~~~~st 236 (623)
T PLN03150 164 AILSIEILQVDDKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGS-------GSDQAIST 236 (623)
T ss_pred ceeEEEEEEcCcccccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCC-------Cccccccc
Confidence 9999999999999995432 346679999999999864 34699999999 999998754321 12333445
Q ss_pred cccccC--CCCCCChhhhhhcceeccCc--eEEEeecCCCCCccceeeeeeecccC-cCCCcceEEEeecCcccccCCce
Q 002358 237 TKNIET--RTREYPPVKVMQTAVVGTEG--VLSYRLNLEDFPANARAFAYFAEIQD-LGPSETRKFKLEQPYFADYSNAV 311 (931)
Q Consensus 237 ~~~i~~--~~~~~pP~~v~qtA~~~~~~--~~~~~~~~~~~~~~~~~~lyFae~~~-~~~~~~R~F~i~~~~~~~~~~~~ 311 (931)
...|+. ..++.+|+.|||||.+..++ .++|.|+. +....|+++|||||++. ....++|+|||+++...... .
T Consensus 237 ~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~~v-~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~--~ 313 (623)
T PLN03150 237 ENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTMDV-DPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFK--D 313 (623)
T ss_pred ccccccccCCCccChHHHhhhhccccCCCCceEEEeec-CCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeec--c
Confidence 555542 35677899999999877653 46666553 23457888999999985 56779999999766533222 2
Q ss_pred eeeeecCCCce-eeeccccceeeeeeEEEEEEeecCCCccccchhhhhhhheeecccCCchhhHHHHHHHHhhcCCCCCC
Q 002358 312 VNIAENANGSY-TLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERT 390 (931)
Q Consensus 312 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~l~p~ina~e~~~~~~~~~~t~~~d~~~L~~l~~~~~~~~~~ 390 (931)
+++.....+.+ .++.-...+++ .+.+++++.|+.++ +|+|||+|+|++.+.+.+|.+.|+.+|..+|+.+......
T Consensus 314 ~di~~~~g~~~~~~~~~~~v~~~-~g~l~isl~p~~~s--~pilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~~~ 390 (623)
T PLN03150 314 VDIVKMSGERYTALVLNKTVAVS-GRTLTIVLQPKKGT--HAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRF 390 (623)
T ss_pred cChhhhcCCcccceEEEeEEeec-CCeEEEEEeeCCCC--cceeeeeeeeeccccccccCchHHHHHHHHHHhcCCcccC
Confidence 33322221111 11110011222 37788999998765 7999999999999998999999999999999988654446
Q ss_pred CCCCCCCCCC--CCceEEeeCCC---CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccE
Q 002358 391 NDRGDPCVPV--PWEWVTCSTTT---PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 464 (931)
Q Consensus 391 ~w~~dpc~~~--~w~~v~c~~~~---~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~ 464 (931)
+|.+|||+|. +|.|+.|+... ...|+.|+|++|+|+|.+|+.|++|++|+.|+|++|+|+|.+| .+++|++|+.
T Consensus 391 ~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~ 470 (623)
T PLN03150 391 GWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV 470 (623)
T ss_pred CCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE
Confidence 8999999874 79999996432 1359999999999999999999999999999999999999999 6999999999
Q ss_pred eecCCccccCCCCCccCCccccccccccccCCCCCCCccccc---CceeeeecCCCCcccc----ccc-cceeeeeeccc
Q 002358 465 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE----SRR-RMRFKLILGTS 536 (931)
Q Consensus 465 L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~~---~~~~l~~~~N~~~c~~----~~~-~~~~~iiv~i~ 536 (931)
|+|++|+|+|.+|+++++|++|+.|+|++|+|+|.+|..+.. ....+.+.+|+.+|+. .|. +.....+++++
T Consensus 471 LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~~~~~~~~i~~~ 550 (623)
T PLN03150 471 LDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAKIGIA 550 (623)
T ss_pred EECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCCCCCcccCCCceEEEEE
Confidence 999999999999999999999999999999999999998754 3456788999999963 232 22334455555
Q ss_pred hhhhhHHHHHhhhhhee
Q 002358 537 IGVLAILLVLFLCSLIV 553 (931)
Q Consensus 537 i~v~~vllll~~~~~~~ 553 (931)
+++++++++++++.+++
T Consensus 551 ~~~~~~~l~~~~~~~~~ 567 (623)
T PLN03150 551 FGVSVAFLFLVICAMCW 567 (623)
T ss_pred hHHHHHHHHHHHHHhhh
Confidence 55554444444443333
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-62 Score=545.61 Aligned_cols=322 Identities=36% Similarity=0.546 Sum_probs=255.7
Q ss_pred EecCCCCC---ccCCCCCeEEecCCccccCCceeeec-----CCCCCcccccccccccCCCccceEEeeec--CCceeEE
Q 002358 28 IDCGSTSN---YTDPSTGLAWISDIGIMNNGKSVKVE-----NPSGNWMQYRTRRDLPIDNKKYCYNLITK--ERRRYLV 97 (931)
Q Consensus 28 idcg~~~~---~~~~~~~~~~~~d~~~~~~g~~~~~~-----~~~~~~~~~~tlr~fp~~~~~~cy~l~~~--~~~~ylv 97 (931)
||||++.+ |+|+.||++|++|.+|+++|++++|+ ......++|.|+|+|| +|.||||+||+. +|+||||
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~-~g~r~cY~l~~~~~~~~~yli 79 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFP-EGSRNCYTLPVTPPGGGKYLI 79 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcC-CCCccEEEeeccCCCCceEEE
Confidence 89997644 88999999999999999999998883 1234568899999999 777899999998 6779999
Q ss_pred EEEEeecCCCCCC-----CCCcEEEEEcCceeEEEEecCCc-cceEEE-EEEecCCCCcccceeecCCCC-ceeeeeeee
Q 002358 98 RATFQYGSLGSEA-----SYPKFQLYLDATLWSTVTVLDAS-RVYAKE-MIIRAPSDSIDVCICCAVTGS-PFISTLELR 169 (931)
Q Consensus 98 r~~f~yg~yd~~~-----~~~~fd~~~~~~~w~~v~~~~~~-~~~~~e-~~~~~~~~~~~vcl~~~~~~~-pfis~le~~ 169 (931)
|+.|+||||||++ +||.|||++|++.|++|+..+.. ..+.+| +|++.++++++|||+++++|+ ||||+||||
T Consensus 80 Rl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~ 159 (347)
T PF12819_consen 80 RLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELR 159 (347)
T ss_pred EEEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEE
Confidence 9999999999874 47899999999999999987621 347789 555555899999999999999 999999999
Q ss_pred ecCCCCCcc-cccccceeEEEEeeccCCCCCCcccCCCCCCCCccccCCCCCCCceeccCCceeeeccccccc---CCCC
Q 002358 170 PLNLSMYAT-DFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIE---TRTR 245 (931)
Q Consensus 170 ~l~~~~y~~-~~~~~~~l~l~~R~~~g~~~~~~~~y~~d~~dR~W~~~~~~~~~~~~~~~~~~~~i~~~~~i~---~~~~ 245 (931)
||++++|+. ....+.+|.++.|.|+|+.. ..+|||+|+|||+|+|+.. .+.|..++++.+|+ ...+
T Consensus 160 ~lp~~ly~~~~~~~s~~L~~~~R~n~G~~~-~~iryp~D~~dR~W~~~~~---------~~~~~~ist~~~i~~~~~~~~ 229 (347)
T PF12819_consen 160 PLPDSLYPDTDANSSQALETVYRLNVGGSS-SFIRYPDDTYDRIWQPYSS---------SPGWSNISTTSNININSSNNP 229 (347)
T ss_pred ECCccceeccccCCCceeEEEEeecCCCcc-cccCCCCCcceeecccccc---------CccccccccceeeecccCCcc
Confidence 999999952 23557889999999999854 3499999999999998621 22455667766665 2368
Q ss_pred CCChhhhhhcceeccCce--EEEeecCCCCCccceeeeeeecccCcCC-CcceEEEeecCcccccCCceeeeeecCCCce
Q 002358 246 EYPPVKVMQTAVVGTEGV--LSYRLNLEDFPANARAFAYFAEIQDLGP-SETRKFKLEQPYFADYSNAVVNIAENANGSY 322 (931)
Q Consensus 246 ~~pP~~v~qtA~~~~~~~--~~~~~~~~~~~~~~~~~lyFae~~~~~~-~~~R~F~i~~~~~~~~~~~~~~~~~~~~~~~ 322 (931)
+.||.+|||||++..+.+ +.+.|...+...+||++|||||++.+.. .++|+|||.++.-..++ .+...... ....
T Consensus 230 ~~~P~~V~~TA~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~-~~~~~~~~-~~~~ 307 (347)
T PF12819_consen 230 YDAPSAVYQTARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYS-DVSPPYLG-ADTV 307 (347)
T ss_pred CcChHHHHHhhhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccC-ccCccccc-Ccce
Confidence 889999999999887665 8888888555567899999999999754 44899999666544433 22221111 1122
Q ss_pred eeeccccceeeeeeEEEEEEeecCCCccccchhhhhhhhe
Q 002358 323 TLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKY 362 (931)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~s~l~p~ina~e~~~~ 362 (931)
.+|......+...+.+.+++.++..|+|||+|||+|+|++
T Consensus 308 ~~~~d~~~~~~~~~~~~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 308 PYYSDYVVNVPDSGFLNISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred EeecceEEEecCCCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence 3344444555566678899999999999999999999874
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=525.99 Aligned_cols=441 Identities=27% Similarity=0.494 Sum_probs=312.3
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
++++.|+|++|.+.|.+|..+++|++|+.|+|++|+++|.+| .+.+|++|+.|+|++|+++|.+|..+.++++|+.|++
T Consensus 499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l 578 (968)
T PLN00113 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578 (968)
T ss_pred hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence 467777777777777777777777788888888888887777 4777788888888888888888887777888888888
Q ss_pred cccCCCCCCCccc-ccCceeeeecCCCCccccc-------ccc----ceeeeeeccchhhhhHHHHHhhhhheeeeeecc
Q 002358 492 ENNSFVGEIPPAL-LTGKVIFKYDNNPKLHKES-------RRR----MRFKLILGTSIGVLAILLVLFLCSLIVLRKLRR 559 (931)
Q Consensus 492 ~~N~l~g~iP~~~-~~~~~~l~~~~N~~~c~~~-------~~~----~~~~iiv~i~i~v~~vllll~~~~~~~~rr~rr 559 (931)
++|+++|.+|..- +.......+.+|+.+|+.. |.. ..+.++++++++++++++++++ +++++++ ++
T Consensus 579 s~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~ 656 (968)
T PLN00113 579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAF-GFVFIRG-RN 656 (968)
T ss_pred cCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHH-HHHHHHh-hh
Confidence 8888887777642 2233445578899888532 221 1122233333333222222222 2222222 11
Q ss_pred cccccccccccccccccCCCCCcccccccCCcccCCCcccccChhhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEE
Q 002358 560 KISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAV 638 (931)
Q Consensus 560 r~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAv 638 (931)
+. ..+..+.... . ... .+........+...++.. .....+.||+|+||.||+|+++ +++.|||
T Consensus 657 ~~-~~~~~~~~~~--------~--~~~----~~~~~~~~~~~~~~~~~~-~~~~~~~ig~G~~g~Vy~~~~~~~~~~vav 720 (968)
T PLN00113 657 NL-ELKRVENEDG--------T--WEL----QFFDSKVSKSITINDILS-SLKEENVISRGKKGASYKGKSIKNGMQFVV 720 (968)
T ss_pred cc-cccccccccc--------c--ccc----cccccccchhhhHHHHHh-hCCcccEEccCCCeeEEEEEECCCCcEEEE
Confidence 11 1111110000 0 000 000001111233344433 2344678999999999999974 7899999
Q ss_pred EEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 002358 639 KIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 718 (931)
Q Consensus 639 K~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia 718 (931)
|+++.... ...+|++.+++++|||||+++|+|.+.+..++||||+++|+|.++++ .++|..+.+++.|++
T Consensus 721 K~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia 790 (968)
T PLN00113 721 KEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIA 790 (968)
T ss_pred EEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHH
Confidence 99865322 12356889999999999999999999999999999999999999986 278999999999999
Q ss_pred HHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHH
Q 002358 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 798 (931)
Q Consensus 719 ~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSl 798 (931)
+||+|||+.+.++|+||||||+||+++.++..++. ||........ ....+++.|+|||++.+..++.++|||||
T Consensus 791 ~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~ 864 (968)
T PLN00113 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGF 864 (968)
T ss_pred HHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhH
Confidence 99999997666899999999999999999888875 6654432211 12357899999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC--CCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 002358 799 GVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN--VKIESIWRIAEVAIQCVEQRGFSRPKMQE 876 (931)
Q Consensus 799 GvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 876 (931)
||++|||+||+.||+ ........+.+|++...........+|+.+... .+.++..++.+++.+||+.+|++||+|+|
T Consensus 865 Gvvl~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~e 943 (968)
T PLN00113 865 GLILIELLTGKSPAD-AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAND 943 (968)
T ss_pred HHHHHHHHhCCCCCC-cccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHH
Confidence 999999999999996 333445567788876665555566677766543 34566778899999999999999999999
Q ss_pred HHHHHHhhhhhh
Q 002358 877 IVLAIQDSIKIE 888 (931)
Q Consensus 877 vl~~L~~~~~~~ 888 (931)
+++.|+++....
T Consensus 944 vl~~L~~~~~~~ 955 (968)
T PLN00113 944 VLKTLESASRSS 955 (968)
T ss_pred HHHHHHHhhccc
Confidence 999999876543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-50 Score=450.11 Aligned_cols=289 Identities=49% Similarity=0.835 Sum_probs=253.7
Q ss_pred ccccChhhHHHHHHhhc--cccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEe
Q 002358 598 AYFIPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 675 (931)
Q Consensus 598 ~~~~~~~~l~~~~~~~~--~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 675 (931)
...+++.++..+|.+|. +.||+|+||.||+|.+.+|+.||||++........++|..|++++.+++|||+|+++|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 45578999999999996 6999999999999999999999999887654331456999999999999999999999999
Q ss_pred cCC-eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEec
Q 002358 676 EEH-QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 754 (931)
Q Consensus 676 ~~~-~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~D 754 (931)
+.+ +.+||||||++|+|.++|+..... .++|.+|++|+.++|+||+|||+.+..+|+|||||++|||||+++++||+|
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 988 599999999999999999975443 899999999999999999999999888999999999999999999999999
Q ss_pred ccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcC
Q 002358 755 FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 834 (931)
Q Consensus 755 FGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 834 (931)
||+++..............||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+........++++|+...+.++
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99997654311221111169999999999999999999999999999999999999987544345566999999999999
Q ss_pred Ceeeccccccc-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 835 DVISIVDPVLI-GNVKI-ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 835 ~~~~i~d~~l~-~~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
.+.+++|+.+. +.++. +++.++.+++.+|++.+|.+||+|.||+++|+.+...
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999988 66665 6888999999999999999999999999999665443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=392.54 Aligned_cols=263 Identities=37% Similarity=0.535 Sum_probs=214.1
Q ss_pred HHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchh--hhhHHHHHHHHHhcCCCCCcceeEEEecCC-eEEEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILV 683 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~lV 683 (931)
......+.+.||+|+||+||+|.|+....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|
T Consensus 39 ~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 39 DPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred ChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 334444566799999999999999954459999998654322 568999999999999999999999999887 79999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCC-eEecCCCCCCccccCCC-ceEEecccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSNILLDINM-RAKVSDFGLSRQA 761 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-ivH~DIkp~NILld~~~-~vkL~DFGla~~~ 761 (931)
||||++|+|.++++.. ....+++..+++|+.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++..
T Consensus 119 tEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999864 46789999999999999999999998 56 99999999999999997 9999999999875
Q ss_pred cccccccccccccCCCccCCCccC--CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~--~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
.... ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||..... .+-+......+....+
T Consensus 195 ~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~ 267 (362)
T KOG0192|consen 195 VISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPPI 267 (362)
T ss_pred cccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCCC
Confidence 5432 2223356999999999999 66999999999999999999999999973332 1212222222222222
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
+......+..++.+||+.||++||++.||+..|+.+.....
T Consensus 268 ---------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 268 ---------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ---------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 22244478899999999999999999999999998876444
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=395.94 Aligned_cols=263 Identities=28% Similarity=0.459 Sum_probs=224.3
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
.++.....++.+.||+|.||.||+|.|+....||+|.++.. ....++|.+|+++|++|+|+|||+++|+|..++.++||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 45667778889999999999999999998889999999865 33447899999999999999999999999998899999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
||||+.|+|.++|+. ..+..+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+||||++...+
T Consensus 280 tE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 999999999999986 356778999999999999999999998 9999999999999999999999999999997766
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
+....+....-+..|.|||.+....++.|||||||||+||||+| |+.|+......+ +.+.+..|-
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~~~le~Gy------- 421 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VLELLERGY------- 421 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HHHHHhccC-------
Confidence 66655655566889999999999999999999999999999999 889986333211 112222221
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
+-..|..++..+.+++..||..+|++|||++.+...|++....
T Consensus 422 --Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 422 --RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred --cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 1123445666899999999999999999999999999887543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=371.98 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=207.4
Q ss_pred hccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC-eEEEEEEecCC
Q 002358 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVYEYMHN 689 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~lV~E~~~~ 689 (931)
..+.||+|..|+||++.++ +++.+|+|++.... ....+++.+|+++++..+||+||.++|.|.... ...++||||.+
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 4578999999999999998 68889999995443 445688999999999999999999999999988 59999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.+++.. .+.+++...-+++.+|++||.|||. .++||||||||+|||++..|++||||||.++.+.+. ..
T Consensus 163 GSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a 234 (364)
T KOG0581|consen 163 GSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA 234 (364)
T ss_pred CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence 999999984 4779999999999999999999996 499999999999999999999999999999887654 44
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccC--ccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--FGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~--~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
....||..|||||.+.+..|+.++||||||++++|+++|+.||.... ......+..++ + .+... .+...
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v-~~ppP-----~lP~~ 305 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---V-DEPPP-----RLPEG 305 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---h-cCCCC-----CCCcc
Confidence 56679999999999999999999999999999999999999997431 12333333322 1 12221 22111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....++..++..||++||.+||+++|+++
T Consensus 306 ---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 306 ---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 13347889999999999999999999975
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=393.68 Aligned_cols=266 Identities=31% Similarity=0.501 Sum_probs=223.4
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecC
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEE 677 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 677 (931)
++......+.+.||+|+||+||+|+.. +.+.||||.+++.... ..++|++|++++..++|||||+++|.|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 455555667889999999999999854 3568999999987766 678999999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCC-------C----CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSV-------N----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 746 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~-------~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~ 746 (931)
+..+||+|||..|+|.++|+... . ..+++..+.+.||.|||.||.||-+ +.+|||||.++|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceecc
Confidence 99999999999999999997533 1 2238889999999999999999998 99999999999999999
Q ss_pred CCceEEecccccccccc-cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHH
Q 002358 747 NMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 824 (931)
Q Consensus 747 ~~~vkL~DFGla~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~ 824 (931)
+..|||+||||++..-. +..+......-+++||+||.+..++++.+||||||||+|||+++ |+.||.+..-
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------- 711 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------- 711 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------
Confidence 99999999999997543 33333333445789999999999999999999999999999999 9999863322
Q ss_pred HHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 825 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 825 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
+.+.+.+++|.+.+ .+...+.++.+|+..||+.+|++||+++||...|+......+
T Consensus 712 ~EVIe~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 712 QEVIECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred HHHHHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 22444556665533 344566689999999999999999999999999998765443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=361.46 Aligned_cols=198 Identities=33% Similarity=0.559 Sum_probs=177.3
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|.+.+.||+|+||+||+|+++ ++..||||.+... .....+.+..|+.+|+.++|||||.++++++..+..+||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 445677999999999999987 5899999998765 4455667889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC------CceEEecccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQA 761 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~------~~vkL~DFGla~~~ 761 (931)
+||+|.++++. .+.+++.+...++.|||.||++||+ ++||||||||.||||+.. -.+||+|||+|+..
T Consensus 92 ~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 92 NGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred CCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999994 5689999999999999999999998 999999999999999764 45899999999987
Q ss_pred cccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccC
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~ 816 (931)
.+. ....+.+|++-|||||+++.++|+.|+|+||+|++||||++|+.||+...
T Consensus 166 ~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 166 QPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred Cch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 643 23445689999999999999999999999999999999999999998443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=376.67 Aligned_cols=248 Identities=27% Similarity=0.452 Sum_probs=210.2
Q ss_pred HHHHhhccccCccCcEEEEEEEE-CCCcEEEEEEccCc---cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
..+|...+.||+|+|+.||.++. ..|+.||+|++.+. .....+...+|+++.++|+|||||+++++|++.+..|+|
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 35677789999999999999998 68999999999763 234567789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
.|.|++++|..+++ ..+.+++.+++.++.||+.||.|||+ ++|+|||||..|+|++++.++||+|||||.....
T Consensus 97 LELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 97 LELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EEecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999988 46789999999999999999999998 9999999999999999999999999999998765
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
+... ..+.+|||.|+|||++....++..+||||+||+||-||.|++||+.....+..+ .++..+..
T Consensus 171 ~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~-------~Ik~~~Y~------ 236 (592)
T KOG0575|consen 171 DGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN-------KIKLNEYS------ 236 (592)
T ss_pred cccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH-------HHHhcCcc------
Confidence 4333 445679999999999999999999999999999999999999998443322221 12211110
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.|.....+-.+||.++|+++|.+|||+++|+.
T Consensus 237 ----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 ----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01122225578999999999999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.79 Aligned_cols=257 Identities=28% Similarity=0.402 Sum_probs=205.2
Q ss_pred hhhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch-------hhhhHHHHHHHHHhcCCCCCcceeEEE
Q 002358 603 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-------RTQQFVTEVALLSRIHHRNLVPLIGYC 674 (931)
Q Consensus 603 ~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-------~~~~~~~E~~il~~l~HpnIv~l~g~~ 674 (931)
.++.....|-+.+.||+|+||.|-+|..+ +|+.||||++++.... ......+|+++|++|+|||||++++++
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f 245 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF 245 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence 34446667778999999999999999765 7999999999763221 223457999999999999999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC---CceE
Q 002358 675 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAK 751 (931)
Q Consensus 675 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~---~~vk 751 (931)
......||||||++||.|.+++-+ .+.+.+..-..++.|++.|+.|||+ .||+||||||+|||+..+ ..+|
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEE
Confidence 999999999999999999999874 4567777778899999999999998 999999999999999765 7799
Q ss_pred EecccccccccccccccccccccCCCccCCCccCCCCC---CccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002358 752 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 828 (931)
Q Consensus 752 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~---s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~ 828 (931)
|+|||+|+..+. .....+.+|||.|.|||++.+..+ ..+.|+||+||+||-+++|.+||....... . +.
T Consensus 320 ItDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s----l~ 391 (475)
T KOG0615|consen 320 ITDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S----LK 391 (475)
T ss_pred ecccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c----HH
Confidence 999999998762 334556789999999999976533 348899999999999999999998433321 1 12
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 829 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 829 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+.+..|+.... |. .-.+..++..+++.+||..||++||++.|+++
T Consensus 392 eQI~~G~y~f~--p~----~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 392 EQILKGRYAFG--PL----QWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHhcCccccc--Ch----hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 23333433211 11 11223346789999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=348.45 Aligned_cols=261 Identities=28% Similarity=0.369 Sum_probs=213.2
Q ss_pred HHHHHhhccccCccCcEEEEEEEE-CCCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeE-EEecCCe-EE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIG-YCEEEHQ-RI 681 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g-~~~~~~~-~~ 681 (931)
.-+.+++.++||+|.||+||++.. .+|..||.|.++=.. ....++...|+.+|++|+|||||++++ -+.++.+ +.
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 345678889999999999999975 489999999886332 334567899999999999999999998 4444444 88
Q ss_pred EEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCC-CeEecCCCCCCccccCCCceEEecccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
+|||+|.+|+|.++++... ..+.+++..+++++.|+++||.++|...+. -|+||||||.||+|+.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999987654 456789999999999999999999974422 38899999999999999999999999999
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
.+....... ....|||.||+||.+.+..|+.||||||+||++|||+.-+.||.++ ++.+ +.+.+..++...+
T Consensus 177 ~l~s~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~-L~~KI~qgd~~~~ 248 (375)
T KOG0591|consen 177 FLSSKTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLS-LCKKIEQGDYPPL 248 (375)
T ss_pred HhcchhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHH-HHHHHHcCCCCCC
Confidence 887655443 3456999999999999999999999999999999999999999854 2222 3455666665444
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
.|.. ....+.+++..|+..||+.||+.-.+++.++.
T Consensus 249 p~~~--------YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 PDEH--------YSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cHHH--------hhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 3322 23478899999999999999997666655554
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=385.58 Aligned_cols=271 Identities=31% Similarity=0.481 Sum_probs=223.0
Q ss_pred hhhHHHHHHhhccccCccCcEEEEEEEECC--Cc----EEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEe
Q 002358 603 LPELEEATNNFCKKIGKGSFGSVYYGKMKD--GK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCE 675 (931)
Q Consensus 603 ~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~~--g~----~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 675 (931)
++++......+.+.||+|+||.||.|...+ |. .||||.++.... ++..+|.+|..+|++++|||||+++|+|-
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 666777777888999999999999998763 43 489999987644 46678999999999999999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceE
Q 002358 676 EEHQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 751 (931)
Q Consensus 676 ~~~~~~lV~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vk 751 (931)
+....++++|||++|+|..+|+..+ ....+....++.++.|||+|+.||++ +++|||||.++|+||+....+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEE
Confidence 9999999999999999999999753 24568889999999999999999998 9999999999999999999999
Q ss_pred Eecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHH
Q 002358 752 VSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 829 (931)
Q Consensus 752 L~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 829 (931)
|+|||+|+.+.+.... ......-..+|||||.+..+.++.|+|||||||+|||++| |..||...+-.+ +.. .
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~~---~ 916 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VLL---D 916 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HHH---H
Confidence 9999999954433322 2222234579999999999999999999999999999999 889997332211 111 1
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCC
Q 002358 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGD 892 (931)
Q Consensus 830 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 892 (931)
..+.+++ ..+..+++.+.+++..||+.+|++||++..|++.+..+.....+..
T Consensus 917 ~~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 917 VLEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred HHhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 2222321 2355667789999999999999999999999999888876665444
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=375.08 Aligned_cols=264 Identities=27% Similarity=0.465 Sum_probs=218.9
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEECC----CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCC
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 678 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 678 (931)
.||...-..+.++||.|.||.||+|+++- ...||||.++.... .+..+|+.|+.||.+..||||+++.|......
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 35555555567899999999999999872 45799999987654 45678999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
...+|+|||++|+|..+|+.. .+.+.+.++..++++||.||+||.. .++|||||.++|||++.+..+|++|||++
T Consensus 704 PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999974 4669999999999999999999997 99999999999999999999999999999
Q ss_pred cccccccccccccc--ccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCC
Q 002358 759 RQAEEDLTHISSVA--RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 835 (931)
Q Consensus 759 ~~~~~~~~~~~~~~--~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 835 (931)
+.++++.....+.. .-+.+|.|||.+..++++.+||||||||+|||.++ |.+||....-.+ +.+.+++|
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------VIkaIe~g- 850 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VIKAIEQG- 850 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-------HHHHHHhc-
Confidence 98766543322222 23579999999999999999999999999999888 999996221111 12222221
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 836 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 836 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
.+--.+++.+..|.+|++.||++|-.+||++.+|+..|.+++.-.
T Consensus 851 --------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 851 --------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred --------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 111224566778999999999999999999999999999887543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=329.93 Aligned_cols=262 Identities=21% Similarity=0.280 Sum_probs=203.7
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch--hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|+...++|+|+||+||+++.+ .|+.||||++.+.... -.+-.++|+++|++++|+|+|.++..|.......||+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 444578999999999999988 4999999999775442 3355789999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
+..-|.+.-+ ....++...+.+++.|+++|+.|+|+ ++++||||||+||||+.++.+||||||+|+.+.....
T Consensus 84 dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 84 DHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred chHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence 8866655433 45668889999999999999999998 8999999999999999999999999999998764222
Q ss_pred cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHH-HHHHh-------hhcCC---
Q 002358 768 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH-WARSM-------IKKGD--- 835 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~-~~~~~-------~~~~~--- 835 (931)
..+....|.+|+|||.+.+ .+|+...||||+||++.||++|.+-|.+...-+....+. -+... .....
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 2233457999999999877 799999999999999999999999998655544432222 11111 11111
Q ss_pred ---eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 836 ---VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 836 ---~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+++.-++......-+.....+++++..|++.||++|++-+|++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111111111222336789999999999999999999973
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.11 Aligned_cols=241 Identities=29% Similarity=0.390 Sum_probs=199.8
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
...++.++||+|+||+|+.++.+ .++.+|+|++++.. ..+.+...+|..+|.+++||.||+++..|++.+.+|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 34456899999999999999876 58899999997643 235677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+.||.|..+|+ .++.+++..+.-++.+|+.||.|||+ ++|+||||||+|||||++|+++|+|||+++.....
T Consensus 105 d~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 105 DYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred eccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999998 46789999999999999999999998 99999999999999999999999999999864433
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.. ...+.+||+.|||||++....|+..+|.||+|+++|||++|..||..++.. ++... +..++. ..
T Consensus 179 ~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~-I~~~k~------~~ 244 (357)
T KOG0598|consen 179 GD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDK-ILKGKL------PL 244 (357)
T ss_pred CC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHH-HhcCcC------CC
Confidence 22 234468999999999999999999999999999999999999999855432 22222 222221 00
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRP 872 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP 872 (931)
. +.-...+..+++.+.++.+|++|-
T Consensus 245 ~---p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 P---PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred C---CccCCHHHHHHHHHHhccCHHHhc
Confidence 0 111122567889999999999995
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=351.15 Aligned_cols=270 Identities=26% Similarity=0.430 Sum_probs=220.8
Q ss_pred ChhhHHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 602 PLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 602 ~~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
..+|+......|.++||+|-||.|.+++...+..||||+++..... ..++|.+|+++|.+++|||||+++|.|..++.+
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 3567778888889999999999999999998899999999986544 458999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++|+|||++|+|.+++.+..... +.....++|+.||+.||+||.+ .+++||||.++|+|+|.++++||+|||+++.
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccc
Confidence 99999999999999998753222 4566778899999999999998 9999999999999999999999999999996
Q ss_pred cccc-ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh--CCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 761 AEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 761 ~~~~-~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt--G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
+-.. ..+......-+++|||||.+..++++.++|||+||+++||+++ ...||.... ....++-...+...+...
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcCCCCcc
Confidence 4433 3333334445789999999999999999999999999999876 778886221 222333333333222221
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
.. ...+...+.++.+++.+||..+.++||++++++..|++.
T Consensus 764 ~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11 122445667899999999999999999999999998864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=357.93 Aligned_cols=265 Identities=32% Similarity=0.482 Sum_probs=213.8
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEECC--C--cE-EEEEEccCc---cchhhhhHHHHHHHHHhcCCCCCcceeEEEec
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMKD--G--KE-VAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 676 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~~--g--~~-vAvK~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 676 (931)
++......+.++||+|+||.||+|+++. + .. ||||..+.. .....++|++|+++|++++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 4445555567999999999999998763 2 23 899998852 35667899999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccc
Q 002358 677 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 756 (931)
Q Consensus 677 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFG 756 (931)
+..+++|||+|.||+|.++|+.. ...++..+++.++.+.|+||+|||+ ++++||||.++|+|++.++.+||+|||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999999864 3469999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhh-hcC
Q 002358 757 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI-KKG 834 (931)
Q Consensus 757 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~-~~~ 834 (931)
+++..... ........-+..|+|||.+....|+.++|||||||++||+++ |..||.+.... . ++..+ .++
T Consensus 308 Ls~~~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~----v~~kI~~~~ 379 (474)
T KOG0194|consen 308 LSRAGSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---E----VKAKIVKNG 379 (474)
T ss_pred cccCCcce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---H----HHHHHHhcC
Confidence 98764311 111112235789999999999999999999999999999999 88898743321 1 22222 222
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 002358 835 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 891 (931)
Q Consensus 835 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 891 (931)
-.. ..+...+..+..++.+||..+|++||+|.++.+.|+.+.......
T Consensus 380 ~r~---------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 380 YRM---------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred ccC---------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 111 112234456778888999999999999999999999887766543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=347.58 Aligned_cols=250 Identities=30% Similarity=0.504 Sum_probs=208.1
Q ss_pred ccccChhhHHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecC
Q 002358 598 AYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 677 (931)
Q Consensus 598 ~~~~~~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 677 (931)
.+.+++++|.+. +-||.|+.|.||+|+++ ++.||||++++-. ..+++-|++|+||||+.+.|+|...
T Consensus 118 ~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 118 LWEIPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hccCCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC
Confidence 466777777654 44999999999999998 8999999876432 2467889999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccc
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 757 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGl 757 (931)
..+|+|||||..|-|...|+ .+..+.......|..+||.||.|||. +.|||||||.-||||..+..+||+|||.
T Consensus 185 PcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred ceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccc
Confidence 99999999999999999998 46678888899999999999999998 8999999999999999999999999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 758 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 758 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
++...+..+.. ..+||..|||||++.+...++|.|||||||||||||||..||..-+.... -|
T Consensus 259 S~e~~~~STkM--SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----Iw----------- 321 (904)
T KOG4721|consen 259 SKELSDKSTKM--SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IW----------- 321 (904)
T ss_pred hHhhhhhhhhh--hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EE-----------
Confidence 98766542222 35699999999999999999999999999999999999999973332111 01
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
.+-...+.--.+..+++.+.-|+++||+..|..||++++|+..|+-
T Consensus 322 GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 322 GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 0111112222345667788899999999999999999999988763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=340.58 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=202.0
Q ss_pred HHhhccccCccCcEEEEEEEECC-CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCC--eEEEEEEe
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYEY 686 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--~~~lV~E~ 686 (931)
.+...+.||+|+||.||++...+ |+..|||..........+.+.+|+++|.+++|||||+++|...... .+.+.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 34557899999999999998875 8999999886543333677899999999999999999999754444 68899999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC-CCceEEecccccccccc--
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEE-- 763 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~~~~-- 763 (931)
+++|+|.+++.+.. ..+++..+.....||++||+|||+ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus 98 ~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred cCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999998642 279999999999999999999998 99999999999999999 79999999999987653
Q ss_pred cccccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
..........||+.|||||++..+ ....++||||+||++.||+||+.||... .....++......+..+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P----- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP----- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC-----
Confidence 222233446799999999999864 3345999999999999999999999732 11112222222222111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
..+.....+..+++.+|++.+|++|||++|+++...-
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 2222233467899999999999999999999876543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=349.44 Aligned_cols=262 Identities=27% Similarity=0.452 Sum_probs=205.2
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhc-CCCCCcceeEEEecC-
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE- 677 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~- 677 (931)
....+++.++||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+.+++++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3456778899999999999999752 356899999875432 3456789999999999 899999999988764
Q ss_pred CeEEEEEEecCCCCHHHHhccCCC--------------------------------------------------------
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSVN-------------------------------------------------------- 701 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 701 (931)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 457899999999999998864311
Q ss_pred ---CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc-ccccccCCC
Q 002358 702 ---QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVG 777 (931)
Q Consensus 702 ---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~ 777 (931)
...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++......... .....+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 1347788899999999999999998 899999999999999999999999999998653322211 222345678
Q ss_pred ccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHH
Q 002358 778 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRI 856 (931)
Q Consensus 778 y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l 856 (931)
|+|||++.+..++.++|||||||++|||++ |..||....... ... ..+..+.... . +......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~----~~~~~~~~~~-----~----~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC----QRLKDGTRMR-----A----PENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH----HHHhcCCCCC-----C----CCCCCHHH
Confidence 999999999999999999999999999997 999997433221 111 1122221111 1 11223368
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 857 AEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 857 ~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
.+++.+||+.+|++||++.||++.|+++..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=349.82 Aligned_cols=245 Identities=27% Similarity=0.431 Sum_probs=207.0
Q ss_pred hccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCC
Q 002358 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 691 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 691 (931)
-.++||+|+.|.||.|... .++.||||++........+-+..|+.+|+..+|+|||.+++.+...+++++|||||++|+
T Consensus 277 ~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggs 356 (550)
T KOG0578|consen 277 DFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGS 356 (550)
T ss_pred chhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCc
Confidence 3478999999999999754 689999999977666666778999999999999999999999988899999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccccc
Q 002358 692 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 771 (931)
Q Consensus 692 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 771 (931)
|.+.+.. ..+++.++..|+.++++||+|||. ++|+|||||.+|||++.+|.+||+|||+|..+...... +..
T Consensus 357 LTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R~T 428 (550)
T KOG0578|consen 357 LTDVVTK----TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-RST 428 (550)
T ss_pred hhhhhhc----ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-ccc
Confidence 9999974 458999999999999999999998 99999999999999999999999999999988766554 445
Q ss_pred cccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHH
Q 002358 772 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 851 (931)
Q Consensus 772 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 851 (931)
..|||.|||||++....|++|.||||||++++||+.|++||-.++... +..++......++-.+. .
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-------AlyLIa~ng~P~lk~~~-------k 494 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTPKLKNPE-------K 494 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-------HHHHHhhcCCCCcCCcc-------c
Confidence 569999999999999999999999999999999999999996433211 11222222222222221 1
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 852 SIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 852 ~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....+.+++.+||+.|+++|++++|+++
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 2236889999999999999999999985
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=331.75 Aligned_cols=261 Identities=25% Similarity=0.341 Sum_probs=207.0
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccC-ccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
...|++.++||.|.-++||+|+.. .++.||||++.- .+..+.+.+.+|++.|..++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 345778899999999999999865 679999999853 345557899999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
||.+|++.++++... ...+++..+..|++++++||.|||+ .|.||||||+.||||+.+|.|||+|||.+..+.+..
T Consensus 105 fMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999998764 3459999999999999999999998 999999999999999999999999999876654433
Q ss_pred ccc--c-cccccCCCccCCCccCC--CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 766 THI--S-SVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 766 ~~~--~-~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
... . ....||+.|||||+++. ..|+.|+||||||++..||.+|..||..... ..-+ ...++ +......
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--mkvL----l~tLq-n~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--MKVL----LLTLQ-NDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--HHHH----HHHhc-CCCCCcc
Confidence 211 1 44579999999999644 4789999999999999999999999973221 1111 11222 2222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
-..+..+........+.+++..||+.||++|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 001111111222336889999999999999999999984
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=337.13 Aligned_cols=268 Identities=23% Similarity=0.259 Sum_probs=205.9
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecC--CeE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQR 680 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~ 680 (931)
.....++-.++||+|.||.||+|+.. +|+.||+|+++-.. .....-..+|+.||++|.||||+++.+...+. ...
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 34556666789999999999999754 79999999986543 23345678999999999999999999998776 689
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
|||+|||++ +|.-++.. ....++..++..++.|++.||+|||. .+|+|||||.+|||||.+|.+||+|||||++
T Consensus 194 YlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceee
Confidence 999999976 77777763 35679999999999999999999998 9999999999999999999999999999998
Q ss_pred ccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee--
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI-- 837 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~-- 837 (931)
+........+...-|.+|+|||++.+ ..|+.+.|+||.||||.||++|++.|.+....+..+.+--+..-..+....
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 77666555566668999999998866 589999999999999999999999998655433333222111111111111
Q ss_pred ecccccc---cCCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVL---IGNVKI-------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l---~~~~~~-------~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+..-.. ...+.. ......++|+..+|..||.+|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0000000 001110 11124578999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=341.79 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=205.0
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV 683 (931)
..+.|.+.||+|+|++|++|+.+ .++.+|||++.+.. ....+-+.+|-.+|.+| .||.|++|+-.|+++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 34568899999999999999876 58999999986532 12334577899999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
+||+++|+|.+++++ .+.+++.....++.+|+.||+|||+ .|||||||||+|||||.||++||+|||.|+.+.+
T Consensus 153 Le~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999984 5789999999999999999999998 9999999999999999999999999999987654
Q ss_pred cccc----------c--ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002358 764 DLTH----------I--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 831 (931)
Q Consensus 764 ~~~~----------~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 831 (931)
.... . .....||..|.+||++.....+..+|+|+|||+||+|+.|++||..... ..+.+.+..
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliFqkI~~-- 301 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIFQKIQA-- 301 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHHHHHHH--
Confidence 2211 1 1346799999999999999999999999999999999999999973321 111111111
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 832 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 832 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
++= .+++..+..+.+|+.+.|..||.+|++.+||.+.
T Consensus 302 --------l~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 --------LDY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --------hcc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 000 1222333467899999999999999999998765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=339.20 Aligned_cols=266 Identities=22% Similarity=0.278 Sum_probs=207.4
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcC-CCCCcceeEEEecCC-eEEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH-QRIL 682 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~-~~~l 682 (931)
....|.+.++||.|.||.||+|+-+ .|+.||||+++.... .+.-.=+||++.|++|+ |||||++...+.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4567889999999999999999865 689999999876432 23333468999999998 999999999998877 8999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
|||||+ .+|+++++.. ++.+++..+..|+.||++||+|+|+ +|+.|||+||+|||+.....+||+|||+|+...
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 999995 5999999864 6789999999999999999999998 999999999999999999999999999999876
Q ss_pred ccccccccccccCCCccCCCcc-CCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeee---
Q 002358 763 EDLTHISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS--- 838 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l-~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~--- 838 (931)
..... +....|.+|+|||++ +...|+.+.||||+||+++|+.+-++-|.+.+.-++..-+-.+.....+....+
T Consensus 162 SkpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SKPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cCCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 55443 334579999999986 668899999999999999999999999976544332211111111111111111
Q ss_pred ---ccc---cccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 839 ---IVD---PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 839 ---i~d---~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.+. |... +..-+....+.++++.+|+..||.+|||++|.++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000 0000 01112244578899999999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.96 Aligned_cols=263 Identities=28% Similarity=0.497 Sum_probs=207.7
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
|+......+.+.||+|.||+||+|.|. ..||||++... ..+..+.|+.|+..+++-+|.||+-+.|+|..... .+
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 333444456789999999999999997 46999998654 34467889999999999999999999999998877 99
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
|+.+|+|-+|+.+|+.. +..++..+.+.|+.|||+||.|||. ++|||||||..||++.+++.|||+|||++..-.
T Consensus 465 iTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 99999999999999964 4678899999999999999999998 999999999999999999999999999986422
Q ss_pred cc-ccccccccccCCCccCCCccCCC---CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeee
Q 002358 763 ED-LTHISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 763 ~~-~~~~~~~~~gt~~y~APE~l~~~---~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 838 (931)
.- ....-....|..-|||||+++.. .|++.+||||||+++|||++|..||.....+. +.-++..| .-
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-------IifmVGrG--~l 610 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-------IIFMVGRG--YL 610 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-------eEEEeccc--cc
Confidence 11 01111122367789999998653 78999999999999999999999997222211 00011111 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 839 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 839 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
..|.. ......++++.+|+..||..++++||.+.+|+..|++++..
T Consensus 611 ~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 611 MPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred Cccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 11111 11234566889999999999999999999999999988774
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=343.19 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=203.0
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc----cc-hhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS----CS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~----~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~ 680 (931)
...|.+.+.||+|.||+|++|.+. .++.||+|++... .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 345677899999999999999765 6899999976543 11 23456778999999998 99999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC-CceEEecccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSR 759 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~-~~vkL~DFGla~ 759 (931)
++||||+.+|+|.+.+.. .+++.+.....++.|++.|++|||+ ++|+||||||+|||++.+ +++||+|||++.
T Consensus 96 ~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 999999999999999984 5678889999999999999999998 999999999999999999 999999999998
Q ss_pred cccccccccccccccCCCccCCCccCCCC-CC-ccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYGNQQ-LT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s-~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+. ..+. ..+..+...
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---~~l~----~ki~~~~~~ 241 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---PNLY----RKIRKGEFK 241 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---HHHH----HHHhcCCcc
Confidence 764 2223345667999999999999877 76 799999999999999999999984222 1111 113222220
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 878 (931)
+..... ..++..++.+|++.+|.+|+++.||+
T Consensus 242 ------~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 242 ------IPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ------CCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 001110 34678999999999999999999998
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=332.72 Aligned_cols=258 Identities=22% Similarity=0.397 Sum_probs=206.1
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC----CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
+....+++.+.||+|+||.||+|.++ .+..||+|+++.... ...+.+.+|+.++++++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 34566778899999999999999864 356899999876533 3346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+|||++.++.++++|||.+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 9999999999999998753 3468899999999999999999998 8999999999999999999999999998765
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
.............++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ...+. +..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~----~~~~~~~-- 227 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKA----VEDGFRL-- 227 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH----HHCCCCC--
Confidence 43222111122235678999999999999999999999999999875 99999733221 12221 2221110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
.. +...+..+.+++.+||+.+|++||+++||++.|++.
T Consensus 228 ---~~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ---PA----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CC----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11 122334688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=344.41 Aligned_cols=261 Identities=30% Similarity=0.452 Sum_probs=219.8
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEECC-CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
.|++.....+.++||.|.||.||.|.|+. .-.||||.++++. ....+|++|+.+|+.++|||+|+++|.|..+...|+
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 35555666678999999999999999984 5689999998653 456899999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
|+|||..|+|.++|++. ++..++...++.++.||+.||.||.. +++|||||.++|+|+.++..+|++||||++.+.
T Consensus 341 iTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999976 45567777889999999999999997 999999999999999999999999999999876
Q ss_pred ccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 763 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
.+.........-.+.|.|||.+....++.|+|||+|||+|||+.| |..||.+-+... +-.+++++
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLEkg------- 482 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLEKG------- 482 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHhcc-------
Confidence 554443334445789999999999999999999999999999999 899997544322 12222222
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
.+-+.+..++.++.+|++.||+.+|.+||+++|+.+.++.+.
T Consensus 483 --yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 483 --YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred --ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 222334556668999999999999999999999999998665
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.49 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=198.8
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccchh---hhhHHHHHHHHHhcCCCCCcceeEEEec----CCeEEEEEEec
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVYEYM 687 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~~~lV~E~~ 687 (931)
..||+|++|.||+|.+. |+.||||+++...... .+.|.+|+++|++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 56999999999999984 8999999987643322 4678899999999999999999999876 34678999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++|+|.+++.. ...+++....+++.|++.||+|||+ ..+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999974 4568899999999999999999997 2478899999999999999999999999987653321
Q ss_pred cccccccCCCccCCCccCC--CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 768 ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .+.. .....+.. +.
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~---~i~~~~~~-----~~-- 242 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYD---LIINKNNS-----LK-- 242 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHhcCCC-----CC--
Confidence 12347889999999976 68999999999999999999999999743221 1111 11111111 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
.+......+.+++.+||+.||++|||++|+++.|++..
T Consensus 243 --~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 --LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11123446889999999999999999999999998764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=334.38 Aligned_cols=264 Identities=26% Similarity=0.404 Sum_probs=203.5
Q ss_pred HHHHhhccccCccCcEEEEEEEECC-----------------CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcc
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 669 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----------------g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~ 669 (931)
...+.+.++||+|+||.||++.+++ +..||+|.+..... ....+|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4566778999999999999998643 33699999876433 34567999999999999999999
Q ss_pred eeEEEecCCeEEEEEEecCCCCHHHHhccCC----------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeE
Q 002358 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV----------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733 (931)
Q Consensus 670 l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~----------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iv 733 (931)
+++++.+.+..++||||+++|+|.+++.... ....+++..+.+++.||+.||+|||+ .+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 9999999999999999999999999886421 11346788899999999999999998 8999
Q ss_pred ecCCCCCCccccCCCceEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh--CCC
Q 002358 734 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKK 810 (931)
Q Consensus 734 H~DIkp~NILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt--G~~ 810 (931)
||||||+|||++.++.+||+|||+++....... .......++..|+|||++....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999976533221 11223345788999999988899999999999999999987 556
Q ss_pred CCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 811 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 811 Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
||..... ......+............. ..+...+..+.+++.+||+.+|++|||++||++.|++
T Consensus 241 p~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTD---EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCH---HHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7753221 22223332222211110000 0112233478899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=338.24 Aligned_cols=244 Identities=29% Similarity=0.396 Sum_probs=206.6
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|.+.+.||+|.||.||||+-+ +.+.||+|.+.+.. ..+.+.+.+|+++++.++|||||.+++.|+...+.++|+||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 456688999999999999877 57899999987643 335577999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
.| +|..+|. ..+.+++..+..++.+++.||.|||+ .+|+|||+||.|||++..+.+|+||||+++-+.. ...
T Consensus 84 ~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~ 155 (808)
T KOG0597|consen 84 VG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTS 155 (808)
T ss_pred hh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc-Cce
Confidence 76 9999998 46789999999999999999999998 9999999999999999999999999999997654 344
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
..+...|||-|||||++.++.|+..+|+||+||++|||++|++||... .+.+.++ .+..++. .
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~-~I~~d~v----------~ 218 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVK-SILKDPV----------K 218 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHH-HHhcCCC----------C
Confidence 455667999999999999999999999999999999999999999722 1222222 2222221 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+......+.+++...+.+||.+|.+..+++.
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 12244457889999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.65 Aligned_cols=263 Identities=22% Similarity=0.270 Sum_probs=205.3
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch--hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+|...++||+|.||.||+|+.. .|+.||||+++-.... -.....+|++.|+.++|+||+.++++|...+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4556789999999999999865 7999999999764322 235678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
|+ .+|+..++. +...+....+..++.++++|++|||+ +.|+||||||.|+|++++|.+||+|||+++.+.....
T Consensus 83 m~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 96 589999885 45678899999999999999999998 8999999999999999999999999999998876544
Q ss_pred ccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee---eccc-
Q 002358 767 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI---SIVD- 841 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~---~i~d- 841 (931)
.... ...|.+|+|||.+.+ ..|+...||||.||++.||+-|.+-|.+...-+....+-.+.....+.... .+.|
T Consensus 157 ~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 157 IQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 3222 257899999998755 689999999999999999999998887554433332222111111111111 1111
Q ss_pred --------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 842 --------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 842 --------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
+.+. ..-+.......+++.+++..+|.+|++++|.++.
T Consensus 236 ~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111 1222333456899999999999999999998753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=347.46 Aligned_cols=260 Identities=28% Similarity=0.444 Sum_probs=204.7
Q ss_pred HHHHHhhccccCccCcEEEEEEEE------CCCcEEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCC
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 678 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~ 678 (931)
....+++.+.||+|+||.||+|.+ ..+..||||+++... ....+.+.+|+++++.+ +||||++++++|....
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345677889999999999999974 235689999987543 33456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC----------------------------------------------------------
Q 002358 679 QRILVYEYMHNGTLRDRLHGSV---------------------------------------------------------- 700 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~---------------------------------------------------------- 700 (931)
..++||||+++|+|.++++...
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999886421
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 701 --------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 701 --------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
....+++..+.+++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 11257888999999999999999998 8999999999999999999999999999986543322
Q ss_pred c-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 767 H-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 767 ~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
. ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .....+++. .+.... .+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~~~~----~~~~~~--~~-- 339 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKMIK----EGYRML--SP-- 339 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHHHHH----hCccCC--CC--
Confidence 1 1122235678999999999999999999999999999998 8889863322 122222222 111100 01
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
.....++.+++.+||+.+|++||+++||++.|++.
T Consensus 340 -----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 -----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11123688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=341.87 Aligned_cols=245 Identities=27% Similarity=0.411 Sum_probs=205.0
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+++++.||.|+-|.|.+|++. .|+.+|||++.+.. ......+.+|+.+|+.+.|||++++++.+++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 456789999999999999875 79999999997652 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|-|.+++- ..+++.+.+..+++.||+.|+.|+|+ .+|+|||+||+|+|||..+++||+|||+|....++
T Consensus 94 v~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 94 VPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred cCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 99999999987 46789999999999999999999998 99999999999999999999999999999864332
Q ss_pred ccccccccCCCccCCCccCCCCCC-ccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
..-.+.+|.|.|.|||++.+..|. .++||||+||+||.||||+.||+++. +.. +...++.|.+
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~-LLlKV~~G~f--------- 229 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRV-LLLKVQRGVF--------- 229 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHH-HHHHHHcCcc---------
Confidence 223456799999999999999884 69999999999999999999998322 222 2223333333
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
+.+.....+..+|+.+|+..||++|.|++||++.
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1122233366799999999999999999999864
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=325.29 Aligned_cols=257 Identities=26% Similarity=0.479 Sum_probs=207.6
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
+....+++.+.||+|++|.||+|.+.+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3445677889999999999999998888899999987543 335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999987532 4568999999999999999999998 899999999999999999999999999998765332
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.........+..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .+..+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~------- 223 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQ----QVDQGYRM------- 223 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCCC-------
Confidence 221111223457999999999999999999999999999999 99999633211 1111 11111100
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
..+......+.+++.+|++.+|++||++++|++.|++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111223478899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=322.52 Aligned_cols=251 Identities=31% Similarity=0.509 Sum_probs=202.8
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
..+++.+.||+|+||.||+++++++..+|+|.+.... ...+++.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3456778999999999999999988899999886432 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|+|.++++.. ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999998743 2458899999999999999999998 899999999999999999999999999987654332222
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+. ......+. .+.. ...+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~----~~~~--~~~~~---- 224 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMIS----RGFR--LYRPK---- 224 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH----CCCC--CCCCC----
Confidence 222235668999999998889999999999999999999 8999963322 22222221 1111 11111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 881 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 881 (931)
.....+.+++.+||+.+|++||+++|+++.|
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1223678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=323.81 Aligned_cols=256 Identities=26% Similarity=0.458 Sum_probs=207.5
Q ss_pred HHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
....+++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 345667789999999999999998888999999986532 3456889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.++++.. ....+++..++.++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999998753 34568889999999999999999998 8999999999999999999999999999987644322
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.......++..|+|||++....++.++|||||||++|||++ |+.||...... ....++. .+... + ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~----~~~~~----~-~~ 226 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQ----RGYRM----P-RM 226 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHH----cCCCC----C-CC
Confidence 22222335678999999988889999999999999999998 99999633221 1222211 11110 1 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
......+.+++.+|+..+|++||+++++.++|++
T Consensus 227 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1123467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=344.89 Aligned_cols=262 Identities=29% Similarity=0.448 Sum_probs=205.1
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEEecC
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 677 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~ 677 (931)
+....+++.+.||+|+||.||+|.+. +++.||+|+++... ......+.+|+++++.+ +|+||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 44567778999999999999999753 24589999997543 23346788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCC---------------------------------------------------------
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSV--------------------------------------------------------- 700 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~--------------------------------------------------------- 700 (931)
...++||||+++|+|.++++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999885321
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc-cc
Q 002358 701 ----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-IS 769 (931)
Q Consensus 701 ----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~-~~ 769 (931)
....+++..+++++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++........ ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 11247888899999999999999998 89999999999999999999999999999765432211 11
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
....++..|+|||++.+..++.++|||||||++|||++ |+.||....... ... ..+..+. .+..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~----~~~~~~~-----~~~~---- 336 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFY----KMVKRGY-----QMSR---- 336 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHH----HHHHccc-----CccC----
Confidence 22235678999999998899999999999999999997 999997332211 111 1111110 0000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
+......+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1111246889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=322.91 Aligned_cols=256 Identities=30% Similarity=0.467 Sum_probs=206.3
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
...+.+.+.||+|++|.||+|.++ .++.||+|.+... ....+++.+|++++++++|+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 344567789999999999999876 5889999998754 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+++... ....+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999998753 24568999999999999999999998 8999999999999999999999999999987544322
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||...+.. ...+ .+..+.. +
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~----~~~~~~~-----~--- 224 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE----LLEKGYR-----M--- 224 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCCCC-----C---
Confidence 22222234668999999999999999999999999999998 99998643321 1111 1111110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
..+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=334.17 Aligned_cols=200 Identities=27% Similarity=0.385 Sum_probs=174.5
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
...|++.+.||+|+||.||+++.+ ++..+|+|++..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 455667889999999999999987 588899999875432 334679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999874 3568899999999999999999997 2469999999999999999999999999987653322
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 815 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~ 815 (931)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 22345899999999999999999999999999999999999999743
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=335.99 Aligned_cols=241 Identities=24% Similarity=0.352 Sum_probs=195.9
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
+.||+|+||.||+++.+ +|+.||+|+++... ......+.+|++++++++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccc
Q 002358 691 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 770 (931)
Q Consensus 691 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 770 (931)
+|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 153 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-ccc
Confidence 99999873 4578899999999999999999998 8999999999999999999999999999875322211 122
Q ss_pred ccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002358 771 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 850 (931)
Q Consensus 771 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 850 (931)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .... .+..+.. .+ +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~----~~~~~~~------~~----p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE----LILMEEI------RF----PR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHH----HHHcCCC------CC----CC
Confidence 345899999999999999999999999999999999999999743221 1111 1111111 11 11
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 851 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 851 ~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
.....+.+++.+||+.||++|| +++++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 2233678999999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=333.11 Aligned_cols=265 Identities=29% Similarity=0.467 Sum_probs=220.1
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEECC---Cc--EEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMKD---GK--EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 678 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~~---g~--~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 678 (931)
++..+...+.+.||+|.||.||+|...+ |+ .||||..+.++ ....+.|+.|..+|++++|||||+++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 5556666678899999999999998642 33 58899988754 34567899999999999999999999999875
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
..++|||.++-|.|..+|+. +...++......++.||+.||+|||+ ++++||||.++|||+.....+||+|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchh
Confidence 57999999999999999986 45678889999999999999999998 99999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 759 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 759 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
+.+.++.....+...-++.|||||.+.-.+++.++|||.|||.+||++. |..||.+-.-.+- ...+++|+..
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-------I~~iEnGeRl 611 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-------IGHIENGERL 611 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-------EEEecCCCCC
Confidence 9988877666665556789999999999999999999999999999988 9999974322111 1112222211
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 891 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 891 (931)
-.++.++-.|..++.+||..+|.+||++.||...|.++...++..
T Consensus 612 ---------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~ 656 (974)
T KOG4257|consen 612 ---------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKIN 656 (974)
T ss_pred ---------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence 123444557889999999999999999999999999888766544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=327.60 Aligned_cols=250 Identities=24% Similarity=0.308 Sum_probs=198.4
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
++..+.||+|+||.||+|... +|+.||+|.+.... ......+.+|++++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 455788999999999999875 78999999986432 12334678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+.+... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999999887643 23468899999999999999999998 8999999999999999999999999999876533221
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........... +...+.... .
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~----------~ 222 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVKEDQ----------E 222 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhhccc----------c
Confidence 1234589999999999999999999999999999999999999974432211111 111111110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 879 (931)
.++......+.+++.+||+.+|++||+ ++|+++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111122336789999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=323.33 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=210.1
Q ss_pred HHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
...|.+.++||+|+||.||+|.+++++.+|+|.+.........++.+|+++++.++|+||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45677889999999999999999989999999998765555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++|+|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999754 34568999999999999999999998 89999999999999999999999999999776443222
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.. ...++..|+|||.+....++.++||||||+++|+|++ |+.||..... ....+... .+.. +
T Consensus 161 ~~-~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~----~~~~-----~---- 223 (261)
T cd05148 161 SS-DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQIT----AGYR-----M---- 223 (261)
T ss_pred cc-CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHH----hCCc-----C----
Confidence 21 2335678999999988899999999999999999998 8999964331 11222111 1100 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
..+......+.+++.+|++.+|++|||+++|++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0112223467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.55 Aligned_cols=249 Identities=39% Similarity=0.613 Sum_probs=194.4
Q ss_pred hccccCccCcEEEEEEEEC-----CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 613 FCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+.+.||.|.||.||+|.+. .+..|+||+++.... ...+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 257899999966433 3478899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc-c
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-L 765 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~-~ 765 (931)
+++|+|.++|... ....+++..+.+|+.||++||+|||+ .+++||||+++||++++++.+||+|||++...... .
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999864 34678999999999999999999998 89999999999999999999999999999876221 1
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
............|+|||.+....++.++||||||+++|||++ |+.||...+ ...+...+ .++....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~----~~~~~~~------ 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKL----KQGQRLP------ 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHH----HTTEETT------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccc----cccccce------
Confidence 122233346778999999998889999999999999999999 678886331 12222221 2222211
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 881 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 881 (931)
.+......+.+++.+||..+|++||+++||++.|
T Consensus 226 ---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111234678999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=331.01 Aligned_cols=202 Identities=26% Similarity=0.393 Sum_probs=175.6
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
+....|++.++||+|+||.||++.++ +++.+|+|.++.... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 44567788899999999999999987 688899998865432 3346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+++||||||+|||+++++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999999874 4568888999999999999999997 35799999999999999999999999999876533
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 815 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~ 815 (931)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 21 22345889999999999989999999999999999999999999743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=324.81 Aligned_cols=257 Identities=28% Similarity=0.472 Sum_probs=207.0
Q ss_pred HHHHhhccccCccCcEEEEEEEECC------CcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
..++.+.+.||+|+||.||+|.+.+ ++.||+|.++..... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4567788999999999999998743 478999998765444 457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC-----------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc
Q 002358 681 ILVYEYMHNGTLRDRLHGSV-----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 749 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~ 749 (931)
++||||+++++|.+++.... ....+++..+..++.|++.|++|||+ ++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999987532 23457889999999999999999998 89999999999999999999
Q ss_pred eEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHH
Q 002358 750 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 827 (931)
Q Consensus 750 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 827 (931)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH
Confidence 99999999876432221 11223345788999999999999999999999999999999 99998633221 122221
Q ss_pred HHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 828 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 828 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
..+..... +......+.+++.+||+.+|++||+++||++.|++
T Consensus 238 ----~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 ----TQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----HcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 12222111 11223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=328.27 Aligned_cols=263 Identities=19% Similarity=0.205 Sum_probs=199.9
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++.+.||+|+||.||+|+++ +++.||+|+++... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 566789999999999999987 57899999987542 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
+++.+..+.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 83 EKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 9887765543 23568889999999999999999998 89999999999999999999999999999875433222
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHH---------HHhhhcCCeee
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA---------RSMIKKGDVIS 838 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~---------~~~~~~~~~~~ 838 (931)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......+........ ...........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 223345899999999999888999999999999999999999999744322211111110 00000000000
Q ss_pred cccccccC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 839 IVDPVLIG------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 839 i~d~~l~~------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+.... .........+.+++.+||+.+|++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00010000 000112346889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=335.50 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=201.5
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|++++..++||||+++++++...+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 456789999999999999987 58999999987542 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 83 VPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999973 4568889999999999999999998 8999999999999999999999999999976543
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhh-HHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+... +..|. ..+.....
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------~~~~~~~~ 222 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK----------ETLQRPVY 222 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc----------ccccCCCC
Confidence 2233458999999999999999999999999999999999999997443322111 11110 00000000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
..........+.+++.+|+..+|++||+++|+++.
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00001223467899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.91 Aligned_cols=252 Identities=30% Similarity=0.480 Sum_probs=202.6
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
..+.+.+.||+|+||.||+|+++++..+|+|.+.... ...+++.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4566788999999999999998877789999987543 234678999999999999999999999998888999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|+|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998753 3368999999999999999999998 899999999999999999999999999987654332222
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+ ..+.....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~~~~~~-------- 222 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKV----SQGLRLYR-------- 222 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH----hcCCCCCC--------
Confidence 222235678999999988889999999999999999999 99998633221 111211 11111000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 223 -~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 -PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1112347889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=330.66 Aligned_cols=241 Identities=24% Similarity=0.361 Sum_probs=194.5
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
+.||+|+||.||+++.+ +|+.||+|+++... ......+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999987532 234456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccc
Q 002358 691 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 770 (931)
Q Consensus 691 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 770 (931)
+|...+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence 99988873 4568899999999999999999998 8999999999999999999999999999875322211 122
Q ss_pred ccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002358 771 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 850 (931)
Q Consensus 771 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 850 (931)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ..+ .+..+.. .+ +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~----~~~~~~~------~~----p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE----LILMEEI------RF----PR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHH----HHhcCCC------CC----CC
Confidence 3458999999999999999999999999999999999999996332211 111 1111111 11 11
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 851 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 851 ~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
.....+.+++.+||+.+|++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1223678999999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=331.56 Aligned_cols=242 Identities=25% Similarity=0.362 Sum_probs=195.9
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
+.||+|+||.||+++.+ +|+.||+|++.... ......+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999876 68999999987532 234467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccc
Q 002358 691 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 770 (931)
Q Consensus 691 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 770 (931)
+|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 153 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK 153 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence 99988863 4568899999999999999999998 8999999999999999999999999999875332211 122
Q ss_pred ccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002358 771 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 850 (931)
Q Consensus 771 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 850 (931)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ..+ .+..+.. .+ +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~----~~~~~~~------~~----p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE----LILMEDI------KF----PR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHH----HhccCCc------cC----CC
Confidence 3468999999999999999999999999999999999999997432211 111 1111111 11 11
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002358 851 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 880 (931)
Q Consensus 851 ~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 880 (931)
.....+.+++.+||+.+|++|| +++|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2223678999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.71 Aligned_cols=255 Identities=30% Similarity=0.526 Sum_probs=204.6
Q ss_pred HHhhccccCccCcEEEEEEEECC------CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
.+++.+.||+|+||.||+|.... .+.||+|.++.... ....+|.+|++++++++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 45678999999999999998653 25799999875433 344678999999999999999999999999899999
Q ss_pred EEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc
Q 002358 683 VYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 749 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~ 749 (931)
+|||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 9999999999999875321 1457889999999999999999998 89999999999999999999
Q ss_pred eEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHH
Q 002358 750 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 827 (931)
Q Consensus 750 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 827 (931)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .+.+
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~-- 237 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIE-- 237 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH--
Confidence 99999999876433221 12223346788999999988899999999999999999998 99999743321 2222
Q ss_pred HHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 828 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 828 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
.+..+.... .+...+..+.+++.+||+.+|++||+++||++.|+.
T Consensus 238 --~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 --MIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 222222211 122234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.58 Aligned_cols=241 Identities=24% Similarity=0.313 Sum_probs=193.2
Q ss_pred cCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 617 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 617 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++.+...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999886 57899999986432 23446788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccccc
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 772 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 772 (931)
.+++.. ...+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 153 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF 153 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence 999874 4568899999999999999999998 8999999999999999999999999999875432221 22334
Q ss_pred ccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002358 773 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 852 (931)
Q Consensus 773 ~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 852 (931)
.||+.|+|||++.+..++.++||||+||++|||++|+.||...... +....... +.. . .+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~-~~~------~----~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQ-EPL------R----FPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHc-CCC------C----CCCcC
Confidence 6899999999999999999999999999999999999999743221 11111111 111 1 11122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002358 853 IWRIAEVAIQCVEQRGFSRPKMQEIVLAI 881 (931)
Q Consensus 853 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L 881 (931)
...+.+++.+||+.+|++||++.++.+.|
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 23678999999999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=324.62 Aligned_cols=263 Identities=22% Similarity=0.283 Sum_probs=196.7
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.|.+.++||+|+||.||+|..+ +++.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 3667789999999999999876 688999999864322 23456789999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
+ |+|.+.+... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 86 D-SDLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred C-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 7 4898888642 3457888999999999999999998 8999999999999999999999999999876432221
Q ss_pred cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc---------CCee
Q 002358 768 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---------GDVI 837 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---------~~~~ 837 (931)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+.............. ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1223457899999998865 56899999999999999999999999754432222111110000000 0000
Q ss_pred ecccccccCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~~~~----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....+...... ......+..+++.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 01111100000 0011235679999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.52 Aligned_cols=250 Identities=29% Similarity=0.488 Sum_probs=201.1
Q ss_pred HHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
.+++.+.||+|+||.||+|.++++..+|+|++..... ....+.+|++++++++||||+++++++......++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4567899999999999999988888999999864322 335688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...+......
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999998743 3468999999999999999999998 8999999999999999999999999999876543322222
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+.. ..... +..+.. . ..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~~~~~~--~-------~~ 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVES----VSAGYR--L-------YR 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHH----HHcCCc--C-------CC
Confidence 22224457999999998899999999999999999999 89998633221 11111 111100 0 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 881 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 881 (931)
+......+.+++.+||..+|++||++.|+++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=327.76 Aligned_cols=242 Identities=23% Similarity=0.311 Sum_probs=197.3
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 456789999999999999886 68999999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 83 VPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 999999999873 4568889999999999999999998 899999999999999999999999999988654321
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...+ .+..+.. .+
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~----~i~~~~~------~~-- 217 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYE----KILAGKL------EF-- 217 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCCc------CC--
Confidence 2345899999999999989999999999999999999999999743221 1111 1111111 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 879 (931)
+......+.+++.+||+.||.+||+ ++|+++
T Consensus 218 --~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 218 --PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 1111235789999999999999995 777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=339.70 Aligned_cols=262 Identities=24% Similarity=0.402 Sum_probs=205.2
Q ss_pred HHHHHhhccccCccCcEEEEEEEECC------CcEEEEEEccCccc-hhhhhHHHHHHHHHhcC-CCCCcceeEEEecCC
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH 678 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~ 678 (931)
....+.+.+.||+|+||.||+|++.. +..||||+++.... ...+.+.+|+++++++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 34566778999999999999998631 34799999975433 33467999999999996 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC----------------------------------------------------------
Q 002358 679 QRILVYEYMHNGTLRDRLHGSV---------------------------------------------------------- 700 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~---------------------------------------------------------- 700 (931)
..++|||||++|+|.++++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999998876421
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc
Q 002358 701 -----------------------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 745 (931)
Q Consensus 701 -----------------------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld 745 (931)
....+++..++.++.|+++||+|||+ .+|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 01247788889999999999999998 8999999999999999
Q ss_pred CCCceEEecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhH
Q 002358 746 INMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 823 (931)
Q Consensus 746 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l 823 (931)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TF 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HH
Confidence 9999999999999865432221 1222346788999999998899999999999999999997 999986322111 11
Q ss_pred HHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 824 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 824 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
.. .+..+... ..+......+.+++.+||+.+|++||++.+|+++|+++.+
T Consensus 350 ~~----~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 YN----KIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HH----HHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11 11111110 0112233478899999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=319.28 Aligned_cols=255 Identities=27% Similarity=0.467 Sum_probs=204.9
Q ss_pred HHHhhccccCccCcEEEEEEEECC----CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
..+++.+.||+|+||.||+|.++. ...||+|.++.... ....+|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 456678999999999999998853 45799999875433 3456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++++|.+++... ...+++..+++++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998753 3468999999999999999999998 8999999999999999999999999999987642
Q ss_pred ccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 764 DLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 764 ~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
... .......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ....+.+ ..+....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~~--- 228 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAV----EDGYRLP--- 228 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHH----HcCCCCC---
Confidence 211 11112234678999999998899999999999999999998 9999863221 1222222 1111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
.+......+.+++.+|++.+|++||+++||++.|+++
T Consensus 229 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.29 Aligned_cols=244 Identities=24% Similarity=0.325 Sum_probs=199.0
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
..|++.+.||+|+||.||+|+++ +++.||+|+++... ....+.+.+|++++++++||||+++++.+.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45677899999999999999987 58899999986532 223467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++|+|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999874 4567888899999999999999998 89999999999999999999999999999865432
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
. ....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ... +.+..+... +
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~----~~i~~~~~~------~ 234 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIY----EKILAGRLK------F 234 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHH----HHHhcCCcC------C
Confidence 2 2345899999999999999999999999999999999999999633211 111 112222110 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 879 (931)
+......+.+++.+||+.||++||+ ++++++
T Consensus 235 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 235 ----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111235789999999999999996 677663
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.30 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=204.1
Q ss_pred HHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
....+++.++||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 4456788899999999999999988888999999875433 34678999999999999999999998854 567899999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.++++.. ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999998753 23458899999999999999999998 8999999999999999999999999999976543322
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||...+. ....+... .+.. .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~----~~~~-----~--- 222 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVE----RGYR-----M--- 222 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH----cCCC-----C---
Confidence 22222235668999999988889999999999999999999 8899863321 11222111 1110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
..+......+.+++.+|++.+|++|||+.++++.|++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 -PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=331.46 Aligned_cols=246 Identities=23% Similarity=0.381 Sum_probs=192.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.+++.++||+|+||.||+|++. +++.||||++..... ...+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4456789999999999999876 689999999865433 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++|+|.+.. ...+..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 999986532 24567788899999999999998 8999999999999999999999999999986543221
Q ss_pred cccccccCCCccCCCccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 768 ISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
......||..|+|||++.. ...+.++|||||||++|||++|+.||......+........ . .... +
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~-~~~~-----~ 294 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---C-MSQP-----P 294 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---h-ccCC-----C
Confidence 1223458999999998743 23456899999999999999999999733322221111111 0 0000 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+.....++.+++.+||+.+|++||+++|+++
T Consensus 295 ----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 295 ----EAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred ----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111122346889999999999999999999986
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.24 Aligned_cols=267 Identities=26% Similarity=0.400 Sum_probs=203.4
Q ss_pred HhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhc--CCCCCcceeEEEecCC----eEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEEH----QRILVY 684 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~g~~~~~~----~~~lV~ 684 (931)
.++.+.+|+|.||.||+|+++ ++.||||++.. .+.+.|..|-+|+... +|+||++++++-.... +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345789999999999999998 69999999973 4567788888887764 7999999999876655 899999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc------CCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------CNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~------~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
||.+.|+|.++|+ ...++|....+|+..+++||+|||+. .+++|+|||||++||||..|+++.|+|||+|
T Consensus 288 ~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 288 EFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999998 45799999999999999999999973 3678999999999999999999999999999
Q ss_pred cccccccccc-ccccccCCCccCCCccCCCC-CC-----ccchhHHHHHHHHHHHhCCCCCCccCcc-----------ch
Q 002358 759 RQAEEDLTHI-SSVARGTVGYLDPEYYGNQQ-LT-----EKSDVYSFGVVLLELISGKKPVSVEDFG-----------AE 820 (931)
Q Consensus 759 ~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~-~s-----~ksDVwSlGvlL~eLltG~~Pf~~~~~~-----------~~ 820 (931)
..+....... .....||.+|||||++.+.- +. .+.||||+|.+||||++...-++....+ ..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 8876543322 22356999999999997642 22 3789999999999999976544311111 11
Q ss_pred hhHHHHHHHh-hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 002358 821 LNIVHWARSM-IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 890 (931)
Q Consensus 821 ~~l~~~~~~~-~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 890 (931)
..+ +.++.. +++...+.+.|. . .....+..+.+.+..||++||+.|-|+.=+-+.+.++....+.
T Consensus 444 Pt~-e~mq~~VV~kK~RP~~p~~-W---~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 444 PTL-EEMQELVVRKKQRPKIPDA-W---RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCH-HHHHHHHHhhccCCCChhh-h---hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 111 111111 111111111111 0 0114456788999999999999999999999999888777654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.22 Aligned_cols=247 Identities=28% Similarity=0.386 Sum_probs=204.0
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.++-.+.||+|.||.||+|... .++.||+|++.-.. .....++.+|+.+|.+++++||.+++|.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 3444588999999999999876 68899999986543 345678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
.||++.+.|+. ...+++..+.-+++++..||.|||. .+.+|||||+.|||+..+|.+||+|||.+-........
T Consensus 94 ~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 94 GGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred cCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 99999999983 3445778888899999999999998 89999999999999999999999999999877655444
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
. .+..||+.|||||++....|+.|+||||||++.+||++|.+|+........ .-.+ .+-.-|.+.+
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-------lflI-----pk~~PP~L~~- 233 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-------LFLI-----PKSAPPRLDG- 233 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-------EEec-----cCCCCCcccc-
Confidence 3 566799999999999988999999999999999999999999973222100 0001 1111233333
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.....+.+++..||..+|+.||+++++++
T Consensus 234 ---~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 ---DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ---ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 33336889999999999999999999985
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=321.62 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=201.4
Q ss_pred hhccccCccCcEEEEEEEE-----CCCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecC--CeEEEE
Q 002358 612 NFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILV 683 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~lV 683 (931)
.+.+.||+|+||+||++.. .+++.||+|.++.... ...+.+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6678999999999988653 3578999999876433 3456788999999999999999999988653 457899
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++|+|.+++.. ..+++..+..++.|+++||+|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999863 358999999999999999999998 8999999999999999999999999999886543
Q ss_pred cccc--cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 764 DLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 764 ~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
.... ......++..|+|||.+....++.++||||||+++|||++|..|+...... ......+...........+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhh
Confidence 2211 112223566799999998888999999999999999999999998633211 0111110000000001111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
.......+...+..+.+++.+||+.+|++||++++|++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111112233457899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=323.68 Aligned_cols=260 Identities=27% Similarity=0.454 Sum_probs=209.1
Q ss_pred HHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
..+.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34556789999999999999753 356799999876665666789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc
Q 002358 683 VYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 749 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~ 749 (931)
||||+++++|.+++.... ....+++..+++++.|++.||+|||+ ++++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999986432 12358899999999999999999998 89999999999999999999
Q ss_pred eEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHH
Q 002358 750 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 827 (931)
Q Consensus 750 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 827 (931)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~-- 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIE-- 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--
Confidence 99999999876533221 12223346788999999999999999999999999999999 99998633221 1222
Q ss_pred HHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 828 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 828 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
.+..+..... +...+..+.+++.+||+.+|++||++++|++.|+++.+.
T Consensus 237 --~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 --CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred --HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1222222111 112234688999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=318.28 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=203.9
Q ss_pred HHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
...+++.++||+|+||.||+|.+.++..||+|+++... ...+.+.+|++++++++||||+++++.+.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 45678899999999999999998877789999987532 234578999999999999999999998754 5578999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++|+|.+++... ....+++..+..++.|+++||+|||+ .+++||||||+||++++++.++|+|||+++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999743 23457899999999999999999998 89999999999999999999999999999765443322
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
......++..|+|||...+..++.++||||||+++|||++ |..||....... .. ..+..+.. .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~----~~~~~~~~-----~---- 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL----DQVERGYR-----M---- 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HH----HHHhcCCC-----C----
Confidence 2223346678999999988899999999999999999999 888886332111 11 11111110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
......+..+.+++.+|++.+|++||+++++++.|++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 01123345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=323.07 Aligned_cols=262 Identities=27% Similarity=0.462 Sum_probs=209.0
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
++..+.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++......
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3456667899999999999999752 3456899998766555667899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC----------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCce
Q 002358 681 ILVYEYMHNGTLRDRLHGSV----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 750 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~v 750 (931)
++||||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 99999999999999986421 12358999999999999999999998 899999999999999999999
Q ss_pred EEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHH
Q 002358 751 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 828 (931)
Q Consensus 751 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 828 (931)
||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~--- 233 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIE--- 233 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---
Confidence 9999999876533221 11222335778999999999999999999999999999998 89998633221 1111
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 829 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 829 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
.+..+..... ... ....+.+++.+||+.+|.+||+++|+++.|+++.+.
T Consensus 234 -~i~~~~~~~~-----~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 -CITQGRVLQR-----PRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HHHcCCcCCC-----CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1222221111 111 223688999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=315.89 Aligned_cols=257 Identities=26% Similarity=0.443 Sum_probs=207.2
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
++...++++.++||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++|+||+++++++. ....+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 345678888999999999999999998999999999875432 3467899999999999999999999874 45689999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++++|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 80 EYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999998753 34568899999999999999999997 89999999999999999999999999998765532
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
.........++..|+|||.+....++.++||||||+++|||++ |+.||..... ......+. .+....
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~----~~~~~~----- 223 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNLE----RGYRMP----- 223 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHH----cCCCCC-----
Confidence 2222223345678999999998889999999999999999999 9999973332 12222111 111100
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
. +......+.+++.+|+..+|++||+++++++.|+.
T Consensus 224 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 R----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1 11123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=325.60 Aligned_cols=261 Identities=24% Similarity=0.421 Sum_probs=204.7
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-CCc----EEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 679 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 679 (931)
+....++..+.||+|+||.||+|++. +++ .||+|+++... ....+++.+|+.+++.++||||++++|+|... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 34556777899999999999999875 333 48999987543 34456789999999999999999999999765 4
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
.++|+||+++|+|.+++... ...+++..++.++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 67999999999999998753 3458889999999999999999998 899999999999999999999999999998
Q ss_pred ccccccccc-ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 760 QAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 760 ~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.. ....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~ 230 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS----ILEKGERL 230 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHhCCCCC
Confidence 754332211 112224678999999999999999999999999999998 99999743221 1111 11111110
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
.. +......+.+++.+||+.+|++||++.++++.+..+....
T Consensus 231 --~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 --PQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred --CC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 00 1112236789999999999999999999999998776433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=344.60 Aligned_cols=262 Identities=22% Similarity=0.278 Sum_probs=209.2
Q ss_pred HHHHhhccccCccCcEEEEEEEECCC-cEEEEEEccCccchhhhhHHHHHHHHHhcC-CCCCcceeEEE-ec------CC
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKDG-KEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYC-EE------EH 678 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~g-~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~-~~------~~ 678 (931)
....++.++|.+|||+.||+|+...+ ..+|+|++-.......+.+.+|+++|++|+ |+|||.+++.. .. .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34455678999999999999998766 999999987666677889999999999997 99999999932 11 23
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
+.+|.||||+||.|-+++..... ..|++.++++|+.|+++|+++||. +..+|||||||.+||||+++++.||||||.+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 67899999999999999886543 449999999999999999999997 5678999999999999999999999999988
Q ss_pred ccccccccc--------cccccccCCCccCCCcc---CCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHH
Q 002358 759 RQAEEDLTH--------ISSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA 827 (931)
Q Consensus 759 ~~~~~~~~~--------~~~~~~gt~~y~APE~l---~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~ 827 (931)
......... ..-....|+.|+|||.+ .+...++|+|||+|||+||-|+....||+....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 753222110 01122368999999986 677889999999999999999999999973211
Q ss_pred HHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 002358 828 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 890 (931)
Q Consensus 828 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 890 (931)
..|++-...---.+.....+.+||+.||+.+|.+||++.+|++.+.++......
T Consensus 264 ---------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 264 ---------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred ---------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 122222111001134566899999999999999999999999999888765543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=324.60 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=202.2
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+++.+.||+|+||.||+|+-+ .|+.+|+|++++.. ..+.+....|-.+|....+|.||+++..|++.+.+||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 445689999999999999876 58999999998754 34567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc---
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--- 763 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~--- 763 (931)
++||++..+|. ....+++..+...+.+.+-|+.-||+ .|+|||||||+|+|||..|++||+||||+.-+..
T Consensus 223 lPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 223 LPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred cCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999998 46789999999999999999999998 9999999999999999999999999999853211
Q ss_pred --------------------cccc---cc--------------------cccccCCCccCCCccCCCCCCccchhHHHHH
Q 002358 764 --------------------DLTH---IS--------------------SVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 800 (931)
Q Consensus 764 --------------------~~~~---~~--------------------~~~~gt~~y~APE~l~~~~~s~ksDVwSlGv 800 (931)
+... .. ....|||.|||||++.+..|+..+|.||+||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0000 00 0124999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCccCcc-chhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHH
Q 002358 801 VLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQE 876 (931)
Q Consensus 801 lL~eLltG~~Pf~~~~~~-~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~e 876 (931)
|+||||.|.+||..++.. ...+++.|-......... ....+..++|.+|+. ||++|-- ++|
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~--------------~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV--------------DLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC--------------cccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 999999999999866654 334666665433322111 011356789999999 9999985 555
Q ss_pred HH
Q 002358 877 IV 878 (931)
Q Consensus 877 vl 878 (931)
|.
T Consensus 442 IK 443 (550)
T KOG0605|consen 442 IK 443 (550)
T ss_pred Hh
Confidence 54
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=314.36 Aligned_cols=248 Identities=28% Similarity=0.460 Sum_probs=196.9
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
+.||+|+||.||+|.++ +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999876 68999999876543 23456799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc-ccc
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 771 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~~ 771 (931)
.+++... ...+++..++.++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++.......... ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998642 3468899999999999999999997 899999999999999999999999999987643321111 111
Q ss_pred cccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002358 772 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 850 (931)
Q Consensus 772 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 850 (931)
...+..|+|||.+.+..++.++||||||+++|||++ |..||...... .. ...+...... ..+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~----~~~~~~~~~~---------~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QT----REAIEQGVRL---------PCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HH----HHHHHcCCCC---------CCcc
Confidence 123457999999999899999999999999999998 88888632211 11 1111111000 1111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 851 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 851 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
.....+.+++.+|++.+|++||++.||.++|++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=328.33 Aligned_cols=247 Identities=22% Similarity=0.350 Sum_probs=196.6
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|+++ +++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999876 68899999997532 23345688899999998 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TT 153 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-cc
Confidence 999988863 4578999999999999999999998 8999999999999999999999999999875322111 12
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccc--hhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--ELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~--~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
....||+.|+|||++.+..++.++|||||||++|||++|+.||+...... .....++..+.+..+... +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~--- 224 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I--- 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C---
Confidence 33468999999999999999999999999999999999999997432221 112223333333322211 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC------HHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPK------MQEIV 878 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs------~~evl 878 (931)
+......+.+++.+||+.+|++||+ +++++
T Consensus 225 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 225 -PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 1112236789999999999999997 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.19 Aligned_cols=247 Identities=29% Similarity=0.464 Sum_probs=199.5
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCHH
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 693 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 693 (931)
+.||+|+||.||+|...+++.+|+|.++..... ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 469999999999999888999999998765432 3456889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccccccc
Q 002358 694 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 773 (931)
Q Consensus 694 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 773 (931)
+++... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 988643 3457899999999999999999997 89999999999999999999999999998764333222222223
Q ss_pred cCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002358 774 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 852 (931)
Q Consensus 774 gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 852 (931)
++..|+|||++.+..++.++||||||+++||+++ |..||...... .... .+..+... ..+...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~----~~~~~~~~---------~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QARE----QVEKGYRM---------SCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHHcCCCC---------CCCCCC
Confidence 4678999999998899999999999999999998 99999633221 1111 11111110 111123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 853 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 853 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
...+.+++.+|+..+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 347889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.38 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=205.8
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc---cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.+++.+.||+|+||.||+|+.+ +++.||||.++.. .....+.+.+|+++++.++||||+++++++...+..++|+|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 3566789999999999999876 6899999987542 22334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 686 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
|+++|+|.+++.... ....++...+..++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 999999998875432 23457888999999999999999998 89999999999999999999999999998865433
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
... .....|++.|+|||.+.+..++.++|+||||+++|||++|+.||...... ...+.+. +..... +..
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~----~~~~~~-----~~~ 228 (267)
T cd08228 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQK----IEQCDY-----PPL 228 (267)
T ss_pred hHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHH----HhcCCC-----CCC
Confidence 221 12234788999999998888999999999999999999999998633221 1122221 111111 111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
........+.+++.+||+.+|++||++.|+++.++++.
T Consensus 229 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 ---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11122346889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=301.45 Aligned_cols=235 Identities=26% Similarity=0.368 Sum_probs=196.8
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.+++.+.||.|+||.|.+++.+ .|..+|+|++.+... .+.+....|..+|+.+.||.++++.+.+.+....+||||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 3456789999999999999987 578899999976533 244567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|++||.|.++|+ +.+++++....-++.||+.||+|||+ .+|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 125 yv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 125 YVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred ccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999998 45779999999999999999999998 99999999999999999999999999999976543
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.-+.+|||.|+|||++....|..++|-|||||++|||+.|..||..... ..+ -+.+-++++
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~i----Y~KI~~~~v--------- 258 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQI----YEKILEGKV--------- 258 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHH----HHHHHhCcc---------
Confidence 3456899999999999999999999999999999999999999974332 111 112222222
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCC
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSR 871 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~R 871 (931)
.++......+.+|+.+.++.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1122222256788889999998888
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=329.68 Aligned_cols=262 Identities=28% Similarity=0.475 Sum_probs=204.9
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhc-CCCCCcceeEEEec-C
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEE-E 677 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~ 677 (931)
....+++.+.||+|+||.||+|.+. .++.||+|+++.... ...+.+.+|+++++++ +|+||++++++|.. +
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3456888999999999999999643 247899999875432 3346788999999999 79999999998864 4
Q ss_pred CeEEEEEEecCCCCHHHHhccCCC--------------------------------------------------------
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSVN-------------------------------------------------------- 701 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 701 (931)
...++++||+++|+|.+.+.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999998864221
Q ss_pred --CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc-ccccccCCCc
Q 002358 702 --QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGY 778 (931)
Q Consensus 702 --~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y 778 (931)
...+++..+.+++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++......... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 1367899999999999999999998 899999999999999999999999999998754332221 2223456789
Q ss_pred cCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHH
Q 002358 779 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIA 857 (931)
Q Consensus 779 ~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~ 857 (931)
+|||++.+..++.++|||||||++|||++ |..||......+ .+. ..+..+.... .+......+.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~~~~---------~~~~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----RRLKEGTRMR---------APEYATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----HHHhccCCCC---------CCccCCHHHH
Confidence 99999999999999999999999999998 999996422211 111 1122211110 0112234688
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 858 EVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 858 ~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
+++.+||+.+|++||++.||++.|+++..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=321.00 Aligned_cols=256 Identities=27% Similarity=0.477 Sum_probs=202.3
Q ss_pred HHHhhccccCccCcEEEEEEEE-----CCCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
..+++.+.||+|+||.||+|.+ .+++.|++|.+.... ....+.+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4566789999999999999985 246789999987533 3344678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC--------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC
Q 002358 683 VYEYMHNGTLRDRLHGSV--------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 748 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~--------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~ 748 (931)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999885321 12347888999999999999999998 8999999999999999999
Q ss_pred ceEEecccccccccccc-cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHH
Q 002358 749 RAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 826 (931)
Q Consensus 749 ~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~ 826 (931)
.+||+|||+++...... ........++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH-
Confidence 99999999998653322 112222335678999999988889999999999999999998 9889863221 12222
Q ss_pred HHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 827 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 827 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
.+....... . +......+.+++.+|++.+|++||++.+|++.|..
T Consensus 238 ---~~~~~~~~~-----~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 ---MVRKRQLLP-----C----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHcCCcCC-----C----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 222221111 1 11122467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=320.15 Aligned_cols=258 Identities=25% Similarity=0.434 Sum_probs=202.9
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 679 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 679 (931)
....+++.+.||+|+||.||+|.++ .+..||+|++..... ....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3456778899999999999999764 256799999865332 344678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCC-------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEE
Q 002358 680 RILVYEYMHNGTLRDRLHGSVN-------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 752 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL 752 (931)
.++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+ .+++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999864321 2346788899999999999999998 89999999999999999999999
Q ss_pred ecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHh
Q 002358 753 SDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 830 (931)
Q Consensus 753 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 830 (931)
+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~----~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR----F 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----H
Confidence 999998765332221 1122345778999999998899999999999999999999 78888633221 1111 1
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 831 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 831 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
+..+..... +......+.+++.+|++.+|++||++.|+++.|++
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111211111 11223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=321.76 Aligned_cols=261 Identities=29% Similarity=0.441 Sum_probs=201.2
Q ss_pred HHhhccccCccCcEEEEEEEEC-----CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEec--CCeEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL 682 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~~l 682 (931)
.+++.+.||+|+||.||++..+ +++.||+|.++.......+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4567889999999999999753 578999999887666666789999999999999999999998754 346789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
|+||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 99999999999998742 3458999999999999999999998 899999999999999999999999999998754
Q ss_pred ccccc--cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccch---------hhHHHHHHHhh
Q 002358 763 EDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE---------LNIVHWARSMI 831 (931)
Q Consensus 763 ~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~---------~~l~~~~~~~~ 831 (931)
..... ......++..|+|||.+.+..++.++||||||+++|||++|..|+........ ........+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 33221 11112234569999999988999999999999999999998877642211100 00001111111
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 832 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 832 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
..+.. ...+......+.+++.+||+.+|++|||++||++.|+.+
T Consensus 240 ~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11100 001112234688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=311.27 Aligned_cols=248 Identities=24% Similarity=0.373 Sum_probs=210.1
Q ss_pred HHHHHhhccccCccCcEEEEEEEE-CCCcEEEEEEccCccch---hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
....|++.+.||+|.||.|-+|.. +.|+.||||.++++... +.-.+.+|++||..|+||||+.++..|+..+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 457888999999999999999975 68999999999876543 33468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||||..+|.|++++. ..+.+++.....++.||..|+.|+|+ .+++|||||.+|||+|+++++||+|||++-.+.
T Consensus 131 vMEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999998 46789999999999999999999997 999999999999999999999999999998765
Q ss_pred ccccccccccccCCCccCCCccCCCCC-CccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 763 EDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
+.. .-++.+|++-|.+||++.+..| ++..|-||+||+||-|+.|..||++.+.. .++ +.+..|...+-
T Consensus 205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lv----rQIs~GaYrEP-- 273 (668)
T KOG0611|consen 205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLV----RQISRGAYREP-- 273 (668)
T ss_pred ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHH----HHhhcccccCC--
Confidence 432 3456789999999999999888 47899999999999999999999855432 222 23333433221
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
+.+....-||+.||..+|++|-|+++|...
T Consensus 274 ---------~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 ---------ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ---------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 222244578899999999999999999754
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=326.89 Aligned_cols=241 Identities=26% Similarity=0.370 Sum_probs=193.9
Q ss_pred cccCccCcEEEEEEEEC----CCcEEEEEEccCcc----chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 615 KKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+.||+|+||.||+++.. .++.||+|+++... ......+.+|+++++.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999753 57899999987532 12335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+.+.. .+.+.+..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999873 4567888888999999999999998 8999999999999999999999999999875432221
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+.. ....... .+.. .+
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~-~~~~------~~-- 219 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKIL-KGKL------NL-- 219 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHH-cCCC------CC--
Confidence 122346899999999999888999999999999999999999999743321 1111111 1111 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
+......+.+++.+||+.+|++|| +++++++
T Consensus 220 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 --PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111223678999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=315.09 Aligned_cols=267 Identities=25% Similarity=0.378 Sum_probs=204.8
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhc--CCCCCcceeEEEecC----CeEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEE----HQRIL 682 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~g~~~~~----~~~~l 682 (931)
.+..+.+.||+|.||.||+|.|+ |+.||||++.. .+.+.+.+|.++++.+ +|+||+.+++.-..+ .+++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 34456789999999999999999 99999999973 3456789999999875 999999999875433 36789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhh-----cCCCCeEecCCCCCCccccCCCceEEecccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-----GCNPGIIHRDVKSSNILLDINMRAKVSDFGL 757 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-----~~~~~ivH~DIkp~NILld~~~~vkL~DFGl 757 (931)
|++|.+.|||.|+|. ...++....++++..+|.||+|||. +.++.|.|||||++|||+..++.+.|+|+||
T Consensus 287 vTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999997 4679999999999999999999995 3468899999999999999999999999999
Q ss_pred cccccccc---cccccccccCCCccCCCccCCCC----C--CccchhHHHHHHHHHHHhC----------CCCCCccCcc
Q 002358 758 SRQAEEDL---THISSVARGTVGYLDPEYYGNQQ----L--TEKSDVYSFGVVLLELISG----------KKPVSVEDFG 818 (931)
Q Consensus 758 a~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~----~--s~ksDVwSlGvlL~eLltG----------~~Pf~~~~~~ 818 (931)
|....+.. ........||.+|||||++...- + -..+||||||+++||++-. +.||..- .+
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~-Vp 441 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV-VP 441 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC-CC
Confidence 98765432 22345567999999999985531 1 1378999999999999763 4666421 11
Q ss_pred chhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 819 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 819 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
.++.. +-+++.+--.++...++.+ ....+.+..+.++++.||..+|..|-|+-.|.+.|.++...+
T Consensus 442 ~DPs~-eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 442 SDPSF-EEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD 507 (513)
T ss_pred CCCCH-HHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence 11111 1122222111111111111 224577888999999999999999999999999998887543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=321.45 Aligned_cols=262 Identities=23% Similarity=0.283 Sum_probs=195.7
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
..|++.+.||+|+||.||+|+.+ +++.||+|++..... .....+.+|+.+++.++||||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 34667899999999999999987 689999999865432 2234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+. ++|.+.+.. ....++...+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 85 VH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 95 678877764 24568888999999999999999998 899999999999999999999999999987543221
Q ss_pred ccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcC---Ceee----
Q 002358 767 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVIS---- 838 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~---~~~~---- 838 (931)
.......|++.|+|||++.+ ..++.++||||+||++|||++|+.||..... .....+.+....... ....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchhhc
Confidence 11223457899999998865 4678899999999999999999999974321 111111111111000 0000
Q ss_pred -cccc-cccCCCCH---------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 839 -IVDP-VLIGNVKI---------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 839 -i~d~-~l~~~~~~---------~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..++ ......+. .....+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 00000000 01135679999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=318.11 Aligned_cols=250 Identities=30% Similarity=0.421 Sum_probs=194.5
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch--------------hhhhHHHHHHHHHhcCCCCCcceeEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--------------RTQQFVTEVALLSRIHHRNLVPLIGY 673 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--------------~~~~~~~E~~il~~l~HpnIv~l~g~ 673 (931)
..|++.+.||+|.||.|-+|+.. +++.||||++.+.... ..+...+|+.+|++++|||||+++.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 45677899999999999999865 7999999998653211 12478899999999999999999999
Q ss_pred Eec--CCeEEEEEEecCCCCHHHHhccCCCCCC-CCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCce
Q 002358 674 CEE--EHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 750 (931)
Q Consensus 674 ~~~--~~~~~lV~E~~~~gsL~~~L~~~~~~~~-l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~v 750 (931)
..+ .+..|||+|||..|.+...- ..+. ++..+.++++.++..||.|||. ++||||||||+|+||+++|++
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcE
Confidence 876 46789999999999876543 2334 8999999999999999999998 999999999999999999999
Q ss_pred EEeccccccccccc-----ccccccccccCCCccCCCccCCCC----CCccchhHHHHHHHHHHHhCCCCCCccCccchh
Q 002358 751 KVSDFGLSRQAEED-----LTHISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 821 (931)
Q Consensus 751 kL~DFGla~~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~----~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~ 821 (931)
||+|||.+...... ..... ...|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-.+. ..
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~-~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~---~~ 325 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLS-RTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF---EL 325 (576)
T ss_pred EeeccceeeecccCCccccHHHHh-hcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch---HH
Confidence 99999998865221 12222 256999999999986632 3568899999999999999999996221 11
Q ss_pred hHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002358 822 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 881 (931)
Q Consensus 822 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 881 (931)
.+. ..+.+ ..+.--..++.-..+.+|+.++|++||++|.+..+|....
T Consensus 326 ~l~----~KIvn--------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 ELF----DKIVN--------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHH----HHHhc--------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 111 11211 1111111113445788999999999999999999987543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=331.38 Aligned_cols=248 Identities=24% Similarity=0.293 Sum_probs=200.3
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECC--CcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~--g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
+....+++.+.||+|+||.||+|.++. +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 344567788999999999999998653 3689999986432 23345788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 107 ~lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 999999999999999874 4568899999999999999999998 8999999999999999999999999999976
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ... +.+..+..
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~----~~i~~~~~---- 245 (340)
T PTZ00426 181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIY----QKILEGII---- 245 (340)
T ss_pred cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHH----HHHhcCCC----
Confidence 5432 12346899999999999888999999999999999999999999743221 111 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 880 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 880 (931)
..+......+.+++.+|++.+|++|+ +++|+++.
T Consensus 246 ------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01111223577999999999999995 88888653
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=329.45 Aligned_cols=243 Identities=24% Similarity=0.355 Sum_probs=195.0
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
+.||+|+||.||++..+ +|+.||+|+++... ......+.+|+++++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccc
Q 002358 691 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 770 (931)
Q Consensus 691 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 770 (931)
+|.+.+.. ...+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~ 154 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MK 154 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-cc
Confidence 99998863 4568999999999999999999996 369999999999999999999999999998753322211 22
Q ss_pred ccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002358 771 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 850 (931)
Q Consensus 771 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 850 (931)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ..+ .+..+.. .+ +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~----~i~~~~~------~~----p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE----LILMEEI------RF----PR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHH----HHhcCCC------CC----CC
Confidence 3458999999999999999999999999999999999999997433211 111 1111111 11 11
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002358 851 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 880 (931)
Q Consensus 851 ~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 880 (931)
.....+.+++.+||+.||++|+ +++++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1223678999999999999996 89988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=344.77 Aligned_cols=250 Identities=20% Similarity=0.326 Sum_probs=201.7
Q ss_pred HhhccccCccCcEEEEEEEEC-C-CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~-g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 667899999999999999765 3 67888888755544555678889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc-
Q 002358 689 NGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT- 766 (931)
Q Consensus 689 ~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~- 766 (931)
+|+|.+.+.... ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999998876432 34568899999999999999999998 8999999999999999999999999999987543322
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+ ... .+.... .
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~---~~~-~~~~~~-----~-- 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQ---QVL-YGKYDP-----F-- 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHH-hCCCCC-----C--
Confidence 1233456899999999999999999999999999999999999999743221 1111 111 111110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.+|++||+++++++
T Consensus 292 --~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 --PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112236889999999999999999999864
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.47 Aligned_cols=257 Identities=24% Similarity=0.419 Sum_probs=203.0
Q ss_pred HHHHhhccccCccCcEEEEEEEECC------CcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
...+++.+.||+|+||.||+|.+.+ ++.||+|+++..... ..+.+.+|+.++.+++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 3457778999999999999998642 578999999755433 346688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC
Q 002358 681 ILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 747 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~ 747 (931)
++++||+.+++|.+++.... ....+++..+..++.|++.||+|||+ .+++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence 99999999999999985311 12357888899999999999999998 899999999999999999
Q ss_pred CceEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHH
Q 002358 748 MRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 825 (931)
Q Consensus 748 ~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~ 825 (931)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ..+.+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~ 237 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIE 237 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence 9999999999886533221 11222335778999999988889999999999999999998 8888863221 11222
Q ss_pred HHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 826 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 826 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
.+..+.... .+...+..+.+++.+||+.+|++||+++||++.|+.
T Consensus 238 ----~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 ----MIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----HHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 122222111 112233468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=320.93 Aligned_cols=260 Identities=21% Similarity=0.272 Sum_probs=193.1
Q ss_pred HHhhccccCccCcEEEEEEEEC--CCcEEEEEEccCccc--hhhhhHHHHHHHHHhc---CCCCCcceeEEEe-----cC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----EE 677 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~g~~~-----~~ 677 (931)
.|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+++++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 3567889999999999999874 468899998865322 2234566788877766 6999999999885 24
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccc
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 757 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGl 757 (931)
...++||||+. ++|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 56889999996 6899888643 23458899999999999999999998 8999999999999999999999999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh---cC
Q 002358 758 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---KG 834 (931)
Q Consensus 758 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~---~~ 834 (931)
++..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+..... ..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~ 231 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE 231 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChh
Confidence 9765432 22233458999999999988899999999999999999999999997433221 1111111110 00
Q ss_pred Cee-------ecccccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 835 DVI-------SIVDPVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 835 ~~~-------~i~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+.. ....+.... .........+.+++.+|++.+|++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 000000000 000112235779999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=330.41 Aligned_cols=262 Identities=22% Similarity=0.303 Sum_probs=193.7
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecC-----CeEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 682 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-----~~~~l 682 (931)
|++.++||+|+||.||+|..+ +++.||||++.... .....++.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 556789999999999999876 68999999986432 23345788999999999999999999987543 34799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||||+. ++|.+.+.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 82 v~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 82 VFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999995 689988863 4568999999999999999999998 899999999999999999999999999997643
Q ss_pred cccc--ccccccccCCCccCCCccCC--CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHH--------HHh
Q 002358 763 EDLT--HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA--------RSM 830 (931)
Q Consensus 763 ~~~~--~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~--------~~~ 830 (931)
.... .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+... ...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 11223458999999999866 67899999999999999999999999744321111110000 000
Q ss_pred hhcCCeeecc---cccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 831 IKKGDVISIV---DPVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 831 ~~~~~~~~i~---d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+ .+.... ...+.....+.+++.+||+.+|++||+++|+++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000000 000000 000011235789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=326.54 Aligned_cols=243 Identities=23% Similarity=0.357 Sum_probs=192.7
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|..+ +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999987532 23345678899988877 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 999988863 4568999999999999999999998 8999999999999999999999999999875322211 12
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCcc--chhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--AELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~--~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......++.+.+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence 2346899999999999999999999999999999999999999632211 111222333333322221 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKM 874 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~ 874 (931)
.+......+.+++.+||+.||++||+.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111223367899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.85 Aligned_cols=254 Identities=27% Similarity=0.436 Sum_probs=202.4
Q ss_pred HHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
...+++.+.||+|++|.||+|.++++..+|+|.+.... ...+.+.+|++++++++|+|++++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 34577788999999999999998877889999886542 234678899999999999999999998754 5678999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++|+|.++++.. ....+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999999753 23457899999999999999999998 89999999999999999999999999999765432222
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
......++..|+|||...+..++.++||||||+++|||++ |+.||...... ...++.. .+...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~~~~--------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVE----RGYRM--------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----cCCCC---------
Confidence 2222235678999999988899999999999999999999 89998633211 1122211 11000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
..+...+..+.+++.+||..+|++||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111233568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=332.10 Aligned_cols=258 Identities=18% Similarity=0.189 Sum_probs=195.6
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
..|.+.+.||+|+||.||++... .++.||+|... .+.+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 45777899999999999999875 68899999753 245788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
. ++|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 5 788888863 3568899999999999999999998 89999999999999999999999999999754332222
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccc----hhhHHHHHHHhhhcC--C------
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA----ELNIVHWARSMIKKG--D------ 835 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~----~~~l~~~~~~~~~~~--~------ 835 (931)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .......+....... .
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 2334569999999999999999999999999999999999998875322110 001111111000000 0
Q ss_pred --eeecc---------cccccCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 836 --VISIV---------DPVLIGNV--KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 836 --~~~i~---------d~~l~~~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..... .+...... .......+.+++.+||+.||++|||++|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00000000 0123447889999999999999999999874
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=327.11 Aligned_cols=250 Identities=24% Similarity=0.311 Sum_probs=196.5
Q ss_pred HhhccccCccCcEEEEEEEEC----CCcEEEEEEccCcc----chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~ 681 (931)
|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+++++.+ +|+||+++++++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 456789999999999999763 57899999986432 22345678899999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 82 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999873 4568899999999999999999998 89999999999999999999999999999865
Q ss_pred cccccccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
............||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......... .+...+...
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~~------ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILKC------ 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhcC------
Confidence 43333223345689999999998765 47889999999999999999999997433221111 111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
++.+.. .....+.+++.+||+.||++|| +++++++
T Consensus 227 ~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 DPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111111 1223578999999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.20 Aligned_cols=257 Identities=28% Similarity=0.473 Sum_probs=207.1
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
+....+.+.++||+|+||.||+|..++++.||||.+.... ...+++.+|+.++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3445677789999999999999998888999999987543 334678999999999999999999999999889999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999753 23468999999999999999999998 899999999999999999999999999988765432
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
........++..|+|||.+.+..++.++||||+|++++||++ |+.||..... ....+... .+.. .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~----~~~~-----~-- 223 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVE----RGYR-----M-- 223 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH----cCCC-----C--
Confidence 222222234678999999998889999999999999999999 9999963321 11111111 1100 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
..+...+..+.+++.+|++.+|++||+++|+++.|+.
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 --PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.69 Aligned_cols=259 Identities=22% Similarity=0.313 Sum_probs=206.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.+++.+.||+|+||.||+|..+ +++.+|||.+.... ....+++.+|+++++.++|+||+++++++...+..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 4567789999999999999865 78999999876422 2344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 686 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
|+++++|.+++.... ....+++..++.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999886422 34568899999999999999999998 89999999999999999999999999998765433
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
... .....|+..|+|||.+.+..++.++|+||||+++|||++|..||...... .....+ . +... ..+..
T Consensus 160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~---~-~~~~-----~~~~~ 228 (267)
T cd08229 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK---K-IEQC-----DYPPL 228 (267)
T ss_pred Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhh---h-hhcC-----CCCCC
Confidence 221 12335788999999998888999999999999999999999999633221 111111 1 1111 11111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
. .......+.+++.+||+.+|++||||.+|++.++++.
T Consensus 229 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 P---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1 1123346889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.76 Aligned_cols=245 Identities=28% Similarity=0.459 Sum_probs=195.6
Q ss_pred ccCccCcEEEEEEEEC---CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 616 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 616 ~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
.||+|+||.||+|.++ +++.+|+|+++.... ...+++.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999764 578999999865432 345678999999999999999999998864 5678999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc--
Q 002358 691 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-- 768 (931)
Q Consensus 691 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~-- 768 (931)
+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999873 3568899999999999999999998 899999999999999999999999999998754432211
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...... ...+ .+..+.... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~i~~~~~~~-----~--- 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQ----MIESGERME-----C--- 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHCCCCCC-----C---
Confidence 112234578999999988889999999999999999998 99999733221 1222 222222111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
+.....++.+++.+||+.+|++||++.+|++.|++
T Consensus 220 -~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 -PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11223467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=323.82 Aligned_cols=240 Identities=27% Similarity=0.391 Sum_probs=190.3
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|+.+ +++.||+|+++... ....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57899999987532 22344566677777654 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999998873 3568889999999999999999998 899999999999999999999999999997643222 222
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .... .+.... +. .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~----~i~~~~------~~----~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFD----SILNDR------PH----FP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHcCC------CC----CC
Confidence 3346899999999999989999999999999999999999999743321 1111 111110 11 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 878 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~-evl 878 (931)
......+.+++.+||+.+|++||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11223577999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=325.37 Aligned_cols=243 Identities=24% Similarity=0.342 Sum_probs=192.1
Q ss_pred hhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHH---HhcCCCCCcceeEEEecCCeEEEEE
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALL---SRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il---~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
++.+.||+|+||.||+|.++ +++.||||+++... ....+.+.+|.+++ +.++||||+++++++...+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45789999999999999876 68999999987532 22345566776665 4567999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++|+|...++. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 82 E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 82 EYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred cCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 99999999988763 468999999999999999999998 89999999999999999999999999998753222
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.. ......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+... ..+ . +..+.. .
T Consensus 155 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~~---~-i~~~~~------~- 219 (324)
T cd05589 155 GD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VFD---S-IVNDEV------R- 219 (324)
T ss_pred CC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHhCCC------C-
Confidence 21 2233568999999999999999999999999999999999999997433211 111 1 111111 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
.+......+.+++.+||+.+|++|| +++++++
T Consensus 220 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 ---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1111234678999999999999999 4566554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.81 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=205.7
Q ss_pred HhhccccCccCcEEEEEEEEC--CCc--EEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK--DGK--EVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~--~g~--~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
..+.|.||+|.||.|++|.|+ .|+ .||||.++..... ...+|++|+.+|.+|+|+|+++++|..-+ ....||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 346689999999999999997 344 6899999876544 66899999999999999999999999987 66789999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
.++.|+|.+.|++ .....+-...+..++.|||.||.||.+ +++|||||.++|+|+-....+||+||||.+.++...
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999997 356678888899999999999999998 999999999999999999999999999999865432
Q ss_pred --cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 766 --THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 766 --~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
........-...|+|||.+....++.++|||+|||++|||+| |..||.+..... +. +.+|.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q---IL-------------~~iD~ 330 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ---IL-------------KNIDA 330 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH---HH-------------Hhccc
Confidence 222233345678999999999999999999999999999999 889987433211 11 11221
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 881 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 881 (931)
.-.-..+..+.+.+.+++..||..+|++||++..|.+.+
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 111123456677899999999999999999999997443
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=320.44 Aligned_cols=266 Identities=24% Similarity=0.453 Sum_probs=210.2
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEEC--------CCcEEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEE
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 674 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~ 674 (931)
++....+.+.+.||+|+||.||+|++. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 455667778899999999999999742 34579999987543 34457799999999999 899999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCC
Q 002358 675 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 741 (931)
Q Consensus 675 ~~~~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~N 741 (931)
......++||||+++|+|.+++.... ....+++..++.++.|+++||+|||+ .+++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccce
Confidence 99999999999999999999987532 12357888999999999999999998 899999999999
Q ss_pred ccccCCCceEEeccccccccccccccc-ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccc
Q 002358 742 ILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 819 (931)
Q Consensus 742 ILld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~ 819 (931)
|++++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~- 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 246 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence 999999999999999998764332221 222335678999999998889999999999999999998 78888633221
Q ss_pred hhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 820 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 820 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
.+. +.+..+.... .+......+.+++.+||+.+|++||++.|+++.|+++.....
T Consensus 247 --~~~----~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 247 --ELF----KLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred --HHH----HHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 111 1122211110 111233468899999999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=320.71 Aligned_cols=261 Identities=26% Similarity=0.451 Sum_probs=206.9
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECC------CcEEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEEecC
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 677 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~ 677 (931)
+....+++.+.||+|+||.||++.+.+ ...+|+|.+.... .....++.+|+++++++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 344556678899999999999998752 3689999987543 33446788999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccC-------------CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc
Q 002358 678 HQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 744 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl 744 (931)
...+++|||+++|+|.++++.. .....+++..+++++.|++.||+|||+ .+|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence 9999999999999999998642 124568899999999999999999998 899999999999999
Q ss_pred cCCCceEEecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhh
Q 002358 745 DINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 822 (931)
Q Consensus 745 d~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~ 822 (931)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence 99999999999999875433221 1122235678999999998899999999999999999998 999986332211
Q ss_pred HHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 823 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 823 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
.. +.+..+... ..+......+.+++.+|++.+|++|||++|+++.|++++
T Consensus 243 ~~----~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LF----KLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH----HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 111111110 111222346889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=333.15 Aligned_cols=263 Identities=26% Similarity=0.434 Sum_probs=206.2
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcC-CCCCcceeEEEec
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEE 676 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~ 676 (931)
++....+.+.+.||+|+||.||+|+++ .++.||+|+++.... ...+.+.+|+++|+++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 445556667899999999999999864 246899999976433 33457889999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCC--------------------------------------------------------
Q 002358 677 EHQRILVYEYMHNGTLRDRLHGSV-------------------------------------------------------- 700 (931)
Q Consensus 677 ~~~~~lV~E~~~~gsL~~~L~~~~-------------------------------------------------------- 700 (931)
....++||||+++|+|.+++++..
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999986531
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCC
Q 002358 701 ---------------------------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 741 (931)
Q Consensus 701 ---------------------------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~N 741 (931)
....+++..+++++.|++.||+|||+ .+++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence 11246778889999999999999997 899999999999
Q ss_pred ccccCCCceEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccc
Q 002358 742 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 819 (931)
Q Consensus 742 ILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~ 819 (931)
||+++++.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |..||......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986533221 11122346788999999998889999999999999999998 889986332211
Q ss_pred hhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 820 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 820 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
. ....+..+... ..+......+.+++.+||..+|++||+++||++.|++++
T Consensus 350 ~------~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 Q------FYNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H------HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 11111111110 011112347889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=324.79 Aligned_cols=242 Identities=24% Similarity=0.366 Sum_probs=193.7
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|+.+ +++.||+|+++... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999886 57899999987532 23345677899998876 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|...+.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 999988873 4568899999999999999999998 8999999999999999999999999999875432222 12
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+. +..+.. . .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~~----i~~~~~---~-------~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFES----ILHDDV---L-------YP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHHH----HHcCCC---C-------CC
Confidence 3345899999999999999999999999999999999999999743321 11111 111111 0 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRP-------KMQEIVLA 880 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RP-------s~~evl~~ 880 (931)
......+.+++.+||+.+|++|| +++++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11123678999999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=322.14 Aligned_cols=264 Identities=30% Similarity=0.503 Sum_probs=205.7
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEEC-CCc--EEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCe
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 679 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~--~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~ 679 (931)
.+....+++.+.||+|+||.||+|.++ ++. .+++|.++... ....+.+.+|++++.++ +||||+++++++..++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 445566778899999999999999876 344 45777776432 33456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC
Q 002358 680 RILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 746 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~ 746 (931)
.++||||+++|+|.++++... ....+++..++.++.|++.||+|||+ .+++||||||+|||+++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecC
Confidence 999999999999999987432 12357899999999999999999998 89999999999999999
Q ss_pred CCceEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHH
Q 002358 747 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 825 (931)
Q Consensus 747 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~ 825 (931)
++.+||+|||++....... ......++..|+|||.+....++.++|||||||++|||+| |..||...+..+ ..+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~ 234 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE 234 (303)
T ss_pred CCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHH
Confidence 9999999999986432111 1111224567999999988889999999999999999998 999996332211 111
Q ss_pred HHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 826 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 826 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
.+..+... ..+......+.+++.+|++.+|++||+++++++.|+++...+.
T Consensus 235 ----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 235 ----KLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ----HHhcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 11111000 0111122367899999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=315.83 Aligned_cols=264 Identities=23% Similarity=0.383 Sum_probs=201.7
Q ss_pred HHHHHhhccccCccCcEEEEEEEECC---------------CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcce
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKD---------------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPL 670 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~---------------g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l 670 (931)
....+++.+.||+|+||.||++...+ ...||+|+++.... .....|.+|++++++++|+|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34567788999999999999987642 23589999876433 344679999999999999999999
Q ss_pred eEEEecCCeEEEEEEecCCCCHHHHhccCC---------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCC
Q 002358 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSV---------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 741 (931)
Q Consensus 671 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~---------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~N 741 (931)
++++......++||||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence 999999999999999999999999886431 11246888999999999999999998 899999999999
Q ss_pred ccccCCCceEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh--CCCCCCccCcc
Q 002358 742 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 818 (931)
Q Consensus 742 ILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt--G~~Pf~~~~~~ 818 (931)
|++++++.+||+|||++........ .......++..|+|||.+....++.++|||||||+++||++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999876433221 11122335678999999988889999999999999999998 56677532221
Q ss_pred chhhHHHHHHHhhhcC-CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 819 AELNIVHWARSMIKKG-DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 819 ~~~~l~~~~~~~~~~~-~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
.......+..... ...... .+...+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 ---QVIENTGEFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHHhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1222111111111 100000 111123478999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=314.03 Aligned_cols=261 Identities=26% Similarity=0.439 Sum_probs=208.0
Q ss_pred HHHHHhhccccCccCcEEEEEEEECC-----CcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEec-CCe
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQ 679 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 679 (931)
....+.+.+.||+|+||.||+|.+.+ ++.|++|++.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34566778999999999999999876 7889999987543 3345678899999999999999999998766 467
Q ss_pred EEEEEEecCCCCHHHHhccCCCC-----CCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEec
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 754 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~-----~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~D 754 (931)
.++++||+++|+|.+++...... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998754322 568999999999999999999997 8999999999999999999999999
Q ss_pred ccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhh
Q 002358 755 FGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 832 (931)
Q Consensus 755 FGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 832 (931)
||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.||...+. ..+..++..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~--- 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKD--- 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHc---
Confidence 9999865332221 1222345678999999988889999999999999999999 9999973322 222222221
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 833 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 833 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
+.. . .. ....+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 235 -~~~--~---~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 -GYR--L---AQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -CCC--C---CC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 110 0 00 11123467899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.82 Aligned_cols=253 Identities=26% Similarity=0.443 Sum_probs=198.0
Q ss_pred hccccCccCcEEEEEEEECCC-c--EEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecC------CeEE
Q 002358 613 FCKKIGKGSFGSVYYGKMKDG-K--EVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRI 681 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~~g-~--~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~~~ 681 (931)
+.+.||+|+||.||+|.+.+. + .+|+|.++... ....+.+.+|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 568899999999999998643 2 68999886542 34457789999999999999999999987432 2468
Q ss_pred EEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
+++||+++|+|.+++.... ....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999998874321 23458899999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 759 RQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 759 ~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
+........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.+ .+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYD----YLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHHcCCC
Confidence 875433221 1122345778999999999999999999999999999999 8889863221 11211 2222221
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
.. .+......+.+++.+||+.+|++||++.||++.|+++
T Consensus 233 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 0112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=324.41 Aligned_cols=236 Identities=25% Similarity=0.385 Sum_probs=190.4
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999886 58899999987532 23445677888888877 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT 153 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence 999998873 4568899999999999999999998 8999999999999999999999999999875322211 12
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ...+ .+..+.. . . +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~----~i~~~~~---~---~----~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFE----AILNDEV---V---Y----P 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHH----HHhcCCC---C---C----C
Confidence 3346899999999999999999999999999999999999999743321 1111 1111111 0 0 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKM 874 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~ 874 (931)
......+.+++.+||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1122367899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.86 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=203.6
Q ss_pred HhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
+++.+.||+|+||.||+|... ....+++|.+..... ...+++.+|+.+++.++||||+++++.+..++..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 346789999999999999864 235789998875433 3456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCC---------------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCc
Q 002358 684 YEYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 742 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NI 742 (931)
+||+.+|+|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheE
Confidence 99999999999886421 12357889999999999999999998 8999999999999
Q ss_pred cccCCCceEEeccccccccccccccc-ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccch
Q 002358 743 LLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 820 (931)
Q Consensus 743 Lld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~ 820 (931)
|+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--- 235 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--- 235 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 99999999999999997653332211 222335678999999988889999999999999999999 9999863322
Q ss_pred hhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 821 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 821 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
..+.+... .+.. .. .+......+.+++.+|++.+|++||+++|+++.|+++..
T Consensus 236 ~~~~~~~~----~~~~-----~~----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLLK----TGYR-----ME----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHh----CCCC-----CC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 12222221 1110 00 111223468899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.87 Aligned_cols=256 Identities=25% Similarity=0.437 Sum_probs=205.5
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
+....+++.+.||+|+||.||++.+.++..+|+|.++.. ....+.+.+|++++++++|+||+++++.+.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 344567788999999999999999888888999988754 2345678999999999999999999999887 77899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999998753 24567889999999999999999997 899999999999999999999999999987654332
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
........++..|+|||++....++.++|+|||||++|++++ |+.||...+. .....+. ..+....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~----~~~~~~~------ 223 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRAL----ERGYRMP------ 223 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----hCCCCCC------
Confidence 222222335678999999998889999999999999999999 8999963322 1122221 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
........+.+++.+|++.+|++||++.++.++|+.
T Consensus 224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=313.21 Aligned_cols=256 Identities=24% Similarity=0.389 Sum_probs=199.8
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCc----EEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
..+++.+.||+|+||.||+|.+. +++ .+++|.+..... ....++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 44566789999999999999875 344 478888754332 234678888889999999999999998864 45778
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999742 3568999999999999999999998 899999999999999999999999999998654
Q ss_pred cccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 763 EDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 763 ~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+ .+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVPD----LLEKGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCCCcCC--
Confidence 3221 11223446778999999998899999999999999999998 99999743221 1111 222222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
.+.. ....+.+++.+||..+|++||++.|+++.|+.+..
T Consensus 232 ~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111 12356789999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=324.76 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=209.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe-EEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ-RILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~-~~lV~E 685 (931)
.|...+++|+|+||.+++.+++ +++.+++|.+.-.. ....+....|+.++++++|||||.+.+.+.+++. .++||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 4667899999999999999887 67899999875432 2334578899999999999999999999999888 899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
||+||++.+.+.... +.-+++.++.+|+.|++.|+.|||+ .+|+|||||+.||+++.++.|||+|||+|+......
T Consensus 85 Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred ecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999998653 5678999999999999999999997 999999999999999999999999999999987665
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.. .....||+.||.||.+.+..|..|+|||||||++|||++-+.+|...+... ++.- +..+. +.| +
T Consensus 161 ~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~k----i~~~~----~~P-l- 226 (426)
T KOG0589|consen 161 SL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILK----INRGL----YSP-L- 226 (426)
T ss_pred hh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHH----Hhhcc----CCC-C-
Confidence 33 345669999999999999999999999999999999999999998555432 2211 11111 111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
+.....++..++..|++.+|+.||++.+++..
T Consensus 227 ---p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 ---PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 22333478899999999999999999999865
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=329.88 Aligned_cols=241 Identities=24% Similarity=0.368 Sum_probs=200.0
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV 683 (931)
...++.++||+|.||+|+++..+ +++.+|||++++.. .++.+..+.|.+++... +||.+++++..|+..+++++|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 34457899999999999999988 57899999998763 34567788899998888 499999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+.||++..+. ....+++.++.-++..|+.||.|||+ ++||+||||.+|||||.+|.+||+|||+++.---
T Consensus 448 mey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 448 MEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999999944333 34679999999999999999999998 9999999999999999999999999999986321
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
. ....++.+|||.|||||++.+..|+.+.|-|||||+|||||.|+.||.+++.++.. + .+.. |..
T Consensus 521 ~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F---d----sI~~-------d~~ 585 (694)
T KOG0694|consen 521 Q-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF---D----SIVN-------DEV 585 (694)
T ss_pred C-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---H----HHhc-------CCC
Confidence 1 22456778999999999999999999999999999999999999999855443221 1 1111 111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 874 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 874 (931)
-++.-...+.++++++.+..+|++|--+
T Consensus 586 ---~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 ---RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2344445577899999999999999866
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.81 Aligned_cols=249 Identities=30% Similarity=0.518 Sum_probs=204.2
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
..+++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 45667899999999999999876 89999999976543 56789999999999999999999999998899999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 99999998743 23368999999999999999999998 8999999999999999999999999999987633222
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
....+..|+|||.+....++.++||||||+++|||++ |..||...... .+.. .+..+....
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~~~--------- 219 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----HVEKGYRME--------- 219 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHhcCCCCC---------
Confidence 2234668999999988899999999999999999997 99998633221 1111 111111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
.+...+..+.+++.+||..+|++||+++|++++|++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=312.96 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=200.2
Q ss_pred hhccccCccCcEEEEEEEECC----CcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe------
Q 002358 612 NFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------ 679 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~------ 679 (931)
.+.+.||+|+||.||+|.+.. +..||+|+++... ......+.+|+++++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 457899999999999998752 3679999987542 2345679999999999999999999998866554
Q ss_pred EEEEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 756 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFG 756 (931)
.++++||+++|+|.+++.... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 789999999999999885432 23468899999999999999999998 899999999999999999999999999
Q ss_pred cccccccccccc-ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcC
Q 002358 757 LSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 834 (931)
Q Consensus 757 la~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 834 (931)
+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+.++. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~----~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYL----RHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcC
Confidence 998654332221 112234678999999988899999999999999999999 8888863221 1222222 111
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 835 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 835 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
.... .+......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 232 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 1122334788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=315.93 Aligned_cols=264 Identities=29% Similarity=0.445 Sum_probs=205.0
Q ss_pred HHHHhhccccCccCcEEEEEEEECC-----------------CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcc
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 669 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~-----------------g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~ 669 (931)
...+++.+.||+|+||.||+|...+ +..||+|++..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3456778999999999999997653 24689999876533 34568899999999999999999
Q ss_pred eeEEEecCCeEEEEEEecCCCCHHHHhccCC--------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCC
Q 002358 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 741 (931)
Q Consensus 670 l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~N 741 (931)
+++++..+...++++|++++++|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999987532 12368999999999999999999998 899999999999
Q ss_pred ccccCCCceEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh--CCCCCCccCcc
Q 002358 742 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 818 (931)
Q Consensus 742 ILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt--G~~Pf~~~~~~ 818 (931)
|+++.++.++|+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999876433221 12223346778999999988889999999999999999998 6777753221
Q ss_pred chhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 819 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 819 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
......+.............. .+...+.++.+++.+|++.+|++||++.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 122222222211111111111 111223478999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=317.85 Aligned_cols=265 Identities=25% Similarity=0.432 Sum_probs=208.4
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEEC--------CCcEEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEE
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 674 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~ 674 (931)
++....+.+.+.||+|+||.||++.+. ++..+|+|.++... .....++.+|+++++++ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 344567788999999999999999763 23579999997643 33456788999999999 799999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCC
Q 002358 675 EEEHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 741 (931)
Q Consensus 675 ~~~~~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~N 741 (931)
......++||||+++|+|.+++..... ...+++..+++++.|++.||+|||+ .+++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHh
Confidence 999999999999999999999975321 2358899999999999999999998 899999999999
Q ss_pred ccccCCCceEEeccccccccccccccc-ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccc
Q 002358 742 ILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 819 (931)
Q Consensus 742 ILld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~ 819 (931)
|+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~- 249 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 249 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-
Confidence 999999999999999987654321111 111224568999999998889999999999999999998 88888633221
Q ss_pred hhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 820 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 820 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
. +...+..+...+ .+......+.+++.+|+..+|++||++.||++.|+++....
T Consensus 250 --~----~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 --E----LFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred --H----HHHHHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1 111122221111 11122347789999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=321.41 Aligned_cols=240 Identities=25% Similarity=0.392 Sum_probs=191.1
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|+++ +++.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999986 47899999987542 22345567788888764 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 999999873 3568889999999999999999998 8999999999999999999999999999875322111 12
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. ...+.+ ..+. +.. +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i----~~~~------~~~----~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSI----RMDN------PCY----P 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHH----HhCC------CCC----C
Confidence 2345899999999999989999999999999999999999999743321 122111 1111 111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 878 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~-evl 878 (931)
......+.+++.+||+.+|++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 11223578999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=293.73 Aligned_cols=245 Identities=26% Similarity=0.401 Sum_probs=204.0
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
.++.+.||+|-||.||.|+.+ ++-.||+|++.+..- .-.+++.+|+++-..|+||||++++++|.+....||++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 456899999999999999876 567899999876432 2346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
..+|.|...|.+. ....+++.....+..|+|.||.|+|. ++|+||||||+|+|++..+.+||+|||-+.... .
T Consensus 104 a~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~ 176 (281)
T KOG0580|consen 104 APRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---S 176 (281)
T ss_pred cCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC---C
Confidence 9999999999854 34568888889999999999999998 999999999999999999999999999876533 3
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
..+.+.+||..|.+||...+..++.+.|+|++|++.||++.|.+||...... ...+.+++ .++.+|
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etYkrI~k-------~~~~~p---- 242 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETYKRIRK-------VDLKFP---- 242 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHHHHHHH-------ccccCC----
Confidence 4455678999999999999999999999999999999999999999744321 11221111 112222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
........+++.+|+..+|.+|.+..|+++
T Consensus 243 ---~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 243 ---STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ---cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 222336789999999999999999999875
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.50 Aligned_cols=256 Identities=26% Similarity=0.423 Sum_probs=202.8
Q ss_pred HHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
..+.+.++||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 34556789999999999999743 356899999877666666789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCC------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCce
Q 002358 683 VYEYMHNGTLRDRLHGSVN------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 750 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~v 750 (931)
+|||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999874321 1357899999999999999999998 899999999999999999999
Q ss_pred EEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHH
Q 002358 751 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 828 (931)
Q Consensus 751 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 828 (931)
||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ...+.
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~-- 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIEC-- 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHHH--
Confidence 9999999875432221 11222335678999999999999999999999999999998 89998632221 11111
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 829 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 829 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
+..+.... .+...+..+.+++.+||+.+|++||+++||++.|+.
T Consensus 237 --~~~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 --ITQGRELE---------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --HHcCccCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111111 011122367899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=307.74 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=207.6
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|++.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+|++++++.+...+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 3567789999999999999987 78999999886421 2335678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 686 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
|+++|+|.+++.... ....+++..++.++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 999999999886532 34558899999999999999999998 89999999999999999999999999998765432
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... +..+... .+..+......
T Consensus 160 ~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~~~~~~---- 229 (267)
T cd08224 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCK-KIEKCDYPPLP---- 229 (267)
T ss_pred Ccc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHh-hhhcCCCCCCC----
Confidence 221 1223578899999999988899999999999999999999999963321 1111111 11111111110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
.......+.+++.+||..+|++||++.+|+++|+++.
T Consensus 230 ----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1123346889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=323.20 Aligned_cols=243 Identities=22% Similarity=0.337 Sum_probs=193.3
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|..+ +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999997542 23345688899999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT 153 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence 999988863 4568999999999999999999998 8999999999999999999999999999875322111 12
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
....||+.|+|||++.+..++.++|||||||++|||++|+.||............++..+.+..... .+ +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~----p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RI----P 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CC----C
Confidence 3346899999999999999999999999999999999999999643322222222333333322211 01 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKM 874 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~ 874 (931)
......+.+++.+||+.||++|+++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1122357799999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.07 Aligned_cols=255 Identities=29% Similarity=0.497 Sum_probs=202.4
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CC---cEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g---~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
..++..+.||+|+||.||+|..+ ++ ..+|+|.++... ....+.+..|++++++++|+|++++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 34556789999999999999876 23 379999987543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998742 3568999999999999999999998 8999999999999999999999999999876543
Q ss_pred cccccc--cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 764 DLTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 764 ~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
...... .....+..|+|||++....++.++|||||||++|||++ |+.||..... ...... +..+...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~----i~~~~~~--- 229 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKA----INDGFRL--- 229 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHH----HhcCCCC---
Confidence 222111 11123457999999988889999999999999999998 9999963322 111111 1111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
+ ........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 230 -~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 -P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=310.68 Aligned_cols=247 Identities=25% Similarity=0.453 Sum_probs=195.5
Q ss_pred ccCccCcEEEEEEEEC---CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCC
Q 002358 616 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 691 (931)
Q Consensus 616 ~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 691 (931)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999875 355799999876543 234678999999999999999999998864 56899999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc--c
Q 002358 692 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI--S 769 (931)
Q Consensus 692 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~--~ 769 (931)
|.+++... ...+++..+++++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......... .
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998742 3568999999999999999999998 899999999999999999999999999997654332211 1
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
....++..|+|||.+....++.++||||||+++|||++ |+.||...... .... .+..+... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~---------~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMS----FIEQGKRL---------DC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH----HHHCCCCC---------CC
Confidence 11223578999999988889999999999999999996 99999633221 1111 11111111 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
+.....++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 222334788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=294.86 Aligned_cols=264 Identities=21% Similarity=0.304 Sum_probs=206.9
Q ss_pred HHHHHhhccccCccCcEEEEEEE-ECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEec-----CCeE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQR 680 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~~~~ 680 (931)
-..+|++.+.||+|||+-||+++ ..+++.+|+|++.-...++.+..++|++..++++|||+++++++... ..+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34677889999999999999998 45789999999987767778889999999999999999999988644 3458
Q ss_pred EEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
|++++|...|+|.+.+.... ++..+++.+++.|+.+|++||.+||+. ..+++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999987654 445799999999999999999999983 2459999999999999999999999999887
Q ss_pred ccccccccc--------ccccccCCCccCCCccC---CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002358 760 QAEEDLTHI--------SSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 828 (931)
Q Consensus 760 ~~~~~~~~~--------~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~ 828 (931)
...-..... -.....|..|+|||.+. +...++++|||||||+||+|+.|..||+..-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 642211100 01123588999999984 45678899999999999999999999972111
Q ss_pred HhhhcCCeee-cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 829 SMIKKGDVIS-IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 829 ~~~~~~~~~~-i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
+.+.+.- +..+.+.---.....+.+.+++..|++.||.+||++.|++..++.+.
T Consensus 247 ---~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 ---QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1122211 11111110001114457889999999999999999999999887653
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=312.29 Aligned_cols=248 Identities=21% Similarity=0.308 Sum_probs=194.3
Q ss_pred cCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 617 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 617 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
||+|+||.||+++.+ +|+.+|+|.+.... ....+.+..|++++++++||||+++++.+..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999876 58999999986432 12334566799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccccc
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 772 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 772 (931)
.+.+... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQR 154 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eecc
Confidence 9888643 33458899999999999999999998 8999999999999999999999999999876543221 2234
Q ss_pred ccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002358 773 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 852 (931)
Q Consensus 773 ~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 852 (931)
.|+..|+|||++.+..++.++||||+||++|||++|+.||...... ....+....... .... . ... ..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~-~~~~-~----~~~----~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLE-DEVK-F----EHQ----NF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhc-cccc-c----ccc----cC
Confidence 5899999999998888999999999999999999999999633221 111111111111 1110 0 001 12
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 853 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 853 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
..++.+++.+||+.+|++||+++|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 235789999999999999999988764443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=327.10 Aligned_cols=238 Identities=26% Similarity=0.354 Sum_probs=192.1
Q ss_pred cccCccCcEEEEEEEE----CCCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 615 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~----~~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
+.||+|+||.||+++. .+|+.||+|++..... .....+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 2578999999875322 234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|+|.+.+.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 154 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 154 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence 9999999863 4568999999999999999999998 8999999999999999999999999999876543322 1
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.. .... . +..... ..
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~---~-i~~~~~----------~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMT---M-ILKAKL----------GM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHH---H-HHcCCC----------CC
Confidence 22346899999999999888999999999999999999999999743221 1111 1 111111 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHH
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPKMQE 876 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs~~e 876 (931)
+......+.+++.+||+.+|++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1112236789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=313.93 Aligned_cols=246 Identities=23% Similarity=0.302 Sum_probs=193.8
Q ss_pred cCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 617 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 617 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
||+|+||+||++..+ +++.||+|++..... ...+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999876 688999999864322 2335678899999999999999999999999999999999999999
Q ss_pred HHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccccc
Q 002358 693 RDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 771 (931)
Q Consensus 693 ~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 771 (931)
.+.+.... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 98875322 34568999999999999999999998 89999999999999999999999999998765433221 223
Q ss_pred cccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHH
Q 002358 772 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 851 (931)
Q Consensus 772 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 851 (931)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||........ ... ....+..+.. ..+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~----------~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKE-LKQRILNDSV----------TYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHH-HHHhhcccCC----------CCccc
Confidence 4589999999999999999999999999999999999999974322111 011 1111111100 11122
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 852 SIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 852 ~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
....+.+++.+||+.+|++|| +++|+++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 234678999999999999999 5666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=322.01 Aligned_cols=241 Identities=26% Similarity=0.365 Sum_probs=193.8
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|.++ +++.||+|+++... ......+.+|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999887 57899999987542 23345677899999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.+.+.. ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 999998873 4568999999999999999999998 8999999999999999999999999999875322211 12
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...+.. .... .+..... . .+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~----~i~~~~~------~----~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQ----SILEDEV------R----YP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHH----HHHcCCC------C----CC
Confidence 2345899999999999999999999999999999999999999743321 1111 1111111 0 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 879 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~ 879 (931)
......+.+++.+||+.||++||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1123467899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=310.04 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=205.8
Q ss_pred HHHHHhhccccCccCcEEEEEEEECCC----cEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g----~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
....+.+.+.||+|+||.||+|.+.+. ..||+|...... ....+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 345566789999999999999987532 468999887654 3455689999999999999999999999876 4568
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999999753 3458999999999999999999998 89999999999999999999999999998865
Q ss_pred cccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
............++..|+|||.+....++.++||||||+++|||++ |..||...... ....+. ..+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~----~~~~~~~-- 228 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRI----ENGERLP-- 228 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH----HcCCcCC--
Confidence 4433222223334568999999988889999999999999999996 99999743321 111211 1111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
. +......+.+++.+|+..+|++||++.|+++.|+++...+
T Consensus 229 ---~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 229 ---M----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred ---C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1 1122346889999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.43 Aligned_cols=257 Identities=29% Similarity=0.465 Sum_probs=201.1
Q ss_pred HHHHhhccccCccCcEEEEEEEECC------CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
...+.+.+.||+|++|.||+|.+.+ +..||+|.+..... .....|.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3456677899999999999998864 56789998865433 3345799999999999999999999999998899
Q ss_pred EEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC---ceEEe
Q 002358 681 ILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVS 753 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~---~vkL~ 753 (931)
++||||+++++|.+++.... ....+++..+++++.||+.||+|||+ .+++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999987542 12358899999999999999999998 8999999999999998654 59999
Q ss_pred ccccccccccccccc-ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhh
Q 002358 754 DFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 831 (931)
Q Consensus 754 DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~ 831 (931)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||....... +.+ .+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~----~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VME----FV 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HH
Confidence 999998653222111 112223568999999998899999999999999999997 999997433221 111 11
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 832 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 832 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
..+... ..+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 235 TGGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 111110 1112223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.57 Aligned_cols=240 Identities=26% Similarity=0.379 Sum_probs=191.1
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|+++ +|+.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999987 58899999987532 22345567788888765 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.+.+.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 999998873 4568889999999999999999998 899999999999999999999999999987432111 122
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .+.+ .+..+. +.+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~----~~~~~~------~~~~---- 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFE----SIRVDT------PHYP---- 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCC------CCCC----
Confidence 3346899999999999999999999999999999999999999743321 1111 111111 1111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 878 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~-evl 878 (931)
.....++.+++.+||+.||++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11223678999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=311.24 Aligned_cols=255 Identities=23% Similarity=0.368 Sum_probs=201.1
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
....|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++.+..++..++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 3456778899999999999999975 688999999876544555678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++++|.++++. ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 87 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999998873 4568899999999999999999998 899999999999999999999999999998654322
Q ss_pred cccccccccCCCccCCCccC---CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 766 THISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
. ......|+..|+|||.+. ...++.++|||||||++|||++|+.||........ ... +.... ...+
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~~-----~~~~~---~~~~ 229 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFL-----MSKSN---FQPP 229 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--hee-----eecCC---CCCC
Confidence 1 122345788999999874 44578899999999999999999999863221110 000 00000 0011
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.... .......+.+++.+||+.+|++||++++|++.
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 1110 11223468899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=322.85 Aligned_cols=240 Identities=25% Similarity=0.338 Sum_probs=191.3
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCC-CCcceeEEEecCCeEEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHR-NLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~Hp-nIv~l~g~~~~~~~~~lV~E 685 (931)
|++.+.||+|+||.||+|+.+ .++.||+|+++... ....+.+..|.+++..++|+ +|+++++++...+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456789999999999999877 47899999987532 23456788899999999764 58889999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 82 YVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999998873 4568889999999999999999998 899999999999999999999999999987532211
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .....+ ..... .+
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i----~~~~~------~~- 220 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSI----MEHNV------SY- 220 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH----HcCCC------CC-
Confidence 1 122345899999999999999999999999999999999999999743321 111111 11110 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 874 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 874 (931)
+......+.+++.+||+.+|++|++.
T Consensus 221 ---~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 ---PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11122367899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=317.45 Aligned_cols=258 Identities=30% Similarity=0.489 Sum_probs=201.6
Q ss_pred HHhhccccCccCcEEEEEEEECC-Cc--EEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKD-GK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~-g~--~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
.+++.+.||+|+||.||+|..++ +. .+++|.++... ....+.+.+|++++.++ +||||+++++++......++|+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 35677899999999999998764 33 47888887532 33456789999999999 7999999999999999999999
Q ss_pred EecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceE
Q 002358 685 EYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 751 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vk 751 (931)
||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence 9999999999986432 11358889999999999999999998 8999999999999999999999
Q ss_pred EecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHh
Q 002358 752 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 830 (931)
Q Consensus 752 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 830 (931)
|+|||++........ ......+..|+|||.+....++.++|||||||++|||++ |..||...... .... .
T Consensus 160 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~~---~- 230 (297)
T cd05089 160 IADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELYE---K- 230 (297)
T ss_pred ECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---H-
Confidence 999999864322111 111123457999999988889999999999999999998 99999633221 1111 1
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 831 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 831 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
+..+. .... +......+.+++.+|++.+|.+||+++++++.|+++....
T Consensus 231 ~~~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 LPQGY-----RMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HhcCC-----CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11110 0001 1112246789999999999999999999999999887655
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.89 Aligned_cols=259 Identities=25% Similarity=0.440 Sum_probs=206.3
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECC------CcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 678 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 678 (931)
+....+.+.+.||+|+||.||+|.+++ +..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 345567778999999999999998753 3689999987543 234567889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC-------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceE
Q 002358 679 QRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 751 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vk 751 (931)
..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEE
Confidence 9999999999999999986532 12347888999999999999999997 8999999999999999999999
Q ss_pred Eeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHH
Q 002358 752 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 829 (931)
Q Consensus 752 L~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 829 (931)
|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...+. .....+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~-- 234 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFV-- 234 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHH--
Confidence 999999876543321 12223346789999999988889999999999999999998 9999863322 1222221
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 830 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
..+..... +......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 235 --~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 --IDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --hcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111111 11124478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=329.45 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=200.7
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|.+.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++..++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 556789999999999999987 68999999987532 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc-
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 765 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~- 765 (931)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 83 MPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999874 3578899999999999999999998 999999999999999999999999999998654432
Q ss_pred ---------------------------cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCcc
Q 002358 766 ---------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 818 (931)
Q Consensus 766 ---------------------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~ 818 (931)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11223345899999999999999999999999999999999999999744321
Q ss_pred chhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 002358 819 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVLA 880 (931)
Q Consensus 819 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~~ 880 (931)
.. ............. +. . ......+.+++.+|+. +|.+||+ ++|+++.
T Consensus 237 ~~------~~~i~~~~~~~~~--p~-~----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ET------YNKIINWKESLRF--PP-D----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH------HHHHhccCCcccC--CC-C----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 1111110000000 00 0 0023467899999997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.27 Aligned_cols=256 Identities=24% Similarity=0.310 Sum_probs=193.0
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCC-----eEEEEEEec
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILVYEYM 687 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~~~lV~E~~ 687 (931)
.+++|.|+||.||+|... .++.||||+...+.. --.+|+++|++++|||||++.-+|.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 578999999999999876 469999998865432 2247999999999999999998885432 234899999
Q ss_pred CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC-CceEEecccccccccccc
Q 002358 688 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 688 ~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~-~~vkL~DFGla~~~~~~~ 765 (931)
+. +|.+.++... .+..++...+.-+..||.+||+|||+ .+|+||||||.|+|+|.+ |.+||||||.|+......
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 75 8888887422 34567778888899999999999998 999999999999999976 889999999999877665
Q ss_pred cccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe-------e
Q 002358 766 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV-------I 837 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~-------~ 837 (931)
...+ ...|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+++..+....+--+.......++ .
T Consensus 181 pniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 181 PNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred Ccee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 5443 335889999998766 58999999999999999999999999876554433222111111111000 0
Q ss_pred ecccccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+...|.+... .......+..+++.++++.+|.+|.++.|++.
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111111111 11223346789999999999999999999874
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=322.55 Aligned_cols=237 Identities=29% Similarity=0.391 Sum_probs=188.1
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHH-HHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||+||+|..+ +|+.||+|++.... ....+.+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999986 68999999986532 122344555555 56789999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 999998873 4568889999999999999999998 899999999999999999999999999987532221 122
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... . ..... .+.. .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~---~~~i~-~~~~------~~~~--- 217 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---M---YDNIL-NKPL------RLKP--- 217 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---H---HHHHH-cCCC------CCCC---
Confidence 33458999999999999999999999999999999999999997433211 1 11111 1111 1111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQ 875 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~ 875 (931)
.....+.+++.+|++.+|++||+++
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 -NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1233678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=310.02 Aligned_cols=255 Identities=27% Similarity=0.483 Sum_probs=203.5
Q ss_pred HHHhhccccCccCcEEEEEEEEC----CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
..+++.+.||+|+||.||+|.+. .+..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45667899999999999999874 23479999987543 23456889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998753 3468899999999999999999998 8999999999999999999999999999987654
Q ss_pred cccccccc--cccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 764 DLTHISSV--ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 764 ~~~~~~~~--~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
........ ..++..|+|||.+.+..++.++|+||||+++||+++ |..||...... .....+. .+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~----~~~~---- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIE----EGYR---- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHh----CCCc----
Confidence 33222111 123568999999998899999999999999999887 99999633221 1222221 1110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
... +...+..+.+++.+|++.+|++||+|.++++.|+++
T Consensus 228 -~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -LPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.05 Aligned_cols=250 Identities=25% Similarity=0.311 Sum_probs=199.1
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|+..+.||+|+||.||++... +++.||+|++..... .....+.+|++++++++||||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 556789999999999999875 689999999865322 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 82 MNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 9999999888643 23568999999999999999999998 8999999999999999999999999999876533221
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||........ .+.+...+.... .
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~----------~ 222 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKEDQ----------E 222 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhcc----------c
Confidence 1223589999999999988999999999999999999999999974332111 111111111111 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
.++......+.+++.+||+.||++|| +++++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 11222334678999999999999999 7778754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=328.10 Aligned_cols=255 Identities=23% Similarity=0.345 Sum_probs=200.1
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
+....+++.+.||+|+||.||+++.+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34456778899999999999999876 58899999986421 223355788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+||||+++|+|.+++.. ..++...+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999863 347788888999999999999998 89999999999999999999999999999865
Q ss_pred cccccccccccccCCCccCCCccCCC----CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
............||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... .. ..........
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~---~~i~~~~~~~ 266 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TY---SKIMDHKNSL 266 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---HH---HHHHcCCCcC
Confidence 44332223345699999999998653 47889999999999999999999997443211 11 1111111110
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 880 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 880 (931)
...+ .......+.+++.+|++.+|++ ||+++|+++.
T Consensus 267 ~~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1100 0012246789999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=318.09 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=205.5
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEEecC
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 677 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~ 677 (931)
+....+.+.+.||+|+||.||+|.+. .+..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44456777899999999999999752 35589999987543 33456789999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccc
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 757 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGl 757 (931)
+..++||||+++|+|.++++... ...+++.++..++.|++.||+|||+ .+++|+||||+|||++.++.++|+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999987432 3348999999999999999999998 8999999999999999999999999999
Q ss_pred cccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCC
Q 002358 758 SRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 835 (931)
Q Consensus 758 a~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 835 (931)
++........ ......++..|+|||.+.+..++.++||||+||++|||++ |..||....... .... .+..+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~----~~~~~~ 261 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYK----LIKEGY 261 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHH----HHHcCC
Confidence 9865433211 1122335678999999999899999999999999999998 999986333211 1111 111111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 836 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 836 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
.. . .+......+.+++.+|++.+|++||++.|+++.|++.
T Consensus 262 ~~-----~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RM-----A----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cC-----C----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 10 0 0111224688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=308.99 Aligned_cols=240 Identities=23% Similarity=0.411 Sum_probs=190.0
Q ss_pred cccCccCcEEEEEEEECC-------------CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 615 KKIGKGSFGSVYYGKMKD-------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~-------------g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
+.||+|+||.||+|.+.+ ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998642 2358999887655555567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc-------eEEec
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-------AKVSD 754 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~-------vkL~D 754 (931)
+||||+++|+|..++... ...+++..+++++.||++||+|||+ .+|+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999888642 3458899999999999999999998 89999999999999987664 89999
Q ss_pred ccccccccccccccccccccCCCccCCCccC-CCCCCccchhHHHHHHHHHHH-hCCCCCCccCccchhhHHHHHHHhhh
Q 002358 755 FGLSRQAEEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAELNIVHWARSMIK 832 (931)
Q Consensus 755 FGla~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvlL~eLl-tG~~Pf~~~~~~~~~~l~~~~~~~~~ 832 (931)
||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+......+... ..
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~- 222 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------FY- 222 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------HH-
Confidence 9998754322 1234788899999886 467899999999999999998 5888886332211110 01
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 833 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 833 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
.+.. ... ......+.+++.+||+.+|++||++++|++.++
T Consensus 223 ~~~~-~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQC-MLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCc-cCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1110 011 112346789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=325.86 Aligned_cols=250 Identities=21% Similarity=0.267 Sum_probs=199.2
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|++.+.||+|+||.||++..+ +|+.||+|+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 556789999999999999876 689999999875422 2445688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++... ...+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 83 QPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999998753 3568899999999999999999998 8999999999999999999999999999987654333
Q ss_pred ccccccccCCCccCCCccC------CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 767 HISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ...............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~~ 231 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFLKFP 231 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCccCCC
Confidence 3333446899999999986 4567889999999999999999999997433211 111111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+ .......+.+++.+|++ +|++||+++++++
T Consensus 232 ~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 232 E-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1 01122357789999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=304.58 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=202.1
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
+.+.+.||+|++|.||+|..+ +++.|++|.+... .....+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 345788999999999999886 6899999987643 2345677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.++++.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++........
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 82 ENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 999999998753 24568899999999999999999997 89999999999999999999999999998865443222
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....|++.|+|||++.+..++.++|+||||+++|||++|+.||..... ...... +..+.... +
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~----~~~~~~~~-----~--- 221 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILK----IIRGVFPP-----V--- 221 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHcCCCCC-----C---
Confidence 2234578899999999998999999999999999999999999974331 111111 11111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+|++.+|++||++.++++
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 222 -SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred -ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1122346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=308.36 Aligned_cols=247 Identities=29% Similarity=0.457 Sum_probs=197.6
Q ss_pred cccCccCcEEEEEEEECC----CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
++||+|+||.||+|.+.. +..+|+|.+..... ...+++.+|+++++++.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997642 26899999876543 34567999999999999999999999876 4567999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.+++.. ...+++..++.++.|++.||+|||. .+++||||||+|||+++++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999974 3368999999999999999999997 8999999999999999999999999999987644332211
Q ss_pred c--ccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 770 S--VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 770 ~--~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
. ...++..|+|||.+.+..++.++||||||+++|||++ |..||...+. .....++. .+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~~~~-------- 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGERLP-------- 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCcCC--------
Confidence 1 1223567999999999999999999999999999998 9999974322 22222222 111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
.+......+.+++.+|+..+|++||++.+|++.|++.
T Consensus 219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=313.60 Aligned_cols=264 Identities=24% Similarity=0.394 Sum_probs=201.8
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-----------------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcc
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-----------------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 669 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-----------------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~ 669 (931)
...+++.+.||+|+||.||++.+. ++..+|+|+++.... ...+++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 345678899999999999998643 234689999875433 34567999999999999999999
Q ss_pred eeEEEecCCeEEEEEEecCCCCHHHHhccCC--------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCC
Q 002358 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 741 (931)
Q Consensus 670 l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~N 741 (931)
+++++...+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 9999999999999999999999999987532 12347788999999999999999998 899999999999
Q ss_pred ccccCCCceEEecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh--CCCCCCccCcc
Q 002358 742 ILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 818 (931)
Q Consensus 742 ILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt--G~~Pf~~~~~~ 818 (931)
||++.++.++|+|||+++........ ......++..|++||......++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999998765332211 1122234678999999888889999999999999999998 67888633221
Q ss_pred chhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 819 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 819 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
. ................ ..+ .+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus 241 ~---~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q---VIENTGEFFRDQGRQV-YLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHHhhccccc-cCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1111111111111000 001 011223578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.34 Aligned_cols=255 Identities=26% Similarity=0.458 Sum_probs=202.5
Q ss_pred HHHhhccccCccCcEEEEEEEECC-C---cEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~-g---~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
..+++.+.||+|+||.||+|.++. + ..||+|+++... ....++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 346678999999999999998763 3 369999987543 33457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998753 3568899999999999999999998 8999999999999999999999999999876543
Q ss_pred cccccc--cccc--cCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeee
Q 002358 764 DLTHIS--SVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 764 ~~~~~~--~~~~--gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 838 (931)
...... .... .+..|+|||.+....++.++|||||||++|||++ |..||...+. .....++.. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~----~~~-- 229 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQ----DYR-- 229 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHc----CCc--
Confidence 221111 1111 2457999999999999999999999999999987 9999963321 122222211 100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 839 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 839 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
... +.+.+..+.+++.+||+.+|++||++++|++.|+++
T Consensus 230 ---~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ---LPP----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---CCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 112234678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=328.23 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=195.5
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+++++.++||||+++++.+.++...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 456789999999999999986 58999999986532 23345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 83 LPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999874 4568999999999999999999998 8999999999999999999999999999875422110
Q ss_pred c-------------------------------------cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCC
Q 002358 767 H-------------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 809 (931)
Q Consensus 767 ~-------------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~ 809 (931)
. ......||+.|+|||++....++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011235899999999999999999999999999999999999
Q ss_pred CCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 002358 810 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVL 879 (931)
Q Consensus 810 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~ 879 (931)
.||...+... ... ............. . ......+.+++.+|+. +|.+|++ ++|+++
T Consensus 237 ~Pf~~~~~~~---~~~---~i~~~~~~~~~~~-----~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQE---TYR---KIINWKETLQFPD-----E--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHH---HHH---HHHcCCCccCCCC-----C--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9997433211 111 1111110000000 0 0112356788889986 9999998 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=315.33 Aligned_cols=260 Identities=26% Similarity=0.448 Sum_probs=203.2
Q ss_pred HHHHHhhccccCccCcEEEEEEEECC------CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 679 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 679 (931)
....+++.+.||+|+||.||+|..++ +..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45667788999999999999997642 45899998865432 334568899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC-------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEE
Q 002358 680 RILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 752 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL 752 (931)
.++||||+++|+|.+++.... ....+.+..+.+++.|++.||+|||+ ++++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997432 12345677888999999999999998 89999999999999999999999
Q ss_pred ecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHh
Q 002358 753 SDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 830 (931)
Q Consensus 753 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 830 (931)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...+ .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~----~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLK----F 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----H
Confidence 999998764332211 1122235678999999998899999999999999999999 78888632221 1111 1
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 831 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 831 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
+..+.... . +......+.+++.+|++.+|++||++.++++.|++..
T Consensus 234 ~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYLD-----Q----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCCC-----C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111111 0 1112347889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=320.72 Aligned_cols=237 Identities=27% Similarity=0.381 Sum_probs=187.5
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHH-HHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
++||+|+||.||+|+.. +++.||+|++.... ......+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999986 58899999986532 122344555554 67889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.+.+.. ...+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 999988863 4567888889999999999999998 899999999999999999999999999987532221 122
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.. ...+ . +..+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~-i~~~~~----------~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYD---N-ILHKPL----------QLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHH---H-HhcCCC----------CCC
Confidence 3346899999999999989999999999999999999999999743321 1111 1 111111 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQ 875 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~ 875 (931)
......+.+++.+|++.+|++||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12234678999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.20 Aligned_cols=248 Identities=26% Similarity=0.363 Sum_probs=195.2
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
+++.+.||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 456789999999999999865 68899999986542 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+++|.... .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 83 GGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 99997542 36778888999999999999998 999999999999999999999999999987654321
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccch-hhHHHHHHHhhhcCCeeecccccccCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ .....+.. .+..... +.+.
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~-- 221 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-CIVDEDP-----PVLP-- 221 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-HHhccCC-----CCCC--
Confidence 2234588999999999998999999999999999999999999964222111 11111111 1111110 1110
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
......++.+++.+|++.+|++||+++|+++.
T Consensus 222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01122357899999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=328.68 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=193.3
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 445789999999999999876 57899999986532 23446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 83 IPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999874 3568888899999999999999998 8999999999999999999999999999754211000
Q ss_pred ----------------------------------------------ccccccccCCCccCCCccCCCCCCccchhHHHHH
Q 002358 767 ----------------------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 800 (931)
Q Consensus 767 ----------------------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGv 800 (931)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012245899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHH
Q 002358 801 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ--CVEQRGFSRPKMQEIV 878 (931)
Q Consensus 801 lL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~--Cl~~dP~~RPs~~evl 878 (931)
++|||++|+.||......... ...+.......+ + .....+. ++.+++.+ |+..++..||+++|++
T Consensus 237 il~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~~--~-~~~~~s~----~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQ------LKVINWENTLHI--P-PQVKLSP----EAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHH------HHHHccccccCC--C-CCCCCCH----HHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999999743321110 111110000000 0 0011222 45667766 6667777799999997
Q ss_pred HH
Q 002358 879 LA 880 (931)
Q Consensus 879 ~~ 880 (931)
+.
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 63
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=314.41 Aligned_cols=262 Identities=23% Similarity=0.410 Sum_probs=202.8
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-----CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecC--Ce
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQ 679 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~ 679 (931)
...+++.+.||+|+||.||++.+. +++.||+|.++... ....+.+.+|++++++++|||++++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 345677899999999999999753 57889999987543 33446799999999999999999999998775 56
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 88999999999999998643 3458999999999999999999998 899999999999999999999999999998
Q ss_pred cccccccc--cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCc---------cchhhHHHHHH
Q 002358 760 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF---------GAELNIVHWAR 828 (931)
Q Consensus 760 ~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~---------~~~~~l~~~~~ 828 (931)
........ ......++..|+|||.+.+..++.++||||||+++|||++++.|...... ........ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR-LV 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH-HH
Confidence 65433221 11223467789999999888899999999999999999998776532110 00001111 11
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 829 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 829 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
..+..+.... .+......+.+++.+|++.+|++||+++++++.|+++
T Consensus 237 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1122111111 1112234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=325.79 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=195.6
Q ss_pred hhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC-----eEEEE
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILV 683 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~~~lV 683 (931)
++.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+++++.++|+||+++++++.... ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 45689999999999999875 78999999986532 234467889999999999999999999998766 78999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
+||+. ++|.+.+. ....+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 83 ~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 83 TELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred eeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99996 57887775 34568999999999999999999998 8999999999999999999999999999986543
Q ss_pred cccccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHH----------------
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW---------------- 826 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~---------------- 826 (931)
..........+++.|+|||.+.+. .++.++||||+||++|||++|+.||...+.......+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 332223334578999999998764 578999999999999999999999975443221111100
Q ss_pred HHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 827 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 827 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....+.......-..+.+. .........+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLY-TLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHHhCCCCCCchHHhc-ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000100000000000000 011112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=312.31 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=201.9
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCc----EEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
...+++.++||+|+||+||+|++. +++ .||+|+++... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 345567799999999999999865 444 48999987543 33456788999999999999999999999754 467
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+++||+++|+|.+.++.. ...+++..++.++.|+++||+|||+ .+++||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998742 3468899999999999999999998 89999999999999999999999999999865
Q ss_pred ccccccc-ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 762 EEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 762 ~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+..++. .+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~----~~~~~~~ 232 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLE----KGERLPQ 232 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH----CCCcCCC
Confidence 4322211 112234678999999998899999999999999999998 8999863322 12222221 1111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
+......+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 233 ---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 233 ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11123467899999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.75 Aligned_cols=251 Identities=30% Similarity=0.522 Sum_probs=201.5
Q ss_pred HHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
.+++.+.||+|+||.||+|.+.+++.+|+|.++.... ...++.+|++++++++|||++++++++......++|+||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 4566789999999999999988788999999875422 345789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 84 GCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999998742 3457889999999999999999998 8999999999999999999999999999876543322222
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
....++.+|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+. +.++. ....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~~--~~~~~~~---- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVET----INAGF--RLYKPRL---- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHH----HhCCC--CCCCCCC----
Confidence 22235678999999998899999999999999999998 99998632211 11111 11110 1111111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
....+.+++.+||+.+|++||+++|+++.|.
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1246889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=313.56 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=201.4
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
..|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 35666789999999999999865 68999999987655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+++.. ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999999863 357889999999999999999998 89999999999999999999999999998765432221
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .+..+ ...+ .... .
T Consensus 173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~----~~~~-~~~~-------~ 237 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLI----ATNG-TPEL-------Q 237 (296)
T ss_pred -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHH----hcCC-CCCC-------C
Confidence 223358899999999998889999999999999999999999997433211 11111 1111 0000 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+......+.+++.+||+.+|++||+++||++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 11122346789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=304.95 Aligned_cols=248 Identities=29% Similarity=0.437 Sum_probs=199.5
Q ss_pred cccCccCcEEEEEEEECC--C--cEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMKD--G--KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~--g--~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 2 3699999987655 566789999999999999999999999988 889999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc--
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-- 767 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~-- 767 (931)
|+|.+.+..... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999875422 568999999999999999999998 89999999999999999999999999999876442211
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ....... .......
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~---~~~~~~~-------- 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKID---KEGERLE-------- 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---hcCCcCC--------
Confidence 1112346788999999999999999999999999999999 99999632221 1111111 1111100
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
.+...+..+.+++.+|++.+|++||++.||++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11122346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=320.48 Aligned_cols=240 Identities=25% Similarity=0.342 Sum_probs=191.8
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
+++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|..++..+ +|++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 456789999999999999877 57899999987532 22334567788888877 58999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 82 YVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999998863 3568899999999999999999998 899999999999999999999999999987533221
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.+.+. ....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~----~~~~--------- 218 (323)
T cd05616 156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIM----EHNV--------- 218 (323)
T ss_pred C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHHH----hCCC---------
Confidence 1 122346899999999999999999999999999999999999999743321 1222111 1111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 874 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 874 (931)
..+.....++.+++.+|++.+|++|++.
T Consensus 219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0111223467899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=309.45 Aligned_cols=250 Identities=30% Similarity=0.515 Sum_probs=196.2
Q ss_pred cccCccCcEEEEEEEECC-Cc--EEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMKD-GK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~-g~--~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|.+++ +. .+++|.++... ....+.+.+|+++++++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999864 43 57888887543 34456788999999999 799999999999999999999999999
Q ss_pred CCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccc
Q 002358 690 GTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 756 (931)
Q Consensus 690 gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFG 756 (931)
|+|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999987432 12357899999999999999999998 899999999999999999999999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCC
Q 002358 757 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 835 (931)
Q Consensus 757 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 835 (931)
++....... .......+..|+|||++....++.++||||||+++|||++ |..||...+.. ...+. +..+.
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~----~~~~~ 228 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK----LPQGY 228 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHHH----HhCCC
Confidence 986422111 1111223567999999988889999999999999999997 99999633221 11111 11111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 836 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 836 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
..+ .+......+.+++.+|+..+|.+||++.|+++.|+++.
T Consensus 229 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 100 11112236789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.50 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=192.6
Q ss_pred cccCccCcEEEEEEEECC---CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 615 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~---g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998754 45799998875443 33457889999999999999999999999999999999999999
Q ss_pred CHHHHhccCC--CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 691 TLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 691 sL~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|.+++.... .....++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999987532 22356777888999999999999998 899999999999999999999999999987543322211
Q ss_pred -ccccccCCCccCCCccCCC-------CCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 769 -SSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 769 -~~~~~gt~~y~APE~l~~~-------~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
.....++..|+|||++... .++.++||||||+++|||++ |+.||......+ .... .+. +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY---TVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH---Hhh-cccCCC
Confidence 2233467889999998542 35789999999999999996 999996332211 1111 011 111122
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
.++.+.. .....+.+++.+|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222221 12235778899998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=305.95 Aligned_cols=249 Identities=30% Similarity=0.497 Sum_probs=199.6
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEe-cCCeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~~~lV~E~~ 687 (931)
..+.+.+.||+|+||.||++... |+.||+|.++... ..+.+.+|+.++++++|+|++++++++. ..+..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 45667899999999999999876 8889999986532 3467899999999999999999999764 556789999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998753 23458899999999999999999998 899999999999999999999999999987543221
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+..+ +..+....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~~-------- 219 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR----VEKGYKMD-------- 219 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HhcCCCCC--------
Confidence 12234678999999999899999999999999999998 9999863322 112221 11111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
.....+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 -APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1112234678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=317.68 Aligned_cols=263 Identities=21% Similarity=0.301 Sum_probs=196.5
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
+|.+.+.||+|+||.||+|+.+ +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 4566789999999999999876 578899999865432 23346788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++ +|.+.+... ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 87 DK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 75 888877642 3457888999999999999999998 89999999999999999999999999998764332211
Q ss_pred cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec------c
Q 002358 768 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI------V 840 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i------~ 840 (931)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+...................+ .
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 222357899999998755 56889999999999999999999999755443322222111100000000000 0
Q ss_pred c---ccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 D---PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d---~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+ +.... ........++.+++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 00000 000112235789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=325.06 Aligned_cols=199 Identities=25% Similarity=0.396 Sum_probs=172.2
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+++.+.||+|+||+||++..+ +++.||+|+++... ......+.+|+.++.+++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 456789999999999999876 58899999986532 22345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 83 LPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999873 4578999999999999999999998 8999999999999999999999999999875432110
Q ss_pred ----------------------------------ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 002358 767 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 812 (931)
Q Consensus 767 ----------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf 812 (931)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012346999999999999999999999999999999999999999
Q ss_pred Ccc
Q 002358 813 SVE 815 (931)
Q Consensus 813 ~~~ 815 (931)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=317.21 Aligned_cols=266 Identities=26% Similarity=0.455 Sum_probs=209.2
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEECC--------CcEEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEE
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGY 673 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~~--------g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~ 673 (931)
.++....+++.+.||+|+||.||+|.... +..||+|.++... ....+++.+|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 35566678889999999999999997531 2368999887543 33457899999999999 79999999999
Q ss_pred EecCCeEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCC
Q 002358 674 CEEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 740 (931)
Q Consensus 674 ~~~~~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~ 740 (931)
+......++++||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccc
Confidence 999999999999999999999987532 22357889999999999999999998 89999999999
Q ss_pred CccccCCCceEEeccccccccccccccc-ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCcc
Q 002358 741 NILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 818 (931)
Q Consensus 741 NILld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~ 818 (931)
|||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999987654322111 112224567999999999999999999999999999998 88888643221
Q ss_pred chhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 819 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 819 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
+ . .. .+..+.... .+......+.+++.+|++.+|++||++.|+++.|+++....
T Consensus 244 ~---~---~~-~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 E---L---FK-LLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred H---H---HH-HHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1 1 11 111111111 11122346889999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=309.03 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=199.6
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEec-----CCeEEEEEE
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRILVYE 685 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~~~~~lV~E 685 (931)
.+.||+|+||.|+.|..+ +|+.||||++... .....++..+|+++|+.++|+||+.+.+++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 578999999999999876 6899999998743 33456788999999999999999999998855 356899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc-
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED- 764 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~- 764 (931)
+| +.+|.+.++ .+..++......++.|+++||+|+|+ .+|+||||||+|+|++.+..+||+|||+|+.....
T Consensus 107 lM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 107 LM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred HH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99 578999998 35569999999999999999999998 99999999999999999999999999999987543
Q ss_pred ccccccccccCCCccCCCccC-CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc---
Q 002358 765 LTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV--- 840 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~--- 840 (931)
.....+....|.+|+|||++. ...|+.+.||||.||++.||++|+.-|.+.+.-+...++..+.....+..+..+-
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 111123445799999999874 5689999999999999999999999998776654444333221111111111010
Q ss_pred -----c-------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 841 -----D-------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 841 -----d-------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
. ..+...++ .....-++++.+||..||.+|+|++|.++.
T Consensus 260 ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 00000111 111245799999999999999999998753
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=322.70 Aligned_cols=241 Identities=28% Similarity=0.401 Sum_probs=189.8
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHH-HHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|+.+ +|+.+|+|++.... ....+.+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999876 68999999986532 223345566655 46778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|...+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TT 153 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cc
Confidence 999988863 4568899999999999999999998 8999999999999999999999999999875322111 22
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...+... .. ..... +.. . + .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~---~~~~~-~~~--~----~----~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MY---DNILH-KPL--V----L----R 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HH---HHHHc-CCc--c----C----C
Confidence 33468999999999999999999999999999999999999997433211 11 11111 111 0 1 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+.....+.+++.+|++.+|++||++++.++
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 112235778999999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=321.44 Aligned_cols=242 Identities=26% Similarity=0.354 Sum_probs=189.2
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHH-HHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999887 57889999986532 122234444544 56788999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.+.+.. ...+....+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~ 153 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT 153 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence 999999873 4567788888999999999999998 8999999999999999999999999999875332211 22
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+ .. ... .+ +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i---~~-~~~------~~----~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNI---LN-KPL------QL----K 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHH---Hh-CCc------CC----C
Confidence 3346899999999999999999999999999999999999999743321 111111 11 111 01 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
......+.+++.+|++.+|.+||++.+.+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1222367899999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.71 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=198.2
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-----chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
+...+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 456789999999999999865 68999999886432 123457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++++|.+.+.. ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.....
T Consensus 84 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 84 EYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999998874 3467888899999999999999998 89999999999999999999999999998765332
Q ss_pred ccccc--cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 765 LTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 765 ~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
..... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||...+.. ..... .......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~---~~~~~~~------ 225 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIFK---IATQPTN------ 225 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHHH---HhccCCC------
Confidence 21111 2345778999999999988999999999999999999999999633211 11111 1111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+......+.+++.+||..+|++||++.|+++
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 226 ---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred ---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 1112223346789999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=314.63 Aligned_cols=263 Identities=25% Similarity=0.448 Sum_probs=206.4
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC--------CCcEEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEEec
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 676 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~ 676 (931)
....+.+.++||+|+||.||+++.. ....+|+|.++... ......+.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3456667899999999999999752 24579999987543 33456788999999999 69999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcc
Q 002358 677 EHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 743 (931)
Q Consensus 677 ~~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIL 743 (931)
....+++|||+++|+|.+++.... ....+++..+++++.|++.||.|||+ .+++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEE
Confidence 899999999999999999986532 12458899999999999999999998 89999999999999
Q ss_pred ccCCCceEEeccccccccccccccc-ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchh
Q 002358 744 LDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 821 (931)
Q Consensus 744 ld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~ 821 (931)
+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--- 243 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--- 243 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 9999999999999998654322111 111224567999999998899999999999999999999 88888633221
Q ss_pred hHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 822 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 822 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
.... .+..+.... .+......+.+++.+|+..+|++||++.|+++.|+++....
T Consensus 244 ~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 244 ELFK----LLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHH----HHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1111 122221111 11222346789999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=310.02 Aligned_cols=239 Identities=24% Similarity=0.385 Sum_probs=187.8
Q ss_pred ccCccCcEEEEEEEECC-------------------------CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcce
Q 002358 616 KIGKGSFGSVYYGKMKD-------------------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 670 (931)
Q Consensus 616 ~LG~G~fG~Vy~a~~~~-------------------------g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l 670 (931)
.||+|+||.||+|.+.. ...|++|++.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997531 13589999876544455678999999999999999999
Q ss_pred eEEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC--
Q 002358 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-- 748 (931)
Q Consensus 671 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~-- 748 (931)
++++......++||||+++|+|..++.. ....+++..++.++.|+++||+|||+ .+|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998864 24568899999999999999999997 8999999999999997643
Q ss_pred -----ceEEecccccccccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHH-hCCCCCCccCccchh
Q 002358 749 -----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAEL 821 (931)
Q Consensus 749 -----~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLl-tG~~Pf~~~~~~~~~ 821 (931)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 3799999987643221 12246788999998865 56899999999999999985 69999864322111
Q ss_pred hHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 822 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 822 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
..+... ... +. ......+.+++.+||+.+|++||++++|++.|+
T Consensus 231 --~~~~~~---~~~--------~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 --ERFYEK---KHR--------LP----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHHHh---ccC--------CC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111110 000 00 011125789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.53 Aligned_cols=252 Identities=32% Similarity=0.518 Sum_probs=199.4
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhh--hhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~--~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++.+.||+|+||+||+++.. +++.+|+|++........ ....+|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999987 466899999987644332 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+++. ....+++..+..++.|+++||++||+ .+++|+||||+||+++.++.++|+|||.+...... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NE 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TS
T ss_pred cccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-cc
Confidence 9999999997 35678999999999999999999998 89999999999999999999999999998754211 22
Q ss_pred cccccccCCCccCCCccC-CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 768 ISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
......++..|+|||.+. +..++.++||||+|+++|+|++|..||................... . ... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----~---~~~-~-- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP----L---PSS-S-- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH----H---HHH-T--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc----c---ccc-c--
Confidence 233445889999999998 8899999999999999999999999998442111111111111000 0 000 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.........+.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011257899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=319.17 Aligned_cols=263 Identities=27% Similarity=0.457 Sum_probs=203.1
Q ss_pred HHHHHHhhccccCccCcEEEEEEEE------CCCcEEEEEEccCccc-hhhhhHHHHHHHHHhc-CCCCCcceeEEEecC
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 677 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~ 677 (931)
+....+++.+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3456788899999999999999974 2478999999975432 3446788999999999 689999999988654
Q ss_pred -CeEEEEEEecCCCCHHHHhccCCC-------------------------------------------------------
Q 002358 678 -HQRILVYEYMHNGTLRDRLHGSVN------------------------------------------------------- 701 (931)
Q Consensus 678 -~~~~lV~E~~~~gsL~~~L~~~~~------------------------------------------------------- 701 (931)
...++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 467899999999999998864210
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc-cccc
Q 002358 702 ---------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSV 771 (931)
Q Consensus 702 ---------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~ 771 (931)
...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 1246788889999999999999998 89999999999999999999999999998765332211 1122
Q ss_pred cccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002358 772 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 850 (931)
Q Consensus 772 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 850 (931)
..++..|+|||.+.+..++.++||||||+++|||++ |..||....... ... ..+..+..... + ...
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~~~~~~--~---~~~-- 307 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRMRA--P---DYT-- 307 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH----HHHhccCCCCC--C---CCC--
Confidence 335678999999988899999999999999999997 999986432211 111 11222211111 1 111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 851 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 851 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
...+.+++.+||+.+|++||++.||++.|+.+..
T Consensus 308 --~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 --TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1257899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=305.68 Aligned_cols=249 Identities=33% Similarity=0.541 Sum_probs=202.9
Q ss_pred cccCccCcEEEEEEEECC----CcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|...+ +..|++|.++..... ..+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998864 789999999765443 367899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCC------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 690 GTLRDRLHGSVN------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 690 gsL~~~L~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
++|.+++..... ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999985421 3678999999999999999999998 9999999999999999999999999999987654
Q ss_pred ccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 764 DLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 764 ~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
... .......++..|+|||.+....++.++||||+|++++||++ |..||..... ..+.+.+ ..+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~---- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYL----RKGYRL---- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----HcCCCC----
Confidence 321 11223447889999999988889999999999999999999 6999974321 1222221 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
..+......+.+++.+|++.+|++||+++|+++.|+
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111122347889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=336.44 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=200.2
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC-------
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------- 678 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~------- 678 (931)
..|.+.+.||+|+||+||+|+.. +|+.||||++.... ......+.+|+.++..++|+|+++++..+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 46677899999999999999865 68999999986532 334567889999999999999999988764322
Q ss_pred -eEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccc
Q 002358 679 -QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 756 (931)
Q Consensus 679 -~~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFG 756 (931)
..++||||+++|+|.+.++... ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 3679999999999999986432 34568899999999999999999998 899999999999999999999999999
Q ss_pred cccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCC
Q 002358 757 LSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 835 (931)
Q Consensus 757 la~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 835 (931)
+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+.... .+.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~~-~~~ 261 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKTL-AGR 261 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHh-cCC
Confidence 9986543221 1223456899999999999999999999999999999999999999743321 1111111 111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 836 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 836 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
... + +......+.+++.+||+.+|++||++.++++
T Consensus 262 ~~~-----~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 262 YDP-----L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCC-----C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 111 1 1122346889999999999999999999875
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=306.07 Aligned_cols=250 Identities=22% Similarity=0.364 Sum_probs=198.8
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
-|++.+.||+|+||.||+|... .+..+++|.+........+.+.+|+++++.++||||+++++++...+..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3567789999999999999887 477889999876555566788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+++|...+.. ....+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 9999988764 23568999999999999999999998 8999999999999999999999999999876433221 1
Q ss_pred ccccccCCCccCCCccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 769 SSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
.....++..|+|||++. ...++.++|||||||++|||++|+.||..... ...... ... ........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~----~~~-~~~~~~~~-- 230 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--MRVLLK----IAK-SEPPTLAQ-- 230 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--HHHHHH----Hhh-cCCCCCCC--
Confidence 22345889999999973 34577899999999999999999999963321 111111 111 11111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.+|++||++.++++
T Consensus 231 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 231 -----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112346789999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=325.29 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=196.5
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
...|++.+.||+|+||.||+++.+ +++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.++...++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 456777889999999999999987 57899999986421 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999863 347888899999999999999998 8999999999999999999999999999987644
Q ss_pred cccccccccccCCCccCCCccCCC----CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
..........||+.|+|||++... .++.++||||+||++|||++|+.||....... ..............
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~~~~~~~ 268 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDHKNSLNF 268 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCcccCC
Confidence 333223345699999999998653 37889999999999999999999997433211 11111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 880 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 880 (931)
.+ .......+.+++.+|++.++.+ ||+++|+++.
T Consensus 269 p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 PE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00 0112235678888999755543 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=304.01 Aligned_cols=247 Identities=32% Similarity=0.489 Sum_probs=198.7
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCHH
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 693 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 693 (931)
++||+|+||.||++...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999887999999998765433 5568999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc-ccc
Q 002358 694 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVA 772 (931)
Q Consensus 694 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~-~~~ 772 (931)
+++... ...+++..++.++.+++.||+|||+ .+++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998643 3467889999999999999999998 8999999999999999999999999999876542221111 122
Q ss_pred ccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHH
Q 002358 773 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 851 (931)
Q Consensus 773 ~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 851 (931)
.++..|+|||.+.+..++.++|+||||+++|||++ |..||....... ..+. +..+. .. ..+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~----~~~~~--~~-------~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRER----IESGY--RM-------PAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHH----HhcCC--CC-------CCCcc
Confidence 23567999999988899999999999999999999 888886332211 1111 11110 00 01112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 852 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 852 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
....+.+++.+|++.+|++||++.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2347889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.36 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=206.8
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
+....+++.+.||+|+||+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 34567788899999999999999876 58899999876543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++++|.+++.. .+.+++..+..++.+++.||.|||+ ..+++||||||+||++++++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999998874 3568999999999999999999996 36899999999999999999999999999865432
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCcc-----chhhHHHHHHHhhhcCCeee
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~-----~~~~l~~~~~~~~~~~~~~~ 838 (931)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ....+..+....+... .
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-- 230 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-P-- 230 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-C--
Confidence 21 12345889999999998889999999999999999999999999743321 1112223333322211 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002358 839 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 881 (931)
Q Consensus 839 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 881 (931)
+.+. .......+.+++.+|++.+|++||+++|+++..
T Consensus 231 ---~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 ---PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111 111334688999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=332.79 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=209.5
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CC----cEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DG----KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g----~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
+...+-.++||.|+||+||+|.|- +| -+||+|++.... ....+++++|+-+|.+|+|||+++++|+|.... ..
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 334445689999999999999874 44 368999987653 345678999999999999999999999998766 78
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
||++||+.|+|.++++. .+..+.....+.|+.|||+||.|||. ++++||||.++|||+..-..+||.|||+++..
T Consensus 774 lvtq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 99999999999999986 45667788899999999999999997 99999999999999999999999999999987
Q ss_pred cccccccc-cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 762 EEDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 762 ~~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
..+..... ....-.+.|||-|.+....|+.++|||||||++||++| |..|++.....+..++ ++.++.
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------le~geR--- 918 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------LEKGER--- 918 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------Hhcccc---
Confidence 65443322 22334678999999999999999999999999999999 9999985544333322 222221
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
-..++-...++..++.+||..|+..||+++|+...+.+..
T Consensus 919 ------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 919 ------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred ------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 1234445557889999999999999999999998887654
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=312.07 Aligned_cols=259 Identities=22% Similarity=0.318 Sum_probs=199.0
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
+++.++||+|+||.||++.+. ++..+|+|.++.... ....++.+|++++++++||||+++++.+.+++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 456789999999999999876 578899998865432 334568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+++|.++++. ...+++..+..++.|+++||+|||+ ..+++||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 83 GGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999999974 3568889999999999999999996 3589999999999999999999999999987643321
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee-----------
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI----------- 837 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~----------- 837 (931)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...+... ...+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCC
Confidence 223457899999999988889999999999999999999999996433211 111111100000000
Q ss_pred ---------eccccccc---CCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 838 ---------SIVDPVLI---GNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 838 ---------~i~d~~l~---~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
+..+.... ...+ ......+.+++.+||..+|++||+++||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 0000 0122358899999999999999999998864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.30 Aligned_cols=238 Identities=26% Similarity=0.435 Sum_probs=189.7
Q ss_pred cccCccCcEEEEEEEECCCc-----------EEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 615 KKIGKGSFGSVYYGKMKDGK-----------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~-----------~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
+.||+|+||.||+|.+++.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999987433 5788877654333 6789999999999999999999999988 778999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC-------ceEEeccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-------RAKVSDFG 756 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~-------~vkL~DFG 756 (931)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998753 2268899999999999999999997 8999999999999999887 79999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCC--CCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhc
Q 002358 757 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKK 833 (931)
Q Consensus 757 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 833 (931)
++..... .....++..|+|||++... .++.++||||||+++|||++ |..||....... ...+.. .
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~~---~- 221 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQ---D- 221 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHHh---c-
Confidence 9886543 1223467789999998776 78999999999999999999 577776332111 111110 0
Q ss_pred CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 834 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 834 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
... . +......+.+++.+||..+|.+||++.||++.|+
T Consensus 222 ~~~--~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHR--L---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCC--C---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0 0001147889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=312.79 Aligned_cols=257 Identities=29% Similarity=0.473 Sum_probs=202.8
Q ss_pred HHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
...+++.+.||+|+||.||+|.++ ++..||+|+++.... ...+++.+|++++++++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 345667789999999999999864 467899999875433 3456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC-------------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCC
Q 002358 681 ILVYEYMHNGTLRDRLHGSV-------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 741 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~-------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~N 741 (931)
++|+||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999986421 12347888999999999999999998 899999999999
Q ss_pred ccccCCCceEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccc
Q 002358 742 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 819 (931)
Q Consensus 742 ILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~ 819 (931)
|++++++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999875433221 11122234668999999988899999999999999999998 88888532221
Q ss_pred hhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 820 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 820 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
.... .+..+..... +......+.+++.+|++.+|++||++.|+++.|++
T Consensus 240 --~~~~----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --EVIY----YVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHH----HHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 2222222111 11223468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=327.85 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=192.9
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++|+||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 456789999999999999876 58999999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc--
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-- 764 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~-- 764 (931)
+++|+|.+++.. .+.++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 83 IPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999874 4567888889999999999999998 89999999999999999999999999997532100
Q ss_pred ----------------------------------------ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHH
Q 002358 765 ----------------------------------------LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLE 804 (931)
Q Consensus 765 ----------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~e 804 (931)
.........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0000112468999999999999999999999999999999
Q ss_pred HHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 002358 805 LISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP---KMQEIVLA 880 (931)
Q Consensus 805 LltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP---s~~evl~~ 880 (931)
|++|+.||........ ............+ +. ....+ ..+.+++.+|+ .+|++|+ ++.|+++.
T Consensus 237 ll~G~~Pf~~~~~~~~------~~~i~~~~~~~~~--~~-~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAET------QLKVINWETTLHI--PS-QAKLS----REASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHH------HHHHhccCccccC--CC-CCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999974432211 1111110000000 00 01112 24567777765 5999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=310.82 Aligned_cols=262 Identities=27% Similarity=0.462 Sum_probs=204.6
Q ss_pred HHHhhccccCccCcEEEEEEEEC-----CCcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEec--CCeE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQR 680 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~ 680 (931)
..+++.+.||+|+||.||+|.+. .++.+|+|++...... ..+.|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34566789999999999999864 3689999999765443 56789999999999999999999999877 5678
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999753 3358999999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccc--cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchh--------hHHHHHHHh
Q 002358 761 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--------NIVHWARSM 830 (931)
Q Consensus 761 ~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~--------~l~~~~~~~ 830 (931)
....... ......++..|++||.+.+..++.++||||||++++||++|+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532211 111223456799999998889999999999999999999999998632221100 001111111
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 831 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 831 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
+..+... ..+...+..+.+++.+||+.+|++||++.||+++|+.+
T Consensus 239 ~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERL---------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcC---------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111110 01112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=304.54 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=199.9
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
...+.+.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 346778899999999999999875 6889999998765555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+++.. .+.+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999999873 4568899999999999999999998 8999999999999999999999999999876543221
Q ss_pred ccccccccCCCccCCCccC---CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 767 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
......|+..|+|||.+. ...++.++|||||||++|||++|+.||....... .... ... ... ..+.
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~----~~~-~~~---~~~~ 230 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFL----MTK-SNF---QPPK 230 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHh----hhc-cCC---CCCc
Confidence 122345899999999874 4568889999999999999999999985322111 1100 000 110 0011
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
... .......+.+++.+|++.+|++||++++|++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 110 0011235789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.07 Aligned_cols=248 Identities=27% Similarity=0.393 Sum_probs=200.6
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+.|...+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++.+..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45666788999999999999875 57899999986443 34456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+++.. ..+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999998863 458889999999999999999997 8999999999999999999999999999876543321
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ...+ +..+. .+.+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~----~~~~~-----~~~~-- 221 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFL----IPKNS-----PPTL-- 221 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhh----hhcCC-----CCCC--
Confidence 1222357889999999999899999999999999999999999986322111 1111 11111 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.......+.+++.+|++.+|++||++.|+++.
T Consensus 222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 --EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12233468899999999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=295.83 Aligned_cols=258 Identities=21% Similarity=0.241 Sum_probs=196.8
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchh--hhhHHHHHHHHHhcCCCCCcceeEEEec--CCeEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVY 684 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~~lV~ 684 (931)
.++...+|++|.||.||+|+.+ +++.||+|+++-..... .-.-++|+.+|.+.+|||||.+-.+... -+..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 3445678999999999999876 68899999997543211 1346799999999999999999887654 45799999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
|||+. +|.+.+... ..++...+..-++.|+++|++|||. ..|+|||||++|+|+.+.|.+||+|||+|+.++..
T Consensus 157 e~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99975 888888753 3678889999999999999999998 89999999999999999999999999999998766
Q ss_pred ccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
.. ..+....|.+|+|||.+.+ ..|+.+.|+||+||++.||+++++-|.+....+..+. +.+.+ |...+.+.|.
T Consensus 231 ~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~---If~ll--GtPte~iwpg 304 (419)
T KOG0663|consen 231 LK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK---IFKLL--GTPSEAIWPG 304 (419)
T ss_pred cc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH---HHHHh--CCCccccCCC
Confidence 33 2344557999999998766 5899999999999999999999999985543332221 11121 1111111111
Q ss_pred -------------------ccCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 844 -------------------LIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 844 -------------------l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+.+.+... ..+.=.+++...+..||.+|-|++|-++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11111111 1123468899999999999999999764
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=324.86 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=193.4
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|.+.+.||+|+||.||++..+ +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 456789999999999999876 68999999986432 22346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 83 LPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999873 4568888899999999999999998 8999999999999999999999999999864221000
Q ss_pred ------------c----------------------------------cccccccCCCccCCCccCCCCCCccchhHHHHH
Q 002358 767 ------------H----------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 800 (931)
Q Consensus 767 ------------~----------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGv 800 (931)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001235899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHH
Q 002358 801 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR---PKMQEI 877 (931)
Q Consensus 801 lL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~~ev 877 (931)
++|||++|+.||....... ... ............+. ......+.+++.+|+. +|.+| +++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~---~~~---~i~~~~~~~~~p~~-------~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENSHE---TYR---KIINWRETLYFPDD-------IHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCHHH---HHH---HHHccCCccCCCCC-------CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 9999999999997433211 111 11110000011000 0112357789999997 66665 599888
Q ss_pred HHH
Q 002358 878 VLA 880 (931)
Q Consensus 878 l~~ 880 (931)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.08 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=200.1
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc-cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+..+...+++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 456789999999999999876 6889999988543 23345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|+|.+.+... ....++...++.++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 156 (255)
T cd08219 82 GGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY- 156 (255)
T ss_pred CCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc-
Confidence 99999988643 23457888999999999999999998 89999999999999999999999999998765433221
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
.....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.. ... . .+..+....+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~---~-~~~~~~~~~~--------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NLI---L-KVCQGSYKPL--------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HHH---H-HHhcCCCCCC---------
Confidence 22345888999999999888999999999999999999999999743221 111 1 1111221111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.+|++||++.||+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 1112235789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=317.36 Aligned_cols=240 Identities=24% Similarity=0.341 Sum_probs=191.6
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 685 (931)
+++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+..|..+++.+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456789999999999999876 68899999987532 233456788999998885 5778889999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 82 YVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999873 3568999999999999999999998 899999999999999999999999999987543222
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+ . ....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i---~-~~~~--------- 218 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSI---M-EHNV--------- 218 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH---H-hCCC---------
Confidence 1 12234589999999999998999999999999999999999999974322 1122211 1 1111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 874 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 874 (931)
.++......+.+++.+||+.+|++|++.
T Consensus 219 -~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111122367899999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.76 Aligned_cols=251 Identities=30% Similarity=0.469 Sum_probs=193.3
Q ss_pred cccCccCcEEEEEEEECC----CcEEEEEEccCc-cchhhhhHHHHHHHHHhcCCCCCcceeEEEe-cCCeEEEEEEecC
Q 002358 615 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVYEYMH 688 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~~~lV~E~~~ 688 (931)
+.||+|+||.||+|.+.+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++. .+...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 457999988543 2344578889999999999999999999875 4556789999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc-
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 767 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~- 767 (931)
+|+|.+++... ....++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998743 3346778889999999999999998 89999999999999999999999999998764332111
Q ss_pred --cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhC-CCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 768 --ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 768 --~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
......++..|+|||.+.+..++.++||||||+++|||++| ..||...+ ...+...+ ..+... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~----~~~~~~-----~~ 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVYL----LQGRRL-----LQ 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH----hcCCCC-----CC
Confidence 11123356789999999888999999999999999999995 45554221 11222221 111110 00
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
+...+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 224 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 11122468899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=307.17 Aligned_cols=240 Identities=25% Similarity=0.439 Sum_probs=189.6
Q ss_pred cccCccCcEEEEEEEECC--------CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 615 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+.||+|+||.||+|..+. ...+|+|.+........+.+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999998752 235888887655555567889999999999999999999999998899999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc--------eEEeccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--------AKVSDFGLS 758 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~--------vkL~DFGla 758 (931)
+++|+|.++++.. ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999753 3368899999999999999999998 99999999999999987765 699999988
Q ss_pred ccccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCC-CCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 759 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 759 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~-~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+...+... .... .. ..
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~~----~~-~~- 221 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQF----YE-DR- 221 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHHH----HH-cc-
Confidence 654321 22347889999999976 45789999999999999999985 5554222111 1110 00 00
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
. ..+.....++.+++.+||+.+|++||++++|++.|+
T Consensus 222 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 H---------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c---------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 111112246889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=305.89 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=200.1
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
..|++.++||+|+||.||+|+.. +++.+++|++........+.+.+|+++++.++||||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 55778899999999999999886 48899999987665566778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|..++... ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 999998887642 3468899999999999999999997 8999999999999999999999999999875433221
Q ss_pred cccccccCCCccCCCccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 768 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
......+++.|+|||++. ...++.++|||||||++|||++|+.||...... ....... .........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~- 237 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIA-KSEPPTLSQ- 237 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHh-cCCCccCCC-
Confidence 122345788999999984 345678999999999999999999999633211 1111111 111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.+|++||+++|+++
T Consensus 238 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 238 ------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1122336789999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=326.14 Aligned_cols=249 Identities=22% Similarity=0.278 Sum_probs=190.5
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+++.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++.+.+....++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 445789999999999999876 58899999986532 23446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc-
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 765 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~- 765 (931)
+++|+|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 83 IPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999874 3467888889999999999999998 899999999999999999999999999975321000
Q ss_pred ---------------------------------------------cccccccccCCCccCCCccCCCCCCccchhHHHHH
Q 002358 766 ---------------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 800 (931)
Q Consensus 766 ---------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGv 800 (931)
........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011235899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHH
Q 002358 801 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEI 877 (931)
Q Consensus 801 lL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~ev 877 (931)
++|||++|+.||...+.... ............. +. ....+. ...+++.+|+ .+|++|++ ++|+
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~--p~-~~~~s~----~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET------QMKVINWQTSLHI--PP-QAKLSP----EASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH------HHHHHccCCCcCC--CC-cccCCH----HHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999974332111 1111110000000 00 011222 4556666665 49999997 7776
Q ss_pred HH
Q 002358 878 VL 879 (931)
Q Consensus 878 l~ 879 (931)
++
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 54
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.57 Aligned_cols=250 Identities=23% Similarity=0.288 Sum_probs=196.7
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
++..+.||+|+||+||+|.+. +++.+|+|.+..... .....+.+|++++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 345678999999999999876 688999999865322 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+.+... ....+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999888643 23468999999999999999999998 8999999999999999999999999999875432211
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.....|+..|+|||.+.+..++.++|+||||+++|||++|+.||......... .. +...+.....
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~-~~~~~~~~~~---------- 222 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EE-VDRRVLETEE---------- 222 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHhhhcccc----------
Confidence 12345899999999999889999999999999999999999999743221111 11 1111111110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 879 (931)
.+.......+.+++.+|++.+|++||+ +.++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 011122235789999999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.11 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=194.6
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
...||+|+||.||+|.+. +++.||+|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 457999999999999866 5788999998776666677899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC-CCceEEecccccccccccccccccc
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSV 771 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~ 771 (931)
.+++.........++..+..++.|+++||+|||+ .+|+||||||+||+++. ++.++|+|||++......... ...
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-TET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-ccc
Confidence 9998753211122778888999999999999998 89999999999999976 678999999998765332221 222
Q ss_pred cccCCCccCCCccCCC--CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 772 ARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 772 ~~gt~~y~APE~l~~~--~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
..|++.|+|||.+... .++.++||||||+++|+|++|+.||....... ...+...... .....+
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~-----------~~~~~~ 234 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK-----------IHPEIP 234 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc-----------cCCCCC
Confidence 3478999999998654 37889999999999999999999996322111 1111110000 001112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......+.+++.+||+.+|++||+++|+++
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 223346789999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=321.70 Aligned_cols=255 Identities=23% Similarity=0.327 Sum_probs=197.8
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
+....|++.+.||+|+||.||+++++ +++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.++...+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34567778899999999999999987 57899999986422 223456788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+||||+++|+|.+++.. ..++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 120 lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 99999999999999863 347888888999999999999998 99999999999999999999999999999876
Q ss_pred cccccccccccccCCCccCCCccCCC----CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
............||+.|+|||++... .++.++|||||||++|||++|+.||...+... . ...........
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~---~~~i~~~~~~~ 266 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---T---YSKIMNHKNSL 266 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH---H---HHHHHcCCCcc
Confidence 44333333445699999999998653 37889999999999999999999997433211 1 11111111111
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 880 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 880 (931)
...+. ......+.+++.+|++..+.+ ||+++|+++.
T Consensus 267 ~~~~~-------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 267 TFPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cCCCc-------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11111 112235678899999844433 7788888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=302.14 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=190.0
Q ss_pred cccCccCcEEEEEEEECC---CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 615 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~---g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
+.||+|+||.||+|...+ ...+|+|.+..... .....+.+|+++++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997653 35788888764432 33467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCC--CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc-c
Q 002358 691 TLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-H 767 (931)
Q Consensus 691 sL~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~-~ 767 (931)
+|.+++..... ....++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999875432 2335677888999999999999998 8999999999999999999999999999875432211 1
Q ss_pred cccccccCCCccCCCccC-------CCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 768 ISSVARGTVGYLDPEYYG-------NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~-------~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
......++..|+|||++. ...++.++|||||||++|||++ |..||...... .. ....+..+ ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~---~~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QV---LKQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH---HHHHhhcc-CccC
Confidence 122234567899999864 3456889999999999999999 78888632211 11 11112211 1122
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
.++.+.. .....+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222221 22235667888898 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=330.50 Aligned_cols=258 Identities=22% Similarity=0.255 Sum_probs=189.4
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecC--------Ce
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--------HQ 679 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--------~~ 679 (931)
..|.+.++||+|+||.||+|... .++.||||++.... ....+|+.+|+.++||||+++++++... ..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 34677899999999999999876 58899999885432 2345799999999999999999876432 24
Q ss_pred EEEEEEecCCCCHHHHhccC-CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC-ceEEecccc
Q 002358 680 RILVYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGL 757 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~-~vkL~DFGl 757 (931)
.++||||+++ +|.+.+... .....+++..+..++.||++||+|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 6689999975 676665432 245678999999999999999999998 8999999999999999665 699999999
Q ss_pred cccccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc---
Q 002358 758 SRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK--- 833 (931)
Q Consensus 758 a~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~--- 833 (931)
++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||......+. +.. +.+....
T Consensus 218 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~-i~~~~~~p~~ 292 (440)
T PTZ00036 218 AKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVR-IIQVLGTPTE 292 (440)
T ss_pred chhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCCH
Confidence 986543222 223457999999998765 4789999999999999999999999974432211 111 1111100
Q ss_pred -------CCeee-----cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 834 -------GDVIS-----IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 834 -------~~~~~-----i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..... +....+...++.....++.+++.+||+.+|.+|||+.|+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000 00011111112223346889999999999999999999873
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=311.88 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=196.1
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.|.+.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|++++++++||||+++++++......++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 4566789999999999999876 57899999986432 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
+ ++|.+.+... ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 87 ~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 87 D-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred c-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 7 5898888643 3457889999999999999999998 89999999999999999999999999998764322211
Q ss_pred cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh---cCCeeeccc--
Q 002358 768 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---KGDVISIVD-- 841 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~---~~~~~~i~d-- 841 (931)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..... ..+..... ......+++
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCChhhchhhhccc
Confidence 122346889999998765 45788999999999999999999999744332111 11111110 000000000
Q ss_pred -------ccccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 842 -------PVLIGN----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 842 -------~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+..... ........+.+++.+|++.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 01112235789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.46 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=202.0
Q ss_pred HHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
..+...+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 44556788999999999999875 2467999988654333 4567999999999999999999999999989999
Q ss_pred EEEEecCCCCHHHHhccCCCC------CCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQ------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 755 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~------~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DF 755 (931)
+||||+++|+|.+++...... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998754322 268999999999999999999997 89999999999999999999999999
Q ss_pred cccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcC
Q 002358 756 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 834 (931)
Q Consensus 756 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 834 (931)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ....... ..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~----~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRL----QAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHH----HcC
Confidence 9987543322222223346778999999988888999999999999999999 7888853221 1222211 111
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 835 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 835 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
..... .+...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 235 ~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11100 01122347889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.51 Aligned_cols=250 Identities=25% Similarity=0.310 Sum_probs=197.2
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
++..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 345688999999999999876 688999998865321 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999988643 23458899999999999999999998 9999999999999999999999999999876433221
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.....|+..|+|||.+.+..++.++||||+|+++|||++|+.||............. ....... .....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~~~------~~~~~ 226 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKEVQ------EEYSE 226 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhhhh------hhcCc
Confidence 122358999999999999999999999999999999999999997432211111111 1110000 00111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 879 (931)
. ....+.+++.+||+.+|++||+ ++|+++
T Consensus 227 ~----~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 K----FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred c----CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1 2235789999999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=294.37 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=199.0
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccC--ccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
...|++.++||+|.|+.||+..+. .|+.+|+|++.. -...+.+++.+|+.|.+.|+|||||++.+.+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456777899999999999998765 688899887743 22346678999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC---CCceEEecccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA 761 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~~ 761 (931)
|+|.|++|..-+-. +-.+++..+-..+.||+++|.|+|. .+|+|||+||+|+|+.. ..-+||+|||++...
T Consensus 90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999654432 2446677778889999999999998 99999999999999943 445899999999987
Q ss_pred cccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
.. ........|||+|||||++...+|+..+|||+.||+||-|+.|.+||.+++.. .+.+ .+..+... ++
T Consensus 164 ~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye----~I~~g~yd--~~ 232 (355)
T KOG0033|consen 164 ND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYE----QIKAGAYD--YP 232 (355)
T ss_pred CC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHH----HHhccccC--CC
Confidence 62 22334456999999999999999999999999999999999999999854432 2222 23233221 12
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 878 (931)
++-.....+ .-.+++++||..||++|.|+.|.+
T Consensus 233 ~~~w~~is~----~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 233 SPEWDTVTP----EAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CcccCcCCH----HHHHHHHHHhccChhhhccHHHHh
Confidence 222222222 457899999999999999999977
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=309.57 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=201.8
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
..|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 56777899999999999999874 79999999987655555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999863 357888999999999999999998 89999999999999999999999999998765433221
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+..... . .....+ . +.. .
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~----~~~~~~-~-----~~~--~ 236 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y----LIATNG-T-----PEL--Q 236 (297)
T ss_pred -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--e----eeccCC-C-----CCC--C
Confidence 22335788999999999988999999999999999999999999743321110 0 000000 0 000 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+......+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122345789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=305.99 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=200.1
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.+++.+.||+|+||.||++.++ .++.||+|.++... ....+.+.+|++++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4667899999999999999987 78999999886532 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+++........+++..+..++.|+++||.|||+ ..+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 999999988754334578999999999999999999996 3699999999999999999999999999987653322
Q ss_pred cccccccCCCccCCCccCCC------CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 768 ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~------~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
.....+++.|+|||.+.+. .++.++|+|||||++|||++|+.||....... ....... +..+...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~-~~~~~~~---- 228 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSA-IVDGDPP---- 228 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHH-HhhcCCC----
Confidence 2223478899999998554 35789999999999999999999996332211 1111111 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+......+.+++.+|++.+|++||+++++++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 -----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 112223446789999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=317.06 Aligned_cols=253 Identities=25% Similarity=0.308 Sum_probs=193.9
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc---cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|++.+.||+|+||.||+++.+ +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 567889999999999999976 5899999998642 122345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 9999999998642 4568889999999999999999998 8999999999999999999999999999876544333
Q ss_pred ccccccccCCCccCCCccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 767 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||...... +.............+..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~~~ 231 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQFPP 231 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcccCCC
Confidence 33333468999999999863 45788999999999999999999999743321 11111111111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQ--RGFSRPKMQEIVLA 880 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~--dP~~RPs~~evl~~ 880 (931)
.... ....+.+++.+|+.. ++..||+++++++.
T Consensus 232 --~~~~----~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 --DVTD----VSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred --ccCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0011 223566777776654 33448899888764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.89 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=197.6
Q ss_pred cccCccCcEEEEEEEECC-------CcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 615 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~-------g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+.||+|+||.||+|++++ ++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999998753 2579999886543 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC-----ceEEecccc
Q 002358 687 MHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-----RAKVSDFGL 757 (931)
Q Consensus 687 ~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~-----~vkL~DFGl 757 (931)
+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999987432 22457889999999999999999997 8999999999999999877 899999999
Q ss_pred ccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCC
Q 002358 758 SRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 835 (931)
Q Consensus 758 a~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 835 (931)
++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+ ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHH----hcCC
Confidence 876533221 11222345678999999999999999999999999999998 9999863221 1222211 1111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 836 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 836 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
.. ..+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10 1112233567899999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=309.60 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=200.6
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.|++.+.||.|++|.||+|... +++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 4566789999999999999864 689999999876555556778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+++|.+++.. ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 100 GGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred CCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 9999998863 358899999999999999999998 89999999999999999999999999998765433221
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..... ... .. ....... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~---~~~---~~-~~~~~~~-------~ 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLI---AT-NGTPELQ-------N 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH---Hh-cCCcccC-------C
Confidence 22345788999999999888999999999999999999999999744322111 111 10 1110100 0
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||..+|++||++.+|++
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1112235778999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=307.65 Aligned_cols=261 Identities=21% Similarity=0.260 Sum_probs=195.8
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++.+.||+|++|.||+|..+ +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 456788999999999999876 689999999864322 23457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
+ ++|.+++........+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR- 156 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence 7 6898888754444678999999999999999999998 8999999999999999999999999999876433211
Q ss_pred cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh--cC---------C
Q 002358 768 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK--KG---------D 835 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~--~~---------~ 835 (931)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ .......... .. .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhHH
Confidence 1122346889999998765 4578899999999999999999999974332111 1110000000 00 0
Q ss_pred ----eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 836 ----VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 836 ----~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
........+. ........++.+++.+||+.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 000012235679999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.53 Aligned_cols=264 Identities=21% Similarity=0.286 Sum_probs=198.9
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCC-CcceeEEEecCC------
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEH------ 678 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~~~------ 678 (931)
..+...++||+|+||+||+|+.+ +|+.||+|+++-... .......+|+.+|++|+|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34555678999999999999876 689999999875433 23345689999999999999 999999998877
Q ss_pred eEEEEEEecCCCCHHHHhccCCCC-CCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 757 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGl 757 (931)
..++|+||++ -+|.+++...... ..++...+..++.||++||+|||+ ++|+||||||.||||++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 5899888764321 457778899999999999999998 9999999999999999999999999999
Q ss_pred cccccccccccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh---c
Q 002358 758 SRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---K 833 (931)
Q Consensus 758 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~---~ 833 (931)
|+...-.... .+...+|..|+|||++.+. .|+...||||+||++.||++++.-|.+....+.. ..+.+.+. +
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql---~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQL---FRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHH---HHHHHHcCCCCc
Confidence 9865422221 3344589999999998776 8999999999999999999999988754432111 11222211 1
Q ss_pred CCeeecc---ccc--ccCC-----CCHHHH---HHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 834 GDVISIV---DPV--LIGN-----VKIESI---WRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 834 ~~~~~i~---d~~--l~~~-----~~~~~~---~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.....+. +-. .... ...... ....+++.+|++.+|++|.|++..++.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111110 100 0000 001111 256799999999999999999998864
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=301.35 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=190.1
Q ss_pred cccCccCcEEEEEEEECCC---cEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 615 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g---~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
+.||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976543 346677665433 234578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc-cccc
Q 002358 691 TLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHI 768 (931)
Q Consensus 691 sL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~-~~~~ 768 (931)
+|.++++... .....++..+..++.|+++||+|||+ .+++||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999987532 22346677788999999999999998 89999999999999999999999999998643211 1112
Q ss_pred ccccccCCCccCCCccCC-------CCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 769 SSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~-------~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... ... ....+. +......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~---~~~~~~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REV---LNHVIK-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHH---HHHHHh-hcccccC
Confidence 223457889999998743 245789999999999999997 5667752221 111 111121 2223334
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
++.+...++ ..+.+++..|| .+|++||+++||++.|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 443332222 35678889999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=300.93 Aligned_cols=249 Identities=28% Similarity=0.420 Sum_probs=201.6
Q ss_pred HHHhhccccCccCcEEEEEEEECC-CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
..|++.+.||+|+||.||+|.+.+ ++.+++|.+..... .+++.+|++++++++|+||+++++.+......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 346678899999999999999875 78999999865422 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+++... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998642 4568999999999999999999998 8999999999999999999999999999887544321
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
......++..|+|||.+.+..++.++||||||+++|||++|+.||......... . .+..... +.+ .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~-----~~~~~~~-----~~~--~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--F-----MIPNKPP-----PTL--S 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--h-----hhccCCC-----CCC--C
Confidence 222344788999999999889999999999999999999999999733221110 0 0000000 000 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+......+.+++.+|++.+|++||+++|+++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11122346889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=340.35 Aligned_cols=260 Identities=22% Similarity=0.350 Sum_probs=202.4
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|++.++||+|+||.||+|... .|+.||+|++..... ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 556789999999999999876 589999999875422 2346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC--------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 687 MHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 687 ~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
+++|+|.+++.... .....++..+++++.||++||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcc
Confidence 99999999886421 12345677889999999999999998 89999999999999999999999999999
Q ss_pred cccccccc-----------------ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchh
Q 002358 759 RQAEEDLT-----------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 821 (931)
Q Consensus 759 ~~~~~~~~-----------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~ 821 (931)
+....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+...
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k-- 238 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK-- 238 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh--
Confidence 86521100 01112458999999999999999999999999999999999999997422211
Q ss_pred hHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhhhh
Q 002358 822 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKI 887 (931)
Q Consensus 822 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~~~~~ 887 (931)
... . ... .++.-.. ...+.+..+.+++.+|++.+|++|| +++++.+.|+.....
T Consensus 239 -i~~-~------~~i---~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 -ISY-R------DVI---LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred -hhh-h------hhc---cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 100 0 000 0000000 0012234678999999999999996 678888888877654
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=303.18 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=201.9
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
..|+..+.||.|+||.||+|.++ .++.||+|++.... ....+.+.+|++++++++||||+++++.+.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 44566788999999999999876 58899999986543 34457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++.. ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998863 357888999999999999999998 8999999999999999999999999999876543322
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
. .....++..|+|||.+.+..++.++|+|||||++|||++|+.||....... ... .+..+. ..
T Consensus 157 ~-~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~----~~~~~~---------~~ 219 (277)
T cd06640 157 K-RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLF----LIPKNN---------PP 219 (277)
T ss_pred c-cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hhh----hhhcCC---------CC
Confidence 1 223357889999999988889999999999999999999999997332111 110 111111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.........+.+++.+||+.+|++||+++++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1233445678899999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=302.75 Aligned_cols=247 Identities=28% Similarity=0.432 Sum_probs=197.6
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch---------hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~---------~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
+.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 345688999999999999875 5889999988643221 225688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999974 3568888999999999999999998 8999999999999999999999999999887
Q ss_pred ccccccc-----cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCC
Q 002358 761 AEEDLTH-----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 835 (931)
Q Consensus 761 ~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 835 (931)
....... ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...... .... . +...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~---~-~~~~- 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIF---K-IGEN- 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHHH---H-Hhcc-
Confidence 6432111 111234788999999999888999999999999999999999999733211 1111 1 1111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 836 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 836 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+.+ +......+.+++.+||+.+|++||++.||++
T Consensus 228 ----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ----ASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----CCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111 1223346789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=314.99 Aligned_cols=251 Identities=27% Similarity=0.387 Sum_probs=207.9
Q ss_pred HHHHHhhccccCccCcEEEEEEEECC-CcEEEEEEccCccch---hhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH---RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~ 681 (931)
....|++.+.||+|.||.||+++.+. |+.+|+|++.+.... ....+.+|+++|+++. |||||.+.+.+++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34567778999999999999999885 999999999765432 3458899999999998 999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC----CceEEecccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGL 757 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~----~~vkL~DFGl 757 (931)
+|||++.||.|.+.+... .+++.....++.|++.+++|||+ .+|+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998854 38999999999999999999998 999999999999999643 5799999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 758 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 758 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||..+....... .+..++.
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF- 255 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-
Confidence 998765 334456679999999999999999999999999999999999999998554322211 2222322
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+..++ .. ........+++.+|+..||.+|++++++++
T Consensus 256 ~f~~~-~w----~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 DFTSE-PW----DDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCC-Cc----cccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 11111 11 122336789999999999999999999987
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=306.54 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=204.5
Q ss_pred HHHHHhhccccCccCcEEEEEEEECC-Cc----EEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKD-GK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~----~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
....+++.+.||+|+||.||+|.+++ |+ .+|+|.+..... ....++.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 34566778999999999999998753 33 589998876543 345678999999999999999999999987 788
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++|+||+++|+|.+++... ...+++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999998753 3458999999999999999999998 8999999999999999999999999999987
Q ss_pred cccccccc-ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeee
Q 002358 761 AEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 761 ~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 838 (931)
........ .....++..|+|||.+....++.++|+||||+++||+++ |+.||...... .+.+ .+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~~ 231 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPD----LLEKGERLP 231 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHhCCCCCC
Confidence 54332211 111224568999999988889999999999999999999 99999743221 1222 122211100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 839 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 839 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
. +......+.+++.+||..+|++||++.++++.|+++.+
T Consensus 232 --~-------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 232 --Q-------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --C-------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 11122367899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=304.56 Aligned_cols=250 Identities=24% Similarity=0.412 Sum_probs=194.8
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEecC------CeE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE------HQR 680 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~------~~~ 680 (931)
..+++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +|+||+++++++... ...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 34566788999999999999876 58899999986442 3345788999999998 699999999998652 468
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+++|+|.+++... ....+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.++|+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 8999999999999998753 23468899999999999999999998 8999999999999999999999999999876
Q ss_pred ccccccccccccccCCCccCCCccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCC
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 835 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 835 (931)
...... ......|+..|+|||++. ...++.++|||||||++|||++|+.||......... . ......
T Consensus 161 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~---~----~~~~~~ 232 (272)
T cd06637 161 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---F----LIPRNP 232 (272)
T ss_pred cccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH---H----HHhcCC
Confidence 543222 223345889999999985 346788999999999999999999999632211100 0 011111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 836 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 836 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..... .......+.+++.+||..+|.+||+++|+++
T Consensus 233 ~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 10111 1112346789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.21 Aligned_cols=262 Identities=25% Similarity=0.305 Sum_probs=191.9
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch--hhhhHHHHHHHHHhc---CCCCCcceeEEEec-----CCe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRI---HHRNLVPLIGYCEE-----EHQ 679 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~il~~l---~HpnIv~l~g~~~~-----~~~ 679 (931)
|++.+.||+|+||.||+|..+ +++.||+|.++..... ....+.+|+++++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456789999999999999877 5889999998653221 224566787777766 69999999998754 345
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
.++||||+. ++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 789999997 5888888643 23458999999999999999999998 899999999999999999999999999998
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchh-hHHHHHHHhhhcCCeee
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKGDVIS 838 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~~~ 838 (931)
....... .....|+..|+|||++.+..++.++||||+||++|||++|+.||......+.. .+...............
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 6543221 22345789999999999889999999999999999999999999643322111 11111100000000000
Q ss_pred ------cccccc---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 839 ------IVDPVL---IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 839 ------i~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+.. .....++....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 00011122346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=303.48 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=201.2
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
..|++.+.||.|++|.||++.+. +++.+|+|.+........+.+.+|++++++++||||+++++.+..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45778899999999999999876 68999999987665566678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999998742 3568999999999999999999998 89999999999999999999999999988764332221
Q ss_pred cccccccCCCccCCCccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 768 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
.....+++.|+|||.+. ...++.++||||||+++|||++|+.||...+.. ... .. +..+....+.
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~----~~-~~~~~~~~~~-- 229 (280)
T cd06611 160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVL----LK-ILKSEPPTLD-- 229 (280)
T ss_pred -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHH----HH-HhcCCCCCcC--
Confidence 22345889999999874 345678999999999999999999999743221 111 11 1111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+......+.+++.+||+.+|++||+++++++
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 230 -----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred -----CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 01122336789999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=309.28 Aligned_cols=195 Identities=25% Similarity=0.384 Sum_probs=159.7
Q ss_pred ccccCccCcEEEEEEEEC---CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEec--CCeEEEEEEecC
Q 002358 614 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYMH 688 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~ 688 (931)
.++||+|+||+||+|+.+ +++.||+|.+.... ....+.+|++++++++||||+++++.+.. +...++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999875 46789999986532 23457889999999999999999998854 456789999985
Q ss_pred CCCHHHHhccCC------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc----cCCCceEEeccccc
Q 002358 689 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS 758 (931)
Q Consensus 689 ~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl----d~~~~vkL~DFGla 758 (931)
++|.+.+.... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58877765321 22358889999999999999999998 899999999999999 45678999999999
Q ss_pred ccccccccc--cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 002358 759 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSV 814 (931)
Q Consensus 759 ~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~ 814 (931)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 875443221 1223468999999999876 4689999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=320.76 Aligned_cols=264 Identities=22% Similarity=0.255 Sum_probs=199.7
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEEC---CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
.+....|++.+.||+|+||.||++... .++.||+|.+... +...+|++++++++||||+++++++......+
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 334456788899999999999999764 3578999987643 34568999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+|||++. ++|.+++. ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 163 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 163 MVMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999995 68888884 34678999999999999999999998 89999999999999999999999999999765
Q ss_pred cccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee--e
Q 002358 762 EEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--S 838 (931)
Q Consensus 762 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~--~ 838 (931)
...... ......||+.|+|||++....++.++|||||||++|||++|+.||.............-+.+.+...... .
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 433222 2223468999999999999999999999999999999999999997544332111111111111110000 0
Q ss_pred -----c------ccccccCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 839 -----I------VDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 839 -----i------~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
+ ........+. ......+.+++.+||+.+|++||++.|++..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0000000000 0112357789999999999999999999853
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=303.78 Aligned_cols=247 Identities=28% Similarity=0.410 Sum_probs=200.8
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.|++.+.||.|++|.||+|... +++.||+|++.... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 3567789999999999999876 58899999986543 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++........
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 82 GGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 99999999874 278999999999999999999998 89999999999999999999999999999876543222
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||...+.. ... ..+..+....+. ..
T Consensus 155 -~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~----~~~~~~~~~~~~-----~~ 221 (274)
T cd06609 155 -RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVL----FLIPKNNPPSLE-----GN 221 (274)
T ss_pred -cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHH----HHhhhcCCCCCc-----cc
Confidence 22335788999999999888999999999999999999999999743311 111 111111111111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.....+.+++.+||..+|++||+++++++
T Consensus 222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02236789999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=298.51 Aligned_cols=250 Identities=33% Similarity=0.556 Sum_probs=201.1
Q ss_pred hhccccCccCcEEEEEEEECC-----CcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 612 NFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
++.+.||+|+||.||++.+.+ +..||+|++...... ..+.+..|+++++.++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 356889999999999998874 488999999765443 56789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++++|.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999987532 1228999999999999999999998 899999999999999999999999999998765442
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
........+++.|+|||.+.+..++.++||||+|++++||++ |..||..... ....+.+. .+.....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~----~~~~~~~----- 225 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLK----KGYRLPK----- 225 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh----cCCCCCC-----
Confidence 222222336789999999988889999999999999999998 7888863221 12222221 1111110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 881 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 881 (931)
+......+.+++.+|+..+|++|||+.|+++.|
T Consensus 226 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111234688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=298.44 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=202.2
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.+++.+.||.|+||.||+|... +++.+++|++........+.+.+|++++++++||||+++++++......+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 4567789999999999999876 578899999876555566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+++|.+++... ...++...+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++........ .
T Consensus 84 ~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 84 GGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 99999988742 2568899999999999999999998 8999999999999999999999999999876543221 1
Q ss_pred ccccccCCCccCCCccCCC---CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 769 SSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~---~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.....++..|+|||.+... .++.++||||||+++|||++|+.||....... .... ...... ..+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~-----~~~~~~---~~~~~- 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFL-----ISKSNF---PPPKL- 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HHhccC---CCccc-
Confidence 2234578899999998776 88899999999999999999999997433211 1111 111100 00111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.........+.+++.+||+.+|++||++++|+.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112223456889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=314.58 Aligned_cols=261 Identities=23% Similarity=0.291 Sum_probs=193.8
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC------
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------ 678 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~------ 678 (931)
...|++.+.||+|+||.||++... .|+.||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 356777899999999999999875 58999999986432 234567889999999999999999999886443
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
..++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57899999965 5666654 237788889999999999999998 89999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhh------------HHH-
Q 002358 759 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN------------IVH- 825 (931)
Q Consensus 759 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~------------l~~- 825 (931)
+...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+...... ...
T Consensus 171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 7643221 1223458999999999999999999999999999999999999997543211100 000
Q ss_pred ---HHHHhhhcCC-e-----eeccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 826 ---WARSMIKKGD-V-----ISIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 826 ---~~~~~~~~~~-~-----~~i~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+........ . .+....-.. ..........+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0010000000 0 000000000 0000111245789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=315.92 Aligned_cols=191 Identities=25% Similarity=0.335 Sum_probs=163.1
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
...|++.+.||+|+||.||+|... .++.||+|+.... ....|+.++++++||||+++++++......++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 345777899999999999999986 4678999975432 345699999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+. ++|.+++.. ....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 139 YS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred cC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 95 688888764 34568999999999999999999998 899999999999999999999999999987532221
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 812 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf 812 (931)
......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 122345899999999999999999999999999999999965554
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=310.69 Aligned_cols=198 Identities=23% Similarity=0.358 Sum_probs=164.9
Q ss_pred hccccCcc--CcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 613 FCKKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 613 ~~~~LG~G--~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
+.++||+| +||+||++..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78999999876 68999999986542 233456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++|+|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999986432 3458899999999999999999998 89999999999999999999999999865443211110
Q ss_pred ------cccccccCCCccCCCccCC--CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 002358 768 ------ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSV 814 (931)
Q Consensus 768 ------~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~ 814 (931)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0112246778999999875 4688999999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=322.00 Aligned_cols=258 Identities=21% Similarity=0.252 Sum_probs=192.2
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.+.+.+.||+|+||.||+|.+. .++.||||... ...+.+|+++|++++|+|||++++++..++..++|||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 3556789999999999999987 47889999642 2346789999999999999999999999999999999995
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc-
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 767 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~- 767 (931)
++|.+++... ...+++..++.++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 244 -~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 244 -SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred -CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 7888887642 3468999999999999999999998 89999999999999999999999999999865432211
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCcc-----chhhHHHHHHHhhh-cCCeeeccc
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AELNIVHWARSMIK-KGDVISIVD 841 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~-----~~~~l~~~~~~~~~-~~~~~~i~d 841 (931)
......||+.|+|||++.+..++.++|||||||++|||++|..|+-..... ....+.+.+..... .........
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 122346899999999999999999999999999999999988665322111 11111111111000 000000000
Q ss_pred ccc------------cCCCC-H------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 842 PVL------------IGNVK-I------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 842 ~~l------------~~~~~-~------~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+ ..... . .....+.+++.+||+.||++|||++|+++
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 000 00000 0 01125778999999999999999999986
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=298.89 Aligned_cols=249 Identities=25% Similarity=0.411 Sum_probs=197.6
Q ss_pred HhhccccCccCcEEEEEEEECCCcEEEEEEccCcc------chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
+...+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+....++|+
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 34568899999999999998889999999886432 122356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 82 EFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999874 3457889999999999999999997 89999999999999999999999999998754221
Q ss_pred c-----cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 765 L-----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 765 ~-----~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
. ........|+..|+|||.+.+..++.++||||||+++|||++|+.||...+... .... .. ...+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~-~~--~~~~~~--- 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFY-IG--AHRGLM--- 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHH-hh--hccCCC---
Confidence 1 111223457889999999999889999999999999999999999996332111 1100 00 000111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+.+. ......+.+++.+||+.+|++||++.|+++
T Consensus 228 --~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 --PRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --CCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 122346789999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=307.44 Aligned_cols=258 Identities=28% Similarity=0.449 Sum_probs=200.6
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCc----EEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
...++..+.||+|+||.||+|.+. +|+ .||+|.+..... ....++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 344456788999999999999875 344 578998875433 2345788999999999999999999998754 467
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998742 3457889999999999999999998 89999999999999999999999999999865
Q ss_pred cccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 762 EEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 762 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....+++ ..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~~~- 231 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLL----EKGERLP- 231 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----HCCCCCC-
Confidence 432221 1112335678999999998899999999999999999998 8999863322 1122222 1111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
. +......+.+++.+||..+|++||+++|+++.|+++...
T Consensus 232 -~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 -Q-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 111223678999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=300.16 Aligned_cols=251 Identities=24% Similarity=0.419 Sum_probs=198.8
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc------hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
|+..+.||+|++|.||+|... +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 345688999999999999864 689999999864321 1346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC-ceEEeccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAE 762 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~ 762 (931)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .+||+|||++....
T Consensus 82 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 82 VEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999873 3568899999999999999999998 8999999999999998776 59999999987764
Q ss_pred ccccc---cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 763 EDLTH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 763 ~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
..... ......++..|+|||.+.+..++.++||||+|+++++|++|..||............. +.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~----- 227 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF---KIASAT----- 227 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH---HHhccC-----
Confidence 43211 1223357889999999988889999999999999999999999996433322111111 111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.....+......+.+++.+|++.+|++||++.|+++
T Consensus 228 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 ----TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011122233346889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=300.83 Aligned_cols=247 Identities=30% Similarity=0.489 Sum_probs=197.5
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
..+++.+.||+|+||.||++.. .++.||+|.++... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4567789999999999999975 58889999986532 345788999999999999999999998664 4789999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+++|.+++... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999998753 23458899999999999999999998 899999999999999999999999999987543221
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....+..|+|||.+.+..++.++|+||||+++|||++ |+.||...... ...+ .+..+.... .
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~~-----~--- 218 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKE----CVEKGYRME-----P--- 218 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHH----HHhCCCCCC-----C---
Confidence 11224568999999988899999999999999999998 99998633221 1111 121111111 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
....+..+.+++.+||+.+|++||++++|++.|++
T Consensus 219 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 -PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11223467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=297.15 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=198.5
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEec-CCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~~lV~E~ 686 (931)
|++.+.||+|++|.||++..+ +++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 567899999999999999876 57899999986432 2345678899999999999999999998764 4467899999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+++... ....+++.++..++.|++.|+++||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 82 CEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred cCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 9999999998753 23468999999999999999999998 8999999999999999999999999999876543222
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
......+++.|+|||.+.+..++.++||||||++++||++|+.||...+.. ....... .+....
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~-~~~~~~-------- 221 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRII-EGKLPP-------- 221 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHH-hcCCCC--------
Confidence 223345789999999999999999999999999999999999999733221 1111111 121111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+......+.+++.+|++.+|++||++.|+++
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 -MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11223346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=320.47 Aligned_cols=270 Identities=22% Similarity=0.251 Sum_probs=206.6
Q ss_pred cChhhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcC-C-----CCCcceeEE
Q 002358 601 IPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H-----RNLVPLIGY 673 (931)
Q Consensus 601 ~~~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H-----pnIv~l~g~ 673 (931)
+-..|...-+|.+.+.||+|+||.|-+|... .++.||||+++.. ..-..+-..|+.+|..|+ | -|+|+++++
T Consensus 178 ~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 178 LVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred EEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 3344444457888999999999999999765 6999999999864 333456678999999997 4 389999999
Q ss_pred EecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC--ceE
Q 002358 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM--RAK 751 (931)
Q Consensus 674 ~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~--~vk 751 (931)
|...++.|||+|.+ ..+|+++++.. +..+++...+..++.||+.||.+||+ .+|||+||||+||||.+.+ .+|
T Consensus 257 F~fr~HlciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 257 FYFRNHLCIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred cccccceeeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCcee
Confidence 99999999999999 56999999976 45569999999999999999999998 9999999999999997543 699
Q ss_pred EecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh-
Q 002358 752 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM- 830 (931)
Q Consensus 752 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~- 830 (931)
|+|||.+....+... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.+++..+....+.-+...
T Consensus 332 VIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 332 VIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred EEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence 999999987544322 345688999999999999999999999999999999998888765543333222111100
Q ss_pred --------------hhc-CCeeec----------------------ccccccC--------CCCHHHHHHHHHHHHHccc
Q 002358 831 --------------IKK-GDVISI----------------------VDPVLIG--------NVKIESIWRIAEVAIQCVE 865 (931)
Q Consensus 831 --------------~~~-~~~~~i----------------------~d~~l~~--------~~~~~~~~~l~~li~~Cl~ 865 (931)
... ...... .+..... .........+++++.+|++
T Consensus 408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~ 487 (586)
T KOG0667|consen 408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE 487 (586)
T ss_pred CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence 000 000000 0000000 0111344578999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 002358 866 QRGFSRPKMQEIVLA 880 (931)
Q Consensus 866 ~dP~~RPs~~evl~~ 880 (931)
.||.+|+|..|.++.
T Consensus 488 ~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 488 WDPAERITPAQALNH 502 (586)
T ss_pred cCchhcCCHHHHhcC
Confidence 999999999998753
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.18 Aligned_cols=254 Identities=22% Similarity=0.378 Sum_probs=199.6
Q ss_pred HhhccccCccCcEEEEEEEECC--CcEEEEEEccCcc----------chhhhhHHHHHHHHHh-cCCCCCcceeEEEecC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC----------SHRTQQFVTEVALLSR-IHHRNLVPLIGYCEEE 677 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~--g~~vAvK~~~~~~----------~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~~ 677 (931)
|.+.+.||+|+||.||+|.++. ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4567889999999999999875 6889999875321 1233557788888875 6999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccc
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 756 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFG 756 (931)
+..+++|||+++++|.+.+.... ....+++..+++++.|++.||.|||+ ..+++||||||+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEeccc
Confidence 99999999999999998875421 34568899999999999999999995 3689999999999999999999999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 757 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 757 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
++....... ......|+..|++||.+.+..++.++||||||+++|||++|+.||...+.. .... .+..+..
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~~----~~~~~~~ 230 (269)
T cd08528 160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLAT----KIVEAVY 230 (269)
T ss_pred ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHHH----HHhhccC
Confidence 998654432 223345888999999999888999999999999999999999999633221 1111 1111111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
... ... .....+.+++.+||+.+|++||++.|+.+++++
T Consensus 231 ~~~----~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 EPL----PEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CcC----Ccc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111 011 112367899999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=312.94 Aligned_cols=253 Identities=23% Similarity=0.295 Sum_probs=194.9
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|++.+.||+|+||.||+++.+ +++.||+|++.... ......+.+|..++..++|+||+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 556789999999999999876 57889999986422 22345588899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 83 YVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999742 3468888999999999999999998 9999999999999999999999999999987654433
Q ss_pred ccccccccCCCccCCCccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 767 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
.......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+... ............. +.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~-~p 230 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQ-FP 230 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCccc-CC
Confidence 33334568999999999865 567889999999999999999999997433211 1111111111000 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 880 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 880 (931)
+.. . .....+.+++.+|+...+++ |++++++++.
T Consensus 231 ~~~-~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 SHI-T----DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Ccc-c----cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 101 1 12236778888988865544 4678877653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=314.67 Aligned_cols=253 Identities=24% Similarity=0.321 Sum_probs=193.9
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+++.++||+|+||.||+++++ .++.+|+|++.+.. ....+.+.+|+.++..++|+||+++++.+.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 556789999999999999987 47789999986421 22334588899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 9999999999742 3468888999999999999999998 9999999999999999999999999999876543333
Q ss_pred ccccccccCCCccCCCccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 767 HISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+.. +..............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~~-- 229 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQF-- 229 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCccccC--
Confidence 3333456999999999985 346788999999999999999999999743321 111111111110000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGF--SRPKMQEIVLA 880 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~--~RPs~~evl~~ 880 (931)
+... ......+.+++.+|+..++. .|++++|+++.
T Consensus 230 p~~~----~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 PAQV----TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCcc----ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1000 11223567788887755444 47899998765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.72 Aligned_cols=249 Identities=22% Similarity=0.354 Sum_probs=201.8
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++.+.||+|+||.||.++.. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 456789999999999999865 5889999987543 2344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++|+|.+++.... ...+++..+..++.|+++||+|||+ .+++||||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 82 NGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred CCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999987542 4568899999999999999999998 8999999999999999999999999999876544332
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
......+++.|+|||.+.+..++.++||||||+++|||++|..||...... +...... .+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-~~~~~~~-------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIV-QGNYTPV-------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-cCCCCCC--------
Confidence 223345889999999998888999999999999999999999999743221 1111111 1211111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
+.....++.+++.+||+.+|++||+++|+++.
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.57 Aligned_cols=246 Identities=28% Similarity=0.409 Sum_probs=197.6
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-----chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
++..+.||+|++|.||+|..+ +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++......++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 345688999999999999987 78999999886432 224567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999874 3458899999999999999999998 89999999999999999999999999998765433
Q ss_pred ccccccccccCCCccCCCccCCCC-CCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
. ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||.... ....... .........
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~~~~~~~----~~~~~~~~~----- 222 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--GVAAVFK----IGRSKELPP----- 222 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--HHHHHHH----HHhcccCCC-----
Confidence 2 122345788999999987766 8999999999999999999999996332 1111111 111011111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+......+.+++.+||+.+|++||++.++++
T Consensus 223 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 ----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11112346789999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=314.67 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=195.4
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecC------C
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------H 678 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~ 678 (931)
...|++.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 346677899999999999999875 58899999987532 23446788999999999999999999988543 3
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
..++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 57899999965 6766664 247888899999999999999998 89999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhh-HHH------------
Q 002358 759 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVH------------ 825 (931)
Q Consensus 759 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l~~------------ 825 (931)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...... ...
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8654322 1233468999999999999999999999999999999999999997543221110 000
Q ss_pred ---HHHHhhhcC-Ceeecccccc-----c---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 826 ---WARSMIKKG-DVISIVDPVL-----I---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 826 ---~~~~~~~~~-~~~~i~d~~l-----~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.+....... ....+..+.. . ..........+.+++.+|++.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000111000 0000000000 0 00111123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=306.03 Aligned_cols=262 Identities=24% Similarity=0.339 Sum_probs=197.5
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++.+.||+|+||.||+|.++ .++.||+|++..... ...+.+.+|+++++.++||||+++++++..+...++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 556789999999999999987 589999999865322 23457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+.... ...+++..++.++.|+++||+|||+ .+++||||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 83 DHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred CccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 99999887653 3458999999999999999999998 8999999999999999999999999999876543322
Q ss_pred cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchh-hHHHHHHHhh-------hcCCee-
Q 002358 768 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMI-------KKGDVI- 837 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~-~l~~~~~~~~-------~~~~~~- 837 (931)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. .+..+..... ......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 1223347889999998865 45788999999999999999999999643321111 1111110000 000000
Q ss_pred ecccccccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVLIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....+.... .........+.+++.+||+.+|++||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=300.68 Aligned_cols=262 Identities=23% Similarity=0.283 Sum_probs=197.9
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++.+.||+|++|.||+|..+ +|+.||+|++..... ...+.+.+|++++++++|+|++++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 556789999999999999987 589999998864322 23356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
+++.|...+.. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 83 DHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred CccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 99988887652 3468999999999999999999998 89999999999999999999999999999875443211
Q ss_pred cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhh-HHHHHHHhhh-------cCC-ee
Q 002358 768 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWARSMIK-------KGD-VI 837 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l~~~~~~~~~-------~~~-~~ 837 (931)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+... +.......+. ... ..
T Consensus 157 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 157 -YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred -ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 122346789999999865 567899999999999999999999997443221111 1111111000 000 00
Q ss_pred ecccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....+......+ ......+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 001111110111 112346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=302.76 Aligned_cols=260 Identities=23% Similarity=0.295 Sum_probs=199.8
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++.+.||+|++|.||+|.+. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 556789999999999999876 68999999987543 234567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
+++|.+++... ...+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 82 -~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 82 -PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred -CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99999998743 3568999999999999999999998 89999999999999999999999999998876543322
Q ss_pred cccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCC-----------
Q 002358 768 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD----------- 835 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~----------- 835 (931)
......|+..|+|||.+.+. .++.++||||+|++++||++|..||...... ....++........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcc
Confidence 22334588999999998654 4688999999999999999998888633221 11111111111000
Q ss_pred -eeeccccccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 836 -VISIVDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 836 -~~~i~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+..+... .....+....+.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 0001122357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=315.93 Aligned_cols=240 Identities=26% Similarity=0.304 Sum_probs=186.1
Q ss_pred cCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhc---CCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 617 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 617 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
||+|+||+||+|+.+ +++.||+|++..... .....+..|..++... +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 589999999864321 2233455677777665 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.+.+.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 999998873 4568899999999999999999998 8999999999999999999999999999875432221 12
Q ss_pred cccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 770 SVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
....||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+... ..+.+..+.. .+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~-~~~~~------ 219 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKV-RFPKN------ 219 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCC-CCCCc------
Confidence 334689999999998654 57899999999999999999999997433211 1111211111 01000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPK----MQEIVL 879 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs----~~evl~ 879 (931)
.....+.+++.+||+.+|++||+ ++|+++
T Consensus 220 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 --VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11235679999999999999994 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=303.81 Aligned_cols=263 Identities=21% Similarity=0.250 Sum_probs=199.8
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++.+.||+|++|.||+|.++ +++.||+|+++... ....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 566789999999999999887 58899999986532 223467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
+++.+..... ....+++..+..++.|+++||+|||+ .+++||||+|+||++++++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 83 ERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 9877776654 23458899999999999999999998 89999999999999999999999999998876544332
Q ss_pred cccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHH-HHHhh--------hcCCe-
Q 002358 768 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW-ARSMI--------KKGDV- 836 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~-~~~~~--------~~~~~- 836 (931)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....... ..... .....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 23334578899999999887 889999999999999999999999974332211110000 00000 00000
Q ss_pred ----eecccccc-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 837 ----ISIVDPVL-IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 837 ----~~i~d~~l-~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....++.. ...++.....++.+++.+||..+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000 00111122457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=304.42 Aligned_cols=244 Identities=27% Similarity=0.388 Sum_probs=197.0
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
...||+|+||.||++... +++.||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 467999999999999875 6889999998765555567789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccccc
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 772 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 772 (931)
.+++.. ..+++..+..++.||+.||+|||+ .+++||||||+||++++++.++|+|||++......... ....
T Consensus 107 ~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 178 (292)
T cd06658 107 TDIVTH----TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSL 178 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Ccee
Confidence 998852 357889999999999999999998 89999999999999999999999999998765433222 2234
Q ss_pred ccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002358 773 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 852 (931)
Q Consensus 773 ~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 852 (931)
.|+..|+|||.+.+..++.++||||||+++|||++|+.||...+... ....+.. .+.+.+... ...
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~---------~~~~~~~~~--~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRRIRD---------NLPPRVKDS--HKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh---------cCCCccccc--ccc
Confidence 57899999999988889999999999999999999999997432211 1111111 011111110 112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 853 IWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 853 ~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+.+++.+|+..+|++|||++|+++
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 235778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=317.02 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=192.2
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+++.+.||+|+||.||++..+ +++.||+|+++... ....+.+.+|+.++.+++||||+++++.+.+.+..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456789999999999999876 58999999986432 23345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 83 LPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999873 4568899999999999999999998 9999999999999999999999999999875422110
Q ss_pred ----------------------------------ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCC
Q 002358 767 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 812 (931)
Q Consensus 767 ----------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf 812 (931)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0011245899999999999999999999999999999999999999
Q ss_pred CccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 002358 813 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVL 879 (931)
Q Consensus 813 ~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~ 879 (931)
........ ............ +.+. . .....+.+++.+|+ .+|++|++ ++|+++
T Consensus 237 ~~~~~~~~------~~~i~~~~~~~~-~p~~----~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 237 CSETPQET------YRKVMNWKETLV-FPPE----V--PISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCHHHH------HHHHHcCCCcee-cCCC----C--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 74332211 111111010000 1110 0 01225667777766 49999996 555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=298.75 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=200.3
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++.+.||+|+||.+|++... +|+.||+|.+... .....+++.+|+.++++++||||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 456789999999999999875 6899999988643 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+.+... ....+++..+++++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 82 EGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 999999988743 23357889999999999999999998 89999999999999999999999999998765433221
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....|++.|+|||.+.+..++.++|+|||||++++|++|+.||...+.. ..+.... .+....
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-~~~~~~--------- 220 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKII-RGSYPP--------- 220 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHh-cCCCCC---------
Confidence 22335788999999999888999999999999999999999999733221 1111111 111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+......+.+++.+|++.+|++||++.||++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11122346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=305.28 Aligned_cols=245 Identities=25% Similarity=0.395 Sum_probs=197.3
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
...||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999875 6899999998654444556788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccccc
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 772 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 772 (931)
.+++.. ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......... ....
T Consensus 106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 177 (297)
T cd06659 106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSL 177 (297)
T ss_pred HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccce
Confidence 998753 458899999999999999999997 89999999999999999999999999998755433221 2234
Q ss_pred ccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002358 773 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 852 (931)
Q Consensus 773 ~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 852 (931)
.|+..|+|||.+.+..++.++||||||+++|||++|+.||...+.. .....+. ...... .. .....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~----~~~~~~-----~~--~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLR----DSPPPK-----LK--NAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh----ccCCCC-----cc--ccCCC
Confidence 5889999999999888999999999999999999999999733221 1111111 111000 00 01112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 853 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 853 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
...+.+++.+|++.+|++||+++|+++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 2357899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=334.88 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=197.5
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEec--CC
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EH 678 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 678 (931)
.+.....|.+.+.||+|+||.||+|.+. .++.||+|.+... .......|..|+.++++++|||||++++++.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3444556788899999999999999886 4678899988643 22345678999999999999999999998854 45
Q ss_pred eEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcC----CCCeEecCCCCCCccccC-------
Q 002358 679 QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC----NPGIIHRDVKSSNILLDI------- 746 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~----~~~ivH~DIkp~NILld~------- 746 (931)
..++||||+++|+|.++|.... ....+++..++.|+.||+.||+|||+.. ..+|+||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999999999999987532 2356899999999999999999999732 145999999999999964
Q ss_pred ----------CCceEEecccccccccccccccccccccCCCccCCCccCC--CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 002358 747 ----------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSV 814 (931)
Q Consensus 747 ----------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~ 814 (931)
...+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2348999999998654322 1233468999999999854 4688999999999999999999999963
Q ss_pred cCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 815 EDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 815 ~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+. ...+. ..+..+.. ..+ .. ....+.+++.+||+.+|.+||++.|+++
T Consensus 246 ~~~--~~qli----~~lk~~p~-----lpi-~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANN--FSQLI----SELKRGPD-----LPI-KG----KSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCc--HHHHH----HHHhcCCC-----CCc-CC----CCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 221 11111 11211110 000 11 1236789999999999999999999983
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=284.79 Aligned_cols=246 Identities=28% Similarity=0.379 Sum_probs=198.3
Q ss_pred hccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--------hhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEE
Q 002358 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~l 682 (931)
-.+.||.|..++|.++.++ .|+..|+|++..... +-.++-.+|+.||+++ .||+|+++.++++.....++
T Consensus 21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl 100 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL 100 (411)
T ss_pred hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence 3578999999999998776 688999998853211 1224566799999999 59999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
|+|.|+.|.|.|+|. ....++++...+|+.|+.+|+.|||. .+|+||||||+|||+|++.++||+|||+++.+.
T Consensus 101 VFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999998 45689999999999999999999998 999999999999999999999999999999876
Q ss_pred ccccccccccccCCCccCCCccC------CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 763 EDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
+.. .-...+|||+|+|||.+. ...|+...|+|++||++|-|+.|.+||....+ .-+.+++.+|..
T Consensus 175 ~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR~ImeGky 245 (411)
T KOG0599|consen 175 PGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLRMIMEGKY 245 (411)
T ss_pred Cch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHHHHHhccc
Confidence 532 223457999999999873 35678899999999999999999999972211 123344545543
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. .-.|. + .+......+++.+||+.||.+|.|.+|.++
T Consensus 246 q-F~spe-W----adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 246 Q-FRSPE-W----ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred c-cCCcc-h----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1 00110 0 112235789999999999999999999975
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=298.06 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=200.4
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEec--CCeEEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYE 685 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~~lV~E 685 (931)
|++.+.||.|+||.||++... +++.+|+|++... .....+++..|++++++++|+||+++++++.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 456788999999999999865 6889999988643 23345678899999999999999999998754 456789999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcC--CCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 686 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
|+++++|.+++.... ....+++..++.++.|+++||+|||..+ ..+++|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 999999999986532 3457899999999999999999999321 3899999999999999999999999999998765
Q ss_pred ccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 763 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
..... .....+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+. ....+. +..+...
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~----~~~~~~~----- 228 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASK----IKEGKFR----- 228 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHH----HhcCCCC-----
Confidence 43321 2233588999999999988899999999999999999999999974431 122221 2222111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+......+.+++.+|++.+|++||++++|++
T Consensus 229 ----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 229 ----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 112233347889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=299.44 Aligned_cols=248 Identities=28% Similarity=0.428 Sum_probs=200.3
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
..+.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45667789999999999999875 68899999876432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999998863 458899999999999999999998 8999999999999999999999999999876543221
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||..... ..... .+..+.. +.+
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~----~~~~~~~-----~~~-- 221 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLF----LIPKNNP-----PTL-- 221 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHH----HHhcCCC-----CCC--
Confidence 12234578899999999888889999999999999999999999963221 11111 1111111 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
+......+.+++.+|++.+|++||+++++++.
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 --EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223467899999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.69 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=191.2
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-----chhhhhHHHHHHHHHhcCCCCCcceeEEEec--CCeEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL 682 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~~l 682 (931)
+...+.||+|+||.||+|... .++.||+|++.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 445789999999999999875 58899999875321 2234578899999999999999999998865 356789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
++||+++++|.+.+.. ...+++.....++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 84 FMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999873 3458889999999999999999997 899999999999999999999999999987643
Q ss_pred ccccc--cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 763 EDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 763 ~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
..... ......++..|+|||.+.+..++.++|||||||++|||++|+.||...+.. ..+........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~~----- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQPT----- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCCC-----
Confidence 21111 112234788999999999888999999999999999999999999733211 11111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+. .+......+.+++ +||..+|++||+++||++
T Consensus 227 ~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111 1222223455666 788899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=326.60 Aligned_cols=260 Identities=19% Similarity=0.280 Sum_probs=189.4
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCC------CCCcceeEEEecC-CeE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH------RNLVPLIGYCEEE-HQR 680 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H------pnIv~l~g~~~~~-~~~ 680 (931)
..|++.++||+|+||+||+|.+. .++.||||+++... ...+.+..|+++++.++| .+++++++++... .+.
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 45677899999999999999875 57889999986432 233456678888877755 4588888888654 578
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC------------
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM------------ 748 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~------------ 748 (931)
++|||++ +++|.+++.. ...+++..+..++.||+.||+|||+ +.+|+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 8999988 7789888863 4568999999999999999999996 25999999999999998765
Q ss_pred ----ceEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHH
Q 002358 749 ----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 824 (931)
Q Consensus 749 ----~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~ 824 (931)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+
T Consensus 282 ~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 499999998764322 223456899999999999999999999999999999999999999754432222211
Q ss_pred HHH---------HH--------hhh-cCCeeeccccccc----CCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 825 HWA---------RS--------MIK-KGDVISIVDPVLI----GNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 825 ~~~---------~~--------~~~-~~~~~~i~d~~l~----~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
... .. ... .+......++... ... .......+.+|+.+||+.||++|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 111 00 000 0000000000000 000 0011235779999999999999999999986
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=303.17 Aligned_cols=194 Identities=26% Similarity=0.395 Sum_probs=158.5
Q ss_pred cccCccCcEEEEEEEECC---CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEe--cCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~---g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~~~lV~E~~~~ 689 (931)
.+||+|+||.||+|+.++ +..||+|.+.... ....+.+|++++++++||||+++++++. .+...++|+||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 579999999999998763 5789999886532 2346788999999999999999999884 3567889999986
Q ss_pred CCHHHHhccCC------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc----cCCCceEEecccccc
Q 002358 690 GTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSR 759 (931)
Q Consensus 690 gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl----d~~~~vkL~DFGla~ 759 (931)
++|.+.+.... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 47777664211 22358889999999999999999998 899999999999999 566789999999998
Q ss_pred cccccccc--cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 002358 760 QAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSV 814 (931)
Q Consensus 760 ~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~ 814 (931)
........ ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 76443221 1223457899999999876 4588999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=295.66 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=202.5
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+...+..++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 567789999999999999875 67899999986532 3356789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc-
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 767 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~- 767 (931)
+++|.+.++.......+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999754334568999999999999999999997 89999999999999999999999999998765443222
Q ss_pred --cccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 768 --ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 768 --~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
......|+..|+|||.+... .++.++|+|||||++|||++|+.||...... ....+. .... . +.+
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~----~~~~-~-----~~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLT----LQND-P-----PSL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHH----hcCC-C-----CCc
Confidence 22334588899999998776 7899999999999999999999999733221 111111 1110 0 111
Q ss_pred cCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... .......+.+++.+|++.+|++||+++||++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1100 0122346789999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=313.53 Aligned_cols=260 Identities=23% Similarity=0.299 Sum_probs=193.9
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecC------Ce
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 679 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~ 679 (931)
..|.+.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 45777899999999999999876 58899999987532 23456788999999999999999999987543 35
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
.++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 7999999965 6777664 237788899999999999999998 899999999999999999999999999998
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHH-H--------H----
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-H--------W---- 826 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~-~--------~---- 826 (931)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+ . +
T Consensus 175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 654322 122345899999999999999999999999999999999999999754332111100 0 0
Q ss_pred ---HHHhhhcCC-ee-----ecccccc---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 827 ---ARSMIKKGD-VI-----SIVDPVL---IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 827 ---~~~~~~~~~-~~-----~i~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+........ .. ....... ...........+.+++.+|++.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000 00 0000000 00001112246789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=310.05 Aligned_cols=240 Identities=32% Similarity=0.473 Sum_probs=197.5
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
.+.||+|+||.||.|+.. +.+.||||++.-.. .....++.+|+..|++++|||+|.+-|++-.+...||||||| -
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-l 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-L 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-h
Confidence 478999999999999865 67899999986432 234578999999999999999999999999999999999999 5
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+-.|++.- ..+++-+..+..|+.+.++||+|||+ ++.||||||+.|||+++.|.|||+|||.+....+.
T Consensus 110 GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 110 GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 688887764 35678899999999999999999998 99999999999999999999999999998765443
Q ss_pred cccccCCCccCCCcc---CCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 770 SVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 770 ~~~~gt~~y~APE~l---~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
....|||.|||||++ ..++|+-|+||||+|++..||...++|+-. +...-.+.+ +..++. |.+.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn--MNAMSALYH-----IAQNes-----PtLq- 246 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALYH-----IAQNES-----PTLQ- 246 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC--chHHHHHHH-----HHhcCC-----CCCC-
Confidence 345699999999987 457999999999999999999999999752 221111221 211221 1222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..++...+.+++..||++-|.+|||.+++++
T Consensus 247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 4566778999999999999999999998873
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=300.10 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=194.9
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEe-----cCCeEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRI 681 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~-----~~~~~~ 681 (931)
..+++.+.||+|+||.||++..+ +++.+|+|++... .....++.+|+.+++++ +||||+++++++. .+...+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 45567789999999999999876 5789999987643 22345688899999999 6999999999874 345689
Q ss_pred EEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
+||||+++++|.+.+.... ....+++..+..++.|+++||.|||+ .+++||||||+||++++++.+||+|||+++.
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceee
Confidence 9999999999999876422 34568889999999999999999998 8999999999999999999999999999876
Q ss_pred ccccccccccccccCCCccCCCccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCC
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 835 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 835 (931)
...... ......|++.|+|||++.. ..++.++||||+||++|||++|+.||....... .+.. .....
T Consensus 174 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~-----~~~~~ 245 (286)
T cd06638 174 LTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK-----IPRNP 245 (286)
T ss_pred cccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh-----ccccC
Confidence 543222 1223458999999998753 457889999999999999999999996332111 1110 00111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 836 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 836 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.....++. .....+.+++.+||+.+|++||+++||++.
T Consensus 246 ~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 PPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11111111 112368899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=295.67 Aligned_cols=252 Identities=27% Similarity=0.378 Sum_probs=201.9
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
+++.+.||+|++|.||++.++ +++.+|+|.+.... ....+++.+|++++++++||||+++++.+......++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 456789999999999999887 68999999987653 3445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+++|.+++.... ..++...+..++.|++.||+|||+ ..+++|+||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 83 GGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 999999987532 678889999999999999999996 379999999999999999999999999998765432221
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. .....+.+...... .. +.+...
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~-~~-----~~~~~~- 227 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNE-PP-----PRLPSG- 227 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcC-CC-----CCCChh-
Confidence 145788999999999999999999999999999999999999643221 11222222222211 11 111110
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.....+.+++.+||..+|++||++.|+++
T Consensus 228 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 --KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 13346889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=300.35 Aligned_cols=246 Identities=22% Similarity=0.342 Sum_probs=205.5
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch--hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
.|.+.+.||+|.|+.|-+|++- .|+.||||++.+..-. ....+..|++.|+.++|||||+++.....+..+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 4556789999999999999865 7999999999764332 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc-cCCCceEEecccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl-d~~~~vkL~DFGla~~~~~~~ 765 (931)
-.+|+|.+++.+. ...+.+....+++.||..|+.|+|+ ..+|||||||+||.+ ..-|-+||.|||++-.+.+..
T Consensus 99 GD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999764 5678889999999999999999998 999999999999877 567889999999997765432
Q ss_pred cccccccccCCCccCCCccCCCCCC-ccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.-.+.+|...|-|||++.+..|+ ++.||||+||+||.|++|+.||+.....+.. .-++|-..
T Consensus 174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDCKY 236 (864)
T KOG4717|consen 174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDCKY 236 (864)
T ss_pred --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcccc
Confidence 23456799999999999999887 5789999999999999999999854443322 12233211
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+.....+..+||..||..||.+|-+.+||+.
T Consensus 237 --tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 --TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 224455568899999999999999999999873
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=313.47 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=200.4
Q ss_pred ccCccCcEEEEEEEECC-CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCHHH
Q 002358 616 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 694 (931)
Q Consensus 616 ~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 694 (931)
+||+|.||+||.|++.+ ...+|||-+........+.+.+|+.+-++|+|.|||+++|.+.+++..-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999775 45789999987766777889999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc-CCCceEEecccccccccccccccccccc
Q 002358 695 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVAR 773 (931)
Q Consensus 695 ~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld-~~~~vkL~DFGla~~~~~~~~~~~~~~~ 773 (931)
.|+..-..-.-.+.++--..+||++||.|||+ ..|||||||-.|||++ -.|.+||+|||.++....-.. ...+..
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCc-cccccc
Confidence 99864333233677888899999999999998 8999999999999997 478899999999988654333 334456
Q ss_pred cCCCccCCCccCCC--CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHH
Q 002358 774 GTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 851 (931)
Q Consensus 774 gt~~y~APE~l~~~--~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 851 (931)
||..|||||++..+ .|+.++|||||||++.||.||++||..-..+. . . +.+-|-. ......+.+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-A--A-----MFkVGmy------KvHP~iPee 803 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-A--A-----MFKVGMY------KVHPPIPEE 803 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-H--h-----hhhhcce------ecCCCCcHH
Confidence 99999999999664 68899999999999999999999996222111 0 0 1111111 112234556
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 852 SIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 852 ~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+...++.+|+.++|.+||+++++++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 6667889999999999999999999985
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=293.19 Aligned_cols=250 Identities=29% Similarity=0.433 Sum_probs=199.2
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|+..+.||+|+||.||+|... +++.|++|.++.... ...+.+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 456789999999999999875 689999999876543 35678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+++.. ...+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 82 SGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999874 3457888999999999999999998 89999999999999999999999999998876443322
Q ss_pred ccc---ccccCCCccCCCccCCCC---CCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 768 ISS---VARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 768 ~~~---~~~gt~~y~APE~l~~~~---~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
... ...++..|+|||.+.... ++.++||||||+++|||++|+.||...+.. ...... +..+..
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~----~~~~~~----- 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFH----VGAGHK----- 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHH----HhcCCC-----
Confidence 211 245788999999998766 889999999999999999999999633211 111111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+.+... ......+.+++.+|++.+|.+||++.|++.
T Consensus 225 ~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111100 011335779999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=302.37 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=193.5
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++.+.||+|+||.||+|..+ +|+.||+|.++.... .....+.+|++++++++||||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 456788999999999999986 689999999864322 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
+ ++|.+.+... ...+++..++.++.||++||.|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 82 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 82 D-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred C-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 7 5787777542 3568999999999999999999998 89999999999999999999999999998765432211
Q ss_pred cccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCC------eeecc
Q 002358 768 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD------VISIV 840 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~------~~~i~ 840 (931)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.|+...... ....+.+.+.....+ .....
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 1223468899999988664 4789999999999999999999886422211 111111111110000 00000
Q ss_pred ccc----ccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPV----LIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~----l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+.. ... ...+.....+.+++.+||+.+|++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 000 001112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=296.87 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=196.9
Q ss_pred hhccccCccCcEEEEEEEEC----CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC------e
Q 002358 612 NFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q 679 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~------~ 679 (931)
.+.+.||+|+||.||+|.+. .++.||||++.... ....+++.+|++++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 45688999999999999864 36889999987543 334567899999999999999999999886532 2
Q ss_pred EEEEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 756 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFG 756 (931)
.++++||+++|+|.+++.... ....+++..+++++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 468899999999988875322 22357888999999999999999998 899999999999999999999999999
Q ss_pred ccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcC
Q 002358 757 LSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 834 (931)
Q Consensus 757 la~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 834 (931)
+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||...+. ..+..+.. .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----~~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI----KG 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH----cC
Confidence 98865432211 1122235678999999998889999999999999999999 8888863322 12222211 11
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 835 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 835 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
.... .+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100 0112234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=311.96 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=192.0
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecC------Ce
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 679 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~ 679 (931)
..|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 46777899999999999999875 678999999865322 2345678899999999999999999887532 45
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
.++++|++ +++|.+.+. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred EEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence 68999988 789988775 3458999999999999999999998 899999999999999999999999999998
Q ss_pred cccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeee
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 838 (931)
..... .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... ...+....... ..+
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~-~~~ 238 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEVVGTP-SPE 238 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCC-CHH
Confidence 65432 223458999999999876 5788999999999999999999999974332111 11111000000 000
Q ss_pred ccc-----------ccccCCCCH--------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 839 IVD-----------PVLIGNVKI--------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 839 i~d-----------~~l~~~~~~--------~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
... ..+. ..+. .....+.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 239 VLKKISSEHARKYIQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHhcchhhHHHHhhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0000 0000 01124679999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=296.57 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=195.3
Q ss_pred hhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc----------hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~----------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
...+.||+|+||.||+|... +|+.+|+|.++.... ...+.+.+|+.++++++|||++++++++...+..
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 34678999999999999865 689999998753211 1124678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+++++|.+.+.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred EEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999874 3568889999999999999999998 8999999999999999999999999999876
Q ss_pred ccccccc-cccccccCCCccCCCccCCCC--CCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 761 AEEDLTH-ISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 761 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~--~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
....... ......|+..|+|||.+.... ++.++|+||||+++|||++|..||...+.. ..+ ..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~----~~~~~-~~~~ 230 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAM----FKLGN-KRSA 230 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHH----HHhhc-cccC
Confidence 5432211 122335788999999987654 789999999999999999999999632211 111 11111 1111
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+.+.. .......+.+++.+|+..+|++||++++|++
T Consensus 231 ~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 231 PPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111111 1122347889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=301.71 Aligned_cols=259 Identities=20% Similarity=0.240 Sum_probs=196.8
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch-----hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
|++.+.||+|++|.||+|..+ +++.||+|.+...... ....+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 456788999999999999876 6899999998754322 2345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+ +|+|.+++... ...+++..++.++.||++||+|||+ .+++||||||+||+++.++.++|+|||+++.....
T Consensus 82 e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 82 EFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred ccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 999 99999999743 2368999999999999999999998 89999999999999999999999999999876443
Q ss_pred ccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc---------C
Q 002358 765 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---------G 834 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---------~ 834 (931)
... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||......+. +.. ....... .
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGK-IFEALGTPTEENWPGVT 231 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHH-HHHHcCCCchhhhhhcc
Confidence 221 122346788999998854 4678899999999999999999888764332111 111 1110000 0
Q ss_pred CeeecccccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 835 DVISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 835 ~~~~i~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
............. ........+.+++.+||+.+|++||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000000 11123457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=301.69 Aligned_cols=253 Identities=23% Similarity=0.290 Sum_probs=198.6
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+++.+.||+|+||.||++..+ .++.|++|.+..... ...+.+.+|+++++.++||||+++++.+..+...++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 456789999999999999887 578999999865432 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc-
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 765 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~- 765 (931)
+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 83 VEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999974 3568899999999999999999998 899999999999999999999999999886421100
Q ss_pred -------------cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh
Q 002358 766 -------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 832 (931)
Q Consensus 766 -------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 832 (931)
........++..|+|||.+....++.++|+||||+++|||++|+.||...... +......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~- 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVI- 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-
Confidence 00111234788999999998888999999999999999999999999633221 1111111
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 833 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 833 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
.+.. ..+.... .....+.+++.+||+.+|++||++.++.+.|+.
T Consensus 230 ~~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SDDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111 1111111 123367899999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=314.77 Aligned_cols=244 Identities=27% Similarity=0.453 Sum_probs=195.7
Q ss_pred hccccCccCcEEEEEEEEC-CCcEEEEEEcc--C--ccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe--EEEEEE
Q 002358 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA--D--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ--RILVYE 685 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~--~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~--~~lV~E 685 (931)
+.++||+|+|-+||+|.+. +|..||--.++ + ......++|..|+++|+.|+|||||+++..+.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4678999999999999875 57777743222 1 123445789999999999999999999998876554 679999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc-CCCceEEeccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld-~~~~vkL~DFGla~~~~~~ 764 (931)
.|..|+|..++++ .+..+.+.+..|++||++||.|||+. +++|||||||..||+|+ ..|.|||+|.|||......
T Consensus 124 L~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999984 56688899999999999999999985 68999999999999997 5689999999999876543
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.. ....|||.|||||.+. ..|.+..||||||+.++||+|+..||..-. ....+..-+..-+....+..+-||
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiKP~sl~kV~dP-- 271 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSGIKPAALSKVKDP-- 271 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcCCCHHHhhccCCH--
Confidence 32 2267999999999988 789999999999999999999999997221 222333333333333333334343
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
++.++|.+|+.. .++|||+.|+++
T Consensus 272 ----------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 272 ----------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 578999999999 999999999985
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=295.88 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=192.6
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-----chhhhhHHHHHHHHHhcCCCCCcceeEEEecC--CeEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 682 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~l 682 (931)
+++.+.||+|+||.||+|..+ +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 455789999999999999876 58999999875321 22346788899999999999999999988663 46789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
+|||+++++|.+++.. ...+++....+++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 84 FMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 9999999999999873 3457888899999999999999998 899999999999999999999999999987643
Q ss_pred ccccc--cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 763 EDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 763 ~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
..... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~----~~~~~~~------ 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--AAI----FKIATQP------ 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--HHH----HHHhcCC------
Confidence 22111 112235788999999998888999999999999999999999999632211 111 1111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.....+......+.+++.+|+. +|++||+++||++
T Consensus 226 ---~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 ---TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0111223334467788999985 9999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=300.17 Aligned_cols=241 Identities=27% Similarity=0.378 Sum_probs=197.2
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|.+.+.||+|+||.||++.+. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.++...++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 556789999999999999876 58999999986532 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+.+.. ...++...+..++.|+++||.|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 83 VPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999874 3578899999999999999999998 99999999999999999999999999998875443
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...+.. ...+ .+..+.. .+
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~~~~~~~------~~-- 217 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYE----KILEGKV------RF-- 217 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHhcCCc------cC--
Confidence 22345889999999998888899999999999999999999999743311 1111 1111111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIV 878 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl 878 (931)
+......+.+++.+||+.+|.+|| +++|++
T Consensus 218 --~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 218 --PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred --CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 111234678999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=291.45 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=198.3
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++.+.||+|++|.||++... +++.+|+|.+... .....+.+.+|++++++++|||++++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 456789999999999999875 6889999998643 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC-CceEEeccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~-~~vkL~DFGla~~~~~~~~ 766 (931)
++++|.+++... ....+++..+.+++.|+++||+|||+ .+++||||||+||+++++ +.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 82 PGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 999999999753 23458899999999999999999998 899999999999999865 4589999999986543321
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ...... .. +....+
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~---~~-~~~~~~------- 221 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKI---MS-GTFAPI------- 221 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHH---Hh-cCCCCC-------
Confidence 22245788999999999888999999999999999999999999743321 111111 11 111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.+|++|||++|+++
T Consensus 222 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 --SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112336889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=300.74 Aligned_cols=261 Identities=22% Similarity=0.320 Sum_probs=193.8
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+....++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 4556789999999999999876 689999999865432 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
. ++|.+++... ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~-~~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 86 D-TDLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred C-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 7 4999988643 3468899999999999999999998 8999999999999999999999999999875432111
Q ss_pred cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc---CCeeec----
Q 002358 768 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISI---- 839 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~~i---- 839 (931)
......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....... .......+.... .....+
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1122236788999998865 568899999999999999999999996433111 111101010000 000000
Q ss_pred ---------c-cccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 840 ---------V-DPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 840 ---------~-d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. ...+.... .......+.+++.+|++.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00000000 0111246789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=291.61 Aligned_cols=250 Identities=30% Similarity=0.410 Sum_probs=204.4
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
+++.+.||+|++|.||+|..+ +++.|++|++..... ...+.+.+|++.+.+++|+|++++++++......++|+||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 456789999999999999987 489999999876543 456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+++|.+++.. ...++...+..++.|+++||+|||+ ..+++||||+|+||+++.++.++|+|||++..........
T Consensus 83 ~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 83 GGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 9999999974 3678999999999999999999995 2799999999999999999999999999988764433221
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
....++..|+|||.+.+..++.++|+||||+++|||++|+.||.............++. .... +..
T Consensus 158 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~-----~~~---- 223 (264)
T cd06623 158 -NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPP-----PSL---- 223 (264)
T ss_pred -cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCC-----CCC----
Confidence 23357889999999999999999999999999999999999997443222222222222 1111 111
Q ss_pred CHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 849 KIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 849 ~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+.. ....+.+++.+|+..+|++||++.|+++
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111 3347889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=304.24 Aligned_cols=250 Identities=26% Similarity=0.331 Sum_probs=197.6
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+++.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+++++.++|+||+++++.+......++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 456788999999999999887 489999999875432 2446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+++... ....+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 83 CPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred cCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999998743 34568999999999999999999998 8999999999999999999999999999875432111
Q ss_pred c----------------------------cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCcc
Q 002358 767 H----------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 818 (931)
Q Consensus 767 ~----------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~ 818 (931)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011235788999999999888999999999999999999999999743322
Q ss_pred chhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 002358 819 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK----MQEIVL 879 (931)
Q Consensus 819 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs----~~evl~ 879 (931)
. .+. .... ... ... ........+.+++.+|++.+|++||+ ++|+++
T Consensus 239 ~--~~~----~~~~-~~~------~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 E--TFS----NILK-KEV------TFP--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H--HHH----HHhc-CCc------cCC--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 111 1111 110 000 01113457899999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=292.29 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=208.0
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.-..+.++||+|+||.||+|.++ .|+.+|||.+.- ..+.+++.+|+.+|++.+.|++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34456789999999999999887 599999998753 456788999999999999999999999888888999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
-.|++.++++. ..+++.+..+..++..-++||+|||. ..-+|||||+.|||++.+|.+||+|||.+-.+.+....
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 99999999886 36789999999999999999999997 78899999999999999999999999999877665443
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
+.+..|||.|||||++..-.|..++||||+|++..||..|++||..-.. . + +.-++. ..|...-.
T Consensus 186 -RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP--M----R-AIFMIP-------T~PPPTF~ 250 (502)
T KOG0574|consen 186 -RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP--M----R-AIFMIP-------TKPPPTFK 250 (502)
T ss_pred -hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc--c----c-eeEecc-------CCCCCCCC
Confidence 4456799999999999999999999999999999999999999962110 0 0 000010 11111223
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+..+..++-+++++||.+.|++|-|+.++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 35566678999999999999999999988875
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=298.23 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=194.3
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEec------CCe
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQ 679 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~------~~~ 679 (931)
...+++.+.||+|+||.||+|... +++.+|+|++.... ....++..|+.+++++ +|+||+++++++.. ...
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 346677889999999999999875 58899999875432 3345688899999998 69999999998853 457
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
.+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 899999999999999887532 3457888889999999999999998 899999999999999999999999999987
Q ss_pred cccccccccccccccCCCccCCCccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcC
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 834 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 834 (931)
........ .....|+..|+|||.+. ...++.++|||||||++|||++|+.||........ .. . ....
T Consensus 170 ~~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~----~-~~~~ 241 (282)
T cd06636 170 QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LF----L-IPRN 241 (282)
T ss_pred hhhccccC-CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hh----h-HhhC
Confidence 65332211 22345889999999875 34678899999999999999999999963321111 00 0 0000
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 835 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 835 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. +... .......+.+++.+||+.+|.+||++.||++
T Consensus 242 ~~-----~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 PP-----PKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CC-----CCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 1110 1122346889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=299.70 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=200.9
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
..+.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 46677899999999999999865 68899999986544455577899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999863 357888999999999999999998 89999999999999999999999999988765433222
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....+++.|+|||.+....++.++||||||+++|+|++|+.||...+..... . .....+ . +.. .
T Consensus 172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~----~~~~~~-~-----~~~--~ 236 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y----LIATNG-T-----PEL--Q 236 (293)
T ss_pred -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--e----ehhcCC-C-----CCC--C
Confidence 22235788999999998888999999999999999999999999743321110 0 000000 0 000 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223467899999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=295.70 Aligned_cols=256 Identities=26% Similarity=0.335 Sum_probs=199.8
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecC--CeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~lV~E~ 686 (931)
+++.+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++.+. ...++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 345689999999999999986 588999999875432 3456789999999999999999999988653 468999999
Q ss_pred cCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 687 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 687 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
+++++|.+++.... ....++...+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 99999998875422 34557888999999999999999998 899999999999999999999999999987543322
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCc--cchhhHHHHHHHhhhcCCeeeccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF--GAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~--~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
. ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... .......+++... ....+.+.
T Consensus 160 ~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~- 231 (287)
T cd06621 160 A---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELKDE- 231 (287)
T ss_pred c---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----CchhhccC-
Confidence 1 123468899999999999999999999999999999999999975432 1222333332221 11111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. ........+.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 10 01123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=297.19 Aligned_cols=259 Identities=23% Similarity=0.272 Sum_probs=196.9
Q ss_pred hhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecC--CeEEEEEEe
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYEY 686 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~lV~E~ 686 (931)
++.+.||+|++|.||+|... +++.+|+|++.... ....+.+.+|++++++++|+|++++++++... ...++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 45688999999999999987 48899999997653 23346788999999999999999999999887 889999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
++ ++|.+.+... ...+++..++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 82 MD-HDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cc-ccHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 97 4888887642 2578999999999999999999998 8999999999999999999999999999987654432
Q ss_pred ccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh---cCCeeeccc-
Q 002358 767 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---KGDVISIVD- 841 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~---~~~~~~i~d- 841 (931)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...+.+... ........+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccccc
Confidence 22233446788999997754 4678999999999999999999999974443211 111111110 000000000
Q ss_pred -------------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 842 -------------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 842 -------------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+...........+.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000111446889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=294.55 Aligned_cols=244 Identities=25% Similarity=0.368 Sum_probs=197.6
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
.+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 578999999999999875 6889999988655444556788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccccc
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 772 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 772 (931)
.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++......... ....
T Consensus 104 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 175 (285)
T cd06648 104 TDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSL 175 (285)
T ss_pred HHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-cccc
Confidence 999874 458889999999999999999998 89999999999999999999999999988754433221 2234
Q ss_pred ccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002358 773 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 852 (931)
Q Consensus 773 ~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 852 (931)
.|++.|+|||.+.+..++.++||||||+++|||++|+.||...+.. ...... ..+....... ....
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~-~~~~~~~~~~-------~~~~ 241 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRI-RDNLPPKLKN-------LHKV 241 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHH-HhcCCCCCcc-------cccC
Confidence 5889999999998888999999999999999999999999643221 111111 1111111100 1112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 853 IWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 853 ~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+.+++.+||+.+|++||+++++++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 246889999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=295.44 Aligned_cols=246 Identities=27% Similarity=0.426 Sum_probs=197.1
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc-cchhhhhHHHHHHHHHhcC---CCCCcceeEEEecCCeEEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~~~~lV~E 685 (931)
|++.+.||+|+||.||+|.+. +++.||+|.+... .....+++.+|++++++++ |||++++++++..+...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 456788999999999999975 6899999998654 2344567889999999997 9999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++++|.+++.. ..+++..++.++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 83 YAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred cCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 9999999998863 368899999999999999999998 899999999999999999999999999988765433
Q ss_pred cccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.. .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||....... ... .+.... .+.+
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~----~~~~~~-----~~~~ 222 (277)
T cd06917 156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR---AMM----LIPKSK-----PPRL 222 (277)
T ss_pred cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh---hhh----ccccCC-----CCCC
Confidence 22 2233588899999988654 56889999999999999999999997432211 111 111111 1111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
... .....+.+++.+||+.+|++||++.|+++
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 12346889999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=296.71 Aligned_cols=263 Identities=21% Similarity=0.295 Sum_probs=197.3
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
|++.+.||+|++|.||+|+.+ +|+.||+|+++.... ...+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 456789999999999999986 588999999875432 234567889999999999999999999999999999999998
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+ +|.+++........+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........ .
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 5 888887654444568999999999999999999998 8999999999999999999999999999876433221 1
Q ss_pred ccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhh-HHHHHH--------HhhhcC----
Q 002358 769 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWAR--------SMIKKG---- 834 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l~~~~~--------~~~~~~---- 834 (931)
.....++..|++||.+.+ ..++.++||||||+++|||++|+.||...+..+... ..+... ......
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 122346889999998865 457889999999999999999999997544321111 110000 000000
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 835 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 835 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......+... ....+.....+.+++.+|++.+|.+||+++|+++
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000 0011122346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=297.72 Aligned_cols=260 Identities=20% Similarity=0.280 Sum_probs=194.2
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|+..+.||+|++|.||+|+.+ +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 345788999999999999876 689999998865332 23357889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
. ++|.+++... ....+++..+..++.|+++||+|||+ .+++||||+|+||++++++.+||+|||++.........
T Consensus 82 ~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 82 H-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred c-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 5 6898888643 24568999999999999999999998 89999999999999999999999999998765432211
Q ss_pred cccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc-------------
Q 002358 768 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------------- 833 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~------------- 833 (931)
.....++..|+|||.+.+. .++.++||||||+++|||+||+.||...+... ...+.....-..
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1223467899999988664 46889999999999999999999997433211 111111100000
Q ss_pred --CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 834 --GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 834 --~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..........+.. ........+.+++.+|++.||++||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000 00111235679999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=312.74 Aligned_cols=267 Identities=28% Similarity=0.420 Sum_probs=202.4
Q ss_pred hccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC------eEEEEE
Q 002358 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QRILVY 684 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~------~~~lV~ 684 (931)
..+.||+|+||.||+|+.+ .|+.||||.+.... ....+...+|+++|++++|+|||++++.-++.. ...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 3588999999999999965 69999999997643 334567899999999999999999999866544 568999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc--CCCc--eEEeccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMR--AKVSDFGLSRQ 760 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld--~~~~--vkL~DFGla~~ 760 (931)
|||.+|+|...|.+..+..++++...+.++.+++.||.|||+ .+|+||||||.||++- .+|+ .||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999998899999999999999999999999998 9999999999999994 3344 69999999998
Q ss_pred ccccccccccccccCCCccCCCccC-CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
..+.. ......||..|++||.+. .+.|+...|.|||||++||+.||..||-....+.....+.|....-....+...
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 87654 334467999999999998 488999999999999999999999999733332211223332222122112222
Q ss_pred ccccccC------------CCCHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHhh
Q 002358 840 VDPVLIG------------NVKIESIWRIAEVAIQCVEQRGFSRP--KMQEIVLAIQDS 884 (931)
Q Consensus 840 ~d~~l~~------------~~~~~~~~~l~~li~~Cl~~dP~~RP--s~~evl~~L~~~ 884 (931)
.++...+ .........+-..+..+|..+|++|. ...+....+..+
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 2221111 11223334556777778888888888 444444444333
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=297.02 Aligned_cols=263 Identities=22% Similarity=0.266 Sum_probs=196.6
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch--hhhhHHHHHHHHHhcCCCCCcceeEEEecC--CeEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 684 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 684 (931)
.|++.+.||+|+||.||+|.++ +++.+|+|.++..... ....+.+|++++++++||||+++++++... ...++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 5677899999999999999987 5889999998654322 234577899999999999999999998777 8899999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+. ++|.+.+... ...+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 86 e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 86 EYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred hhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9997 5999888743 2368999999999999999999998 89999999999999999999999999998876543
Q ss_pred ccccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhh-HHH---------HHH--Hhh
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVH---------WAR--SMI 831 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l~~---------~~~--~~~ 831 (931)
... .....+++.|+|||.+.+. .++.++|+||+|+++|||++|..||.......... +.. |.. ...
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 211 1223478899999988654 46889999999999999999999997443221110 000 000 000
Q ss_pred --hcCCeeecccccccCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 832 --KKGDVISIVDPVLIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 832 --~~~~~~~i~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
............+....+.. ....+.+++.+||+.+|++||+++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000001111111111111 2446789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=289.37 Aligned_cols=257 Identities=25% Similarity=0.280 Sum_probs=205.3
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEECC-CcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 679 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 679 (931)
..+.-...++.+.||.|.-|+||++++++ +..+|+|++.+..- ....+...|-+||+.+.||.+..+++.++.++.
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 34445566678999999999999999985 58899999976533 334567789999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
.|+|||||+||+|...+++. ..+.+++..+.-++.+|+-||+|||- .|||.|||||+||||.++|++.|+||.|+.
T Consensus 152 ~cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred eEEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccc
Confidence 99999999999999988754 56779999999999999999999997 999999999999999999999999999875
Q ss_pred cccc-----------------------------c---c-c----------------------ccccccccCCCccCCCcc
Q 002358 760 QAEE-----------------------------D---L-T----------------------HISSVARGTVGYLDPEYY 784 (931)
Q Consensus 760 ~~~~-----------------------------~---~-~----------------------~~~~~~~gt~~y~APE~l 784 (931)
.... . . . ..+....||-.|+|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 4210 0 0 0 001123489999999999
Q ss_pred CCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHcc
Q 002358 785 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 864 (931)
Q Consensus 785 ~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl 864 (931)
.+...+.+.|.|+|||++|||+.|.-||.+..-.+. +..-+ -+.+.--..++......+||++.|
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~NIv-------------~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--LRNIV-------------GQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--HHHHh-------------cCCCcCCCCCcchhHHHHHHHHHh
Confidence 999999999999999999999999999986554322 11111 111110111234457889999999
Q ss_pred ccCCCCCCC----HHHHHH
Q 002358 865 EQRGFSRPK----MQEIVL 879 (931)
Q Consensus 865 ~~dP~~RPs----~~evl~ 879 (931)
.+||++|-- ++||.+
T Consensus 373 vKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ccChhhhhccccchHHhhc
Confidence 999999998 777754
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=292.48 Aligned_cols=252 Identities=28% Similarity=0.409 Sum_probs=197.2
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEecCC------eE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH------QR 680 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~------~~ 680 (931)
..|++.+.||+|++|.||+|..+ +++.+++|++..... ..+++.+|+.+++++ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 45677899999999999999986 578999999875433 346789999999999 6999999999986544 48
Q ss_pred EEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
++||||+++++|.+++.... ....+++..+..++.|+++||.|||+ .+++||||+|+||++++++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 99999999999999886432 24578899999999999999999998 899999999999999999999999999987
Q ss_pred cccccccccccccccCCCccCCCccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcC
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 834 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 834 (931)
........ .....|+..|+|||.+.. ..++.++||||||+++++|++|+.||..... ...+.+ .. .+
T Consensus 162 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~----~~-~~ 233 (275)
T cd06608 162 QLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRALFK----IP-RN 233 (275)
T ss_pred ecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--HHHHHH----hh-cc
Confidence 65432222 223458889999998753 3567899999999999999999999963221 111111 11 11
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 835 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 835 ~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... +. .+......+.+++.+||..||++|||++|+++
T Consensus 234 ~~~~-----~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 PPPT-----LK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCC-----CC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 11 11223447889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=300.58 Aligned_cols=264 Identities=21% Similarity=0.277 Sum_probs=194.7
Q ss_pred HhhccccCccCcEEEEEEEECC---CcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecC--CeEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 682 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~---g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~l 682 (931)
|++.++||+|+||.||+|..+. ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 4567889999999999999764 7899999987633 33346678899999999999999999999887 78999
Q ss_pred EEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC----CCceEEeccc
Q 002358 683 VYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFG 756 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~----~~~vkL~DFG 756 (931)
||||+++ +|.+.+.... ....++...+..++.|++.||+|||+ .+++||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 6766664322 22368899999999999999999998 89999999999999999 9999999999
Q ss_pred cccccccccc--ccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccch-------hhHHHH
Q 002358 757 LSRQAEEDLT--HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-------LNIVHW 826 (931)
Q Consensus 757 la~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~-------~~l~~~ 826 (931)
+++....... .......++..|+|||.+.+ ..++.++||||||++++||++|+.||........ ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9886543322 11223457889999998766 4578999999999999999999999975443220 001111
Q ss_pred HHHhhhc------------CCeeecccccccCCCC---H--------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 827 ARSMIKK------------GDVISIVDPVLIGNVK---I--------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 827 ~~~~~~~------------~~~~~i~d~~l~~~~~---~--------~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+ ..+.. .......+.......+ . .....+.+++.+|++.+|++|||+.|+++
T Consensus 238 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 F-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred H-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 00000 0000000000000001 0 12236789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-33 Score=304.91 Aligned_cols=251 Identities=22% Similarity=0.365 Sum_probs=204.4
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcE-EEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~-vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.-++++..||.|+||.||+|..++... .|.|++.........+|+-|++||....||+||++++.|..++.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 446677889999999999999886444 4668887777778889999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
.||-...++-. -+..+.+.++.-++.|++.||.|||+ .+|||||||+.|||++-+|.++|+|||.+...... ..
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ 185 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence 99999887654 35679999999999999999999998 99999999999999999999999999987643322 22
Q ss_pred cccccccCCCccCCCcc-----CCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 768 ISSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l-----~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
......|||.|||||+. ...+|+.++||||||++|.||..+.+|-.. .+... +.-.+.+...+.++.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMR-VllKiaKSePPTLlq- 257 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMR-VLLKIAKSEPPTLLQ- 257 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHH-HHHHHhhcCCCcccC-
Confidence 34456799999999986 457899999999999999999999988651 12222 111222223333332
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+..+...+.+++.+||..+|..||++.++++
T Consensus 258 ------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 3345567899999999999999999999884
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=295.32 Aligned_cols=251 Identities=27% Similarity=0.370 Sum_probs=194.7
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEecC-----CeEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE-----HQRIL 682 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~-----~~~~l 682 (931)
.+.+.+.||+|+||.||++..+ +++.+|+|++.... .....+.+|+.+++++ +|||++++++++... ...++
T Consensus 23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l 101 (291)
T cd06639 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101 (291)
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence 4556789999999999999875 68899999986532 2345678899999999 799999999998653 35899
Q ss_pred EEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
|+||+++|+|.++++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 999999999999886432 34568899999999999999999998 89999999999999999999999999998765
Q ss_pred cccccccccccccCCCccCCCccCCC-----CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQ-----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~-----~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
...... .....|+..|+|||.+... .++.++|||||||++|||++|+.||..... ...+.++ ..+..
T Consensus 179 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~~~~~~-----~~~~~ 250 (291)
T cd06639 179 TSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLFKI-----PRNPP 250 (291)
T ss_pred cccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HHHHHHH-----hcCCC
Confidence 432211 2233578899999998543 367899999999999999999999963221 1111111 11111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+.+ +......+.+++.+|++.+|++||++.|+++
T Consensus 251 ~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 251 PTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 1122346889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=286.37 Aligned_cols=248 Identities=29% Similarity=0.480 Sum_probs=202.2
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
|...+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++.+......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 345688999999999999986 6899999999776555667899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
++|.+.+... ...+++..+..++.|+++||++||+ .+++||||+|+||++++++.++|+|||.+........ .
T Consensus 82 ~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 82 GSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 9999998753 2578999999999999999999997 9999999999999999999999999999887654332 2
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
....++..|++||.+....++.++||||||+++++|++|+.||...+... ..... .. .......++
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~---~~-~~~~~~~~~------- 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALFKI---AT-NGPPGLRNP------- 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHH---Hh-cCCCCcCcc-------
Confidence 33457889999999988889999999999999999999999997332111 11111 11 111111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......+.+++.+|++.+|++|||+.|+++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111346889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=296.58 Aligned_cols=246 Identities=30% Similarity=0.415 Sum_probs=195.1
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
..|++.+.||+|+||.||+|... +++.||+|++.... ....+++.+|+++++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777899999999999999876 68999999886432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+. |++.+.+... ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 6777766532 3468999999999999999999998 89999999999999999999999999998754322
Q ss_pred ccccccccccCCCccCCCccC---CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 765 LTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||...+... .. .. +......
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~---~~---~~-~~~~~~~---- 232 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---AL---YH-IAQNDSP---- 232 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH---HH---HH-HhcCCCC----
Confidence 2234788999999874 4568889999999999999999999986332211 11 11 1111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.+ ........+.+++.+||+.+|++||++.+|++.
T Consensus 233 -~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 233 -TL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 112234478899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=297.05 Aligned_cols=264 Identities=23% Similarity=0.287 Sum_probs=196.6
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCC----
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH---- 678 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~---- 678 (931)
.....+++.+.||+|+||.||+|.++ +|+.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34556778899999999999999987 588999999865422 23356788999999999999999999887654
Q ss_pred ------eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEE
Q 002358 679 ------QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 752 (931)
Q Consensus 679 ------~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL 752 (931)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence 78999999976 677766542 3468999999999999999999998 89999999999999999999999
Q ss_pred ecccccccccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002358 753 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 831 (931)
Q Consensus 753 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 831 (931)
+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||........... +.+..
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~---~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL---ISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHh
Confidence 9999988654433222222345778999998764 4578899999999999999999999974332111111 11111
Q ss_pred hc---CCeeecc--------cc------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 832 KK---GDVISIV--------DP------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 832 ~~---~~~~~i~--------d~------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. .....+. ++ ...... ...+..+.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000000 00 000000 012346889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=296.77 Aligned_cols=253 Identities=28% Similarity=0.370 Sum_probs=193.4
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
+...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++......+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 335678999999999999876 58999999986533 244567889999999996 999999999999888999999998
Q ss_pred CCCCHHHHhcc--CCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 688 HNGTLRDRLHG--SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 688 ~~gsL~~~L~~--~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
. +++.++... ......+++..+..++.|+++||+|||+ ..+++||||||+||+++.++.+||+|||+++......
T Consensus 86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 6 455543321 1123568999999999999999999997 3599999999999999999999999999987654322
Q ss_pred cccccccccCCCccCCCccCCC---CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~---~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
.. ....|+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ...+.+.+... +.. +
T Consensus 163 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~~-----~ 229 (288)
T cd06616 163 AK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GDP-----P 229 (288)
T ss_pred cc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CCC-----C
Confidence 21 223578899999998776 68899999999999999999999996322 11111222111 111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+...........+.+++.+|++.+|++||+++||++
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111223446889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=293.91 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=191.3
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHH-HHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVAL-LSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~i-l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
+++.+.||+|+||.||+|.++ +|+.||+|+++... .....++..|+.+ ++.++||||+++++++..+...+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 456788999999999999886 68999999987543 2334556666665 56678999999999999999999999999
Q ss_pred CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 688 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 688 ~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+ |+|.+.+.... ....+++..+..++.|++.||+|||+ +.+++||||||+||+++.++.+||+|||++........
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 6 68888775432 34568999999999999999999997 23899999999999999999999999999876543221
Q ss_pred ccccccccCCCccCCCccCC----CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 767 HISSVARGTVGYLDPEYYGN----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..... .... ...... +....+...
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~----~~~~~~-~~~~~~~~~ 231 (283)
T cd06617 160 --KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-PFQQ----LKQVVE-EPSPQLPAE 231 (283)
T ss_pred --cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-CHHH----HHHHHh-cCCCCCCcc
Confidence 222457889999998864 4568899999999999999999999963211 1111 111111 111111100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.....+.+++.+||..+|++||+++++++
T Consensus 232 --------~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 232 --------KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12246889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=293.21 Aligned_cols=246 Identities=25% Similarity=0.331 Sum_probs=199.7
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|++.+.||.|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++.+.+....++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456789999999999999987 58999999986532 23457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 82 LLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 999999999874 3578899999999999999999997 899999999999999999999999999987654332
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||........ .+........ ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~----------~~ 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQETA----------DV 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhccc----------cc
Confidence 12234578899999999888899999999999999999999999974443211 1111111110 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKM--QEIV 878 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~--~evl 878 (931)
..+......+.+++.+||+.+|.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1122233578899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=288.93 Aligned_cols=242 Identities=24% Similarity=0.336 Sum_probs=194.8
Q ss_pred cCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 617 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 617 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
||.|++|.||+++.. .++.+|+|++.... ....+.+.+|++++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 48999999986532 23446799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccccc
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 772 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 772 (931)
.+++.. ...+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999974 3458889999999999999999998 999999999999999999999999999988764432 12223
Q ss_pred ccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002358 773 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 852 (931)
Q Consensus 773 ~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 852 (931)
.++..|++||.+....++.++|+||+|+++|||++|+.||...... .. +.......... ....+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~---~~~~~~~~~~~---------~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PM---EIYNDILKGNG---------KLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HH---HHHHHHhccCC---------CCCCCccc
Confidence 5788999999998888999999999999999999999999744321 11 11111111000 01112222
Q ss_pred HHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002358 853 IWRIAEVAIQCVEQRGFSRPK-----MQEIVL 879 (931)
Q Consensus 853 ~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 879 (931)
...+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 447889999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=294.74 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=194.4
Q ss_pred hhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
++.+.||+|++|.||+|..+ +|+.||+|++.... ....+.+.+|++++++++|||++++++++.+....+++|||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 45688999999999999876 79999999986442 2233568889999999999999999999999999999999995
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
++|.+++.... ...+++..++.++.|+++||+|||+ .+++||||+|+||+++.++.++|+|||++.........
T Consensus 82 -~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 82 -LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred -cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 68999887432 2468999999999999999999998 89999999999999999999999999998765332211
Q ss_pred ccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcC--------C----
Q 002358 769 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--------D---- 835 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~--------~---- 835 (931)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...+... .+.+..+...... .
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1122467899999987654 57889999999999999999999997433211 1111111000000 0
Q ss_pred ---eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 836 ---VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 836 ---~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......+.. ..........+.+++.+|++.+|++||+++|+++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0011122246789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=324.57 Aligned_cols=264 Identities=26% Similarity=0.427 Sum_probs=212.0
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEEC----C----CcEEEEEEccCccc-hhhhhHHHHHHHHHhc-CCCCCcceeEEE
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMK----D----GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYC 674 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~----~----g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~ 674 (931)
|+......+.+.||+|+||.|++|..+ . ...||||+++.... .+.+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 444455567779999999999999754 1 45799999987543 4567899999999999 699999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHhccCC-----CC--------CCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCC
Q 002358 675 EEEHQRILVYEYMHNGTLRDRLHGSV-----NQ--------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 741 (931)
Q Consensus 675 ~~~~~~~lV~E~~~~gsL~~~L~~~~-----~~--------~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~N 741 (931)
...+..++|+||++.|+|.++|+..+ .. ..++....+.++.|||.||+||++ .+++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhh
Confidence 99999999999999999999998654 01 238889999999999999999998 899999999999
Q ss_pred ccccCCCceEEecccccccccccccccccccc--cCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCcc
Q 002358 742 ILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 818 (931)
Q Consensus 742 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~--gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~ 818 (931)
||+..+..+||+|||+++...+.......... -+..|||||.+....|+.|+|||||||+||||+| |..||.+ ..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~--~~ 526 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG--IP 526 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC--CC
Confidence 99999999999999999975554433322222 2457999999999999999999999999999999 8899864 22
Q ss_pred chhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 819 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 819 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
....+.+++ ++|... ..+.....++.++++.||+.+|++||++.|+++.++..+.
T Consensus 527 ~~~~l~~~l----~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEELLEFL----KEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHHHHHH----hcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 122333333 333221 1233334578899999999999999999999999998643
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=289.21 Aligned_cols=248 Identities=29% Similarity=0.429 Sum_probs=198.6
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
+.+.+.||+|+||.||+|..+ +|+.+|+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 446788999999999999886 58899999986431 234467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc-eEEeccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~-vkL~DFGla~~~~~~~~ 766 (931)
++++|.+.+... ....+++..+..++.|+++||+|||+ .+++|+||||+||++++++. +||+|||.+........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 82 DGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999998753 23357899999999999999999998 89999999999999998754 69999999876543322
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
. .....|++.|+|||.+.+..++.++|+||||+++|||++|+.||..... .++...... +....+
T Consensus 158 ~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~~------- 222 (257)
T cd08225 158 L-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GYFAPI------- 222 (257)
T ss_pred c-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccCCCC-------
Confidence 2 2234588899999999888899999999999999999999999963321 222222221 111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.......+.+++.+|++.+|++||++.|+++
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1122346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=292.38 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=200.9
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.+++.+.||+|++|.||+|.++ +++.+++|++..... ..+.+.+|++++++++|+|++++++.+......++|+||++
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 3556788999999999999987 689999999876544 45678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 99 ~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 99 GGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 999999998532 378999999999999999999998 9999999999999999999999999998875443221 1
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
.....++..|++||.+.+..++.++||||||+++|+|++|+.||...+... .. .... ........+
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~~---~~~~-~~~~~~~~~------- 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---AL---FLIT-TKGIPPLKN------- 238 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHH-hcCCCCCcc-------
Confidence 223347889999999988889999999999999999999999996332211 11 1111 111111110
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.......+.+++.+|++.+|.+||++.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112346889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=291.18 Aligned_cols=246 Identities=28% Similarity=0.369 Sum_probs=196.3
Q ss_pred cCccCcEEEEEEEECC-CcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 617 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 617 LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
||+|+||.||++++.+ |+.+++|.+..... ...+.+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999874 89999999865433 3456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc------
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------ 766 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~------ 766 (931)
.+++.. ...+++..+..++.|+++||+|||+ .+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999874 3468999999999999999999998 8999999999999999999999999999876433211
Q ss_pred -ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 -HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 -~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.......++..|++||.......+.++||||||+++|||++|+.||...... ...+.. ..+.... +
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~----~~~~~~~---~--- 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQNI----LNGKIEW---P--- 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----hcCCcCC---C---
Confidence 1122345788999999998888999999999999999999999999743321 111111 1111100 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
.. ......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 ~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 222 ED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred cc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00 0013467899999999999999999777666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=292.49 Aligned_cols=256 Identities=23% Similarity=0.264 Sum_probs=192.5
Q ss_pred hhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcC-CCCCcceeEEEecC--CeEEEEEEe
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILVYEY 686 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~--~~~~lV~E~ 686 (931)
++.+.||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 46788999999999999875 68999999987542 222334567899999885 99999999999887 889999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
++ |+|.+.+... ...+++..+..++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++.......
T Consensus 82 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 82 MD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred CC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 97 5888877642 3468999999999999999999998 89999999999999999 9999999999986543322
Q ss_pred ccccccccCCCccCCCccC-CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh-----------cC
Q 002358 767 HISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK-----------KG 834 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~-----------~~ 834 (931)
. ....++..|+|||.+. +..++.++||||+||++|||++|+.||...+.. ..+.+...... ..
T Consensus 155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhccc
Confidence 1 2234788999999764 456788999999999999999999999744322 11222211110 00
Q ss_pred CeeecccccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 835 DVISIVDPVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 835 ~~~~i~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.......+...+ .........+.+++.+||+.+|++||+++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000 001123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=288.78 Aligned_cols=260 Identities=24% Similarity=0.354 Sum_probs=209.2
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECC------CcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEec-C
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE-E 677 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 677 (931)
+.+.+.+....+-+|.||.||+|.|.+ .+.|.+|.++....+ +...++.|.-.+..+.|||+.++.+.+.+ .
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 344444456679999999999997763 456788888765443 55678899999999999999999998755 4
Q ss_pred CeEEEEEEecCCCCHHHHhc-----cCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEE
Q 002358 678 HQRILVYEYMHNGTLRDRLH-----GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 752 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~-----~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL 752 (931)
...+++|.++.-|+|..+|. +....+.+...+...++.|++.|++|||. .+|+|.||.++|++||+..++||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEe
Confidence 56788999999999999998 33355667888899999999999999997 99999999999999999999999
Q ss_pred ecccccccccccc-cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHh
Q 002358 753 SDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 830 (931)
Q Consensus 753 ~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 830 (931)
+|=.+++..-+.. .........+..||+||.+....|+.++|||||||+||||+| |+.|+..-+.-+.. ..
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-------~y 510 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-------HY 510 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-------HH
Confidence 9999999754433 333444456889999999999999999999999999999999 99999733322211 11
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 831 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 831 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
+..|- +-..+.++++++..++.-||...|++||++++++.-|.+-
T Consensus 511 lkdGy---------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 511 LKDGY---------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred Hhccc---------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 22221 1123567778999999999999999999999999988753
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=294.86 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=191.9
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+++++.++|+||+++++++..+...++|+||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 3556789999999999999875 6899999998654322 2346788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
. ++|.+.+... ...+.+..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++........
T Consensus 86 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 86 H-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred c-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 5 6777766532 3457788888999999999999998 89999999999999999999999999998754332211
Q ss_pred cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh-------------c
Q 002358 768 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK-------------K 833 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~-------------~ 833 (931)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..+.+ ...... .
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 160 -YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEK-IWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred -CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHH-HHHHcCCCChhhhhhhhhcc
Confidence 122346889999999865 457889999999999999999999997433211 11110 000000 0
Q ss_pred CCeeecccccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 834 GDVISIVDPVLIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 834 ~~~~~i~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....+.......... .......+.+++.+|++.+|++|||++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 0011346779999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=319.52 Aligned_cols=268 Identities=18% Similarity=0.231 Sum_probs=187.8
Q ss_pred HHHHHhhccccCccCcEEEEEEEECC--CcEEEEE------------------EccCccchhhhhHHHHHHHHHhcCCCC
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVK------------------IMADSCSHRTQQFVTEVALLSRIHHRN 666 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~--g~~vAvK------------------~~~~~~~~~~~~~~~E~~il~~l~Hpn 666 (931)
....|++.+.||+|+||+||++.++. +...++| .+. ........+.+|+++|++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 34678889999999999999987652 2222222 111 11223456889999999999999
Q ss_pred CcceeEEEecCCeEEEEEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc
Q 002358 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 744 (931)
Q Consensus 667 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl 744 (931)
|+++++++...+..++|+|++. ++|.+++.... .........+..++.||+.||+|||+ ++|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence 9999999999999999999985 57777664321 11223456677899999999999998 899999999999999
Q ss_pred cCCCceEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCc-cchhhH
Q 002358 745 DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF-GAELNI 823 (931)
Q Consensus 745 d~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~-~~~~~l 823 (931)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++..... .....+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987655433333345699999999999999999999999999999999998754432221 111122
Q ss_pred HHHHHHhhh-cCCee-------ecccccccC----CC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 824 VHWARSMIK-KGDVI-------SIVDPVLIG----NV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 824 ~~~~~~~~~-~~~~~-------~i~d~~l~~----~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+.+..... ..... ..++..... .. .......+.+++.+||+.||++||+++|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111110000 00000 000000000 00 0011235678899999999999999999986
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=296.34 Aligned_cols=261 Identities=20% Similarity=0.238 Sum_probs=186.2
Q ss_pred hhhHHHHHHhhccccCccCcEEEEEEEECCC----cEEEEEEccCccchh-----------hhhHHHHHHHHHhcCCCCC
Q 002358 603 LPELEEATNNFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADSCSHR-----------TQQFVTEVALLSRIHHRNL 667 (931)
Q Consensus 603 ~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~~g----~~vAvK~~~~~~~~~-----------~~~~~~E~~il~~l~HpnI 667 (931)
..++....|++.+.||+|+||.||+|.+.++ ..+|+|+........ ......+...+..+.|+|+
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 3445556788899999999999999997643 456666543221110 0112234445566789999
Q ss_pred cceeEEEecCC----eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcc
Q 002358 668 VPLIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 743 (931)
Q Consensus 668 v~l~g~~~~~~----~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIL 743 (931)
+++++.+.... ..++++|++. .++.+.+.. ....++..+..++.|+++||+|||+ .+|+||||||+|||
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nil 158 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIM 158 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence 99998765443 3467778763 466666553 2335678889999999999999998 89999999999999
Q ss_pred ccCCCceEEecccccccccccccc------cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCc
Q 002358 744 LDINMRAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 817 (931)
Q Consensus 744 ld~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~ 817 (931)
++.++.++|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999865322111 11223589999999999999999999999999999999999999975432
Q ss_pred cchh-h--HHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 818 GAEL-N--IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 818 ~~~~-~--l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
.... . ..++..+. ..+.. . ....+..+.+++..|++.+|++||++++|++.++
T Consensus 239 ~~~~~~~~~~~~~~~~-~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 NGNLIHAAKCDFIKRL-HEGKI--------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred chHHHHHhHHHHHHHh-hhhhh--------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 2111 1 11111111 11111 0 1112356889999999999999999999998763
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=295.34 Aligned_cols=261 Identities=21% Similarity=0.267 Sum_probs=191.9
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCe-----EE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ-----RI 681 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~-----~~ 681 (931)
|++.+.||+|+||.||+|.+. +++.||+|+++.... .....+.+|+.+++.++ ||||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 456789999999999999876 689999998765432 23357888999999995 6999999999877665 79
Q ss_pred EEEEecCCCCHHHHhccCCC--CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC-CCceEEeccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLS 758 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla 758 (931)
+||||+++ +|.+++..... ...+++..++.++.||++||.|||+ .+++||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 78888764322 3568999999999999999999998 89999999999999998 889999999998
Q ss_pred ccccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCC--
Q 002358 759 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD-- 835 (931)
Q Consensus 759 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~-- 835 (931)
+........ .....+++.|+|||.+.+ ..++.++||||||+++|||++|..||....... .+.. +...+....
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~~ 234 (295)
T cd07837 159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLH-IFKLLGTPTEQ 234 (295)
T ss_pred eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-HHHHhCCCChh
Confidence 765332111 112246788999998755 467899999999999999999999997432211 1111 001110000
Q ss_pred -eeeccc-------cccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 836 -VISIVD-------PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 836 -~~~i~d-------~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.....+ +... ....+.....+.+++.+||+.+|++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 0000 0000123346889999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=291.75 Aligned_cols=242 Identities=23% Similarity=0.287 Sum_probs=186.6
Q ss_pred ccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHh---cCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 616 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSR---IHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 616 ~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~---l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..+++. .+||||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 588999998865321 222334455544444 479999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|+|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999998873 4568999999999999999999998 899999999999999999999999999987543322
Q ss_pred ccccccCCCccCCCccC-CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 769 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....|+..|+|||.+. +..++.++||||+||++|||++|..||..........+ . ..... ....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~---~~~~~------~~~~---- 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-D---RMTLT------VNVE---- 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH-H---HHhhc------CCcC----
Confidence 12235899999999886 45688999999999999999999999974332221111 1 11100 0111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 880 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 880 (931)
.+.....++.+++.+|++.+|++|| +++|+++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1222334678999999999999999 58888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=297.75 Aligned_cols=266 Identities=20% Similarity=0.263 Sum_probs=194.4
Q ss_pred cccCcc--CcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G--~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+| +||+||++.+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999875 79999999986432 23446788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc-
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI- 768 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~- 768 (931)
++|.+.+.... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999887542 3458889999999999999999998 899999999999999999999999998654322111100
Q ss_pred -----ccccccCCCccCCCccCCC--CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh-----------
Q 002358 769 -----SSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM----------- 830 (931)
Q Consensus 769 -----~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~----------- 830 (931)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ...+.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence 1112245679999998763 57899999999999999999999997432211 111100000
Q ss_pred ---------------------hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhh
Q 002358 831 ---------------------IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDSIK 886 (931)
Q Consensus 831 ---------------------~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~~~~ 886 (931)
...+....+.+..+...........+.+++.+||+.+|++|||++|+++ .++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0000000111111111112234567899999999999999999999963 4454444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=283.40 Aligned_cols=248 Identities=27% Similarity=0.404 Sum_probs=201.4
Q ss_pred hhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecC--CeEEEEEEe
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYEY 686 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~lV~E~ 686 (931)
...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++++||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 44688999999999999987 689999999875542 4567899999999999999999999999888 889999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+++... ..+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 83 VSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999998743 378999999999999999999998 8999999999999999999999999999887654332
Q ss_pred c-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 H-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
. ......++..|+|||.+.....+.++||||||+++++|++|+.||...+. . ...+.........
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~---~~~~~~~~~~~~~--------- 222 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--P---MAALYKIGSSGEP--------- 222 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--h---HHHHHhccccCCC---------
Confidence 1 12234578899999999888899999999999999999999999974431 1 1111111110111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+......+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1112222457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=304.47 Aligned_cols=260 Identities=23% Similarity=0.321 Sum_probs=193.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecC-----CeEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 682 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-----~~~~l 682 (931)
.|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++|+||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 4567889999999999999875 68999999986432 23446688899999999999999999987543 35789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
|+||+. ++|.+.+. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 86 VQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred Eehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999996 58888775 3468999999999999999999998 899999999999999999999999999987654
Q ss_pred cccccc--ccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCC---e
Q 002358 763 EDLTHI--SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---V 836 (931)
Q Consensus 763 ~~~~~~--~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~---~ 836 (931)
...... .....|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+... ....+........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence 322111 122457899999998654 568899999999999999999999997443211 1111111111100 0
Q ss_pred eecccccc---------cCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 837 ISIVDPVL---------IGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 837 ~~i~d~~l---------~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
..+.+... ....+ +.....+.+++.+||+.+|++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 00000 1123468899999999999999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=296.67 Aligned_cols=260 Identities=22% Similarity=0.236 Sum_probs=192.8
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch--hhhhHHHHHHHHHhcCCCCCcceeEEEecC--CeEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 684 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 684 (931)
.|++.+.||+|+||.||+|..+ +|+.||+|+++..... ....+.+|+.++++++|+||+++++++... +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 4566789999999999999876 5899999998643222 223567899999999999999999998654 5689999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+. ++|.+.+... ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 88 e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 88 EYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred ecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9996 5888887643 3568999999999999999999998 89999999999999999999999999999876433
Q ss_pred ccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc--CCee----
Q 002358 765 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK--GDVI---- 837 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~--~~~~---- 837 (931)
.. ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...+.... ..-+...... ....
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhchhhh
Confidence 21 1222335788999999865 5678999999999999999999999974332211 1111111100 0000
Q ss_pred --------ecccccccC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 --------SIVDPVLIG--NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 --------~i~d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......... .........+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 000012345779999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=283.16 Aligned_cols=246 Identities=26% Similarity=0.437 Sum_probs=200.6
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|.+.+.||+|++|.||++... +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.+++..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 456789999999999999876 578999999876543 45578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 82 ENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999874 3578999999999999999999997 89999999999999999999999999999876543322
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....++..|+|||.+.+..++.++||||+|+++++|++|+.||...+. ...... ... ... +.+
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--~~~~~~----~~~-~~~-----~~~--- 219 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--MAALFR----IVQ-DDH-----PPL--- 219 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--HHHHHH----Hhc-cCC-----CCC---
Confidence 2234578899999999888889999999999999999999999963321 111111 111 111 111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||..+|++||++.|++.
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 -PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122346789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=301.44 Aligned_cols=261 Identities=23% Similarity=0.284 Sum_probs=195.4
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEecC------C
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------H 678 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~ 678 (931)
...|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 455677899999999999999876 6899999998643 223445678899999999999999999988543 3
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
..++||||+. ++|.+.+.. .++...+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 5799999995 588887753 27888899999999999999998 89999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhh-H-----------HHH
Q 002358 759 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-I-----------VHW 826 (931)
Q Consensus 759 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l-----------~~~ 826 (931)
+....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...... + ...
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 86543221 223357889999999999999999999999999999999999997443211100 0 000
Q ss_pred ----HHHhhhcCC------eeeccccc----ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 827 ----ARSMIKKGD------VISIVDPV----LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 827 ----~~~~~~~~~------~~~i~d~~----l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......... ..++.... ............+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000000 00010000 000111123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=296.17 Aligned_cols=249 Identities=31% Similarity=0.426 Sum_probs=196.0
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
+..+...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|||++++++++.++...++|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 344667789999999999999875 68899999986432 23345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+. |+|.+.+... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 104 ~e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 104 MEYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EeCCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99996 5787776532 4568999999999999999999998 8999999999999999999999999998875432
Q ss_pred cccccccccccCCCccCCCccC---CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 764 DLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
. ....|++.|+|||.+. ...++.++|||||||++|||++|+.||...+.. ..+..+ ...+ ..
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~----~~~~-~~--- 242 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHI----AQNE-SP--- 242 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHH----Hhcc-CC---
Confidence 2 2235788999999873 457889999999999999999999998633211 111111 1111 10
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
.. ........+.+++.+|++.+|.+||++.++++.+-
T Consensus 243 --~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 243 --TL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred --CC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 00 01122346889999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=284.16 Aligned_cols=249 Identities=29% Similarity=0.456 Sum_probs=202.9
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|.+.+.||+|+||.||++... +++.+++|++..... ...+.+.+|+++++.++|+|++++++.+......++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 445688999999999999876 689999999875433 45567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 688 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 688 ~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
++++|.+.+.... ....+++..+..++.++++||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 9999999987532 24678999999999999999999998 899999999999999999999999999988754433
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.......|++.|+|||.+....++.++||||+|+++++|++|+.||...+.. .+. .... ......
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~---~~~~-~~~~~~-------- 222 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELA---LKIL-KGQYPP-------- 222 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHH---HHHh-cCCCCC--------
Confidence 1223345888999999998888999999999999999999999999643321 111 1111 111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+......+.+++.+||..+|++||++.|+++
T Consensus 223 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 -IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11122346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=290.38 Aligned_cols=241 Identities=23% Similarity=0.286 Sum_probs=189.0
Q ss_pred cCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 617 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 617 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
||+|+||+||++..+ +|+.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 68999999986432 22345677899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccccc
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 772 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 772 (931)
.+++.... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 99987532 2468999999999999999999998 899999999999999999999999999987654321 11223
Q ss_pred ccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002358 773 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 852 (931)
Q Consensus 773 ~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 852 (931)
.++..|+|||.+.+..++.++||||+|+++++|++|+.||........... +....... .. ..+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~------~~----~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE---LKRRTLEM------AV----EYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH---HHhccccc------cc----cCCccC
Confidence 478899999999888899999999999999999999999974332111110 11111000 00 111112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHH
Q 002358 853 IWRIAEVAIQCVEQRGFSRPKMQE 876 (931)
Q Consensus 853 ~~~l~~li~~Cl~~dP~~RPs~~e 876 (931)
...+.+++.+||+.+|++||+.+|
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCc
Confidence 336789999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=295.26 Aligned_cols=264 Identities=20% Similarity=0.235 Sum_probs=192.0
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCC--------
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-------- 678 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-------- 678 (931)
.|++.+.||+|+||.||+|..+ +++.||||.+..... .....+.+|++++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4677889999999999999876 689999998864322 22345678999999999999999999986643
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
..++||||+. ++|.+.+... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4599999996 5788877642 3468999999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccc---cccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcC
Q 002358 759 RQAEEDLTH---ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 834 (931)
Q Consensus 759 ~~~~~~~~~---~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 834 (931)
......... ......++..|+|||.+.+. .++.++||||||+++|||++|..||...+..........+.......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 765432211 11223467889999987654 47889999999999999999999997543322222222111111000
Q ss_pred Ceeec-----ccc-cccCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 835 DVISI-----VDP-VLIGNV---------KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 835 ~~~~i-----~d~-~l~~~~---------~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..... .+. ...... +......+.+++.+||..+|++||+++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 000 000000 0001135678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=286.39 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=201.2
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++.+.||+|++|.||+++.+ +++.+++|.+.... ......+.+|++++++++|+||+++++++......++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 456789999999999999866 67899999986532 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 688 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 688 ~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
++++|.+++.... ....+++..++.++.|+++||+|||+ .+++||||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 9999999886532 23568899999999999999999998 899999999999999999999999999998765441
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.....+++.|++||.+.+..++.++|+||+|+++|||++|+.||...+.. .+.. .+..+....
T Consensus 158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~~-------- 220 (256)
T cd08530 158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY----KVQRGKYPP-------- 220 (256)
T ss_pred --cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHhcCCCCC--------
Confidence 22245788999999999999999999999999999999999999743321 1111 111111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+......+.+++.+|++.+|++||++.|+++
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 -IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11233456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=290.59 Aligned_cols=244 Identities=26% Similarity=0.371 Sum_probs=196.1
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
..+||+|+||.||++..+ +++.||+|++..........+.+|+.+++.++|+|++++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 468999999999999875 6899999998655455567799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccccc
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 772 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 772 (931)
.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++......... ....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-~~~~ 176 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSL 176 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-cccc
Confidence 998752 357889999999999999999998 89999999999999999999999999988765432211 2234
Q ss_pred ccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002358 773 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 852 (931)
Q Consensus 773 ~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 852 (931)
.|++.|+|||.+.+..++.++|+||+|+++|||++|+.||...... .......... .+.+.. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~~---------~~~~~~--~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNL---------PPKLKN--LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhC---------CcccCC--cccC
Confidence 5788999999998888899999999999999999999999643221 1111111100 011100 0111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 853 IWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 853 ~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 235778999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=291.92 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=197.6
Q ss_pred hhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
++.+.||+|++|.||+|... +++.+++|++..... .....+.+|++++++++|+||+++++++..+...++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 45678999999999999876 688999999865433 245678899999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+ +|.+.+... ...+++..+..++.|+++||.|||+ .+++|+||||+||+++.++.++|+|||.+....... ..
T Consensus 82 ~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 82 T-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred C-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 5 888887643 3578999999999999999999998 899999999999999999999999999987765433 11
Q ss_pred ccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc---CCeeeccc---
Q 002358 769 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISIVD--- 841 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~~i~d--- 841 (931)
.....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+..+. .......... .......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhhh
Confidence 2223477889999998776 789999999999999999999999964332111 1111111100 00000000
Q ss_pred --------cccc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 842 --------PVLI--GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 842 --------~~l~--~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... .........++.+++.+||+.+|.+||+++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011223457889999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=274.62 Aligned_cols=247 Identities=23% Similarity=0.383 Sum_probs=193.4
Q ss_pred hccccCccCcEEEEEEEEC-CCcEEEEEEccCc-cchhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEEecCC
Q 002358 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+...||.|..|.|++++.+ .|..+|||.+... ..+..++++..+.++..-+ .|+||+.+|+|..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 4577999999999999887 5899999998764 3455677888888776654 8999999999999988999999883
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
..+..++++. .+++++.-+-++...+.+||.||.+ +++|+|||+||+|||+|+.|++||||||++-++.+...+.
T Consensus 175 ~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht- 249 (391)
T KOG0983|consen 175 TCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT- 249 (391)
T ss_pred HHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccccc-
Confidence 3455555543 4568888888899999999999998 6999999999999999999999999999998776554443
Q ss_pred cccccCCCccCCCccCC---CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 770 SVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
...|-+.|||||.+.- ..|+.++||||||++|+||.||+.||..-+.+- .. +...+. +....+++...
T Consensus 250 -rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~---ltkvln--~ePP~L~~~~g- 320 (391)
T KOG0983|consen 250 -RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EV---LTKVLN--EEPPLLPGHMG- 320 (391)
T ss_pred -cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HH---HHHHHh--cCCCCCCcccC-
Confidence 3458899999999854 578899999999999999999999998533321 11 111121 11122222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+. ..+.+++..||++|+.+||...++++
T Consensus 321 -FS----p~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 321 -FS----PDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -cC----HHHHHHHHHHhhcCcccCcchHHHhc
Confidence 22 36789999999999999999999875
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=291.21 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=199.3
Q ss_pred HhhccccCccCcEEEEEEEEC----CCcEEEEEEccCcc----chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~ 681 (931)
+++.+.||+|++|.||++... +++.||||+++... ....+.+.+|++++.++ +||||+++++.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 456789999999999999753 57889999986432 12345688999999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+||||+++|+|.+.+.. ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 82 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999998873 3568889999999999999999998 89999999999999999999999999998765
Q ss_pred cccccccccccccCCCccCCCccCCCC--CCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~~--~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
............|+..|+|||.+.+.. .+.++||||||+++|||++|..||....... ......+.....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~------ 227 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS------ 227 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc------
Confidence 443322223345789999999987654 7889999999999999999999996322111 111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
.+.. +......+.+++.+||+.+|++|||++++.+.|+..
T Consensus 228 -~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 -KPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -CCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0111 111223678999999999999999999988877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=285.32 Aligned_cols=244 Identities=27% Similarity=0.310 Sum_probs=188.8
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHH-hcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLS-RIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~-~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|... +++.||+|++..... .....+..|..++. ..+|+|++++++.+...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 589999999865321 22234455555444 45899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
++|.+++.. ...+++..+..++.|+++||.|||+ .+++||||+|+||+++.++.++|+|||+++.... .
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 999999874 3468889999999999999999998 8999999999999999999999999999875432 2
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
....++..|+|||.+.+..++.++||||||+++|||++|..||...+... ..+ . +..+... ..... .
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~-~~~~~~~--~~~~~----~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFD---N-ILSRRIN--WPEEV----K 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHH---H-HHhcccC--CCCcc----c
Confidence 22347889999999988888999999999999999999999997433211 111 1 1111110 00001 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
......+.+++.+||+.+|++||++.++.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 122346889999999999999998876665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=302.14 Aligned_cols=264 Identities=20% Similarity=0.307 Sum_probs=195.6
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEec----CCeEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRI 681 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~~~ 681 (931)
..|.+.+.||+|+||.||+|..+ +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 34566789999999999999876 689999999875422 344677889999999999999999988753 35689
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+|+||+. |+|.+.+.. ...+++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 689988863 4558999999999999999999998 89999999999999999999999999998765
Q ss_pred cccccc---cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH--------H
Q 002358 762 EEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------S 829 (931)
Q Consensus 762 ~~~~~~---~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~--------~ 829 (931)
...... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...+............ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 432211 1123357889999998765 568899999999999999999999997543321111100000 0
Q ss_pred hhhcCCeeecccc-cccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 830 MIKKGDVISIVDP-VLIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 830 ~~~~~~~~~i~d~-~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......+.+..+. ...... .......+.+++.+||+.+|++||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000000000 000000 1122457899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=298.81 Aligned_cols=265 Identities=25% Similarity=0.329 Sum_probs=195.3
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc--cchhhhhHHHHHHHHHhc-CCCCCcceeEEEecC--CeEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE--HQRI 681 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~--~~~~ 681 (931)
...+.+.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456777899999999999999876 5889999988542 223445678899999999 999999999988653 4679
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+||||++ ++|.+.+.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 599888863 267888999999999999999998 89999999999999999999999999998865
Q ss_pred cccccc----cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHH-------
Q 002358 762 EEDLTH----ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS------- 829 (931)
Q Consensus 762 ~~~~~~----~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~------- 829 (931)
...... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432211 1223357889999998754 5678899999999999999999999974432211110000000
Q ss_pred -hhhcCCeeeccccccc------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 830 -MIKKGDVISIVDPVLI------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 830 -~~~~~~~~~i~d~~l~------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.+.......+++.... ..........+.+++.+||+.+|++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000100000 00001123468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=292.80 Aligned_cols=263 Identities=21% Similarity=0.266 Sum_probs=191.9
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++.+.||+|++|.||+|..+ +|+.||+|.+..... ...+.+.+|++++++++||||+++++++......++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 556789999999999999876 689999999865322 23456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC-CCceEEeccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~~~~~~~ 766 (931)
+ ++|.+.+... ....+++..+..++.||+.||+|||+ ++++||||+|+||+++. ++.+||+|||++........
T Consensus 84 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 84 D-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred c-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 6 5788877543 23346788888999999999999998 89999999999999985 56799999999976543211
Q ss_pred ccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchh-hHHHHHHHhhhcC-----Ceeec
Q 002358 767 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKG-----DVISI 839 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~-----~~~~i 839 (931)
......+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+..+.. ............. .....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 159 -TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred -ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 1122346889999998865 45789999999999999999999999743322111 1111000000000 00000
Q ss_pred c--cccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 840 V--DPVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 840 ~--d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. -+.... .........+.+++.+|++.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000000 001112235789999999999999999999885
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=285.03 Aligned_cols=239 Identities=23% Similarity=0.320 Sum_probs=184.7
Q ss_pred hhccc--cCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEec
Q 002358 612 NFCKK--IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 612 ~~~~~--LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.+.+. ||+|+||.||++..+ +++.+|+|.+....... .|+.....+ +||||+++++.+...+..++||||+
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 34444 599999999999875 67889999986432111 122222223 6999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC-ceEEeccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~~~~ 766 (931)
++|+|.+++.. ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++.......
T Consensus 92 ~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 164 (267)
T PHA03390 92 KDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS- 164 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-
Confidence 99999999974 3478999999999999999999998 8999999999999999988 99999999987654321
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
...++..|+|||++.+..++.++||||+|+++|||++|+.||.... ........+.... . ... . .
T Consensus 165 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~-~-~~~-~-----~-- 229 (267)
T PHA03390 165 ----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE-DEELDLESLLKRQ-Q-KKL-P-----F-- 229 (267)
T ss_pred ----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-cchhhHHHHHHhh-c-ccC-C-----c--
Confidence 2357899999999999899999999999999999999999997332 2222222322221 1 000 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~ 879 (931)
.......+.+++.+||+.+|.+||+ ++|+++
T Consensus 230 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 230 --IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0112236789999999999999995 688863
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=286.32 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=193.5
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc-----cchhhhhHHHHHHHHHhcCCCCCcceeEEEecC--CeEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 682 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~l 682 (931)
+++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 456789999999999999875 5899999987432 123446788999999999999999999998654 46789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
++||+++++|.+.+.. ...+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 84 FVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 9999999999999873 3457888999999999999999998 899999999999999999999999999998653
Q ss_pred cccc--ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 763 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 763 ~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
.... .......++..|+|||.+.+..++.++|+|||||+++||++|+.||...... ... .+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~----~~~~~~~------ 225 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAI----FKIATQP------ 225 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHH----HHHHcCC------
Confidence 2111 1112235788999999999888999999999999999999999999732211 111 1111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.....+......+.+++.+|++ +|.+||+..+++.
T Consensus 226 ---~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 ---TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0111222333568899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=301.08 Aligned_cols=262 Identities=23% Similarity=0.317 Sum_probs=194.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEecC-----CeEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI 681 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-----~~~~ 681 (931)
.|.+.+.||+|+||+||+|... +++.||||.+... .......+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 3556789999999999999875 6899999998653 223345678899999999999999999987654 3479
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+|+||+. ++|.+.+.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 86 lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 86 IVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 9999995 789888863 4568999999999999999999998 89999999999999999999999999999865
Q ss_pred cccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHH--------hhh
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS--------MIK 832 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~--------~~~ 832 (931)
.... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+..........+.. .+.
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 4332 11223357889999998764 5688999999999999999999999975432211111000000 000
Q ss_pred cCCe-------eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 833 KGDV-------ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 833 ~~~~-------~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.... ....++... .........+.+++.+||+.+|++||+++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred chhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000 000000000 0011223467899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=288.49 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=193.2
Q ss_pred hhccccCccCcEEEEEEEECC-CcEEEEEEccCccc--hhhhhHHHHHHHHHhc---CCCCCcceeEEEecCCe-----E
Q 002358 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQ-----R 680 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~~~~-----~ 680 (931)
++.+.||+|+||.||+|+++. ++.+|+|+++.... .....+.+|+.+++++ +|+|++++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 456889999999999999874 89999999874322 2234566788877766 59999999999987776 8
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
+++|||+. ++|.+++.... ...+++..++.++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 99999997 58988886432 3358999999999999999999998 8999999999999999999999999999877
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe--e-
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV--I- 837 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~--~- 837 (931)
....... ....++..|+|||.+.+..++.++|+|||||++|||++|..||......+ .+............. .
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCC
Confidence 5433211 12346889999999999899999999999999999999999987433221 111111110000000 0
Q ss_pred ------eccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 ------SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ------~i~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
........ .....+....+.+++.+||+.+|++||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0111123356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=296.51 Aligned_cols=256 Identities=20% Similarity=0.208 Sum_probs=192.3
Q ss_pred hccccCccCcEEEEEEEEC-CCcEEEEEEccCccchh--------------hhhHHHHHHHHHhcCCCCCcceeEEEecC
Q 002358 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--------------TQQFVTEVALLSRIHHRNLVPLIGYCEEE 677 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~--------------~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 677 (931)
+.+.||+|+||.||+|..+ +++.||+|+++...... ...+.+|++++++++|+||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3577999999999999876 68999999986432211 12477899999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccc
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 757 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGl 757 (931)
+..++||||+. |+|.+.+.. ...+++.....++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999996 689998863 4568899999999999999999998 8999999999999999999999999999
Q ss_pred cccccccc-------------cccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhH
Q 002358 758 SRQAEEDL-------------THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 823 (931)
Q Consensus 758 a~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l 823 (931)
+....... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||...+..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~--- 242 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ--- 242 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 87654110 0111123467889999998764 468899999999999999999999974433211
Q ss_pred HHHHHHhhhcCC---eeecc------------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 824 VHWARSMIKKGD---VISIV------------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 824 ~~~~~~~~~~~~---~~~i~------------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+........ ..... .+.... ........+.+++.+|++.+|++||+++|++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 111111111000 00000 000000 00112346789999999999999999999985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=299.31 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=200.6
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC-----eEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRIL 682 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-----~~~l 682 (931)
|++.+.||+|++|.||+|... .++.||+|++.... ....+.+.+|+++++.++|+||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 456789999999999999976 48999999987643 344577999999999999999999999987765 7899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||||++ ++|.+.+.. ...+++..++.++.|+++||+|||+ .+++||||||+|||++.++.++|+|||++....
T Consensus 82 v~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 82 VTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred Eecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 999997 589888873 3478999999999999999999998 899999999999999999999999999998754
Q ss_pred cccc--ccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc------
Q 002358 763 EDLT--HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------ 833 (931)
Q Consensus 763 ~~~~--~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~------ 833 (931)
.... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......... ..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChhHh
Confidence 4321 112223478899999999887 8899999999999999999999999744422111 111110000
Q ss_pred -----CCeeecccc-ccc-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhh
Q 002358 834 -----GDVISIVDP-VLI-----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDS 884 (931)
Q Consensus 834 -----~~~~~i~d~-~l~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~ 884 (931)
......+.. ... ..........+.+++.+||+.+|++||+++++++. +++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 000000000 000 00011123467899999999999999999999863 5543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=288.74 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=194.2
Q ss_pred HhhccccCccCcEEEEEEEEC----CCcEEEEEEccCcc----chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~ 681 (931)
+++.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+++++++ +|+||+++++.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 456789999999999999863 68999999986532 22346688899999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+|+||+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++||||||+|||++.++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 82 LILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999874 3567888999999999999999998 89999999999999999999999999998765
Q ss_pred cccccccccccccCCCccCCCccCCC--CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
............|+..|+|||.+... .++.++||||||+++|+|++|+.||....... .............
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~----- 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE----- 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC-----
Confidence 44322222234588899999998653 46789999999999999999999996332211 1111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
+. ++......+.+++.+|++.+|++|| ++++++.
T Consensus 229 --~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 --PP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --CC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00 1111223678999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=299.79 Aligned_cols=243 Identities=28% Similarity=0.417 Sum_probs=202.1
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch--hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
.|.+.+.||+|.|+.|.+|++. .+..||||.+.+..-. ..+.+.+|+++|..|+|||||+++.+...+..+++||||
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 4556789999999999999876 6899999999875432 335589999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+.+|.+++++.. .+.........++.|+.+|++|||+ +.|+|||||++||||+.+.++||+|||++..+.. .
T Consensus 137 a~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~ 208 (596)
T KOG0586|consen 137 ASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--G 208 (596)
T ss_pred ccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc--c
Confidence 999999999984 4455557888899999999999998 9999999999999999999999999999988763 3
Q ss_pred ccccccccCCCccCCCccCCCCC-CccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
......+|++.|.|||++.+..| ++++|+||+|+++|-|+.|.+||++.... ++-++.+.
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------~Lr~rvl~ 269 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------ELRPRVLR 269 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------cccchhee
Confidence 34556789999999999988776 57999999999999999999999843321 11122222
Q ss_pred CCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 846 GNVK--IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 846 ~~~~--~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+.+. ....-+..+++++++..+|.+|++++++.+
T Consensus 270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 2221 122235779999999999999999999864
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=293.88 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=199.2
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCcc--chhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~l 682 (931)
+....|++.++||.||.+.||++.-.+.+.+|+|++.... ......|..|+..|.+|+ |.+||++++|-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3445677889999999999999999988999998875432 234567999999999995 9999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||||= ..+|..+|+... .....| .++.+..|++.++.++|+ .||||.||||.|+|+- .|.+||+|||+|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 99986 468999998542 222334 677899999999999998 9999999999999984 5789999999999876
Q ss_pred cccccc-ccccccCCCccCCCccCCC-----------CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002358 763 EDLTHI-SSVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 830 (931)
Q Consensus 763 ~~~~~~-~~~~~gt~~y~APE~l~~~-----------~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 830 (931)
.+.+.. +...+||+.||+||.+... ..++++||||+||+||+|+.|+.||. +..+...
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~-----~~~n~~a----- 580 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG-----QIINQIA----- 580 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH-----HHHHHHH-----
Confidence 655433 4456799999999998432 25679999999999999999999996 2222222
Q ss_pred hhcCCeeecccccccCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 831 IKKGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 831 ~~~~~~~~i~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+..+.||.-.=+++ ....+++++++..||+.||.+||+..|+++
T Consensus 581 ----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 ----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 133445553221221 122334899999999999999999999985
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=289.69 Aligned_cols=260 Identities=22% Similarity=0.247 Sum_probs=191.2
Q ss_pred hccccCccCcEEEEEEEECCCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
+.+.+|.|+++.||++.. +++.||+|++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 345566666666666655 5999999998654 3345578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc----
Q 002358 691 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT---- 766 (931)
Q Consensus 691 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~---- 766 (931)
+|.+++.... ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999987542 3458888999999999999999998 8999999999999999999999999998865432111
Q ss_pred --ccccccccCCCccCCCccCC--CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh----hcCC---
Q 002358 767 --HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI----KKGD--- 835 (931)
Q Consensus 767 --~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~----~~~~--- 835 (931)
.......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... ....+...... ....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhh
Confidence 11122346778999999866 35889999999999999999999999743211 11111111000 0000
Q ss_pred ----eee----ccccccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 836 ----VIS----IVDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 836 ----~~~----i~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
... ..++... ..........+.+++.+||+.+|++||+++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 0000000 0111222346789999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=288.86 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=193.2
Q ss_pred HHHhhccccCccCcEEEEEEEECC-CcEEEEEEccCcc-chhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 685 (931)
..+++.+.||+|++|.||+|.+++ ++.||||.++... ......+.+|+.++.+.. ||||+++++++.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 345678999999999999999875 8999999987543 234456777887777775 9999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+. ++|.+.+... ...+++..+..++.|+++||+|||+ ..+++||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 5777766542 3478899999999999999999996 3589999999999999999999999999987654322
Q ss_pred cccccccccCCCccCCCccCCCC----CCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~----~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
.. ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ... ....... .......
T Consensus 170 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~---~~~~~~~-~~~~~~~ 241 (296)
T cd06618 170 AK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEV---LTKILQE-EPPSLPP 241 (296)
T ss_pred cc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHH---HHHHhcC-CCCCCCC
Confidence 21 2234778999999987554 788999999999999999999999632211 111 1111111 1111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
. ......+.+++.+||+.+|++||+++++++.
T Consensus 242 ~-------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 N-------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-------CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0123468899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=285.34 Aligned_cols=241 Identities=22% Similarity=0.284 Sum_probs=186.0
Q ss_pred ccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHH---HHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 616 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVAL---LSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 616 ~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~i---l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.||+|+||.||+|... .++.||+|.+..... .....+..|..+ ++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 588999999865321 122234444443 444579999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|+|.+++.. ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 9999998863 4568999999999999999999998 8999999999999999999999999999876533221
Q ss_pred ccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 769 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........... . ..... .++.+..
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~---~~~~~------~~~~~~~- 220 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-D---RMTLT------MAVELPD- 220 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-H---HHhhc------cCCCCCC-
Confidence 233589999999998754 689999999999999999999999974432221111 1 11110 0111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
.....+.+++.+|+..+|++|| ++.|+++
T Consensus 221 ---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 ---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1234688999999999999999 8999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=285.73 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=194.9
Q ss_pred hhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEEecC
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.+.+.||+|++|+||+|... +++.|++|++..... .......+|+..+++++ |+|++++++++..+...++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45788999999999999986 478999999865432 23334567999999999 999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|+|.+.+.... ...+++..++.++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (283)
T cd07830 81 EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY- 155 (283)
T ss_pred CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence 889999887532 3468999999999999999999998 89999999999999999999999999998765432221
Q ss_pred ccccccCCCccCCCccC-CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhh-HHH---------HHHHhhhcCCee
Q 002358 769 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVH---------WARSMIKKGDVI 837 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l~~---------~~~~~~~~~~~~ 837 (931)
....++..|+|||.+. ...++.++|+||||++++||++|+.||......+... ... |...........
T Consensus 156 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 156 -TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred -CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 2234788999999874 4567899999999999999999999996443221110 000 111100000000
Q ss_pred eccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+..... ..........+.+++.+||+.+|++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 0000111356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=288.65 Aligned_cols=248 Identities=29% Similarity=0.417 Sum_probs=194.4
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc---cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
...++...+.||+|+||.||+|... +++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 4455666788999999999999976 5788999988642 22334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
|+||+. |++.+.+... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 93 v~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 93 VMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 999996 6887776532 3458899999999999999999998 899999999999999999999999999987643
Q ss_pred ccccccccccccCCCccCCCccC---CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 763 EDLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
.. ....++..|+|||.+. ...++.++|||||||++|||++|+.||...+... ....+ . .+....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~----~-~~~~~~- 233 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHI----A-QNESPA- 233 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHHH----h-hcCCCC-
Confidence 32 2234788999999874 3567889999999999999999999986322111 11111 1 111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.. .......+.+++.+||+.+|++||+++++++.
T Consensus 234 ----~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 234 ----LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ----cC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 00 11223467899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=287.92 Aligned_cols=246 Identities=27% Similarity=0.389 Sum_probs=198.6
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 685 (931)
|.+.+.||+|++|.||+|..+ +++.||+|++.... ....+.+.+|++++++++ ||||+++++.+...+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 556788999999999999876 68999999986532 233467889999999998 9999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
++++++|.+.+.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 83 YAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999974 3479999999999999999999998 899999999999999999999999999987654332
Q ss_pred c-------------------ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002358 766 T-------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 826 (931)
Q Consensus 766 ~-------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~ 826 (931)
. .......++..|+|||.+....++.++||||||++++++++|+.||..... ....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~ 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTFQK 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHH
Confidence 1 112233578899999999888899999999999999999999999974331 111111
Q ss_pred HHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 002358 827 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM----QEIVL 879 (931)
Q Consensus 827 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~----~evl~ 879 (931)
. .. .. ...+......+.+++.+||+.+|++||++ +++++
T Consensus 234 ~---~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 I---LK-LE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H---Hh-cC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1 11 00 01111223468899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=284.93 Aligned_cols=243 Identities=30% Similarity=0.429 Sum_probs=191.2
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+...++||+|+||.||+|... +++.|++|++.... ....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 344578999999999999875 68899999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+. |++.+.+... ...+++..++.++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 95 6787777532 3468899999999999999999998 8999999999999999999999999998864322
Q ss_pred ccccccccCCCccCCCccC---CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 767 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
.....|+..|+|||.+. ...++.++||||||+++|||++|..||...+.. .... ..... ......
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~~---~~~~~-~~~~~~--- 241 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALY---HIAQN-DSPTLQ--- 241 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHH---HHHhc-CCCCCC---
Confidence 12345788999999974 456888999999999999999999998643221 1111 11111 111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.......+.+++.+||+.+|.+||++.++++
T Consensus 242 -----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 242 -----SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112235789999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=290.80 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=191.2
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch--hhhhHHHHHHHHHhcCCCCCcceeEEEecC--------
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEE-------- 677 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-------- 677 (931)
..|++.+.||+|+||.||+|.++ +++.+|+|++...... ....+.+|++++++++||||+++++++...
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 45667889999999999999976 6899999988543222 234678899999999999999999987443
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccc
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 757 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGl 757 (931)
...++|+||+.+ +|.+.+.. ....+++..+..++.|+++||+|||+ .+++||||||+||++++++.++|+|||+
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 346899999964 67776653 24568999999999999999999998 8999999999999999999999999999
Q ss_pred cccccccccc----------cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002358 758 SRQAEEDLTH----------ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 826 (931)
Q Consensus 758 a~~~~~~~~~----------~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~ 826 (931)
++........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9764332211 1122346788999998765 4588999999999999999999999974433221111110
Q ss_pred HHHhhhc------CCeeecccccccCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 827 ARSMIKK------GDVISIVDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 827 ~~~~~~~------~~~~~i~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....... .......+.......+ ......+.+++.+|++.+|++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 0000000000000000 111246789999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=281.20 Aligned_cols=248 Identities=26% Similarity=0.367 Sum_probs=192.9
Q ss_pred HhhccccCccCcEEEEEEEECC-CcEEEEEEccCcc-----chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
|.+.+.||+|+||.||++.+.. +..+++|+++... .....++.+|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5567899999999999998763 4456666654321 223346778999999999999999999999888999999
Q ss_pred EecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 685 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
||+++++|.+.+.... ....+++..++.++.|+++||.|||+ .+++|+||||+||++++ +.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999999886422 34578999999999999999999998 89999999999999975 5699999999876543
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ .+.. +.
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~-~~~~-----~~ 224 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIV-EGPT-----PS 224 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH-cCCC-----CC
Confidence 222 12234578899999999888889999999999999999999999963221 11111111 1111 11
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+......+.+++.+|++.+|++||++.|+++
T Consensus 225 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 ----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 12233347889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=283.64 Aligned_cols=257 Identities=24% Similarity=0.307 Sum_probs=196.3
Q ss_pred hhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
++.+.||+|++|.||+|+.. +++.+|+|++.... ....+.+..|++++++++|+|++++++++.+....++|+||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 34578999999999999987 48999999987643 2334678889999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
++|.+++... ...+++..+..++.|+++||+|||+ .+++||||+|+||++++++.++|+|||++.........
T Consensus 82 -~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 154 (282)
T cd07829 82 -MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT- 154 (282)
T ss_pred -cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-
Confidence 5899998743 1468999999999999999999998 89999999999999999999999999998765433221
Q ss_pred ccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc--------------
Q 002358 769 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK-------------- 833 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~-------------- 833 (931)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ...+.+....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccccc
Confidence 1223357789999998766 889999999999999999999999974432211 1111111000
Q ss_pred --CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 834 --GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 834 --~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
........... ....+.....+.+++.+||+.+|++||++++++.
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000 0000112347899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=274.25 Aligned_cols=238 Identities=24% Similarity=0.348 Sum_probs=195.1
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
..+.++||+|.||.|.+++.+ .|+.+|+|++++... .....-+.|-++|+.-+||.+..+--.|+..+++|+||||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 456799999999999999877 689999999987543 3445567799999999999999999899999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
..||.|.-+|.+ ...+++....-....|+.||.|||+ .+|+.||||.+|.|+|.+|++||+|||+++.--...
T Consensus 250 anGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g- 322 (516)
T KOG0690|consen 250 ANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG- 322 (516)
T ss_pred ccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccccc-
Confidence 999999998874 5678888888899999999999998 999999999999999999999999999998643322
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
....+.+|||.|+|||++....|+.+.|-|.+||++|||++|+.||...+.+.-..++- ..+- +...
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-----~ed~--------kFPr 389 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-----MEDL--------KFPR 389 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-----hhhc--------cCCc
Confidence 23456789999999999999999999999999999999999999998555433222221 1111 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRP 872 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RP 872 (931)
...+ +...++...|.+||.+|-
T Consensus 390 ~ls~----eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 390 TLSP----EAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred cCCH----HHHHHHHHHhhcChHhhc
Confidence 1222 346778888999999996
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=322.13 Aligned_cols=245 Identities=28% Similarity=0.385 Sum_probs=193.3
Q ss_pred ccccCccCcEEEEEEEE-CCCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 614 CKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
...||.|.||.||-|.. .+|+..|+|.++-. .....+.+.+|..++..|+|||+|+++|+-.+.+..++.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 35699999999999975 46889999987543 2234467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc---c
Q 002358 691 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT---H 767 (931)
Q Consensus 691 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~---~ 767 (931)
+|.+.+.. +.-.++.....+..|++.|++|||+ .|||||||||.||+++.+|.+|++|||.|..+..... .
T Consensus 1320 sLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1320 SLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred cHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 99999873 4446667777788999999999998 9999999999999999999999999999988655431 1
Q ss_pred cccccccCCCccCCCccCCC---CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 768 ISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~---~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.-....||+.|||||++.+. ....++||||+|||+.||+||+.||...+ ....+.-. +..|..+.+...
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d--ne~aIMy~----V~~gh~Pq~P~~-- 1465 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD--NEWAIMYH----VAAGHKPQIPER-- 1465 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc--chhHHHhH----HhccCCCCCchh--
Confidence 12345699999999999654 34568999999999999999999997333 22222221 222333222221
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+=.+++.+|++.||++|.++.|+++
T Consensus 1466 -------ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1466 -------LSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred -------hhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1223468899999999999999887764
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=274.79 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=194.2
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEecCCCC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 691 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 691 (931)
..||.|+||+|++-.++ .|+..|||+++.... .++++++.|.+...+- +.||||+++|.+..++..++.||.|. .|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 56999999999999887 699999999987554 4567888888875554 69999999999999999999999994 56
Q ss_pred HHHHhccC--CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 692 LRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 692 L~~~L~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|..+-+.- .....+++.-+-.|....++||.||.+ +..|||||+||+|||+|..|.+||||||++-.+.+... .
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--k 224 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--K 224 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--h
Confidence 65443211 134567777788888889999999998 68999999999999999999999999999987654433 2
Q ss_pred cccccCCCccCCCccCC--CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 770 SVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
+.-.|...|||||.+.. ..|+.+|||||||++|+|+.||+.|+...+ ...+.+.+.+. |+.+.+..+.-
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~-gdpp~l~~~~~--- 295 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVI-GDPPILLFDKE--- 295 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHc-CCCCeecCccc---
Confidence 33458889999999854 348899999999999999999999997222 23333433332 33332221111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
..+....+..++.-|+.+|-..||+..++.+.
T Consensus 296 -~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 296 -CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 12234478899999999999999999998753
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=295.51 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=189.7
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecC-----------
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE----------- 677 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~----------- 677 (931)
.|.+.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++.+...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 4566789999999999999876 5889999998665555567788999999999999999999766543
Q ss_pred ---CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc-CCCceEEe
Q 002358 678 ---HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVS 753 (931)
Q Consensus 678 ---~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld-~~~~vkL~ 753 (931)
...++|+||++ ++|.+.+. ...+++..+..++.||++||.|||+ .+++||||||+||+++ +++.+||+
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 58888775 2458899999999999999999998 8999999999999997 45678999
Q ss_pred ccccccccccccccc--ccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002358 754 DFGLSRQAEEDLTHI--SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 830 (931)
Q Consensus 754 DFGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 830 (931)
|||+++......... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||..................
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999987653322211 122347889999997654 56788999999999999999999999643321111000000000
Q ss_pred hhcCCee-------e-cccccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 831 IKKGDVI-------S-IVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 831 ~~~~~~~-------~-i~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....... . ......... .......++.+++.+||+.+|++||+++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 0 000000000 00112246789999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=274.67 Aligned_cols=236 Identities=30% Similarity=0.379 Sum_probs=192.1
Q ss_pred cCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 617 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 617 LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
||+|+||.||++... +++.+|+|++..... ...+.+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999886 589999999865432 2456789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccccc
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 772 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 772 (931)
.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF 153 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence 999974 3468999999999999999999998 9999999999999999999999999999876543321 12334
Q ss_pred ccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002358 773 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 852 (931)
Q Consensus 773 ~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 852 (931)
.++..|++||...+...+.++|+||||+++|||++|+.||...+. ....+.+. . +.. ..+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~---~-~~~----------~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKIL---K-DPL----------RFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh---c-CCC----------CCCCCC
Confidence 578899999999888889999999999999999999999964332 11111111 1 100 111112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHH
Q 002358 853 IWRIAEVAIQCVEQRGFSRPKMQE 876 (931)
Q Consensus 853 ~~~l~~li~~Cl~~dP~~RPs~~e 876 (931)
...+.+++.+||..+|++||++++
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 346789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=291.10 Aligned_cols=261 Identities=22% Similarity=0.288 Sum_probs=189.2
Q ss_pred HhhccccCccCcEEEEEEEEC-C--CcEEEEEEccCcc--chhhhhHHHHHHHHHhc-CCCCCcceeEEEec----CCeE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-D--GKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQR 680 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~--g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~----~~~~ 680 (931)
+++.+.||+|+||.||+++.. . ++.||+|++.... ....+.+.+|+++++++ +||||+++++.+.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456789999999999999976 3 7799999986532 22345788899999999 59999999987533 2456
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++++|++. ++|.+.+. ....+++..++.++.||+.||+|||+ .+++||||||+||++++++.+||+|||+++.
T Consensus 82 ~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 82 YLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 78888885 68988886 34568999999999999999999998 8999999999999999999999999999986
Q ss_pred ccccccc---cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhH-H--------HHH
Q 002358 761 AEEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI-V--------HWA 827 (931)
Q Consensus 761 ~~~~~~~---~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l-~--------~~~ 827 (931)
....... ......|+..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...+....... . ++.
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5432211 1122358899999998765 5688999999999999999999999974432111000 0 000
Q ss_pred HHhhhcC------CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 828 RSMIKKG------DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 828 ~~~~~~~------~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....... .........+. .........+.+++.+|++.+|++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00000000000 000111346889999999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=285.78 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=191.9
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEec-CCeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~~lV~ 684 (931)
..|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....++++
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 34566789999999999999866 78999999875432 2234678899999999999999999998865 56788999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+ +++|.+.++ ...+++..+..++.|+++||+|||+ .+++||||+|+||++++++.++|+|||++......
T Consensus 90 e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 90 ELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred ehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 998 568988876 2457788888999999999999998 89999999999999999999999999998754322
Q ss_pred ccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchh-hHHHH--------HHHhhhcC
Q 002358 765 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHW--------ARSMIKKG 834 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~-~l~~~--------~~~~~~~~ 834 (931)
. ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .+.++ ...... +
T Consensus 162 ~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (328)
T cd07856 162 M----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS-E 236 (328)
T ss_pred c----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc-h
Confidence 1 22346789999998765 57899999999999999999999999744321111 01111 110000 0
Q ss_pred Ceeecccc-cccCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 835 DVISIVDP-VLIGNVKI-----ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 835 ~~~~i~d~-~l~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+.+.. ......+. .....+.+++.+|++.+|++||+++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 00001111 12347889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=292.46 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=191.9
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecC------CeE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 680 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~~ 680 (931)
.+.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++... ...
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 3445688999999999999875 68999999986532 22235688999999999999999999988654 346
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++|+||+. .+|.+... ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 96 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 96 YLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 89999996 47766542 357889999999999999999998 8999999999999999999999999999876
Q ss_pred ccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH--------Hhh
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMI 831 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~--------~~~ 831 (931)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+............ +..
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 4322 122346889999999866 468899999999999999999999997543221111110000 000
Q ss_pred hcCC-------eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhh
Q 002358 832 KKGD-------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDSIK 886 (931)
Q Consensus 832 ~~~~-------~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~~~~ 886 (931)
.... ........+.... +.....+.+++.+||+.+|++||+++|+++ .++....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000 0000000000000 012235789999999999999999999984 3666544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=268.22 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=196.2
Q ss_pred ccccCccCcEEEEEEE-ECCCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEEecCCCC
Q 002358 614 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGT 691 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gs 691 (931)
.+.||+|+++.|--+. +..|.++|||++.+...+...+..+|++++.+.+ |+||+.++.+|+++...|||||-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 5789999999999885 5689999999998887888889999999999985 9999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc---eEEecccccccccc--ccc
Q 002358 692 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEE--DLT 766 (931)
Q Consensus 692 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~---vkL~DFGla~~~~~--~~~ 766 (931)
|.++++ +++.+++.++.++..+|+.||.|||. ++|.|||+||+|||-.+... +|||||.+..-+.. +..
T Consensus 163 lLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQ---KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999998 46779999999999999999999997 99999999999999976544 89999988754321 111
Q ss_pred ccc----cccccCCCccCCCcc-----CCCCCCccchhHHHHHHHHHHHhCCCCCCccCcc----chh---hHHH-HHHH
Q 002358 767 HIS----SVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AEL---NIVH-WARS 829 (931)
Q Consensus 767 ~~~----~~~~gt~~y~APE~l-----~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~----~~~---~l~~-~~~~ 829 (931)
..+ .+..|+..|||||+. ....|+.++|.|||||+||-||+|.+||.+.-.. +.. ...+ -+-.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 111 234588899999986 3346888999999999999999999999743221 111 1111 1112
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 830 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+++|.. +..|... .....+-.+++...+..++.+|-++.+++.
T Consensus 317 sIQEGkY-eFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGKY-EFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccCC-cCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 2333322 1111110 011124567888888899999999988876
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=285.08 Aligned_cols=241 Identities=24% Similarity=0.296 Sum_probs=194.5
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
-++||+|+||.||-++.+ .|+.+|.|.+.+.. .......+.|-.+|++++.+.||.+--.++..+.+++|+..|+|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 578999999999999876 58999999875432 22334577899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.-+|... ....+++..++-.+.+|+.||.+||. .+||.||+||+|||+|+.|+++|+|.|||..+........
T Consensus 270 GDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~ 345 (591)
T KOG0986|consen 270 GDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRG 345 (591)
T ss_pred CceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCcccc
Confidence 9999888754 34679999999999999999999997 9999999999999999999999999999998776554432
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
..||.+|||||++.+..|+...|-||+||++|||+.|+.||..........- +.+.+.+.. .+++
T Consensus 346 --rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE---vdrr~~~~~----------~ey~ 410 (591)
T KOG0986|consen 346 --RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE---VDRRTLEDP----------EEYS 410 (591)
T ss_pred --ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH---HHHHHhcch----------hhcc
Confidence 3699999999999999999999999999999999999999972221111101 111111110 1233
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPK 873 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs 873 (931)
.....+..++.+..|+.||++|--
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhcc
Confidence 333346678888889999998863
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=286.22 Aligned_cols=258 Identities=24% Similarity=0.352 Sum_probs=191.3
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC------e
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q 679 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~------~ 679 (931)
..|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 34666789999999999999865 68999999985432 223456889999999999999999999886543 4
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
.++||||+ +++|.+++. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 95 ~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred EEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 58999999 789988875 2468899999999999999999998 899999999999999999999999999987
Q ss_pred cccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchh-hHH--------HHHHH
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIV--------HWARS 829 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~-~l~--------~~~~~ 829 (931)
...... ....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+..... .+. .+...
T Consensus 167 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 167 QTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 654321 22346889999998866 46889999999999999999999999743321110 000 00000
Q ss_pred hhhcCCeeeccc--cccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 830 MIKKGDVISIVD--PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 830 ~~~~~~~~~i~d--~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+.......... +... ..........+.+++.+|++.+|++||++.++++
T Consensus 243 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 243 -LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred -hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 0000 0000112235789999999999999999999883
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=289.94 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=189.2
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecC------CeE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 680 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~~ 680 (931)
.|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence 4555788999999999999864 68999999986532 22346688899999999999999999987543 346
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
+++++++ +++|.+.+.. ..+++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++.
T Consensus 98 ~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 98 YLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred EEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 7888876 7899888752 358899999999999999999998 8999999999999999999999999999876
Q ss_pred ccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhh-HHHHH-------HHhh
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWA-------RSMI 831 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l~~~~-------~~~~ 831 (931)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+...... +.... ...+
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 170 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred cccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 4322 223457889999998866 567889999999999999999999996433211111 00000 0000
Q ss_pred hcCC-------eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 832 KKGD-------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 832 ~~~~-------~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.... .......... .........+.+++.+|++.+|.+||++.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 0000000000 0000112357899999999999999999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=268.20 Aligned_cols=242 Identities=24% Similarity=0.357 Sum_probs=191.7
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEec----CCeEEEEEEec
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRILVYEYM 687 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~----~~~~~lV~E~~ 687 (931)
.++||-|-.|.|-.+.++ .|+.+|+|++.+. ....+|+++--.. .|||||++++++.+ ...+.+|||.|
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 378999999999999877 6899999998754 3456788775544 59999999998754 45678999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC---CCceEEeccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~~~~~ 764 (931)
+||.|.+.++.. ....+++.++..|+.||+.|+.|||+ .+|.||||||+|+|... +-.+||+|||+++.....
T Consensus 142 eGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 142 EGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred cchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 999999999864 45679999999999999999999998 99999999999999964 556899999999975542
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.. -.+.+-||.|.|||++...+|+..+|+||+||++|-|++|.+||.... + ..+.--+++.++.|..
T Consensus 218 ~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h-g--~aispgMk~rI~~gqy-------- 284 (400)
T KOG0604|consen 218 GD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH-G--LAISPGMKRRIRTGQY-------- 284 (400)
T ss_pred cc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC-C--ccCChhHHhHhhccCc--------
Confidence 22 233457999999999999999999999999999999999999996221 1 1222223333433322
Q ss_pred cCCCCHHH----HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIES----IWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~----~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.++.++ .+...++|+..|..+|.+|-|++|+..
T Consensus 285 --~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 285 --EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred --cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 122222 235678999999999999999999864
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=291.13 Aligned_cols=255 Identities=21% Similarity=0.309 Sum_probs=192.0
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe------E
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------R 680 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~------~ 680 (931)
.|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|+|++++++++...+. .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 4556789999999999999986 57899999986532 2334667889999999999999999987765554 8
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++..
T Consensus 96 ~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 96 YLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 9999998 6799998863 468999999999999999999998 8999999999999999999999999999886
Q ss_pred ccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc------
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------ 833 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~------ 833 (931)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..........
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ---LKRIMNLVGTPDEELL 240 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCCHHHH
Confidence 5432 223357889999998765 4678899999999999999999999974332111 1111110000
Q ss_pred -----CCeeecccc---cccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 834 -----GDVISIVDP---VLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 834 -----~~~~~i~d~---~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......+.. .....+ .......+.+++.+|++.+|++|||+.||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000 000000 0011346889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=266.15 Aligned_cols=203 Identities=26% Similarity=0.380 Sum_probs=167.9
Q ss_pred HHHhhccccCccCcEEEEEEEECC-----CcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEec-CCeE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQR 680 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 680 (931)
..|+.+..||+|.||.||+|.-++ .+.+|+|+++.... .-.....+|+.+++.++|||++.++.++-. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 356678899999999999996442 33789999976532 223467899999999999999999998866 7889
Q ss_pred EEEEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC----CceEEec
Q 002358 681 ILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSD 754 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~----~~vkL~D 754 (931)
++++||.+. +|..+++-.+ ..+.++...+..|+.||+.|+.|||+ .=|+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 7877765332 34578889999999999999999998 679999999999999877 8999999
Q ss_pred cccccccccccccc--ccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 002358 755 FGLSRQAEEDLTHI--SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVE 815 (931)
Q Consensus 755 FGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~ 815 (931)
+|+++.+.+..... ......|.+|+|||.+.+ ..|+.+.||||.||++.||+|-++-|.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999876654332 334567999999998866 57899999999999999999998888644
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=292.77 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=203.9
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEec-----CCeEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE-----EHQRIL 682 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-----~~~~~l 682 (931)
+.+|.++||.|.+|.||+++.+ +++.+|+|++..... ..+++..|.++|+.. .|||++.++|++.. +++++|
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 4557899999999999999865 688999999876543 346788899999988 59999999998843 568999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
|||||.+|+..|+++... +..+.|..+..|+..++.|+.|||. ..++|||||-.|||++.++.|||+|||.+....
T Consensus 99 VMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 999999999999998765 7789999999999999999999997 899999999999999999999999999998765
Q ss_pred ccccccccccccCCCccCCCccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 763 EDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
... ....+..||+.|||||++.- ..|+.++|+||||++..||..|.+|+.... -...+..
T Consensus 175 sT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH------PmraLF~-------- 239 (953)
T KOG0587|consen 175 STV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH------PMRALFL-------- 239 (953)
T ss_pred ccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc------hhhhhcc--------
Confidence 433 33445679999999999843 457779999999999999999999996211 1111111
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..-.|......+..+..++.++|..||.+|.++||++.++++
T Consensus 240 IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111222333345567779999999999999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=287.79 Aligned_cols=239 Identities=25% Similarity=0.370 Sum_probs=191.9
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
...|.+...+|.|+|+.|-++.+. +++..++|++.+. ..+-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 345677788999999999999876 6889999998765 23344677666665 69999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc-cCCCceEEeccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl-d~~~~vkL~DFGla~~~~~~ 764 (931)
.+.++-+.+.+... .... ..+..|+.+|+.|+.|||+ +|++||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999888887642 2222 6777899999999999998 999999999999999 69999999999999876655
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
....+-|..|.|||++....|++++|+||||++||+||+|+.||.....+ .+ +...+..+...
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e----i~~~i~~~~~s------- 532 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE----IHTRIQMPKFS------- 532 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH----HHHhhcCCccc-------
Confidence 12223578999999999999999999999999999999999999743322 22 22233333222
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
........+|+.+||+.||.+||+|.++..
T Consensus 533 -----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 -----ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -----cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 122235679999999999999999999863
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=269.36 Aligned_cols=220 Identities=22% Similarity=0.208 Sum_probs=175.3
Q ss_pred cCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCHHHHhcc
Q 002358 620 GSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 698 (931)
Q Consensus 620 G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~ 698 (931)
|.+|.||++..+ +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999876 68999999987542 233455555566799999999999999999999999999999999874
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccccccccCCCc
Q 002358 699 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 778 (931)
Q Consensus 699 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y 778 (931)
...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 3458899999999999999999998 899999999999999999999999999876544321 123356789
Q ss_pred cCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHH
Q 002358 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 858 (931)
Q Consensus 779 ~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~ 858 (931)
+|||.+....++.++||||+|+++|||++|+.|+...... .... ....+ +......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~-----~~~~~----~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTH-----TTLNI----PEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------cccc-----cccCC----cccCCHHHHH
Confidence 9999998888999999999999999999999887521110 0000 00001 1112236789
Q ss_pred HHHHccccCCCCCCCHH
Q 002358 859 VAIQCVEQRGFSRPKMQ 875 (931)
Q Consensus 859 li~~Cl~~dP~~RPs~~ 875 (931)
++.+|++.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=301.38 Aligned_cols=246 Identities=28% Similarity=0.410 Sum_probs=182.0
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEec---------------
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------------- 676 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------------- 676 (931)
.+.||+||||.||+++.+ ||+.+|||++.-.. ......+.+|++.|.+|+|||||+++..+.+
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 468999999999999988 89999999986543 2334678899999999999999998621100
Q ss_pred --------------------------------------------------------------------------------
Q 002358 677 -------------------------------------------------------------------------------- 676 (931)
Q Consensus 677 -------------------------------------------------------------------------------- 676 (931)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ----------------C--------CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCe
Q 002358 677 ----------------E--------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732 (931)
Q Consensus 677 ----------------~--------~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i 732 (931)
+ ..+|+=||||+...+.++++...-.. .....++++.+|++||+|+|+ .+|
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~---~gi 718 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD---QGI 718 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh---Cce
Confidence 0 12467799999988888887532111 356778999999999999998 899
Q ss_pred EecCCCCCCccccCCCceEEeccccccccc------c-----------cccccccccccCCCccCCCccCCC---CCCcc
Q 002358 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAE------E-----------DLTHISSVARGTVGYLDPEYYGNQ---QLTEK 792 (931)
Q Consensus 733 vH~DIkp~NILld~~~~vkL~DFGla~~~~------~-----------~~~~~~~~~~gt~~y~APE~l~~~---~~s~k 792 (931)
|||||||.||++|++..|||+|||++.... + ......+...||.-|+|||++.+. .|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999998721 0 001122345699999999999665 49999
Q ss_pred chhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 002358 793 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP 872 (931)
Q Consensus 793 sDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 872 (931)
+|+||+||+++||+. ||. ..++ ... +...++.+.++.- .++..+....=..++++++++||++||
T Consensus 799 iDmYSLGIVlFEM~y---PF~-TsME-Ra~----iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFG-TSME-RAS----ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCC-chHH-HHH----HHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCC
Confidence 999999999999984 454 1111 111 1222334444332 111222222346899999999999999
Q ss_pred CHHHHHH
Q 002358 873 KMQEIVL 879 (931)
Q Consensus 873 s~~evl~ 879 (931)
|+.|++.
T Consensus 864 tA~eLL~ 870 (1351)
T KOG1035|consen 864 TATELLN 870 (1351)
T ss_pred CHHHHhh
Confidence 9999874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=303.37 Aligned_cols=144 Identities=32% Similarity=0.459 Sum_probs=128.5
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|.+.++||+|+||.||+|.+. +++.||||+++... ......+.+|+.+++.++||||+++++.+......++|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 3556789999999999999987 68999999986532 2234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
|+++++|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999874 3467888999999999999999998 899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=279.98 Aligned_cols=243 Identities=26% Similarity=0.396 Sum_probs=191.0
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
.++||.|.||+||-|.++ .|+.||||++.+.. ..+..++.+|++||++++||.||.+...|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 689999999999999876 79999999997642 34457789999999999999999999999999999999999954
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC---CCceEEecccccccccccccc
Q 002358 691 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 691 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~~~~~~~~ 767 (931)
+..+++-.. ..+.+++....-+..||+.||.|||. ++|+|+||||+|||+.+ --++||||||+++.+++..-
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 555544333 45678888888899999999999997 99999999999999964 35699999999999876432
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
+....|||.|+|||+++.+.|...-|+||.||++|--++|..||..+.. +-+ .+++.. -+.-+..+.+
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----Ind----QIQNAa--FMyPp~PW~e 790 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----IND----QIQNAA--FMYPPNPWSE 790 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhH----Hhhccc--cccCCCchhh
Confidence 3446799999999999999999999999999999999999999973221 111 111111 1122233333
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 878 (931)
... .-+++|...|+..-++|-+...-+
T Consensus 791 is~----~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 791 ISP----EAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cCH----HHHHHHHHHHHHHHHHhcchHhhc
Confidence 333 345777777788878888776543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=260.22 Aligned_cols=238 Identities=31% Similarity=0.437 Sum_probs=192.7
Q ss_pred CcEEEEEEEECC-CcEEEEEEccCccchh-hhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCHHHHhcc
Q 002358 621 SFGSVYYGKMKD-GKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 698 (931)
Q Consensus 621 ~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~ 698 (931)
+||.||+|.+.+ ++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999874 8999999997654444 67899999999999999999999999999999999999999999999874
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccccccccCCCc
Q 002358 699 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 778 (931)
Q Consensus 699 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y 778 (931)
. ..+++..+..++.++++++.+||+ .+++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 3 238899999999999999999998 899999999999999999999999999998765432 22334578899
Q ss_pred cCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHH
Q 002358 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 858 (931)
Q Consensus 779 ~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~ 858 (931)
++||.+....++.++||||||+++++|++|..||.... ......++.. .+..... .........+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~----~~~~~~~-------~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIG----KPKPPFP-------PPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHh----ccCCCCc-------cccccCCHHHHH
Confidence 99999988888999999999999999999999996321 1122222221 1111000 000002347889
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 002358 859 VAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 859 li~~Cl~~dP~~RPs~~evl~ 879 (931)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=297.28 Aligned_cols=205 Identities=30% Similarity=0.381 Sum_probs=182.3
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
+....+.+.++||+|+||.|..++++ .++.+|+|++.+.. .....-|..|-.+|..-+.+=|+.++-.|.+..++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 34556778899999999999999987 57889999998742 344567899999999888888999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+|||||+||+|-.++... ..+++..+.-++..|+-||.-||+ .|+|||||||.|||||..|++||+|||.|..+
T Consensus 152 lVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred EEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 999999999999999843 378888888899999999999998 99999999999999999999999999999988
Q ss_pred cccccccccccccCCCccCCCccC----C-CCCCccchhHHHHHHHHHHHhCCCCCCccC
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYG----N-QQLTEKSDVYSFGVVLLELISGKKPVSVED 816 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~----~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~ 816 (931)
..+....+....|||.|++||++. + +.|+..+|.||+||++|||+.|.-||..+.
T Consensus 226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 877777788888999999999983 2 679999999999999999999999997443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=270.15 Aligned_cols=244 Identities=25% Similarity=0.347 Sum_probs=194.7
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEECC-CcEEEEEEccCccch---hhhhHHHHHHHHHhc-CCCCCcceeEEEecCCe
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH---RTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 679 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~---~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~ 679 (931)
.+.....+|..+||+|+||.|-+|+.+. .+.+|||+++++..- +.+--+.|-++|... +-|.+++++..|+.-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4455667889999999999999998774 577999999876432 223345577777766 57889999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
+++||||+.||+|--+++ +-+.+.+..+.-.+.+||-||-+||+ ++|+.||||..|||+|.+|++||+|||+++
T Consensus 425 LyFVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeeEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999988887 35667788888999999999999998 999999999999999999999999999998
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
.---+ .....+.+|||.|+|||++...+|+...|.|||||+||||+.|+.||++++..+ +.+- +.
T Consensus 499 Eni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF~a----I~------- 563 (683)
T KOG0696|consen 499 ENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQA----IM------- 563 (683)
T ss_pred ccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHH----HH-------
Confidence 62211 122445689999999999999999999999999999999999999998665432 2211 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP 872 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 872 (931)
+... .++.....+...+....+...|.+|-
T Consensus 564 -ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 -EHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -HccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 1111 23334444667788888899998885
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=236.66 Aligned_cols=259 Identities=20% Similarity=0.275 Sum_probs=197.3
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
.++||+|.||+|++|+.+ .++.||+|..+-+.. .-.....+|+-+|+.++|.|||++++....++...+|+|||. .
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-q 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-Q 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-H
Confidence 478999999999999865 578899999864332 233567899999999999999999999999999999999995 4
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccc
Q 002358 691 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 770 (931)
Q Consensus 691 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 770 (931)
+|..+... -.+.++......++.|+++||.|+|+ +++.|||+||.|.||+.+|++|++|||+++-++-....-+
T Consensus 86 dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrcys- 159 (292)
T KOG0662|consen 86 DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS- 159 (292)
T ss_pred HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee-
Confidence 77776654 24568888899999999999999998 9999999999999999999999999999987665433322
Q ss_pred ccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeee---ccccccc
Q 002358 771 VARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS---IVDPVLI 845 (931)
Q Consensus 771 ~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~---i~d~~l~ 845 (931)
....|..|.+|.++.+. -|+...|+||-||++.|+.. |++-|.+.+..+...-+-|+.....++.... +.|-...
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 23368999999998664 67889999999999999998 6666666665555444444444444433222 2232222
Q ss_pred CCCCHHHH---------HHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 846 GNVKIESI---------WRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 846 ~~~~~~~~---------~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..++.... ..=.+++++.+.-+|.+|.++++.++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 22322111 12257777888889999999988764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=264.55 Aligned_cols=261 Identities=25% Similarity=0.341 Sum_probs=197.4
Q ss_pred hhhHHHHHHhhccccCccCcEEEEEEEE-CCCcEEEEEEccCc--cch-----hhhhHHHHHHHHHhcCCCCCcceeEEE
Q 002358 603 LPELEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS--CSH-----RTQQFVTEVALLSRIHHRNLVPLIGYC 674 (931)
Q Consensus 603 ~~~l~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~--~~~-----~~~~~~~E~~il~~l~HpnIv~l~g~~ 674 (931)
..-+...+|-+.+.||+|+|+.||+|.+ ...+.||||+-.-. ..+ ..+...+|.+|-+.|.||.||++++++
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 3445667788889999999999999964 46788999975322 111 235678999999999999999999998
Q ss_pred ec-CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc---CCCce
Q 002358 675 EE-EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRA 750 (931)
Q Consensus 675 ~~-~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld---~~~~v 750 (931)
.- .+..|-|+|||+|.+|.-+|+ ..+.++++.+..|+.||+.||.||.+. +.+|||-||||.|||+- .-|.+
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred eeccccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccccee
Confidence 64 566789999999999999998 456789999999999999999999974 58999999999999994 45789
Q ss_pred EEecccccccccccccc------cccccccCCCccCCCccC----CCCCCccchhHHHHHHHHHHHhCCCCCCccCccch
Q 002358 751 KVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYG----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 820 (931)
Q Consensus 751 kL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~ 820 (931)
||+|||+++.+.++... ......||.+|++||++. ....+.|.||||.||++|+++.|+.||......
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-- 690 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-- 690 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--
Confidence 99999999987654322 234557999999999874 346788999999999999999999999732211
Q ss_pred hhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002358 821 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878 (931)
Q Consensus 821 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 878 (931)
..+. .++.+...-.-.+.. .+....+...+|++||+.--++|.+..++.
T Consensus 691 QdIL-------qeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 691 QDIL-------QENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHHH-------hhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111 122221111100000 011112456899999999999998887775
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=290.37 Aligned_cols=258 Identities=20% Similarity=0.260 Sum_probs=166.7
Q ss_pred HHHhhccccCccCcEEEEEEEECC-----CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEE------EecC
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY------CEEE 677 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~------~~~~ 677 (931)
..|.+.+.||+|+||.||+|++.+ ++.||+|++...... +.+..| .+....+.++..++.. +...
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 345678999999999999999864 689999987643211 111111 1122222222222211 2456
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCC-----------------CCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCC
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSVNQ-----------------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 740 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~~~-----------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~ 740 (931)
...++|+||+.+++|.+++...... .......+..++.|++.||+|||+ .+|+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHH
Confidence 6789999999999999988643110 011223456799999999999998 89999999999
Q ss_pred CccccC-CCceEEecccccccccccccccccccccCCCccCCCccCCC----------------------CCCccchhHH
Q 002358 741 NILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ----------------------QLTEKSDVYS 797 (931)
Q Consensus 741 NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~----------------------~~s~ksDVwS 797 (931)
|||++. ++.+||+|||+++..............+++.|+|||.+... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999986 57899999999986544433334455689999999965322 2345679999
Q ss_pred HHHHHHHHHhCCCCCCccCcc-------chhhHHHHHHHhhhcCCeeecccccccCCCC--HHHHHHHHHHHHHccccCC
Q 002358 798 FGVVLLELISGKKPVSVEDFG-------AELNIVHWARSMIKKGDVISIVDPVLIGNVK--IESIWRIAEVAIQCVEQRG 868 (931)
Q Consensus 798 lGvlL~eLltG~~Pf~~~~~~-------~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~--~~~~~~l~~li~~Cl~~dP 868 (931)
|||+||||+++..|++..... .......|....... ..+.+...++ ........+++.+||+.||
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999999987775421100 001112221111000 0000000000 0011134589999999999
Q ss_pred CCCCCHHHHHH
Q 002358 869 FSRPKMQEIVL 879 (931)
Q Consensus 869 ~~RPs~~evl~ 879 (931)
++|||++|+++
T Consensus 439 ~kR~ta~e~L~ 449 (566)
T PLN03225 439 RQRISAKAALA 449 (566)
T ss_pred ccCCCHHHHhC
Confidence 99999999986
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-29 Score=264.36 Aligned_cols=269 Identities=21% Similarity=0.284 Sum_probs=204.5
Q ss_pred cChhhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcC-C-CC----CcceeEE
Q 002358 601 IPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H-RN----LVPLIGY 673 (931)
Q Consensus 601 ~~~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-H-pn----Iv~l~g~ 673 (931)
+...|.....|.+...+|+|.||.|-.+... .+..||||+++.. ....++.+-|+++|+++. + |+ +|.+.++
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 4456777888999999999999999999765 4689999998754 334456677999999994 2 32 6778888
Q ss_pred EecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC-------
Q 002358 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI------- 746 (931)
Q Consensus 674 ~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~------- 746 (931)
|.-.++.|+|+|.+ |-|+.++|..+ +..+++...+..|+.|++++++|||+ .+++|-||||+|||+-+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEe
Confidence 99999999999998 67999999865 56789999999999999999999998 99999999999999932
Q ss_pred -------------CCceEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 002358 747 -------------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 813 (931)
Q Consensus 747 -------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~ 813 (931)
+..++|+|||.|....+.. .....|..|+|||++.+-.++.++||||+||+|.|+.||..-|+
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 3458999999998754433 33457899999999999999999999999999999999999987
Q ss_pred ccCccchhhHHHHHHH-----hh---------hcCCe-----------eeccccc--cc--CCCCHHHHHHHHHHHHHcc
Q 002358 814 VEDFGAELNIVHWARS-----MI---------KKGDV-----------ISIVDPV--LI--GNVKIESIWRIAEVAIQCV 864 (931)
Q Consensus 814 ~~~~~~~~~l~~~~~~-----~~---------~~~~~-----------~~i~d~~--l~--~~~~~~~~~~l~~li~~Cl 864 (931)
.-+..+.....+.+.. ++ ..+.+ ....++. +. -.....+..+|.+|+++||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 4432222211111100 00 01100 0001100 00 0112345567999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 002358 865 EQRGFSRPKMQEIVL 879 (931)
Q Consensus 865 ~~dP~~RPs~~evl~ 879 (931)
..||.+|+|+.|+++
T Consensus 391 ~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 391 EFDPARRITLREALS 405 (415)
T ss_pred ccCccccccHHHHhc
Confidence 999999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=276.69 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=176.2
Q ss_pred HHhhccccCccCcEEEEEEEE-----------------CCCcEEEEEEccCccchhhhh--------------HHHHHHH
Q 002358 610 TNNFCKKIGKGSFGSVYYGKM-----------------KDGKEVAVKIMADSCSHRTQQ--------------FVTEVAL 658 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~-----------------~~g~~vAvK~~~~~~~~~~~~--------------~~~E~~i 658 (931)
.+.+.++||+|+||+||+|.+ .+++.||||++........++ +..|+.+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 455678999999999999964 235689999986543322223 3447777
Q ss_pred HHhcCCCCC-----cceeEEEec--------CCeEEEEEEecCCCCHHHHhccCCC---------------------CCC
Q 002358 659 LSRIHHRNL-----VPLIGYCEE--------EHQRILVYEYMHNGTLRDRLHGSVN---------------------QKP 704 (931)
Q Consensus 659 l~~l~HpnI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~L~~~~~---------------------~~~ 704 (931)
+.+++|.++ ++++++|.. ++..++||||+++|+|.++++.... ...
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 778876654 677777743 3568999999999999999874211 123
Q ss_pred CCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccccccccCCCccCCCcc
Q 002358 705 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784 (931)
Q Consensus 705 l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l 784 (931)
+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++..............+++.|+|||.+
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 4677888999999999999998 8999999999999999999999999999976543222111222357899999987
Q ss_pred CCCCC----------------------CccchhHHHHHHHHHHHhCCC-CCCccCc-cch-----hhHHHHHHHhhhcCC
Q 002358 785 GNQQL----------------------TEKSDVYSFGVVLLELISGKK-PVSVEDF-GAE-----LNIVHWARSMIKKGD 835 (931)
Q Consensus 785 ~~~~~----------------------s~ksDVwSlGvlL~eLltG~~-Pf~~~~~-~~~-----~~l~~~~~~~~~~~~ 835 (931)
..... ..+.||||+||+++||++|.. |+..... ... ..+..|.. .....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~~ 460 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQK 460 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcccC
Confidence 54321 124799999999999999875 6642111 110 11112211 11111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 002358 836 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRG---FSRPKMQEIVL 879 (931)
Q Consensus 836 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP---~~RPs~~evl~ 879 (931)
. +-... ........+++.+++..+| .+|+|++|+++
T Consensus 461 ~----~~~~~----d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 Y----DFSLL----DRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred C----Ccccc----cccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 10011 1112356788889998766 68999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=240.52 Aligned_cols=201 Identities=24% Similarity=0.374 Sum_probs=166.4
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHh-cCCCCCcceeEEEecCCeEEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSR-IHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
+....-.+.||+|++|.|-+-++. +|+..|+|.++... .+..++.++|+.+..+ ..+|.+|.++|........++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 333344678999999999888876 79999999987653 3455678888887555 47999999999999999999999
Q ss_pred EecCCCCHHHHhccC-CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 685 EYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 685 E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|.|. .||..+-+.- ..++.+++.-+-+|+..+..||.|||+ +..++|||+||+||||+.+|++|+||||++-.+.+
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9994 5776654332 256778899999999999999999999 68999999999999999999999999999987655
Q ss_pred cccccccccccCCCccCCCccCC----CCCCccchhHHHHHHHHHHHhCCCCCC
Q 002358 764 DLTHISSVARGTVGYLDPEYYGN----QQLTEKSDVYSFGVVLLELISGKKPVS 813 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~----~~~s~ksDVwSlGvlL~eLltG~~Pf~ 813 (931)
.... +...|...|||||.+.. ..|+.|+||||||+++.||.+++.||+
T Consensus 202 SiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 202 SIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred hhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 4332 22357889999999743 478999999999999999999999997
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-29 Score=251.58 Aligned_cols=264 Identities=21% Similarity=0.313 Sum_probs=190.3
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEcc-Cccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEec--------CC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------EH 678 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~-~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------~~ 678 (931)
.|.-..+||+|.||.|++|+.+ .|+.||+|+.- +... .-.....+|+++|+.|+|+|++.++..|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3444578999999999999877 57788887642 2211 223456789999999999999999988743 23
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
..++|+.+|+. +|.-+|.. ....++..++.+++.++..||.|+|. ..|+|||+||.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 47899999975 78877763 23568889999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccc---cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcC
Q 002358 759 RQAEEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 834 (931)
Q Consensus 759 ~~~~~~~~~---~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 834 (931)
+.+...... ..+....|..|++||.+.+ ..|+++.|||.-||++.||+|+.+-+++.......+++..+...+..+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 765332211 1233446899999998755 689999999999999999999998887443333333333222222111
Q ss_pred Ceeeccc----------ccccCCCC--HHHHH------HHHHHHHHccccCCCCCCCHHHHHH
Q 002358 835 DVISIVD----------PVLIGNVK--IESIW------RIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 835 ~~~~i~d----------~~l~~~~~--~~~~~------~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+.+.. |...+.+. .+..+ .-.+++.+++..||.+|+++.+++.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1111110 10011110 01111 4568899999999999999998873
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-29 Score=269.11 Aligned_cols=241 Identities=22% Similarity=0.293 Sum_probs=198.6
Q ss_pred HHhhccccCccCcEEEEEEEECCCc-EEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~g~-~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
..+....||-|+||.|=++..+... .+|+|++++.. ..+.+.+..|-.+|...+.|.||+++..|.++...|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3345678999999999999877443 48888887643 3455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
-|-||.|...|+ .++.++..+..-++..+.+|++|||+ ++||.|||||+|+++|.+|=+||.|||+++.+....
T Consensus 501 aClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 501 ACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999998 56788888899999999999999998 999999999999999999999999999999876542
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
..-+.+|||.|.|||++.+...+.++|.||+|+++|||++|.+||...+.-...+++--...++.
T Consensus 575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~------------- 639 (732)
T KOG0614|consen 575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE------------- 639 (732)
T ss_pred --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh-------------
Confidence 34467899999999999999999999999999999999999999987665444443322111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPK 873 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs 873 (931)
++....+.-.+++++.+..+|.+|--
T Consensus 640 --~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 --FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred --cccccchhHHHHHHHHHhcCcHhhhc
Confidence 11122234568899999999999975
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-28 Score=276.14 Aligned_cols=241 Identities=25% Similarity=0.426 Sum_probs=184.9
Q ss_pred ccccCccCcE-EEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEecCCCC
Q 002358 614 CKKIGKGSFG-SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 691 (931)
Q Consensus 614 ~~~LG~G~fG-~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 691 (931)
.+++|.|+.| .||+|... |+.||||++-.. -.+-..+|++.|+.- .|||||++++.-.++...|+..|.|. .+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 3678999988 57999987 899999988643 234567899999988 59999999999999999999999995 59
Q ss_pred HHHHhccC-CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC---C--CceEEecccccccccccc
Q 002358 692 LRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---N--MRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 692 L~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---~--~~vkL~DFGla~~~~~~~ 765 (931)
|.+++... ...........+.++.|++.||+|||+ .+|+||||||.||||+. + ..++|+|||+++......
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99999863 111111113456788999999999998 99999999999999975 3 468999999999876554
Q ss_pred ccc--ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhC-CCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 766 THI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 766 ~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
... .....||-+|+|||++....-+.+.||||+||++|+.++| ..||. +....+.|+..-. ..+.. +.+
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG-d~~~R~~NIl~~~------~~L~~-L~~ 737 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG-DSLERQANILTGN------YTLVH-LEP 737 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC-chHHhhhhhhcCc------cceee-ecc
Confidence 332 3345699999999999998888899999999999999995 89996 3332333332110 01100 111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 878 (931)
..++ +-.+||.+|+.++|..||++.+|+
T Consensus 738 ------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 738 ------LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ------CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1111 567999999999999999999998
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=245.57 Aligned_cols=244 Identities=22% Similarity=0.359 Sum_probs=193.7
Q ss_pred hhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEe
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
++.++||+|+|+.|-+++++ ..+.+|+|++++.. .++.+-.+.|-.+..+. +||.+|.++.+|..+..+++|.||
T Consensus 253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 34678999999999999987 57889999987643 23344456677777766 699999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
++||+|--+++ .+..+++..+.-...+|+-||.|||+ .||+.||||..|||+|..|++||+|+|+++.--.+..
T Consensus 333 v~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 333 VNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred ecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 99999977666 45678888888899999999999998 9999999999999999999999999999986433332
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCcc-chhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~-~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
..++.+|||.|+|||++.+..|....|.|++||+++||+.|+.||+..... .+.+--+++.+.+-+..+. +
T Consensus 407 -~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-i------ 478 (593)
T KOG0695|consen 407 -TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-I------ 478 (593)
T ss_pred -ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-c------
Confidence 345678999999999999999999999999999999999999999844332 3344444555544433221 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRP 872 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RP 872 (931)
+.....+...++..-+.+||.+|-
T Consensus 479 ---prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 ---PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---cceeehhhHHHHHHhhcCCcHHhc
Confidence 111112345677788899998875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-26 Score=232.70 Aligned_cols=210 Identities=38% Similarity=0.612 Sum_probs=182.5
Q ss_pred cCccCcEEEEEEEECC-CcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCHHH
Q 002358 617 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 694 (931)
Q Consensus 617 LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 694 (931)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999875 899999998765332 34679999999999999999999999999899999999999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC-CCceEEecccccccccccccccccccc
Q 002358 695 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVAR 773 (931)
Q Consensus 695 ~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~~ 773 (931)
++.... ..+++..+..++.++++++++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 987431 468899999999999999999998 89999999999999999 89999999999876544321 122234
Q ss_pred cCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002358 774 GTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 852 (931)
Q Consensus 774 gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 852 (931)
+...|++||..... .++.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 67899999999887 888999999999999999
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 853 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 853 ~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
..+.+++.+|++.+|++||+++++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 257799999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=256.62 Aligned_cols=199 Identities=26% Similarity=0.383 Sum_probs=166.8
Q ss_pred ccccCccCcEEEEEEEECC-CcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 614 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
++.||-|+||.|.++.-.| ...+|+|.+++.. ..+.....+|..||.....+=||+|+-.|.+++.+|+||+|++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 3569999999999997544 5678999987642 34556788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc-------
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE------- 762 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~------- 762 (931)
|++-.+|.+ .+-+++..+.-.+.++..|+++.|. .|+|||||||.|||||.+|++||+|||||.-+.
T Consensus 714 GDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 714 GDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred ccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999998873 4567777777788899999999997 999999999999999999999999999985320
Q ss_pred -cccccc---------------------------------ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhC
Q 002358 763 -EDLTHI---------------------------------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG 808 (931)
Q Consensus 763 -~~~~~~---------------------------------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG 808 (931)
....+. .....||+.|+|||++....|+..+|.||.||+||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 000000 0112499999999999999999999999999999999999
Q ss_pred CCCCCccCcc
Q 002358 809 KKPVSVEDFG 818 (931)
Q Consensus 809 ~~Pf~~~~~~ 818 (931)
+.||......
T Consensus 868 ~~pf~~~tp~ 877 (1034)
T KOG0608|consen 868 QPPFLADTPG 877 (1034)
T ss_pred CCCccCCCCC
Confidence 9999754443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-28 Score=245.29 Aligned_cols=261 Identities=22% Similarity=0.285 Sum_probs=191.6
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecC-----CeEEEEEE
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRILVYE 685 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-----~~~~lV~E 685 (931)
.+-||-|+||.||...+. +|+.||+|++.... -...+.+.+|+++|...+|.|++..+++..-. ++.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 477999999999999765 89999999886532 23457889999999999999999998876543 35678888
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
.|. .+|..++- ....++...+.-++.||++||+|||+ .+|.||||||.|.|++.+-.+||||||+++..+.+.
T Consensus 138 LmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 884 56777665 45667888888899999999999998 999999999999999999999999999999876555
Q ss_pred cccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH--------HhhhcCCe
Q 002358 766 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKGDV 836 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~~ 836 (931)
....+....|..|+|||++++ ..|+.+.||||.||++.||+..+.-|+....-....++.-+. +.--+|..
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 444444456889999999877 578999999999999999999998887444332222211100 00001111
Q ss_pred eeccc--------ccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002358 837 ISIVD--------PVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 881 (931)
Q Consensus 837 ~~i~d--------~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 881 (931)
.-++. +.+..-. +...-.+-..+..+++..||..|.+.++.+..+
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111 1111111 111122445788889999999999988877654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-26 Score=245.49 Aligned_cols=142 Identities=25% Similarity=0.418 Sum_probs=120.4
Q ss_pred ccccChhhHHH-HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcC-----C---CCC
Q 002358 598 AYFIPLPELEE-ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----H---RNL 667 (931)
Q Consensus 598 ~~~~~~~~l~~-~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-----H---pnI 667 (931)
...+.++|+-. .+|-+.++||-|.|++||++.+. ..+.||+|+.+. ..+..+..+.|+++|++++ | .+|
T Consensus 66 YHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 66 YHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred CceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 34455667666 78888999999999999999765 578899999864 4556677889999999994 2 369
Q ss_pred cceeEEEec----CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcc
Q 002358 668 VPLIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 743 (931)
Q Consensus 668 v~l~g~~~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIL 743 (931)
|+++++|.. +.+.|||+|++ |.+|...+... +.+.++...+.+|+.||+.||.|||. +.+|||-||||+|||
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvL 220 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVL 220 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceee
Confidence 999999865 56899999999 77899888765 56789999999999999999999999 469999999999999
Q ss_pred c
Q 002358 744 L 744 (931)
Q Consensus 744 l 744 (931)
+
T Consensus 221 l 221 (590)
T KOG1290|consen 221 L 221 (590)
T ss_pred e
Confidence 9
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-27 Score=256.30 Aligned_cols=278 Identities=22% Similarity=0.267 Sum_probs=215.9
Q ss_pred CCCcccccChhhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcC------CCC
Q 002358 594 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH------HRN 666 (931)
Q Consensus 594 ~~~~~~~~~~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~------Hpn 666 (931)
+....+.+.+.|+....|.+....|+|-|++|.+|... -|..||||++...... .+.=++|+++|++|+ .-|
T Consensus 417 DaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 417 DAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred cccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhH
Confidence 33456778899999999999999999999999999865 5889999999865432 344568999999995 347
Q ss_pred CcceeEEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC
Q 002358 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 746 (931)
Q Consensus 667 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~ 746 (931)
+++++..|...+++|||+|-+ ..+|.+.|+.......+....+..++.|+.-||.+|.. .+|+|.||||.|||+++
T Consensus 496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEecc
Confidence 999999999999999999988 57999999987777789999999999999999999997 99999999999999987
Q ss_pred CC-ceEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHH
Q 002358 747 NM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 825 (931)
Q Consensus 747 ~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~ 825 (931)
.. .+||||||.|....+... +....+..|.|||++.+..|+...|+||.||+||||.||+..|.+..-.....+..
T Consensus 572 ~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred CcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 65 479999999987654332 22334567999999999999999999999999999999999998655433332222
Q ss_pred HHH-----HhhhcCCe---------------------------eecccc------cccC--CCCH---HHHHHHHHHHHH
Q 002358 826 WAR-----SMIKKGDV---------------------------ISIVDP------VLIG--NVKI---ESIWRIAEVAIQ 862 (931)
Q Consensus 826 ~~~-----~~~~~~~~---------------------------~~i~d~------~l~~--~~~~---~~~~~l~~li~~ 862 (931)
-++ .+++.+.+ ...+.| .+.+ .++. .....+.+|+.+
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 221 11222111 001111 1111 1222 334578899999
Q ss_pred ccccCCCCCCCHHHHHH
Q 002358 863 CVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 863 Cl~~dP~~RPs~~evl~ 879 (931)
|+..||++|.|..+.++
T Consensus 729 ml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALK 745 (752)
T ss_pred HhccChhhcCCHHHHhc
Confidence 99999999999998764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=228.06 Aligned_cols=254 Identities=19% Similarity=0.317 Sum_probs=188.5
Q ss_pred HHHHhhccccCccCcEEEEEEEECC-CcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeE-EEecCCeEEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG-YCEEEHQRILVY 684 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g-~~~~~~~~~lV~ 684 (931)
...|++.+.||+|.||.+-+++++. .+.+++|-+... ....++|.+|..---.| .|.||+..++ .|+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4567888999999999999999984 677888987644 34567899998876566 5899998876 467778888999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc--CCCceEEeccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAE 762 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld--~~~~vkL~DFGla~~~~ 762 (931)
||++.|+|.+-+.. .++.+....+++.|++.|+.|+|+ +++||||||.+||||- +...+||||||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999998763 567788889999999999999998 9999999999999993 34579999999987654
Q ss_pred ccccccccccccCCCccCCCccCCC-----CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 763 EDLTHISSVARGTVGYLDPEYYGNQ-----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l~~~-----~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
..... ..-+-.|.+||..... ...+.+|+|.||++++.++||+.||+ ........+.+|..-.-+...
T Consensus 175 ~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 175 TTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred ceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHhcccCc--
Confidence 32221 1235579999986432 44678999999999999999999998 444444444444432222111
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
++...+.. ......++.++-+.+++++|-...++.++..
T Consensus 248 -----~~P~~F~~-fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 248 -----ALPKKFNP-FSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred -----cCchhhcc-cCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 11111111 1124567888899999999966666655543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-25 Score=230.47 Aligned_cols=196 Identities=37% Similarity=0.618 Sum_probs=171.2
Q ss_pred hhccccCccCcEEEEEEEECC-CcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 356889999999999999875 899999999866554 667899999999999999999999999998999999999999
Q ss_pred CCHHHHhccCCCCCC-CCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 690 gsL~~~L~~~~~~~~-l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
++|.+++... .. +++..+..++.++++++.+||+ .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 ~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 82 GDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999998743 23 7889999999999999999998 899999999999999999999999999988765432112
Q ss_pred ccccccCCCccCCCcc-CCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 002358 769 SSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVS 813 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l-~~~~~s~ksDVwSlGvlL~eLltG~~Pf~ 813 (931)
.....++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2234577889999998 66778889999999999999999999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=220.90 Aligned_cols=256 Identities=19% Similarity=0.313 Sum_probs=190.0
Q ss_pred HHHHhhccccCccCcEEEEEEEE-CCCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CCCCcceeEEEecC--CeEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILV 683 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~--~~~~lV 683 (931)
...|++.+++|+|-++.|+.|.. .+.+.++||++++. ..+.+.+|+.+|+.|+ ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45678889999999999999974 57889999999853 4577899999999997 99999999998764 456799
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC-CceEEeccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAE 762 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~-~~vkL~DFGla~~~~ 762 (931)
+||+++.+...+-. .++...+...+.+++.||.|+|+ .||.|||+||+|++||.. ..++|+|+|+|.++.
T Consensus 114 FE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99999988776543 46667788899999999999998 999999999999999964 569999999998876
Q ss_pred ccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcC-------
Q 002358 763 EDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------- 834 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------- 834 (931)
+..... ....+..|--||.+-. ..|+..-|+|||||++..|+..+.||-.. .....+++.-++ .+.-.
T Consensus 185 p~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG-~dN~DQLVkIak-VLGt~el~~Yl~ 260 (338)
T KOG0668|consen 185 PGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG-HDNYDQLVKIAK-VLGTDELYAYLN 260 (338)
T ss_pred CCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC-CCCHHHHHHHHH-HhChHHHHHHHH
Confidence 543321 2234667888998744 67888999999999999999999999622 222223333221 11000
Q ss_pred CeeecccccccC---CC---------CH----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 835 DVISIVDPVLIG---NV---------KI----ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 835 ~~~~i~d~~l~~---~~---------~~----~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...--+||.... .. +. -...+.++++.+.|..|-++|+|++|...
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 000012222111 00 00 00125678899999999999999999764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=248.23 Aligned_cols=195 Identities=25% Similarity=0.426 Sum_probs=165.5
Q ss_pred HHhhccccCccCcEEEEEEEECC-CcEEEEEEccCccc--------hhhhhHHHHHHHHHhcC---CCCCcceeEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS--------HRTQQFVTEVALLSRIH---HRNLVPLIGYCEEE 677 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~ 677 (931)
.|...+.||+|+||.|++|.++. ...|+||++.+... ......-.|++||..|+ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 34456889999999999999884 67899999875321 11123567999999997 99999999999999
Q ss_pred CeEEEEEEec-CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccc
Q 002358 678 HQRILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 756 (931)
Q Consensus 678 ~~~~lV~E~~-~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFG 756 (931)
+.++|+||-. ++-+|.+++.. ...+++.....|++||+.|++|||+ .+|+|||||-+||.++.+|-+||+|||
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeecc
Confidence 9999999975 56799999983 5678999999999999999999997 999999999999999999999999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCC-CccchhHHHHHHHHHHHhCCCCCC
Q 002358 757 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVS 813 (931)
Q Consensus 757 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~ 813 (931)
.+...... .-....||.+|.|||++.+..| +..-|||++|++||-++....||.
T Consensus 716 saa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98765432 2234569999999999999887 456899999999999998888875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-25 Score=230.39 Aligned_cols=254 Identities=24% Similarity=0.291 Sum_probs=187.8
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecC------CeEEEEE
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRILVY 684 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~~~lV~ 684 (931)
.+.+|.|+- .|..|.+. .+++||+|++.... ....++..+|..++..++|+||++++.++.-. .+.++||
T Consensus 22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence 456888887 55555443 58999999875431 23446778999999999999999999988543 4578999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
|+| .++|...+. -.++-.++..++.|++.|++|||+ .+|+||||||+||++..+..+||.|||+++.....
T Consensus 101 e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 101 ELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred Hhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc
Confidence 999 468888776 236778889999999999999998 99999999999999999999999999999875443
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhH----------------HHHHH
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI----------------VHWAR 828 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l----------------~~~~~ 828 (931)
...+....|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.+.-+.... ..-++
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 345566788999999999888899999999999999999999998875543222110 00011
Q ss_pred Hhhhc------CCeeec-ccccccC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 829 SMIKK------GDVISI-VDPVLIG--NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 829 ~~~~~------~~~~~i-~d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+. -...+. .|..... +.+.-......+++.+||..+|++|.+.+++++
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 11110 001111 1111111 111223345679999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=251.72 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=201.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.|++..++|.|.+|.|||++.+ .++..|+|+++-....+.+-+..|+-+++.-+|||||.++|-+-.....+++||||-
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 4567789999999999999876 689999999987767777778899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|+|++.-+ .-+++++.++..++++..+||+|||+ .+-+|||||-.|||+++.|.+|++|||.+-.+.....+
T Consensus 96 ggslQdiy~---~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K- 168 (829)
T KOG0576|consen 96 GGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK- 168 (829)
T ss_pred CCcccceee---ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhhh-
Confidence 999999877 35789999999999999999999998 88899999999999999999999999998776544333
Q ss_pred ccccccCCCccCCCcc---CCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 769 SSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l---~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
+....||+.|||||+. +.+.|..++|||+.|+...|+-.-+.|... ... ..+..+..+ ...+|.-.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd--lhp-----mr~l~LmTk----S~~qpp~l 237 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD--LHP-----MRALFLMTK----SGFQPPTL 237 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc--cch-----HHHHHHhhc----cCCCCCcc
Confidence 3445699999999985 556788999999999999999888777531 110 111111111 11222111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+ +...-..+-++++.|+..+|++||+++.+++
T Consensus 238 kD-k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 KD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 1223335779999999999999999988763
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-24 Score=263.86 Aligned_cols=195 Identities=19% Similarity=0.290 Sum_probs=138.1
Q ss_pred hcCC-CCCcceeEEE-------ecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCe
Q 002358 661 RIHH-RNLVPLIGYC-------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732 (931)
Q Consensus 661 ~l~H-pnIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i 732 (931)
.++| +||++++++| .+....++++|++ +++|.++|.. ....+++..++.++.||++||+|||+ ++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 4455 5788888877 2223566788887 6699999974 24568999999999999999999998 999
Q ss_pred EecCCCCCCccccC-------------------CCceEEecccccccccccc---------------cccccccccCCCc
Q 002358 733 IHRDVKSSNILLDI-------------------NMRAKVSDFGLSRQAEEDL---------------THISSVARGTVGY 778 (931)
Q Consensus 733 vH~DIkp~NILld~-------------------~~~vkL~DFGla~~~~~~~---------------~~~~~~~~gt~~y 778 (931)
+||||||+||||+. ++.+|++|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456666777665421100 0001123478899
Q ss_pred cCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHH
Q 002358 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 858 (931)
Q Consensus 779 ~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~ 858 (931)
||||++.+..++.++|||||||+||||++|..|+.... .... .. ... ...+.. ........+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~---~~-~~~----~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMS---SL-RHR----VLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHH---HH-HHh----hcChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999988865211 0100 00 000 011111 011223568
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 002358 859 VAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 859 li~~Cl~~dP~~RPs~~evl~ 879 (931)
++.+||+.+|.+||+|+|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999974
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=205.70 Aligned_cols=169 Identities=21% Similarity=0.205 Sum_probs=126.3
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.++++.. ...+++..++.++.|+++||+|||+ .+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence 7899998742 4569999999999999999999998 44 999999999999999 99987654322
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..+... ..... +... ...
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~-~~~~~------~~~~-~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLNG-MPADD------PRDR-SNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHHH-hccCC------cccc-ccH
Confidence 24889999999999999999999999999999999999999633211 1111111111 11100 0000 001
Q ss_pred HHHH--HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 850 IESI--WRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 850 ~~~~--~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
.... ..+.+++.+||+.+|++||++.|+++.+.....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 1112 258999999999999999999999998876644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.3e-23 Score=220.27 Aligned_cols=193 Identities=30% Similarity=0.445 Sum_probs=159.5
Q ss_pred HhhccccCccCcEEEEEEEEC----CCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 685 (931)
+...++||+|.|++||++.+. ..+.||+|.+.... ....+..|+++|..+. +.||+++.+++..++...+|+|
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 445789999999999999754 36789999886432 3356889999999995 9999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC-CCceEEeccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~~~~~ 764 (931)
|++.....++... ++...+...++.+..||+++|+ .|||||||||+|+|.+. .+.-.|.|||++...+..
T Consensus 116 ~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 116 YFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred ccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999999888763 5678888999999999999998 99999999999999985 456899999998721100
Q ss_pred c------c-------c------------------------------cccccccCCCccCCCccCC-CCCCccchhHHHHH
Q 002358 765 L------T-------H------------------------------ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGV 800 (931)
Q Consensus 765 ~------~-------~------------------------------~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGv 800 (931)
. . . ......||++|.|||++.. +..++++||||.||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 0 0 0112359999999999755 56788999999999
Q ss_pred HHHHHHhCCCCCCc
Q 002358 801 VLLELISGKKPVSV 814 (931)
Q Consensus 801 lL~eLltG~~Pf~~ 814 (931)
+++-+++++.||-.
T Consensus 267 I~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFK 280 (418)
T ss_pred eeehhhcccccccc
Confidence 99999999999963
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-23 Score=210.42 Aligned_cols=253 Identities=22% Similarity=0.376 Sum_probs=192.6
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
+.-...++..+|.+...|..|+|+|+ |..+++|++.-. .....++|..|.-.|+...||||+.++|.|.......++
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 33445567788999999999999998 566666776432 233347899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEe--cccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS--DFGLSRQA 761 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~--DFGla~~~ 761 (931)
..||+.|+|+..|++. .....+..+..+++.++|+|++|||+- ++-|..--|..+.|+||++.+++|. |--++..
T Consensus 266 sq~mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq- 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ- 342 (448)
T ss_pred eeeccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee-
Confidence 9999999999999965 234567788999999999999999983 3444555789999999999998874 3333221
Q ss_pred cccccccccccccCCCccCCCccCCCCCC---ccchhHHHHHHHHHHHhCCCCCCccCc-cchhhHHHHHHHhhhcCCee
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQQLT---EKSDVYSFGVVLLELISGKKPVSVEDF-GAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s---~ksDVwSlGvlL~eLltG~~Pf~~~~~-~~~~~l~~~~~~~~~~~~~~ 837 (931)
.....-.|.||+||.++..+-+ .++|+|||++++|||.|...||..-.. +.+..+.
T Consensus 343 -------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------------- 402 (448)
T KOG0195|consen 343 -------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------------- 402 (448)
T ss_pred -------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-------------
Confidence 1122346899999999776543 489999999999999999999973221 1111110
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
-..++-..++.....+.+++.-|+..||.+||.+..|+-.||.+.
T Consensus 403 ---leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 ---LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 111222334444557789999999999999999999999998764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8e-21 Score=212.17 Aligned_cols=262 Identities=24% Similarity=0.300 Sum_probs=196.6
Q ss_pred HHhhccccCccCcEEEEEEEECCC--cEEEEEEccCccchhhhhHHHHHHHHHhcCC----CCCcceeEEE-ecCCeEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKDG--KEVAVKIMADSCSHRTQQFVTEVALLSRIHH----RNLVPLIGYC-EEEHQRIL 682 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~g--~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H----pnIv~l~g~~-~~~~~~~l 682 (931)
.+.+.+.||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 577789999999999999997653 4788888765433333378889999999873 5889999888 47778899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC-----CceEEecccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-----MRAKVSDFGL 757 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~-----~~vkL~DFGl 757 (931)
||+.+ |.+|.++..... .+.++..+.+.++.|++.+|.+||+ .|++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 889999776443 5789999999999999999999998 999999999999999765 4699999999
Q ss_pred cc--cccccc----ccc---ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002358 758 SR--QAEEDL----THI---SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 828 (931)
Q Consensus 758 a~--~~~~~~----~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~ 828 (931)
++ .+.... ... .....||..|.+++...+...+.+.|+||++.++.|++.|..||.............
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~--- 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE--- 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---
Confidence 98 322111 111 223459999999999999999999999999999999999999996443322211111
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 829 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 829 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
+....... .. .....+ ..+.++...+-..+..++|....+...+++.....
T Consensus 251 ~~~~~~~~----~~--~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRKLLT----DR--FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhhhcc----cc--ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111001 10 111122 24455555555689999999999999988877655
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=216.04 Aligned_cols=173 Identities=18% Similarity=0.161 Sum_probs=131.2
Q ss_pred HHHHhhccccCccCcEEEEEEEEC--CCcEEEEEEccCcc-----chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
...|.+.+.||+|+||+||+|.++ +++.||||++.... ....+.|.+|+++|++++|+|+++.+..+ +..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCc
Confidence 345677899999999999999875 57788999865321 12345689999999999999999644322 457
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCC-CCCCccccCCCceEEecccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DI-kp~NILld~~~~vkL~DFGla~ 759 (931)
++||||+++++|... .. .. ...++.|++++|+|||+ .+|+|||| ||+|||++.++.+||+|||+++
T Consensus 94 ~LVmE~~~G~~L~~~-~~---~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-RP---HG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred EEEEEccCCCCHHHh-Cc---cc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 999999999999732 11 11 14678899999999998 89999999 9999999999999999999998
Q ss_pred cccccccccc-------cccccCCCccCCCccCCCC------CCccchhH
Q 002358 760 QAEEDLTHIS-------SVARGTVGYLDPEYYGNQQ------LTEKSDVY 796 (931)
Q Consensus 760 ~~~~~~~~~~-------~~~~gt~~y~APE~l~~~~------~s~ksDVw 796 (931)
.......... ....+++.|+|||.+...+ .+..+|-|
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 7654321111 2445788999999985432 23346666
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=195.26 Aligned_cols=262 Identities=19% Similarity=0.248 Sum_probs=201.6
Q ss_pred HHhhccccCccCcEEEEEEE-ECCCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
-|++.++||+|.||.++.|+ +-+++.||||.-. ...+..++..|.+..+.|. .+.|...+-|..++.+..||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 46678999999999999997 4479999999743 2344567888999999885 789999988888888999999998
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC-----CceEEeccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-----MRAKVSDFGLSRQAE 762 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~-----~~vkL~DFGla~~~~ 762 (931)
|-||+|+..- .+..++.++++.+|.|++.-++|+|+ +.+|.|||||+|+||... ..+.|+|||+++.+.
T Consensus 107 -GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8899998765 46789999999999999999999998 999999999999999643 348999999999876
Q ss_pred cccccc------ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 763 EDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 763 ~~~~~~------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
+..+.. .....||.+||+-....+.+.+.+.|+=|+|.++++.|-|..||++-..+....-.+-+.+..+...+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 654432 23345999999999999999999999999999999999999999866554333222222222222222
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
.++. .. .+.++...+.-.-..+-.+-|+.+-+...+.+++...
T Consensus 261 ~~Lc-----~g----~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 261 EVLC-----EG----FPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred HHHH-----hc----CHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 1111 11 2234445554455677788899998888887766443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.8e-19 Score=196.18 Aligned_cols=260 Identities=29% Similarity=0.426 Sum_probs=196.5
Q ss_pred HhhccccCccCcEEEEEEEECCCcEEEEEEccCccch---hhhhHHHHHHHHHhcCCC-CCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHR-NLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~Hp-nIv~l~g~~~~~~~~~lV~E~ 686 (931)
+.+.+.||.|+||.||++... +.+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 345678999999999999987 88999998765433 367899999999999988 799999999777778999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC-ceEEecccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~~~ 765 (931)
+.++++.+.+........+.......++.|++.++.|+|+ .+++|||+||+||+++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 9999999776632111368888999999999999999998 8899999999999999988 79999999988554433
Q ss_pred cc-----cccccccCCCccCCCccCC---CCCCccchhHHHHHHHHHHHhCCCCCCccCcc-chhhHHHHHHHhhhcCCe
Q 002358 766 TH-----ISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDV 836 (931)
Q Consensus 766 ~~-----~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~-~~~~l~~~~~~~~~~~~~ 836 (931)
.. ......|+..|+|||.+.. ..+....|+||+|++++++++|..||...... ........+.. ...
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~----~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE----LPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh----cCC
Confidence 22 2345569999999999987 57889999999999999999999997633321 01111111111 111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
. .................+.+++.+|+..+|..|.++.+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000001000001223467899999999999999999887764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=182.69 Aligned_cols=262 Identities=21% Similarity=0.293 Sum_probs=194.7
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEE-CCCcEEEEEEccCccchhhhhHHHHHHHHHhcCC-CCCcceeEEEecCCeEEE
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~~~~~~l 682 (931)
.+....|.+.++||.|+||.+|.|.. .+|+.||||+-+... ...++..|.++...|+| ..|..+.-+..+.....+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 34456678899999999999999974 579999999865443 33568889999999975 567777778888888999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC---CCceEEecccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSR 759 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~ 759 (931)
||+.+ |-+|++...- ....++.++++-++.|++.-++|+|. ++++||||||+|+|+.- ...+.++|||+++
T Consensus 89 VMdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchh
Confidence 99988 8899988764 34568889999999999999999997 99999999999999963 4568999999999
Q ss_pred cccccccc------cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc
Q 002358 760 QAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 833 (931)
Q Consensus 760 ~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 833 (931)
.+.+..+. ......||.+|.+-....+...+.+.|+=|+|.+|.+..-|..||++-.......-.+- +.+
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk----I~E 238 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK----ISE 238 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH----HHH
Confidence 86543222 12334589999998888877888999999999999999999999985544333222222 222
Q ss_pred CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 834 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 834 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
......+.. +-..+|. ++...+.-|-..--++-|+..-+.+...-
T Consensus 239 kK~s~~ie~-LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 239 KKMSTPIEV-LCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred hhcCCCHHH-HhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 111111111 1122222 45566667777777788877766665543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.6e-20 Score=219.28 Aligned_cols=252 Identities=22% Similarity=0.245 Sum_probs=184.1
Q ss_pred hccccCccCcEEEEEEEEC-CCcEEEEEEcc----Cccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA----DSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~----~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
..+.+|.|++|.|+..... +.+..+.|..+ .... .....+..|+-+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3578999999987777543 34444444432 2111 111226667777788899999888887777666666699
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
||++ +|..++.. ...+....+..++.|+..|++|+|+ .+|.|||+|++|+++..++.+||+|||.+....-..
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 99999874 3467778888999999999999998 999999999999999999999999999987643332
Q ss_pred ---cccccccccCCCccCCCccCCCCCCc-cchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 766 ---THISSVARGTVGYLDPEYYGNQQLTE-KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 766 ---~~~~~~~~gt~~y~APE~l~~~~~s~-ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
........|+..|+|||.+....|.+ ..||||.|+++..|.+|+.||......+... ......+... +
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~-~-- 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRN-I-- 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccc-c--
Confidence 24556677999999999999999876 6799999999999999999998554432211 0000000000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..-....-...+.....++.++|+.+|.+|-|+++|++
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000011233446788999999999999999999974
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-19 Score=187.49 Aligned_cols=175 Identities=15% Similarity=0.187 Sum_probs=135.9
Q ss_pred hhhHHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhh---------hHHHHHHHHHhcCCCCCcceeEE
Q 002358 603 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ---------QFVTEVALLSRIHHRNLVPLIGY 673 (931)
Q Consensus 603 ~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~---------~~~~E~~il~~l~HpnIv~l~g~ 673 (931)
..++....++..+.||.|+||.||++.. +++.+|+|++++......+ .+.+|++.+.+++|++|..+.++
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 3456677888899999999999999766 5778999999765433222 26889999999999999999988
Q ss_pred EecC--------CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc
Q 002358 674 CEEE--------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 745 (931)
Q Consensus 674 ~~~~--------~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld 745 (931)
+... ...++||||++|.+|.+... ++. ....+++.+|..+|+ .+++|||+||+||+++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVS 169 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEe
Confidence 6533 35789999999999988632 221 345699999999998 9999999999999999
Q ss_pred CCCceEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHH
Q 002358 746 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 806 (931)
Q Consensus 746 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLl 806 (931)
.++ ++|+|||.......+... ..+.....+..++|+|+||+++..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999987654322111 01334445667999999999987653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.6e-19 Score=182.20 Aligned_cols=140 Identities=18% Similarity=0.182 Sum_probs=109.6
Q ss_pred ccccCccCcEEEEEEEECCCcEEEEEEccCccch--h-------hh-----------------hHHHHHHHHHhcCCCCC
Q 002358 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--R-------TQ-----------------QFVTEVALLSRIHHRNL 667 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~--~-------~~-----------------~~~~E~~il~~l~HpnI 667 (931)
.+.||+|+||.||+|...+|+.||||+++..... . .. ....|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998754211 0 11 22349999999988877
Q ss_pred cceeEEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHh-hhcCCCCeEecCCCCCCccccC
Q 002358 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDVKSSNILLDI 746 (931)
Q Consensus 668 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~ivH~DIkp~NILld~ 746 (931)
.....+... ..++||||++++++..... ....++......++.|++.+|.++ |+ .+|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-
Confidence 544433222 2389999999887765432 235688899999999999999999 66 8999999999999998
Q ss_pred CCceEEeccccccccc
Q 002358 747 NMRAKVSDFGLSRQAE 762 (931)
Q Consensus 747 ~~~vkL~DFGla~~~~ 762 (931)
++.++|+|||++....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4e-18 Score=193.85 Aligned_cols=218 Identities=28% Similarity=0.408 Sum_probs=165.6
Q ss_pred HHhcCCCCCcceeEEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCe-EecCC
Q 002358 659 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI-IHRDV 737 (931)
Q Consensus 659 l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i-vH~DI 737 (931)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.-...+.++|+.||+|||. .+| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeee
Confidence 3568899999999999999999999999999999999985 35678999999999999999999997 444 99999
Q ss_pred CCCCccccCCCceEEecccccccccccc-cccccccccCCCccCCCccCCC-------CCCccchhHHHHHHHHHHHhCC
Q 002358 738 KSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELISGK 809 (931)
Q Consensus 738 kp~NILld~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~-------~~s~ksDVwSlGvlL~eLltG~ 809 (931)
+++|+++|....+||+|||+........ ........-..-|.|||.+... ..+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987653210 0111111124569999998663 1466899999999999999999
Q ss_pred CCCCccCccch-hhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 810 KPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 810 ~Pf~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
.||+....... ..++.+++. .....+.|.+.... +....+..++..||..+|++||++++|-..++.+.+..
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred CccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 99985444322 344444333 11122223222111 33336889999999999999999999998888765543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.4e-19 Score=209.31 Aligned_cols=247 Identities=21% Similarity=0.309 Sum_probs=176.3
Q ss_pred HhhccccCccCcEEEEEEEECCCcEEEEEEccCcc-chhhhhHH---HHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-SHRTQQFV---TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~-~~~~~~~~---~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
..+.+.||.+.|=+|.+|++++|. |+||++-+.. .-..+.|. +|++ ...++|||.+++.-....+...|||-+|
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 445788999999999999999888 8889885432 22333343 3444 5556899999988877777778889899
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc--cccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEED 764 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~--~~~~ 764 (931)
+.+ +|+|+|. .+..+...+.+.|+.|++.||..+|. .+|+|||||.+||||+.-.=+.|+||..-+. +.++
T Consensus 103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 854 8999987 45677888889999999999999997 9999999999999999988899999986554 2222
Q ss_pred ccccc----cccccCCCccCCCccCCC-----------CCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHH
Q 002358 765 LTHIS----SVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 828 (931)
Q Consensus 765 ~~~~~----~~~~gt~~y~APE~l~~~-----------~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 828 (931)
....- .+...-..|+|||.+... ..+++-||||+||++.||++ |++||... +-..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---------QL~a 246 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---------QLLA 246 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---------HHHh
Confidence 21111 111123469999987431 25678999999999999998 68888621 1111
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 829 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 829 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
- +.+. .......+.+.-+ ..+.+++..|++.||++|-++++.++...
T Consensus 247 Y--r~~~-~~~~e~~Le~Ied----~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 247 Y--RSGN-ADDPEQLLEKIED----VSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred H--hccC-ccCHHHHHHhCcC----ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 1 0110 0000001110001 14679999999999999999999998743
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.3e-18 Score=172.86 Aligned_cols=141 Identities=21% Similarity=0.256 Sum_probs=111.8
Q ss_pred ccccCccCcEEEEEEEECCCcEEEEEEccCccch--h------------------------hhhHHHHHHHHHhcCCCCC
Q 002358 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--R------------------------TQQFVTEVALLSRIHHRNL 667 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~--~------------------------~~~~~~E~~il~~l~HpnI 667 (931)
.+.||+|++|.||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999888999999998754211 0 1123578999999999988
Q ss_pred cceeEEEecCCeEEEEEEecCCCCHHHH-hccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC
Q 002358 668 VPLIGYCEEEHQRILVYEYMHNGTLRDR-LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 746 (931)
Q Consensus 668 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~ 746 (931)
.....+.... .++||||++++++... +. ...++......++.|++.++.++|+ ..+|+||||||+|||++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 6555444332 4899999998855433 32 3456778889999999999999996 37999999999999999
Q ss_pred CCceEEecccccccccc
Q 002358 747 NMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 747 ~~~vkL~DFGla~~~~~ 763 (931)
++.++|+|||++....+
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=168.86 Aligned_cols=183 Identities=15% Similarity=0.135 Sum_probs=139.8
Q ss_pred ccccCccCcEEEEEEEECCCcEEEEEEccCccch----hhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEEecC
Q 002358 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH----RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
...|++|+||+||.+.- ++.+++.+.+...... ....+.+|+++|++|+ |+++.+++++ ...+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 47899999999997766 5888888877654331 1225789999999995 5889999886 34699999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCC-CCCCccccCCCceEEecccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DI-kp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
|.+|.+.+.. ....++.|++++|.++|+ .+|+|||| ||.|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 82 GAAMYQRPPR----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred CccHHhhhhh----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 9999765421 113577899999999998 99999999 799999999999999999999864432210
Q ss_pred ----c--------ccccccCCCccCCCccCCC-CCC-ccchhHHHHHHHHHHHhCCCCCCc
Q 002358 768 ----I--------SSVARGTVGYLDPEYYGNQ-QLT-EKSDVYSFGVVLLELISGKKPVSV 814 (931)
Q Consensus 768 ----~--------~~~~~gt~~y~APE~l~~~-~~s-~ksDVwSlGvlL~eLltG~~Pf~~ 814 (931)
. ......++.|++|+...-. ..+ .+.+.++-|.-+|.++|+..+...
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 1122367888888754332 333 577889999999999999988753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.9e-18 Score=181.09 Aligned_cols=230 Identities=21% Similarity=0.305 Sum_probs=149.1
Q ss_pred hccccCccCcEEEEEEEECC-CcEEEEEEccCcc---chhhhhHHHHHHHHHhcC----------CCCCcceeEEEe---
Q 002358 613 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC---SHRTQQFVTEVALLSRIH----------HRNLVPLIGYCE--- 675 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~----------HpnIv~l~g~~~--- 675 (931)
..+.||.|+++.||.+++.+ |+++|||++.-.. ....+++.+|.-....+. |-.++-.++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 35789999999999999874 8999999975332 234566777665555432 222333333221
Q ss_pred ------cC---C-----eEEEEEEecCCCCHHHHhcc----CCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCC
Q 002358 676 ------EE---H-----QRILVYEYMHNGTLRDRLHG----SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV 737 (931)
Q Consensus 676 ------~~---~-----~~~lV~E~~~~gsL~~~L~~----~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DI 737 (931)
.. . ..+++|+-+ .++|.+++.. ......+....++.+..|+++.+++||+ .|++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEeccc
Confidence 11 1 235677777 5788877542 1112234556667788999999999998 99999999
Q ss_pred CCCCccccCCCceEEecccccccccccccccccccccCCCccCCCccCC--------CCCCccchhHHHHHHHHHHHhCC
Q 002358 738 KSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--------QQLTEKSDVYSFGVVLLELISGK 809 (931)
Q Consensus 738 kp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~s~ksDVwSlGvlL~eLltG~ 809 (931)
||+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|.++.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999987765543332 224578999997633 35788999999999999999999
Q ss_pred CCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCC
Q 002358 810 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 871 (931)
Q Consensus 810 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 871 (931)
.||........... ....+. +.++.+..+|..+|+.+|++|
T Consensus 248 lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99984433211110 112334 667789999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-17 Score=188.98 Aligned_cols=225 Identities=26% Similarity=0.344 Sum_probs=174.5
Q ss_pred ccCccCcEEEEEEE----ECCCcEEEEEEccCccch--hhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEEecC
Q 002358 616 KIGKGSFGSVYYGK----MKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 616 ~LG~G~fG~Vy~a~----~~~g~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
++|+|+||.|++++ .+.|+.+|+|++++.... .......|..++...+ ||.+|++.-.++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999764 345778899988654321 1124556888888887 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|.|..++. +...+...........++-+++++|+ .+++|||+|++||+++.+|++++.|||+++..-+....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999999887 34556666677778889999999998 99999999999999999999999999999875433221
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
+||..|||||++. ....++|-||||++++||+||..||.. +-+++.... .-..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~-----------~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA-----------ELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh-----------ccCC
Confidence 7999999999998 467789999999999999999999973 111111110 0112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPKM 874 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs~ 874 (931)
+.+......+++..++..+|..|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 33333455677778888888887644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=163.09 Aligned_cols=134 Identities=16% Similarity=0.166 Sum_probs=104.8
Q ss_pred ccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhc-----CCCCCcceeEEEecCC---e-EEEEE
Q 002358 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLVPLIGYCEEEH---Q-RILVY 684 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~g~~~~~~---~-~~lV~ 684 (931)
.+.||+|+||.||. +.+....+||++........+.+.+|+++++.+ .||||++++|++.++. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 46899999999996 443333479988654444567899999999999 5799999999998864 3 33789
Q ss_pred Ee--cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHh-HHhhhcCCCCeEecCCCCCCccccC----CCceEEecccc
Q 002358 685 EY--MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL-EYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGL 757 (931)
Q Consensus 685 E~--~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~ivH~DIkp~NILld~----~~~vkL~DFGl 757 (931)
|| +.+|+|.+++.. ..+++. ..++.|++.++ +|||+ .+|+||||||+|||++. +..++|+||+.
T Consensus 85 e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 667999999964 234444 35677888777 99998 99999999999999974 34799999554
Q ss_pred c
Q 002358 758 S 758 (931)
Q Consensus 758 a 758 (931)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-16 Score=190.14 Aligned_cols=250 Identities=23% Similarity=0.271 Sum_probs=177.5
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcC---CCCCcceeEEEecCCeEE
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~~~~ 681 (931)
++....+.+.+.||+|+||.||+|...+|+.||+|+-++....+ |.--.+++.+|+ -+-|..+.....-.+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 33444556678999999999999999999999999987765442 222233444444 233445545455566778
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc-------CCCceEEec
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-------INMRAKVSD 754 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld-------~~~~vkL~D 754 (931)
+|+||.+.|+|.+++. ..+..+|.-.+.+..|+++-+++||. .+||||||||+|+||. +...++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999998 56778999999999999999999998 9999999999999993 234589999
Q ss_pred cccccccc--ccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh
Q 002358 755 FGLSRQAE--EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 832 (931)
Q Consensus 755 FGla~~~~--~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 832 (931)
||.+-.+. .+.. .-...++|-.+-.+|...++.++..+|.|.++-+++-||.|+.-- ..
T Consensus 845 fG~siDm~lfp~~~-~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~~ 905 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGT-KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------VK 905 (974)
T ss_pred cccceeeeEcCCCc-EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------hc
Confidence 99876432 2221 223345788999999999999999999999999999999987421 11
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 833 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 833 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
.|.. ..++..+......+.. -++....|..+-..=|...+|...|++...
T Consensus 906 ~g~~-~~~~~~~~Ry~~~~~W---~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 906 NGSS-WMVKTNFPRYWKRDMW---NKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred CCcc-eeccccchhhhhHHHH---HHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 1111 1222222222222333 344445555555566777777777776654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.4e-16 Score=163.12 Aligned_cols=141 Identities=21% Similarity=0.244 Sum_probs=109.2
Q ss_pred HhhccccCccCcEEEEEEE--ECCCcEEEEEEccCccch------------------------hhhhHHHHHHHHHhcCC
Q 002358 611 NNFCKKIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSH------------------------RTQQFVTEVALLSRIHH 664 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~--~~~g~~vAvK~~~~~~~~------------------------~~~~~~~E~~il~~l~H 664 (931)
+.+.+.||+|++|.||+|. ..+|+.||+|+++..... ....+.+|++++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5567899999999999998 558999999998753210 01235689999999976
Q ss_pred CC--CcceeEEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCC-eEecCCCCCC
Q 002358 665 RN--LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSN 741 (931)
Q Consensus 665 pn--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-ivH~DIkp~N 741 (931)
.. +.+++++ ...++||||+++++|..... ............++.|++.++++||+ .+ ++||||||+|
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 33 3344432 23589999999988866542 22345556678899999999999998 88 9999999999
Q ss_pred ccccCCCceEEeccccccccc
Q 002358 742 ILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 742 ILld~~~~vkL~DFGla~~~~ 762 (931)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=159.28 Aligned_cols=134 Identities=25% Similarity=0.407 Sum_probs=113.6
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccc--------hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+.||+|++|.||+|.+ .|..+++|+...... .....+.+|++++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 578899998654321 1124578899999999999998888887777788999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++|++|.+.+... . . .+..++.+++.+|.++|+ .+++|||++|+|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~---~---~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN---G---M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc---c---H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988632 1 1 778899999999999998 8999999999999999 78899999998764
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=9.5e-15 Score=176.38 Aligned_cols=126 Identities=25% Similarity=0.445 Sum_probs=98.9
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCc-ccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSL-PNLQELH 490 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l-~~L~~l~ 490 (931)
++|+.|+|++|+|.|.+|+.+++|++|+.|+|++|+|+|.+| .+++|++|+.|+|++|+|+|.+|..++.+ .++..++
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 589999999999999999999999999999999999999999 49999999999999999999999998764 5778899
Q ss_pred ccccCCCCCCCcccccCceeeeecCCCCccccc-cccceeeeeeccchhhhhHHHHHhhhhhe
Q 002358 491 IENNSFVGEIPPALLTGKVIFKYDNNPKLHKES-RRRMRFKLILGTSIGVLAILLVLFLCSLI 552 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~~~~~l~~~~N~~~c~~~-~~~~~~~iiv~i~i~v~~vllll~~~~~~ 552 (931)
+.+|...+.+|.. ..|... .......++++++++++++++.++++...
T Consensus 522 ~~~N~~lc~~p~l--------------~~C~~~~~~~~~i~~~~~~~~~~l~~~~~~~~~~~~ 570 (623)
T PLN03150 522 FTDNAGLCGIPGL--------------RACGPHLSVGAKIGIAFGVSVAFLFLVICAMCWWKR 570 (623)
T ss_pred ecCCccccCCCCC--------------CCCcccCCCceEEEEEhHHHHHHHHHHHHHhhheee
Confidence 9999855445431 123222 23345666777776665555555444443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.8e-15 Score=155.53 Aligned_cols=137 Identities=20% Similarity=0.236 Sum_probs=108.7
Q ss_pred HhhccccCccCcEEEEEEEECCCcEEEEEEccCccch----------------------hhhhHHHHHHHHHhcCCC--C
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH----------------------RTQQFVTEVALLSRIHHR--N 666 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~----------------------~~~~~~~E~~il~~l~Hp--n 666 (931)
+.+.+.||+|+||.||++.+++|+.||||++...... ....+..|..++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5667899999999999999988999999987543210 112367789999999877 4
Q ss_pred CcceeEEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC
Q 002358 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 746 (931)
Q Consensus 667 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~ 746 (931)
+.+.++. ...++||||+++++|.+.... .....++.+++.++.++|+ .+++||||||+||++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 4444442 345899999999999765431 2345788999999999998 89999999999999999
Q ss_pred CCceEEecccccccccc
Q 002358 747 NMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 747 ~~~vkL~DFGla~~~~~ 763 (931)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.9e-15 Score=155.26 Aligned_cols=130 Identities=25% Similarity=0.418 Sum_probs=107.2
Q ss_pred ccCccCcEEEEEEEECCCcEEEEEEccCccc--------hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 616 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 616 ~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.||+|+||.||+|.+. |+.|++|+...... ....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999964 78899998653211 12356788999999999988766666666666779999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
+|++|.+.+... . ..++.+++++|.+||+ .+++|||++|+||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~---~-------~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG---N-------DELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc---H-------HHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999987632 1 0789999999999998 9999999999999999 88999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.5e-15 Score=158.16 Aligned_cols=197 Identities=21% Similarity=0.240 Sum_probs=134.7
Q ss_pred CCCCCcceeEEEec---------------------------CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHH
Q 002358 663 HHRNLVPLIGYCEE---------------------------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH 715 (931)
Q Consensus 663 ~HpnIv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~ 715 (931)
+|||||++.++|.+ ....|+||..++ .+|.+++.. ...+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 59999999887633 335788998875 478888763 3455666777899
Q ss_pred HHHHHhHHhhhcCCCCeEecCCCCCCccc--cCCCc--eEEecccccccccccc---cccc--cccccCCCccCCCccCC
Q 002358 716 DAAKGLEYLHTGCNPGIIHRDVKSSNILL--DINMR--AKVSDFGLSRQAEEDL---THIS--SVARGTVGYLDPEYYGN 786 (931)
Q Consensus 716 qia~aL~yLH~~~~~~ivH~DIkp~NILl--d~~~~--vkL~DFGla~~~~~~~---~~~~--~~~~gt~~y~APE~l~~ 786 (931)
|+++|+.|||+ ++|.|||+|++|||+ |+|+. +.|+|||++.-..... ...+ -..-|...-||||+...
T Consensus 349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999998 999999999999999 44443 6889999875422211 1111 11236678899999754
Q ss_pred CC------CCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHH
Q 002358 787 QQ------LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVA 860 (931)
Q Consensus 787 ~~------~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li 860 (931)
.. .-.|+|.|+.|-+.||+++...||.... ........ .++..+ |.+.. ..+-.+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~-----Yqe~qL-----Palp~----~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRT-----YQESQL-----PALPS----RVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhh-----hhhhhC-----CCCcc----cCChHHHHHH
Confidence 32 1358999999999999999999997311 11111111 111112 12222 2223577899
Q ss_pred HHccccCCCCCCCHHHHHHHHH
Q 002358 861 IQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 861 ~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
...++.||++|++..-....|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999876665554
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.3e-15 Score=175.90 Aligned_cols=132 Identities=24% Similarity=0.370 Sum_probs=109.0
Q ss_pred hccccCccCcEEEEEEEECCCcEEEEEE-ccCccc-------hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKI-MADSCS-------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~-~~~~~~-------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
..+.||+|+||.||+|.+.+.. +++|+ ...... ...+.+.+|+++++.++|++++....++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 4688999999999999887444 44433 222111 12356889999999999999998888887777789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
||+++++|.+.+. ....++.+++++|.+||+ .+++||||||+|||+ +++.++|+|||+++.
T Consensus 416 E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 416 EYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999875 346789999999999998 899999999999999 678999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.2e-15 Score=170.36 Aligned_cols=173 Identities=27% Similarity=0.377 Sum_probs=131.8
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
..++.|++|+..+|.+.+.+.......++...+.++.|++.|+.| ++.+|+|+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 467999999999999999877677778889999999999999999 57899999999999999999999999998
Q ss_pred ccccccc-----cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhh
Q 002358 759 RQAEEDL-----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 832 (931)
Q Consensus 759 ~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 832 (931)
....... ....+...||..||+||.+.+..|+.|+||||||++|+|++. =..++. ... ...-++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----r~~-----t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----RIA-----TLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----HHH-----hhhhhh
Confidence 7655443 222344569999999999999999999999999999999987 222221 000 011122
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 002358 833 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQE 876 (931)
Q Consensus 833 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 876 (931)
.+.+ +|....+++.+ ..++.+++...|.+||++.+
T Consensus 474 ~g~i----p~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGII----PPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCCC----ChHHhhcCcHH-----HHHHHHhcCCCcccCchHHH
Confidence 2222 22222233322 47889999999999994443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=135.43 Aligned_cols=134 Identities=22% Similarity=0.207 Sum_probs=113.8
Q ss_pred ccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCC--CCCcceeEEEecCCeEEEEEEecCCCC
Q 002358 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGT 691 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gs 691 (931)
.+.||+|.++.||++...+ +.+++|....... ...+.+|+.+++.++| .++.+++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999864 8899999865433 4678899999999976 589999998888888999999998876
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 692 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 692 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
+... +......++.+++++|+++|.....+++|||++|+||++++.+.+++.|||.+..
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6543 4456678899999999999974445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.3e-13 Score=141.46 Aligned_cols=137 Identities=23% Similarity=0.316 Sum_probs=98.8
Q ss_pred ccccCccCcEEEEEEEECCCcEEEEEEccCccch--hhhh----------------------HHHHHHHHHhcCCCC--C
Q 002358 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQ----------------------FVTEVALLSRIHHRN--L 667 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~--~~~~----------------------~~~E~~il~~l~Hpn--I 667 (931)
.+.||+|+||.||+|...+|+.||||+++..... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999998653221 1111 135666666665432 4
Q ss_pred cceeEEEecCCeEEEEEEecCCCCHHH-HhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC
Q 002358 668 VPLIGYCEEEHQRILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 746 (931)
Q Consensus 668 v~l~g~~~~~~~~~lV~E~~~~gsL~~-~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~ 746 (931)
.+.++. ...++||||++++.+.. .+... ... .....++.+++.++.++|+ ..+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 444443 23589999999954322 11110 011 4567899999999999996 37999999999999999
Q ss_pred CCceEEeccccccccc
Q 002358 747 NMRAKVSDFGLSRQAE 762 (931)
Q Consensus 747 ~~~vkL~DFGla~~~~ 762 (931)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2e-14 Score=170.60 Aligned_cols=207 Identities=25% Similarity=0.341 Sum_probs=138.4
Q ss_pred hhccccCccCcEEEEEEEECC-CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
+.++.+..|++|.||..+++. .+.+|+|+-++. -+.+- ++.....|.+| |
T Consensus 86 ~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv---------------------g 136 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV---------------------G 136 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee---------------------c
Confidence 346889999999999999884 577888543321 11111 22222233332 4
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc------
Q 002358 691 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED------ 764 (931)
Q Consensus 691 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~------ 764 (931)
+-...++ +-+.++... +.+++|||+ .+|+|||+||.|.+|..-|++|+.|||+++.....
T Consensus 137 Dc~tllk---~~g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 137 DCATLLK---NIGPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhhhhcc---cCCCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 4444444 233343322 778999997 99999999999999999999999999988752111
Q ss_pred --c------cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 765 --L------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 765 --~------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
. .......+||+.|+|||++....|+...|.|++|+++||.+.|+.||.++..++-. ...+...
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------g~visd~-- 274 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------GQVISDD-- 274 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------hhhhhhh--
Confidence 0 11123457999999999999999999999999999999999999999855432211 1111100
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ 875 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 875 (931)
....+.+...+.+..+++.+.|+.+|..|--..
T Consensus 275 ------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 275 ------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ------ccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 000111222223567888889999999987433
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.4e-13 Score=142.28 Aligned_cols=135 Identities=19% Similarity=0.246 Sum_probs=105.1
Q ss_pred ccccC-ccCcEEEEEEEECCCcEEEEEEccCcc-------------chhhhhHHHHHHHHHhcCCCCC--cceeEEEecC
Q 002358 614 CKKIG-KGSFGSVYYGKMKDGKEVAVKIMADSC-------------SHRTQQFVTEVALLSRIHHRNL--VPLIGYCEEE 677 (931)
Q Consensus 614 ~~~LG-~G~fG~Vy~a~~~~g~~vAvK~~~~~~-------------~~~~~~~~~E~~il~~l~HpnI--v~l~g~~~~~ 677 (931)
...|| .|+.|+||++... +..++||.+.... ......+.+|++++.+|+|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999886 7788998774311 1223567889999999998875 6777765432
Q ss_pred C----eEEEEEEecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEE
Q 002358 678 H----QRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 752 (931)
Q Consensus 678 ~----~~~lV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL 752 (931)
. ..++|+|++++ .+|.+++.. ..++.. .+.+++++|.+||+ .||+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 689988763 234432 36789999999998 99999999999999999999999
Q ss_pred eccccccc
Q 002358 753 SDFGLSRQ 760 (931)
Q Consensus 753 ~DFGla~~ 760 (931)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998865
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.8e-13 Score=142.35 Aligned_cols=201 Identities=25% Similarity=0.376 Sum_probs=142.7
Q ss_pred HHHHhcCCCCCcceeEEEecC-----CeEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCC
Q 002358 657 ALLSRIHHRNLVPLIGYCEEE-----HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730 (931)
Q Consensus 657 ~il~~l~HpnIv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~ 730 (931)
.-|-++-|-|||+++.|+.+. .+..++.|||+.|++.++|++.. +++.+......+|+.||..||.|||+ |.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 345556799999999988553 35789999999999999998654 56778888899999999999999997 789
Q ss_pred CeEecCCCCCCccccCCCceEEecccccccc---cccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh
Q 002358 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 807 (931)
Q Consensus 731 ~ivH~DIkp~NILld~~~~vkL~DFGla~~~---~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt 807 (931)
+|+|+++..+-|++..+|-+|+.---..... ............+-++|.+||.-.....+.++|||+||....||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999998888532111110 0011111222346789999999888888889999999999999988
Q ss_pred CCCCCCccCcc--chhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 808 GKKPVSVEDFG--AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 808 G~~Pf~~~~~~--~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+..--...... .+.++.. .+...-++ + =...+.+|++..|..||+|.+++.
T Consensus 278 lEiq~tnseS~~~~ee~ia~---------~i~~len~-l-----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIAN---------VIIGLENG-L-----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhhh---------heeeccCc-c-----------ccCcCcccccCCCCCCcchhhhhc
Confidence 76542211110 1011100 01011111 1 135677999999999999999863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.6e-14 Score=169.15 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=183.3
Q ss_pred HhhccccCccCcEEEEEEEECC--CcEEEEEEccCcc--chhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC--SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~--g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 685 (931)
+++.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++++++...+.+..+++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 4456779999999998887643 3456666654332 222334445777766676 9999999999999999999999
Q ss_pred ecCCCCHHHHh-ccCCCCCCCCHHHHHHHHHHHHHHhHHhh-hcCCCCeEecCCCCCCccccCCC-ceEEeccccccccc
Q 002358 686 YMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLH-TGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAE 762 (931)
Q Consensus 686 ~~~~gsL~~~L-~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~ 762 (931)
+..++++.+.+ +.. ....+.......+.|+..++.|+| . .++.|+||||+|.+++..+ ..+++|||++..+.
T Consensus 102 ~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cccccccccccccCC--ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999888 422 114455556678999999999999 6 8999999999999999999 99999999998765
Q ss_pred c--ccccccccccc-CCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeee
Q 002358 763 E--DLTHISSVARG-TVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 763 ~--~~~~~~~~~~g-t~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 838 (931)
. .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...... .....|.... +..
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~---~~~-- 250 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK---GRF-- 250 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc---ccc--
Confidence 5 22333344567 9999999998884 45678999999999999999999998444332 2222222211 000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002358 839 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878 (931)
Q Consensus 839 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 878 (931)
....... ......+++.+++..+|..|.+.+++.
T Consensus 251 --~~~~~~~----~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 251 --TQLPWNS----ISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred --ccCcccc----CChhhhhcccccccCCchhcccccccc
Confidence 0011111 112456788889999999999998875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.35 E-value=2e-12 Score=166.03 Aligned_cols=147 Identities=28% Similarity=0.521 Sum_probs=103.8
Q ss_pred cCCchhhHHHHHHHHhhcCCC--CCCCCCC-CCCCCCCCceEEeeCCCCCcEEEEEeCCCCCcccCCccccCccccceec
Q 002358 367 AKTEWQDVMVLEALRSISDES--ERTNDRG-DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELW 443 (931)
Q Consensus 367 ~~t~~~d~~~L~~l~~~~~~~--~~~~w~~-dpc~~~~w~~v~c~~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~ 443 (931)
.-+.++|..+|.++|+.+.++ ...+|+. +.|| .|.|++|+.. .+|+.|+|++|+++|.+|+.|..|++|+.|+
T Consensus 24 ~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~--~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~ 99 (968)
T PLN00113 24 SMLHAEELELLLSFKSSINDPLKYLSNWNSSADVC--LWQGITCNNS--SRVVSIDLSGKNISGKISSAIFRLPYIQTIN 99 (968)
T ss_pred cCCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC--cCcceecCCC--CcEEEEEecCCCccccCChHHhCCCCCCEEE
Confidence 445778999999999988532 3457853 4443 6999999753 4899999999999999998899999999999
Q ss_pred ccCCcCCCCCCC--ccccccccEeecCCccccC----------------------CCCCccCCccccccccccccCCCCC
Q 002358 444 LDGNFLTGPLPD--MSRLIDLRIVHLENNELTG----------------------SLPSYMGSLPNLQELHIENNSFVGE 499 (931)
Q Consensus 444 Ls~N~l~g~~p~--~~~l~~L~~L~L~~N~l~g----------------------~iP~~l~~l~~L~~l~l~~N~l~g~ 499 (931)
|++|+++|.+|. +.++++|++|+|++|+++| .+|..+++|++|+.|+|++|.+.+.
T Consensus 100 Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~ 179 (968)
T PLN00113 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179 (968)
T ss_pred CCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccccc
Confidence 999999888873 4466666666666666655 4555555566666666666666655
Q ss_pred CCccccc--CceeeeecCCC
Q 002358 500 IPPALLT--GKVIFKYDNNP 517 (931)
Q Consensus 500 iP~~~~~--~~~~l~~~~N~ 517 (931)
+|..+.. .+..+.+++|.
T Consensus 180 ~p~~~~~l~~L~~L~L~~n~ 199 (968)
T PLN00113 180 IPNSLTNLTSLEFLTLASNQ 199 (968)
T ss_pred CChhhhhCcCCCeeeccCCC
Confidence 6655433 44555555554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.8e-12 Score=148.39 Aligned_cols=141 Identities=24% Similarity=0.301 Sum_probs=101.0
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccchhh----------------------------------------hhHHH
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT----------------------------------------QQFVT 654 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~----------------------------------------~~~~~ 654 (931)
+.||.|++|.||+|++++|+.||||+.++...... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 46999999999999999999999999876421110 12555
Q ss_pred HHHHHHhcC----CCCCcceeEEE-ecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHH-HhHHhhhcC
Q 002358 655 EVALLSRIH----HRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-GLEYLHTGC 728 (931)
Q Consensus 655 E~~il~~l~----HpnIv~l~g~~-~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~-aL~yLH~~~ 728 (931)
|++.+.+++ |.+-+.+-..+ ......++||||++|++|.+...... ... .+.+++.++++ .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~ql~~-- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLNQVLR-- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHHHHHh--
Confidence 666666653 32223332233 22445799999999999988764321 112 23456666666 4678887
Q ss_pred CCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 729 ~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
.|++|+|+||.||++++++.++++|||++....+
T Consensus 276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8999999999999999999999999999977643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.1e-10 Score=117.57 Aligned_cols=129 Identities=18% Similarity=0.180 Sum_probs=96.0
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCc-ceeEEEecCCeEEEEEEecCCCCHH
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-PLIGYCEEEHQRILVYEYMHNGTLR 693 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~g~~~~~~~~~lV~E~~~~gsL~ 693 (931)
+.|+.|.++.||+++.. ++.+++|+...... ....+.+|+++++.+.+.+++ +++.+.. ...++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 57899999999999876 78899998765432 233567899999999765554 4444432 3457999999998775
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcC--CCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 694 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 694 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
+. . .....++.+++++|+.||+.. ...++|||++|.||+++ ++.++++|||.+.
T Consensus 80 ~~-~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TE-D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc-c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 43 0 011345679999999999721 12369999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.11 E-value=2e-10 Score=134.60 Aligned_cols=141 Identities=20% Similarity=0.287 Sum_probs=92.2
Q ss_pred cccCccCcEEEEEEEECC-CcEEEEEEccCccchh----------------------------------h------hhHH
Q 002358 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR----------------------------------T------QQFV 653 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~----------------------------------~------~~~~ 653 (931)
+.||.|++|.||+|++++ |+.||||+.++..... . -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 9999999997542110 0 1244
Q ss_pred HHHHHHHhcC----CCCCcceeEEEec-CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHH-hHHhhhc
Q 002358 654 TEVALLSRIH----HRNLVPLIGYCEE-EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG-LEYLHTG 727 (931)
Q Consensus 654 ~E~~il~~l~----HpnIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~a-L~yLH~~ 727 (931)
+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.+.-.-. ....+.. .++...++. +..++.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~--~~g~d~~---~la~~~v~~~~~Qif~- 278 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR--AAGTDMK---LLAERGVEVFFTQVFR- 278 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH--hcCCCHH---HHHHHHHHHHHHHHHh-
Confidence 5555555553 3344443343332 45678999999999998742111 1112211 122222211 122233
Q ss_pred CCCCeEecCCCCCCccccCCC----ceEEecccccccccc
Q 002358 728 CNPGIIHRDVKSSNILLDINM----RAKVSDFGLSRQAEE 763 (931)
Q Consensus 728 ~~~~ivH~DIkp~NILld~~~----~vkL~DFGla~~~~~ 763 (931)
.|++|+|+||.||+++.++ ++++.|||++....+
T Consensus 279 --~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 279 --DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 7999999999999999888 999999999887644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.8e-09 Score=124.60 Aligned_cols=169 Identities=20% Similarity=0.199 Sum_probs=125.9
Q ss_pred ECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHH
Q 002358 630 MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 709 (931)
Q Consensus 630 ~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~ 709 (931)
..++.+|.|+..+...........+-++.|+.++||||++++...+.++..|+|+|.+. .|...+... ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHHH
Confidence 34688898888765544444567778889999999999999999999999999999884 566666532 2345
Q ss_pred HHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccccccccCCCccCCCccCCCCC
Q 002358 710 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 789 (931)
Q Consensus 710 ~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 789 (931)
....+.||+.||.|||. +.+++|++|.-..|+++..|..||++|.++........ ......---.|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 55678999999999997 58999999999999999999999999988764322111 001111112456666543322
Q ss_pred CccchhHHHHHHHHHHHhCCCC
Q 002358 790 TEKSDVYSFGVVLLELISGKKP 811 (931)
Q Consensus 790 s~ksDVwSlGvlL~eLltG~~P 811 (931)
-..|.|-||++++|++.|..+
T Consensus 182 -~s~D~~~Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGSLL 202 (690)
T ss_pred -cchhhhhHHHHHHHHhCcccC
Confidence 356999999999999999433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.6e-10 Score=132.17 Aligned_cols=253 Identities=23% Similarity=0.242 Sum_probs=180.2
Q ss_pred hhHHHHHHhhccccCc--cCcEEEEEEEE--C-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcC-CCCCcceeEEEe
Q 002358 604 PELEEATNNFCKKIGK--GSFGSVYYGKM--K-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIH-HRNLVPLIGYCE 675 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~--G~fG~Vy~a~~--~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~-HpnIv~l~g~~~ 675 (931)
.+.......+.+.+|. |.+|.||.+.. . ++..+|+|.-+.... .....=.+|+...++++ |+|.++....+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3455566667889999 99999999987 3 688899998443322 23333456777777774 999999888899
Q ss_pred cCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHH----HhHHhhhcCCCCeEecCCCCCCccccCC-Cce
Q 002358 676 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK----GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRA 750 (931)
Q Consensus 676 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~ivH~DIkp~NILld~~-~~v 750 (931)
..+..++-+|.+. .+|.++.+.. ...++.........+..+ ||.++|. .+++|-|+||.||++..+ ...
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheeccccccee
Confidence 9999999999984 7888877642 233566667777777777 9999998 899999999999999999 889
Q ss_pred EEecccccccccccccc----cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002358 751 KVSDFGLSRQAEEDLTH----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 826 (931)
Q Consensus 751 kL~DFGla~~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~ 826 (931)
+++|||+...+.+..-. ......|...|++||...+ .++.++|+|++|.+..+-.++..+....... .|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W 335 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------SW 335 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc
Confidence 99999999877654321 1222257888999998766 5688999999999999998887665422111 11
Q ss_pred HHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 827 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 827 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. ++.+- +-+ ++-...-..+...+..+++.+|..|++.+++..
T Consensus 336 ~~--~r~~~---ip~-----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 SQ--LRQGY---IPL-----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cc--ccccc---Cch-----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00 00000 001 110011123445888999999999998887753
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.6e-11 Score=134.96 Aligned_cols=175 Identities=22% Similarity=0.311 Sum_probs=144.0
Q ss_pred eeEEEEEEeecCCCccccchhhhhhhheeecccCCchhhHHHHHHHHhhcCCCCCCCCCC--CCCCCCCCceEEeeCCCC
Q 002358 335 NFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRG--DPCVPVPWEWVTCSTTTP 412 (931)
Q Consensus 335 ~~~~~~~~~~~~~s~l~p~ina~e~~~~~~~~~~t~~~d~~~L~~l~~~~~~~~~~~w~~--dpc~~~~w~~v~c~~~~~ 412 (931)
-.++.++-+....+.+||-|..+.++.-+.++....+.-.++|..+......+...|--. .-|. ..|
T Consensus 199 L~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~-~~W---------- 267 (1255)
T KOG0444|consen 199 LSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTE-GEW---------- 267 (1255)
T ss_pred hhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccH-HHH----------
Confidence 345556666777889999999999999999999999998899988876654332222211 1121 112
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCC--CCCCCccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~--g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.+|.+|+||+|+|+ .+|..+.+|++|+.|++.+|+|+ |++..+++|.+|+++.+++|+|. .+|+++..|.+|+.|.
T Consensus 268 ~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~ 345 (1255)
T KOG0444|consen 268 ENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLK 345 (1255)
T ss_pred hhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhc
Confidence 38999999999999 99999999999999999999985 55557999999999999999999 9999999999999999
Q ss_pred ccccCCCCCCCccc--ccCceeeeecCCCCccccc
Q 002358 491 IENNSFVGEIPPAL--LTGKVIFKYDNNPKLHKES 523 (931)
Q Consensus 491 l~~N~l~g~iP~~~--~~~~~~l~~~~N~~~c~~~ 523 (931)
|++|+|- ++|+.+ +..+..+.+..||.+-..+
T Consensus 346 L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 346 LDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred cccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 9999999 999975 5688889999999886433
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.4e-11 Score=115.85 Aligned_cols=104 Identities=27% Similarity=0.423 Sum_probs=89.9
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
..+++.|-||+|.|+ .+|+.|+.|.+|+.|+|++|+|+..+++++.|++|+.|+++-|+|. .+|..||.+|.|+.|||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 357899999999999 9999999999999999999999999999999999999999999999 99999999999999999
Q ss_pred cccCCC-CCCCccccc--CceeeeecCCC
Q 002358 492 ENNSFV-GEIPPALLT--GKVIFKYDNNP 517 (931)
Q Consensus 492 ~~N~l~-g~iP~~~~~--~~~~l~~~~N~ 517 (931)
.+|+++ ..+|-.++. .+..+.+..|.
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dnd 138 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDND 138 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCC
Confidence 999987 235655543 33334444443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.2e-11 Score=116.02 Aligned_cols=165 Identities=25% Similarity=0.416 Sum_probs=130.6
Q ss_pred EEeecCCCccccchhhhhhhheeeccc---CCchhhHHHHHHHHhhcCCCCCCCCCCCCCCCCCCceEEeeCCCCCcEEE
Q 002358 341 SFVKTRDSTLGPLLNAIEISKYQKIAA---KTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITK 417 (931)
Q Consensus 341 ~~~~~~~s~l~p~ina~e~~~~~~~~~---~t~~~d~~~L~~l~~~~~~~~~~~w~~dpc~~~~w~~v~c~~~~~~~l~~ 417 (931)
++....-+.+||-|..+.+++++.+.. ...+.....|..++..-..-++.+- -| .|. +..|.++.
T Consensus 39 tLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~--lp------rgf----gs~p~lev 106 (264)
T KOG0617|consen 39 TLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNI--LP------RGF----GSFPALEV 106 (264)
T ss_pred hcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhc--Cc------ccc----CCCchhhh
Confidence 344666778899999999998888764 3556667777776643321111111 11 121 23468999
Q ss_pred EEeCCCCCcc-cCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccccccCC
Q 002358 418 IALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 496 (931)
Q Consensus 418 L~L~~n~l~g-~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l 496 (931)
|||+.|+|.. .+|..|..++.|+-|+|+.|.+.-.+|++++|++|+.|.|..|.|- ++|.+++.|..|++|.+.+|++
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 9999999974 5899999999999999999999999999999999999999999999 9999999999999999999999
Q ss_pred CCCCCccccc-----CceeeeecCCCCc
Q 002358 497 VGEIPPALLT-----GKVIFKYDNNPKL 519 (931)
Q Consensus 497 ~g~iP~~~~~-----~~~~l~~~~N~~~ 519 (931)
+ .+|+++.. ....+....|||.
T Consensus 186 ~-vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 186 T-VLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred e-ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 9 99998865 4445667889886
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.4e-09 Score=107.76 Aligned_cols=136 Identities=15% Similarity=0.181 Sum_probs=98.3
Q ss_pred cccCccCcEEEEEEEECC-------CcEEEEEEccCccc----------------------hhhhhH----HHHHHHHHh
Q 002358 615 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSCS----------------------HRTQQF----VTEVALLSR 661 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~-------g~~vAvK~~~~~~~----------------------~~~~~~----~~E~~il~~ 661 (931)
..||.|--+.||.|.-.+ +..+|||+.+.... ...+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 47999998653210 011223 379999999
Q ss_pred cCC--CCCcceeEEEecCCeEEEEEEecCCCCHHH-HhccCCCCCCCCHHHHHHHHHHHHHHhHHh-hhcCCCCeEecCC
Q 002358 662 IHH--RNLVPLIGYCEEEHQRILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDV 737 (931)
Q Consensus 662 l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~L~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~ivH~DI 737 (931)
+.. -++..++++ ...++||||+.++.+.. .++ ...++......+..+++.+|..| |+ .+++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 953 455666654 45689999997654422 222 12344455677889999999999 76 89999999
Q ss_pred CCCCccccCCCceEEeccccccccc
Q 002358 738 KSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 738 kp~NILld~~~~vkL~DFGla~~~~ 762 (931)
++.||+++ ++.++|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.1e-09 Score=110.66 Aligned_cols=142 Identities=21% Similarity=0.319 Sum_probs=110.1
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCC--CCCcceeEEEecCC---eEEEEEEecC
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEH---QRILVYEYMH 688 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~---~~~lV~E~~~ 688 (931)
+.|+.|..+.+|+++..+|+.+++|+...... .....+..|+++++.+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999988778999999765332 134578899999999975 34577787776542 5689999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc-----------------------------------------
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG----------------------------------------- 727 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~----------------------------------------- 727 (931)
|.++.+.+.. ..++...+..++.+++++|..||+.
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888765431 3466677778888888888888852
Q ss_pred ------------CCCCeEecCCCCCCccccC--CCceEEeccccccc
Q 002358 728 ------------CNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQ 760 (931)
Q Consensus 728 ------------~~~~ivH~DIkp~NILld~--~~~vkL~DFGla~~ 760 (931)
....++|||+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1356799999999999998 66789999997754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.8e-08 Score=99.86 Aligned_cols=131 Identities=25% Similarity=0.389 Sum_probs=101.9
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEcc-Cccch-------hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~-~~~~~-------~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
..+++|+-+.+|.+.+. |.++++|.-. +.-.. ....-.+|++++.+++--.|.-..=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999886 4446666532 21111 224567899999999766666666677777788999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++|..|.+.+... ...++..+=.-+.-||. .+|+||||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888743 24567777888889997 9999999999999998765 99999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2e-09 Score=123.33 Aligned_cols=242 Identities=21% Similarity=0.220 Sum_probs=169.5
Q ss_pred hccccCccCcEEEEEEEEC--CCcEEEEEEccCccchhhh--hHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEec
Q 002358 613 FCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQ--QFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~~~~~~~~~~~--~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.+..||.|.|+.|+....+ ++..+++|.+.+....... .-..|+.+...+ .|.+++.....+......++=.|||
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 3578999999999988644 5788999988765433222 234566666666 4888888877777777778999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC-CceEEeccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~-~~vkL~DFGla~~~~~~~~ 766 (931)
+++++...+. -...++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||++..+.-.
T Consensus 349 ~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-- 420 (524)
T KOG0601|consen 349 EGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-- 420 (524)
T ss_pred cCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccccee--
Confidence 9998876652 23346677788999999999999998 999999999999999876 77899999988642111
Q ss_pred ccccccccCCCcc--CCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 767 HISSVARGTVGYL--DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 767 ~~~~~~~gt~~y~--APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
........++. +++......+..+.|++|||..+.|.+++..--. +..+|. .++.+....
T Consensus 421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~--------~~~~~~--~i~~~~~p~------ 482 (524)
T KOG0601|consen 421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE--------SGVQSL--TIRSGDTPN------ 482 (524)
T ss_pred --cccccccccccccchhhccccccccccccccccccccccccCcccCc--------ccccce--eeecccccC------
Confidence 11111233344 5556666788899999999999999998874332 111111 111121111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
.+..- ..+..+...+...++..||.+.++....+..
T Consensus 483 ---~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 483 ---LPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---CCchH-HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 11111 4566778888999999999999887655443
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.83 E-value=8.6e-10 Score=124.14 Aligned_cols=163 Identities=17% Similarity=0.250 Sum_probs=86.5
Q ss_pred ecCCCccccchhhhhhhheeecccCCchhhHHHHHHHHhhcCCCCCCCCCCCCCCCCCCceEEeeCCCCCcEEEEEeCCC
Q 002358 344 KTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGK 423 (931)
Q Consensus 344 ~~~~s~l~p~ina~e~~~~~~~~~~t~~~d~~~L~~l~~~~~~~~~~~w~~dpc~~~~w~~v~c~~~~~~~l~~L~L~~n 423 (931)
.-.+|.+||-|-.++-+.++.++.....+-..-|+.-|.++..+..-|.... .|.+ -+.....|-.||||+|
T Consensus 89 ~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~Iet--IPn~------lfinLtDLLfLDLS~N 160 (1255)
T KOG0444|consen 89 NLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIET--IPNS------LFINLTDLLFLDLSNN 160 (1255)
T ss_pred ccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCcccc--CCch------HHHhhHhHhhhccccc
Confidence 3456788999999999999999876555555556665555432211111100 0000 0112335677888888
Q ss_pred CCcccCCccccCccccceecccCCcCCCCC-CCccccccccEeecCCcccc-CCCCCccCCccccccccccccCCCCCCC
Q 002358 424 NLKGEIPPELKNMEALTELWLDGNFLTGPL-PDMSRLIDLRIVHLENNELT-GSLPSYMGSLPNLQELHIENNSFVGEIP 501 (931)
Q Consensus 424 ~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~-p~~~~l~~L~~L~L~~N~l~-g~iP~~l~~l~~L~~l~l~~N~l~g~iP 501 (931)
.|. .+|+.+.+|..|+.|.||+|.|.-.- -.+..|++|++|++++.+-+ ..||.+|..|.+|..+|||.|+|. .+|
T Consensus 161 rLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vP 238 (1255)
T KOG0444|consen 161 RLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVP 238 (1255)
T ss_pred hhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cch
Confidence 887 78888888888888888888764211 11222233333333332211 134444444444555555555544 444
Q ss_pred ccccc--CceeeeecCC
Q 002358 502 PALLT--GKVIFKYDNN 516 (931)
Q Consensus 502 ~~~~~--~~~~l~~~~N 516 (931)
+.+.+ ++..+++++|
T Consensus 239 ecly~l~~LrrLNLS~N 255 (1255)
T KOG0444|consen 239 ECLYKLRNLRRLNLSGN 255 (1255)
T ss_pred HHHhhhhhhheeccCcC
Confidence 44433 3333444444
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.9e-08 Score=96.23 Aligned_cols=142 Identities=21% Similarity=0.263 Sum_probs=105.0
Q ss_pred ccccCccCcEEEEEEEECCCcEEEEEEc-cCccch-------hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIM-ADSCSH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~-~~~~~~-------~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
...+-+|+-+.|+++.+. |+..+||.- .+.-.+ ..++..+|+++|.+++--.|.-..-++.+...-.++||
T Consensus 12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 367889999999999998 777777653 222111 23567889999999876566555556767777789999
Q ss_pred ecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc---eEEeccccccc
Q 002358 686 YMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQ 760 (931)
Q Consensus 686 ~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~---vkL~DFGla~~ 760 (931)
|+++ -++.+++....... ........++.+|-+.+.-||. ..|+||||..+||++..++. +.+.|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9976 36777776543222 2223336788999999999997 89999999999999965543 58999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.7e-07 Score=99.83 Aligned_cols=140 Identities=16% Similarity=0.160 Sum_probs=100.2
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccch-hh----------hhHHHHHHHHHhcCCCC--CcceeEEEec-----
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RT----------QQFVTEVALLSRIHHRN--LVPLIGYCEE----- 676 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~-~~----------~~~~~E~~il~~l~Hpn--Iv~l~g~~~~----- 676 (931)
+.+-+-....|.+.++. |+.+.||........ .. ..+.+|...+.++...+ ...++++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 33443444456677764 789999976432211 11 14789999998885333 3455666543
Q ss_pred CCeEEEEEEecCCC-CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC-------CC
Q 002358 677 EHQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------NM 748 (931)
Q Consensus 677 ~~~~~lV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~-------~~ 748 (931)
....++|+|++++- +|.+++.... ....+......++.++++.++-||. .||+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCc
Confidence 23578999999886 8998875321 2344556677899999999999998 99999999999999975 46
Q ss_pred ceEEecccccc
Q 002358 749 RAKVSDFGLSR 759 (931)
Q Consensus 749 ~vkL~DFGla~ 759 (931)
.+.++||+.+.
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 79999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.5e-07 Score=94.48 Aligned_cols=126 Identities=25% Similarity=0.318 Sum_probs=82.3
Q ss_pred EEEEEEECCCcEEEEEEccCccch--------------------------hhhhHHHHHHHHHhcCCC--CCcceeEEEe
Q 002358 624 SVYYGKMKDGKEVAVKIMADSCSH--------------------------RTQQFVTEVALLSRIHHR--NLVPLIGYCE 675 (931)
Q Consensus 624 ~Vy~a~~~~g~~vAvK~~~~~~~~--------------------------~~~~~~~E~~il~~l~Hp--nIv~l~g~~~ 675 (931)
.||.|...+|..+|||+.+..... ......+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999999999999986532100 112467899999999765 455665442
Q ss_pred cCCeEEEEEEecC--CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHH-hhhcCCCCeEecCCCCCCccccCCCceEE
Q 002358 676 EEHQRILVYEYMH--NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY-LHTGCNPGIIHRDVKSSNILLDINMRAKV 752 (931)
Q Consensus 676 ~~~~~~lV~E~~~--~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~y-LH~~~~~~ivH~DIkp~NILld~~~~vkL 752 (931)
..++||||++ |..+..+... .++......++.++++.+.. +|. .+++|||+.+.||+++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence 3479999998 5555443321 11123455677888886666 465 899999999999999988 9999
Q ss_pred eccccccccc
Q 002358 753 SDFGLSRQAE 762 (931)
Q Consensus 753 ~DFGla~~~~ 762 (931)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.4e-06 Score=97.98 Aligned_cols=169 Identities=21% Similarity=0.305 Sum_probs=128.4
Q ss_pred cEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEe----cCCeEEEEEEecCC-CCHHHH
Q 002358 622 FGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE----EEHQRILVYEYMHN-GTLRDR 695 (931)
Q Consensus 622 fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~ 695 (931)
-.+.|++... ||..+++|+++............-+++++++.|+|+|++..++. .+..+++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578999765 89999999996544333333445688999999999999998875 34568899999986 577765
Q ss_pred hccCC------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 696 LHGSV------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 696 L~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
--... .....++..++.++.|+..||.++|+ .|+.-+-|.+++|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 43211 23346778899999999999999998 8999999999999999999999998887655433
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~P 811 (931)
+.. |.+.+ -.+-|.=.||.+++.|.||..-
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 220 11111 1256899999999999999654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-08 Score=110.69 Aligned_cols=136 Identities=21% Similarity=0.221 Sum_probs=98.1
Q ss_pred CchhhHHHHHHHHhhcCC-CCCCCCCCCCCCCCCCceEEeeCCCCCcEEEEEeCCCCCcccCCccccCccccceecccCC
Q 002358 369 TEWQDVMVLEALRSISDE-SERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGN 447 (931)
Q Consensus 369 t~~~d~~~L~~l~~~~~~-~~~~~w~~dpc~~~~w~~v~c~~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N 447 (931)
+.|.+...|.++...+.. ....+|-+. .-+..++++.|+|++|-|. .+|.+++.+..||.|+||+|
T Consensus 402 elPk~L~~lkelvT~l~lsnn~isfv~~------------~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~N 468 (565)
T KOG0472|consen 402 ELPKRLVELKELVTDLVLSNNKISFVPL------------ELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFN 468 (565)
T ss_pred hhhhhhHHHHHHHHHHHhhcCccccchH------------HHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccc
Confidence 566666666666655432 234444331 1123468999999999998 99999999999999999999
Q ss_pred cCCCCCCCccccccccEeecCCccccCCCCCc-cCCccccccccccccCCCCCCCccccc--CceeeeecCCCCc
Q 002358 448 FLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (931)
Q Consensus 448 ~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~-l~~l~~L~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~ 519 (931)
+|.-.+.-+..+..|+.+-.++|++. .+|.+ +++|.+|..|||.+|.+. .||+.+++ ++..+.++|||..
T Consensus 469 rFr~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 469 RFRMLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccccchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 88765445566666777777777777 55554 777888888888888887 78877765 6677777888764
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.6e-08 Score=100.12 Aligned_cols=100 Identities=27% Similarity=0.445 Sum_probs=39.9
Q ss_pred cEEEEEeCCCCCcccCCcccc-CccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCcc-CCccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHI 491 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~-~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l-~~l~~L~~l~l 491 (931)
++++|+|.+|+|+ .|. .++ .|++|+.|+|++|+|+.. +.+..|++|+.|+|++|+++ .+++.+ ..|++|+.|+|
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYL 95 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEEC
Confidence 7899999999998 564 576 689999999999999974 67889999999999999999 777655 46999999999
Q ss_pred cccCCCCCCCcc----cccCceeeeecCCCC
Q 002358 492 ENNSFVGEIPPA----LLTGKVIFKYDNNPK 518 (931)
Q Consensus 492 ~~N~l~g~iP~~----~~~~~~~l~~~~N~~ 518 (931)
++|++. .+-+- -++.+..+.+.+||.
T Consensus 96 ~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 96 SNNKIS-DLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp TTS----SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred cCCcCC-ChHHhHHHHcCCCcceeeccCCcc
Confidence 999998 55431 134778889999986
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.55 E-value=9.9e-09 Score=111.03 Aligned_cols=103 Identities=21% Similarity=0.347 Sum_probs=80.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++.-|+|.+|.|. .+| +|..+..|.+|+++.|+|+-.+.+ ..+|.+|.+|||-.|++. +.|+++.-|.+|..||+
T Consensus 206 ~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDl 282 (565)
T KOG0472|consen 206 ESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDL 282 (565)
T ss_pred hhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcc
Confidence 45666677777776 666 677777777777777777665555 448888999999999999 89999999999999999
Q ss_pred cccCCCCCCCccccc-CceeeeecCCCCc
Q 002358 492 ENNSFVGEIPPALLT-GKVIFKYDNNPKL 519 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~-~~~~l~~~~N~~~ 519 (931)
++|.++ .+|.++++ .+..+.+.|||..
T Consensus 283 SNN~is-~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 283 SNNDIS-SLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred cCCccc-cCCcccccceeeehhhcCCchH
Confidence 999998 78888877 5566777888854
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.2e-08 Score=81.77 Aligned_cols=58 Identities=40% Similarity=0.512 Sum_probs=29.3
Q ss_pred ccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccccccccC
Q 002358 438 ALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 495 (931)
Q Consensus 438 ~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~ 495 (931)
+|+.|+|++|+|+...+ .|.++++|+.|+|++|+++..-|+.|.+|++|+.|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555554444 24555555555555555553333345555555555555554
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.3e-06 Score=93.84 Aligned_cols=263 Identities=16% Similarity=0.156 Sum_probs=156.7
Q ss_pred ccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEE----E---ecCCeEEEEEE
Q 002358 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY----C---EEEHQRILVYE 685 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~----~---~~~~~~~lV~E 685 (931)
.+.||+|+-+.+|-.-. -...+.|+.+........+. ++.|.+. .||-+-.-+.+ . ..+...-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 57899999999995421 12234566654433222222 2233333 45533221111 1 11223567888
Q ss_pred ecCCC-CHHHHhccC---CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 686 YMHNG-TLRDRLHGS---VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 686 ~~~~g-sL~~~L~~~---~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
.+++. ....++... +......|.-.++.++.+|.+.+-||. .|.+-||+.++|+|+++++.+.|.|=..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 77664 233333221 233457899999999999999999997 89999999999999999999999875432222
Q ss_pred cccccccccccccCCCccCCCccC-----CCCCCccchhHHHHHHHHHHHhC-CCCCCccCcc-chhhHHHHHHHhhhcC
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFG-AELNIVHWARSMIKKG 834 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG-~~Pf~~~~~~-~~~~l~~~~~~~~~~~ 834 (931)
.....+ ....|...|.+||.-. +..-+...|-|.+||++++++.| +.||.+-... +..+-.+ ..+..+
T Consensus 168 ~ng~~~--~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~g 242 (637)
T COG4248 168 ANGTLH--LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAHG 242 (637)
T ss_pred cCCceE--ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhcc
Confidence 222221 1234788999999753 33456789999999999999886 9999854332 1111111 011122
Q ss_pred Ceeeccccccc-----CCCCH-HHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHhhhhhhc
Q 002358 835 DVISIVDPVLI-----GNVKI-ESIWRIAEVAIQCVEQR--GFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 835 ~~~~i~d~~l~-----~~~~~-~~~~~l~~li~~Cl~~d--P~~RPs~~evl~~L~~~~~~~~ 889 (931)
.+....|.... ...+- ..+-.+..+..+|+... +.-||+++.++..|.++....+
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 22222221110 01111 11124566777888654 5689999999998876655443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.50 E-value=6.6e-08 Score=79.89 Aligned_cols=60 Identities=35% Similarity=0.482 Sum_probs=54.6
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNEL 472 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l 472 (931)
|+|+.|+|++|+|+..-+..|.++++|+.|+|++|+|+...| .|.+|++|+.|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 479999999999995555688999999999999999999888 599999999999999986
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=4e-08 Score=118.06 Aligned_cols=242 Identities=19% Similarity=0.214 Sum_probs=156.2
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCc---cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
.+-+-.|.++.+..+.-. .|...+.|+.... ...+.+...++-.++-..+||-++...--+.-.....|+++|..+
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 456788999988877543 2434444433221 111222233333333333456555544444445677899999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc------
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE------ 763 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~------ 763 (931)
++|...|+. ....+..........+.+++++||. ..+.|+|++|.|.++..++..++.|||......-
T Consensus 889 ~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 889 GDLPSKLHN---SGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred CCchhhhhc---CCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 999999984 3345544555666778899999997 6689999999999999999999999983322100
Q ss_pred ---------------c---------ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccc
Q 002358 764 ---------------D---------LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 819 (931)
Q Consensus 764 ---------------~---------~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~ 819 (931)
. .........||+.|.+||.+.+......+|.|+.|+.++|.++|..||..+....
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 0 0011223458999999999999999999999999999999999999997433321
Q ss_pred hhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 002358 820 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ 875 (931)
Q Consensus 820 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 875 (931)
.. +.+..+++ .. ...+.+......+++.+.+..+|.+|-.+.
T Consensus 1043 ~f-------~ni~~~~~---~~----p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 IF-------ENILNRDI---PW----PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hh-------hccccCCC---CC----CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 11 11111111 01 111222222445677778888998888776
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=5.7e-08 Score=115.07 Aligned_cols=104 Identities=29% Similarity=0.422 Sum_probs=93.6
Q ss_pred CcEEEEEeCCCCCcccCCcc-ccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~-~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.+|+.|+|++|.|. ++|.+ +.+|..|++|+||+|+|+..+-.+.++..|++|...+|+|. .+| ++.+++.|+.+||
T Consensus 383 ~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDl 459 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDL 459 (1081)
T ss_pred cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEec
Confidence 58999999999998 88864 89999999999999999998878999999999999999999 999 8999999999999
Q ss_pred cccCCC-CCCCcccc-cCceeeeecCCCCc
Q 002358 492 ENNSFV-GEIPPALL-TGKVIFKYDNNPKL 519 (931)
Q Consensus 492 ~~N~l~-g~iP~~~~-~~~~~l~~~~N~~~ 519 (931)
+.|+|+ +.+|..+- +.++.+.+.||+++
T Consensus 460 S~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 460 SCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred ccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 999997 44566665 57888999999965
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.3e-06 Score=91.69 Aligned_cols=135 Identities=23% Similarity=0.242 Sum_probs=95.9
Q ss_pred HhhccccCccCcEEEEEEEECCCcEEEEEEccCccc----------------------hhhhhHHHHHHHHHhcCCC--C
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----------------------HRTQQFVTEVALLSRIHHR--N 666 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~----------------------~~~~~~~~E~~il~~l~Hp--n 666 (931)
+.++..||.|--+.||.|...+|.++|||.=+.... .......+|.++|++|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345788999999999999999999999996322100 0123467899999999644 6
Q ss_pred CcceeEEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC
Q 002358 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 746 (931)
Q Consensus 667 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~ 746 (931)
+.+.+++ +...+|||+++|-.|...- ++......++..|++-+..+-. .|++|||+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence 6666643 4568999999986665431 1122233344444444444444 79999999999999999
Q ss_pred CCceEEeccccccc
Q 002358 747 NMRAKVSDFGLSRQ 760 (931)
Q Consensus 747 ~~~vkL~DFGla~~ 760 (931)
+|.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999965543
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.39 E-value=7.5e-07 Score=90.17 Aligned_cols=135 Identities=21% Similarity=0.425 Sum_probs=75.8
Q ss_pred EEEecCCCCCccCCCCCeEEecCCccccCCcee--e-------ecC----C-CCCcccccccccccCCCccceEEeeecC
Q 002358 26 ISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSV--K-------VEN----P-SGNWMQYRTRRDLPIDNKKYCYNLITKE 91 (931)
Q Consensus 26 ~~idcg~~~~~~~~~~~~~~~~d~~~~~~g~~~--~-------~~~----~-~~~~~~~~tlr~fp~~~~~~cy~l~~~~ 91 (931)
+.|+||+... +| ..|+.|.+|..|..++..- . ... . ....+.|+|-|+=| ....|.+|..+
T Consensus 3 ~~IN~Gg~~~-~~-~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~---~~f~Y~ip~~~ 77 (174)
T PF11721_consen 3 LRINAGGPAY-TD-SSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGP---SSFSYDIPVVP 77 (174)
T ss_dssp EEEEETSSSE-EE-TTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----S---SSEEEEEE--S
T ss_pred EEEECCCCcc-cC-CCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCC---CceEEEEecCC
Confidence 6799998777 55 8899999999996555510 0 000 0 11124577888854 35799999999
Q ss_pred CceeEEEEEE---eecCCCCCCCCC---cEEEEEcCce-eEEEEecCCc---c-ceEEEE-EEecCCCCcccceee----
Q 002358 92 RRRYLVRATF---QYGSLGSEASYP---KFQLYLDATL-WSTVTVLDAS---R-VYAKEM-IIRAPSDSIDVCICC---- 155 (931)
Q Consensus 92 ~~~ylvr~~f---~yg~yd~~~~~~---~fd~~~~~~~-w~~v~~~~~~---~-~~~~e~-~~~~~~~~~~vcl~~---- 155 (931)
.|.|-||..| +++. ++..+.| +||+.++|+. ...+++.... . ....+. -+.+.+..+.++|..
T Consensus 78 ~G~Y~V~L~FaE~~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~ 156 (174)
T PF11721_consen 78 NGTYTVRLHFAELYFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKG 156 (174)
T ss_dssp -EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--S
T ss_pred CcEEEEEEEeccccccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCC
Confidence 9999999999 3444 4444444 7999999954 4555442111 1 233344 234578889999996
Q ss_pred -------cCCCCceeeee
Q 002358 156 -------AVTGSPFISTL 166 (931)
Q Consensus 156 -------~~~~~pfis~l 166 (931)
...|.|.||+|
T Consensus 157 ~~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 157 TLCIPFIGSYGNPLISAI 174 (174)
T ss_dssp EEEEEEESSSSSSSEEEE
T ss_pred cEEeeccccCCCcEEeeC
Confidence 44566888876
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.9e-08 Score=110.86 Aligned_cols=107 Identities=20% Similarity=0.290 Sum_probs=92.4
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCC---ccCCcccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS---YMGSLPNLQE 488 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~---~l~~l~~L~~ 488 (931)
++|.+|+|++|+|+..-+.+|.-|..|+.|+|++|++...-. .|..|++|+.|||++|.|++.|-+ .+..|++|+.
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 589999999999996666779999999999999999998877 589999999999999999988876 4677999999
Q ss_pred ccccccCCCCCCCccccc---CceeeeecCCCCcc
Q 002358 489 LHIENNSFVGEIPPALLT---GKVIFKYDNNPKLH 520 (931)
Q Consensus 489 l~l~~N~l~g~iP~~~~~---~~~~l~~~~N~~~c 520 (931)
|.|.+|+|. .||...+. ++..+.+.+|+...
T Consensus 397 L~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaS 430 (873)
T KOG4194|consen 397 LRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIAS 430 (873)
T ss_pred eeecCceee-ecchhhhccCcccceecCCCCccee
Confidence 999999999 99987765 56667788887654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=8.7e-08 Score=111.32 Aligned_cols=151 Identities=18% Similarity=0.266 Sum_probs=104.9
Q ss_pred HHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc--------cccccccCCCccCCCccC
Q 002358 714 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--------ISSVARGTVGYLDPEYYG 785 (931)
Q Consensus 714 ~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~--------~~~~~~gt~~y~APE~l~ 785 (931)
+.+++.||.|+|. ..++||++|.|++|.++..+..||+.|+.+......... ......-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4456699999998 589999999999999999999999999987653331111 111122456799999999
Q ss_pred CCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHcc
Q 002358 786 NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 864 (931)
Q Consensus 786 ~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl 864 (931)
....+.++|+||+||++|-+.. |+.-+............ ...+..-...+..+.+.++.+-+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHh
Confidence 9888999999999999999994 55444422222111111 011111111223445567888899999
Q ss_pred ccCCCCCCCHHHHHH
Q 002358 865 EQRGFSRPKMQEIVL 879 (931)
Q Consensus 865 ~~dP~~RPs~~evl~ 879 (931)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998887753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.6e-06 Score=101.41 Aligned_cols=140 Identities=23% Similarity=0.294 Sum_probs=92.8
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccchhh----------------------------------------hhHHH
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT----------------------------------------QQFVT 654 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~----------------------------------------~~~~~ 654 (931)
+-|+.++-|.||+|++++|+.||||+.++...... -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 45889999999999999999999999876432211 02334
Q ss_pred HHHHHHhcC-----CCCCcceeEEEe-cCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHH-hHHhhhc
Q 002358 655 EVALLSRIH-----HRNLVPLIGYCE-EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG-LEYLHTG 727 (931)
Q Consensus 655 E~~il~~l~-----HpnIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~a-L~yLH~~ 727 (931)
|...+.+++ .+++ ++=..++ -.....|+|||++|-.+.+...-. ....+... ++..++++ +..+-
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k~---ia~~~~~~f~~q~~-- 282 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDRKE---LAELLVRAFLRQLL-- 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCHHH---HHHHHHHHHHHHHH--
Confidence 555555542 2222 2222333 356679999999998888774321 23344333 33333332 11111
Q ss_pred CCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 728 ~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
..++.|+|.+|.||+++.++.+.+.|||+...+.+
T Consensus 283 -~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 -RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 26899999999999999999999999999876654
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.1e-07 Score=102.97 Aligned_cols=111 Identities=26% Similarity=0.319 Sum_probs=86.3
Q ss_pred CCCCCCCCCCceEEeeCC----------CCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-Ccccccc
Q 002358 393 RGDPCVPVPWEWVTCSTT----------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLID 461 (931)
Q Consensus 393 ~~dpc~~~~w~~v~c~~~----------~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~ 461 (931)
...||.+..-+|..++|. -|+..++|+|..|+|+-..|..|+.|++|+.||||+|+|+.+-| .|.+|.+
T Consensus 37 CP~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~ 116 (498)
T KOG4237|consen 37 CPAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLAS 116 (498)
T ss_pred CCCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHh
Confidence 456776544456555553 26688999999999994444579999999999999999999999 5999999
Q ss_pred ccEeecCC-ccccCCCCC-ccCCccccccccccccCCCCCCCcccc
Q 002358 462 LRIVHLEN-NELTGSLPS-YMGSLPNLQELHIENNSFVGEIPPALL 505 (931)
Q Consensus 462 L~~L~L~~-N~l~g~iP~-~l~~l~~L~~l~l~~N~l~g~iP~~~~ 505 (931)
|..|-|-+ |+|+ .+|. .|++|..|+.|.+.-|++. .++...+
T Consensus 117 l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~-Cir~~al 160 (498)
T KOG4237|consen 117 LLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHIN-CIRQDAL 160 (498)
T ss_pred hhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhc-chhHHHH
Confidence 77766655 9999 8886 5788988888888888877 5554443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.31 E-value=7e-06 Score=84.54 Aligned_cols=137 Identities=20% Similarity=0.230 Sum_probs=102.4
Q ss_pred CccCcEEEEEEEECCCcEEEEEEccCcc------chhhhhHHHHHHHHHhcCC--CCCcceeEEEec-----CCeEEEEE
Q 002358 618 GKGSFGSVYYGKMKDGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHH--RNLVPLIGYCEE-----EHQRILVY 684 (931)
Q Consensus 618 G~G~fG~Vy~a~~~~g~~vAvK~~~~~~------~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~-----~~~~~lV~ 684 (931)
|+||.+.|++-... |+.+-+|.-.... ......|.+|...+++|.. -.+.+++ ++.. ....+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 56889999998776 5578888865211 2245789999999999953 2244444 3321 22467999
Q ss_pred EecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc--eEEeccccccc
Q 002358 685 EYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQ 760 (931)
Q Consensus 685 E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~--vkL~DFGla~~ 760 (931)
|-+.+ -+|.+.+... .-.+.+...+..+..++++.++-||+ .++.|+|+.++||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98865 5888887643 22345677778999999999999998 99999999999999986667 99999986653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.9e-06 Score=86.87 Aligned_cols=106 Identities=27% Similarity=0.294 Sum_probs=83.5
Q ss_pred hhhHHHHHHHHHhcCC--CCCcceeEEEecC----CeEEEEEEecCCC-CHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 002358 649 TQQFVTEVALLSRIHH--RNLVPLIGYCEEE----HQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 721 (931)
Q Consensus 649 ~~~~~~E~~il~~l~H--pnIv~l~g~~~~~----~~~~lV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL 721 (931)
.....+|...+..|.. =.+.+.+++.... ...++|+|++++. +|.+++.... ..+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 3467888888888853 3356667766542 2458999999884 7999887421 255566788999999999
Q ss_pred HHhhhcCCCCeEecCCCCCCccccCCC---ceEEeccccccc
Q 002358 722 EYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQ 760 (931)
Q Consensus 722 ~yLH~~~~~~ivH~DIkp~NILld~~~---~vkL~DFGla~~ 760 (931)
+-||+ .+|+|+|++++|||++.+. .+.++||+-++.
T Consensus 132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99998 9999999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.25 E-value=4.2e-07 Score=91.48 Aligned_cols=82 Identities=24% Similarity=0.392 Sum_probs=42.7
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCc-cccccccEeecCCccccCCCC--CccCCccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP--SYMGSLPNLQEL 489 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~-~~l~~L~~L~L~~N~l~g~iP--~~l~~l~~L~~l 489 (931)
.+++.|+|++|+|+ .++ .+..|+.|+.|+|++|+|+...+.+ ..+++|+.|+|++|++. .+- ..++.|++|+.|
T Consensus 42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L~~L 118 (175)
T PF14580_consen 42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKLRVL 118 (175)
T ss_dssp TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--EE
T ss_pred cCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCccee
Confidence 48999999999999 665 5888999999999999999876555 46999999999999998 443 357789999999
Q ss_pred cccccCCC
Q 002358 490 HIENNSFV 497 (931)
Q Consensus 490 ~l~~N~l~ 497 (931)
+|.+|.++
T Consensus 119 ~L~~NPv~ 126 (175)
T PF14580_consen 119 SLEGNPVC 126 (175)
T ss_dssp E-TT-GGG
T ss_pred eccCCccc
Confidence 99999998
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.5e-06 Score=106.47 Aligned_cols=97 Identities=25% Similarity=0.380 Sum_probs=70.0
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
++.++.|+|++|+|+ .+|..+. ++|+.|+|++|+|++.+..+. .+|+.|+|++|+++ .||..+. .+|+.|+|
T Consensus 198 p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 198 PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 347888889988888 7777665 488888888888886543443 35777777777777 7777664 46777777
Q ss_pred cccCCCCCCCcccccCceeeeecCCC
Q 002358 492 ENNSFVGEIPPALLTGKVIFKYDNNP 517 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~~~~~l~~~~N~ 517 (931)
++|+|+ .+|..+..++..+.+++|.
T Consensus 270 s~N~L~-~LP~~l~~sL~~L~Ls~N~ 294 (754)
T PRK15370 270 FHNKIS-CLPENLPEELRYLSVYDNS 294 (754)
T ss_pred cCCccC-ccccccCCCCcEEECCCCc
Confidence 777777 6777666666667776664
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.2e-06 Score=97.12 Aligned_cols=134 Identities=20% Similarity=0.287 Sum_probs=95.9
Q ss_pred hhhHHHHHHHHhhcCCCCCCCCCCCCCCCCCCceEEeeCCCCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCC
Q 002358 371 WQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 450 (931)
Q Consensus 371 ~~d~~~L~~l~~~~~~~~~~~w~~dpc~~~~w~~v~c~~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~ 450 (931)
.++..++.+++..-...+...--..||.|.. .++++|+|++|.|+..--..|.+|.+|..|.|+.|.++
T Consensus 142 se~L~~l~alrslDLSrN~is~i~~~sfp~~-----------~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit 210 (873)
T KOG4194|consen 142 SEELSALPALRSLDLSRNLISEIPKPSFPAK-----------VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT 210 (873)
T ss_pred HHHHHhHhhhhhhhhhhchhhcccCCCCCCC-----------CCceEEeeccccccccccccccccchheeeecccCccc
Confidence 3455555555543222233333456665522 47999999999998555677899999999999999999
Q ss_pred CCCC-CccccccccEeecCCccccCCC-CCccCCccccccccccccCCCCCCCccccc---CceeeeecCCC
Q 002358 451 GPLP-DMSRLIDLRIVHLENNELTGSL-PSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNP 517 (931)
Q Consensus 451 g~~p-~~~~l~~L~~L~L~~N~l~g~i-P~~l~~l~~L~~l~l~~N~l~g~iP~~~~~---~~~~l~~~~N~ 517 (931)
..++ .|.+|++|+.|+|..|+|. .+ --.|..|++|+.|.|..|.++ .+.++.|- ++..+.+..|.
T Consensus 211 tLp~r~Fk~L~~L~~LdLnrN~ir-ive~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~L~~N~ 280 (873)
T KOG4194|consen 211 TLPQRSFKRLPKLESLDLNRNRIR-IVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLNLETNR 280 (873)
T ss_pred ccCHHHhhhcchhhhhhcccccee-eehhhhhcCchhhhhhhhhhcCcc-cccCcceeeecccceeecccch
Confidence 9888 6888999999999999987 44 345778888888888888888 77777654 44555555553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.9e-05 Score=83.60 Aligned_cols=138 Identities=13% Similarity=0.147 Sum_probs=85.6
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCC--CcceeEEEecCCeEEEEEEecCCCC-
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYCEEEHQRILVYEYMHNGT- 691 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gs- 691 (931)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 25568889876533 3345688999999986433 4667788777777889999999863
Q ss_pred HHHH---------------------hccCCCCCCCCHHHHH-HHHHH----------HHH-HhHHhhh-cCCCCeEecCC
Q 002358 692 LRDR---------------------LHGSVNQKPLDWLTRL-QIAHD----------AAK-GLEYLHT-GCNPGIIHRDV 737 (931)
Q Consensus 692 L~~~---------------------L~~~~~~~~l~~~~~~-~i~~q----------ia~-aL~yLH~-~~~~~ivH~DI 737 (931)
+... +|... .......... .+-.+ +.+ ..++|.. .....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 12110 0011111100 00000 000 1112211 11346789999
Q ss_pred CCCCccccCCCceEEecccccc
Q 002358 738 KSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 738 kp~NILld~~~~vkL~DFGla~ 759 (931)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.3e-06 Score=104.39 Aligned_cols=97 Identities=25% Similarity=0.369 Sum_probs=61.5
Q ss_pred cEEEEEeCCCCCcccCCccccC-----------------ccccceecccCCcCCCCCCCccccccccEeecCCccccCCC
Q 002358 414 RITKIALSGKNLKGEIPPELKN-----------------MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL 476 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~-----------------L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~i 476 (931)
+|+.|+|++|+|+ .+|....+ +.+|+.|+|++|+|++.++. .++|+.|+|++|+|+ .|
T Consensus 343 ~Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~Ls-sI 417 (788)
T PRK15387 343 GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVL---PSELKELMVSGNRLT-SL 417 (788)
T ss_pred ccceEecCCCccC-CCCCCCcccceehhhccccccCcccccccceEEecCCcccCCCCc---ccCCCEEEccCCcCC-CC
Confidence 5666666666666 34432221 13456666666666653322 245777777777777 56
Q ss_pred CCccCCccccccccccccCCCCCCCccccc--CceeeeecCCCCc
Q 002358 477 PSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (931)
Q Consensus 477 P~~l~~l~~L~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~ 519 (931)
|... .+|+.|+|++|+|+ .||..+.. .+..+.+++|+..
T Consensus 418 P~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 418 PMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred Ccch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCC
Confidence 6532 46777888888887 78877643 6667788888765
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.12 E-value=5.7e-07 Score=101.66 Aligned_cols=102 Identities=23% Similarity=0.340 Sum_probs=91.1
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~ 493 (931)
-|..|-+++|+|+ .+|++++.+..|..||.+.|.+...++.+++|.+|+.|.+..|++. .+|++++.| .|..||+++
T Consensus 144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfSc 220 (722)
T KOG0532|consen 144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSC 220 (722)
T ss_pred cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeeccc
Confidence 3788899999998 9999999889999999999999999999999999999999999999 899998855 588999999
Q ss_pred cCCCCCCCccccc--CceeeeecCCCCc
Q 002358 494 NSFVGEIPPALLT--GKVIFKYDNNPKL 519 (931)
Q Consensus 494 N~l~g~iP~~~~~--~~~~l~~~~N~~~ 519 (931)
|+++ .||-++.. .+..+.+++||..
T Consensus 221 Nkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 221 NKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred Ccee-ecchhhhhhhhheeeeeccCCCC
Confidence 9999 99998865 6778888999865
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.9e-07 Score=86.24 Aligned_cols=92 Identities=26% Similarity=0.318 Sum_probs=83.0
Q ss_pred CCcEEEEEeCCCCCcccCCccccCc-cccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNM-EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L-~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
..+++.++|++|++. .+|+.|... +.++.|+|++|.|+..+.++..|+.|+.|+++.|.|. ..|.-+..|.+|-.|+
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 357999999999999 888887655 6999999999999998889999999999999999999 8999898899999999
Q ss_pred ccccCCCCCCCccccc
Q 002358 491 IENNSFVGEIPPALLT 506 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~ 506 (931)
..+|.+. +||-.++.
T Consensus 130 s~~na~~-eid~dl~~ 144 (177)
T KOG4579|consen 130 SPENARA-EIDVDLFY 144 (177)
T ss_pred CCCCccc-cCcHHHhc
Confidence 9999999 99987664
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.2e-06 Score=106.68 Aligned_cols=84 Identities=29% Similarity=0.401 Sum_probs=73.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~ 492 (931)
..|..|+|++|.|+ .+|..+ ++|+.|+|++|+|++ +|.+ ..+|+.|+|++|+|+ .||+++++|++|+.|+|+
T Consensus 382 ~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Lss-IP~l--~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 382 SGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTS-LPML--PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred cccceEEecCCccc-CCCCcc---cCCCEEEccCCcCCC-CCcc--hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 46899999999999 577643 679999999999997 4543 357889999999999 999999999999999999
Q ss_pred ccCCCCCCCccc
Q 002358 493 NNSFVGEIPPAL 504 (931)
Q Consensus 493 ~N~l~g~iP~~~ 504 (931)
+|+|+|.+|..+
T Consensus 454 ~N~Ls~~~~~~L 465 (788)
T PRK15387 454 GNPLSERTLQAL 465 (788)
T ss_pred CCCCCchHHHHH
Confidence 999999888866
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.4e-06 Score=103.34 Aligned_cols=96 Identities=20% Similarity=0.335 Sum_probs=71.8
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~ 493 (931)
.|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++.++.+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++
T Consensus 263 ~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~ 334 (754)
T PRK15370 263 ALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGE 334 (754)
T ss_pred CCCEEECcCCccC-ccccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccC
Confidence 6788888888887 6777664 478888888888887544443 46788888888888 5776553 5788888888
Q ss_pred cCCCCCCCcccccCceeeeecCCCC
Q 002358 494 NSFVGEIPPALLTGKVIFKYDNNPK 518 (931)
Q Consensus 494 N~l~g~iP~~~~~~~~~l~~~~N~~ 518 (931)
|.|+ .+|..+..++..+.+++|..
T Consensus 335 N~Lt-~LP~~l~~sL~~L~Ls~N~L 358 (754)
T PRK15370 335 NALT-SLPASLPPELQVLDVSKNQI 358 (754)
T ss_pred Cccc-cCChhhcCcccEEECCCCCC
Confidence 8888 58877777777788887754
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.03 E-value=2.3e-07 Score=107.07 Aligned_cols=126 Identities=23% Similarity=0.285 Sum_probs=97.3
Q ss_pred CCCCCCCCCCCce---EEeeCCC----------CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-Ccc
Q 002358 392 DRGDPCVPVPWEW---VTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMS 457 (931)
Q Consensus 392 w~~dpc~~~~w~~---v~c~~~~----------~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~ 457 (931)
-.||.|...+|.- ..|+|.. .+.+++|||++|+++. .- .+..|++|++|||+.|.|...+- +..
T Consensus 153 cggd~~ns~~Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~ 230 (1096)
T KOG1859|consen 153 CGGDISNSPVWNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLRHVPQLSMV 230 (1096)
T ss_pred hccccccchhhhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhccccccchh
Confidence 3467777666654 4566542 5689999999999983 33 88999999999999999998765 556
Q ss_pred ccccccEeecCCccccCCCCCccCCccccccccccccCCCCC---CCcccccCceeeeecCCCCcccc
Q 002358 458 RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGE---IPPALLTGKVIFKYDNNPKLHKE 522 (931)
Q Consensus 458 ~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~---iP~~~~~~~~~l~~~~N~~~c~~ 522 (931)
++. |+.|.|.||-++ ++- .|.+|.+|+.|||++|-|++- .|-+.+..+..+.+.|||.-|..
T Consensus 231 gc~-L~~L~lrnN~l~-tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 231 GCK-LQLLNLRNNALT-TLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hhh-heeeeecccHHH-hhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 666 999999999998 554 378999999999999998843 12233346777889999988853
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.01 E-value=3e-05 Score=80.25 Aligned_cols=139 Identities=17% Similarity=0.209 Sum_probs=88.9
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhh---------HHHHHHHHHhcCCC---CCcceeE
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ---------FVTEVALLSRIHHR---NLVPLIG 672 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~---------~~~E~~il~~l~Hp---nIv~l~g 672 (931)
++....+...+++-......|.+-..+ |+.+++|..+.......+. ..+++..+.+++.. ....++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 344444555566666666666665554 8999999876543322222 23344444555332 2233222
Q ss_pred EEe-----cCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC
Q 002358 673 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 747 (931)
Q Consensus 673 ~~~-----~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~ 747 (931)
... -....+++|||++|..|.+... ++. .++..+.+++.-||+ .|++|||.+|.|++++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC
Confidence 222 2344568999999988766532 111 245667888999998 999999999999999865
Q ss_pred CceEEecccccc
Q 002358 748 MRAKVSDFGLSR 759 (931)
Q Consensus 748 ~~vkL~DFGla~ 759 (931)
+ +++.||+..+
T Consensus 172 ~-i~iID~~~k~ 182 (229)
T PF06176_consen 172 G-IRIIDTQGKR 182 (229)
T ss_pred c-EEEEECcccc
Confidence 5 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1e-06 Score=104.82 Aligned_cols=100 Identities=27% Similarity=0.431 Sum_probs=89.9
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~ 493 (931)
+|.+|||++|.++ ..|..+..+.+|+.|+++.|.|...+-+.+++++|++|.|.+|++. .+|.++..+.+|+.|+++.
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 5999999999998 9999999999999999999999998888999999999999999999 9999999999999999999
Q ss_pred cCCCCCCCccccc--CceeeeecCC
Q 002358 494 NSFVGEIPPALLT--GKVIFKYDNN 516 (931)
Q Consensus 494 N~l~g~iP~~~~~--~~~~l~~~~N 516 (931)
|+|. .+|..+.. ....+...+|
T Consensus 124 N~f~-~~Pl~i~~lt~~~~~~~s~N 147 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEVLTAEEELAASNN 147 (1081)
T ss_pred hccC-CCchhHHhhhHHHHHhhhcc
Confidence 9998 99987643 2333445556
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.99 E-value=6.1e-05 Score=78.72 Aligned_cols=137 Identities=24% Similarity=0.314 Sum_probs=95.5
Q ss_pred ccCccCcEEEEEEEECCCcEEEEEEccCccchh-------------------hh-----hHHHHHHHHHhcC--CCCCcc
Q 002358 616 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR-------------------TQ-----QFVTEVALLSRIH--HRNLVP 669 (931)
Q Consensus 616 ~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~-------------------~~-----~~~~E~~il~~l~--HpnIv~ 669 (931)
.|+.|--+.||+|.-.++..+|||+++...... .+ -..+|+.-|.++. +=.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 578899999999998889999999986432110 00 1346888888874 344555
Q ss_pred eeEEEecCCeEEEEEEecCCCC-HHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC
Q 002358 670 LIGYCEEEHQRILVYEYMHNGT-LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 748 (931)
Q Consensus 670 l~g~~~~~~~~~lV~E~~~~gs-L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~ 748 (931)
.+++.. ..|||||+.... -.-.| ...++.......+..++++.+.-|-. ..++||+||+.-|||+. ++
T Consensus 135 Pi~~~~----nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceeecC----CeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CC
Confidence 555443 479999995431 11111 22233333566777888888888775 47999999999999999 88
Q ss_pred ceEEecccccccccc
Q 002358 749 RAKVSDFGLSRQAEE 763 (931)
Q Consensus 749 ~vkL~DFGla~~~~~ 763 (931)
.+.|+|||-+....+
T Consensus 204 ~p~iID~~QaV~~~h 218 (268)
T COG1718 204 EPYIIDVSQAVTIDH 218 (268)
T ss_pred eEEEEECccccccCC
Confidence 999999998765543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.5e-05 Score=91.21 Aligned_cols=142 Identities=21% Similarity=0.279 Sum_probs=91.7
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccchhh-------------------------------------hhHHHHHH
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-------------------------------------QQFVTEVA 657 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~-------------------------------------~~~~~E~~ 657 (931)
+.||.-+.|.||+|++++|+.||||+-++...... -+|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 56999999999999999999999999876432210 02444554
Q ss_pred HHHhc----CCCCCcc---eeEEEe-cCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCC
Q 002358 658 LLSRI----HHRNLVP---LIGYCE-EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729 (931)
Q Consensus 658 il~~l----~HpnIv~---l~g~~~-~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 729 (931)
-..+. +|-+... +=.+++ -.....|+||||+|..+.|.-.- ....++.. .++..+.++ |++....
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~---~i~~~l~~~--~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPH---DILNKLVEA--YLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHH---HHHHHHHHH--HHHHHHh
Confidence 44433 3444111 222232 24567999999999877654221 12334444 334444443 2222223
Q ss_pred CCeEecCCCCCCccccC----CCceEEecccccccccc
Q 002358 730 PGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 730 ~~ivH~DIkp~NILld~----~~~vkL~DFGla~~~~~ 763 (931)
.|++|+|-+|.||+++. ++.+.+.|||+...+.+
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 68999999999999984 67899999999876544
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.2e-05 Score=104.91 Aligned_cols=106 Identities=19% Similarity=0.334 Sum_probs=90.0
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
+.+|+.|+|++|.|. .+|..+..|++|+.|+|++|...+.+|+++.+++|+.|+|++|.....+|.++++|++|+.|+|
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 358999999999998 8899999999999999999887788899999999999999998776799999999999999999
Q ss_pred cccCCCCCCCccc-ccCceeeeecCCCC
Q 002358 492 ENNSFVGEIPPAL-LTGKVIFKYDNNPK 518 (931)
Q Consensus 492 ~~N~l~g~iP~~~-~~~~~~l~~~~N~~ 518 (931)
++|..-+.+|..+ ...+..+.+.+|..
T Consensus 689 ~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 689 SRCENLEILPTGINLKSLYRLNLSGCSR 716 (1153)
T ss_pred CCCCCcCccCCcCCCCCCCEEeCCCCCC
Confidence 9876555888865 33666677777653
|
syringae 6; Provisional |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.94 E-value=5.8e-05 Score=79.57 Aligned_cols=142 Identities=20% Similarity=0.276 Sum_probs=85.1
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCC--CCcceeEEEec---CCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR--NLVPLIGYCEE---EHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~g~~~~---~~~~~lV~E~~~~ 689 (931)
+.|+.|..+.||+....+ +.+++|..... .....+.+|..+++.+... .+.+++..... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999987 69999987654 4556788899999888533 34566664432 3346899999999
Q ss_pred CCHHH----------------H---hccC-CCCCCCCHHH---------HHHH------------HHHHHH-HhHHhhh-
Q 002358 690 GTLRD----------------R---LHGS-VNQKPLDWLT---------RLQI------------AHDAAK-GLEYLHT- 726 (931)
Q Consensus 690 gsL~~----------------~---L~~~-~~~~~l~~~~---------~~~i------------~~qia~-aL~yLH~- 726 (931)
..+.. . ++.. .......... .... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87766 1 1111 0111111110 0000 111222 2333332
Q ss_pred ---cCCCCeEecCCCCCCcccc-CCCceEEecccccc
Q 002358 727 ---GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSR 759 (931)
Q Consensus 727 ---~~~~~ivH~DIkp~NILld-~~~~vkL~DFGla~ 759 (931)
.....++|+|+.++||+++ +++.+-|.||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1346799999999999999 66666799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=2.6e-06 Score=92.63 Aligned_cols=111 Identities=23% Similarity=0.329 Sum_probs=88.6
Q ss_pred EeeCCCCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcc
Q 002358 406 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLP 484 (931)
Q Consensus 406 ~c~~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~ 484 (931)
.|.|++.. =..++-++-+|+ .+|..+- ..-..|+|..|+|+.++| .|+.+++|+.||||+|+|+-.-|+.|..|+
T Consensus 40 pC~Cs~~~-g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~ 115 (498)
T KOG4237|consen 40 PCTCSDVE-GGIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLA 115 (498)
T ss_pred CcccCCCC-CceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhH
Confidence 46666432 456788888998 8886554 366789999999999999 699999999999999999977789999999
Q ss_pred ccccccccc-cCCCCCCCcccccCceeee-ecCCCCccc
Q 002358 485 NLQELHIEN-NSFVGEIPPALLTGKVIFK-YDNNPKLHK 521 (931)
Q Consensus 485 ~L~~l~l~~-N~l~g~iP~~~~~~~~~l~-~~~N~~~c~ 521 (931)
+|..|-+-+ |+|+ .||...+.++..+. +..|++.|.
T Consensus 116 ~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~ 153 (498)
T KOG4237|consen 116 SLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHIN 153 (498)
T ss_pred hhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhc
Confidence 997766655 9999 99999988665443 366666654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.91 E-value=2.7e-06 Score=97.95 Aligned_cols=184 Identities=20% Similarity=0.233 Sum_probs=134.3
Q ss_pred hccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCC-CcceeEEEecCCeEEEEEEecCCC-
Q 002358 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEHQRILVYEYMHNG- 690 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~E~~~~g- 690 (931)
+-+.+++|+.+.++|.+-...+....+.+... ....-++++|.+++||| .+..++-++.+...+++++++.++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34668899999999987554444445555432 33456889999999999 777777777778888999999877
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccc
Q 002358 691 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 770 (931)
Q Consensus 691 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 770 (931)
+-..-. ......+...+...+++.-++++++||+ ..-+|+| ||+..+ +..+..||+....+.... ...
T Consensus 321 s~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 321 SSALEM--TVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred cccccC--ChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 221111 1122334445556677788899999997 4457888 777654 778999999887765543 234
Q ss_pred ccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 002358 771 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 813 (931)
Q Consensus 771 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~ 813 (931)
...+++.++|||+.....+..+-|+|+.|+-..++.-|..|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 4568999999999999999999999999998788877877755
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.87 E-value=3.8e-06 Score=88.12 Aligned_cols=36 Identities=28% Similarity=0.551 Sum_probs=17.4
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCC
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 450 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~ 450 (931)
|.+..|+||+|+|. .+.. +..|.+|+.||||+|.|+
T Consensus 307 Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls 342 (490)
T KOG1259|consen 307 PKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA 342 (490)
T ss_pred cceeEEecccccee-eehh-hhhcccceEeecccchhH
Confidence 44555555555554 2222 444455555555555544
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.84 E-value=7e-06 Score=94.58 Aligned_cols=102 Identities=28% Similarity=0.506 Sum_probs=88.8
Q ss_pred CcEEEEEeCCCCCcccCCccccCcc-ccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~-~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
..++.|++.+|.++ .||+..+.++ +|+.|++++|++...+..+..+++|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 46899999999999 8999999885 999999999999988878999999999999999999 89988888899999999
Q ss_pred cccCCCCCCCcc--cccCceeeeecCCC
Q 002358 492 ENNSFVGEIPPA--LLTGKVIFKYDNNP 517 (931)
Q Consensus 492 ~~N~l~g~iP~~--~~~~~~~l~~~~N~ 517 (931)
++|+++ .+|.. ....+..+...+|+
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 999999 89886 44457777777775
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.84 E-value=6.8e-06 Score=62.85 Aligned_cols=36 Identities=36% Similarity=0.506 Sum_probs=16.7
Q ss_pred ccceecccCCcCCCCCCCccccccccEeecCCcccc
Q 002358 438 ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 473 (931)
Q Consensus 438 ~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~ 473 (931)
+|++|+|++|+|+...|.+++|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC
Confidence 445555555555543333555555555555555544
|
... |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.83 E-value=3.1e-06 Score=88.72 Aligned_cols=85 Identities=24% Similarity=0.306 Sum_probs=70.3
Q ss_pred CCCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccc
Q 002358 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (931)
Q Consensus 410 ~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l 489 (931)
.+-..+++||||+|.++ .|.+++.-++.++.|+||+|.|...-. +..|++|+.||||+|.|+ .+-.+-.+|-+.+.|
T Consensus 281 dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred chHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 33457999999999999 999999999999999999999986544 899999999999999998 666655556666666
Q ss_pred cccccCCC
Q 002358 490 HIENNSFV 497 (931)
Q Consensus 490 ~l~~N~l~ 497 (931)
.|++|.+.
T Consensus 358 ~La~N~iE 365 (490)
T KOG1259|consen 358 KLAQNKIE 365 (490)
T ss_pred ehhhhhHh
Confidence 66666654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.82 E-value=2.6e-06 Score=96.54 Aligned_cols=103 Identities=26% Similarity=0.415 Sum_probs=94.2
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~ 492 (931)
..++.|||+.|+|+ .+|..+..|+ |+.|-+++|+++..+++++.+..|..||.+.|++. .+|..++.|.+|+.|++.
T Consensus 121 ~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr 197 (722)
T KOG0532|consen 121 EALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR 197 (722)
T ss_pred hHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence 47899999999999 9999999886 89999999999999999999999999999999999 999999999999999999
Q ss_pred ccCCCCCCCccccc-CceeeeecCCCCc
Q 002358 493 NNSFVGEIPPALLT-GKVIFKYDNNPKL 519 (931)
Q Consensus 493 ~N~l~g~iP~~~~~-~~~~l~~~~N~~~ 519 (931)
.|++. .+|+++.. .+..+.|+.|...
T Consensus 198 Rn~l~-~lp~El~~LpLi~lDfScNkis 224 (722)
T KOG0532|consen 198 RNHLE-DLPEELCSLPLIRLDFSCNKIS 224 (722)
T ss_pred hhhhh-hCCHHHhCCceeeeecccCcee
Confidence 99999 99999886 6677788888654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00018 Score=76.99 Aligned_cols=140 Identities=19% Similarity=0.171 Sum_probs=85.4
Q ss_pred ccCccCc-EEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEEecCCCCHH
Q 002358 616 KIGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLR 693 (931)
Q Consensus 616 ~LG~G~f-G~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 693 (931)
.|..|.. ..||+.... +..+++|+..... .....+|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3455555 788998765 5788889875432 345678999998884 434556777777666789999999988775
Q ss_pred HHh-------------------ccCCC-CCCCCH--HHHHHHHHH--------------------HHHHhHHhhh----c
Q 002358 694 DRL-------------------HGSVN-QKPLDW--LTRLQIAHD--------------------AAKGLEYLHT----G 727 (931)
Q Consensus 694 ~~L-------------------~~~~~-~~~l~~--~~~~~i~~q--------------------ia~aL~yLH~----~ 727 (931)
... +.... ..++.. ......... +.+.+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 11100 001110 000000000 1111112211 1
Q ss_pred CCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 728 ~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
....++|+|+.|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13568999999999999998778899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.77 E-value=8.9e-06 Score=62.21 Aligned_cols=37 Identities=38% Similarity=0.666 Sum_probs=23.7
Q ss_pred ccccEeecCCccccCCCCCccCCccccccccccccCCC
Q 002358 460 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 497 (931)
Q Consensus 460 ~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~ 497 (931)
++|++|+|++|+|+ .+|..|++|++|+.|++++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 35666777777776 66666667777777777777666
|
... |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=97.75 E-value=3.5e-05 Score=100.51 Aligned_cols=101 Identities=19% Similarity=0.290 Sum_probs=71.9
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
+++|+.|+|++|...+.+|.++++|++|+.|+|++|...+.+|...++++|+.|+|++|.....+|.. ..+|+.|+|
T Consensus 777 ~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 777 SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred cccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 35899999999988889999999999999999999876666775446777777777776544455543 245666677
Q ss_pred cccCCCCCCCccccc--CceeeeecCC
Q 002358 492 ENNSFVGEIPPALLT--GKVIFKYDNN 516 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~--~~~~l~~~~N 516 (931)
++|.++ .+|.++.. .+..+.+.++
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C 879 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGC 879 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCC
Confidence 777766 66665432 4445555543
|
syringae 6; Provisional |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00011 Score=75.33 Aligned_cols=105 Identities=24% Similarity=0.218 Sum_probs=83.6
Q ss_pred HHHHHHHHhcCC-CCCcceeEEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCC
Q 002358 653 VTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731 (931)
Q Consensus 653 ~~E~~il~~l~H-pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 731 (931)
..|.-+++.+++ +++.+++|+|-. ++|.||...+++...-.....-...+|..+.+|+.++++.+.+|+.+....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888999976 699999999943 789999987766432110001234689999999999999999999866566
Q ss_pred eEecCCCCCCccccCCCceEEecccccccc
Q 002358 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 732 ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+.-.|++++|+-+++++++|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=1.2e-06 Score=82.10 Aligned_cols=92 Identities=20% Similarity=0.258 Sum_probs=78.4
Q ss_pred CCcEEEEEeCCCCCcccCCccc---cCccccceecccCCcCCCCCCCcccc-ccccEeecCCccccCCCCCccCCccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPEL---KNMEALTELWLDGNFLTGPLPDMSRL-IDLRIVHLENNELTGSLPSYMGSLPNLQ 487 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~---~~L~~L~~L~Ls~N~l~g~~p~~~~l-~~L~~L~L~~N~l~g~iP~~l~~l~~L~ 487 (931)
...+..|+|+++.|- .|+... .....|+..+|++|.|...++.|... +-++.|+|++|+|+ .+|++++.++.|+
T Consensus 26 akE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr 103 (177)
T KOG4579|consen 26 AKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALR 103 (177)
T ss_pred HHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhh
Confidence 346778999999987 777664 55567777799999999999987654 58999999999999 9999999999999
Q ss_pred cccccccCCCCCCCccccc
Q 002358 488 ELHIENNSFVGEIPPALLT 506 (931)
Q Consensus 488 ~l~l~~N~l~g~iP~~~~~ 506 (931)
.|+++.|.|. ..|.-++.
T Consensus 104 ~lNl~~N~l~-~~p~vi~~ 121 (177)
T KOG4579|consen 104 SLNLRFNPLN-AEPRVIAP 121 (177)
T ss_pred hcccccCccc-cchHHHHH
Confidence 9999999999 77776665
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 931 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-59 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-58 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-55 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-35 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-34 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-24 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-24 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-24 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-23 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-23 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-23 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-22 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-22 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-22 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-22 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-22 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-22 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-22 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-22 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-22 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-22 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-22 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-22 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-22 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-22 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-22 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-22 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-22 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-22 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-21 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-21 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-21 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-19 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-18 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-11 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 7e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 9e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 457 bits (1179), Expect = e-155
Identities = 127/319 (39%), Positives = 193/319 (60%), Gaps = 7/319 (2%)
Query: 575 TSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKK--IGKGSFGSVYYGKMKD 632
+ + + + A ++ +Y +PL +LEEATNNF K IG G FG VY G ++D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 633 GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692
G +VA+K S ++F TE+ LS H +LV LIG+C+E ++ IL+Y+YM NG L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 693 RDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 751
+ L+GS + W RL+I AA+GL YLHT IIHRDVKS NILLD N K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 752 VSDFGLSRQA-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 810
++DFG+S++ E D TH+S+V +GT+GY+DPEY+ +LTEKSDVYSFGVVL E++ +
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 811 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS 870
+ +N+ WA G + IVDP L ++ ES+ + + A++C+
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299
Query: 871 RPKMQEIVLAIQDSIKIEK 889
RP M +++ ++ ++++++
Sbjct: 300 RPSMGDVLWKLEYALRLQE 318
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-126
Identities = 112/282 (39%), Positives = 173/282 (61%), Gaps = 6/282 (2%)
Query: 605 ELEEATNNFCK--KIGKGSFGSVYYGKMKDGKEVAVK-IMADSCSHRTQQFVTEVALLSR 661
EL+ A++NF +G+G FG VY G++ DG VAVK + + QF TEV ++S
Sbjct: 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM 83
Query: 662 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKG 720
HRNL+ L G+C +R+LVY YM NG++ L +P LDW R +IA +A+G
Sbjct: 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 143
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 780
L YLH C+P IIHRDVK++NILLD A V DFGL++ + TH+++ RGT+G++
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 781 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--LNIVHWARSMIKKGDVIS 838
PEY + +EK+DV+ +GV+LLELI+G++ + + + ++ W + ++K+ + +
Sbjct: 204 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263
Query: 839 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880
+VD L GN K E + ++ +VA+ C + RPKM E+V
Sbjct: 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 369 bits (951), Expect = e-121
Identities = 102/292 (34%), Positives = 153/292 (52%), Gaps = 26/292 (8%)
Query: 605 ELEEATNNF--------CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ----F 652
EL+ TNNF K+G+G FG VY G + + VAVK +A T++ F
Sbjct: 19 ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 653 VTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ 712
E+ ++++ H NLV L+G+ + LVY YM NG+L DRL PL W R +
Sbjct: 78 DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 713 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSV 771
IA AA G+ +LH IHRD+KS+NILLD AK+SDFGL+R + + T ++S
Sbjct: 138 IAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194
Query: 772 ARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARS 829
GT Y+ PE G ++T KSD+YSFGVVLLE+I+G V D ++
Sbjct: 195 IVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAV---DEHREPQLLLDIKEE 249
Query: 830 MIK-KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880
+ + + +D + + S+ + VA QC+ ++ RP ++++
Sbjct: 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 3e-86
Identities = 74/308 (24%), Positives = 118/308 (38%), Gaps = 31/308 (10%)
Query: 601 IPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 658
+ L + + +G FG V+ ++ + VAVKI ++ Q EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ-DKQSWQNEYEVYS 71
Query: 659 LSRIHHRNLVPLIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 714
L + H N++ IG + + L+ + G+L D L + W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIA 127
Query: 715 HDAAKGLEYLHT-------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767
A+GL YLH G P I HRD+KS N+LL N+ A ++DFGL+ + E +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 768 ISSVAR-GTVGYLDPEY-----YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 821
+ + GT Y+ PE + + D+Y+ G+VL EL S L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 822 NIVHWARSMIKKGDVISIV-----DPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQ 875
D+ +V PVL K + + E +C + +R
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 876 EIVLAIQD 883
+ I
Sbjct: 308 CVGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 2e-73
Identities = 86/213 (40%), Positives = 123/213 (57%), Gaps = 10/213 (4%)
Query: 601 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 658
IP +L +KIG GSFG+V+ + G +VAVKI+ + H R +F+ EVA+
Sbjct: 34 IPWCDLN-----IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 659 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 718
+ R+ H N+V +G + +V EY+ G+L LH S ++ LD RL +A+D A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 778
KG+ YLH NP I+HR++KS N+L+D KV DFGLSR S A GT +
Sbjct: 148 KGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEW 205
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ PE ++ EKSDVYSFGV+L EL + ++P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-72
Identities = 84/328 (25%), Positives = 144/328 (43%), Gaps = 39/328 (11%)
Query: 599 YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 658
+ I E+E + +G+G+FG V K + K+VA+K + + F+ E+
Sbjct: 3 HMIDYKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQ 54
Query: 659 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 718
LSR++H N+V L G C LV EY G+L + LHG+ + +
Sbjct: 55 LSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLTHISSVARGTVG 777
+G+ YLH+ +IHRD+K N+LL K+ DFG + + +T+ +G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN----NKGSAA 168
Query: 778 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--- 834
++ PE + +EK DV+S+G++L E+I+ +KP ++ G + WA + G
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWA---VHNGTRP 223
Query: 835 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQK 894
+I + I + +C + RP M+EIV + ++ G D+
Sbjct: 224 PLIKNLPK------------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
Query: 895 F----SSSSSKGQSSRKTLLTSFLEIES 918
S G+ R F E
Sbjct: 272 LQYPCQHSLPPGEDGRVEPYVDFAEFYR 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-68
Identities = 75/240 (31%), Positives = 120/240 (50%), Gaps = 29/240 (12%)
Query: 587 ARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC 645
A GG + + E+E + K+IGKG FG V+ G++ D VA+K +
Sbjct: 2 AMGGSEFPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 646 SH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 698
S + Q+F EV ++S ++H N+V L G +V E++ G L RL
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD 114
Query: 699 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-----INMRAKVS 753
P+ W +L++ D A G+EY+ NP I+HRD++S NI L + AKV+
Sbjct: 115 --KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 754 DFGLSRQAEEDLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
DFGLS+Q+ ++ G ++ PE + TEK+D YSF ++L +++G+ P
Sbjct: 172 DFGLSQQSVHSVSG----LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 7e-66
Identities = 48/218 (22%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 601 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 658
I +L F K+ + G ++ G+ + G ++ VK++ +++ F E
Sbjct: 7 IDFKQLN-----FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 659 LSRIHHRNLVPLIGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 716
L H N++P++G C+ + +M G+L + LH +D ++ A D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALD 119
Query: 717 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 776
A+G+ +LHT P I + S ++++D +M A++S + + S
Sbjct: 120 MARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAP 172
Query: 777 GYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKP 811
++ PE + +D++SF V+L EL++ + P
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 9e-66
Identities = 75/223 (33%), Positives = 103/223 (46%), Gaps = 25/223 (11%)
Query: 601 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM----ADSCSHRTQQFVTEV 656
I EL + IG G FG VY G EVAVK + S + E
Sbjct: 4 IDFAELT-----LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 657 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 716
L + + H N++ L G C +E LV E+ G L L G K + + A
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQ 113
Query: 717 AAKGLEYLHTGCNPGIIHRDVKSSNILLD--------INMRAKVSDFGLSRQAEEDLTHI 768
A+G+ YLH IIHRD+KSSNIL+ N K++DFGL+R E T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTK 171
Query: 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
S A G ++ PE ++ SDV+S+GV+L EL++G+ P
Sbjct: 172 MSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-65
Identities = 72/339 (21%), Positives = 128/339 (37%), Gaps = 48/339 (14%)
Query: 601 IPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTE--V 656
E +N + IG+G +G+VY G + D + VAVK+ + Q F+ E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNI 58
Query: 657 ALLSRIHHRNLVPLIGYCEE-----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL 711
+ + H N+ I E + +LV EY NG+L L DW++
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSC 114
Query: 712 QIAHDAAKGLEYLHT------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR------ 759
++AH +GL YLHT P I HRD+ S N+L+ + +SDFGLS
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 760 -QAEEDLTHISSVARGTVGYLDPEY-------YGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ + + GT+ Y+ PE + ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 812 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWR--------IAEVAI 861
+ + E + + + + V K W+ + E
Sbjct: 235 LFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 862 QCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSS 900
C +Q +R Q + + + I + ++
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 3e-63
Identities = 68/217 (31%), Positives = 113/217 (52%), Gaps = 19/217 (8%)
Query: 601 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 658
IP ++ ++IG GSFG+VY GK +VAVK++ + + Q F EV +
Sbjct: 21 IPDGQIT-----VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 659 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 718
L + H N++ +GY I V ++ +L LH ++ + + IA A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTA 130
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVG 777
+G++YLH IIHRD+KS+NI L + K+ DFGL+ ++ +H G++
Sbjct: 131 RGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 778 YLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
++ PE + + +SDVY+FG+VL EL++G+ P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 4e-63
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 601 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM--ADSCSHRTQQFVTEVAL 658
IP +LE + IGKG FG VY+G+ EVA++++ + + F EV
Sbjct: 30 IPFEQLE-----IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 659 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 718
+ H N+V +G C ++ TL + + LD QIA +
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIV 140
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR----QAEEDLTHISSVARG 774
KG+ YLH GI+H+D+KS N+ D N + ++DFGL + G
Sbjct: 141 KGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 775 TVGYLDPEYYGNQQL---------TEKSDVYSFGVVLLELISGKKP 811
+ +L PE ++ SDV++ G + EL + + P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 5e-61
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 613 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 671
+ +GKG FG ++ G+ + +K + + F+ EV ++ + H N++ I
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
G ++ + + EY+ GTLR + W R+ A D A G+ YLH +
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-------------GTVGY 778
IIHRD+ S N L+ N V+DFGL+R ++ T + G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ PE + EK DV+SFG+VL E+I
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 3e-60
Identities = 77/324 (23%), Positives = 130/324 (40%), Gaps = 44/324 (13%)
Query: 603 LPELEEATNN----FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 658
LP L + T K+IGKG +G V+ GK + G++VAVK+ + + TE+
Sbjct: 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-EASWFRETEIYQ 84
Query: 659 LSRIHHRNLVPLIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 714
+ H N++ I + L+ +Y NG+L D L LD + L++A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLA 140
Query: 715 HDAAKGLEYLHT-----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769
+ + GL +LHT P I HRD+KS NIL+ N ++D GL+ + D +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 770 SVARGTVG---YLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 820
VG Y+ PE + Q +D+YSFG++L E+ E
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS----GGIVE 256
Query: 821 LNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWR-------IAEVAIQCVEQRGFSR 871
+ + + + + V I + + W + ++ +C SR
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316
Query: 872 PKMQEIVLAIQDSIKIEKGGDQKF 895
+ + K+ + D K
Sbjct: 317 LTALRVKKTLA---KMSESQDIKL 337
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 8e-58
Identities = 78/318 (24%), Positives = 136/318 (42%), Gaps = 40/318 (12%)
Query: 603 LPELEEATN----NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 658
LP L + T + IGKG FG V+ GK + G+EVAVKI S R+ E+
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQ 89
Query: 659 LSRIHHRNLVPLIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 714
+ H N++ I +++ LV +Y +G+L D L+ + + +++A
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLA 145
Query: 715 HDAAKGLEYLH-----TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLT 766
A GL +LH T P I HRD+KS NIL+ N ++D GL+ A + +
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 767 HISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 820
+ GT Y+ PE + + +++D+Y+ G+V E+ + + +
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE-DYQ 264
Query: 821 LNIVHWARSMIKKGDVISIVD------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 874
L S ++ +V + E++ +A++ +C G +R
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 875 QEIV-----LAIQDSIKI 887
I L+ Q+ IK+
Sbjct: 325 LRIKKTLSQLSQQEGIKM 342
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-57
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFV--TEVALLSRIHHRNLVPL 670
+ +GKG +G V+ G + G+ VAVKI + S + + TE+ + H N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67
Query: 671 IGYC----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
I Q L+ Y G+L D L LD ++ L+I A GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 727 -----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGY 778
P I HRD+KS NIL+ N + ++D GL+ Q+ L ++ GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 779 LDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
+ PE ++ D+++FG+VL E+ + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 671
+IG+GSF +VY G + EVA + D ++ Q+F E +L + H N+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 672 GY----CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
+ + +LV E M +GTL+ L + K L R QI KGL++LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR-QIL----KGLQFLH 146
Query: 726 TGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
T P IIHRD+K NI + K+ D GL+ + +V GT ++ PE Y
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAV-IGTPEFMAPEMY 202
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKP 811
++ E DVY+FG+ +LE+ + + P
Sbjct: 203 -EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-42
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL 670
++IG+G+FG V+ G+++ VAVK ++ + F+ E +L + H N+V L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
IG C ++ +V E + G L L T LQ+ DAA G+EYL +
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL-----DPEYYG 785
IHRD+ + N L+ K+SDFG+SR+ + A G + + PE
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG----VYAASGGLRQVPVKWTAPEALN 288
Query: 786 NQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ + +SDV+SFG++L E S G P
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASP 315
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 7/200 (3%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
K++G G FG V GK K +VAVK++ + +F E + ++ H LV G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYG 70
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
C +E+ +V EY+ NG L + L + K L+ L++ +D +G+ +L +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLE---SHQF 125
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
IHRD+ + N L+D ++ KVSDFG++R +D S + V + PE + + + K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 793 SDVYSFGVVLLELIS-GKKP 811
SDV++FG+++ E+ S GK P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
F ++IG G FG V+ G + +VA+K + + + F+ E ++ ++ H LV L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYG 70
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
C E+ LV E+M +G L D L + L L + D +G+ YL +
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL--LGMCLDVCEGMAYL---EEACV 125
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + + + K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 793 SDVYSFGVVLLELIS-GKKP 811
SDV+SFGV++ E+ S GK P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-41
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 7/201 (3%)
Query: 613 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 671
K+G G +G VY G K VAVK + + ++F+ E A++ I H NLV L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 282
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE---KKN 338
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
IHR++ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 792 KSDVYSFGVVLLELIS-GKKP 811
KSDV++FGV+L E+ + G P
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP 419
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-41
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
K+G+G FG V+ G VA+K + + F+ E ++ ++ H LV L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
EE I V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 247 VVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 793 SDVYSFGVVLLELIS-GKKP 811
SDV+SFG++L EL + G+ P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 4e-41
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
F K++G G FG V YGK + +VA+K++ + +F+ E ++ + H LV L G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYG 86
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
C ++ ++ EYM NG L + L + L++ D + +EYL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
+HRD+ + N L++ KVSDFGLSR +D S ++ V + PE + + K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 793 SDVYSFGVVLLELIS-GKKP 811
SD+++FGV++ E+ S GK P
Sbjct: 202 SDIWAFGVLMWEIYSLGKMP 221
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+ IG G FG V+ K + DGK +K + + ++ EV L+++ H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 674 CEEEHQRI----------------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 717
+ + E+ GTL + + LD + L++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQI 131
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 777
KG++Y+H + +I+RD+K SNI L + K+ DFGL + D S GT+
Sbjct: 132 TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLR 186
Query: 778 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
Y+ PE +Q ++ D+Y+ G++L EL+
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 5e-41
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
K+G+G FG V+ G VA+K + + F+ E ++ ++ H LV L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 329
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
EE I V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 330 VVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 384
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 793 SDVYSFGVVLLELIS-GKKP 811
SDV+SFG++L EL + G+ P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+++G G FG V+ G +VAVK + F+ E L+ ++ H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
+E I + EYM NG+L D L + L L +A A+G+ ++
Sbjct: 76 VVTQEPIYI-ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 793 SDVYSFGVVLLELIS-GKKP 811
SDV+SFG++L E+++ G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 7/201 (3%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 671
K+G G +G VY G K VAVK + + ++F+ E A++ I H NLV L+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 75
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 792 KSDVYSFGVVLLELIS-GKKP 811
KSDV++FGV+L E+ + G P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-40
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
KK+G G FG V+ +VAVK M + F+ E ++ + H LV L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
+E I + E+M G+L D L + + A+G+ ++
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNY 305
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
IHRD++++NIL+ ++ K++DFGL+R E++ A+ + + PE T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 793 SDVYSFGVVLLELIS-GKKP 811
SDV+SFG++L+E+++ G+ P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-40
Identities = 53/226 (23%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 594 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHR 648
++ + + E + K +G G+FG+VY G E VA+K + ++ S +
Sbjct: 5 NQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 649 TQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 707
+ + E +++ + + ++ L+G C L+ + M G L D + ++ +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGS 116
Query: 708 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLT 766
L AKG+ YL + ++HRD+ + N+L+ K++DFGL++ E+
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ + + + ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-40
Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253
Query: 673 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 309
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
+HRD+ + N+L+ + AKVSDFGL++ + + + V + PE ++ +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 792 KSDVYSFGVVLLELIS-GKKP 811
KSDV+SFG++L E+ S G+ P
Sbjct: 366 KSDVWSFGILLWEIYSFGRVP 386
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 616 KIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 671
++G G+FGSV G + K+ VA+K++ + + E ++ ++ + +V LI
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
G C+ E +LV E G L L G ++ + ++ H + G++YL
Sbjct: 77 GVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQL 789
+HRD+ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 790 TEKSDVYSFGVVLLELIS-GKKP 811
+ +SDV+S+GV + E +S G+KP
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+ +G+G FG V+ K K D A+K + + ++ + EV L+++ H +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 673 YCEEEH---------QRILVY---EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 720
E++ ++ +Y + L+D ++G + + L I A+
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR------- 773
+E+LH + G++HRD+K SNI ++ KV DFGL ++D + +
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 774 ----GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 806
GT Y+ PE + K D++S G++L EL+
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVP 669
+ IG+G FG V+ G + VA+K + S ++ F+ E + + H ++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
LIG E I + E G LR L + LD + + A+ + L YL +
Sbjct: 81 LIGVITENPVWI-IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE---S 134
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 789
+HRD+ + N+L+ N K+ DFGLSR E+ + +S + + ++ PE ++
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 790 TEKSDVYSFGVVLLELIS-GKKP 811
T SDV+ FGV + E++ G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNL 667
K IG G G V YG+++ + VA+K + + R ++ F++E +++ + H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
+ L G ++V EYM NG+L L + + + + G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSD- 169
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE--Y 783
G +HRD+ + N+L+D N+ KVSDFGLSR + + D + ++ + + + PE
Sbjct: 170 --LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 784 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ + SDV+SFGVV+ E+++ G++P
Sbjct: 228 FR--TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALL 659
+ + +G+G FG VY G + K VAVK C+ ++ F++E ++
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 660 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 719
+ H ++V LIG EEE I + E G L L N+ L LT + + K
Sbjct: 68 KNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICK 124
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 779
+ YL + +HRD+ NIL+ K+ DFGLSR E++ + +SV R + ++
Sbjct: 125 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
PE ++ T SDV+ F V + E++S GK+P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 20/214 (9%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+K+G+G F V + + DG A+K + ++ E + +H N++ L+ Y
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 674 CEEEHQR----ILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
C E L+ + GTL + + L L + +GLE +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--------GTVGYLD 780
G HRD+K +NILL + + D G QA + T+ Y
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 781 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
PE + + E++DV+S G VL ++ G+ P
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-39
Identities = 66/228 (28%), Positives = 98/228 (42%), Gaps = 21/228 (9%)
Query: 594 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYG--KMKDGKE--VAVKIM-ADSCSHR 648
+ + I +L +K+G GSFG V G GK VAVK + D S
Sbjct: 8 LQSLTCLIGEKDLR-----LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP 62
Query: 649 TQQ--FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 706
F+ EV + + HRNL+ L G ++ V E G+L DRL L
Sbjct: 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG 121
Query: 707 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEED 764
L + A A+G+ YL + IHRD+ + N+LL K+ DFGL R +D
Sbjct: 122 TL--SRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176
Query: 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ + + PE + + SD + FGV L E+ + G++P
Sbjct: 177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-39
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 603 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVA 657
+ +F + IG+G FG VY+G + D AVK + F+TE
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78
Query: 658 LLSRIHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 716
++ H N++ L+G C E ++V YM +G LR+ + +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 136
Query: 717 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHISSVAR 773
AKG++YL + +HRD+ + N +LD KV+DFGL+R + H + A+
Sbjct: 137 VAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 774 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
V ++ E Q+ T KSDV+SFGV+L EL++ G P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-38
Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 24/296 (8%)
Query: 534 GTSIGVLAILLVLFLC--------SLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYS 585
+I L+ C S I+ + + + + A++ + + + S
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362
Query: 586 IARG-GHFMDEGVAYFIPLP---ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VA 637
+DE Y +P E++ + IG+G FG V+ G + VA
Sbjct: 363 ETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVA 422
Query: 638 VKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL 696
+K + S ++ F+ E + + H ++V LIG E ++ E G LR L
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL 481
Query: 697 HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 756
+ LD + + A+ + L YL + +HRD+ + N+L+ N K+ DFG
Sbjct: 482 QV--RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 757 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
LSR E+ + +S + + ++ PE ++ T SDV+ FGV + E++ G KP
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 67/201 (33%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 81
Query: 673 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 137
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
+HRD+ + N+L+ + AKVSDFGL+++A + V + PE ++ +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFST 193
Query: 792 KSDVYSFGVVLLELIS-GKKP 811
KSDV+SFG++L E+ S G+ P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVP 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 615 KKIGKGSFGSVYYGKMKDGK---EVAVKIM-ADSCSHRTQQ-FVTEVALLSRIHHRNLVP 669
K++G G+FG+V G + K VAVKI+ ++ + + E ++ ++ + +V
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
+IG CE E + V E G L L + + +++ H + G++YL
Sbjct: 83 MIGICEAESWML-VMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---E 135
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 787
+HRD+ + N+LL AK+SDFGLS+ +A+E+ + + V + PE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 788 QLTEKSDVYSFGVVLLELIS-GKKP 811
+ + KSDV+SFGV++ E S G+KP
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALL 659
+ EE F +++GKG+FGSV + G+ VAVK + S + F E+ +L
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 660 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 717
+ H N+V G C +R L+ EY+ G+LRD L +++ +D + LQ
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 123
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 775
KG+EYL T IHRD+ + NIL++ R K+ DFGL++ +++ +
Sbjct: 124 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 776 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 807
+ + PE + + SDV+SFGVVL EL +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 53/226 (23%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 594 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHR 648
++ + + E + K +G G+FG+VY G E VA+K + ++ S +
Sbjct: 5 NQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 649 TQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 707
+ + E +++ + + ++ L+G C L+ + M G L D + ++ +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGS 116
Query: 708 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLT 766
L AKG+ YL + ++HRD+ + N+L+ K++DFGL++ E+
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ + + + ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-38
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT----QQFVTEVALLSRIHHRNLVP 669
+KIG+GSFG K DG++ +K + + S + ++ EVA+L+ + H N+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEI--NISRMSSKEREESRREVAVLANMKHPNIVQ 87
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYL 724
EE +V +Y G L R++ + LDW QI L+++
Sbjct: 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICL----ALKHV 141
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
H + I+HRD+KS NI L + ++ DFG++R + + GT YL PE
Sbjct: 142 H---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEIC 197
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKP 811
N+ KSD+++ G VL EL + K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 666
K IG G FG VY G +K VA+K + + + + F+ E ++ + H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
++ L G + +++ EYM NG L L L + + A G++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA- 164
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYY 784
N +HRD+ + NIL++ N+ KVSDFGLSR + + + T+ +S + + + PE
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 785 GNQQLTEKSDVYSFGVVLLELIS-GKKP 811
++ T SDV+SFG+V+ E+++ G++P
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 54/229 (23%), Positives = 101/229 (44%), Gaps = 32/229 (13%)
Query: 603 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQFVT 654
++ F + +G+G+F ++ G ++ EV +K++ + + ++ F
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 655 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 714
+++S++ H++LV G C + ILV E++ G+L L + N + W L++A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVA 119
Query: 715 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--------NMRAKVSDFGLSRQAEEDLT 766
A + +L +IH +V + NILL K+SD G+S
Sbjct: 120 KQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-- 174
Query: 767 HISSVARGTVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ + + ++ PE N L +D +SFG L E+ S G KP
Sbjct: 175 ---DILQERIPWVPPECIENPKN--LNLATDKWSFGTTLWEICSGGDKP 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 16/220 (7%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQ-FVTEVAL 658
E+ + +G+G FG V + G++VAVK + E+ +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 659 LSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 716
L ++H N+V G C E+ L+ E++ +G+L++ L N+ ++ +L+ A
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQ 134
Query: 717 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARG 774
KG++YL + +HRD+ + N+L++ + K+ DFGL++ + +++ +
Sbjct: 135 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 775 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 813
V + PE + SDV+SFGV L EL++ S
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-38
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL 670
++G G+FGSV G + K+ VA+K++ + + E ++ ++ + +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
IG C+ E +LV E G L L G ++ + ++ H + G++YL
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEK 455
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQ 788
+HR++ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 789 LTEKSDVYSFGVVLLELIS-GKKP 811
+ +SDV+S+GV + E +S G+KP
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-38
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 15/217 (6%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYG-----KMKDGKEVAVKIMADSCSHRTQQFVTEVALL 659
EE + ++GKG+FGSV G VAVK + S + + F E+ +L
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 660 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 717
+H +V G ++ LV EY+ +G LRD L ++ LD L +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQI 136
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 775
KG+EYL + +HRD+ + NIL++ K++DFGL++ ++D + +
Sbjct: 137 CKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 776 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ + PE + + +SDV+SFGVVL EL + K
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-38
Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRT-QQFVTEVALLSRIHHRNLVPL 670
KKIG+G F VY DG VA+K + D + + E+ LL +++H N++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-------LDWLTRLQIAHDAAKGLEY 723
E+++ +V E G L + QK + Q+ LE+
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV--QLCS----ALEH 151
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLD 780
+H + ++HRD+K +N+ + K+ D GL R + ++ A VG Y+
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMS 204
Query: 781 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 835
PE KSD++S G +L E+ + + P F + ++ I++ D
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP-----FYGDKMNLYSLCKKIEQCD 254
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYG-----KMKDGKEVAVKIMADSCSHRTQQFVTEVALL 659
+ EE F +++GKG+FGSV + G+ VAVK + S + F E+ +L
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 660 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 717
+ H N+V G C +R L+ EY+ G+LRD L +++ +D + LQ
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 154
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 775
KG+EYL T IHRD+ + NIL++ R K+ DFGL++ +++ +
Sbjct: 155 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 776 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 807
+ + PE + + SDV+SFGVVL EL +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 671
IG GS+G + K DGK + K + S + Q V+EV LL + H N+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 672 GYCEEEHQRIL--VYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
+ L V EY G L + G+ ++ LD L++ L+ H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 729 NPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
+ G ++HRD+K +N+ LD K+ DFGL+R D + + GT Y+ PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 787 QQLTEKSDVYSFGVVLLELISGKKP 811
EKSD++S G +L EL + P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-37
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 603 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVA 657
+ +F + IG+G FG VY+G + D AVK + QF+TE
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 658 LLSRIHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 716
++ H N++ L+G C E ++V YM +G LR+ + +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 200
Query: 717 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVAR 773
AKG+++L + +HRD+ + N +LD KV+DFGL+R E D H + A+
Sbjct: 201 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 774 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
V ++ E Q+ T KSDV+SFGV+L EL++ G P
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLV 668
K +G G FG+V+ G E V +K++ D ++ Q + + + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
L+G C ++ V +Y+ G+L D + ++ L L AKG+ YL
Sbjct: 79 RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLE--- 132
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQ 787
G++HR++ + N+LL + +V+DFG++ +D + S A+ + ++ E
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 788 QLTEKSDVYSFGVVLLELIS-GKKP 811
+ T +SDV+S+GV + EL++ G +P
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 48/231 (20%)
Query: 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 671
+G+G+FG V + D + A+K + + ++EV LL+ ++H+ +V
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 672 G-YCEEEHQRI------------LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHD 716
+ E + + EY NGTL D + Q+ W QI
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL-- 126
Query: 717 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--- 773
+ L Y+H + GIIHRD+K NI +D + K+ DFGL++ L + ++
Sbjct: 127 --EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 774 ----------GTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISG 808
GT Y+ E +Y EK D+YS G++ E+I
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYN-----EKIDMYSLGIIFFEMIYP 227
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-37
Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNL 667
K +G G FG V G++K + VA+K + + + ++ F+ E +++ + H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
+ L G + ++V EYM NG+L L + + + + A G++YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSD- 165
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYG 785
G +HRD+ + NIL++ N+ KVSDFGL R + + + + + + + + PE
Sbjct: 166 --MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 786 NQQLTEKSDVYSFGVVLLELIS-GKKP 811
++ T SDV+S+G+VL E++S G++P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLVP 669
+ IGKG FG VY+G+ D + A+K ++ + + F+ E L+ ++H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 670 LIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
LIG E ++ YM +G L + Q+ + A+G+EYL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLA--- 141
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT---VGYLDPEYYG 785
+HRD+ + N +LD + KV+DFGL+R + + R V + E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 786 NQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ T KSDV+SFGV+L EL++ G P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 669
K+G G +VY + +VA+K + ++ + EV S++ H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
+I EE+ LV EY+ TL + + + PL T + + G+++ H +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAH---D 129
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQQ 788
I+HRD+K NIL+D N K+ DFG+++ +E LT + V GTV Y PE +
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEA 188
Query: 789 LTEKSDVYSFGVVLLELISGKKP 811
E +D+YS G+VL E++ G+ P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-37
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 673
+G G+ G++ Y M D ++VAVK + C + EV LL H N++
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIRYFCT 86
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
++ + + E TL++ + L + + GL +LH + I+
Sbjct: 87 EKDRQFQYIAIELC-AATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLH---SLNIV 140
Query: 734 HRDVKSSNILL-----DINMRAKVSDFGLSRQAEED---LTHISSVARGTVGYLDPEYY- 784
HRD+K NIL+ ++A +SDFGL ++ + S V GT G++ PE
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPEMLS 199
Query: 785 --GNQQLTEKSDVYSFGVVLLELISGKKP 811
+ T D++S G V +IS
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-37
Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 46/251 (18%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIM-----------------ADSCSHRTQQFVTEVA 657
+ + +G F + + KD K A+K S + F E+
Sbjct: 37 RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 658 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQ--- 712
+++ I + + G + ++YEYM N ++ +++ ++
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 713 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 772
I Y+H I HRDVK SNIL+D N R K+SDFG S + S
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210
Query: 773 RGTVGYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 825
RGT ++ PE Y G K D++S G+ L + P F ++++V
Sbjct: 211 RGTYEFMPPEFFSNESSYNG-----AKVDIWSLGICLYVMFYNVVP-----FSLKISLVE 260
Query: 826 WARSMIKKGDV 836
+ I+ ++
Sbjct: 261 -LFNNIRTKNI 270
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 18/220 (8%)
Query: 605 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVAL 658
+ + +G+G FG V + VAVK + + + + E+ +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 659 LSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 716
L ++H +++ G CE+ LV EY+ G+LRD L + + L A
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP----RHSIGLAQLLLFAQQ 142
Query: 717 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARG 774
+G+ YLH IHRD+ + N+LLD + K+ DFGL++ + +
Sbjct: 143 ICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 775 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 813
V + PE + SDV+SFGV L EL++ S
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 19/237 (8%)
Query: 591 HFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADS 644
+ + L E+ + +G G+FG VY G++ +VAVK + +
Sbjct: 12 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 645 CSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGS 699
CS + + F+ E ++S+ +H+N+V IG + R ++ E M G LR+
Sbjct: 72 CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131
Query: 700 VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFG 756
L L L +A D A G +YL IHRD+ + N LL AK+ DFG
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 757 LSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
++R A V ++ PE + T K+D +SFGV+L E+ S G P
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 665
+++G+GSFG VY G K + VA+K + ++ S R + F+ E +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTR---LQIAHDAA 718
++V L+G + +++ E M G LR N L + +Q+A + A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVG 777
G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 778 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
++ PE + T SDV+SFGVVL E+ + ++P
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPL 670
+ +GKG FG+VY + K +A+K++ + + Q EV + S + H N++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
GY + + L+ EY GT+ L D + A L Y H +
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH---SK 128
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
+IHRD+K N+LL K++DFG S A GT+ YL PE +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGRMHD 185
Query: 791 EKSDVYSFGVVLLELISGKKP 811
EK D++S GV+ E + GK P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNL 667
F IG+G+FG V ++K A+K M + S + F E+ +L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIA 714
+ L+G CE L EY +G L D L S L L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 715 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 774
D A+G++YL IHRD+ + NIL+ N AK++DFGLSR +++ ++ R
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203
Query: 775 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
V ++ E T SDV+S+GV+L E++S G P
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 19/279 (6%)
Query: 549 CSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEE 608
I + S ++ + S ++T + + + L E+
Sbjct: 11 DYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR 70
Query: 609 ATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQQ-FVTEVALLSR 661
+ +G G+FG VY G++ +VAVK + + CS + + F+ E ++S+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 662 IHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTRLQIAHDA 717
+H+N+V IG + R ++ E M G LR+ L L L +A D
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ-AEEDLTHISSVAR 773
A G +YL IHRD+ + N LL AK+ DFG++R A
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 774 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
V ++ PE + T K+D +SFGV+L E+ S G P
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE----VAVKIM-ADSCSHRTQQ-FVTEVALLSRIHHRNLV 668
K +G+G FGSV G +K VAVK M D+ S R + F++E A + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 669 PLIGYCEEEHQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTR---LQIAHDAAKG 720
L+G C E + ++ +M G L L S + + L+ D A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYL 779
+EYL +HRD+ + N +L +M V+DFGLS++ D +A+ V ++
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
E ++ T KSDV++FGV + E+ + G P
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE----VAVKIM-ADSCSHR-TQQFVTEVALLSRIHHRNLV 668
+ +GKG FGSV ++K VAVK++ AD + ++F+ E A + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 669 PLIGYCEEEHQRI------LVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAK 719
L+G + ++ +M +G L L S N L T ++ D A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGY 778
G+EYL + IHRD+ + N +L +M V+DFGLSR+ D ++ V +
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
L E + T SDV++FGV + E+++ G+ P
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 669
+ +G+G G VY + + VA+K+M+++ S F T E R+ ++VP
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
+ + E + Q + ++ L L Q PL + I L+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQQ 788
G HRDVK NIL+ + A + DFG++ +E LT + + GT+ Y+ PE +
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESH 211
Query: 789 LTEKSDVYSFGVVLLELISGKKP 811
T ++D+Y+ VL E ++G P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 24/220 (10%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 672
+ + +G F VY + + G+E A+K + + + + + EV + ++ H N+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 673 YCEEEHQR-------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
+ L+ + G L + L ++ PL T L+I + + ++++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-----------RG 774
P IIHRD+K N+LL K+ DFG + + S
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 775 TVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
T Y PE Y N + EK D+++ G +L L + P
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 33/243 (13%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRIHHRNL--VPL 670
K+IG G V+ + + A+K + + ++T + E+A L+++ + + L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
Y + +V E N L L +K +D R + + + +H
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 146
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 782
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V GTV Y+ PE
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 203
Query: 783 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 258
Query: 837 ISI 839
I
Sbjct: 259 IEF 261
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 670
+ +GKG FG+VY + K +A+K++ S Q E+ + S + H N++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGLEYLHTGCN 729
Y + + L+ E+ G L L D + + A L Y H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSA-TFMEELADALHYCH---E 132
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 789
+IHRD+K N+L+ K++DFG S A GT+ YL PE +
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTH 189
Query: 790 TEKSDVYSFGVVLLELISGKKP 811
EK D++ GV+ E + G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 670
+GKGSF VY + + G EVA+K++ + Q+ EV + ++ H +++ L
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 726
Y E+ + LV E HNG + L KP R QI G+ YLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQII----TGMLYLH- 129
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEY 783
+ GI+HRD+ SN+LL NM K++DFGL+ Q + GT Y+ PE
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP----HEKHYTLCGTPNYISPEI 183
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKP 811
+SDV+S G + L+ G+ P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-35
Identities = 59/241 (24%), Positives = 98/241 (40%), Gaps = 41/241 (17%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 673
K +G GS G+V + G+ VAVK M E+ LL+ H N++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRYYCS 77
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLHT 726
+ + E N L+D + ++ D +LQ ++ G+ +LH
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLV---ESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 132
Query: 727 GCNPGIIHRDVKSSNILLDI-------------NMRAKVSDFGLSRQAEEDLTHISSVAR 773
+ IIHRD+K NIL+ N+R +SDFGL ++ + + +
Sbjct: 133 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 774 ---GTVGYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 823
GT G+ PE ++LT D++S G V ++S K + + E NI
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 824 V 824
+
Sbjct: 251 I 251
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+GKG++G VY G+ +A+K + + S +Q E+AL + H+N+V +G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLHTGC 728
E + E + G+L L + + T+ QI GL+YLH
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLH--- 139
Query: 729 NPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--YYG 785
+ I+HRD+K N+L++ + K+SDFG S++ + GT+ Y+ PE G
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKG 198
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKP 811
+ + +D++S G ++E+ +GK P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-35
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
++G+GSFG V+ K K G + AVK + E+ + + +VPL G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 118
Query: 674 CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
E + E + G+L + G + + + Q +GLEYLH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-QAL----EGLEYLH---TRR 170
Query: 732 IIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYGN 786
I+H DVK+ N+LL + RA + DFG + + D S + GT ++ PE
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 787 QQLTEKSDVYSFGVVLLELISGKKP 811
+ K D++S ++L +++G P
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-35
Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 603 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQFVTEV 656
+ ++ ++G+G+FG V+ + + VAVK + ++ Q F E
Sbjct: 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 94
Query: 657 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKP 704
LL+ + H+++V G C E ++V+EYM +G L R HG V P
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 705 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEE 763
L L +A A G+ YL +HRD+ + N L+ + K+ DFG+SR
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 764 DLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
D + + ++ PE Y + T +SDV+SFGVVL E+ + GK+P
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQFVTEVALLSRIHHRN 666
+++G+G+FG V+ + + VAVK + D + F E LL+ + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG-----------SVNQKPLDWLTRLQI 713
+V G C + I+V+EYM +G L R HG + L L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 714 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVA 772
A A G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D +
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 773 RGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ ++ PE Y + T +SDV+SFGV+L E+ + GK+P
Sbjct: 196 MLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 57/233 (24%), Positives = 108/233 (46%), Gaps = 29/233 (12%)
Query: 603 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTE 655
L E+ + F +++G+ FG VY G + VA+K + D ++ F E
Sbjct: 3 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 656 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG-----------SVNQ 702
L +R+ H N+V L+G ++ +++ Y +G L + + +
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 703 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-A 761
L+ + + A G+EYL + ++H+D+ + N+L+ + K+SD GL R+
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 762 EEDLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
D + + + ++ PE YG + + SD++S+GVVL E+ S G +P
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 33/243 (13%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRI--HHRNLVPL 670
K+IG G V+ + + A+K + + ++T + E+A L+++ H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
Y + +V E N L L +K +D R + + + +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 127
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 782
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V GTV Y+ PE
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 184
Query: 783 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 239
Query: 837 ISI 839
I
Sbjct: 240 IEF 242
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 669
+ +G G V+ + ++D ++VAVK++ + R F E + ++H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 670 LIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
+ E E +V EY+ TLRD +H + P+ +++ DA + L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSH 133
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPE 782
GIIHRDVK +NI++ KV DFG++R + +T ++V GT YL PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPE 189
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ +SDVYS G VL E+++G+ P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 669
+G+G+ +V+ G+ K G A+K+ S + E +L +++H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 670 LIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
L EE R +L+ E+ G+L L N L L + D G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 728 CNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
GI+HR++K NI+ D K++DFG +R+ E+D +S GT YL P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186
Query: 784 Y--------GNQQLTEKSDVYSFGVVLLELISGKKP 811
Y ++ D++S GV +G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 664
F K +G G+FG V + VAVK++ S ++ ++E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------HGSVNQKPLDWLT 709
N+V L+G C +++ EY G L + L ++ LD
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 710 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHI 768
L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
AR V ++ PE N T +SDV+S+G+ L EL S G P
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 670
+ +GKG F + + A KI+ S H+ ++ E+++ + H+++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 726
G+ E+ +V E +L + +K L R QI G +YLH
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIV----LGCQYLH- 158
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
+IHRD+K N+ L+ ++ K+ DFGL+ + E D V GT Y+ PE
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 215
Query: 787 QQLTEKSDVYSFGVVLLELISGKKP 811
+ + + DV+S G ++ L+ GK P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 670
+ +GKG F + + A KI+ S H+ ++ E+++ + H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 726
G+ E+ +V E +L + +K L R QI G +YLH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIV----LGCQYLH- 132
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
+IHRD+K N+ L+ ++ K+ DFGL+ + E D V GT Y+ PE
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 189
Query: 787 QQLTEKSDVYSFGVVLLELISGKKP 811
+ + + DV+S G ++ L+ GK P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 71/285 (24%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 558 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN--FCK 615
R+ + +S +S + + S A P+ E + K
Sbjct: 28 RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87
Query: 616 KIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHR 665
+G+G FG V K K+ VAVK++ D + + V+E+ ++ I H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTRLQ 712
N++ L+G C ++ ++ EY G LR+ L V ++ + + +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 713 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 772
+ A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D+ +I
Sbjct: 208 CTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYK 260
Query: 773 RGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ T G L PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+KIG+G+ G+VY G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 730
+ +V EY+ G+L D + + + QIA + + LE+LH+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN--- 135
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
+IHRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 791 EKSDVYSFGVVLLELISGKKP 811
K D++S G++ +E+I G+ P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 33/243 (13%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRIHHRNL--VPL 670
K+IG G V+ + + A+K + + ++T + E+A L+++ + + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
Y + +V E N L L +K +D R + + + +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 174
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 782
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V G V Y+ PE
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GAVNYMPPEAIKDM 231
Query: 783 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 286
Query: 837 ISI 839
I
Sbjct: 287 IEF 289
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 36/228 (15%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE--------VAVKIMADSCSHRTQQ-FVTEVALLSRI- 662
K +G+G+FG V + + VAVK++ D + + V+E+ ++ I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 663 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLT 709
H+N++ L+G C ++ ++ EY G LR+ L V ++ + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 710 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769
+ + A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D+ +I
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 770 SVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ T G L PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-34
Identities = 67/252 (26%), Positives = 110/252 (43%), Gaps = 21/252 (8%)
Query: 613 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT-EVALLSRIHHRNLVPL 670
+++G G FG V +D G++VA+K S + ++ E+ ++ +++H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 671 IGYCEEE------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
+ +L EY G LR L+ N L + D + L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 725 HTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 781
H IIHRD+K NI+L + K+ D G +++ ++ V GT+ YL P
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLAP 192
Query: 782 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841
E ++ T D +SFG + E I+G +P F V W + +K + +V
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP-----FLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 842 PVLIGNVKIESI 853
L G VK S+
Sbjct: 248 DDLTGAVKFSSV 259
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 41/233 (17%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 665
K +G+G FG V K VAVK++ ++ S + ++E +L +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------------HGSVNQKP 704
+++ L G C ++ +L+ EY G+LR L +++
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 705 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764
L + A ++G++YL ++HRD+ + NIL+ + K+SDFGLSR D
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSR----D 199
Query: 765 LTHISSVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ S + + G + E + T +SDV+SFGV+L E+++ G P
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 35/227 (15%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 664
K +G+G+FG V + VAVK++ + +H + ++E+ +L I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 665 RNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTR 710
N+V L+G C + +++ E+ G L L + + L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 711 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 770
+ + AKG+E+L + IHRD+ + NILL K+ DFGL+R D+
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPD 203
Query: 771 VARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
R L PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 70/278 (25%), Positives = 118/278 (42%), Gaps = 39/278 (14%)
Query: 564 QKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFG 623
Q YE + T S+ Y ++D + E F K +G G+FG
Sbjct: 6 QFRYESQLQMVQVTGSSDNEY------FYVDFREYEYDLKWEFPRENLEFGKVLGSGAFG 59
Query: 624 SVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLIGYCE 675
V + VAVK++ + ++ ++E+ +++++ H N+V L+G C
Sbjct: 60 KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119
Query: 676 EEHQRILVYEYMHNGTLRDRL-----------------HGSVNQKPLDWLTR---LQIAH 715
L++EY G L + L ++ L+ LT L A+
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179
Query: 716 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARG 774
AKG+E+L +HRD+ + N+L+ K+ DFGL+R + + AR
Sbjct: 180 QVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236
Query: 775 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
V ++ PE T KSDV+S+G++L E+ S G P
Sbjct: 237 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 50/201 (24%), Positives = 76/201 (37%), Gaps = 13/201 (6%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRTQQFVTEVALLSRI-HHRNLVPL 670
++G GS+G V+ + K DG+ AVK + + EV ++ H V L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
EE L E +L+ L D L +LH +
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
G++H DVK +NI L R K+ DFGL + G Y+ PE
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPELL-QGSYG 233
Query: 791 EKSDVYSFGVVLLELISGKKP 811
+DV+S G+ +LE+ +
Sbjct: 234 TAADVFSLGLTILEVACNMEL 254
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-34
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 669
+G+G+ +V+ G+ K G A+K+ S + E +L +++H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 670 LIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
L EE R +L+ E+ G+L L N L L + D G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 728 CNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
GI+HR++K NI+ D K++DFG +R+ E+D +S GT YL P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186
Query: 784 Y--------GNQQLTEKSDVYSFGVVLLELISGKKP 811
Y ++ D++S GV +G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 664
F K +G G+FG V + VAVK++ + ++ ++E+ ++S + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQ---------KPLDWLTRLQI 713
N+V L+G C +++ EY G L + R V + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 714 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVA 772
+ A+G+ +L + IHRDV + N+LL AK+ DFGL+R + + A
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 773 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
R V ++ PE + T +SDV+S+G++L E+ S G P
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 68/246 (27%), Positives = 101/246 (41%), Gaps = 67/246 (27%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 665
+ + IG+G+FG V+ + VAVK++ + S Q F E AL++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------------HGSVNQKP 704
N+V L+G C L++EYM G L + L S P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 705 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764
L +L IA A G+ YL +HRD+ + N L+ NM K++DFGLSR
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 765 LTHISSVARGTVGYLDPEYY---GNQQL---------------TEKSDVYSFGVVLLELI 806
+YY GN + T +SDV+++GVVL E+
Sbjct: 228 -----------------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
Query: 807 S-GKKP 811
S G +P
Sbjct: 271 SYGLQP 276
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
KIG+GS G V + K G++VAVK+M R + EV ++ H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 730
+ ++ E++ G L D + L QIA + L YLH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLH---AQ 160
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
G+IHRD+KS +ILL ++ R K+SDFG Q +D+ S+ GT ++ PE
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYA 219
Query: 791 EKSDVYSFGVVLLELISGKKP 811
+ D++S G++++E++ G+ P
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPP 240
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-33
Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 36/226 (15%)
Query: 615 KKIGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 664
K +G+G+FG V + +VAVK++ + + ++E+ ++ I H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTRL 711
+N++ L+G C ++ ++ EY G LR+ L ++ L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 712 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 771
A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R D+ HI
Sbjct: 195 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247
Query: 772 ARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
+ T G L PE ++ T +SDV+SFGV+L E+ + G P
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 8e-33
Identities = 40/263 (15%), Positives = 82/263 (31%), Gaps = 28/263 (10%)
Query: 571 DSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFC--KKIGKGSFGSVYYG 628
L + ++Y + P E + + +G+G+F VY
Sbjct: 28 FKLLSGLSKPVSSYP---NTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEA 84
Query: 629 KMKD------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682
D ++ +K+ + + L + ++ +L
Sbjct: 85 TQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144
Query: 683 VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 740
V E GTL + + + + +K + + A +E +H IIH D+K
Sbjct: 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPD 201
Query: 741 NILL-----------DINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYLDPEYYGNQQ 788
N +L D++ + D G S + A+ T G+ E N+
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261
Query: 789 LTEKSDVYSFGVVLLELISGKKP 811
+ D + + ++ G
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYM 284
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+KIGKGSFG V+ G K VA+KI+ + + E+ +LS+ + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCN 729
++ + ++ EY+ G+ D L L QIA + KGL+YLH +
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLH---S 137
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGN 786
IHRD+K++N+LL + K++DFG++ Q LT VG ++ PE
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQ----LTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 787 QQLTEKSDVYSFGVVLLELISGKKP 811
K+D++S G+ +EL G+ P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+ IG G+ V ++VA+K + + C + + E+ +S+ HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW--LTRLQIA---HDAAKGLEYLHTG 727
+ + LV + + G++ D + V + L IA + +GLEYLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-- 138
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VG---YLDPE- 782
G IHRDVK+ NILL + +++DFG+S + R T VG ++ PE
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 783 -----YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
Y K+D++SFG+ +EL +G P
Sbjct: 198 MEQVRGYD-----FKADIWSFGITAIELATGAAP 226
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-32
Identities = 43/204 (21%), Positives = 77/204 (37%), Gaps = 23/204 (11%)
Query: 616 KIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIG 672
I G G +Y +G+ V +K + S Q + E L+ + H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 673 YCEEEHQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
+ E + +V EY+ +L+ L + + L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-- 199
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 787
+ G+++ D+K NI+L + K+ D G + + + GT G+ PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR----INSFGYLY-GTPGFQAPEIVRTG 252
Query: 788 QLTEKSDVYSFGVVLLELISGKKP 811
T +D+Y+ G L L
Sbjct: 253 P-TVATDIYTVGRTLAALTLDLPT 275
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
++G G+FG VY K K+ G A K++ + ++ E+ +L+ H +V L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 730
+ + ++ E+ G + + LT QI + L +LH+
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQIQVVCRQMLEALNFLHSK--- 136
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
IIHRD+K+ N+L+ + +++DFG+S + + L S GT ++ PE + +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMK 195
Query: 791 E-----KSDVYSFGVVLLELISGKKP 811
+ K+D++S G+ L+E+ + P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 4e-31
Identities = 24/232 (10%), Positives = 59/232 (25%), Gaps = 42/232 (18%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 670
+ + G V+ + + ++ A+K+ A++ ++ +R+ +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 671 IGYC--------------------------EEEHQRILVYEYMH--NGTLRDRLH-GSVN 701
+L+ L L V
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 702 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761
+ L + + L + G++H N+ + + R + D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 762 EEDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKP 811
S V Y E+ T + + G+ + + P
Sbjct: 245 GTRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+K+G+GS+GSVY K+ G+ VA+K + Q+ + E++++ + ++V G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 730
+ +V EY G++ D + + K L +IA KGLEYLH
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLT---EDEIATILQSTLKGLEYLHFM--- 144
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
IHRD+K+ NILL+ AK++DFG++ Q + + ++V GT ++ PE
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYN 203
Query: 791 EKSDVYSFGVVLLELISGKKP 811
+D++S G+ +E+ GK P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 43/222 (19%), Positives = 79/222 (35%), Gaps = 33/222 (14%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRTQQFVTEVALLSRI-HHRNLVPL 670
+KIG G FGSV+ + DG A+K + S Q + EV + + H ++V
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
E+ ++ EY + G+L D + + +GL Y+H +
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133
Query: 730 PGIIHRDVKSSNILLDIN-------------------MRAKVSDFGLSRQAEEDLTHISS 770
++H D+K SNI + + K+ D G +
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191
Query: 771 VARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
G +L E N K+D+++ + ++ +
Sbjct: 192 ---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 7e-31
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 613 FCKKIGKG--SFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNL 667
IGKG +V + K G+ V V+ + ++CS+ F+ E+ + +H N+
Sbjct: 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYL 724
VP +++ +V +M G+ +D + + L IA K L+Y+
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG----MNELAIAYILQGVLKALDYI 144
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR------GTVGY 778
H + G +HR VK+S+IL+ ++ + +S + V + +
Sbjct: 145 H---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 779 LDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
L PE Y KSD+YS G+ EL +G P
Sbjct: 202 LSPEVLQQNLQGYD-----AKSDIYSVGITACELANGHVP 236
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 23/232 (9%)
Query: 594 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRT 649
+ + + E+ ++G G+ G V+ K+ G +A K++ +
Sbjct: 23 QKQKVGELKDDDFEK-----ISELGAGNGGVVF--KVSHKPSGLVMARKLIHLEIKPAIR 75
Query: 650 QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 709
Q + E+ +L + +V G + + + E+M G+L D++ + P L
Sbjct: 76 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILG 134
Query: 710 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--TH 767
+ ++ KGL YL I+HRDVK SNIL++ K+ DFG+S Q + + +
Sbjct: 135 K--VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190
Query: 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 819
+ GT Y+ PE + +SD++S G+ L+E+ G+ P+ D
Sbjct: 191 V-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-30
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNL 667
+ +GKGSFG V K K G+E AVK+++ + + EV LL ++ H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
+ L + E++ LV E G L D + ++ + R Q+ G+ Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-QV----LSGITYMH 143
Query: 726 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 782
I+HRD+K N+LL + ++ DFGLS E + GT Y+ PE
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPE 198
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ EK DV+S GV+L L+SG P
Sbjct: 199 VL-HGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 672
+ +G G++G VY G+ G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 673 ------YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 723
+ Q LV E+ G++ D + + L IA + +GL +
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT----LKEEWIAYICREILRGLSH 144
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLD 780
LH +IHRD+K N+LL N K+ DFG+S Q L +G ++
Sbjct: 145 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ----LDRTVGRRNTFIGTPYWMA 197
Query: 781 PEYYGNQQLTE-----KSDVYSFGVVLLELISGKKP 811
PE + + KSD++S G+ +E+ G P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 41/272 (15%), Positives = 88/272 (32%), Gaps = 61/272 (22%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH--- 664
+G+ + + G+ V + + + ++ V + LL I +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 665 -----RNLVPLIGYCEEEHQRI----------------LVYEYMH--NGTLRDRL-HGSV 700
R + P + + +++ +Y M T + L S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 701 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760
K L RLQ+ + L LH + G++H ++ +I+LD ++ F +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 761 AEEDLTHISSVARGTVGYLDPEY-----------YGNQQLTEKSDVYSFGVVLLELISGK 809
+ + + G+ PE +T D ++ G+V+ +
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 810 KP--------VSVEDFGAELNIVHWARSMIKK 833
P S F + NI R++++
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLEG 342
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 615 KKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRTQQFVTEVA-LLSRIHHRNLVP 669
++G+G++G V KM+ G+ +AVK + A S ++ + ++ + + V
Sbjct: 13 MELGRGAYGVVE--KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLH 725
G E + E M + +L D+ + V K P D L + IA K LE+LH
Sbjct: 71 FYGALFREGDVWICMELM-DTSL-DKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLH 126
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 781
+ +IHRDVK SN+L++ + K+ DFG+S + VA+ G Y+ P
Sbjct: 127 S--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDAGCKPYMAP 178
Query: 782 E----YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
E + + KSD++S G+ ++EL + P
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-30
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVP 669
KK+G G++G V + K E A+KI+ + + + + EVA+L + H N++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
L + E++ LV E G L D + N+ + + Q+ G+ YLH
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK-QV----LSGVTYLH-- 153
Query: 728 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
I+HRD+K N+LL + + K+ DFGLS E + GT Y+ PE
Sbjct: 154 -KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVL 210
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKP 811
++ EK DV+S GV+L L++G P
Sbjct: 211 -RKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 60/249 (24%), Positives = 90/249 (36%), Gaps = 53/249 (21%)
Query: 613 FCKKIGKGSFGSVYYGKMKD-GKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRN 666
IG+GS+G V A+KI + ++ TEV L+ ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----------- 715
+ L E+E LV E H G L D+L+ ++ +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 716 -------------------DAAK-------GLEYLHTGCNPGIIHRDVKSSNILL--DIN 747
+ L YLH N GI HRD+K N L + +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206
Query: 748 MRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE--YYGNQQLTEKSDVYSFGVVL 802
K+ DFGLS++ + GT ++ PE N+ K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 803 LELISGKKP 811
L+ G P
Sbjct: 267 HLLLMGAVP 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 670
F + +G G+F V+ K + GK A+K + S + R E+A+L +I H N+V L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
E LV + + G L DR+ G +K + + Q+ ++YLH
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-QV----LSAVKYLH--- 123
Query: 729 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 785
GI+HRD+K N+L + N + ++DFGLS+ + + +S+ GT GY+ PE
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYVAPEVLA 180
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKP 811
+ ++ D +S GV+ L+ G P
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-29
Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIHHR 665
K +G G+ G V + K+VA++I++ + TE+ +L +++H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 723
++ + + + E +V E M G L D++ + + + Q+ ++Y
Sbjct: 201 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QMLL----AVQY 254
Query: 724 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 780
LH GIIHRD+K N+LL + + K++DFG S+ E + GT YL
Sbjct: 255 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 309
Query: 781 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 835
PE G D +S GV+L +SG P S L + I G
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGK 361
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 68/207 (32%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 670
++IG GSFG+VY+ + + VA+K M + + Q + EV L ++ H N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTG 727
G EH LV EY G+ D L V++KPL ++IA H A +GL YLH+
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLLE--VHKKPLQ---EVEIAAVTHGALQGLAYLHSH 173
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 787
+IHRDVK+ NILL K+ DFG + + + GT ++ PE
Sbjct: 174 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 225
Query: 788 QLTE---KSDVYSFGVVLLELISGKKP 811
+ K DV+S G+ +EL K P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-29
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKI-------------MADSCSHRTQQFVTEVAL 658
+K+G G++G V K K E A+K+ + ++ E++L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 659 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHD 716
L + H N++ L E++ LV E+ G L +++ ++ + + QI
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK-QI--- 155
Query: 717 AAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVAR 773
G+ YLH I+HRD+K NILL + + K+ DFGLS +D +
Sbjct: 156 -LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-- 209
Query: 774 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
GT Y+ PE ++ EK DV+S GV++ L+ G P
Sbjct: 210 GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-29
Identities = 28/236 (11%), Positives = 66/236 (27%), Gaps = 42/236 (17%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHHRNL 667
+G+ + + G+ V + + + ++ V + LL I ++
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 668 ------------------VPLIGYCEEEHQRILVYEY--------MHNGTLRDRLHGSV- 700
+ + + + V + T + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 701 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760
K L RLQ+ + L LH + G++H ++ +I+LD ++ F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 761 AEEDLTHISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ +T D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---------ADSCSHRTQQFVTEVALLSRI-H 663
+ +G+G V K KE AVKI+ A+ + + EV +L ++
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 664 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 721
H N++ L E LV++ M G L D L ++++K + R + + +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR-ALL----EVI 137
Query: 722 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 781
LH I+HRD+K NILLD +M K++DFG S Q + GT YL P
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYLAP 192
Query: 782 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
E + ++ D++S GV++ L++G P
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 615 KKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRTQQFVTEVA-LLSRIHHRNLVP 669
+IG+G++GSV KM G+ +AVK + + +Q + ++ ++ +V
Sbjct: 28 GEIGRGAYGSVN--KMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLH 725
G E + E M + + + P + L + I K L +L
Sbjct: 86 FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKALNHLK 142
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 781
N IIHRD+K SNILLD + K+ DFG+S Q + S+A+ G Y+ P
Sbjct: 143 E--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSIAKTRDAGCRPYMAP 194
Query: 782 E----YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
E Q +SDV+S G+ L EL +G+ P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 25/210 (11%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 670
IG+GS+G V K A K + +F E+ ++ + H N++ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
E+ LV E G L +R+ + + + + + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK-DV----LSAVAYCH--- 123
Query: 729 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--- 782
+ HRD+K N L + K+ DFGL+ + + + V GT Y+ P+
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLE 181
Query: 783 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
YG + D +S GV++ L+ G P
Sbjct: 182 GLYG-----PECDEWSAGVMMYVLLCGYPP 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 36/238 (15%)
Query: 590 GHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSC 645
G+ G Y + +LE ++G G+ G V+ KM+ G +AVK M
Sbjct: 11 GYLTIGGQRYQAEINDLEN-----LGEMGSGTCGQVW--KMRFRKTGHVIAVKQMRRSGN 63
Query: 646 SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQ 702
++ + ++ +L +V G + E M + R+ G + +
Sbjct: 64 KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE 123
Query: 703 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762
+ L ++ K L YL G+IHRDVK SNILLD + K+ DFG+S +
Sbjct: 124 RILG-----KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL- 175
Query: 763 EDLTHISSVAR----GTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ A+ G Y+ PE ++DV+S G+ L+EL +G+ P
Sbjct: 176 -----VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLV 668
N +GKGSFG V K + +E AVK++ + + T + EV LL ++ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
L E+ +V E G L D + ++ + + Q+ G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QV----FSGITYMH- 138
Query: 727 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
I+HRD+K NILL + + K+ DFGLS +++ + GT Y+ PE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKP 811
EK DV+S GV+L L+SG P
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 669
F +K+G G+FG V+ + + G E +K + D +Q E+ +L + H N++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLE 722
+ E+ H +V E G L +R+ + + L+ A+ L
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARG--KALSE----GYVAELMKQMMNALA 138
Query: 723 YLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 779
Y H + ++H+D+K NIL + K+ DFGL+ + D ++ GT Y+
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYM 193
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
PE + + +T K D++S GVV+ L++G P
Sbjct: 194 APEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLV 668
N +GKGSFG V K + +E AVK++ + + T + EV LL ++ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
L E+ +V E G L D + ++ + + Q+ G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QV----FSGITYMH- 138
Query: 727 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE- 782
I+HRD+K NILL + + K+ DFGLS +++ + GT Y+ PE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 783 ---YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
Y EK DV+S GV+L L+SG P
Sbjct: 195 LRGTYD-----EKCDVWSAGVILYILLSGTPP 221
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 30/217 (13%)
Query: 613 FCKKIGKGSFGSVYYGKMKD-GKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRN 666
C+ IGKG F V ++ G++ AVKI S T+ E ++ + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK----- 719
+V L+ + +V+E+M L + + A+
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV----YSE----AVASHYMRQI 139
Query: 720 --GLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARG 774
L Y H + IIHRDVK +LL + + K+ FG++ Q E G
Sbjct: 140 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-G 195
Query: 775 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
T ++ PE + + DV+ GV+L L+SG P
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 19/228 (8%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 672
K +G+GSF K + AVKI++ TQ+ E+ L H N+V L
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHE 73
Query: 673 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
++ LV E ++ G L +R+ ++ ++ R ++ + ++H +
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-KL----VSAVSHMH---DV 125
Query: 731 GIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 787
G++HRD+K N+L + N+ K+ DFG +R D + + T+ Y PE
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQN 184
Query: 788 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 835
E D++S GV+L ++SG+ P D IKKGD
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNLV 668
+ +++GKG+F V K G E A KI+ S R Q + E + ++ H N+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
L +EE LV++ + G L + + ++ + QI + + Y H
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI----LESIAYCH- 122
Query: 727 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
+ GI+HR++K N+LL K++DFGL+ + + GT GYL PE
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEV 178
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKP 811
++ D+++ GV+L L+ G P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIH-H 664
IG+G V + G E AVKIM + + E +L ++ H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 722
+++ LI E LV++ M G L D L ++++K + R + + +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR-SLL----EAVS 214
Query: 723 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 782
+LH I+HRD+K NILLD NM+ ++SDFG S E GT GYL PE
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GTPGYLAPE 269
Query: 783 ------YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ ++ D+++ GV+L L++G P
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 48/206 (23%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 670
+ +++G G+FG V+ K G+ K + E+++++++HH L+ L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTG 727
E++++ +L+ E++ G L DR+ + ++ ++ + A +GL+++H
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRI---AAED--YKMSEAEVINYMRQACEGLKHMH-- 166
Query: 728 CNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 785
I+H D+K NI+ K+ DFGL+ + D I V T + PE
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVD 223
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKP 811
+ + +D+++ GV+ L+SG P
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH 664
+ +++G G F V + K G E A K + A ++ EV++L ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 722
N++ L E +L+ E + G L D L S++++ + QI G+
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVN 129
Query: 723 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 778
YLH I H D+K NI+L K+ DFGL+ + E+ GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEF 184
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ PE + L ++D++S GV+ L+SG P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 50/234 (21%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--------ADSCSHRTQQFVT----------- 654
+IGKGS+G V D A+K++ A +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 655 -------EVALLSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPL 705
E+A+L ++ H N+V L+ ++ ++ +V+E ++ G + + KPL
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV----PTLKPL 134
Query: 706 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765
D KG+EYLH IIHRD+K SN+L+ + K++DFG+S + +
Sbjct: 135 SEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 766 THISSVARGTVGYLDPE--------YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+S+ GT ++ PE + G + DV++ GV L + G+ P
Sbjct: 192 ALLSNTV-GTPAFMAPESLSETRKIFSG-----KALDVWAMGVTLYCFVFGQCP 239
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-27
Identities = 54/265 (20%), Positives = 106/265 (40%), Gaps = 21/265 (7%)
Query: 558 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATN-----N 612
+K D + +++ + + P P + + +
Sbjct: 101 LIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYD 160
Query: 613 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 671
+++G G+FG V+ + G A K + + E+ +S + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
E++++ +++YE+M G L +++ H +++ R Q+ KGL ++H
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR-QV----CKGLCHMH--- 272
Query: 729 NPGIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
+H D+K NI+ K+ DFGL+ + V GT + PE
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEG 330
Query: 787 QQLTEKSDVYSFGVVLLELISGKKP 811
+ + +D++S GV+ L+SG P
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIHHR 665
K +G G+ G V + K+VA+KI++ + TE+ +L +++H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 723
++ + + + E +V E M G L D++ + + + Q+ ++Y
Sbjct: 76 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QML----LAVQY 129
Query: 724 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 780
LH GIIHRD+K N+LL + + K++DFG S+ E + GT YL
Sbjct: 130 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 184
Query: 781 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 835
PE G D +S GV+L +SG P S L + I G
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGK 236
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 672
+G+G+ V +E AVKI+ H + EV +L + HRN++ LI
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+ EEE + LV+E M G++ +H N+ + + + A L++LH N
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-DV----ASALDFLH---NK 130
Query: 731 GIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVAR------GTVGYLDP 781
GI HRD+K NIL + K+ DF L + + G+ Y+ P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 782 E-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
E ++ D++S GV+L L+SG P
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-27
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 613 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVP 669
+++GKG+F V G+E A I+ + Q+ E + + H N+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
L EE L+++ + G L + + ++ + QI + + + H
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QI----LEAVLHCH-- 127
Query: 728 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
G++HR++K N+LL K++DFGL+ + E + A GT GYL PE
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVL 185
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKP 811
+ D+++ GV+L L+ G P
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHH 664
+++G G F V + K GKE A K + ++ EV +L I H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 722
N++ L E + +L+ E + G L D L S+ + + QI G+
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-QI----LDGVH 122
Query: 723 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 778
YLH + I H D+K NI+L N R K+ DFG++ + E + GT +
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEF 177
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ PE + L ++D++S GV+ L+SG P
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 50/267 (18%), Positives = 90/267 (33%), Gaps = 73/267 (27%)
Query: 615 KKIGKGSFGSVYYGKMK-DG-----KEVA--------------VKIMA------------ 642
+ +G+G FG V+ K K D K + VK +A
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 643 ---------------------------DSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 675
S ++ + +N V +
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 676 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 735
+ + + L+D ++ + + + L I A+ +E+LH + G++HR
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHR 188
Query: 736 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----------GTVGYLDPEYY 784
D+K SNI ++ KV DFGL ++D + + GT Y+ PE
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKP 811
+ K D++S G++L EL+
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHH 664
+ +++G G F V + K G + A K + + EV++L I H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 722
N++ L E + IL+ E + G L D L S+ ++ + QI G+
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-QI----LNGVY 128
Query: 723 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 778
YLH + I H D+K NI+L R K+ DFGL+ + + + GT +
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEF 183
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ PE + L ++D++S GV+ L+SG P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 613 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNLVP 669
+++GKG+F V K G E A KI+ S R Q + E + ++ H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
L +EE LV++ + G L + + ++ + QI + + Y H
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI----LESIAYCH-- 145
Query: 728 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
+ GI+HR++K N+LL K++DFGL+ + + GT GYL PE
Sbjct: 146 -SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVL 202
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKP 811
++ D+++ GV+L L+ G P
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH 664
+ +++G G F V + K G E A K + A ++ EV++L ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 722
N++ L E +L+ E + G L D L S++++ + QI G+
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVN 129
Query: 723 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 778
YLH I H D+K NI+L K+ DFGL+ + E+ GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEF 184
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ PE + L ++D++S GV+ L+SG P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 43/207 (20%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV-TEVALLSRIHHRNLVP 669
+ +G+G FG V+ K K + Q V E+++L+ HRN++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILH 65
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
L E + ++++E++ + +R+ +N++ + Q+ + L++LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-QV----CEALQFLH- 119
Query: 727 GCNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
+ I H D++ NI+ + K+ +FG +RQ + + Y PE +
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVH 175
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKP 811
+ ++ +D++S G ++ L+SG P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 45/222 (20%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA----DSCSHRTQQFVTEVALLSRIHHRNLVP 669
+G+GS+G V + AVKI+ + E+ LL R+ H+N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 670 L--IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------G 720
L + Y EE+ + +V EY G + SV +K R + A G
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEK------RFPV-CQAHGYFCQLIDG 121
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTV 776
LEYLH + GI+H+D+K N+LL K+S G++ A +D S G+
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GSP 175
Query: 777 GYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ PE + G K D++S GV L + +G P
Sbjct: 176 AFQPPEIANGLDTFSG-----FKVDIWSAGVTLYNITTGLYP 212
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 57/257 (22%), Positives = 100/257 (38%), Gaps = 52/257 (20%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 665
+G G+FG V+ + KEV VK + + + E+A+LSR+ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGT-LRDRL--HGSVNQKPLDWLTRL---QIAHDAAK 719
N++ ++ E + LV E +G L + H +++ L Q+
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LASYIFRQLVS---- 141
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 779
+ YL IIHRD+K NI++ + K+ DFG + E + GT+ Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYC 196
Query: 780 DPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF----GAELNIVHW--- 826
PE Y G + +++S GV L L+ + P + A ++ +
Sbjct: 197 APEVLMGNPYRG-----PELEMWSLGVTLYTLVFEENP--FCELEETVEAAIHPPYLVSK 249
Query: 827 -ARSMIKKGDVISIVDP 842
S++ + P
Sbjct: 250 ELMSLVSG---LLQPVP 263
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 40/216 (18%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+ +G+G++G V + VAVKI+ + E+ + ++H N+V G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLH 725
+ E + + L EY G L DR+ + DA + G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMP-------EPDAQRFFHQLMAGVVYLH 122
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTVGYLDP 781
GI HRD+K N+LLD K+SDFGL+ E L + GT+ Y+ P
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAP 176
Query: 782 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
E ++ E DV+S G+VL +++G+ P
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELP 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 36/222 (16%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ----QFVTEVALLSRI-HHRNLV 668
K++G+G F V K G+E A K + R Q + + E+A+L ++
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GL 721
L E + IL+ EY G + + + ++ +D + G+
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSL----CLPELAEMVSE----NDVIRLIKQILEGV 144
Query: 722 EYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 778
YLH I+H D+K NILL K+ DFG+SR+ GT Y
Sbjct: 145 YYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEY 199
Query: 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 820
L PE +T +D+++ G++ L++ P F E
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSP-----FVGE 236
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLI 671
K IGKG+F V + + G+EVA+KI+ + Q+ EV ++ ++H N+V L
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
E E L+ EY G + D L HG + +K R QI ++Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVS----AVQYCH---Q 132
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------Y 783
I+HRD+K+ N+LLD +M K++DFG S + G Y PE Y
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKY 190
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKP 811
G + DV+S GV+L L+SG P
Sbjct: 191 DG-----PEVDVWSLGVILYTLVSGSLP 213
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 63/264 (23%), Positives = 114/264 (43%), Gaps = 37/264 (14%)
Query: 558 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKI 617
R + ++++ A + P + A+ G Y + E +
Sbjct: 51 RMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF---YTVSKTE----------IL 97
Query: 618 GKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 676
G G FG V+ + G ++A KI+ ++ E+++++++ H NL+ L E
Sbjct: 98 GGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES 157
Query: 677 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNPGII 733
++ +LV EY+ G L DR+ +++ LT L +G+ ++H I+
Sbjct: 158 KNDIVLVMEYVDGGELFDRI---IDES--YNLTELDTILFMKQICEGIRHMH---QMYIL 209
Query: 734 HRDVKSSNILL------DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 787
H D+K NIL I K+ DFGL+R+ + V GT +L PE
Sbjct: 210 HLDLKPENILCVNRDAKQI----KIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNYD 263
Query: 788 QLTEKSDVYSFGVVLLELISGKKP 811
++ +D++S GV+ L+SG P
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 40/216 (18%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+ +G+G++G V + VAVKI+ + E+ + ++H N+V G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLH 725
+ E + + L EY G L DR+ + DA + G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMP-------EPDAQRFFHQLMAGVVYLH 122
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTVGYLDP 781
GI HRD+K N+LLD K+SDFGL+ E L + GT+ Y+ P
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAP 176
Query: 782 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
E ++ E DV+S G+VL +++G+ P
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELP 207
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 672
+ +G G G V + G++ A+K++ DS R EV + ++V ++
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILD 89
Query: 673 YCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 725
E H ++ E M G L R+ ++ T + I D +++LH
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 726 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 782
+ I HRDVK N+L + + K++DFG +++ ++ + + T Y+ PE
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPE 199
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
G ++ + D++S GV++ L+ G P
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS-CSHRTQQFVTEVALLSR-IHHRNLV 668
+ IG GS+ K E AVKI+ S E+ +L R H N++
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EIEILLRYGQHPNII 79
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
L ++ +V E M G L D++ +++ + I K +EYLH
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF-TI----TKTVEYLH- 133
Query: 727 GCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 782
G++HRD+K SNIL ++ DFG ++Q + + + T ++ PE
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPE 190
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
Q D++S GV+L +++G P
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 41/219 (18%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-----DSCSHRTQQFVT-EVALLSRIHHR-- 665
+G G FGSVY G + D VA+K + D V EV LL ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 666 NLVPLIGYCEEEHQRILVYEYMHN-GTLRDRL--HGSVNQKPLDWLTRL---QIAHDAAK 719
++ L+ + E +L+ E L D + G++ ++ L R Q+
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE----LARSFFWQVLE---- 160
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGY 778
+ + H N G++HRD+K NIL+D+N K+ DFG ++ + GT Y
Sbjct: 161 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVY 214
Query: 779 LDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
PE Y+G + V+S G++L +++ G P
Sbjct: 215 SPPEWIRYHRYHG-----RSAAVWSLGILLYDMVCGDIP 248
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 613 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 671
++G+G+ VY K K K A+K++ + + TE+ +L R+ H N++ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK-------GLE 722
E + LV E + G L DR+ G +++ DAA +
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSER------------DAADAVKQILEAVA 162
Query: 723 YLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 779
YLH GI+HRD+K N+L + K++DFGLS+ E + + GT GY
Sbjct: 163 YLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYC 217
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836
PE + D++S G++ L+ G +P E + I +
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF------RRILNCEY 268
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 670
+G G+FG V G+ G +VAVKI+ + E+ L H +++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
+V EY+ G L D + HG V + L + QI ++Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ-QILS----AVDYCH--- 128
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 782
++HRD+K N+LLD +M AK++DFGLS + + G+ Y PE
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRL 186
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
Y G + D++S GV+L L+ G P
Sbjct: 187 YAG-----PEVDIWSCGVILYALLCGTLP 210
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 6/119 (5%)
Query: 391 NDRGDPCVPVPWEWVTCSTTT-PPRITKIALSGKNLKGE--IPPELKNMEALTELWL-DG 446
D C W V C T T R+ + LSG NL IP L N+ L L++
Sbjct: 28 LPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI 86
Query: 447 NFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
N L GP+P +++L L +++ + ++G++P ++ + L L N+ G +PP++
Sbjct: 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 28/106 (26%), Positives = 46/106 (43%), Gaps = 1/106 (0%)
Query: 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 474
+ + LS L+G+ + + ++ L N L L + +L + L NN + G
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYG 258
Query: 475 SLPSYMGSLPNLQELHIENNSFVGEIPPAL-LTGKVIFKYDNNPKL 519
+LP + L L L++ N+ GEIP L + Y NN L
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 27/91 (29%), Positives = 40/91 (43%), Gaps = 3/91 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEAL-TELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 470
P + I G + G IP + L T + + N LTG +P + L +L V L N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 501
L G GS N Q++H+ NS ++
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 2e-17
Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 7/93 (7%)
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----MSRLIDLRIVHLENNE 471
+ S L G +PP + ++ L + DGN ++G +PD S+L + + N
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL--FTSMTISRNR 185
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
LTG +P +L NL + + N G+
Sbjct: 186 LTGKIPPTFANL-NLAFVDLSRNMLEGDASVLF 217
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 22/88 (25%), Positives = 39/88 (44%), Gaps = 3/88 (3%)
Query: 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT 473
KI L+ +L ++ ++ + L L L N + G LP +++L L +++ N L
Sbjct: 223 TQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 474 GSLPSYMGSLPNLQELHIENNSFVGEIP 501
G +P G+L NN + P
Sbjct: 282 GEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 2e-06
Identities = 17/69 (24%), Positives = 27/69 (39%), Gaps = 2/69 (2%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE-NN 470
+ + L + G +P L ++ L L + N L G +P L + N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 471 ELTGS-LPS 478
L GS LP+
Sbjct: 303 CLCGSPLPA 311
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 23/214 (10%), Positives = 58/214 (27%), Gaps = 40/214 (18%)
Query: 616 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLI 671
G + ++VA+ + Q+ ++ LSRI + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
++V E++ G+L++ + ++ A + H G
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA---G 149
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
+ S + + I+ ++ +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA-------NP 181
Query: 792 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 825
+ D+ G L L+ + P+ + L
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE 215
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 52/258 (20%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-----DSCSHRTQQFVT-EVALLSRIH---- 663
+GKG FG+V+ G + D +VA+K++ EVALL ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 664 HRNLVPLIGYCEEEHQRILVYEYMHNGT-LRDRL--HGSVNQKPLDWLTRL---QIAHDA 717
H ++ L+ + E + +LV E L D + G + + +R Q+
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG----PSRCFFGQVVA-- 150
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTV 776
+++ H + G++HRD+K NIL+D+ AK+ DFG ++ GT
Sbjct: 151 --AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTR 202
Query: 777 GYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--FGAELNIVHW-- 826
Y PE Y+ + V+S G++L +++ G P + AEL+
Sbjct: 203 VYSPPEWISRHQYHA-----LPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVS 257
Query: 827 --ARSMIKKGDVISIVDP 842
++I++ P
Sbjct: 258 PDCCALIRR---CLAPKP 272
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 667
F K +G+GSF +V + +E A+KI+ + + E ++SR+ H
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAK------- 719
V L +++ + Y NG L L ++ ++ +
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIV 140
Query: 720 -GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----- 773
LEYLH GIIHRD+K NILL+ +M +++DFG ++ + S AR
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----SKQARANSFV 193
Query: 774 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
GT Y+ PE + + SD+++ G ++ +L++G P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 672
+ +G G G V K ++ A+K++ D R EV L R ++V ++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVD 122
Query: 673 YCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 725
E + +V E + G L R+ + T + I + ++YLH
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 726 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 782
+ I HRDVK N+L N K++DFG +++ + + T Y+ PE
Sbjct: 179 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPE 233
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
G ++ + D++S GV++ L+ G P
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 31/211 (14%)
Query: 614 CKKIGKGSFGSVYYGKMKDGKEVAVK-IMADSC-SHRTQQFVTEVALLSRIHHRNLVPLI 671
CK IG GSFG V+ K+ + EVA+K ++ D +R E+ ++ + H N+V L
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR------ELQIMRIVKHPNVVDLK 98
Query: 672 ------GYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRL---QIAHDAAKG 720
G ++E LV EY+ T+ R + + Q L +L Q+ +
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQL----LRS 153
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYL 779
L Y+H+ GI HRD+K N+LLD K+ DFG ++ ++S + + Y
Sbjct: 154 LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYR 208
Query: 780 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 809
PE +G T D++S G V+ EL+ G+
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-23
Identities = 61/212 (28%), Positives = 89/212 (41%), Gaps = 18/212 (8%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQ--QFVTEVALLSRIHHRNL 667
K IG+G+F V KMK +V A+KIM R + F E +L R +
Sbjct: 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 668 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
L + ++ + LV EY G L L + P + R +A + ++ +H
Sbjct: 124 TQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSVH- 179
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
G +HRD+K NILLD +++DFG + D T S VA GT YL PE
Sbjct: 180 --RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 787 QQLTEKSDVY-------SFGVVLLELISGKKP 811
+ Y + GV E+ G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIHHRNL 667
+ IGKGSFG V + D K++ A+K M C R + E+ ++ + H L
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 668 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
V L Y ++ + + +V + + G LR L N + +L I + L+YL
Sbjct: 78 VNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFIC-ELVMALDYLQ- 132
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
N IIHRD+K NILLD + ++DF ++ + +++A GT Y+ PE + +
Sbjct: 133 --NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-TTMA-GTKPYMAPEMFSS 188
Query: 787 QQLTEKS---DVYSFGVVLLELISGKKP 811
++ S D +S GV EL+ G++P
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-22
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVT--EVALLSRIHHRNL 667
+ +GKG FG V +++ ++ A K + R + + E +L +++ R +
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246
Query: 668 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
V L Y E + LV M+ G L+ ++ + A GLE LH
Sbjct: 247 VSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH- 303
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
I++RD+K NILLD + ++SD GL+ E T V GTVGY+ PE N
Sbjct: 304 --RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKN 359
Query: 787 QQLTEKSDVYSFGVVLLELISGKKPVSVED 816
++ T D ++ G +L E+I+G+ P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
K IG G+FG + + VAVK + + + + E+ + H N+V
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 674 CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
++ EY G L +R+ G ++ + + Q+ G+ Y H +
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-QLLS----GVSYCH---SMQ 136
Query: 732 IIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------Y 783
I HRD+K N LLD + R K+ DFG S+ + S+V GT Y+ PE Y
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLRQEY 194
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKP 811
G + +DV+S GV L ++ G P
Sbjct: 195 DG-----KIADVWSCGVTLYVMLVGAYP 217
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 29/239 (12%)
Query: 589 GGHFMDEGVAYFIPLPELEEATN-NFCKKIGKGSFGSVYYGKMKD-GKEVAVK-IMAD-S 644
G M A +E + G+G+FG+V GK K G VA+K ++ D
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 645 CSHRTQQFVTEVALLSRIHHRNLVPLIGY----CEEEHQRI---LVYEYMHNGTLRD--R 695
+R Q + L+ +HH N+V L Y E + + I +V EY+ TL R
Sbjct: 62 FRNRELQ---IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCR 117
Query: 696 LHGSVNQKPLDWLTRL---QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAK 751
+ P L ++ Q+ + + LH + HRD+K N+L++ + K
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLK 172
Query: 752 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 809
+ DFG +++ +++ + + Y PE +GNQ T D++S G + E++ G+
Sbjct: 173 LCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 670
+ +G+GSFG V K ++VA+K ++ S + E++ L + H +++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
++V EY G L D + + + + QI +EY H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQ-QIIC----AIEYCH--- 125
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 782
I+HRD+K N+LLD N+ K++DFGLS + + + G+ Y PE
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGKL 183
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
Y G + DV+S G+VL ++ G+ P
Sbjct: 184 YAG-----PEVDVWSCGIVLYVMLVGRLP 207
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVT--EVALLSRIHHRNL 667
+ +G+G FG V+ +MK ++ A K + R E +L+++H R +
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 668 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKGLEYLH 725
V L Y E + LV M+ G +R ++ P R GLE+LH
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 785
II+RD+K N+LLD + ++SD GL+ + + T A GT G++ PE
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLL 362
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKP 811
++ D ++ GV L E+I+ + P
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 670
+G G+FG V GK G +VAVKI+ + E+ L H +++ L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
+V EY+ G L D + +G +++K L + QI G++Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ-QILS----GVDYCH--- 133
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPE----- 782
++HRD+K N+LLD +M AK++DFGLS ++ + S G+ Y PE
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGR 190
Query: 783 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 811
Y G + D++S GV+L L+ G P
Sbjct: 191 LYAG-----PEVDIWSSGVILYALLCGTLP 215
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-22
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 32/212 (15%)
Query: 614 CKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSC-SHRTQQFVTEVALLSRIHHRNLVPL 670
K IG GSFG VY K+ D G+ VA+K ++ D +R E+ ++ ++ H N+V L
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 112
Query: 671 IGYCEEEHQRI------LVYEYMHNGTLRD--RLHGSVNQKPLDWLTRL---QIAHDAAK 719
+ ++ LV +Y+ T+ R + Q +L Q+ +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF----R 167
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 778
L Y+H+ GI HRD+K N+LLD + K+ DFG ++Q ++S + + Y
Sbjct: 168 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYY 222
Query: 779 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 809
PE +G T DV+S G VL EL+ G+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-21
Identities = 41/107 (38%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 399 PVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MS 457
+P + S ++ + L L+GEIP EL ++ L L LD N LTG +P +S
Sbjct: 433 TIPSSLGSLS-----KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
Query: 458 RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+L + L NN LTG +P ++G L NL L + NNSF G IP L
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 7e-21
Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 14/150 (9%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 471
+ + L +L GEIP L N L + L N LTG +P + RL +L I+ L NN
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL-----------LTGKVIFKYDNNPKLH 520
+G++P+ +G +L L + N F G IP A+ + GK N+
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585
Query: 521 K--ESRRRMRFKLILGTSIGVLAILLVLFL 548
+ + + F+ I + L+ +
Sbjct: 586 ECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 9e-21
Identities = 26/119 (21%), Positives = 50/119 (42%), Gaps = 5/119 (4%)
Query: 399 PVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSR 458
WV + +A+SG + G++ + L L + N + +P +
Sbjct: 166 ANVVGWVLSDGCG--ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD 221
Query: 459 LIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG-KVIFKYDNN 516
L+ + + N+L+G + + L+ L+I +N FVG IPP L + + +N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENK 280
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-20
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 1/96 (1%)
Query: 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLE 468
+ ++ L G+IPP L N L L L N+L+G +P + L LR + L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
N L G +P + + L+ L ++ N GEIP L
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 486
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 9e-19
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 470
+T + LSG + G +PP + L L L N +G LP + ++ L+++ L N
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353
Query: 471 ELTGSLPSYMGSL-PNLQELHIENNSFVGEIPPAL 504
E +G LP + +L +L L + +N+F G I P L
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-18
Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 412 PPRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLE 468
+ + LS N G I P L L EL+L N TG +P +S +L +HL
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
N L+G++PS +GSL L++L + N GEIP L
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-18
Identities = 26/120 (21%), Positives = 49/120 (40%), Gaps = 11/120 (9%)
Query: 391 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLK---GEIPPELKNMEALTELWLDGN 447
+ +PC ++ VTC ++T I LS K L + L ++ L L+L +
Sbjct: 34 SSNKNPCT---FDGVTCRDD---KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNS 87
Query: 448 FLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM--GSLPNLQELHIENNSFVGEIPPALL 505
+ G + L + L N L+G + + GS L+ L++ +N+ +
Sbjct: 88 HINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG 147
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-18
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 4/95 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 470
+ + +S G IPP +++L L L N TG +PD L + L N
Sbjct: 247 TELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL 505
G++P + GS L+ L + +N+F GE+P L
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-17
Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN 470
+ ++L+ GEIP L + LT L L GN G +P L + L +N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 471 ELTGSLP-SYMGSLPNLQELHIENNSFVGEIPPAL 504
+G LP + + L+ L + N F GE+P +L
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-17
Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD-MSRL-IDLRIVHLEN 469
+ +ALS N GE+P + L M L L L N +G LP+ ++ L L + L +
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 470 NELTGSLPSYMG--SLPNLQELHIENNSFVGEIPPAL 504
N +G + + LQEL+++NN F G+IPP L
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-16
Identities = 31/133 (23%), Positives = 56/133 (42%), Gaps = 26/133 (19%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 471
++ + G P N ++ L + N L+G +P + + L I++L +N+
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL---------------LTGKV----IFK 512
++GS+P +G L L L + +N G IP A+ L+G + F+
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 513 ------YDNNPKL 519
+ NNP L
Sbjct: 728 TFPPAKFLNNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-15
Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 7/101 (6%)
Query: 413 PRITKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTG--PLPDMSRLIDLRIVHLE 468
+T + LS +L G + L + L L + N L + +L L ++ L
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 469 NNELTGSLPS---YMGSLPNLQELHIENNSFVGEIPPALLT 506
N ++G+ L+ L I N G++ +
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCV 200
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-14
Identities = 17/88 (19%), Positives = 33/88 (37%), Gaps = 1/88 (1%)
Query: 418 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSL 476
A + +G +L + + G + + + N L+G +
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648
Query: 477 PSYMGSLPNLQELHIENNSFVGEIPPAL 504
P +GS+P L L++ +N G IP +
Sbjct: 649 PKEIGSMPYLFILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-13
Identities = 15/89 (16%), Positives = 30/89 (33%), Gaps = 3/89 (3%)
Query: 419 ALSGKNLKGEIPPELKNMEALTELWLDGNF--LTGPLP-DMSRLIDLRIVHLENNELTGS 475
++ + G+ +KN E GN G ++RL ++ + G
Sbjct: 564 KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623
Query: 476 LPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ ++ L + N G IP +
Sbjct: 624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIM--ADSCSHR-TQQFVTEVALLSRIHHRNL 667
K IG+G+FG V K+K+ +V A+KI+ + T F E +L + +
Sbjct: 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 668 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
L Y ++ + LV +Y G L L ++ P + R +A + ++ +H
Sbjct: 137 TTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLA-EMVIAIDSVH- 192
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
+HRD+K NIL+D+N +++DFG + ED T SSVA GT Y+ PE
Sbjct: 193 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 787 QQLTEKS-----DVYSFGVVLLELISGKKP 811
+ + D +S GV + E++ G+ P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 671
+G G++GSV + G++VA+K ++ ++ E+ LL + H N++ L+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 672 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRL---QIAHDAAKGLE 722
LV +M D L + K + + Q+ KGL+
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT----D-LQKIMGLKFSEEKIQYLVYQML----KGLK 140
Query: 723 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 782
Y+H+ G++HRD+K N+ ++ + K+ DFGL+R A+ ++T V T Y PE
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG--YVV--TRWYRAPE 193
Query: 783 -YYGNQQLTEKSDVYSFGVVLLELISGK 809
+ D++S G ++ E+++GK
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 3e-21
Identities = 64/268 (23%), Positives = 109/268 (40%), Gaps = 37/268 (13%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 671
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 672 ------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
EE LV E M + L V Q LD + + G+++LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDA----N-LC-QVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 785
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 182 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 236
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845
E D++S G ++ E++ K D+ + N +++ +
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK---------------VIE--QL 279
Query: 846 GNVKIESIWRIAEVAIQCVEQRGFSRPK 873
G E + ++ VE R
Sbjct: 280 GTPCPEFMKKLQPTVRNYVENRPKYAGL 307
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 5e-21
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIH---H 664
+ + IG+G FG VY + D ++ A+K + + + + E +LS +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 665 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 721
+V + Y ++ + + M+ G L L HG ++ R A + GL
Sbjct: 252 PFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAA-EIILGL 305
Query: 722 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 781
E++H N +++RD+K +NILLD + ++SD GL+ + H +SV GT GY+ P
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-ASV--GTHGYMAP 359
Query: 782 EYYGNQQLTEKS-DVYSFGVVLLELISGKKP 811
E + S D +S G +L +L+ G P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 6e-21
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 37/268 (13%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 671
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 672 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
EE Q + +V E M + L V Q LD + + G+++LH
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELMDA----N-LC-QVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 785
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 145 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 199
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845
E D++S G ++ E+I G D + N +++ +
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK---------------VIE--QL 242
Query: 846 GNVKIESIWRIAEVAIQCVEQRGFSRPK 873
G E + ++ VE R
Sbjct: 243 GTPCPEFMKKLQPTVRTYVENRPKYAGY 270
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 7e-21
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 671
+G G++GSV K G VAVK ++ ++ E+ LL + H N++ L+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 672 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
EE + LV M G D L+ V + L + + +GL+Y+H
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLM--GA--D-LNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY- 784
+ IIHRD+K SN+ ++ + K+ DFGL+R +++T GY+ +Y
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT----------GYVATRWYR 196
Query: 785 ------GNQQLTEKSDVYSFGVVLLELISGK 809
+ D++S G ++ EL++G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 671
+ +G G++G+V + G +VA+K + ++ E+ LL + H N++ L+
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 672 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
++ LV +M D L + + L + + KGL Y+H
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMGT----D-LGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-Y 784
GIIHRD+K N+ ++ + K+ DFGL+RQA+ ++T V T Y PE
Sbjct: 146 AA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG--YVV--TRWYRAPEVIL 198
Query: 785 GNQQLTEKSDVYSFGVVLLELISGK 809
+ T+ D++S G ++ E+I+GK
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHHRNL 667
K IG+G+FG V + K ++V A+K+++ + F E +++ + +
Sbjct: 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------- 719
V L +++ +V EYM G L ++ ++ + A+
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEKWARFYTAEVVL 179
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 779
L+ +H + G IHRDVK N+LLD + K++DFG + ++ A GT Y+
Sbjct: 180 ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 780 DPE---YYGNQQLTEKS-DVYSFGVVLLELISGKKP 811
PE G + D +S GV L E++ G P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT-----------EVALLSRIH 663
+ I GS+G+V G +G VA+K + ++ S + E+ LL+ H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 664 HRNLVPL----IGYCEEEHQRI-LVYEYMHNGTLRDRLHG--SVNQKPLDWLTRLQ-IAH 715
H N++ L + + E ++ LV E M D L + + +Q +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT----D-LAQVIHDQRIVIS-PQHIQYFMY 141
Query: 716 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 775
GL LH G++HRD+ NILL N + DF L+R+ D V
Sbjct: 142 HILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--H 196
Query: 776 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 809
Y PE + T+ D++S G V+ E+ + K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHR--TQQFVTEVALLSRIHHRNL 667
+ K +GKG+FG V K K A+KI+ + + +TE +L H L
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 668 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
L Y + H R+ V EY + G L H S + + R A + L+YLH+
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLHS 266
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
+++RD+K N++LD + K++DFGL ++ +D + + GT YL PE +
Sbjct: 267 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLED 323
Query: 787 QQLTEKSDVYSFGVVLLELISGKKPVSVED 816
D + GVV+ E++ G+ P +D
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL-- 670
+K+G+G + V+ + + ++V VKI+ + ++ E+ +L + N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 98
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTG 727
I LV+E+++N + + LT I ++ K L+Y H+
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFK---------QLYQTLTDYDIRFYMYEILKALDYCHSM 149
Query: 728 CNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
GI+HRDVK N+++D R ++ D+GL+ + VA + + PE +
Sbjct: 150 ---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVD 204
Query: 787 QQLTEKS-DVYSFGVVLLELISGKKP 811
Q+ + S D++S G +L +I K+P
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQF-----VT---EVALLSRIHHRN 666
+K+G+G++G VY K G+ VA+K + R T E++LL +HH N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI------RLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKG 720
+V LI E LV+E+M D L +++ Q+ +G
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK----D-LKKVLDENKTGLQDSQIKIYLYQLL----RG 131
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 777
+ + H I+HRD+K N+L++ + K++DFGL+R TH V T+
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE--VV--TLW 184
Query: 778 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 809
Y P+ G+++ + D++S G + E+I+GK
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 47/211 (22%), Positives = 80/211 (37%), Gaps = 47/211 (22%)
Query: 613 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL 670
+ +G G G V K ++ A+K++ D R EV L R ++V +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRI 76
Query: 671 IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEY 723
+ E + +V E + G L R+ + T + I + ++Y
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQY 132
Query: 724 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 780
LH + I HRDVK N+L N K++DFG +++
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------------TT 171
Query: 781 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
E Y + D++S GV++ L+ G P
Sbjct: 172 GEKYD-----KSCDMWSLGVIMYILLCGYPP 197
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 616 KIGKGSFGSVYYGKMKD-GKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIHHRNL 667
K+G G++ +VY G K G VA+K + S + R E++L+ + H N+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR------EISLMKELKHENI 65
Query: 668 VPLIGYCEEEHQRILVYEYMHN--GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
V L E++ LV+E+M N D + L+ +GL + H
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 782
I+HRD+K N+L++ + K+ DFGL+R + V T+ Y P+
Sbjct: 126 EN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VV--TLWYRAPD 178
Query: 783 Y-YGNQQLTEKSDVYSFGVVLLELISGK 809
G++ + D++S G +L E+I+GK
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 7e-19
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 71/270 (26%)
Query: 613 FCKKIGKGSFGSVYYG------KMKDGKEVAVKIMADSCSHR-TQQFVTEVALLSRI-HH 664
K +G+G+FG V K + VAVK++ + +H + ++E+ +L I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 665 RNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQ--------------------- 702
N+V L+G C + +++ E+ G L L N+
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 703 -----KPLDWLTRLQIAHDAA----KGLEYLHTGCNPGIIHRDVKSSNILLDI------- 746
+ LD +T Q + + K L + P +++D + L+
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 747 -----------------------NMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPE 782
K+ DFGL+R +D ++ AR + ++ PE
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 783 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 811
++ T +SDV+SFGV+L E+ S G P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 665
KIG+GS+G V+ + +D G+ VA+K + R E+ +L ++ H
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR------EIRMLKQLKHP 62
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
NLV L+ + + LV+EY + T+ L Q+ + I + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 782
IHRDVK NIL+ + K+ DFG +R + VA T Y PE
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD--EVA--TRWYRSPE 172
Query: 783 Y-YGNQQLTEKSDVYSFGVVLLELISGK 809
G+ Q DV++ G V EL+SG
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 50/243 (20%), Positives = 91/243 (37%), Gaps = 62/243 (25%)
Query: 614 CKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL- 670
K +G GSFG V + GK A+K ++ D + E+ ++ + H N++ L
Sbjct: 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNR---ELDIMKVLDHVNIIKLV 66
Query: 671 -IGYCEEEHQRI------------------------------------LVYEYMHNGTLR 693
Y + + ++ EY+ TL
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH 125
Query: 694 D--RLHGSVNQKPLDWLTRL---QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 748
+ + L + Q+ + + ++H+ GI HRD+K N+L++
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIKPQNLLVNSKD 178
Query: 749 -RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELI 806
K+ DFG +++ ++ + + Y PE G + T D++S G V ELI
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 807 SGK 809
GK
Sbjct: 237 LGK 239
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 665
+G+GS+G V + KD G+ VA+K + R E+ LL ++ H
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR------EIKLLKQLRHE 84
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
NLV L+ C+++ + LV+E++ + T+ D L + LD+ + G+ + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 782
+ IIHRD+K NIL+ + K+ DFG +R E VA T Y PE
Sbjct: 142 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VA--TRWYRAPE 194
Query: 783 Y-YGNQQLTEKSDVYSFGVVLLELISGK 809
G+ + + DV++ G ++ E+ G+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 40/212 (18%)
Query: 616 KIGKGSFGSVYYGKMKDGKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHRNL 667
KIG+G++G VY + G+ A+K + S + R E+++L + H N+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR------EISILKELKHSNI 62
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKGL 721
V L + + +LV+E++ D L ++ + LQ+ G+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ----D-LKKLLDVCEGGLESVTAKSFLLQLL----NGI 113
Query: 722 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGY 778
Y H ++HRD+K N+L++ K++DFGL+R TH + T+ Y
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IV--TLWY 166
Query: 779 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 809
P+ G+++ + D++S G + E+++G
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-- 671
K +G G G V+ K VA+K + + + + E+ ++ R+ H N+V +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 672 ------------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 719
G E + +V EYM T D L + Q PL + +
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYM--ET--D-LANVLEQGPLLEEHARLFMYQLLR 131
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISS----VARG 774
GL+Y+H+ ++HRD+K +N+ ++ ++ K+ DFGL+R + +H +
Sbjct: 132 GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-- 186
Query: 775 TVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGK 809
T Y P + T+ D+++ G + E+++GK
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 616 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF-----VT---EVALLSRIHHRN 666
KIG+G++G+V+ K ++ + VA+K + R + E+ LL + H+N
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKHKN 62
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKG 720
+V L + + LV+E+ D L + D Q+ KG
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ----D-LKKYFDSCNGDLDPEIVKSFLFQLL----KG 113
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 777
L + H+ ++HRD+K N+L++ N K+++FGL+R + V T+
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA--EVV--TLW 166
Query: 778 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKP 811
Y P+ +G + + D++S G + EL + +P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-18
Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLI- 671
+G+G++G V G+ VA+K I + + E+ +L H N++ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 672 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLE 722
E ++ ++ E M T D LH ++ + L + Q + ++
Sbjct: 77 IQRPDSFENFNEVYIIQELM--QT--D-LHRVISTQMLSDDHIQYFIY-QTL----RAVK 126
Query: 723 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV---GYL 779
LH +IHRD+K SN+L++ N KV DFGL+R +E S ++
Sbjct: 127 VLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 780 DPEYY-------GNQQLTEKSDVYSFGVVLLELISGK 809
+Y + + + DV+S G +L EL +
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 45/227 (19%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIH-HRNLVPL 670
KK+GKG++G V+ + G+ VAVK + D+ + T Q+ E+ +L+ + H N+V L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 671 --IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEY 723
+ + + LV++YM T D LH + L+ ++ Q+ K ++Y
Sbjct: 75 LNVLRADNDRDVYLVFDYM--ET--D-LHAVIRANILEPVHKQYVVY-QLI----KVIKY 124
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
LH+G G++HRD+K SNILL+ KV+DFGLSR +++ +
Sbjct: 125 LHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 784 YGNQQLTE---------------------KSDVYSFGVVLLELISGK 809
LT+ D++S G +L E++ GK
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMA-DSCSH--RTQQFVTEVALLSRIHHRNLVP 669
IG+G++G V + VA+K I + ++ RT + E+ +L R H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LREIKILLRFRHENIIG 89
Query: 670 LI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
+ E+ +V + M T D L+ + + L + +GL+Y+
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDLM--ET--D-LYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS----VARGTVGYLD 780
H+ ++HRD+K SN+LL+ K+ DFGL+R A+ D H VA T Y
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRWYRA 199
Query: 781 PEYYGN-QQLTEKSDVYSFGVVLLELISGK 809
PE N + T+ D++S G +L E++S +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 27/212 (12%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 672
+KIG GSFG +Y G + G+EVA+K+ H Q E + + +P +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 72
Query: 673 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
E ++V E + G L + + K T L +A +EY+H
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLK-----TVLLLADQMISRIEYIH--- 122
Query: 729 NPGIIHRDVKSSNILLDINMRAK---VSDFGLSRQ--AEEDLTHISSVA----RGTVGYL 779
+ IHRDVK N L+ + + + DFGL+++ HI GT Y
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ + + + D+ S G VL+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 616 KIGKGSFGSVYYGKMKD---GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 671
K+G+G++G VY K KD K+ A+K I S E+ALL + H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQ 84
Query: 672 GYCEEEHQRI--LVYEYMHN--GTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEYL 724
R L+++Y + + S K L R + + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 725 HTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 777
H ++HRD+K +NIL+ R K++D G +R + L + V T
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 778 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 809
Y PE G + T+ D+++ G + EL++ +
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIHHRNL 667
++ K +GKG+FG V + K A+KI+ + + + VTE +L H L
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 668 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK--- 719
L Y + H R+ V EY + G L L + A+
Sbjct: 68 TALK-YAFQTHDRLCFVMEYANGGEL---------------FFHLSRERVFTEERARFYG 111
Query: 720 -----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR- 773
LEYLH + +++RD+K N++LD + K++DFGL + E ++ + +
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISD-GATMKT 164
Query: 774 --GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
GT YL PE + D + GVV+ E++ G+ P +D
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 2e-17
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 667
+ +G GSFG V+ + + A+K++ R +Q E +LS + H +
Sbjct: 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK---- 719
+ + G ++ Q ++ +Y+ G L + L+ + AK
Sbjct: 69 IRMWGTFQDAQQIFMIMDYIEGGEL---------------FSLLRKSQRFPNPVAKFYAA 113
Query: 720 ----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 775
LEYLH + II+RD+K NILLD N K++DFG ++ D+T+ GT
Sbjct: 114 EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY-VPDVTY---TLCGT 166
Query: 776 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
Y+ PE + + D +SFG+++ E+++G P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 55/226 (24%)
Query: 616 KIGKGSFGSVYYGKMKD-GKEVAVK------------IMADSCSHRTQQFVTEVALLSRI 662
KIG+G+FG V+ + + G++VA+K I A + E+ +L +
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA----------LREIKILQLL 73
Query: 663 HHRNLVPLIGYCEEEHQRI--------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 714
H N+V LI C + LV+++ + D L G ++ + T +I
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----D-LAGLLSNVLVK-FTLSEIK 127
Query: 715 HDAA---KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-------QAEED 764
GL Y+H I+HRD+K++N+L+ + K++DFGL+R
Sbjct: 128 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 765 LTHISSVARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 809
T+ V T+ Y PE G + D++ G ++ E+ +
Sbjct: 185 YTNR--VV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 667
+ K +G GSFG V K K+ A+KI+ + +Q + E +L ++ L
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK---- 719
V L ++ +V EY+ G + + L+ A+
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEM---------------FSHLRRIGRFSEPHARFYAA 148
Query: 720 ----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 775
EYLH + +I+RD+K N+L+D +V+DFG +++ + T GT
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTW---TLCGT 201
Query: 776 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
L PE ++ + D ++ GV++ E+ +G P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 39/224 (17%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIM--ADSCSHRTQQFVTEVALLSRIHHR 665
K +G+GSFG V+ K G + A+K++ A + E +L ++H
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86
Query: 666 NLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK- 719
+V L Y + ++ L+ +++ G L TRL + K
Sbjct: 87 FIVKLH-YAFQTEGKLYLILDFLRGGDL---------------FTRLSKEVMFTEEDVKF 130
Query: 720 -------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 772
L++LH + GII+RD+K NILLD K++DFGLS+++ + S
Sbjct: 131 YLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 187
Query: 773 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
GTV Y+ PE + T+ +D +SFGV++ E+++G P +D
Sbjct: 188 -GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-17
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 38/214 (17%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQF-VT---EVALLSRIHHRNLV 668
+G+G F +VY + + VA+K I S T E+ LL + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 669 PLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPLD------WLTRLQIAHDAAK 719
L+ + LV+++M ++D N L ++ L +
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKD------NSLVLTPSHIKAYM--LMTL----Q 123
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTV 776
GLEYLH I+HRD+K +N+LLD N K++DFGL++ TH V T
Sbjct: 124 GLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VV--TR 176
Query: 777 GYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 809
Y PE +G + D+++ G +L EL+
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 7e-17
Identities = 52/243 (21%), Positives = 87/243 (35%), Gaps = 55/243 (22%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 671
IG+GS+G VY K VA+K + ++ + E+ +L+R+ ++ L
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 672 GYCEEEHQRI-----LVYEYMHNGTLRDRLHGSV--NQKPLDWLTRL-------QIAHDA 717
+ +V E + D L LT +
Sbjct: 92 DLIIPDDLLKFDELYIVLEIA--DS--D-LKKLFKTPIF----LTEEHIKTILYNLL--- 139
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTV 776
G ++H GIIHRD+K +N LL+ + KV DFGL+R + T+I +
Sbjct: 140 -LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 777 GYLDPEYYGNQQLTE--------------------KS-DVYSFGVVLLELISGKKPVSVE 815
+QLT KS D++S G + EL++ + +
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 816 DFG 818
Sbjct: 256 PTN 258
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 9e-17
Identities = 52/228 (22%), Positives = 97/228 (42%), Gaps = 45/228 (19%)
Query: 612 NFCKKIGKGSFGSVY---YGKMKDGKEV-AVKIMA-DSCSHRTQQFV---TEVALLSRIH 663
+ +GKG +G V+ + ++ A+K++ + E +L +
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 664 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAA 718
H +V LI Y + ++ L+ EY+ G L +L+ D A
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGEL---------------FMQLEREGIFMEDTA 123
Query: 719 K--------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHI 768
L +LH GII+RD+K NI+L+ K++DFGL +++ + +TH
Sbjct: 124 CFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH- 179
Query: 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
+ GT+ Y+ PE D +S G ++ ++++G P + E+
Sbjct: 180 -TFC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 42/219 (19%)
Query: 611 NNFCK--KIGKGSFGSVYYGK-MKDGKEVAVKIM-------ADSCSHRTQQFVTEVALLS 660
+ K K+G+G++ +VY GK VA+K + A + R EV+LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR------EVSLLK 55
Query: 661 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIA 714
+ H N+V L E LV+EY+ +D L ++ Q+
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLD----KD-LKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 715 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSV 771
+GL Y H ++HRD+K N+L++ K++DFGL+R + + V
Sbjct: 111 ----RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--V 161
Query: 772 ARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 809
T+ Y P+ G+ + + D++ G + E+ +G+
Sbjct: 162 V--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 33/197 (16%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 671
IG GS+G V + + VA+K + ++ + E+A+L+R++H ++V ++
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 672 -----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH------DAAKG 720
E+ + +V E D K L H + G
Sbjct: 119 DIVIPKDVEKFDELYVVLEIAD----SD-FK-----KLFRTPVYLTELHIKTLLYNLLVG 168
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG------ 774
++Y+H+ GI+HRD+K +N L++ + KV DFGL+R + S +
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 775 TVGYLDPEYYGNQQLTE 791
+ +QLT
Sbjct: 226 NLVTFPHTKNLKRQLTG 242
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 23/157 (14%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 672
KKIG G+FG + GK + + VA+K+ Q E ++ + +P +
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYY 72
Query: 673 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
+ +V E + G L D + + K T L IA +EY+H
Sbjct: 73 FGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLK-----TVLMIAIQLISRMEYVH--- 122
Query: 729 NPGIIHRDVKSSNILLDINMRAKVS-----DFGLSRQ 760
+ +I+RDVK N L+ DF L+++
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-16
Identities = 61/226 (26%), Positives = 93/226 (41%), Gaps = 44/226 (19%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 666
+F K IGKGSFG V + K + AVK++ + + ++ LL + H
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 667 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK-- 719
LV L + + ++ V +Y++ G L LQ A+
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGEL---------------FYHLQRERCFLEPRARFY 144
Query: 720 ------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 773
L YLH + I++RD+K NILLD ++DFGL + E++ H +S
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEH-NSTTS 197
Query: 774 ---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
GT YL PE Q D + G VL E++ G P +
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 43/214 (20%), Positives = 84/214 (39%), Gaps = 29/214 (13%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 672
++IG+GSFG ++ G + + ++VA+K Q E + +P +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 73
Query: 673 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
+ +E +LV + + G L D + K T A ++ +H
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVK-----TVAMAAKQMLARVQSIH--- 123
Query: 729 NPGIIHRDVKSSNILLDINMRAK-----VSDFGLSRQAEEDLT--HISSVA----RGTVG 777
+++RD+K N L+ V DFG+ + + +T HI GT
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 778 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
Y+ + ++ + + D+ + G V + + G P
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 35/212 (16%)
Query: 616 KIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHRN 666
K+G+G++G VY + VA+K + + R EV+LL + HRN
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR------EVSLLKELQHRN 94
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
++ L H+ L++EY N L+ + + + G+ + H+
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 727 GCNPGIIHRDVKSSNILLDINMRA-----KVSDFGLSRQ---AEEDLTHISSVARGTVGY 778
+HRD+K N+LL ++ + K+ DFGL+R TH + T+ Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE--II--TLWY 203
Query: 779 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 809
PE G++ + D++S + E++
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---------- 663
+K+G G F +V+ K M + VA+KI+ + + E+ LL R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSM 83
Query: 664 -HRNLVPLIGY-----CEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHD 716
+++ L+ + H ++V+E + L + ++ PL + QI+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHV-VMVFEVLGE-NLLALIKKYEHRGIPLI-YVK-QISKQ 139
Query: 717 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA------KVSDFGLSRQAEEDLT-HIS 769
GL+Y+H C IIH D+K N+L++I K++D G + +E T I
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 809
+ Y PE +D++S ++ ELI+G
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 6e-16
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 672
+KIG GSFG +Y G ++ +EVA+K+ H Q + E + + +P +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70
Query: 673 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
+ E +LV + + G L + ++ K T L +A +E++H
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLK-----TVLMLADQMINRVEFVH--- 120
Query: 729 NPGIIHRDVKSSNILLDINMRAK---VSDFGLSRQAEEDLT--HISSVA----RGTVGYL 779
+ +HRD+K N L+ + RA + DFGL+++ + T HI GT Y
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ + + + D+ S G VL+ + G P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 49/232 (21%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIMA-DSCSHRTQQFV---TEVALLSRI- 662
K +G G++G V+ + G + A+K++ + + + TE +L I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 663 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DA 717
LV L Y + ++ L+ +Y++ G L T L
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGEL---------------FTHLSQRERFTEHE 160
Query: 718 AK--------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769
+ LE+LH GII+RD+K NILLD N ++DFGLS+ E + +
Sbjct: 161 VQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADET 214
Query: 770 SVAR---GTVGYLDPE-YYGNQQLTEKS-DVYSFGVVLLELISGKKPVSVED 816
A GT+ Y+ P+ G +K+ D +S GV++ EL++G P +V+
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 616 KIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQF-VT---EVALLSRIH---HRN 666
+IG G++G+VY + G VA+K + + ++ EVALL R+ H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 667 LVPLI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAA 718
+V L+ + E + LV+E++ +D L +++ P L I
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVD----QD-LRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 778
+GL++LH I+HRD+K NIL+ K++DFGL+R + V T+ Y
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWY 185
Query: 779 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 809
PE + T D++S G + E+ K
Sbjct: 186 RAPEVLLQSTYATP-VDMWSVGCIFAEMFRRK 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 1e-15
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 663
NF +GKGSFG V + K E+ AVK ++ D T E +L+
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM---VEKRVLALPGK 400
Query: 664 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 722
L L C + R+ V EY++ G L H + + A + A GL
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLM--YHIQQVGRFKEPHAVFYAA-EIAIGLF 456
Query: 723 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYL 779
+L + GII+RD+K N++LD K++DFG+ + E++ + GT Y+
Sbjct: 457 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWD-GVTTKTFCGTPDYI 509
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 663
+ + IG+GS+ V ++K + A+K + D Q TE + + +
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQASN 68
Query: 664 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGL 721
H LV L C + R+ V EY++ G L + Q+ L R A + + L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLAL 123
Query: 722 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYL 779
YLH GII+RD+K N+LLD K++D+G+ ++ D T GT Y+
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYI 177
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
PE + D ++ GV++ E+++G+ P
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 663
+ + IG+GS+ V ++K + A++ + D Q TE + + +
Sbjct: 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ---TEKHVFEQASN 111
Query: 664 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGL 721
H LV L C + R+ V EY++ G L + Q+ L R A + + L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLAL 166
Query: 722 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYL 779
YLH GII+RD+K N+LLD K++D+G+ ++ D T GT Y+
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYI 220
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
PE + D ++ GV++ E+++G+ P
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 663
F + +GKGSFG V ++K+ ++ AVK I+ D T TE +LS +
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM---TEKRILSLARN 82
Query: 664 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 722
H L L C + R+ V E+++ G L H +++ + R A + L
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLM--FHIQKSRRFDEARARFYAA-EIISALM 138
Query: 723 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLD 780
+LH GII+RD+K N+LLD K++DFG+ ++ T ++ GT Y+
Sbjct: 139 FLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFC-GTPDYIA 192
Query: 781 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
PE D ++ GV+L E++ G P E+
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 666
K +GKGSFG V+ + K + A+K + D T V L H
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 667 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
L + + + + V EY++ G L + K A + GL++LH
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAA-EIILGLQFLH 135
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE 782
+ GI++RD+K NILLD + K++DFG+ + E++ + GT Y+ PE
Sbjct: 136 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLG-DAKTNTFCGTPDYIAPE 188
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
Q+ D +SFGV+L E++ G+ P +D
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 663
NF +GKGSFG V + K E+ AVK ++ D T E +L+
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM---VEKRVLALPGK 79
Query: 664 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 722
L L C + R+ V EY++ G L + V + A + A GL
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPH-AVFYAA-EIAIGLF 135
Query: 723 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYL 779
+L + GII+RD+K N++LD K++DFG+ + E++ + GT Y+
Sbjct: 136 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWD-GVTTKTFCGTPDYI 188
Query: 780 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 40/231 (17%), Positives = 80/231 (34%), Gaps = 45/231 (19%)
Query: 615 KKIGKGSFGSVYYGK---------MKDGKEVAVKI-MADSCSHRTQQF------VTEVAL 658
+ + G +Y ++ ++K+ D Q F +V
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 659 LSRIHHRNL--VPLIGYC--EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 714
+++ L +P ++ R LV + G + L + LQ+A
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVA 165
Query: 715 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV--SDFGLSRQAEEDLTHI---- 768
LE+LH +H +V + NI +D +++V + +G + + H+
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 769 --SSVARGTVGYLDPEY------YGNQQLTEKSDVYSFGVVLLELISGKKP 811
S G + E+ G + +SD+ S G +L+ + G P
Sbjct: 223 GSRSPHEGDL-----EFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLP 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 53/254 (20%), Positives = 92/254 (36%), Gaps = 60/254 (23%)
Query: 601 IPLPELEEATNNFC------KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFV 653
+P PE + + KKIG G FG +Y ++ A ++
Sbjct: 23 MPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE-YQENGPLF 81
Query: 654 TEVALLSRIHHRNL--------------VPLIGYC-----EEEHQRILVYEYMHNGT-LR 693
+E+ R+ ++ +PL + R +V E + G L+
Sbjct: 82 SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ 139
Query: 694 D--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 751
+G+ + T LQ+ LEY+H +H D+K++N+LL +
Sbjct: 140 KISGQNGTFKKS-----TVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191
Query: 752 V--SDFGLSRQAEEDLTHISSVAR------GTVGYLDPEY------YGNQQLTEKSDVYS 797
V +D+GLS + + H GT+ E+ G + +SDV
Sbjct: 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTI-----EFTSLDAHKGVAL-SRRSDVEI 245
Query: 798 FGVVLLELISGKKP 811
G +L + GK P
Sbjct: 246 LGYCMLRWLCGKLP 259
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-14
Identities = 20/136 (14%), Positives = 41/136 (30%), Gaps = 12/136 (8%)
Query: 391 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 450
N + + V+ ++ R+T ++L G G +P + + L L L +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNG--RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK 118
Query: 451 GP-----LPDMSRLIDLRIVHLENNELTGSLPSYMG--SLPNLQELHIENNSFVGEIPPA 503
+S + + Y +L + I ++ I +
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178
Query: 504 ---LLTGKVIFKYDNN 516
L I + NN
Sbjct: 179 SRITLKDTQIGQLSNN 194
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 415 ITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 473
I I + NLK + L+ M+ L L N L G LP I L ++L N++T
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQIT 366
Query: 474 GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK 508
++ G ++ L +N IP
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-13
Identities = 16/98 (16%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---------LPDMSRLIDLRI 464
+T + + ++P LK + + + + N L D ++I
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 465 VHLENNEL-TGSLPSYMGSLPNLQELHIENNSFVGEIP 501
+++ N L T + + + + L L N G++P
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-11
Identities = 16/126 (12%), Positives = 38/126 (30%), Gaps = 22/126 (17%)
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--------------------D 455
T+I N+ + + + L + ++ +
Sbjct: 186 TQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK 244
Query: 456 MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDN 515
L DL V + N LP+++ +LP +Q +++ N + + +
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADAPV 303
Query: 516 NPKLHK 521
K+
Sbjct: 304 GEKIQI 309
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 15/110 (13%), Positives = 36/110 (32%), Gaps = 19/110 (17%)
Query: 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 473
+ K ++ + I + T++ N +T + RL LR ++ N+
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 474 G-------------------SLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ +L +L ++ + N + ++P L
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 18/103 (17%), Positives = 33/103 (32%), Gaps = 12/103 (11%)
Query: 413 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPD----MSRLIDLRIVH 466
+T I L L + + + + L + L N + P S L I +
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545
Query: 467 ---LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
+ N P + P+L +L I +N + +
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP 587
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 21/98 (21%), Positives = 32/98 (32%), Gaps = 10/98 (10%)
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--------PLPDMSRLIDLRIVHL 467
+ I LS + L+ + L GN LT + L + L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 468 ENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIPPAL 504
N+LT +LP L + + NSF + P
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQP 532
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 20/116 (17%), Positives = 42/116 (36%), Gaps = 19/116 (16%)
Query: 409 TTTPPRI-------TKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTG-------P 452
T P ++ + LK IP + K++ ++ + N + P
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 453 LP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L + I++ ++L NN+++ + L +++ N EIP L
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML-TEIPKNSLKD 479
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-10
Identities = 11/89 (12%), Positives = 31/89 (34%), Gaps = 4/89 (4%)
Query: 420 LSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRL-IDLRIVHLENNELTGSL 476
+ + + L + ++ + + SR+ + + +N +T +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FV 198
Query: 477 PSYMGSLPNLQELHIENNSFVGEIPPALL 505
+ L L++ ++ N+ FV E
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAW 227
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 11/95 (11%), Positives = 32/95 (33%), Gaps = 10/95 (10%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT----- 473
+ N++ LT++ + LP + L +++++++ N
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291
Query: 474 ---GSLPSYMGSLPNLQELHIENNSF-VGEIPPAL 504
+ +Q ++I N+ + +L
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-09
Identities = 20/118 (16%), Positives = 39/118 (33%), Gaps = 15/118 (12%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTEL------WLDGNFLTGPLPD-MSRLIDLRIV 465
P + I LS + P + N L GN P+ ++ L +
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571
Query: 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT----GKVIFKYDNNPKL 519
+ +N++ + PN+ L I++N + + G + YD +
Sbjct: 572 QIGSNDIR-KVNE--KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDI 626
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 43/218 (19%)
Query: 616 KIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQF-----VT---EVALL---S 660
+IG+G++G V+ K +D K VA+K + R Q ++ EVA+L
Sbjct: 18 EIGEGAYGKVF--KARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 661 RIHHRNLVPLI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-- 713
H N+V L + E + LV+E++ +D L +++ P + I
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QD-LTTYLDKVPEPGVPTETIKD 124
Query: 714 -AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 772
+GL++LH+ ++HRD+K NIL+ + + K++DFGL+R + S V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 773 RGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 809
T+ Y PE + T D++S G + E+ K
Sbjct: 182 --TLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRK 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 48/253 (18%), Positives = 84/253 (33%), Gaps = 57/253 (22%)
Query: 602 PLPELEEATNNFC------KKIGKGSFGSVYYGKMKDGKEVAVKI--MADSCSHRTQQFV 653
E T+ IG+G FG +Y M + V +
Sbjct: 22 QFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF 81
Query: 654 TEVALLSRIHHRNL--------------VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS 699
TE+ R VP + Y +M + DR
Sbjct: 82 TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFGSD 137
Query: 700 VNQKPLDWLTR-------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 752
+ QK + + LQ++ LEY+H +H D+K+SN+LL+ +V
Sbjct: 138 L-QKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV 193
Query: 753 --SDFGLSRQAEEDLTHISSVAR------GTVGYLDPEY------YGNQQLTEKSDVYSF 798
D+GL+ + + H + A GT+ E+ G + + D+
Sbjct: 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTI-----EFTSIDAHNGVAP-SRRGDLEIL 247
Query: 799 GVVLLELISGKKP 811
G +++ ++G P
Sbjct: 248 GYCMIQWLTGHLP 260
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NL 667
K IGKGSFG V K + VA+K++ + Q E+ +L + + N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNV 161
Query: 668 VPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAK 719
+ ++ C + +E + L + + + + L ++ AH +
Sbjct: 162 IHMLENFTFRNHIC-------MTFELLSM-NLYELIKKN-KFQGFS-LPLVRKFAHSILQ 211
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDL-THISSVARGTV 776
L+ LH IIH D+K NILL R+ KV DFG S + + T+I S R
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS--R--- 263
Query: 777 GYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 809
Y PE + D++S G +L EL++G
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 1/96 (1%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
P + + LS ++ +++ L+ L L GN + S L L+ +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L +G L L+EL++ +N P +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 17/87 (19%), Positives = 32/87 (36%), Gaps = 2/87 (2%)
Query: 420 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 477
++G + + P+ + LT L L L P + L L+++++ +N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 478 SYMGSLPNLQELHIENNSFVGEIPPAL 504
L +LQ L N + L
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQEL 538
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 17/94 (18%), Positives = 36/94 (38%), Gaps = 2/94 (2%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
++ + L+G ++ + +L +L L L L+ +++ +N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 472 LTG-SLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ LP Y +L NL+ L + +N L
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-12
Identities = 16/97 (16%), Positives = 31/97 (31%), Gaps = 3/97 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 470
+ + LS + + +E L L + L L +L + + +
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ L +L+ L + NSF P + T
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-11
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 2/91 (2%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 471
+T + LS L+ P ++ +L L + N L L+++ N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 472 LTGSLPSYMGSLP-NLQELHIENNSFVGEIP 501
+ S + P +L L++ N F
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-11
Identities = 16/82 (19%), Positives = 25/82 (30%), Gaps = 1/82 (1%)
Query: 424 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP-SYMGS 482
+ KG +L L L N + + L L + +++ L S S
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 483 LPNLQELHIENNSFVGEIPPAL 504
L NL L I +
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIF 441
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-10
Identities = 17/86 (19%), Positives = 26/86 (30%), Gaps = 4/86 (4%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 478
N +IP L + L L N L +L+++ L E+
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 479 YMGSLPNLQELHIENNSFVGEIPPAL 504
SL +L L + N A
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAF 96
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-10
Identities = 19/98 (19%), Positives = 37/98 (37%), Gaps = 6/98 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDM-SRLIDLRIVHLENN 470
+ K+ NL + +++ L EL + N + LP+ S L +L + L +N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 471 ELTGSLPSYMGSLPNLQ----ELHIENNSFVGEIPPAL 504
++ + + L + L + N P A
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-07
Identities = 12/96 (12%), Positives = 30/96 (31%), Gaps = 4/96 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLI--DLRIVHLENN 470
+ + +S N K + +L L N + + L ++L N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 471 ELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPAL 504
+ + ++ + + ++L +E P
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 8e-07
Identities = 16/94 (17%), Positives = 33/94 (35%), Gaps = 5/94 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALT----ELWLDGNFLTGPLPDMSRLIDLRIVHLE 468
+ + LS ++ +L+ + + L L N + P + I L + L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 469 NNELTGSLPSY-MGSLPNLQELHIENNSFVGEIP 501
NN + ++ + L L+ + F E
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 15/114 (13%), Positives = 30/114 (26%), Gaps = 11/114 (9%)
Query: 414 RITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG----PLPDMSRLIDLRIVHLE 468
R+ K+ L + ++ + L L D S L L + +E
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 469 NNELT------GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 516
L + L N+ + + + + G + N
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC 314
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 54/258 (20%), Positives = 91/258 (35%), Gaps = 73/258 (28%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--------HR 665
+K+G G F +V+ ++ K VA+K++ S H T+ + E+ LL +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 666 NLVPLIGY-----CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 720
+V L+ H +V+E + + L + S N + L +I +G
Sbjct: 102 MVVQLLDDFKISGVNGTHI-CMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQG 158
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDIN--------------------------------- 747
L+YLHT C IIH D+K NILL +N
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 748 ----------------MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
++ K++D G + + T T Y E
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNT 272
Query: 792 KSDVYSFGVVLLELISGK 809
+D++S + EL +G
Sbjct: 273 PADIWSTACMAFELATGD 290
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.4 bits (166), Expect = 2e-12
Identities = 33/193 (17%), Positives = 57/193 (29%), Gaps = 54/193 (27%)
Query: 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIH-- 663
C+KIG+G FG V+ D VA+KI+A S ++ + E+ + +
Sbjct: 25 CEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLL 83
Query: 664 -------HRNLVPLIGYC------------------------------EEEHQRILVYEY 686
+ L ++ Q +V E+
Sbjct: 84 SGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 143
Query: 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 746
G +++ K T I H L + HRD+ N+LL
Sbjct: 144 EFGGIDLEQMR----TKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKK 197
Query: 747 NMRAKVSDFGLSR 759
K+ +
Sbjct: 198 TSLKKLHYTLNGK 210
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 27/95 (28%), Positives = 41/95 (43%), Gaps = 4/95 (4%)
Query: 411 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 469
T P + L L + P + + L + +D L LPD M + L + L
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLAR 136
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
N L +LP+ + SL L+EL I + E+P L
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 21/95 (22%), Positives = 41/95 (43%), Gaps = 12/95 (12%)
Query: 420 LSGKNLKGEIPPELKNMEA---------LTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 469
+ E+P L + +A L L L+ + LP ++ L +L+ + + N
Sbjct: 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRN 215
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ L+ +L + LP L+EL + + + PP
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 19/106 (17%), Positives = 39/106 (36%), Gaps = 3/106 (2%)
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 475
+ L ++ +P + N++ L L + + L+ P + L L + L +
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRN 244
Query: 476 LPSYMGSLPNLQELHIENNSFVGEIPPAL--LTGKVIFKYDNNPKL 519
P G L+ L +++ S + +P + LT L
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 4/89 (4%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWL-DGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP 477
L G PP L L L D + L LP + RL L + L LP
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 478 SYMGSLPNLQELHIENNSFVGEIPPALLT 506
S + LP + + + ++
Sbjct: 295 SLIAQLPANCIILVPPH-LQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 15/100 (15%)
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHL-ENNELT 473
+ + L E+P ++ L L L N L LP ++ L LR + + ELT
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELT 164
Query: 474 GSLPSYMGS---------LPNLQELHIENNSFVGEIPPAL 504
LP + S L NLQ L +E +P ++
Sbjct: 165 -ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI 202
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 13/69 (18%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN---ELTGS 475
L + +P ++ + L +L L G LP +++L I+ + + +L
Sbjct: 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
Query: 476 LPSYMGSLP 484
P + P
Sbjct: 320 RPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 11/107 (10%), Positives = 23/107 (21%), Gaps = 24/107 (22%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRL-------------------- 459
G L + + + +
Sbjct: 19 FQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDA 78
Query: 460 --IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ L + L P L +LQ + I+ + E+P +
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-11
Identities = 17/98 (17%), Positives = 34/98 (34%), Gaps = 6/98 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELK---NMEALTELWLDGNFLTGPLPDM---SRLIDLRIVH 466
R+ + L+ L + +L ++ L L + L+ + +L ++
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 467 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
L N L LP L+ +E N+ +L
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-11
Identities = 18/111 (16%), Positives = 33/111 (29%), Gaps = 9/111 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLEN 469
+ + LS L +E L EL L N + + L+ + L +
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 520
N++ P ++ L L + N + L N +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL------CLELANTSIR 225
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 22/93 (23%), Positives = 33/93 (35%), Gaps = 1/93 (1%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
P + + L L LTEL L N + + + +L + L +N
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
L+ + L NLQEL + NN L
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 23/94 (24%), Positives = 41/94 (43%), Gaps = 1/94 (1%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
P IT + L+ L+ LT L + N ++ P++ +L L++++L++N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
EL+ NL ELH+ +NS
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-11
Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 1/93 (1%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
++T + + + P + + L L L N L+ + +L +HL +N
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ + NL L + +N
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ 141
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 1/89 (1%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 478
L G LK + L L L+ N ++ L +L+I+ L N L S
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 479 YMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ +L+ L+++ N
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 27/139 (19%), Positives = 44/139 (31%), Gaps = 4/139 (2%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG---PLPDMSRLIDLRIVHLEN 469
I +I LS + +L L L L L +L I+ L N
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRF 529
N + + L L+ L +++N+ + G I+ LH + F
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHILNLESNGF 548
Query: 530 KLILGTSIGVLAILLVLFL 548
I L L ++ L
Sbjct: 549 DEIPVEVFKDLFELKIIDL 567
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 16/96 (16%), Positives = 37/96 (38%), Gaps = 3/96 (3%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
+T++ L +++ + L L L N L+ +L +L+ + L NN
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
Query: 471 ELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPAL 504
++ + + +L++L + +N P
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 19/99 (19%), Positives = 36/99 (36%), Gaps = 6/99 (6%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM----SRLIDLRIVHL 467
+ K+ LS +K P + L L+L+ L L + +R + L
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229
Query: 468 ENNELTGSLPSYMGSL--PNLQELHIENNSFVGEIPPAL 504
N++L+ + + L NL L + N+ +
Sbjct: 230 SNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 16/103 (15%), Positives = 33/103 (32%), Gaps = 4/103 (3%)
Query: 406 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLR 463
T + + + L+ + + L L L N + L L ++
Sbjct: 374 TFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 464 IVHLENNELTGSLPSYMGSLPNLQELHIENNSF--VGEIPPAL 504
++L N+ + +P+LQ L + + V P
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-10
Identities = 22/101 (21%), Positives = 36/101 (35%), Gaps = 9/101 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT---------GPLPDMSRLIDLR 463
+T + LS N+ L+ +E L L L N L GP+ + L L
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 464 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
I++LE+N L L+ + + N+
Sbjct: 540 ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-10
Identities = 15/100 (15%), Positives = 32/100 (32%), Gaps = 5/100 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS-----RLIDLRIVHL 467
+ + + ++ G + L L L +F + L I++L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 468 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N+++ L +L+ L + N E+ G
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 19/90 (21%), Positives = 35/90 (38%), Gaps = 7/90 (7%)
Query: 420 LSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 477
S L ++P +L N +T L L N L + +R L + + N ++ P
Sbjct: 11 CSHLKLT-QVPDDLPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEP 66
Query: 478 SYMGSLPNLQELHIENNSFVGEIPPALLTG 507
LP L+ L++++N +
Sbjct: 67 ELCQKLPMLKVLNLQHNELSQ-LSDKTFAF 95
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 26/146 (17%), Positives = 49/146 (33%), Gaps = 15/146 (10%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----------MSRLIDL 462
P++ L N++ L + + L L +F + L L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKE 522
+++E+N++ G + L NL+ L + N+ F + LH
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNE-----TFVSLAHSPLHIL 386
Query: 523 SRRRMRFKLILGTSIGVLAILLVLFL 548
+ + + I + L L VL L
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDL 412
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 18/110 (16%), Positives = 31/110 (28%), Gaps = 5/110 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENN 470
+ I L NL N +L L L N +T + +L + + N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP---PALLTGKVIFKYDNNP 517
+ S + + E H P G + +D +
Sbjct: 620 PFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSS 669
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 10/81 (12%), Positives = 29/81 (35%), Gaps = 4/81 (4%)
Query: 424 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSL 483
N I ++ + L ++ + T +D + + + + +L
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNI----AVDWEDANSDYAKQYENEELSWSNL 490
Query: 484 PNLQELHIENNSFVGEIPPAL 504
+L ++ + N + ++P L
Sbjct: 491 KDLTDVELYNCPNMTQLPDFL 511
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 17/103 (16%), Positives = 31/103 (30%), Gaps = 13/103 (12%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---------LPDM-SRLIDL 462
+T + L ++P L ++ L L + N L D +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 463 RIVHLENNELTGSLPSY-MGSLPNLQELHIENNSFVGEIPPAL 504
+I ++ N L S + + L L +N A
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAF 591
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 21/110 (19%), Positives = 41/110 (37%), Gaps = 12/110 (10%)
Query: 420 LSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPD----MSRLIDLRIVH---LENN 470
L L + + + + L+ + + N + P S+L I H E N
Sbjct: 735 LRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGN 792
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 520
+ P+ + + P+L +L I +N ++ L I +NP +
Sbjct: 793 RILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 22/100 (22%), Positives = 35/100 (35%), Gaps = 14/100 (14%)
Query: 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLENN 470
+T I +N KN LT + L N LT L D + L L + + N
Sbjct: 708 LMTSIP---ENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYN 763
Query: 471 ELTGSLPSYMGSLPNLQELHIE------NNSFVGEIPPAL 504
+ S P+ + L+ I N + + P +
Sbjct: 764 CFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 9e-10
Identities = 13/108 (12%), Positives = 32/108 (29%), Gaps = 4/108 (3%)
Query: 391 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 450
N + + V R+T ++L+G KG +P + + L L + T
Sbjct: 303 NFNKELDMWGDQPGVDLDNNG--RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSET 360
Query: 451 GPLPDMSRL-IDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSF 496
+ + + + ++ L + ++
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAI 408
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-09
Identities = 19/104 (18%), Positives = 36/104 (34%), Gaps = 10/104 (9%)
Query: 413 PRITKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTGPLPDMS------RLIDLRI 464
++ + S LK IP K++ + + N + ++S + I+
Sbjct: 619 DQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677
Query: 465 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK 508
V L NE+ + + + + NN IP L K
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLM-TSIPENSLKPK 720
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 3e-09
Identities = 20/99 (20%), Positives = 35/99 (35%), Gaps = 7/99 (7%)
Query: 413 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 470
P+I + NL+ E P L+ M L L N + L + L + L+ N
Sbjct: 548 PKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYN 605
Query: 471 ELTGSLPSYMGS-LPNLQELHIENNSFVGEIPPALLTGK 508
++ +P + ++ L +N IP
Sbjct: 606 QIE-EIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 20/118 (16%), Positives = 41/118 (34%), Gaps = 15/118 (12%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTEL------WLDGNFLTGPLPD-MSRLIDLRIV 465
P ++ + +S P + N L +GN + P ++ L +
Sbjct: 753 PYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811
Query: 466 HLENNELTGSLPSYMGSLPNLQELHIENNSF----VGEIPPALLTGKVIFKYDNNPKL 519
+ +N++ + + P L L I +N V + P + G + YD +
Sbjct: 812 QIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 11/94 (11%), Positives = 29/94 (30%), Gaps = 8/94 (8%)
Query: 420 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG---- 474
++ L + L L + + P+M + + L++ ++
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISLKDTQIGNLTNR 436
Query: 475 --SLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
+ + L LQ ++ N+ F +
Sbjct: 437 ITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWE 470
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 24/148 (16%), Positives = 43/148 (29%), Gaps = 8/148 (5%)
Query: 417 KIALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
AL GKN + N EL + G+ L + R+ L L
Sbjct: 278 WEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL---SLAGFG 334
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKL 531
G +P +G L L+ L +S + + ++M
Sbjct: 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY 394
Query: 532 ILGTSIGVLAILLVLFLCSLIVLRKLRR 559
++ L + + ++K R
Sbjct: 395 DQRLNLSDLLQDAINRNPEMKPIKKDSR 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-10
Identities = 14/97 (14%), Positives = 24/97 (24%), Gaps = 3/97 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--PLPDMSRLIDLRIVHLENN 470
+ + LS + +E L L + L L L + +
Sbjct: 376 NSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L +L L + NSF +
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-10
Identities = 19/97 (19%), Positives = 38/97 (39%), Gaps = 3/97 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
++ + L+G ++ P + +L L L +LI L+ +++ +N
Sbjct: 80 HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139
Query: 472 LTG-SLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ LP+Y +L NL + + N I L
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQF 175
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 18/88 (20%), Positives = 30/88 (34%), Gaps = 3/88 (3%)
Query: 420 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 477
++G + K N LT L L L + L L+++++ +N L
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
Query: 478 SYMGSLPNLQELHIENNSFVGEIPPALL 505
S+ L +L L N L
Sbjct: 515 SHYNQLYSLSTLDCSFNRIET-SKGILQ 541
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 15/89 (16%), Positives = 29/89 (32%), Gaps = 5/89 (5%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 478
+ L ++P ++ + + L N L S +L+ + L E+
Sbjct: 18 CMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK 74
Query: 479 YMGSLPNLQELHIENNSFVGEIPPALLTG 507
L +L L + N P +G
Sbjct: 75 AWHGLHHLSNLILTGNPIQS-FSPGSFSG 102
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-09
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 1/96 (1%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
+ + LS ++ + L+ L L GN + P S L L + +
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L +G L L++L++ +N PA +
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 18/94 (19%), Positives = 24/94 (25%), Gaps = 1/94 (1%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
P I LS LK N L L L + L L + L N
Sbjct: 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ P L +L+ L +
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 16/86 (18%), Positives = 28/86 (32%), Gaps = 1/86 (1%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
+T + LS L+ + L L + N L ++L L + N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSF 496
+ S +L ++ NNS
Sbjct: 532 RIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 18/101 (17%), Positives = 30/101 (29%), Gaps = 7/101 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPD-MSRLIDLRIVHLENN 470
+ + L + + L +L + NF+ LP S L +L V L N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 471 ELTGSLPSYMGSLPNL----QELHIENNSFVGEIPPALLTG 507
+ + + L L + N I G
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQG 203
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 18/98 (18%), Positives = 34/98 (34%), Gaps = 6/98 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLEN 469
P + + L+ KG I + + +L+ L L N L+ LR + L
Sbjct: 328 PFLKSLTLT--MNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N + + L LQ L ++++ +
Sbjct: 386 NGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 13/77 (16%), Positives = 30/77 (38%), Gaps = 4/77 (5%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 479
L+ N + + + ++ + L G + L D+ + + + + +L P+
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQLK-QFPT- 324
Query: 480 MGSLPNLQELHIENNSF 496
LP L+ L + N
Sbjct: 325 -LDLPFLKSLTLTMNKG 340
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 65/247 (26%), Positives = 101/247 (40%), Gaps = 25/247 (10%)
Query: 574 RTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKD 632
+S K Y+ + D+ Y + E IGKGSFG V +
Sbjct: 23 MSSHKKERKVYN----DGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVE 78
Query: 633 GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NLVPLIGYCEEEHQRILVYEY 686
+ VA+KI+ + + Q EV LL ++ +V L + + LV+E
Sbjct: 79 QEWVAIKIIKNKKAFL-NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137
Query: 687 MHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 745
+ L D L + N + + L + A L +L T IIH D+K NILL
Sbjct: 138 LSY-NLYDLLRNT-NFRGVS-LNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLC 193
Query: 746 INMRA--KVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 802
R+ K+ DFG S Q + + +I S R Y PE D++S G +L
Sbjct: 194 NPKRSAIKIVDFGSSCQLGQRIYQYIQS--R---FYRSPEVLLGMPYDLAIDMWSLGCIL 248
Query: 803 LELISGK 809
+E+ +G+
Sbjct: 249 VEMHTGE 255
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 22/154 (14%), Positives = 46/154 (29%), Gaps = 6/154 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ + L + ++ ++ L L L N L P+ + + L NN+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKY---DNNPKLHKESRRRMRF 529
+ + NL+ + N F + + KL ++
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 530 KLILGTSIGVLAILLVLFLCSLIVLRKLRRKISN 563
+ L F LI L++ + +
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLS 319
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ ++ LSG L +L L L L N L D+ L LR + L NN +
Sbjct: 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYV 92
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L P+++ LH NN+ + + G
Sbjct: 93 Q-ELL----VGPSIETLHAANNNI-SRVSCSRGQG 121
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 4/91 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
R ++ +LK + ++ + EL L GN L+ + L +++L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
L + SL L+ L + NN E+
Sbjct: 70 LY-ETLD-LESLSTLRTLDLNNNYV-QELLV 97
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 3/76 (3%)
Query: 432 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491
EL ++ L N ++ + SR + ++L NN++T G +Q L +
Sbjct: 94 ELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 492 ENNSFVGEIPPALLTG 507
+ N + A L
Sbjct: 152 KLNEID-TVNFAELAA 166
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 11/87 (12%), Positives = 29/87 (33%), Gaps = 5/87 (5%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDM-SRLIDLRIVHLENNELTGSLP 477
L+ + + + L L N + ++ + L ++L+ N + +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185
Query: 478 SYMGSLPNLQELHIENNSFVGEIPPAL 504
+ L+ L + +N + P
Sbjct: 186 GQV-VFAKLKTLDLSSNKLA-FMGPEF 210
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 10/69 (14%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 435 NMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493
N + + L L + +++ + L N L+ + + L+ L++ +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 494 NSFVGEIPP 502
N E
Sbjct: 68 NVLY-ETLD 75
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 18/94 (19%), Positives = 29/94 (30%)
Query: 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 473
+ I L L EL L L+ + L L+ + L N+
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFE 314
Query: 474 GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ P+L L I+ N+ E+ L
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 19/91 (20%), Positives = 30/91 (32%), Gaps = 2/91 (2%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENN 470
+ + LS K L L L L L L++++L ++
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 501
L S LP LQ L+++ N F
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 19/99 (19%), Positives = 38/99 (38%), Gaps = 4/99 (4%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 468
P +T +++ G + E+ L+N+E L EL L + + ++ L L+ ++L
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
NE P L+ L + + +
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 16/97 (16%), Positives = 23/97 (23%), Gaps = 2/97 (2%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
P + S L + LT L L + D L + L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L + + L+ L I L
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHN 127
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-09
Identities = 15/84 (17%), Positives = 35/84 (41%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
R+ + LS +L +++ + + L N LT + + ++L +N +
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHI 535
Query: 473 TGSLPSYMGSLPNLQELHIENNSF 496
+ LPS + L + +++ N
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 8e-09
Identities = 14/96 (14%), Positives = 32/96 (33%), Gaps = 2/96 (2%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
R+ + L+ L L +AL L+ ++ L ++L +N
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
++ L+ L +NN+ + ++
Sbjct: 141 ISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSS 175
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 13/93 (13%), Positives = 29/93 (31%), Gaps = 1/93 (1%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
+T + L+ + ++ L L L N L S L+ +
Sbjct: 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
++ + + L+ L++ +N P
Sbjct: 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKG 149
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 5/89 (5%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 478
L EIP L + L N L SRLI+L + L ++
Sbjct: 19 CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 479 YMGSLPNLQELHIENNSFVGEIPPALLTG 507
S L L + N + + L+G
Sbjct: 76 TFQSQHRLDTLVLTANPLIF-MAETALSG 103
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 17/99 (17%), Positives = 31/99 (31%), Gaps = 4/99 (4%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
P + + + L N + L L+L N ++ L+++ +NN
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 471 ELTGSLPSYMGSLPNLQ--ELHIENNSFVGEIPPALLTG 507
+ M SL L++ N I P
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDS 201
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 18/97 (18%), Positives = 30/97 (30%), Gaps = 4/97 (4%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 467
+ + LS L + AL L L GN + + L I+ L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 468 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+L+ SL + + + +N AL
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-07
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 5/99 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 470
+ K+ LS + N +LT L + GN L + L +LR + L ++
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
Query: 471 ELTGSLPSYM--GSLPNLQELHIENNSFVGEIPPALLTG 507
++ S + +L +LQ L++ N + +
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLS-LKTEAFKE 398
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 15/97 (15%), Positives = 30/97 (30%), Gaps = 6/97 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPDM---SRLIDLRIVHL 467
+ G I LKN +++L + P + + + ++L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261
Query: 468 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ + + LQEL + E+P L
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGL 297
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 13/99 (13%), Positives = 32/99 (32%), Gaps = 7/99 (7%)
Query: 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLENN 470
+ L+G ++ I P + L G + S + L + E+
Sbjct: 180 TNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 471 ELTGSLPSYMGSLP--NLQELHIENNSFVGEIPPALLTG 507
+ P+ L +++ ++++ + F I
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFHC 276
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 17/99 (17%), Positives = 35/99 (35%), Gaps = 7/99 (7%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS---RLIDLRIVHLEN 469
+ + LS + + +E L L + L + + S L +L + + +
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISH 135
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+ + L +L+ L + NSF P + T
Sbjct: 136 THTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 412 PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTG---PLPDMSRLIDLRIVHL 467
P T++ L L+ +P + LT+L L N L+ L+ + L
Sbjct: 27 PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85
Query: 468 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
N + ++ S L L+ L ++++ ++
Sbjct: 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSE 118
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 13/100 (13%), Positives = 31/100 (31%), Gaps = 8/100 (8%)
Query: 413 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLE 468
++ + NLK ++ ++ L L + + + L L ++ +
Sbjct: 101 EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMA 158
Query: 469 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
N + + L NL L + ++ P
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNS 197
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 14/80 (17%), Positives = 25/80 (31%), Gaps = 4/80 (5%)
Query: 430 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM--GSLPNLQ 487
+L L L N + + L L + +++ L + + SL NL
Sbjct: 71 SQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI 129
Query: 488 ELHIENNSFVGEIPPALLTG 507
L I + + G
Sbjct: 130 YLDISHTHTR-VAFNGIFNG 148
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 6/88 (6%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
+T + LS L+ ++ P ++ +L L + N L L L+++
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSL 232
Query: 470 NELTGSLPSYMGSLP-NLQELHIENNSF 496
N + S + P +L L++ N F
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 9e-10
Identities = 20/91 (21%), Positives = 36/91 (39%), Gaps = 11/91 (12%)
Query: 414 RITKI-ALSG-KNLKG--------EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 463
+IT + L+ L +K++ L L + N ++ + ++ L L
Sbjct: 232 KITDLSPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLN 290
Query: 464 IVHLENNELTGSLPSYMGSLPNLQELHIENN 494
+ L NN+L +G L NL L + N
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 7e-09
Identities = 16/83 (19%), Positives = 31/83 (37%), Gaps = 5/83 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
++ + + + L N+ L L+L+ N L ++ L +L + L N
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 472 LTGSLPSYMGSLPNLQELHIENN 494
+T P + SL + N
Sbjct: 323 ITDIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 9e-09
Identities = 18/92 (19%), Positives = 42/92 (45%), Gaps = 5/92 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
R+ + + + + P L N+ LT L + N ++ + + L L+++++ +N++
Sbjct: 221 TRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQI 277
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ S + +L L L + NN E +
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDMEVI 307
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-08
Identities = 17/92 (18%), Positives = 38/92 (41%), Gaps = 15/92 (16%)
Query: 414 RITKI-ALSG-KNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL 462
++ + ++ +L +I P L ++ +L N +T + ++ + L
Sbjct: 166 KVKDVTPIANLTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITD-ITPVANMTRL 223
Query: 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENN 494
+ + NN++T P + +L L L I N
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTN 253
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 23/90 (25%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
ITK+ ++G+ + ++ + L L L+GN +T + +S L+ L +++ N++
Sbjct: 44 ESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
T S + +L NL+EL++ ++ I P
Sbjct: 101 TD--ISALQNLTNLRELYLNEDNISD-ISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 7e-08
Identities = 14/82 (17%), Positives = 37/82 (45%), Gaps = 4/82 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++T + + + L+N+ L EL+L+ + ++ + ++ L + ++L N
Sbjct: 88 VKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHN 144
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
S S + ++ L L + +
Sbjct: 145 L-SDLSPLSNMTGLNYLTVTES 165
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 21/94 (22%), Positives = 39/94 (41%), Gaps = 4/94 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ ++ L+ N+ I P L N+ + L L N L +S + L + + +++
Sbjct: 110 TNLRELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
P + +L +L L + N P A LT
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISPLASLT 199
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 2e-07
Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 3/76 (3%)
Query: 431 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490
+ N+ L L L+ N + + ++ L L N++T P + ++ L L
Sbjct: 171 TPIANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227
Query: 491 IENNSFVGEIPPALLT 506
I NN P A L+
Sbjct: 228 IGNNKITDLSPLANLS 243
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 13/80 (16%), Positives = 29/80 (36%), Gaps = 4/80 (5%)
Query: 427 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 486
+I P ++ L +T + L + + + ++ S+ + L NL
Sbjct: 13 NQIFP-DADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVA-SIQG-IEYLTNL 68
Query: 487 QELHIENNSFVGEIPPALLT 506
+ L++ N P + L
Sbjct: 69 EYLNLNGNQITDISPLSNLV 88
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 1/61 (1%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++ + L+ L E + + LT L+L N +T + ++ L + N +
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMDSADFANQVI 345
Query: 473 T 473
Sbjct: 346 K 346
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 5/105 (4%)
Query: 406 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS---RLIDL 462
+ S + + LS + + +E L L + L + + S L +L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNL 423
Query: 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ + + + L +L+ L + NSF P + T
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 5e-08
Identities = 19/99 (19%), Positives = 41/99 (41%), Gaps = 7/99 (7%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 469
++ + L+G ++ + + +L +L L L + + L L+ +++ +
Sbjct: 76 SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAH 133
Query: 470 NELT-GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N + LP Y +L NL+ L + +N I L
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-08
Identities = 18/87 (20%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
+ + ++G + + P+ + LT L L L P + L L+++++ +N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 471 ELTGSLPSYM-GSLPNLQELHIENNSF 496
+L S+P + L +LQ++ + N +
Sbjct: 505 QLK-SVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 17/89 (19%), Positives = 28/89 (31%), Gaps = 5/89 (5%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 478
N +IP L + L L N L +L+++ L E+
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 479 YMGSLPNLQELHIENNSFVGEIPPALLTG 507
SL +L L + N + +G
Sbjct: 71 AYQSLSHLSTLILTGNPIQ-SLALGAFSG 98
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 8e-07
Identities = 16/99 (16%), Positives = 30/99 (30%), Gaps = 6/99 (6%)
Query: 412 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLE 468
P + LS L+ + + L L L + + D + L L + L
Sbjct: 27 PFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILT 84
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N + L +LQ+L + + +
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGH 122
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 7/101 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-GPLPD-MSRLIDLRIVHLENN 470
+ K+ NL + +++ L EL + N + LP+ S L +L + L +N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 471 ELTGSLPSYMGSLPNLQ----ELHIENNSFVGEIPPALLTG 507
++ + + L + L + N I P
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKE 199
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 20/97 (20%), Positives = 37/97 (38%), Gaps = 3/97 (3%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
P + + LS ++ I +++ L+ L L GN + S L L+ +
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L +G L L+EL++ +N P +
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 16/95 (16%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 468
+ ++ + N G E+ ++ +L L L N L+ S L+ + L
Sbjct: 324 LKSLKRLTFTS-NKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 503
N + ++ S L L+ L ++++ ++
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF 414
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 21/99 (21%), Positives = 33/99 (33%), Gaps = 6/99 (6%)
Query: 413 PRITKIALSGKNL--KGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 470
P + + LS L KG +L L L N + + L L + +++
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 471 ELTGSLP--SYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L + S SL NL L I + + G
Sbjct: 407 NLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNG 443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
PP + + +S L+ ++P EL+N L + +D N L LPD+ L + NN+
Sbjct: 130 PPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQ 184
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
L LP + +LP L ++ +NNS ++P
Sbjct: 185 LE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLP 214
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 29/99 (29%), Positives = 40/99 (40%), Gaps = 10/99 (10%)
Query: 409 TTTPPRI---TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIV 465
P I L E PEL+N+ LT ++ D N L LPD+ L +
Sbjct: 208 KKLPDLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLKT-LPDL--PPSLEAL 262
Query: 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
++ +N LT LP SL L + E+PP L
Sbjct: 263 NVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNL 299
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 22/96 (22%), Positives = 36/96 (37%), Gaps = 12/96 (12%)
Query: 409 TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE 468
+ PP + + S ++ + + L EL + N L LP + L +
Sbjct: 293 SELPPNLYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLIE-LPAL--PPRLERLIAS 345
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
N L +P NL++LH+E N E P
Sbjct: 346 FNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 26/110 (23%), Positives = 42/110 (38%), Gaps = 25/110 (22%)
Query: 411 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 470
PP + ++ +S L E+P L L N L +P++ +L+ +H+E N
Sbjct: 315 LPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPEL--PQNLKQLHVEYN 367
Query: 471 ELTGSLPSYMGSL----------------PNLQELHIENNSFVGEIPPAL 504
L P S+ NL++LH+E N E P
Sbjct: 368 PLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIP 415
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 26/99 (26%), Positives = 39/99 (39%), Gaps = 20/99 (20%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP---------DMSRLID-----LRIV 465
NL E+P E +N+++ TE + + P +SRL D +
Sbjct: 18 RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76
Query: 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
L N L+ SLP P+L+ L NS E+P
Sbjct: 77 ELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELP 110
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 21/105 (20%), Positives = 33/105 (31%), Gaps = 18/105 (17%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEA-------------LTELWLDGNFLTGPLPDMSRL 459
T+ + + PP EL L+ L+ LP+
Sbjct: 34 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE--LP 90
Query: 460 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
L + N LT LP SL +L + + ++PP L
Sbjct: 91 PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL-SDLPPLL 133
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 16/88 (18%), Positives = 32/88 (36%), Gaps = 9/88 (10%)
Query: 409 TTTPPRITKI-ALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVH 466
P + L + E+P +N L +L ++ N L PD + DLR
Sbjct: 370 REFPDIPESVEDLRMNSHLAEVPELPQN---LKQLHVETNPLRE-FPDIPESVEDLR--- 422
Query: 467 LENNELTGSLPSYMGSLPNLQELHIENN 494
+ + + + L++ E++
Sbjct: 423 MNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 26/129 (20%), Positives = 49/129 (37%), Gaps = 28/129 (21%)
Query: 411 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRI----- 464
PPR+ ++ S +L E+P +N L +L ++ N L PD + DLR+
Sbjct: 335 LPPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPESVEDLRMNSHLA 389
Query: 465 -----------VHLENNELTGSLPSYMGSLPNLQELHIENNSFVG--EIPPALLTGKVIF 511
+H+E N L P ++++L + + V E
Sbjct: 390 EVPELPQNLKQLHVETNPLR-EFPD---IPESVEDLRMNSERVVDPYEFAHETTDKLEDD 445
Query: 512 KYDNNPKLH 520
++++ H
Sbjct: 446 VFEHHHHHH 454
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 15/104 (14%), Positives = 42/104 (40%), Gaps = 6/104 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+T + L N+ P + ++ L L+ N ++ + ++ L ++ + +N++
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQI 365
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 516
+ P + +L + +L + + ++ P I N
Sbjct: 366 SDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKN 406
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 5/89 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ +++L+G LK L ++ LT+L L N ++ L +S L L + L N++
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 277
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIP 501
+ P + L L L + N P
Sbjct: 278 SNISP--LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 24/94 (25%), Positives = 41/94 (43%), Gaps = 5/94 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+T + L+ + P L + LTEL L N ++ + ++ L L + L N+L
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQL 299
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
S + +L NL L + N+ P + LT
Sbjct: 300 ED--ISPISNLKNLTYLTLYFNNISDISPVSSLT 331
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 24/82 (29%), Positives = 38/82 (46%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++T++ L + P L + ALT L L+ N L + +S L +L + L N +
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNI 321
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
+ P + SL LQ L NN
Sbjct: 322 SDISP--VSSLTKLQRLFFYNN 341
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-08
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 5/94 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ ++ +S + L + L L N ++ + + L +L + L N+L
Sbjct: 177 TTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQL 233
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
+ SL NL +L + NN P + LT
Sbjct: 234 KD--IGTLASLTNLTDLDLANNQISNLAPLSGLT 265
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 20/94 (21%), Positives = 39/94 (41%), Gaps = 5/94 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++T + +K ++ + LT++ N LT + + L L + + NN++
Sbjct: 46 DQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI 102
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
+ + +L NL L + NN P LT
Sbjct: 103 AD--ITPLANLTNLTGLTLFNNQITDIDPLKNLT 134
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 5/89 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ + + + P L + L EL L+GN L + ++ L +L + L NN++
Sbjct: 199 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQI 255
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIP 501
+ P + L L EL + N P
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 5/92 (5%)
Query: 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 474
K L N+ + +++ +T L D + + + L +L ++ NN+LT
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTD 82
Query: 475 SLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
P + +L L ++ + NN P A LT
Sbjct: 83 ITP--LKNLTKLVDILMNNNQIADITPLANLT 112
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 23/81 (28%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 474
+T+I S L I P LKN+ L ++ ++ N + + ++ L +L + L NN++T
Sbjct: 70 LTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITD 126
Query: 475 SLPSYMGSLPNLQELHIENNS 495
P + +L NL L + +N+
Sbjct: 127 IDP--LKNLTNLNRLELSSNT 145
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 19/94 (20%), Positives = 37/94 (39%), Gaps = 6/94 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ ++ LS + L + +L +L L ++ L L + + +N++
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD--LKPLANLTTLERLDISSNKV 189
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
+ S + L NL+ L NN P +LT
Sbjct: 190 SD--ISVLAKLTNLESLIATNNQISDITPLGILT 221
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 14/107 (13%), Positives = 31/107 (28%), Gaps = 10/107 (9%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
I ++ + P L N+ +T+L L+ T + + +
Sbjct: 353 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 519
P+ + + E I N T +V + + +
Sbjct: 411 L-IAPATISDGGSYTEPDITWNL-------PSYTNEVSYTFSQPVTI 449
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 23/112 (20%), Positives = 46/112 (41%), Gaps = 9/112 (8%)
Query: 411 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHL 467
PP +T++ L G + ++ LK + L +L L N ++ + + ++ LR +HL
Sbjct: 190 LPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHL 247
Query: 468 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 519
NN+L +P + +Q +++ NN+ I
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYN--TKKASY 295
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 25/98 (25%), Positives = 41/98 (41%), Gaps = 7/98 (7%)
Query: 412 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 469
PP + L + EI KN++ L L L N ++ P + L+ L ++L
Sbjct: 51 PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N+L LP LQEL + N ++ ++ G
Sbjct: 110 NQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNG 143
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 17/101 (16%), Positives = 41/101 (40%), Gaps = 9/101 (8%)
Query: 411 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT-GPLPDM--SRLIDLRIVH 466
P + ++ + + ++ + + + L N L + + + L +
Sbjct: 119 MPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177
Query: 467 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ + +T ++P G P+L ELH++ N ++ A L G
Sbjct: 178 IADTNIT-TIPQ--GLPPSLTELHLDGNKI-TKVDAASLKG 214
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 12/91 (13%), Positives = 33/91 (36%), Gaps = 10/91 (10%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-------GPLPDMSRLIDLRIV 465
P + ++ L+ L ++P L + + + ++L N ++ P ++ V
Sbjct: 240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 298
Query: 466 HLENNELT-GSLPSYM-GSLPNLQELHIENN 494
L +N + + + + + N
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 21/103 (20%), Positives = 40/103 (38%), Gaps = 9/103 (8%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
+ K+ LS ++ + L N L EL L+ N L ++ +++V+L NN
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274
Query: 472 LTG------SLPSYMGSLPNLQELHIENNSF-VGEIPPALLTG 507
++ P Y + + + +N EI P+
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 22/98 (22%), Positives = 42/98 (42%), Gaps = 7/98 (7%)
Query: 412 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 469
P T + L ++ E+ + K ++ L L L N ++ S L L+ +++
Sbjct: 53 SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N L +P +L EL I +N ++P + +G
Sbjct: 112 NHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSG 145
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 14/91 (15%), Positives = 32/91 (35%), Gaps = 10/91 (10%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-------GPLPDMSRLIDLRIV 465
P + ++ L L +P L +++ L ++L N +T P+ + +
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299
Query: 466 HLENNELT-GSLPSYM-GSLPNLQELHIENN 494
L NN + + + + + N
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 7/87 (8%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 478
+S L IP +L E L EL LD N + L D+ R L + L +N++ + +
Sbjct: 179 ISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIEN 234
Query: 479 YM-GSLPNLQELHIENNSFVGEIPPAL 504
LP L+ELH++NN +P L
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 16/98 (16%), Positives = 34/98 (34%), Gaps = 7/98 (7%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
+ + L N +I + + L +L++ N L +P L + + +N
Sbjct: 78 QHLYALVLVN-NKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL-PSSLVELRIHDNR 134
Query: 472 LTGSLPSYM-GSLPNLQELHIENNSF-VGEIPPALLTG 507
+ +P + L N+ + + N P G
Sbjct: 135 IR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 14/71 (19%), Positives = 35/71 (49%), Gaps = 1/71 (1%)
Query: 433 LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491
+ + L L + G +T +P++S L L ++ + ++ S+ + + +LP + + +
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 492 ENNSFVGEIPP 502
N + +I P
Sbjct: 144 SYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 15/90 (16%), Positives = 38/90 (42%), Gaps = 3/90 (3%)
Query: 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 474
+T I L+ N+ ++ ++ + +L ++ T +S L +L + + ++T
Sbjct: 46 LTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTS 102
Query: 475 SLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ L +L L I +++ I +
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 10/82 (12%), Positives = 32/82 (39%), Gaps = 2/82 (2%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+T + +S I ++ + + + L N + + L +L+ ++++ + +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
+ P L +L+ +
Sbjct: 172 HDY--RGIEDFPKLNQLYAFSQ 191
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 15/95 (15%), Positives = 31/95 (32%), Gaps = 3/95 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ + L + ++ ++ L L L N L P+ + + L NN+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ + NL+ + N F +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 15/93 (16%), Positives = 35/93 (37%), Gaps = 8/93 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 470
P I + + N+ + + ++L N +T L D ++ + L+ N
Sbjct: 99 PSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLN 154
Query: 471 ELTG-SLPSYMGSLPNLQELHIENNSFVGEIPP 502
E+ + S L+ L+++ N ++
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 21/91 (23%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNE 471
R ++ +LK + ++ + EL L GN L+ D++ L +++L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
L + SL L+ L + NN E+
Sbjct: 70 LY-ETLD-LESLSTLRTLDLNNNYV-QELLV 97
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 16/77 (20%), Positives = 30/77 (38%), Gaps = 3/77 (3%)
Query: 432 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491
EL ++ L N ++ + SR + ++L NN++T G +Q L +
Sbjct: 94 ELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 492 ENNSFVGEIPPALLTGK 508
+ N + A L
Sbjct: 152 KLNEID-TVNFAELAAS 167
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 11/75 (14%), Positives = 26/75 (34%), Gaps = 2/75 (2%)
Query: 429 IPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 487
I +N + + L L + +++ + L N L+ + + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 488 ELHIENNSFVGEIPP 502
L++ +N E
Sbjct: 62 LLNLSSNVLY-ETLD 75
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
P + + +S NL L L EL++ N L LPD S L ++ + N+
Sbjct: 430 PQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLKT-LPDASLFPVLLVMKISRNQ 484
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFV 497
L L +LQ++ + N +
Sbjct: 485 LKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 22/154 (14%), Positives = 47/154 (30%), Gaps = 4/154 (2%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENN 470
+ + + EI + +L EL + L + + D+ + L +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFK 530
E L + L +++ L + + + + L + F
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 531 LILGTSIGVLAILLVLFL-CSLIVLRKLRRKISN 563
+L +L + V F C+L L S+
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 21/100 (21%), Positives = 37/100 (37%), Gaps = 7/100 (7%)
Query: 412 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLE 468
+ + LS + I L+ L L L + + + L L + L
Sbjct: 25 TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLS 82
Query: 469 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+N L+ SL S G L +L+ L++ N + +L
Sbjct: 83 DNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 11/98 (11%), Positives = 29/98 (29%), Gaps = 4/98 (4%)
Query: 413 PRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLEN 469
+ + L G + + N+ L L + + D + L L + ++
Sbjct: 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L + S+ ++ L + + +
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSES-AFLLEIFADI 194
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 16/101 (15%), Positives = 35/101 (34%), Gaps = 6/101 (5%)
Query: 406 TCSTTTPPRITKIALSGKNLK--GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 463
+ P + + LS +L+ + L ++ LT L + N +R
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMR 413
Query: 464 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
++L + + + + L+ L + NN+ L
Sbjct: 414 FLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNL-DSFSLFL 450
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 20/100 (20%), Positives = 39/100 (39%), Gaps = 11/100 (11%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 467
++ +I + + +P +++++L L L N + S L+ + L
Sbjct: 310 EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
Query: 468 ENNELTGSLPSYMG---SLPNLQELHIENNSFVGEIPPAL 504
N L S+ +L NL L I N+F +P +
Sbjct: 369 SQNHLR-SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSC 406
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 34/111 (30%), Positives = 43/111 (38%), Gaps = 11/111 (9%)
Query: 405 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 456
V C T PP + T + LS L L LT+L LD LT L
Sbjct: 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD 73
Query: 457 SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L L + L +N+L SLP +LP L L + N +P L G
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRG 122
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 7/86 (8%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 469
P +T + +S L +P + + L EL+L GN L LP ++ L + L N
Sbjct: 100 PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLAN 157
Query: 470 NELTGSLPSYM-GSLPNLQELHIENN 494
N LT LP+ + L NL L ++ N
Sbjct: 158 NNLT-ELPAGLLNGLENLDTLLLQEN 182
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.9 bits (139), Expect = 2e-08
Identities = 113/703 (16%), Positives = 199/703 (28%), Gaps = 202/703 (28%)
Query: 75 DLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASR 134
D +Y Y I F+ F D V D +
Sbjct: 8 DFETGEHQYQYKDILS---------VFE----------DAFVDNFDCK-----DVQDMPK 43
Query: 135 -VYAKE---MIIRAPSDSIDVCICCAVTGSPFI-STLELRPLNLSMYATDFEDNFFLKVA 189
+ +KE II + V+G+ + TL + M F++
Sbjct: 44 SILSKEEIDHIIMSKDA---------VSGTLRLFWTLLSKQEE--MVQK------FVEEV 86
Query: 190 ARVNFGALTKDALRY-PDDPYD--RIWDSDLDRRPNFVVGAASGTV-RINTTKNIETRTR 245
R+N+ L ++ P R++ DR N A V R+ +
Sbjct: 87 LRINYKFLM-SPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL 145
Query: 246 EYPPVKVMQTAVVGTEG----VL------SYRLNLEDFPANARAFAYF--------AEIQ 287
E P K + + G G + SY++ F F +
Sbjct: 146 ELRPAKNV--LIDGVLGSGKTWVALDVCLSYKV-QCKMD-----FKIFWLNLKNCNSPET 197
Query: 288 DLGPSETRKFKLEQPYFADYSNAVVNIAENANG-----SYTLYEPSYMNVTLNFVL---- 338
L + ++++ + S+ NI + L Y N L VL
Sbjct: 198 VLEMLQKLLYQIDPNW-TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL--VLLNVQ 254
Query: 339 ------SFSF-----VKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDES 387
+F+ + TR + + + + I+ L DE
Sbjct: 255 NAKAWNAFNLSCKILLTTRFKQV---TDFLSAATTTHISL------DHHSMTLTP--DEV 303
Query: 388 ERTNDRGDPCVPVPWEWVTCSTTT-PPRITKI---ALSGKNLKGEIPPELKNMEALTELW 443
+ + +++ C P + LS I +++ A + W
Sbjct: 304 KS----------LLLKYLDCRPQDLPREVLTTNPRRLSI------IAESIRDGLATWDNW 347
Query: 444 LDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI-ENNSFVGEIPP 502
N ++ +I+ + LE E L + ++ IP
Sbjct: 348 KHVNC-----DKLTTIIESSLNVLEPAEYR----------KMFDRLSVFPPSA---HIPT 389
Query: 503 ALLTGKVIFKYDNNP--------KLHKES---RRRMRFKLILGTSIGVLAILLVLFLCSL 551
LL + +D KLHK S ++ +I + +I L L L
Sbjct: 390 ILL---SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES------TISIPSIYLEL-KVKL 439
Query: 552 IVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATN 611
L R I + + K P Y + GH + E E
Sbjct: 440 ENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNI--------EHPERMT 491
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 671
F V+ D + + KI DS + + L ++ + P I
Sbjct: 492 LFRM---------VFL----DFRFLEQKIRHDSTAWNASGSILN--TLQQL--KFYKPYI 534
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 714
+ +++R LV + L + K D L+IA
Sbjct: 535 CDNDPKYER-LVNAILDF--LPKIEENLICSKYTDL---LRIA 571
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 5e-06
Identities = 50/319 (15%), Positives = 88/319 (27%), Gaps = 101/319 (31%)
Query: 640 IMADSCSHRTQQFVTEVA------LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 693
+ Q+FV EV L+S I P + Y R
Sbjct: 70 TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM--------YIEQ-----R 116
Query: 694 DRLHGSVNQKPLDWLTRLQIAHDAAKGLE--------YLH--TGCNPGIIHRDVKSS--- 740
DRL+ ++RLQ + L + G G K+
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS--G------KTWVAL 168
Query: 741 NILLDINMRAKVSD------FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 794
++ L ++ K+ E L + + +DP + T +SD
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY----QIDPNW------TSRSD 218
Query: 795 VYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS--IVDPVLIGNVKIES 852
S + + AEL R + K ++ NV+
Sbjct: 219 -----------HSSNIKLRIHSIQAELR-----RLLKSKPYENCLLVLL-----NVQNAK 257
Query: 853 IWRIAEVAIQCVEQRGFSRPKMQEIVL----AIQDSIKIEKGGD---QKFSSSSSKGQSS 905
W + C K+ ++ + D + S + + +
Sbjct: 258 AWN--AFNLSC---------KI--LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV- 303
Query: 906 RKTLLTSFLEIESPDLSNE 924
K+LL +L+ DL E
Sbjct: 304 -KSLLLKYLDCRPQDLPRE 321
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 2e-08
Identities = 22/84 (26%), Positives = 37/84 (44%), Gaps = 5/84 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+T + LS L+ +PP L + L L N L + ++ L L+ + L NN L
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRL 520
Query: 473 TGSLPS--YMGSLPNLQELHIENN 494
+ + S P L L+++ N
Sbjct: 521 Q-QSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 3e-07
Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 4/87 (4%)
Query: 408 STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL 467
+ + L+ K+L + L+ + +T L L N L P ++ L L ++
Sbjct: 436 LKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQA 493
Query: 468 ENNELTGSLPSYMGSLPNLQELHIENN 494
+N L ++ + +LP LQEL + NN
Sbjct: 494 SDNALE-NVDG-VANLPRLQELLLCNN 518
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 13/65 (20%), Positives = 24/65 (36%), Gaps = 7/65 (10%)
Query: 431 PELKNMEALTELWLDGNFLTGP--LPDMSRLIDLRIVHLENNELTGSLPSY----MGSLP 484
+ N+ L EL L N L + + L +++L+ N L LP
Sbjct: 502 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLP 560
Query: 485 NLQEL 489
++ +
Sbjct: 561 SVSSI 565
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 17/97 (17%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
P + ++ L I + + L L L + +P+++ L+ L + + N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNH 229
Query: 472 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+ L +L++L + N+ V I G
Sbjct: 230 FP-EIRPGSFHGLSSLKKLWVMNSQ-VSLIERNAFDG 264
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-07
Identities = 23/98 (23%), Positives = 39/98 (39%), Gaps = 5/98 (5%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
+ + L +++ +I + +L L L N+LT L LR + L NN
Sbjct: 99 HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNN 157
Query: 471 ELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+ S+PSY +P+L L + + I G
Sbjct: 158 PIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 21/91 (23%), Positives = 43/91 (47%), Gaps = 11/91 (12%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHL 467
+ ++ +SG + EI P + +L +LW+ + ++ ++ L ++L
Sbjct: 218 VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL---VELNL 273
Query: 468 ENNELTGSLPSYM-GSLPNLQELHIENNSFV 497
+N L+ SLP + L L ELH+ +N +
Sbjct: 274 AHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 4/79 (5%)
Query: 431 PELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQE 488
P L + L EL + GN P L L+ + + N++++ + L +L E
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVE 270
Query: 489 LHIENNSFVGEIPPALLTG 507
L++ +N+ +P L T
Sbjct: 271 LNLAHNNLS-SLPHDLFTP 288
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
P + ++ L I + + L L L L +P+++ LI L + L N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNH 218
Query: 472 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
L+ ++ L +LQ+L + + I
Sbjct: 219 LS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDN 253
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 7/99 (7%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 469
+ + LS +++ I + L L L N LT +P+ L L+ + L N
Sbjct: 88 RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRN 145
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
N + S+PSY +P+L+ L + + I G
Sbjct: 146 NPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 21/88 (23%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
++ ++ LSG +L I P + + L +LW+ + + + L L ++L +N
Sbjct: 207 IKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265
Query: 471 ELTGSLPSYM-GSLPNLQELHIENNSFV 497
LT LP + L +L+ +H+ +N +
Sbjct: 266 NLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 24/94 (25%), Positives = 38/94 (40%), Gaps = 9/94 (9%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHL-E 468
+ + L L IP + L ELWL N + +P +R+ LR + L E
Sbjct: 112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGE 169
Query: 469 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIP 501
L+ + L NL+ L++ + EIP
Sbjct: 170 LKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP 201
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 19/82 (23%), Positives = 35/82 (42%), Gaps = 10/82 (12%)
Query: 431 PELKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPN 485
P L + L EL L GN L+ G + L L + +++ + +L +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL---WMIQSQIQ-VIERNAFDNLQS 256
Query: 486 LQELHIENNSFVGEIPPALLTG 507
L E+++ +N+ +P L T
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTP 277
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 19/110 (17%), Positives = 44/110 (40%), Gaps = 8/110 (7%)
Query: 408 STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL 467
S +T + ++ ++ ++ + LT+L N +T D+S+ +L +
Sbjct: 37 SEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITT--LDLSQNTNLTYLAC 92
Query: 468 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 517
++N+LT +L + L L L+ + N ++ + N
Sbjct: 93 DSNKLT-NLD--VTPLTKLTYLNCDTNKL-TKLDVSQNPLLTYLNCARNT 138
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 24/107 (22%), Positives = 39/107 (36%), Gaps = 9/107 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ ++ N+ ++ L LT L N LT D++ L L N L
Sbjct: 191 KLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE--IDVTPLTQLTYFDCSVNPL 245
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 519
T L + +L L LH + EI T + F+ + K+
Sbjct: 246 T-ELD--VSTLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKI 288
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 15/82 (18%), Positives = 30/82 (36%), Gaps = 7/82 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++T++ ++ LT L N +T D+S+ L ++ + N +
Sbjct: 148 TQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITE--LDVSQNKLLNRLNCDTNNI 203
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
T L + L L +N
Sbjct: 204 T-KLD--LNQNIQLTFLDCSSN 222
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 16/75 (21%), Positives = 28/75 (37%), Gaps = 5/75 (6%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 479
+ + ++ + L L +T L D+S+ L ++L N ELT L
Sbjct: 280 FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELT-ELD-- 334
Query: 480 MGSLPNLQELHIENN 494
+ L+ L N
Sbjct: 335 VSHNTKLKSLSCVNA 349
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 19/94 (20%), Positives = 34/94 (36%), Gaps = 8/94 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++ + + E+ L L L+L+ LT L D+S L+ + N +
Sbjct: 297 TQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-L-DVSHNTKLKSLSCVNAHI 351
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
S +G +P L + +P LT
Sbjct: 352 Q-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLT 382
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 19/97 (19%), Positives = 37/97 (38%), Gaps = 8/97 (8%)
Query: 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 469
+T ++T + +L EI L + L +G L D++ L ++ +
Sbjct: 251 STLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL-DVTHNTQLYLLDCQA 306
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
+T L + P L L++ N E+ + T
Sbjct: 307 AGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVSHNT 339
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 16/84 (19%), Positives = 26/84 (30%), Gaps = 7/84 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++T + L ++ + LT L N LT D+S L + N+
Sbjct: 106 TKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT--EIDVSHNTQLTELDCHLNKK 160
Query: 473 TGSLPSYMGSLPNLQELHIENNSF 496
L + L L N
Sbjct: 161 ITKLD--VTPQTQLTTLDCSFNKI 182
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 25/115 (21%), Positives = 39/115 (33%), Gaps = 10/115 (8%)
Query: 412 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 469
+ + LS + I L+ L L L N + D S L L + L
Sbjct: 51 TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPA----LLTGKVIFKYDNNPKL 519
N L+ +L S L +L L++ N + + LT I + N
Sbjct: 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTF 162
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 11/65 (16%), Positives = 27/65 (41%), Gaps = 2/65 (3%)
Query: 433 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHI 491
L + + L + ++++ L + N+L S+P + L +LQ++ +
Sbjct: 250 LIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWL 308
Query: 492 ENNSF 496
N +
Sbjct: 309 HTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 23/99 (23%), Positives = 36/99 (36%), Gaps = 6/99 (6%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLEN 469
+ + LS L + K + +LT L L GN G S L L+I+ + N
Sbjct: 100 GSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+ + L L+EL I+ + P L
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKS 196
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 8/99 (8%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
+TK+ +S + + + +++ L L + N L + S L L + LE
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEK 161
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
LT S+P+ L L L + + + I
Sbjct: 162 CNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKR 198
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 22/100 (22%), Positives = 40/100 (40%), Gaps = 8/100 (8%)
Query: 412 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLE 468
P + L +K + + + L EL L+ N ++ + + L +LR + L
Sbjct: 31 PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLR 88
Query: 469 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+N L +P + L NL +L I N V + +
Sbjct: 89 SNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQD 126
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 18/97 (18%), Positives = 35/97 (36%), Gaps = 4/97 (4%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
+ ++ L NL IP E L ++ L L L + RL L+++ + +
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
++ NL L I + + +P +
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRH 246
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 20/91 (21%), Positives = 39/91 (42%), Gaps = 11/91 (12%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHL 467
+ + LS + I L + L E+ L G L ++ L R++++
Sbjct: 248 VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL---RVLNV 303
Query: 468 ENNELTGSLPSYM-GSLPNLQELHIENNSFV 497
N+LT +L + S+ NL+ L +++N
Sbjct: 304 SGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 18/98 (18%), Positives = 41/98 (41%), Gaps = 6/98 (6%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
+T ++++ NL +P ++++ L L L N ++ M L+ L+ + L
Sbjct: 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282
Query: 471 ELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+L + Y L L+ L++ N + ++
Sbjct: 283 QLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 7e-08
Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 2/85 (2%)
Query: 411 TPPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 469
TP + ++ L K+ G+I L L L L + ++ +L L+ + L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSE 80
Query: 470 NELTGSLPSYMGSLPNLQELHIENN 494
N + G L LPNL L++ N
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGN 105
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 15/84 (17%), Positives = 36/84 (42%), Gaps = 4/84 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
R+ ++ +S L + + + L L L N L + + L ++L++N +
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 336
Query: 473 TGSLPSYMGSLPNLQELHIENNSF 496
+L + + L+ L + +N +
Sbjct: 337 V-TLK--LSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 22/99 (22%), Positives = 42/99 (42%), Gaps = 8/99 (8%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
I K+ + ++ +PP + +N+ LT L L+ N L+ LP L + + N
Sbjct: 99 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 156
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
N L + + +LQ L + +N + +L+
Sbjct: 157 NNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS 193
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 14/100 (14%), Positives = 37/100 (37%), Gaps = 6/100 (6%)
Query: 411 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLE 468
T + ++ ++P L + + L L+ + + ++ +++
Sbjct: 49 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 107
Query: 469 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
N + LP ++ ++P L L +E N +P +
Sbjct: 108 FNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 145
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 21/99 (21%), Positives = 41/99 (41%), Gaps = 8/99 (8%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
++ + L+ ++ EI + +L++ N + LP + L ++ LE
Sbjct: 75 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLER 132
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
N+L+ SLP + + P L L + NN+ I
Sbjct: 133 NDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQA 169
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 7/94 (7%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
P + ++ S ++ + + LT L L N LT + L V L NE
Sbjct: 210 PIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNE 265
Query: 472 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPAL 504
L + + + L+ L+I NN V +
Sbjct: 266 LE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYG 297
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 8e-06
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 8/87 (9%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
P +T + L +L +P + N LT L + N L + D L+ + L +
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 180
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSF 496
N LT + +P+L ++ N
Sbjct: 181 NRLT-HVDL--SLIPSLFHANVSYNLL 204
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 469
+ P + +S L L A+ EL N + + ++L I+ L++
Sbjct: 189 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQH 241
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N LT + + P L E+ + N +I
Sbjct: 242 NNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVK 276
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 10/80 (12%), Positives = 31/80 (38%), Gaps = 6/80 (7%)
Query: 431 PELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQ 487
E + + + + LP + + +++L + ++ + +Y +Q
Sbjct: 45 FEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQ 102
Query: 488 ELHIENNSFVGEIPPALLTG 507
+L++ N+ +PP +
Sbjct: 103 KLYMGFNAIR-YLPPHVFQN 121
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 20/85 (23%), Positives = 39/85 (45%), Gaps = 2/85 (2%)
Query: 411 TPPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 469
TP + ++ L ++ +G++ E L L LT + ++ +L L+ + L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSD 73
Query: 470 NELTGSLPSYMGSLPNLQELHIENN 494
N ++G L PNL L++ N
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGN 98
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 22/83 (26%), Positives = 37/83 (44%), Gaps = 7/83 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP--LPDMSRLIDLRIVHLENN 470
++ K+ LS + G + + LT L L GN + + + +L +L+ + L N
Sbjct: 64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
Query: 471 ELTGSLPSY----MGSLPNLQEL 489
E+T +L Y LP L L
Sbjct: 124 EVT-NLNDYRENVFKLLPQLTYL 145
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 22/115 (19%), Positives = 39/115 (33%), Gaps = 13/115 (11%)
Query: 395 DPCVPVPWEWVTCS----TTTPPRI------TKIALSGKNLKGEIPPE-LKNMEALTELW 443
D C P + C+ + + T++ + + + L+ + L L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 444 LDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 497
+ + L PD L ++L N L SL +LQEL + N
Sbjct: 63 IVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 18/95 (18%), Positives = 33/95 (34%), Gaps = 7/95 (7%)
Query: 428 EIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGS-LP 484
+ L E LTEL+++ L + L +LR + + + L + P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 485 NLQELHIENNSFVGEIPPALLTGK--VIFKYDNNP 517
L L++ N+ + + G NP
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNP 114
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 8/88 (9%)
Query: 412 PPRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHL 467
P + LS NL + E + L L L N L + + +LR + L
Sbjct: 38 PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDL 95
Query: 468 ENNELTGSLPSYM-GSLPNLQELHIENN 494
+N L +L ++ L L+ L + NN
Sbjct: 96 SSNHLH-TLDEFLFSDLQALEVLLLYNN 122
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 35/174 (20%), Positives = 60/174 (34%), Gaps = 25/174 (14%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
+ + LS +L I E + L L L N L L + S L L ++ L N
Sbjct: 64 TNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYN 121
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMR 528
N + + + LQ+L++ N P L+ + PKL +
Sbjct: 122 NHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKD-----GNKLPKLMLLDLSSNK 174
Query: 529 FKLILGTSIGVLAILLVLFL----------CSLIVLRK--LRRKISNQKSYEKA 570
K + T + L + L C L L R++S+ +++
Sbjct: 175 LKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQED 228
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 13/99 (13%), Positives = 37/99 (37%), Gaps = 8/99 (8%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 469
+ ++ ++P L + + L L+ + + + ++ +++
Sbjct: 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 102
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
N + LP ++ ++P L L +E N +P +
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 139
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 21/93 (22%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNE 471
+T + L NL L N L E+ L N L ++ L +++ NN
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
L +L Y +P L+ L + +N + +
Sbjct: 284 LV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 314
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 8/87 (9%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 469
P +T + L +L +P + N LT L + N L + D L+ + L +
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 174
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSF 496
N LT + +P+L ++ N
Sbjct: 175 NRLT-HVDL--SLIPSLFHANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 469
+ P + +S L L A+ EL N + + ++L I+ L++
Sbjct: 183 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQH 235
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N LT + + P L E+ + N +I
Sbjct: 236 NNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVK 270
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 19/95 (20%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
P + + LS +L + + L L+LD N + L +S L+ + L +N+
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDW 351
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ S N+ +++ +I L G
Sbjct: 352 DCN--SLRALFRNVARPAVDDADQHCKIDYQLEHG 384
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 8/99 (8%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
R+ + L L+ E+ P + + AL L+L N L LPD L +L + L
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHG 162
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
N ++ S+P L +L L + N + P
Sbjct: 163 NRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 7/84 (8%)
Query: 428 EIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSL 483
+ P + L L LD L L L L+ ++L++N L +LP L
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152
Query: 484 PNLQELHIENNSFVGEIPPALLTG 507
NL L + N +P G
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRG 175
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 20/104 (19%), Positives = 41/104 (39%), Gaps = 9/104 (8%)
Query: 406 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRI 464
C + + L+ +P + A ++L GN ++ P +L I
Sbjct: 7 VCYNEPK---VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTI 60
Query: 465 VHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+ L +N L + + L L++L + +N+ + + PA G
Sbjct: 61 LWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHG 103
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 7/89 (7%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 469
+T + L G + +P + + +L L L N + + L L ++L
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210
Query: 470 NELTGSLPSY-MGSLPNLQELHIENNSFV 497
N L+ +LP+ + L LQ L + +N +V
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 26/96 (27%), Positives = 38/96 (39%), Gaps = 12/96 (12%)
Query: 409 TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE 468
P + K+ + G L +P L EL + N L LP + +L +
Sbjct: 117 PALPSGLCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLAS-LPAL--PSELCKLWAY 169
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
NN+LT SLP LQEL + +N +P
Sbjct: 170 NNQLT-SLPM---LPSGLQELSVSDNQLA-SLPTLP 200
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 22/89 (24%), Positives = 32/89 (35%), Gaps = 8/89 (8%)
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 475
+ + L +P L +T L + N LT LP +LR + + N+LT S
Sbjct: 43 AVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLT-S 95
Query: 476 LPSYMGSLPNLQELHIENNSFVGEIPPAL 504
LP L L +P L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLP-ALPSGL 123
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 26/95 (27%), Positives = 38/95 (40%), Gaps = 12/95 (12%)
Query: 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 469
T P + K+ L +P L EL + GN LT LP + +L+ + +
Sbjct: 198 TLPSELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLTS-LPVL--PSELKELMVSG 250
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
N LT SLP L L + N +P +L
Sbjct: 251 NRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESL 280
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 26/110 (23%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNM-----------------EALTELWLDGNFLTGPLP 454
PP + + +SG L +P + L +LW+ GN LT LP
Sbjct: 80 PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS-LP 137
Query: 455 DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
L+ + + +N+L SLP+ L +L NN +P
Sbjct: 138 V--LPPGLQELSVSDNQLA-SLPA---LPSELCKLWAYNNQLT-SLPMLP 180
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 28/108 (25%), Positives = 40/108 (37%), Gaps = 22/108 (20%)
Query: 406 TCSTTT---------------PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFL 449
TCS P IT+I L +K IPP + L + L N +
Sbjct: 10 TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI 68
Query: 450 TGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 494
+ L L L + L N++T LP + L +LQ L + N
Sbjct: 69 SE-LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNAN 114
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 20/84 (23%), Positives = 36/84 (42%), Gaps = 5/84 (5%)
Query: 416 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNEL 472
+ L G + E+P L + + +L L L+ N + L L +L ++ L +N+L
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKL 140
Query: 473 TGSLPSYMGSLPNLQELHIENNSF 496
L +Q +H+ N F
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 65/236 (27%)
Query: 615 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------N 666
+G+G+FG V + +VA+KI+ + +R + E+ +L +I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFL 83
Query: 667 LVPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAA 718
V + + C + +E + + L + N +P L ++ +A+
Sbjct: 84 CVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLKEN-NFQPYP-LPHVRHMAYQLC 133
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------KVSDFGLSR 759
L +LH + H D+K NIL + +V+DFG +
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 760 QAEEDL-THISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGK 809
E T +++ R Y PE + + DV+S G +L E G
Sbjct: 191 FDHEHHTTIVAT--R---HYRPPEVILELGWA-----QPCDVWSIGCILFEYYRGF 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 20/82 (24%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++ ++L + +I L ++ L L+L N +T + +SRL L + LE+N++
Sbjct: 112 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 168
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
+ + + L LQ L++ N
Sbjct: 169 S-DIVP-LAGLTKLQNLYLSKN 188
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 17/62 (27%), Positives = 33/62 (53%), Gaps = 3/62 (4%)
Query: 433 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492
LK+++ L L L+ N ++ + + L L ++L NN++T + + L L L +E
Sbjct: 108 LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLE 164
Query: 493 NN 494
+N
Sbjct: 165 DN 166
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 16/85 (18%), Positives = 37/85 (43%), Gaps = 3/85 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++ ++L + +I P L + L L+L N ++ L ++ L +L ++ L + E
Sbjct: 156 TKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQEC 212
Query: 473 TGSLPSYMGSLPNLQELHIENNSFV 497
++ +L + + S V
Sbjct: 213 LNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 21/82 (25%), Positives = 45/82 (54%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
I +I + ++K + ++ + +T+L+L+GN LT + ++ L +L + L+ N++
Sbjct: 46 NSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKV 102
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
L S + L L+ L +E+N
Sbjct: 103 K-DLSS-LKDLKKLKSLSLEHN 122
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
P +TK+ L+G L +I P L N++ L L+LD N + L + L L+ + LE+N +
Sbjct: 68 PNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGI 124
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
+ + + LP L+ L++ NN
Sbjct: 125 S-DING-LVHLPQLESLYLGNN 144
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 18/106 (16%), Positives = 37/106 (34%), Gaps = 16/106 (15%)
Query: 402 WEWVTCS----TTTPPRI----TKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTG 451
V CS P I ++ L+ + K + L ++ N +T
Sbjct: 13 GTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD 71
Query: 452 PLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 494
+ + + + L +N L ++ M L +L+ L + +N
Sbjct: 72 -IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSN 115
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 22/86 (25%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 416 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELT 473
+I L+ L+ + ++ K +E+L L L N +T D L +R++ L +N++T
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 474 GSLPSYMG---SLPNLQELHIENNSF 496
++ G +L +L L++ N F
Sbjct: 143 -TVAP--GAFDTLHSLSTLNLLANPF 165
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 21/106 (19%), Positives = 46/106 (43%), Gaps = 6/106 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ +++ + ++ P L N+ LT L D N ++ + ++ L +L VHL+NN++
Sbjct: 151 TNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQI 207
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPK 518
+ + + + NL + + N + P V+ P
Sbjct: 208 S-DVSP-LANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPS 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 23/105 (21%), Positives = 44/105 (41%), Gaps = 5/105 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ + L + I P L + L L + ++ L ++ L L + ++N++
Sbjct: 129 SNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKI 185
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 517
+ + + SLPNL E+H++NN P A + I N
Sbjct: 186 S-DISP-LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQT 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 18/82 (21%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
I + L+ ++ P L + L L+LD N +T + ++ L +L+ + + N ++
Sbjct: 107 QSIKTLDLTS-TQITDVTP-LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQV 163
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
+ L + +L L L ++N
Sbjct: 164 S-DLTP-LANLSKLTTLKADDN 183
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 17/90 (18%), Positives = 39/90 (43%), Gaps = 6/90 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
IT ++ G + I ++ + L L L N +T L + L + + L N L
Sbjct: 41 DGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPL 97
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
++ + + L +++ L + + + ++ P
Sbjct: 98 K-NVSA-IAGLQSIKTLDLTSTQ-ITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 23/90 (25%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ + L + ++ P LKN+ +TEL L GN L + ++ L ++ + L + ++
Sbjct: 63 NNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQI 119
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
T + + L NLQ L+++ N + I P
Sbjct: 120 TD--VTPLAGLSNLQVLYLDLNQ-ITNISP 146
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 18/82 (21%), Positives = 37/82 (45%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
KIA N+ + +++ +T L G +T + + L +L + L++N++
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQI 75
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
T L + +L + EL + N
Sbjct: 76 T-DLAP-LKNLTKITELELSGN 95
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 21/103 (20%), Positives = 43/103 (41%), Gaps = 6/103 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++T + + +I P L ++ L E+ L N ++ + ++ +L IV L N +
Sbjct: 173 SKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTI 229
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDN 515
T + P + NL ++ I PA ++ + N
Sbjct: 230 T-NQPVFY--NNNLVVPNVVKGPSGAPIAPATISDNGTYASPN 269
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 15/87 (17%), Positives = 33/87 (37%), Gaps = 6/87 (6%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 469
+ T + +S + ++ ++ L L + N + L +L + L +
Sbjct: 20 SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSH 78
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSF 496
N+L + NL+ L + N+F
Sbjct: 79 NKLV-KISC--HPTVNLKHLDLSFNAF 102
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 15/100 (15%), Positives = 31/100 (31%), Gaps = 6/100 (6%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 467
+ S L + ++ L L L N L L ++ + L+ + +
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDI 381
Query: 468 ENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLT 506
N ++ +L L++ +N I L
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP 421
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 17/86 (19%), Positives = 37/86 (43%), Gaps = 4/86 (4%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
+ + +S L I L + L L N + + +L L+ +++ +N+
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQ 455
Query: 472 LTGSLPSYM-GSLPNLQELHIENNSF 496
L S+P + L +LQ++ + N +
Sbjct: 456 LK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 27/142 (19%), Positives = 45/142 (31%), Gaps = 10/142 (7%)
Query: 439 LTELWLDGNFLTGPLPDM---SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 495
L L L N LP + L+ + L L S + L + L + +
Sbjct: 92 LKHLDLSFNAFDA-LPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 496 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 555
+ + P L + N LH F IL S+ +A L + + ++
Sbjct: 151 YGEKEDPEGL------QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204
Query: 556 KLRRKISNQKSYEKADSLRTST 577
K +S + L T
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLT 226
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 17/90 (18%), Positives = 33/90 (36%), Gaps = 7/90 (7%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 478
NL ++P L L L N++ L L+++ L + ++
Sbjct: 11 YRFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 479 YM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+LPNL+ L + ++ + P G
Sbjct: 67 EAFRNLPNLRILDLGSSKIY-FLHPDAFQG 95
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 27/112 (24%), Positives = 44/112 (39%), Gaps = 9/112 (8%)
Query: 412 PPRITKIALSGKNLKGEIPPEL-----KNMEALTELWLDGNFLTGPLPDM-SRLIDLRIV 465
P + ++ L L+ EL + + L L+L+ N+L P + S L LR +
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509
Query: 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 517
L +N LT L NL+ L I N + P + + +N
Sbjct: 510 SLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPDVFVSLSVLDITHNK 558
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 7/100 (7%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLE 468
P + + L + + P+ + + L EL L L+ + L L + L
Sbjct: 73 PNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131
Query: 469 NNELTG-SLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N++ L G L +L+ + +N + L
Sbjct: 132 KNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEP 170
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 16/85 (18%), Positives = 34/85 (40%), Gaps = 5/85 (5%)
Query: 415 ITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNEL 472
+ + LS + + + ++ L L L N + + L +L++++L N L
Sbjct: 268 VRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 473 TGSLPSYM-GSLPNLQELHIENNSF 496
L S LP + + ++ N
Sbjct: 327 G-ELYSSNFYGLPKVAYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 18/103 (17%), Positives = 34/103 (33%), Gaps = 10/103 (9%)
Query: 413 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTG------PLPDMSRLIDLRI 464
P + + L+ + +L +L+L N L L L++
Sbjct: 426 PHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484
Query: 465 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
++L +N L P L L+ L + +N + L
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPA 526
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 22/146 (15%), Positives = 44/146 (30%), Gaps = 10/146 (6%)
Query: 420 LSGKNLKGEIPPE--LKNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGS 475
L L + + +N++ALT L L N + P +L L+ + +N++
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163
Query: 476 LPSYMGSL--PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLIL 533
+ L L + NS + F+ N L + + +
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR---NMVLEILDVSGNGWTVDI 220
Query: 534 -GTSIGVLAILLVLFLCSLIVLRKLR 558
G ++ L +
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAG 246
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 16/86 (18%), Positives = 31/86 (36%), Gaps = 3/86 (3%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENN 470
+ + L+ + +I E ++ L L L N L + L + + L+ N
Sbjct: 290 KDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSF 496
+ L LQ L + +N+
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNAL 374
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 18/92 (19%), Positives = 30/92 (32%), Gaps = 5/92 (5%)
Query: 408 STTTPPRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 466
++ + LS +L+ L L L L + L ++
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPA--KLSVLD 280
Query: 467 LENNELTGSLPSYMGSLPNLQELHIENNSFVG 498
L N L PS LP + L ++ N F+
Sbjct: 281 LSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 15/99 (15%), Positives = 32/99 (32%), Gaps = 8/99 (8%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--------DMSRLIDLR 463
P + ++++ + +++ AL+ L L N G L L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 464 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
+ + +G + + LQ L + +NS
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 21/114 (18%), Positives = 39/114 (34%), Gaps = 4/114 (3%)
Query: 395 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP 454
+PC + P + E+ +++E L +D G
Sbjct: 4 EPCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYL-LKRVDTEADLGQFT 62
Query: 455 DMSRLIDLRIVHLENNELTGSLPSYM---GSLPNLQELHIENNSFVGEIPPALL 505
D+ + + L+ + + + + + LQEL +EN G PP LL
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 16/96 (16%), Positives = 30/96 (31%), Gaps = 7/96 (7%)
Query: 413 PRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPDMSRLID-----LRIV 465
+ ++ L + G PP L L L L ++ L L+++
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 501
+ + P L L + +N +GE
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 52/241 (21%), Positives = 91/241 (37%), Gaps = 71/241 (29%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLV 668
+K+G G+FG V + + + K AVK++ + + + E +L +I ++ N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-RSAKIEADILKKIQNDDINNNNIV 99
Query: 669 PLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKG 720
G C L++E + +L + + + N + ++ + K
Sbjct: 100 KYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRN-NYNGFH-IEDIKLYCIEILKA 149
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------------KVSDF 755
L YL + H D+K NILLD K+ DF
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 756 GLSRQAEEDL-THISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISG 808
G + + + I++ R Y PE + SD++SFG VL EL +G
Sbjct: 207 GCATFKSDYHGSIINT--R---QYRAPEVILNLGW------DVSSDMWSFGCVLAELYTG 255
Query: 809 K 809
Sbjct: 256 S 256
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 20/115 (17%), Positives = 38/115 (33%), Gaps = 17/115 (14%)
Query: 395 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PL 453
DP CS + L ++P + + + L N +
Sbjct: 2 DPGTS------ECSVIG----YNAICINRGLH-QVPELPAH---VNYVDLSLNSIAELNE 47
Query: 454 PDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
SRL DL+ + +E + + L +L L ++ N F+ ++ G
Sbjct: 48 TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNG 101
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 20/86 (23%), Positives = 36/86 (41%), Gaps = 7/86 (8%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 469
+ ++ L+ + +I + L +L L NFL + L L ++ L
Sbjct: 299 TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSY 356
Query: 470 NELTGSLPSYM-GSLPNLQELHIENN 494
N + +L LPNL+EL ++ N
Sbjct: 357 NHIR-ALGDQSFLGLPNLKELALDTN 381
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 7/85 (8%)
Query: 416 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNEL 472
K+ LS L I + +N++ L L L N + L D S L +L+ + L+ N+L
Sbjct: 326 LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQL 383
Query: 473 TGSLPSYM-GSLPNLQELHIENNSF 496
S+P + L +LQ++ + N +
Sbjct: 384 K-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 14/87 (16%), Positives = 27/87 (31%), Gaps = 6/87 (6%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 468
+ + L ++ + L L L L G L L L ++ L
Sbjct: 79 SSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137
Query: 469 NNELTGSLPSYM-GSLPNLQELHIENN 494
+N + P+ ++ L + N
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFN 164
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 22/100 (22%), Positives = 39/100 (39%), Gaps = 6/100 (6%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGN-FLTGPLPDM-SRLIDLRIVHLEN 469
P I++I +S ++ N+ +T + + LT PD L L+ + + N
Sbjct: 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114
Query: 470 NELTGSLP--SYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L P + + S L I +N ++ IP G
Sbjct: 115 TGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 19/108 (17%), Positives = 37/108 (34%), Gaps = 19/108 (17%)
Query: 406 TCSTTTPPRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLPDM--SRLID 461
C ++ K+++ +PP L L L +P S L +
Sbjct: 9 ECHQEE-----DFRVTCKDIQRIPSLPPST------QTLKLIETHLRT-IPSHAFSNLPN 56
Query: 462 LRIVHL-ENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+ +++ + L L S+ +L + + I N + I P L
Sbjct: 57 ISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKE 103
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 21/101 (20%), Positives = 40/101 (39%), Gaps = 16/101 (15%)
Query: 409 TTTPPRI-----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 463
+ +++ L+ NL +P L +T L + N L LP++ L
Sbjct: 50 VSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPEL--PASLE 103
Query: 464 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ +N L+ +LP +L+ L ++NN +P
Sbjct: 104 YLDACDNRLS-TLPE---LPASLKHLDVDNNQLT-MLPELP 139
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 23/104 (22%), Positives = 34/104 (32%), Gaps = 16/104 (15%)
Query: 409 TTTPPRI---TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIV 465
T P I L +P + L L + N LT LP++ L +
Sbjct: 133 TMLPELPALLEYINADNNQLT-MLPELPTS---LEVLSVRNNQLTF-LPEL--PESLEAL 185
Query: 466 HLENNELTGSLPSYMGSLPNLQE----LHIENNSFVGEIPPALL 505
+ N L SLP+ + +E N IP +L
Sbjct: 186 DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 21/82 (25%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++ ++L + +I L ++ L L+L N +T + +SRL L + LE+N++
Sbjct: 109 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 165
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
+ + G L LQ L++ N
Sbjct: 166 S-DIVPLAG-LTKLQNLYLSKN 185
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 19/82 (23%), Positives = 40/82 (48%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ + L +K ++ LK+++ L L L+ N ++ + + L L ++L NN++
Sbjct: 87 KNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKI 143
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
T + + L L L +E+N
Sbjct: 144 TD--ITVLSRLTKLDTLSLEDN 163
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 13/82 (15%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
K L K++ + + ++ ++ + + + + + L ++ + L N+L
Sbjct: 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 77
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
T + + +L NL L ++ N
Sbjct: 78 T-DI-KPLTNLKNLGWLFLDEN 97
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 17/92 (18%), Positives = 39/92 (42%), Gaps = 5/92 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
P++ + L + +I L + L L L+ N ++ + ++ L L+ ++L N +
Sbjct: 131 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 187
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ L + L NL L + + + +
Sbjct: 188 S-DL-RALAGLKNLDVLELFSQECLNKPINHQ 217
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 3e-04
Identities = 27/82 (32%), Positives = 47/82 (57%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
P +TK+ L+G L +I P L N++ L L+LD N + L + L L+ + LE+N +
Sbjct: 65 PNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGI 121
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
+ + + + LP L+ L++ NN
Sbjct: 122 S-DI-NGLVHLPQLESLYLGNN 141
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 7e-06
Identities = 49/236 (20%), Positives = 90/236 (38%), Gaps = 65/236 (27%)
Query: 615 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------N 666
+G+G+FG V G+ VAVKI+ + + + +E+ +L ++
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-EAARSEIQVLEHLNTTDPNSTFR 78
Query: 667 LVPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAA 718
V ++ + C +V+E + + D + + P L ++ +A+
Sbjct: 79 CVQMLEWFEHHGHIC-------IVFELLGL-STYDFIKEN-GFLPFR-LDHIRKMAYQIC 128
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------KVSDFGLSR 759
K + +LH + + H D+K NIL + KV DFG +
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 760 QAEEDL-THISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGK 809
+E T +S+ R Y PE + + DV+S G +L+E G
Sbjct: 186 YDDEHHSTLVST--R---HYRAPEVILALGWS-----QPCDVWSIGCILIEYYLGF 231
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 24/83 (28%), Positives = 40/83 (48%), Gaps = 7/83 (8%)
Query: 416 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNEL 472
+ L+ L+ +P + K ++ L LW+ N L LP +L++L + L+ N+L
Sbjct: 64 RLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQL 121
Query: 473 TGSLPSYM-GSLPNLQELHIENN 494
SLP + SL L L + N
Sbjct: 122 K-SLPPRVFDSLTKLTYLSLGYN 143
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 29/102 (28%), Positives = 44/102 (43%), Gaps = 15/102 (14%)
Query: 405 VTCS----TTTPPRI----TKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD 455
V CS T P I K+ L L +P + + L L+L+ N L LP
Sbjct: 21 VDCSSKKLTAIPSNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPA 78
Query: 456 M--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 494
L +L + + +N+L +LP + L NL EL ++ N
Sbjct: 79 GIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRN 119
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 19/108 (17%)
Query: 406 TCSTTTPPRITKIALSGKNLK---GEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLI 460
+C+ + S K L IP + +L L N L+ LP RL
Sbjct: 13 SCNNNK----NSVDCSSKKLTAIPSNIPADT------KKLDLQSNKLSS-LPSKAFHRLT 61
Query: 461 DLRIVHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
LR+++L +N+L +LP+ + L NL+ L + +N +P +
Sbjct: 62 KLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQ 107
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 18/100 (18%), Positives = 39/100 (39%), Gaps = 9/100 (9%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
++ + L+G ++ + + +L +L L L + L L+ +++ +
Sbjct: 76 SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAH 133
Query: 470 NELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPALLTG 507
N + S Y +L NL+ L + +N I L
Sbjct: 134 NLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 22/119 (18%), Positives = 33/119 (27%), Gaps = 28/119 (23%)
Query: 395 DPCVPVPWEWVTCSTTT---------------PPRITKIALSGKNLKGEIPPE-LKNMEA 438
+PCV T P + LS L+ + +
Sbjct: 1 EPCV------EVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPE 53
Query: 439 LTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 494
L L L + + D L L + L N + SL L +LQ+L
Sbjct: 54 LQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVET 110
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 17/83 (20%), Positives = 31/83 (37%), Gaps = 2/83 (2%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
R ++ L G + I ++ + N + L L L+ + + NN
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNR 75
Query: 472 LTGSLPSYMGSLPNLQELHIENN 494
+ +LP+L EL + NN
Sbjct: 76 ICRIGEGLDQALPDLTELILTNN 98
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 17/56 (30%), Positives = 29/56 (51%), Gaps = 2/56 (3%)
Query: 440 TELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 494
TEL+LDGN T ++S L ++ L NN ++ +L + ++ L L + N
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 27/101 (26%), Positives = 41/101 (40%), Gaps = 14/101 (13%)
Query: 405 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 455
V CS P I T++ L G +P EL N + LT + L N ++ L +
Sbjct: 15 VRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQ 72
Query: 456 -MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 494
S + L + L N L +P L +L+ L + N
Sbjct: 73 SFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGN 112
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 29/103 (28%), Positives = 39/103 (37%), Gaps = 17/103 (16%)
Query: 405 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 455
V C + P I K+ L L + + LT L LD N L L
Sbjct: 19 VDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAG 77
Query: 456 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 494
L +L + L NN+L SLP G L L +L++ N
Sbjct: 78 VFDDLTELGTLGLANNQLA-SLPL--GVFDHLTQLDKLYLGGN 117
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 8/88 (9%)
Query: 412 PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLE 468
PPR ++LS ++ E+ ++ + L L L N + L DL + +
Sbjct: 51 PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVS 108
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSF 496
+N L ++ + +L+ L + N F
Sbjct: 109 HNRLQ-NISC--CPMASLRHLDLSFNDF 133
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 2/77 (2%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 478
LS + + + T L N T S L L+ + L+ N L +
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394
Query: 479 YMGSLPNLQELHIENNS 495
N+ L + S
Sbjct: 395 VALMTKNMSSLETLDVS 411
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 20/91 (21%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 407 CSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 466
+ I + LS L G + L + L L N + D++ L L+ ++
Sbjct: 422 RTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELN 479
Query: 467 LENNELTGSLP-SYMGSLPNLQELHIENNSF 496
+ +N+L S+P L +LQ + + +N +
Sbjct: 480 VASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 22/91 (24%), Positives = 39/91 (42%), Gaps = 11/91 (12%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 478
S +NL +P +L L L N ++ +PD+S L +LR++ L +N + SL
Sbjct: 38 YSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF 93
Query: 479 YMG---SLPNLQELHIENNSFVGEIPPALLT 506
+L+ L + +N I +
Sbjct: 94 --HVFLFNQDLEYLDVSHNRLQ-NISCCPMA 121
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 5/99 (5%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWL-DGNFLTGPLPDM-SRLIDLRIVHLEN 469
+ KI +S ++ I + N+ L E+ + N L P+ L +L+ + + N
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 113
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+ LP L I++N + I G
Sbjct: 114 TGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 17/103 (16%)
Query: 405 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 455
V C T+ P I T + L +LK + +LT+L+L GN L LP+
Sbjct: 12 VECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNG 70
Query: 456 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 494
++L L ++L N+L SLP+ G L L+EL + N
Sbjct: 71 VFNKLTSLTYLNLSTNQLQ-SLPN--GVFDKLTQLKELALNTN 110
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 16/100 (16%), Positives = 38/100 (38%), Gaps = 13/100 (13%)
Query: 405 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 456
+T S P K L K++ + + + ++ ++ + + + + +
Sbjct: 3 ITVSTPIKQIFPDDAFAETIKANLKKKSVT-DAVTQ-NELNSIDQIIANNSDIKS-VQGI 59
Query: 457 SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 496
L ++R + L N+L + + L NL L + N
Sbjct: 60 QYLPNVRYLALGGNKLH-DISAL-KELTNLTYLILTGNQL 97
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 24/83 (28%), Positives = 37/83 (44%), Gaps = 7/83 (8%)
Query: 415 ITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 473
I +I + ++K L N + L L GN L + + L +L + L N+L
Sbjct: 43 IDQIIANNSDIKSVQGIQYLPN---VRYLALGGNKLH-DISALKELTNLTYLILTGNQLQ 98
Query: 474 GSLPS-YMGSLPNLQELHIENNS 495
SLP+ L NL+EL + N
Sbjct: 99 -SLPNGVFDKLTNLKELVLVENQ 120
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 9e-04
Identities = 24/61 (39%), Positives = 31/61 (50%), Gaps = 9/61 (14%)
Query: 439 LTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIEN 493
L EL L N L LPD +L +L ++L +N+L SLP G L NL EL +
Sbjct: 111 LKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SLPK--GVFDKLTNLTELDLSY 166
Query: 494 N 494
N
Sbjct: 167 N 167
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 28/103 (27%), Positives = 40/103 (38%), Gaps = 17/103 (16%)
Query: 405 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 455
V C + P I + L + P ++ L EL+L N L LP
Sbjct: 24 VDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVG 82
Query: 456 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 494
L L ++ L N+LT LPS L +L+EL + N
Sbjct: 83 VFDSLTQLTVLDLGTNQLT-VLPS--AVFDRLVHLKELFMCCN 122
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 21/58 (36%), Positives = 30/58 (51%), Gaps = 4/58 (6%)
Query: 439 LTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494
LT L L N LT LP RL+ L+ + + N+LT LP + L +L L ++ N
Sbjct: 90 LTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 26/102 (25%), Positives = 50/102 (49%), Gaps = 15/102 (14%)
Query: 414 RITKIA-LSG-KNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL 462
I KI+ LSG +NL+ +I + L ELW+ N + L + +L++L
Sbjct: 59 NIEKISSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LSGIEKLVNL 117
Query: 463 RIVHLENNELT--GSLPSYMGSLPNLQELHIENNSFVGEIPP 502
R++++ NN++T G + + +L L++L + N +
Sbjct: 118 RVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKE 158
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 931 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.68 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.64 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.51 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.51 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.48 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.47 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.43 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.4 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.4 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.39 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.37 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.37 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.33 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.32 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.31 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.29 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.28 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.28 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.28 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.28 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.26 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.25 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.25 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.24 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.22 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.21 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.2 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.2 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.19 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.18 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.18 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.18 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.17 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.17 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.16 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.15 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.15 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.12 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.1 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.1 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.1 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.1 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.1 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.09 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.09 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.08 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.06 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.06 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.06 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.06 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.05 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.05 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.05 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.04 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.04 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.03 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.02 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.01 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.01 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.01 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.0 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 98.99 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.99 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.99 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.98 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.98 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.98 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.98 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.98 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.98 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.96 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.96 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.96 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.95 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.95 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.94 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.94 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.93 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.93 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.93 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.91 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.91 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.9 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.89 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.89 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.89 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.89 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.87 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.87 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.85 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.85 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.85 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.85 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.83 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.82 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.8 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.8 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.78 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.78 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.78 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.78 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.77 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.71 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.7 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.7 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.69 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.68 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.66 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.66 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.66 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.64 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.64 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.64 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.63 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.6 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.57 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.55 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.54 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.52 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.5 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.5 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.46 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 98.45 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.41 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.4 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.39 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.38 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.31 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.29 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.26 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.25 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.24 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.2 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.15 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.09 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.08 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.07 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.93 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.89 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.82 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.77 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.64 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.63 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.6 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.51 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.5 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.41 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.35 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.34 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.23 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.15 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.08 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 96.9 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 96.8 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.75 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.73 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.68 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.58 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.56 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.52 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.39 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.39 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.39 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.19 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.18 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.1 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.02 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 95.93 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.78 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.68 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.21 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 95.03 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 94.87 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.86 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.01 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 91.93 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 89.12 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.02 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 87.92 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 87.73 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 86.86 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 85.25 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 85.23 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 83.83 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=443.44 Aligned_cols=259 Identities=26% Similarity=0.429 Sum_probs=207.5
Q ss_pred HHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
...+.++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++|
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3456789999999999999875 4788999999876666678899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceE
Q 002358 684 YEYMHNGTLRDRLHGSV------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 751 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vk 751 (931)
||||++|+|.++++... ...+++|.+++.|+.|||+||+|||+ ++|+||||||+||||++++.+|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEE
Confidence 99999999999997542 23469999999999999999999998 8999999999999999999999
Q ss_pred Eecccccccccccc-cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHH
Q 002358 752 VSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 829 (931)
Q Consensus 752 L~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 829 (931)
|+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||..... ..+...
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~~--- 272 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDC--- 272 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHHH---
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHHH---
Confidence 99999998754432 223344569999999999999999999999999999999999 8999974332 122222
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 830 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
+..+...+ .+...+..+.+++.+||+.||++||||+||++.|+.+...
T Consensus 273 -i~~g~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 -ITQGRELE---------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -HHHTCCCC---------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -HHcCCCCC---------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 22222111 1122334688999999999999999999999999987653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=442.16 Aligned_cols=261 Identities=28% Similarity=0.457 Sum_probs=214.9
Q ss_pred HHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
...+.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 344567899999999999999875 47789999998776666788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCC----------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceE
Q 002358 682 LVYEYMHNGTLRDRLHGSV----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 751 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vk 751 (931)
+|||||++|+|.++|+... ....++|..++.++.|||+||+|||+ ++|+||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEE
Confidence 9999999999999997531 34579999999999999999999998 8999999999999999999999
Q ss_pred Eeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHH
Q 002358 752 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 829 (931)
Q Consensus 752 L~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 829 (931)
|+|||+++....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||..... ..+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~---- 241 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIE---- 241 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHH----
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----
Confidence 999999987544332 22334568999999999999999999999999999999999 8999974332 12222
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 830 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
.+..+.... .+...+.++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 242 ~i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 CITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 222232211 1222334688999999999999999999999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=442.36 Aligned_cols=263 Identities=24% Similarity=0.413 Sum_probs=215.0
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEec
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE 676 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 676 (931)
.|+...+.+|.++||+|+||+||+|++. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 3445556778899999999999999874 467899999976533 345789999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcc
Q 002358 677 EHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 743 (931)
Q Consensus 677 ~~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIL 743 (931)
++..++|||||++|+|.++|.... ....++|..+++++.|||+||+|||+ ++|+||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceE
Confidence 999999999999999999996432 12468999999999999999999998 89999999999999
Q ss_pred ccCCCceEEecccccccccccc-cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchh
Q 002358 744 LDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 821 (931)
Q Consensus 744 ld~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~ 821 (931)
|++++.+||+|||+++...... ........||+.|||||++.+..|+.++|||||||+||||+| |+.||..... .
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~ 254 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q 254 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---H
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---H
Confidence 9999999999999998764432 223345579999999999999999999999999999999999 8999974332 2
Q ss_pred hHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 822 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 822 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
.+.+ .+..+.... .+...+..+.+++.+||+.||++||||+||++.|+...
T Consensus 255 ~~~~----~i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 255 DVVE----MIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHH----HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHH----HHHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 2222 233332221 12233446889999999999999999999999998653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=429.64 Aligned_cols=259 Identities=31% Similarity=0.497 Sum_probs=203.0
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
....+.++||+|+||+||+|++++ .||||+++... ....+.|.+|+++|++++|||||+++|++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 344678999999999999999763 69999987432 3455789999999999999999999999865 568999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc-
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 765 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~- 765 (931)
|++|+|.++|+.. ...+++..++.|+.|||+||+|||+ ++|+||||||+||||++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999743 4569999999999999999999998 899999999999999999999999999998754322
Q ss_pred cccccccccCCCccCCCccCC---CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 766 THISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
........||+.|||||++.+ ..|+.++|||||||+||||+||+.||...... ..+ ...+..+.. .|
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~----~~~~~~~~~----~p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQI----IFMVGRGYA----SP 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHH----HHHHHTTCC----CC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHH----HHHHhcCCC----CC
Confidence 223344579999999999854 46899999999999999999999999743221 111 112222211 11
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
.+ ...+...+..+.+++.+||+.+|++||||+||++.|+.+..
T Consensus 258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11 11222334578899999999999999999999999987754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=423.47 Aligned_cols=260 Identities=23% Similarity=0.256 Sum_probs=209.1
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+++.++||+|+||.||+|+++ +|+.||||+++... ...+|+.+|++++|||||++++++.+++..+||||||+|
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 455788999999999999986 68999999997532 235799999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC-ceEEecccccccccccccc-
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTH- 767 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~~~~~- 767 (931)
|+|.++++. .+.+++..+..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+|+........
T Consensus 135 g~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 135 GSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999974 4579999999999999999999998 8999999999999999987 6999999999876543221
Q ss_pred ---cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 768 ---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 768 ---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||......... ..+ .. +... +
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i---~~-~~~~------~ 275 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKI---AS-EPPP------I 275 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---HHH---HH-SCCG------G
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHH---Hc-CCCC------c
Confidence 123356999999999999999999999999999999999999999754433221 111 11 1110 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCCCcc
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF 895 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 895 (931)
...+......+.+++.+||+.||++|||++||++.|...+.....-..++
T Consensus 276 -~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw 325 (336)
T 4g3f_A 276 -REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325 (336)
T ss_dssp -GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred -hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence 01122233467899999999999999999999999988876655444444
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=425.75 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=206.6
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..+||||||+
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3666789999999999999987 699999999976555556778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+........
T Consensus 155 gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~- 226 (346)
T 4fih_A 155 GGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR- 226 (346)
T ss_dssp TEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-
T ss_pred CCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-
Confidence 9999999973 458999999999999999999998 89999999999999999999999999999876544332
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||...... .... .+..+.......
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~----~i~~~~~~~~~~------- 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMK----MIRDNLPPRLKN------- 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH----HHHHSSCCCCSC-------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHH----HHHcCCCCCCCc-------
Confidence 34457999999999999999999999999999999999999999743321 1111 122221111110
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.......+.+++.+||+.||++|||++|+++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1112236789999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=424.56 Aligned_cols=249 Identities=27% Similarity=0.383 Sum_probs=201.2
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
.|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4778899999999999999986 69999999996542 33457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
|+||+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 105 ~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 9999999999753 34567889999999999999999998 9999999999999999999999999999987654322
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. .+ +.+ +..+.... +..
T Consensus 181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~---~~~-i~~~~~~~-----~~~ 247 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NL---VLK-IISGSFPP-----VSL 247 (350)
T ss_dssp -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH---HHH-HHHTCCCC-----CCT
T ss_pred -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HH---HHH-HHcCCCCC-----CCc
Confidence 223456999999999999999999999999999999999999999744321 11 111 22222211 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. ..++.+++.+||+.||++|||++|+++
T Consensus 248 ~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 HY----SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22 236789999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=418.62 Aligned_cols=268 Identities=26% Similarity=0.366 Sum_probs=201.5
Q ss_pred HhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCC----eEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~~lV~E~ 686 (931)
+.+.++||+|+||+||+|+++ |+.||||+++... .....+.+|+..+.+++|||||+++|+|.+.+ ..+|||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 456789999999999999985 8999999986432 22223344566667889999999999997653 57999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcC-----CCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-----NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
|++|+|.++++. ..++|..+++++.|+++||+|||+.+ .++|+||||||+||||+.++.+||+|||+++..
T Consensus 83 ~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 83 HEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999974 45899999999999999999999731 249999999999999999999999999999876
Q ss_pred cccccc---cccccccCCCccCCCccCCC------CCCccchhHHHHHHHHHHHhCCCCCCccCccch--------hhHH
Q 002358 762 EEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--------LNIV 824 (931)
Q Consensus 762 ~~~~~~---~~~~~~gt~~y~APE~l~~~------~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~--------~~l~ 824 (931)
...... ......||+.|||||++.+. .++.++|||||||+||||+||+.|+........ ....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 543322 22335699999999998764 467899999999999999999887753222110 0011
Q ss_pred HHHHHhhhcCCeeecccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 825 HWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 825 ~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
+.+...+..+. .+|.+... ...+.+..+.+++.+||+.||++||||+||++.|+++...+
T Consensus 239 ~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 239 EEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 12222222111 12222211 13356678899999999999999999999999999886543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=410.23 Aligned_cols=244 Identities=29% Similarity=0.423 Sum_probs=196.2
Q ss_pred hhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEec----CCeEEEEE
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 684 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~~~lV~ 684 (931)
++.++||+|+||+||+|.++ +++.||+|++.... ....+.|.+|+++|++++|||||++++++.+ +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999987 58899999986532 3345679999999999999999999999865 35679999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCC--eEecCCCCCCccccC-CCceEEecccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDI-NMRAKVSDFGLSRQA 761 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--ivH~DIkp~NILld~-~~~vkL~DFGla~~~ 761 (931)
|||++|+|.+++.. ...+++..+..++.||++||+|||+ ++ |+||||||+||||+. ++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999974 4678999999999999999999998 55 999999999999984 799999999999864
Q ss_pred cccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
... ......||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ...+. ..+..+......+
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~----~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIY----RRVTSGVKPASFD 252 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHH----HHHTTTCCCGGGG
T ss_pred CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHH----HHHHcCCCCCCCC
Confidence 332 2334579999999999875 599999999999999999999999963221 11121 2222222211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+ ..+ .++.+++.+||+.||++|||++|+++
T Consensus 253 ~----~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 K----VAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G----CCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 112 25789999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=427.37 Aligned_cols=266 Identities=26% Similarity=0.407 Sum_probs=215.2
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEECC------CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCC-CCCcceeEEEec
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH-RNLVPLIGYCEE 676 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~ 676 (931)
|+....+++.+.||+|+||+||+|++.. ++.||||+++.... ...++|.+|+++|.+++| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 3445667889999999999999998753 36899999976543 345789999999999965 899999999976
Q ss_pred C-CeEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCc
Q 002358 677 E-HQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 742 (931)
Q Consensus 677 ~-~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NI 742 (931)
. +..++|||||++|+|.++|+... ....+++..++.++.|||+||+|||+ ++|+||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccce
Confidence 4 56899999999999999997532 13458999999999999999999998 8999999999999
Q ss_pred cccCCCceEEecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccch
Q 002358 743 LLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 820 (931)
Q Consensus 743 Lld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~ 820 (931)
|+++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.......
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~- 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence 9999999999999999876544332 3344568999999999999999999999999999999998 999997433221
Q ss_pred hhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 821 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 821 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
. +.+.+..+..... +.....++.+++.+||+.||++|||++||++.|+++++..
T Consensus 296 -~----~~~~i~~g~~~~~---------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 296 -E----FCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp -H----HHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -H----HHHHHHcCCCCCC---------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 1 2222333322111 1122336789999999999999999999999999887643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=425.22 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=206.6
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||+|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 667789999999999999987 6899999999765555667899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
|+|.++++. ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.+...... .
T Consensus 233 G~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~ 304 (423)
T 4fie_A 233 GALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R 304 (423)
T ss_dssp EEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-B
T ss_pred CcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-c
Confidence 999999973 458999999999999999999998 89999999999999999999999999999876544332 3
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .... .+..+....+.. ....
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~----~i~~~~~~~~~~---~~~~- 373 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMK----MIRDNLPPRLKN---LHKV- 373 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH----HHHHSCCCCCSC---TTSS-
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHH----HHHcCCCCCCcc---cccC-
Confidence 4457999999999999999999999999999999999999999743321 1111 122221111111 1112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+.+++.+||+.||++|||++|+++
T Consensus 374 ---s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 374 ---SPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ---CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 236789999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=414.27 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=205.9
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4788999999999999999986 68999999996532 2334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
||+||+|.+++.. .+.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 113 y~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 113 YAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred cCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999974 4679999999999999999999998 999999999999999999999999999998765432
Q ss_pred -cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 -THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 -~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+.. .+.+ .+..+.. .+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~----~i~~~~~------~~ 253 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIFA----KIIKLEY------DF 253 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCC------CC
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHcCCC------CC
Confidence 22344567999999999999999999999999999999999999999744322 1211 1222221 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 878 (931)
....+ .++.+++.+||+.||++|||++|++
T Consensus 254 p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 PEKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 11222 3578999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=400.27 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=190.3
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4778899999999999999876 69999999986542 2234679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+ +|+|.+.+.. .+.+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...+..
T Consensus 94 y~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp CC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred CC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 99 6899999874 4679999999999999999999998 899999999999999999999999999998754332
Q ss_pred cccccccccCCCccCCCccCCCCC-CccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
......||+.|||||++.+..+ +.++||||+||++|||++|+.||...+.. .+.+ .+..+.. .+
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~----~i~~~~~------~~ 231 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFK----NISNGVY------TL 231 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCC------CC
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHcCCC------CC
Confidence 2234579999999999998876 57999999999999999999999743321 1111 2222221 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....+ ..+.+++.+||+.||++|||++|+++
T Consensus 232 p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11222 35789999999999999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=407.57 Aligned_cols=241 Identities=26% Similarity=0.344 Sum_probs=192.2
Q ss_pred HHhhccccCccCcEEEEEEEEC----CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
.|++.+.||+|+||+||+|+.. .++.||||+++... ......+.+|+++|++++|||||++++++.+++..++|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4778899999999999999863 46899999997542 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
||||+||+|.+++.. .+.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 105 mEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp ECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999974 4579999999999999999999998 9999999999999999999999999999986543
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||...+..+ +.. .+..+.. .
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~----~i~~~~~------~ 244 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMT----MILKAKL------G 244 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCC------C
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHH----HHHcCCC------C
Confidence 322 2334579999999999999999999999999999999999999997443221 111 1212211 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 874 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 874 (931)
+....+ .++.+++.+||+.||++|||+
T Consensus 245 ~p~~~s----~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 245 MPQFLS----PEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CCTTSC----HHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCcCC----HHHHHHHHHHcccCHHHCCCC
Confidence 111222 357899999999999999984
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=396.90 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=187.7
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCC---------
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--------- 678 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--------- 678 (931)
.|++.+.||+|+||+||+|+++ +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 3677899999999999999986 689999999865433 34567999999999999999999999986544
Q ss_pred ---eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecc
Q 002358 679 ---QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 755 (931)
Q Consensus 679 ---~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DF 755 (931)
..++|||||++|+|.+++.........++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence 368999999999999999854333345667788999999999999998 89999999999999999999999999
Q ss_pred cccccccccccc-----------cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHH
Q 002358 756 GLSRQAEEDLTH-----------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 824 (931)
Q Consensus 756 Gla~~~~~~~~~-----------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~ 824 (931)
|+|+........ .....+||+.|||||++.+..|+.++|||||||++|||++ ||... .+..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~~ 234 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MERV 234 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHHH
Confidence 999876543211 1223469999999999999999999999999999999996 77521 1111
Q ss_pred HHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 825 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 825 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+. .+......... ......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~-~~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTLT-DVRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-HHHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-HHhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 11222211111 112224578999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=383.01 Aligned_cols=277 Identities=41% Similarity=0.716 Sum_probs=242.0
Q ss_pred HHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
.|++.+.||+|+||.||+|++++++.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 40 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 119 (321)
T 2qkw_B 40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119 (321)
T ss_dssp CCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred ccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence 34557889999999999999988999999998876666678899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc-cc
Q 002358 690 GTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-TH 767 (931)
Q Consensus 690 gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~-~~ 767 (931)
|+|.+++.... ....+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 196 (321)
T 2qkw_B 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196 (321)
T ss_dssp CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 99999987543 23468999999999999999999998 899999999999999999999999999998643322 22
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.............|.......+.+...+++.+...
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276 (321)
T ss_dssp CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccc
Confidence 23344589999999999888999999999999999999999999986555555667777777777777888888888777
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
...+....+.+++.+||+.||++|||++|+++.|+.+.+..+
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 888889999999999999999999999999999999887654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=394.83 Aligned_cols=259 Identities=19% Similarity=0.328 Sum_probs=199.0
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEec------CCeE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQR 680 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~~ 680 (931)
.|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 4777899999999999999986 69999999997543 2345678999999999999999999998754 3678
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++|||||+ |+|.+++.. .+.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 135 ~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 99999996 689999973 5679999999999999999999998 9999999999999999999999999999987
Q ss_pred ccccc---cccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 761 AEEDL---THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 761 ~~~~~---~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....+ .........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~g~p~~ 284 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVLGTPSP 284 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCCCCG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhcCCCCh
Confidence 54321 2223456799999999998775 5689999999999999999999999755432222111 111100000
Q ss_pred eeccc-----------ccccCC--CC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 837 ISIVD-----------PVLIGN--VK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 837 ~~i~d-----------~~l~~~--~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... ..+... .+ +.....+.+|+.+||+.||++|||++|+++
T Consensus 285 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 285 -AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 000000 00 011235789999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=380.39 Aligned_cols=286 Identities=39% Similarity=0.701 Sum_probs=242.2
Q ss_pred ccChhhHHHHH--HhhccccCccCcEEEEEEEECCCcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEec
Q 002358 600 FIPLPELEEAT--NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE 676 (931)
Q Consensus 600 ~~~~~~l~~~~--~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 676 (931)
.++..++.... |++.+.||+|+||.||+|.+++|+.||||++...... ....+.+|++++++++||||+++++++..
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 34555655444 4457899999999999999888999999999764332 33478999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecc
Q 002358 677 EHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 755 (931)
Q Consensus 677 ~~~~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DF 755 (931)
....++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 999999999999999999998653 3445899999999999999999999833339999999999999999999999999
Q ss_pred cccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCc--cchhhHHHHHHHhhhc
Q 002358 756 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF--GAELNIVHWARSMIKK 833 (931)
Q Consensus 756 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~--~~~~~l~~~~~~~~~~ 833 (931)
|+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .......+|+......
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence 99987655444444555699999999999888899999999999999999999999963222 2344567788888888
Q ss_pred CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 834 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 834 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
.....+.+..+......+....+.+++.+||+.+|++|||++||++.|++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 8888888888888888889999999999999999999999999999998743
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=377.97 Aligned_cols=194 Identities=25% Similarity=0.416 Sum_probs=166.8
Q ss_pred HHhhccccCccCcEEEEEEEEC----CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
.|++.++||+|+||+||+|+.+ .++.||+|++.... ...++.+|+++|+.+ +|||||++++++.+.++.++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 4777899999999999999864 46789999986542 345688999999998 6999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC-CceEEecccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEE 763 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~-~~vkL~DFGla~~~~~ 763 (931)
|||++|+|.+++. .+++..+..++.|++.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+...+
T Consensus 100 E~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 100 PYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp ECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred eCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999985 37899999999999999999998 999999999999999876 7999999999976433
Q ss_pred cccc---------------------------cccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCc
Q 002358 764 DLTH---------------------------ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSV 814 (931)
Q Consensus 764 ~~~~---------------------------~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~ 814 (931)
.... .....+||+.|+|||++.+. .|+.++||||+||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 2111 11234699999999998775 589999999999999999999999963
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=399.97 Aligned_cols=250 Identities=21% Similarity=0.349 Sum_probs=206.8
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+++|+.++|||||++++++.+....++|||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 4677899999999999999986 689999999977655666789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC--CceEEeccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~--~~vkL~DFGla~~~~~~~~ 766 (931)
||+|.+++.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 238 gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 238 GGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred CCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999999864 24569999999999999999999998 999999999999999854 8899999999987654322
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+ ... .+..+.. . +.+....
T Consensus 313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~~~----~i~~~~~-~-~~~~~~~ 381 (573)
T 3uto_A 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLR----NVKSCDW-N-MDDSAFS 381 (573)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH----HHHTTCC-C-CCSGGGT
T ss_pred --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH----HHHhCCC-C-CCccccc
Confidence 234569999999999999999999999999999999999999997443221 111 1212111 0 1111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+ ..+.+|+.+||+.||++|||++|+++
T Consensus 382 ~~s----~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 382 GIS----EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222 35779999999999999999999976
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=394.91 Aligned_cols=246 Identities=22% Similarity=0.283 Sum_probs=196.5
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHH---HHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVT---EVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~---E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
|++.++||+|+||.||+|+.+ +|+.||||++.+... .....+.+ ++.+++.++|||||++++++.+.+..++|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 566789999999999999987 689999999864321 12223334 45666777899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
||||+||+|.++|.. .+.+++..+..++.||+.||+|||+ ++|+||||||+||||+.+|.+||+|||+|+....
T Consensus 271 mEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp ECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999974 4679999999999999999999998 9999999999999999999999999999987654
Q ss_pred cccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
.. ....+||+.|||||++.. ..|+.++|+||+||++|||++|+.||......+...+.. .+.....
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~----~i~~~~~------ 411 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLTMAV------ 411 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH----HHHHCCC------
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hhcCCCC------
Confidence 32 234579999999999964 579999999999999999999999997544333222222 1111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 879 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 879 (931)
.+....+ .++.+++.+||+.||++|++ ++||++
T Consensus 412 ~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 ELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1111222 35789999999999999998 677653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=367.37 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=212.8
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
..+.+.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 45667899999999999999986 58999999987666667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++|+|.+++... ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999999853 4568999999999999999999998 89999999999999999999999999999875433221
Q ss_pred c-------------ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccch---hhHHHHHHHhh
Q 002358 768 I-------------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE---LNIVHWARSMI 831 (931)
Q Consensus 768 ~-------------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~---~~l~~~~~~~~ 831 (931)
. .....||+.|+|||++.+..++.++||||||+++|||++|..|+........ .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~---- 240 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL---- 240 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH----
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc----
Confidence 1 1144689999999999999999999999999999999999999863322211 1111111
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 832 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 832 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
++...... ...+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 241 ---------~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 241 ---------DRYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp ---------HHTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---------cccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 11111111 2257899999999999999999999999998876554
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=364.33 Aligned_cols=262 Identities=34% Similarity=0.507 Sum_probs=203.4
Q ss_pred HHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
....+++.+.||+|+||.||+|++. |+.||||++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 3456778899999999999999885 8999999987543 234567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCC--eEecCCCCCCccccCCCceEEeccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||+++|+|.+++........+++..++.++.|+++||+|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 999999999999854323348999999999999999999998 78 9999999999999999999999999997644
Q ss_pred ccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 763 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+. ......
T Consensus 191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~~~---~~~~~~----- 258 (309)
T 3p86_A 191 STFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAVG---FKCKRL----- 258 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHHH---HSCCCC-----
T ss_pred cccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---hcCCCC-----
Confidence 3322 223346899999999999999999999999999999999999999743321 1111111 111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
.+ +......+.+++.+||+.+|++|||++||++.|+.+....
T Consensus 259 ~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 259 EI----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 11 1122236889999999999999999999999999887654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=367.24 Aligned_cols=263 Identities=24% Similarity=0.453 Sum_probs=213.6
Q ss_pred HHHHhhccccCccCcEEEEEEEEC--------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhc-CCCCCcceeEEEecC
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 677 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~ 677 (931)
...+++.+.||+|+||.||+|++. ++..||||+++.... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 355677899999999999999863 356799999976533 3457899999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 744 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl 744 (931)
+..++||||+++|+|.+++.... ....+++..++.++.||++||+|||+ .+|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 99999999999999999997542 12458899999999999999999998 899999999999999
Q ss_pred cCCCceEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhh
Q 002358 745 DINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 822 (931)
Q Consensus 745 d~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~ 822 (931)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999986544322 12233457889999999999999999999999999999999 999997443322
Q ss_pred HHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 823 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 823 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
+... +..+... ..+......+.+++.+||+.+|++||+++|+++.|+++.....
T Consensus 314 ~~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 314 LFKL----LKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp HHHH----HHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHH----HhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 2211 2222111 1112223468899999999999999999999999999887654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.17 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=211.8
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
..+++.+.||+|+||.||+|.+.+++.||+|++..... ..+++.+|++++++++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 45677899999999999999998899999999976433 34679999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|+|.+++... ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 99999999742 4568999999999999999999998 899999999999999999999999999998765443333
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ..... +..+.. ...
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~----~~~~~~--~~~------ 228 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED----ISTGFR--LYK------ 228 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----HHTTCC--CCC------
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH----HhcCcc--CCC------
Confidence 344457888999999998899999999999999999999 99999743321 11111 111110 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
+......+.+++.+||+.+|++||+++|+++.|+++..
T Consensus 229 -~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 -PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11122368899999999999999999999999998865
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=351.65 Aligned_cols=280 Identities=36% Similarity=0.586 Sum_probs=225.1
Q ss_pred cccChhhHHHHHHhhc--------cccCccCcEEEEEEEECCCcEEEEEEccCcc----chhhhhHHHHHHHHHhcCCCC
Q 002358 599 YFIPLPELEEATNNFC--------KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRN 666 (931)
Q Consensus 599 ~~~~~~~l~~~~~~~~--------~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~Hpn 666 (931)
..+++.++...+.+|. +.||+|+||.||+|.+ +++.||||++.... ....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 3466788888888875 5699999999999987 48999999986532 234567999999999999999
Q ss_pred CcceeEEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC
Q 002358 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 746 (931)
Q Consensus 667 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~ 746 (931)
|+++++++.+.+..++||||+++|+|.+++........+++..++.++.|+++||+|||+ .+++||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcC
Confidence 999999999999999999999999999999755445679999999999999999999998 89999999999999999
Q ss_pred CCceEEecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHH
Q 002358 747 NMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 825 (931)
Q Consensus 747 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~ 825 (931)
++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||........ ...
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHH
Confidence 999999999999865433221 2233468999999998865 588999999999999999999999974433221 111
Q ss_pred HHHHhhh-cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 826 WARSMIK-KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 826 ~~~~~~~-~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
+...... ...+.+.+++.+ ...+......+.+++.+||+.+|++||+++||++.|+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1111111 122333444433 23456677789999999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=352.68 Aligned_cols=260 Identities=28% Similarity=0.468 Sum_probs=212.5
Q ss_pred HHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
....+++.+.||+|+||.||+|+++++..||+|+++.... ..+++.+|++++++++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3456777899999999999999999888999999975433 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+++... ...+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999998752 3458999999999999999999998 8999999999999999999999999999987655443
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... . +..+.. ...+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~-~~~~~~--~~~~--- 227 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---VVL---K-VSQGHR--LYRP--- 227 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH---H-HHTTCC--CCCC---
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---HHH---H-HHcCCC--CCCC---
Confidence 33334456788999999998889999999999999999999 999997433211 111 1 111111 0111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
......+.+++.+||+.+|++|||++|+++.|+.+....
T Consensus 228 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 228 ----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp ----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred ----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 111236889999999999999999999999999886644
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=354.66 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=204.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.|++.+.||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 4666789999999999999864 689999999876555556778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 101 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 101 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp TCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 9999999974 358899999999999999999998 89999999999999999999999999998876543332
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.... .......+.. ... .
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~~-~~~-------~ 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP-ELQ-------N 238 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC-CCS-------C
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC-CCC-------C
Confidence 3345699999999999999999999999999999999999999974332111 1111111111 110 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1122346789999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=362.98 Aligned_cols=264 Identities=26% Similarity=0.494 Sum_probs=212.1
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEEC----CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 679 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 679 (931)
++....|++.+.||+|+||.||+|.+. .+..||||+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 444567778899999999999999985 34569999997653 3445779999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
.++||||+++|+|.++++.. ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred cEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999999742 4568999999999999999999998 899999999999999999999999999998
Q ss_pred cccccccc--cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 760 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 760 ~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ..... +..+..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~----~~~~~~ 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVISS----VEEGYR 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHH----HHTTCC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----HHcCCC
Confidence 76543222 1222346778999999998899999999999999999999 99999643221 11111 111111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
. ..+......+.+++.+||+.+|++||+++||++.|+.+.....
T Consensus 273 ~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 273 L---------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred C---------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 0 0112223468899999999999999999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=364.02 Aligned_cols=265 Identities=26% Similarity=0.352 Sum_probs=207.3
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCC----eEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~~lV~ 684 (931)
..|++.+.||+|+||.||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++.... ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 45667899999999999999987 8999999986542 33445677999999999999999999997744 469999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCC----------CeEecCCCCCCccccCCCceEEec
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP----------GIIHRDVKSSNILLDINMRAKVSD 754 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~----------~ivH~DIkp~NILld~~~~vkL~D 754 (931)
||+++|+|.++++. ..+++..++.++.|+++||+|||+ . +|+||||||+|||++.++.+||+|
T Consensus 102 e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 102 AFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999974 358999999999999999999997 6 999999999999999999999999
Q ss_pred ccccccccccccc-cccccccCCCccCCCccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhh------
Q 002358 755 FGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN------ 822 (931)
Q Consensus 755 FGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~------ 822 (931)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999875543322 2233568999999999876 356678999999999999999999997543321111
Q ss_pred ----HHHHHHHhhhcCCeeecccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 823 ----IVHWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 823 ----l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
...+...... ... .+.+... ........+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 255 ~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 255 QHPSLEDMQEVVVH-KKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SSCCHHHHHHHHTT-SCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhc-ccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111111 111 1111111 1224556799999999999999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=363.31 Aligned_cols=268 Identities=28% Similarity=0.452 Sum_probs=209.3
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-----CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEec--CC
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EH 678 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 678 (931)
+....+++.+.||+|+||.||+|++. +++.||||++........+.+.+|++++++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 34456778899999999999999852 588999999987666667889999999999999999999999865 35
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred ceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 589999999999999999753 3458999999999999999999998 89999999999999999999999999999
Q ss_pred cccccccc--ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCcc---------chhhHHHHH
Q 002358 759 RQAEEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWA 827 (931)
Q Consensus 759 ~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~---------~~~~l~~~~ 827 (931)
+....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... .........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 87644322 1223344677899999999889999999999999999999999998632211 001111112
Q ss_pred HHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 828 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 828 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
...+..+... ..+......+.+++.+||+.+|++|||++||++.|+++...
T Consensus 242 ~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 242 IELLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhccCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 2222221111 11222334788999999999999999999999999988653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=352.91 Aligned_cols=261 Identities=27% Similarity=0.455 Sum_probs=211.4
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
+....+++.+.||+|+||.||+|.+++++.||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 33456777899999999999999999889999999976533 34678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99999999999742 3468999999999999999999998 899999999999999999999999999998765443
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ..... +..+.. ...
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~-----~~~ 242 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEH----IAQGLR-----LYR 242 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHH----HHTTCC-----CCC
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHH----HhcccC-----CCC
Confidence 333334457788999999998889999999999999999998 99999743321 11111 111110 000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
+......+.+++.+||+.+|++|||++|+++.|+++...+
T Consensus 243 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 243 ----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 1111236889999999999999999999999999987654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=353.65 Aligned_cols=263 Identities=26% Similarity=0.403 Sum_probs=207.8
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
..|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 45677899999999999999876 68999999985432 234567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++|+|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999974 3568999999999999999999998 89999999999999999999999999999876544
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.........||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .....+.. ..... ....
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~-~~~~~-~~~~ 236 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQD-SVPNV-TTDV 236 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSS-CCCCH-HHHS
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhc-cCCCc-chhc
Confidence 3333444568999999999999999999999999999999999999997433211 11111211 11111 0111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhhhhhc
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~~~~~~~ 889 (931)
....+..+.+++.+|++.+|++|| +++++.+.|++......
T Consensus 237 ----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 237 ----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred ----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 122234688999999999999999 99999999998766543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=352.10 Aligned_cols=259 Identities=26% Similarity=0.390 Sum_probs=200.9
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHh--cCCCCCcceeEEEec----CCeEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--IHHRNLVPLIGYCEE----EHQRIL 682 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~g~~~~----~~~~~l 682 (931)
..|++.+.||+|+||.||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++.. ....++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 4566789999999999999998 5899999998643 34556677777777 789999999998654 356889
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhh--------hcCCCCeEecCCCCCCccccCCCceEEec
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH--------TGCNPGIIHRDVKSSNILLDINMRAKVSD 754 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~ivH~DIkp~NILld~~~~vkL~D 754 (931)
||||+++|+|.++++ ...+++..++.++.|+++||+||| + .+|+||||||+|||++.++.+||+|
T Consensus 84 v~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred ehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence 999999999999996 346899999999999999999999 6 8999999999999999999999999
Q ss_pred cccccccccccccc---ccccccCCCccCCCccCCC------CCCccchhHHHHHHHHHHHhC----------CCCCCcc
Q 002358 755 FGLSRQAEEDLTHI---SSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISG----------KKPVSVE 815 (931)
Q Consensus 755 FGla~~~~~~~~~~---~~~~~gt~~y~APE~l~~~------~~s~ksDVwSlGvlL~eLltG----------~~Pf~~~ 815 (931)
||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654432221 2234689999999999876 556799999999999999999 8888633
Q ss_pred CccchhhHHHHHHHhhh-cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 816 DFGAELNIVHWARSMIK-KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 816 ~~~~~~~l~~~~~~~~~-~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
..... .... ...... ......+.. ...+......+.+++.+||+.||++|||++||++.|+++
T Consensus 237 ~~~~~-~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDP-SFED-MRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSC-CHHH-HHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCc-chhh-hhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22211 1111 111111 111111110 112234567899999999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=351.66 Aligned_cols=245 Identities=25% Similarity=0.398 Sum_probs=202.9
Q ss_pred hccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCC
Q 002358 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 691 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 691 (931)
..+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 49 ~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 128 (321)
T 2c30_A 49 SYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128 (321)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred ccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCC
Confidence 4568999999999999987 799999999976655566789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccccc
Q 002358 692 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 771 (931)
Q Consensus 692 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 771 (931)
|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++......... ...
T Consensus 129 L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 200 (321)
T 2c30_A 129 LTDIVSQ----VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKS 200 (321)
T ss_dssp HHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-BCC
T ss_pred HHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-ccc
Confidence 9999863 468999999999999999999998 89999999999999999999999999999876543222 234
Q ss_pred cccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHH
Q 002358 772 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 851 (931)
Q Consensus 772 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~ 851 (931)
..||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+. ......... ...
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~~~~~----~~~~~~~~~-------~~~ 266 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLR----DSPPPKLKN-------SHK 266 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH----HSSCCCCTT-------GGG
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHh----cCCCCCcCc-------ccc
Confidence 5699999999999999999999999999999999999999974322 11111111 111111100 111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 852 SIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 852 ~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....+.+++.+||+.||++|||++|+++
T Consensus 267 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 267 VSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2236789999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=371.47 Aligned_cols=259 Identities=29% Similarity=0.433 Sum_probs=210.5
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
...+.+.+.||+|+||.||+|.++ +++.||||+++.... ...++|.+|+++|++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 345667899999999999999987 789999999876533 344678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.++++.. ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999999742 3458899999999999999999998 899999999999999999999999999998654332
Q ss_pred cccc-cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 766 THIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 766 ~~~~-~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
.... ....+++.|+|||.+....++.++|||||||++|||++ |..||...... ... ..+..+....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~~----- 335 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTR----EFVEKGGRLP----- 335 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHH----HHHHTTCCCC-----
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCCC-----
Confidence 2111 12235778999999998899999999999999999998 99999743221 111 2222221111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
.+...+..+.+++.+||+.+|++|||++||++.|+++.+.
T Consensus 336 ----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 ----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1112234688999999999999999999999999988653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=356.83 Aligned_cols=245 Identities=25% Similarity=0.410 Sum_probs=202.3
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
.|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 3667899999999999999984 79999999986542 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 96 ASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp CTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 999999999874 3568999999999999999999998 899999999999999999999999999998654332
Q ss_pred ccccccccCCCccCCCccCCCCCC-ccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
......||+.|+|||++.+..+. .++||||+||++|||++|+.||...+... +. ..+..+... +
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~----~~i~~~~~~------~- 233 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LR----ERVLRGKYR------I- 233 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHCCCC------C-
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhCCCC------C-
Confidence 23345699999999999887765 79999999999999999999997443221 11 112222110 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.||++|||++|+++
T Consensus 234 ---p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 234 ---PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ---CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ---CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1112235789999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=369.91 Aligned_cols=262 Identities=27% Similarity=0.481 Sum_probs=200.9
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC----CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
+....+++.+.||+|+||.||+|+++ ++..||||+++... ....+.|.+|++++++++||||+++++++.+....
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 33456677899999999999999875 57789999997653 33456899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+++|+|.++++.. ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999999742 4568999999999999999999998 8999999999999999999999999999987
Q ss_pred cccccccc--ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 761 AEEDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 761 ~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ....+. +..+..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~----i~~~~~- 268 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKA----VDEGYR- 268 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHH----HHTTEE-
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcCCC-
Confidence 65432221 112235778999999998999999999999999999998 9999974322 112221 111111
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
...+......+.+++.+||+.+|++||+++||++.|+++....
T Consensus 269 --------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 --------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred --------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0111223346889999999999999999999999999887543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=378.18 Aligned_cols=259 Identities=24% Similarity=0.419 Sum_probs=210.7
Q ss_pred HHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
....+++.+.||+|+||.||+|.+++++.||||+++... ...++|.+|+++|++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 344567789999999999999999989999999997643 34678999999999999999999999987 5678999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.++++.. ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999999742 12357888999999999999999998 8999999999999999999999999999987654332
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.......+++.|+|||++....++.++|||||||++|||++ |+.||...... ...+.+ ..+...
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i----~~~~~~-------- 404 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ERGYRM-------- 404 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH----HHTCCC--------
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCCCC--------
Confidence 22333446789999999988899999999999999999999 99999743321 222221 111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
..+...+..+.+++.+||+.+|++|||+++|++.|+++...
T Consensus 405 -~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 405 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 01112234688999999999999999999999999987643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=379.78 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=213.1
Q ss_pred HHHHhhccccCccCcEEEEEEEECC-CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
...+++.+.||+|+||.||+|.++. ++.||||+++... ...++|.+|+++|++++||||++++++|......++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4456778999999999999999885 8899999997643 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++... ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999999754 34568999999999999999999998 8999999999999999999999999999987654333
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.......+++.|+|||++....++.++|||||||++|||++ |+.||...+... ..+. +..+..
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~--------- 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----LEKDYR--------- 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH----HHTTCC---------
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCCC---------
Confidence 33333446789999999998899999999999999999999 999997443322 2221 111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
...+......+.+++.+||+.+|++||+++||++.|+.+..
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 01122233468899999999999999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=347.21 Aligned_cols=272 Identities=22% Similarity=0.316 Sum_probs=212.9
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC--eEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--~~~lV~E 685 (931)
.|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 4567899999999999999987 48999999987543 234567889999999999999999999987655 7899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc----cCCCceEEecccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQA 761 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl----d~~~~vkL~DFGla~~~ 761 (931)
|+++|+|.+++........+++..++.++.|+++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999999865444559999999999999999999998 899999999999999 78888999999999876
Q ss_pred cccccccccccccCCCccCCCccC--------CCCCCccchhHHHHHHHHHHHhCCCCCCccCccc-hhhHHHHHHHhhh
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYG--------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA-ELNIVHWARSMIK 832 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~--------~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~-~~~l~~~~~~~~~ 832 (931)
..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||....... .......+.....
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 54332 22345899999999875 5788999999999999999999999996433221 1122221111111
Q ss_pred cCCeeecc-----------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 833 KGDVISIV-----------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 833 ~~~~~~i~-----------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
......+. +..............+.+++.+||+.||++|||++|+++..++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 11111110 0011123445677789999999999999999999999998887554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=362.92 Aligned_cols=272 Identities=24% Similarity=0.438 Sum_probs=217.7
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEEC--------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhc-CCCCCcceeEEE
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYC 674 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~ 674 (931)
++....+.+.+.||+|+||.||+|++. .++.||||+++.... ...+++.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344556778899999999999999863 246799999976543 3457899999999999 899999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCC
Q 002358 675 EEEHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 741 (931)
Q Consensus 675 ~~~~~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~N 741 (931)
...+..++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+ .+|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcce
Confidence 999999999999999999999975421 2458999999999999999999998 899999999999
Q ss_pred ccccCCCceEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccc
Q 002358 742 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 819 (931)
Q Consensus 742 ILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~ 819 (931)
||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~- 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999987644322 22233457889999999999999999999999999999999 99999743321
Q ss_pred hhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCCCcc
Q 002358 820 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF 895 (931)
Q Consensus 820 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~ 895 (931)
.+.+ .+..+..... +......+.+++.+||+.+|++||+++||++.|+++...........
T Consensus 301 --~~~~----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~ 361 (382)
T 3tt0_A 301 --ELFK----LLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGY 361 (382)
T ss_dssp --HHHH----HHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC---
T ss_pred --HHHH----HHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCC
Confidence 1222 2222211111 11223368899999999999999999999999999988776554443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=343.02 Aligned_cols=264 Identities=16% Similarity=0.192 Sum_probs=212.9
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEe
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
..|++.+.||+|+||.||+|... +++.||||++... ...+.+.+|+++++++ +|+|++++++++.+....++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 35667899999999999999974 7899999998643 2345788999999999 799999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc-----eEEecccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-----AKVSDFGLSRQA 761 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~-----vkL~DFGla~~~ 761 (931)
+ +++|.+++... ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++. +||+|||+++..
T Consensus 88 ~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 88 L-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 9 99999999853 3468999999999999999999998 89999999999999987776 999999999876
Q ss_pred cccccc------cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCC
Q 002358 762 EEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 835 (931)
Q Consensus 762 ~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 835 (931)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+........
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 543221 22345699999999999999999999999999999999999999985443333333222222211111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 836 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 836 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
... +... .+..+.+++.+||+.+|++||++++|++.|+++.....
T Consensus 242 ~~~-----~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 242 LRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHH-----HHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 111 1111 22468899999999999999999999999999876543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=347.99 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=199.7
Q ss_pred HHHHHhhccccCccCcEEEEEEEECC----CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
....|++.+.||+|+||.||+|.+.. +..||+|+++.... ...+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34567788999999999999998753 45799999876433 34567999999999999999999999985 45688
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+||||+++|+|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999999753 3468999999999999999999998 89999999999999999999999999999876
Q ss_pred cccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
............+++.|+|||.+....++.++||||||+++|||++ |..||......+ ....+ ..+....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i----~~~~~~~-- 237 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENGERLP-- 237 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCCCC--
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHH----HcCCCCC--
Confidence 5443333334457789999999988889999999999999999997 999997443322 22211 1111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
. +......+.+++.+||+.+|++||+++|+++.|+++...++
T Consensus 238 ---~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 238 ---M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp ---C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1 11223468899999999999999999999999999877653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=351.40 Aligned_cols=261 Identities=19% Similarity=0.235 Sum_probs=210.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.|++.+.||+|+||.||+|+.. +|+.||||++.... ..+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 4567899999999999999974 78999999986542 235688999999999 8999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc-----eEEeccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-----AKVSDFGLSRQAE 762 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~-----vkL~DFGla~~~~ 762 (931)
+++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++...
T Consensus 88 -~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 88 -GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred -CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999999853 4579999999999999999999998 89999999999999998887 9999999998754
Q ss_pred ccccc------cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 763 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 763 ~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 43221 123456999999999999999999999999999999999999999855433333332222211111100
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
..+.. ..+ .+.+++.+||+.+|.+||++++|++.|+++....
T Consensus 242 -----~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 242 -----EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp -----HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 00000 112 6889999999999999999999999999877543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=353.12 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=202.2
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.+++.+.||+|+||.||+|+.+ +|+.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 4567899999999999999987 68999999987532 2344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 86 YANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999874 4568999999999999999999998 899999999999999999999999999998643322
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.+ .+..+.. .+
T Consensus 160 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~----~i~~~~~------~~- 224 (337)
T 1o6l_A 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE----LILMEEI------RF- 224 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------CC-
T ss_pred C-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCC------CC-
Confidence 2 233456999999999999999999999999999999999999999743321 1111 1111111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
+......+.+++.+||+.||++|| +++||++
T Consensus 225 ---p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 225 ---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 111223678999999999999999 8999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.08 Aligned_cols=256 Identities=29% Similarity=0.456 Sum_probs=210.8
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
..+++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 35667899999999999999998899999999976533 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+++|.+++... ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++..........
T Consensus 87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 99999999753 3568899999999999999999998 899999999999999999999999999998764433222
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... +..+.. .. .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----i~~~~~--~~---~--- 226 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVED----ISTGFR--LY---K--- 226 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----HHTTCC--CC---C---
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHH----HhcCCc--CC---C---
Confidence 333457789999999988889999999999999999999 89999743221 11111 111111 00 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
+......+.+++.+||+.+|++||+++|+++.|+++..
T Consensus 227 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 -PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11122367899999999999999999999999998865
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=348.60 Aligned_cols=261 Identities=22% Similarity=0.287 Sum_probs=199.9
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
..|++.+.||+|+||+||+|+.++|+.||+|++..... ...+.+.+|++++++++||||+++++++.++...++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 34667899999999999999998899999999875432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
++ |+|.+.+.. ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 101 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 101 ME-KDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CS-EEHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CC-CCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 98 488888764 34568999999999999999999998 8999999999999999999999999999987643322
Q ss_pred ccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCC---eee----
Q 002358 767 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VIS---- 838 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~---~~~---- 838 (931)
. .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+... .+........ ...
T Consensus 175 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 175 S-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP---KIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH---HHHHHHCCCCTTTSGGGTTS
T ss_pred c-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHHCCCChHHhhhhhcc
Confidence 2 233458999999999876 568999999999999999999999997544332221 1111111100 000
Q ss_pred ---------cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 839 ---------IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 839 ---------i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+.............++.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000000111236789999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=348.38 Aligned_cols=262 Identities=29% Similarity=0.515 Sum_probs=203.5
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
..+++.+.||+|+||.||+|++. ++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 34567899999999999999986 789999998643 345789999999999999999999998874 4789999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc-eEEecccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~-vkL~DFGla~~~~~~~~~ 767 (931)
+|+|.+++........+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++.......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 9999999986433345788999999999999999999744468999999999999998886 7999999997654321
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .... .|. ...+... .....
T Consensus 161 --~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~-~~~---~~~~~~~-----~~~~~ 228 (307)
T 2eva_A 161 --TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-AFRI-MWA---VHNGTRP-----PLIKN 228 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-HHHH-HHH---HHTTCCC-----CCBTT
T ss_pred --ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-HHHH-HHH---HhcCCCC-----Ccccc
Confidence 2235899999999999999999999999999999999999999733221 1111 111 1111111 11112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCCC
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQ 893 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 893 (931)
. ...+.+++.+||+.+|++|||++|+++.|+++.........
T Consensus 229 ~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 229 L----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred c----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 2 23678999999999999999999999999998876654443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=347.41 Aligned_cols=263 Identities=29% Similarity=0.450 Sum_probs=216.8
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEECC-CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
++....+++.+.||+|+||.||+|.++. ++.||+|++... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3445667788999999999999999874 889999998754 33457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++++|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 88 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999999754 34568999999999999999999998 8999999999999999999999999999987655
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
..........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+... ..+.+. .... .
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~~----~~~~-----~ 231 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE----KDYR-----M 231 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHH----TTCC-----C
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----ccCC-----C
Confidence 44434444557889999999988899999999999999999999 999997443322 122111 1110 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
..+......+.+++.+||+.+|++||+++|+++.|+++....
T Consensus 232 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 232 ----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111122346889999999999999999999999999877543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=363.68 Aligned_cols=266 Identities=27% Similarity=0.452 Sum_probs=212.3
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecC
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 677 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~ 677 (931)
++....+++.+.||+|+||.||+|++. +++.||||+++... .....++.+|+.++++++||||+++++++...
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 444556778899999999999999854 46789999997543 34456799999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC---ce
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RA 750 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~---~v 750 (931)
...++||||+++|+|.+++.... ....+++..++.++.||++||+|||+ .+|+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999987532 23468999999999999999999998 8999999999999999555 59
Q ss_pred EEecccccccccccc-cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHH
Q 002358 751 KVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 828 (931)
Q Consensus 751 kL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 828 (931)
||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~-- 298 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF-- 298 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH--
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH--
Confidence 999999998653322 122233457899999999988899999999999999999998 99999743321 12221
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 829 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 829 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
+..+.... .+......+.+++.+||+.+|++||+++||++.|+.+.....
T Consensus 299 --i~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 299 --VTSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp --HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred --HHcCCCCC---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 22221111 111223368899999999999999999999999998876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=373.87 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=205.7
Q ss_pred HHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
....+++.+.||+|+||.||+|.++++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 344567789999999999999999988899999997643 234679999999999999999999999876 678999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++... ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999742 23458899999999999999999998 8999999999999999999999999999987654333
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.......+++.|+|||.+....++.++||||||+++|||++ |+.||...... .... .+..+...
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~----~i~~~~~~-------- 400 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD----QVERGYRM-------- 400 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCCC--------
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC--------
Confidence 23333457889999999988899999999999999999999 99999743221 1111 12222110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
..+...+..+.+++.+||+.+|++|||+++|++.|+++....
T Consensus 401 -~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 401 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 111223346889999999999999999999999999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=370.66 Aligned_cols=254 Identities=30% Similarity=0.486 Sum_probs=206.8
Q ss_pred HHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCC-eEEEEEEe
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVYEY 686 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-~~~lV~E~ 686 (931)
...+++.+.||+|+||.||+|.++ |+.||||+++... ..+.|.+|+++|++++||||+++++++.... ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 345667899999999999999987 7899999997643 4578999999999999999999999987655 78999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++|+|.+++... ....+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 9999999999853 23347899999999999999999998 899999999999999999999999999998543221
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
....+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ ... .+..+...
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~----~i~~~~~~-------- 405 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKGYKM-------- 405 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH----HHHTTCCC--------
T ss_pred ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCC--------
Confidence 22347889999999999999999999999999999999 999997443322 111 12222111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
..+...+..+.+++.+||+.+|++|||++||++.|+++...+
T Consensus 406 -~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 406 -DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 111222347889999999999999999999999999886543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=354.44 Aligned_cols=267 Identities=24% Similarity=0.402 Sum_probs=208.1
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEE-----CCCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecC-
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE- 677 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~- 677 (931)
.+....+++.+.||+|+||.||+|++ .+++.||+|+++... ....+.+.+|++++++++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 34445577789999999999999985 368899999987543 23446789999999999999999999999876
Q ss_pred -CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccc
Q 002358 678 -HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 756 (931)
Q Consensus 678 -~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFG 756 (931)
...++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CceEEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccc
Confidence 668999999999999999964 24568999999999999999999998 899999999999999999999999999
Q ss_pred cccccccccc--ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCc--------cchhhHHHH
Q 002358 757 LSRQAEEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF--------GAELNIVHW 826 (931)
Q Consensus 757 la~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~--------~~~~~l~~~ 826 (931)
++........ .......||..|+|||.+.+..++.++||||||+++|||++|..|+..... .........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 9987654332 223344578889999999998999999999999999999999998752210 000011111
Q ss_pred HHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 827 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 827 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
....+..+... ..+......+.+++.+||+.||++|||++|+++.|++++
T Consensus 252 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 252 LVNTLKEGKRL---------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCCC---------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11122211111 112223346889999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=350.60 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=212.2
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 679 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 679 (931)
....|.+.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3455677899999999999999862 45889999997643 3445789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCC---------------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCC
Q 002358 680 RILVYEYMHNGTLRDRLHGSVN---------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 738 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIk 738 (931)
.++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+ .+|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 9999999999999999975432 2348899999999999999999998 899999999
Q ss_pred CCCccccCCCceEEecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccC
Q 002358 739 SSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVED 816 (931)
Q Consensus 739 p~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~ 816 (931)
|+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999865443222 2233457889999999998899999999999999999999 999997443
Q ss_pred ccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 817 FGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 817 ~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
... +... +..+.... .+......+.+++.+||+.||++||+++|+++.|+++...
T Consensus 258 ~~~---~~~~----~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PER---LFNL----LKTGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGG---HHHH----HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHH---HHHH----hhcCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 322 1111 11111111 1112234688999999999999999999999999988654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=351.87 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=200.0
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 4567899999999999999987 789999999864432 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc-c
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-T 766 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~-~ 766 (931)
++|+|.+++. ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 88 ~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 88 SGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp TTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999987 34569999999999999999999998 899999999999999999999999999998654322 2
Q ss_pred ccccccccCCCccCCCccCCCCC-CccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ......|..... . ..+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~----~---~~~--- 230 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKEKKT----Y---LNP--- 230 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-SHHHHHHHTTCT----T---STT---
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhcccc----c---CCc---
Confidence 22334569999999999987765 77999999999999999999999743322 122222221110 0 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.......+.+++.+||+.||++|||++|+++
T Consensus 231 ---~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 231 ---WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0112235779999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=352.48 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=203.4
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch------hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
..|++.+.||+|+||.||+|..+ +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 34667899999999999999987 6899999998754322 2467899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC----ceEEecccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFGL 757 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~----~vkL~DFGl 757 (931)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 92 lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 92 LILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999973 4579999999999999999999998 8999999999999998776 799999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 758 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 758 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... .+..+...
T Consensus 166 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~~----~i~~~~~~ 236 (361)
T 2yab_A 166 AHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA----NITAVSYD 236 (361)
T ss_dssp CEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH----HHHTTCCC
T ss_pred ceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhcCCC
Confidence 987654321 234569999999999999999999999999999999999999997433211 111 11111110
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.++...... ...+.+++.+||+.||++|||++|+++
T Consensus 237 --~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 --FDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --CCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111111 235789999999999999999999884
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=353.88 Aligned_cols=262 Identities=27% Similarity=0.445 Sum_probs=210.6
Q ss_pred HHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
...+++.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 345667889999999999999985 348899999976533 3456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCC---------------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCC
Q 002358 681 ILVYEYMHNGTLRDRLHGSVN---------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 739 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp 739 (931)
++||||+++|+|.+++..... ...+++..++.++.||++||+|||+ .+|+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCc
Confidence 999999999999999975321 2568999999999999999999998 8999999999
Q ss_pred CCccccCCCceEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCc
Q 002358 740 SNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDF 817 (931)
Q Consensus 740 ~NILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~ 817 (931)
+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 999999999999999999986543322 22233457899999999988889999999999999999999 9999974322
Q ss_pred cchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 818 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 818 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
. ... ..+..+..... +......+.+++.+||+.+|++||+++||++.|+++....
T Consensus 283 ~---~~~----~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 283 E---EVI----YYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp H---HHH----HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred H---HHH----HHHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 1 111 12222222111 1122346889999999999999999999999999886544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=353.52 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=204.5
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-----chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 679 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 679 (931)
+....|++.+.||+|+||.||+|..+ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 44677889999999999999999886 68999999985421 1135678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc---eEEecc
Q 002358 680 RILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDF 755 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~---vkL~DF 755 (931)
.++||||+++|+|.+.+.... ....+++..+..++.||++||+|||+ .+|+||||||+|||++.++. +||+||
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecC
Confidence 999999999999988775432 34458999999999999999999998 89999999999999986655 999999
Q ss_pred cccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCC
Q 002358 756 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 835 (931)
Q Consensus 756 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 835 (931)
|+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.. .+..+.
T Consensus 178 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~----~i~~~~ 248 (351)
T 3c0i_A 178 GVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFE----GIIKGK 248 (351)
T ss_dssp TTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHH----HHHHTC
T ss_pred cceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHH----HHHcCC
Confidence 99987654322 2234469999999999999999999999999999999999999997421 11111 111111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 836 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 836 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. ..+...... ...+.+++.+||+.||++||++.|+++
T Consensus 249 ~~--~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YK--MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 011111111 236789999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=354.65 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=206.3
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
.......|++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 3445677888999999999999999986 68999999986542 23456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC---CceEEecccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGL 757 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~---~~vkL~DFGl 757 (931)
++||||+++|+|.+.+.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.+ +.+||+|||+
T Consensus 104 ~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEEECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 999999999999999873 4568999999999999999999998 899999999999999865 4599999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 758 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 758 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+... +..+...
T Consensus 178 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~----i~~~~~~ 248 (362)
T 2bdw_A 178 AIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQ----IKAGAYD 248 (362)
T ss_dssp CBCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHTCCC
T ss_pred ceEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHH----HHhCCCC
Confidence 987653322 23356999999999999999999999999999999999999999743321 12211 1122111
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+ ... .....+.+++.+||+.||++||+++|+++
T Consensus 249 -~~~~-~~~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 249 -YPSP-EWD----TVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -CCTT-GGG----GSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -CCcc-ccc----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 001 12236789999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.43 Aligned_cols=259 Identities=23% Similarity=0.412 Sum_probs=202.3
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC-CCc----EEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
....|++.+.||+|+||.||+|++. +++ .||+|.++... ....+.+.+|++++++++||||+++++++.+.. .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 3455677899999999999999975 344 46888876433 234578999999999999999999999998765 7
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++|+||+++|+|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 8999999999999999753 4568999999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeee
Q 002358 761 AEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 761 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 838 (931)
....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +.. .+..+...
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~~~- 238 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERL- 238 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCC-
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH----HHHcCCCC-
Confidence 5443222 2223346889999999999999999999999999999999 999997443322 111 11111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 839 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 839 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
..+......+.+++.+||+.+|++||+++|+++.|+.+...
T Consensus 239 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11122234688999999999999999999999999987653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=358.75 Aligned_cols=268 Identities=25% Similarity=0.372 Sum_probs=210.9
Q ss_pred HHHHhhccccCccCcEEEEEEEE-----CCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEe--cCCeE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQR 680 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~~ 680 (931)
...+++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35677789999999999999985 358899999998776666778999999999999999999999886 45668
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999999742 3458999999999999999999998 8999999999999999999999999999987
Q ss_pred cccccc--ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccc--------hhhHHHHHHHh
Q 002358 761 AEEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--------ELNIVHWARSM 830 (931)
Q Consensus 761 ~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~--------~~~l~~~~~~~ 830 (931)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .......+...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 643322 12233457888999999998889999999999999999999999986322110 00001111111
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 831 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 831 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
+..+. ....+......+.+++.+||+.||++|||++|+++.|+.+.....
T Consensus 257 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 LEEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hhccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11111 111122333468899999999999999999999999998876554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=348.29 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=204.0
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch------hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
...|++.+.||+|+||.||+|..+ +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456788999999999999999987 6899999998654321 346799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC----ceEEeccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 756 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~----~vkL~DFG 756 (931)
++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999973 4578999999999999999999998 8999999999999998877 79999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 757 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 757 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+. ....
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~----~~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVS----AVNY 234 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH----HTCC
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHH----hcCC
Confidence 9987643221 233468999999999999999999999999999999999999997433211 111111 1110
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. ..+..... ....+.+++.+||+.||++|||++|+++
T Consensus 235 -~-~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 -E-FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -C-CCHHHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -C-cCcccccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00001111 1236789999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=341.04 Aligned_cols=254 Identities=31% Similarity=0.517 Sum_probs=202.3
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchh-------hhhHHHHHHHHHhcCCCCCcceeEEEecCC
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR-------TQQFVTEVALLSRIHHRNLVPLIGYCEEEH 678 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~-------~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 678 (931)
....|++.+.||+|+||.||+|++. +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3455777899999999999999985 78999999986532211 167899999999999999999999997665
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCC--eEecCCCCCCccccCCCc-----eE
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMR-----AK 751 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--ivH~DIkp~NILld~~~~-----vk 751 (931)
++||||+++|+|.+.+.. ....+++..++.++.|+++||+|||+ .+ |+||||||+|||++.++. +|
T Consensus 97 --~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred --eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 699999999999998864 34578999999999999999999998 77 999999999999988776 99
Q ss_pred EecccccccccccccccccccccCCCccCCCcc--CCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHH
Q 002358 752 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY--GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 829 (931)
Q Consensus 752 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l--~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 829 (931)
|+|||+++..... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||........ ......
T Consensus 170 l~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~-- 242 (287)
T 4f0f_A 170 VADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMI-- 242 (287)
T ss_dssp ECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHHH--
T ss_pred eCCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHHH--
Confidence 9999999754332 2334689999999998 455678999999999999999999999974433221 111111
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 830 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
...+.. +.+ +......+.+++.+||+.||++||+++|+++.|+++
T Consensus 243 -~~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 -REEGLR-----PTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -HHSCCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -hccCCC-----CCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111 111 122234688999999999999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=344.31 Aligned_cols=261 Identities=26% Similarity=0.433 Sum_probs=210.9
Q ss_pred HHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
....+++.+.||+|+||.||+|..++++.||+|+++... ...+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 345677889999999999999999988899999987543 235679999999999999999999999874 458999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+++... ....+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999998742 12368899999999999999999998 8999999999999999999999999999987654433
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+. +..+.. ...
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~----~~~~~~-----~~~- 231 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQN----LERGYR-----MVR- 231 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----HHTTCC-----CCC-
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHH----HhcccC-----CCC-
Confidence 33334457889999999988889999999999999999999 99999743221 12221 111111 011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
+......+.+++.+|++.+|++|||++++++.|+++.....
T Consensus 232 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ---cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 11223468899999999999999999999999999876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=358.60 Aligned_cols=264 Identities=27% Similarity=0.427 Sum_probs=209.8
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhc-CCCCCcceeEEEecCC
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 678 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~ 678 (931)
....+++.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 3456777899999999999999843 467999999976543 3456799999999999 7999999999998755
Q ss_pred -eEEEEEEecCCCCHHHHhccCCC--------------------------------------------------------
Q 002358 679 -QRILVYEYMHNGTLRDRLHGSVN-------------------------------------------------------- 701 (931)
Q Consensus 679 -~~~lV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 701 (931)
..++||||+++|+|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 48999999999999999975432
Q ss_pred -------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc-ccccccc
Q 002358 702 -------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVAR 773 (931)
Q Consensus 702 -------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~ 773 (931)
...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .......
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 1228899999999999999999998 8999999999999999999999999999986543322 2233456
Q ss_pred cCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002358 774 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 852 (931)
Q Consensus 774 gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~ 852 (931)
||+.|+|||++.+..++.++||||||+++|||++ |+.||....... .... .+..+.... . +...
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~~~~~-----~----~~~~ 321 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTRMR-----A----PDYT 321 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHHHTCCCC-----C----CTTC
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHHcCCCCC-----C----CCCC
Confidence 8899999999998999999999999999999998 999997443321 1111 122221111 1 1112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 853 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 853 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
...+.+++.+||+.+|++|||++|+++.|++++...
T Consensus 322 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 236789999999999999999999999999987643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=350.77 Aligned_cols=264 Identities=29% Similarity=0.440 Sum_probs=213.0
Q ss_pred HHHHHhhccccCccCcEEEEEEEE------CCCcEEEEEEccCccc-hhhhhHHHHHHHHHhc-CCCCCcceeEEEecCC
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 678 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~------~~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~ 678 (931)
....+++.+.||+|+||.||+|++ .+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 345677889999999999999986 2468999999976543 3457799999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCC---------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVN---------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 743 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIL 743 (931)
..++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+ .+|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence 99999999999999999975432 2258999999999999999999998 89999999999999
Q ss_pred ccCCCceEEecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchh
Q 002358 744 LDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 821 (931)
Q Consensus 744 ld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~ 821 (931)
++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 255 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--
Confidence 999999999999999876544322 2233457889999999988899999999999999999999 999997443221
Q ss_pred hHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 822 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 822 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
..... +..+.. +. .+......+.+++.+||+.||++||+++|+++.|+++....
T Consensus 256 ~~~~~----~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 256 KFYKM----IKEGFR-----ML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHH----HHHTCC-----CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHH----hccCCC-----CC----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 11111 111111 00 11122346889999999999999999999999999987643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.85 Aligned_cols=262 Identities=24% Similarity=0.389 Sum_probs=208.4
Q ss_pred hhccccCccCcEEEEEEEEC-----CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEec--CCeEEEE
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILV 683 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-----~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~~lV 683 (931)
++.+.||+|+||.||++.++ +++.||||+++.... ...+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 67899999999999998764 588999999976543 345679999999999999999999999987 4678999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 114 ~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp ECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999974 348999999999999999999998 8999999999999999999999999999987654
Q ss_pred ccc--ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccc--------hhhHHHHHHHhhhc
Q 002358 764 DLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--------ELNIVHWARSMIKK 833 (931)
Q Consensus 764 ~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~--------~~~l~~~~~~~~~~ 833 (931)
... .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||....... .......+...+..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 322 12233457888999999999899999999999999999999999997322110 00011111122221
Q ss_pred CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 834 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 834 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
+.. ...+......+.+++.+||+.+|++|||++|+++.|+++.....
T Consensus 267 ~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 267 GER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 111 11122233478899999999999999999999999998876554
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.44 Aligned_cols=250 Identities=30% Similarity=0.431 Sum_probs=192.8
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccc----hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
..+++.+.||+|+||.||+|.+. ++.||||+++.... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 34667899999999999999986 89999999875432 23467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCC---eEecCCCCCCccccC--------CCceEEe
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG---IIHRDVKSSNILLDI--------NMRAKVS 753 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~---ivH~DIkp~NILld~--------~~~vkL~ 753 (931)
||+++++|.+++. ...+++..+..++.|+++||+|||+ .+ |+||||||+|||++. ++.+||+
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999986 3468999999999999999999998 66 999999999999986 7789999
Q ss_pred cccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc
Q 002358 754 DFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 833 (931)
Q Consensus 754 DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 833 (931)
|||+++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+... ... .....
T Consensus 159 Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~---~~~~~ 229 (271)
T 3dtc_A 159 DFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---VAY---GVAMN 229 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHH---HHHTS
T ss_pred cCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---hhhcC
Confidence 9999986543322 23458999999999998889999999999999999999999997432211 111 11111
Q ss_pred CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 834 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 834 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
... ...+......+.+++.+||+.+|++|||++|+++.|+++
T Consensus 230 -~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 -KLA--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -CCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -CCC--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 110 011122234688999999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=347.88 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=197.8
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC--------
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-------- 678 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~-------- 678 (931)
..|++.+.||+|+||.||+|+++ +|+.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45677899999999999999987 79999999987543 335578999999999999999999999885543
Q ss_pred -------------------------------------------------eEEEEEEecCCCCHHHHhccCCCCCCCCHHH
Q 002358 679 -------------------------------------------------QRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 709 (931)
Q Consensus 679 -------------------------------------------------~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~ 709 (931)
..++||||+++|+|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3789999999999999998655445567778
Q ss_pred HHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc-----------ccccccccCCCc
Q 002358 710 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-----------HISSVARGTVGY 778 (931)
Q Consensus 710 ~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~-----------~~~~~~~gt~~y 778 (931)
++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 89999999999999998 8999999999999999999999999999987654321 122334689999
Q ss_pred cCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHH
Q 002358 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 858 (931)
Q Consensus 779 ~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~ 858 (931)
+|||.+.+..++.++||||||+++|||++|..|+. ...... ........... .......+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~----~~~~~~~~~~~---------~~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRII----TDVRNLKFPLL---------FTQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHH----HHHHTTCCCHH---------HHHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHH----HHhhccCCCcc---------cccCChhHHH
Confidence 99999999999999999999999999999877653 111111 11111111110 1122335689
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 002358 859 VAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 859 li~~Cl~~dP~~RPs~~evl~ 879 (931)
++.+||+.||++||+++|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 999999999999999999985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=356.63 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=198.2
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
.+++.++||+|+||.||+|+++ +++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+.+..++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 4667899999999999999987 57899999987542 23345688999999887 8999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 133 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 133 EYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999874 4568999999999999999999998 89999999999999999999999999999863322
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccc--hhhHHHHHHHhhhcCCeeecccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--ELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~--~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+.+.+.+.....
T Consensus 207 ~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 207 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp T-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred C-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 2 22334579999999999999999999999999999999999999996432221 11112222222322221
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 874 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 874 (931)
.+ +......+.+++.+||+.||++||++
T Consensus 280 ~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 RI----PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CC----CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11 11122367899999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=350.72 Aligned_cols=265 Identities=26% Similarity=0.423 Sum_probs=196.8
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECCC----cEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 679 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~g----~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 679 (931)
+....|++.+.||+|+||.||+|.+... ..||||+++.. .....+.+.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 3445677889999999999999987643 27999998764 33456789999999999999999999999987665
Q ss_pred E------EEEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCce
Q 002358 680 R------ILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 750 (931)
Q Consensus 680 ~------~lV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~v 750 (931)
. ++||||+++|+|.+++.... ....+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCE
Confidence 5 89999999999999986432 22368999999999999999999998 899999999999999999999
Q ss_pred EEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHH
Q 002358 751 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 828 (931)
Q Consensus 751 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 828 (931)
||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... ....
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~-- 251 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYNY-- 251 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH--
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHHH--
Confidence 9999999987544322 12223346789999999999899999999999999999999 999997443322 1111
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 829 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 829 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
+..+... ..+......+.+++.+||+.||++|||+.|+++.|++++....
T Consensus 252 --~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 252 --LIGGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp --HHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred --HhcCCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 1111111 1112223468899999999999999999999999999886554
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=354.77 Aligned_cols=267 Identities=27% Similarity=0.425 Sum_probs=209.8
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEEec
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 676 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~ 676 (931)
++....+++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 344566778899999999999999862 45689999997543 23457799999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCCCC--------------------CCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecC
Q 002358 677 EHQRILVYEYMHNGTLRDRLHGSVNQ--------------------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 736 (931)
Q Consensus 677 ~~~~~lV~E~~~~gsL~~~L~~~~~~--------------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~D 736 (931)
.+..++||||+++|+|.+++...... ..+++..++.++.|+++||+|||+ .+|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence 99999999999999999999754321 347899999999999999999998 8999999
Q ss_pred CCCCCccccCCCceEEecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 002358 737 VKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSV 814 (931)
Q Consensus 737 Ikp~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~ 814 (931)
|||+|||++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999876443322 2233457889999999988899999999999999999998 9999974
Q ss_pred cCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 815 EDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 815 ~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
..... .... .+..+... ..+......+.+++.+||+.||++||+++||++.|+.+.....
T Consensus 278 ~~~~~--~~~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 278 IPVDA--NFYK----LIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCCSH--HHHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CCcHH--HHHH----HHhcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 43221 1112 12221111 1111223468899999999999999999999999998876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=342.07 Aligned_cols=259 Identities=19% Similarity=0.283 Sum_probs=197.5
Q ss_pred HhhccccCccCcEEEEEEEECCCcEEEEEEccCccch--hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
|++.+.||+|+||.||+|+..+|+.||+|++...... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 5667899999999999999988999999998654322 23678899999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+ +|.+.+... ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 156 (288)
T 1ob3_A 84 Q-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK- 156 (288)
T ss_dssp E-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred C-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc-
Confidence 5 899988743 3568999999999999999999998 89999999999999999999999999999765432221
Q ss_pred ccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCC---eee-----c
Q 002358 769 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VIS-----I 839 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~---~~~-----i 839 (931)
.....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ...+.+...... ... .
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhcccc
Confidence 223458999999999876 4689999999999999999999999974332211 111111111100 000 0
Q ss_pred cccccc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 840 VDPVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 840 ~d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.++... ..........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 011100 0011122346789999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=344.76 Aligned_cols=272 Identities=25% Similarity=0.398 Sum_probs=205.7
Q ss_pred hhhHHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhc--CCCCCcceeEEEecC---
Q 002358 603 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEE--- 677 (931)
Q Consensus 603 ~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~g~~~~~--- 677 (931)
..+.....|++.+.||+|+||.||+|++. ++.||||++... ....+.+|.+++..+ +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 34555678888999999999999999987 899999998643 234455666666655 899999999999876
Q ss_pred -CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcC-----CCCeEecCCCCCCccccCCCceE
Q 002358 678 -HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-----NPGIIHRDVKSSNILLDINMRAK 751 (931)
Q Consensus 678 -~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~ivH~DIkp~NILld~~~~vk 751 (931)
...++||||+++|+|.++++. ..+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 788999999999999999974 35899999999999999999999710 12999999999999999999999
Q ss_pred Eeccccccccccccccc---ccccccCCCccCCCccCCCCCCcc------chhHHHHHHHHHHHhC----------CCCC
Q 002358 752 VSDFGLSRQAEEDLTHI---SSVARGTVGYLDPEYYGNQQLTEK------SDVYSFGVVLLELISG----------KKPV 812 (931)
Q Consensus 752 L~DFGla~~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~k------sDVwSlGvlL~eLltG----------~~Pf 812 (931)
|+|||+++......... .....||+.|+|||++.+.....+ +|||||||++|||++| +.||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999997654332221 123468999999999988766665 9999999999999999 6666
Q ss_pred CccCccchhhHHHHHHHhhhcCCeeecccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 813 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 813 ~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
........ .. ............ .+..... ...+....+.+++.+||+.||++|||++||++.|+++....
T Consensus 263 ~~~~~~~~-~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 263 HDLVPSDP-SY-EDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTSCSSC-CH-HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhhcCCCC-ch-hhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 53222111 11 111111111111 1111111 12256678999999999999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=341.65 Aligned_cols=247 Identities=28% Similarity=0.392 Sum_probs=193.5
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--------------------------hhhhhHHHHHHHHHhc
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------------------------HRTQQFVTEVALLSRI 662 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--------------------------~~~~~~~~E~~il~~l 662 (931)
.|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 4667899999999999999876 688999999865321 1235689999999999
Q ss_pred CCCCCcceeEEEec--CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCC
Q 002358 663 HHRNLVPLIGYCEE--EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 740 (931)
Q Consensus 663 ~HpnIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~ 740 (931)
+||||+++++++.+ ....++||||+++|+|.+++. ...+++..+..++.|+++||+|||+ .+|+||||||+
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 99999999999986 568899999999999987653 4578999999999999999999998 89999999999
Q ss_pred CccccCCCceEEecccccccccccccccccccccCCCccCCCccCCCC---CCccchhHHHHHHHHHHHhCCCCCCccCc
Q 002358 741 NILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDF 817 (931)
Q Consensus 741 NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~s~ksDVwSlGvlL~eLltG~~Pf~~~~~ 817 (931)
|||++.++.+||+|||+++........ .....||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999999876543222 23346899999999997765 47789999999999999999999974322
Q ss_pred cchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 818 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 818 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. .+. ..+...... ..+ ... ....+.+++.+||+.||++||+++|+++
T Consensus 246 ~---~~~----~~~~~~~~~-~~~---~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 M---CLH----SKIKSQALE-FPD---QPD----IAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H---HHH----HHHHHCCCC-CCS---SSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H---HHH----HHHhcccCC-CCC---ccc----cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 111 111111110 000 111 2236889999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=344.84 Aligned_cols=255 Identities=22% Similarity=0.396 Sum_probs=203.4
Q ss_pred HHHHHhhccccCccCcEEEEEEEECC-C-------cEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCC
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKD-G-------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 678 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~-g-------~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 678 (931)
....+.+.+.||+|+||.||+|.++. + +.||+|++........+.+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 34567778999999999999998763 3 579999997766666788999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc--------e
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--------A 750 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~--------v 750 (931)
..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++. +
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999999853 3448999999999999999999998 89999999999999998887 9
Q ss_pred EEecccccccccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHH
Q 002358 751 KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 829 (931)
Q Consensus 751 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 829 (931)
||+|||++...... ....|++.|+|||.+.+ ..++.++||||||+++|||++|..|+...... ........
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~~~~- 232 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQFYE- 232 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHH-
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHHHhh-
Confidence 99999998765332 22347889999999987 77899999999999999999965544312111 11111111
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 830 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
....... .. ...+.+++.+||+.||++|||++|+++.|+++....
T Consensus 233 --~~~~~~~--------~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 233 --DRHQLPA--------PK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp --TTCCCCC--------CS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred --ccCCCCC--------CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1111111 11 125779999999999999999999999999886643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=345.33 Aligned_cols=249 Identities=19% Similarity=0.311 Sum_probs=202.7
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.|++.+.||+|+||.||+|..+ +++.||+|++... ......+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 4567889999999999999987 5889999998754 3445678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC--CCceEEeccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~--~~~vkL~DFGla~~~~~~~~ 766 (931)
+|+|.+++.. ....+++..+..++.|+++||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 85 g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 85 GLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999974 23468999999999999999999998 89999999999999987 78999999999987644322
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...... .... .... +... .++....
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~---~i~~-~~~~--~~~~~~~ 228 (321)
T 1tki_A 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIE---NIMN-AEYT--FDEEAFK 228 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HHHH-TCCC--CCHHHHT
T ss_pred --cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHH---HHHc-CCCC--CChhhhc
Confidence 23345899999999999988999999999999999999999999743321 1111 1111 1110 0110111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. ...+.+++.+||+.||++|||++|+++
T Consensus 229 ~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 229 EI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 236789999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=351.78 Aligned_cols=270 Identities=17% Similarity=0.235 Sum_probs=207.9
Q ss_pred HHHHhhccccCccCcEEEEEEEECC------CcEEEEEEccCccchh-----------hhhHHHHHHHHHhcCCCCCcce
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHR-----------TQQFVTEVALLSRIHHRNLVPL 670 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~~~-----------~~~~~~E~~il~~l~HpnIv~l 670 (931)
...|++.+.||+|+||.||+|.++. ++.||||++....... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3457778999999999999999875 4789999986543211 1234456667778889999999
Q ss_pred eEEEecC----CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc-
Q 002358 671 IGYCEEE----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD- 745 (931)
Q Consensus 671 ~g~~~~~----~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld- 745 (931)
++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEec
Confidence 9998764 4589999999 9999999975 34679999999999999999999998 8999999999999999
Q ss_pred -CCCceEEeccccccccccccccc------ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCcc
Q 002358 746 -INMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 818 (931)
Q Consensus 746 -~~~~vkL~DFGla~~~~~~~~~~------~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~ 818 (931)
.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999998764432211 12345999999999999999999999999999999999999999743222
Q ss_pred chhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 819 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 819 ~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
.....+...... ..+.+++++.+... ..+..+.+++.+||+.+|++||++++|++.|+++.....
T Consensus 268 --~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 268 --PKYVRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp --HHHHHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --HHHHHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 222222222111 12333344333211 123468899999999999999999999999999886543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=348.59 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=180.0
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
+.||+|+||.||+|.++ +++.||||++... ....+.+|+.+++.++ ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999986 6899999998643 3456789999999997 99999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC---ceEEecccccccccccccccc
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~---~vkL~DFGla~~~~~~~~~~~ 769 (931)
.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++ .+||+|||+++........ .
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-~ 166 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-L 166 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-c
Confidence 999984 4579999999999999999999998 8999999999999998765 7999999999865433222 2
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..........+...+..+.... .....
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~---- 240 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--EGEAW---- 240 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC--CSHHH----
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC--Ccccc----
Confidence 334589999999999999999999999999999999999999975433211111112222232222210 00000
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 112246889999999999999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=342.16 Aligned_cols=259 Identities=28% Similarity=0.448 Sum_probs=205.4
Q ss_pred HHHhhccccCccCcEEEEEEEECC----CcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
..+.+.+.||+|+||.||+|.+.+ +..||+|+++... ....+.+.+|++++++++||||+++++++.++ ..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence 456678999999999999998653 3469999987653 34567899999999999999999999998754 56899
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++++|.+++... ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 91 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 91 MELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 9999999999999752 4568999999999999999999998 8999999999999999999999999999987655
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+ ..+....
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~----~~~~~~~---- 234 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL----EKGDRLP---- 234 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH----HHTCCCC----
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH----hcCCCCC----
Confidence 43333344457889999999988889999999999999999998 999997433222 11111 1111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
. +......+.+++.+||+.+|++||+++|+++.|+++...+.
T Consensus 235 -~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 235 -K----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp -C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -C----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 1 11122368899999999999999999999999999877654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=359.63 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=204.0
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
....|++.+.||+|+||.||+|... +|+.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3466888999999999999999876 68999999987543 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc---CCCceEEeccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQ 760 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld---~~~~vkL~DFGla~~ 760 (931)
|||+++|+|.+.+.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999874 4568999999999999999999998 8999999999999998 467899999999987
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
....... .....||+.|+|||++.+..++.++||||+||++|+|++|..||...+.. .+.+ .+..+... ..
T Consensus 163 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~----~i~~~~~~-~~ 233 (444)
T 3soa_A 163 VEGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQ----QIKAGAYD-FP 233 (444)
T ss_dssp CCTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH----HHHHTCCC-CC
T ss_pred ecCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHH----HHHhCCCC-CC
Confidence 6543322 23356999999999999999999999999999999999999999743321 1111 12222111 11
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+ ..... ...+.+++.+||+.||++|||++|+++
T Consensus 234 ~~-~~~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 SP-EWDTV----TPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TT-TTTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cc-ccccC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11 11112 236789999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.63 Aligned_cols=260 Identities=21% Similarity=0.283 Sum_probs=197.7
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++.+.||+|+||+||+|..+ +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 566789999999999999986 589999999865432 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++ ++.+.+.. ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 84 DQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp SE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred CC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 75 55555543 24569999999999999999999998 89999999999999999999999999999876433222
Q ss_pred cccccccCCCccCCCccCCCC-CCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcC---Ceeecc---
Q 002358 768 ISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVISIV--- 840 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~-~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~---~~~~i~--- 840 (931)
.....||+.|+|||++.+.. ++.++||||+||++|||++|..|+..... .......+.+..... ......
T Consensus 158 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 23345899999999987765 79999999999999999999888642221 111122222111110 000000
Q ss_pred c---------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 D---------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d---------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+ ..............+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00000111123346789999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=349.12 Aligned_cols=266 Identities=24% Similarity=0.447 Sum_probs=212.8
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC--------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhc-CCCCCcceeEEEe
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCE 675 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~ 675 (931)
+....|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 33456778899999999999999874 467899999976533 3457799999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCc
Q 002358 676 EEHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 742 (931)
Q Consensus 676 ~~~~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NI 742 (931)
..+..++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+ .+|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceE
Confidence 99999999999999999999985431 2348899999999999999999998 8999999999999
Q ss_pred cccCCCceEEecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccch
Q 002358 743 LLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 820 (931)
Q Consensus 743 Lld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~ 820 (931)
|++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 266 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 266 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--
Confidence 9999999999999999875543221 1223346789999999988889999999999999999999 99999743321
Q ss_pred hhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 002358 821 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 890 (931)
Q Consensus 821 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~ 890 (931)
.+... +..+.... . +......+.+++.+||+.+|++||+++|+++.|+++......
T Consensus 267 -~~~~~----~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 267 -ELFKL----LKEGHRMD-----K----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp -HHHHH----HHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -HHHHH----HhcCCCCC-----C----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 12221 11121111 1 112234688999999999999999999999999999876654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=348.39 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=198.8
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
.+++.+.||+|+||.||+|+++ +++.||+|+++... ....+.+.+|..+++++ +||||+++++++.+....++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 4567899999999999999987 58899999997542 23456688999999988 8999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 90 EYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999874 3568999999999999999999998 89999999999999999999999999999864322
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccch--hhHHHHHHHhhhcCCeeecccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--LNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~--~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+.+.+..+..
T Consensus 164 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred CC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 22 23345699999999999999999999999999999999999999964322111 1111222222222211
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 874 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 874 (931)
.+ +......+.+++.+||+.||++||++
T Consensus 237 ~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 RI----PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CC----CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11 11222367899999999999999995
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=344.33 Aligned_cols=269 Identities=25% Similarity=0.403 Sum_probs=212.4
Q ss_pred hhhHHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHh--cCCCCCcceeEEEecCC--
Q 002358 603 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--IHHRNLVPLIGYCEEEH-- 678 (931)
Q Consensus 603 ~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~g~~~~~~-- 678 (931)
..+.....|++.+.||+|+||.||+|++. |+.||||++... ..+.+.+|.+++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 34566778888999999999999999985 899999998643 34567889999988 68999999999998775
Q ss_pred --eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhh--------hcCCCCeEecCCCCCCccccCCC
Q 002358 679 --QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH--------TGCNPGIIHRDVKSSNILLDINM 748 (931)
Q Consensus 679 --~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~ivH~DIkp~NILld~~~ 748 (931)
..++||||+++|+|.+++.. ..+++..++.++.|+++||+||| + .+|+||||||+|||++.++
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTS
T ss_pred cceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCC
Confidence 78999999999999999974 35899999999999999999999 6 8999999999999999999
Q ss_pred ceEEecccccccccccccc---cccccccCCCccCCCccCCC------CCCccchhHHHHHHHHHHHhC----------C
Q 002358 749 RAKVSDFGLSRQAEEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISG----------K 809 (931)
Q Consensus 749 ~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~------~~s~ksDVwSlGvlL~eLltG----------~ 809 (931)
.+||+|||+++........ ......||+.|+|||.+.+. .++.++||||||+++|||++| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999875443322 22344689999999998775 334789999999999999999 7
Q ss_pred CCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 810 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 810 ~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
.||....... .....+.. .+..... .+.+... ...+....+.+++.+||+.+|++||+++||++.|+++...+
T Consensus 265 ~p~~~~~~~~-~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 265 LPYYDLVPSD-PSVEEMRK-VVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CTTTTTSCSS-CCHHHHHH-HHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCccccCcCc-ccHHHHHH-HHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 7886332221 11112221 1211111 1111111 13356678999999999999999999999999999987654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=349.88 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=192.5
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CCCCcceeEEEe--------c
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCE--------E 676 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~--------~ 676 (931)
....|++.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3446778899999999999999976 68999999987666666778999999999996 999999999983 3
Q ss_pred CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCC--eEecCCCCCCccccCCCceEEec
Q 002358 677 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSD 754 (931)
Q Consensus 677 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--ivH~DIkp~NILld~~~~vkL~D 754 (931)
....++||||+. |+|.+++........+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEec
Confidence 455789999995 7999988754445679999999999999999999998 77 99999999999999999999999
Q ss_pred ccccccccccccc-----------cccccccCCCccCCCcc---CCCCCCccchhHHHHHHHHHHHhCCCCCCccCccch
Q 002358 755 FGLSRQAEEDLTH-----------ISSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 820 (931)
Q Consensus 755 FGla~~~~~~~~~-----------~~~~~~gt~~y~APE~l---~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~ 820 (931)
||+++........ ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 9999875432211 11134589999999998 56778999999999999999999999996322110
Q ss_pred hhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 821 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 821 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
. .. +... ....... ...+.+++.+||+.+|++||+++|+++.|+++.....
T Consensus 261 --~---~~-----~~~~----~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 --I---VN-----GKYS----IPPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ---------------CC----CCTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --h---hc-----Cccc----CCccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 0 00 0000 0000111 1247789999999999999999999999998876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=360.43 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=202.8
Q ss_pred HHhhccccCccCcEEEEEEEECC-CcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.+++.++||+|+||+||+|++++ ++.||+|+++.... ...+.+.+|..++..++||||+++++++.+.+..++|||
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence 45567899999999999999874 78999999865322 223458999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
||++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 155 y~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 155 YYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp CCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 99999999999752 4568999999999999999999998 899999999999999999999999999998765544
Q ss_pred cccccccccCCCccCCCccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 766 THISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+. ...+......-..
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~~~~~---- 302 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMNHKERFQF---- 302 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHHCCC----
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---HHhhhhccccccC----
Confidence 44444567999999999986 56799999999999999999999999974433221 1111110000011
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~ 879 (931)
|...... ...+.+++.+||..+|++ ||+++|+++
T Consensus 303 -p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 303 -PTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp -CSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred -CcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111112 235789999999888888 999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=354.80 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=198.3
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~ 681 (931)
....+++.+.||+|+||.||+|+.+ +|+.||||+++... ....+.+.+|.++++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3345677899999999999999987 58999999987542 23345688999999988 6999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999974 4568999999999999999999998 89999999999999999999999999999864
Q ss_pred cccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ..+ .+..+..
T Consensus 175 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~----~i~~~~~----- 241 (353)
T 3txo_A 175 ICNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFE----AILNDEV----- 241 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCC-----
T ss_pred ccCCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HHH----HHHcCCC-----
Confidence 32222 2334569999999999998899999999999999999999999997443221 111 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM------QEIVL 879 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~------~evl~ 879 (931)
.++......+.+++.+||+.+|++||++ +|+++
T Consensus 242 -----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 -----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0111122367899999999999999998 66654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=341.82 Aligned_cols=264 Identities=30% Similarity=0.541 Sum_probs=198.6
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
.|+....+++.+.||+|+||.||+|++. ..||+|+++... ....+.+.+|++++++++||||+++++++. ....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccE
Confidence 3555667788899999999999999865 359999986543 334577999999999999999999999664 55689
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+||||+++++|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 96 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccc
Confidence 999999999999999643 4568999999999999999999998 89999999999999999999999999999765
Q ss_pred cccc-cccccccccCCCccCCCccC---CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 762 EEDL-THISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 762 ~~~~-~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
.... ........||+.|+|||.+. ...++.++||||||+++|||++|+.||..... ...+.. .+..+...
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~----~~~~~~~~ 244 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIE----MVGRGSLS 244 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHH----HHHHTSCC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHH----HhcccccC
Confidence 4321 12223346899999999986 56788899999999999999999999974322 112222 22222221
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
.... ......+..+.+++.+||+.+|++||+++|+++.|+++.+
T Consensus 245 ~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 245 PDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1111 1112233478899999999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=377.45 Aligned_cols=261 Identities=27% Similarity=0.437 Sum_probs=211.5
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
+....+++.+.||+|+||.||+|.++++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3345567789999999999999999988899999997643 234679999999999999999999999876 67899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.+++... ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999742 23458899999999999999999998 899999999999999999999999999998765433
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
........++..|+|||.+....++.++|||||||++|||++ |+.||...... .+.+ .+..+...
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~----~i~~~~~~------- 483 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD----QVERGYRM------- 483 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHH----HHHTTCCC-------
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC-------
Confidence 222333446789999999988899999999999999999999 99999743221 1222 12222111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
..+......+.+++.+||+.+|++||++++|++.|+++....
T Consensus 484 --~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 484 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 011222346889999999999999999999999999876433
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=352.35 Aligned_cols=250 Identities=21% Similarity=0.336 Sum_probs=204.6
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.|++.+.||+|+||.||+|..+ +|+.||+|++..........+.+|++++++++||||+++++++.+....++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 4677899999999999999886 689999999976655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC--CCceEEeccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~--~~~vkL~DFGla~~~~~~~~ 766 (931)
+|+|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 132 gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 132 GGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999874 23468999999999999999999998 89999999999999974 57799999999987654322
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+ .. .... .++....
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i---~~-~~~~--~~~~~~~ 275 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNV---KR-CDWE--FDEDAFS 275 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHH---HH-CCCC--CCSSTTT
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHH---Hh-CCCC--CCccccc
Confidence 22346899999999999999999999999999999999999999743321 111111 11 1110 1111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. ....+.+++.+||+.||++|||++|+++
T Consensus 276 ~----~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 276 S----VSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp T----SCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred c----CCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 2 2236789999999999999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=351.84 Aligned_cols=257 Identities=25% Similarity=0.419 Sum_probs=202.5
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcE----EEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKE----VAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~----vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
..+++.+.||+|+||.||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. +...++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 34667899999999999999976 3443 7888875432 233467889999999999999999999986 456889
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999999743 3568889999999999999999998 899999999999999999999999999998765
Q ss_pred ccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 763 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 763 ~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
..... ......|+..|+|||.+.+..++.++||||||+++|||++ |+.||....... ... .+..+.....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~~~- 238 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPD----LLEKGERLAQ- 238 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHH----HHHTTCBCCC-
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHH----HHHcCCCCCC-
Confidence 43322 2334457889999999998899999999999999999999 999997443322 111 1112211111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
+ ......+.+++.+||+.+|++||+++|+++.|+++...
T Consensus 239 -~-------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 239 -P-------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp -C-------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred -C-------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 01112467899999999999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=351.56 Aligned_cols=249 Identities=24% Similarity=0.336 Sum_probs=203.2
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
..|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+++|+.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45677899999999999999987 58899999986532 223467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999983 4569999999999999999999998 89999999999999999999999999999875433
Q ss_pred ccccccccccCCCccCCCccCC---CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||................. ...
T Consensus 169 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~~~----- 237 (384)
T 4fr4_A 169 T--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----TVV----- 237 (384)
T ss_dssp C--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----CCC-----
T ss_pred C--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----ccc-----
Confidence 2 2334569999999999864 4589999999999999999999999975443333333222211 110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVL 879 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~ 879 (931)
.++......+.+++.+||+.+|++||+ +++|.+
T Consensus 238 -----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 -----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111222346889999999999999998 777653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.77 Aligned_cols=243 Identities=22% Similarity=0.364 Sum_probs=201.3
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.+++.+.||+|+||.||+|+.+ +|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 4567899999999999999986 689999999875422 234668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 87 YIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999974 4568999999999999999999998 89999999999999999999999999999865432
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .. ...... +.. ..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~---~~~i~~-~~~------~~- 222 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KT---YEKILN-AEL------RF- 222 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HH---HHHHHH-CCC------CC-
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHHHHh-CCC------CC-
Confidence 23456999999999999999999999999999999999999999743321 11 111111 111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
+......+.+++.+||+.+|++|| +++|+++
T Consensus 223 ---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 ---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 111223678999999999999999 8888874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.91 Aligned_cols=252 Identities=21% Similarity=0.367 Sum_probs=203.5
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecC--CeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 684 (931)
..+++.+.||+|+||.||+|+++ ++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 45667899999999999999986 8999999987543 34456799999999999999999999999877 7889999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCC--eEecCCCCCCccccCCCceEEeccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||+++|+|.+++... ....+++..++.++.|+++||+|||+ .+ ++||||||+||+++.++.++|+|||+.....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999853 23368999999999999999999997 77 9999999999999999999999998875432
Q ss_pred ccccccccccccCCCccCCCccCCCCCCc---cchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 763 EDLTHISSVARGTVGYLDPEYYGNQQLTE---KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~---ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
. ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||....... ........+..
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~--- 229 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEGLR--- 229 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSCCC---
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcCCC---
Confidence 2 2235899999999998765554 7999999999999999999997332211 11111211111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
+.. +......+.+++.+||+.+|++|||++|+++.|+++..
T Consensus 230 --~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 --PTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111 11223368899999999999999999999999998743
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=336.59 Aligned_cols=259 Identities=24% Similarity=0.415 Sum_probs=209.5
Q ss_pred Hhhcc-ccCccCcEEEEEEEEC---CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 611 NNFCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 611 ~~~~~-~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
+.+.+ .||+|+||.||+|.+. +++.||+|+++... ....+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 34444 8999999999999864 57889999997653 34567899999999999999999999999 4566899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++++|.+++.. ....+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 90 MAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp CCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred eCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999874 34568999999999999999999998 899999999999999999999999999998764332
Q ss_pred cc--cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 766 TH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 766 ~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... +..+...
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~----i~~~~~~----- 232 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGKRM----- 232 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH----HHTTCCC-----
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHH----HhcCCcC-----
Confidence 22 1223346889999999988889999999999999999999 99999743321 22222 2222111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 891 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 891 (931)
..+......+.+++.+||+.+|++||+++|+++.|+++.......
T Consensus 233 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 233 ----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 111222347889999999999999999999999999998766543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=335.33 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=206.4
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEE-ecCCeEEEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYE 685 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~-~~~~~~~lV~E 685 (931)
...|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+++++.++|++++..++.+ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 356778899999999999999974 68999999865432 335688999999999988877777665 56778899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc---cCCCceEEeccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl---d~~~~vkL~DFGla~~~~ 762 (931)
|+ +++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred cc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99 99999998743 3468999999999999999999998 899999999999999 789999999999998765
Q ss_pred ccccc------cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 763 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 763 ~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 43221 123456899999999999999999999999999999999999999754433222222222111111110
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
+.+...+ ...+.+++.+||+.+|++||+++||++.|+++.....
T Consensus 240 -----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 240 -----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0011112 2368899999999999999999999999999876553
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.43 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=197.1
Q ss_pred hhhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhc-CCCCCcceeEEEecCC
Q 002358 603 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 678 (931)
Q Consensus 603 ~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~ 678 (931)
..++....+++.++||+|+||+||+|++. +|+.||||++..... .....+.+|+..+.++ +||||+++++++.+.+
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 44666788889999999999999999987 799999999865332 3334556666666655 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
..++||||+ +++|.+.+... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred EEEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceee
Confidence 999999999 77999888753 4569999999999999999999998 89999999999999999999999999998
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeee
Q 002358 759 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 759 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 838 (931)
....... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... . . ..+..+...
T Consensus 205 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~-~----~~~~~~~~~- 270 (311)
T 3p1a_A 205 VELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----G-W----QQLRQGYLP- 270 (311)
T ss_dssp EECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----H-H----HHHTTTCCC-
T ss_pred eecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----H-H----HHHhccCCC-
Confidence 7654332 2233458999999999876 78999999999999999999977664211 1 1 111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 839 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 839 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+.+... ....+.+++.+||+.||++|||++|+++
T Consensus 271 ---~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 ---PEFTAG----LSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---cccccC----CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111111 2246889999999999999999999885
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.15 Aligned_cols=262 Identities=21% Similarity=0.307 Sum_probs=189.5
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.|++.+.||+|+||.||+|..+ +|+.||+|+++.... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 4667899999999999999876 689999999865432 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 688 HNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 688 ~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
+ |+|.+++.... ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 69998876421 23468899999999999999999998 89999999999999999999999999999875433
Q ss_pred ccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcC---Ceeec-
Q 002358 765 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVISI- 839 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~---~~~~i- 839 (931)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+....... .....
T Consensus 162 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 162 VNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp CCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGGGG
T ss_pred ccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhhhh
Confidence 221 223458999999999876 4689999999999999999999999974433221 11111111100 00000
Q ss_pred ----ccccc------------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 840 ----VDPVL------------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 840 ----~d~~l------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+.+ ...........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 00000112236889999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=339.21 Aligned_cols=263 Identities=21% Similarity=0.310 Sum_probs=201.3
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc---cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|++.+.||+|+||.||+|... +|+.||+|+++.. .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 5777899999999999999875 7899999998752 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 686 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
|+++|+|.+++.... ....+++..++.++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 999999999886422 34568999999999999999999998 89999999999999999999999999998865443
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...+.. .+..........
T Consensus 190 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~~~~~~~--- 260 (310)
T 2wqm_A 190 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK----KIEQCDYPPLPS--- 260 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHH----HHHTTCSCCCCT---
T ss_pred Ccc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHH----HhhcccCCCCcc---
Confidence 221 22345899999999999999999999999999999999999999743221 111211 122222211111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
.. ....+.+++.+||+.||++||+++||++.|+++.....
T Consensus 261 -~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 261 -DH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp -TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -cc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11 22368899999999999999999999999999887665
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=344.98 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=192.6
Q ss_pred HHHHhhccccCccCcEEEEEEEE----CCCcEEEEEEccCcc----chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 679 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 679 (931)
...|++.+.||+|+||.||+++. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 34577889999999999999987 478999999997642 2234568899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999874 3568899999999999999999998 899999999999999999999999999997
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...+ .... ...
T Consensus 170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~~-~~~--- 238 (327)
T 3a62_A 170 ESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTID---KILK-CKL--- 238 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH---HHHH-TCC---
T ss_pred ccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHh-CCC---
Confidence 6433222 223346899999999999999999999999999999999999999743321 1111 1111 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
. .+......+.+++.+||+.+|++|| +++|+++
T Consensus 239 ---~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ---N----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---C----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---C----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 1112234678999999999999999 6777764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=352.92 Aligned_cols=274 Identities=22% Similarity=0.308 Sum_probs=213.3
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC--eEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--~~~lV~E 685 (931)
.|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 4567899999999999999987 48999999987543 233567889999999999999999999987655 7799999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc----cCCCceEEecccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQA 761 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl----d~~~~vkL~DFGla~~~ 761 (931)
|+++|+|.+++........+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999999865444559999999999999999999998 899999999999999 77888999999999876
Q ss_pred cccccccccccccCCCccCCCccCC--------CCCCccchhHHHHHHHHHHHhCCCCCCccCcc-chhhHHHHHHHhhh
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGN--------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIK 832 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~--------~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~-~~~~l~~~~~~~~~ 832 (931)
..... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ........+.....
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred cCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 44322 223458999999999864 56788999999999999999999999643322 11112111111111
Q ss_pred cCCeeecc-----------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 833 KGDVISIV-----------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 833 ~~~~~~i~-----------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
......+. +..............+.+++.+||+.||++||+++|+++.+++++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 11111100 001112334567778899999999999999999999999998887643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=357.40 Aligned_cols=251 Identities=23% Similarity=0.305 Sum_probs=201.3
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.+++.+.||+|+||.||+|+++ +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4556789999999999999987 58899999986532 1233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.++++. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 150 ~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 150 YMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp CCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 9999999999874 358899999999999999999998 899999999999999999999999999998765544
Q ss_pred cccccccccCCCccCCCccCCCC----CCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~----~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.... ...+......-.. .+
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~~~~~~~~~---p~ 296 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSKIMNHKNSLTF---PD 296 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHHCCC---CT
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH---HHHHHhccccccC---CC
Confidence 33344567999999999987654 78999999999999999999999974433211 1111110000000 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 880 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~~ 880 (931)
.... ...+.+++.+||+.+|.+ ||+++||++.
T Consensus 297 ---~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 ---DNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---TCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---cccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0011 236789999999999988 9999998853
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=347.33 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=198.8
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|.+.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+++++.++||||+++++++......++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 4667899999999999999985 689999999864321 223578999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+ +|+|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 90 ~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 90 YA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred CC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99 7899988863 4568999999999999999999998 899999999999999999999999999998754432
Q ss_pred cccccccccCCCccCCCccCCCCC-CccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
. .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......... .+..+. .
T Consensus 163 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------~i~~~~------~-- 225 (336)
T 3h4j_B 163 F--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------KVNSCV------Y-- 225 (336)
T ss_dssp T--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------CCCSSC------C--
T ss_pred c--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------HHHcCC------C--
Confidence 2 234469999999999988776 789999999999999999999997433221100 000000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+......+.+++.+||+.||.+|||++|+++
T Consensus 226 --~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 --VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp --CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred --CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111122336789999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=341.69 Aligned_cols=266 Identities=24% Similarity=0.291 Sum_probs=198.3
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-----hhhhhHHHHHHHHHhcC---CCCCcceeEEE
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-----HRTQQFVTEVALLSRIH---HRNLVPLIGYC 674 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-----~~~~~~~~E~~il~~l~---HpnIv~l~g~~ 674 (931)
+++....|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 4555667888999999999999999975 689999999864321 12346778888887775 99999999999
Q ss_pred ecCC-----eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc
Q 002358 675 EEEH-----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 749 (931)
Q Consensus 675 ~~~~-----~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~ 749 (931)
.... ..++||||+. |+|.+++... ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSC
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCC
Confidence 7654 5789999997 6999998854 23448999999999999999999998 89999999999999999999
Q ss_pred eEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHH
Q 002358 750 AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 829 (931)
Q Consensus 750 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 829 (931)
+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..
T Consensus 159 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~ 233 (308)
T 3g33_A 159 VKLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFD 233 (308)
T ss_dssp EEECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHH
T ss_pred EEEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHH
Confidence 99999999986543322 2345689999999999999999999999999999999999999974433221 111111
Q ss_pred hhhc---CCeeecc---cccccC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 830 MIKK---GDVISIV---DPVLIG-------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 830 ~~~~---~~~~~i~---d~~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... ....... ...... ....+....+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1110 0000000 000000 001122346789999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=338.47 Aligned_cols=260 Identities=21% Similarity=0.317 Sum_probs=199.3
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
..|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 45677899999999999999986 688999999875432 23467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 114 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 114 RLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp ECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999974 3568999999999999999999998 89999999999999999999999999999876544
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .+...+..... .. ...
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~-~~--~~~ 257 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP-RP--STV 257 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC-CG--GGT
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC-Cc--ccc
Confidence 333333456899999999999999999999999999999999999999743221 11112211111 00 011
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhhhhh
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIE 888 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~~~~~~ 888 (931)
+......+.+++.+||+.+|++|| +++++++.|++.....
T Consensus 258 ----~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 258 ----RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp ----STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ----CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 111223688999999999999999 9999999999876544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=349.02 Aligned_cols=269 Identities=19% Similarity=0.211 Sum_probs=201.1
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEEC----CCcEEEEEEccCccch-----------hhhhHHHHHHHHHhcCCCCCcc
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSH-----------RTQQFVTEVALLSRIHHRNLVP 669 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~~~-----------~~~~~~~E~~il~~l~HpnIv~ 669 (931)
++....|.+.+.||+|+||.||+|.+. .+..+|+|++...... ..+.+.+|+..++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 344456778899999999999999986 5788999998754321 1234778899999999999999
Q ss_pred eeEEEec----CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc
Q 002358 670 LIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 745 (931)
Q Consensus 670 l~g~~~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld 745 (931)
+++++.. ....++||||+ +++|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEE
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEc
Confidence 9999987 67899999999 99999998743 378999999999999999999998 8999999999999999
Q ss_pred CCC--ceEEecccccccccccccc------cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCc
Q 002358 746 INM--RAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 817 (931)
Q Consensus 746 ~~~--~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~ 817 (931)
.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 877 9999999999876433211 11344689999999999999999999999999999999999999963222
Q ss_pred cchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 818 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 818 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
. .... .......... ....+..... .......+.+++.+||+.+|++||++++|++.|++...
T Consensus 266 ~-~~~~-~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 266 D-PVAV-QTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp C-HHHH-HHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred c-cHHH-HHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1 1111 1111111111 1111100000 00122368899999999999999999999999987643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=350.49 Aligned_cols=246 Identities=25% Similarity=0.376 Sum_probs=200.6
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV 683 (931)
..+++.+.||+|+||.||+|+++ +|+.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 34667899999999999999987 58999999997542 23345678899999887 899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 999999999999974 3568999999999999999999998 8999999999999999999999999999986432
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.+ .+..+.. .
T Consensus 171 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~----~i~~~~~------~ 236 (345)
T 1xjd_A 171 GDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFH----SIRMDNP------F 236 (345)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------C
T ss_pred CCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHhCCC------C
Confidence 221 233456999999999999999999999999999999999999999743321 1111 1111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 878 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl 878 (931)
.... ....+.+++.+||+.+|++||++. ||+
T Consensus 237 ~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 237 YPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1111 223678999999999999999997 654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=336.62 Aligned_cols=258 Identities=29% Similarity=0.460 Sum_probs=202.3
Q ss_pred HhhccccCccCcEEEEEEEECC----CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEe-cCCeEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVY 684 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~~~lV~ 684 (931)
+++.+.||+|+||.||+|.+.+ ...||+|.+..... ...+.+.+|+.++++++||||+++++++. .++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 5567899999999999998753 23689999876433 34577999999999999999999999864 456789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++|+|.+++.. ....+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 107 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 107 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp ECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999974 34568899999999999999999998 89999999999999999999999999999875443
Q ss_pred cc---ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 765 LT---HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 765 ~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||....... ...... .+... .
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~~----~~~~~--~ 252 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLL----QGRRL--L 252 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHHH----TTCCC--C
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHHh----cCCCC--C
Confidence 22 12233457889999999998899999999999999999999 555554322211 111111 11110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
. +......+.+++.+||+.+|++||+++|+++.|+++.....
T Consensus 253 ~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 253 Q-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred C-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 11122368899999999999999999999999999877554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=355.86 Aligned_cols=253 Identities=24% Similarity=0.258 Sum_probs=200.7
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
..+++.+.||+|+||.||+|+.+ +|+.||||++++.. ....+.+.+|..++.+++||||+++++++.+.+..++||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 34556789999999999999986 68999999986532 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++|+|.+++... +..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 141 E~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp CCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred cCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 999999999999742 3468999999999999999999998 89999999999999999999999999999876554
Q ss_pred ccccccccccCCCccCCCccC-------CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 765 LTHISSVARGTVGYLDPEYYG-------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~-------~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||...+.... ...+......-..
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i~~~~~~~~~- 291 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET---YGKIVHYKEHLSL- 291 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHHCCC-
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH---HHHHHhcccCcCC-
Confidence 433334457999999999986 46789999999999999999999999974433211 1111110000001
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR---PKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~~evl~ 879 (931)
+...... ...+.+++.+||+ +|++| |+++||++
T Consensus 292 ----p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 292 ----PLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ----C----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ----CccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111112 2367899999999 99998 58888864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=333.89 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=207.1
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEec------
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------ 676 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 676 (931)
+......|++.+.||+|+||.||+|.+. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 4556677888999999999999999987 79999999987542 467789999999999999999998854
Q ss_pred ----------CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC
Q 002358 677 ----------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 746 (931)
Q Consensus 677 ----------~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~ 746 (931)
....++||||+++|+|.+++... ....+++..++.++.|+++||.|||+ .+|+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVD 157 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcC
Confidence 45578999999999999999743 23568999999999999999999998 89999999999999999
Q ss_pred CCceEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHH
Q 002358 747 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 826 (931)
Q Consensus 747 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~ 826 (931)
++.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+... ....
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~-- 228 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFF-- 228 (284)
T ss_dssp TTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHH--
T ss_pred CCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHH--
Confidence 99999999999987654322 22345899999999999999999999999999999999999887411 1111
Q ss_pred HHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 827 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 827 ~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
..+..+... ..++ ..+.+++.+||+.||++||++.|+++.|+.+.+...
T Consensus 229 --~~~~~~~~~--------~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 229 --TDLRDGIIS--------DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp --HHHHTTCCC--------TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred --HHhhccccc--------ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 111112111 1122 357899999999999999999999999998765443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=350.19 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=198.1
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
.+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999876 6899999999876556677899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc--cCCCceEEeccccccccccccccccc
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISS 770 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl--d~~~~vkL~DFGla~~~~~~~~~~~~ 770 (931)
.+.+.. ....+++..++.++.||++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....... ..
T Consensus 174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 998864 23468999999999999999999998 899999999999999 5678899999999987644322 22
Q ss_pred ccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002358 771 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 850 (931)
Q Consensus 771 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~ 850 (931)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ........ . ... +......
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~---~~~i~~~~-~-~~~-~~~~~~~-- 315 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---T---LNNILACR-W-DLE-DEEFQDI-- 315 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHHHHHTC-C-CSC-SGGGTTS--
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhcc-C-CCC-hhhhccC--
Confidence 3458999999999999999999999999999999999999997443211 1 11111111 0 000 1111112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHh
Q 002358 851 ESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQD 883 (931)
Q Consensus 851 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 883 (931)
...+.+++.+||+.+|++||+++|+++ .+++
T Consensus 316 --~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 316 --SEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp --CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred --CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 236789999999999999999999986 4443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.29 Aligned_cols=263 Identities=23% Similarity=0.320 Sum_probs=207.0
Q ss_pred HHhhccccCccCcEEEEEEEE-CCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEE-ecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~-~~~~~~~lV~E~~ 687 (931)
.|++.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+++++.++|++++..+.++ ......++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 456789999999999999997 478999999986543 235688999999999998877776665 5667789999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc---cCCCceEEeccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl---d~~~~vkL~DFGla~~~~~~ 764 (931)
+++|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 -~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 88 -GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999999743 3568999999999999999999998 899999999999999 58899999999999876543
Q ss_pred ccc------cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeee
Q 002358 765 LTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 765 ~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 838 (931)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+.........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 239 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch--
Confidence 321 123456899999999999999999999999999999999999999854433222222222111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 839 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 839 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
+.+...++ ..+.+++.+||+.+|++||+++||++.|+++.....
T Consensus 240 ---~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 240 ---EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ---HHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ---HHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 01111222 368899999999999999999999999999876543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=346.00 Aligned_cols=263 Identities=29% Similarity=0.485 Sum_probs=204.6
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECC-----CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 679 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~-----g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~ 679 (931)
+....+.+.+.||+|+||.||+|.++. +..||||+++.... .....+.+|++++++++||||+++++++...+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 334455667899999999999998753 24699999976433 345679999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
.++||||+++|+|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999999999752 4568999999999999999999998 899999999999999999999999999998
Q ss_pred cccccccc--cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 760 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 760 ~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.. .+..+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~----~~~~~~~ 268 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMK----AINDGFR 268 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH----HHHTTCC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHH----HHHCCCc
Confidence 76443221 1222346788999999998899999999999999999999 99999633221 1211 1222211
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
.. .+......+.+++.+||+.+|++||+++|+++.|+++.....
T Consensus 269 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 269 LP---------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CC---------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CC---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 00 111223468899999999999999999999999998876443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=337.97 Aligned_cols=260 Identities=27% Similarity=0.398 Sum_probs=205.6
Q ss_pred hhccccCccCcEEEEEEEECC-C---cEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE-EEEEE
Q 002358 612 NFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR-ILVYE 685 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~~-g---~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~-~lV~E 685 (931)
+..+.||+|+||.||+|.+.+ + ..||+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++|||
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 345889999999999998643 2 3799999876433 4457899999999999999999999999776655 89999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+.+|+|.+++.. ....+++..+..++.|+++||+|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 104 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 104 YMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp CCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred cccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999975 34668999999999999999999998 899999999999999999999999999998654332
Q ss_pred c---ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 766 T---HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 766 ~---~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
. .......+++.|+|||.+.+..++.++||||||+++|||++|..|+..... .......+. .+....
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~----~~~~~~---- 248 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLA----QGRRLP---- 248 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHH----TTCCCC----
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhh----cCCCCC----
Confidence 1 122334578899999999999999999999999999999996655532221 112222211 111100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 891 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 891 (931)
.+......+.+++.+||+.+|++|||++|+++.|+++.......
T Consensus 249 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 249 -----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred -----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 11112236889999999999999999999999999998766543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=340.83 Aligned_cols=263 Identities=23% Similarity=0.298 Sum_probs=197.3
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
.|++.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 3566789999999999999987 589999999865433 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 84 CDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 999999998873 4568999999999999999999998 8999999999999999999999999999987543322
Q ss_pred ccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH--------HhhhcCCe-
Q 002358 767 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKGDV- 836 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~--------~~~~~~~~- 836 (931)
. .....||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+......... ........
T Consensus 158 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 Y-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred c-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2 223458999999999865 678999999999999999999999997544332221111100 00000000
Q ss_pred --eecccccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 837 --ISIVDPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 837 --~~i~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+.++.-... ........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00001100000 00112335789999999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=349.06 Aligned_cols=260 Identities=21% Similarity=0.289 Sum_probs=201.4
Q ss_pred HHhhccccCcc--CcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 610 TNNFCKKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 610 ~~~~~~~LG~G--~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
.|++.+.||+| +||.||+|+.+ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 46678999999 99999999987 69999999987543 334567888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++|+|.+++... ....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 106 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 106 SFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp ECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999998754 23568999999999999999999998 89999999999999999999999999988654322
Q ss_pred cc------ccccccccCCCccCCCccCC--CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 765 LT------HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 765 ~~------~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..... +..
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~-----~~~ 254 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLN-----GTV 254 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhc-----CCC
Confidence 11 11223368999999999987 67999999999999999999999999744332211 11000 000
Q ss_pred eecccc------------------------------cc------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 837 ISIVDP------------------------------VL------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 837 ~~i~d~------------------------------~l------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
..+.+. .. ...........+.+++.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000 00 000111122368899999999999999999999853
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=341.73 Aligned_cols=262 Identities=23% Similarity=0.313 Sum_probs=204.0
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEe----cCCeEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE----EEHQRIL 682 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~~~~~~l 682 (931)
...|++.+.||+|+||.||+++.. +++.||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 345777899999999999999984 78999999987655566778999999999999999999999986 3457889
Q ss_pred EEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
||||+++|+|.+++.... ....+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999887522 34668999999999999999999998 89999999999999999999999999998764
Q ss_pred cccccc--------cccccccCCCccCCCccCCCC---CCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002358 762 EEDLTH--------ISSVARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 830 (931)
Q Consensus 762 ~~~~~~--------~~~~~~gt~~y~APE~l~~~~---~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 830 (931)
...... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||....... ......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~---- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALA---- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHHH----
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhHH----
Confidence 321111 011234799999999987654 6889999999999999999999996311111 011111
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 831 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 831 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
.... . .. .. .......+.+++.+||+.||++||+++|+++.|+.+..
T Consensus 260 ~~~~-~-~~---~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 VQNQ-L-SI---PQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHCC----C---CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhcc-C-CC---Cc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 1110 0 00 00 11122368899999999999999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=331.18 Aligned_cols=250 Identities=21% Similarity=0.280 Sum_probs=203.2
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
...|++.+.||+|+||.||+|..+ +++.||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 456778899999999999999987 4779999998776555677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc---cCCCceEEecccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl---d~~~~vkL~DFGla~~~~~ 763 (931)
+++++|.+.+.. ...+++..+..++.|+++||+|||+ .+|+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999998874 4568999999999999999999998 899999999999999 7889999999999986543
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
... .....||+.|+|||.+.+. ++.++||||||+++|||++|+.||....... ... .+..+.... . ..
T Consensus 162 ~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~----~~~~~~~~~-~-~~ 229 (277)
T 3f3z_A 162 GKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---VML----KIREGTFTF-P-EK 229 (277)
T ss_dssp TSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCCCC-C-HH
T ss_pred ccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH---HHH----HHHhCCCCC-C-ch
Confidence 322 2334589999999998765 8999999999999999999999997433211 111 111111100 0 00
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... ....+.+++.+||+.+|++||++.|+++
T Consensus 230 ~~~~----~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 DWLN----VSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001 1236789999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=337.54 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=204.6
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch------hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
...|++.+.||+|+||.||+|..+ +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 567888999999999999999987 6899999998654321 346799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC----ceEEeccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 756 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~----~vkL~DFG 756 (931)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999973 4568999999999999999999998 8999999999999999887 79999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 757 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 757 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ... . +.....
T Consensus 165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~-i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA---N-ITSVSY 235 (321)
T ss_dssp TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---H-HHTTCC
T ss_pred cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HHH---H-HHhccc
Confidence 9987654322 233458999999999999999999999999999999999999997433211 111 1 111111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..++...... ...+.+++.+||+.||++|||++|+++
T Consensus 236 --~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 --DFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --ccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0111111111 236789999999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=349.05 Aligned_cols=266 Identities=28% Similarity=0.443 Sum_probs=210.7
Q ss_pred HHHHhhccccCccCcEEEEEEEE-----CCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCC--eE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QR 680 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~--~~ 680 (931)
...+++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 44567789999999999999985 368899999998766666788999999999999999999999987644 67
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999753 3568999999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccc--cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCcc---------chhhHHHHHHH
Q 002358 761 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWARS 829 (931)
Q Consensus 761 ~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~---------~~~~l~~~~~~ 829 (931)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ........+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6543221 122344677899999998888999999999999999999999998622110 00111111222
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 830 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
.+..+... ..+......+.+++.+||+.+|++||+++||++.|+++...
T Consensus 275 ~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 275 LLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhhcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 22221111 11122234688999999999999999999999999988754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=346.79 Aligned_cols=243 Identities=23% Similarity=0.299 Sum_probs=201.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|++.+.||+|+||.||+|+.+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 4566789999999999999987 68999999986532 1234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 122 YVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999974 3568999999999999999999998 89999999999999999999999999999875432
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ...+ .+..+.. .+
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~----~i~~~~~------~~- 257 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYE----KIVSGKV------RF- 257 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------CC-
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HHHH----HHHcCCC------CC-
Confidence 22346899999999999999999999999999999999999999743321 1111 1111211 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 879 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 879 (931)
+......+.+++.+||+.||++||+ ++||++
T Consensus 258 ---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 ---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1112236789999999999999998 777764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=350.79 Aligned_cols=260 Identities=29% Similarity=0.460 Sum_probs=197.4
Q ss_pred HhhccccCccCcEEEEEEEECC--C--cEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEec-CCeEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKD--G--KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVY 684 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~--g--~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~~lV~ 684 (931)
+++.+.||+|+||.||+|.+.+ + ..||+|.++... ....++|.+|+.++++++||||+++++++.. ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 4557899999999999998752 2 368999987543 3456789999999999999999999998754 56789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++|+|.+++.. ....+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 171 e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 171 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp ECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred ECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999974 34568899999999999999999998 89999999999999999999999999999865432
Q ss_pred ccc---cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 765 LTH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 765 ~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||......+ ....+ ..+... .
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~----~~~~~~--~ 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL----LQGRRL--L 316 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH----HTTCCC--C
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH----HcCCCC--C
Confidence 211 1223457789999999999999999999999999999999 677776433222 11111 111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 891 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 891 (931)
. +......+.+++.+||+.+|++||+++|+++.|+++.....+.
T Consensus 317 ~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 317 Q-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 1 1122346889999999999999999999999999988765433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=350.45 Aligned_cols=204 Identities=26% Similarity=0.322 Sum_probs=177.1
Q ss_pred hhhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcC-----CCCCcceeEEEec
Q 002358 603 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----HRNLVPLIGYCEE 676 (931)
Q Consensus 603 ~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-----HpnIv~l~g~~~~ 676 (931)
..++....|++.++||+|+||.||+|++. +++.||||+++.. ....+.+..|+++++.++ ||||+++++++..
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 34455567888999999999999999985 6899999998743 334566788999999996 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC----------
Q 002358 677 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---------- 746 (931)
Q Consensus 677 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---------- 746 (931)
.+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred CCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccch
Confidence 99999999999 99999999854 23458999999999999999999998 89999999999999975
Q ss_pred ---------------CCceEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 002358 747 ---------------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811 (931)
Q Consensus 747 ---------------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~P 811 (931)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred hcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 788999999999864432 2234689999999999999999999999999999999999999
Q ss_pred CCccC
Q 002358 812 VSVED 816 (931)
Q Consensus 812 f~~~~ 816 (931)
|....
T Consensus 259 f~~~~ 263 (360)
T 3llt_A 259 FRTHE 263 (360)
T ss_dssp CCCSS
T ss_pred CCCCc
Confidence 97543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=347.32 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=194.0
Q ss_pred HHhhccccCccCcEEEEEEEECCCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCC--CCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~~~~lV~E 685 (931)
.|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|++++++++| |||+++++++......++|||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 89 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence 356789999999999999999889999999986542 3345778999999999976 999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
+.+|+|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++ ++.+||+|||+++......
T Consensus 90 -~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 90 -CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp -CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred -CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 568899999984 4578999999999999999999998 8999999999999997 6789999999998765433
Q ss_pred cc-cccccccCCCccCCCccCC-----------CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc
Q 002358 766 TH-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 833 (931)
Q Consensus 766 ~~-~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 833 (931)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... . .......+.
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~---~~~~~~~~~- 235 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--Q---ISKLHAIID- 235 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--H---HHHHHHHHC-
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--H---HHHHHHHhc-
Confidence 22 2334569999999999854 6788999999999999999999999963211 1 111111111
Q ss_pred CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 834 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 834 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
+......+......+.+++.+||+.||++|||++|+++.
T Consensus 236 --------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 236 --------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111111121222367899999999999999999999854
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.11 Aligned_cols=262 Identities=24% Similarity=0.427 Sum_probs=210.7
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCC
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 678 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 678 (931)
+....|++.+.||+|+||.||+|.+. .++.||+|++..... .....+.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34456778899999999999999865 367899999975433 34567899999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC-------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceE
Q 002358 679 QRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 751 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vk 751 (931)
..++||||+++|+|.+++.... ....+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEE
Confidence 9999999999999999987421 12457899999999999999999998 8999999999999999999999
Q ss_pred Eecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHH
Q 002358 752 VSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 829 (931)
Q Consensus 752 L~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 829 (931)
|+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~---- 251 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLR---- 251 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHH----
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HHHH----
Confidence 9999999865443221 2223356889999999988889999999999999999999 89998743221 1111
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 830 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
.+..+..... +......+.+++.+||+.+|++||+++|+++.|++...
T Consensus 252 ~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 FVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1222221111 11223468899999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=350.00 Aligned_cols=264 Identities=26% Similarity=0.405 Sum_probs=210.6
Q ss_pred HHHHHhhccccCccCcEEEEEEEECC------CcEEEEEEccCccc-hhhhhHHHHHHHHHhc-CCCCCcceeEEEecCC
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 678 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~------g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~ 678 (931)
....+++.+.||+|+||.||+|.+.. ++.||+|++..... ...+.+.+|+++++++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 34556778999999999999999753 24799999976533 3456799999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC-----------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC
Q 002358 679 QRILVYEYMHNGTLRDRLHGSV-----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 747 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~ 747 (931)
..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCC
Confidence 9999999999999999986421 13457899999999999999999998 899999999999999999
Q ss_pred CceEEecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHH
Q 002358 748 MRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 825 (931)
Q Consensus 748 ~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~ 825 (931)
+.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||....... ....
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~ 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYK 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHH
Confidence 99999999999865443222 2233457889999999988889999999999999999999 999997433221 1111
Q ss_pred HHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 826 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 826 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
.+ ..+... ..+......+.+++.+||+.+|++||+++||++.|+++....
T Consensus 279 ~~----~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 279 LV----KDGYQM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HH----HHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH----hcCCCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 11 111110 011112346889999999999999999999999999877654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=344.78 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=187.3
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
..|++.+.||+|+||.||+|+++ +++.||||+++... ..+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 34667899999999999999987 57899999987542 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC---CCceEEeccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~~~~~ 764 (931)
++|+|.+.+.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 131 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 131 TGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999973 4568999999999999999999998 89999999999999975 889999999999865432
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ..+...... ...+ .
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~----~~i~~~~~~-~~~~-~ 274 (349)
T 2w4o_A 205 V--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMF----RRILNCEYY-FISP-W 274 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHH----HHHHTTCCC-CCTT-T
T ss_pred c--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHH----HHHHhCCCc-cCCc-h
Confidence 2 1233468999999999999999999999999999999999999996332211 111 111111111 1111 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. ......+.+++.+||+.||++|||++|+++
T Consensus 275 ~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 275 W----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp T----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h----hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 122336789999999999999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=347.03 Aligned_cols=247 Identities=25% Similarity=0.334 Sum_probs=200.3
Q ss_pred HHHhhccccCccCcEEEEEEEECC-CcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV 683 (931)
..+++.+.||+|+||.||+|+.+. ++.||||+++... ....+.+.+|..++..+ +||||+++++++.+.+..++|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 446678999999999999999874 7899999987542 23345688899999988 799999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999974 3568999999999999999999998 8999999999999999999999999999986432
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.+. +..+.. .
T Consensus 174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~----i~~~~~------~ 239 (353)
T 2i0e_A 174 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQS----IMEHNV------A 239 (353)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHCCC------C
T ss_pred CCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHHH----HHhCCC------C
Confidence 222 233456999999999999999999999999999999999999999743321 11111 111111 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 879 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 879 (931)
++......+.+++.+||+.+|++||+ ++||++
T Consensus 240 ----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 ----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11122236789999999999999995 466653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=344.16 Aligned_cols=259 Identities=23% Similarity=0.390 Sum_probs=200.5
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCc----EEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
...|++.+.||+|+||.||+|.+. +++ .||+|.+.... ....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 345677899999999999999975 344 35777775432 345578999999999999999999999998765 78
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+|+|++++|+|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999999753 4568999999999999999999998 89999999999999999999999999999876
Q ss_pred cccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 762 EEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 762 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........ ... +..+....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~----~~~~~~~~- 239 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSI----LEKGERLP- 239 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHH----HHTTCCCC-
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHH----HHcCCCCC-
Confidence 433221 2223346789999999999999999999999999999999 9999974433221 111 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
.+......+.+++.+||+.+|++||+++|+++.|+++....
T Consensus 240 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 240 --------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp --------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred --------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 11122336889999999999999999999999999887543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=368.85 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=202.3
Q ss_pred ccCccCcEEEEEEEEC---CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCC
Q 002358 616 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 691 (931)
Q Consensus 616 ~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 691 (931)
.||+|+||.||+|.++ ++..||||+++... ....++|.+|+++|++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 46689999997653 3356789999999999999999999999976 56899999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc--c
Q 002358 692 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI--S 769 (931)
Q Consensus 692 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~--~ 769 (931)
|.+++... ...+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++......... .
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99999743 4568999999999999999999998 899999999999999999999999999998764332211 2
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.+ .+..+.... .
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~----~i~~~~~~~---------~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGKRME---------C 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHH----HHHTTCCCC---------C
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHH----HHHcCCCCC---------C
Confidence 22335689999999998899999999999999999998 99999743322 2222 222222111 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
+...+..+.+++.+||+.+|++||++++|++.|+++.....
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 22233478899999999999999999999999998876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=344.34 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=200.1
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
...|++.+.||+|+||.||+|..+ +|+.||||++.... ....+|++++.++ +||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 456778899999999999999987 68899999986542 2345788888888 79999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC----CceEEecccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQA 761 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~----~~vkL~DFGla~~~ 761 (931)
|+++|+|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||+.++ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999873 4568999999999999999999998 899999999999998433 35999999999876
Q ss_pred cccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+.. .+..+...
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~i~~~~~~---- 241 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----RIGSGKFS---- 241 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH----HHHHCCCC----
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH----HHccCCcc----
Confidence 44322 2234468999999999988889999999999999999999999997433222222222 22222221
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+...........+.+++.+||+.||++||+++|+++
T Consensus 242 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 --LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111122346789999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=343.03 Aligned_cols=256 Identities=25% Similarity=0.295 Sum_probs=197.5
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc-----cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
...|++.+.||+|+||.||+|..+ +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 466778999999999999999886 6889999998643 2334578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCC-------------------------------------CCCCCCHHHHHHHHHHHHHHhHHh
Q 002358 682 LVYEYMHNGTLRDRLHGSV-------------------------------------NQKPLDWLTRLQIAHDAAKGLEYL 724 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~-------------------------------------~~~~l~~~~~~~i~~qia~aL~yL 724 (931)
+||||+++|+|.+++.... ....+++..+..++.|+++||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999985211 011235677888999999999999
Q ss_pred hhcCCCCeEecCCCCCCccccCCC--ceEEeccccccccccccc---ccccccccCCCccCCCccCC--CCCCccchhHH
Q 002358 725 HTGCNPGIIHRDVKSSNILLDINM--RAKVSDFGLSRQAEEDLT---HISSVARGTVGYLDPEYYGN--QQLTEKSDVYS 797 (931)
Q Consensus 725 H~~~~~~ivH~DIkp~NILld~~~--~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS 797 (931)
|+ .+|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.++||||
T Consensus 185 H~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 98 8999999999999998776 899999999986543221 12234568999999999865 67899999999
Q ss_pred HHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 002358 798 FGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 877 (931)
Q Consensus 798 lGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev 877 (931)
||+++|||++|+.||......+ ........... ...+.. ......+.+++.+||+.+|++||++.|+
T Consensus 262 lG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~--~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKLC--FENPNY-----NVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC--TTSGGG-----GGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHCCCCCCCCChHH------HHHHHHhcccc--cCCccc-----ccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9999999999999997433221 11111111110 001110 1122367899999999999999999999
Q ss_pred HH
Q 002358 878 VL 879 (931)
Q Consensus 878 l~ 879 (931)
++
T Consensus 329 l~ 330 (345)
T 3hko_A 329 LQ 330 (345)
T ss_dssp HH
T ss_pred hc
Confidence 76
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=339.46 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=210.0
Q ss_pred HHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhc-CCCCCcceeEEEecCC-
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH- 678 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~- 678 (931)
...|++.+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 456777899999999999999852 468999999976543 3456799999999999 7999999999987654
Q ss_pred eEEEEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 745 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld 745 (931)
..++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+ .+|+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEEC
Confidence 58999999999999999985432 2238899999999999999999998 8999999999999999
Q ss_pred CCCceEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhH
Q 002358 746 INMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 823 (931)
Q Consensus 746 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l 823 (931)
.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |..||....... ..
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~ 260 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF 260 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--HH
Confidence 999999999999987544322 22233457889999999988899999999999999999998 999997433221 11
Q ss_pred HHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 824 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 824 ~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
.. .+..+.... .... ....+.+++.+||+.+|++||+++||++.|++++...
T Consensus 261 ~~----~~~~~~~~~-----~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 261 CR----RLKEGTRMR-----APDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HH----HHHHTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH----HhccCccCC-----CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11 111121111 1111 2236789999999999999999999999999987654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=343.26 Aligned_cols=269 Identities=25% Similarity=0.411 Sum_probs=197.2
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHH--HHhcCCCCCcceeEEEec-----CCeEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL--LSRIHHRNLVPLIGYCEE-----EHQRI 681 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~i--l~~l~HpnIv~l~g~~~~-----~~~~~ 681 (931)
..+++.+.||+|+||.||+|++ +++.||||++... ....+..|.++ +..++||||+++++.+.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 3466789999999999999987 4899999998643 23344455555 445899999999985532 33678
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCC---------CeEecCCCCCCccccCCCceEE
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP---------GIIHRDVKSSNILLDINMRAKV 752 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~---------~ivH~DIkp~NILld~~~~vkL 752 (931)
+||||+++|+|.+++.. ...++..+..++.|+++||+|||+ . +|+||||||+|||++.++.+||
T Consensus 89 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEE
Confidence 99999999999999974 345889999999999999999998 6 9999999999999999999999
Q ss_pred ecccccccccccc-------cccccccccCCCccCCCccCC-------CCCCccchhHHHHHHHHHHHhCCCCCCccCcc
Q 002358 753 SDFGLSRQAEEDL-------THISSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 818 (931)
Q Consensus 753 ~DFGla~~~~~~~-------~~~~~~~~gt~~y~APE~l~~-------~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~ 818 (931)
+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 9999998754321 111223458999999999977 45677999999999999999997776422221
Q ss_pred ch-hhH----------HHHHHHhhhcCCeeecccccccCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 819 AE-LNI----------VHWARSMIKKGDVISIVDPVLIGN--VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 819 ~~-~~l----------~~~~~~~~~~~~~~~i~d~~l~~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
.. ... ............. .+.+... ........+.+++.+||+.||++|||++|+++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 11 000 0011111111111 1111111 12235567999999999999999999999999999998
Q ss_pred hhhcCCC
Q 002358 886 KIEKGGD 892 (931)
Q Consensus 886 ~~~~~~~ 892 (931)
.......
T Consensus 318 ~~~~~~~ 324 (336)
T 3g2f_A 318 MIWERNK 324 (336)
T ss_dssp HCCCC--
T ss_pred HHHHhcc
Confidence 7665443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=332.06 Aligned_cols=247 Identities=27% Similarity=0.424 Sum_probs=180.9
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|++.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 4667889999999999999975 789999999864322 223678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++++|.+++... ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 92 MCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp CCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred cCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 99999999999742 3568999999999999999999998 899999999999999999999999999998654322
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..... . +...
T Consensus 167 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~------~~~~- 231 (278)
T 3cok_A 167 EK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NKVVL-A------DYEM- 231 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS-S------CCCC-
T ss_pred Cc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HHHhh-c------ccCC-
Confidence 21 22345899999999999989999999999999999999999999744322110 00000 0 0111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.||++||+++|+++
T Consensus 232 ---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 ---PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1122336789999999999999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=346.36 Aligned_cols=252 Identities=24% Similarity=0.297 Sum_probs=192.0
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
..|++.+.||+|+||.||+++.+ +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 35677899999999999999987 78999999987543 23356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc--eEEecccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQAEEDL 765 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~--vkL~DFGla~~~~~~~ 765 (931)
++|+|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++. +||+|||+++......
T Consensus 99 ~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 99 SGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999873 4568999999999999999999998 89999999999999987765 9999999987532221
Q ss_pred cccccccccCCCccCCCccCCCCCCcc-chhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEK-SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~k-sDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||......... ......... ... ...+
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~-~~~-~~~~--- 243 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILS-VKY-SIPD--- 243 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHT-TCC-CCCT---
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhc-CCC-CCCC---
Confidence 1233458999999999988777665 89999999999999999999744332211 111111111 111 0000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.......+.+++.+||+.+|++|||++|+++.
T Consensus 244 ----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 ----DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00112367899999999999999999999853
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=332.83 Aligned_cols=245 Identities=26% Similarity=0.412 Sum_probs=198.1
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 4567899999999999999877 577999999865321 224578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 90 YAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999874 3568999999999999999999998 899999999999999999999999999986543322
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .. .+.....
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~----~~~~~~~--------- 224 (279)
T 3fdn_A 164 ---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YK----RISRVEF--------- 224 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH----HHHHTCC---------
T ss_pred ---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---HH----HHHhCCC---------
Confidence 2234589999999999999999999999999999999999999974332211 11 1111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
..+......+.+++.+||+.+|++||+++|+++.
T Consensus 225 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111122367899999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=343.96 Aligned_cols=265 Identities=16% Similarity=0.196 Sum_probs=207.0
Q ss_pred HHHhhccccCccCcEEEEEEEECC---------CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcc----------
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKD---------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP---------- 669 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~---------g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~---------- 669 (931)
..|++.+.||+|+||.||+|+... ++.||+|++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 356678999999999999999874 789999998643 46889999999999999887
Q ss_pred -----eeEEEec-CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcc
Q 002358 670 -----LIGYCEE-EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 743 (931)
Q Consensus 670 -----l~g~~~~-~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIL 743 (931)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||++||+|||+ .+|+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence 6777765 67889999999 99999999853 23579999999999999999999998 89999999999999
Q ss_pred ccCCC--ceEEecccccccccccccc------cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 002358 744 LDINM--RAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 815 (931)
Q Consensus 744 ld~~~--~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~ 815 (931)
++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999876543221 113346899999999999999999999999999999999999999744
Q ss_pred CccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 816 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 816 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
... ...+......... ....+.+..... ......+.+++.+||+.||++||+++||++.|+++.....
T Consensus 272 ~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 272 LPN-TEDIMKQKQKFVD--KPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TTC-HHHHHHHHHHHHH--SCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CcC-HHHHHHHHHhccC--Chhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 322 1222222221111 111121111100 0112368899999999999999999999999999876654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=339.91 Aligned_cols=264 Identities=26% Similarity=0.424 Sum_probs=199.8
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC----CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC-
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH- 678 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~- 678 (931)
+....|.+.+.||+|+||.||+|.+. .++.||+|+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34456677899999999999999865 24589999987542 334567999999999999999999999997754
Q ss_pred ----eEEEEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceE
Q 002358 679 ----QRILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 751 (931)
Q Consensus 679 ----~~~lV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vk 751 (931)
..++||||+++|+|.+++.... ....+++..++.++.|+++||.|||+ .+|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEE
Confidence 3499999999999999985322 34568999999999999999999998 8999999999999999999999
Q ss_pred Eeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHH
Q 002358 752 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 829 (931)
Q Consensus 752 L~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 829 (931)
|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ....+
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~-- 262 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDYL-- 262 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH--
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHH--
Confidence 999999987543322 12233457889999999999999999999999999999999 889987433221 11111
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 830 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
..+.... . +......+.+++.+||+.+|++||+++|+++.|+++....
T Consensus 263 --~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 --LHGHRLK-----Q----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp --HTTCCCC-----C----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --HcCCCCC-----C----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111111 1 1122246889999999999999999999999999987644
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=340.80 Aligned_cols=260 Identities=24% Similarity=0.369 Sum_probs=196.0
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe----E
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ----R 680 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~----~ 680 (931)
..|++.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|++++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 45677899999999999999974 789999999976432 234578999999999999999999999876543 4
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+++|+|.+++.. ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred EEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 999999999999999974 3568999999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccc--cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeee
Q 002358 761 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 761 ~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 838 (931)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .............
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~ 239 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIPP 239 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCCH
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCCc
Confidence 5443221 2233458999999999999999999999999999999999999997433211 1111122111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHH-HHHHHHhhhhh
Q 002358 839 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQE-IVLAIQDSIKI 887 (931)
Q Consensus 839 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e-vl~~L~~~~~~ 887 (931)
..... .....+.+++.+||+.||++||+..+ +.+.+.+....
T Consensus 240 ---~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 240 ---SARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ---HHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ---ccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 00011 12236889999999999999996555 45556555443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=345.61 Aligned_cols=265 Identities=30% Similarity=0.497 Sum_probs=208.6
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEEC-CCcE--EEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCC
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKE--VAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 678 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~--vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~ 678 (931)
+.+....+++.+.||+|+||.||+|++. +++. +|+|.++... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 3444456778899999999999999876 4554 4999887532 33456799999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 745 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld 745 (931)
..++||||+++|+|.+++.... ....+++..++.++.|+++||+|||+ .+|+||||||+|||++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEc
Confidence 9999999999999999997532 23478999999999999999999998 8999999999999999
Q ss_pred CCCceEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHH
Q 002358 746 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 824 (931)
Q Consensus 746 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~ 824 (931)
.++.+||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~ 251 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY 251 (327)
T ss_dssp GGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH
T ss_pred CCCeEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHH
Confidence 99999999999987533221 1223346889999999988889999999999999999998 99999743321 111
Q ss_pred HHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 825 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 825 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
..+..+.. .. .+......+.+++.+||+.+|++||+++|+++.|+++.....
T Consensus 252 ----~~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 252 ----EKLPQGYR-----LE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp ----HHGGGTCC-----CC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ----HHhhcCCC-----CC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11221111 01 111223468899999999999999999999999999887553
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=335.24 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=204.9
Q ss_pred HHHhhcc-ccCccCcEEEEEEEEC---CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 609 ATNNFCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 609 ~~~~~~~-~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
..+.+.+ .||+|+||.||+|.+. .++.||||+++.... ...+++.+|++++++++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 3455556 8999999999999653 468899999875432 2357799999999999999999999999 5667899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||||+++++|.+++.. ...+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999984 3568999999999999999999998 899999999999999999999999999998764
Q ss_pred cccccc--ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 763 EDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 763 ~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
...... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .+..+....
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~~~- 240 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA----MLEKGERMG- 240 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCCCC-
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCCCC-
Confidence 433221 222346788999999988889999999999999999999 99999743321 1222 222222111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
.+......+.+++.+||+.||++||+++|+++.|+++.....
T Consensus 241 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 241 --------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 112223468899999999999999999999999999876654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=327.39 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=203.2
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
..|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 56778899999999999999987 68999999986433 33457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+++. ....+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999987 34578999999999999999999998 8999999999999999999999999999976543221
Q ss_pred -ccccccccCCCccCCCccCCCCC-CccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 767 -HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 767 -~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ......|... ... .. .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~----~~~---~~--~ 230 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKEK----KTY---LN--P 230 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT-SHHHHHHHTT----CTT---ST--T
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHhhhc----ccc---cC--c
Confidence 12234568999999999987765 77999999999999999999999743322 1222222211 000 00 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.......+.+++.+||+.+|++|||++|+++
T Consensus 231 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 ----WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0112236789999999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=360.15 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=193.0
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc---cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
..|++.+.||+|+||.||+|... +|+.||||+++.. .......+.+|++++++++||||+++++++...+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 34677899999999999999876 6899999998753 2234466888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++|+|.+++.. ...+++..+..++.||++||+|||+ ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus 228 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 228 EYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred eeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999874 4568999999999999999999995 278999999999999999999999999999864333
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+... +..+.. .+
T Consensus 303 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~----i~~~~~------~~ 368 (446)
T 4ejn_A 303 GAT-MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL----ILMEEI------RF 368 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHCCC------CC
T ss_pred Ccc-cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHH----HHhCCC------CC
Confidence 222 23456999999999999999999999999999999999999999743322 11111 111111 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
... ....+.+++.+||+.||++|| +++|+++
T Consensus 369 p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 PRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred Ccc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 111 223678999999999999999 9999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=349.99 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=194.8
Q ss_pred HHhhccccCccCcEEEEEEEECCCcEEEEEEccCcc--chhhhhHHHHHHHHHhcC--CCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+++|++++ ||||+++++++...+..++|||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 367789999999999999998889999999986532 334578999999999996 5999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
+.+++|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++ ++.+||+|||+++......
T Consensus 137 -~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 137 -CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp -CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred -cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 668999999984 3478888999999999999999998 8999999999999995 5889999999998765433
Q ss_pred cc-cccccccCCCccCCCccCC-----------CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc
Q 002358 766 TH-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 833 (931)
Q Consensus 766 ~~-~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 833 (931)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... . ...+...+..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~---~~~~~~~~~~ 283 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--Q---ISKLHAIIDP 283 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--H---HHHHHHHHCT
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--H---HHHHHHHhCc
Confidence 22 2334569999999999864 4688999999999999999999999963211 1 1111111211
Q ss_pred CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 834 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 834 ~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
. .....+......+.+++.+||+.||++||+++|+++.
T Consensus 284 ~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 284 N---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp T---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred c---------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1 1111111112367899999999999999999999853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=332.89 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=201.6
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
...|.+.+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467788999999999999999986 6899999999865544556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc---cCCCceEEecccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl---d~~~~vkL~DFGla~~~~~ 763 (931)
+++++|.+.+.. ...+++..+..++.|++.||+|||+ .+++||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999998864 3468899999999999999999998 899999999999999 7889999999999876433
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .+.. .+..+... . ...
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~----~i~~~~~~-~-~~~ 229 (304)
T 2jam_A 162 GI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFE----KIKEGYYE-F-ESP 229 (304)
T ss_dssp BT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH----HHHHCCCC-C-CTT
T ss_pred Cc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHcCCCC-C-Ccc
Confidence 21 22345899999999999999999999999999999999999999743221 1111 12122110 0 111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. ......+.+++.+||+.||++||+++|+++
T Consensus 230 ~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 FW----DDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TT----TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 122346889999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=330.66 Aligned_cols=252 Identities=24% Similarity=0.384 Sum_probs=197.0
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
...|.+.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 356788999999999999999986 68899999986543 2345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc---cCCCceEEecccccccc
Q 002358 686 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQA 761 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl---d~~~~vkL~DFGla~~~ 761 (931)
|+++|+|.+.+.... ....+++..+..++.|+++||+|||+ .+|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999885421 24568999999999999999999998 899999999999999 45678999999999865
Q ss_pred cccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
..... .....||+.|+|||.+. ..++.++||||||+++|||++|+.||....... ..... ......... .
T Consensus 178 ~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~~~~~---~~~~~~~~~-~ 247 (285)
T 3is5_A 178 KSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---VQQKA---TYKEPNYAV-E 247 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHCCCCCCC--
T ss_pred CCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---HHhhh---ccCCccccc-c
Confidence 44322 23345899999999986 468899999999999999999999997443221 11111 111100000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... ...+.+++.+||+.||++|||++|+++
T Consensus 248 ---~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 ---CRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---cCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011 236779999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=340.59 Aligned_cols=246 Identities=29% Similarity=0.413 Sum_probs=198.6
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
...++..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 355677889999999999999874 78999999986532 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+. |+|.+.+.. ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 688887753 24568999999999999999999998 8999999999999999999999999999976543
Q ss_pred cccccccccccCCCccCCCccC---CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 764 DLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.||...... .......... .....
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~-~~~~~ 274 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE-SPALQ 274 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-CCCCC
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcC-CCCCC
Confidence 2 2346899999999983 567899999999999999999999999633221 1111122211 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
... ....+.+++.+||+.+|++|||++|+++
T Consensus 275 ----~~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 275 ----SGH----WSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ----CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCC----CCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111 2236789999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=328.49 Aligned_cols=257 Identities=25% Similarity=0.313 Sum_probs=204.0
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch------hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
...|++.+.||+|+||.||+|... +++.||+|+++..... ..+.+.+|++++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 456788999999999999999987 6899999998654221 356799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC----ceEEeccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 756 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~----~vkL~DFG 756 (931)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999974 4568999999999999999999998 8999999999999998877 79999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 757 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 757 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
++........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ... .+.....
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~----~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLT----NISAVNY 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH----HHHTTCC
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHH----HhHhccc
Confidence 9986543322 223458999999999999999999999999999999999999997433211 111 1111111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhh
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDSI 885 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~~~ 885 (931)
. .++..... ....+.+++.+||+.+|++||+++|+++ .++++.
T Consensus 229 ~--~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 229 D--FDEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp C--CCHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred C--Ccchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0 01111111 1236789999999999999999999986 455543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=340.89 Aligned_cols=242 Identities=23% Similarity=0.323 Sum_probs=200.1
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--------hhhhhHHHHHHHHHhcCCCCCcceeEEEecCC
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 678 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 678 (931)
...|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 456778899999999999999875 688999999875421 13456788999999999999999999999999
Q ss_pred eEEEEEEecCCC-CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccc
Q 002358 679 QRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 757 (931)
Q Consensus 679 ~~~lV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGl 757 (931)
..++||||+.+| +|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999777 99999973 4569999999999999999999998 8999999999999999999999999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCC-CccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 758 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 758 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ... ..
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~~-~~- 240 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------TVE-AA- 240 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------GTT-TC-
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------HHh-hc-
Confidence 987654322 223458999999999988776 7899999999999999999999963111 000 00
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
..+ +......+.+++.+||+.+|++|||++|+++.
T Consensus 241 ---~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 ---IHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---CCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---cCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 11112367899999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=336.91 Aligned_cols=253 Identities=30% Similarity=0.471 Sum_probs=198.8
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecC-CeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-HQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~~lV~E~~ 687 (931)
..+++.+.||+|+||.||+|+++ |+.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||||+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 45677899999999999999986 8999999987543 456789999999999999999999987554 4789999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++|+|.+++... ....+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 98 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 999999998742 12237888999999999999999998 899999999999999999999999999987654322
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... .+..+.. ...
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~----~~~~~~~-----~~~-- 235 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKGYK-----MDA-- 235 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH----HHTTTCC-----CCC--
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhcCCC-----CCC--
Confidence 22347889999999988899999999999999999998 999997433221 111 1111111 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
+......+.+++.+||+.+|++||+++|+++.|+++...+
T Consensus 236 --~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 236 --PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 1122346889999999999999999999999999986544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=330.11 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=196.6
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
...||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 358999999999999975 6889999999776555667899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC-CCceEEecccccccccccccccccc
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSV 771 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~ 771 (931)
.+++........+++..+..++.|+++||+|||+ .+++||||||+||+++. ++.+||+|||++........ ....
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 182 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTET 182 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cccc
Confidence 9999865445567788999999999999999998 89999999999999987 89999999999986543222 1233
Q ss_pred cccCCCccCCCccCCC--CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 772 ARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 772 ~~gt~~y~APE~l~~~--~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
..|++.|+|||.+.+. .++.++||||||+++|||++|+.||........ .... .... . ..+.+ +
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~---~~~~-~-----~~~~~----~ 248 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFK---VGMF-K-----VHPEI----P 248 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHHH---HHHH-C-----CCCCC----C
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHHh---hccc-c-----ccccc----c
Confidence 4589999999998664 378999999999999999999999963222111 1111 0000 0 01111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......+.+++.+||+.+|++||+++|+++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 122336789999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=369.79 Aligned_cols=249 Identities=27% Similarity=0.467 Sum_probs=199.4
Q ss_pred cccCccCcEEEEEEEEC---CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.||+|+||.||+|.+. .++.||||+++.... ...+++.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999764 467899999976432 335789999999999999999999999965 458899999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc--c
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT--H 767 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~--~ 767 (931)
|+|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999974 4568999999999999999999998 8999999999999999999999999999987644322 1
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+. ..+..+....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~----~~i~~~~~~~-------- 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVT----AMLEKGERMG-------- 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTCCCC--------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCCC--------
Confidence 2223346789999999999999999999999999999998 99999743321 111 2222222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
.+......+.+++.+||+.||++||++++|++.|+++..
T Consensus 593 -~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 -CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122233478899999999999999999999999998654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=334.76 Aligned_cols=257 Identities=24% Similarity=0.340 Sum_probs=195.5
Q ss_pred Hhh-ccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEec
Q 002358 611 NNF-CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 611 ~~~-~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
|++ .+.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence 444 368999999999999865 6899999999766555567899999999985 7999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc---eEEeccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEED 764 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~---vkL~DFGla~~~~~~ 764 (931)
++|+|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++. +||+|||++......
T Consensus 94 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 94 RGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred CCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999974 3568999999999999999999998 89999999999999988776 999999998765322
Q ss_pred cc------ccccccccCCCccCCCccCC-----CCCCccchhHHHHHHHHHHHhCCCCCCccCccch--------hhHHH
Q 002358 765 LT------HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--------LNIVH 825 (931)
Q Consensus 765 ~~------~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~--------~~l~~ 825 (931)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+. .....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11123458999999999865 5688999999999999999999999974432210 00001
Q ss_pred HHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 826 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 826 ~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+...+..+... ...+ .... ....+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~i~~~~~~-~~~~-~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 248 MLFESIQEGKYE-FPDK-DWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHCCCC-CCHH-HHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhccCcc-cCch-hccc----CCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111122222110 0000 0011 1236889999999999999999999976
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=354.91 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=202.1
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|.+.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4667899999999999999987 799999999865321 234578999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 97 YVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp CCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999973 4569999999999999999999998 899999999999999999999999999998764432
Q ss_pred cccccccccCCCccCCCccCCCCC-CccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... .+.. .+..+... .
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~----~i~~~~~~------~ 235 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFK----KICDGIFY------T 235 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHH----HHHTTCCC------C
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHH----HHhcCCcC------C
Confidence 2234569999999999988765 68999999999999999999999743322 1111 12222110 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.||++|||++|+++
T Consensus 236 ----p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 ----PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1111236789999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.16 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=201.9
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 4566799999999999999987 57899999986542 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 96 LCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp CCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999998873 3568999999999999999999998 899999999999999999999999999998754322
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .. . .+..+.. .+.
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~---~-~~~~~~~------~~~ 235 (294)
T 2rku_A 170 ER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TY---L-RIKKNEY------SIP 235 (294)
T ss_dssp CC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---H-HHHTTCC------CCC
T ss_pred cc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---H-HHhhccC------CCc
Confidence 22 233458999999999999999999999999999999999999997433211 11 1 1111111 011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. ....+.+++.+||+.+|++||+++|+++
T Consensus 236 ~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 236 KH----INPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp TT----SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cc----cCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11 2236789999999999999999999886
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=344.85 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=201.9
Q ss_pred HHHhhccccCccCcEEEEEEEE----CCCcEEEEEEccCcc----chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCe
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 679 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~ 679 (931)
..|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4567789999999999999998 368999999987532 22345678899999999 69999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
.++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999974 3468999999999999999999998 899999999999999999999999999998
Q ss_pred cccccccccccccccCCCccCCCccCC--CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .......... .
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~-~-- 282 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS-E-- 282 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC-C--
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhcc-C--
Confidence 765444433444569999999999975 45789999999999999999999999744332211 1111111111 0
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 880 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~~ 880 (931)
+. .+......+.+++.+||+.||++|| +++|+++.
T Consensus 283 ----~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 ----PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ----CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----CC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11 1122234678999999999999999 89998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=348.64 Aligned_cols=249 Identities=26% Similarity=0.356 Sum_probs=192.6
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHH-HHhcCCCCCcceeEEEecCCeEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVAL-LSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~i-l~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
..+++.+.||+|+||.||+|+.+ +++.||||+++.... ...+.+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 45678899999999999999987 588999999975432 234556777776 5678999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999874 3568899999999999999999998 8999999999999999999999999999986432
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ...+ .... +.. .
T Consensus 192 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~-~~~------~ 257 (373)
T 2r5t_A 192 HNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYD---NILN-KPL------Q 257 (373)
T ss_dssp CCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HHHH---HHHH-SCC------C
T ss_pred CCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHH---HHHh-ccc------C
Confidence 222 233456999999999999999999999999999999999999999743321 1111 1111 111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 881 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 881 (931)
+... ....+.+++.+||+.||++||++.+.++.+
T Consensus 258 ~~~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 258 LKPN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp CCSS----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred CCCC----CCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 1111 223678999999999999999986444333
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=342.21 Aligned_cols=267 Identities=27% Similarity=0.455 Sum_probs=208.3
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEec
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 676 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 676 (931)
.++....|++.+.||+|+||.||+|++. +++.||||++.... .....++.+|+.++++++||||+++++++..
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 3455567788999999999999999842 47789999997543 3455679999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC---CCc
Q 002358 677 EHQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMR 749 (931)
Q Consensus 677 ~~~~~lV~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---~~~ 749 (931)
....++||||+++|+|.+++.... ....+++..++.++.|+++||.|||+ .+|+||||||+|||++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcce
Confidence 999999999999999999998643 12458899999999999999999998 89999999999999984 446
Q ss_pred eEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHH
Q 002358 750 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 827 (931)
Q Consensus 750 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 827 (931)
+||+|||+++....... .......|++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....+.
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~- 257 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEF- 257 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHH-
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHHH-
Confidence 99999999876433221 22233457889999999988889999999999999999998 9999974322 122222
Q ss_pred HHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 828 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 828 ~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
+..+.... . +......+.+++.+||+.+|++||+++||++.|+.+.....
T Consensus 258 ---~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 258 ---VTSGGRMD-----P----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp ---HHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ---HhcCCCCC-----C----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 11121111 1 11222368899999999999999999999999998775443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=341.65 Aligned_cols=263 Identities=23% Similarity=0.336 Sum_probs=197.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
.|++.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 4667899999999999999987 489999999865432 2346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+++++|.+++. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 106 ~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 106 VDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp CSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999998876 34568999999999999999999998 8999999999999999999999999999986544322
Q ss_pred ccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhh-HHHHH-------HHhhhcCC-e
Q 002358 767 HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWA-------RSMIKKGD-V 836 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~-l~~~~-------~~~~~~~~-~ 836 (931)
. .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.......... ..... ........ .
T Consensus 180 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 V-YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred c-cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 2 2334589999999998775 78999999999999999999999997443321111 10000 00000000 0
Q ss_pred eecccccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 837 ISIVDPVLIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 837 ~~i~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.....+.+.... .......+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000001111111 1122346889999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.09 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=201.1
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
.|++.+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 4567899999999999999986 58999999986542 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc---eEEecccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEE 763 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~---vkL~DFGla~~~~~ 763 (931)
+++|+|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++.....
T Consensus 87 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 87 VTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999988874 3568999999999999999999998 89999999999999986655 99999999976544
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..... +..+... ...+
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~----~~~~~~~-~~~~- 229 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQ----IKAGAYD-YPSP- 229 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHTCCC-CCTT-
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHH----HHhcccc-CCch-
Confidence 322 22346899999999999999999999999999999999999999743321 11111 1111110 0011
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..... ...+.+++.+||+.+|++|||++|+++
T Consensus 230 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 230 EWDTV----TPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhccc----CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00112 236789999999999999999999976
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=345.44 Aligned_cols=267 Identities=22% Similarity=0.302 Sum_probs=203.2
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
++....|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 334456777889999999999999987 68999999987653 3345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||||+++|+|.+++.. ...+++..+..++.|+++||+|||+ ..+|+||||||+|||++.++.+||+|||++....
T Consensus 109 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999999974 3468899999999999999999997 1389999999999999999999999999987653
Q ss_pred ccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH--------------
Q 002358 763 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR-------------- 828 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~-------------- 828 (931)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+............
T Consensus 184 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 184 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HHC-------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ccc---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 321 223468999999999999999999999999999999999999997433221110000000
Q ss_pred ---------HhhhcCCeeecccc----cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 829 ---------SMIKKGDVISIVDP----VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 829 ---------~~~~~~~~~~i~d~----~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.........+.++. .............+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000000000 0000000112336889999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=340.02 Aligned_cols=259 Identities=21% Similarity=0.311 Sum_probs=193.3
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 566789999999999999987 6899999998654322 22356689999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
|+|.+.+... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 84 -~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~- 156 (324)
T 3mtl_A 84 -KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 156 (324)
T ss_dssp -EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred -cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc-
Confidence 5898888753 4568999999999999999999998 89999999999999999999999999999765433222
Q ss_pred ccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc---CCeeecccc--
Q 002358 769 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISIVDP-- 842 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~~i~d~-- 842 (931)
.....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ...+.+.... .........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhhhcchh
Confidence 223458999999999876 5789999999999999999999999975443222 2222221111 001000000
Q ss_pred -------cccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 843 -------VLIGN----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 843 -------~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..... ........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000 00112236789999999999999999999976
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=341.11 Aligned_cols=260 Identities=18% Similarity=0.256 Sum_probs=191.1
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch--hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
..|++.+.||+|+||.||+|... +++.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 35777899999999999999876 6899999999754322 34567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc-----CCCceEEeccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-----INMRAKVSDFGLSRQ 760 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld-----~~~~vkL~DFGla~~ 760 (931)
|++ |+|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++ .++.+||+|||+++.
T Consensus 114 ~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 114 YAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp CCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred cCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 997 599999874 3468999999999999999999998 8999999999999994 455699999999986
Q ss_pred ccccccccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc---CCe
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDV 836 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~ 836 (931)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +.. +...... ...
T Consensus 187 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 187 FGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFK-IFEVLGLPDDTTW 262 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCTTTS
T ss_pred cCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHH-HHHHhCCCchhhh
Confidence 5433222 2334579999999998774 589999999999999999999999974332211 111 1111100 000
Q ss_pred eecc--------cccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 837 ISIV--------DPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 837 ~~i~--------d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... .+..... ........+.+++.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 0000000 00012246789999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=328.20 Aligned_cols=245 Identities=29% Similarity=0.431 Sum_probs=195.0
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEec----CCeEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILV 683 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~~~lV 683 (931)
+++.+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 445678999999999999886 57899999986532 3445779999999999999999999998865 4568999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCC--eEecCCCCCCcccc-CCCceEEeccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQ 760 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--ivH~DIkp~NILld-~~~~vkL~DFGla~~ 760 (931)
|||+++|+|.+++.. ...+++..+..++.|+++||+|||+ .+ |+||||||+|||++ .++.+||+|||++..
T Consensus 108 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999974 3568899999999999999999998 67 99999999999997 789999999999975
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
..... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...... ..... .+..+......
T Consensus 182 ~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~----~~~~~~~~~~~ 251 (290)
T 1t4h_A 182 KRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYR----RVTSGVKPASF 251 (290)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHH----HHTTTCCCGGG
T ss_pred ccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHH----HHhccCCcccc
Confidence 43322 223458999999998874 5899999999999999999999999732221 11111 11112111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+. .. ...+.+++.+||+.+|++|||++|+++
T Consensus 252 ~~----~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 DK----VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG----CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC----CC----CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 11 136889999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=347.92 Aligned_cols=203 Identities=31% Similarity=0.457 Sum_probs=163.2
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc--cchhhhhHHHHHHHHHhcC-CCCCcceeEEEecC--Ce
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQ 679 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~--~~ 679 (931)
.....|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+++++. ||||+++++++... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34456778899999999999999876 6899999998653 2345567889999999997 99999999999754 37
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
.++|||||+ |+|.+.+.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999997 689998874 468899999999999999999998 899999999999999999999999999998
Q ss_pred cccccc--------------------cccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccC
Q 002358 760 QAEEDL--------------------THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVED 816 (931)
Q Consensus 760 ~~~~~~--------------------~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~ 816 (931)
...... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 653210 111233469999999999876 678999999999999999999999997544
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=348.54 Aligned_cols=262 Identities=21% Similarity=0.292 Sum_probs=207.9
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCC-CCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.|++.++||+|+||.||+|++. +++.||||++.... ..+++.+|+++++.++| +++..+..++......++||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 4667899999999999999975 68999999876433 23468899999999986 55666666677788899999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc---cCCCceEEeccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl---d~~~~vkL~DFGla~~~~~~ 764 (931)
+++|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||| +.++.+||+|||+++.....
T Consensus 86 -g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 -GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999999743 4569999999999999999999998 899999999999999 68899999999999876543
Q ss_pred ccc------cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeee
Q 002358 765 LTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 765 ~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 838 (931)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 321 12245699999999999999999999999999999999999999985544333333332222211111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 839 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 839 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
+ ...+ ..++.+++.+||+.+|++||++++|++.|+++....
T Consensus 240 l-----~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 240 L-----CRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp H-----HTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H-----hcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 1 1122 236889999999999999999999999999886543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.08 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=201.2
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
..|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 35677899999999999999987 578899999864321 22467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++|+|.+.+.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999874 3468999999999999999999998 89999999999999999999999999998754432
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .. . .+..... ..
T Consensus 168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~-~~~~~~~------~~ 231 (284)
T 2vgo_A 168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---TH---R-RIVNVDL------KF 231 (284)
T ss_dssp C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---H-HHHTTCC------CC
T ss_pred c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HH---H-HHhcccc------CC
Confidence 1 233468999999999999999999999999999999999999997433211 11 1 1111111 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.+|++||+++|+++
T Consensus 232 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 232 ----PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1122346789999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=339.90 Aligned_cols=254 Identities=16% Similarity=0.167 Sum_probs=204.5
Q ss_pred HHHHhhccccCccCcEEEEEEE------ECCCcEEEEEEccCccchhhhhHHHHHHHHHhcC---CCCCcceeEEEecCC
Q 002358 608 EATNNFCKKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEH 678 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~------~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~ 678 (931)
...|.+.+.||+|+||.||+|. ...++.||||+++.. ...++.+|++++++++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3456678899999999999994 346899999999754 3456778888888886 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC----------
Q 002358 679 QRILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---------- 746 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---------- 746 (931)
..++||||+++|+|.+++.... ....+++..++.++.||++||+|||+ .+|+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccc
Confidence 9999999999999999997422 34679999999999999999999998 89999999999999998
Q ss_pred -CCceEEeccccccccccc-ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHH
Q 002358 747 -NMRAKVSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 824 (931)
Q Consensus 747 -~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~ 824 (931)
++.+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 899999999999764321 1222344569999999999999999999999999999999999999996322110
Q ss_pred HHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHhhhhhh
Q 002358 825 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR-PKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 825 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R-Ps~~evl~~L~~~~~~~ 888 (931)
. .+...+.... ....+.+++.+|++.+|.+| |+++++.+.|++.....
T Consensus 293 ------------~-~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 ------------C-KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ------------E-EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------e-eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0 0111111111 13356789999999999998 58999999999887654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=334.97 Aligned_cols=260 Identities=21% Similarity=0.257 Sum_probs=203.4
Q ss_pred cChhhHHHHHHhhc-cccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcC-CCCCcceeEEEe
Q 002358 601 IPLPELEEATNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIH-HRNLVPLIGYCE 675 (931)
Q Consensus 601 ~~~~~l~~~~~~~~-~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~-HpnIv~l~g~~~ 675 (931)
+...+.....|.+. +.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++ ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33445556666665 88999999999999887 689999999875432 23567899999999995 699999999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC---CCceEE
Q 002358 676 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKV 752 (931)
Q Consensus 676 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---~~~vkL 752 (931)
+....++||||+++|+|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999998643 34678999999999999999999998 89999999999999987 789999
Q ss_pred ecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh
Q 002358 753 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 832 (931)
Q Consensus 753 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 832 (931)
+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+.... ...+..
T Consensus 176 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~--- 247 (327)
T 3lm5_A 176 VDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---YLNISQ--- 247 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH---
T ss_pred eeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHHh---
Confidence 99999987643322 2234689999999999999999999999999999999999999974332211 111111
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 833 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 833 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
... .............+.+++.+||+.+|++|||++|+++
T Consensus 248 -~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 248 -VNV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -TCC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -ccc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 110 0000111122346789999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.02 Aligned_cols=246 Identities=21% Similarity=0.302 Sum_probs=198.2
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~l 682 (931)
....|++.+.||+|+||.||+|... +++.||+|++.... .....++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3466778899999999999999987 79999999987532 33456788999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC--------------
Q 002358 683 VYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-------------- 747 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~-------------- 747 (931)
||||+++|+|.+++.... ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999987432 12568999999999999999999998 899999999999999844
Q ss_pred -----CceEEecccccccccccccccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchh
Q 002358 748 -----MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 821 (931)
Q Consensus 748 -----~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~ 821 (931)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|..|+....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 479999999998754432 23489999999998765 66689999999999999999998764221
Q ss_pred hHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 822 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 822 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. . .+..+.... +.... ...+.+++.+||+.||++||+++|+++
T Consensus 236 ~~-~----~~~~~~~~~-----~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 QW-H----EIRQGRLPR-----IPQVL----SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HH-H----HHHTTCCCC-----CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-H----HHHcCCCCC-----CCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11 1 112222211 11122 236889999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=330.92 Aligned_cols=247 Identities=29% Similarity=0.437 Sum_probs=203.6
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 3566889999999999999875 68999999986543 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 103 ~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 103 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp TTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 99999999863 468999999999999999999998 89999999999999999999999999999876443222
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... +..+.. +.+...
T Consensus 176 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~----~~~~~~-----~~~~~~ 242 (303)
T 3a7i_A 176 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFL----IPKNNP-----PTLEGN 242 (303)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH----HHHSCC-----CCCCSS
T ss_pred -cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHH----hhcCCC-----CCCccc
Confidence 23346899999999999999999999999999999999999999733221 11111 111111 111222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
++ ..+.+++.+||+.+|++||+++|+++.
T Consensus 243 ~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 243 YS----KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 22 368899999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=350.81 Aligned_cols=259 Identities=22% Similarity=0.284 Sum_probs=192.5
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEecC------CeE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 680 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~~ 680 (931)
.|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+++++.++||||+++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 4667899999999999999876 6899999999754 233457789999999999999999999999654 467
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+++ +|.+.+.. .+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 143 ~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 999999976 46666642 38899999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHH-HH-------------
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HW------------- 826 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~-~~------------- 826 (931)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+ +.
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 64422 233456899999999999999999999999999999999999999754432211110 00
Q ss_pred --HHHhhhcCC------eeecccccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 827 --ARSMIKKGD------VISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 827 --~~~~~~~~~------~~~i~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....+.... ........+.... .......+.+++.+||+.||++|||++|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 0000000000000 0112446889999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=336.44 Aligned_cols=247 Identities=23% Similarity=0.360 Sum_probs=202.5
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
..|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 34667899999999999999987 47899999986542 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++++|.+++.. ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 121 ELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp CCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999998873 3568999999999999999999998 89999999999999999999999999999875432
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.. ......|++.|+|||++.+..++.++||||||+++|||++|+.||....... ... . +..+.. .+
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~-~~~~~~------~~ 260 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYL---R-IKKNEY------SI 260 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---H-HHHTCC------CC
T ss_pred cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HHH---H-HhcCCC------CC
Confidence 22 1233468999999999999899999999999999999999999997433211 111 1 111111 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... ...+.+++.+||+.||++||+++|+++
T Consensus 261 ~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 261 PKHI----NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112 236789999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=357.69 Aligned_cols=250 Identities=26% Similarity=0.324 Sum_probs=203.0
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.+++.+.||+|+||.||+|+.+ +|+.||+|++.... ......+.+|+++|++++||||+++++++.+.+..++|||
T Consensus 185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 264 (576)
T 2acx_A 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 264 (576)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 3556789999999999999986 68999999986532 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.+++... ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 265 y~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 265 LMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 99999999998753 23458999999999999999999998 899999999999999999999999999998764432
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccch-hhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+.. .+.....
T Consensus 341 ~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~----~i~~~~~-------- 406 (576)
T 2acx_A 341 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----LVKEVPE-------- 406 (576)
T ss_dssp C--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH----HHHHCCC--------
T ss_pred c--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH----Hhhcccc--------
Confidence 2 2234699999999999999999999999999999999999999975433221 11221 1111110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
.++......+.+++.+||+.||++|| +++||++
T Consensus 407 --~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 --EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11111223678999999999999999 6788764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=338.05 Aligned_cols=262 Identities=20% Similarity=0.212 Sum_probs=196.3
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch-----hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
...|++.+.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+....+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 356777899999999999999986 5899999998753221 1356889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+||||+++ +|.+.+.. ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 89 lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 99999985 89888874 34568888999999999999999998 89999999999999999999999999999876
Q ss_pred cccccccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc---CCee
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVI 837 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~ 837 (931)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|..||......+ ....+...... ....
T Consensus 163 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 163 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSS
T ss_pred cCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChhhhh
Confidence 44322 22334689999999998654 58899999999999999999999997443221 11111111110 0000
Q ss_pred ec---ccc---cccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SI---VDP---VLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i---~d~---~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. .+. ......+ ......+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 000 0000001 112247889999999999999999999876
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=341.55 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=187.5
Q ss_pred cccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHh-cCCCCCcceeEEEec----CCeEEEEEEecC
Q 002358 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSR-IHHRNLVPLIGYCEE----EHQRILVYEYMH 688 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~----~~~~~lV~E~~~ 688 (931)
+.||+|+||.||+|.++ +++.||||+++.. ..+.+|++++.+ .+||||+++++++.. ....++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 68999999999999987 6899999998642 456788888754 489999999998865 567899999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC---CCceEEecccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~~~~~~ 765 (931)
+|+|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 143 gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 143 GGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp SEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 99999999853 23468999999999999999999998 89999999999999987 7889999999998654322
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccch-hhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... .+..+... ...+ .
T Consensus 219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~~~-~~~~-~ 290 (400)
T 1nxk_A 219 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQYE-FPNP-E 290 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTCCC-CCTT-T
T ss_pred --ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCccc-CCCc-c
Confidence 12345689999999999999999999999999999999999999974432211 11111 11111110 0000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.. .....+.+++.+||+.||++|||++|+++.
T Consensus 291 ~~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 291 WS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01 122367899999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=338.23 Aligned_cols=265 Identities=20% Similarity=0.269 Sum_probs=197.7
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEec--------C
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------E 677 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------~ 677 (931)
..|++.+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 35677899999999999999985 789999999865432 234578899999999999999999999876 4
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccc
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 757 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGl 757 (931)
+..++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999975 777777642 3568999999999999999999998 8999999999999999999999999999
Q ss_pred cccccccc---cccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc
Q 002358 758 SRQAEEDL---THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 833 (931)
Q Consensus 758 a~~~~~~~---~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 833 (931)
++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.........
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98654221 122234468999999998876 56899999999999999999999999854332222211111111111
Q ss_pred CCeeeccccccc-------C-CCCH-HH------HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 834 GDVISIVDPVLI-------G-NVKI-ES------IWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 834 ~~~~~i~d~~l~-------~-~~~~-~~------~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......-+.... . .... +. ...+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000000000000 0 0000 11 124789999999999999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=330.65 Aligned_cols=253 Identities=26% Similarity=0.371 Sum_probs=200.6
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEe--cCCeEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILVY 684 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~~~lV~ 684 (931)
.|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++. .....++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 4567899999999999999986 68999999987542 334567999999999999999999999874 467889999
Q ss_pred EecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCC-----eEecCCCCCCccccCCCceEEeccccc
Q 002358 685 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-----IIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-----ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
||+++|+|.+++.... ....+++..++.++.|+++||+|||+ .+ ++||||||+||+++.++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999999999987532 33458999999999999999999998 66 999999999999999999999999998
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeee
Q 002358 759 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 759 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 838 (931)
+........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+.. .+..+....
T Consensus 164 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~----~i~~~~~~~ 235 (279)
T 2w5a_A 164 RILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAG----KIREGKFRR 235 (279)
T ss_dssp HHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHTCCCC
T ss_pred eeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHH----HHhhccccc
Confidence 765433221 2234589999999999998999999999999999999999999974332 11211 222222211
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002358 839 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882 (931)
Q Consensus 839 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 882 (931)
+... ....+.+++.+||+.+|++||+++||++.+.
T Consensus 236 -----~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 236 -----IPYR----YSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -----CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -----CCcc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1112 2246889999999999999999999987543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=331.89 Aligned_cols=251 Identities=20% Similarity=0.359 Sum_probs=197.1
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
..|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 34667899999999999999987 58999999987665556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++++|.+++... ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 172 (302)
T 2j7t_A 99 PGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ- 172 (302)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-
Confidence 999999988642 3568999999999999999999998 8999999999999999999999999998764322211
Q ss_pred cccccccCCCccCCCcc-----CCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 768 ISSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l-----~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
......|++.|+|||.+ ....++.++||||||+++|||++|+.||...+.. .. ...... ........
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---~~~~~~-~~~~~~~~- 244 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RV---LLKIAK-SDPPTLLT- 244 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HH---HHHHHH-SCCCCCSS-
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH---HH---HHHHhc-cCCcccCC-
Confidence 12234589999999998 4677899999999999999999999999743221 11 111111 11111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.+|++|||++|+++
T Consensus 245 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 ------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1122346889999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=348.16 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=192.3
Q ss_pred hHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--------chhhhhHHHHHHHHHhcCCCCCcceeEEEe
Q 002358 605 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--------SHRTQQFVTEVALLSRIHHRNLVPLIGYCE 675 (931)
Q Consensus 605 ~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--------~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 675 (931)
......|.+.+.||+|+||.||+|..+ +++.||||++.... ......+.+|+++|++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 445567888999999999999999876 58999999986432 112346889999999999999999999986
Q ss_pred cCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC---CceEE
Q 002358 676 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKV 752 (931)
Q Consensus 676 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~---~~vkL 752 (931)
. +..++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.+ ..+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred c-CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEE
Confidence 4 457899999999999998873 4678999999999999999999998 899999999999999754 45999
Q ss_pred ecccccccccccccccccccccCCCccCCCccCC---CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHH
Q 002358 753 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 829 (931)
Q Consensus 753 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 829 (931)
+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..
T Consensus 284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~---- 355 (419)
T 3i6u_A 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD---- 355 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHH----
T ss_pred eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHH----
Confidence 9999998765432 2234568999999999853 677889999999999999999999997433221 1111
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 830 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+..+.... .+..... ....+.+++.+||+.||++||+++|+++
T Consensus 356 ~i~~~~~~~--~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 QITSGKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHTTCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCC--Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111121110 0111111 1236789999999999999999999885
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.14 Aligned_cols=259 Identities=28% Similarity=0.420 Sum_probs=197.0
Q ss_pred HHHHhhccccCccCcEEEEEEEEC--CCc--EEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK--DGK--EVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~--~g~--~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
...|++.+.||+|+||.||+|++. +++ .||+|+++... ....+.+.+|++++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 345778899999999999999864 233 68999987542 344578999999999999999999999998765 7
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++|+||+++|+|.+.+... ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998742 3568899999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccc--cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 761 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 761 ~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .....+...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~~~~~~~~~ 244 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILH---KIDKEGERL 244 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---HHHTSCCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHH---HHHccCCCC
Confidence 6443221 1223457888999999988889999999999999999999 99999743321 1111 111111110
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
.. +......+.+++.+||+.+|++||+++++++.|+++...
T Consensus 245 -----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 245 -----PR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -----CC----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 01 112234688999999999999999999999999987643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=325.68 Aligned_cols=245 Identities=24% Similarity=0.395 Sum_probs=193.2
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|.+.+.||+|+||.||+|.++ +|+.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4667899999999999999987 799999999865321 234578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 92 YVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred ccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999874 3468899999999999999999998 899999999999999999999999999998754432
Q ss_pred cccccccccCCCccCCCccCCCCC-CccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
. .....|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... ...+ .+..+.. .+
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~~~~~------~~ 230 (276)
T 2h6d_A 166 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFK----KIRGGVF------YI 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------CC
T ss_pred c--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHH----HhhcCcc------cC
Confidence 1 223458999999999988765 68999999999999999999999743221 1111 1211111 01
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.||++||+++|+++
T Consensus 231 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 231 ----PEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1112236789999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=330.01 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=198.8
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
.....|++.+.||+|+||.||+|.++ +|+.||+|++.... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34456777899999999999999987 58999999987532 3467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999863 24568999999999999999999998 89999999999999999999999999999775443
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ... . +..........
T Consensus 179 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~-~~~~~~~~~~~--- 247 (314)
T 3com_A 179 MAK-RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AIF---M-IPTNPPPTFRK--- 247 (314)
T ss_dssp BSC-BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH---H-HHHSCCCCCSS---
T ss_pred ccc-cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HHH---H-HhcCCCcccCC---
Confidence 222 233458999999999999999999999999999999999999997332211 111 1 11111111111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.||++||+++|+++
T Consensus 248 ----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 ----PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1112346889999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=341.21 Aligned_cols=268 Identities=22% Similarity=0.272 Sum_probs=204.4
Q ss_pred ChhhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcC--------CCCCcceeE
Q 002358 602 PLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--------HRNLVPLIG 672 (931)
Q Consensus 602 ~~~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~--------HpnIv~l~g 672 (931)
...++....|++.++||+|+||.||+|... +++.||||+++.. ....+.+.+|++++++++ |+||+++++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 344445567888999999999999999875 6889999999754 344567889999999996 788999999
Q ss_pred EEe----cCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCC-CeEecCCCCCCccccCC
Q 002358 673 YCE----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDIN 747 (931)
Q Consensus 673 ~~~----~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~ivH~DIkp~NILld~~ 747 (931)
++. .....++||||+ +++|.+.+... ....+++..++.++.||++||+|||+ + +|+||||||+|||++.+
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCC
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEecc
Confidence 987 566889999999 56666666543 23568999999999999999999998 6 99999999999999877
Q ss_pred C-------------------------------------------------ceEEecccccccccccccccccccccCCCc
Q 002358 748 M-------------------------------------------------RAKVSDFGLSRQAEEDLTHISSVARGTVGY 778 (931)
Q Consensus 748 ~-------------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y 778 (931)
+ .+||+|||+++..... .....||+.|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y 259 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGG
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcc
Confidence 5 7999999999875433 2234589999
Q ss_pred cCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchh---hHHHHHHHhhhc--------C-----------Ce
Q 002358 779 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL---NIVHWARSMIKK--------G-----------DV 836 (931)
Q Consensus 779 ~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~---~l~~~~~~~~~~--------~-----------~~ 836 (931)
+|||++.+..++.++|||||||++|||++|+.||......... .....+.+.... + ..
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 339 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence 9999999999999999999999999999999999754432211 111111111110 0 00
Q ss_pred eecccccc---------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 837 ISIVDPVL---------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 837 ~~i~d~~l---------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+.+... ....+......+.+++.+||+.||++|||++|+++
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000000 00224556678999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=348.41 Aligned_cols=193 Identities=26% Similarity=0.379 Sum_probs=153.6
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEec-----CCeE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQR 680 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~~~~ 680 (931)
..|++.+.||+|+||.||+|.++ +++.||||++.... ....+.+.+|+++|++++||||+++++++.. ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 35777899999999999999876 68999999986532 2345779999999999999999999999843 3578
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+ +|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 133 ~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 9999998 5799999873 4679999999999999999999998 8999999999999999999999999999987
Q ss_pred cccccc--------------------------ccccccccCCCccCCCcc-CCCCCCccchhHHHHHHHHHHHhC
Q 002358 761 AEEDLT--------------------------HISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISG 808 (931)
Q Consensus 761 ~~~~~~--------------------------~~~~~~~gt~~y~APE~l-~~~~~s~ksDVwSlGvlL~eLltG 808 (931)
...... .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 542211 112334689999999976 566799999999999999999993
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=331.51 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=196.9
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CCCCcceeEEEec--CCeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEE--EHQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~~~lV~ 684 (931)
..|++.+.||+|+||.||+|... +++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 45777899999999999999875 6899999998743 3467899999999997 9999999999987 66789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC-ceEEecccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEE 763 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~ 763 (931)
||+++++|.+++. .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999885 27888999999999999999998 8999999999999999776 899999999986543
Q ss_pred cccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH--------HhhhcC
Q 002358 764 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKG 834 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~--------~~~~~~ 834 (931)
... .....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+..... ..+...
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHHHh
Confidence 322 233458999999999877 67899999999999999999999999532221 111111000 000000
Q ss_pred Ce--------------eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 835 DV--------------ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 835 ~~--------------~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. ...................+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0000000011111112347889999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=340.09 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=191.9
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC------eE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 680 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~------~~ 680 (931)
.|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 4667889999999999999985 68999999986532 234567899999999999999999999997653 46
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 9999999 8899999874 458899999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCC----
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---- 835 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~---- 835 (931)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+... .+........
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~---~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK---EIMKVTGTPPAEFV 250 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCHHHH
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCCHHHH
Confidence 5432 223468999999999876 689999999999999999999999997544322111 1111000000
Q ss_pred --------------eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 836 --------------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 836 --------------~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
........+. .........+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000000 011122346789999999999999999999886
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=349.24 Aligned_cols=251 Identities=28% Similarity=0.418 Sum_probs=198.4
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
....|++.+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567888999999999999999987 68899999987543 23356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC---CCceEEeccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ 760 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~ 760 (931)
|||+++|+|.+.+.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++. ++.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999998873 3568999999999999999999998 89999999999999976 45599999999987
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
...... .....||+.|+|||++. ..++.++||||+||++|+|++|..||...... .+.. .+..+... .
T Consensus 189 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~----~i~~~~~~-~- 256 (494)
T 3lij_A 189 FENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILR----KVEKGKYT-F- 256 (494)
T ss_dssp CBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCCC-C-
T ss_pred CCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCCCC-C-
Confidence 654322 23356999999999986 46899999999999999999999999743322 1111 12122111 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+....... ...+.+++.+||+.+|++|||++|+++
T Consensus 257 ~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSPEWKNV----SEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSGGGTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CchhcccC----CHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 11111112 236789999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=342.61 Aligned_cols=197 Identities=25% Similarity=0.352 Sum_probs=165.7
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecC-----CeEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI 681 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-----~~~~ 681 (931)
.|++.+.||+|+||.||+|.++ +++.||||++.... ....+.+.+|+++|++++||||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 5677899999999999999986 57899999997532 23457899999999999999999999999765 5789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+||||+. |+|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 107 lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 9999986 699999973 4569999999999999999999998 89999999999999999999999999999875
Q ss_pred cccccc---------------------cccccccCCCccCCCcc-CCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 002358 762 EEDLTH---------------------ISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVS 813 (931)
Q Consensus 762 ~~~~~~---------------------~~~~~~gt~~y~APE~l-~~~~~s~ksDVwSlGvlL~eLltG~~Pf~ 813 (931)
...... ......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 433211 12445689999999985 56679999999999999999998655554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=351.99 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=199.3
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
+++.+.||+|+||.||+|+++ +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 445678999999999999986 689999999865322 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 687 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 687 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
+++|+|.+++.... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 99999999987542 24568999999999999999999998 899999999999999999999999999998765433
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccch-hhHHHHHHHhhhcCCeeecccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~-~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+.+ .+.....
T Consensus 344 ~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~----~i~~~~~-------- 410 (543)
T 3c4z_A 344 TK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----RVLEQAV-------- 410 (543)
T ss_dssp CC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH----HHHHCCC--------
T ss_pred cc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH----HHhhccc--------
Confidence 22 2334699999999999999999999999999999999999999975432211 11211 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKM 874 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 874 (931)
.++......+.+++.+||+.+|++||++
T Consensus 411 --~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 --TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred --CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 1111223367899999999999999976
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=350.33 Aligned_cols=245 Identities=16% Similarity=0.156 Sum_probs=187.6
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCc---cchhhhhHHHHHH---HHHhcCCCCCccee-------EEEe
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVA---LLSRIHHRNLVPLI-------GYCE 675 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~---il~~l~HpnIv~l~-------g~~~ 675 (931)
.|++.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|++ ++++++|||||+++ +++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 3556789999999999999974 6999999998642 2345578999995 45555799999998 6665
Q ss_pred cCC-----------------eEEEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEe
Q 002358 676 EEH-----------------QRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 734 (931)
Q Consensus 676 ~~~-----------------~~~lV~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH 734 (931)
..+ ..++||||+ +|+|.+++.... ....+++..++.++.||++||+|||+ .+|+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 543 278999999 689999987421 11234468888999999999999998 89999
Q ss_pred cCCCCCCccccCCCceEEecccccccccccccccccccccCCCccCCCccCCC-----------CCCccchhHHHHHHHH
Q 002358 735 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLL 803 (931)
Q Consensus 735 ~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~s~ksDVwSlGvlL~ 803 (931)
|||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999999999999999986433 2233457 999999999877 8999999999999999
Q ss_pred HHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HH
Q 002358 804 ELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AI 881 (931)
Q Consensus 804 eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L 881 (931)
||++|+.||......... ..+.. . .... ...+.+++.+||+.||++||++.|+++ .+
T Consensus 305 elltg~~Pf~~~~~~~~~---------------~~~~~-~-~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 305 WIWCADLPITKDAALGGS---------------EWIFR-S-CKNI----PQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp HHHHSSCCC------CCS---------------GGGGS-S-CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred HHHHCCCCCcccccccch---------------hhhhh-h-ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 999999999733221110 00000 0 0122 236789999999999999999999985 44
Q ss_pred Hhh
Q 002358 882 QDS 884 (931)
Q Consensus 882 ~~~ 884 (931)
+++
T Consensus 364 ~~~ 366 (377)
T 3byv_A 364 EQL 366 (377)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.25 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=199.9
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--------hhhhhHHHHHHHHHhc-CCCCCcceeEEEecCC
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 678 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~ 678 (931)
..|++.+.||+|+||.||+|.++ +|+.||||++..... ...+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 45666789999999999999986 799999999865431 1235688999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 99999999999999999873 3568999999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccC------CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh
Q 002358 759 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 832 (931)
Q Consensus 759 ~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 832 (931)
........ .....||+.|+|||++. ...++.++|||||||++|||++|+.||...... .... .+.
T Consensus 248 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~----~i~ 318 (365)
T 2y7j_A 248 CHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLR----MIM 318 (365)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHH
T ss_pred cccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHH----HHH
Confidence 87654322 23356899999999885 346889999999999999999999999743221 1111 111
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 833 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 833 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+... ...+. .... ...+.+++.+||+.||++||+++|+++
T Consensus 319 ~~~~~-~~~~~-~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EGQYQ-FSSPE-WDDR----SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HTCCC-CCHHH-HSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCC-CCCcc-cccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11110 00000 0111 235889999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=327.70 Aligned_cols=251 Identities=21% Similarity=0.310 Sum_probs=184.9
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-h-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-H-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
..+++.+.||+|+||.||+|... +|+.||+|+++.... . ..+.+.++...++.++||||+++++++.+++..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 45677899999999999999985 689999999876432 2 23344555556888899999999999999999999999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCC-CeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 686 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|++ |+|.+++.... ....+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++....
T Consensus 87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 997 58877765321 34679999999999999999999998 6 999999999999999999999999999987544
Q ss_pred cccccccccccCCCccCCCcc----CCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 764 DLTHISSVARGTVGYLDPEYY----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l----~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
... .....||+.|+|||.+ .+..++.++||||+|+++|||++|+.||...... ...+ ......... ..
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~----~~~~~~~~~-~~ 234 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-FQQL----KQVVEEPSP-QL 234 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-HHHH----HHHHHSCCC-CC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-HHHH----HHHhccCCC-Cc
Confidence 322 2233589999999996 5667899999999999999999999999732221 1111 112221111 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. .......+.+++.+||+.+|++|||++|+++
T Consensus 235 ~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 P--------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred c--------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 1112236789999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=330.47 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=198.4
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--------hhhhhHHHHHHHHHhcCCCCCcceeEEE
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYC 674 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~g~~ 674 (931)
+......|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++
T Consensus 5 ~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 5 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp CHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 3455678889999999999999999886 578999999865321 2234688999999999999999999998
Q ss_pred ecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc---eE
Q 002358 675 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AK 751 (931)
Q Consensus 675 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~---vk 751 (931)
..+. .++||||+++|+|.+.+.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++. +|
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred cCCc-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEE
Confidence 7655 8999999999999999873 4578999999999999999999998 89999999999999987654 99
Q ss_pred EecccccccccccccccccccccCCCccCCCcc---CCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHH
Q 002358 752 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 828 (931)
Q Consensus 752 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l---~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~ 828 (931)
|+|||+++...... ......||+.|+|||++ ....++.++|||||||++|||++|+.||........ +...
T Consensus 158 l~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~-- 231 (322)
T 2ycf_A 158 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ-- 231 (322)
T ss_dssp ECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHH--
T ss_pred EccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHH--
Confidence 99999998754322 12234589999999986 356789999999999999999999999974332211 1111
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 829 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 829 ~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+..+.... .+..... ....+.+++.+||+.||++||+++|+++
T Consensus 232 --~~~~~~~~--~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 --ITSGKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HHHTCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHhCcccc--Cchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11111110 0111111 1236789999999999999999999984
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=324.38 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=195.6
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc----chhhhhHHHHHHHHHhcCCCCCcceeEEE--ecCCeEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYC--EEEHQRIL 682 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~~~l 682 (931)
.|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++ .+....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 4567899999999999999975 68899999987532 23456799999999999999999999998 44567899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||||++++ |.+.+... ....+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 99999877 77776643 34578999999999999999999998 899999999999999999999999999998654
Q ss_pred ccc-cccccccccCCCccCCCccCCCC--CCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 763 EDL-THISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 763 ~~~-~~~~~~~~gt~~y~APE~l~~~~--~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
... ........|++.|+|||++.+.. ++.++||||||+++|||++|+.||...... ...+ .+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~i~~~~~--- 230 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFE----NIGKGSY--- 230 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH----HHHHCCC---
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHH----HHhcCCC---
Confidence 322 12223445899999999987643 477999999999999999999999743321 1111 1222211
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 880 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 880 (931)
.+.... ...+.+++.+||+.||++||+++|+++.
T Consensus 231 ---~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ---AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111122 2367899999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=332.24 Aligned_cols=257 Identities=24% Similarity=0.342 Sum_probs=183.6
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
..|++.+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 44667899999999999999865 68999999986532 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccC-----CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 687 MHNGTLRDRLHGS-----VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 687 ~~~gsL~~~L~~~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+++++|.+++... .....+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 9999999988631 124568999999999999999999998 89999999999999999999999999998765
Q ss_pred ccccc----ccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 762 EEDLT----HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 762 ~~~~~----~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
..... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ... ... +..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~---~~~-~~~ 244 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LML---TLQ-NDP 244 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHH---HHT-SSC
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HHH---Hhc-cCC
Confidence 43211 11233468999999999865 5689999999999999999999999974332211 111 111 111
Q ss_pred ee----cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 837 IS----IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 837 ~~----i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. ..++.....++ ..+.+++.+||+.||++||+++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cccccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11 11111222222 36789999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=350.65 Aligned_cols=251 Identities=27% Similarity=0.366 Sum_probs=201.3
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
....|++.+.||+|+||+||+|..+ +++.||||++.... ......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3567888999999999999999986 68999999986432 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc---CCCceEEeccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQ 760 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld---~~~~vkL~DFGla~~ 760 (931)
|||+++|+|.+.+.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999998874 3568999999999999999999998 8999999999999995 456799999999986
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
...... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .... .+..+....
T Consensus 174 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~----~i~~~~~~~-- 241 (486)
T 3mwu_A 174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILK----RVETGKYAF-- 241 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCCCS--
T ss_pred CCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCCCCC--
Confidence 543321 233468999999999876 5899999999999999999999999743321 1111 111221110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+..... .....+.+++.+||+.+|++|||++|+++
T Consensus 242 ~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 242 DLPQWR----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp CSGGGG----GSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCcccC----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000001 12236789999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=363.15 Aligned_cols=261 Identities=25% Similarity=0.399 Sum_probs=207.0
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECC----CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
+....+++.+.||+|+||.||+|.+.. +..||+|+++.... ...+.+.+|+.++++++||||+++++++.+ +..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 344567778999999999999998753 46799999876433 344679999999999999999999999854 568
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999999753 3468999999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... .....+ ..+....
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i----~~~~~~~- 612 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI----ENGERLP- 612 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH----HHTCCCC-
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH----HcCCCCC-
Confidence 65443333334457889999999988899999999999999999997 99999743321 122211 1111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
. +......+.+++.+||+.||++||++.||++.|+++...+
T Consensus 613 ----~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 613 ----M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----C----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1 1122346889999999999999999999999999987654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=342.32 Aligned_cols=251 Identities=10% Similarity=0.035 Sum_probs=178.9
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhc--CCCCCccee-------EEEecC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI--HHRNLVPLI-------GYCEEE 677 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l--~HpnIv~l~-------g~~~~~ 677 (931)
|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++.+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 556789999999999999976 789999999986432 3445678886555555 599988755 444332
Q ss_pred -----------------CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHH------HHHHHHHHHHhHHhhhcCCCCeEe
Q 002358 678 -----------------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKGLEYLHTGCNPGIIH 734 (931)
Q Consensus 678 -----------------~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~------~~i~~qia~aL~yLH~~~~~~ivH 734 (931)
...++||||++ |+|.+++... ...+++..+ ..++.||++||+|||+ .+|+|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivH 217 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVH 217 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCcc
Confidence 34799999998 8999999753 223455555 7788999999999998 89999
Q ss_pred cCCCCCCccccCCCceEEecccccccccccccccccccccCCCccCCCccCC--CCCCccchhHHHHHHHHHHHhCCCCC
Q 002358 735 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPV 812 (931)
Q Consensus 735 ~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf 812 (931)
|||||+|||++.++.+||+|||+++....... ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEEE----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCcc----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999986543221 3346799999999987 78999999999999999999999999
Q ss_pred CccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 813 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 813 ~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
........... ..............-.........+.+++.+||+.||++|||++|+++
T Consensus 294 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 74432211000 000000000000000001122347889999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=342.29 Aligned_cols=258 Identities=23% Similarity=0.278 Sum_probs=191.9
Q ss_pred HHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCC------eEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QRILV 683 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~------~~~lV 683 (931)
.|++.+.||+|+||.||+|++.++..||+|++.... +...+|+++++.++||||+++++++.... ..++|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 467789999999999999999887789999876432 22347999999999999999999985543 37899
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc-CCCceEEeccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAE 762 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld-~~~~vkL~DFGla~~~~ 762 (931)
|||++++.+............+++..+..++.|+++||+|||+ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 9999876444433222235678999999999999999999998 8999999999999999 79999999999998754
Q ss_pred ccccccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh---------
Q 002358 763 EDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK--------- 832 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~--------- 832 (931)
.... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...+..+. +...++ ...
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~-~~g~p~~~~~~~ 268 (394)
T 4e7w_A 194 AGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIK-VLGTPSREQIKT 268 (394)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-HHCCCCHHHHHH
T ss_pred CCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH-HhCCCCHHHHHh
Confidence 3322 2234589999999998664 689999999999999999999999975443221 111111 100
Q ss_pred ------cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 833 ------KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 833 ------~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......+....+....+......+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000000000000011112346889999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=331.67 Aligned_cols=264 Identities=22% Similarity=0.296 Sum_probs=203.0
Q ss_pred HHHHHHhhccccCccCcEEEEEEEE-C-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCC------CcceeEEEecC
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKM-K-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN------LVPLIGYCEEE 677 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~-~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~g~~~~~ 677 (931)
+....|++.+.||+|+||.||+|.. + +++.||||+++.. ....+.+.+|+++++.++|++ ++++++++...
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 3345677889999999999999987 3 6889999998754 334567889999999997654 99999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC-----------
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----------- 746 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~----------- 746 (931)
+..++||||+ +++|.+++... ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred CcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcc
Confidence 9999999999 89999998754 23468899999999999999999998 89999999999999987
Q ss_pred --------CCceEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCcc
Q 002358 747 --------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 818 (931)
Q Consensus 747 --------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~ 818 (931)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999764432 22346899999999999999999999999999999999999999754432
Q ss_pred chhhHHHHHHHh-----hhcCCeeec---------------------cccc-ccCCCCHHHHHHHHHHHHHccccCCCCC
Q 002358 819 AELNIVHWARSM-----IKKGDVISI---------------------VDPV-LIGNVKIESIWRIAEVAIQCVEQRGFSR 871 (931)
Q Consensus 819 ~~~~l~~~~~~~-----~~~~~~~~i---------------------~d~~-l~~~~~~~~~~~l~~li~~Cl~~dP~~R 871 (931)
+........... ......... ..+. -...........+.+++.+||+.||++|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 222111111000 000000000 0000 0001123455678999999999999999
Q ss_pred CCHHHHHH
Q 002358 872 PKMQEIVL 879 (931)
Q Consensus 872 Ps~~evl~ 879 (931)
||++|+++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=348.61 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=204.5
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
+....|++.+.||+|+||.||+|..+ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 44567888999999999999999987 78999999986432 234567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc---cCCCceEEeccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLS 758 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl---d~~~~vkL~DFGla 758 (931)
+||||+.+|+|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 103 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EEECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999999999873 4579999999999999999999998 899999999999999 56789999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeee
Q 002358 759 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 759 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 838 (931)
+....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .... .+..+....
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~----~i~~~~~~~ 246 (484)
T 3nyv_A 177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DILK----KVEKGKYTF 246 (484)
T ss_dssp HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCCCC
T ss_pred EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHcCCCCC
Confidence 86544322 223458999999999876 6899999999999999999999999743321 1222 122222110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 839 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 839 i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. .+ ... .....+.+++.+||+.+|++|||++|+++
T Consensus 247 ~-~~-~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 E-LP-QWK----KVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp C-SG-GGG----GSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C-Cc-ccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 00 001 12236789999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=362.27 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=201.5
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV 683 (931)
..+++.+.||+|+||.||+|+.+ +++.||||+++... ....+.+..|..++..+ +||+|+++++++.+.+..++|
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 34667899999999999999987 58899999987532 23446688899999988 799999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 421 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999999984 3568999999999999999999998 8999999999999999999999999999986433
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.+ .+..+..
T Consensus 495 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~~----~i~~~~~------- 559 (674)
T 3pfq_A 495 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ----SIMEHNV------- 559 (674)
T ss_dssp TTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHSSCC-------
T ss_pred CCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHHH----HHHhCCC-------
Confidence 222 233456999999999999999999999999999999999999999744321 1111 1212111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM-----QEIV 878 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl 878 (931)
.++......+.+++.+||+.||++||++ +||+
T Consensus 560 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 560 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred ---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 1112223467899999999999999997 5655
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=341.26 Aligned_cols=258 Identities=21% Similarity=0.223 Sum_probs=192.8
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEec-----------
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----------- 676 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----------- 676 (931)
..|++.+.||+|+||.||+|... +|+.||||++.... +...+|+++++.++||||+++++++..
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 35667899999999999999875 78999999986542 233479999999999999999999843
Q ss_pred ---------------------------CCeEEEEEEecCCCCHHHHhccC-CCCCCCCHHHHHHHHHHHHHHhHHhhhcC
Q 002358 677 ---------------------------EHQRILVYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728 (931)
Q Consensus 677 ---------------------------~~~~~lV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~ 728 (931)
....++||||++ |+|.+.+... .....+++..+..++.|+++||+|||+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-- 159 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-- 159 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--
Confidence 334789999998 5877766532 135679999999999999999999998
Q ss_pred CCCeEecCCCCCCcccc-CCCceEEecccccccccccccccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHH
Q 002358 729 NPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELI 806 (931)
Q Consensus 729 ~~~ivH~DIkp~NILld-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLl 806 (931)
.+|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+||++|||+
T Consensus 160 -~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 160 -LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp -TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred -CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 8999999999999998 689999999999987544322 2234589999999998764 5899999999999999999
Q ss_pred hCCCCCCccCccchhhHHHHHHHhhhcC---------------CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCC
Q 002358 807 SGKKPVSVEDFGAELNIVHWARSMIKKG---------------DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 871 (931)
Q Consensus 807 tG~~Pf~~~~~~~~~~l~~~~~~~~~~~---------------~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 871 (931)
+|+.||......+. +...+ +..... ..............+......+.+++.+||+.+|++|
T Consensus 237 ~g~~pf~~~~~~~~--~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 237 LGKPLFSGETSIDQ--LVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HSSCSSCCSSHHHH--HHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred hCCCCCCCCChHHH--HHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999975433221 11111 111000 0000000000001122233468899999999999999
Q ss_pred CCHHHHHH
Q 002358 872 PKMQEIVL 879 (931)
Q Consensus 872 Ps~~evl~ 879 (931)
||+.|+++
T Consensus 314 ~t~~e~l~ 321 (383)
T 3eb0_A 314 INPYEAMA 321 (383)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=330.72 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=198.1
Q ss_pred HHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
...+++.+.||+|+||.||+|.+++ .+|+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 3446678999999999999999864 49999986532 2334668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++++|.+++... ...+++..+..++.|+++||+|||+ .+++||||||+|||++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999999752 3468999999999999999999998 8999999999999998 6799999999987643211
Q ss_pred ----cccccccccCCCccCCCccCC---------CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh
Q 002358 766 ----THISSVARGTVGYLDPEYYGN---------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 832 (931)
Q Consensus 766 ----~~~~~~~~gt~~y~APE~l~~---------~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 832 (931)
........|++.|+|||.+.. ..++.++||||||+++|||++|+.||...... .... .+.
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~----~~~ 256 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AIIW----QMG 256 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHHH----HHH
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----Hhc
Confidence 112223458999999999864 45788999999999999999999999743321 1111 111
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 833 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 833 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
.+........ .. ...+.+++.+||+.+|++||+++|+++.|+++....
T Consensus 257 ~~~~~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 257 TGMKPNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TTCCCCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred cCCCCCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 2211111111 11 125789999999999999999999999999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=331.72 Aligned_cols=259 Identities=21% Similarity=0.293 Sum_probs=198.2
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecC-----CeEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 682 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-----~~~~l 682 (931)
.|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 4667899999999999999876 688999999975433 3447789999999999999999999999654 46899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 108 v~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999997 599998873 458999999999999999999998 899999999999999999999999999998765
Q ss_pred cccccc--ccccccCCCccCCCccC-CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee--
Q 002358 763 EDLTHI--SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI-- 837 (931)
Q Consensus 763 ~~~~~~--~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~-- 837 (931)
...... .....||+.|+|||++. ...++.++|||||||++|||++|+.||......+.... +..........
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGSPSQEDL 256 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH---HHHHHCSCCHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH---HHHHhCCCCHHHH
Confidence 432221 23446899999999864 45689999999999999999999999975443322211 11111000000
Q ss_pred -------------eccccccc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 -------------SIVDPVLI--GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 -------------~i~d~~l~--~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....+... ..........+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 0000111236789999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.40 Aligned_cols=260 Identities=22% Similarity=0.278 Sum_probs=198.2
Q ss_pred HHhhccccCccCcEEEEEEEEC--CCcEEEEEEccCccc--hhhhhHHHHHHHHHhc---CCCCCcceeEEEe-----cC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----EE 677 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~g~~~-----~~ 677 (931)
.|++.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 4667899999999999999983 688999999865332 2234677888888777 7999999999987 56
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccc
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 757 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGl 757 (931)
...++||||++ |+|.+++... ....+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 67899999997 6999998754 23458999999999999999999998 8999999999999999999999999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcC---
Q 002358 758 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--- 834 (931)
Q Consensus 758 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~--- 834 (931)
++...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+.......
T Consensus 167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 167 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE 241 (326)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGG
T ss_pred cccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCcc
Confidence 98654332 2233468999999999999999999999999999999999999997443221 111111111100
Q ss_pred Ceee-------ccc---ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 835 DVIS-------IVD---PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 835 ~~~~-------i~d---~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... ... ..............+.+++.+||+.||++||+++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 000 00000111122346789999999999999999999984
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=321.44 Aligned_cols=250 Identities=24% Similarity=0.397 Sum_probs=191.7
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEec-----------
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----------- 676 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----------- 676 (931)
..|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 45677899999999999999976 7899999998643 3445778999999999999999999998754
Q ss_pred --CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEec
Q 002358 677 --EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 754 (931)
Q Consensus 677 --~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~D 754 (931)
....++||||+++|+|.+++... ...+++..++.++.|+++||+|||+ .+++||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence 45688999999999999999752 3467888999999999999999998 8999999999999999999999999
Q ss_pred ccccccccccc-------------cccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccch
Q 002358 755 FGLSRQAEEDL-------------THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 820 (931)
Q Consensus 755 FGla~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~ 820 (931)
||++....... ........|++.|+|||.+.+. .++.++||||||+++|||++ ||... ...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~~ 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--MER 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hhH
Confidence 99998654321 1112234589999999998764 78999999999999999998 55411 111
Q ss_pred hhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 821 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 821 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...... +.... ..+....+......+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~----~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKK----LRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHH----HHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHh----ccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111 11111 11112223333456789999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=337.64 Aligned_cols=260 Identities=22% Similarity=0.278 Sum_probs=190.9
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccch-----------hhhhHHHHHHHHHhcCCCCCcceeEEEec-
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-----------RTQQFVTEVALLSRIHHRNLVPLIGYCEE- 676 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~-----------~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 676 (931)
..|++.+.||+|+||.||+|...+|+.||||++...... ..+.+.+|++++++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 455668899999999999999988999999998643221 13678999999999999999999999843
Q ss_pred ----CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEE
Q 002358 677 ----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 752 (931)
Q Consensus 677 ----~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL 752 (931)
....++||||++ |+|.+.+.. ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEE
Confidence 346899999997 688888874 34568999999999999999999998 89999999999999999999999
Q ss_pred ecccccccccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002358 753 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 831 (931)
Q Consensus 753 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 831 (931)
+|||+++....... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...+....
T Consensus 176 ~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~ 250 (362)
T 3pg1_A 176 CDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ---LNKIVEVV 250 (362)
T ss_dssp CCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH
T ss_pred EecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHc
Confidence 99999975433222 233458999999999876 6789999999999999999999999975432211 11111111
Q ss_pred hcCCeee-----------ccccccc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 832 KKGDVIS-----------IVDPVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 832 ~~~~~~~-----------i~d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
....... .+...+. ..........+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1000000 0000000 0001112236889999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=328.77 Aligned_cols=259 Identities=21% Similarity=0.292 Sum_probs=190.7
Q ss_pred HHhhccccCccCcEEEEEEEECC-CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEe-------------
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE------------- 675 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~------------- 675 (931)
.|++.+.||+|+||.||+|.... ++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 45667899999999999999874 8999999987665566788999999999999999999999873
Q ss_pred -cCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc-CCCceEEe
Q 002358 676 -EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVS 753 (931)
Q Consensus 676 -~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld-~~~~vkL~ 753 (931)
+....++||||++ |+|.+++. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++ +++.+||+
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 69999986 3468899999999999999999998 8999999999999997 56799999
Q ss_pred cccccccccccccc--cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002358 754 DFGLSRQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 830 (931)
Q Consensus 754 DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 830 (931)
|||+++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||......... ..+...
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~ 240 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLILES 240 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHh
Confidence 99999876432211 1223457899999998755 67899999999999999999999999744322111 111100
Q ss_pred hhc----------CCeeeccccccc-C-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 831 IKK----------GDVISIVDPVLI-G-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 831 ~~~----------~~~~~i~d~~l~-~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
... ......+..... . .........+.+++.+||+.||++||+++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 000000000000 0 000112346889999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=347.43 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=198.1
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-------------hhhhhHHHHHHHHHhcCCCCCcceeEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 674 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-------------~~~~~~~~E~~il~~l~HpnIv~l~g~~ 674 (931)
..|.+.++||+|+||.||+|..+ +++.||+|++..... ...+.+.+|++++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45777899999999999999987 578999999865321 2246789999999999999999999999
Q ss_pred ecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC---ceE
Q 002358 675 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAK 751 (931)
Q Consensus 675 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~---~vk 751 (931)
.+....++||||+++|+|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999998874 3568999999999999999999998 8999999999999998776 699
Q ss_pred EecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhh
Q 002358 752 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 831 (931)
Q Consensus 752 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 831 (931)
|+|||+++....... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||...... .+.. .+
T Consensus 190 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~----~i 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIK----KV 259 (504)
T ss_dssp ECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HH
T ss_pred EEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HH
Confidence 999999987654322 233469999999999874 6899999999999999999999999743322 1111 12
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 832 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 832 ~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+.... +....... ...+.+++.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~--~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 EKGKYYF--DFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHCCCCC--CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HcCCCCC--CccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2222110 00001111 236789999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=340.72 Aligned_cols=199 Identities=26% Similarity=0.326 Sum_probs=171.8
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc------CCCCCcceeEEEecCCeE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI------HHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~g~~~~~~~~ 680 (931)
...|++.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+++++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 345777899999999999999876 5899999999754 33346778899988887 467999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc--eEEeccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLS 758 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~--vkL~DFGla 758 (931)
++||||+. ++|.+++... ....+++..+..++.||++||+|||+ .+|+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 6999988754 23458999999999999999999998 89999999999999999887 999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccC
Q 002358 759 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816 (931)
Q Consensus 759 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~ 816 (931)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 764332 223468999999999999999999999999999999999999997544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=327.24 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=192.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEec------CCeEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQRI 681 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~------~~~~~ 681 (931)
.|++.+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++.. ....+
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 4567899999999999999985 68999999986542 3456789999999999 79999999999876 46789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 104 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 999999999999999754 23568899999999999999999998 89999999999999999999999999998865
Q ss_pred cccccccccccccCCCccCCCccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
..... ......|++.|+|||.+. +..++.++||||||+++|||++|+.||....... ... . +.....
T Consensus 180 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~-~~~~~~ 251 (326)
T 2x7f_A 180 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---ALF---L-IPRNPA 251 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH---H-HHHSCC
T ss_pred CcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHH---H-hhcCcc
Confidence 43222 122345899999999986 5678899999999999999999999996332211 111 1 111111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..... ..+ ...+.+++.+||+.+|++||+++|+++
T Consensus 252 ~~~~~----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 PRLKS----KKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCSC----SCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCc----ccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111 111 236889999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=322.54 Aligned_cols=249 Identities=26% Similarity=0.321 Sum_probs=199.7
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---------chhhhhHHHHHHHHHhcC-CCCCcceeEEEecCC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---------SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH 678 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---------~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~ 678 (931)
.|++.+.||+|+||.||+|..+ +|+.||||++.... ....+.+.+|++++++++ ||||+++++++....
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 4566889999999999999986 68999999986532 122456889999999996 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
..++||||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999974 3568999999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccC------CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh
Q 002358 759 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 832 (931)
Q Consensus 759 ~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 832 (931)
........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||...... .... .+.
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~ 242 (298)
T 1phk_A 172 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LMLR----MIM 242 (298)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHH
T ss_pred hhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHHH----HHh
Confidence 87543322 22345899999999874 557889999999999999999999999743221 1111 111
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 833 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 833 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+... ...+. .......+.+++.+||+.+|++||+++|+++
T Consensus 243 ~~~~~-~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNYQ-FGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCCC-CCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCcc-cCccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111 00010 0122346889999999999999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=332.51 Aligned_cols=259 Identities=23% Similarity=0.289 Sum_probs=189.5
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC------eE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 680 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~------~~ 680 (931)
.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 4667899999999999999876 68899999987532 234567889999999999999999999997654 78
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||++ |+|.+.+. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 106 YIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 99999997 57888875 247889999999999999999998 8999999999999999999999999999986
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHH----------------
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV---------------- 824 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~---------------- 824 (931)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 54322 123346899999999999999999999999999999999999999754322111000
Q ss_pred HHHHHhhhcCC------eeecccccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 825 HWARSMIKKGD------VISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 825 ~~~~~~~~~~~------~~~i~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+........ ............. .......+.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000000 0000000000000 1122457889999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=345.08 Aligned_cols=258 Identities=24% Similarity=0.271 Sum_probs=190.8
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecC------CeEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRIL 682 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~~~l 682 (931)
.|++.+.||+|+||.||+|++. +|+.||||++.... +.+.+|+++|++++||||+++++++... ...++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4666889999999999999986 58999999986532 2345799999999999999999988532 23679
Q ss_pred EEEecCCCCHHHHhccC-CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC-CceEEeccccccc
Q 002358 683 VYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQ 760 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~-~~vkL~DFGla~~ 760 (931)
||||+++ +|.+.+... .....+++..+..++.||++||+|||+ .+|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999975 565554421 135678999999999999999999998 899999999999999965 5689999999987
Q ss_pred ccccccccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh-------hh
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-------IK 832 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~-------~~ 832 (931)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+.+.++.. +.
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHH
T ss_pred cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHH
Confidence 543322 2234689999999998764 78999999999999999999999997543221 121111100 00
Q ss_pred --cCCeeecccccccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 833 --KGDVISIVDPVLIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 833 --~~~~~~i~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.....+..-+.+.. .++......+.+++.+||+.||++||++.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00111111111100 011122346889999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=336.90 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=180.9
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecC------Ce
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 679 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~ 679 (931)
..|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 35667899999999999999875 68999999986532 23456788999999999999999999998654 56
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 680 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
.++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 109 ~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred EEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 79999999 7899888763 468999999999999999999998 899999999999999999999999999998
Q ss_pred cccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeee
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 838 (931)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+.. ..+.+.+... ..+
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~p-~~~ 252 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVGTP-GAE 252 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSC-CHH
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCC-CHH
Confidence 65432 223468999999999877 68899999999999999999999999754432211 1111111100 000
Q ss_pred cccc-----------ccc--CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 839 IVDP-----------VLI--GNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 839 i~d~-----------~l~--~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+.. .+. ...+ ......+.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000 000 0000 011235789999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=330.46 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=202.0
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchh-----------------hhhHHHHHHHHHhcCCCCCccee
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR-----------------TQQFVTEVALLSRIHHRNLVPLI 671 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~-----------------~~~~~~E~~il~~l~HpnIv~l~ 671 (931)
..|++.+.||+|+||.||+|.. +|+.||+|++....... .+.+.+|++++++++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3566789999999999999999 89999999986432111 17899999999999999999999
Q ss_pred EEEecCCeEEEEEEecCCCCHHHH------hccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc
Q 002358 672 GYCEEEHQRILVYEYMHNGTLRDR------LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 745 (931)
Q Consensus 672 g~~~~~~~~~lV~E~~~~gsL~~~------L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld 745 (931)
+++.+.+..++||||+++|+|.++ +... ....+++..+..++.|+++||+|||+ ..+++||||||+||+++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 999999999999999999999998 5432 25679999999999999999999996 37999999999999999
Q ss_pred CCCceEEecccccccccccccccccccccCCCccCCCccCCC-CCCc-cchhHHHHHHHHHHHhCCCCCCccCccchhhH
Q 002358 746 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTE-KSDVYSFGVVLLELISGKKPVSVEDFGAELNI 823 (931)
Q Consensus 746 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~-ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l 823 (931)
.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||...... ...
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~ 261 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VEL 261 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH
Confidence 9999999999999875433 22344689999999999877 6666 999999999999999999999743321 122
Q ss_pred HHHHHHhhhcCCeeeccc------cccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 824 VHWARSMIKKGDVISIVD------PVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 824 ~~~~~~~~~~~~~~~i~d------~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+. +..+......+ +... ..........+.+++.+||+.||++||+++|+++
T Consensus 262 ~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 FNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 221 11221110000 0000 0000122346889999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=335.49 Aligned_cols=201 Identities=24% Similarity=0.379 Sum_probs=154.5
Q ss_pred HHhh-ccccCccCcEEEEEEEEC---CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEe--cCCeEEEE
Q 002358 610 TNNF-CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILV 683 (931)
Q Consensus 610 ~~~~-~~~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~~~lV 683 (931)
.|++ .++||+|+||.||+|+++ +++.||||++.... ..+.+.+|+++|++++||||+++++++. .....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3444 568999999999999976 47899999997542 2346889999999999999999999994 46789999
Q ss_pred EEecCCCCHHHHhccCC------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc----cCCCceEEe
Q 002358 684 YEYMHNGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVS 753 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl----d~~~~vkL~ 753 (931)
|||++ |+|.+.+.... ....+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99996 57877765211 22358999999999999999999998 899999999999999 678899999
Q ss_pred ccccccccccccc--ccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccC
Q 002358 754 DFGLSRQAEEDLT--HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVED 816 (931)
Q Consensus 754 DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~ 816 (931)
|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999987654321 22234568999999999877 458999999999999999999999997443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=322.70 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=194.1
Q ss_pred HHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCcc--chhhhhHHHHHHHHHhcC--CCCCcceeEEEecCCeEEE
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~~~~~~l 682 (931)
....|++.+.||+|+||.||++...+++.||||++.... ....+.+.+|++++++++ ||||+++++++......++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 334567789999999999999999889999999986432 334578899999999997 5999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||| +.+++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||+++ +.+||+|||+++...
T Consensus 106 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999 668999999984 3578999999999999999999998 89999999999999964 899999999998764
Q ss_pred ccccc-cccccccCCCccCCCccCC-----------CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh
Q 002358 763 EDLTH-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 830 (931)
Q Consensus 763 ~~~~~-~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 830 (931)
..... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .. ......
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~----~~~~~~ 252 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QI----SKLHAI 252 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-HH----HHHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-HH----HHHHHH
Confidence 43221 2233468999999999865 4788899999999999999999999963221 11 111111
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 831 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 831 ~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...... ...+......+.+++.+||+.+|++||+++|+++
T Consensus 253 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 253 IDPNHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HCTTSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Hhcccc---------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 211111 1111111246889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=334.17 Aligned_cols=263 Identities=19% Similarity=0.245 Sum_probs=185.1
Q ss_pred HHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe------
Q 002358 607 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------ 679 (931)
Q Consensus 607 ~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~------ 679 (931)
.-..|++.+.||+|+||.||+|++. +|+.||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 3445667899999999999999986 68999999886542 233466788888999999999999999865433
Q ss_pred -EEEEEEecCCCCHHHHhcc-CCCCCCCCHHHHHHHHHHHHHHhHHhh--hcCCCCeEecCCCCCCccccC-CCceEEec
Q 002358 680 -RILVYEYMHNGTLRDRLHG-SVNQKPLDWLTRLQIAHDAAKGLEYLH--TGCNPGIIHRDVKSSNILLDI-NMRAKVSD 754 (931)
Q Consensus 680 -~~lV~E~~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~qia~aL~yLH--~~~~~~ivH~DIkp~NILld~-~~~vkL~D 754 (931)
.++||||+++ +|.+.+.. ......+++..+..++.|++.||.||| + .+|+||||||+|||++. ++.+||+|
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEee
Confidence 7899999986 44443321 224567889999999999999999999 6 89999999999999996 89999999
Q ss_pred ccccccccccccccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc
Q 002358 755 FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 833 (931)
Q Consensus 755 FGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 833 (931)
||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+..... .. +.+....
T Consensus 176 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~-~~~~~~~ 250 (360)
T 3e3p_A 176 FGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HE-IVRVLGC 250 (360)
T ss_dssp CTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHHHCC
T ss_pred CCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HH-HHHHcCC
Confidence 999987654332 2234589999999998654 4899999999999999999999999754332211 11 1111100
Q ss_pred C------------Ceeeccc------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 834 G------------DVISIVD------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 834 ~------------~~~~i~d------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. ......+ ..............+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0000000 00001112223457899999999999999999999875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=330.05 Aligned_cols=200 Identities=28% Similarity=0.309 Sum_probs=170.1
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CC-----CCcceeEEEecCCeEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HR-----NLVPLIGYCEEEHQRI 681 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-Hp-----nIv~l~g~~~~~~~~~ 681 (931)
..|++.+.||+|+||.||+|... +++.||||+++.. ....+++.+|+++++.++ |+ +|+++++++...+..+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 45777899999999999999876 6889999999753 234567788999999885 55 4999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc--CCCceEEecccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSR 759 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld--~~~~vkL~DFGla~ 759 (931)
+||||+. |+|.+++... ....+++..+..++.|++.||.|||+. +.+|+||||||+|||++ .++.+||+|||+++
T Consensus 133 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 9999996 5999998754 234589999999999999999999942 27999999999999995 47889999999998
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccC
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~ 816 (931)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 210 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 210 QLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 76432 223468999999999999999999999999999999999999997543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=329.25 Aligned_cols=262 Identities=21% Similarity=0.317 Sum_probs=198.6
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcC-----------CCCCcceeEEEe
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----------HRNLVPLIGYCE 675 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~g~~~ 675 (931)
...|.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 346778899999999999999975 6899999998753 334567889999999886 899999999987
Q ss_pred cCC----eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCC-CeEecCCCCCCcccc-----
Q 002358 676 EEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLD----- 745 (931)
Q Consensus 676 ~~~----~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~ivH~DIkp~NILld----- 745 (931)
... ..++|||++ +++|.+++... ....+++..+..++.||+.||+|||+ . +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence 654 789999999 89999998754 23458999999999999999999998 6 999999999999995
Q ss_pred -CCCceEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccch---h
Q 002358 746 -INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE---L 821 (931)
Q Consensus 746 -~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~---~ 821 (931)
..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 34479999999998664332 234589999999999999999999999999999999999999974432211 1
Q ss_pred hHHHHHHHhhhc--------C----------Ceee-ccccc-------c--cCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 002358 822 NIVHWARSMIKK--------G----------DVIS-IVDPV-------L--IGNVKIESIWRIAEVAIQCVEQRGFSRPK 873 (931)
Q Consensus 822 ~l~~~~~~~~~~--------~----------~~~~-i~d~~-------l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 873 (931)
.....+...+.. + .... +.... + ....+......+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111111100 0 0000 00000 0 01234566778999999999999999999
Q ss_pred HHHHHH
Q 002358 874 MQEIVL 879 (931)
Q Consensus 874 ~~evl~ 879 (931)
++|+++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=328.27 Aligned_cols=263 Identities=19% Similarity=0.265 Sum_probs=200.8
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEEC-CC-cEEEEEEccCccchhhhhHHHHHHHHHhcCCCC------CcceeEEEe
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMK-DG-KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN------LVPLIGYCE 675 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g-~~vAvK~~~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~g~~~ 675 (931)
++.....|++.+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++.
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 3344556788899999999999999875 34 68999999753 334567889999999998765 899999999
Q ss_pred cCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc-----------
Q 002358 676 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----------- 744 (931)
Q Consensus 676 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl----------- 744 (931)
..+..++||||+ +++|.+.+... ....+++..+..++.||++||+|||+ .+|+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECC
T ss_pred eCCeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccc
Confidence 999999999999 66777776643 23568999999999999999999998 899999999999999
Q ss_pred --------cCCCceEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccC
Q 002358 745 --------DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816 (931)
Q Consensus 745 --------d~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~ 816 (931)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 66889999999999764332 223468999999999999999999999999999999999999997443
Q ss_pred ccchhhHHHHHHHhhhc--------CCeeecc-c-------------------ccc--cCCCCHHHHHHHHHHHHHcccc
Q 002358 817 FGAELNIVHWARSMIKK--------GDVISIV-D-------------------PVL--IGNVKIESIWRIAEVAIQCVEQ 866 (931)
Q Consensus 817 ~~~~~~l~~~~~~~~~~--------~~~~~i~-d-------------------~~l--~~~~~~~~~~~l~~li~~Cl~~ 866 (931)
....... +...... ....... . +.+ ...........+.+++.+||+.
T Consensus 244 ~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 244 NREHLVM---MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp HHHHHHH---HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred HHHHHHH---HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 3221111 1111100 0000000 0 000 0011223445788999999999
Q ss_pred CCCCCCCHHHHHH
Q 002358 867 RGFSRPKMQEIVL 879 (931)
Q Consensus 867 dP~~RPs~~evl~ 879 (931)
||++|||++|+++
T Consensus 321 dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 321 DPAQRITLAEALL 333 (355)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=330.68 Aligned_cols=258 Identities=21% Similarity=0.252 Sum_probs=195.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecC-----CeEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 682 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-----~~~~l 682 (931)
.|++.+.||+|+||.||+|.+. +|+.||||++..... .....+.+|++++++++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 4567889999999999999987 689999999975432 3456788999999999999999999988654 67899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||||+. |+|.+.+.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 999997 689998874 468999999999999999999998 899999999999999999999999999998754
Q ss_pred ccccc---------cccccccCCCccCCCccC-CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh
Q 002358 763 EDLTH---------ISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 832 (931)
Q Consensus 763 ~~~~~---------~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 832 (931)
..... ......||+.|+|||++. +..++.++|||||||++|||++|+.||...+...... .+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~ 240 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFGIIG 240 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhC
Confidence 32211 112245899999999875 4788999999999999999999999997544321111 1111110
Q ss_pred cCC----eee--------cc-------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 833 KGD----VIS--------IV-------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 833 ~~~----~~~--------i~-------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
... ... .+ ...+. .........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 000 00 00000 000112346789999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.29 Aligned_cols=254 Identities=27% Similarity=0.365 Sum_probs=202.8
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~ 680 (931)
.......|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3455678888999999999999999986 68999999986532 23456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC---CceEEecccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGL 757 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~---~~vkL~DFGl 757 (931)
++||||+++++|.+.+.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.+ +.+||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 999999999999998863 3468999999999999999999998 899999999999999754 4699999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 758 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 758 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
+........ .....|++.|+|||.+.+. ++.++||||||+++|+|++|+.||...... .... .+..+...
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~ 240 (287)
T 2wei_A 171 STCFQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILK----RVETGKYA 240 (287)
T ss_dssp GGTBCCCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCCC
T ss_pred ceeecCCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHcCCCC
Confidence 986543322 1223478999999998764 899999999999999999999999743221 1111 12222211
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. +....... ...+.+++.+||+.+|++|||++|+++
T Consensus 241 ~--~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 F--DLPQWRTI----SDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp C--CSGGGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C--Cchhhhhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 00001112 236789999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=329.81 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=193.0
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeE-----
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR----- 680 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~----- 680 (931)
..|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 35667889999999999999876 68999999997643 23357789999999999999999999999877654
Q ss_pred -EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 681 -ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 681 -~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
++||||+. ++|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 122 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred EEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999997 68888774 348999999999999999999998 899999999999999999999999999998
Q ss_pred cccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeee
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 838 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 838 (931)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.. ..+....... ..+
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~-~~~ 264 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVP-GTE 264 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCC-CHH
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCC-cHH
Confidence 65432 223458999999999877 78899999999999999999999999754322111 1111100000 000
Q ss_pred cc---------------cccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 839 IV---------------DPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 839 i~---------------d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. ....... ........+.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00 0000000 00112346889999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=328.26 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=192.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe------E
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------R 680 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~------~ 680 (931)
.|.+.+.||+|+||.||+|.++ +|+.||||++.... ....+.+.+|+.++++++||||+++++++..... .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 4566789999999999999986 68999999986542 2335678999999999999999999999987654 4
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+. |+|.+.+. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp EEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 99999997 68877764 248999999999999999999998 8999999999999999999999999999986
Q ss_pred ccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcC-----
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG----- 834 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~----- 834 (931)
.... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+. ...+.......
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFV 248 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHHH
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHH
Confidence 5432 223458999999999877 6789999999999999999999999975433211 11111110000
Q ss_pred -------------CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 835 -------------DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 835 -------------~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.......+.+ ..........+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 0111223347889999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=324.69 Aligned_cols=253 Identities=26% Similarity=0.345 Sum_probs=176.3
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-hhhhhHHHHHH-HHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
.+++.+.||+|+||.||+|..+ +|+.||||+++.... ....++..|+. +++.++||||+++++++...+..++||||
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence 3556789999999999999986 689999999976432 33455666666 67778999999999999999999999999
Q ss_pred cCCCCHHHHhccC--CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCC-CeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 687 MHNGTLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 687 ~~~gsL~~~L~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
+++ +|.+.+... .....+++..+..++.|+++||.|||+ . +|+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 985 787776521 124668999999999999999999998 6 999999999999999999999999999987644
Q ss_pred cccccccccccCCCccCCCcc----CCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 764 DLTHISSVARGTVGYLDPEYY----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l----~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||...... .+...... .+..
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~~~~--- 247 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQLTQVV-KGDP--- 247 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC-CSCC---
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHHHHHHh-cCCC---
Confidence 322 2223589999999998 4567899999999999999999999999732211 01111111 1111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+.+...........+.+++.+||+.||++||+++|+++
T Consensus 248 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 --PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111122346889999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=334.35 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=184.4
Q ss_pred ccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 5789999999998777778999999998643 235678899999987 89999999999999999999999995 699
Q ss_pred HHHhccCCCCC----CCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC-------------CceEEecc
Q 002358 693 RDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-------------MRAKVSDF 755 (931)
Q Consensus 693 ~~~L~~~~~~~----~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~-------------~~vkL~DF 755 (931)
.+++....... ...+..++.++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99997542111 11233457899999999999998 899999999999999754 48999999
Q ss_pred cccccccccccc---cccccccCCCccCCCccCC-------CCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHH
Q 002358 756 GLSRQAEEDLTH---ISSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 824 (931)
Q Consensus 756 Gla~~~~~~~~~---~~~~~~gt~~y~APE~l~~-------~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~ 824 (931)
|+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||..... ...++
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-~~~~i- 250 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS-RESNI- 250 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT-HHHHH-
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh-hHHHH-
Confidence 999876543222 1223469999999999865 678999999999999999999 9999963221 11111
Q ss_pred HHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 825 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 825 ~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..... .. +......+......+.+++.+||+.||++||++.|+++
T Consensus 251 --~~~~~---~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 251 --IRGIF---SL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHTCC---CC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --hcCCC---Cc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11110 00 01111123445567899999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=321.98 Aligned_cols=250 Identities=20% Similarity=0.291 Sum_probs=169.9
Q ss_pred HHhhc-cccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEec----CCeEEEE
Q 002358 610 TNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILV 683 (931)
Q Consensus 610 ~~~~~-~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~~~lV 683 (931)
.|.+. +.||+|+||.||+|.++ +|+.||||++.... +...+....++.++||||+++++++.. ....++|
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 45553 46999999999999987 68999999986531 122223334566799999999999876 4558999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC---CCceEEeccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ 760 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~ 760 (931)
|||+++|+|.+++... ....+++..++.++.|+++||+|||+ .+|+||||||+|||++. ++.+||+|||+++.
T Consensus 105 ~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 105 MECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 9999999999999854 23579999999999999999999998 89999999999999976 45599999999976
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ......+..+.. ...
T Consensus 181 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~-~~~ 253 (336)
T 3fhr_A 181 TTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---PGMKRRIRLGQY-GFP 253 (336)
T ss_dssp C-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CCC
T ss_pred ccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---hhHHHhhhcccc-ccC
Confidence 54322 22345899999999999999999999999999999999999999633321110 000111111100 000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+ . .......+.+++.+||+.||++|||++|+++
T Consensus 254 ~~-~----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 254 NP-E----WSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp TT-T----STTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ch-h----hccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0 1122346889999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=321.99 Aligned_cols=244 Identities=26% Similarity=0.421 Sum_probs=189.8
Q ss_pred hhHHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc------hhhhhHHHHHHHHHhc----CCCCCcceeE
Q 002358 604 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRI----HHRNLVPLIG 672 (931)
Q Consensus 604 ~~l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~il~~l----~HpnIv~l~g 672 (931)
.+.....|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3455677888999999999999999875 688999999965432 2334567899999999 8999999999
Q ss_pred EEecCCeEEEEEEe-cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc-CCCce
Q 002358 673 YCEEEHQRILVYEY-MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRA 750 (931)
Q Consensus 673 ~~~~~~~~~lV~E~-~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld-~~~~v 750 (931)
++...+..++|+|+ +.+++|.+++.. ...+++..++.++.|+++||+|||+ .+|+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeE
Confidence 99999999999999 789999999974 3468999999999999999999998 8999999999999999 88999
Q ss_pred EEecccccccccccccccccccccCCCccCCCccCCCCCC-ccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHH
Q 002358 751 KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 829 (931)
Q Consensus 751 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 829 (931)
||+|||+++...... .....|++.|+|||++.+..+. .++||||||+++|||++|+.||.... ..
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~------ 245 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EI------ 245 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH------
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HH------
Confidence 999999998764432 2234589999999998766654 58999999999999999999996211 10
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 830 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. ... .+ +......+.+++.+||+.+|++||+++|+++
T Consensus 246 -~~-~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 -LE-AEL------HF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HH-TCC------CC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -hh-hcc------CC----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 100 01 1112236789999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=315.70 Aligned_cols=249 Identities=23% Similarity=0.335 Sum_probs=177.7
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch-h-hhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-R-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-~-~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
.|++.+.||+|+||.||+|.++ +|+.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 4567789999999999999986 6899999998754322 2 23445555678888999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCC-CeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
+ ++.+...... ....+++..+..++.|+++||+|||+ . +++||||||+||+++.++.+||+|||++.......
T Consensus 106 ~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 106 M-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp C-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred c-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 9 5566655542 24568999999999999999999997 5 99999999999999999999999999997654332
Q ss_pred cccccccccCCCccCCCccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 766 THISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
. .....|++.|+|||.+. ...++.++||||||+++|||++|+.||..... .... ........ .....
T Consensus 180 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~---~~~~~~~~-~~~~~ 251 (318)
T 2dyl_A 180 A--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEV---LTKVLQEE-PPLLP 251 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHH---HHHHHHSC-CCCCC
T ss_pred c--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHH---HHHHhccC-CCCCC
Confidence 2 22345899999999984 56788999999999999999999999973221 1111 11122211 11110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. ... ....+.+++.+||+.||++||+++|+++
T Consensus 252 ~---~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 252 G---HMG----FSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp S---SSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c---cCC----CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 001 1236789999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=346.04 Aligned_cols=269 Identities=22% Similarity=0.313 Sum_probs=205.6
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEec------CCeE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQR 680 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~~ 680 (931)
..|++.+.||+|+||.||+|.+. +|+.||||+++... ....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 56888999999999999999875 68999999987643 3445779999999999999999999998765 6778
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCc---eEEecccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGL 757 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~---vkL~DFGl 757 (931)
++||||+++|+|.+++........+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 9999999999999999875555578999999999999999999998 89999999999999997665 99999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 758 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 758 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
+........ .....||+.|+|||.+.+..++.++||||||+++|||++|..||..... ...|...........
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC------
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccchh
Confidence 987654322 2335689999999999999999999999999999999999999963221 122221111111111
Q ss_pred eccccc------------ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHhhhhh
Q 002358 838 SIVDPV------------LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQE-----IVLAIQDSIKI 887 (931)
Q Consensus 838 ~i~d~~------------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e-----vl~~L~~~~~~ 887 (931)
...... ............+.+++.+||+.||++|||++| +.+.++++...
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 111100 111233446678999999999999999999988 44556655543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=322.99 Aligned_cols=240 Identities=25% Similarity=0.392 Sum_probs=196.0
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccch------hhhhHHHHHHHHHhcC--CCCCcceeEEEecCC
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIH--HRNLVPLIGYCEEEH 678 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~il~~l~--HpnIv~l~g~~~~~~ 678 (931)
...|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++ |+||+++++++...+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 445777899999999999999875 6899999998654221 2356778999999996 599999999999999
Q ss_pred eEEEEEEecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc-CCCceEEeccc
Q 002358 679 QRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFG 756 (931)
Q Consensus 679 ~~~lV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld-~~~~vkL~DFG 756 (931)
..++|+|++.+ ++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++ +++.+||+|||
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred cEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999986 899999874 4568999999999999999999998 8999999999999999 78999999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCC-CccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCC
Q 002358 757 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 835 (931)
Q Consensus 757 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 835 (931)
+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .. .. +.
T Consensus 196 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~-------~~-~~ 259 (320)
T 3a99_A 196 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-------IR-GQ 259 (320)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-------HH-CC
T ss_pred ccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hh-------hc-cc
Confidence 998765332 223458999999999876665 678999999999999999999996221 00 11 11
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 836 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 836 ~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. ...... ...+.+++.+||+.+|++||+++||++
T Consensus 260 ~------~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 V------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp C------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c------cccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011112 236789999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=329.38 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=183.8
Q ss_pred HHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.+++.+.||+|+||+||.....+++.||||++.... ...+.+|+++|+++ +|||||++++++.+....++||||+.
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 355578999999999776666679999999986532 23467899999999 79999999999999999999999996
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC-----CCceEEecccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~-----~~~vkL~DFGla~~~~~ 763 (931)
|+|.+++.... .......++.++.||++||+|||+ .+|+||||||+|||++. ...+||+|||+++....
T Consensus 102 -g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 102 -ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp -EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred -CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 69999997542 234444567899999999999998 89999999999999943 23578999999987653
Q ss_pred ccc--ccccccccCCCccCCCccC---CCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 764 DLT--HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 764 ~~~--~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
... .......||+.|+|||++. ...++.++|||||||++|||++ |..||..... ... ....... ..
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-~~~------~~~~~~~-~~ 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-RQA------NILLGAC-SL 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-HHH------HHHTTCC-CC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-HHH------HHHhccC-Cc
Confidence 321 2233456999999999997 4567889999999999999999 9999863221 111 1111111 11
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... ........+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 DCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111 11223345789999999999999999999983
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=303.87 Aligned_cols=237 Identities=14% Similarity=0.192 Sum_probs=184.3
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
+....|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++.+++||||+++++++.+.+..+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 33455778899999999999999987 489999999976432 23477999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+||||+++++|.++++. . .....+.+++.|+++||+|||+ .+|+||||||+|||++.++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 99999999999999863 2 3455788999999999999998 899999999999999999999998543
Q ss_pred cccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
|++ .++.++|||||||++|||++|+.||............ ..... +.. ..
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~-~~~---~~ 224 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTA-GQP---IE 224 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCTT-SCB---CC
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHhc-cCC---CC
Confidence 333 2688999999999999999999999754332110000 00000 000 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
+ ..........+.+++.+||+.||++| |++|+++.|+++.....
T Consensus 225 ~---~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 225 P---ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp H---HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred h---hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0 00111223468899999999999999 99999999999876554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=346.81 Aligned_cols=242 Identities=18% Similarity=0.283 Sum_probs=193.8
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC--CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCe---
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ--- 679 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~--~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~--- 679 (931)
+....|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 33456788899999999999999986 58999999986543 3345678999999999999999999999987655
Q ss_pred --EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccc
Q 002358 680 --RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 757 (931)
Q Consensus 680 --~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGl 757 (931)
.++||||+++++|.+.+.. .+++..++.++.||++||.|||+ .+|+||||||+|||++.+ .+||+|||+
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEeccc
Confidence 7999999999999887652 68999999999999999999998 899999999999999885 899999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 758 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 758 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
++..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||....... +.
T Consensus 228 a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~ 285 (681)
T 2pzi_A 228 VSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LP 285 (681)
T ss_dssp CEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CC
T ss_pred chhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------cc
Confidence 9875433 3346899999999987654 889999999999999999998886321110 00
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhh
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSI 885 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~~~ 885 (931)
...........+.+++.+||+.||++|| +++++.+.|....
T Consensus 286 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0000011224678999999999999999 5777777776654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-32 Score=297.69 Aligned_cols=224 Identities=21% Similarity=0.305 Sum_probs=175.0
Q ss_pred Hhhc-cccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHH-HhcCCCCCcceeEEEec----CCeEEEE
Q 002358 611 NNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALL-SRIHHRNLVPLIGYCEE----EHQRILV 683 (931)
Q Consensus 611 ~~~~-~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~g~~~~----~~~~~lV 683 (931)
|.+. +.||+|+||.||+|... +++.||+|+++.. ..+.+|++++ +.++||||+++++++.. ....++|
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 3444 77999999999999885 6899999998642 4567888888 55689999999999876 6778999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC---CCceEEeccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ 760 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~~ 760 (931)
|||+++|+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||++..
T Consensus 94 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 94 MECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp ECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 9999999999999864 33569999999999999999999998 89999999999999998 78899999999864
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
.. +..++.++|||||||++|||++|+.||........ .......+.
T Consensus 170 ~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~~ 215 (299)
T 3m2w_A 170 TT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRIR 215 (299)
T ss_dssp CT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSC
T ss_pred cc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHHh
Confidence 32 23467899999999999999999999963322110 000000000
Q ss_pred cccccCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPVLIGNVK----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... ..+ ......+.+++.+||+.||++|||++|+++
T Consensus 216 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 216 MGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp TTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 011 112346889999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=315.60 Aligned_cols=237 Identities=16% Similarity=0.135 Sum_probs=177.0
Q ss_pred hhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCC-CCC---------cceeEE----
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHH-RNL---------VPLIGY---- 673 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~H-pnI---------v~l~g~---- 673 (931)
...+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++.++| +|. +.....
T Consensus 81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (413)
T 3dzo_A 81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160 (413)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence 34678999999999999965 699999999874322 235779999999999977 221 111111
Q ss_pred --------Eec-----CCeEEEEEEecCCCCHHHHhcc----CCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecC
Q 002358 674 --------CEE-----EHQRILVYEYMHNGTLRDRLHG----SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 736 (931)
Q Consensus 674 --------~~~-----~~~~~lV~E~~~~gsL~~~L~~----~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~D 736 (931)
+.. ....+++|+.+ +++|.+++.. ......+++..++.++.|+++||+|||+ .+|+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrD 236 (413)
T 3dzo_A 161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTY 236 (413)
T ss_dssp C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSC
T ss_pred CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence 111 12346666655 6899988842 1134567888999999999999999998 8999999
Q ss_pred CCCCCccccCCCceEEecccccccccccccccccccccCCCccCCCcc----------CCCCCCccchhHHHHHHHHHHH
Q 002358 737 VKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY----------GNQQLTEKSDVYSFGVVLLELI 806 (931)
Q Consensus 737 Ikp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l----------~~~~~s~ksDVwSlGvlL~eLl 806 (931)
|||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999998865443 233457 999999998 6667899999999999999999
Q ss_pred hCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002358 807 SGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878 (931)
Q Consensus 807 tG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 878 (931)
+|+.||......... ..++.. .... +..+.+++.+||+.+|++||++.|++
T Consensus 312 tg~~Pf~~~~~~~~~---------------~~~~~~--~~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 312 CADLPNTDDAALGGS---------------EWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HSSCCCCTTGGGSCS---------------GGGGSS--CCCC----CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HCCCCCCCcchhhhH---------------HHHHhh--cccC----CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999743321110 011110 0112 24688999999999999999977774
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-33 Score=311.76 Aligned_cols=243 Identities=18% Similarity=0.226 Sum_probs=184.6
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccc--------hhhhhHHHHHHHHHhcC---------CCCCc
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIH---------HRNLV 668 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~---------HpnIv 668 (931)
+....|++.+.||+|+||.||+|++ +|+.||||++..... ...+.+.+|+++++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3456788899999999999999998 589999999875421 22367889999999886 88888
Q ss_pred ceeEEEe------------------------------cCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 002358 669 PLIGYCE------------------------------EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 718 (931)
Q Consensus 669 ~l~g~~~------------------------------~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia 718 (931)
++.+.+. .....++||||+++|++.+.+.. ..+++..+..++.||+
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLT 171 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHH
Confidence 7777642 26789999999999977666642 4589999999999999
Q ss_pred HHhHHhh-hcCCCCeEecCCCCCCccccCCC--------------------ceEEecccccccccccccccccccccCCC
Q 002358 719 KGLEYLH-TGCNPGIIHRDVKSSNILLDINM--------------------RAKVSDFGLSRQAEEDLTHISSVARGTVG 777 (931)
Q Consensus 719 ~aL~yLH-~~~~~~ivH~DIkp~NILld~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 777 (931)
.||+||| + .+|+||||||+|||++.++ .+||+|||+++..... ...||+.
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 7 8999999999999999887 8999999999876432 2368999
Q ss_pred ccCCCccCCCCCCccchhHHHHHH-HHHHHhCCCCCCccCccchhhHHHHHHHhhh-cCCeeecccccccCCCCHHHHHH
Q 002358 778 YLDPEYYGNQQLTEKSDVYSFGVV-LLELISGKKPVSVEDFGAELNIVHWARSMIK-KGDVISIVDPVLIGNVKIESIWR 855 (931)
Q Consensus 778 y~APE~l~~~~~s~ksDVwSlGvl-L~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~-~~~~~~i~d~~l~~~~~~~~~~~ 855 (931)
|+|||++.+.. +.++||||++++ .+++++|..||... .........+. ..... ..............
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccC----cccchhhhhhcCHH
Confidence 99999998766 889999998777 77788899998511 01011111111 10110 00011112345567
Q ss_pred HHHHHHHccccCCCCCCCHHHHH
Q 002358 856 IAEVAIQCVEQRGFSRPKMQEIV 878 (931)
Q Consensus 856 l~~li~~Cl~~dP~~RPs~~evl 878 (931)
+.+++.+||+.+ |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 899999999866 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-27 Score=281.35 Aligned_cols=186 Identities=17% Similarity=0.141 Sum_probs=130.6
Q ss_pred cccCccCcEEEEEEEE-CCCcEEEEEEccCcc----------chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEE
Q 002358 615 KKIGKGSFGSVYYGKM-KDGKEVAVKIMADSC----------SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~-~~g~~vAvK~~~~~~----------~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~l 682 (931)
...+.|++|.+..++. --|+.+|+|++.... ....++|.+|+++|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 4567777776666543 258999999986532 12345799999999999 69999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||||++|++|.+.|.. .+.++.. +|+.||+.||+|||+ ++||||||||+|||+++++.+||+|||+++...
T Consensus 320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999984 4556653 588999999999998 999999999999999999999999999998765
Q ss_pred ccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCC
Q 002358 763 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~P 811 (931)
..... .....||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 391 ~~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 44332 234569999999999876 467789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.4e-24 Score=251.76 Aligned_cols=183 Identities=17% Similarity=0.204 Sum_probs=146.0
Q ss_pred ccccCccCcEEEEEEEECCCcEEEEEEccCccc--------hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.+.||+|+||.||+|.+. ++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 568999999999999554 78899988643211 123558999999999999999977666667777899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. .+||+|||+++......
T Consensus 420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999873 46899999999999998 89999999999999998 99999999999865432
Q ss_pred ccc------ccccccCCCccCCCccCC--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 002358 766 THI------SSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVS 813 (931)
Q Consensus 766 ~~~------~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvlL~eLltG~~Pf~ 813 (931)
... .....||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 221 234569999999999976 567888999999999888888777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.8e-21 Score=210.25 Aligned_cols=141 Identities=15% Similarity=0.113 Sum_probs=115.1
Q ss_pred hccccCccCcEEEEEEEECCCcEEEEEEccCccc------------------hhhhhHHHHHHHHHhcCCCCCcceeEEE
Q 002358 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 674 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~------------------~~~~~~~~E~~il~~l~HpnIv~l~g~~ 674 (931)
+.+.||+|+||.||+|.+.+|+.||+|+++.... .....+.+|++++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 3588999999999999997799999999864321 13456899999999999 4 6666655
Q ss_pred ecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEec
Q 002358 675 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 754 (931)
Q Consensus 675 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~D 754 (931)
.. +..++||||+++|+|.+ +.. .....++.|+++||.|||+ .+|+||||||+|||++ ++.+||+|
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECC
T ss_pred ec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 43 45699999999999988 531 1245799999999999998 9999999999999999 99999999
Q ss_pred ccccccccccccccccccccCCCccCCCccC
Q 002358 755 FGLSRQAEEDLTHISSVARGTVGYLDPEYYG 785 (931)
Q Consensus 755 FGla~~~~~~~~~~~~~~~gt~~y~APE~l~ 785 (931)
||+++. +..++|||++.
T Consensus 236 FG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE--------------TTSTTHHHHHH
T ss_pred CCCCeE--------------CCCCCHHHHHH
Confidence 999863 34578888864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.6e-17 Score=178.20 Aligned_cols=135 Identities=23% Similarity=0.246 Sum_probs=105.3
Q ss_pred hhccccCccCcEEEEEEEE-CCCcE--EEEEEccCccch------------------------hhhhHHHHHHHHHhcCC
Q 002358 612 NFCKKIGKGSFGSVYYGKM-KDGKE--VAVKIMADSCSH------------------------RTQQFVTEVALLSRIHH 664 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~-~~g~~--vAvK~~~~~~~~------------------------~~~~~~~E~~il~~l~H 664 (931)
++.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|+++|.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3567899999999999998 67989 999987543111 11367899999999998
Q ss_pred CCC--cceeEEEecCCeEEEEEEecCC-C----CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhh-hcCCCCeEecC
Q 002358 665 RNL--VPLIGYCEEEHQRILVYEYMHN-G----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH-TGCNPGIIHRD 736 (931)
Q Consensus 665 pnI--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~ivH~D 736 (931)
+++ ..+++. ...++||||+.+ | +|.+.... .++..+..++.|+++||.||| + .+|+|||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~givHrD 196 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE---AELVHAD 196 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence 864 334432 356899999942 4 67776432 224456789999999999999 7 8999999
Q ss_pred CCCCCccccCCCceEEecccccccc
Q 002358 737 VKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 737 Ikp~NILld~~~~vkL~DFGla~~~ 761 (931)
|||+|||+++ .++|+|||++...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.68 E-value=3.9e-17 Score=180.24 Aligned_cols=150 Identities=27% Similarity=0.494 Sum_probs=130.2
Q ss_pred CchhhHHHHHHHHhhcCCC-CCCCCCC-CCCCCCCCceEEeeCCC-CCcEEEEEeCCCCCcc--cCCccccCccccceec
Q 002358 369 TEWQDVMVLEALRSISDES-ERTNDRG-DPCVPVPWEWVTCSTTT-PPRITKIALSGKNLKG--EIPPELKNMEALTELW 443 (931)
Q Consensus 369 t~~~d~~~L~~l~~~~~~~-~~~~w~~-dpc~~~~w~~v~c~~~~-~~~l~~L~L~~n~l~g--~ip~~~~~L~~L~~L~ 443 (931)
..++|..||.++|+.+..+ ...+|.. .+||.+.|.||.|+... ..+|+.|+|++|+++| .+|+.|++|++|+.|+
T Consensus 3 c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~ 82 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred CCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeee
Confidence 5678999999999998543 4557753 34444569999997542 3589999999999999 9999999999999999
Q ss_pred ccC-CcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccccccccCCCCCCCccccc--CceeeeecCCCC
Q 002358 444 LDG-NFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPK 518 (931)
Q Consensus 444 Ls~-N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~~ 518 (931)
|++ |++.+.+| .|+++++|+.|+|++|+++|.+|..++++++|+.|+|++|+++|.+|..+.. .+..+.+++|..
T Consensus 83 L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 161 (313)
T 1ogq_A 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcc
Confidence 995 99999999 5999999999999999999999999999999999999999999999988754 778888888864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.1e-16 Score=194.61 Aligned_cols=166 Identities=19% Similarity=0.234 Sum_probs=133.9
Q ss_pred CCccccchhhhhhhheeecc---cCCchhhHHHHHHHHhhcCCCCCCCCCCCC------CCCCCC------------ceE
Q 002358 347 DSTLGPLLNAIEISKYQKIA---AKTEWQDVMVLEALRSISDESERTNDRGDP------CVPVPW------------EWV 405 (931)
Q Consensus 347 ~s~l~p~ina~e~~~~~~~~---~~t~~~d~~~L~~l~~~~~~~~~~~w~~dp------c~~~~w------------~~v 405 (931)
.....-.-|+++-.+.+++. ..+..+|..||.++|+.+... +|+.+. |++|.| .||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV 317 (876)
T 4ecn_A 241 GESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGV 317 (876)
T ss_dssp CCCEEECTTSEEEEEEEEECCCCCCHHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTE
T ss_pred CCceEEeecccccccccceeccccccchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCce
Confidence 33333334443445555554 245568999999999998643 675322 223689 999
Q ss_pred EeeCCCCCcEEEEEeCCCCCcccCCccccCccccceecc-cCCcCCCC--------------------------------
Q 002358 406 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWL-DGNFLTGP-------------------------------- 452 (931)
Q Consensus 406 ~c~~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~L-s~N~l~g~-------------------------------- 452 (931)
+|++. .+|+.|+|++|+|.|.+|++|++|++|+.|+| ++|.++|.
T Consensus 318 ~C~~~--~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~ 395 (876)
T 4ecn_A 318 DLDNN--GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYD 395 (876)
T ss_dssp EECTT--SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCC
T ss_pred EecCC--CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccC
Confidence 99874 69999999999999999999999999999999 88766554
Q ss_pred --------------------------------------------CC-CccccccccEeecCCccccC-------------
Q 002358 453 --------------------------------------------LP-DMSRLIDLRIVHLENNELTG------------- 474 (931)
Q Consensus 453 --------------------------------------------~p-~~~~l~~L~~L~L~~N~l~g------------- 474 (931)
+| +|++|++|+.|+|++|+|+|
T Consensus 396 ~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n 475 (876)
T 4ecn_A 396 QRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD 475 (876)
T ss_dssp GGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSH
T ss_pred cchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccc
Confidence 66 58999999999999999998
Q ss_pred ----CCCCccC--CccccccccccccCCCCCCCccccc--CceeeeecCCC
Q 002358 475 ----SLPSYMG--SLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNP 517 (931)
Q Consensus 475 ----~iP~~l~--~l~~L~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~ 517 (931)
.||++++ +|++|+.|+|++|++.|.+|..+.. .+..+.+++|.
T Consensus 476 ~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 476 YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp HHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred cccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 4999998 9999999999999999999988765 78888899987
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.3e-15 Score=184.41 Aligned_cols=146 Identities=18% Similarity=0.237 Sum_probs=124.5
Q ss_pred CCchhhHHHHHHHHhhcCCCCCC----------CCCCCCCCCCCC---ceEEeeCCCCCcEEEEEeCCCCCcccCCcccc
Q 002358 368 KTEWQDVMVLEALRSISDESERT----------NDRGDPCVPVPW---EWVTCSTTTPPRITKIALSGKNLKGEIPPELK 434 (931)
Q Consensus 368 ~t~~~d~~~L~~l~~~~~~~~~~----------~w~~dpc~~~~w---~~v~c~~~~~~~l~~L~L~~n~l~g~ip~~~~ 434 (931)
.....|..||.+++..+....+. +|+.+.+ +|.| .||+|+.. .+|+.|+|++|+++|.+|++|+
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~-~c~w~~~~GV~C~~~--~~V~~L~L~~~~l~g~lp~~l~ 102 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKE-LDMWGAQPGVSLNSN--GRVTGLSLEGFGASGRVPDAIG 102 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSC-GGGTTCCTTEEECTT--CCEEEEECTTSCCEEEECGGGG
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCC-cccccCCCCeEEcCC--CCEEEEEecCcccCCcCChHHh
Confidence 34457999999999887644332 6764321 2369 99999865 5999999999999999999999
Q ss_pred CccccceecccCCc------------------------------------------------------------------
Q 002358 435 NMEALTELWLDGNF------------------------------------------------------------------ 448 (931)
Q Consensus 435 ~L~~L~~L~Ls~N~------------------------------------------------------------------ 448 (931)
+|++|+.|+|++|.
T Consensus 103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 182 (636)
T 4eco_A 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182 (636)
T ss_dssp GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred cCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence 99999999999984
Q ss_pred ------------CCCCCC-CccccccccEeecCCccccCC-----------------CCCccC--CccccccccccccCC
Q 002358 449 ------------LTGPLP-DMSRLIDLRIVHLENNELTGS-----------------LPSYMG--SLPNLQELHIENNSF 496 (931)
Q Consensus 449 ------------l~g~~p-~~~~l~~L~~L~L~~N~l~g~-----------------iP~~l~--~l~~L~~l~l~~N~l 496 (931)
|+| +| .+++|++|+.|+|++|+|+|. +|++++ +|++|+.|+|++|++
T Consensus 183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l 261 (636)
T 4eco_A 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261 (636)
T ss_dssp CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence 446 66 599999999999999999986 999999 999999999999999
Q ss_pred CCCCCccccc--CceeeeecCCC
Q 002358 497 VGEIPPALLT--GKVIFKYDNNP 517 (931)
Q Consensus 497 ~g~iP~~~~~--~~~~l~~~~N~ 517 (931)
.|.+|..+.. .+..+.+++|.
T Consensus 262 ~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 262 LTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CSSCCTTTTTCSSCCEEECTTCT
T ss_pred CccChHHHhcCCCCCEEECcCCC
Confidence 9999998765 78888889886
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.51 E-value=1.9e-14 Score=161.22 Aligned_cols=137 Identities=16% Similarity=0.148 Sum_probs=99.6
Q ss_pred HhhccccCccCcEEEEEEEECCCcEEEEEEccCccch--------------hh--------hhHHHHHHHHHhcCCCCCc
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--------------RT--------QQFVTEVALLSRIHHRNLV 668 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~--------------~~--------~~~~~E~~il~~l~HpnIv 668 (931)
|++.+.||+|++|.||+|...+|+.||||+++..... .. ....+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4567889999999999999999999999987532110 00 1124567777777655443
Q ss_pred ceeEEEecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC
Q 002358 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 748 (931)
Q Consensus 669 ~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~ 748 (931)
...-+... ..++||||++|++|.+.... + ....++.|++.+|.+||+ .+||||||||.|||+++++
T Consensus 177 vp~p~~~~--~~~LVME~i~G~~L~~l~~~-------~--~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 177 VPEPIAQS--RHTIVMSLVDALPMRQVSSV-------P--DPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCCEEEEE--TTEEEEECCSCEEGGGCCCC-------S--CHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEE
T ss_pred CCeeeecc--CceEEEEecCCccHhhhccc-------H--HHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCC
Confidence 22222222 23799999999888664321 1 235688999999999998 8999999999999998876
Q ss_pred ----------ceEEecccccccc
Q 002358 749 ----------RAKVSDFGLSRQA 761 (931)
Q Consensus 749 ----------~vkL~DFGla~~~ 761 (931)
.+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3899999966543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.9e-14 Score=145.82 Aligned_cols=121 Identities=23% Similarity=0.304 Sum_probs=106.0
Q ss_pred CCCceEEeeCC--------CCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCc
Q 002358 400 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 470 (931)
Q Consensus 400 ~~w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N 470 (931)
|.|..+.|+.. .+++++.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+ .|.+|++|+.|+|++|
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 35666777542 2458999999999999 899999999999999999999999998 5999999999999999
Q ss_pred cccCCCCCccCCccccccccccccCCCCCCCccccc---CceeeeecCCCCcccc
Q 002358 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 471 ~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~~---~~~~l~~~~N~~~c~~ 522 (931)
+|++..|..|..+++|+.|+|++|+|+ .+|...+. .+..+.+.+||+.|..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCeecCC
Confidence 999877788999999999999999999 77776443 6788899999999864
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=9.7e-15 Score=180.80 Aligned_cols=111 Identities=32% Similarity=0.436 Sum_probs=103.0
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++++.|+|++|+++|.+|.+|++|++|+.|+|++|+|+|.+| ++++|++|+.|||++|+|+|.||..+++|++|+.|+
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 3579999999999999999999999999999999999999999 599999999999999999999999999999999999
Q ss_pred ccccCCCCCCCccc-ccCceeeeecCCCCcccc
Q 002358 491 IENNSFVGEIPPAL-LTGKVIFKYDNNPKLHKE 522 (931)
Q Consensus 491 l~~N~l~g~iP~~~-~~~~~~l~~~~N~~~c~~ 522 (931)
|++|+|+|.||..- +.......+.|||.+|+.
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEEST
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcCC
Confidence 99999999999853 345566788999999964
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.47 E-value=5.4e-14 Score=143.55 Aligned_cols=123 Identities=19% Similarity=0.215 Sum_probs=107.2
Q ss_pred CCCceEEeeCC--------CCCcEEEEEeCCCCCcccCCc-cccCccccceecccCCcCCCCCC-CccccccccEeecCC
Q 002358 400 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN 469 (931)
Q Consensus 400 ~~w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip~-~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~ 469 (931)
|.|..+.|+.. .+.+++.|+|++|+|++..+. .|+++++|+.|+|++|+|++.+| .|.++++|+.|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 46788888643 234899999999999966664 49999999999999999999988 599999999999999
Q ss_pred ccccCCCCCccCCccccccccccccCCCCCCCccccc--CceeeeecCCCCcccc
Q 002358 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 470 N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~c~~ 522 (931)
|+|++..|..++++++|+.|+|++|+|++.+|..+.. .+..+.+++|++.|..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 9999888888999999999999999999877877644 7888999999998863
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.3e-13 Score=136.62 Aligned_cols=126 Identities=21% Similarity=0.310 Sum_probs=107.3
Q ss_pred CCCCCCCCceEEeeCCC--------CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEe
Q 002358 395 DPCVPVPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIV 465 (931)
Q Consensus 395 dpc~~~~w~~v~c~~~~--------~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L 465 (931)
+.|. |.|.++.|+... +++++.|+|++|++++..+..|+++++|+.|+|++|+|++.++. +.++++|+.|
T Consensus 3 ~~C~-C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 81 (177)
T 2o6r_A 3 SRCS-CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTIL 81 (177)
T ss_dssp TTCE-EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCE-eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEE
Confidence 3453 579999997532 45899999999999966666789999999999999999998885 7999999999
Q ss_pred ecCCccccCCCCCccCCccccccccccccCCCCCCCcccc---cCceeeeecCCCCcccc
Q 002358 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPKLHKE 522 (931)
Q Consensus 466 ~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~---~~~~~l~~~~N~~~c~~ 522 (931)
+|++|+|++..|..++++++|+.|+|++|+|+ .+|...+ ..+..+.+++|++.|..
T Consensus 82 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 82 YLHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ECCCCCccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccC
Confidence 99999999766677899999999999999999 6777654 36788899999988753
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=2.1e-13 Score=168.91 Aligned_cols=130 Identities=19% Similarity=0.324 Sum_probs=81.1
Q ss_pred CCchhhHHHHHHHHhhcCCC-CCCCCC-CCCCCCCCCceEEeeCCCCCcEEEEEeCCCCCccc---CCccccCcccccee
Q 002358 368 KTEWQDVMVLEALRSISDES-ERTNDR-GDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGE---IPPELKNMEALTEL 442 (931)
Q Consensus 368 ~t~~~d~~~L~~l~~~~~~~-~~~~w~-~dpc~~~~w~~v~c~~~~~~~l~~L~L~~n~l~g~---ip~~~~~L~~L~~L 442 (931)
....+|..||.++|+.+.++ ...+|. +..| |.|+||+|+ ..+|+.|+|+++++.|. +|+.|++|+.|+.+
T Consensus 8 ~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~--C~w~gv~C~---~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 8 QSLYREIHQLISFKDVLPDKNLLPDWSSNKNP--CTFDGVTCR---DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCG--GGSTTEEEE---TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred cCCHHHHHHHHHHHhhCCCcccccCCCCCCCC--cCCcceEEC---CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 34567999999999988643 466886 3334 369999998 36999999999999998 76655555444444
Q ss_pred cccCCcCCCCCCCccccccccEeecCCccccCCCCC--ccCCccccccccccccCCCCCCCc
Q 002358 443 WLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQELHIENNSFVGEIPP 502 (931)
Q Consensus 443 ~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~--~l~~l~~L~~l~l~~N~l~g~iP~ 502 (931)
+++.|.+...++.+++|++|++|+|++|+++|.+|. .+++|++|++|+|++|.++|.+|.
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~ 144 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKV 144 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCH
Confidence 444444433223444555555555555555544444 445555555555555554444444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.40 E-value=5.5e-13 Score=140.00 Aligned_cols=122 Identities=22% Similarity=0.308 Sum_probs=92.3
Q ss_pred CCCCCCCCCCCceEEeeCC--------CCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccc
Q 002358 392 DRGDPCVPVPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDL 462 (931)
Q Consensus 392 w~~dpc~~~~w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L 462 (931)
|..+.| .|+++.|+.. .+++++.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. |.++++|
T Consensus 14 ~~~~~C---s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L 90 (229)
T 3e6j_A 14 PSQCSC---SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90 (229)
T ss_dssp CTTCEE---ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCCCEE---eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCc
Confidence 334455 5999999753 245789999999999988888888899999999999998777764 6888888
Q ss_pred cEeecCCccccCCCCCccCCccccccccccccCCCCCCCccccc--CceeeeecCCC
Q 002358 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNP 517 (931)
Q Consensus 463 ~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~ 517 (931)
+.|+|++|+|++..+..+..+++|+.|+|++|+|+ .+|..+.. .+..+.+++|.
T Consensus 91 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~ 146 (229)
T 3e6j_A 91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146 (229)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSC
T ss_pred CEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCc
Confidence 88888888888555556777888888888888887 77766533 45555555554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=4.3e-13 Score=139.94 Aligned_cols=111 Identities=19% Similarity=0.198 Sum_probs=99.3
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|.|++..|..|.++++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..+..+++|+.|+
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 35899999999999987778999999999999999999999885 89999999999999999988899999999999999
Q ss_pred ccccCCCCCCCccccc--CceeeeecCCCCcccc
Q 002358 491 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~c~~ 522 (931)
|++|+|++..|..+.. .+..+.+++|++.|..
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 9999999666766643 7788899999998863
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.2e-13 Score=153.27 Aligned_cols=146 Identities=21% Similarity=0.249 Sum_probs=119.4
Q ss_pred CCchhhHHHHHHHHhhcCC---CCCCCCC----CCCCCCCCCceEEeeC-------CCCCcEEEEEeCCCCCcccCCccc
Q 002358 368 KTEWQDVMVLEALRSISDE---SERTNDR----GDPCVPVPWEWVTCST-------TTPPRITKIALSGKNLKGEIPPEL 433 (931)
Q Consensus 368 ~t~~~d~~~L~~l~~~~~~---~~~~~w~----~dpc~~~~w~~v~c~~-------~~~~~l~~L~L~~n~l~g~ip~~~ 433 (931)
....+|..+|.++|..+.. .....|. ..+ ..|.|.|+.|.. ...++|+.|+|++|+++ .+|+.+
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~-~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNP-QIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCT-TSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccc-cccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 3456788999999987632 1223562 221 123699999952 23468999999999999 999999
Q ss_pred cCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccccccccCCCCCCCccc--------
Q 002358 434 KNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL-------- 504 (931)
Q Consensus 434 ~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~-------- 504 (931)
++|++|++|+|++|+|+ .+| .++++++|+.|+|++|+|+ .+|..+++|++|+.|+|++|++.|.+|..+
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 99999999999999999 566 6999999999999999999 999999999999999999999999999987
Q ss_pred ---ccCceeeeecCCC
Q 002358 505 ---LTGKVIFKYDNNP 517 (931)
Q Consensus 505 ---~~~~~~l~~~~N~ 517 (931)
...+..+.+++|.
T Consensus 179 ~~~l~~L~~L~L~~n~ 194 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTG 194 (328)
T ss_dssp EEESTTCCEEEEEEEC
T ss_pred hccCCCCCEEECcCCC
Confidence 3466777777764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.37 E-value=8.7e-13 Score=137.63 Aligned_cols=110 Identities=20% Similarity=0.279 Sum_probs=94.2
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|.|++..|..|.+|++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..+..+++|+.|+
T Consensus 55 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 134 (220)
T 2v9t_B 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence 35789999999999988888999999999999999999987775 78899999999999999988888999999999999
Q ss_pred ccccCCCCCCCcc-cc--cCceeeeecCCCCcccc
Q 002358 491 IENNSFVGEIPPA-LL--TGKVIFKYDNNPKLHKE 522 (931)
Q Consensus 491 l~~N~l~g~iP~~-~~--~~~~~l~~~~N~~~c~~ 522 (931)
|++|+|+ .+|.. +. ..+..+.+.+||+.|..
T Consensus 135 L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 135 LYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCCCcCC-EECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 9999999 55554 33 26778889999998853
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.33 E-value=1.7e-12 Score=129.80 Aligned_cols=103 Identities=27% Similarity=0.341 Sum_probs=87.4
Q ss_pred EEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccccccc
Q 002358 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494 (931)
Q Consensus 416 ~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N 494 (931)
+.|++++|+|+ .+|..+. ++|+.|+|++|+|++.+| .|.+|++|+.|+|++|+|++..|..+.++++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 57899999998 6888774 899999999999999988 4899999999999999999655566789999999999999
Q ss_pred CCCCCCCcccc---cCceeeeecCCCCcccc
Q 002358 495 SFVGEIPPALL---TGKVIFKYDNNPKLHKE 522 (931)
Q Consensus 495 ~l~g~iP~~~~---~~~~~l~~~~N~~~c~~ 522 (931)
+|+ .+|+..+ ..+..+.+++|++.|..
T Consensus 89 ~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLK-SIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccC-EeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 999 5666533 36778889999998864
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.9e-12 Score=128.59 Aligned_cols=103 Identities=22% Similarity=0.345 Sum_probs=89.4
Q ss_pred EEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccccccc
Q 002358 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494 (931)
Q Consensus 416 ~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N 494 (931)
+.|++++|+|+ .+|..+. ++|+.|+|++|+|++.+| .|.+|++|+.|+|++|+|++..+..++++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57999999997 8998875 899999999999999988 5999999999999999999544445799999999999999
Q ss_pred CCCCCCCcccc---cCceeeeecCCCCcccc
Q 002358 495 SFVGEIPPALL---TGKVIFKYDNNPKLHKE 522 (931)
Q Consensus 495 ~l~g~iP~~~~---~~~~~l~~~~N~~~c~~ 522 (931)
+|+ .+|...+ ..+..+.+.+|++.|..
T Consensus 92 ~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 92 HLK-SIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ccc-eeCHHHhccccCCCEEEeCCCCccccc
Confidence 999 6777643 37788899999998754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.31 E-value=2.9e-12 Score=134.46 Aligned_cols=109 Identities=23% Similarity=0.227 Sum_probs=96.6
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|+|++..+..|.+|++|+.|+|++|+|++.++. |..+++|+.|+|++|+|+ .+|..+..+++|+.|+
T Consensus 63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 141 (229)
T 3e6j_A 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEE
T ss_pred ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEE
Confidence 35899999999999854456689999999999999999999885 799999999999999999 9999999999999999
Q ss_pred ccccCCCCCCCccccc---CceeeeecCCCCcccc
Q 002358 491 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~---~~~~l~~~~N~~~c~~ 522 (931)
|++|+|+ .+|...+. .+..+.+.+||+.|..
T Consensus 142 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 142 LDQNQLK-SIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCCCcCC-ccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 9999999 67665433 6788899999999864
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.29 E-value=4.9e-12 Score=130.35 Aligned_cols=122 Identities=23% Similarity=0.356 Sum_probs=97.6
Q ss_pred CCCCCCCCceEEeeCC--------CCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEe
Q 002358 395 DPCVPVPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIV 465 (931)
Q Consensus 395 dpc~~~~w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L 465 (931)
+.| .|.|.++.|+.. .+++++.|+|++|++++..+..|+++++|+.|+|++|+|++.++. |.++++|+.|
T Consensus 3 ~~C-~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 81 (208)
T 2o6s_A 3 SRC-SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYL 81 (208)
T ss_dssp TTC-EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCC-EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEE
Confidence 345 357999999753 245799999999999966666688999999999999999988775 7899999999
Q ss_pred ecCCccccCCCCCccCCccccccccccccCCCCCCCcccc---cCceeeeecCCCC
Q 002358 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 518 (931)
Q Consensus 466 ~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~---~~~~~l~~~~N~~ 518 (931)
+|++|+|++..+..++++++|+.|+|++|+|+ .+|...+ ..+..+.+++|..
T Consensus 82 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l 136 (208)
T 2o6s_A 82 NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136 (208)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred ECCCCcCCccCHhHhcCccCCCEEEcCCCcCc-ccCHhHhccCCcCCEEECCCCcc
Confidence 99999999655566789999999999999998 5555432 3667777777754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.28 E-value=6e-13 Score=146.58 Aligned_cols=109 Identities=26% Similarity=0.307 Sum_probs=100.4
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~ 493 (931)
.|+.|+|++|.+++.+|..|+++++|+.|+|++|++++.+|.+..+++|+.|+|++|+|+|.+|..++++++|+.|+|++
T Consensus 198 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 277 (313)
T 1ogq_A 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred cccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcC
Confidence 38999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCccc-ccCceeeeecCCCCcccc
Q 002358 494 NSFVGEIPPAL-LTGKVIFKYDNNPKLHKE 522 (931)
Q Consensus 494 N~l~g~iP~~~-~~~~~~l~~~~N~~~c~~ 522 (931)
|+|+|.+|... +..+..+.+.+|+++|+.
T Consensus 278 N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp SEEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred CcccccCCCCccccccChHHhcCCCCccCC
Confidence 99999999862 236677889999999974
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.9e-11 Score=122.51 Aligned_cols=141 Identities=15% Similarity=0.199 Sum_probs=98.3
Q ss_pred eEEEecCCCCCccCCCCCeEEecCCccccCCceeeecC------C-CCCcccccccccccCCCccceEEeeecCCceeEE
Q 002358 25 FISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVEN------P-SGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLV 97 (931)
Q Consensus 25 ~~~idcg~~~~~~~~~~~~~~~~d~~~~~~g~~~~~~~------~-~~~~~~~~tlr~fp~~~~~~cy~l~~~~~~~ylv 97 (931)
-+.||||+.. .+| ..+++|.+|..|...|....... . ....+.|+|.|.|| .+.+|.+|+.++++|+|
T Consensus 7 ~~~INcGg~~-~~d-~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~---~~~tY~f~v~~~G~Y~V 81 (174)
T 2jwp_A 7 IWAVNAGGES-HVD-VHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNE---DSFGYDIPIKEEGEYVL 81 (174)
T ss_dssp EEEEEETSSS-EEE-TTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCC---SCEEEEEECCSCEEEEE
T ss_pred EEEEECCCCC-ccC-CCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCC---CCeEEEEEeCCCeEEEE
Confidence 4789999765 455 67999999998864453221111 0 01234689999998 47899999999999999
Q ss_pred EEEEeecCCCCCCCCCcEEEEEcCce-eEEEEecC---CccceEEEEEEe-------------cCCCCcccceeecCCCC
Q 002358 98 RATFQYGSLGSEASYPKFQLYLDATL-WSTVTVLD---ASRVYAKEMIIR-------------APSDSIDVCICCAVTGS 160 (931)
Q Consensus 98 r~~f~yg~yd~~~~~~~fd~~~~~~~-w~~v~~~~---~~~~~~~e~~~~-------------~~~~~~~vcl~~~~~~~ 160 (931)
|..|.--.|.+ .....||++++|.. ....++.. ....+..+..+. ..+..+.|.|.....+.
T Consensus 82 rLhF~ei~~~~-~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~ 160 (174)
T 2jwp_A 82 VLKFAEVYFAQ-SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDN 160 (174)
T ss_dssp EEEEECCSCCC-SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCS
T ss_pred EEEEeccccCC-CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCC
Confidence 99998776654 56679999999965 23333321 223454555554 24556888887654668
Q ss_pred ceeeeeeeeec
Q 002358 161 PFISTLELRPL 171 (931)
Q Consensus 161 pfis~le~~~l 171 (931)
||||+||+.+-
T Consensus 161 a~inaIEI~~~ 171 (174)
T 2jwp_A 161 PKVCALFIMKG 171 (174)
T ss_dssp SSEEEEEEESS
T ss_pred cEEEEEEEEeC
Confidence 99999999874
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.28 E-value=3.6e-12 Score=127.29 Aligned_cols=102 Identities=23% Similarity=0.265 Sum_probs=89.6
Q ss_pred CCCceEEeeCC--------CCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCc
Q 002358 400 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN 470 (931)
Q Consensus 400 ~~w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N 470 (931)
|.|+.+.|+.. .+.+++.|+|++|+|++..|..|++|++|+.|+|++|+|++.+|. |.+|++|+.|+|++|
T Consensus 9 C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 46777877643 245799999999999988899999999999999999999999885 799999999999999
Q ss_pred cccCCCCCccCCccccccccccccCCCCCCC
Q 002358 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 501 (931)
Q Consensus 471 ~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP 501 (931)
+|++..|..+.++++|+.|+|++|.+++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9996666679999999999999999985543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.28 E-value=4.9e-12 Score=131.91 Aligned_cols=119 Identities=23% Similarity=0.247 Sum_probs=100.8
Q ss_pred CCCceEEeeCC--------CCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCc
Q 002358 400 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 470 (931)
Q Consensus 400 ~~w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N 470 (931)
|.|..+.|+.. .+++++.|+|++|+|++..+..|.++++|+.|+|++|+|++..| .|.+|++|+.|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 46788888643 23579999999999997777799999999999999999999988 5999999999999999
Q ss_pred cccCCCCC-ccCCccccccccccccCCCCCCCccccc--CceeeeecCCCCc
Q 002358 471 ELTGSLPS-YMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (931)
Q Consensus 471 ~l~g~iP~-~l~~l~~L~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~ 519 (931)
+|+ .+|. .+..+++|+.|+|++|+|++..|..+.. .+..+.+++|...
T Consensus 91 ~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (220)
T 2v9t_B 91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141 (220)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred cCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC
Confidence 999 5555 5789999999999999999655555543 6788888888654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.26 E-value=8.5e-12 Score=135.86 Aligned_cols=110 Identities=27% Similarity=0.325 Sum_probs=97.6
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++++.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..+..+.++++|+.|+
T Consensus 99 l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 178 (290)
T 1p9a_G 99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178 (290)
T ss_dssp CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEE
Confidence 46899999999999976678899999999999999999998885 78999999999999999944444568899999999
Q ss_pred ccccCCCCCCCccccc--CceeeeecCCCCcccc
Q 002358 491 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~c~~ 522 (931)
|++|+|+ .+|..++. .+..+.+.+||+.|..
T Consensus 179 L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 9999999 99998876 5778889999999863
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=7.1e-12 Score=130.70 Aligned_cols=123 Identities=15% Similarity=0.182 Sum_probs=103.5
Q ss_pred CCCCCCCceEEeeCCC--------CCcEEEEEeCCCCCcccCCc-cccCccccceecccCCcCCCCCC-CccccccccEe
Q 002358 396 PCVPVPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIV 465 (931)
Q Consensus 396 pc~~~~w~~v~c~~~~--------~~~l~~L~L~~n~l~g~ip~-~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L 465 (931)
.|. |.|..+.|+... +..++.|+|++|+|++..|. .|.++++|+.|+|++|+|++..| .|.++++|+.|
T Consensus 8 ~C~-C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 86 (220)
T 2v70_A 8 KCR-CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI 86 (220)
T ss_dssp TCE-EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCE-ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEE
Confidence 343 567878886532 34688999999999977664 58999999999999999999998 69999999999
Q ss_pred ecCCccccCCCCCccCCccccccccccccCCCCCCCccccc--CceeeeecCCCCc
Q 002358 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (931)
Q Consensus 466 ~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~ 519 (931)
+|++|+|++..|..++.+++|+.|+|++|+|++..|..+.. .+..+.+++|...
T Consensus 87 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 142 (220)
T 2v70_A 87 LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142 (220)
T ss_dssp ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCC
T ss_pred ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCC
Confidence 99999999777778999999999999999999666766643 6778888888654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=4.3e-12 Score=141.55 Aligned_cols=102 Identities=20% Similarity=0.226 Sum_probs=89.8
Q ss_pred EEeCCC-CCcccCCccccCccccceecccC-CcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccccccc
Q 002358 418 IALSGK-NLKGEIPPELKNMEALTELWLDG-NFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494 (931)
Q Consensus 418 L~L~~n-~l~g~ip~~~~~L~~L~~L~Ls~-N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N 494 (931)
++++++ +|+ .||. |..+++|+.|+|++ |+|++.+| .|.+|++|+.|+|++|+|+|..|..|++|++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 466676 888 6898 99999999999996 99999998 5999999999999999999888889999999999999999
Q ss_pred CCCCCCCccccc--CceeeeecCCCCcccc
Q 002358 495 SFVGEIPPALLT--GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 495 ~l~g~iP~~~~~--~~~~l~~~~N~~~c~~ 522 (931)
+|+ .+|..++. .+..+.+.+|++.|..
T Consensus 91 ~l~-~~~~~~~~~~~L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 91 ALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (347)
T ss_dssp CCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred ccc-eeCHHHcccCCceEEEeeCCCccCCC
Confidence 999 78877665 4778889999998863
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.24 E-value=1.5e-11 Score=130.75 Aligned_cols=109 Identities=21% Similarity=0.264 Sum_probs=95.6
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..++.+++|+.|+
T Consensus 82 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 161 (251)
T 3m19_A 82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLS 161 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEE
Confidence 36899999999999977777889999999999999999998885 79999999999999999966666899999999999
Q ss_pred ccccCCCCCCCc-ccc--cCceeeeecCCCCccc
Q 002358 491 IENNSFVGEIPP-ALL--TGKVIFKYDNNPKLHK 521 (931)
Q Consensus 491 l~~N~l~g~iP~-~~~--~~~~~l~~~~N~~~c~ 521 (931)
|++|+|+ .+|. .+. ..+..+.+.+|++.|.
T Consensus 162 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 162 LSTNQLQ-SVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCCcCC-ccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999999 5555 443 3678899999999875
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.22 E-value=2.4e-11 Score=125.20 Aligned_cols=109 Identities=21% Similarity=0.286 Sum_probs=94.7
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|++++..+..|.++++|++|+|++|+|++.++. +.++++|+.|+|++|+|++..|..++++++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 35899999999999965556689999999999999999998885 79999999999999999966666789999999999
Q ss_pred ccccCCCCCCCcccc---cCceeeeecCCCCccc
Q 002358 491 IENNSFVGEIPPALL---TGKVIFKYDNNPKLHK 521 (931)
Q Consensus 491 l~~N~l~g~iP~~~~---~~~~~l~~~~N~~~c~ 521 (931)
|++|+++ .+|...+ ..+..+.+++|++.|.
T Consensus 131 l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~ 163 (208)
T 2o6s_A 131 LYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCT 163 (208)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred CCCCccc-eeCHHHhccCCCccEEEecCCCeecC
Confidence 9999999 5666543 3778889999998875
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.21 E-value=8.5e-12 Score=127.15 Aligned_cols=91 Identities=22% Similarity=0.341 Sum_probs=86.4
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++.+|..++.+++|+.|+
T Consensus 53 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (192)
T 1w8a_A 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEE
Confidence 46899999999999999999999999999999999999999995 99999999999999999999999999999999999
Q ss_pred ccccCCCCCCCc
Q 002358 491 IENNSFVGEIPP 502 (931)
Q Consensus 491 l~~N~l~g~iP~ 502 (931)
|++|.+++..+.
T Consensus 133 L~~N~l~c~c~l 144 (192)
T 1w8a_A 133 LASNPFNCNCHL 144 (192)
T ss_dssp CTTCCBCCSGGG
T ss_pred eCCCCccCcCcc
Confidence 999999987764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.20 E-value=3.3e-11 Score=129.76 Aligned_cols=111 Identities=18% Similarity=0.162 Sum_probs=96.9
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|++++..|..|+++++|+.|+|++|+|++.+|. +.++++|+.|+|++|+|++..|..++.+++|+.|+
T Consensus 108 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 187 (272)
T 3rfs_A 108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLR 187 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEE
Confidence 36899999999999977777799999999999999999998885 79999999999999999977777789999999999
Q ss_pred ccccCCCCCCCcccc--cCceeeeecCCCCcccc
Q 002358 491 IENNSFVGEIPPALL--TGKVIFKYDNNPKLHKE 522 (931)
Q Consensus 491 l~~N~l~g~iP~~~~--~~~~~l~~~~N~~~c~~ 522 (931)
|++|++++..|..+. ..+..+.+.+|++.|..
T Consensus 188 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 221 (272)
T 3rfs_A 188 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 221 (272)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCCcCCccCHHHHhCCcCCCEEEccCCCccccC
Confidence 999999965444333 37888999999988753
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.20 E-value=1e-11 Score=123.32 Aligned_cols=105 Identities=22% Similarity=0.266 Sum_probs=90.4
Q ss_pred CCcEEEEEeCCCCCc-ccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~-g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
+++|+.|+|++|+++ |.+|..+..+++|+.|+|++|+|++. +.+..+++|+.|+|++|++++.+|..++++++|+.|+
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 468999999999998 89999999999999999999999988 7899999999999999999987888888899999999
Q ss_pred ccccCCCCCCC--cccc--cCceeeeecCCCC
Q 002358 491 IENNSFVGEIP--PALL--TGKVIFKYDNNPK 518 (931)
Q Consensus 491 l~~N~l~g~iP--~~~~--~~~~~l~~~~N~~ 518 (931)
|++|+++ .+| ..+. ..+..+.+++|+.
T Consensus 102 Ls~N~l~-~~~~~~~l~~l~~L~~L~l~~N~l 132 (168)
T 2ell_A 102 LSGNKLK-DISTLEPLKKLECLKSLDLFNCEV 132 (168)
T ss_dssp CBSSSCC-SSGGGGGGSSCSCCCEEECCSSGG
T ss_pred ccCCccC-cchhHHHHhcCCCCCEEEeeCCcC
Confidence 9999998 555 3443 2667777888864
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.19 E-value=7.9e-12 Score=121.56 Aligned_cols=104 Identities=19% Similarity=0.252 Sum_probs=89.5
Q ss_pred CcEEEEEeCCCCCc-ccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 413 PRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 413 ~~l~~L~L~~n~l~-g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
++++.|+|++|+++ |.+|..+..+++|+.|+|++|+|++. +.+.++++|+.|+|++|++++.+|..++.+++|+.|+|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 57999999999998 89999999999999999999999988 77999999999999999999778888888999999999
Q ss_pred cccCCCCCCC--ccccc--CceeeeecCCCC
Q 002358 492 ENNSFVGEIP--PALLT--GKVIFKYDNNPK 518 (931)
Q Consensus 492 ~~N~l~g~iP--~~~~~--~~~~l~~~~N~~ 518 (931)
++|++++ +| ..+.. .+..+.+++|+.
T Consensus 96 s~N~i~~-~~~~~~~~~l~~L~~L~l~~N~l 125 (149)
T 2je0_A 96 SGNKIKD-LSTIEPLKKLENLKSLDLFNCEV 125 (149)
T ss_dssp TTSCCCS-HHHHGGGGGCTTCCEEECTTCGG
T ss_pred CCCcCCC-hHHHHHHhhCCCCCEEeCcCCcc
Confidence 9999984 43 44433 677788888854
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.8e-11 Score=135.78 Aligned_cols=107 Identities=16% Similarity=0.239 Sum_probs=94.3
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++|+.|+|++|+|+ .+|..++++++|+.|+|++|++++.++.++++++|+.|+|++|++.+.+|..++++++|+.|+|
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 358999999999998 8999999999999999999999987778999999999999999999999999999999999999
Q ss_pred cccCCCCCCCccccc--CceeeeecCCCCc
Q 002358 492 ENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~--~~~~l~~~~N~~~ 519 (931)
++|++.+.+|..+.. .+..+.+++|+..
T Consensus 261 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp TTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred CCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 999999899987654 6778888888754
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.18 E-value=3.2e-11 Score=120.91 Aligned_cols=90 Identities=19% Similarity=0.272 Sum_probs=81.1
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
+.+++.|+|++|+|++..|..|++|++|+.|+|++|+|++.++. |.+|++|+.|+|++|+|++..|..++.+++|+.|+
T Consensus 32 ~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 32 PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY 111 (174)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEE
Confidence 45799999999999988899999999999999999999998886 79999999999999999955455699999999999
Q ss_pred ccccCCCCCCCc
Q 002358 491 IENNSFVGEIPP 502 (931)
Q Consensus 491 l~~N~l~g~iP~ 502 (931)
|++|.+. ..|.
T Consensus 112 L~~N~~~-c~~~ 122 (174)
T 2r9u_A 112 LYNNPWD-CECR 122 (174)
T ss_dssp CCSSCBC-TTBG
T ss_pred eCCCCcc-cccc
Confidence 9999998 4444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.18 E-value=4e-11 Score=127.39 Aligned_cols=106 Identities=23% Similarity=0.289 Sum_probs=90.0
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
+++++.|+|++|++++..|..|+++++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..++.+++|+.|+
T Consensus 34 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 113 (251)
T 3m19_A 34 PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLY 113 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEE
Confidence 45789999999999988888899999999999999999998885 89999999999999999966667789999999999
Q ss_pred ccccCCCCCCCcccc---cCceeeeecCCCC
Q 002358 491 IENNSFVGEIPPALL---TGKVIFKYDNNPK 518 (931)
Q Consensus 491 l~~N~l~g~iP~~~~---~~~~~l~~~~N~~ 518 (931)
|++|+|+ .+|...+ ..+..+.+++|..
T Consensus 114 L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l 143 (251)
T 3m19_A 114 LGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143 (251)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred cCCCcCC-CcChhHhccCCcccEEECcCCcC
Confidence 9999999 6666543 3677777888754
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.17 E-value=4.6e-11 Score=128.44 Aligned_cols=110 Identities=22% Similarity=0.282 Sum_probs=97.6
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|.+++..|..|+++++|+.|+|++|+|++.++. |.++++|+.|+|++|++++..|..+.++++|+.|+
T Consensus 108 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 187 (270)
T 2o6q_A 108 LVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLK 187 (270)
T ss_dssp CSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred ccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEE
Confidence 35899999999999977777899999999999999999998885 89999999999999999966666799999999999
Q ss_pred ccccCCCCCCCccccc---CceeeeecCCCCcccc
Q 002358 491 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~---~~~~l~~~~N~~~c~~ 522 (931)
|++|+++ .+|...+. .+..+.+.+||+.|..
T Consensus 188 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 188 LDNNQLK-RVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred CCCCcCC-cCCHHHhccccCCCEEEecCCCeeCCC
Confidence 9999999 67765443 6778999999999864
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=2.1e-11 Score=146.60 Aligned_cols=111 Identities=16% Similarity=0.178 Sum_probs=99.5
Q ss_pred CCcEEEEEeCCCCCc-ccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccc
Q 002358 412 PPRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~-g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l 489 (931)
.+.++.|+|++|++. +.+|..|..|++|+.|+|++|+|++.+| .|.+|++|+.|+|++|+|++..|..++.|++|+.|
T Consensus 468 ~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L 547 (635)
T 4g8a_A 468 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 547 (635)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEE
T ss_pred chhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEE
Confidence 468999999999854 4578889999999999999999999999 59999999999999999998888889999999999
Q ss_pred cccccCCCCCCCcccc---cCceeeeecCCCCcccc
Q 002358 490 HIENNSFVGEIPPALL---TGKVIFKYDNNPKLHKE 522 (931)
Q Consensus 490 ~l~~N~l~g~iP~~~~---~~~~~l~~~~N~~~c~~ 522 (931)
+|++|+|++..|..+. ..+..+.+++||+.|.+
T Consensus 548 ~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 548 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp ECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred ECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 9999999977777664 36788999999999974
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=2.6e-11 Score=143.71 Aligned_cols=117 Identities=17% Similarity=0.200 Sum_probs=101.2
Q ss_pred CCCceEEeeCCC----------CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecC
Q 002358 400 VPWEWVTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLE 468 (931)
Q Consensus 400 ~~w~~v~c~~~~----------~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~ 468 (931)
|+|.|+ |+|+. +++|+.|+|++|++++..|..|+++++|++|+|++|++++.+| .|.++++|++|+|+
T Consensus 4 C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls 82 (549)
T 2z81_A 4 CDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82 (549)
T ss_dssp ECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECC
Confidence 579998 98752 3589999999999998889999999999999999999999988 59999999999999
Q ss_pred CccccCCCCCccCCccccccccccccCCCC-CCCccccc--CceeeeecCCC
Q 002358 469 NNELTGSLPSYMGSLPNLQELHIENNSFVG-EIPPALLT--GKVIFKYDNNP 517 (931)
Q Consensus 469 ~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g-~iP~~~~~--~~~~l~~~~N~ 517 (931)
+|++++..|..++++++|+.|+|++|++++ .+|..+.. .+..+.+++|.
T Consensus 83 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 134 (549)
T 2z81_A 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134 (549)
T ss_dssp TSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred CCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCc
Confidence 999997777779999999999999999985 45555533 67777787776
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.15 E-value=4.7e-11 Score=128.34 Aligned_cols=127 Identities=22% Similarity=0.339 Sum_probs=95.3
Q ss_pred CCCCCCCCCC-CCceEEeeCC--------CCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccc
Q 002358 391 NDRGDPCVPV-PWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLI 460 (931)
Q Consensus 391 ~w~~dpc~~~-~w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~ 460 (931)
.|.|..|.+. .|..+.|+.. .++.++.|+|++|++++..+..|+++++|++|+|++|+|++.++. |.+++
T Consensus 6 ~~~~~~C~c~~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~ 85 (270)
T 2o6q_A 6 KKDGGVCSCNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELK 85 (270)
T ss_dssp GGGTCSBEEETTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCT
T ss_pred CCCCCCCEeCCCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCC
Confidence 4556666332 3455555432 134688999999999866666899999999999999999987775 68899
Q ss_pred cccEeecCCccccCCCCCccCCccccccccccccCCCCCCCcccc---cCceeeeecCCCC
Q 002358 461 DLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 518 (931)
Q Consensus 461 ~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~---~~~~~l~~~~N~~ 518 (931)
+|+.|+|++|++++..+..+.++++|+.|+|++|+++ .+|...+ ..+..+.+++|..
T Consensus 86 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l 145 (270)
T 2o6q_A 86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145 (270)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccC-eeCHHHhCcCcCCCEEECCCCcC
Confidence 9999999999999655567788999999999999998 4554432 3677777877753
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=2.5e-11 Score=145.86 Aligned_cols=106 Identities=15% Similarity=0.064 Sum_probs=91.7
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
|+.++.|+|++|+|++..|..|.+|++|++|+|++|+|++.+| .|.+|++|++|+|++|+|++..|..|++|++|+.|+
T Consensus 51 p~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 51 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred CcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 4589999999999997777889999999999999999999988 599999999999999999955556789999999999
Q ss_pred ccccCCCCCCCcccc---cCceeeeecCCCC
Q 002358 491 IENNSFVGEIPPALL---TGKVIFKYDNNPK 518 (931)
Q Consensus 491 l~~N~l~g~iP~~~~---~~~~~l~~~~N~~ 518 (931)
|++|+|+ .+|+..+ ..+..+.+++|..
T Consensus 131 Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l 160 (635)
T 4g8a_A 131 AVETNLA-SLENFPIGHLKTLKELNVAHNLI 160 (635)
T ss_dssp CTTSCCC-CSTTCCCTTCTTCCEEECCSSCC
T ss_pred CCCCcCC-CCChhhhhcCcccCeeccccCcc
Confidence 9999999 5665433 2677788888864
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=4.9e-11 Score=137.85 Aligned_cols=111 Identities=20% Similarity=0.235 Sum_probs=99.2
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|.+++..|..|+++++|+.|+|++|+|++.+| .+.++++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 298 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 377 (455)
T 3v47_A 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELA 377 (455)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEE
Confidence 4689999999999998889999999999999999999999888 589999999999999999988899999999999999
Q ss_pred ccccCCCCCCCcccc---cCceeeeecCCCCccccc
Q 002358 491 IENNSFVGEIPPALL---TGKVIFKYDNNPKLHKES 523 (931)
Q Consensus 491 l~~N~l~g~iP~~~~---~~~~~l~~~~N~~~c~~~ 523 (931)
|++|+|+ .+|...+ ..+..+.+++|+..|..+
T Consensus 378 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 378 LDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCccc-cCCHhHhccCCcccEEEccCCCcccCCC
Confidence 9999999 5776553 377888999999988643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.10 E-value=7.4e-12 Score=146.55 Aligned_cols=107 Identities=21% Similarity=0.191 Sum_probs=95.2
Q ss_pred CcEEEEEeCCCCCcccCCcccc-CccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~-~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
++|+.|+|++|.|++.+|..+. +|++|+.|+|++|.|++. |.+..+++|+.|+|++|+|++ +|..++.+++|+.|+|
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~L 221 (487)
T 3oja_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISL 221 (487)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEEC
T ss_pred CCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEe
Confidence 5899999999999999999887 899999999999999988 545579999999999999995 6666999999999999
Q ss_pred cccCCCCCCCccccc--CceeeeecCCCCcccc
Q 002358 492 ENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~--~~~~l~~~~N~~~c~~ 522 (931)
++|+|+ .+|..+.. .+..+.+++|+..|..
T Consensus 222 s~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~~ 253 (487)
T 3oja_A 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253 (487)
T ss_dssp TTSCCC-EECTTCCCCTTCCEEECTTCCBCHHH
T ss_pred cCCcCc-ccchhhccCCCCCEEEcCCCCCcCcc
Confidence 999999 58887643 7788999999999853
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=6.6e-11 Score=132.31 Aligned_cols=116 Identities=21% Similarity=0.264 Sum_probs=98.9
Q ss_pred CCCCceEEeeCCC----------CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeec
Q 002358 399 PVPWEWVTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHL 467 (931)
Q Consensus 399 ~~~w~~v~c~~~~----------~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L 467 (931)
+|+|.++ |+|+. +++|+.|+|++|++++..+..|.++++|+.|+|++|++++..| .|.++++|+.|+|
T Consensus 29 ~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 29 SCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp EECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 4578887 88752 3489999999999997666689999999999999999999988 5999999999999
Q ss_pred CCccccCCCCC-ccCCccccccccccccCCCCCCCc-ccc---cCceeeeecCCC
Q 002358 468 ENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIPP-ALL---TGKVIFKYDNNP 517 (931)
Q Consensus 468 ~~N~l~g~iP~-~l~~l~~L~~l~l~~N~l~g~iP~-~~~---~~~~~l~~~~N~ 517 (931)
++|+++ .+|. .++++++|+.|+|++|+++ .+|. ..+ ..+..+.+++|.
T Consensus 108 s~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~ 160 (353)
T 2z80_A 108 SYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160 (353)
T ss_dssp CSSCCS-SCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESS
T ss_pred CCCcCC-cCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCc
Confidence 999999 4555 4899999999999999999 7887 333 367778888874
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.10 E-value=6.8e-11 Score=129.28 Aligned_cols=111 Identities=16% Similarity=0.169 Sum_probs=99.5
Q ss_pred CCcEEEEEeCCCCCcc-cCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccc
Q 002358 412 PPRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g-~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l 489 (931)
.++|+.|+|++|.+++ .+|..+.++++|+.|+|++|+|++.+| .+.++++|+.|+|++|++++..+..+..+++|+.|
T Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 228 (306)
T 2z66_A 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228 (306)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEE
T ss_pred CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEe
Confidence 3689999999999997 689999999999999999999999988 59999999999999999997666689999999999
Q ss_pred cccccCCCCCCCccccc---CceeeeecCCCCcccc
Q 002358 490 HIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 490 ~l~~N~l~g~iP~~~~~---~~~~l~~~~N~~~c~~ 522 (931)
+|++|++++..|..+.. .+..+.+++|+..|..
T Consensus 229 ~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp ECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred ECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 99999999888877653 6778999999988753
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=5.7e-11 Score=128.57 Aligned_cols=110 Identities=19% Similarity=0.278 Sum_probs=97.0
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|.+++..+..|+++++|+.|+|++|+|++.++. +.++++|+.|+|++|++++..|..++++++|+.|+
T Consensus 128 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 207 (285)
T 1ozn_A 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (285)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEee
Confidence 36899999999999966666799999999999999999998884 99999999999999999988899999999999999
Q ss_pred ccccCCCCCCCcc-cc--cCceeeeecCCCCcccc
Q 002358 491 IENNSFVGEIPPA-LL--TGKVIFKYDNNPKLHKE 522 (931)
Q Consensus 491 l~~N~l~g~iP~~-~~--~~~~~l~~~~N~~~c~~ 522 (931)
|++|++++ +|.. +. ..+..+.+++|++.|..
T Consensus 208 l~~n~l~~-~~~~~~~~l~~L~~L~l~~N~~~c~~ 241 (285)
T 1ozn_A 208 LFANNLSA-LPTEALAPLRALQYLRLNDNPWVCDC 241 (285)
T ss_dssp CCSSCCSC-CCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred CCCCcCCc-CCHHHcccCcccCEEeccCCCccCCC
Confidence 99999994 6644 33 36778999999998854
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.10 E-value=8.5e-11 Score=132.01 Aligned_cols=120 Identities=21% Similarity=0.149 Sum_probs=93.4
Q ss_pred CCCceEEeeCC--------CCCcEEEEEeCCCCCcccCCcccc-CccccceecccCCcCCCCCC-CccccccccEeecCC
Q 002358 400 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN 469 (931)
Q Consensus 400 ~~w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip~~~~-~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~ 469 (931)
|.+.-+.|+.. .+..++.|+|++|+|++..+..+. +|++|+.|+|++|+|++..| .|.+|++|+.|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 45666777643 134688999999999977777777 89999999999999998888 488999999999999
Q ss_pred ccccCCCCCccCCccccccccccccCCCCCCCccccc--CceeeeecCCCCc
Q 002358 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (931)
Q Consensus 470 N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~ 519 (931)
|+|++..+..|.+|++|+.|+|++|+|++..|..+.. .+..+.+++|...
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 149 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC
Confidence 9998666667888999999999999998544544432 6677777777543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=4e-11 Score=138.58 Aligned_cols=108 Identities=16% Similarity=0.183 Sum_probs=94.8
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC--CccccccccEeecCCccccCCCCCccCCccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p--~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l 489 (931)
+++|+.|+|++|.+++..|..|++|++|++|+|++|.+.+.++ .|.++++|++|+|++|++++..|..++++++|+.|
T Consensus 29 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 108 (455)
T 3v47_A 29 PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVL 108 (455)
T ss_dssp CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEE
T ss_pred CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEE
Confidence 3679999999999998889999999999999999999998775 49999999999999999998889999999999999
Q ss_pred cccccCCCCCCCcc--cc--cCceeeeecCCCCc
Q 002358 490 HIENNSFVGEIPPA--LL--TGKVIFKYDNNPKL 519 (931)
Q Consensus 490 ~l~~N~l~g~iP~~--~~--~~~~~l~~~~N~~~ 519 (931)
+|++|++++.+|.. +. ..+..+.+++|...
T Consensus 109 ~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~ 142 (455)
T 3v47_A 109 TLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142 (455)
T ss_dssp ECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCC
T ss_pred eCCCCCCCccccCcccccCcccCCEEECCCCccC
Confidence 99999999766654 32 36777888888643
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.09 E-value=8.8e-11 Score=135.52 Aligned_cols=108 Identities=24% Similarity=0.335 Sum_probs=97.7
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++..| .|.++++|+.|+|++|+|++..|..|.++++|+.|+
T Consensus 184 l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 261 (440)
T 3zyj_A 184 LSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261 (440)
T ss_dssp CSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEE
T ss_pred ccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEE
Confidence 468999999999999 777 58999999999999999999988 599999999999999999988889999999999999
Q ss_pred ccccCCCCCCCccccc---CceeeeecCCCCcccc
Q 002358 491 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~---~~~~l~~~~N~~~c~~ 522 (931)
|++|+|+ .+|...+. .+..+.+++||+.|+.
T Consensus 262 L~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 262 LAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp CTTSCCC-CCCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred CCCCCCC-ccChhHhccccCCCEEEcCCCCccCCC
Confidence 9999999 67766543 6778899999999874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=2.8e-10 Score=121.46 Aligned_cols=140 Identities=14% Similarity=0.072 Sum_probs=110.3
Q ss_pred HhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEEecCC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
+.+...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. |..+.++++++...+..++||||++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 445667888888999999865 7899999986532233457899999999995 67788999999888899999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc------------------------------------------
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------------------------------------------ 727 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~------------------------------------------ 727 (931)
.+|.+.+.. ......++.+++++|+.||+.
T Consensus 95 ~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 95 VLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp EEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred eehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 999876421 112346888999999999971
Q ss_pred --------------CCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 728 --------------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 728 --------------~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
....++|||+++.||+++++..+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876556799999764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.08 E-value=2e-10 Score=125.03 Aligned_cols=107 Identities=28% Similarity=0.348 Sum_probs=95.5
Q ss_pred CCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccc
Q 002358 411 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (931)
Q Consensus 411 ~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l 489 (931)
..++|+.|+|++|.|+ .+|..+..+++|+.|+|++|+|++.+| .|.++++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 75 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 153 (290)
T 1p9a_G 75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153 (290)
T ss_dssp CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEE
Confidence 3468999999999999 899999999999999999999999998 49999999999999999996666678999999999
Q ss_pred cccccCCCCCCCccccc---CceeeeecCCCCc
Q 002358 490 HIENNSFVGEIPPALLT---GKVIFKYDNNPKL 519 (931)
Q Consensus 490 ~l~~N~l~g~iP~~~~~---~~~~l~~~~N~~~ 519 (931)
+|++|+|+ .+|...+. .+..+.+++|...
T Consensus 154 ~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp ECTTSCCS-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCC-ccCHHHhcCcCCCCEEECCCCcCC
Confidence 99999999 78887654 6777888888754
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.08 E-value=1.1e-10 Score=129.99 Aligned_cols=103 Identities=20% Similarity=0.234 Sum_probs=85.8
Q ss_pred CCCCCCCceEEeeCC-C---------CCcEEEEEeCC-CCCcccCCccccCccccceecccCCcCCCCCCC-cccccccc
Q 002358 396 PCVPVPWEWVTCSTT-T---------PPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLR 463 (931)
Q Consensus 396 pc~~~~w~~v~c~~~-~---------~~~l~~L~L~~-n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~ 463 (931)
.|..|.|..+.|+.. . ..+|+.|+|++ |.|++..|..|++|++|+.|+|++|+|++.+|. |.+|++|+
T Consensus 4 ~c~~C~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 83 (347)
T 2ifg_A 4 ACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (347)
T ss_dssp SSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred cCccccCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCC
Confidence 353457888888754 1 24699999996 999987778999999999999999999999994 89999999
Q ss_pred EeecCCccccCCCCCccCCccccccccccccCCCCC
Q 002358 464 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGE 499 (931)
Q Consensus 464 ~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~ 499 (931)
.|+|++|+|++..|..+..++ |+.|+|.+|.|...
T Consensus 84 ~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 84 RLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp EEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred EEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 999999999954444555555 99999999999843
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.7e-10 Score=139.55 Aligned_cols=107 Identities=16% Similarity=0.215 Sum_probs=99.1
Q ss_pred CcEEEEEeCCCCCcccCCcccc--CccccceecccCCcCCCCCCCccccccccEeec------CCccccCCCCCccCCcc
Q 002358 413 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL------ENNELTGSLPSYMGSLP 484 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~--~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L------~~N~l~g~iP~~l~~l~ 484 (931)
++|+.|+|++|+|+ .+|..++ .+++|+.|+|++|+|++.++.+.++++|+.|+| ++|++.+.+|..+++|+
T Consensus 488 ~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~ 566 (636)
T 4eco_A 488 YLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566 (636)
T ss_dssp GGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCS
T ss_pred CCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCC
Confidence 38999999999999 8999998 999999999999999994447999999999999 56889999999999999
Q ss_pred ccccccccccCCCCCCCcccccCceeeeecCCCCccc
Q 002358 485 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHK 521 (931)
Q Consensus 485 ~L~~l~l~~N~l~g~iP~~~~~~~~~l~~~~N~~~c~ 521 (931)
+|+.|+|++|+| +.||..+...+..+.+++|+..|-
T Consensus 567 ~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 567 SLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISI 602 (636)
T ss_dssp SCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEE
T ss_pred CCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCccc
Confidence 999999999999 699999988999999999998863
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=7.5e-11 Score=141.64 Aligned_cols=110 Identities=19% Similarity=0.136 Sum_probs=99.9
Q ss_pred CCcEEEEEeCCCCCcc-cCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccc
Q 002358 412 PPRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g-~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l 489 (931)
.++|+.|+|++|.+++ .+|..|+++++|+.|+|++|++++.+| .+.++++|+.|+|++|++++.+|..++++++|+.|
T Consensus 447 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 526 (606)
T 3vq2_A 447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL 526 (606)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEE
Confidence 4689999999999998 478899999999999999999999988 49999999999999999998889999999999999
Q ss_pred cccccCCCCCCCccccc---CceeeeecCCCCcccc
Q 002358 490 HIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 490 ~l~~N~l~g~iP~~~~~---~~~~l~~~~N~~~c~~ 522 (931)
+|++|+|+ .+|..+.. .+..+.+++||+.|..
T Consensus 527 ~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c 561 (606)
T 3vq2_A 527 DCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACIC 561 (606)
T ss_dssp ECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred ECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCC
Confidence 99999999 89987543 4788899999999864
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.06 E-value=8.3e-11 Score=123.87 Aligned_cols=125 Identities=20% Similarity=0.269 Sum_probs=99.7
Q ss_pred CCCCCCCCCCCceEEeeCC-------CCCcEEEEEeCCCCCcccCCccccCccccceecccCCc-CCCCCC-Cccccccc
Q 002358 392 DRGDPCVPVPWEWVTCSTT-------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF-LTGPLP-DMSRLIDL 462 (931)
Q Consensus 392 w~~dpc~~~~w~~v~c~~~-------~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~-l~g~~p-~~~~l~~L 462 (931)
|..++|.+..|.++.++|. .+++++.|+|++|++++..+..|+++++|+.|+|++|+ +++..+ .|.++++|
T Consensus 3 ~cp~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L 82 (239)
T 2xwt_C 3 CSSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKV 82 (239)
T ss_dssp CCSSSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTC
T ss_pred CCCCCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCC
Confidence 3445666544566553332 24589999999999997777789999999999999997 888887 59999999
Q ss_pred cEeecCC-ccccCCCCCccCCccccccccccccCCCCCCCccccc--Cce---eeeecCCCC
Q 002358 463 RIVHLEN-NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKV---IFKYDNNPK 518 (931)
Q Consensus 463 ~~L~L~~-N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~~--~~~---~l~~~~N~~ 518 (931)
+.|+|++ |+|++..|..+.++++|+.|+|++|+++ .+|. +.. .+. .+.+++|+.
T Consensus 83 ~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~~L~l~~N~~ 142 (239)
T 2xwt_C 83 THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD-LTKVYSTDIFFILEITDNPY 142 (239)
T ss_dssp CEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCC-SCCC-CTTCCBCCSEEEEEEESCTT
T ss_pred cEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCc-cccc-cccccccccccEEECCCCcc
Confidence 9999999 9999655578999999999999999999 5887 322 444 778888843
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.5e-10 Score=130.08 Aligned_cols=107 Identities=22% Similarity=0.297 Sum_probs=60.4
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCcc----CCccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYM----GSLPNLQ 487 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l----~~l~~L~ 487 (931)
++|+.|+|++|.|++..+..|.+|++|+.|+|++|+|++..| .|.+|++|+.|+|++|+|+ .+|..+ ..+++|+
T Consensus 88 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~ 166 (361)
T 2xot_A 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLM 166 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCC
T ss_pred CCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCC
Confidence 456666666666664444456666666666666666666555 3566666666666666666 344432 4466666
Q ss_pred cccccccCCCCCCCcccccC-----ceeeeecCCCCccc
Q 002358 488 ELHIENNSFVGEIPPALLTG-----KVIFKYDNNPKLHK 521 (931)
Q Consensus 488 ~l~l~~N~l~g~iP~~~~~~-----~~~l~~~~N~~~c~ 521 (931)
.|+|++|+|+ .+|...+.. +..+.+.+||+.|.
T Consensus 167 ~L~L~~N~l~-~l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 167 LLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp EEECCSSCCC-CCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred EEECCCCCCC-ccCHHHhhhccHhhcceEEecCCCccCC
Confidence 6666666666 455332221 13456677777765
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.5e-10 Score=141.93 Aligned_cols=105 Identities=27% Similarity=0.360 Sum_probs=87.3
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
...|+.|+|++|.|. .+|..+++|++|+.|+|++|+|+..+++|++|++|+.|+|++|+|+ .||.+|++|++|+.|+|
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 300 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYF 300 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEEC
T ss_pred CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEEC
Confidence 457888999999888 8888888899999999999998843336888999999999999988 88888888999999999
Q ss_pred cccCCCCCCCccccc--CceeeeecCCCCc
Q 002358 492 ENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~--~~~~l~~~~N~~~ 519 (931)
++|.|+ .||..+.. .+..+.+++|+..
T Consensus 301 ~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 301 FDNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp CSSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred CCCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 999887 88887654 6777888888754
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=1.8e-10 Score=124.01 Aligned_cols=107 Identities=15% Similarity=0.030 Sum_probs=91.4
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
+++++.|+|++|++++..+..|+++++|+.|+|++|++++..+ .|.++++|+.|+|++|++++..|..++++++|+.|+
T Consensus 27 ~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (276)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence 3469999999999997777799999999999999999999888 599999999999999999977778899999999999
Q ss_pred ccccCCCCCCCcccc--cCceeeeecCCCC
Q 002358 491 IENNSFVGEIPPALL--TGKVIFKYDNNPK 518 (931)
Q Consensus 491 l~~N~l~g~iP~~~~--~~~~~l~~~~N~~ 518 (931)
+++|++++..+..+. ..+..+.+++|..
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 136 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLI 136 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCC
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCcc
Confidence 999999944333443 3677788888764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.05 E-value=3.3e-10 Score=121.82 Aligned_cols=107 Identities=22% Similarity=0.271 Sum_probs=91.0
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|++++..+..|+++++|+.|+|++|++++.+|. +.++++|+.|+|++|+|++..|..++.+++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 35899999999999977777789999999999999999998885 89999999999999999976677789999999999
Q ss_pred ccccCCCCCCCccc-c--cCceeeeecCCCCc
Q 002358 491 IENNSFVGEIPPAL-L--TGKVIFKYDNNPKL 519 (931)
Q Consensus 491 l~~N~l~g~iP~~~-~--~~~~~l~~~~N~~~ 519 (931)
|++|+++ .+|... . ..+..+.+.+|...
T Consensus 164 l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 164 LSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCCcC-ccCHHHhcCCccCCEEECCCCcCC
Confidence 9999999 455543 2 36778888888644
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=1.6e-10 Score=137.54 Aligned_cols=101 Identities=25% Similarity=0.320 Sum_probs=72.3
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~ 493 (931)
.++.|+|++|+|++ +|. |++|++|+.|+|++|+|+..++.+++|++|+.|+|++|+|++ +| .+++|++|+.|+|++
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 46677777777774 665 777777777778777777433357777777777887777774 66 677777777777777
Q ss_pred cCCCCCC-Cccccc--CceeeeecCCCC
Q 002358 494 NSFVGEI-PPALLT--GKVIFKYDNNPK 518 (931)
Q Consensus 494 N~l~g~i-P~~~~~--~~~~l~~~~N~~ 518 (931)
|+|++.+ |..+.. .+..+.+++|+.
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l 545 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSL 545 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcC
Confidence 7777554 666543 666677777764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.04 E-value=1.5e-10 Score=134.10 Aligned_cols=108 Identities=23% Similarity=0.316 Sum_probs=97.2
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++..| .|.++++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 195 l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 272 (452)
T 3zyi_A 195 LFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELN 272 (452)
T ss_dssp CTTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEE
Confidence 468999999999999 455 69999999999999999999988 599999999999999999988899999999999999
Q ss_pred ccccCCCCCCCccccc---CceeeeecCCCCcccc
Q 002358 491 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~---~~~~l~~~~N~~~c~~ 522 (931)
|++|+|+ .+|...+. .+..+.+++||+.|..
T Consensus 273 L~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 273 LAHNNLS-SLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp CCSSCCS-CCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred CCCCcCC-ccChHHhccccCCCEEEccCCCcCCCC
Confidence 9999999 67765543 6778899999999874
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.03 E-value=2.5e-10 Score=132.11 Aligned_cols=116 Identities=21% Similarity=0.245 Sum_probs=98.2
Q ss_pred CceEEeeCC--------CCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccc
Q 002358 402 WEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNEL 472 (931)
Q Consensus 402 w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l 472 (931)
|..+.|+.. .+++++.|+|++|+|++..|..|++|++|+.|+|++|+|++..| .|.++++|+.|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 455667543 24589999999999999889999999999999999999999988 599999999999999999
Q ss_pred cCCCCCccCCccccccccccccCCCCCCCccccc---CceeeeecCCCC
Q 002358 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPK 518 (931)
Q Consensus 473 ~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~~---~~~~l~~~~N~~ 518 (931)
++..+..++.+++|+.|+|++|+|+ .+|...+. .+..+.+++|..
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~~ 183 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTT
T ss_pred CccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCCC
Confidence 9666667999999999999999999 67765443 666777777543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.02 E-value=2.7e-10 Score=114.10 Aligned_cols=90 Identities=22% Similarity=0.338 Sum_probs=80.3
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|+|++..+..|+++++|+.|+|++|+|++.++. +.++++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 130 (177)
T 2o6r_A 51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130 (177)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred cccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEE
Confidence 35899999999999966666689999999999999999999885 79999999999999999955455578999999999
Q ss_pred ccccCCCCCCC
Q 002358 491 IENNSFVGEIP 501 (931)
Q Consensus 491 l~~N~l~g~iP 501 (931)
|++|++.+..|
T Consensus 131 l~~N~~~~~~~ 141 (177)
T 2o6r_A 131 LHTNPWDCSCP 141 (177)
T ss_dssp CCSSCBCCCHH
T ss_pred ecCCCeeccCc
Confidence 99999998766
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=3.5e-10 Score=135.75 Aligned_cols=107 Identities=18% Similarity=0.066 Sum_probs=83.2
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
+++++.|+|++|++++..|..|+++++|++|+|++|++++..| .|.++++|+.|+|++|++++..|+.|++|++|+.|+
T Consensus 31 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 4578888888888887777788888888888888888888877 488888888888888888877788888888888888
Q ss_pred ccccCCCCCCCccccc--CceeeeecCCCC
Q 002358 491 IENNSFVGEIPPALLT--GKVIFKYDNNPK 518 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~--~~~~l~~~~N~~ 518 (931)
|++|++++..|..+.. .+..+.+++|..
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 140 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFI 140 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCC
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcc
Confidence 8888887433344432 566666666654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.01 E-value=3.4e-10 Score=140.56 Aligned_cols=105 Identities=17% Similarity=0.282 Sum_probs=96.1
Q ss_pred cEEEEEeCCCCCcccCCcccc--CccccceecccCCcCCCCCCCccccccccEeecCC------ccccCCCCCccCCccc
Q 002358 414 RITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN------NELTGSLPSYMGSLPN 485 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~--~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~------N~l~g~iP~~l~~l~~ 485 (931)
+|+.|+|++|+|+ .+|..++ +|++|+.|+|++|+|++.++.+.+|++|+.|+|++ |++.+.+|..|++|++
T Consensus 729 ~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~ 807 (876)
T 4ecn_A 729 LLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPS 807 (876)
T ss_dssp GCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSS
T ss_pred CccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCC
Confidence 8999999999999 8999998 99999999999999999544799999999999976 8899999999999999
Q ss_pred cccccccccCCCCCCCcccccCceeeeecCCCCcc
Q 002358 486 LQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 520 (931)
Q Consensus 486 L~~l~l~~N~l~g~iP~~~~~~~~~l~~~~N~~~c 520 (931)
|+.|+|++|+| +.||..+...+..+.+++|+...
T Consensus 808 L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 808 LIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841 (876)
T ss_dssp CCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTCE
T ss_pred CCEEECCCCCC-CccCHhhcCCCCEEECCCCCCCc
Confidence 99999999999 69999988888999999998753
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.01 E-value=4.1e-10 Score=131.09 Aligned_cols=119 Identities=22% Similarity=0.257 Sum_probs=99.7
Q ss_pred CCceEEeeCC--------CCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCcc
Q 002358 401 PWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 471 (931)
Q Consensus 401 ~w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~ 471 (931)
.|..+.|... .+++++.|+|++|+|++..|..|.++++|+.|+|++|+|++..| .|.+|++|+.|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 3567777643 24589999999999998888999999999999999999999988 59999999999999999
Q ss_pred ccCCCCCccCCccccccccccccCCCCCCCccccc--CceeeeecCCCCc
Q 002358 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (931)
Q Consensus 472 l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~ 519 (931)
|++..+..++++++|+.|+|++|++++..|..+.. .+..+.+++|...
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~ 141 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCC
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccc
Confidence 99544456899999999999999999666665543 6778888888643
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.00 E-value=4.2e-10 Score=124.45 Aligned_cols=106 Identities=23% Similarity=0.283 Sum_probs=95.4
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
++|+.|+|++|.+++..|..|.++++|+.|+|++|++++.++ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 270 (330)
T 1xku_A 192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270 (330)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence 589999999999998889999999999999999999999988 6999999999999999999 99999999999999999
Q ss_pred cccCCCCCCCccccc---------CceeeeecCCCCcc
Q 002358 492 ENNSFVGEIPPALLT---------GKVIFKYDNNPKLH 520 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~---------~~~~l~~~~N~~~c 520 (931)
++|+++ .+|...+. .+..+.+.+||..+
T Consensus 271 ~~N~i~-~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 271 HNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp CSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CCCcCC-ccChhhcCCcccccccccccceEeecCcccc
Confidence 999999 67765542 34567789998764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.99 E-value=3.4e-10 Score=115.36 Aligned_cols=88 Identities=25% Similarity=0.284 Sum_probs=80.1
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|.|++..+..|.+|++|+.|+|++|+|++.+| .|.+|++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 53 l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (193)
T 2wfh_A 53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLA 132 (193)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEE
Confidence 3589999999999997777889999999999999999999999 599999999999999999955555789999999999
Q ss_pred ccccCCCCC
Q 002358 491 IENNSFVGE 499 (931)
Q Consensus 491 l~~N~l~g~ 499 (931)
|++|.+...
T Consensus 133 L~~N~~~C~ 141 (193)
T 2wfh_A 133 IGANPLYCD 141 (193)
T ss_dssp CCSSCEECS
T ss_pred eCCCCeecC
Confidence 999999754
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=7.4e-10 Score=119.75 Aligned_cols=107 Identities=21% Similarity=0.295 Sum_probs=90.3
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCcc-ccCCCCCccCCccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE-LTGSLPSYMGSLPNLQEL 489 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~-l~g~iP~~l~~l~~L~~l 489 (931)
+++++.|+|++|++++..+..|+++++|+.|+|++|++++..| .|.++++|+.|+|++|+ +++..|..+..+++|+.|
T Consensus 31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 4589999999999997777889999999999999999999877 59999999999999997 775558889999999999
Q ss_pred cccccCCCCCCCcccc--cCceeeeecCCCC
Q 002358 490 HIENNSFVGEIPPALL--TGKVIFKYDNNPK 518 (931)
Q Consensus 490 ~l~~N~l~g~iP~~~~--~~~~~l~~~~N~~ 518 (931)
+|++|++++..|..+. ..+..+.+++|..
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 141 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcc
Confidence 9999999955555443 3677788888754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.99 E-value=3.1e-10 Score=115.85 Aligned_cols=105 Identities=14% Similarity=0.198 Sum_probs=87.7
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|.+++..|..|++|++|+.|+|++|++++..| .+.++++|+.|+|++|++.+.+| .++.+++|+.|+
T Consensus 87 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~ 165 (197)
T 4ezg_A 87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLN 165 (197)
T ss_dssp CTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEE
T ss_pred CCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEE
Confidence 3589999999999998889999999999999999999998777 58999999999999998444787 689999999999
Q ss_pred ccccCCCCCCCc-ccccCceeeeecCCCC
Q 002358 491 IENNSFVGEIPP-ALLTGKVIFKYDNNPK 518 (931)
Q Consensus 491 l~~N~l~g~iP~-~~~~~~~~l~~~~N~~ 518 (931)
|++|+++ .+|. .-+..+..+.+.+|+.
T Consensus 166 l~~n~i~-~~~~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 166 IQFDGVH-DYRGIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp CTTBCCC-CCTTGGGCSSCCEEEECBC--
T ss_pred CCCCCCc-ChHHhccCCCCCEEEeeCccc
Confidence 9999998 4652 2234677888888863
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.7e-10 Score=130.69 Aligned_cols=108 Identities=18% Similarity=0.199 Sum_probs=97.8
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++|+.|+|++|.+++..|..|.++++|+.|+|++|++++..+.+..+++|+.|+|++|+++ .+|..++.+++|+.|+|
T Consensus 247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L 325 (390)
T 3o6n_A 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325 (390)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEEC
T ss_pred CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEEC
Confidence 36899999999999988899999999999999999999997767889999999999999999 78888999999999999
Q ss_pred cccCCCCCCCcccccCceeeeecCCCCccc
Q 002358 492 ENNSFVGEIPPALLTGKVIFKYDNNPKLHK 521 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~~~~~l~~~~N~~~c~ 521 (931)
++|+++ .+|......+..+.+++|++.|.
T Consensus 326 ~~N~i~-~~~~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 326 DHNSIV-TLKLSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp CSSCCC-CCCCCTTCCCSEEECCSSCEEHH
T ss_pred CCCccc-eeCchhhccCCEEEcCCCCccch
Confidence 999998 77766667888999999998874
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.98 E-value=2.3e-10 Score=133.88 Aligned_cols=113 Identities=16% Similarity=0.121 Sum_probs=93.2
Q ss_pred CceEEeeCCCCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-Ccc-ccccccEeecCCccccCCCCCc
Q 002358 402 WEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMS-RLIDLRIVHLENNELTGSLPSY 479 (931)
Q Consensus 402 w~~v~c~~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~-~l~~L~~L~L~~N~l~g~iP~~ 479 (931)
..++.|. ..++|+.|+|++|.|++..|..|+++++|+.|+|++|+|++.+| .+. +|++|+.|+|++|+|++. |.
T Consensus 111 l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~- 186 (487)
T 3oja_A 111 ISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG- 186 (487)
T ss_dssp CCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-
T ss_pred CCCCCcc--ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-
Confidence 3444443 24689999999999999889999999999999999999999888 465 899999999999999955 44
Q ss_pred cCCccccccccccccCCCCCCCccccc--CceeeeecCCCCc
Q 002358 480 MGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (931)
Q Consensus 480 l~~l~~L~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~ 519 (931)
+..+++|+.|+|++|+|++ +|+.+.. .+..+.+++|...
T Consensus 187 ~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 187 QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC
T ss_pred cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc
Confidence 4469999999999999995 6665543 6788888888654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=4.2e-10 Score=135.09 Aligned_cols=129 Identities=13% Similarity=0.012 Sum_probs=100.0
Q ss_pred CCCCCCCCCC-CCceEEeeCC--------CCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-Cccccc
Q 002358 391 NDRGDPCVPV-PWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLI 460 (931)
Q Consensus 391 ~w~~dpc~~~-~w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~ 460 (931)
.|...+|.+. .+.-+.|... -+..++.|+|++|.|++..|..|+++++|++|+|++|++++..| .|.+++
T Consensus 2 ~~~~~~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~ 81 (606)
T 3t6q_A 2 TSSDQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQH 81 (606)
T ss_dssp ----CCCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCT
T ss_pred ccccCceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCcc
Confidence 3556667542 2333555432 24589999999999998889999999999999999999999988 599999
Q ss_pred cccEeecCCccccCCCCCccCCccccccccccccCCCCCCCcccc--cCceeeeecCCCCc
Q 002358 461 DLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL--TGKVIFKYDNNPKL 519 (931)
Q Consensus 461 ~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~--~~~~~l~~~~N~~~ 519 (931)
+|+.|+|++|++++..|..++++++|+.|+|++|++++..|..+. ..+..+.+++|...
T Consensus 82 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~ 142 (606)
T 3t6q_A 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142 (606)
T ss_dssp TCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCC
T ss_pred ccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCccc
Confidence 999999999999988899999999999999999999943244333 36677777777543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.98 E-value=9.5e-10 Score=116.64 Aligned_cols=130 Identities=17% Similarity=0.090 Sum_probs=98.7
Q ss_pred ccC-ccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCC--CcceeEEEecCCeEEEEEEecCCCCH
Q 002358 616 KIG-KGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 616 ~LG-~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
.++ .|..+.||++...+|+.+++|+.... ....+.+|+++++.+++.+ +.+++++....+..++||||++|.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 56669999998877889999997643 2356889999999996545 45688888887888999999999887
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcC--------------------------------------------
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-------------------------------------------- 728 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-------------------------------------------- 728 (931)
. ... .+ ...++.++++.|+.||+..
T Consensus 103 ~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 103 L--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp T--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred C--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 4 221 11 2356778888888888621
Q ss_pred -----------CCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 729 -----------NPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 729 -----------~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
...++|||++|.||++++++.+.|+||+.+.
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1229999999999999877667799999875
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.98 E-value=3.2e-10 Score=113.51 Aligned_cols=102 Identities=23% Similarity=0.256 Sum_probs=84.8
Q ss_pred CcEEEEEeCCCCCcccCCccccCcc-ccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCc-cCCcccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELH 490 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~-~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~-l~~l~~L~~l~ 490 (931)
.+++.|+|++|+++ .+|. +..+. +|+.|+|++|+|++. +.+.++++|+.|+|++|+|+ .+|.. ++.+++|+.|+
T Consensus 19 ~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 19 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELI 94 (176)
T ss_dssp TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEE
T ss_pred CCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEE
Confidence 47999999999999 5654 66665 999999999999987 78999999999999999999 55654 48999999999
Q ss_pred ccccCCCCCCCc--ccc--cCceeeeecCCCCc
Q 002358 491 IENNSFVGEIPP--ALL--TGKVIFKYDNNPKL 519 (931)
Q Consensus 491 l~~N~l~g~iP~--~~~--~~~~~l~~~~N~~~ 519 (931)
|++|+|+ .+|. .+. ..+..+.+++|+..
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 9999996 7886 443 36778888888753
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=3.1e-10 Score=135.07 Aligned_cols=88 Identities=28% Similarity=0.334 Sum_probs=82.4
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCC-CCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL-PSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~i-P~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|.|+ .+|..|++|++|+.|+|++|+|++ +|.+++|++|+.|+|++|+|++.+ |..|++|++|+.|+
T Consensus 462 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred cccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 458999999999999 999999999999999999999999 569999999999999999999777 99999999999999
Q ss_pred ccccCCCCCCC
Q 002358 491 IENNSFVGEIP 501 (931)
Q Consensus 491 l~~N~l~g~iP 501 (931)
|++|+|++..|
T Consensus 540 L~~N~l~~~~~ 550 (567)
T 1dce_A 540 LQGNSLCQEEG 550 (567)
T ss_dssp CTTSGGGGSSS
T ss_pred ecCCcCCCCcc
Confidence 99999995544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.96 E-value=5e-10 Score=140.00 Aligned_cols=107 Identities=16% Similarity=0.156 Sum_probs=77.6
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCC-C-CccccccccEeecCCccccCCCCCccCCccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPL-P-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~-p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l 489 (931)
+++++.|+|++|.+++..|..|++|++|+.|+|++|.+.+.+ | .|.+|++|++|+|++|++++..|+.|++|++|+.|
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 467888888888888777777888888888888877666665 3 47777777777777777777677777777777777
Q ss_pred cccccCCCCCCCcc--cc--cCceeeeecCCCC
Q 002358 490 HIENNSFVGEIPPA--LL--TGKVIFKYDNNPK 518 (931)
Q Consensus 490 ~l~~N~l~g~iP~~--~~--~~~~~l~~~~N~~ 518 (931)
+|++|++++.+|.. +. ..+..+.+++|..
T Consensus 103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l 135 (844)
T 3j0a_A 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135 (844)
T ss_dssp ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCC
T ss_pred eCcCCCCCcccccCccccccCCCCEEECCCCcc
Confidence 77777777666654 22 2556666666653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.96 E-value=2.2e-10 Score=137.49 Aligned_cols=108 Identities=18% Similarity=0.199 Sum_probs=98.4
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++|+.|+|++|.+++.+|..|++|++|+.|+|++|+|++.++.+..+++|+.|+|++|+|+ .+|..++.+++|+.|+|
T Consensus 253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L 331 (597)
T 3oja_B 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 331 (597)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEEC
T ss_pred CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEEC
Confidence 36899999999999999999999999999999999999997667888999999999999999 89999999999999999
Q ss_pred cccCCCCCCCcccccCceeeeecCCCCccc
Q 002358 492 ENNSFVGEIPPALLTGKVIFKYDNNPKLHK 521 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~~~~~l~~~~N~~~c~ 521 (931)
++|+|+ .+|...+..+..+.+++||+.|.
T Consensus 332 ~~N~l~-~~~~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 332 DHNSIV-TLKLSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CSSCCC-CCCCCTTCCCSEEECCSSCEEHH
T ss_pred CCCCCC-CcChhhcCCCCEEEeeCCCCCCh
Confidence 999998 67766677888999999998875
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.96 E-value=4.8e-10 Score=133.27 Aligned_cols=111 Identities=19% Similarity=0.191 Sum_probs=97.4
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCC-CCCC-CccccccccEeecCCccccCCCCCccCCccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-GPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~-g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l 489 (931)
.++++.|+|++|.+.+.+|..+.++++|+.|+|++|+++ +.+| .+..+++|+.|+|++|++++..|..++++++|+.|
T Consensus 420 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 499 (570)
T 2z63_A 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499 (570)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEE
Confidence 468999999999999999999999999999999999998 5677 59999999999999999998889999999999999
Q ss_pred cccccCCCCCCCcccc--cCceeeeecCCCCcccc
Q 002358 490 HIENNSFVGEIPPALL--TGKVIFKYDNNPKLHKE 522 (931)
Q Consensus 490 ~l~~N~l~g~iP~~~~--~~~~~l~~~~N~~~c~~ 522 (931)
+|++|++++..|..+. ..+..+.+++|++.|..
T Consensus 500 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred eCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence 9999999965554443 36788899999998864
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.95 E-value=2e-10 Score=114.99 Aligned_cols=101 Identities=19% Similarity=0.218 Sum_probs=86.5
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCc-cccccccEeecCCccccCCCCC--ccCCccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS--YMGSLPNLQEL 489 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~-~~l~~L~~L~L~~N~l~g~iP~--~l~~l~~L~~l 489 (931)
++|+.|+|++|.|++. +.|+++++|+.|+|++|+|++.+|.+ ..+++|+.|+|++|+|+ .+|. .++.+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 4899999999999965 78999999999999999999987774 99999999999999997 7887 89999999999
Q ss_pred cccccCCCCCCCcc----cc--cCceeeeecCCC
Q 002358 490 HIENNSFVGEIPPA----LL--TGKVIFKYDNNP 517 (931)
Q Consensus 490 ~l~~N~l~g~iP~~----~~--~~~~~l~~~~N~ 517 (931)
+|++|.++ .+|.. +. ..+..+.+.+|+
T Consensus 119 ~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~ 151 (176)
T 1a9n_A 119 CILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVK 151 (176)
T ss_dssp ECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECC
T ss_pred EecCCCCC-CcHhHHHHHHHHCCccceeCCCcCC
Confidence 99999998 77774 22 245555555554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=9.3e-10 Score=118.39 Aligned_cols=105 Identities=19% Similarity=0.240 Sum_probs=64.7
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
++|+.|+|++|.+++..+..|.++++|+.|+|++|+|++..| .+.++++|+.|+|++|++++..+..++++++|+.|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 456666666666665555566666666666666666666665 3666666666666666666544445666666666666
Q ss_pred cccCCCC-CCCccccc--CceeeeecCCC
Q 002358 492 ENNSFVG-EIPPALLT--GKVIFKYDNNP 517 (931)
Q Consensus 492 ~~N~l~g-~iP~~~~~--~~~~l~~~~N~ 517 (931)
++|++++ .+|..+.. .+..+.+++|.
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~ 160 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred cCCccceecCchhhccCCCCCEEECCCCC
Confidence 6666663 24554432 55555565554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=2.5e-10 Score=142.71 Aligned_cols=107 Identities=22% Similarity=0.315 Sum_probs=92.2
Q ss_pred CCcEEEEEeCCCCCc-----ccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCccc
Q 002358 412 PPRITKIALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPN 485 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~-----g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~ 485 (931)
.++|+.|+|++|.++ +..|..|.+|++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..+. ++
T Consensus 450 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~ 527 (844)
T 3j0a_A 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--AN 527 (844)
T ss_dssp CTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SC
T ss_pred CCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--cc
Confidence 368999999999997 45556789999999999999999999995 89999999999999999966666665 89
Q ss_pred cccccccccCCCCCCCcccccCceeeeecCCCCccc
Q 002358 486 LQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHK 521 (931)
Q Consensus 486 L~~l~l~~N~l~g~iP~~~~~~~~~l~~~~N~~~c~ 521 (931)
|+.|+|++|+|+|.+|.. +..+..+.+++||+.|.
T Consensus 528 L~~L~Ls~N~l~~~~~~~-~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 528 LEILDISRNQLLAPNPDV-FVSLSVLDITHNKFICE 562 (844)
T ss_dssp CCEEEEEEECCCCCCSCC-CSSCCEEEEEEECCCCS
T ss_pred ccEEECCCCcCCCCChhH-hCCcCEEEecCCCcccc
Confidence 999999999999777765 45788899999999883
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.3e-10 Score=140.27 Aligned_cols=93 Identities=31% Similarity=0.399 Sum_probs=85.4
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++|+.|+|++|.|+ .+|..|++|++|+.|+|++|+|+..+.+|++|++|+.|+|++|+|+ .||.+|++|++|+.|+|
T Consensus 246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L 323 (727)
T 4b8c_D 246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV 323 (727)
T ss_dssp CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence 468999999999999 9999999999999999999999955447999999999999999998 99999999999999999
Q ss_pred cccCCCCCCCccccc
Q 002358 492 ENNSFVGEIPPALLT 506 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~ 506 (931)
++|+|+|.+|..+..
T Consensus 324 ~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 324 EGNPLEKQFLKILTE 338 (727)
T ss_dssp TTSCCCSHHHHHHHH
T ss_pred CCCccCCCChHHHhh
Confidence 999999888877643
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.94 E-value=4.3e-10 Score=130.91 Aligned_cols=108 Identities=19% Similarity=0.241 Sum_probs=96.9
Q ss_pred CcEEEEEeCCCCCcccCC-ccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 413 PRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip-~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.+|+.|+|++|+|+ .+| ..|.++++|+.|+|++|+|++..+ .|.++++|+.|+|++|++++..|..+.++++|+.|+
T Consensus 224 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 302 (477)
T 2id5_A 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLN 302 (477)
T ss_dssp CCCSEEEEESSCCC-SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEE
T ss_pred ccccEEECcCCccc-ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEE
Confidence 37999999999999 555 679999999999999999999888 499999999999999999988899999999999999
Q ss_pred ccccCCCCCCCccccc---CceeeeecCCCCcccc
Q 002358 491 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~---~~~~l~~~~N~~~c~~ 522 (931)
|++|+|+ .+|...+. .+..+.+++||+.|..
T Consensus 303 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 303 VSGNQLT-TLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp CCSSCCS-CCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred CCCCcCc-eeCHhHcCCCcccCEEEccCCCccCcc
Confidence 9999999 67766543 6778899999998864
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.94 E-value=6.1e-10 Score=123.32 Aligned_cols=106 Identities=22% Similarity=0.198 Sum_probs=94.6
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
++++.|+|++|.+++..|..|.++++|+.|+|++|+|++.+| .+..+++|+.|+|++|+|+ .+|..++.+++|+.|+|
T Consensus 193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 271 (332)
T 2ft3_A 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271 (332)
T ss_dssp SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence 589999999999998888899999999999999999999998 5999999999999999999 99999999999999999
Q ss_pred cccCCCCCCCccccc---------CceeeeecCCCCcc
Q 002358 492 ENNSFVGEIPPALLT---------GKVIFKYDNNPKLH 520 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~---------~~~~l~~~~N~~~c 520 (931)
++|+++ .+|...+. .+..+.+.+||..+
T Consensus 272 ~~N~l~-~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~ 308 (332)
T 2ft3_A 272 HTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPY 308 (332)
T ss_dssp CSSCCC-BCCTTSSSCSSCCSSSCCBSEEECCSSSSCG
T ss_pred CCCCCC-ccChhHccccccccccccccceEeecCcccc
Confidence 999999 66654432 34567889999764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.3e-10 Score=125.75 Aligned_cols=106 Identities=18% Similarity=0.222 Sum_probs=80.7
Q ss_pred CcEEEEEeCCCCCcccCCccc--cCccccceecccCCcCCCCCCCcccc-----ccccEeecCCccccCCCCCccCCccc
Q 002358 413 PRITKIALSGKNLKGEIPPEL--KNMEALTELWLDGNFLTGPLPDMSRL-----IDLRIVHLENNELTGSLPSYMGSLPN 485 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~--~~L~~L~~L~Ls~N~l~g~~p~~~~l-----~~L~~L~L~~N~l~g~iP~~l~~l~~ 485 (931)
++|+.|+|++|+++|.+|..+ +.+++|++|+|++|+|++.++.++++ ++|+.|+|++|++++..|+.++++++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 478888888888888888876 78888888888888888883346666 88888888888888777788888888
Q ss_pred cccccccccCCCCCC--Cccc----ccCceeeeecCCCC
Q 002358 486 LQELHIENNSFVGEI--PPAL----LTGKVIFKYDNNPK 518 (931)
Q Consensus 486 L~~l~l~~N~l~g~i--P~~~----~~~~~~l~~~~N~~ 518 (931)
|+.|+|++|++.|.+ |..+ ...+..+.+++|..
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l 213 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCC
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcC
Confidence 888888888877652 3332 23566777777753
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.1e-09 Score=126.17 Aligned_cols=116 Identities=19% Similarity=0.208 Sum_probs=97.3
Q ss_pred CceEEeeCC--------CCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccc
Q 002358 402 WEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNEL 472 (931)
Q Consensus 402 w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l 472 (931)
|..+.|... .+++++.|+|++|++++..+..|.+|++|+.|+|++|+|++..+ .|.++++|+.|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 456777643 24578999999999998888999999999999999999999887 599999999999999999
Q ss_pred cCCCCCccCCccccccccccccCCCCCCCccccc---CceeeeecCCCC
Q 002358 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPK 518 (931)
Q Consensus 473 ~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~~---~~~~l~~~~N~~ 518 (931)
++..+..+..+++|+.|+|++|+++ .+|...+. .+..+.+.+|..
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~~ 172 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKR 172 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTT
T ss_pred CeeCHhHhhccccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCCC
Confidence 9555567999999999999999999 66664443 667777777543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=5.8e-10 Score=133.82 Aligned_cols=110 Identities=20% Similarity=0.204 Sum_probs=86.7
Q ss_pred CCcEEEEEeCCCCCccc---CCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccc
Q 002358 412 PPRITKIALSGKNLKGE---IPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 487 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~---ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~ 487 (931)
.++|+.|+|++|.+.+. .+..+..+++|+.|+|++|++++.+| .|.++++|+.|+|++|++++.+|+.+.++++|
T Consensus 448 l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L- 526 (606)
T 3t6q_A 448 LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI- 526 (606)
T ss_dssp CTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-
T ss_pred CCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-
Confidence 45788888888888763 23568888888888888888888877 58888888888888888888888888888888
Q ss_pred cccccccCCCCCCCcccc--cCceeeeecCCCCcccc
Q 002358 488 ELHIENNSFVGEIPPALL--TGKVIFKYDNNPKLHKE 522 (931)
Q Consensus 488 ~l~l~~N~l~g~iP~~~~--~~~~~l~~~~N~~~c~~ 522 (931)
.|+|++|++++..|..+. ..+..+.+++||+.|..
T Consensus 527 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 527 YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 888888888855554433 36778888999988853
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.1e-09 Score=121.15 Aligned_cols=115 Identities=22% Similarity=0.334 Sum_probs=97.5
Q ss_pred CCCceEEeeCC--------CCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCc
Q 002358 400 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 470 (931)
Q Consensus 400 ~~w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N 470 (931)
|.|..+.|+.. .+++++.|+|++|++++..|..|+++++|+.|+|++|++++..| .|.++++|+.|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 46888888643 23579999999999997778899999999999999999999988 5999999999999999
Q ss_pred cccCCCCCccCCccccccccccccCCCCCCCcccc---cCceeeeecCCCC
Q 002358 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 518 (931)
Q Consensus 471 ~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~---~~~~~l~~~~N~~ 518 (931)
+++ .+|..+. ++|+.|++++|+++ .+|...+ ..+..+.+++|..
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l 159 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPL 159 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCC
T ss_pred cCC-ccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCcc
Confidence 999 8898776 89999999999999 6776543 3677778888865
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.93 E-value=5.3e-10 Score=123.06 Aligned_cols=106 Identities=21% Similarity=0.200 Sum_probs=93.1
Q ss_pred CcEEEEEeCCCCCcccCCcccc-CccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~-~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
++|+.|+|++|.+++..|..+. .+++|+.|+|++|+|++. |....+++|+.|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L 221 (317)
T 3o53_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221 (317)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEEC
T ss_pred CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCC-cchhhhcccCcccEEEC
Confidence 5899999999999988787774 799999999999999987 55556999999999999999 57777999999999999
Q ss_pred cccCCCCCCCccccc--CceeeeecCCCCccc
Q 002358 492 ENNSFVGEIPPALLT--GKVIFKYDNNPKLHK 521 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~--~~~~l~~~~N~~~c~ 521 (931)
++|+|+ .+|..+.. .+..+.+++|+..|.
T Consensus 222 ~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp TTSCCC-EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred cCCccc-chhhHhhcCCCCCEEEccCCCccCc
Confidence 999999 78887644 788899999999874
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.91 E-value=6e-10 Score=110.46 Aligned_cols=87 Identities=28% Similarity=0.282 Sum_probs=41.0
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCC--CCccccccccEeecCCccccCCCC---CccCCcccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPL--PDMSRLIDLRIVHLENNELTGSLP---SYMGSLPNLQE 488 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~--p~~~~l~~L~~L~L~~N~l~g~iP---~~l~~l~~L~~ 488 (931)
+|+.|+|++|.+++.+|..+.++++|+.|+|++|+|++.. +.+..+++|+.|+|++|.+++..+ ..+..+++|+.
T Consensus 72 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~ 151 (168)
T 2ell_A 72 KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTY 151 (168)
T ss_dssp SCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCE
T ss_pred CCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcE
Confidence 4455555555555444444444555555555555554432 234445555555555555552222 14444555555
Q ss_pred ccccccCCCCCCC
Q 002358 489 LHIENNSFVGEIP 501 (931)
Q Consensus 489 l~l~~N~l~g~iP 501 (931)
|++++|.+. ++|
T Consensus 152 L~l~~n~~~-~~~ 163 (168)
T 2ell_A 152 LDGYDREDQ-EAP 163 (168)
T ss_dssp ETTEETTSC-BCC
T ss_pred ecCCCCChh-hcc
Confidence 555555544 444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.91 E-value=1.2e-09 Score=129.97 Aligned_cols=104 Identities=17% Similarity=0.207 Sum_probs=90.0
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
+++++.|+|++|++++..|..|+++++|++|+|++|+|++..| .|.++++|++|+|++|+|+ .+|.. .+++|+.|+
T Consensus 51 ~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 51 PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 4689999999999997777899999999999999999999988 4999999999999999999 88887 899999999
Q ss_pred ccccCCCC-CCCccccc--CceeeeecCCCC
Q 002358 491 IENNSFVG-EIPPALLT--GKVIFKYDNNPK 518 (931)
Q Consensus 491 l~~N~l~g-~iP~~~~~--~~~~l~~~~N~~ 518 (931)
|++|++++ .+|..+.. .+..+.+++|..
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l 158 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF 158 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBC
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCcc
Confidence 99999985 34566543 677788888764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.90 E-value=1.4e-09 Score=129.54 Aligned_cols=106 Identities=23% Similarity=0.329 Sum_probs=81.3
Q ss_pred CcEEEEEeCCCCCcccCCcc-ccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~-~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
++++.|+|++|.+++.+|.. +..+++|+.|+|++|+|++.+|. +. ++|+.|+|++|+|+ .||..+..+++|+.|+
T Consensus 403 ~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~ 479 (562)
T 3a79_B 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELN 479 (562)
T ss_dssp TTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEE
T ss_pred CCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEE
Confidence 46777777777777656554 66677777777777777666553 33 68888999999888 8998888999999999
Q ss_pred ccccCCCCCCCcccc---cCceeeeecCCCCcccc
Q 002358 491 IENNSFVGEIPPALL---TGKVIFKYDNNPKLHKE 522 (931)
Q Consensus 491 l~~N~l~g~iP~~~~---~~~~~l~~~~N~~~c~~ 522 (931)
|++|+|+ .+|...+ ..+..+.+++||+.|..
T Consensus 480 L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 480 VASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp CCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred CCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 9999999 8888733 26677889999998863
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.89 E-value=1.2e-09 Score=119.33 Aligned_cols=108 Identities=19% Similarity=0.259 Sum_probs=94.1
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCC-CCC-CccccccccEeecCCccccCCCCCccCCccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g-~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l 489 (931)
.++|+.|+|++|.+.+..|..+.++++|+.|+|++|++++ .+| .+..+++|+.|+|++|++++..|..++++++|+.|
T Consensus 125 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 204 (306)
T 2z66_A 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204 (306)
T ss_dssp CTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEE
Confidence 3589999999999999999999999999999999999998 456 59999999999999999998889999999999999
Q ss_pred cccccCCCCCCCcccc--cCceeeeecCCCCc
Q 002358 490 HIENNSFVGEIPPALL--TGKVIFKYDNNPKL 519 (931)
Q Consensus 490 ~l~~N~l~g~iP~~~~--~~~~~l~~~~N~~~ 519 (931)
+|++|++++..+..+. ..+..+.+++|...
T Consensus 205 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 236 (306)
T 2z66_A 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236 (306)
T ss_dssp ECTTSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred ECCCCccCccChhhccCcccCCEeECCCCCCc
Confidence 9999999944333433 37788888988754
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=2.2e-09 Score=118.62 Aligned_cols=115 Identities=24% Similarity=0.395 Sum_probs=91.7
Q ss_pred CCCceEEeeCC--------CCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCc
Q 002358 400 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 470 (931)
Q Consensus 400 ~~w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N 470 (931)
|.|..+.|+.. .++.++.|+|++|++++..+..|+++++|++|+|++|++++..| .|.++++|+.|+|++|
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 46777777642 24578999999999997777789999999999999999999877 5899999999999999
Q ss_pred cccCCCCCccCCccccccccccccCCCCCCCcc-cc--cCceeeeecCCCC
Q 002358 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA-LL--TGKVIFKYDNNPK 518 (931)
Q Consensus 471 ~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~-~~--~~~~~l~~~~N~~ 518 (931)
+++ .+|..+. ++|+.|++++|+++ .+|.. +. ..+..+.+++|..
T Consensus 111 ~l~-~l~~~~~--~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l 157 (330)
T 1xku_A 111 QLK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPL 157 (330)
T ss_dssp CCS-BCCSSCC--TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCC
T ss_pred cCC-ccChhhc--ccccEEECCCCccc-ccCHhHhcCCccccEEECCCCcC
Confidence 998 7888775 78999999999998 45443 32 3666777777754
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.89 E-value=4.3e-10 Score=109.13 Aligned_cols=88 Identities=18% Similarity=0.212 Sum_probs=78.5
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCC-CCCccCCccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGS-LPSYMGSLPNLQEL 489 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~-iP~~l~~l~~L~~l 489 (931)
.++++.|+|++|.+++. ..++++++|+.|+|++|++++.+|. +.++++|+.|+|++|++++. .|..++.+++|+.|
T Consensus 41 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L 118 (149)
T 2je0_A 41 FEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118 (149)
T ss_dssp CTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEE
T ss_pred cCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEE
Confidence 46899999999999965 8899999999999999999998885 67799999999999999962 44889999999999
Q ss_pred cccccCCCCCCCc
Q 002358 490 HIENNSFVGEIPP 502 (931)
Q Consensus 490 ~l~~N~l~g~iP~ 502 (931)
++++|++++ +|.
T Consensus 119 ~l~~N~l~~-~~~ 130 (149)
T 2je0_A 119 DLFNCEVTN-LND 130 (149)
T ss_dssp ECTTCGGGG-STT
T ss_pred eCcCCcccc-hHH
Confidence 999999994 454
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.89 E-value=2.3e-09 Score=128.74 Aligned_cols=106 Identities=19% Similarity=0.190 Sum_probs=85.3
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|.|++..|..|++|++|+.|+|++|.|++.++. |+++++|+.|+|++|+|++..|..|+++++|+.|+
T Consensus 98 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 177 (597)
T 3oja_B 98 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 177 (597)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEE
Confidence 45788888888888877777788888888888888888877775 68888888888888888877777888888888888
Q ss_pred ccccCCCCCCCcccccCceeeeecCCCC
Q 002358 491 IENNSFVGEIPPALLTGKVIFKYDNNPK 518 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~~~~~l~~~~N~~ 518 (931)
|++|.|+ .+|...+..+..+.+++|..
T Consensus 178 L~~N~l~-~~~~~~l~~L~~L~l~~n~l 204 (597)
T 3oja_B 178 LSSNRLT-HVDLSLIPSLFHANVSYNLL 204 (597)
T ss_dssp CTTSCCS-BCCGGGCTTCSEEECCSSCC
T ss_pred CcCCCCC-CcChhhhhhhhhhhcccCcc
Confidence 8888888 46666666677777776643
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.87 E-value=2.5e-09 Score=130.21 Aligned_cols=106 Identities=23% Similarity=0.293 Sum_probs=70.5
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
+++++.|+|++|++++..+..|+++++|+.|+|++|++++.+|. |+++++|++|+|++|++++..+..|+++++|++|+
T Consensus 24 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp CTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 34678888888888765556677777777777777777777774 67777777777777777733333577777777777
Q ss_pred ccccCCCCCCCccccc--CceeeeecCCC
Q 002358 491 IENNSFVGEIPPALLT--GKVIFKYDNNP 517 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~--~~~~l~~~~N~ 517 (931)
|++|++++..|..+.. .+..+.+++|.
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 132 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNG 132 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCc
Confidence 7777776332333322 45555566554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.87 E-value=1.2e-09 Score=111.51 Aligned_cols=80 Identities=15% Similarity=0.296 Sum_probs=39.3
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~ 492 (931)
+|+.|+|++|.++ .++.+.++++|+.|+|++|++++..| .+++|++|+.|+|++|++++..|..++.+++|+.|+|+
T Consensus 67 ~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~ 144 (197)
T 4ezg_A 67 NIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144 (197)
T ss_dssp TCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECC
T ss_pred CCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEcc
Confidence 4555555555332 22344555555555555555554333 34555555555555555554444445555555555555
Q ss_pred ccC
Q 002358 493 NNS 495 (931)
Q Consensus 493 ~N~ 495 (931)
+|+
T Consensus 145 ~n~ 147 (197)
T 4ezg_A 145 YNG 147 (197)
T ss_dssp SCT
T ss_pred CCC
Confidence 554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.85 E-value=4e-09 Score=119.39 Aligned_cols=106 Identities=19% Similarity=0.190 Sum_probs=92.0
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|.+++..|..|+++++|++|+|++|+|+..++. |.++++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (390)
T 3o6n_A 92 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 171 (390)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEE
T ss_pred CCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEE
Confidence 46899999999999987788899999999999999999987776 68999999999999999977788899999999999
Q ss_pred ccccCCCCCCCcccccCceeeeecCCCC
Q 002358 491 IENNSFVGEIPPALLTGKVIFKYDNNPK 518 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~~~~~l~~~~N~~ 518 (931)
|++|+++ .++...+..+..+.+++|..
T Consensus 172 l~~n~l~-~~~~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 172 LSSNRLT-HVDLSLIPSLFHANVSYNLL 198 (390)
T ss_dssp CCSSCCS-BCCGGGCTTCSEEECCSSCC
T ss_pred CCCCcCC-ccccccccccceeecccccc
Confidence 9999998 56766666777777777753
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.85 E-value=8.4e-10 Score=121.01 Aligned_cols=106 Identities=17% Similarity=0.196 Sum_probs=81.9
Q ss_pred CCcEEEEEeCCCCCccc--CC--ccccCccccceecccCCcCCCCCCC----ccccccccEeecCCccccCCCCCccCCc
Q 002358 412 PPRITKIALSGKNLKGE--IP--PELKNMEALTELWLDGNFLTGPLPD----MSRLIDLRIVHLENNELTGSLPSYMGSL 483 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~--ip--~~~~~L~~L~~L~Ls~N~l~g~~p~----~~~l~~L~~L~L~~N~l~g~iP~~l~~l 483 (931)
.++|+.|+|++|++.|. ++ ..++++++|++|+|++|+|+...+. +.++++|+.|+|++|+|++.+|+.++.+
T Consensus 168 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 168 FPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp CTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 45788888888888753 32 2347888888888888888654331 4678888888888888887778887777
Q ss_pred ---cccccccccccCCCCCCCcccccCceeeeecCCCC
Q 002358 484 ---PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPK 518 (931)
Q Consensus 484 ---~~L~~l~l~~N~l~g~iP~~~~~~~~~l~~~~N~~ 518 (931)
++|+.|+|++|+|+ .+|..++..+..+.+++|..
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l 284 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRL 284 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCC
T ss_pred cCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcC
Confidence 58888888888888 88888877778888888864
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.85 E-value=1.2e-09 Score=128.51 Aligned_cols=107 Identities=14% Similarity=0.138 Sum_probs=87.0
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCC--CCC-CccccccccEeecCCccccCCCCCc-cCCccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--PLP-DMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQ 487 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g--~~p-~~~~l~~L~~L~L~~N~l~g~iP~~-l~~l~~L~ 487 (931)
.++++.|+|++|.+++.+|..++++++|+.|+|++|++++ .+| .+.++++|+.|+|++|++++.+|.. +..+++|+
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 3578888888888888888888888888888888888887 444 4788888888888888888767765 77888888
Q ss_pred cccccccCCCCCCCcccccCceeeeecCCCC
Q 002358 488 ELHIENNSFVGEIPPALLTGKVIFKYDNNPK 518 (931)
Q Consensus 488 ~l~l~~N~l~g~iP~~~~~~~~~l~~~~N~~ 518 (931)
.|+|++|++++.+|..+...+..+.+++|..
T Consensus 403 ~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l 433 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLPPRIKVLDLHSNKI 433 (520)
T ss_dssp EEECCSSCCCGGGGGSCCTTCCEEECCSSCC
T ss_pred EEECcCCCCCcchhhhhcccCCEEECCCCcc
Confidence 8888888888888877766777777777754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.85 E-value=9.9e-10 Score=129.30 Aligned_cols=103 Identities=15% Similarity=0.124 Sum_probs=78.8
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
++++.|+|++|++++..|..|.+|++|++|+|++|+|++..| .|.+|++|++|+|++|+|+ .+|.. .+++|+.|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 478888888888886666778888888888888888888777 5788888888888888888 67776 7888888888
Q ss_pred cccCCCC-CCCccccc--CceeeeecCCCC
Q 002358 492 ENNSFVG-EIPPALLT--GKVIFKYDNNPK 518 (931)
Q Consensus 492 ~~N~l~g-~iP~~~~~--~~~~l~~~~N~~ 518 (931)
++|++++ .+|..+.. .+..+.+++|..
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l 127 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHL 127 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSC
T ss_pred cCCccccccchhhhccCCcceEEEecCccc
Confidence 8888875 46666543 666677777654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=2.2e-09 Score=127.11 Aligned_cols=106 Identities=19% Similarity=0.195 Sum_probs=74.8
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccC-CCCCccCCcccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTG-SLPSYMGSLPNLQELH 490 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g-~iP~~l~~l~~L~~l~ 490 (931)
++|+.|+|++|++++..|..|++|++|++|+|++|++++.+|. |++|++|+.|+|++|++++ .+|..++++++|+.|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 4677777777777776777777777777777777777777774 7777777777777777775 3566777777777777
Q ss_pred ccccCCCCCCCccccc---CceeeeecCCCC
Q 002358 491 IENNSFVGEIPPALLT---GKVIFKYDNNPK 518 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~---~~~~l~~~~N~~ 518 (931)
+++|++.+.+|...+. .+..+.+.+|..
T Consensus 130 L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 7777755566653322 445555666643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.82 E-value=4e-09 Score=117.78 Aligned_cols=105 Identities=20% Similarity=0.224 Sum_probs=87.1
Q ss_pred CCCCCceEEeeCCC--------CCcEEEEEeCCCCCcccCC-ccccCccccceecccCCcCCCCCC--CccccccccE-e
Q 002358 398 VPVPWEWVTCSTTT--------PPRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRI-V 465 (931)
Q Consensus 398 ~~~~w~~v~c~~~~--------~~~l~~L~L~~n~l~g~ip-~~~~~L~~L~~L~Ls~N~l~g~~p--~~~~l~~L~~-L 465 (931)
|.|.|..|.|+... +.++++|+|++|+|+ .|| ..|.+|++|+.|+|++|++.+.+| .|.+|++|+. +
T Consensus 7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l 85 (350)
T 4ay9_X 7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85 (350)
T ss_dssp SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence 34567788897532 357999999999999 555 579999999999999999998877 3899998765 7
Q ss_pred ecCCccccCCCCCccCCccccccccccccCCCCCCCccc
Q 002358 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504 (931)
Q Consensus 466 ~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~ 504 (931)
.++.|+|++..|+.+..|++|+.|++++|+++ .+|+..
T Consensus 86 ~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~~~ 123 (350)
T 4ay9_X 86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVH 123 (350)
T ss_dssp EEEETTCCEECTTSBCCCTTCCEEEEEEECCS-SCCCCT
T ss_pred cccCCcccccCchhhhhccccccccccccccc-cCCchh
Confidence 77889999666788999999999999999999 566543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=4.8e-09 Score=127.71 Aligned_cols=106 Identities=22% Similarity=0.184 Sum_probs=84.7
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
++|+.|+|++|++++..+..|++|++|++|+|++|++++.+| .|+++++|+.|+|++|++++..|..++++++|+.|+|
T Consensus 73 ~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 152 (680)
T 1ziw_A 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLL 152 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEEC
T ss_pred cCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEc
Confidence 578899999999884444468899999999999999988887 5888999999999999998888888888999999999
Q ss_pred cccCCCCCCCcccc----cCceeeeecCCCC
Q 002358 492 ENNSFVGEIPPALL----TGKVIFKYDNNPK 518 (931)
Q Consensus 492 ~~N~l~g~iP~~~~----~~~~~l~~~~N~~ 518 (931)
++|++++..|..+. ..+..+.+++|..
T Consensus 153 ~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l 183 (680)
T 1ziw_A 153 SNNKIQALKSEELDIFANSSLKKLELSSNQI 183 (680)
T ss_dssp CSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred cCCcccccCHHHhhccccccccEEECCCCcc
Confidence 99998855554332 3566777777754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.80 E-value=2.7e-09 Score=112.24 Aligned_cols=103 Identities=21% Similarity=0.260 Sum_probs=77.1
Q ss_pred CcEEEEEeCC-CCCcccCCccccCccccceecccCCcCCCCCCCcccccccc---EeecCCc-cccCCCCCccCCccccc
Q 002358 413 PRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR---IVHLENN-ELTGSLPSYMGSLPNLQ 487 (931)
Q Consensus 413 ~~l~~L~L~~-n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~---~L~L~~N-~l~g~iP~~l~~l~~L~ 487 (931)
++|+.|+|++ |+|++..+..|.++++|+.|+|++|++++ +|++.++++|+ .|+|++| ++++..+..+.++++|+
T Consensus 80 ~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~ 158 (239)
T 2xwt_C 80 SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET 158 (239)
T ss_dssp TTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSE
T ss_pred cCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccccccccccccccEEECCCCcchhhcCcccccchhcce
Confidence 4788888887 88886556678888888888888888887 45577777777 8888888 88754445678888888
Q ss_pred -cccccccCCCCCCCccccc--CceeeeecCCC
Q 002358 488 -ELHIENNSFVGEIPPALLT--GKVIFKYDNNP 517 (931)
Q Consensus 488 -~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~ 517 (931)
.|+|++|+++ .+|...+. .+..+.+++|+
T Consensus 159 ~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 159 LTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred eEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 8888888888 77776554 45556667774
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.78 E-value=6.3e-09 Score=123.61 Aligned_cols=107 Identities=18% Similarity=0.280 Sum_probs=74.5
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccC-CCCCccCCccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTG-SLPSYMGSLPNLQEL 489 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g-~iP~~l~~l~~L~~l 489 (931)
.++|+.|+|++|.+++..|..|++|++|++|+|++|++++..+ .++++++|+.|+|++|++++ .+|..+++|++|+.|
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L 154 (570)
T 2z63_A 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154 (570)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEE
T ss_pred chhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEE
Confidence 3577777777777776666777777777777777777777766 57777777777777777775 467777777777777
Q ss_pred cccccCCCCCCCccccc--Cc----eeeeecCCCC
Q 002358 490 HIENNSFVGEIPPALLT--GK----VIFKYDNNPK 518 (931)
Q Consensus 490 ~l~~N~l~g~iP~~~~~--~~----~~l~~~~N~~ 518 (931)
++++|++++..|..+.. .+ ..+.+++|..
T Consensus 155 ~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l 189 (570)
T 2z63_A 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189 (570)
T ss_dssp ECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCC
T ss_pred eCcCCccceecHHHccchhccchhhhhcccCCCCc
Confidence 77777777444443322 22 3455666654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.78 E-value=4.6e-09 Score=117.27 Aligned_cols=105 Identities=18% Similarity=0.219 Sum_probs=82.3
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCC--ccCCcccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQE 488 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~--~l~~l~~L~~ 488 (931)
.++|+.|+|++|++++..|..|+++++|++|+|++|+|++.++. +.++++|+.|+|++|+++ .+|. .++++++|+.
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 35788999999999877778888999999999999999887775 888899999999999988 5665 7888899999
Q ss_pred ccccccC-CCCCCCcc-ccc--CceeeeecCCCC
Q 002358 489 LHIENNS-FVGEIPPA-LLT--GKVIFKYDNNPK 518 (931)
Q Consensus 489 l~l~~N~-l~g~iP~~-~~~--~~~~l~~~~N~~ 518 (931)
|++++|+ +. .++.. +.. .+..+.+++|..
T Consensus 154 L~l~~n~~~~-~~~~~~~~~l~~L~~L~l~~n~l 186 (353)
T 2z80_A 154 LRVGNMDTFT-KIQRKDFAGLTFLEELEIDASDL 186 (353)
T ss_dssp EEEEESSSCC-EECTTTTTTCCEEEEEEEEETTC
T ss_pred EECCCCcccc-ccCHHHccCCCCCCEEECCCCCc
Confidence 9999885 55 55443 322 556666777753
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.78 E-value=2.6e-09 Score=126.69 Aligned_cols=102 Identities=25% Similarity=0.398 Sum_probs=57.2
Q ss_pred CCceE-EeeCCCCCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCc
Q 002358 401 PWEWV-TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 479 (931)
Q Consensus 401 ~w~~v-~c~~~~~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~ 479 (931)
.|.++ .|.|. +|+.|+|++|+|++ +|..+. ++|+.|+|++|+|+. +| ..+++|+.|+|++|+|++ ||.
T Consensus 49 ~~~~l~~C~~~---~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~-ip--~~l~~L~~L~Ls~N~l~~-ip~- 117 (571)
T 3cvr_A 49 AVSLLKECLIN---QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-LP--ELPASLEYLDACDNRLST-LPE- 117 (571)
T ss_dssp HHHHHHHHHHT---TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSC-CC--CCCTTCCEEECCSSCCSC-CCC-
T ss_pred hhhhccccccC---CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcc-cc--cccCCCCEEEccCCCCCC-cch-
Confidence 36666 56543 56666666666664 665553 556666666666663 33 345566666666666664 555
Q ss_pred cCCccccccccccccCCCCCCCcccccCceeeeecCCC
Q 002358 480 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 517 (931)
Q Consensus 480 l~~l~~L~~l~l~~N~l~g~iP~~~~~~~~~l~~~~N~ 517 (931)
+++ +|+.|+|++|+|++ ||. ....+..+.+++|.
T Consensus 118 l~~--~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls~N~ 151 (571)
T 3cvr_A 118 LPA--SLKHLDVDNNQLTM-LPE-LPALLEYINADNNQ 151 (571)
T ss_dssp CCT--TCCEEECCSSCCSC-CCC-CCTTCCEEECCSSC
T ss_pred hhc--CCCEEECCCCcCCC-CCC-cCccccEEeCCCCc
Confidence 443 55555555555553 555 33444555555553
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.78 E-value=2.7e-09 Score=117.01 Aligned_cols=84 Identities=17% Similarity=0.198 Sum_probs=48.3
Q ss_pred cEEEEEeCCCCCcccCCccc--cCccccceecccCCcCCCCCCC-----ccccccccEeecCCccccCCCCCccCCcccc
Q 002358 414 RITKIALSGKNLKGEIPPEL--KNMEALTELWLDGNFLTGPLPD-----MSRLIDLRIVHLENNELTGSLPSYMGSLPNL 486 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~--~~L~~L~~L~Ls~N~l~g~~p~-----~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L 486 (931)
+|++|+|++|.+++.+|..+ +++++|+.|+|++|++++..|. +..+++|+.|+|++|++++..|..++.+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 35556666666665555555 5566666666666666555442 2345556666666666655555555566666
Q ss_pred ccccccccCCC
Q 002358 487 QELHIENNSFV 497 (931)
Q Consensus 487 ~~l~l~~N~l~ 497 (931)
+.|+|++|++.
T Consensus 172 ~~L~Ls~N~l~ 182 (310)
T 4glp_A 172 TSLDLSDNPGL 182 (310)
T ss_dssp CEEECCSCTTC
T ss_pred CEEECCCCCCc
Confidence 66666666554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.77 E-value=4.5e-09 Score=115.33 Aligned_cols=102 Identities=19% Similarity=0.165 Sum_probs=65.7
Q ss_pred CcEEEEEeCCCCCcc--cCCc-cccCccccceecccCCcCCCCCC--CccccccccEeecCCccccCCCCCccCCccccc
Q 002358 413 PRITKIALSGKNLKG--EIPP-ELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 487 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g--~ip~-~~~~L~~L~~L~Ls~N~l~g~~p--~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~ 487 (931)
++|+.|+|++|+|++ .++. .+.++++|+.|+|++|+|++.+| .+..+++|+.|+|++|+|+ .+|..+. ++|+
T Consensus 201 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~ 277 (312)
T 1wwl_A 201 PTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLS 277 (312)
T ss_dssp TTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEE
T ss_pred CCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCce
Confidence 467777777777762 2232 23566777777777777777664 3566777777777777777 6777665 6777
Q ss_pred cccccccCCCCCCCcccc--cCceeeeecCCCCc
Q 002358 488 ELHIENNSFVGEIPPALL--TGKVIFKYDNNPKL 519 (931)
Q Consensus 488 ~l~l~~N~l~g~iP~~~~--~~~~~l~~~~N~~~ 519 (931)
.|+|++|+|+ .+|. +. ..+..+.+++|+..
T Consensus 278 ~L~Ls~N~l~-~~p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 278 VLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp EEECCSSCCC-SCCC-TTTSCEEEEEECTTCTTT
T ss_pred EEECCCCCCC-CChh-HhhCCCCCEEeccCCCCC
Confidence 7777777777 3454 32 24555666777643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.77 E-value=1.3e-08 Score=113.83 Aligned_cols=141 Identities=16% Similarity=0.231 Sum_probs=106.2
Q ss_pred ccccCccCcEEEEEEEECCCcEEEEEEcc--Ccc-chhhhhHHHHHHHHHhcC--CCCCcceeEEEecC---CeEEEEEE
Q 002358 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMA--DSC-SHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEE---HQRILVYE 685 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~--~~~-~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~~---~~~~lV~E 685 (931)
.+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+++++.++ +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 357899999999999876 4678888765 322 123457889999999997 45688899988776 45799999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcC-------------------------------------
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC------------------------------------- 728 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------- 728 (931)
|++|..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99987774321 123667788889999999999999720
Q ss_pred ------------------CCCeEecCCCCCCccccCCCc--eEEeccccccc
Q 002358 729 ------------------NPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQ 760 (931)
Q Consensus 729 ------------------~~~ivH~DIkp~NILld~~~~--vkL~DFGla~~ 760 (931)
...++|||+++.|||++.++. +.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998864
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.73 E-value=8.2e-09 Score=112.19 Aligned_cols=101 Identities=23% Similarity=0.388 Sum_probs=82.7
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++|+.|+|++|++++ + +.+.++++|+.|+|++|++++. +.+..+++|+.|+|++|++++..| ++.+++|+.|+|
T Consensus 111 l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L 185 (291)
T 1h6t_A 111 LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185 (291)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEEC
Confidence 3589999999999985 4 5788999999999999999887 778999999999999999995444 889999999999
Q ss_pred cccCCCCCCCcccc--cCceeeeecCCCCc
Q 002358 492 ENNSFVGEIPPALL--TGKVIFKYDNNPKL 519 (931)
Q Consensus 492 ~~N~l~g~iP~~~~--~~~~~l~~~~N~~~ 519 (931)
++|+++ .+|. +. ..+..+.+++|+..
T Consensus 186 ~~N~i~-~l~~-l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 186 SKNHIS-DLRA-LAGLKNLDVLELFSQECL 213 (291)
T ss_dssp CSSCCC-BCGG-GTTCTTCSEEEEEEEEEE
T ss_pred CCCcCC-CChh-hccCCCCCEEECcCCccc
Confidence 999998 5664 32 26677778887654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.71 E-value=1.7e-08 Score=107.97 Aligned_cols=100 Identities=26% Similarity=0.338 Sum_probs=69.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~ 492 (931)
++|+.|+|++|+|++ +|+ +++|++|+.|+|++|+|++..+ +.. ++|+.|+|++|++++ +| .++.+++|+.|+|+
T Consensus 63 ~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls 136 (263)
T 1xeu_A 63 TNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKNLNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIR 136 (263)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSCCTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECT
T ss_pred CCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCCcCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECC
Confidence 578888888888874 444 8888888888888888877433 333 778888888888774 44 47777888888888
Q ss_pred ccCCCCCCCc-ccccCceeeeecCCCCc
Q 002358 493 NNSFVGEIPP-ALLTGKVIFKYDNNPKL 519 (931)
Q Consensus 493 ~N~l~g~iP~-~~~~~~~~l~~~~N~~~ 519 (931)
+|+++ .+|. .-...+..+.+++|...
T Consensus 137 ~N~i~-~~~~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 137 NNKLK-SIVMLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp TSCCC-BCGGGGGCTTCCEEECTTSCCC
T ss_pred CCcCC-CChHHccCCCCCEEECCCCcCc
Confidence 88877 4542 11235666667777543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.70 E-value=7.7e-09 Score=113.33 Aligned_cols=103 Identities=22% Similarity=0.369 Sum_probs=72.2
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++|+.|+|++|.+++ +++ ++++++|+.|+|++|++++..+ +.++++|+.|+|++|++++ +|. +..+++|+.|+|
T Consensus 128 l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L 202 (308)
T 1h6u_A 128 LSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHL 202 (308)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEEC
T ss_pred CCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCc-Chh-hcCCCCCCEEEc
Confidence 4577888888888874 333 7778888888888888877555 7778888888888888874 443 777788888888
Q ss_pred cccCCCCCCCcccccCceeeeecCCCCc
Q 002358 492 ENNSFVGEIPPALLTGKVIFKYDNNPKL 519 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~~~~~l~~~~N~~~ 519 (931)
++|++++..|-.-...+..+.+++|+..
T Consensus 203 ~~N~l~~~~~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 203 KNNQISDVSPLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp TTSCCCBCGGGTTCTTCCEEEEEEEEEE
T ss_pred cCCccCccccccCCCCCCEEEccCCeee
Confidence 8888874333222235666777777654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.70 E-value=7.5e-09 Score=114.98 Aligned_cols=104 Identities=21% Similarity=0.279 Sum_probs=81.2
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++++.|+|++|.+++ + +.+..+++|+.|+|++|++++. |.+..+++|+.|+|++|++++..|..++++++|+.|+|
T Consensus 242 l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 318 (347)
T 4fmz_A 242 LSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318 (347)
T ss_dssp CTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEEC
T ss_pred CCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEc
Confidence 3578888888888884 3 4688888888888888888885 66888888888888888888878888888888888888
Q ss_pred cccCCCCCCCcccccCceeeeecCCCC
Q 002358 492 ENNSFVGEIPPALLTGKVIFKYDNNPK 518 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~~~~~l~~~~N~~ 518 (931)
++|++++..|-.-+..+..+.+++|+.
T Consensus 319 ~~n~l~~~~~~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 319 SQNHITDIRPLASLSKMDSADFANQVI 345 (347)
T ss_dssp CSSSCCCCGGGGGCTTCSEESSSCC--
T ss_pred cCCccccccChhhhhccceeehhhhcc
Confidence 888888655534445677777777763
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.69 E-value=1.7e-08 Score=110.52 Aligned_cols=102 Identities=25% Similarity=0.438 Sum_probs=85.5
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++|+.|+|++|++++ +|. +.++++|+.|+|++|++++..+ +.++++|+.|+|++|++++ +|. +..+++|+.|+|
T Consensus 106 l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 180 (308)
T 1h6u_A 106 LQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKA 180 (308)
T ss_dssp CTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEEC
Confidence 4689999999999985 554 9999999999999999998766 9999999999999999994 555 899999999999
Q ss_pred cccCCCCCCCc-ccccCceeeeecCCCCc
Q 002358 492 ENNSFVGEIPP-ALLTGKVIFKYDNNPKL 519 (931)
Q Consensus 492 ~~N~l~g~iP~-~~~~~~~~l~~~~N~~~ 519 (931)
++|+++ .+|. .-...+..+.+++|...
T Consensus 181 ~~n~l~-~~~~l~~l~~L~~L~L~~N~l~ 208 (308)
T 1h6u_A 181 DDNKIS-DISPLASLPNLIEVHLKNNQIS 208 (308)
T ss_dssp CSSCCC-CCGGGGGCTTCCEEECTTSCCC
T ss_pred CCCccC-cChhhcCCCCCCEEEccCCccC
Confidence 999999 4554 22347778888888654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.68 E-value=1.9e-08 Score=109.33 Aligned_cols=102 Identities=24% Similarity=0.309 Sum_probs=73.5
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++|+.|+|++|.+++ +| .++++++|+.|+|++|+|++. +.+..+++|+.|+|++|++++ + ..++.+++|+.|+|
T Consensus 89 l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L 163 (291)
T 1h6t_A 89 LKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSL 163 (291)
T ss_dssp CTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCc-c-hhhccCCCCCEEEc
Confidence 3578888888888874 33 478888888888888888774 667888888888888888884 3 56778888888888
Q ss_pred cccCCCCCCCcccccCceeeeecCCCC
Q 002358 492 ENNSFVGEIPPALLTGKVIFKYDNNPK 518 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~~~~~l~~~~N~~ 518 (931)
++|++++..|-.-...+..+.+++|..
T Consensus 164 ~~N~l~~~~~l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 164 EDNQISDIVPLAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp CSSCCCCCGGGTTCTTCCEEECCSSCC
T ss_pred cCCccccchhhcCCCccCEEECCCCcC
Confidence 888888433312223666677777754
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.66 E-value=3.5e-10 Score=115.61 Aligned_cols=103 Identities=24% Similarity=0.220 Sum_probs=76.7
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++|+.|+|++|++++ +| .+.++++|+.|+|++|+|+..++.+..+++|+.|+|++|++++ +| .++.+++|+.|+|
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 3578888888888885 77 8888888888888888888543346677888888888888884 66 5778888888888
Q ss_pred cccCCCCCCCc--cc--ccCceeeeecCCCCc
Q 002358 492 ENNSFVGEIPP--AL--LTGKVIFKYDNNPKL 519 (931)
Q Consensus 492 ~~N~l~g~iP~--~~--~~~~~~l~~~~N~~~ 519 (931)
++|+++ .+|. .+ ...+..+.+++|+..
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~ 153 (198)
T 1ds9_A 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSCHHH
T ss_pred CCCcCC-chhHHHHHhcCCCCCEEEecCCccc
Confidence 888887 4443 22 235667777777654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.66 E-value=2.1e-08 Score=120.07 Aligned_cols=102 Identities=23% Similarity=0.370 Sum_probs=76.4
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++|+.|+|++|.|++ + +.+.+|++|+.|+|++|+|++. +.+..|++|+.|+|++|+|++..| +..|++|+.|+|
T Consensus 108 l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 182 (605)
T 1m9s_A 108 LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 182 (605)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEEC
Confidence 4578888888888884 3 4688888888888888888876 678888888888888888886555 888888888888
Q ss_pred cccCCCCCCCcc-cccCceeeeecCCCCc
Q 002358 492 ENNSFVGEIPPA-LLTGKVIFKYDNNPKL 519 (931)
Q Consensus 492 ~~N~l~g~iP~~-~~~~~~~l~~~~N~~~ 519 (931)
++|+|+ .+|.- -+..+..+.+++|+..
T Consensus 183 s~N~i~-~l~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 183 SKNHIS-DLRALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp CSSCCC-BCGGGTTCTTCSEEECCSEEEE
T ss_pred cCCCCC-CChHHccCCCCCEEEccCCcCc
Confidence 888888 45431 1236666777777543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.66 E-value=2.5e-08 Score=106.62 Aligned_cols=100 Identities=20% Similarity=0.302 Sum_probs=85.7
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++|+.|+|++|+++ .+| .+..+++|+.|+|++|+|++..| +.++++|+.|+|++|+++ .+|.... ++|+.|+|
T Consensus 40 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~-~l~~~~~--~~L~~L~L 113 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLK-NLNGIPS--ACLSRLFL 113 (263)
T ss_dssp HTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCS-CCTTCCC--SSCCEEEC
T ss_pred cCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccC-CcCcccc--CcccEEEc
Confidence 358999999999998 777 79999999999999999999887 999999999999999999 5776444 99999999
Q ss_pred cccCCCCCCCcccc--cCceeeeecCCCCc
Q 002358 492 ENNSFVGEIPPALL--TGKVIFKYDNNPKL 519 (931)
Q Consensus 492 ~~N~l~g~iP~~~~--~~~~~l~~~~N~~~ 519 (931)
++|+++ .+|. +. ..+..+.+++|...
T Consensus 114 ~~N~l~-~~~~-l~~l~~L~~L~Ls~N~i~ 141 (263)
T 1xeu_A 114 DNNELR-DTDS-LIHLKNLEILSIRNNKLK 141 (263)
T ss_dssp CSSCCS-BSGG-GTTCTTCCEEECTTSCCC
T ss_pred cCCccC-CChh-hcCcccccEEECCCCcCC
Confidence 999999 4653 32 36778888888643
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.64 E-value=3.3e-08 Score=117.19 Aligned_cols=96 Identities=22% Similarity=0.279 Sum_probs=67.7
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccc------
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL------ 486 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L------ 486 (931)
++|+.|+|++|.|++ +|. .+++|+.|+|++|+|++. |.|. ++|+.|+|++|+|+ .+|. +.. +|
T Consensus 140 ~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~l-p~l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~ 208 (571)
T 3cvr_A 140 ALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFL-PELP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEET 208 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC-CCCC--TTCCEEECCSSCCS-SCCC-CC----------C
T ss_pred ccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCc-chhh--CCCCEEECcCCCCC-chhh-HHH--hhhccccc
Confidence 467788888888874 665 567788888888888774 3355 77888888888887 7777 554 66
Q ss_pred -ccccccccCCCCCCCccccc--CceeeeecCCCCcc
Q 002358 487 -QELHIENNSFVGEIPPALLT--GKVIFKYDNNPKLH 520 (931)
Q Consensus 487 -~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~c 520 (931)
+.|+|++|+|+ .||..++. .+..+.+++|+..+
T Consensus 209 L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 209 EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp CEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCH
T ss_pred ceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCC
Confidence 77888888887 67776654 56667777777654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.64 E-value=4.7e-10 Score=114.63 Aligned_cols=102 Identities=23% Similarity=0.332 Sum_probs=78.0
Q ss_pred cEEEEEeCCCCCcccCCc------cccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccc
Q 002358 414 RITKIALSGKNLKGEIPP------ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 487 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~------~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~ 487 (931)
+++.++|+.+.++|.+|. .|+++++|+.|+|++|+|++ +|.+.++++|+.|+|++|+++ .+|..+..+++|+
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence 566666777777777776 88888888888888888888 458888888888888888888 7888777788888
Q ss_pred cccccccCCCCCCCcccc--cCceeeeecCCCCc
Q 002358 488 ELHIENNSFVGEIPPALL--TGKVIFKYDNNPKL 519 (931)
Q Consensus 488 ~l~l~~N~l~g~iP~~~~--~~~~~l~~~~N~~~ 519 (931)
.|+|++|+++ .+| .+. ..+..+.+++|...
T Consensus 97 ~L~L~~N~l~-~l~-~~~~l~~L~~L~l~~N~i~ 128 (198)
T 1ds9_A 97 ELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKIT 128 (198)
T ss_dssp EEEEEEEECC-CHH-HHHHHHHSSEEEESEEECC
T ss_pred EEECcCCcCC-cCC-ccccCCCCCEEECCCCcCC
Confidence 8888888888 466 332 25666777777543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.64 E-value=2e-08 Score=120.25 Aligned_cols=80 Identities=21% Similarity=0.382 Sum_probs=51.9
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~ 492 (931)
++|+.|+|++|.|++. +.|+.|++|+.|+|++|+|++.+| +..|++|+.|+|++|+|++ +| .+..|++|+.|+|+
T Consensus 131 ~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~ 205 (605)
T 1m9s_A 131 PQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 205 (605)
T ss_dssp TTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECC
T ss_pred CccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEcc
Confidence 4666666666666643 556666666666666666666655 6666666666666666663 33 46666666666666
Q ss_pred ccCCC
Q 002358 493 NNSFV 497 (931)
Q Consensus 493 ~N~l~ 497 (931)
+|+++
T Consensus 206 ~N~l~ 210 (605)
T 1m9s_A 206 SQECL 210 (605)
T ss_dssp SEEEE
T ss_pred CCcCc
Confidence 66666
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.63 E-value=1.3e-08 Score=111.94 Aligned_cols=105 Identities=14% Similarity=0.084 Sum_probs=89.9
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-c-cccccccEeecCCccccCCCCCccCCccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-M-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~-~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l 489 (931)
.++++.|+|++|.+++..|..++.+++|+.|+|++|++++..|. + ..+++|+.|+|++|+++ .+|.. ..+++|+.|
T Consensus 119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~-~~l~~L~~L 196 (317)
T 3o53_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTL 196 (317)
T ss_dssp CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC-EEECC-CCCTTCCEE
T ss_pred cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc-ccccc-cccccCCEE
Confidence 35899999999999988788999999999999999999998874 5 57999999999999999 45543 459999999
Q ss_pred cccccCCCCCCCccccc--CceeeeecCCCCc
Q 002358 490 HIENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (931)
Q Consensus 490 ~l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~ 519 (931)
+|++|+++ .+|+.+.. .+..+.+++|...
T Consensus 197 ~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp ECCSSCCC-EECGGGGGGTTCSEEECTTSCCC
T ss_pred ECCCCcCC-cchhhhcccCcccEEECcCCccc
Confidence 99999999 67776543 7788888888654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.60 E-value=1.1e-08 Score=111.66 Aligned_cols=186 Identities=22% Similarity=0.237 Sum_probs=119.5
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CCC--CcceeEEEecCC---eEEEEEEecC
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRN--LVPLIGYCEEEH---QRILVYEYMH 688 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-Hpn--Iv~l~g~~~~~~---~~~lV~E~~~ 688 (931)
+.++.|....||+.. +.+++|+.... .....+.+|+++|+.+. +.. +.+++....... ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568899999999863 56888986432 34567889999999884 333 344554443333 3478999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc-----------------------------------------
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG----------------------------------------- 727 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~----------------------------------------- 727 (931)
|.+|.+... ..++..++..++.++++.|+.||+.
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988765332 1355666777888888888888851
Q ss_pred --------------CCCCeEecCCCCCCccccC--CCceEEecccccccccccccccccccccCCCccCCCccCC-----
Q 002358 728 --------------CNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN----- 786 (931)
Q Consensus 728 --------------~~~~ivH~DIkp~NILld~--~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~----- 786 (931)
....++|||+++.||++++ +..+.|.||+.+..-..... ........ .-..|+....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~~~~~~~-~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FISLMEDD-EEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HHTTCCTT-TSCCHHHHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HHHHHhhc-cccCHHHHHHHHHHc
Confidence 1245899999999999998 45678999998765322111 00000000 0012221100
Q ss_pred CC---------CCccchhHHHHHHHHHHHhCCCCCC
Q 002358 787 QQ---------LTEKSDVYSFGVVLLELISGKKPVS 813 (931)
Q Consensus 787 ~~---------~s~ksDVwSlGvlL~eLltG~~Pf~ 813 (931)
+. .....+.|+++.++|++.+|..+|-
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 00 1123689999999999999987763
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.57 E-value=3.4e-08 Score=114.68 Aligned_cols=102 Identities=25% Similarity=0.287 Sum_probs=68.2
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~ 492 (931)
++|+.|+|++|.+.+..| ++.+++|+.|+|++|++++..| +..+++|+.|+|++|++++. ..++++++|+.|+++
T Consensus 287 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~ 361 (466)
T 1o6v_A 287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAG 361 (466)
T ss_dssp TTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECC
T ss_pred CccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCC
Confidence 467777777777774332 6677777777777777777665 66777777777777777743 356777777777777
Q ss_pred ccCCCCCCCcccccCceeeeecCCCCc
Q 002358 493 NNSFVGEIPPALLTGKVIFKYDNNPKL 519 (931)
Q Consensus 493 ~N~l~g~iP~~~~~~~~~l~~~~N~~~ 519 (931)
+|++++..|-.-...+..+.+++|++.
T Consensus 362 ~n~l~~~~~~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 362 HNQISDLTPLANLTRITQLGLNDQAWT 388 (466)
T ss_dssp SSCCCBCGGGTTCTTCCEEECCCEEEE
T ss_pred CCccCccchhhcCCCCCEEeccCCccc
Confidence 777776665333345566666666554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.55 E-value=9.6e-08 Score=110.64 Aligned_cols=96 Identities=25% Similarity=0.257 Sum_probs=62.7
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~ 492 (931)
++|+.|+|++|++++ +| ++++++|++|+|++|+|++. | ++++++|+.|+|++|+|++ +| ++.+++|+.|+++
T Consensus 64 ~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~ 135 (457)
T 3bz5_A 64 TGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCA 135 (457)
T ss_dssp TTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECT
T ss_pred CCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECC
Confidence 467777777777764 33 66777777777777777764 2 6677777777777777774 44 6677777777777
Q ss_pred ccCCCCCCCcccccCceeeeecCCC
Q 002358 493 NNSFVGEIPPALLTGKVIFKYDNNP 517 (931)
Q Consensus 493 ~N~l~g~iP~~~~~~~~~l~~~~N~ 517 (931)
+|+|++ +|-.-...+..+.+++|.
T Consensus 136 ~N~l~~-l~l~~l~~L~~L~l~~n~ 159 (457)
T 3bz5_A 136 RNTLTE-IDVSHNTQLTELDCHLNK 159 (457)
T ss_dssp TSCCSC-CCCTTCTTCCEEECTTCS
T ss_pred CCccce-eccccCCcCCEEECCCCC
Confidence 777774 553333455666666664
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.54 E-value=5.8e-08 Score=112.68 Aligned_cols=80 Identities=33% Similarity=0.472 Sum_probs=43.7
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~ 492 (931)
++|+.|+|++|.+++ +|+ +..+++|+.|+|++|++++..| +..+++|+.|+|++|++++..| ++.+++|+.|+++
T Consensus 265 ~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~ 339 (466)
T 1o6v_A 265 TKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339 (466)
T ss_dssp TTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECC
T ss_pred CCCCEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECC
Confidence 355555555555553 222 5555555555555555555433 5555555555555555554443 4555555555555
Q ss_pred ccCCC
Q 002358 493 NNSFV 497 (931)
Q Consensus 493 ~N~l~ 497 (931)
+|+++
T Consensus 340 ~n~l~ 344 (466)
T 1o6v_A 340 NNKVS 344 (466)
T ss_dssp SSCCC
T ss_pred CCccC
Confidence 55555
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.52 E-value=1e-07 Score=110.34 Aligned_cols=76 Identities=21% Similarity=0.286 Sum_probs=35.6
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~ 493 (931)
+++.|+|++|++++ +| ++.+++|+.|+|++|+|++. +++.+++|+.|+|++|+|++ +| ++.+++|+.|++++
T Consensus 171 ~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~ 242 (457)
T 3bz5_A 171 QLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSV 242 (457)
T ss_dssp TCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCS
T ss_pred cCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeC
Confidence 44444444444443 33 44444444444444444443 24444444444444444443 33 44444444444444
Q ss_pred cCCC
Q 002358 494 NSFV 497 (931)
Q Consensus 494 N~l~ 497 (931)
|+|+
T Consensus 243 N~l~ 246 (457)
T 3bz5_A 243 NPLT 246 (457)
T ss_dssp SCCS
T ss_pred CcCC
Confidence 4444
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.50 E-value=1.7e-07 Score=108.42 Aligned_cols=97 Identities=30% Similarity=0.411 Sum_probs=78.2
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~ 492 (931)
++++.|+|++|++++ +| +|+++++|++|+|++|++++ +|.. +.+|+.|+|++|++++ +| .++++++|+.|+++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~--~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC--cccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 579999999999995 88 69999999999999999998 4432 2489999999999995 77 58999999999999
Q ss_pred ccCCCCCCCcccccCceeeeecCCCC
Q 002358 493 NNSFVGEIPPALLTGKVIFKYDNNPK 518 (931)
Q Consensus 493 ~N~l~g~iP~~~~~~~~~l~~~~N~~ 518 (931)
+|+++ .+|... ..+..+.+++|..
T Consensus 204 ~N~l~-~l~~~~-~~L~~L~l~~n~l 227 (454)
T 1jl5_A 204 NNSLK-KLPDLP-LSLESIVAGNNIL 227 (454)
T ss_dssp SSCCS-SCCCCC-TTCCEEECCSSCC
T ss_pred CCcCC-cCCCCc-CcccEEECcCCcC
Confidence 99998 466543 4567777777743
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.50 E-value=7.5e-08 Score=106.84 Aligned_cols=103 Identities=18% Similarity=0.326 Sum_probs=84.7
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++++.|+|++|+++ .+|+ +..+++|+.|+|++|++++. +.+..+++|+.|+|++|++++ +| .+..+++|+.|+|
T Consensus 220 ~~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L 294 (347)
T 4fmz_A 220 MTRLNSLKIGNNKIT-DLSP-LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFL 294 (347)
T ss_dssp CTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEEC
T ss_pred CCcCCEEEccCCccC-CCcc-hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEEC
Confidence 358999999999998 4554 88999999999999999885 678899999999999999994 54 5888999999999
Q ss_pred cccCCCCCCCcccc--cCceeeeecCCCCc
Q 002358 492 ENNSFVGEIPPALL--TGKVIFKYDNNPKL 519 (931)
Q Consensus 492 ~~N~l~g~iP~~~~--~~~~~l~~~~N~~~ 519 (931)
++|++++..|..+. ..+..+.+++|+..
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 324 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSCC
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCccc
Confidence 99999866666553 36778888888754
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.46 E-value=9.7e-08 Score=110.49 Aligned_cols=85 Identities=28% Similarity=0.498 Sum_probs=48.4
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccC--CCCCccCCc-------
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG--SLPSYMGSL------- 483 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g--~iP~~l~~l------- 483 (931)
++++.|+|++|++++ +|.. +++|+.|+|++|++++ +|. .+++|+.|+|++|+++| .+|.++++|
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~--~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~ 389 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE--LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLA 389 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC---
T ss_pred CcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc--hhhhccEEECCCCCCCcCCCChHHHHhhhhccccc
Confidence 477888888888874 6654 5778888888888885 444 47788888888888887 778888777
Q ss_pred ------cccccccccccCCCC--CCCccc
Q 002358 484 ------PNLQELHIENNSFVG--EIPPAL 504 (931)
Q Consensus 484 ------~~L~~l~l~~N~l~g--~iP~~~ 504 (931)
++|+.|++++|+++| .+|.++
T Consensus 390 ~i~~~~~~L~~L~ls~N~l~~~~~iP~sl 418 (454)
T 1jl5_A 390 EVPELPQNLKQLHVETNPLREFPDIPESV 418 (454)
T ss_dssp -----------------------------
T ss_pred ccccccCcCCEEECCCCcCCccccchhhH
Confidence 778888888888876 676654
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=2.4e-07 Score=92.49 Aligned_cols=152 Identities=19% Similarity=0.099 Sum_probs=88.1
Q ss_pred EEeeccCCCCCCcccCCCCCCCCccccCCCCCCCceeccCCceeeecccccccCCCCCCChhhhhhcceeccCceEEEee
Q 002358 189 AARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGVLSYRL 268 (931)
Q Consensus 189 ~~R~~~g~~~~~~~~y~~d~~dR~W~~~~~~~~~~~~~~~~~~~~i~~~~~i~~~~~~~pP~~v~qtA~~~~~~~~~~~~ 268 (931)
+-|.|+|+.. +. |..+|.|+++...... +..+.. ...+.....+.+|..|+|||=... .++++..
T Consensus 7 ~~~INcGg~~---~~---d~~gr~w~~D~~~~~~---g~~~~~-----~~~~~~~~~~~~~~~lY~TaR~~~-~~~tY~f 71 (174)
T 2jwp_A 7 IWAVNAGGES---HV---DVHGIHYRKDPLEGRV---GRASDY-----GMKLPILRSNPEDQVLYQTERYNE-DSFGYDI 71 (174)
T ss_dssp EEEEEETSSS---EE---ETTTEEECSSCSSTTC---CCCCCC-----CTTSCCSSSCHHHHHTTTCCCCCC-SCEEEEE
T ss_pred EEEEECCCCC---cc---CCCCCEEcCCcCcccC---Cccccc-----ccceEecccCCCCchhhhhhccCC-CCeEEEE
Confidence 4599999743 22 6789999998542211 111100 001111122446889999998753 5677777
Q ss_pred cCCCCCccceeeeeeecccCcCCCcceEEEeecCcccccCCceeeeeecCCCceeeecccccee------------eeee
Q 002358 269 NLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNV------------TLNF 336 (931)
Q Consensus 269 ~~~~~~~~~~~~lyFae~~~~~~~~~R~F~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~ 336 (931)
+.. .+-.|.+-|||+|+.. ...+.|.|||.++...-. ..+++...+++...++.--..++ +..+
T Consensus 72 ~v~-~~G~Y~VrLhF~ei~~-~~~~~rvFdV~ing~~~l--~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g 147 (174)
T 2jwp_A 72 PIK-EEGEYVLVLKFAEVYF-AQSQQKVFDVRVNGHTVV--KDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTG 147 (174)
T ss_dssp ECC-SCEEEEEEEEEECCSC-CCSSSSCEEEEETTEEEE--EEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCS
T ss_pred EeC-CCeEEEEEEEEecccc-CCCCCeEeEEEECCEEee--cCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCC
Confidence 653 2346667799999974 457999999966543332 23455433322111111000111 2456
Q ss_pred EEEEEEeecCCCccccchhhhhhhh
Q 002358 337 VLSFSFVKTRDSTLGPLLNAIEISK 361 (931)
Q Consensus 337 ~~~~~~~~~~~s~l~p~ina~e~~~ 361 (931)
.+.+++.|. ..-.|+|||+|+++
T Consensus 148 ~L~I~f~p~--~~~~a~inaIEI~~ 170 (174)
T 2jwp_A 148 KLSVEFVKG--YYDNPKVCALFIMK 170 (174)
T ss_dssp EEEEEEECS--SSCSSSEEEEEEES
T ss_pred eEEEEEecc--CCCCcEEEEEEEEe
Confidence 788888864 35579999999965
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.41 E-value=3e-07 Score=110.26 Aligned_cols=94 Identities=26% Similarity=0.353 Sum_probs=63.4
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~ 493 (931)
+|+.|+|++|.|+ .+|.. +++|+.|+|++|+|++.+ ..+++|+.|+|++|+|+ .||. .+++|+.|+|++
T Consensus 202 ~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~ 270 (622)
T 3g06_A 202 ELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYR 270 (622)
T ss_dssp TCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCS
T ss_pred hhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCC
Confidence 4555555555555 34432 366777777777777743 45577788888888887 6776 567788888888
Q ss_pred cCCCCCCCccccc--CceeeeecCCCCc
Q 002358 494 NSFVGEIPPALLT--GKVIFKYDNNPKL 519 (931)
Q Consensus 494 N~l~g~iP~~~~~--~~~~l~~~~N~~~ 519 (931)
|+|+ .||..+.. .+..+.+++|+..
T Consensus 271 N~L~-~lp~~l~~l~~L~~L~L~~N~l~ 297 (622)
T 3g06_A 271 NQLT-RLPESLIHLSSETTVNLEGNPLS 297 (622)
T ss_dssp SCCC-SCCGGGGGSCTTCEEECCSCCCC
T ss_pred CCCC-cCCHHHhhccccCEEEecCCCCC
Confidence 8888 77776543 5666777777754
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.40 E-value=1.6e-08 Score=114.33 Aligned_cols=105 Identities=16% Similarity=0.216 Sum_probs=58.5
Q ss_pred cEEEEEeCCCCCc--c---cCCccccCccccceecccCCcCC----CCCC-CccccccccEeecCCccccCC----CCCc
Q 002358 414 RITKIALSGKNLK--G---EIPPELKNMEALTELWLDGNFLT----GPLP-DMSRLIDLRIVHLENNELTGS----LPSY 479 (931)
Q Consensus 414 ~l~~L~L~~n~l~--g---~ip~~~~~L~~L~~L~Ls~N~l~----g~~p-~~~~l~~L~~L~L~~N~l~g~----iP~~ 479 (931)
+|+.|+|++|+++ | .+|..+.++++|+.|+|++|.|+ +.+| .+..+++|+.|+|++|+|++. +|..
T Consensus 188 ~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~ 267 (386)
T 2ca6_A 188 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 267 (386)
T ss_dssp TCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHH
T ss_pred CcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHH
Confidence 5666666666665 2 23335566666666666666664 3344 355666666666666666544 4454
Q ss_pred c--CCccccccccccccCCCC----CCCccc---ccCceeeeecCCCC
Q 002358 480 M--GSLPNLQELHIENNSFVG----EIPPAL---LTGKVIFKYDNNPK 518 (931)
Q Consensus 480 l--~~l~~L~~l~l~~N~l~g----~iP~~~---~~~~~~l~~~~N~~ 518 (931)
+ +++++|+.|+|++|++++ .+|..+ +..+..+.+++|+.
T Consensus 268 l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l 315 (386)
T 2ca6_A 268 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315 (386)
T ss_dssp HHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred HhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcC
Confidence 4 335666666666666664 255544 23455555555543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.39 E-value=1.2e-07 Score=113.75 Aligned_cols=85 Identities=26% Similarity=0.307 Sum_probs=76.6
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~ 492 (931)
++|+.|+|++|+|++ +| ..+++|+.|+|++|+|++.++ .+++|+.|+|++|+|+ .||..++++++|+.|+|+
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 589999999999995 77 567899999999999997554 7789999999999999 999999999999999999
Q ss_pred ccCCCCCCCcccc
Q 002358 493 NNSFVGEIPPALL 505 (931)
Q Consensus 493 ~N~l~g~iP~~~~ 505 (931)
+|+|+|.+|..+.
T Consensus 293 ~N~l~~~~~~~l~ 305 (622)
T 3g06_A 293 GNPLSERTLQALR 305 (622)
T ss_dssp SCCCCHHHHHHHH
T ss_pred CCCCCCcCHHHHH
Confidence 9999988887653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.38 E-value=2e-08 Score=113.50 Aligned_cols=107 Identities=21% Similarity=0.323 Sum_probs=87.3
Q ss_pred CcEEEEEeCCCCCc-ccCC---ccccCccccceecccCCcCC--C---CCC-CccccccccEeecCCcccc----CCCCC
Q 002358 413 PRITKIALSGKNLK-GEIP---PELKNMEALTELWLDGNFLT--G---PLP-DMSRLIDLRIVHLENNELT----GSLPS 478 (931)
Q Consensus 413 ~~l~~L~L~~n~l~-g~ip---~~~~~L~~L~~L~Ls~N~l~--g---~~p-~~~~l~~L~~L~L~~N~l~----g~iP~ 478 (931)
++|+.|+|++|+++ +.+| ..+.++++|+.|+|++|+|+ | .+| .+.++++|+.|+|++|+|+ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 47899999999997 5566 56788899999999999998 4 456 6888999999999999996 67888
Q ss_pred ccCCccccccccccccCCCCC----CCccc----ccCceeeeecCCCCc
Q 002358 479 YMGSLPNLQELHIENNSFVGE----IPPAL----LTGKVIFKYDNNPKL 519 (931)
Q Consensus 479 ~l~~l~~L~~l~l~~N~l~g~----iP~~~----~~~~~~l~~~~N~~~ 519 (931)
.+..+++|+.|+|++|++++. +|..+ ...+..+.+++|...
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~ 287 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCC
Confidence 889999999999999999865 55554 446778888888754
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.31 E-value=7.2e-08 Score=108.03 Aligned_cols=105 Identities=18% Similarity=0.176 Sum_probs=71.2
Q ss_pred CcEEEEEeCCCCCcccCC----ccccCcc-ccceecccCCcCCCCCC-Ccccc-----ccccEeecCCccccCCCCCccC
Q 002358 413 PRITKIALSGKNLKGEIP----PELKNME-ALTELWLDGNFLTGPLP-DMSRL-----IDLRIVHLENNELTGSLPSYMG 481 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip----~~~~~L~-~L~~L~Ls~N~l~g~~p-~~~~l-----~~L~~L~L~~N~l~g~iP~~l~ 481 (931)
.+|+.|+|++|.|++..+ ..|.+++ +|+.|+|++|+|++..+ .+..+ ++|+.|+|++|++++..+..++
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 357888888888775555 5667777 78888888888877766 35554 7788888888888766666444
Q ss_pred Cc-----cccccccccccCCCCCCCcccc-------cCceeeeecCCC
Q 002358 482 SL-----PNLQELHIENNSFVGEIPPALL-------TGKVIFKYDNNP 517 (931)
Q Consensus 482 ~l-----~~L~~l~l~~N~l~g~iP~~~~-------~~~~~l~~~~N~ 517 (931)
.+ ++|+.|+|++|++++..+..+. ..+..+.+++|.
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 149 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGND 149 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSC
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCc
Confidence 43 6788888888887744433321 255666676664
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.29 E-value=1.8e-07 Score=99.66 Aligned_cols=65 Identities=26% Similarity=0.411 Sum_probs=29.2
Q ss_pred CccccceecccCCcCCCC--CCC-ccccccccEeecCCccccCCCCCccCCcc--ccccccccccCCCCCCC
Q 002358 435 NMEALTELWLDGNFLTGP--LPD-MSRLIDLRIVHLENNELTGSLPSYMGSLP--NLQELHIENNSFVGEIP 501 (931)
Q Consensus 435 ~L~~L~~L~Ls~N~l~g~--~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~--~L~~l~l~~N~l~g~iP 501 (931)
+|++|+.|+|++|+|++. +|+ +..+++|+.|+|++|+|++. +.+..+. +|+.|+|++|.+++.+|
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 344455555555555442 222 34455555555555555432 2222222 45555555555554444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.25 E-value=5.2e-08 Score=107.50 Aligned_cols=103 Identities=12% Similarity=0.080 Sum_probs=66.0
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCC-CC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP-LP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~-~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
++++.|+|++|.+.+.++. +.++++|+.|+|++|.+++. +| .+.++++|+.|+|++|++++.+|..++++++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4667777777777655443 55677777777777776654 55 366677777777777777766677777777777777
Q ss_pred cccc-CCCCC-CCccc--ccCceeeeecCC
Q 002358 491 IENN-SFVGE-IPPAL--LTGKVIFKYDNN 516 (931)
Q Consensus 491 l~~N-~l~g~-iP~~~--~~~~~~l~~~~N 516 (931)
|++| .+++. +|..+ ...+..+.+++|
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 178 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWC 178 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCC
Confidence 7777 56542 44322 225556666665
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=6.1e-06 Score=87.95 Aligned_cols=134 Identities=17% Similarity=0.117 Sum_probs=96.9
Q ss_pred ccCccCcE-EEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 616 KIGKGSFG-SVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 616 ~LG~G~fG-~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
.+..|..| .||+.... ++..+++|+-.. .....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44455555 68988765 467899998653 23456888999999884 33367788999888999999999999888
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc---------------------------------------------
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG--------------------------------------------- 727 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~--------------------------------------------- 727 (931)
.+..... ......++.++++.|+-||+.
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7765421 112334566677777777741
Q ss_pred ----------CCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 728 ----------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 728 ----------~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
....++|||+.+.|||+++++.+-|.||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01237999999999999987777899999775
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.15 E-value=2.2e-07 Score=102.51 Aligned_cols=112 Identities=19% Similarity=0.291 Sum_probs=94.7
Q ss_pred CCceEEeeCCCCCcEEEEEeCCCCCcccCCccccCc--cccceecccCCcCCCCCCCccccccccEeecCCccccCC-CC
Q 002358 401 PWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNM--EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS-LP 477 (931)
Q Consensus 401 ~w~~v~c~~~~~~~l~~L~L~~n~l~g~ip~~~~~L--~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~-iP 477 (931)
.|..+.|+ +..++.|+|++|++. |..+..+ ++|+.|+|++|.+.+.++.+.++++|+.|+|++|++++. +|
T Consensus 38 ~W~~~~~~---~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~ 111 (336)
T 2ast_B 38 RWYRLASD---ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 111 (336)
T ss_dssp HHHHHHTC---STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHH
T ss_pred HHHHHhcC---chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHH
Confidence 35555443 235789999999887 5678888 999999999999999999999999999999999999976 89
Q ss_pred CccCCccccccccccccCCCCCCCccccc--CceeeeecCCCC
Q 002358 478 SYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPK 518 (931)
Q Consensus 478 ~~l~~l~~L~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~~ 518 (931)
..+..+++|+.|+|++|++++.+|..+.. .+..+.+++|..
T Consensus 112 ~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~ 154 (336)
T 2ast_B 112 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG 154 (336)
T ss_dssp HHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBS
T ss_pred HHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCC
Confidence 99999999999999999999877776643 677888888743
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1.3e-05 Score=87.49 Aligned_cols=135 Identities=15% Similarity=0.189 Sum_probs=93.0
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCC---CCcceeEEEe-cCCeEEEEEEecCCC
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR---NLVPLIGYCE-EEHQRILVYEYMHNG 690 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~g~~~-~~~~~~lV~E~~~~g 690 (931)
+.++.|....||+. |+.+++|+-.. ......+.+|+++|+.+.+. .+.+++.++. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 56788998999987 57788888432 23456788999999999753 3556666664 455678999999998
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc-------------------------------------------
Q 002358 691 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------------------------------------------- 727 (931)
Q Consensus 691 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~------------------------------------------- 727 (931)
.+.+..-. .++......++.++++.|+.||+.
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 77653211 123344445555555555555531
Q ss_pred --------------CCCCeEecCCCCCCccccC---CCc-eEEeccccccc
Q 002358 728 --------------CNPGIIHRDVKSSNILLDI---NMR-AKVSDFGLSRQ 760 (931)
Q Consensus 728 --------------~~~~ivH~DIkp~NILld~---~~~-vkL~DFGla~~ 760 (931)
....++|||+++.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2345799999999999987 455 48999997754
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.09 E-value=3.5e-07 Score=102.38 Aligned_cols=102 Identities=14% Similarity=0.043 Sum_probs=87.1
Q ss_pred EEEeCCCCCcccCCccccCccccceecccCCcCCCCCC----C-ccccc-cccEeecCCccccCCCCCccCCc-----cc
Q 002358 417 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP----D-MSRLI-DLRIVHLENNELTGSLPSYMGSL-----PN 485 (931)
Q Consensus 417 ~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p----~-~~~l~-~L~~L~L~~N~l~g~iP~~l~~l-----~~ 485 (931)
.++|++|+++|.+|..+...++|+.|+|++|+|++..+ + +.+++ +|+.|+|++|+|++..+..++.+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999988888899999999999999886 2 67888 89999999999998888888776 99
Q ss_pred cccccccccCCCCCCCcccc-------cCceeeeecCCCC
Q 002358 486 LQELHIENNSFVGEIPPALL-------TGKVIFKYDNNPK 518 (931)
Q Consensus 486 L~~l~l~~N~l~g~iP~~~~-------~~~~~l~~~~N~~ 518 (931)
|+.|+|++|++++..+..+. ..+..+.+++|..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l 121 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcC
Confidence 99999999999976665432 3567788888863
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.08 E-value=4.1e-07 Score=96.96 Aligned_cols=79 Identities=22% Similarity=0.339 Sum_probs=66.9
Q ss_pred CCcEEEEEeCCCCCcc--cCCccccCccccceecccCCcCCCCCCCccccc--cccEeecCCccccCCCCC-------cc
Q 002358 412 PPRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLPDMSRLI--DLRIVHLENNELTGSLPS-------YM 480 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g--~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~--~L~~L~L~~N~l~g~iP~-------~l 480 (931)
.++|+.|+|++|+|++ .+|..+..|++|+.|+|++|+|++. .++..|. +|+.|+|++|.+++.+|+ .+
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il 247 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIR 247 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCcCccccCcchhHHHHHH
Confidence 4689999999999998 6778889999999999999999987 4444444 999999999999998884 36
Q ss_pred CCccccccccc
Q 002358 481 GSLPNLQELHI 491 (931)
Q Consensus 481 ~~l~~L~~l~l 491 (931)
..+++|+.||=
T Consensus 248 ~~~P~L~~LDg 258 (267)
T 3rw6_A 248 ERFPKLLRLDG 258 (267)
T ss_dssp HHCTTCCEESS
T ss_pred HHCcccCeECC
Confidence 77888888763
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.07 E-value=5.2e-06 Score=92.34 Aligned_cols=58 Identities=21% Similarity=0.161 Sum_probs=26.5
Q ss_pred EEEEEeCCCCCcccCCccccCccccceecccC-CcCCCCCCC-ccccccccEeecCCcccc
Q 002358 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDG-NFLTGPLPD-MSRLIDLRIVHLENNELT 473 (931)
Q Consensus 415 l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~-N~l~g~~p~-~~~l~~L~~L~L~~N~l~ 473 (931)
++.|+|++|+|+ .||+.++..++|+.|+|++ |.++..+++ |.++++|+.|||++|+|+
T Consensus 156 l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~ 215 (350)
T 4ay9_X 156 SVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215 (350)
T ss_dssp CEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred hhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence 444555555554 4444444444455555543 223322222 445555555555555555
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=1.7e-05 Score=88.22 Aligned_cols=79 Identities=4% Similarity=0.017 Sum_probs=56.6
Q ss_pred ccc-CccCcEEEEEEEEC-------CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcC-C--CCCcceeEEEecC---
Q 002358 615 KKI-GKGSFGSVYYGKMK-------DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-H--RNLVPLIGYCEEE--- 677 (931)
Q Consensus 615 ~~L-G~G~fG~Vy~a~~~-------~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~-H--pnIv~l~g~~~~~--- 677 (931)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88999999998765 26788999865432 111256788999999885 3 3567788887665
Q ss_pred CeEEEEEEecCCCCHH
Q 002358 678 HQRILVYEYMHNGTLR 693 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~ 693 (931)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999886654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.82 E-value=4e-07 Score=105.00 Aligned_cols=105 Identities=19% Similarity=0.162 Sum_probs=64.0
Q ss_pred CcEEEEEeCCCCCccc----CCccccCccccceecccCCcCCCCCC-Ccc-----ccccccEeecCCccccCC----CCC
Q 002358 413 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPLP-DMS-----RLIDLRIVHLENNELTGS----LPS 478 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~-----~l~~L~~L~L~~N~l~g~----iP~ 478 (931)
++++.|+|++|++++. ++..+.++++|+.|+|++|.+++..+ .+. ..++|+.|+|++|++++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 4677777777777653 56666667777777777777655433 222 225677777777777654 455
Q ss_pred ccCCccccccccccccCCCCCCCcccc-------cCceeeeecCCC
Q 002358 479 YMGSLPNLQELHIENNSFVGEIPPALL-------TGKVIFKYDNNP 517 (931)
Q Consensus 479 ~l~~l~~L~~l~l~~N~l~g~iP~~~~-------~~~~~l~~~~N~ 517 (931)
.+..+++|+.|+|++|++++..+..+. ..+..+.+++|.
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence 566667777777777777644333222 145555666654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.77 E-value=1e-06 Score=101.44 Aligned_cols=106 Identities=18% Similarity=0.200 Sum_probs=69.5
Q ss_pred CcEEEEEeCCCCCcccCCccccCc-----cccceecccCCcCCCC----CC-CccccccccEeecCCccccCCCCCccCC
Q 002358 413 PRITKIALSGKNLKGEIPPELKNM-----EALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELTGSLPSYMGS 482 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L-----~~L~~L~Ls~N~l~g~----~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~ 482 (931)
++++.|+|++|.+++..+..+... ++|+.|+|++|.+++. ++ .+..+++|+.|+|++|++++..+..+..
T Consensus 284 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 363 (461)
T 1z7x_W 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHH
Confidence 467788888887765544444433 5777888888877765 23 3566777888888888777554444432
Q ss_pred -----ccccccccccccCCCC----CCCcccc--cCceeeeecCCCC
Q 002358 483 -----LPNLQELHIENNSFVG----EIPPALL--TGKVIFKYDNNPK 518 (931)
Q Consensus 483 -----l~~L~~l~l~~N~l~g----~iP~~~~--~~~~~l~~~~N~~ 518 (931)
+++|+.|+|++|++++ .+|..+. ..+..+.+++|+.
T Consensus 364 ~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i 410 (461)
T 1z7x_W 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSC
T ss_pred HHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCC
Confidence 5677788888887775 5665543 3566677777754
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.64 E-value=2.9e-05 Score=85.41 Aligned_cols=91 Identities=15% Similarity=0.127 Sum_probs=78.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-Ccccccccc-EeecCCccccCCCC-CccCCccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLR-IVHLENNELTGSLP-SYMGSLPNLQEL 489 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~-~L~L~~N~l~g~iP-~~l~~l~~L~~l 489 (931)
++|+.|+|++|+++..-+..|.+|++|+.|+|++| ++.+.+ .|.++++|+ .|+|.+ +++ .|+ ..|.+|++|+.|
T Consensus 226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRYV 302 (329)
T ss_dssp TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEEE
T ss_pred CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCEE
Confidence 48999999999999444456999999999999998 776666 599999999 999998 777 555 679999999999
Q ss_pred cccccCCCCCCCcccccC
Q 002358 490 HIENNSFVGEIPPALLTG 507 (931)
Q Consensus 490 ~l~~N~l~g~iP~~~~~~ 507 (931)
++++|+++ .|+...+.+
T Consensus 303 ~l~~n~i~-~I~~~aF~~ 319 (329)
T 3sb4_A 303 LATGDKIT-TLGDELFGN 319 (329)
T ss_dssp EECSSCCC-EECTTTTCT
T ss_pred EeCCCccC-ccchhhhcC
Confidence 99999999 888877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.63 E-value=8.6e-05 Score=81.60 Aligned_cols=140 Identities=16% Similarity=0.232 Sum_probs=79.9
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCC--CCCcceeE------EEecCCeEEEEEEe
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIG------YCEEEHQRILVYEY 686 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~g------~~~~~~~~~lV~E~ 686 (931)
+.|+.|..+.||+....+| .+++|+.... ...+..|..+++.|.. -.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677889999987654 5889988652 2334456666665531 12333332 12345678899999
Q ss_pred cCCCCHH--------------HHhccCCC----C-------CCCCHHHH-------------------------------
Q 002358 687 MHNGTLR--------------DRLHGSVN----Q-------KPLDWLTR------------------------------- 710 (931)
Q Consensus 687 ~~~gsL~--------------~~L~~~~~----~-------~~l~~~~~------------------------------- 710 (931)
++|..+. ..+|.... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986431 11221100 0 01123211
Q ss_pred HHHHHHHHHHhHHhhh----------cCCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 711 LQIAHDAAKGLEYLHT----------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 711 ~~i~~qia~aL~yLH~----------~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
..+..++.+++.+|++ .....++|||+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666652 124789999999999999888889999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00014 Score=82.13 Aligned_cols=75 Identities=15% Similarity=0.187 Sum_probs=49.8
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCccc-------hhhhhHHHHHHHHHhcCC--CC-CcceeEEEecCCeEEE
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-------HRTQQFVTEVALLSRIHH--RN-LVPLIGYCEEEHQRIL 682 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~-------~~~~~~~~E~~il~~l~H--pn-Iv~l~g~~~~~~~~~l 682 (931)
.+.||.|..+.||++... +++.++||....... .....+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357999999999999765 468999998654321 123456789999988842 33 3455544 3344689
Q ss_pred EEEecCCC
Q 002358 683 VYEYMHNG 690 (931)
Q Consensus 683 V~E~~~~g 690 (931)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.51 E-value=4.5e-06 Score=93.82 Aligned_cols=61 Identities=25% Similarity=0.226 Sum_probs=27.4
Q ss_pred cccceecccCCcCCCC----CC-CccccccccEeecCCccccC----CCCCccCCccccccccccccCCC
Q 002358 437 EALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELTG----SLPSYMGSLPNLQELHIENNSFV 497 (931)
Q Consensus 437 ~~L~~L~Ls~N~l~g~----~p-~~~~l~~L~~L~L~~N~l~g----~iP~~l~~l~~L~~l~l~~N~l~ 497 (931)
++|+.|+|++|.|+.. ++ .+..+++|+.|+|++|+|+. .+++.+..+++|+.|+|++|.|+
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence 4455555555544331 11 12344455555555555442 12333444445555555555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.50 E-value=5.3e-06 Score=93.18 Aligned_cols=86 Identities=22% Similarity=0.199 Sum_probs=70.9
Q ss_pred CcEEEEEeCCCCCcc----cCCccccCccccceecccCCcCCCCC----C-CccccccccEeecCCccccC----CCCCc
Q 002358 413 PRITKIALSGKNLKG----EIPPELKNMEALTELWLDGNFLTGPL----P-DMSRLIDLRIVHLENNELTG----SLPSY 479 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g----~ip~~~~~L~~L~~L~Ls~N~l~g~~----p-~~~~l~~L~~L~L~~N~l~g----~iP~~ 479 (931)
++|+.|+|++|.|+. .++..+..+++|++|+|++|+|+..- + .+..+++|+.|+|++|+|+. .++..
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 479999999999974 35566788999999999999998642 3 36778899999999999984 34555
Q ss_pred cCCccccccccccccCCCC
Q 002358 480 MGSLPNLQELHIENNSFVG 498 (931)
Q Consensus 480 l~~l~~L~~l~l~~N~l~g 498 (931)
+..+++|+.|+|++|.|+.
T Consensus 235 L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 235 AREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHCSSCCEEECTTSSCCH
T ss_pred HHhCCCCCEEeccCCCCCH
Confidence 6677999999999999973
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00038 Score=74.84 Aligned_cols=74 Identities=19% Similarity=0.275 Sum_probs=55.1
Q ss_pred ccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCC---CCcceeEEEecCCeEEEEEEecCCC
Q 002358 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR---NLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
.+.+|.|..+.||+.++.||+.|++|+...........|.+|++.|+.|... -+.++++.. ..++||||++++
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~ 95 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDER 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeeccc
Confidence 3668999999999999999999999987654333345688999999988421 244455442 237899999876
Q ss_pred C
Q 002358 691 T 691 (931)
Q Consensus 691 s 691 (931)
.
T Consensus 96 ~ 96 (288)
T 3f7w_A 96 P 96 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00063 Score=74.20 Aligned_cols=137 Identities=18% Similarity=0.230 Sum_probs=91.2
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcC---CCCCcceeEEEecCCeEEEEEEecCCCC
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYEYMHNGT 691 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~~~~lV~E~~~~gs 691 (931)
+.|+.|....+|+... +++.+++|+.... ....+.+|++.|+.|. ...+.++++++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 4689999999999886 4778899986532 3566889999999884 3568888888888888999999999875
Q ss_pred HH--------H---HhccCCCCC-------------------CCCHHHHH---HHH----------------HHHHHHh-
Q 002358 692 LR--------D---RLHGSVNQK-------------------PLDWLTRL---QIA----------------HDAAKGL- 721 (931)
Q Consensus 692 L~--------~---~L~~~~~~~-------------------~l~~~~~~---~i~----------------~qia~aL- 721 (931)
+. . .|+...... .-+|.... ++. .++++.+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 31 1 233221100 12344321 111 1111111
Q ss_pred HHhhh-cCCCCeEecCCCCCCccccCCCceEEeccc
Q 002358 722 EYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFG 756 (931)
Q Consensus 722 ~yLH~-~~~~~ivH~DIkp~NILld~~~~vkL~DFG 756 (931)
..|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 1247899999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00027 Score=80.59 Aligned_cols=80 Identities=11% Similarity=0.105 Sum_probs=49.3
Q ss_pred CCCeEecCCCCCCccccCCCceEEecccccccccccccccccccccCCCccCCCccCCC---CCCccchhHHHHHHHHHH
Q 002358 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLEL 805 (931)
Q Consensus 729 ~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~s~ksDVwSlGvlL~eL 805 (931)
...++|||+++.|||++.++ ++|.||+.+..-.....-......-...|++|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 47899999999999998876 99999998875332111100000011345666554321 112245566888888888
Q ss_pred HhCC
Q 002358 806 ISGK 809 (931)
Q Consensus 806 ltG~ 809 (931)
+.+.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.23 E-value=1.4e-05 Score=80.52 Aligned_cols=105 Identities=20% Similarity=0.277 Sum_probs=74.1
Q ss_pred CcEEEEEeCCC-CCccc----CCccccCccccceecccCCcCCCCCC-----CccccccccEeecCCccccCC----CCC
Q 002358 413 PRITKIALSGK-NLKGE----IPPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELTGS----LPS 478 (931)
Q Consensus 413 ~~l~~L~L~~n-~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~L~~N~l~g~----iP~ 478 (931)
+.|++|+|++| .|... +...+...++|++|+|++|+|...-- .+...+.|+.|+|++|+|+.. +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 47899999998 88632 45567777899999999999865321 255667899999999998843 566
Q ss_pred ccCCccccccccc--cccCCCCCCCcccc------cCceeeeecCCC
Q 002358 479 YMGSLPNLQELHI--ENNSFVGEIPPALL------TGKVIFKYDNNP 517 (931)
Q Consensus 479 ~l~~l~~L~~l~l--~~N~l~g~iP~~~~------~~~~~l~~~~N~ 517 (931)
.+...++|+.|+| ++|.|...--..+. ..+..+.+++|.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~ 162 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 162 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCC
Confidence 7777888999999 78988732111111 145566666654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00021 Score=78.50 Aligned_cols=38 Identities=16% Similarity=0.162 Sum_probs=22.7
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCC
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG 451 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g 451 (931)
.+|++|+|.+ +++..-+..|.+|++|+.|+|++|.+..
T Consensus 101 ~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~ 138 (329)
T 3sb4_A 101 QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPN 138 (329)
T ss_dssp TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCE
T ss_pred CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccc
Confidence 3566677766 6663333456667777777777766543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.08 E-value=3.2e-05 Score=92.00 Aligned_cols=105 Identities=15% Similarity=0.084 Sum_probs=59.0
Q ss_pred CcEEEEEeC----CCCCccc-----CCccccCccccceecccCC--cCCCCCC-Ccc-ccccccEeecCCccccC-CCCC
Q 002358 413 PRITKIALS----GKNLKGE-----IPPELKNMEALTELWLDGN--FLTGPLP-DMS-RLIDLRIVHLENNELTG-SLPS 478 (931)
Q Consensus 413 ~~l~~L~L~----~n~l~g~-----ip~~~~~L~~L~~L~Ls~N--~l~g~~p-~~~-~l~~L~~L~L~~N~l~g-~iP~ 478 (931)
++|+.|+|+ .|.+++. ++..+.++++|+.|+|+++ .+++..+ .+. .+++|+.|+|++|++++ .++.
T Consensus 403 ~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~ 482 (592)
T 3ogk_B 403 KNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLME 482 (592)
T ss_dssp CSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHH
T ss_pred CCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHH
Confidence 456677774 5566542 3333556677777777532 3444433 232 36667777777777664 3444
Q ss_pred ccCCccccccccccccCCCCCCCccc---ccCceeeeecCCC
Q 002358 479 YMGSLPNLQELHIENNSFVGEIPPAL---LTGKVIFKYDNNP 517 (931)
Q Consensus 479 ~l~~l~~L~~l~l~~N~l~g~iP~~~---~~~~~~l~~~~N~ 517 (931)
.+..+++|+.|+|++|.|++.....+ ...+..+.+++|.
T Consensus 483 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 483 FSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 55666777777777777654322222 2355566666665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.90 E-value=4.6e-05 Score=76.55 Aligned_cols=85 Identities=15% Similarity=0.246 Sum_probs=68.3
Q ss_pred CcEEEEEeCCCCCccc----CCccccCccccceecccCCcCCCC----CC-CccccccccEeec--CCccccCC----CC
Q 002358 413 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHL--ENNELTGS----LP 477 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~----~p-~~~~l~~L~~L~L--~~N~l~g~----iP 477 (931)
++|++|+|++|.|... +...+...+.|++|+|++|.|... +. .+...+.|+.|+| ++|.|+.. +.
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~ 144 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 144 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence 4799999999999742 445566678999999999999864 22 4777889999999 88999843 44
Q ss_pred CccCCccccccccccccCCC
Q 002358 478 SYMGSLPNLQELHIENNSFV 497 (931)
Q Consensus 478 ~~l~~l~~L~~l~l~~N~l~ 497 (931)
+.+...++|+.|+|++|.+.
T Consensus 145 ~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 145 NMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCcCEEeccCCCCC
Confidence 55666789999999999986
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00032 Score=83.30 Aligned_cols=55 Identities=5% Similarity=-0.010 Sum_probs=22.0
Q ss_pred cEEEEEeCCCCCc----ccCCccccCccccceecccCCcCCCCCCCccccccccEeecC
Q 002358 414 RITKIALSGKNLK----GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE 468 (931)
Q Consensus 414 ~l~~L~L~~n~l~----g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~ 468 (931)
+|+.|+|++|+++ +.++..+.++++|+.|+|++|.+.+....+.++++|+.|+++
T Consensus 193 ~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~ 251 (592)
T 3ogk_B 193 SLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGG 251 (592)
T ss_dssp CCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEEC
T ss_pred CccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhccc
Confidence 3444444444443 222333334444444444444444322223334444444443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0026 Score=72.64 Aligned_cols=70 Identities=16% Similarity=0.313 Sum_probs=49.6
Q ss_pred cccCccCcEEEEEEEECC--------CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCC-cceeEEEecCCeEEEEEE
Q 002358 615 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~~~lV~E 685 (931)
+.|+.|....+|+....+ ++.+++|+...... ...+.+|..+++.|...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 568888889999998763 57899998754211 1456689999998853344 567776543 38999
Q ss_pred ecCCC
Q 002358 686 YMHNG 690 (931)
Q Consensus 686 ~~~~g 690 (931)
|++|.
T Consensus 153 ~l~G~ 157 (429)
T 1nw1_A 153 YIPSR 157 (429)
T ss_dssp CCCEE
T ss_pred EeCCc
Confidence 99863
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.00015 Score=86.11 Aligned_cols=102 Identities=12% Similarity=0.156 Sum_probs=72.5
Q ss_pred CcEEEEEeCCCCCcccCCcccc-CccccceecccCC-cCCCC-CCC-ccccccccEeecCCccccCCCCCcc----CCcc
Q 002358 413 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGN-FLTGP-LPD-MSRLIDLRIVHLENNELTGSLPSYM----GSLP 484 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~-~L~~L~~L~Ls~N-~l~g~-~p~-~~~l~~L~~L~L~~N~l~g~iP~~l----~~l~ 484 (931)
++|++|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++. +.++++|+.|+|++|.+++..+..+ ..++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4788899999888877777776 6889999999888 55442 344 3478889999999988886554444 3667
Q ss_pred ccccccccccCCCCCCCccc-------ccCceeeeecCC
Q 002358 485 NLQELHIENNSFVGEIPPAL-------LTGKVIFKYDNN 516 (931)
Q Consensus 485 ~L~~l~l~~N~l~g~iP~~~-------~~~~~~l~~~~N 516 (931)
+|+.|+|++|. +.++... ...+..+.+.+|
T Consensus 185 ~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 185 SLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp CCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred cCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 88999998887 2443321 235666777666
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0035 Score=67.63 Aligned_cols=138 Identities=14% Similarity=0.104 Sum_probs=76.1
Q ss_pred ccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCC-cceeEEEecCCeEEEEEEec-CCCC
Q 002358 614 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYEYM-HNGT 691 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~-~~gs 691 (931)
.+.|+.|....+|+. +.+++|+...... ......+|+.+++.+....+ .++++++ .+..++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 467888999999998 5688888764321 12234568888888853333 3555543 33347899999 5543
Q ss_pred HHH------------------HhccCCCC--CCCCH-HHHHHHHHH--------------HHHHhH----Hhh-hcCCCC
Q 002358 692 LRD------------------RLHGSVNQ--KPLDW-LTRLQIAHD--------------AAKGLE----YLH-TGCNPG 731 (931)
Q Consensus 692 L~~------------------~L~~~~~~--~~l~~-~~~~~i~~q--------------ia~aL~----yLH-~~~~~~ 731 (931)
+.. .+|..... ..... ..+..+... +.+.+. .|. ......
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 321 11211100 00111 111111100 111111 111 112356
Q ss_pred eEecCCCCCCccccCCCceEEeccccccc
Q 002358 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 732 ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 6677789999987754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0091 Score=65.33 Aligned_cols=141 Identities=12% Similarity=0.063 Sum_probs=74.2
Q ss_pred cccCccCcEE-EEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCC--CCCcceeEEEecCCeEEEEEEecCCCC
Q 002358 615 KKIGKGSFGS-VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGT 691 (931)
Q Consensus 615 ~~LG~G~fG~-Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gs 691 (931)
+.|+.|+... +|+....+|+.+++|...... ...+..|+++++.+.. -.+.+++.+....+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4566565554 567665447788888654321 1345567777777742 23556666644433 78999997766
Q ss_pred HHHHhccC---------------------CCC--CCCCHHHHH-------HHH-------------HHHHHHhHHhh---
Q 002358 692 LRDRLHGS---------------------VNQ--KPLDWLTRL-------QIA-------------HDAAKGLEYLH--- 725 (931)
Q Consensus 692 L~~~L~~~---------------------~~~--~~l~~~~~~-------~i~-------------~qia~aL~yLH--- 725 (931)
+.+.+... ... ..++..... .+. ..+.+.++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65433211 000 111111100 000 01111222221
Q ss_pred hcCCCCeEecCCCCCCccccCC----CceEEeccccccc
Q 002358 726 TGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQ 760 (931)
Q Consensus 726 ~~~~~~ivH~DIkp~NILld~~----~~vkL~DFGla~~ 760 (931)
......++|||+.+.||+++.+ +.+.|.||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1124689999999999999874 6789999998764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.00011 Score=87.14 Aligned_cols=105 Identities=15% Similarity=0.127 Sum_probs=72.4
Q ss_pred CcEEEEEeC--C----CCCcc-----cCCccccCccccceecccCCcCCCCCC-Cccc-cccccEeecCCccccCCCCCc
Q 002358 413 PRITKIALS--G----KNLKG-----EIPPELKNMEALTELWLDGNFLTGPLP-DMSR-LIDLRIVHLENNELTGSLPSY 479 (931)
Q Consensus 413 ~~l~~L~L~--~----n~l~g-----~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~-l~~L~~L~L~~N~l~g~iP~~ 479 (931)
++|+.|+|+ + +++++ .++..+.++++|+.|+|++ .+++..+ .+.. +++|+.|+|++|.+++..+..
T Consensus 397 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~ 475 (594)
T 2p1m_B 397 PNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHH 475 (594)
T ss_dssp TTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHH
T ss_pred CCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHH
Confidence 578888888 4 55552 2222367788899999977 5555443 4554 888999999999887665555
Q ss_pred c-CCccccccccccccCCCCCCCccc---ccCceeeeecCCCC
Q 002358 480 M-GSLPNLQELHIENNSFVGEIPPAL---LTGKVIFKYDNNPK 518 (931)
Q Consensus 480 l-~~l~~L~~l~l~~N~l~g~iP~~~---~~~~~~l~~~~N~~ 518 (931)
+ ..+++|+.|+|++|.+++..+..+ ...+..+.+++|+.
T Consensus 476 l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 476 VLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 5 668889999999998864433322 23667777888764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0095 Score=64.67 Aligned_cols=142 Identities=14% Similarity=0.194 Sum_probs=79.6
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCC--CcceeEE------EecCCeEEEEEEe
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGY------CEEEHQRILVYEY 686 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g~------~~~~~~~~lV~E~ 686 (931)
+.|+.|....+|+....+| .+++|+.... .....+..|+.+++.+.... +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577788899999987755 6888987652 12345667888888774222 2333321 1223567899999
Q ss_pred cCCCCHHH--------------HhccC---CCCC---C---CCHHHHHHH------------HHHHHHHhHHhhhc----
Q 002358 687 MHNGTLRD--------------RLHGS---VNQK---P---LDWLTRLQI------------AHDAAKGLEYLHTG---- 727 (931)
Q Consensus 687 ~~~gsL~~--------------~L~~~---~~~~---~---l~~~~~~~i------------~~qia~aL~yLH~~---- 727 (931)
++|..+.. .++.. .... . ..|.....- ...+.+.++.+++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98854310 12211 0000 0 112221100 01133445555431
Q ss_pred CCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 728 ~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
....++|+|+++.|||++++..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23579999999999999887666899998765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0089 Score=66.86 Aligned_cols=141 Identities=17% Similarity=0.196 Sum_probs=84.5
Q ss_pred cccCccCcEEEEEEEEC--------CCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEE
Q 002358 615 KKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~--------~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 685 (931)
+.|..|....+|+.... +++.+++|+.... ........+|.++++.|. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46777888889998875 2578999986432 223455678999999885 3333566766654 29999
Q ss_pred ecCCCCHHH-----------------HhccCC--CCCCCC--HHHHHHHHHHHHH-------------------HhHHhh
Q 002358 686 YMHNGTLRD-----------------RLHGSV--NQKPLD--WLTRLQIAHDAAK-------------------GLEYLH 725 (931)
Q Consensus 686 ~~~~gsL~~-----------------~L~~~~--~~~~l~--~~~~~~i~~qia~-------------------aL~yLH 725 (931)
|++|..|.. .||... ..+... +.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998754421 122211 112222 4455555554432 123332
Q ss_pred h-----cCCCCeEecCCCCCCccccCC----CceEEeccccccc
Q 002358 726 T-----GCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQ 760 (931)
Q Consensus 726 ~-----~~~~~ivH~DIkp~NILld~~----~~vkL~DFGla~~ 760 (931)
+ .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 124578999999999999876 7899999997753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0033 Score=59.06 Aligned_cols=55 Identities=31% Similarity=0.408 Sum_probs=37.5
Q ss_pred EEEeCCCCCc-ccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCcccc
Q 002358 417 KIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT 473 (931)
Q Consensus 417 ~L~L~~n~l~-g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~ 473 (931)
.++.++++|+ ..+|..|. ++|+.|+|++|+|+...+. |..|++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6778888886 45665432 3577777777777776663 667777777777777654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.39 E-value=0.013 Score=63.83 Aligned_cols=141 Identities=12% Similarity=0.174 Sum_probs=80.5
Q ss_pred ccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCC--CcceeEE-----EecCCeEEEEEEecC
Q 002358 616 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGY-----CEEEHQRILVYEYMH 688 (931)
Q Consensus 616 ~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g~-----~~~~~~~~lV~E~~~ 688 (931)
.++ |....||+....+|+.+++|+..... .....+..|..+++.+.... +.+++.. ....+..++++|+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 77789999887778889999986431 12346677888888874222 3334432 122455678999998
Q ss_pred CCCHH-----------H---HhccC---C---CCCCCCHHHH----HHH---------------HHHHHHHhHHhhh---
Q 002358 689 NGTLR-----------D---RLHGS---V---NQKPLDWLTR----LQI---------------AHDAAKGLEYLHT--- 726 (931)
Q Consensus 689 ~gsL~-----------~---~L~~~---~---~~~~l~~~~~----~~i---------------~~qia~aL~yLH~--- 726 (931)
|..+. . .++.. . .....++... ..+ ...+.+.++.+.+
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 74321 1 11110 0 0111222111 000 0011112222221
Q ss_pred -cCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 727 -GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 727 -~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
.....++|||+++.|||++ + .+.|.||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1246789999999999999 4 899999987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0078 Score=66.97 Aligned_cols=72 Identities=13% Similarity=0.191 Sum_probs=45.3
Q ss_pred cccCccCcEEEEEEEECC---------CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCC-cceeEEEecCCeEEEEE
Q 002358 615 KKIGKGSFGSVYYGKMKD---------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVY 684 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~---------g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~~~lV~ 684 (931)
+.|+.|....+|+....+ ++.+++|+..... ........|.++++.+...++ .++++... .++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 567888888999998764 2689999875432 112234678888888853343 46665542 26899
Q ss_pred EecCCCC
Q 002358 685 EYMHNGT 691 (931)
Q Consensus 685 E~~~~gs 691 (931)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998743
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.18 E-value=0.00054 Score=67.87 Aligned_cols=83 Identities=11% Similarity=0.081 Sum_probs=63.0
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCc-CCCCC-CCcccc----ccccEeecCCcc-ccCCCCCccCCccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF-LTGPL-PDMSRL----IDLRIVHLENNE-LTGSLPSYMGSLPN 485 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~-l~g~~-p~~~~l----~~L~~L~L~~N~-l~g~iP~~l~~l~~ 485 (931)
-+|++|||+++.++..-=..+..+++|+.|+|+++. |+..- ..++.+ ++|+.|+|++|. +|..==..|.+|++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999875434567899999999999985 55422 235554 479999999985 76332335778999
Q ss_pred cccccccccC
Q 002358 486 LQELHIENNS 495 (931)
Q Consensus 486 L~~l~l~~N~ 495 (931)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.10 E-value=0.017 Score=66.31 Aligned_cols=72 Identities=10% Similarity=0.072 Sum_probs=47.9
Q ss_pred cccCccCcEEEEEEEECC-CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCC-cceeEEEecCCeEEEEEEecCCCC
Q 002358 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYEYMHNGT 691 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~~gs 691 (931)
+.|+.|....+|+....+ ++.+++|+....... .-.-.+|..+++.|...++ .++++.+. + .+||||++|..
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 568889899999998875 578899987543211 1122589999999965445 46777663 2 35999998743
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.02 E-value=0.00082 Score=74.88 Aligned_cols=105 Identities=14% Similarity=0.238 Sum_probs=61.4
Q ss_pred CcEEEEEeCCCCCcccCCcccc--CccccceecccC--CcCCCC--C----CCc--cccccccEeecCCccccCCCCCcc
Q 002358 413 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDG--NFLTGP--L----PDM--SRLIDLRIVHLENNELTGSLPSYM 480 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~--~L~~L~~L~Ls~--N~l~g~--~----p~~--~~l~~L~~L~L~~N~l~g~iP~~l 480 (931)
++|+.|+|..+++....-..++ +|++|+.|+|+. |...|. + +.+ ..+++|+.|+|.+|.+.+..+..+
T Consensus 193 ~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~l 272 (362)
T 2ra8_A 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF 272 (362)
T ss_dssp TTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred CCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence 4778888877776544333444 677888887753 222221 1 112 346778888888887764443333
Q ss_pred ---CCccccccccccccCCCCC----CCccc--ccCceeeeecCCC
Q 002358 481 ---GSLPNLQELHIENNSFVGE----IPPAL--LTGKVIFKYDNNP 517 (931)
Q Consensus 481 ---~~l~~L~~l~l~~N~l~g~----iP~~~--~~~~~~l~~~~N~ 517 (931)
..+++|+.|+|+.|.|.+. ++..+ +..+..+.+++|.
T Consensus 273 a~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~ 318 (362)
T 2ra8_A 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY 318 (362)
T ss_dssp HHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBB
T ss_pred HhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCc
Confidence 2477788888888877643 22221 2245566666553
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=95.93 E-value=0.00053 Score=76.44 Aligned_cols=103 Identities=17% Similarity=0.156 Sum_probs=59.2
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-Cc--cccccccEeecCC--ccccCC-----CCCcc-
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DM--SRLIDLRIVHLEN--NELTGS-----LPSYM- 480 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~--~~l~~L~~L~L~~--N~l~g~-----iP~~l- 480 (931)
.|+|++|+|++|.-. .+++ + .+++|+.|+|..|.++...- .+ ..+++|+.|+|+. |...|. +-..+
T Consensus 171 ~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp CTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred CCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 467888888776311 3443 3 37788888887777644322 23 3678888888753 222221 11112
Q ss_pred -CCccccccccccccCCCCCCCccc-----ccCceeeeecCCC
Q 002358 481 -GSLPNLQELHIENNSFVGEIPPAL-----LTGKVIFKYDNNP 517 (931)
Q Consensus 481 -~~l~~L~~l~l~~N~l~g~iP~~~-----~~~~~~l~~~~N~ 517 (931)
+.+++|+.|+|.+|.+....+..+ .+.+..+.++.|.
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~ 290 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGV 290 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSC
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCC
Confidence 347788888888887764333222 2356666666664
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.78 E-value=0.0085 Score=56.24 Aligned_cols=47 Identities=32% Similarity=0.460 Sum_probs=24.1
Q ss_pred eecccCCcCC-CCCC-CccccccccEeecCCccccCCCCC-ccCCcccccccc
Q 002358 441 ELWLDGNFLT-GPLP-DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELH 490 (931)
Q Consensus 441 ~L~Ls~N~l~-g~~p-~~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~~l~ 490 (931)
.++.++++|+ ..+| .+. .+|+.|+|++|+|+ .||. .|..+++|+.|+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~ 61 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAH 61 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEE
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEE
Confidence 5666666666 2333 322 24666666666666 4443 334455444443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.68 E-value=0.024 Score=62.39 Aligned_cols=68 Identities=13% Similarity=0.244 Sum_probs=44.0
Q ss_pred CccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcC---CCCCcceeEE------EecCCeEEEEEEecC
Q 002358 618 GKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGY------CEEEHQRILVYEYMH 688 (931)
Q Consensus 618 G~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~------~~~~~~~~lV~E~~~ 688 (931)
|.|....||+....+| .+++|+...... .+|+.+++.|. -|.+.+++.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3444679999988777 899998765431 35666666663 1224444432 233567889999999
Q ss_pred CCCH
Q 002358 689 NGTL 692 (931)
Q Consensus 689 ~gsL 692 (931)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=95.03 E-value=0.018 Score=64.96 Aligned_cols=99 Identities=15% Similarity=0.173 Sum_probs=63.0
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCC----CCC--CccccccccEeecCCccccCCCCC-ccCCcccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG----PLP--DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNL 486 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g----~~p--~~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L 486 (931)
+|+.|.| .++++..-+..|.++++|+.|+|.+|.+.. .++ .|.++++|+.|+|. |+++ .|+. .|.+|++|
T Consensus 249 ~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~-~I~~~aF~~c~~L 325 (401)
T 4fdw_A 249 GITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR-ILGQGLLGGNRKV 325 (401)
T ss_dssp CCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC-EECTTTTTTCCSC
T ss_pred CccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE-EEhhhhhcCCCCc
Confidence 5667777 455663335567778888888887777651 233 37777888888887 3466 5544 56777788
Q ss_pred ccccccccCCCCCCCccccc--CceeeeecCCC
Q 002358 487 QELHIENNSFVGEIPPALLT--GKVIFKYDNNP 517 (931)
Q Consensus 487 ~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~ 517 (931)
+.|.|.+| ++ .|+...+. ++..+.+.+|.
T Consensus 326 ~~l~lp~~-l~-~I~~~aF~~~~L~~l~l~~n~ 356 (401)
T 4fdw_A 326 TQLTIPAN-VT-QINFSAFNNTGIKEVKVEGTT 356 (401)
T ss_dssp CEEEECTT-CC-EECTTSSSSSCCCEEEECCSS
T ss_pred cEEEECcc-cc-EEcHHhCCCCCCCEEEEcCCC
Confidence 88877544 55 56665544 45555666653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=94.87 E-value=0.027 Score=63.51 Aligned_cols=89 Identities=11% Similarity=0.137 Sum_probs=71.0
Q ss_pred CcEEEEEeCCCCCc-----ccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCC-CccCCccc
Q 002358 413 PRITKIALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPN 485 (931)
Q Consensus 413 ~~l~~L~L~~n~l~-----g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP-~~l~~l~~ 485 (931)
.+|+.|+|.+|.+. -.-+..|.+|++|+.|+|. |+++.+.. .|.++++|+.|+|.+| ++ .|+ ..|.++ +
T Consensus 271 ~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~aF~~~-~ 346 (401)
T 4fdw_A 271 PELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT-QINFSAFNNT-G 346 (401)
T ss_dssp TTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC-EECTTSSSSS-C
T ss_pred CCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc-EEcHHhCCCC-C
Confidence 47899999888765 2344679999999999999 45776666 5999999999999666 66 554 578889 9
Q ss_pred cccccccccCCCCCCCccccc
Q 002358 486 LQELHIENNSFVGEIPPALLT 506 (931)
Q Consensus 486 L~~l~l~~N~l~g~iP~~~~~ 506 (931)
|+.|.+++|.+. .++...+.
T Consensus 347 L~~l~l~~n~~~-~l~~~~F~ 366 (401)
T 4fdw_A 347 IKEVKVEGTTPP-QVFEKVWY 366 (401)
T ss_dssp CCEEEECCSSCC-BCCCSSCC
T ss_pred CCEEEEcCCCCc-cccccccc
Confidence 999999999987 67665554
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.86 E-value=0.19 Score=50.99 Aligned_cols=105 Identities=11% Similarity=0.051 Sum_probs=69.3
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccccc
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 769 (931)
-+|.++|.. .+.++++.+++.++.|.+.+|.-+-.. ..-..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 378999875 367899999999999999998776211 1112334456888999999888764 1110
Q ss_pred cccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCC
Q 002358 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 813 (931)
Q Consensus 770 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~ 813 (931)
.....+.+||... ...+.+.=|||+|+++|.-+--..|-+
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~ 137 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN 137 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence 0123466888764 345678899999999999988666644
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.01 E-value=0.17 Score=57.31 Aligned_cols=140 Identities=14% Similarity=0.208 Sum_probs=85.0
Q ss_pred cccCccCcEEEEEEEECC--------CcEEEEEEccCccchhhhhHHHHHHHHHhcCCCC-CcceeEEEecCCeEEEEEE
Q 002358 615 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~E 685 (931)
+.+..|....+|+....+ ++.+++|+..... ...-+..+|.++++.+...+ ..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 567778888999998763 5889999865432 22223467899998885333 345565432 278999
Q ss_pred ecCCCCHHH-----------------HhccC-------C---CCCCCCHHHHHHHHHHHH-------------------H
Q 002358 686 YMHNGTLRD-----------------RLHGS-------V---NQKPLDWLTRLQIAHDAA-------------------K 719 (931)
Q Consensus 686 ~~~~gsL~~-----------------~L~~~-------~---~~~~l~~~~~~~i~~qia-------------------~ 719 (931)
|++|..|.. .+|.. . ...+.-+.++.++..++- +
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865310 01110 0 111112444444433221 2
Q ss_pred HhHHhhh---------------------cCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 720 GLEYLHT---------------------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 720 aL~yLH~---------------------~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
.+..|.+ .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2233321 11356899999999999 8888999999998753
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=91.93 E-value=0.018 Score=57.90 Aligned_cols=83 Identities=13% Similarity=0.177 Sum_probs=59.7
Q ss_pred CcEEEEEeCCC-CCcc----cCCccccCccccceecccCCcCCCCCC-----CccccccccEeecCCccccCC----CCC
Q 002358 413 PRITKIALSGK-NLKG----EIPPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELTGS----LPS 478 (931)
Q Consensus 413 ~~l~~L~L~~n-~l~g----~ip~~~~~L~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~L~~N~l~g~----iP~ 478 (931)
+.|++|+|++| +|.. .|-+.+..-+.|+.|+|++|+|...-- .+..-+.|+.|+|++|+|... |-+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 36889999986 6642 244556777899999999999974321 145567899999999999732 333
Q ss_pred ccCCccccccccccccC
Q 002358 479 YMGSLPNLQELHIENNS 495 (931)
Q Consensus 479 ~l~~l~~L~~l~l~~N~ 495 (931)
.+..-+.|+.|+|++|.
T Consensus 121 aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQR 137 (197)
T ss_dssp HTTTTCCCSEEECCCCS
T ss_pred HHhhCCceeEEECCCCc
Confidence 45555679999998763
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=89.12 E-value=0.35 Score=53.41 Aligned_cols=88 Identities=14% Similarity=0.145 Sum_probs=60.4
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCC-ccCCccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHI 491 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~~l~l 491 (931)
.++.+.+..+ +.-.-...|.++++|+.+.|.+|.++.+.. .|.++.+|+.+.|.++ ++ .|.+ .|.+|.+|+.+.+
T Consensus 264 ~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 264 ALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISY 340 (379)
T ss_dssp TCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCC
T ss_pred hhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEE
Confidence 5666777543 552333457788888888888888877666 4888888888888755 55 5654 5788888888887
Q ss_pred cccCCCCCCCccccc
Q 002358 492 ENNSFVGEIPPALLT 506 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~ 506 (931)
..| ++ .|.+..+.
T Consensus 341 p~~-v~-~I~~~aF~ 353 (379)
T 4h09_A 341 PKS-IT-LIESGAFE 353 (379)
T ss_dssp CTT-CC-EECTTTTT
T ss_pred CCc-cC-EEchhHhh
Confidence 654 55 55554443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.02 E-value=1.2 Score=49.81 Aligned_cols=30 Identities=30% Similarity=0.383 Sum_probs=25.0
Q ss_pred CeEecCCCCCCccc------cCCCceEEeccccccc
Q 002358 731 GIIHRDVKSSNILL------DINMRAKVSDFGLSRQ 760 (931)
Q Consensus 731 ~ivH~DIkp~NILl------d~~~~vkL~DFGla~~ 760 (931)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999988753
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=87.92 E-value=0.74 Score=51.24 Aligned_cols=96 Identities=13% Similarity=0.216 Sum_probs=49.1
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCC-ccCCccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHI 491 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~~l~l 491 (931)
.++.+.|.++-.. .-...|.++++|+.+.+. +.++.... .|.++.+|+.++|..| ++ .|.+ .|.+|.+|+.+.|
T Consensus 266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 266 YLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEE
T ss_pred cccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEE
Confidence 4555555443322 333445666666666664 33443333 3666666666666543 44 3433 4566666666666
Q ss_pred cccCCCCCCCccccc---CceeeeecC
Q 002358 492 ENNSFVGEIPPALLT---GKVIFKYDN 515 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~---~~~~l~~~~ 515 (931)
..+ ++ .|.+..+. .+..+.+.+
T Consensus 342 p~s-v~-~I~~~aF~~C~~L~~i~~~~ 366 (394)
T 4gt6_A 342 PSS-VT-KIPESAFSNCTALNNIEYSG 366 (394)
T ss_dssp CTT-CC-BCCGGGGTTCTTCCEEEESS
T ss_pred Ccc-cC-EEhHhHhhCCCCCCEEEECC
Confidence 433 44 55554443 334444443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=87.73 E-value=0.081 Score=52.16 Aligned_cols=92 Identities=11% Similarity=0.105 Sum_probs=58.8
Q ss_pred cCCccccCccccceecccCCcCCCC-CCCccccccccEeecCCcc-ccCCCCCccCCc----cccccccccccC-CCCCC
Q 002358 428 EIPPELKNMEALTELWLDGNFLTGP-LPDMSRLIDLRIVHLENNE-LTGSLPSYMGSL----PNLQELHIENNS-FVGEI 500 (931)
Q Consensus 428 ~ip~~~~~L~~L~~L~Ls~N~l~g~-~p~~~~l~~L~~L~L~~N~-l~g~iP~~l~~l----~~L~~l~l~~N~-l~g~i 500 (931)
.+|.....--+|+.|||+++.++.. +..+.++++|+.|+|+++. ++..-=..|+.+ ++|+.|+|+++. ++-.=
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~G 131 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKG 131 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHH
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHH
Confidence 4455433335799999999987654 3357899999999999995 663322345553 479999999975 65100
Q ss_pred Cccc--ccCceeeeecCCCCc
Q 002358 501 PPAL--LTGKVIFKYDNNPKL 519 (931)
Q Consensus 501 P~~~--~~~~~~l~~~~N~~~ 519 (931)
=..+ +..+..+.+.+.+..
T Consensus 132 l~~L~~~~~L~~L~L~~c~~I 152 (176)
T 3e4g_A 132 IIALHHFRNLKYLFLSDLPGV 152 (176)
T ss_dssp HHHGGGCTTCCEEEEESCTTC
T ss_pred HHHHhcCCCCCEEECCCCCCC
Confidence 0001 235566666665543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=86.86 E-value=0.5 Score=52.62 Aligned_cols=77 Identities=12% Similarity=0.086 Sum_probs=48.2
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCC-ccCCccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHI 491 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~~l~l 491 (931)
+|+.+.|.++ ++-.-...|.++++|+.++|.++ ++.+-. .|.++++|+.++|..| ++ .|++ .|.+|++|+.+.|
T Consensus 298 ~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~l 373 (394)
T 4fs7_A 298 SLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVEL 373 (394)
T ss_dssp TCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEE
T ss_pred cccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEE
Confidence 5666666543 55223345777777777777643 544444 4777777777777666 55 4543 5677777777777
Q ss_pred ccc
Q 002358 492 ENN 494 (931)
Q Consensus 492 ~~N 494 (931)
..|
T Consensus 374 p~~ 376 (394)
T 4fs7_A 374 PKR 376 (394)
T ss_dssp EGG
T ss_pred CCC
Confidence 544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=85.25 E-value=0.83 Score=50.35 Aligned_cols=88 Identities=16% Similarity=0.122 Sum_probs=66.6
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCC-ccCCccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHI 491 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~~l~l 491 (931)
.|+.+.|..+ ++..-...|.++.+|+.+.+..+ +..... .|.++++|+.+.|.+|.++ .|++ .|.+|.+|+.+.|
T Consensus 241 ~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 241 ALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCEEEC
T ss_pred cceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccc-eehhhhhcCCCCCCEEEc
Confidence 6778888765 65344456888999999999754 554444 4899999999999999888 6664 6889999999999
Q ss_pred cccCCCCCCCccccc
Q 002358 492 ENNSFVGEIPPALLT 506 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~ 506 (931)
.++ ++ .|+...+.
T Consensus 318 p~~-l~-~I~~~aF~ 330 (379)
T 4h09_A 318 PTA-LK-TIQVYAFK 330 (379)
T ss_dssp CTT-CC-EECTTTTT
T ss_pred Ccc-cc-EEHHHHhh
Confidence 754 66 67776554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=85.23 E-value=0.74 Score=51.20 Aligned_cols=80 Identities=13% Similarity=0.205 Sum_probs=59.8
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCC-ccCCcccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELH 490 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~~l~ 490 (931)
..|+.+.+. ++++..-...|.++++|+.++|..| ++.+-. .|.++.+|+.+.|..+ ++ .|.+ .|.+|++|+.++
T Consensus 288 ~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~ 363 (394)
T 4gt6_A 288 PALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIE 363 (394)
T ss_dssp TTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEE
T ss_pred cccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEE
Confidence 367788885 5566333456888999999999765 555444 4889999999999755 66 6664 688999999999
Q ss_pred ccccCC
Q 002358 491 IENNSF 496 (931)
Q Consensus 491 l~~N~l 496 (931)
+.+|..
T Consensus 364 ~~~~~~ 369 (394)
T 4gt6_A 364 YSGSRS 369 (394)
T ss_dssp ESSCHH
T ss_pred ECCcee
Confidence 988754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=83.83 E-value=0.071 Score=53.56 Aligned_cols=83 Identities=17% Similarity=0.167 Sum_probs=55.4
Q ss_pred CcEEEEEeCCCCCccc----CCccccCccccceecccCCcCCCCCC-----CccccccccEeecCCccc---cC----CC
Q 002358 413 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNEL---TG----SL 476 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~L~~N~l---~g----~i 476 (931)
..|+.|+|++|+|... |...+..-+.|+.|+|++|+|...-- .+..-+.|+.|+|++|.. .. .|
T Consensus 70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~i 149 (197)
T 1pgv_A 70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 149 (197)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHH
Confidence 4799999999999743 23344456899999999999985322 255556799999997643 21 12
Q ss_pred CCccCCccccccccccccC
Q 002358 477 PSYMGSLPNLQELHIENNS 495 (931)
Q Consensus 477 P~~l~~l~~L~~l~l~~N~ 495 (931)
-+.+..-+.|+.|+++.|.
T Consensus 150 a~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 150 MMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHHHCSSCCEEECCCCC
T ss_pred HHHHHhCCCcCeEeccCCC
Confidence 2333334566666665544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 931 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-04 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 2e-66
Identities = 78/276 (28%), Positives = 137/276 (49%), Gaps = 25/276 (9%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPL 670
++IG GSFG+VY GK +VAVK++ + + Q F EV +L + H N++
Sbjct: 12 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+GY +V ++ +L LH + + + + IA A+G++YLH
Sbjct: 70 MGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH---AK 123
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQ- 788
IIHRD+KS+NI L ++ K+ DFGL+ + +H G++ ++ PE Q
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 789 --LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846
+ +SDVY+FG+VL EL++G+ P S +N M+ +G + P L
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRG----YLSPDL-S 232
Query: 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882
V+ + + +C++++ RP +I+ +I+
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 4e-64
Identities = 67/271 (24%), Positives = 122/271 (45%), Gaps = 21/271 (7%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+++G G FG V+ G +VAVK + S F+ E L+ ++ H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
+E ++ EYM NG+L D L + L L +A A+G+ ++
Sbjct: 76 VVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 793 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 852
SDV+SFG++L E+++ + E+ +++G + D
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNCP-------- 236
Query: 853 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883
+ ++ C ++R RP + ++D
Sbjct: 237 -EELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 2e-63
Identities = 72/272 (26%), Positives = 124/272 (45%), Gaps = 21/272 (7%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 671
F ++IG G FG V+ G + +VA+K + + + F+ E ++ ++ H LV L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLY 66
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
G C E+ LV+E+M +G L D + + T L + D +G+ YL
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYL---EEAC 121
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
+IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 792 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 851
KSDV+SFGV++ E+ S K +E+ I G + P L
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG--FRLYKPRLAST---- 229
Query: 852 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883
+ ++ C ++R RP ++ + +
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-63
Identities = 74/301 (24%), Positives = 132/301 (43%), Gaps = 34/301 (11%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 674
+ IGKG FG V+ GK + G+EVAVKI S R+ E+ + H N++ I
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 675 EEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-- 728
+++ Q LV +Y +G+L D L+ + + +++A A GL +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 729 ---NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE 782
P I HRD+KS NIL+ N ++D GL+ + + I GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 783 YY------GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIVHWARSMIK 832
+ + +++D+Y+ G+V E+ + + +L + ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 833 KGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIV-----LAIQDSIK 886
K + P + + E++ +A++ +C G +R I L+ Q+ IK
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302
Query: 887 I 887
+
Sbjct: 303 M 303
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 5e-63
Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 21/272 (7%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 671
F K++G G FG V YGK + +VA+K++ + S +F+ E ++ + H LV L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
G C ++ ++ EYM NG L + L + L++ D + +EYL +
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQ 120
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
+HRD+ + N L++ KVSDFGLSR +D S ++ V + PE + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 792 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 851
KSD+++FGV++ E+ S K +E I +G + + P L
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQG--LRLYRPHLASE---- 228
Query: 852 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883
++ + C ++ RP + ++ I D
Sbjct: 229 ---KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 5e-62
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 12/215 (5%)
Query: 606 LEEATNNF--CKKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLSR 661
+E ++F ++G G+ G V+ K G +A K++ + Q + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 662 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 721
+ +V G + + + E+M G+L L + +++ KGL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 722 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 781
YL I+HRDVK SNIL++ K+ DFG+S Q + + + GT Y+ P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSP 172
Query: 782 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816
E + +SD++S G+ L+E+ G+ P+ D
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-60
Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 67
Query: 673 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 123
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
+HRD+ + N+L+ + AKVSDFGL+++A + V + PE ++ +
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFST 179
Query: 792 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 851
KSDV+SFG++L E+ S + ++ ++KG + D
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCP------- 226
Query: 852 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883
+ EV C RP ++ ++
Sbjct: 227 --PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-59
Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 21/274 (7%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
K+G+G FG V+ G VA+K + + + F+ E ++ ++ H LV L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
EE +V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 80 VVSEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 134
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 793 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 852
SDV+SFG++L EL + + E+ +++G +
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPCPPECPE------- 241
Query: 853 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886
+ ++ QC + RP + + ++D
Sbjct: 242 --SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (511), Expect = 1e-58
Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 49/311 (15%)
Query: 603 LPELEEATNNF--CKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQ-QFV 653
L LE NN + IG+G+FG V+ + VAVK++ + S Q F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 654 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG--------------- 698
E AL++ + N+V L+G C L++EYM G L + L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 699 ------SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 752
S PL +L IA A G+ YL +HRD+ + N L+ NM K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181
Query: 753 SDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
+DFGLSR D + ++ PE + T +SDV+++GVVL E+ S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 812 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 871
E+ ++ G++++ + + + + C + R
Sbjct: 242 PYYGMAHEEV------IYYVRDGNILACPENCPL---------ELYNLMRLCWSKLPADR 286
Query: 872 PKMQEIVLAIQ 882
P I +Q
Sbjct: 287 PSFCSIHRILQ 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 5e-58
Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 29/276 (10%)
Query: 615 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 669
K++G G+FG+V G + K VAVKI+ + + + + E ++ ++ + +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
+IG CE E +LV E G L L + + +++ H + G++YL
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---E 125
Query: 730 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVGYLDPEYYGNQ 787
+HRD+ + N+LL AK+SDFGLS+ D + + + V + PE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 788 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847
+ + KSDV+SFGV++ E S + G+E+ +M++KG+ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGERMGCPAGCP--- 236
Query: 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883
+ ++ C +RP + L +++
Sbjct: 237 ------REMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (504), Expect = 7e-58
Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 21/276 (7%)
Query: 612 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 670
K+G G +G VY G K VAVK + + + ++F+ E A++ I H NLV L
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL 78
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KK 134
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 791 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 850
KSDV++FGV+L E+ + I V +++
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRMERPE 239
Query: 851 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886
++ E+ C + RP EI A + +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 7e-58
Identities = 75/274 (27%), Positives = 116/274 (42%), Gaps = 30/274 (10%)
Query: 613 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 669
F +IG+GSF +VY G + EVA + D ++ Q+F E +L + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 670 LIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
E + +LV E M +GTL+ L K + KGL++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 726 TGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
T P IIHRD+K NI + K+ D GL+ GT ++ PE Y
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMY 185
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844
++ E DVY+FG+ +LE+ + + P S E + G + D V
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878
I VK E+ C+ Q R +++++
Sbjct: 239 IPEVK--------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-57
Identities = 63/288 (21%), Positives = 123/288 (42%), Gaps = 30/288 (10%)
Query: 605 ELEEATNNFC---KKIGKGSFGSVYYGKMK---DGKEVAVKIM-ADSCSHRTQQFVTEVA 657
+L +N ++G G+FGSV G + +VA+K++ + T++ + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 658 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 717
++ ++ + +V LIG C+ +LV E G L L G ++ + ++ H
Sbjct: 62 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQV 118
Query: 718 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 775
+ G++YL +HRD+ + N+LL AK+SDFGLS+ D S +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 776 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 835
+ + PE ++ + +SDV+S+GV + E +S + + G E+ + I++G
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGK 229
Query: 836 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883
+ + + C + RP + ++
Sbjct: 230 RMECPPECP---------PELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (500), Expect = 3e-57
Identities = 72/303 (23%), Positives = 136/303 (44%), Gaps = 42/303 (13%)
Query: 605 ELEEATNNFC-----------KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT 649
+ EA F + IG G FG V G +K + VA+K + + +
Sbjct: 11 DPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ 70
Query: 650 -QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWL 708
+ F++E +++ + H N++ L G + +++ E+M NG+L L N +
Sbjct: 71 RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVI 128
Query: 709 TRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768
+ + A G++YL + +HRD+ + NIL++ N+ KVSDFGLSR E+D +
Sbjct: 129 QLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 769 SSVA----RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 823
+ + + + + PE ++ T SDV+S+G+V+ E++S G++P +N
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245
Query: 824 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883
+ + D S + ++ + C ++ RPK +IV +
Sbjct: 246 IEQDYRLPPPMDCPS----------------ALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
Query: 884 SIK 886
I+
Sbjct: 290 MIR 292
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 9e-57
Identities = 68/275 (24%), Positives = 110/275 (40%), Gaps = 25/275 (9%)
Query: 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLV 668
IG GS+G + K DGK + K + Q V+EV LL + H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 669 PLIGYCEEEHQRIL--VYEYMHNGTLRDRLH-GSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
+ L V EY G L + G+ ++ LD L++ L+ H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 726 --TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
+ ++HRD+K +N+ LD K+ DFGL+R D + + GT Y+ PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPYYMSPEQ 185
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843
EKSD++S G +L EL + P + I++G I
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-------KIREGKFRRIPYRY 238
Query: 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878
+ E+ + + + + RP ++EI+
Sbjct: 239 SD---------ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 1e-56
Identities = 68/271 (25%), Positives = 113/271 (41%), Gaps = 33/271 (12%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 670
++IG GSFG+VY+ + + + VA+K M + + Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
G EH LV EY ++KPL + + H A +GL YLH +
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY---GNQ 787
+IHRDVK+ NILL K+ DFG + + + GT ++ PE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 788 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847
Q K DV+S G+ +EL K P+ + + L I + + ++
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQNESPALQSGHWSEY 242
Query: 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878
+ C+++ RP + ++
Sbjct: 243 FR--------NFVDSCLQKIPQDRPTSEVLL 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-56
Identities = 75/286 (26%), Positives = 121/286 (42%), Gaps = 29/286 (10%)
Query: 607 EEATNNFCKKIGKGSFGSVYYGKMKDGK----EVAVKIM-ADSCSHRTQQFVTEVALLSR 661
+F + IG+G FG VY+G + D AVK + + QF+TE ++
Sbjct: 25 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 662 IHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 720
H N++ L+G C E ++V YM +G LR+ + AKG
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKG 142
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVG 777
+ + +HRD+ + N +LD KV+DFGL+R E D H + A+ V
Sbjct: 143 M---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 778 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837
++ E Q+ T KSDV+SFGV+L EL++ P ++N + +G +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITV-YLLQGRRL 253
Query: 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883
+ + EV ++C + RP E+V I
Sbjct: 254 LQPE---------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 4e-56
Identities = 58/269 (21%), Positives = 114/269 (42%), Gaps = 26/269 (9%)
Query: 615 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
++G G+FG VY + K+ A K++ + ++ E+ +L+ H N+V L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
E+ ++ E+ G + + ++PL + L YLH + II
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLH---DNKII 132
Query: 734 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-----YGNQQ 788
HRD+K+ NIL ++ K++DFG+S + + S GT ++ PE ++
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEVVMCETSKDRP 191
Query: 789 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848
K+DV+S G+ L+E+ + P + L I K + ++ P +
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-------KIAKSEPPTLAQPSRWSS- 243
Query: 849 KIESIWRIAEVAIQCVEQRGFSRPKMQEI 877
+ +C+E+ +R ++
Sbjct: 244 ------NFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-55
Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 28/280 (10%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLV 668
K IG G FG VY G +K VA+K + + + + F+ E ++ + H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
L G + +++ EYM NG L L L + + A G++YL
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA--- 127
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGN 786
N +HRD+ + NIL++ N+ KVSDFGLSR E+D T+ +S + + + PE
Sbjct: 128 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 787 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846
++ T SDV+SFG+V+ E+++ + E +V+ ++
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERPYWEL---------------SNHEVMKAINDGFRL 232
Query: 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886
++ I ++ +QC +Q RPK +IV + I+
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-55
Identities = 67/268 (25%), Positives = 109/268 (40%), Gaps = 30/268 (11%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPL 670
+ +GKG FG+VY + K +A+K++ + + Q EV + S + H N++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
GY + + L+ EY GT+ L D + A L Y H +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCH---SK 125
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
+IHRD+K N+LL K++DFG S A GT+ YL PE +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIEGRMHD 182
Query: 791 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 850
EK D++S GV+ E + GK P F A + R + V
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRISRVEFTFPDFVTEGAR----- 232
Query: 851 ESIWRIAEVAIQCVEQRGFSRPKMQEIV 878
++ + ++ RP ++E++
Sbjct: 233 -------DLISRLLKHNPSQRPMLREVL 253
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 4e-55
Identities = 74/298 (24%), Positives = 124/298 (41%), Gaps = 41/298 (13%)
Query: 613 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 664
F K +G G+FG V VAVK++ + + ++E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG---------------SVNQKPLDWLT 709
N+V L+G C +++ EY G L + L ++ LD
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 710 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-I 768
L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R + D + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 828
AR V ++ PE N T +SDV+S+G+ L EL S + +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFY 258
Query: 829 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886
MIK+G + + + ++ C + RP ++IV I+ I
Sbjct: 259 KMIKEGFRMLSPEHAP---------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-54
Identities = 54/198 (27%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+KIG+G+ G+VY G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
+ +V EY+ G+L D + + +D + + + LE+LH + +I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 734 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 793
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 794 DVYSFGVVLLELISGKKP 811
D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-54
Identities = 77/296 (26%), Positives = 128/296 (43%), Gaps = 38/296 (12%)
Query: 612 NFCKKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHR-TQQFVTEVALLSRI-HHRN 666
F IG+G+FG V ++K + A+K M + S + F E+ +L ++ HH N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 667 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTRLQI 713
++ L+G CE L EY +G L D L + L L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 714 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 773
A D A+G++YL IHRD+ + NIL+ N AK++DFGLSR E + ++ R
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGR 187
Query: 774 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 833
V ++ E T SDV+S+GV+L E++S AEL + +
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQ 241
Query: 834 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889
G + + ++ QC ++ + RP +I++++ ++ K
Sbjct: 242 GYRLEKPLNCD---------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-53
Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 46/295 (15%)
Query: 613 FCKKIGKGSFGSVYYGKMKD------GKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 664
F K +G G+FG V +VAVK++ + S + ++E+ +++++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 665 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG--------------------SVNQKP 704
N+V L+G C L++EY G L + L +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 705 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764
L + L A+ AKG+E+L +HRD+ + N+L+ K+ DFGL+R D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 765 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 823
+ + AR V ++ PE T KSDV+S+G++L E+ S
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------------ 265
Query: 824 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878
+ + ++ + + I + C RP +
Sbjct: 266 --PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 9e-53
Identities = 68/281 (24%), Positives = 112/281 (39%), Gaps = 29/281 (10%)
Query: 613 FCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHR 665
+K+G GSFG V G+ VAVK + + + F+ EV + + HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
NL+ L G ++ V E G+L DRL +Q T + A A+G+ YL
Sbjct: 72 NLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYLDPEY 783
+ IHRD+ + N+LL K+ DFGL R ++ H + + + PE
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843
+ + SD + FGV L E+ + + LN + K+G+ + +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884
I V +QC + RP + + ++
Sbjct: 241 ---------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 1e-52
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 12/211 (5%)
Query: 603 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLS 660
+P +E+ + +G+G++G V + + VAVKI+ + E+ +
Sbjct: 1 VPFVEDWD--LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 58
Query: 661 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 720
++H N+V G+ E + + L EY G L DR+ + + H G
Sbjct: 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAG 115
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYL 779
+ YLH GI HRD+K N+LLD K+SDFGL+ + + + GT+ Y+
Sbjct: 116 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 780 DPEYYGNQQL-TEKSDVYSFGVVLLELISGK 809
PE ++ E DV+S G+VL +++G+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-52
Identities = 63/282 (22%), Positives = 117/282 (41%), Gaps = 26/282 (9%)
Query: 613 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNL 667
+ IG+G FG V+ G + VA+K + S ++F+ E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
V LIG E ++ E G LR V + LD + + A+ + L YL
Sbjct: 71 VKLIGVITENP-VWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLE-- 125
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 787
+ +HRD+ + N+L+ N K+ DFGLSR E+ + +S + + ++ PE +
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 788 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847
+ T SDV+ FGV + E++ ++ I+ G+ + +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPPNCPP-- 236
Query: 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889
+ + +C RP+ E+ + ++ EK
Sbjct: 237 -------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-51
Identities = 65/289 (22%), Positives = 123/289 (42%), Gaps = 33/289 (11%)
Query: 613 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHR 665
+++G+GSFG VY G K VA+K + ++ S R +F+ E +++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------GSVNQKPLDWLTRLQIAHDAA 718
++V L+G + +++ E M G L+ L + P +Q+A + A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 719 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 777
G+ YL +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 778 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837
++ PE + T SDV+SFGVVL E+ + + ++ + +G ++
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVMEGGLL 254
Query: 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886
D + E+ C + RP EI+ +I++ ++
Sbjct: 255 DKPDNCP---------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (453), Expect = 3e-50
Identities = 45/200 (22%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+++G G+FG V+ G+ K + E+++++++HH L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
E++++ +L+ E++ G L DR+ + + A +GL+++H I+
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149
Query: 734 HRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
H D+K NI+ + K+ DFGL+ + D + T + PE + +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGF 207
Query: 792 KSDVYSFGVVLLELISGKKP 811
+D+++ GV+ L+SG P
Sbjct: 208 YTDMWAIGVLGYVLLSGLSP 227
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (452), Expect = 6e-50
Identities = 46/200 (23%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+++G G+FG V+ + G A K + + E+ +S + H LV L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
E++++ +++YE+M G L +++ + ++ KGL ++H +
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 146
Query: 734 HRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
H D+K NI+ + K+ DFGL+ + + + GT + PE + +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGY 204
Query: 792 KSDVYSFGVVLLELISGKKP 811
+D++S GV+ L+SG P
Sbjct: 205 YTDMWSVGVLSYILLSGLSP 224
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-49
Identities = 60/271 (22%), Positives = 127/271 (46%), Gaps = 28/271 (10%)
Query: 615 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLV 668
K +G G+FG+VY G E VA+K + ++ S + ++ + E +++ + + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
L+G C + L+ + M G L D + ++ + L AKG+ YL
Sbjct: 75 RLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 128
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQ 787
+ ++HRD+ + N+L+ K++DFGL++ E+ + + + + ++ E ++
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 788 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847
T +SDV+S+GV + EL++ +E+ S+++KG+ + I
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLPQPPICTI-- 240
Query: 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 878
+ + ++C SRPK +E++
Sbjct: 241 -------DVYMIMVKCWMIDADSRPKFRELI 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 9e-49
Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 40/297 (13%)
Query: 613 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 664
K +G+G+FG V + VAVK++ + +H + ++E+ +L I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 665 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTR 710
N+V L+G C + + ++ E+ G L L + + L
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 711 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-S 769
+ + AKG+E+L + IHRD+ + NILL K+ DFGL+R +D ++
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 770 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 829
AR + ++ PE ++ T +SDV+SFGV+L E+ S + I
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 248
Query: 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886
+K+G + D + + + C RP E+V + + ++
Sbjct: 249 RLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-48
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 613 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLV 668
F K +G+GSF +V + + +E A+KI+ ++ E ++SR+ H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
L +++ + Y NG L + D + LEYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH--- 125
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQ 787
GIIHRD+K NILL+ +M +++DFG ++ + E ++ GT Y+ PE +
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 788 QLTEKSDVYSFGVVLLELISGKKP 811
+ SD+++ G ++ +L++G P
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-47
Identities = 64/294 (21%), Positives = 123/294 (41%), Gaps = 42/294 (14%)
Query: 613 FCKKIGKGSFGSVYYGKMK--------DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI- 662
K +G+G+FG V + +VAVK++ +D+ ++E+ ++ I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 663 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------------GSVNQKPLDWLT 709
H+N++ L+G C ++ ++ EY G LR+ L ++ L
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 710 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 769
+ A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 770 S-VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 828
+ R V ++ PE ++ T +SDV+SFGV+L E+ + V
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY------PGVPVEELF 247
Query: 829 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 882
++K+G + + + C RP +++V +
Sbjct: 248 KLLKEGHRMDKPSNCT---------NELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 6e-47
Identities = 61/322 (18%), Positives = 136/322 (42%), Gaps = 36/322 (11%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+ +G+G FG V+ K K + + + E+++L+ HRN++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHES 69
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
E + ++++E++ + +R++ + L+ + H + L++LH + I
Sbjct: 70 FESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 734 HRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
H D++ NI+ + K+ +FG +RQ + Y PE + + ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182
Query: 792 KSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKG------DVISIVDPVL 844
+D++S G ++ L+SG P E + NI++ + ++ + + VD +L
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL 242
Query: 845 IGNVK--------------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 890
+ K + I R++ I+ ++ R + +++ + + + +I G
Sbjct: 243 VKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCG 302
Query: 891 GDQKFSSSSSKGQSSRKTLLTS 912
G + S KG S K + S
Sbjct: 303 G----AIRSQKGVSVAKVKVAS 320
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (415), Expect = 6e-46
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 670
+ +G G V+ + ++ ++VAVK++ + +F E + ++H +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 671 IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
E E +V EY+ TLRD +H + P+ +++ DA + L +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFS-- 127
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYY 784
GIIHRDVK +NI++ KV DFG++R + ++ A GT YL PE
Sbjct: 128 -HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKP 811
+ +SDVYS G VL E+++G+ P
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (411), Expect = 2e-45
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIM---------ADSCSHRTQQFVTEVALLSRIH- 663
+ +G+G V K KE AVKI+ A+ + + EV +L ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 664 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 723
H N++ L E LV++ M G L D L + L +I + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICA 125
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
LH I+HRD+K NILLD +M K++DFG S Q + GT YL PE
Sbjct: 126 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEI 180
Query: 784 Y------GNQQLTEKSDVYSFGVVLLELISGKKP 811
+ ++ D++S GV++ L++G P
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 164 bits (417), Expect = 3e-45
Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 19/230 (8%)
Query: 611 NNF--CKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSR 661
N+F + IG+G FG VY + D GK A+K + ++L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 662 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 721
+V + + + + M+ G L L A + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 722 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 781
E++H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ P
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174
Query: 782 EYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 830
E +D +S G +L +L+ G P + I +M
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 3e-45
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 612 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 669
+F +G G+F V + + K VA+K +A + + E+A+L +I H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 670 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 729
L E L+ + + G L DR+ + ++ ++YLH
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG- 127
Query: 730 PGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
I+HRD+K N+L D + + +SDFGLS+ + ++ GT GY+ PE
Sbjct: 128 --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC--GTPGYVAPEVLAQ 183
Query: 787 QQLTEKSDVYSFGVVLLELISGKKP 811
+ ++ D +S GV+ L+ G P
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-44
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 12/227 (5%)
Query: 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR---TQQFVTEVALLSR-IHHRNL 667
K +GKGSFG V+ + K + A+K + + + E +LS H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
+ + + V EY++ G L + + D A + GL++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL--- 119
Query: 728 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 787
+ GI++RD+K NILLD + K++DFG+ ++ ++ GT Y+ PE Q
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 788 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 834
+ D +SFGV+L E++ G+ P +D + + +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 225
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (407), Expect = 2e-44
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 670
+ +G GSFG V+ + + +G+ A+K++ R +Q E +LS + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
G ++ Q ++ +Y+ G L L + A + LEYLH +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLH---SK 123
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
II+RD+K NILLD N K++DFG ++ + + GT Y+ PE +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL----CGTPDYIAPEVVSTKPYN 179
Query: 791 EKSDVYSFGVVLLELISGKKP 811
+ D +SFG+++ E+++G P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 4e-44
Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 28/283 (9%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+KIG GSFG +Y G + G+EVA+K+ H Q E + + +P I +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70
Query: 674 C-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
C E ++V E + + T L +A +EY+H +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNF 124
Query: 733 IHRDVKSSNIL---LDINMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPEY 783
IHRDVK N L + DFGL+++ + TH + GT Y
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843
+ + + + D+ S G VL+ G P + +S V
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MSTPIEV 239
Query: 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886
L E A C R +P + ++
Sbjct: 240 LCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (400), Expect = 8e-44
Identities = 42/199 (21%), Positives = 89/199 (44%), Gaps = 8/199 (4%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIG 672
+KIG+G++G VY + G+ A+K + + E+++L + H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
+ + +LV+E++ + + L+ +T G+ Y H + +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 792
+HRD+K N+L++ K++DFGL+R + + G+++ +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 793 SDVYSFGVVLLELISGKKP 811
D++S G + E+++G
Sbjct: 182 IDIWSVGCIFAEMVNGTPL 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-42
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 607 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 665
+E + K IG GSFG VY K+ D G+ VA+K + + E+ ++ ++ H
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 666 NLVPLIGYCEEEHQR------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 719
N+V L + ++ LV +Y+ R H S ++ L + + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 720 GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGY 778
L Y+H + GI HRD+K N+LLD + K+ DFG ++Q ++S + Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YY 188
Query: 779 LDP-EYYGNQQLTEKSDVYSFGVVLLELISGKKP 811
P +G T DV+S G VL EL+ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 155 bits (392), Expect = 1e-42
Identities = 42/284 (14%), Positives = 91/284 (32%), Gaps = 28/284 (9%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
++IG+GSFG ++ G + + ++VA+K Q E + +P + Y
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 674 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 733
+E ++ + +L D L + + T A ++ +H ++
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123
Query: 734 HRDVKSSNILLD-----INMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPE 782
+RD+K N L+ V DFG+ + + +T GT Y+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 783 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842
+ ++ + + D+ + G V + + G P + +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-----R 238
Query: 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886
L E + + P + ++
Sbjct: 239 ELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-42
Identities = 43/200 (21%), Positives = 88/200 (44%), Gaps = 8/200 (4%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 671
+KIG+G++G VY + K G+ VA+K + + E++LL ++H N+V L+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
E++ LV+E++H + + +GL + +
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC---HSHR 122
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
++HRD+K N+L++ K++DFGL+R + + G + +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 792 KSDVYSFGVVLLELISGKKP 811
D++S G + E+++ +
Sbjct: 183 AVDIWSLGCIFAEMVTRRAL 202
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 9e-42
Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 15/231 (6%)
Query: 615 KKIGKGSFGSVYYGKMK--DGKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNL 667
+IG+G++G V+ + G+ VA+K + + T + V + L H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 724
V L C + + V + + T + +GL++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 725 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
H + ++HRD+K NIL+ + + K++DFGL+R + S V T+ Y PE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVL 187
Query: 785 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 835
D++S G + E+ K +L + + + D
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 14/204 (6%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNLV 668
+G+G F +VY + K + VA+K + +++ + + E+ LL + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
L+ + LV+++M N L +GLEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH--- 117
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQ 787
I+HRD+K +N+LLD N K++DFGL++ + T Y PE G +
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 788 QLTEKSDVYSFGVVLLELISGKKP 811
D+++ G +L EL+
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPF 200
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-41
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 23/231 (9%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 672
+ +G G G V K ++ A+K++ D + EV L R ++V ++
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD 72
Query: 673 YCE----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
E ++V E + G L R+ + +I + ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 729 NPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 785
+ I HRDVK N+L N K++DFG +++ + + T Y+ PE G
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLG 186
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836
++ + D++S GV++ L+ G P L I ++ I+ G
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---GLAISPGMKTRIRMGQY 234
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-41
Identities = 54/232 (23%), Positives = 103/232 (44%), Gaps = 8/232 (3%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 672
IG+G++G V + VA+K + Q+ + E+ +L R H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 673 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 732
+ Y+ + L+ + + L + +GL+Y+H + +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130
Query: 733 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQL- 789
+HRD+K SN+LL+ K+ DFGL+R A+ D H + T Y PE N +
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 790 TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841
T+ D++S G +L E++S + + + +LN + + D+ I++
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-40
Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 9/200 (4%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 671
+KIG+G++G+V+ K + + VA+K + D + E+ LL + H+N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 731
+ + LV+E+ + LD KGL + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 732 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 791
++HRD+K N+L++ N K+++FGL+R + S+ +G + +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 792 KSDVYSFGVVLLELISGKKP 811
D++S G + EL + +P
Sbjct: 182 SIDMWSAGCIFAELANAGRP 201
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 4e-40
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT------QQFVTEVALLSRIHHRNL 667
+++G G F V + K G + A K + + + + EV++L I H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 668 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 727
+ L E + IL+ E + G L D L ++ L + G+ YLH
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLH-- 130
Query: 728 CNPGIIHRDVKSSNILLD----INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 783
+ I H D+K NI+L R K+ DFGL+ + + + GT ++ PE
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEI 187
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKP 811
+ L ++D++S GV+ L+SG P
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-40
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 11/216 (5%)
Query: 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLV 668
+ K +GKG+FG V + K G+ A+KI+ VTE +L H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 669 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
L + + V EY + G L L T + A+ + L
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLH 122
Query: 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 788
+ +++RD+K N++LD + K++DFGL ++ D + + GT YL PE +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 181
Query: 789 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 824
D + GVV+ E++ G+ P +D ++
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 49/223 (21%), Positives = 87/223 (39%), Gaps = 24/223 (10%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIH--HR 665
+G G FGSVY G + D VA+K + + EV LL ++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
++ L+ + E +L+ E + L + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC- 126
Query: 726 TGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 784
N G++HRD+K NIL+D+N K+ DFG ++ + GT Y PE+
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSPPEWI 181
Query: 785 -GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 826
++ + V+S G++L +++ G P F + I+
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRG 219
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (368), Expect = 6e-39
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 14/218 (6%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 670
K +G GSFG V K K G A+KI+ + +Q + E +L ++ LV L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 671 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
++ +V EY+ G + L A EYLH +
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
+I+RD+K N+L+D +V+DFG +++ + + GT L PE ++
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL----CGTPEALAPEIILSKGYN 216
Query: 791 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 828
+ D ++ GV++ E+ +G P + + +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-38
Identities = 50/225 (22%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 671
KIG+G+FG V+ + K G++VA+K + + + E+ +L + H N+V LI
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 672 GYCEE--------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 723
C + LV+++ + + L T +I L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------VLVKFTLSEIKRVMQMLLNG 129
Query: 724 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLD 780
L+ I+HRD+K++N+L+ + K++DFGL+R A+ + + T+ Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 781 PEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 824
PE G + D++ G ++ E+ + + +L ++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-36
Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 10/201 (4%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 671
+ +G G++G+V + G +VA+K + ++ E+ LL + H N++ L+
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 672 GYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 730
+ ++ G + + L + + KGL Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AA 140
Query: 731 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 790
GIIHRD+K N+ ++ + K+ DFGL+RQA+ ++T + T
Sbjct: 141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---GYVVTRWYRAPEVILNWMRYT 197
Query: 791 EKSDVYSFGVVLLELISGKKP 811
+ D++S G ++ E+I+GK
Sbjct: 198 QTVDIWSVGCIMAEMITGKTL 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (338), Expect = 4e-35
Identities = 45/205 (21%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 613 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL 670
+K+G+G + V+ + ++V VKI+ + ++ E+ +L + N++ L
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITL 95
Query: 671 IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 728
++ R LV+E+++N + + L ++ K L+Y H
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH--- 146
Query: 729 NPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 786
+ GI+HRDVK N+++D + + ++ D+GL+ + V + + PE
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDY 204
Query: 787 QQLTEKSDVYSFGVVLLELISGKKP 811
Q D++S G +L +I K+P
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 4e-35
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 615 KKIGKGSFGSVYYGK----MKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRI-HHR 665
K +G G++G V+ + GK A+K++ + T+ TE +L I
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 666 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
LV L + E + L+ +Y++ G L L + T ++ + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALE 143
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--Y 783
GII+RD+K NILLD N ++DFGLS++ D T + GT+ Y+ P+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 784 YGNQQLTEKSDVYSFGVVLLELISGKKP 811
G+ + D +S GV++ EL++G P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-31
Identities = 44/205 (21%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 671
+G G++GSV K G VAVK ++ ++ E+ LL + H N++ L+
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 672 GYCEE-----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 726
E + + ++ L + + + L + + +GL+Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 727 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 786
+ IIHRD+K SN+ ++ + K+ DFGL+R + ++
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNW 193
Query: 787 QQLTEKSDVYSFGVVLLELISGKKP 811
+ D++S G ++ EL++G+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-31
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 20/217 (9%)
Query: 615 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 671
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 672 GYC------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 725
EE LV E M + Q LD + + G+++LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLH 136
Query: 726 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 785
+ IHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--VTRYYRAPEVIL 191
Query: 786 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 822
E D++S G ++ E++ K D+ + N
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 123 bits (308), Expect = 6e-31
Identities = 50/238 (21%), Positives = 94/238 (39%), Gaps = 27/238 (11%)
Query: 615 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 673
+K+G G F +V+ K M + VA+KI+ T+ E+ LL R++ +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 674 CEEEHQRILVY-------------EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 720
++L + + G L + + + QI+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQAEEDLTHISSVARG 774
L+Y+H GIIH D+K N+L++I ++ K++D G + +E T+
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQ 191
Query: 775 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 832
T Y PE +D++S ++ ELI+G ++ + +I+
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.0 bits (225), Expect = 1e-21
Identities = 24/163 (14%), Positives = 49/163 (30%), Gaps = 28/163 (17%)
Query: 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHH 664
K +G+G +V+ + E VK + + F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 665 RNLVPLIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 720
R L L G + ++ E + + ++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEE 115
Query: 721 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763
+ + + GI+H D+ N+L+ + DF S + E
Sbjct: 116 VAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.3 bits (163), Expect = 3e-12
Identities = 12/93 (12%), Positives = 37/93 (39%), Gaps = 5/93 (5%)
Query: 402 WEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID 461
+ +T + L N+ P + ++ L L+ N ++ ++ L +
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLANLTN 352
Query: 462 LRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494
+ + +N+++ P + +L + +L + +
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 8e-09
Identities = 21/72 (29%), Positives = 35/72 (48%), Gaps = 3/72 (4%)
Query: 435 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494
N++ LT L L N ++ P +S L L+ + NN+++ S + +L N+ L +N
Sbjct: 305 NLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 495 SFVGEIPPALLT 506
P A LT
Sbjct: 362 QISDLTPLANLT 373
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 2e-05
Identities = 17/78 (21%), Positives = 35/78 (44%), Gaps = 5/78 (6%)
Query: 417 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL 476
K L N+ + +++ +T L D + + + L +L ++ NN+LT
Sbjct: 26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDIT 82
Query: 477 PSYMGSLPNLQELHIENN 494
P + +L L ++ + NN
Sbjct: 83 P--LKNLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 2e-04
Identities = 12/73 (16%), Positives = 26/73 (35%), Gaps = 3/73 (4%)
Query: 434 KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493
+ + L +T + + L + + + + S+ + L NL +++ N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 494 NSFVGEIPPALLT 506
N P LT
Sbjct: 76 NQLTDITPLKNLT 88
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 0.001
Identities = 28/125 (22%), Positives = 49/125 (39%), Gaps = 23/125 (18%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
+ +++L+G LK L ++ LT+L L N ++ L +S L L + L N+
Sbjct: 218 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQ 274
Query: 472 LTGSLP--------------------SYMGSLPNLQELHIENNSFVGEIPPALLTGKVIF 511
++ P S + +L NL L + N+ P + LT
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRL 334
Query: 512 KYDNN 516
+ NN
Sbjct: 335 FFANN 339
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.002
Identities = 16/67 (23%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 435 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494
+ L L N ++ P +L + L N+L + SL NL +L + NN
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL-TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 495 SFVGEIP 501
P
Sbjct: 252 QISNLAP 258
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 61.3 bits (147), Expect = 2e-10
Identities = 18/84 (21%), Positives = 29/84 (34%), Gaps = 2/84 (2%)
Query: 397 CVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 456
+ + + L + G +P L ++ L L + N L G +P
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 457 SRLIDLRIVHLENN-ELTGS-LPS 478
L + NN L GS LP+
Sbjct: 288 GNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.8 bits (143), Expect = 4e-10
Identities = 34/141 (24%), Positives = 64/141 (45%), Gaps = 9/141 (6%)
Query: 372 QDVMVLEALR-SISDESERT--NDRGDPCVPVPWEWVTCS-TTTPPRITKIALSGKNLKG 427
QD L ++ + + + + D C W V C T R+ + LSG NL
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 428 --EIPPELKNMEALTELWLDG--NFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSL 483
IP L N+ L L++ G N + P +++L L +++ + ++G++P ++ +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 484 PNLQELHIENNSFVGEIPPAL 504
L L N+ G +PP++
Sbjct: 125 KTLVTLDFSYNALSGTLPPSI 145
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 4e-09
Identities = 19/55 (34%), Positives = 26/55 (47%), Gaps = 1/55 (1%)
Query: 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP-ALLTGKVIFKYDNNPKL 519
L NN + G+LP + L L L++ N+ GEIP L + Y NN L
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 5e-09
Identities = 16/60 (26%), Positives = 26/60 (43%), Gaps = 2/60 (3%)
Query: 443 WLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 501
L N + G LP +++L L +++ N L G +P G+L NN + P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.1 bits (126), Expect = 6e-08
Identities = 23/112 (20%), Positives = 40/112 (35%), Gaps = 11/112 (9%)
Query: 406 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 464
C + S L+ ++P +L L L N +T D L +L
Sbjct: 9 QCHLRV------VQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHT 59
Query: 465 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 516
+ L NN+++ P L L+ L++ N E+P + + N
Sbjct: 60 LILINNKISKISPGAFAPLVKLERLYLSKNQL-KELPEKMPKTLQELRVHEN 110
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.8 bits (94), Expect = 6e-04
Identities = 22/124 (17%), Positives = 41/124 (33%), Gaps = 31/124 (25%)
Query: 411 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF---------------------- 448
PP +T++ L G + LK + L +L L N
Sbjct: 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228
Query: 449 --LTGPLPDMSRLIDLRIVHLENNELTG------SLPSYMGSLPNLQELHIENNSF-VGE 499
L ++ +++V+L NN ++ P Y + + + +N E
Sbjct: 229 NKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288
Query: 500 IPPA 503
I P+
Sbjct: 289 IQPS 292
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 19/84 (22%), Positives = 36/84 (42%), Gaps = 8/84 (9%)
Query: 404 WVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 463
+ PP + ++ +S L E+P L L N L +P++ + +L+
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPELPQ--NLK 327
Query: 464 IVHLENNELTGSLPSYMGSLPNLQ 487
+H+E N L P S+ +L+
Sbjct: 328 QLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 5e-06
Identities = 22/116 (18%), Positives = 37/116 (31%), Gaps = 9/116 (7%)
Query: 391 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 450
+ P + + + EI +L EL + N L
Sbjct: 238 DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 297
Query: 451 GPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF--VGEIPPAL 504
LP + L + N L +P NL++LH+E N +IP ++
Sbjct: 298 E-LPAL--PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.004
Identities = 15/53 (28%), Positives = 26/53 (49%), Gaps = 4/53 (7%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRI 464
PPR+ ++ S +L E+P +N L +L ++ N L + DLR+
Sbjct: 303 PPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 4e-07
Identities = 23/103 (22%), Positives = 38/103 (36%), Gaps = 25/103 (24%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL----------------- 462
L+ K+L + L+ + +T L L N L P ++ L L
Sbjct: 5 LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 463 -----RIVHLENNELTG-SLPSYMGSLPNLQELHIENNSFVGE 499
+ + L NN L + + S P L L+++ NS E
Sbjct: 63 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 18/64 (28%), Positives = 33/64 (51%), Gaps = 3/64 (4%)
Query: 430 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489
L N+ LT L D N ++ + ++ L +L VHL+NN+++ P + + NL +
Sbjct: 166 LTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 490 HIEN 493
+ N
Sbjct: 223 TLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 15/53 (28%), Positives = 28/53 (52%), Gaps = 2/53 (3%)
Query: 454 PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
++ L L + ++N+++ P + SLPNL E+H++NN P A +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTS 217
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 15/75 (20%), Positives = 30/75 (40%), Gaps = 6/75 (8%)
Query: 439 LTELWLDGNFLT-GPLPDM-SRLIDLRIVHLENNELTG----SLPSYMGSLPNLQELHIE 492
+ L + L+ ++ L ++V L++ LT + S + P L EL++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 493 NNSFVGEIPPALLTG 507
+N +L G
Sbjct: 64 SNELGDVGVHCVLQG 78
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 4e-04
Identities = 23/127 (18%), Positives = 39/127 (30%), Gaps = 19/127 (14%)
Query: 395 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP 454
D C P + C+ + L E LTEL+++ L
Sbjct: 3 DACCPHGSSGLRCT-------------RDGAL-DSLHHLPGAENLTELYIENQQHLQHLE 48
Query: 455 D--MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG--KVI 510
+ L +LR + + + L P P L L++ N+ + + G
Sbjct: 49 LRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQE 107
Query: 511 FKYDNNP 517
NP
Sbjct: 108 LVLSGNP 114
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 4/94 (4%)
Query: 427 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 486
+I + L +T + + L + + N+++ + LPN+
Sbjct: 15 KQIFS-DDAFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQG--IQYLPNV 70
Query: 487 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 520
+L + N P A L D N
Sbjct: 71 TKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD 104
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 8e-04
Identities = 16/75 (21%), Positives = 29/75 (38%), Gaps = 2/75 (2%)
Query: 432 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491
E+ + + E+ D LT PD+ + D I+HL N L + + L +L++
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 492 ENNSFVGEIPPALLT 506
+ L
Sbjct: 63 DRAELTKLQVDGTLP 77
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 38.4 bits (88), Expect = 0.003
Identities = 17/135 (12%), Positives = 45/135 (33%), Gaps = 10/135 (7%)
Query: 604 PELEEATNNF-CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI 662
PEL++ + C K +G + Y + + + + +K+ T E ++ +
Sbjct: 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWL 66
Query: 663 HHRNLVP-LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 721
+ VP ++ + + L+ + D + +I A+ +
Sbjct: 67 EGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE--------YEDEQSPEKIIELYAECI 118
Query: 722 EYLHTGCNPGIIHRD 736
H+ + +
Sbjct: 119 RLFHSIDISDCPYTN 133
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 17/112 (15%), Positives = 33/112 (29%), Gaps = 29/112 (25%)
Query: 420 LSGKNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 470
+ GK+LK + L +++ E+ L GN +
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG-------------------T 45
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFK-YDNNPKLHK 521
E L + S +L+ + +++ + PKLH
Sbjct: 46 EAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHT 97
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 931 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.82 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.43 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.22 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.22 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.21 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.13 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.07 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.06 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.04 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.04 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.96 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.91 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.82 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.7 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.62 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.61 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.54 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.53 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.43 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.43 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.37 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.37 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.35 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.34 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.27 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.2 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.18 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.1 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.96 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.8 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.75 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.69 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.64 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.37 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.0 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.87 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.87 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.45 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.17 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.09 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 95.84 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 95.8 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 95.71 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.59 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.1 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 93.71 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 90.23 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 87.63 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=412.00 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=199.3
Q ss_pred HhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
+++.+.||+|+||.||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|+|..++..++||||+++|
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 45678999999999999999989999999997643 33467999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccc
Q 002358 691 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 770 (931)
Q Consensus 691 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 770 (931)
+|.+++.. ....+++..++.++.|||+||+|||+ .+|+||||||+|||+++++.+||+|||+++...........
T Consensus 86 ~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 86 CLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp BHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred cHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999875 34568899999999999999999998 89999999999999999999999999999876655444444
Q ss_pred ccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCC-CCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 771 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 771 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~-~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
...||+.|+|||++.+..++.++|||||||++|||+|+. .|+.... ...+.+.+. .+.. ...|
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i~----~~~~--~~~p------- 224 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDIS----TGFR--LYKP------- 224 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHHH----HTCC--CCCC-------
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHHHH----hcCC--CCCc-------
Confidence 556899999999999999999999999999999999954 4444221 122222222 1211 1111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
.....++.+++.+||+.||++||||+||++.|+++..
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1122367899999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8e-48 Score=418.42 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=214.5
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
+....+++.+.||+|+||+||+|+++ +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 44456777899999999999999987 58899999997553 34567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
|||++|+|.+++... ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 93 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999998754 34678999999999999999999998 89999999999999999999999999999987655
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.........|++.|+|||++.+..++.++|||||||++|||++|..|+.... ....+.+ .+..+...
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~~~~----~i~~~~~~------- 235 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYE----LLEKDYRM------- 235 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHH----HHHTTCCC-------
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHHHHH----HHhcCCCC-------
Confidence 4444445568999999999999999999999999999999999877764221 1112222 22222111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
..+......+.+++.+||+.||++|||++||++.|+.+.
T Consensus 236 --~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 236 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112222346889999999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=409.64 Aligned_cols=260 Identities=30% Similarity=0.522 Sum_probs=202.7
Q ss_pred HHHhhccccCccCcEEEEEEEECCCcEEEEEEccCc--cchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
..+++.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+++|++++|||||+++|++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 34567899999999999999875 36999998654 23456789999999999999999999998865 568999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
|++|+|.+++... ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 85 CEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999743 4569999999999999999999998 8999999999999999999999999999987644322
Q ss_pred -ccccccccCCCccCCCccCC---CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 767 -HISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 767 -~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
.......||+.|||||++.+ ..++.++|||||||++|||+||+.||....... .+. ..+..+... +
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~----~~~~~~~~~----p 229 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QII----FMVGRGYLS----P 229 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHH----HHHHHTSCC----C
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHH----HHHhcCCCC----C
Confidence 23344569999999999864 357899999999999999999999997432211 111 122222111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
.+ ...+...+..+.+++.+||+.+|++|||++||++.|+.+.+.
T Consensus 230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 11 011222334788999999999999999999999999987653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=414.42 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=210.2
Q ss_pred HHHHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
+....+++.+.||+|+||.||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 3345677889999999999999999988999999997543 345679999999999999999999998865 55789999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+++|+|.+++... ....+++..+++++.||++||+|||+ ++|+||||||+||||++++.+||+|||+++...+..
T Consensus 88 y~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999987643 23458999999999999999999998 899999999999999999999999999999876554
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
........||+.|+|||++.+..++.++|||||||++|||+||..|+.... ......+. +..+... ..
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~~~~~~~----i~~~~~~-----~~- 231 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQN----LERGYRM-----VR- 231 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHH----HHTTCCC-----CC-
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CHHHHHHH----HHhcCCC-----CC-
Confidence 444455668999999999998999999999999999999999766654221 11222222 2222111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
+......+.+++.+||+.+|++||||+||++.|++.-
T Consensus 232 ---p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1122346889999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-46 Score=409.81 Aligned_cols=256 Identities=26% Similarity=0.465 Sum_probs=198.8
Q ss_pred HhhccccCccCcEEEEEEEECC-C---cEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~-g---~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
+++.+.||+|+||+||+|+++. + ..||||++..... ...++|.+|+++|++++|||||+++|++.+++..++|||
T Consensus 28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~E 107 (299)
T d1jpaa_ 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 107 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 4445789999999999999863 3 3689999876433 445789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
||++|+|.+++.. ....+++..++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 108 y~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 108 FMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp CCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred ecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999998874 34569999999999999999999998 899999999999999999999999999998765432
Q ss_pred ccc----ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 766 THI----SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 766 ~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||..... ..+...+ ..+...
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i----~~~~~~--- 252 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAI----EQDYRL--- 252 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHH----HTTCCC---
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHH----HcCCCC---
Confidence 211 122357899999999999999999999999999999998 8999974322 1222222 222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
..+.+.+..+.+++.+||+.+|++|||++||++.|++++..
T Consensus 253 ------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 253 ------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11222344688999999999999999999999999988653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=399.17 Aligned_cols=252 Identities=28% Similarity=0.479 Sum_probs=210.7
Q ss_pred HhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCCC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 690 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 690 (931)
+++.++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|+|.+++..++||||+++|
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 457899999999999999999889999999976533 3568999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccccc
Q 002358 691 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 770 (931)
Q Consensus 691 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 770 (931)
+|.+++... ...+++..+++++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++...........
T Consensus 85 ~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 85 CLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp EHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred cHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 999987643 4568899999999999999999998 89999999999999999999999999999876554444444
Q ss_pred ccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCCC
Q 002358 771 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 849 (931)
Q Consensus 771 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~ 849 (931)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+. ..+..+... ..|
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~----~~i~~~~~~--~~p------- 223 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA----EHIAQGLRL--YRP------- 223 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH----HHHHTTCCC--CCC-------
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHH----HHHHhCCCC--CCc-------
Confidence 4568999999999999999999999999999999998 89999744321 122 222222211 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 850 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 850 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
......+.+++.+||+.+|++|||++||++.|.++
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12224688999999999999999999999988753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-46 Score=403.05 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=205.5
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.|++.+.||+|+||+||+|..+ +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++|||||+
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 4677899999999999999875 699999999876544556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 101 gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~- 172 (293)
T d1yhwa1 101 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (293)
T ss_dssp TCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc-
Confidence 9999998763 468999999999999999999998 89999999999999999999999999999876543322
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 848 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~ 848 (931)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .+......+.. .+. .
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~-~~~-------~ 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP-ELQ-------N 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC-CCS-------S
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCCC-CCC-------C
Confidence 334569999999999999999999999999999999999999997433211 11112222111 110 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 849 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 849 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122346789999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=399.20 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=200.3
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 667899999999999999986 68999999986543 2344679999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc-cc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-TH 767 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~-~~ 767 (931)
+|+|.+++. ....+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+|+...... ..
T Consensus 87 gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 87 GGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp TEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999987 35679999999999999999999998 899999999999999999999999999998764432 22
Q ss_pred cccccccCCCccCCCccCCCCC-CccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
......||+.|||||++.+..+ +.++||||+||++|||++|+.||....... .....+ ........ .
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~~~----~~~~~~~~-----~-- 228 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW----KEKKTYLN-----P-- 228 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-HHHHHH----HTTCTTST-----T--
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-HHHHHH----hcCCCCCC-----c--
Confidence 3345679999999999988776 578999999999999999999997433221 111111 11111100 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.......+.+++.+||+.||++|||++|+++
T Consensus 229 --~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 --WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111235778999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=398.92 Aligned_cols=244 Identities=26% Similarity=0.424 Sum_probs=203.8
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|++.+.||+|+||+||+|+++ +++.||+|++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 3677899999999999999986 68999999986432 2234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
||++|+|.+++.. ...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 87 y~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 87 YAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred ecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999974 4568999999999999999999998 899999999999999999999999999998754332
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .. ..+..+.. .+
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~----~~i~~~~~------~~- 223 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TY----KRISRVEF------TF- 223 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH----HHHHTTCC------CC-
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HH----HHHHcCCC------CC-
Confidence 234569999999999999999999999999999999999999997433211 11 11222211 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+.....++.+++.+||+.||++|||++|+++
T Consensus 224 ---p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 ---PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112236789999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=401.63 Aligned_cols=250 Identities=22% Similarity=0.356 Sum_probs=205.3
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||+
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 3667889999999999999986 689999999987666677889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|+|.+++.. ....+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 93 ~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~ 166 (288)
T d2jfla1 93 GGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 166 (288)
T ss_dssp TEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-H
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-c
Confidence 9999998764 24569999999999999999999998 8999999999999999999999999999976543322 2
Q ss_pred ccccccCCCccCCCccC-----CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 769 SSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
.....||+.|+|||++. ...|+.++|||||||++|||++|+.||......+ ... ... .+....+..
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~---~i~-~~~~~~~~~-- 237 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLL---KIA-KSEPPTLAQ-- 237 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH---HHH-HSCCCCCSS--
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHH---HHH-cCCCCCCCc--
Confidence 23456999999999983 4568899999999999999999999997443222 111 111 121111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
+......+.+++.+||+.||++|||++|+++
T Consensus 238 -----~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 -----PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122346789999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=404.91 Aligned_cols=258 Identities=29% Similarity=0.458 Sum_probs=201.9
Q ss_pred HHhhccccCccCcEEEEEEEECCC-----cEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKDG-----KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~g-----~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
.+++.+.||+|+||.||+|.++.. ..||||+++.... ....+|.+|++++++++|||||+++|++.+.+..++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 345678999999999999988742 3799999876433 3456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
|||+.+|++.+.+.. ....+++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 88 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 88 TEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999998765 34679999999999999999999998 8999999999999999999999999999987644
Q ss_pred ccc--ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 764 DLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 764 ~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
... .......||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...+.+. +..+...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~----i~~~~~~---- 232 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKA----INDGFRL---- 232 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHH----HHTTCCC----
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHHH----HhccCCC----
Confidence 322 222334589999999999999999999999999999999997666642221 1122222 2222111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
..+...+..+.+++.+||+.+|++||||+||++.|+++++.
T Consensus 233 -----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 233 -----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11222334688999999999999999999999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=399.97 Aligned_cols=253 Identities=25% Similarity=0.435 Sum_probs=206.3
Q ss_pred hcc-ccCccCcEEEEEEEEC---CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 613 FCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 613 ~~~-~LG~G~fG~Vy~a~~~---~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
+.+ +||+|+||+||+|.++ ++..||||+++.... ...++|.+|+++|++++|||||+++|++.. +..++|||||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 445 4999999999999875 355799999976543 456789999999999999999999999875 4588999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc-
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT- 766 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~- 766 (931)
++|+|.+++.. ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 91 ~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 91 GGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp TTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 99999998864 34579999999999999999999998 8999999999999999999999999999987654332
Q ss_pred -ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 767 -HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 767 -~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
.......||+.|+|||++....++.++|||||||++|||+| |+.||...... .+.. .+..+...+.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~----~i~~~~~~~~----- 233 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGKRMEC----- 233 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH----HHHTTCCCCC-----
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCCCC-----
Confidence 22334458999999999999999999999999999999998 89999743321 2222 2333322211
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
+...+.++.+++.+||+.+|++||||.+|++.|+.....
T Consensus 234 ----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 234 ----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 122234688999999999999999999999999876543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-46 Score=398.22 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=192.9
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEec--CCeEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVY 684 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~~lV~ 684 (931)
.|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+ .+..++||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 3677899999999999999886 68999999986543 2345678999999999999999999999864 45689999
Q ss_pred EecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcC--CCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 685 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
|||++|+|.+++.... ....+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 9999999999986432 3467999999999999999999999721 135999999999999999999999999999876
Q ss_pred cccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+.. .+ ...+..+....+
T Consensus 165 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~----~~~i~~~~~~~~-- 234 (269)
T d2java1 165 NHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---EL----AGKIREGKFRRI-- 234 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH----HHHHHHTCCCCC--
T ss_pred ccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HH----HHHHHcCCCCCC--
Confidence 543322 23456999999999999999999999999999999999999999743321 11 122223332211
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...++ .++.+++.+||+.||++|||++|+++
T Consensus 235 ---~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 ---PYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11222 36889999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=396.70 Aligned_cols=248 Identities=27% Similarity=0.467 Sum_probs=200.0
Q ss_pred cccCccCcEEEEEEEECC---CcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecCC
Q 002358 615 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 689 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~---g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 689 (931)
++||+|+||+||+|.+++ ++.||||+++... ....++|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998753 4689999986532 2345689999999999999999999999965 457899999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc--
Q 002358 690 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-- 767 (931)
Q Consensus 690 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~-- 767 (931)
|+|.++++. ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999984 4569999999999999999999998 89999999999999999999999999999876543322
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+. ..+..+....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~----~~i~~~~~~~-------- 230 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVT----AMLEKGERMG-------- 230 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTCCCC--------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHH----HHHHcCCCCC--------
Confidence 2233468999999999999999999999999999999998 89999743321 222 2233332211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
.+...+..+.+++.+||+.||++|||++||++.|+...
T Consensus 231 -~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 231 -CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 11222346889999999999999999999999887653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=392.06 Aligned_cols=244 Identities=29% Similarity=0.425 Sum_probs=195.3
Q ss_pred hhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEec----CCeEEEEE
Q 002358 612 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 684 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~~~lV~ 684 (931)
++.++||+|+||+||+|.++ +++.||+|++.... ....+.|.+|+++|++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999986 58899999986532 3345679999999999999999999999864 35678999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCC--eEecCCCCCCcccc-CCCceEEecccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQA 761 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--ivH~DIkp~NILld-~~~~vkL~DFGla~~~ 761 (931)
||+++|+|.+++.. ...+++..+..++.||++||+|||+ .+ |+||||||+|||++ +++.+||+|||+++..
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999974 4578999999999999999999997 55 99999999999996 5789999999999864
Q ss_pred cccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
... ......||+.|||||++.+ .++.++|||||||++|||++|+.||..... ...+. +.+..+......+
T Consensus 166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~----~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIY----RRVTSGVKPASFD 235 (270)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHH----HHHTTTCCCGGGG
T ss_pred cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHH----HHHHcCCCCcccC
Confidence 332 2234569999999999876 599999999999999999999999963221 11111 2222222211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+ .++.+++.+||+.||++|||++|+++
T Consensus 236 ----~~~~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 ----KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1112 25789999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=400.12 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=203.8
Q ss_pred HHHHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
...+++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 34578899999999999999999988899999997543 345789999999999999999999999865 5578999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
++|+|...+... ....++|..++.++.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++...+....
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999988753 23468999999999999999999998 89999999999999999999999999999876554444
Q ss_pred cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 768 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
......||+.|+|||++....++.++|||||||++|||++|..|+.... ........+. .+... ..
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~--~~~~~~~~i~----~~~~~-----~~--- 235 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVE----RGYRM-----PC--- 235 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHH----TTCCC-----CC---
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC--CHHHHHHHHH----hcCCC-----CC---
Confidence 4445568999999999999999999999999999999999776664222 1122222222 11111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
+.....++.+++.+||+.||++||+|++|+++|++...
T Consensus 236 -~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 12223468899999999999999999999999998654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=406.96 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=205.9
Q ss_pred HHHHhhccccCccCcEEEEEEEECC-C-----cEEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCe
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKD-G-----KEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 679 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~-g-----~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~ 679 (931)
...+++.++||+|+||+||+|++.. + ..||+|++.... ......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3456788999999999999998753 2 369999986543 33456799999999998 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCC--------------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCC
Q 002358 680 RILVYEYMHNGTLRDRLHGSVN--------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 739 (931)
Q Consensus 680 ~~lV~E~~~~gsL~~~L~~~~~--------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp 739 (931)
.++|||||++|+|.++++.... ...+++..++.++.||++||+|||+ ++|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 9999999999999999975421 2358899999999999999999998 8999999999
Q ss_pred CCccccCCCceEEecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCc
Q 002358 740 SNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDF 817 (931)
Q Consensus 740 ~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~ 817 (931)
+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876544332 2334568999999999999999999999999999999998 8999974333
Q ss_pred cchhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 002358 818 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 883 (931)
Q Consensus 818 ~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 883 (931)
.. .+.+ .+..+... ..+......+.+++.+||+.+|++|||++||++.|..
T Consensus 273 ~~--~~~~----~~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 DA--NFYK----LIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SH--HHHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH--HHHH----HHhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 21 1222 22222111 1122223468899999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=407.04 Aligned_cols=201 Identities=26% Similarity=0.397 Sum_probs=176.9
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
...|++.+.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|+++|++++|||||+++++|.+.++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 445777899999999999999986 68999999987543 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
||++|+|.+++.+ .+.+++..+..++.|+++||.|||+ ..+|+||||||+|||+++++.+||+|||+|+...+..
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 9999999999974 4568999999999999999999997 1489999999999999999999999999998754322
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccC
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 816 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~ 816 (931)
.....||+.|+|||++.+..|+.++||||+||++|||++|+.||...+
T Consensus 160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 234579999999999999999999999999999999999999997543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=392.04 Aligned_cols=260 Identities=25% Similarity=0.403 Sum_probs=200.6
Q ss_pred HHHHhhccccCccCcEEEEEEEECC----CcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
...+++.+.||+|+||.||+|++.. +..||||+++.... ...+.|.+|+++|++++|||||+++|++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 3457788999999999999998753 35689999865433 345679999999999999999999999964 67899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998764 34578999999999999999999998 999999999999999999999999999998765
Q ss_pred ccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeeccc
Q 002358 763 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 841 (931)
Q Consensus 763 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d 841 (931)
...........||+.|+|||.+.+..++.++|||||||++|||++ |..||......+ +... +..+....
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~----i~~~~~~~--- 229 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENGERLP--- 229 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCCCC---
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcCCCCC---
Confidence 544444455668999999999999999999999999999999998 899997443322 2222 22222211
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 002358 842 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 889 (931)
Q Consensus 842 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 889 (931)
. +...+..+.+++.+||+.||++|||++||++.|+.++..++
T Consensus 230 --~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 230 --M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp --C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --C----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 1 12223468899999999999999999999999998876553
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=395.82 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=201.8
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 4778899999999999999986 68999999986432 2234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
||++|+|.+++.. .+.+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 89 y~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 89 YAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999998873 4679999999999999999999998 899999999999999999999999999998765432
Q ss_pred -cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 766 -THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 766 -~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .+. ..+..+.. .+
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~----~~i~~~~~------~~ 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIF----QKIIKLEY------DF 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHTTCC------CC
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHH----HHHHcCCC------CC
Confidence 22233456999999999999999999999999999999999999999743321 111 11222221 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... ..++.+++.+||+.||++|||++|+++
T Consensus 230 p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 PEKF----FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CccC----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1122 236789999999999999999999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-44 Score=392.99 Aligned_cols=246 Identities=28% Similarity=0.385 Sum_probs=200.9
Q ss_pred HHHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
+..|+..+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 345777899999999999999876 688999999865432 3346799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
||||++|+|..++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 94 ~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999999876653 4679999999999999999999998 8999999999999999999999999999986543
Q ss_pred cccccccccccCCCccCCCccCC---CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 840 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~ 840 (931)
. ....||+.|||||++.+ ..|+.++|||||||++|||++|+.||...... +....... +......
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~-~~~~~~~ 235 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ-NESPALQ 235 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-SCCCCCS
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh-CCCCCCC
Confidence 2 23469999999999854 46899999999999999999999999733221 11111121 1111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 841 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 841 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. ..+ ...+.+++.+||+.||++|||++|+++
T Consensus 236 ~----~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 S----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C----CCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 112 236789999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.8e-44 Score=398.20 Aligned_cols=250 Identities=21% Similarity=0.333 Sum_probs=206.3
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.|++.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4778899999999999999986 689999999987666667789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc--CCCceEEeccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld--~~~~vkL~DFGla~~~~~~~~ 766 (931)
+|+|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++.......
T Consensus 107 gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 107 GGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp SCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999864 24569999999999999999999998 9999999999999995 467899999999987654332
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.....||+.|||||++.+..++.++||||+||++|||++|+.||...+..+ ... . +..+... .+....
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~---~-i~~~~~~--~~~~~~- 249 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLR---N-VKSCDWN--MDDSAF- 249 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H-HHHTCCC--SCCGGG-
T ss_pred --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HHH---H-HHhCCCC--CCcccc-
Confidence 234568999999999999999999999999999999999999997443221 111 1 1111110 011111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......+.+++.+||+.||++|||++|+++
T Consensus 250 ---~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 250 ---SGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ---GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112236789999999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-44 Score=393.55 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=189.4
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
..|++.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 44778899999999999999986 68999999987543 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc---CCCceEEecccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld---~~~~vkL~DFGla~~~~~ 763 (931)
|++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+++....
T Consensus 89 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 89 VSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred cCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999973 5679999999999999999999998 8999999999999994 578999999999986543
Q ss_pred cccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 843 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 843 (931)
... .....||+.|||||++.+..++.++||||+||++|||++|+.||...... ..... +..+... ....
T Consensus 163 ~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~----i~~~~~~--~~~~ 231 (307)
T d1a06a_ 163 GSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQ----ILKAEYE--FDSP 231 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH----HHTTCCC--CCTT
T ss_pred CCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHH----HhccCCC--CCCc
Confidence 322 23456999999999999999999999999999999999999999743321 11111 1111110 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 844 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 844 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..... ...+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 232 YWDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11122 236789999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=391.40 Aligned_cols=251 Identities=29% Similarity=0.475 Sum_probs=198.3
Q ss_pred HHhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEec-CCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~~lV~E~~~ 688 (931)
.+++.+.||+|+||.||+|+++ |+.||||+++.. ...+.|.+|++++++++||||++++|+|.+ .+..++||||++
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 3567899999999999999996 789999999754 344679999999999999999999999855 456899999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 768 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 768 (931)
+|+|.+++... ....+++..+++++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 85 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 99999998743 22358999999999999999999998 899999999999999999999999999998654332
Q ss_pred ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccCC
Q 002358 769 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 847 (931)
Q Consensus 769 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~~ 847 (931)
....+++.|+|||++.+..++.++|||||||++|||+| |+.||..... ..+..++ .++...++
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i----~~~~~~~~-------- 221 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV----EKGYKMDA-------- 221 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHH----TTTCCCCC--------
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHH----HcCCCCCC--------
Confidence 23357899999999998999999999999999999998 6777763322 2233332 22222111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 848 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 848 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
+......+.+++.+||+.||++|||++||++.|++++.-
T Consensus 222 -~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 222 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 112223678999999999999999999999999987643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.9e-44 Score=396.59 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=206.7
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.|++.+.||+|+||.||+|... +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++|||||+
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4778899999999999999975 699999999977655566788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc--CCCceEEeccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld--~~~~vkL~DFGla~~~~~~~~ 766 (931)
+|+|.+.+.. ....+++..++.++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++......
T Consensus 110 gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 110 GGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999988764 34569999999999999999999998 9999999999999997 67899999999998765432
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. ..... +..+... ..+....
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~----i~~~~~~--~~~~~~~ 253 (352)
T d1koba_ 184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQN----VKRCDWE--FDEDAFS 253 (352)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHH----HHHCCCC--CCSSTTT
T ss_pred -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCCCC--CCccccc
Confidence 233456899999999999999999999999999999999999999743322 11111 1111110 0111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. ....+.+++.+||+.||++|||++|+++
T Consensus 254 ~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 254 S----VSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp T----SCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred C----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2 2236789999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-44 Score=393.26 Aligned_cols=257 Identities=27% Similarity=0.440 Sum_probs=208.0
Q ss_pred HHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccch-hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
.+++.+.||+|+||+||+|+++ +++.||||+++..... ..++|.+|+++|++++||||++++++|...+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 4667899999999999999875 3578999999765443 45679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC---------------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCC
Q 002358 683 VYEYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 741 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~N 741 (931)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccc
Confidence 999999999999986421 12358899999999999999999998 899999999999
Q ss_pred ccccCCCceEEecccccccccccc-cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCC-CCCCccCccc
Q 002358 742 ILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGA 819 (931)
Q Consensus 742 ILld~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~-~Pf~~~~~~~ 819 (931)
||++.++.+||+|||+++...+.. ........|++.|+|||.+.+..++.++|||||||++|||++|. .||...+.
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~-- 248 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-- 248 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH--
Confidence 999999999999999998654432 22333456889999999999999999999999999999999986 56653322
Q ss_pred hhhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 002358 820 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 885 (931)
Q Consensus 820 ~~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~ 885 (931)
..+.. .+..+....+ +...+..+.+++.+||+.+|++||||.||++.|+++.
T Consensus 249 -~e~~~----~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 -EEVIY----YVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -HHHHH----HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -HHHHH----HHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 12222 2333333221 1122336889999999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=386.67 Aligned_cols=250 Identities=23% Similarity=0.300 Sum_probs=203.1
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc------hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~ 681 (931)
..|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35778899999999999999985 689999999864321 23467999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC----ceEEecccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFGL 757 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~----~vkL~DFGl 757 (931)
+|||||++|+|.+++.. .+.+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999974 4579999999999999999999998 8999999999999998776 499999999
Q ss_pred cccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 758 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 758 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+ ... .+..+...
T Consensus 164 a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~----~i~~~~~~ 234 (293)
T d1jksa_ 164 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA----NVSAVNYE 234 (293)
T ss_dssp CEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHTTCCC
T ss_pred hhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHH----HHHhcCCC
Confidence 987644322 234568999999999999999999999999999999999999997433211 111 11111110
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..+..... ....+.+++.+||+.||++|||++|+++
T Consensus 235 --~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 --FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CCHHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCchhcCC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001111 1236789999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=387.01 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=204.6
Q ss_pred hhccccCccCcEEEEEEEECCC----cEEEEEEccCc-cchhhhhHHHHHHHHHhcCCCCCcceeEEEec-CCeEEEEEE
Q 002358 612 NFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYE 685 (931)
Q Consensus 612 ~~~~~LG~G~fG~Vy~a~~~~g----~~vAvK~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~~lV~E 685 (931)
+|.++||+|+||+||+|.+.++ ..||||+++.. .....++|.+|+++|++++|||||+++|++.. +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 3467899999999999998642 26899998753 34456789999999999999999999999865 568899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
||++|+|.+++.. .....++..+++++.|+++||.|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 110 YMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EeecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999999875 34567888999999999999999998 899999999999999999999999999998764432
Q ss_pred cc---cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 766 TH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 766 ~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
.. ......||+.|+|||.+....++.++||||||+++|||+||+.||..... ...+..++ ..+... ..|
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i----~~g~~~--~~p 256 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYL----LQGRRL--LQP 256 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTCCC--CCC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHH----HcCCCC--CCc
Confidence 22 22334689999999999999999999999999999999998888763221 11222222 222211 111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
......+.+++.+||+.||++||+|+||++.|+++...
T Consensus 257 -------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11234688999999999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=388.00 Aligned_cols=254 Identities=23% Similarity=0.420 Sum_probs=201.4
Q ss_pred HhhccccCccCcEEEEEEEEC-CCc----EEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
|++.++||+|+||+||+|.+. +|+ .||+|+++... ....++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 677899999999999999876 344 58999886543 33467899999999999999999999999875 567889
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
|++.+|+|.+.+.. ....+++..+++++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 90 QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp ECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999999998875 35678999999999999999999998 89999999999999999999999999999876543
Q ss_pred ccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 765 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 765 ~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... +.. .+..+...
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~~~~~----- 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERL----- 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHHTCCC-----
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCCC-----
Confidence 322 2233458999999999999999999999999999999999 788987443322 111 12222111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
..+......+.+++.+||+.+|++|||++||++.|+.+..
T Consensus 233 ----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1112223468899999999999999999999999887754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=388.13 Aligned_cols=245 Identities=24% Similarity=0.365 Sum_probs=203.6
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|++.+.||+|+||.||+|+.+ +|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 667899999999999999986 69999999987532 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
|++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||+++.......
T Consensus 87 ~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 87 ANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred cCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999999884 4568899999999999999999998 9999999999999999999999999999987543322
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
......||+.|+|||++.+..|+.++||||+||++|||++|+.||...+... +. +.+..+.+ .+..
T Consensus 161 -~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~----~~i~~~~~------~~p~ 226 (337)
T d1o6la_ 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF----ELILMEEI------RFPR 226 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHCCC------CCCT
T ss_pred -ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HH----HHHhcCCC------CCCc
Confidence 2334569999999999999999999999999999999999999997544321 11 12222221 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 879 (931)
..+ .++.+++.+||+.||++||+ ++|+++
T Consensus 227 ~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 227 TLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 222 35789999999999999995 777765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=382.38 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=195.8
Q ss_pred HHhhccccCccCcEEEEEEEECC--C--cEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKD--G--KEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~--g--~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~l 682 (931)
.+++.+.||+|+||.||+|+++. + ..||||++.... ....++|.+|+++|++++|||||+++|+|.+ +..++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence 36678999999999999998752 2 378999986542 3345689999999999999999999999976 46789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 762 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~ 762 (931)
||||+++|++.+.+... ...+++..++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999887642 4569999999999999999999998 899999999999999999999999999998765
Q ss_pred ccccc--cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 763 EDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 763 ~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
..... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||...+.. ....++ .+.+...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~~i---~~~~~~~~- 235 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKI---DKEGERLP- 235 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---HTSCCCCC-
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHHHH---HhCCCCCC-
Confidence 44322 2333457889999999999999999999999999999998 89999743322 222222 22221111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 884 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~ 884 (931)
. +...+..+.+++.+||+.||++|||++||++.|++.
T Consensus 236 ----~----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 ----R----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----C----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 112224688999999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-43 Score=383.43 Aligned_cols=266 Identities=26% Similarity=0.378 Sum_probs=201.6
Q ss_pred HhhccccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHH--HHHHHHhcCCCCCcceeEEEecCC----eEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLIGYCEEEH----QRILVY 684 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~--E~~il~~l~HpnIv~l~g~~~~~~----~~~lV~ 684 (931)
+.+.++||+|+||.||+|+++ |+.||||+++... .+.+.+ |+..+.+++|||||++++++.+++ ..++||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 445789999999999999975 8999999986432 233444 444556779999999999997653 578999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcC-----CCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-----NPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
|||++|+|.+++++ ..++|..+++++.|+|.||+|||+.. +++|+||||||+||||++++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999984 35899999999999999999999621 3699999999999999999999999999998
Q ss_pred cccccccc---cccccccCCCccCCCccCCC------CCCccchhHHHHHHHHHHHhCCCCCCccCccch--------hh
Q 002358 760 QAEEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--------LN 822 (931)
Q Consensus 760 ~~~~~~~~---~~~~~~gt~~y~APE~l~~~------~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~--------~~ 822 (931)
........ ......||+.|+|||++.+. .++.++|||||||+||||+||..|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76443322 23345699999999998764 367799999999999999999988753222110 01
Q ss_pred HHHHHHHhhhcCCeeecccccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 823 IVHWARSMIKKGDVISIVDPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 823 l~~~~~~~~~~~~~~~i~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
..+........+. .+|.+.... +.+....+.+++.+||+.||++|||+.||++.|+++...+
T Consensus 237 ~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 1122222222211 122222221 3356677999999999999999999999999999887654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=385.60 Aligned_cols=264 Identities=26% Similarity=0.398 Sum_probs=200.2
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEEecC
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 677 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~ 677 (931)
+....+++.++||+|+||.||+|++. +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 33456778899999999999999864 24689999997643 34456788888888887 689999999988654
Q ss_pred -CeEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcc
Q 002358 678 -HQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 743 (931)
Q Consensus 678 -~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NIL 743 (931)
...++|||||++|+|.++++... ....+++..++.++.||++||+|||+ ++|+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCcccee
Confidence 56899999999999999997532 13458899999999999999999998 89999999999999
Q ss_pred ccCCCceEEecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCC-CCCCccCccchh
Q 002358 744 LDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAEL 821 (931)
Q Consensus 744 ld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~-~Pf~~~~~~~~~ 821 (931)
|++++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||...... .
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~ 244 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E 244 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--H
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--H
Confidence 999999999999999875443322 233456999999999999999999999999999999999975 567533222 1
Q ss_pred hHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 822 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 822 ~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
.+ ...+..+..... +......+.+++.+||+.||++|||++||++.|+++++.
T Consensus 245 ~~----~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 245 EF----CRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HH----HHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HHHHhcCCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 12 222222322211 111223688999999999999999999999999988653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.7e-43 Score=384.43 Aligned_cols=242 Identities=22% Similarity=0.359 Sum_probs=201.9
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 667899999999999999986 68999999986532 23356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
|++|+|...+.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 86 IEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred cCCccccccccc---cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 999999998874 4567888889999999999999998 89999999999999999999999999999876543
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+... .. .+ +..+.. ..
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~---~~-i~~~~~------~~-- 220 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TY---EK-ILNAEL------RF-- 220 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HH-HHHCCC------CC--
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---HH---HH-HHcCCC------CC--
Confidence 234569999999999999999999999999999999999999997433211 11 11 111211 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
+......+.+++.+||+.||++|| +++|+++
T Consensus 221 --p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 221 --PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 111223678999999999999996 8999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=386.76 Aligned_cols=259 Identities=29% Similarity=0.484 Sum_probs=205.4
Q ss_pred HHHhhccccCccCcEEEEEEEECC-Cc--EEEEEEccCcc-chhhhhHHHHHHHHHhc-CCCCCcceeEEEecCCeEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMKD-GK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~~-g~--~vAvK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~~~~~lV 683 (931)
..+++.++||+|+||.||+|++++ |. .||||+++... ....++|.+|+++|+++ +|||||+++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 445678999999999999999874 44 57888876443 33557899999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhccC-------------CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCce
Q 002358 684 YEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 750 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~v 750 (931)
|||+++|+|.++++.. .....+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999999753 134679999999999999999999998 899999999999999999999
Q ss_pred EEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCC-CCCccCccchhhHHHHHHH
Q 002358 751 KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK-PVSVEDFGAELNIVHWARS 829 (931)
Q Consensus 751 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~-Pf~~~~~~~~~~l~~~~~~ 829 (931)
||+|||+++....... .....||..|+|||.+....++.++|||||||++|||++|.. ||...+. ..+.+
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~---- 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE---- 237 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH----
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHH----
Confidence 9999999986543322 223458999999999999999999999999999999999764 5653221 12222
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 830 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
.+..+... .. +......+.+++.+||+.||++||||+||++.|+++....
T Consensus 238 ~i~~~~~~-----~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 238 KLPQGYRL-----EK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HGGGTCCC-----CC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHhcCCC-----CC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 22222111 11 1222346889999999999999999999999999987644
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=384.51 Aligned_cols=264 Identities=28% Similarity=0.421 Sum_probs=212.1
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhc-CCCCCcceeEEEecC
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 677 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~ 677 (931)
+....+++.++||+|+||.||+|++. .++.||||+++.... ....+|.+|+.+++++ +|||||+++|+|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 44456778999999999999999863 457899999976443 3456799999999999 699999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCC---------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCc
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSV---------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 742 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~---------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NI 742 (931)
+..++|||||++|+|.++++... ....+++..+..++.||++||+|||+ ++++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccc
Confidence 99999999999999999987542 23368899999999999999999998 8999999999999
Q ss_pred cccCCCceEEeccccccccccccc-ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhC-CCCCCccCccch
Q 002358 743 LLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAE 820 (931)
Q Consensus 743 Lld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG-~~Pf~~~~~~~~ 820 (931)
|++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|+ .+|+......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999987654332 233445789999999999999999999999999999999995 5555432221
Q ss_pred hhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 821 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 821 ~~l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
..+.+. +..+... ..+......+.+|+.+||+.||++||||+||+++|++.+..
T Consensus 255 ~~~~~~----i~~~~~~---------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 SKFYKM----IKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHH----HHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHH----HhcCCCC---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 112222 2222111 11122234688999999999999999999999999987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-42 Score=375.24 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=200.6
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHHHHHHHHhcCCCCCcceeEEEecCC----eEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRI 681 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~~ 681 (931)
.|++.+.||+|+||+||+|++. +|+.||||+++.... ...+.|.+|++++++++|||||++++++.... ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 4677899999999999999975 689999999975432 33467999999999999999999999987643 478
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
+||||+++|+|.+.+.. .+.+++..++.++.||++||+|||+ .+|+||||||+|||++.++..+|+|||.+...
T Consensus 88 lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence 99999999999998873 4579999999999999999999998 89999999999999999999999999998764
Q ss_pred cccc--cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 762 EEDL--THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 762 ~~~~--~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
.... ........||+.|+|||++.+..++.++||||+||++|||+||+.||...... +...+.+..+....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~~- 234 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPP- 234 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCG-
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCCC-
Confidence 3322 22233456999999999999999999999999999999999999999743321 11222233222111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhh
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSI 885 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~~~ 885 (931)
....... ...+.+++.+||+.||++|| |++|+++.|.++.
T Consensus 235 --~~~~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 --SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --GGTSSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --chhccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0111122 23688999999999999999 8999999888764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-43 Score=382.98 Aligned_cols=261 Identities=25% Similarity=0.437 Sum_probs=207.8
Q ss_pred HHHHhhccccCccCcEEEEEEEECC--------CcEEEEEEccCccc-hhhhhHHHHHHHHHhc-CCCCCcceeEEEecC
Q 002358 608 EATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 677 (931)
Q Consensus 608 ~~~~~~~~~LG~G~fG~Vy~a~~~~--------g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~ 677 (931)
...+++.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3467788999999999999998642 24799999977554 3457889999999888 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccc
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 744 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILl 744 (931)
+..++||||+++|+|.+++.... ....+++..+++++.||++||+|||+ .+|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 99999999999999999997542 13468999999999999999999998 999999999999999
Q ss_pred cCCCceEEecccccccccccccc-cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHh-CCCCCCccCccchhh
Q 002358 745 DINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 822 (931)
Q Consensus 745 d~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLlt-G~~Pf~~~~~~~~~~ 822 (931)
+.++.+||+|||+++........ ......|++.|+|||.+.++.|+.++|||||||++|||++ |..||...... .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H
Confidence 99999999999999876554332 2334568999999999999999999999999999999998 68888633321 2
Q ss_pred HHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 823 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 823 l~~~~~~~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
+ .+.+..+..... ... ....+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 246 ~----~~~i~~~~~~~~-----p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 L----FKLLKEGHRMDK-----PSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp H----HHHHHTTCCCCC-----CSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H----HHHHHcCCCCCC-----Ccc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 2 222333322211 111 223688999999999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.5e-42 Score=370.71 Aligned_cols=249 Identities=26% Similarity=0.316 Sum_probs=201.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---------hhhhhHHHHHHHHHhcC-CCCCcceeEEEecCC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---------HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH 678 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---------~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~ 678 (931)
.|++.+.||+|+||+||+|+.+ +|+.||||+++.... ...+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 4567899999999999999985 689999999865321 12246889999999997 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccc
Q 002358 679 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 758 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla 758 (931)
..++|||||++|+|.++++. .+.+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999974 4579999999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccccccccccCCCccCCCccC------CCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhh
Q 002358 759 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 832 (931)
Q Consensus 759 ~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 832 (931)
+....... .....||+.|+|||.+. ...++.++||||+||++|||++|+.||....... . .+.+.
T Consensus 158 ~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~----~~~i~ 228 (277)
T d1phka_ 158 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---M----LRMIM 228 (277)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHH
T ss_pred eEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---H----HHHHH
Confidence 87654322 23456999999999974 3457889999999999999999999997443211 1 11222
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 833 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 833 ~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+... ...+ . ......++.+++.+||+.+|++|||++||++
T Consensus 229 ~~~~~-~~~~-~----~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGNYQ-FGSP-E----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTCCC-CCTT-T----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCCCC-CCCc-c----cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22211 0001 1 1122236889999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=377.17 Aligned_cols=256 Identities=20% Similarity=0.213 Sum_probs=194.8
Q ss_pred ccccCccCcEEEEEEEEC-CCcEEEEEEccCccch-----hhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 614 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.++||+|+||+||+|+++ +|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999976 6899999998653221 2356899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
.++++..... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9888777665 35668889999999999999999998 99999999999999999999999999999876544322
Q ss_pred cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc---CCeeeccc--
Q 002358 768 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISIVD-- 841 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~~i~d-- 841 (931)
.....||+.|+|||++.. ..++.++||||+||++|||++|+.||......+. ...+.+.... ........
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSST
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccchhccc
Confidence 233468999999998865 4679999999999999999999999974432221 1111111110 00000000
Q ss_pred -cccc---CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 842 -PVLI---GNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 842 -~~l~---~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... ...+ ......+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000 0001 111246889999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=381.87 Aligned_cols=262 Identities=24% Similarity=0.412 Sum_probs=210.3
Q ss_pred HHHHHHhhccccCccCcEEEEEEEEC------CCcEEEEEEccCccc-hhhhhHHHHHHHHHhcCCCCCcceeEEEecCC
Q 002358 606 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 678 (931)
Q Consensus 606 l~~~~~~~~~~LG~G~fG~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~ 678 (931)
+....+++.+.||+|+||.||+|.++ +++.||||+++.... .....|.+|++++++++|||||+++|+|..++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 33455678899999999999999874 257899999976433 34467999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC-------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceE
Q 002358 679 QRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 751 (931)
Q Consensus 679 ~~~lV~E~~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vk 751 (931)
..++||||+++|+|.+++.... ....+++..+.+++.|+++||.|||+ ++|+||||||+|||++.++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEE
Confidence 9999999999999999876421 23457899999999999999999998 8999999999999999999999
Q ss_pred Eeccccccccccccccc-ccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCC-CCCCccCccchhhHHHHHHH
Q 002358 752 VSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARS 829 (931)
Q Consensus 752 L~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~-~Pf~~~~~~~~~~l~~~~~~ 829 (931)
|+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||. .||..... .+...
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~- 246 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLR- 246 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHH-
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHH-
Confidence 99999998765443322 23345899999999999999999999999999999999985 66653221 11111
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 002358 830 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 886 (931)
Q Consensus 830 ~~~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~ 886 (931)
.+..+..... +......+.+++.+||+.+|++||||+||++.|++.+.
T Consensus 247 ~i~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 247 FVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHhCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2222222111 11122468899999999999999999999999987644
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-42 Score=382.84 Aligned_cols=243 Identities=23% Similarity=0.305 Sum_probs=202.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 685 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E 685 (931)
.|++.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 4677899999999999999986 69999999986432 2234578999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccc
Q 002358 686 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 765 (931)
Q Consensus 686 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~ 765 (931)
|+.+|+|.+.+.. .+.+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999874 4568999999999999999999998 89999999999999999999999999999876533
Q ss_pred cccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeeccccccc
Q 002358 766 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 845 (931)
Q Consensus 766 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~ 845 (931)
.....||+.|||||++.+..++.++|||||||++|||++|+.||...+.. .... .+..+.. ...
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~----~i~~~~~------~~p 258 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYE----KIVSGKV------RFP 258 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------CCC
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HHHH----HHhcCCC------CCC
Confidence 23456999999999999999999999999999999999999999743321 1111 1222211 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002358 846 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 879 (931)
Q Consensus 846 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 879 (931)
... ...+.+++.+||+.||++|+ +++|+++
T Consensus 259 ~~~----s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 SHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ccC----CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 122 23678999999999999994 8999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=380.42 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=200.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc---chhhhhHHHHHHHHH-hcCCCCCcceeEEEecCCeEEEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLS-RIHHRNLVPLIGYCEEEHQRILVY 684 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~il~-~l~HpnIv~l~g~~~~~~~~~lV~ 684 (931)
.|++.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+..|..++. .++|||||++++++.+++..++||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 3667899999999999999986 68999999996532 223455677777765 689999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
|||++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 83 Ey~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 83 EYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999974 4568899999999999999999998 89999999999999999999999999999865443
Q ss_pred ccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccc
Q 002358 765 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 844 (931)
Q Consensus 765 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l 844 (931)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+... + ...+..+.. ..
T Consensus 157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~----~~~i~~~~~------~~ 222 (320)
T d1xjda_ 157 DAK-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---L----FHSIRMDNP------FY 222 (320)
T ss_dssp TCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHCCC------CC
T ss_pred ccc-ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---H----HHHHHcCCC------CC
Confidence 322 334569999999999999999999999999999999999999997443221 1 112222221 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 002358 845 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL 879 (931)
Q Consensus 845 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl~ 879 (931)
.... ..++.+++.+||+.||++||+++ |+++
T Consensus 223 p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 PRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1122 23578999999999999999996 6753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.6e-42 Score=382.36 Aligned_cols=246 Identities=22% Similarity=0.275 Sum_probs=195.6
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc---hhhhhHHH---HHHHHHhcCCCCCcceeEEEecCCeEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVT---EVALLSRIHHRNLVPLIGYCEEEHQRILV 683 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~---E~~il~~l~HpnIv~l~g~~~~~~~~~lV 683 (931)
|++.+.||+|+||.||+|+.+ +|+.||||++..... .....+.+ |+++++.++|||||++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 567899999999999999986 689999999864321 11223444 46667777899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccc
Q 002358 684 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 763 (931)
Q Consensus 684 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~ 763 (931)
||||++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 mE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp ECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999974 4568899999999999999999998 9999999999999999999999999999987654
Q ss_pred cccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc
Q 002358 764 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 842 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 842 (931)
.. .....||+.|+|||++.. ..++.++|||||||++|||+||+.||..........+. +...... .
T Consensus 160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~~~------~ 226 (364)
T d1omwa3 160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTMA------V 226 (364)
T ss_dssp SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSSSCC------C
T ss_pred Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhcccCC------C
Confidence 32 234569999999999865 56899999999999999999999999754433322211 1111111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002358 843 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 879 (931)
Q Consensus 843 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 879 (931)
......+ ..+.+++.+||+.||++||| ++|+++
T Consensus 227 ~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111222 35789999999999999999 577764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=374.08 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=202.0
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEecC
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 688 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 688 (931)
.|++.+.||+|+||+||+|.++ +|+.||||+++... .+...+.+|+++|++++|||||++++++.+++..++|||||+
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 3677899999999999999986 68899999997643 344568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCC--CceEEeccccccccccccc
Q 002358 689 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 689 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~--~~vkL~DFGla~~~~~~~~ 766 (931)
+|+|.+++... ...+++..+..++.||++||+|||+ ++|+||||||+|||++.+ ..+||+|||+++.......
T Consensus 85 gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 85 GLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999742 3468999999999999999999998 999999999999999854 5799999999987543322
Q ss_pred ccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccccccC
Q 002358 767 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 846 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~l~~ 846 (931)
.....||+.|+|||.+.+..++.++||||+||++|||++|+.||......+ ... . +..+... ++.....
T Consensus 160 --~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~---~-i~~~~~~--~~~~~~~ 228 (321)
T d1tkia_ 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIE---N-IMNAEYT--FDEEAFK 228 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---H-HHHTCCC--CCHHHHT
T ss_pred --ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHhCCCC--CChhhcc
Confidence 233458999999999999999999999999999999999999997443211 111 1 1111110 0111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 847 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 847 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.. ..++.+++.+||+.||++|||++|+++
T Consensus 229 ~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 EI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 235789999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=376.32 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=194.9
Q ss_pred HHhhc-cccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhc-CCCCCcceeEEEec----CCeEEE
Q 002358 610 TNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRIL 682 (931)
Q Consensus 610 ~~~~~-~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~----~~~~~l 682 (931)
.|++. +.||+|+||+||+|++. +++.||||+++.. +.+.+|++++.++ +|||||++++++.+ +...++
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 35554 56999999999999875 6899999998642 4577899987655 89999999999865 467899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC---CCceEEecccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSR 759 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~---~~~vkL~DFGla~ 759 (931)
|||||+||+|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||+++ ++.+||+|||+++
T Consensus 87 vmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence 99999999999999743 34579999999999999999999998 99999999999999985 5679999999998
Q ss_pred cccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 760 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 760 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
....... .....||+.|+|||++.+..|+.++|||||||++|||+||+.||........ ...+...+..+..
T Consensus 163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~~--- 234 (335)
T d2ozaa1 163 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQY--- 234 (335)
T ss_dssp ECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS---
T ss_pred eccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCCC---
Confidence 7654322 2345699999999999999999999999999999999999999974332211 1111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+..........++.+++.+||+.||++|||++|+++
T Consensus 235 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 ---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000001122346889999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.4e-41 Score=367.27 Aligned_cols=260 Identities=18% Similarity=0.257 Sum_probs=198.1
Q ss_pred HHhhccccCccCcEEEEEEEECCCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.|++.++||+|+||+||+|++++|+.||||+++.... ...+.+.+|+.+|++++|||||++++++...+..++++|++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 3566789999999999999999999999999865432 23468999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 767 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~~ 767 (931)
.++.+..+.. ..+.+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 83 DQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp SEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred hhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 8877777665 35679999999999999999999998 89999999999999999999999999999876443222
Q ss_pred cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcC---Cee---e--
Q 002358 768 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVI---S-- 838 (931)
Q Consensus 768 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~---~~~---~-- 838 (931)
.....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.. ..+....... ... .
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 157 -YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGST
T ss_pred -cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH---HHHHHhhCCCChhhccchhhhh
Confidence 233458999999999865 45689999999999999999999999744322111 1111111000 000 0
Q ss_pred -------cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 839 -------IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 839 -------i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
...+.............+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000111112246789999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-41 Score=367.89 Aligned_cols=259 Identities=21% Similarity=0.299 Sum_probs=195.9
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc--hhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
.|++.+.||+|+||+||+|++. +|+.||||+++.... ...+++.+|+++|++++|||||++++++.++...++||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 3566789999999999999975 689999999865432 2356799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+.++ +.+.+... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 83 LHQD-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CSEE-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred cCCc-hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9755 44444322 35679999999999999999999998 8999999999999999999999999999987644332
Q ss_pred ccccccccCCCccCCCccCCCC-CCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeecccc---
Q 002358 767 HISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP--- 842 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~-~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i~d~--- 842 (931)
......||+.|+|||.+.... ++.++||||+||++|||++|+.||...+..+. +.. +.... +...+...+
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~-i~~~~--~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFR-IFRTL--GTPDEVVWPGVT 231 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHH--CCCCTTTSTTGG
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHH-HHHhc--CCCchhhccccc
Confidence 233446999999999876655 57899999999999999999999974432211 111 11110 000000000
Q ss_pred ---cccCC------CC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 843 ---VLIGN------VK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 843 ---~l~~~------~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
..... .+ .....++.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000 00 111246789999999999999999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=365.16 Aligned_cols=238 Identities=25% Similarity=0.400 Sum_probs=194.0
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccc------hhhhhHHHHHHHHHhcC--CCCCcceeEEEecCCeE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQR 680 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~il~~l~--HpnIv~l~g~~~~~~~~ 680 (931)
.|++.+.||+|+||+||+|+.. +|+.||||++..... ....++.+|+.+|++++ |||||++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 4677899999999999999976 689999999864321 12345778999999996 89999999999999999
Q ss_pred EEEEEecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC-CCceEEeccccc
Q 002358 681 ILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLS 758 (931)
Q Consensus 681 ~lV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~-~~~vkL~DFGla 758 (931)
++||||+.+ +++.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 85 ~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 999999976 688888763 4578999999999999999999998 99999999999999985 579999999999
Q ss_pred ccccccccccccccccCCCccCCCccCCCCC-CccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee
Q 002358 759 RQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 837 (931)
Q Consensus 759 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 837 (931)
+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+ .+ .+ +..
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i-------~~-~~~- 221 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-------IR-GQV- 221 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-------HH-CCC-
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH-------hh-ccc-
Confidence 865432 2334569999999999977665 567899999999999999999997321 11 11 111
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......+ .++.+++.+||+.||++|||++|+++
T Consensus 222 -----~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -----FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -----CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111222 36789999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=364.16 Aligned_cols=264 Identities=20% Similarity=0.250 Sum_probs=195.9
Q ss_pred HHHhhccccCccCcEEEEEEEEC-C-CcEEEEEEccCccc--hhhhhHHHHHHHHHhc---CCCCCcceeEEEec-----
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEE----- 676 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~-g~~vAvK~~~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~g~~~~----- 676 (931)
..|++.++||+|+||+||+|++. + ++.||||+++.... .....+.+|+.+|+.| +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 35677899999999999999974 4 56799999865322 2334677888888776 79999999999853
Q ss_pred CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccc
Q 002358 677 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 756 (931)
Q Consensus 677 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFG 756 (931)
....+++||+++++.+...... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence 3567899999998877655442 45678999999999999999999998 899999999999999999999999999
Q ss_pred ccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 757 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 757 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..+....+............
T Consensus 162 ~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 988654332 234456999999999999999999999999999999999999999754432221111111000000000
Q ss_pred e------eccc----ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 837 I------SIVD----PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 837 ~------~i~d----~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. .... ..............+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 0000 00000111112235778999999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-39 Score=352.71 Aligned_cols=262 Identities=16% Similarity=0.198 Sum_probs=209.9
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCC-CCCcceeEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~~~~~~lV~E~~ 687 (931)
.|++.+.||+|+||+||+|++. +|+.||||++... ...+.+.+|++.++.++| +|++.+++++..+...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 4677899999999999999976 6899999987543 234568889999999975 89999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccC-----CCceEEeccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAE 762 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~-----~~~vkL~DFGla~~~~ 762 (931)
+++|.+.+... ...+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+++...
T Consensus 84 -~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 -GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 78999988753 4568999999999999999999998 99999999999999964 5789999999998764
Q ss_pred ccccc------cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCe
Q 002358 763 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 836 (931)
Q Consensus 763 ~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 836 (931)
..... ......||+.|||||++.+..++.++|||||||++|||++|+.||..............+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 43211 123456999999999999999999999999999999999999999865554433333322222211111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 002358 837 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 888 (931)
Q Consensus 837 ~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 888 (931)
.+ +....+ .++.+++..|+..+|++||+++.+.+.|+++....
T Consensus 238 ~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 238 RE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HH-----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 11 111222 36889999999999999999999999999876543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=358.57 Aligned_cols=265 Identities=18% Similarity=0.224 Sum_probs=193.9
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEec--------C
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------E 677 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------~ 677 (931)
..|++.++||+|+||+||+|+++ +|+.||||++.... ....+++.+|+++|++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 35677899999999999999985 79999999986432 2334678999999999999999999998855 3
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccc
Q 002358 678 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 757 (931)
Q Consensus 678 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGl 757 (931)
...++||||+.++.+..... ....++...+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 46789999998877765544 35668889999999999999999998 8999999999999999999999999999
Q ss_pred ccccccccc---ccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc
Q 002358 758 SRQAEEDLT---HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 833 (931)
Q Consensus 758 a~~~~~~~~---~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 833 (931)
++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.....................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 976543221 122334689999999998765 6899999999999999999999999744332222211111110000
Q ss_pred CCeeeccccc--------ccCCCCHH-H------HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 834 GDVISIVDPV--------LIGNVKIE-S------IWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 834 ~~~~~i~d~~--------l~~~~~~~-~------~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.......... ........ . ...+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0000000000 00000111 0 124678999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-39 Score=352.16 Aligned_cols=260 Identities=22% Similarity=0.293 Sum_probs=198.6
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcce-eEEEecCCeEEEEEEec
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-IGYCEEEHQRILVYEYM 687 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l-~g~~~~~~~~~lV~E~~ 687 (931)
.|++.+.||+|+||.||+|++. +|+.||||++.... ..+++.+|++++++++|+|++.. .++..+.+..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4678899999999999999875 68999999976542 33568899999999987765555 55557778889999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCcccc---CCCceEEeccccccccccc
Q 002358 688 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 688 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld---~~~~vkL~DFGla~~~~~~ 764 (931)
+++|.+.+.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+++.....
T Consensus 86 -~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 86 -GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp -CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred -CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 5667666553 34678999999999999999999998 9999999999999875 4667999999999876543
Q ss_pred ccc------cccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHH-HHHHHhhhcCCee
Q 002358 765 LTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HWARSMIKKGDVI 837 (931)
Q Consensus 765 ~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~-~~~~~~~~~~~~~ 837 (931)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ .+...... ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~- 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI- 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCH-
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CCh-
Confidence 221 223456999999999999999999999999999999999999999754433222211 11111111 111
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 002358 838 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 887 (931)
Q Consensus 838 ~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~~~~~ 887 (931)
+.+....+ .++.+++.+||+.+|++||+++++.+.|++....
T Consensus 238 ----~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 238 ----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ----HHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----hHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 11111222 3688999999999999999999999999887553
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=363.35 Aligned_cols=261 Identities=25% Similarity=0.255 Sum_probs=192.0
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCCcceeEEEec------CCeEEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQRIL 682 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~~~l 682 (931)
+|+..++||+|+||+||+|+++ +|+.||||++.... ..+.+|+++|++++||||+++++++.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4566789999999999999986 68999999986542 233479999999999999999999854 235789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC-ceEEecccccccc
Q 002358 683 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQA 761 (931)
Q Consensus 683 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~ 761 (931)
|||||+++.+............+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999876544443322345679999999999999999999998 9999999999999999775 8999999999876
Q ss_pred cccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHH-H--------HHHHhh
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-H--------WARSMI 831 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~-~--------~~~~~~ 831 (931)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+ . +.....
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 44322 233468999999998764 57899999999999999999999999744322211110 0 000000
Q ss_pred ---hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 832 ---KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 832 ---~~~~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.......................++.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011100000001111122336789999999999999999999885
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=355.03 Aligned_cols=258 Identities=21% Similarity=0.298 Sum_probs=192.5
Q ss_pred HhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc-chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC----eEEEEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVY 684 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~----~~~lV~ 684 (931)
|++.+.||+|+||+||+|..+ +|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 667899999999999999875 79999999997543 344568999999999999999999999986543 234555
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 764 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~ 764 (931)
+++.+|+|.+++.. ..+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 90 THLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 67779999999973 358999999999999999999998 89999999999999999999999999999875443
Q ss_pred ccc--cccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCee----
Q 002358 765 LTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI---- 837 (931)
Q Consensus 765 ~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~---- 837 (931)
... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+........ .......
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~ 239 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI---LGSPSQEDLNC 239 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH---HCSCCHHHHHT
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh---ccCCChhhhhh
Confidence 222 2344568999999999854 56788999999999999999999999754432211111110 0000000
Q ss_pred -------e--cccccccCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 838 -------S--IVDPVLIGNVKI-----ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 838 -------~--i~d~~l~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
. ...+.. ...+. ....++.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 240 IINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000 00000 11125789999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=355.79 Aligned_cols=262 Identities=22% Similarity=0.309 Sum_probs=192.6
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCC------eE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 680 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~------~~ 680 (931)
.|++.+.||+|+||+||+|..+ +|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+ +.
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 5667899999999999999976 69999999997532 234567899999999999999999999997654 57
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+ +++|....+ ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence 9999999 667888775 3469999999999999999999998 9999999999999999999999999999987
Q ss_pred ccccccccccccccCCCccCCCccCC-CCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHh-----hhcC
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-----IKKG 834 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~-----~~~~ 834 (931)
..... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.............. ....
T Consensus 171 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 65432 33568999999999865 45789999999999999999999999754332211111100000 0000
Q ss_pred C----------eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhh
Q 002358 835 D----------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDS 884 (931)
Q Consensus 835 ~----------~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~--L~~~ 884 (931)
. ..+.....+. .........+.+++.+||+.||++|||++|+++. ++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred cchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0 0000000000 0011112356799999999999999999999863 4443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-39 Score=353.95 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=199.9
Q ss_pred HhhccccCccCcEEEEEEEEC----CCcEEEEEEccCcc----chhhhhHHHHHHHHHhcCC-CCCcceeEEEecCCeEE
Q 002358 611 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRI 681 (931)
Q Consensus 611 ~~~~~~LG~G~fG~Vy~a~~~----~g~~vAvK~~~~~~----~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~~~~~~ 681 (931)
|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 778899999999999999863 47899999986532 2234678899999999976 89999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
++|||+.+|+|.+++.. ...+....+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999874 3456788889999999999999998 89999999999999999999999999999876
Q ss_pred cccccccccccccCCCccCCCccCCC--CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcCCeeec
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 839 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~i 839 (931)
............|++.|+|||.+.+. .++.++||||+||+||||++|+.||...........+. ..... ..
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~~-~~---- 252 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILK-SE---- 252 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHH-CC----
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhccc-CC----
Confidence 55544444556799999999998654 46889999999999999999999997554433221111 11111 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002358 840 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 879 (931)
Q Consensus 840 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 879 (931)
+.. +.....++.+++.+||+.||++||+ ++|+++
T Consensus 253 --~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 --PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --CCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111 1122346889999999999999995 778764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=344.34 Aligned_cols=261 Identities=20% Similarity=0.254 Sum_probs=200.3
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecCCeEEEEEEe
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 686 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 686 (931)
.|++.++||+|+||+||+|++. +|+.||||+++... ....+++.+|+.+|+.++||||+++++++.+....++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 3567899999999999999986 68999999986443 23457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccccccccc
Q 002358 687 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 766 (931)
Q Consensus 687 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~~~~~~ 766 (931)
+.+++|..++. ..+.+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||.++.......
T Consensus 83 ~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 83 CDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ccccccccccc---cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99999988876 45678899999999999999999998 8999999999999999999999999999987654332
Q ss_pred ccccccccCCCccCCCccCCCC-CCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhc---CCee---ec
Q 002358 767 HISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVI---SI 839 (931)
Q Consensus 767 ~~~~~~~gt~~y~APE~l~~~~-~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~~~---~i 839 (931)
. .....+++.|+|||.+.... ++.++||||+||++|||++|+.||..... ......-+...... .... ..
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp C-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred c-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 2 22334778999999887654 68999999999999999999999752221 11111111111110 0000 00
Q ss_pred cc---------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 840 VD---------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 840 ~d---------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.+ ..-...........+.+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000111122235789999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.4e-38 Score=345.96 Aligned_cols=257 Identities=19% Similarity=0.278 Sum_probs=193.7
Q ss_pred HHHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CCCCcceeEEEec--CCeEEEEE
Q 002358 609 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEE--EHQRILVY 684 (931)
Q Consensus 609 ~~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~~~lV~ 684 (931)
..|++.++||+|+||+||+|+.. +|+.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 35778899999999999999985 6899999998753 3457889999999995 9999999999874 45689999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC-ceEEecccccccccc
Q 002358 685 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEE 763 (931)
Q Consensus 685 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~-~vkL~DFGla~~~~~ 763 (931)
|||.+|+|.... +.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987653 358899999999999999999998 9999999999999998655 689999999987654
Q ss_pred cccccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchh--h---------HHHHHHHhh
Q 002358 764 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--N---------IVHWARSMI 831 (931)
Q Consensus 764 ~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~--~---------l~~~~~~~~ 831 (931)
... .....||+.|+|||.+.+. .++.++||||+||+++||++|+.||......... . ...|.....
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 322 2344689999999997765 5799999999999999999999999743322110 0 111111100
Q ss_pred hcCC--eeeccc--------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 832 KKGD--VISIVD--------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 832 ~~~~--~~~i~d--------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.... ...... .............++.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000000 00000011112235789999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-37 Score=343.42 Aligned_cols=259 Identities=22% Similarity=0.276 Sum_probs=187.5
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEec------CCeE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQR 680 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~~ 680 (931)
.|++.++||+|+||+||+|.++ +|+.||||++.... ....+.+.+|+.++++++|||||++++++.. ....
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 3667889999999999999987 69999999997543 2344678999999999999999999999853 4678
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEeccccccc
Q 002358 681 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 681 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
++||||+.++.+ +.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+++.
T Consensus 98 ~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 98 YLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence 999999976544 4443 347899999999999999999998 8999999999999999999999999999876
Q ss_pred ccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHH-H--------------
Q 002358 761 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-H-------------- 825 (931)
Q Consensus 761 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~-~-------------- 825 (931)
..... ......||+.|+|||++.+..++.++||||+||+++||++|+.||...+.......+ .
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 54322 223446899999999999999999999999999999999999999754322111100 0
Q ss_pred -HHHHhhhcC-C-----eeecccccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 826 -WARSMIKKG-D-----VISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 826 -~~~~~~~~~-~-----~~~i~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
......... . ............. .......+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000001100 0 0001111111111 1223456889999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=345.33 Aligned_cols=255 Identities=20% Similarity=0.303 Sum_probs=191.4
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCcc--chhhhhHHHHHHHHHhcCCCCCcceeEEEecC-----CeEE
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI 681 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-----~~~~ 681 (931)
.|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++... ...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 4777899999999999999875 69999999997543 23456789999999999999999999998632 3446
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEecccccccc
Q 002358 682 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 761 (931)
Q Consensus 682 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~DFGla~~~ 761 (931)
++++++.+|+|.+++. .+.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++...
T Consensus 99 ~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp EEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhccc
Confidence 7778888999999986 3469999999999999999999998 89999999999999999999999999998765
Q ss_pred cccccccccccccCCCccCCCccCCC-CCCccchhHHHHHHHHHHHhCCCCCCccCccchhhHHHHHHHhhhcC------
Q 002358 762 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------ 834 (931)
Q Consensus 762 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------ 834 (931)
... .....|++.|+|||.+.+. .++.++||||+||++|+|++|+.||...+.......+ .......
T Consensus 172 ~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i---~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 172 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGAELLK 244 (348)
T ss_dssp TGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCHHHHT
T ss_pred Ccc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCChHHhh
Confidence 432 2334588999999987665 5688999999999999999999999754332211111 1110000
Q ss_pred ------------CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002358 835 ------------DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 879 (931)
Q Consensus 835 ------------~~~~i~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 879 (931)
.........+.. ........+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000000000 00011235789999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-34 Score=319.56 Aligned_cols=268 Identities=20% Similarity=0.287 Sum_probs=191.7
Q ss_pred HHhhccccCccCcEEEEEEEEC-CCcEEEEEEccCccchhhhhHHHHHHHHHhcC-----------CCCCcceeEEEec-
Q 002358 610 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----------HRNLVPLIGYCEE- 676 (931)
Q Consensus 610 ~~~~~~~LG~G~fG~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~g~~~~- 676 (931)
.|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4788999999999999999985 69999999997543 23457788999988875 5789999988754
Q ss_pred -CCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCC------c
Q 002358 677 -EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM------R 749 (931)
Q Consensus 677 -~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~------~ 749 (931)
....+++++++..+..............+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 34566777776555433332222345678889999999999999999997 47899999999999998665 3
Q ss_pred eEEecccccccccccccccccccccCCCccCCCccCCCCCCccchhHHHHHHHHHHHhCCCCCCccCccchh----hHHH
Q 002358 750 AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL----NIVH 825 (931)
Q Consensus 750 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvlL~eLltG~~Pf~~~~~~~~~----~l~~ 825 (931)
++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||......... .+..
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 999999998764332 23456899999999999999999999999999999999999999744332111 1111
Q ss_pred HHHHhhhc--------C----------Ceeecccc----------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 002358 826 WARSMIKK--------G----------DVISIVDP----------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 877 (931)
Q Consensus 826 ~~~~~~~~--------~----------~~~~i~d~----------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev 877 (931)
.+. .+.. + .....+.. .............+.+++.+||+.||++|||++|+
T Consensus 247 ~~~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 247 IIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHH-HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111 0000 0 00000000 00112234556688999999999999999999999
Q ss_pred HHH--HHhhh
Q 002358 878 VLA--IQDSI 885 (931)
Q Consensus 878 l~~--L~~~~ 885 (931)
++. +++..
T Consensus 326 L~Hp~f~~~~ 335 (362)
T d1q8ya_ 326 VNHPWLKDTL 335 (362)
T ss_dssp HTCGGGTTCT
T ss_pred hcCcccCCCC
Confidence 763 44443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.82 E-value=3.1e-21 Score=195.02 Aligned_cols=162 Identities=15% Similarity=0.152 Sum_probs=119.7
Q ss_pred hccccCccCcEEEEEEEECCCcEEEEEEccCccc------------------hhhhhHHHHHHHHHhcCCCCCcceeEEE
Q 002358 613 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 674 (931)
Q Consensus 613 ~~~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~------------------~~~~~~~~E~~il~~l~HpnIv~l~g~~ 674 (931)
+.++||+|+||+||+|+..+|+.||||+++.... .....+.+|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 5689999999999999999999999998753211 0123356788999999999999988654
Q ss_pred ecCCeEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCCeEecCCCCCCccccCCCceEEec
Q 002358 675 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 754 (931)
Q Consensus 675 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH~DIkp~NILld~~~~vkL~D 754 (931)
. .+++|||++++.+.+ ++......++.|++++|+|||+ .+|+||||||+|||++++ .++|+|
T Consensus 84 ~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 G----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp T----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred C----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence 2 379999998765433 2233456789999999999998 899999999999999865 589999
Q ss_pred ccccccccccccccccccccCCCccCC------CccCCCCCCccchhHHHHHHH
Q 002358 755 FGLSRQAEEDLTHISSVARGTVGYLDP------EYYGNQQLTEKSDVYSFGVVL 802 (931)
Q Consensus 755 FGla~~~~~~~~~~~~~~~gt~~y~AP------E~l~~~~~s~ksDVwSlGvlL 802 (931)
||++....++... .|... |. ....|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9999765433211 01110 11 135678899999975443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.72 E-value=2.6e-18 Score=186.86 Aligned_cols=151 Identities=26% Similarity=0.489 Sum_probs=130.3
Q ss_pred CchhhHHHHHHHHhhcCC-CCCCCCC-CCCCCCCCCceEEeeCCC-CCcEEEEEeCCCCCcc--cCCccccCccccceec
Q 002358 369 TEWQDVMVLEALRSISDE-SERTNDR-GDPCVPVPWEWVTCSTTT-PPRITKIALSGKNLKG--EIPPELKNMEALTELW 443 (931)
Q Consensus 369 t~~~d~~~L~~l~~~~~~-~~~~~w~-~dpc~~~~w~~v~c~~~~-~~~l~~L~L~~n~l~g--~ip~~~~~L~~L~~L~ 443 (931)
+.++|.+||.++|+.+.+ ....+|. +..||.+.|.||+|+... ..||++|+|++|+++| .+|++|++|++|++|+
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~ 82 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccc
Confidence 578999999999998865 3456775 445556689999998653 4589999999999998 5899999999999999
Q ss_pred ccC-CcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccccccccCCCCCCCccccc--CceeeeecCCCCc
Q 002358 444 LDG-NFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (931)
Q Consensus 444 Ls~-N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~ 519 (931)
|++ |+++|.+| +|++|++|++|+|++|+|+|..|..+.++.+|+.+++++|++.+.+|..+.. .+..+.+++|...
T Consensus 83 Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~ 162 (313)
T d1ogqa_ 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162 (313)
T ss_dssp EEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCE
T ss_pred cccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccccc
Confidence 997 89999998 6999999999999999999999999999999999999999999999988765 5666777777643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.43 E-value=6.1e-14 Score=140.72 Aligned_cols=122 Identities=19% Similarity=0.217 Sum_probs=104.0
Q ss_pred CCCceEEeeCC--------CCCcEEEEEeCCCCCcccCC-ccccCccccceecccCCcCCCCCC-CccccccccEeecCC
Q 002358 400 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN 469 (931)
Q Consensus 400 ~~w~~v~c~~~--------~~~~l~~L~L~~n~l~g~ip-~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~ 469 (931)
|.|..|.|+.. -+++++.|+|++|.|++.++ ..|+++++|+.|+|++|++.+.++ .+..+++|+.|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 35777778643 24589999999999987664 567999999999999999999998 589999999999999
Q ss_pred ccccCCCCCccCCccccccccccccCCCCCCCccccc---CceeeeecCCCCcccc
Q 002358 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 470 N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~~~~~---~~~~l~~~~N~~~c~~ 522 (931)
|+|++..|+.|.++++|+.|+|++|+|+ .||+..+. .+..+.+.+|++.|..
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ccccccCHHHHhCCCcccccccCCcccc-ccCHHHhcCCccccccccccccccccc
Confidence 9999666778999999999999999999 67766554 6778899999998753
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.22 E-value=1e-12 Score=141.92 Aligned_cols=109 Identities=26% Similarity=0.307 Sum_probs=99.4
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~ 493 (931)
....++++++.+.|.+|..++.+++|+.|++++|.+++.+|+++.+++|+.|+|++|+|+|.+|++|++|++|+.|+|++
T Consensus 198 ~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~ 277 (313)
T d1ogqa_ 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence 34579999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCccc-ccCceeeeecCCCCcccc
Q 002358 494 NSFVGEIPPAL-LTGKVIFKYDNNPKLHKE 522 (931)
Q Consensus 494 N~l~g~iP~~~-~~~~~~l~~~~N~~~c~~ 522 (931)
|+|+|.||..- +..+..+.+.+|+.+|+.
T Consensus 278 N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp SEEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred CcccccCCCcccCCCCCHHHhCCCccccCC
Confidence 99999999742 236667888999998864
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=9e-12 Score=120.27 Aligned_cols=103 Identities=18% Similarity=0.184 Sum_probs=87.3
Q ss_pred EEeCCCCCcccCCccccCccccceecccCCc-CCCCCC-CccccccccEeecCCccccCCCCCccCCccccccccccccC
Q 002358 418 IALSGKNLKGEIPPELKNMEALTELWLDGNF-LTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 495 (931)
Q Consensus 418 L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~-l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~ 495 (931)
++++++++. .+|..+..+++|+.|+|++|+ |+...+ .|.+|++|+.|+|++|+|+..-|..|..+++|+.|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 455566676 778889999999999998764 887766 59999999999999999995556779999999999999999
Q ss_pred CCCCCCccccc--CceeeeecCCCCcccc
Q 002358 496 FVGEIPPALLT--GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 496 l~g~iP~~~~~--~~~~l~~~~N~~~c~~ 522 (931)
|+ .+|...+. .+..+.+++||+.|..
T Consensus 92 l~-~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 92 LE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp CS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred Cc-ccChhhhccccccccccCCCcccCCc
Confidence 99 89988775 6678889999998864
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.21 E-value=7.9e-12 Score=115.76 Aligned_cols=98 Identities=26% Similarity=0.354 Sum_probs=80.9
Q ss_pred EEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccccccCC
Q 002358 417 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 496 (931)
Q Consensus 417 ~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l 496 (931)
.|+|++|+|+ .++ .+++|++|++|+|++|+|+..++.++.+++|+.|+|++|+|+ .+|+ ++++++|+.|++++|++
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRL 77 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccCc-cccccccCeEECCCCcc
Confidence 6899999998 666 489999999999999999876667999999999999999999 6664 88999999999999999
Q ss_pred CCCCCc--ccc--cCceeeeecCCCCc
Q 002358 497 VGEIPP--ALL--TGKVIFKYDNNPKL 519 (931)
Q Consensus 497 ~g~iP~--~~~--~~~~~l~~~~N~~~ 519 (931)
+ .+|. .+. ..+..+.+++|+..
T Consensus 78 ~-~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 78 Q-QSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp C-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred C-CCCCchhhcCCCCCCEEECCCCcCC
Confidence 8 5654 232 26677888888753
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.13 E-value=4.9e-11 Score=125.46 Aligned_cols=110 Identities=27% Similarity=0.325 Sum_probs=100.4
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++++.|+|++|.+.+..+..+..+.+|+.|++++|.+++..+. +..+++|+.|++++|+|++..|+.++.+++|+.|+
T Consensus 99 l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~ 178 (266)
T d1p9ag_ 99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178 (266)
T ss_dssp CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred ccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceee
Confidence 46899999999999977778899999999999999999998885 78899999999999999977778899999999999
Q ss_pred ccccCCCCCCCccccc--CceeeeecCCCCcccc
Q 002358 491 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 522 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~c~~ 522 (931)
|++|+|+ .||++++. .+..+.+++|||.|+.
T Consensus 179 Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 9999999 99998875 6778999999999974
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.07 E-value=5.1e-11 Score=110.17 Aligned_cols=82 Identities=28% Similarity=0.363 Sum_probs=76.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCC--CccCCcccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQELH 490 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP--~~l~~l~~L~~l~ 490 (931)
.+|++|+|++|.|+ .+|+.|+.+++|+.|+|++|+|++. |++.++++|+.|++++|+++ .+| ..++.+++|+.|+
T Consensus 20 ~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L~ 96 (124)
T d1dcea3 20 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLN 96 (124)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEEE
T ss_pred CCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCccC-CCCCchhhcCCCCCCEEE
Confidence 58999999999998 8999999999999999999999975 67999999999999999999 555 4689999999999
Q ss_pred ccccCCC
Q 002358 491 IENNSFV 497 (931)
Q Consensus 491 l~~N~l~ 497 (931)
+++|+++
T Consensus 97 l~~N~i~ 103 (124)
T d1dcea3 97 LQGNSLC 103 (124)
T ss_dssp CTTSGGG
T ss_pred CCCCcCC
Confidence 9999998
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.06 E-value=5.3e-11 Score=126.33 Aligned_cols=110 Identities=19% Similarity=0.246 Sum_probs=97.3
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
...++.|++++|+|++..+..|..+++|+.|+|++|+|++.++ .|.++++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence 3579999999999996666778999999999999999999888 589999999999999999988899999999999999
Q ss_pred ccccCCCCCCCccccc--CceeeeecCCCCccc
Q 002358 491 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHK 521 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~c~ 521 (931)
+++|++.+..|..+.. .+..+.+++||+.|.
T Consensus 208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred ccccccccccccccccccccCEEEecCCCCCCC
Confidence 9999999544444433 678889999999985
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.04 E-value=3.4e-11 Score=120.26 Aligned_cols=90 Identities=22% Similarity=0.353 Sum_probs=82.9
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++|+.|+|++|++.+..+..+..+++|+.|+|++|+|++.+|. |.+|++|+.|+|++|+|++..|+.|..+++|+.|+
T Consensus 53 l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~ 132 (192)
T d1w8aa_ 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccc
Confidence 46899999999999989999999999999999999999999984 99999999999999999976677899999999999
Q ss_pred ccccCCCCCCC
Q 002358 491 IENNSFVGEIP 501 (931)
Q Consensus 491 l~~N~l~g~iP 501 (931)
|++|.+.+..+
T Consensus 133 L~~N~~~~~~~ 143 (192)
T d1w8aa_ 133 LASNPFNCNCH 143 (192)
T ss_dssp CTTCCBCCSGG
T ss_pred ccccccccccc
Confidence 99999985544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.04 E-value=6.5e-11 Score=114.83 Aligned_cols=102 Identities=23% Similarity=0.275 Sum_probs=87.8
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCc-cCCccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHI 491 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~-l~~l~~L~~l~l 491 (931)
.++++|+|++|+|+ .||..+..+++|+.|+|++|+|+.. +.+..+++|+.|+|++|+++ .+|+. +..+++|+.|+|
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhccccccc-CCCcccccccccccccee
Confidence 47999999999999 7887778899999999999999965 77999999999999999999 56655 567999999999
Q ss_pred cccCCCCCCCc--cc--ccCceeeeecCCCC
Q 002358 492 ENNSFVGEIPP--AL--LTGKVIFKYDNNPK 518 (931)
Q Consensus 492 ~~N~l~g~iP~--~~--~~~~~~l~~~~N~~ 518 (931)
++|+++ .+++ .+ +..+..+.+.+||.
T Consensus 95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 95 TNNSLV-ELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGG
T ss_pred cccccc-ccccccccccccccchhhcCCCcc
Confidence 999998 6664 22 23677888999975
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.96 E-value=3.7e-10 Score=120.76 Aligned_cols=107 Identities=23% Similarity=0.304 Sum_probs=96.7
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++++.|+|++|.+.+..+..|.+++.++.|++++|.+++..+ .+.++++|+.|+|++|+|+ .||++|.++++|+.|+
T Consensus 170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~ 248 (305)
T d1xkua_ 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248 (305)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEE
Confidence 3589999999999999999999999999999999999999988 5899999999999999999 8999999999999999
Q ss_pred ccccCCCCCCCccccc---------CceeeeecCCCCcc
Q 002358 491 IENNSFVGEIPPALLT---------GKVIFKYDNNPKLH 520 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~---------~~~~l~~~~N~~~c 520 (931)
|++|+|+ .|+...+. .+..+.+.+||+.+
T Consensus 249 Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 249 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 9999999 88765432 46678889999865
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.91 E-value=5.9e-10 Score=116.95 Aligned_cols=103 Identities=29% Similarity=0.260 Sum_probs=83.4
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
+++++.|+|++|.|++..+..|.+|++|+.|+|++|+|+. +|.++.+++|+.|+|++|+|+ .+|..+.++++|+.|++
T Consensus 30 p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CcCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-ccccccccccccccccccccc-ccccccccccccccccc
Confidence 3579999999999996556779999999999999999985 456788999999999999999 67888899999999999
Q ss_pred cccCCCCCCCccccc---CceeeeecCCC
Q 002358 492 ENNSFVGEIPPALLT---GKVIFKYDNNP 517 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~---~~~~l~~~~N~ 517 (931)
++|.+. .++...+. ....+.+.+|.
T Consensus 108 ~~~~~~-~~~~~~~~~l~~l~~L~l~~n~ 135 (266)
T d1p9ag_ 108 SFNRLT-SLPLGALRGLGELQELYLKGNE 135 (266)
T ss_dssp CSSCCC-CCCSSTTTTCTTCCEEECTTSC
T ss_pred cccccc-eeeccccccccccccccccccc
Confidence 999988 56555443 44556666664
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.82 E-value=1.5e-09 Score=104.34 Aligned_cols=102 Identities=23% Similarity=0.241 Sum_probs=86.8
Q ss_pred CCCCCCCCceEEeeCC----------CCCcEEEEEeCCCC-CcccCCccccCccccceecccCCcCCCCCCC-ccccccc
Q 002358 395 DPCVPVPWEWVTCSTT----------TPPRITKIALSGKN-LKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDL 462 (931)
Q Consensus 395 dpc~~~~w~~v~c~~~----------~~~~l~~L~L~~n~-l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L 462 (931)
+.|.+..++++.|+.. ..+++++|+|++|+ |+..-+..|.+|++|+.|+|++|+|+.+.|. |.++++|
T Consensus 3 ~~C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L 82 (156)
T d2ifga3 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82 (156)
T ss_dssp SSSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC
T ss_pred CCCCcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccc
Confidence 5687778889999752 23588999998775 8844456799999999999999999999885 9999999
Q ss_pred cEeecCCccccCCCCCccCCccccccccccccCCC
Q 002358 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 497 (931)
Q Consensus 463 ~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~ 497 (931)
+.|+|++|+|+ .+|..+....+|+.|+|++|.|.
T Consensus 83 ~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 99999999999 88887666668999999999985
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.70 E-value=2.4e-09 Score=103.46 Aligned_cols=86 Identities=22% Similarity=0.242 Sum_probs=76.7
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCC-ccccccccEeecCCccccCCCCC--ccCCccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQEL 489 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~--~l~~l~~L~~l 489 (931)
++|+.|+|++|.|+ .++ .|..|++|+.|+|++|+|+...+. +..+++|+.|+|++|+++ .+++ .+..+++|+.|
T Consensus 41 ~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L 117 (162)
T d1a9na_ 41 DQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 117 (162)
T ss_dssp TCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred ccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccchh
Confidence 57999999999999 664 589999999999999999998886 578999999999999999 6664 68899999999
Q ss_pred cccccCCCCCCCc
Q 002358 490 HIENNSFVGEIPP 502 (931)
Q Consensus 490 ~l~~N~l~g~iP~ 502 (931)
++++|.++ .+|.
T Consensus 118 ~l~~N~i~-~~~~ 129 (162)
T d1a9na_ 118 CILRNPVT-NKKH 129 (162)
T ss_dssp ECCSSGGG-GSTT
T ss_pred hcCCCccc-cccc
Confidence 99999998 5653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=2.2e-08 Score=105.53 Aligned_cols=108 Identities=19% Similarity=0.190 Sum_probs=94.6
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCcccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~ 490 (931)
.++++.|+|++|++.+..+..+..+++|+.|++++|+|++.++ .|..+++|+.|+|++|+|++..|..+.++++|+.|+
T Consensus 104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence 3589999999999997777789999999999999999999888 488999999999999999977778899999999999
Q ss_pred ccccCCCCCCCccccc--CceeeeecCCCCc
Q 002358 491 IENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~--~~~~l~~~~N~~~ 519 (931)
+++|++++..|..+.. .+..+.+++|...
T Consensus 184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~ 214 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred hhhccccccChhHhhhhhhcccccccccccc
Confidence 9999999766766653 6677888888654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.61 E-value=2.3e-08 Score=106.37 Aligned_cols=95 Identities=23% Similarity=0.305 Sum_probs=51.2
Q ss_pred EeCCCCCcccCCccccCccccceecccCCcCCCCCC-CccccccccEeecCCccccCCCCCccCCccccccccccccCCC
Q 002358 419 ALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 497 (931)
Q Consensus 419 ~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~N~l~ 497 (931)
+-++++|+ .+|..|. ++|++|+|++|+|+..++ +|.++++|+.|++++|.++...|..|.+|++|+.|++++|+++
T Consensus 16 ~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~ 92 (305)
T d1xkua_ 16 QCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92 (305)
T ss_dssp ECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS
T ss_pred EecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC
Confidence 33344455 5555443 455556666666555555 3555556666666666655444555555566666666666655
Q ss_pred CCCCcccccCceeeeecCCC
Q 002358 498 GEIPPALLTGKVIFKYDNNP 517 (931)
Q Consensus 498 g~iP~~~~~~~~~l~~~~N~ 517 (931)
.+|......+..+....|.
T Consensus 93 -~l~~~~~~~l~~L~~~~n~ 111 (305)
T d1xkua_ 93 -ELPEKMPKTLQELRVHENE 111 (305)
T ss_dssp -BCCSSCCTTCCEEECCSSC
T ss_pred -cCccchhhhhhhhhccccc
Confidence 5555554444444444443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.54 E-value=8.5e-10 Score=110.48 Aligned_cols=103 Identities=25% Similarity=0.233 Sum_probs=84.9
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
..+|+.|+|++|+|+ .++ .|.+|++|+.|+|++|+|+...+-+..+++|+.|+|++|+++ .++ .+..+++|+.|+|
T Consensus 47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEE
T ss_pred ccccceeECcccCCC-Ccc-cccCCccccChhhccccccccccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 468999999999998 676 599999999999999999865433556778999999999999 565 4888999999999
Q ss_pred cccCCCCCCCc--cc--ccCceeeeecCCCCc
Q 002358 492 ENNSFVGEIPP--AL--LTGKVIFKYDNNPKL 519 (931)
Q Consensus 492 ~~N~l~g~iP~--~~--~~~~~~l~~~~N~~~ 519 (931)
++|+++ .+++ .+ +..+..+.+++||..
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccchhc-cccccccccCCCccceeecCCCccc
Confidence 999998 6653 22 236788899999743
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.53 E-value=5e-08 Score=97.22 Aligned_cols=99 Identities=23% Similarity=0.336 Sum_probs=56.4
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~ 493 (931)
++++|+|++|+++ .++ .+..|++|++|+|++|+|++..| +++|++|+.|++++|.+. .+|. ++++++|+.|++++
T Consensus 41 ~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~ 115 (199)
T d2omxa2 41 QVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFN 115 (199)
T ss_dssp TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCS
T ss_pred CCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc-ccCCcccccccccccccc-cccc-cccccccccccccc
Confidence 5666666666665 343 35666666666666666665443 666666666666666665 4443 56666666666666
Q ss_pred cCCCCCCCcccccCceeeeecCCC
Q 002358 494 NSFVGEIPPALLTGKVIFKYDNNP 517 (931)
Q Consensus 494 N~l~g~iP~~~~~~~~~l~~~~N~ 517 (931)
|.+....+-.-+..+..+.+++|.
T Consensus 116 ~~~~~~~~~~~l~~L~~L~l~~n~ 139 (199)
T d2omxa2 116 NQITDIDPLKNLTNLNRLELSSNT 139 (199)
T ss_dssp SCCCCCGGGTTCTTCSEEECCSSC
T ss_pred cccccccccchhhhhHHhhhhhhh
Confidence 666532221222344455555553
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.43 E-value=4.6e-08 Score=106.97 Aligned_cols=79 Identities=23% Similarity=0.309 Sum_probs=37.5
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~ 493 (931)
.+..+++..|.+.+ ...+..+++|+.|+|++|+|++.. .+..+++|+.|+|++|+|+ .+| .+++|++|+.|+|++
T Consensus 286 ~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~ 360 (384)
T d2omza2 286 ALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGH 360 (384)
T ss_dssp TCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCS
T ss_pred cccccccccccccc--ccccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCC
Confidence 34444445554442 123444455555555555554432 2444555555555555554 233 344555555555555
Q ss_pred cCCC
Q 002358 494 NSFV 497 (931)
Q Consensus 494 N~l~ 497 (931)
|+|+
T Consensus 361 N~l~ 364 (384)
T d2omza2 361 NQIS 364 (384)
T ss_dssp SCCC
T ss_pred CcCC
Confidence 5555
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.43 E-value=1.3e-07 Score=94.91 Aligned_cols=79 Identities=25% Similarity=0.463 Sum_probs=45.0
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~ 493 (931)
+++.|++++|+++ .++ .+..|++|++|+|++|+|++. +.+++|++|+.|+|++|+++ .+| .+.++++|+.|++++
T Consensus 47 ~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~l-~~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 47 SIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDI-KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEH 121 (210)
T ss_dssp TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTT
T ss_pred CccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccCc-cccccCcccccccccccccc-ccc-ccccccccccccccc
Confidence 4556666666655 233 255566666666666666553 23555666666666666665 344 355566666666666
Q ss_pred cCCC
Q 002358 494 NSFV 497 (931)
Q Consensus 494 N~l~ 497 (931)
|.+.
T Consensus 122 ~~~~ 125 (210)
T d1h6ta2 122 NGIS 125 (210)
T ss_dssp SCCC
T ss_pred cccc
Confidence 6554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.37 E-value=1.3e-07 Score=103.21 Aligned_cols=78 Identities=15% Similarity=0.371 Sum_probs=68.4
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++++.|+|++|++++ ++ .+..|++|+.|+|++|+|++ ++.+.+|++|+.|+|++|+|++.+| +++|++|+.|+|
T Consensus 306 ~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L 380 (384)
T d2omza2 306 LKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380 (384)
T ss_dssp CTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEEC
T ss_pred hcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeC
Confidence 3578999999999995 44 38999999999999999987 4579999999999999999996544 899999999999
Q ss_pred ccc
Q 002358 492 ENN 494 (931)
Q Consensus 492 ~~N 494 (931)
++|
T Consensus 381 ~~N 383 (384)
T d2omza2 381 NDQ 383 (384)
T ss_dssp CCE
T ss_pred CCC
Confidence 998
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.37 E-value=1.9e-07 Score=93.73 Aligned_cols=101 Identities=29% Similarity=0.416 Sum_probs=72.1
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
.++|++|+|++|++++ ++ .+++|++|+.|+|++|+|++ +|.+.++++|+.|++++|.+. .++ .+..+++|+.+++
T Consensus 67 l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYL 141 (210)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEEC
T ss_pred CCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-ccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 3578888888888884 44 46888888888888888876 456888888888888888876 444 4677777788888
Q ss_pred cccCCCCCCCcccccCceeeeecCCC
Q 002358 492 ENNSFVGEIPPALLTGKVIFKYDNNP 517 (931)
Q Consensus 492 ~~N~l~g~iP~~~~~~~~~l~~~~N~ 517 (931)
++|.+++..+..-+..+..+.+++|.
T Consensus 142 ~~n~l~~~~~~~~l~~L~~l~l~~n~ 167 (210)
T d1h6ta2 142 GNNKITDITVLSRLTKLDTLSLEDNQ 167 (210)
T ss_dssp CSSCCCCCGGGGGCTTCSEEECCSSC
T ss_pred cccccccccccccccccccccccccc
Confidence 88777732222233455666666664
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.35 E-value=1.2e-07 Score=96.33 Aligned_cols=75 Identities=21% Similarity=0.395 Sum_probs=42.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~ 492 (931)
++++.|++++|.+.+ ++ .+++|++|+.|+|++|++++ +|.+.++++|+.|+|++|+|+ .+|. ++++++|+.|+|+
T Consensus 151 ~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt-~i~~-l~~l~~L~~L~ls 225 (227)
T d1h6ua2 151 TNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLT 225 (227)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCC-BCGG-GTTCTTCCEEEEE
T ss_pred ccccccccccccccc-ch-hhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCC-CCcc-cccCCCCCEEEee
Confidence 355666666665552 22 25566666666666666654 334556666666666666666 3442 5566666666654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.34 E-value=1.8e-07 Score=95.74 Aligned_cols=102 Identities=21% Similarity=0.258 Sum_probs=83.1
Q ss_pred CCCceEEeeCCC--------CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCC--CccccccccEeecC-
Q 002358 400 VPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLE- 468 (931)
Q Consensus 400 ~~w~~v~c~~~~--------~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p--~~~~l~~L~~L~L~- 468 (931)
|....+.|+... +.++++|+|++|.|+...+..|.+|++|++|+|++|.+...+| .|.++++++.|.+.
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 355678887532 3479999999999984444568999999999999999998776 48899999999876
Q ss_pred CccccCCCCCccCCccccccccccccCCCCCCCc
Q 002358 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 502 (931)
Q Consensus 469 ~N~l~g~iP~~l~~l~~L~~l~l~~N~l~g~iP~ 502 (931)
.|++....|..+.++++|+.|++++|++. .+|.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~-~~~~ 120 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPD 120 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCC-SCCC
T ss_pred cccccccccccccccccccccccchhhhc-cccc
Confidence 47788677778999999999999999998 4544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.27 E-value=4.7e-07 Score=89.93 Aligned_cols=99 Identities=26% Similarity=0.441 Sum_probs=67.2
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~ 492 (931)
++|+.|+|++|.+++ +++ |++|++|+.|++++|.+... +.+.++++|+.|++++|.+.. ++ .+..+++|+.|+++
T Consensus 62 ~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~~~~~~-~~-~~~~l~~L~~L~l~ 136 (199)
T d2omxa2 62 NNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADI-TPLANLTNLTGLTLFNNQITD-ID-PLKNLTNLNRLELS 136 (199)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECC
T ss_pred CCcCcCccccccccC-ccc-ccCCcccccccccccccccc-ccccccccccccccccccccc-cc-ccchhhhhHHhhhh
Confidence 578888888888874 443 78888888888888877654 357777788888888777763 32 36677778888888
Q ss_pred ccCCCCCCCcc-cccCceeeeecCCC
Q 002358 493 NNSFVGEIPPA-LLTGKVIFKYDNNP 517 (931)
Q Consensus 493 ~N~l~g~iP~~-~~~~~~~l~~~~N~ 517 (931)
+|++. .+|.- -...+..+.+.+|.
T Consensus 137 ~n~l~-~~~~l~~~~~L~~L~l~~n~ 161 (199)
T d2omxa2 137 SNTIS-DISALSGLTSLQQLNFSSNQ 161 (199)
T ss_dssp SSCCC-CCGGGTTCTTCSEEECCSSC
T ss_pred hhhhc-cccccccccccccccccccc
Confidence 88776 45431 12245555555553
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.20 E-value=1.5e-08 Score=101.15 Aligned_cols=83 Identities=22% Similarity=0.421 Sum_probs=74.1
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCC--CccCCcccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQELH 490 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP--~~l~~l~~L~~l~ 490 (931)
++|+.|+|++|.|+ .+|..+..+++|+.|+|++|+|+.. +.+.++++|+.|+|++|+++ .++ ..++.|++|+.|+
T Consensus 70 ~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 146 (198)
T d1m9la_ 70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLL 146 (198)
T ss_dssp TTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEE
T ss_pred ccccChhhcccccc-ccccccccccccccccccccccccc-ccccccccccccccccchhc-cccccccccCCCccceee
Confidence 48999999999998 7887777788999999999999974 56899999999999999999 666 4689999999999
Q ss_pred ccccCCCC
Q 002358 491 IENNSFVG 498 (931)
Q Consensus 491 l~~N~l~g 498 (931)
|++|++..
T Consensus 147 L~~N~l~~ 154 (198)
T d1m9la_ 147 LAGNPLYN 154 (198)
T ss_dssp ECSSHHHH
T ss_pred cCCCcccc
Confidence 99999873
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.18 E-value=6.6e-07 Score=90.61 Aligned_cols=96 Identities=20% Similarity=0.363 Sum_probs=76.8
Q ss_pred CcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCcccccccccc
Q 002358 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~ 492 (931)
+.+..+.++++.+... ..+.++++|+.|++++|.+++.. .++++++|+.|+|++|+++ .+|. +++|++|+.|+|+
T Consensus 129 ~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls 203 (227)
T d1h6ua2 129 SNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLK 203 (227)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECT
T ss_pred cchhhhhchhhhhchh--hhhccccccccccccccccccch-hhcccccceecccCCCccC-CChh-hcCCCCCCEEECc
Confidence 5778889999888743 34788999999999999998654 4899999999999999999 5665 8999999999999
Q ss_pred ccCCCCCCCc-ccccCceeeeec
Q 002358 493 NNSFVGEIPP-ALLTGKVIFKYD 514 (931)
Q Consensus 493 ~N~l~g~iP~-~~~~~~~~l~~~ 514 (931)
+|+++ .+|+ .-+..+..+.++
T Consensus 204 ~N~lt-~i~~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 204 NNQIS-DVSPLANTSNLFIVTLT 225 (227)
T ss_dssp TSCCC-BCGGGTTCTTCCEEEEE
T ss_pred CCcCC-CCcccccCCCCCEEEee
Confidence 99999 6764 223355555543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.10 E-value=4.5e-06 Score=85.94 Aligned_cols=136 Identities=14% Similarity=0.093 Sum_probs=95.0
Q ss_pred cccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcC-CCCCcceeEEEecCCeEEEEEEecCCCCHH
Q 002358 615 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLR 693 (931)
Q Consensus 615 ~~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 693 (931)
+..+.++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.+....+..++||++++|.++.
T Consensus 20 ~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~ 98 (263)
T d1j7la_ 20 KDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred EcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccc
Confidence 3333344568998865 46778888876554445556888999988874 333667788888888899999999998886
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc----------------------------------------------
Q 002358 694 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG---------------------------------------------- 727 (931)
Q Consensus 694 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~---------------------------------------------- 727 (931)
+..... .....++.++++.++.||+.
T Consensus 99 ~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (263)
T d1j7la_ 99 EEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp HHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHH
T ss_pred cccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHH
Confidence 654311 11233455666666666641
Q ss_pred ----------CCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 728 ----------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 728 ----------~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
....++|+|+.|.|||+++++..-|.||+.+.
T Consensus 171 ~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237999999999999987667799999775
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.96 E-value=5.4e-06 Score=88.49 Aligned_cols=91 Identities=26% Similarity=0.348 Sum_probs=49.5
Q ss_pred cEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l~~ 493 (931)
+++.|+|++|+|+ .+|+. +++|++|+|++|+|+.. |+. +.+|+.|++++|+++ .+++- .+.|++|++++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~l-p~~--~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTEL-PEL--PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSC-CCC--CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCccc-ccc--hhhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence 4556667776666 56643 34566666777766633 321 345666666666666 44431 12466666666
Q ss_pred cCCCCCCCccc-ccCceeeeecCC
Q 002358 494 NSFVGEIPPAL-LTGKVIFKYDNN 516 (931)
Q Consensus 494 N~l~g~iP~~~-~~~~~~l~~~~N 516 (931)
|.++ .+|... ...+..+.+.+|
T Consensus 108 n~l~-~lp~~~~l~~L~~L~l~~~ 130 (353)
T d1jl5a_ 108 NQLE-KLPELQNSSFLKIIDVDNN 130 (353)
T ss_dssp SCCS-SCCCCTTCTTCCEEECCSS
T ss_pred cccc-cccchhhhccceeeccccc
Confidence 6666 555421 124444444444
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.80 E-value=1.8e-05 Score=80.90 Aligned_cols=130 Identities=17% Similarity=0.116 Sum_probs=85.7
Q ss_pred ccCccCc-EEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCC--CCCcceeEEEecCCeEEEEEEecCCCCH
Q 002358 616 KIGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGTL 692 (931)
Q Consensus 616 ~LG~G~f-G~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL 692 (931)
.+..|.. +.||+...+++..+++|..... ....+.+|...++.+.. -.+.+++++..+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 6799999888888999986543 23457788888887743 3356678888888889999999987654
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhh----------------------------------------------
Q 002358 693 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT---------------------------------------------- 726 (931)
Q Consensus 693 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~---------------------------------------------- 726 (931)
.+.. .. ....+.++++.|+-||+
T Consensus 94 ~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 2210 00 01112223333333332
Q ss_pred -----c----CCCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 727 -----G----CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 727 -----~----~~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
. ....++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12347999999999999987767899999764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.75 E-value=1.6e-05 Score=84.75 Aligned_cols=82 Identities=28% Similarity=0.478 Sum_probs=67.7
Q ss_pred CCcEEEEEeCCCCCcccCCccccCccccceecccCCcCCCCCCCccccccccEeecCCccccCCCCCccCCccccccccc
Q 002358 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (931)
Q Consensus 412 ~~~l~~L~L~~n~l~g~ip~~~~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~l~l 491 (931)
+++|++|+|++|+|+ .+|..+ .+|+.|++++|+++.. +.+. +.|+.|+|++|+++ .+|. ++.+++|+.|++
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~~lp--~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-SDLP--PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV 127 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-CSCC--TTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchh-hhhc--cccccccccccccc-cccc-hhhhccceeecc
Confidence 468999999999999 899765 4688889999998754 3332 46999999999999 7886 688999999999
Q ss_pred cccCCCCCCCcc
Q 002358 492 ENNSFVGEIPPA 503 (931)
Q Consensus 492 ~~N~l~g~iP~~ 503 (931)
++|.++ ..|..
T Consensus 128 ~~~~~~-~~~~~ 138 (353)
T d1jl5a_ 128 DNNSLK-KLPDL 138 (353)
T ss_dssp CSSCCS-CCCCC
T ss_pred cccccc-ccccc
Confidence 999998 55543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.69 E-value=2.2e-06 Score=82.01 Aligned_cols=73 Identities=25% Similarity=0.214 Sum_probs=52.1
Q ss_pred cCCccccCccccceecccCCcCCCCCC--C-ccccccccEeecCCccccCCCCC-ccCCccccccccccccCCCCCCC
Q 002358 428 EIPPELKNMEALTELWLDGNFLTGPLP--D-MSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIP 501 (931)
Q Consensus 428 ~ip~~~~~L~~L~~L~Ls~N~l~g~~p--~-~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~~l~l~~N~l~g~iP 501 (931)
.++..+.++++|+.|+|++|+|+..-+ . +..+++|+.|+|++|+++ .+++ ......+|+.|++++|.++....
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence 444445678888888888888887643 2 667888888888888888 5655 22234468888888888875444
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.64 E-value=4.3e-05 Score=77.25 Aligned_cols=96 Identities=16% Similarity=0.123 Sum_probs=48.4
Q ss_pred cEEEEEeCCCCCcccCCccccCcc-ccceecccCCcCCCCCCCcccccccc-EeecCCccccCCCCC-ccCCcccccccc
Q 002358 414 RITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLR-IVHLENNELTGSLPS-YMGSLPNLQELH 490 (931)
Q Consensus 414 ~l~~L~L~~n~l~g~ip~~~~~L~-~L~~L~Ls~N~l~g~~p~~~~l~~L~-~L~L~~N~l~g~iP~-~l~~l~~L~~l~ 490 (931)
.+..+..+++++...-+..+..++ .++.|++++|+++...+...++.+++ .+++++|+|+ .||. .+.++++|+.|+
T Consensus 129 ~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~ 207 (242)
T d1xwdc1 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILD 207 (242)
T ss_dssp CEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEE
T ss_pred ccccccccccccccccccccccccccceeeecccccccccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEE
Confidence 455555555555533334444443 55556666666655444433333333 2344555555 4443 345566666666
Q ss_pred ccccCCCCCCCcccccCceee
Q 002358 491 IENNSFVGEIPPALLTGKVIF 511 (931)
Q Consensus 491 l~~N~l~g~iP~~~~~~~~~l 511 (931)
|++|+|+ .+|...+.++..+
T Consensus 208 Ls~N~l~-~l~~~~~~~l~~L 227 (242)
T d1xwdc1 208 ISRTRIH-SLPSYGLENLKKL 227 (242)
T ss_dssp CTTSCCC-CCCSSSCTTCCEE
T ss_pred CCCCcCC-ccCHHHHcCCccc
Confidence 6666665 5555544443333
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.37 E-value=1.7e-05 Score=75.54 Aligned_cols=39 Identities=31% Similarity=0.452 Sum_probs=17.8
Q ss_pred ccccccEeecCCccccCCC---CCccCCccccccccccccCCC
Q 002358 458 RLIDLRIVHLENNELTGSL---PSYMGSLPNLQELHIENNSFV 497 (931)
Q Consensus 458 ~l~~L~~L~L~~N~l~g~i---P~~l~~l~~L~~l~l~~N~l~ 497 (931)
++++|++|+|++|+|+ .+ +..+..|++|+.|+|++|.++
T Consensus 63 ~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 63 NIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp HCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred hCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCccc
Confidence 3444555555555544 22 122334445555555555544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.00 E-value=0.00071 Score=73.60 Aligned_cols=76 Identities=16% Similarity=0.183 Sum_probs=48.9
Q ss_pred ccccCccCcEEEEEEEECC-CcEEEEEEccCcc-------chhhhhHHHHHHHHHhcC-C--CCCcceeEEEecCCeEEE
Q 002358 614 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-------SHRTQQFVTEVALLSRIH-H--RNLVPLIGYCEEEHQRIL 682 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~-g~~vAvK~~~~~~-------~~~~~~~~~E~~il~~l~-H--pnIv~l~g~~~~~~~~~l 682 (931)
.+.||.|....||+....+ ++.++||.-.+.. .....+...|.+.|+.+. + ..+.+++.+. ....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 3578999999999998764 6789999754311 112234567888888773 2 3355555543 445589
Q ss_pred EEEecCCCC
Q 002358 683 VYEYMHNGT 691 (931)
Q Consensus 683 V~E~~~~gs 691 (931)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.87 E-value=3.2e-05 Score=85.27 Aligned_cols=37 Identities=41% Similarity=0.624 Sum_probs=16.8
Q ss_pred cccEeecCCccccCC----CCCccCCccccccccccccCCC
Q 002358 461 DLRIVHLENNELTGS----LPSYMGSLPNLQELHIENNSFV 497 (931)
Q Consensus 461 ~L~~L~L~~N~l~g~----iP~~l~~l~~L~~l~l~~N~l~ 497 (931)
+|+.|+|++|+++.. ++..+..+++|+.|+|++|.++
T Consensus 85 ~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 85 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 345555555544421 2333444444555555554443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.87 E-value=3e-05 Score=85.45 Aligned_cols=106 Identities=17% Similarity=0.173 Sum_probs=77.3
Q ss_pred CcEEEEEeCCCCCccc-CCccccCccccceecccCCcCCC----CCC-CccccccccEeecCCccccC----CCCCccC-
Q 002358 413 PRITKIALSGKNLKGE-IPPELKNMEALTELWLDGNFLTG----PLP-DMSRLIDLRIVHLENNELTG----SLPSYMG- 481 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~-ip~~~~~L~~L~~L~Ls~N~l~g----~~p-~~~~l~~L~~L~L~~N~l~g----~iP~~l~- 481 (931)
++|++|||+.|++++. +..-+..+++|+.|+|++|.|+- .+. .+..+++|+.|||++|+|+. .+...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 4799999999999864 24456778999999999998873 223 26789999999999999862 1333333
Q ss_pred CccccccccccccCCCCC----CCcccc--cCceeeeecCCCC
Q 002358 482 SLPNLQELHIENNSFVGE----IPPALL--TGKVIFKYDNNPK 518 (931)
Q Consensus 482 ~l~~L~~l~l~~N~l~g~----iP~~~~--~~~~~l~~~~N~~ 518 (931)
...+|+.|+|++|+++.. ++..+. ..+..+.+++|..
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i 124 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL 124 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBC
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccc
Confidence 235799999999999732 233332 2667778888764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.45 E-value=0.0041 Score=65.42 Aligned_cols=135 Identities=12% Similarity=0.139 Sum_probs=78.3
Q ss_pred EEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCC--cceeE-----EEecCCeEEEEEEecCCCCH---
Q 002358 623 GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL--VPLIG-----YCEEEHQRILVYEYMHNGTL--- 692 (931)
Q Consensus 623 G~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnI--v~l~g-----~~~~~~~~~lV~E~~~~gsL--- 692 (931)
-.||+++.++|+.+++|+.++. ....+++..|.+.+..|....+ +..+. .+...+..+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999998654 2234668889998888853222 11111 22445667889999876432
Q ss_pred --H-------------HHhccCC--CCCCCCHH----------------------HHHHHHHHHHHHhHHh-hhcCCCCe
Q 002358 693 --R-------------DRLHGSV--NQKPLDWL----------------------TRLQIAHDAAKGLEYL-HTGCNPGI 732 (931)
Q Consensus 693 --~-------------~~L~~~~--~~~~l~~~----------------------~~~~i~~qia~aL~yL-H~~~~~~i 732 (931)
. ....... .....++. .....+.++...+.-+ .+....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1 0111110 11111111 1122222333222221 12234679
Q ss_pred EecCCCCCCccccCCCceEEeccccccc
Q 002358 733 IHRDVKSSNILLDINMRAKVSDFGLSRQ 760 (931)
Q Consensus 733 vH~DIkp~NILld~~~~vkL~DFGla~~ 760 (931)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 45789997753
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.17 E-value=0.00082 Score=69.59 Aligned_cols=82 Identities=22% Similarity=0.301 Sum_probs=53.2
Q ss_pred CcEEEEEeCCC--CCccc-CCccccCccccceecccCC-cCCCCCC-CccccccccEeecCC-ccccCCCCCccCCcccc
Q 002358 413 PRITKIALSGK--NLKGE-IPPELKNMEALTELWLDGN-FLTGPLP-DMSRLIDLRIVHLEN-NELTGSLPSYMGSLPNL 486 (931)
Q Consensus 413 ~~l~~L~L~~n--~l~g~-ip~~~~~L~~L~~L~Ls~N-~l~g~~p-~~~~l~~L~~L~L~~-N~l~g~iP~~l~~l~~L 486 (931)
++++.|+|++. +++.. +..-+.++++|++|+|++| .+++... .+.++++|+.|+|++ +.+++.....++++++|
T Consensus 148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 46777777754 33321 3333456677888888764 4665443 577777788888877 45666666667777778
Q ss_pred cccccccc
Q 002358 487 QELHIENN 494 (931)
Q Consensus 487 ~~l~l~~N 494 (931)
+.|+++++
T Consensus 228 ~~L~l~~~ 235 (284)
T d2astb2 228 KTLQVFGI 235 (284)
T ss_dssp CEEECTTS
T ss_pred CEEeeeCC
Confidence 88777765
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.09 E-value=0.00064 Score=70.47 Aligned_cols=103 Identities=19% Similarity=0.193 Sum_probs=56.8
Q ss_pred CcEEEEEeCCC-CCcc-cCCccccCc-cccceecccCC--cCCCC-CCC-ccccccccEeecCCc-cccCCCCCccCCcc
Q 002358 413 PRITKIALSGK-NLKG-EIPPELKNM-EALTELWLDGN--FLTGP-LPD-MSRLIDLRIVHLENN-ELTGSLPSYMGSLP 484 (931)
Q Consensus 413 ~~l~~L~L~~n-~l~g-~ip~~~~~L-~~L~~L~Ls~N--~l~g~-~p~-~~~l~~L~~L~L~~N-~l~g~iP~~l~~l~ 484 (931)
++|++|+|+++ +++. .+...+..+ ++|+.|+|++. .++.. +.. +.++++|+.|+|++| .+++..+..+++++
T Consensus 121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 46777777764 3432 122233333 56777777753 23321 222 345677777777765 46666667777777
Q ss_pred cccccccccc-CCCCCCCccccc--CceeeeecC
Q 002358 485 NLQELHIENN-SFVGEIPPALLT--GKVIFKYDN 515 (931)
Q Consensus 485 ~L~~l~l~~N-~l~g~iP~~~~~--~~~~l~~~~ 515 (931)
+|+.|+|+++ .++......+.. .+..+.+.+
T Consensus 201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~ 234 (284)
T d2astb2 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 234 (284)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeC
Confidence 7777777773 455333333322 344444444
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=95.84 E-value=0.00041 Score=73.89 Aligned_cols=84 Identities=20% Similarity=0.289 Sum_probs=37.3
Q ss_pred cEEEEEeCCCCCcc----cCCccccCccccceecccCCcCCCC-----C-CCccccccccEeecCCccccCC----CCCc
Q 002358 414 RITKIALSGKNLKG----EIPPELKNMEALTELWLDGNFLTGP-----L-PDMSRLIDLRIVHLENNELTGS----LPSY 479 (931)
Q Consensus 414 ~l~~L~L~~n~l~g----~ip~~~~~L~~L~~L~Ls~N~l~g~-----~-p~~~~l~~L~~L~L~~N~l~g~----iP~~ 479 (931)
.++.|++++|.+.- .+...+..++.|+.|+|++|+++.. + ..+..+++|+.|+|++|.++.. +...
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 238 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence 44455555554431 1222233444555555555554421 1 1234445555555555554311 2233
Q ss_pred cCCccccccccccccCCC
Q 002358 480 MGSLPNLQELHIENNSFV 497 (931)
Q Consensus 480 l~~l~~L~~l~l~~N~l~ 497 (931)
+..+++|+.|+|++|.|+
T Consensus 239 l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp GGGCTTCCEEECTTCCCC
T ss_pred ccccccchhhhhhcCccC
Confidence 444555555555555544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=95.80 E-value=0.0005 Score=73.21 Aligned_cols=106 Identities=16% Similarity=0.172 Sum_probs=72.4
Q ss_pred CcEEEEEeCCCCCccc-----CCccccCccccceecccCCcCCCC----C-CCccccccccEeecCCccccCCCC----C
Q 002358 413 PRITKIALSGKNLKGE-----IPPELKNMEALTELWLDGNFLTGP----L-PDMSRLIDLRIVHLENNELTGSLP----S 478 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~-----ip~~~~~L~~L~~L~Ls~N~l~g~----~-p~~~~l~~L~~L~L~~N~l~g~iP----~ 478 (931)
+.++.|+|++|++... +...+..+++|+.|+|++|.++.. + ..+..+++|+.|+|++|.|++.-. +
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 4789999999998632 445577889999999999988643 2 236788999999999999875422 2
Q ss_pred ccCC--ccccccccccccCCCCC----CCcccc---cCceeeeecCCCC
Q 002358 479 YMGS--LPNLQELHIENNSFVGE----IPPALL---TGKVIFKYDNNPK 518 (931)
Q Consensus 479 ~l~~--l~~L~~l~l~~N~l~g~----iP~~~~---~~~~~l~~~~N~~ 518 (931)
.+.. .+.|+.|+|++|+++.. +...+. ..+..+.+++|..
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~ 314 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence 2322 35789999999998632 112111 1355566666654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=95.71 E-value=0.00055 Score=65.02 Aligned_cols=85 Identities=14% Similarity=0.172 Sum_probs=63.9
Q ss_pred CcEEEEEeCCC-CCccc----CCccccCccccceecccCCcCCCCCC-----CccccccccEeecCCccccCC----CCC
Q 002358 413 PRITKIALSGK-NLKGE----IPPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELTGS----LPS 478 (931)
Q Consensus 413 ~~l~~L~L~~n-~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~L~~N~l~g~----iP~ 478 (931)
++|++|+|+++ .++.. +-..+...+.|+.|+|++|.|...-. .+...+.|+.|+|++|.++.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 58999999974 45432 33457777899999999999874321 255678899999999998843 233
Q ss_pred ccCCccccccccccccCCC
Q 002358 479 YMGSLPNLQELHIENNSFV 497 (931)
Q Consensus 479 ~l~~l~~L~~l~l~~N~l~ 497 (931)
.+...++|+.|+|++|.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 5677788999999999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.59 E-value=0.015 Score=62.72 Aligned_cols=72 Identities=15% Similarity=0.299 Sum_probs=49.6
Q ss_pred ccccCccCcEEEEEEEECCC--------cEEEEEEccCccchhhhhHHHHHHHHHhcCCCCC-cceeEEEecCCeEEEEE
Q 002358 614 CKKIGKGSFGSVYYGKMKDG--------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVY 684 (931)
Q Consensus 614 ~~~LG~G~fG~Vy~a~~~~g--------~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~~~lV~ 684 (931)
.+.|+.|-.-.+|+....++ +.|.+++.... . ......+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35688889999999987643 56777776532 2 22345679999998853344 467777753 6899
Q ss_pred EecCCCC
Q 002358 685 EYMHNGT 691 (931)
Q Consensus 685 E~~~~gs 691 (931)
||++|..
T Consensus 121 efi~g~~ 127 (395)
T d1nw1a_ 121 EYIPSRP 127 (395)
T ss_dssp CCCCEEE
T ss_pred EEecccc
Confidence 9998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.10 E-value=0.038 Score=57.11 Aligned_cols=141 Identities=13% Similarity=0.142 Sum_probs=73.5
Q ss_pred ccCccCcEEEEEEEECCCcEEEEEEccCccchhhhhHHHHHHHHHhcCCCCC--cceeE------EEecCCeEEEEEEec
Q 002358 616 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL--VPLIG------YCEEEHQRILVYEYM 687 (931)
Q Consensus 616 ~LG~G~fG~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnI--v~l~g------~~~~~~~~~lV~E~~ 687 (931)
.|..|---+.|+.+..+|+ +++|+..... ..+++..|++++..|.+.++ ...+. +.........++.++
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence 3556777788999887654 8999876432 23456667777777743222 11111 112234556677776
Q ss_pred CCCCHH--------------HHhc----cCCCCC--CCCH------------------HHHHHHHHHHHHHhHHhh-hcC
Q 002358 688 HNGTLR--------------DRLH----GSVNQK--PLDW------------------LTRLQIAHDAAKGLEYLH-TGC 728 (931)
Q Consensus 688 ~~gsL~--------------~~L~----~~~~~~--~l~~------------------~~~~~i~~qia~aL~yLH-~~~ 728 (931)
.+.... ..++ ...... .... ......+..+...+.-.+ ...
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L 181 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 181 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence 653321 0011 000000 0000 011111222222222222 123
Q ss_pred CCCeEecCCCCCCccccCCCceEEecccccc
Q 002358 729 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR 759 (931)
Q Consensus 729 ~~~ivH~DIkp~NILld~~~~vkL~DFGla~ 759 (931)
..++||+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5789999999999999988777899999775
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=93.71 E-value=0.0028 Score=59.91 Aligned_cols=83 Identities=17% Similarity=0.131 Sum_probs=59.1
Q ss_pred CcEEEEEeCCCCCcccC----CccccCccccceecccCCcCCCCCC-----CccccccccEeecCCccccCC-------C
Q 002358 413 PRITKIALSGKNLKGEI----PPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELTGS-------L 476 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~i----p~~~~~L~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~L~~N~l~g~-------i 476 (931)
..|++|+|++|.+...- ...+...+.|+.|+|++|.|+..-- .+..-+.|+.|+|++|++... +
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l 123 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 123 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence 47999999999997432 2345566899999999999986422 366778899999999986621 2
Q ss_pred CCccCCccccccccccccC
Q 002358 477 PSYMGSLPNLQELHIENNS 495 (931)
Q Consensus 477 P~~l~~l~~L~~l~l~~N~ 495 (931)
...+...++|+.|+++.+.
T Consensus 124 ~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 124 MMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHHCSSCCEEECCCCC
T ss_pred HHHHHhCCCccEeeCcCCC
Confidence 3344445677777775543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=90.23 E-value=0.014 Score=54.54 Aligned_cols=85 Identities=20% Similarity=0.264 Sum_probs=58.0
Q ss_pred CcEEEEEeCC-CCCccc----CCccccCccccceecccCCcCCCCCC-----CccccccccEeecCCccccCC----CCC
Q 002358 413 PRITKIALSG-KNLKGE----IPPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELTGS----LPS 478 (931)
Q Consensus 413 ~~l~~L~L~~-n~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~L~~N~l~g~----iP~ 478 (931)
+.|++|+|++ +.++.. +-..+...++|+.|+|++|.++..-- .+...+.|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 5788999987 456422 23446678889999999998865422 156678899999999888633 334
Q ss_pred ccCCccccccc--cccccCCC
Q 002358 479 YMGSLPNLQEL--HIENNSFV 497 (931)
Q Consensus 479 ~l~~l~~L~~l--~l~~N~l~ 497 (931)
.+...++|+.+ ++++|.+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCC
T ss_pred HHHhCccccEEeeccCCCcCc
Confidence 56677788764 44566664
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=87.63 E-value=0.014 Score=54.71 Aligned_cols=84 Identities=14% Similarity=0.231 Sum_probs=61.9
Q ss_pred CcEEEEEeCCCCCccc----CCccccCccccceecccCCcCCCCC-----CCccccccccEeec--CCccccC----CCC
Q 002358 413 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPL-----PDMSRLIDLRIVHL--ENNELTG----SLP 477 (931)
Q Consensus 413 ~~l~~L~L~~n~l~g~----ip~~~~~L~~L~~L~Ls~N~l~g~~-----p~~~~l~~L~~L~L--~~N~l~g----~iP 477 (931)
++|++|+|++|.++.. +-..+...+.|+.|++++|.+.... ..+...++|+.++| ++|.+.. .|.
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La 125 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 125 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence 5799999999998754 2334666799999999999987542 24677888987555 5677752 355
Q ss_pred CccCCccccccccccccCC
Q 002358 478 SYMGSLPNLQELHIENNSF 496 (931)
Q Consensus 478 ~~l~~l~~L~~l~l~~N~l 496 (931)
+.+...++|+.|+++.|+.
T Consensus 126 ~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 126 NMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCCCcCEEeCcCCCC
Confidence 5666788899998876654
|